Citrus Sinensis ID: 012320
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 466 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SCU5 | 549 | Probable serine/threonine | yes | no | 0.888 | 0.754 | 0.701 | 1e-173 | |
| Q9LVL5 | 571 | Probable serine/threonine | no | no | 0.847 | 0.691 | 0.721 | 1e-170 | |
| Q2QYL8 | 619 | Probable serine/threonine | yes | no | 0.828 | 0.623 | 0.627 | 1e-135 | |
| Q2RBE3 | 622 | Probable serine/threonine | yes | no | 0.832 | 0.623 | 0.617 | 1e-134 | |
| Q0D598 | 704 | Probable serine/threonine | no | no | 0.896 | 0.593 | 0.525 | 1e-133 | |
| A2YMV6 | 704 | Probable serine/threonine | N/A | no | 0.896 | 0.593 | 0.525 | 1e-132 | |
| Q8S8Y9 | 568 | Serine/threonine-protein | no | no | 0.817 | 0.670 | 0.551 | 1e-129 | |
| Q9STK6 | 516 | Probable serine/threonine | no | no | 0.830 | 0.75 | 0.581 | 1e-127 | |
| Q65X23 | 621 | Probable serine/threonine | no | no | 0.828 | 0.621 | 0.529 | 1e-125 | |
| Q2V338 | 492 | Probable serine/threonine | no | no | 0.815 | 0.772 | 0.522 | 1e-124 |
| >sp|Q9SCU5|WNK5_ARATH Probable serine/threonine-protein kinase WNK5 OS=Arabidopsis thaliana GN=WNK5 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 607 bits (1564), Expect = e-173, Method: Compositional matrix adjust.
Identities = 299/426 (70%), Positives = 351/426 (82%), Gaps = 12/426 (2%)
Query: 6 QLAGAADEAKAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNE 65
+++ A+D++ I Y+ETDP+GRYG F EVLGKGAMKTVYKA D+VLG+EVAWNQV+LNE
Sbjct: 4 EISSASDDS---IAYVETDPSGRYGRFREVLGKGAMKTVYKAFDQVLGMEVAWNQVKLNE 60
Query: 66 LMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKY 125
+ RSP+ LQRLYSEVHLL L H+SIIR+ TSWIDV+++TFNFITE+FTSGTLREYR+KY
Sbjct: 61 VFRSPEPLQRLYSEVHLLKNLNHESIIRYCTSWIDVNRRTFNFITELFTSGTLREYRRKY 120
Query: 126 RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185
++VDIRAIKSWARQIL GL YLH DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR
Sbjct: 121 QKVDIRAIKSWARQILNGLAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 180
Query: 186 GSKSAHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKV 245
GS++AHSVIGTPEFMAPELYEEDYNELVD+YSFGMCVLEM T EYPYSEC NPAQIYKKV
Sbjct: 181 GSQNAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTGEYPYSECTNPAQIYKKV 240
Query: 246 TSGKLPGAFYSIQDLEAQRFIGRCLVNASKRLSAKELLLDPFL-ASDEVKLLSKTKLNQK 304
TSGKLP +F+ IQ EAQRF+G+CL S+RL AKELL DPFL A+DE L +L Q+
Sbjct: 241 TSGKLPDSFHLIQHTEAQRFVGKCLETVSRRLPAKELLADPFLAATDERDLAPLFRLPQQ 300
Query: 305 PFL-----NETELEKLQLSDDPPR-TDMTITGKLNPEDDTIFLKVQIADKDGPGRNIYFP 358
+ N T +E L + DP R TDM+ITGK+N ED TIFL+VQI D DG RNI FP
Sbjct: 301 LAIQNLAANGTVVEHLPSTTDPTRTTDMSITGKMNSEDHTIFLQVQILDGDGHMRNIQFP 360
Query: 359 FDILNDTPLDVAREMVKELEITDWEPFEIAKMIDEEISVLVPHWKKREWPHPEAYHTFNY 418
F+IL+DTPL+VA EMVKELEITDW+P EIA MI+ EIS+LVP+W+ + + +F +
Sbjct: 361 FNILSDTPLEVALEMVKELEITDWDPLEIAAMIENEISLLVPNWRAND--SSIRHESFGH 418
Query: 419 EEDEDG 424
E+DED
Sbjct: 419 EDDEDN 424
|
Regulates flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LVL5|WNK4_ARATH Probable serine/threonine-protein kinase WNK4 OS=Arabidopsis thaliana GN=WNK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 599 bits (1544), Expect = e-170, Method: Compositional matrix adjust.
Identities = 288/399 (72%), Positives = 328/399 (82%), Gaps = 4/399 (1%)
Query: 20 YIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSE 79
Y+ETDP GRYG F E+LG+GAMKTVYKAIDE LG+EVAW+QV+L E++RS DLQRLYSE
Sbjct: 9 YVETDPTGRYGRFAEILGRGAMKTVYKAIDEKLGIEVAWSQVKLKEVLRSSVDLQRLYSE 68
Query: 80 VHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQ 139
VHLLSTL H SIIRFYTSWIDV T NFITE+FTSGTLR+Y+ KY R+DIRAIKSWARQ
Sbjct: 69 VHLLSTLNHKSIIRFYTSWIDVHNHTLNFITELFTSGTLRQYKNKYLRIDIRAIKSWARQ 128
Query: 140 ILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF 199
IL+GLVYLH DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA +LR SAHS+IGTPEF
Sbjct: 129 ILEGLVYLHEHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLARMLRDCHSAHSIIGTPEF 188
Query: 200 MAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259
MAPELYEE+YNEL+DVYSFGMC LEM T E+PYSEC +PAQIYKKV GKLPGAFY + D
Sbjct: 189 MAPELYEENYNELIDVYSFGMCFLEMITSEFPYSECNHPAQIYKKVVGGKLPGAFYRVGD 248
Query: 260 LEAQRFIGRCLVNASKRLSAKELLLDPFLASDEVKLLSKTKL-NQKPFLNETELEKLQLS 318
+EAQRFIG+CLV+ASKR+SAKELL DPFLASDE ++ + N KPFLNE E++ L+L
Sbjct: 249 IEAQRFIGKCLVSASKRVSAKELLQDPFLASDESWMVYTSGAGNPKPFLNENEMDTLKLE 308
Query: 319 DDPPRTDMTITGKLNPEDDTIFLKVQIADKDGPGRNIYFPFDILNDTPLDVAREMVKELE 378
DD RT+M+I GKL ED+ I L+VQIA +G N++FPFDI+NDT +DVA+EMVKELE
Sbjct: 309 DDELRTEMSIAGKLGAEDNKIDLEVQIAYDNGLANNVFFPFDIMNDTSIDVAKEMVKELE 368
Query: 379 ITDWEPFEIAKMIDEEISVLVPHWKKR---EWPHPEAYH 414
I DWEP EIAKMID IS LV WK E PH H
Sbjct: 369 IIDWEPVEIAKMIDGAISSLVSDWKYEEDDETPHDHHRH 407
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QYL8|WNK8_ORYSJ Probable serine/threonine-protein kinase WNK8 OS=Oryza sativa subsp. japonica GN=WNK8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 481 bits (1239), Expect = e-135, Method: Compositional matrix adjust.
Identities = 249/397 (62%), Positives = 300/397 (75%), Gaps = 11/397 (2%)
Query: 19 GYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYS 78
GY+ETDP GRYG EVLGKGAMKTVY+ DE+ GVEVAWNQ +++++R+PD L R+Y+
Sbjct: 24 GYVETDPTGRYGRLSEVLGKGAMKTVYRGFDELRGVEVAWNQATISDVLRTPDALHRMYA 83
Query: 79 EVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWAR 138
EV LL+ L+HD+II F+ SW+ ++TFNFITE+F+SGTLR YR +Y RV RA+ +WAR
Sbjct: 84 EVSLLADLRHDAIIAFHASWVHPSRRTFNFITELFSSGTLRSYRLRYPRVSRRAVAAWAR 143
Query: 139 QILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPE 198
IL+GL YLHSR VIHRDLKCDNIFVNGHLGQVKIGDLGLAA+LRG SA SVIGTPE
Sbjct: 144 AILRGLAYLHSRG--VIHRDLKCDNIFVNGHLGQVKIGDLGLAAVLRGCTSARSVIGTPE 201
Query: 199 FMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258
FMAPE+Y+E Y VDVYSFGMC+LEM T EYPYSEC NPAQIYKKVT+GKLP AFY +
Sbjct: 202 FMAPEMYDECYGVGVDVYSFGMCMLEMLTNEYPYSECDNPAQIYKKVTAGKLPDAFYLLT 261
Query: 259 DLEAQRFIGRCLVNASKRLSAKELLLDPFLA-----SDEVKLLSKTKLNQKPFL---NET 310
D +A+RFIGRCLV+A+ R SA+ELLLDPFL+ D + T L N +
Sbjct: 262 DADARRFIGRCLVDAAHRPSAEELLLDPFLSPPQNHDDHNTIAHATAPPPPLPLACSNSS 321
Query: 311 ELEKLQLSDDPPRTDMTITGKLNPEDDTIFLKVQIADKDGPGRNIYFPFDILNDTPLDVA 370
E ++ + + T M ITGKLN E DTIFLKVQI G RNIYFPFD+ NDT ++VA
Sbjct: 322 EEQEEEEAPAAKTTGMAITGKLNKEHDTIFLKVQIG-GGGNVRNIYFPFDVANDTAMEVA 380
Query: 371 REMVKELEITDWEPFEIAKMIDEEISVLVPHWKKREW 407
EMVKEL+I D EP EIA MI++EI LVP +K+ E+
Sbjct: 381 TEMVKELDIADREPTEIAAMIEQEIVRLVPGYKQHEY 417
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2RBE3|WNK7_ORYSJ Probable serine/threonine-protein kinase WNK7 OS=Oryza sativa subsp. japonica GN=WNK7 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 479 bits (1233), Expect = e-134, Method: Compositional matrix adjust.
Identities = 247/400 (61%), Positives = 301/400 (75%), Gaps = 12/400 (3%)
Query: 19 GYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYS 78
GY+ETDP GRYG EVLGKGAMKTVY+ DE+ GVEVAWNQ +++++R+PD L R+Y+
Sbjct: 24 GYVETDPTGRYGRLSEVLGKGAMKTVYRGFDELRGVEVAWNQATISDVLRTPDALHRMYA 83
Query: 79 EVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWAR 138
EV LL+ L+HD+II F+ SW+ ++TFNFITE+F+SGTLR YR +Y RV RA+ +WAR
Sbjct: 84 EVSLLADLRHDAIIAFHASWVHPSRRTFNFITELFSSGTLRSYRLRYPRVSRRAVAAWAR 143
Query: 139 QILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPE 198
IL+GL YLH+R VIHRDLKCDNIFVNGHLGQVKIGDLGLAA+LRG SA SVIGTPE
Sbjct: 144 AILRGLAYLHARG--VIHRDLKCDNIFVNGHLGQVKIGDLGLAAVLRGCASARSVIGTPE 201
Query: 199 FMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258
FMAPE+Y+E Y VDVYSFGMC+LEM T EYPYSEC NPAQIYKKVT+GKLP AFY +
Sbjct: 202 FMAPEMYDECYGVGVDVYSFGMCMLEMLTNEYPYSECDNPAQIYKKVTAGKLPDAFYRLT 261
Query: 259 DLEAQRFIGRCLVNASKRLSAKELLLDPFLA----SDEVKLLSKTKLNQKPFL-----NE 309
D +A+RFIGRCLV+A+ R SA+ELLLDPFL+ D+ +++ P +
Sbjct: 262 DADARRFIGRCLVDAAHRPSAEELLLDPFLSPSQNHDDHNIIAHATAPPPPLPLACSNSS 321
Query: 310 TELEKLQLSDDPPRTDMTITGKLNPEDDTIFLKVQIADKDGPGRNIYFPFDILNDTPLDV 369
E E+ + TDM ITGKLN E DTIFLKVQI RNIYFPFD+ NDT ++V
Sbjct: 322 EEQEEAAPAPAAKTTDMAITGKLNKEHDTIFLKVQIGGGRNV-RNIYFPFDVANDTAMEV 380
Query: 370 AREMVKELEITDWEPFEIAKMIDEEISVLVPHWKKREWPH 409
A EMVKEL+I D EP EIA MI++EI LVP +K+ E+ +
Sbjct: 381 ATEMVKELDIADREPTEIAAMIEQEIVRLVPGYKQHEYSY 420
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D598|WNK1_ORYSJ Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. japonica GN=WNK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 473 bits (1218), Expect = e-133, Method: Compositional matrix adjust.
Identities = 252/480 (52%), Positives = 314/480 (65%), Gaps = 62/480 (12%)
Query: 20 YIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSE 79
Y E DP GRYG + +VLGKGA KTVY+A DE G+EVAWNQV+L++ ++SP+DL+RLY E
Sbjct: 17 YAEVDPTGRYGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYCE 76
Query: 80 VHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQ 139
+HLL TLKH +I++FYTSW+DV ++ NFITEMFTSGTLR+YR+K+ RV+I A+K W RQ
Sbjct: 77 IHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCRQ 136
Query: 140 ILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF 199
IL GL+YLHS DPP+IHRDLKCDNIFVNG+ G+VKIGDLGLAAILR S + H V GTPEF
Sbjct: 137 ILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVHCV-GTPEF 195
Query: 200 MAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259
MAPE+YEE+YNELVD+YSFGMCVLEM T EYPYSEC +P QIYKKV SG P A Y ++D
Sbjct: 196 MAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPEALYKVKD 255
Query: 260 LEAQRFIGRCLVNASKRLSAKELLLDPFLASDEVKLL------SKTKLNQKPFLNETELE 313
++F+ +CL AS+RLSA+ELL DPFL D++ S ++P+L
Sbjct: 256 PMVRQFVEKCLATASRRLSARELLKDPFLQVDDLVFCPGDGDYSLMNYLRQPYLEHAYSN 315
Query: 314 KLQLSD--------DPP-----------------------------RTDMTITGKLNPED 336
+S+ D P D+TI G+ ED
Sbjct: 316 VSMMSNGLSESIDEDTPTEDRWDCEDDDIKADGIDLFNGHEDEPLGNVDITIKGR-KSED 374
Query: 337 DTIFLKVQIADKDGPGRNIYFPFDILNDTPLDVAREMVKELEITDWEPFEIAKMIDEEIS 396
+IFL+++IAD DG RNIYFPFDI DT L VA EMV EL+ITD E IA+MID E+S
Sbjct: 375 GSIFLRLRIADNDGHVRNIYFPFDIEADTALSVATEMVAELDITDHEVTRIAEMIDGEVS 434
Query: 397 VLVPHWKKREWPHPEAYHTFNYEEDED-GYHHPLYSFPSCSSSQASLPGLVTYDHDWLKG 455
LVP W+ P P EE +D Y H +C S+ +S L Y +G
Sbjct: 435 ALVPDWR----PGP------GIEESQDTTYCH------NCGSNVSSCGSLYAYMSSAARG 478
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YMV6|WNK1_ORYSI Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. indica GN=WNK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 473 bits (1218), Expect = e-132, Method: Compositional matrix adjust.
Identities = 252/480 (52%), Positives = 314/480 (65%), Gaps = 62/480 (12%)
Query: 20 YIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSE 79
Y E DP GRYG + +VLGKGA KTVY+A DE G+EVAWNQV+L++ ++SP+DL+RLY E
Sbjct: 17 YAEVDPTGRYGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYCE 76
Query: 80 VHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQ 139
+HLL TLKH +I++FYTSW+DV ++ NFITEMFTSGTLR+YR+K+ RV+I A+K W RQ
Sbjct: 77 IHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCRQ 136
Query: 140 ILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF 199
IL GL+YLHS DPP+IHRDLKCDNIFVNG+ G+VKIGDLGLAAILR S + H V GTPEF
Sbjct: 137 ILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVHCV-GTPEF 195
Query: 200 MAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259
MAPE+YEE+YNELVD+YSFGMCVLEM T EYPYSEC +P QIYKKV SG P A Y ++D
Sbjct: 196 MAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPEALYKVKD 255
Query: 260 LEAQRFIGRCLVNASKRLSAKELLLDPFLASDEVKLL------SKTKLNQKPFLNETELE 313
++F+ +CL AS+RLSA+ELL DPFL D++ S ++P+L
Sbjct: 256 PMVRQFVEKCLATASRRLSARELLKDPFLQVDDLVFCPGDGDYSLMNYLRQPYLEHAYSN 315
Query: 314 KLQLSD--------DPP-----------------------------RTDMTITGKLNPED 336
+S+ D P D+TI G+ ED
Sbjct: 316 VSMMSNGLSESIDEDTPTEDRWDCEDDDIKADGIDLFNGHEDEPLGNVDITIKGR-KSED 374
Query: 337 DTIFLKVQIADKDGPGRNIYFPFDILNDTPLDVAREMVKELEITDWEPFEIAKMIDEEIS 396
+IFL+++IAD DG RNIYFPFDI DT L VA EMV EL+ITD E IA+MID E+S
Sbjct: 375 GSIFLRLRIADNDGHVRNIYFPFDIEADTALSVATEMVAELDITDHEVTRIAEMIDGEVS 434
Query: 397 VLVPHWKKREWPHPEAYHTFNYEEDED-GYHHPLYSFPSCSSSQASLPGLVTYDHDWLKG 455
LVP W+ P P EE +D Y H +C S+ +S L Y +G
Sbjct: 435 ALVPDWR----PGP------GIEESQDTTYCH------NCGSNVSSCGSLYAYMSSAARG 478
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8S8Y9|WNK2_ARATH Serine/threonine-protein kinase WNK2 OS=Arabidopsis thaliana GN=WNK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 461 bits (1187), Expect = e-129, Method: Compositional matrix adjust.
Identities = 225/408 (55%), Positives = 296/408 (72%), Gaps = 27/408 (6%)
Query: 20 YIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSE 79
++E DP+GRYG ++E+LGKGA KTVY+A DE G+EVAWNQV+L R+P++L++ + E
Sbjct: 14 FVEIDPSGRYGRYDEILGKGASKTVYRAFDEYEGIEVAWNQVKLRNFTRNPEELEKFFRE 73
Query: 80 VHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQ 139
+HLL TL H +I++FYTSW+D + + NF+TE+FTSGTLR+YR ++RRV+IRA+K W +Q
Sbjct: 74 IHLLKTLNHQNIMKFYTSWVDTNNLSINFVTELFTSGTLRQYRLRHRRVNIRAVKQWCKQ 133
Query: 140 ILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF 199
IL+GL+YLHSR PP+IHRDLKCDNIF+NG+ G+VKIGDLGLAAILR S + V GTPEF
Sbjct: 134 ILKGLLYLHSRSPPIIHRDLKCDNIFINGNQGEVKIGDLGLAAILRKSHAVRCV-GTPEF 192
Query: 200 MAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259
MAPE+Y+E+YNELVDVY+FGMCVLEM T +YPYSEC +PAQIYKKVTSGK P AFY ++D
Sbjct: 193 MAPEVYDEEYNELVDVYAFGMCVLEMVTFDYPYSECTHPAQIYKKVTSGKKPEAFYLVKD 252
Query: 260 LEAQRFIGRCLVNASKRLSAKELLLDPFLAS-----------------DEVKLLSKTKLN 302
E + F+ +CL N + RL+A ELL DPFL DE + + L
Sbjct: 253 PEVREFVEKCLANVTCRLTALELLQDPFLQDDNMDGFVMRPIDYYNGYDETGVFLRHPLI 312
Query: 303 QKPFLNETELEKLQL-------SDDPPRTDMTITGKLNPEDDTIFLKVQIADKDGPGRNI 355
P ++ + E Q+ +DD D++I GK N DD IFL+++I+D +G RNI
Sbjct: 313 DDPLYHD-QFESSQICEIDLFANDDEDHVDISIKGKRNG-DDGIFLRLRISDAEGRIRNI 370
Query: 356 YFPFDILNDTPLDVAREMVKELEITDWEPFEIAKMIDEEISVLVPHWK 403
YFPF+ DT VA EMV EL+IT+ + +IA+MID EI+ LVP WK
Sbjct: 371 YFPFETAIDTAWSVAVEMVSELDITNQDVAKIAEMIDAEIAALVPDWK 418
|
Regulates flowering time by modulating the photoperiod pathway. Possesses kinase activity in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9STK6|WNK3_ARATH Probable serine/threonine-protein kinase WNK3 OS=Arabidopsis thaliana GN=WNK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 457 bits (1175), Expect = e-127, Method: Compositional matrix adjust.
Identities = 228/392 (58%), Positives = 288/392 (73%), Gaps = 5/392 (1%)
Query: 12 DEAKAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPD 71
DE + ++E DP GRYG ++EVLGKGA K VY+A D++ G+EVAWNQV+L++ S +
Sbjct: 4 DENNSEEEFVEIDPTGRYGRYKEVLGKGAFKEVYRAFDQLEGIEVAWNQVKLDDKFCSSE 63
Query: 72 DLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIR 131
DL RLYSEVHLL TLKH SII+FYTSWID T N ITE+FTSG LR+YRKK++ VD+R
Sbjct: 64 DLDRLYSEVHLLKTLKHKSIIKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHKCVDLR 123
Query: 132 AIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH 191
A+K W+RQIL+GLVYLHS DPPVIHRDLKCDNIF+NG+ G+VKIGDLGLAAIL ++SAH
Sbjct: 124 ALKKWSRQILEGLVYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRARSAH 183
Query: 192 SVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP 251
SVIGTPEFMAPELYEEDYN LVD+Y+FGMC+LE+ T EYPYSEC N AQIY+KVTSG P
Sbjct: 184 SVIGTPEFMAPELYEEDYNVLVDIYAFGMCLLELVTFEYPYSECTNAAQIYRKVTSGIKP 243
Query: 252 GAFYSIQDLEAQRFIGRCLVNASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNETE 311
A ++ D + + FI +C+ S+RLSAKELL DPFL + + + + +
Sbjct: 244 AALLNVTDPQVRAFIEKCIAKVSQRLSAKELLDDPFLKCYKENTENVSSHKENGYNGNGI 303
Query: 312 LEKLQLSDDPPRTDMTITGKLNPEDDTIFLKVQIADKDGPGRNIYFPFDILNDTPLDVAR 371
++KL D +T+ G+ + +TIFLK++I D G RNI+FPF+I DT VA
Sbjct: 304 VDKLS---DSEVGLLTVEGQ-RKDLNTIFLKLRITDSKGQIRNIHFPFNIETDTSFSVAI 359
Query: 372 EMVKELEITDWEPFE-IAKMIDEEISVLVPHW 402
EMV+EL++TD + IAKMID EI +P W
Sbjct: 360 EMVEELDLTDDQDISTIAKMIDTEIHSHIPDW 391
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica GN=WNK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 449 bits (1155), Expect = e-125, Method: Compositional matrix adjust.
Identities = 223/421 (52%), Positives = 292/421 (69%), Gaps = 35/421 (8%)
Query: 20 YIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSE 79
+ E DP RYG + EVLGKGA KTVYKA D++ G+EVAWNQ+++ +++R+ DDL+RL SE
Sbjct: 18 FAEVDPTARYGRYTEVLGKGAFKTVYKAFDQLEGLEVAWNQIKVGDILRNNDDLERLRSE 77
Query: 80 VHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQ 139
V LL TLKH +II+FY SW+D NFITE+FTSGTLR+YR K+++VD+RA+K W+RQ
Sbjct: 78 VRLLKTLKHKNIIKFYNSWLDKKNNNINFITEVFTSGTLRQYRIKHKKVDVRALKKWSRQ 137
Query: 140 ILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF 199
IL GLVYLHS DPPVIHRDLKCDNIFVNG+ G+VKIGDLGLA IL ++SAHS+IGTPEF
Sbjct: 138 ILSGLVYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLATILDNARSAHSIIGTPEF 197
Query: 200 MAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259
MAPELY+E+YNELVD+Y+FGMC+LE+ T EYPY EC+N AQIYKKV+ G+ P + I+D
Sbjct: 198 MAPELYDEEYNELVDIYAFGMCLLELVTFEYPYCECSNAAQIYKKVSDGEKPSSLAKIED 257
Query: 260 LEAQRFIGRCLVNASKRLSAKELLLDPFLASDEVK----LLSKTKLNQKPFLNETEL--- 312
E + FI +C+ AS+RLSA+ELL+DPFL D K L S TK + + + +
Sbjct: 258 PEVRFFIEKCIAKASQRLSAQELLMDPFLRDDGEKIFYPLQSNTKASDGAGSSNSSMGYK 317
Query: 313 ------------EKLQLSDDPPRTDMTITGKLNPED---------------DTIFLKVQI 345
+++ P +D I ++P+ +TIFLK++I
Sbjct: 318 YDRDASSMAIREHTGSFAEEHP-SDRYIHSTMDPQAAAGRIITVESQMKDLNTIFLKLRI 376
Query: 346 ADKDGPGRNIYFPFDILNDTPLDVAREMVKELEITDWEPFEIAKMIDEEISVLVPHWKKR 405
AD G +NI+FPFDI DT + VA EMV +L++TD + IA+MID EI +P W
Sbjct: 377 ADSTGHAQNIHFPFDIEADTSISVATEMVVQLDLTDQDVTAIAEMIDAEIRAHIPDWALE 436
Query: 406 E 406
E
Sbjct: 437 E 437
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2V338|WNK9_ARATH Probable serine/threonine-protein kinase WNK9 OS=Arabidopsis thaliana GN=WNK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 446 bits (1148), Expect = e-124, Method: Compositional matrix adjust.
Identities = 224/429 (52%), Positives = 292/429 (68%), Gaps = 49/429 (11%)
Query: 20 YIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSE 79
Y+E DP GRYG + EVLGKG+ KTVY+ DE G+EVAWNQV+L + ++SP +L+RLY E
Sbjct: 15 YVEVDPTGRYGRYNEVLGKGSSKTVYRGFDEYQGIEVAWNQVKLYDFLQSPQELERLYCE 74
Query: 80 VHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQ 139
+HLL TLKH SI++FY SW+D D + NF+TEMFTSGTLR+YR K++RV+IRA+K+W RQ
Sbjct: 75 IHLLKTLKHKSIMKFYASWVDTDNRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKNWCRQ 134
Query: 140 ILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF 199
IL+GL YLH+ DPPVIHRDLKCDNIF+NG+ G+VKIGDLGLAA L+ S +AH V GTPEF
Sbjct: 135 ILRGLNYLHTHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAACLQHSHAAHCV-GTPEF 193
Query: 200 MAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259
MAPE+Y+E+YN+LVD+YSFGMCVLEM T +YPYSEC++PAQIYK+V SGK P ++D
Sbjct: 194 MAPEVYKEEYNQLVDIYSFGMCVLEMVTFDYPYSECSHPAQIYKRVISGKKPDGLDKVKD 253
Query: 260 LEAQRFIGRCLVNASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNET--------- 310
E + FI +CL S RLSA ELL D FL DE + + ++K ++E
Sbjct: 254 PEVRGFIEKCLATVSLRLSACELLDDHFLCIDESDM--RRVESEKGLIDEAGTPLRHSYH 311
Query: 311 ----------------------------ELEKLQLSDDPP---------RTDMTITGKLN 333
E++ L+ +D D++I GK
Sbjct: 312 IPHYSNGYYSLYNQNQWDYNGDETVESHEIDLLEFQNDDDEEEEDKRFGSVDISIKGKRR 371
Query: 334 PEDDTIFLKVQIADKDGPGRNIYFPFDILNDTPLDVAREMVKELEITDWEPFEIAKMIDE 393
D +FL+++ +K+G RNIYFPFDI DT + VAREMV+ELE+ D + +IA MID
Sbjct: 372 DNGDGLFLRLKTVNKEGCVRNIYFPFDIETDTAISVAREMVEELEMDDRDVTKIANMIDG 431
Query: 394 EISVLVPHW 402
EI+ LVP+W
Sbjct: 432 EIASLVPNW 440
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 466 | ||||||
| 225434355 | 631 | PREDICTED: probable serine/threonine-pro | 0.967 | 0.714 | 0.778 | 0.0 | |
| 224124748 | 608 | predicted protein [Populus trichocarpa] | 0.935 | 0.717 | 0.801 | 0.0 | |
| 255554483 | 606 | kinase, putative [Ricinus communis] gi|2 | 0.914 | 0.702 | 0.814 | 0.0 | |
| 224145457 | 606 | predicted protein [Populus trichocarpa] | 0.918 | 0.706 | 0.759 | 0.0 | |
| 449463284 | 645 | PREDICTED: probable serine/threonine-pro | 0.920 | 0.665 | 0.740 | 0.0 | |
| 449524218 | 645 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.920 | 0.665 | 0.740 | 0.0 | |
| 164374639 | 634 | NN mitogen-activated protein kinase [Nic | 0.933 | 0.686 | 0.729 | 0.0 | |
| 83281402 | 615 | mitogen-activated protein kinase [Nicoti | 0.901 | 0.682 | 0.732 | 0.0 | |
| 357491463 | 575 | With no lysine kinase [Medicago truncatu | 0.877 | 0.711 | 0.739 | 0.0 | |
| 351724503 | 595 | with no lysine kinase 12 [Glycine max] g | 0.849 | 0.665 | 0.796 | 0.0 |
| >gi|225434355|ref|XP_002268300.1| PREDICTED: probable serine/threonine-protein kinase WNK4 [Vitis vinifera] gi|297745773|emb|CBI15829.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 713 bits (1840), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/464 (77%), Positives = 395/464 (85%), Gaps = 13/464 (2%)
Query: 1 MYSNKQLAGAADEAKAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQ 60
MY K L +E K GY ETDP GRYG +EVLGKGAMKTVYKAIDEVLG+EVAWNQ
Sbjct: 1 MYRTK-LGELTNEGKDESGYAETDPTGRYGRLDEVLGKGAMKTVYKAIDEVLGMEVAWNQ 59
Query: 61 VRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLRE 120
V+LNE++RSPD+LQRLYSEVHLLS L HDSII+FYTSWIDV++KTFNFITE FTSGTLRE
Sbjct: 60 VKLNEVLRSPDELQRLYSEVHLLSALNHDSIIQFYTSWIDVERKTFNFITEFFTSGTLRE 119
Query: 121 YRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180
YRKKY+RVDIRAIK WARQIL+GLVYLH DPPVIHRDLKCDNIFVNGHLG+VKIGDLGL
Sbjct: 120 YRKKYKRVDIRAIKCWARQILRGLVYLHGHDPPVIHRDLKCDNIFVNGHLGEVKIGDLGL 179
Query: 181 AAILRGSKSAHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQ 240
AAILRGS+SAHSVIGTPEFMAPELYEE+YNELVDVYSFGMCVLEM T EYPYSEC+NPAQ
Sbjct: 180 AAILRGSQSAHSVIGTPEFMAPELYEENYNELVDVYSFGMCVLEMLTSEYPYSECSNPAQ 239
Query: 241 IYKKVTSGKLPGAFYSIQDLEAQRFIGRCLVNASKRLSAKELLLDPFLASDEVKLLSKTK 300
IYKKVTSGKLPGAFY IQDLEAQRFIG+CLV ASKRL AKELLLDPFLASDE K L K K
Sbjct: 240 IYKKVTSGKLPGAFYRIQDLEAQRFIGKCLVTASKRLPAKELLLDPFLASDEAKRLPKPK 299
Query: 301 L-NQKPFLNETELEKLQLSDDPPRTDMTITGKLNPEDDTIFLKVQIADKDGPGRNIYFPF 359
L +QKPFLN+ +EKL+LSDD RT+MTITG LNP+DDTIFLKVQ ADKDG RNIYFPF
Sbjct: 300 LGSQKPFLNDIRIEKLRLSDDRVRTNMTITGTLNPDDDTIFLKVQTADKDGSARNIYFPF 359
Query: 360 DILNDTPLDVAREMVKELEITDWEPFEIAKMIDEEISVLVPHWKKREWPHPEAYH-TFNY 418
DI+ DTP+DVA EMVKELEITDWEPFEIA MID EIS LVP WKK W P+ +H F+Y
Sbjct: 360 DIVTDTPIDVAMEMVKELEITDWEPFEIADMIDGEISALVPQWKK--WDMPQQHHYAFDY 417
Query: 419 EEDEDGYHHPLYSFPSCSSSQASLPGLVTYDH--------DWLK 454
+E+++G++HP SF SCSSSQAS P L T DWLK
Sbjct: 418 QEEDEGHNHPFRSFSSCSSSQASFPCLSTSHRLDTMAQGGDWLK 461
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224124748|ref|XP_002319412.1| predicted protein [Populus trichocarpa] gi|222857788|gb|EEE95335.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 709 bits (1831), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/438 (80%), Positives = 387/438 (88%), Gaps = 2/438 (0%)
Query: 12 DEAKAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPD 71
DE K GY ETDP GRYG FEEVLGKGAMKTVYKAIDE LG+EVAWN+V+LN+++ SPD
Sbjct: 13 DETKGDHGYAETDPTGRYGRFEEVLGKGAMKTVYKAIDEFLGIEVAWNRVKLNQVLCSPD 72
Query: 72 DLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIR 131
DLQRLYSEVHLLSTL HDSII+FYTSWIDV +KTFNFITEMFTSGTLREYRKKY RV+IR
Sbjct: 73 DLQRLYSEVHLLSTLNHDSIIKFYTSWIDVRRKTFNFITEMFTSGTLREYRKKYTRVNIR 132
Query: 132 AIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH 191
AIK WARQIL+G+VYLH DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS+SAH
Sbjct: 133 AIKKWARQILEGIVYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQSAH 192
Query: 192 SVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP 251
SVIGTPEFMAPELYEE+YNELVDVYSFGMCVLEM T EYPYSEC NPAQIYKKVTSGKLP
Sbjct: 193 SVIGTPEFMAPELYEENYNELVDVYSFGMCVLEMLTSEYPYSECTNPAQIYKKVTSGKLP 252
Query: 252 GAFYSIQDLEAQRFIGRCLVNASKRLSAKELLLDPFLASDEVKLLSKTKL-NQKPFLNET 310
F+ IQDLEAQRFIG+CLV A+KRLSAKELLLDPFLASDE +L + QKPFLN+
Sbjct: 253 AVFHRIQDLEAQRFIGKCLVTAAKRLSAKELLLDPFLASDEAELPHVPRFRKQKPFLNDR 312
Query: 311 ELEKLQLSDDPPRTDMTITGKLNPEDDTIFLKVQIADKDGPGRNIYFPFDILNDTPLDVA 370
E+EKLQL+D PPRTDMTITGKLNPEDDTIFLKVQIA++DG RNI+FPFDIL+DTP+DVA
Sbjct: 313 EMEKLQLNDHPPRTDMTITGKLNPEDDTIFLKVQIANEDGTLRNIFFPFDILHDTPIDVA 372
Query: 371 REMVKELEITDWEPFEIAKMIDEEISVLVPHWKKREWPHPEAYHTFNYEEDEDGYHHPLY 430
EMVKELEI DWEPFEIA MID IS LVP+WKK + PH E++HTF+Y+ED DG+ HP +
Sbjct: 373 MEMVKELEIDDWEPFEIADMIDGAISALVPNWKKWDLPHIESHHTFDYQED-DGHDHPFH 431
Query: 431 SFPSCSSSQASLPGLVTY 448
S SCSSS ASL GL+ +
Sbjct: 432 SSSSCSSSPASLSGLMPH 449
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255554483|ref|XP_002518280.1| kinase, putative [Ricinus communis] gi|223542500|gb|EEF44040.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 679 bits (1751), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/431 (81%), Positives = 388/431 (90%), Gaps = 5/431 (1%)
Query: 19 GYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYS 78
GY+ETDP GRYG EEVLGKGAMKTVYKAIDEVLG+EVAWNQV+LNE++RSP+DLQRLYS
Sbjct: 18 GYVETDPTGRYGRLEEVLGKGAMKTVYKAIDEVLGMEVAWNQVKLNEVLRSPEDLQRLYS 77
Query: 79 EVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWAR 138
EVHLLSTL HDSII+FYTSWIDV +KTFNFITEMFTSGTLREYR+KY+RV+I+AIK+WAR
Sbjct: 78 EVHLLSTLNHDSIIQFYTSWIDVHRKTFNFITEMFTSGTLREYRRKYKRVNIQAIKNWAR 137
Query: 139 QILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPE 198
QILQGLVYLH DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS+ AHSVIGTPE
Sbjct: 138 QILQGLVYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQLAHSVIGTPE 197
Query: 199 FMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258
FMAPELYEE+YNELVDVYSFGMCVLEM T EYPYSEC NPAQIYKKVTSGKLP AFY +Q
Sbjct: 198 FMAPELYEEEYNELVDVYSFGMCVLEMLTSEYPYSECVNPAQIYKKVTSGKLPAAFYRVQ 257
Query: 259 DLEAQRFIGRCLVNASKRLSAKELLLDPFLASDEVKL--LSKTKLNQKPFLNETELEKLQ 316
DLEAQ+FIG+CLV ASKRLSAKELLLDPFLASDE + LS+++ NQKPFLN++E++KL
Sbjct: 258 DLEAQKFIGKCLVAASKRLSAKELLLDPFLASDEAESPPLSRSE-NQKPFLNDSEMKKLH 316
Query: 317 LSDDPPRTDMTITGKLNPEDDTIFLKVQIADKDGPGRNIYFPFDILNDTPLDVAREMVKE 376
L +DPPRTDMTITGKL EDDTIFLKVQIA+KDG RNIYFPFDILNDT +DVA EMVK+
Sbjct: 317 L-NDPPRTDMTITGKLKSEDDTIFLKVQIANKDGSLRNIYFPFDILNDTSMDVAMEMVKD 375
Query: 377 LEITDWEPFEIAKMIDEEISVLVPHWKKREWPHPEAYHTFNYEEDEDGYHHPLYSFPSCS 436
L+I DWEPFEIA+MID EI LVP+WKK + P EAYHTFNY+ED DG HP +S SCS
Sbjct: 376 LDIDDWEPFEIAEMIDGEICSLVPNWKKWDLPQIEAYHTFNYQED-DGLDHPFHSSSSCS 434
Query: 437 SSQASLPGLVT 447
SSQASL GL+
Sbjct: 435 SSQASLSGLMA 445
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224145457|ref|XP_002325649.1| predicted protein [Populus trichocarpa] gi|222862524|gb|EEF00031.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 667 bits (1721), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 328/432 (75%), Positives = 364/432 (84%), Gaps = 4/432 (0%)
Query: 1 MYSNKQLAGAADEAKAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQ 60
MY + DE +A GY ETDP GRYG EEVLG+GAMKTVYKAIDE LG+EVAWNQ
Sbjct: 1 MYRKQVEVRPFDETEADHGYAETDPTGRYGRLEEVLGRGAMKTVYKAIDEFLGIEVAWNQ 60
Query: 61 VRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLRE 120
+L+ ++ SP+DLQRLYSEVHLL L HDSII+FY SWIDV KTFNFITEMFTSGTLR+
Sbjct: 61 AKLSRVLCSPEDLQRLYSEVHLLRILNHDSIIKFYASWIDVRGKTFNFITEMFTSGTLRQ 120
Query: 121 YRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180
YR+KY RV+IRAIK WARQIL+G+ YLH DPPVIHRDLKCDNIFVNGHLGQVKIGDLGL
Sbjct: 121 YRQKYTRVNIRAIKKWARQILEGIEYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180
Query: 181 AAILRGSKSAHSVIG-TPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPA 239
AAILRGS+SAHSVIG TPEFMAPELYEE+YNELVDVYSFGMCVLEM T EYPYSEC NPA
Sbjct: 181 AAILRGSQSAHSVIGSTPEFMAPELYEENYNELVDVYSFGMCVLEMLTAEYPYSECTNPA 240
Query: 240 QIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLVNASKRLSAKELLLDPFLASDEVKLLSKT 299
QIYKKVTSGKLP FY IQDLEAQRFIG+CL ASKRL AKELLLDPFLASDE +L
Sbjct: 241 QIYKKVTSGKLPAVFYRIQDLEAQRFIGKCLETASKRLPAKELLLDPFLASDEAELSRVP 300
Query: 300 KL-NQKPFLNETELEKLQLSDDPPRTDMTITGKLNPEDDTIFLKVQIADKDGPGRNIYFP 358
++ NQK FLN+ E+EKLQL+D PPRTDM ITGKLN DDTIFLKVQIA++DG RNI+FP
Sbjct: 301 RIRNQKSFLNDREMEKLQLNDHPPRTDMIITGKLN-RDDTIFLKVQIANEDGTPRNIFFP 359
Query: 359 FDILNDTPLDVAREMVKELEITDWEPFEIAKMIDEEISVLVPHWKKREWPHPEAYHTFNY 418
FDIL+DTP+DVA EMVKELEI DWEPFEIA MID IS LVP+WKK + PH E H F+Y
Sbjct: 360 FDILHDTPIDVAMEMVKELEIGDWEPFEIADMIDGAISDLVPNWKKWDLPHTEPRHIFDY 419
Query: 419 EEDEDGYHHPLY 430
+ED DG++HP +
Sbjct: 420 QED-DGHNHPFH 430
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449463284|ref|XP_004149364.1| PREDICTED: probable serine/threonine-protein kinase WNK4-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 666 bits (1719), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 325/439 (74%), Positives = 366/439 (83%), Gaps = 10/439 (2%)
Query: 13 EAKAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDD 72
+ K+ GY+ETDP RYG FEEVLGKGAMKTVYKAIDE LG+EVAW+QV+LNE++RSP+D
Sbjct: 16 DCKSEFGYVETDPTCRYGRFEEVLGKGAMKTVYKAIDEFLGIEVAWSQVKLNEVLRSPED 75
Query: 73 LQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRA 132
LQRLYSEVHLLSTLKH+SI+RFYTSWIDVD+KTFNFITE+FTSGTLREY KKYRRVDIRA
Sbjct: 76 LQRLYSEVHLLSTLKHESIMRFYTSWIDVDKKTFNFITELFTSGTLREYGKKYRRVDIRA 135
Query: 133 IKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS 192
IKSWARQILQGL+YLH DPP+IHRDLKCDNIFVNGHLGQVKIGDLGLAAIL GS+SAHS
Sbjct: 136 IKSWARQILQGLIYLHEHDPPIIHRDLKCDNIFVNGHLGQVKIGDLGLAAILHGSRSAHS 195
Query: 193 VIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG 252
VIGTPEFMAPELYEE+YNELVDVYSFGMCVLEM T EYPYSEC+NPAQIYKKVTSGKLP
Sbjct: 196 VIGTPEFMAPELYEENYNELVDVYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPA 255
Query: 253 AFYSIQDLEAQRFIGRCLVNASKRLSAKELLLDPFLASDEVKLLSKTKL-NQKPFLNETE 311
A Y IQD++AQRFI +CLV S R SAKELL D FL D + S + NQKPFLN E
Sbjct: 256 ALYKIQDVDAQRFIKKCLVPVSMRASAKELLADSFLKVDGNRPSSVGRTQNQKPFLNAKE 315
Query: 312 LEKLQLSDDPPRTDMTITGKLNPEDDTIFLKVQIADKDGPGRNIYFPFDILNDTPLDVAR 371
+E LS+ RT+MTITGKLNPEDDT+FL+VQ ADKDG RNIYFPFDI+NDT LDVA
Sbjct: 316 MENFHLSEGLSRTNMTITGKLNPEDDTLFLRVQTADKDGSLRNIYFPFDIVNDTALDVAM 375
Query: 372 EMVKELEITDWEPFEIAKMIDEEISVLVPHWKKREWPHPEAYHTFNY---EEDEDGYHHP 428
EMVKELEI+DWEPFEIA MI+ EIS LVP+W + E + H+ + EED++ HH
Sbjct: 376 EMVKELEISDWEPFEIADMIEGEISALVPNWNRSELTN----HSLGFSCAEEDDNVSHHT 431
Query: 429 LYSFPSCSSSQASLPGLVT 447
S SSSQA+ GL++
Sbjct: 432 FRSIS--SSSQATTLGLIS 448
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449524218|ref|XP_004169120.1| PREDICTED: LOW QUALITY PROTEIN: probable serine/threonine-protein kinase WNK4-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 665 bits (1716), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 325/439 (74%), Positives = 365/439 (83%), Gaps = 10/439 (2%)
Query: 13 EAKAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDD 72
+ K+ GY+ETDP RYG FEEVLGKGAMKTVYKAIDE LG+EVAW+QV+LNE++RSP+D
Sbjct: 16 DCKSEFGYVETDPTCRYGRFEEVLGKGAMKTVYKAIDEFLGIEVAWSQVKLNEVLRSPED 75
Query: 73 LQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRA 132
LQRLYSEVHLLSTLKH+SI+RFYTSWIDVD KTFNFITE+FTSGTLREY KKYRRVDIRA
Sbjct: 76 LQRLYSEVHLLSTLKHESIMRFYTSWIDVDXKTFNFITELFTSGTLREYGKKYRRVDIRA 135
Query: 133 IKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS 192
IKSWARQILQGL+YLH DPP+IHRDLKCDNIFVNGHLGQVKIGDLGLAAIL GS+SAHS
Sbjct: 136 IKSWARQILQGLIYLHEHDPPIIHRDLKCDNIFVNGHLGQVKIGDLGLAAILHGSRSAHS 195
Query: 193 VIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG 252
VIGTPEFMAPELYEE+YNELVDVYSFGMCVLEM T EYPYSEC+NPAQIYKKVTSGKLP
Sbjct: 196 VIGTPEFMAPELYEENYNELVDVYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPA 255
Query: 253 AFYSIQDLEAQRFIGRCLVNASKRLSAKELLLDPFLASDEVKLLSKTKL-NQKPFLNETE 311
A Y IQD++AQRFI +CLV S R SAKELL D FL D + S + NQKPFLN E
Sbjct: 256 ALYKIQDVDAQRFIKKCLVPVSMRASAKELLADSFLKVDGNRPSSVGRTQNQKPFLNAKE 315
Query: 312 LEKLQLSDDPPRTDMTITGKLNPEDDTIFLKVQIADKDGPGRNIYFPFDILNDTPLDVAR 371
+E LS+ RT+MTITGKLNPEDDT+FL+VQ ADKDG RNIYFPFDI+NDT LDVA
Sbjct: 316 MENFHLSEGLSRTNMTITGKLNPEDDTLFLRVQTADKDGSLRNIYFPFDIVNDTALDVAM 375
Query: 372 EMVKELEITDWEPFEIAKMIDEEISVLVPHWKKREWPHPEAYHTFNY---EEDEDGYHHP 428
EMVKELEI+DWEPFEIA MI+ EIS LVP+W + E + H+ + EED++ HH
Sbjct: 376 EMVKELEISDWEPFEIADMIEGEISALVPNWNRSELTN----HSLGFSCAEEDDNVSHHT 431
Query: 429 LYSFPSCSSSQASLPGLVT 447
S SSSQA+ GL++
Sbjct: 432 FRSVS--SSSQATTLGLIS 448
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|164374639|gb|ABY52426.1| NN mitogen-activated protein kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 648 bits (1672), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 319/437 (72%), Positives = 369/437 (84%), Gaps = 2/437 (0%)
Query: 13 EAKAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDD 72
E++ + Y+E DP RYG FEEVLGKGAMKTVY+AIDE+LG+EVAWNQ++LN+L+ SP+D
Sbjct: 12 ESEDDLRYVEIDPTARYGRFEEVLGKGAMKTVYRAIDELLGMEVAWNQIKLNDLLHSPED 71
Query: 73 LQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRA 132
++RLYSEVHLLSTL H SI+RFYTSWIDV+ +TFNFITEMFTSGTLR YRKKY+RVDIRA
Sbjct: 72 MERLYSEVHLLSTLNHHSIMRFYTSWIDVEHRTFNFITEMFTSGTLRGYRKKYQRVDIRA 131
Query: 133 IKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS 192
IK+WARQIL+GLVYLH DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS+ AHS
Sbjct: 132 IKNWARQILEGLVYLHEHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQRAHS 191
Query: 193 VIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG 252
VIGTPEFMAPELYEE+YNELVDVYSFGMC+LEM T EYPYSEC NPAQIYKKVTSGK P
Sbjct: 192 VIGTPEFMAPELYEENYNELVDVYSFGMCMLEMLTGEYPYSECVNPAQIYKKVTSGKRPR 251
Query: 253 AFYSIQDLEAQRFIGRCLVNASKRLSAKELLLDPFLASDEVKLLSKTKLN-QKPFLNE-T 310
AFY +QDL+AQRFI +CL ASKRLSAKEL++DPFL + V S T + QKPFLN+
Sbjct: 252 AFYKVQDLDAQRFIRKCLEPASKRLSAKELMVDPFLVFNNVDGKSVTMMQLQKPFLNDKI 311
Query: 311 ELEKLQLSDDPPRTDMTITGKLNPEDDTIFLKVQIADKDGPGRNIYFPFDILNDTPLDVA 370
+E L L++D PRT+MTITGKLNPEDDTI +KVQIADK G RN+YFPFDI+ DTP +VA
Sbjct: 312 AIEDLHLNEDAPRTNMTITGKLNPEDDTILIKVQIADKKGDVRNVYFPFDIVTDTPTEVA 371
Query: 371 REMVKELEITDWEPFEIAKMIDEEISVLVPHWKKREWPHPEAYHTFNYEEDEDGYHHPLY 430
EMVKELEITDW+P+EIA MID EIS LVP WKK YH +Y++D++ +H+P
Sbjct: 372 NEMVKELEITDWKPYEIANMIDGEISGLVPQWKKWNQFESADYHVLSYKDDDNDHHNPFR 431
Query: 431 SFPSCSSSQASLPGLVT 447
F SCSSSQ SL GL++
Sbjct: 432 GFSSCSSSQVSLSGLLS 448
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|83281402|gb|AAQ83971.2| mitogen-activated protein kinase [Nicotiana tabacum] gi|85001472|gb|ABC68393.1| serine/thronine protein kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 646 bits (1667), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 309/422 (73%), Positives = 357/422 (84%), Gaps = 2/422 (0%)
Query: 13 EAKAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDD 72
E++ + Y+E DP RYG FEEVLGKGAMKTVY+AIDE+LG+EVAWNQ++LN+L+ SP+D
Sbjct: 12 ESEDDLRYVEIDPTARYGRFEEVLGKGAMKTVYRAIDELLGMEVAWNQIKLNDLLHSPED 71
Query: 73 LQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRA 132
++RLYSEVHLLSTL H SI+RFYTSWIDV+ +TFNFITEMFTSGTLR YRKKY+RVDIRA
Sbjct: 72 MERLYSEVHLLSTLNHHSIMRFYTSWIDVEHRTFNFITEMFTSGTLRGYRKKYQRVDIRA 131
Query: 133 IKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS 192
IK+WARQIL+GLVYLH DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS+ AHS
Sbjct: 132 IKNWARQILEGLVYLHEHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQRAHS 191
Query: 193 VIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG 252
VIGTPEFMAPELYEE+YNELVDVYSFGMC+LEM T EYPYSEC NPAQIYKKVTSGK P
Sbjct: 192 VIGTPEFMAPELYEENYNELVDVYSFGMCMLEMLTGEYPYSECVNPAQIYKKVTSGKRPR 251
Query: 253 AFYSIQDLEAQRFIGRCLVNASKRLSAKELLLDPFLASDEVKLLSKTKLN-QKPFLNE-T 310
AFY +QDL+AQRFI +CL ASKRLSAKEL++DPFL + V S T + QKPFLN+
Sbjct: 252 AFYKVQDLDAQRFIRKCLEPASKRLSAKELMVDPFLVFNNVDGKSVTMMQLQKPFLNDKI 311
Query: 311 ELEKLQLSDDPPRTDMTITGKLNPEDDTIFLKVQIADKDGPGRNIYFPFDILNDTPLDVA 370
+E L L++D PRT+MTITGKLNPEDDTI +KVQIADK G RN+YFPFDI+ DTP +VA
Sbjct: 312 AIEDLHLNEDAPRTNMTITGKLNPEDDTILIKVQIADKKGDVRNVYFPFDIVTDTPTEVA 371
Query: 371 REMVKELEITDWEPFEIAKMIDEEISVLVPHWKKREWPHPEAYHTFNYEEDEDGYHHPLY 430
EMVKELEITDW+P+EIA MID EIS LVP WKK YH +Y++D++ +H+P
Sbjct: 372 NEMVKELEITDWKPYEIANMIDGEISGLVPQWKKWNQFESADYHVLSYKDDDNDHHNPFR 431
Query: 431 SF 432
F
Sbjct: 432 GF 433
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357491463|ref|XP_003616019.1| With no lysine kinase [Medicago truncatula] gi|355517354|gb|AES98977.1| With no lysine kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 646 bits (1667), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 306/414 (73%), Positives = 359/414 (86%), Gaps = 5/414 (1%)
Query: 10 AADEAKAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRS 69
+ +E K Y+ETDP GRYG F +VLGKGAMKTVYKAIDEVLG+EVAWNQVRLNE++ +
Sbjct: 7 SMEEFKEENRYVETDPTGRYGRFGDVLGKGAMKTVYKAIDEVLGIEVAWNQVRLNEVLNT 66
Query: 70 PDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVD 129
PDDLQRLYSEVHLLSTLKH SI+RFYTSWID+D K FNF+TEMFTSG+LREYR+KY+RV
Sbjct: 67 PDDLQRLYSEVHLLSTLKHRSIMRFYTSWIDIDNKNFNFVTEMFTSGSLREYRRKYKRVS 126
Query: 130 IRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS 189
++AIKSWARQILQGLVYLH DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL+GS+S
Sbjct: 127 LQAIKSWARQILQGLVYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILQGSQS 186
Query: 190 AHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK 249
AHSVIGTPEFMAPE+YEE+YNEL DVYSFGMCVLEM T +YPYSEC NPAQIYKKVTSGK
Sbjct: 187 AHSVIGTPEFMAPEMYEEEYNELADVYSFGMCVLEMLTSDYPYSECTNPAQIYKKVTSGK 246
Query: 250 LPGAFYSIQDLEAQRFIGRCLVNASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNE 309
LP +F+ I+D EA+RFIG+CL A+ R SAK+LLL+PFL++D+ K K+ QKPFLNE
Sbjct: 247 LPMSFFRIEDGEARRFIGKCLEPAANRPSAKDLLLEPFLSTDDTSSAMKLKI-QKPFLNE 305
Query: 310 TELEKLQLSDDPPRTDMTITGKLNPEDDTIFLKVQIADKDGPGRNIYFPFDILNDTPLDV 369
E+EKLQLSD+ RT+M + GKLNPEDDTIFLKVQI+DK RN+YFPFDIL DTP+DV
Sbjct: 306 NEMEKLQLSDEFQRTEMKVIGKLNPEDDTIFLKVQISDKKCSVRNVYFPFDILTDTPIDV 365
Query: 370 AREMVKELEITDWEPFEIAKMIDEEISVLVPH-WKKREWPHPEAYHTFNYEEDE 422
A EMVKELEI+DW+PF+IA MI+ EIS L+PH WK + +++HTF+Y++D+
Sbjct: 366 AMEMVKELEISDWDPFDIANMINREISALLPHRWKN---DYSDSFHTFSYQDDD 416
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351724503|ref|NP_001236036.1| with no lysine kinase 12 [Glycine max] gi|225348653|gb|ACN87288.1| with no lysine kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 644 bits (1661), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 318/399 (79%), Positives = 351/399 (87%), Gaps = 3/399 (0%)
Query: 20 YIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSE 79
Y+ETDP GRYG F +VLGKGAMKTVYKAIDEVLG+EVAWNQVRLNE +R+PDDLQRLYSE
Sbjct: 6 YVETDPTGRYGRFGDVLGKGAMKTVYKAIDEVLGIEVAWNQVRLNEALRTPDDLQRLYSE 65
Query: 80 VHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQ 139
VHLLSTLKH SIIRFYTSWID+D + FNFITE+FTSG+LREYRK Y+RV+I+AIK+WA Q
Sbjct: 66 VHLLSTLKHQSIIRFYTSWIDIDNRAFNFITELFTSGSLREYRKNYKRVNIQAIKNWACQ 125
Query: 140 ILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF 199
ILQGLVYLH DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS+ AHSVIGTPEF
Sbjct: 126 ILQGLVYLHCHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQLAHSVIGTPEF 185
Query: 200 MAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259
MAPELYEE+YNEL DVYSFGMCVLEM T EYPYSEC+NPAQIYKKVTSGKLP AF+ I+D
Sbjct: 186 MAPELYEEEYNELADVYSFGMCVLEMLTSEYPYSECSNPAQIYKKVTSGKLPMAFFRIED 245
Query: 260 LEAQRFIGRCLVNASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNETELEKLQLSD 319
+EAQRFIGRCLV A KR SAKELLLDPFL SD+ K + QKPFLN E+EKLQLSD
Sbjct: 246 MEAQRFIGRCLVPAEKRPSAKELLLDPFLVSDDPSSTKKFAI-QKPFLNVNEMEKLQLSD 304
Query: 320 DPPRTDMTITGKLNPEDDTIFLKVQIADKDGPGRNIYFPFDILNDTPLDVAREMVKELEI 379
D PRT M + GKLNPEDDTIFLKVQI+DKDG RN++FPFDIL+DTP+DVA EMVKELEI
Sbjct: 305 DLPRTGMKVIGKLNPEDDTIFLKVQISDKDGSARNVFFPFDILSDTPIDVATEMVKELEI 364
Query: 380 TDWEPFEIAKMIDEEISVLVPHWKKREWPHPEAYHTFNY 418
DWEPFEIA MID EIS L+PH +R+ +A+HTFNY
Sbjct: 365 ADWEPFEIANMIDREISALLPH--RRQSSCSDAFHTFNY 401
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 466 | ||||||
| TAIR|locus:2098242 | 549 | WNK5 "with no lysine (K) kinas | 0.944 | 0.801 | 0.676 | 7.7e-158 | |
| TAIR|locus:2161278 | 571 | WNK4 "with no lysine (K) kinas | 0.920 | 0.751 | 0.684 | 3e-156 | |
| TAIR|locus:2114845 | 700 | WNK1 "with no lysine (K) kinas | 0.583 | 0.388 | 0.673 | 3.5e-122 | |
| TAIR|locus:2182039 | 492 | WNK9 [Arabidopsis thaliana (ta | 0.583 | 0.552 | 0.652 | 1.8e-118 | |
| TAIR|locus:504955638 | 516 | WNK3 "with no lysine (K) kinas | 0.830 | 0.75 | 0.584 | 5.4e-118 | |
| TAIR|locus:2093994 | 567 | WNK6 "with no lysine (K) kinas | 0.706 | 0.580 | 0.564 | 5.6e-109 | |
| TAIR|locus:2028521 | 557 | WNK7 [Arabidopsis thaliana (ta | 0.680 | 0.569 | 0.579 | 5e-108 | |
| TAIR|locus:2165790 | 563 | WNK8 "with no lysine (K) kinas | 0.697 | 0.577 | 0.577 | 7.2e-107 | |
| TAIR|locus:2019404 | 524 | WNK10 "with no lysine (K) kina | 0.587 | 0.522 | 0.625 | 1.2e-102 | |
| TAIR|locus:2176135 | 314 | AT5G55560 [Arabidopsis thalian | 0.594 | 0.882 | 0.566 | 3.1e-83 |
| TAIR|locus:2098242 WNK5 "with no lysine (K) kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1538 (546.5 bits), Expect = 7.7e-158, P = 7.7e-158
Identities = 308/455 (67%), Positives = 362/455 (79%)
Query: 6 QLAGAADEAKAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNE 65
+++ A+D++ I Y+ETDP+GRYG F EVLGKGAMKTVYKA D+VLG+EVAWNQV+LNE
Sbjct: 4 EISSASDDS---IAYVETDPSGRYGRFREVLGKGAMKTVYKAFDQVLGMEVAWNQVKLNE 60
Query: 66 LMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKY 125
+ RSP+ LQRLYSEVHLL L H+SIIR+ TSWIDV+++TFNFITE+FTSGTLREYR+KY
Sbjct: 61 VFRSPEPLQRLYSEVHLLKNLNHESIIRYCTSWIDVNRRTFNFITELFTSGTLREYRRKY 120
Query: 126 RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185
++VDIRAIKSWARQIL GL YLH DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR
Sbjct: 121 QKVDIRAIKSWARQILNGLAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 180
Query: 186 GSKSAHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKV 245
GS++AHSVIGTPEFMAPELYEEDYNELVD+YSFGMCVLEM T EYPYSEC NPAQIYKKV
Sbjct: 181 GSQNAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTGEYPYSECTNPAQIYKKV 240
Query: 246 TSGKLPGAFYSIQDLEAQRFIGRCLVNASKRLSAKELLLDPFLAS-DEVKLLSKTKLNQK 304
TSGKLP +F+ IQ EAQRF+G+CL S+RL AKELL DPFLA+ DE L +L Q+
Sbjct: 241 TSGKLPDSFHLIQHTEAQRFVGKCLETVSRRLPAKELLADPFLAATDERDLAPLFRLPQQ 300
Query: 305 PFL-----NETELEKLQLSDDPPRT-DMTITGKLNPEDDTIFLKVQIADKDGPGRNIYFP 358
+ N T +E L + DP RT DM+ITGK+N ED TIFL+VQI D DG RNI FP
Sbjct: 301 LAIQNLAANGTVVEHLPSTTDPTRTTDMSITGKMNSEDHTIFLQVQILDGDGHMRNIQFP 360
Query: 359 FDILNDTPLDVAREMVKELEITDWEPFEIAKMIDEEISVLVPHWKKREWPHPEAYHTFNY 418
F+IL+DTPL+VA EMVKELEITDW+P EIA MI+ EIS+LVP+W+ + + +F +
Sbjct: 361 FNILSDTPLEVALEMVKELEITDWDPLEIAAMIENEISLLVPNWRAND--SSIRHESFGH 418
Query: 419 EEDEDG--YHHPLYSFPSCSSSQASLPGLVTYDHD 451
E+DED F S SSS S P V ++D
Sbjct: 419 EDDEDNGDTEGRTRLFSSASSSHDS-PVAVRENND 452
|
|
| TAIR|locus:2161278 WNK4 "with no lysine (K) kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1523 (541.2 bits), Expect = 3.0e-156, P = 3.0e-156
Identities = 299/437 (68%), Positives = 345/437 (78%)
Query: 20 YIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSE 79
Y+ETDP GRYG F E+LG+GAMKTVYKAIDE LG+EVAW+QV+L E++RS DLQRLYSE
Sbjct: 9 YVETDPTGRYGRFAEILGRGAMKTVYKAIDEKLGIEVAWSQVKLKEVLRSSVDLQRLYSE 68
Query: 80 VHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQ 139
VHLLSTL H SIIRFYTSWIDV T NFITE+FTSGTLR+Y+ KY R+DIRAIKSWARQ
Sbjct: 69 VHLLSTLNHKSIIRFYTSWIDVHNHTLNFITELFTSGTLRQYKNKYLRIDIRAIKSWARQ 128
Query: 140 ILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF 199
IL+GLVYLH DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA +LR SAHS+IGTPEF
Sbjct: 129 ILEGLVYLHEHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLARMLRDCHSAHSIIGTPEF 188
Query: 200 MAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259
MAPELYEE+YNEL+DVYSFGMC LEM T E+PYSEC +PAQIYKKV GKLPGAFY + D
Sbjct: 189 MAPELYEENYNELIDVYSFGMCFLEMITSEFPYSECNHPAQIYKKVVGGKLPGAFYRVGD 248
Query: 260 LEAQRFIGRCLVNASKRLSAKELLLDPFLASDEVKLLSKTKL-NQKPFLNETELEKLQLS 318
+EAQRFIG+CLV+ASKR+SAKELL DPFLASDE ++ + N KPFLNE E++ L+L
Sbjct: 249 IEAQRFIGKCLVSASKRVSAKELLQDPFLASDESWMVYTSGAGNPKPFLNENEMDTLKLE 308
Query: 319 DDPPRTDMTITGKLNPEDDTIFLKVQIADKDGPGRNIYFPFDILNDTPLDVAREMVKELE 378
DD RT+M+I GKL ED+ I L+VQIA +G N++FPFDI+NDT +DVA+EMVKELE
Sbjct: 309 DDELRTEMSIAGKLGAEDNKIDLEVQIAYDNGLANNVFFPFDIMNDTSIDVAKEMVKELE 368
Query: 379 ITDWEPFEIAKMIDEEISVLVPHWKKREWPHPEAYHTFNYEEDEDGYHHPLYSFPSCSSS 438
I DWEP EIAKMID IS LV WK E E H ++ D +H S SSS
Sbjct: 369 IIDWEPVEIAKMIDGAISSLVSDWKYEE--DDETPHD-HHRHRTDSFHS---SSSHASSS 422
Query: 439 QASLPGLVTYD-HDWLK 454
QASL + DW++
Sbjct: 423 QASLSNYMARGLQDWVQ 439
|
|
| TAIR|locus:2114845 WNK1 "with no lysine (K) kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1011 (360.9 bits), Expect = 3.5e-122, Sum P(2) = 3.5e-122
Identities = 184/273 (67%), Positives = 225/273 (82%)
Query: 20 YIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSE 79
++E DP GRYG + EVLGKGA KTVY+A DE G+EVAWNQV+L + ++SP+DL+RLY E
Sbjct: 14 FVEVDPTGRYGRYNEVLGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCE 73
Query: 80 VHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQ 139
+HLL TLKH +I++FYTSW+D + NF+TE+FTSGTLR+YR +++RV+IRA+K W RQ
Sbjct: 74 IHLLKTLKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHKRVNIRAMKHWCRQ 133
Query: 140 ILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF 199
IL+GL YLHS DPPVIHRDLKCDNIFVNG+ G+VKIGDLGLAAILR S +AH V GTPEF
Sbjct: 134 ILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCV-GTPEF 192
Query: 200 MAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259
MAPE+YEE YNELVD+YSFGMC+LEM T +YPYSEC +PAQIYKKV SGK P A Y ++D
Sbjct: 193 MAPEVYEEAYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMSGKKPDALYKVKD 252
Query: 260 LEAQRFIGRCLVNASKRLSAKELLLDPFLASDE 292
E + FI +CL S R+SA+ELL DPFL D+
Sbjct: 253 PEVKCFIEKCLATVSLRVSARELLDDPFLRIDD 285
|
|
| TAIR|locus:2182039 WNK9 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 982 (350.7 bits), Expect = 1.8e-118, Sum P(2) = 1.8e-118
Identities = 178/273 (65%), Positives = 221/273 (80%)
Query: 20 YIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSE 79
Y+E DP GRYG + EVLGKG+ KTVY+ DE G+EVAWNQV+L + ++SP +L+RLY E
Sbjct: 15 YVEVDPTGRYGRYNEVLGKGSSKTVYRGFDEYQGIEVAWNQVKLYDFLQSPQELERLYCE 74
Query: 80 VHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQ 139
+HLL TLKH SI++FY SW+D D + NF+TEMFTSGTLR+YR K++RV+IRA+K+W RQ
Sbjct: 75 IHLLKTLKHKSIMKFYASWVDTDNRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKNWCRQ 134
Query: 140 ILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF 199
IL+GL YLH+ DPPVIHRDLKCDNIF+NG+ G+VKIGDLGLAA L+ S +AH V GTPEF
Sbjct: 135 ILRGLNYLHTHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAACLQHSHAAHCV-GTPEF 193
Query: 200 MAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259
MAPE+Y+E+YN+LVD+YSFGMCVLEM T +YPYSEC++PAQIYK+V SGK P ++D
Sbjct: 194 MAPEVYKEEYNQLVDIYSFGMCVLEMVTFDYPYSECSHPAQIYKRVISGKKPDGLDKVKD 253
Query: 260 LEAQRFIGRCLVNASKRLSAKELLLDPFLASDE 292
E + FI +CL S RLSA ELL D FL DE
Sbjct: 254 PEVRGFIEKCLATVSLRLSACELLDDHFLCIDE 286
|
|
| TAIR|locus:504955638 WNK3 "with no lysine (K) kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1162 (414.1 bits), Expect = 5.4e-118, P = 5.4e-118
Identities = 229/392 (58%), Positives = 289/392 (73%)
Query: 12 DEAKAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPD 71
DE + ++E DP GRYG ++EVLGKGA K VY+A D++ G+EVAWNQV+L++ S +
Sbjct: 4 DENNSEEEFVEIDPTGRYGRYKEVLGKGAFKEVYRAFDQLEGIEVAWNQVKLDDKFCSSE 63
Query: 72 DLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIR 131
DL RLYSEVHLL TLKH SII+FYTSWID T N ITE+FTSG LR+YRKK++ VD+R
Sbjct: 64 DLDRLYSEVHLLKTLKHKSIIKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHKCVDLR 123
Query: 132 AIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH 191
A+K W+RQIL+GLVYLHS DPPVIHRDLKCDNIF+NG+ G+VKIGDLGLAAIL ++SAH
Sbjct: 124 ALKKWSRQILEGLVYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRARSAH 183
Query: 192 SVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP 251
SVIGTPEFMAPELYEEDYN LVD+Y+FGMC+LE+ T EYPYSEC N AQIY+KVTSG P
Sbjct: 184 SVIGTPEFMAPELYEEDYNVLVDIYAFGMCLLELVTFEYPYSECTNAAQIYRKVTSGIKP 243
Query: 252 GAFYSIQDLEAQRFIGRCLVNASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNETE 311
A ++ D + + FI +C+ S+RLSAKELL DPFL + + + + +
Sbjct: 244 AALLNVTDPQVRAFIEKCIAKVSQRLSAKELLDDPFLKCYKENTENVSSHKENGYNGNGI 303
Query: 312 LEKLQLSDDPPRTDMTITGKLNPEDDTIFLKVQIADKDGPGRNIYFPFDILNDTPLDVAR 371
++KL SD +T+ G+ + +TIFLK++I D G RNI+FPF+I DT VA
Sbjct: 304 VDKL--SDSEVGL-LTVEGQ-RKDLNTIFLKLRITDSKGQIRNIHFPFNIETDTSFSVAI 359
Query: 372 EMVKELEITDWEPFE-IAKMIDEEISVLVPHW 402
EMV+EL++TD + IAKMID EI +P W
Sbjct: 360 EMVEELDLTDDQDISTIAKMIDTEIHSHIPDW 391
|
|
| TAIR|locus:2093994 WNK6 "with no lysine (K) kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 977 (349.0 bits), Expect = 5.6e-109, Sum P(2) = 5.6e-109
Identities = 187/331 (56%), Positives = 251/331 (75%)
Query: 21 IETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEV 80
+E DP RY ++EV+GKGA KTVYKA DEV G+EVAWNQVR++++++SP+ L+RLYSEV
Sbjct: 19 LEVDPTFRYIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVRIDDVLQSPNCLERLYSEV 78
Query: 81 HLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQI 140
LL +LKH++IIRFY SWID KT N ITE+FTSG+LR YRKK+R+V+++A+K+WARQI
Sbjct: 79 RLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHRKVNMKAVKNWARQI 138
Query: 141 LQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFM 200
L GL YLH ++PP+IHRDLKCDNIF+NG+ G+VKIGDLGLA ++ + +A SVIGTPEFM
Sbjct: 139 LMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQA-NAKSVIGTPEFM 197
Query: 201 APELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL 260
APELY+E+YNEL D+YSFGMC+LEM T +YPY EC N AQIYKKV+SG P + ++D
Sbjct: 198 APELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIKPASLSRVKDP 257
Query: 261 EAQRFIGRCLVNASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNETEL-EKLQLSD 319
E ++FI +CL+ AS+RLSAKELLLDPFL + + + + L E ++ +S+
Sbjct: 258 EVKQFIEKCLLPASERLSAKELLLDPFLQLNGLTMNNPLPLPDIVMPKEGAFGDRCLMSE 317
Query: 320 DPPRTDMTITGKLNPEDDTIFLKVQIADKDG 350
PP T + T ++ ++D+ V +D G
Sbjct: 318 GPPTTRPSKTLSIDLDEDSNLPIVTFSDNSG 348
|
|
| TAIR|locus:2028521 WNK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 961 (343.3 bits), Expect = 5.0e-108, Sum P(2) = 5.0e-108
Identities = 186/321 (57%), Positives = 245/321 (76%)
Query: 21 IETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEV 80
+E DP RY ++EV+GKGA KTV+K DEV G+EVAWNQVR+++L++SPD L+RLYSEV
Sbjct: 19 LEIDPTCRYIRYKEVIGKGASKTVFKGFDEVDGIEVAWNQVRIDDLLQSPDCLERLYSEV 78
Query: 81 HLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQI 140
LL +LKH +IIRFY SWID KT N ITE+FTSG+LR+YRKK+R+V+++A+K WARQI
Sbjct: 79 RLLKSLKHKNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYRKKHRKVNMKAVKCWARQI 138
Query: 141 LQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFM 200
L GL YLHS+DPP+IHRD+KCDNIF+NG+ G+VKIGDLGLA ++ + +A SVIGTPEFM
Sbjct: 139 LTGLKYLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLATVMEQA-NAKSVIGTPEFM 197
Query: 201 APELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL 260
APELY+E+YNEL D+YSFGMC+LEM T EYPY EC N AQIYKKV+SG P + ++D
Sbjct: 198 APELYDENYNELADIYSFGMCMLEMVTFEYPYCECRNSAQIYKKVSSGIKPASLSKVKDP 257
Query: 261 EAQRFIGRCLVNASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNETEL-EKLQLSD 319
E +FI +CL+ AS+RLSA+ELLLD FL + + + + L E E+ +S+
Sbjct: 258 EVMKFIEKCLLPASERLSAEELLLDSFLNVNGLVMNNPLPLPDIVMPKEGSFGERCLMSE 317
Query: 320 DPPRT-DMTITGKLNPEDDTI 339
PP + T++ L+ ED+ +
Sbjct: 318 GPPNARNRTMSMNLD-EDNNL 337
|
|
| TAIR|locus:2165790 WNK8 "with no lysine (K) kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 968 (345.8 bits), Expect = 7.2e-107, Sum P(2) = 7.2e-107
Identities = 191/331 (57%), Positives = 246/331 (74%)
Query: 20 YIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSE 79
+ E DP+GRY +++VLG+GA KTVYKA DEV G+EVAWN V + ++M+ P L+RLYSE
Sbjct: 19 FAEKDPSGRYIRYDDVLGRGAFKTVYKAFDEVDGIEVAWNLVSIEDVMQMPGQLERLYSE 78
Query: 80 VHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQ 139
VHLL LKH++II+ + SW+D KT N ITE+FTSG+LR YRKK+R+VD +AIK+WARQ
Sbjct: 79 VHLLKALKHENIIKLFYSWVDEKNKTINMITELFTSGSLRVYRKKHRKVDPKAIKNWARQ 138
Query: 140 ILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF 199
IL+GL YLHS++PPVIHRDLKCDNIFVNG+ G+VKIGDLGLA +L+ +A SVIGTPEF
Sbjct: 139 ILKGLNYLHSQNPPVIHRDLKCDNIFVNGNTGEVKIGDLGLATVLQ-QPTARSVIGTPEF 197
Query: 200 MAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259
MAPELYEE+YNELVD+YSFGMC+LEM TCEYPY+EC N AQIYKKVTS P + + D
Sbjct: 198 MAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYNECRNQAQIYKKVTSNIKPQSLGKVDD 257
Query: 260 LEAQRFIGRCLVNASKRLSAKELLLDPFLASDEVK---LLSKTKLNQKPFLNETELEKLQ 316
+ ++FI +CL+ AS R +A EL DPFLA D K LL+ + + K ++ +LE L
Sbjct: 258 PQVRQFIEKCLLPASSRPTALELSKDPFLARDGGKDSALLASSSTSSK-YVRPPQLEHLP 316
Query: 317 LSDDPPRTDMTITGKLNPEDDTIFLKVQIAD 347
+ D + + P TI L+ +IA+
Sbjct: 317 MDVDHNENKSVSSNEDYPWSQTIELQ-RIAE 346
|
|
| TAIR|locus:2019404 WNK10 "with no lysine (K) kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 922 (329.6 bits), Expect = 1.2e-102, Sum P(2) = 1.2e-102
Identities = 172/275 (62%), Positives = 217/275 (78%)
Query: 20 YIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSE 79
+++ DP GRY + +VLG+GA KTVYKA DEV G+EVAWN + + ++++ P L RLYSE
Sbjct: 6 FVQKDPTGRYIRYNDVLGRGAFKTVYKAFDEVEGIEVAWNLMSIEDVLQMPGQLDRLYSE 65
Query: 80 VHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQ 139
VHLL++LKHD+II+ + SW+D K+ N ITE+FTSG+L YRKK+R+VD +AI +WARQ
Sbjct: 66 VHLLNSLKHDNIIKLFYSWVDDHNKSINMITELFTSGSLTLYRKKHRKVDPKAIMNWARQ 125
Query: 140 ILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF 199
IL+GL YLHS+ PPVIHRDLKCDNIFVNG+ G+VKIGDLGLAA+++ +A SVIGTPEF
Sbjct: 126 ILKGLHYLHSQTPPVIHRDLKCDNIFVNGNTGKVKIGDLGLAAVMQ-QPTARSVIGTPEF 184
Query: 200 MAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259
MAPELYEE+YNELVD+YSFGMC+LEM TCEYPY EC N AQIYKKVTSG P + + D
Sbjct: 185 MAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYRECRNQAQIYKKVTSGIKPQSLSKVDD 244
Query: 260 LEAQRFIGRCLVNASKRLSAKELLLDPFLASDEVK 294
+ ++FI +CL+ A R +A ELL D LA D K
Sbjct: 245 PQVKQFIEKCLLPAPSRPTALELLKDQLLAVDGAK 279
|
|
| TAIR|locus:2176135 AT5G55560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 834 (298.6 bits), Expect = 3.1e-83, P = 3.1e-83
Identities = 157/277 (56%), Positives = 201/277 (72%)
Query: 11 ADEAKAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSP 70
+++ K ++E DP GRYG + E+LG GA+K VY+A D+ G+EVAWNQV+L P
Sbjct: 12 SEKDKDSESFVEVDPTGRYGRYGELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRCFSDDP 71
Query: 71 DDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDI 130
+RLYSEV LL LK+ +II Y W D T NFITE+ TSG LREYRKK+R V +
Sbjct: 72 AMTERLYSEVRLLKNLKNSNIITLYKVWRDERNNTLNFITEICTSGNLREYRKKHRHVSM 131
Query: 131 RAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA 190
RA+K W++QIL+GL YLH+ DP +IHRDL C NIFVNG++GQVKIGDLGLAAI+ + A
Sbjct: 132 RALKKWSKQILKGLDYLHTHDPCIIHRDLNCSNIFVNGNIGQVKIGDLGLAAIVGKNHLA 191
Query: 191 HSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL 250
HS++GTPEFMAPELYEE+Y E+VD+YS+GMCVLE+ + E PYSEC + A+IYK+V+ G
Sbjct: 192 HSILGTPEFMAPELYEENYTEMVDIYSYGMCVLELVSLEIPYSECDSVAKIYKRVSKGLK 251
Query: 251 PGAFYSIQDLEAQRFIGRCLVNASKRLSAKELLLDPF 287
P A + D EA+ FI +C+ R SA ELL DPF
Sbjct: 252 PEALNKVNDPEAKAFIEKCIAQPRARPSAAELLCDPF 288
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9SCU5 | WNK5_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7018 | 0.8884 | 0.7540 | yes | no |
| Q2QYL8 | WNK8_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6272 | 0.8283 | 0.6235 | yes | no |
| Q2RBE3 | WNK7_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6175 | 0.8326 | 0.6237 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 466 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-67 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-65 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-54 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-49 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-47 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-46 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-45 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-45 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-44 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-41 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-38 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-37 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-37 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-36 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-35 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-35 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-35 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-34 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-34 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-34 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-34 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-32 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-32 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-32 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-32 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-31 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-30 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-29 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-29 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-29 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-28 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-28 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-28 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-28 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-27 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-27 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-27 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-27 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-26 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-26 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-26 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-25 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-25 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-24 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-24 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-23 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-21 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-21 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-20 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-20 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-19 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-19 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-18 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-16 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-15 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-15 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-14 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-13 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-08 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-08 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-08 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-07 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-07 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-07 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-06 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-06 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-06 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-06 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 6e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 3e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 0.001 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 0.002 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 214 bits (547), Expect = 8e-67
Identities = 87/261 (33%), Positives = 135/261 (51%), Gaps = 13/261 (4%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
E LG+G+ VY A D+ G VA ++ ++ D +R+ E+ +L LKH +I
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI---KKDRERILREIKILKKLKHPNI 59
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRD 151
+R Y + D + + E G L + KK R+ + + RQIL L YLHS+
Sbjct: 60 VRLYDVFED--EDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 152 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE-LYEEDYN 210
++HRDLK +NI ++ G VK+ D GLA L + + +GTPE+MAPE L + Y
Sbjct: 118 --IVHRDLKPENILLDED-GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174
Query: 211 ELVDVYSFGMCVL-EMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQ-DLEAQRFIGR 268
+ VD++S G +L E+ T + P+ +++KK+ K P EA+ I +
Sbjct: 175 KAVDIWSLG-VILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRK 233
Query: 269 CLV-NASKRLSAKELLLDPFL 288
LV + KRL+A+E L PF
Sbjct: 234 LLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 211 bits (539), Expect = 2e-65
Identities = 97/260 (37%), Positives = 145/260 (55%), Gaps = 10/260 (3%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
E+LG+G+ +VY A+D+ G +A V L+ S ++L+ L E+ +LS+L+H +I+R
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSG--DSEEELEALEREIRILSSLQHPNIVR 63
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPP 153
+Y S D ++ T N E + G+L KK+ ++ I+ + RQIL+GL YLHS
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG-- 121
Query: 154 VIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA---HSVIGTPEFMAPELYE-EDY 209
++HRD+K NI V G VK+ D G A L ++ SV GTP +MAPE+ E+Y
Sbjct: 122 IVHRDIKGANILV-DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180
Query: 210 NELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRC 269
D++S G V+EM T + P+SE NP K+ S P EA+ F+ +C
Sbjct: 181 GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKC 240
Query: 270 LV-NASKRLSAKELLLDPFL 288
L + KR +A ELL PFL
Sbjct: 241 LRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 2e-54
Identities = 85/265 (32%), Positives = 127/265 (47%), Gaps = 15/265 (5%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
LG G+ TVYKA + G VA ++ Q E+ +L L H +I
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS--EKSKKDQTARREIRILRRLSHPNI 60
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRD 151
+R ++ D+ + E G L +Y + + K A QIL+GL YLHS
Sbjct: 61 VRLIDAF--EDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118
Query: 152 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS-AHSVIGTPEFMAPE--LYEED 208
+IHRDLK +NI ++ + G VKI D GLA L S S + +GTP +MAPE L
Sbjct: 119 --IIHRDLKPENILLDEN-GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 209 YNELVDVYSFGMCVLEMFTCEYPYSEC--ANPAQIYKKVTSGKLPGAFYSIQDL--EAQR 264
Y VDV+S G+ + E+ T + P+S + Q+ +++ L EA+
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235
Query: 265 FIGRCL-VNASKRLSAKELLLDPFL 288
I +CL + SKR +A+E+L P+
Sbjct: 236 LIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 3e-49
Identities = 73/256 (28%), Positives = 120/256 (46%), Gaps = 46/256 (17%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95
LG+G TVY A D+ G +VA ++ + ++L R E+ +L L H +I++ Y
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLR---EIEILKKLNHPNIVKLY 57
Query: 96 TSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVYLHSRDPPV 154
+ D + + E G+L++ ++ ++ I QIL+GL YLHS +
Sbjct: 58 GVFED--ENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN--GI 113
Query: 155 IHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS-AHSVIGTPEFMAPELYEE--DYNE 211
IHRDLK +NI ++ G+VK+ D GL+ +L KS +++GTP +MAPE+ Y+E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 212 LVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCL- 270
D++S G+ + E+ E + I + L
Sbjct: 174 KSDIWSLGVILYELP----------------------------------ELKDLIRKMLQ 199
Query: 271 VNASKRLSAKELLLDP 286
+ KR SAKE+L
Sbjct: 200 KDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 1e-47
Identities = 87/266 (32%), Positives = 147/266 (55%), Gaps = 22/266 (8%)
Query: 31 LFE--EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH 88
LFE E +GKG VYKA + G EVA ++L S + +++ +E+ +L KH
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKL----ESKEKKEKIINEIQILKKCKH 56
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTS-GTLRE-YRKKYRRVDIRAIKSWARQILQGLVY 146
+I+++Y S++ K +I F S G+L++ + + + I +++L+GL Y
Sbjct: 57 PNIVKYYGSYLK---KDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEY 113
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE-LY 205
LHS +IHRD+K NI + G+VK+ D GL+A L +K+ ++++GTP +MAPE +
Sbjct: 114 LHSNG--IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVIN 170
Query: 206 EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG--KLP-GAFYSIQDLEA 262
+ Y+ D++S G+ +E+ + PYSE ++K T+G L +S E
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWS---DEF 227
Query: 263 QRFIGRCLV-NASKRLSAKELLLDPF 287
+ F+ +CL N KR +A++LL PF
Sbjct: 228 KDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 4e-46
Identities = 91/268 (33%), Positives = 142/268 (52%), Gaps = 30/268 (11%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
E +G+GA VYKA D G EVA ++RL + + + + +E+ ++ KH +I+
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRK-----QNKELIINEILIMKDCKHPNIVD 79
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTL----REYRKKYRRVDIRAIKSWARQILQGLVYLHS 149
+Y S++ + E G+L + + I + R++LQGL YLHS
Sbjct: 80 YYDSYL--VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV---CREVLQGLEYLHS 134
Query: 150 RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA-HSVIGTPEFMAPELYE-E 207
+ VIHRD+K DNI ++ G VK+ D G AA L KS +SV+GTP +MAPE+ + +
Sbjct: 135 Q--NVIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRK 191
Query: 208 DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL-----EA 262
DY VD++S G+ +EM E PY P + +T+ +P +++ E
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPPYLR-EPPLRALFLITTKGIP----PLKNPEKWSPEF 246
Query: 263 QRFIGRCLV-NASKRLSAKELLLDPFLA 289
+ F+ +CLV + KR SA+ELL PFL
Sbjct: 247 KDFLNKCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-45
Identities = 83/258 (32%), Positives = 132/258 (51%), Gaps = 12/258 (4%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
+++G+GA VYK ++ G VA Q+ L ++ + L+ + E+ LL LKH +I++
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPP 153
+ S + I E +G+LR+ KK+ + + Q+LQGL YLH +
Sbjct: 64 YIGSI--ETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG-- 119
Query: 154 VIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SKSAHSVIGTPEFMAPELYE-EDYNE 211
VIHRD+K NI G VK+ D G+A L SK SV+GTP +MAPE+ E +
Sbjct: 120 VIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAST 178
Query: 212 LVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV 271
D++S G V+E+ T PY + NP ++ P I E + F+ +C
Sbjct: 179 ASDIWSLGCTVIELLTGNPPYYD-LNPMAALFRIVQDDHPPLPEGISP-ELKDFLMQCFQ 236
Query: 272 -NASKRLSAKELLLDPFL 288
+ + R +AK+LL P++
Sbjct: 237 KDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 5e-45
Identities = 78/265 (29%), Positives = 135/265 (50%), Gaps = 22/265 (8%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
+ +GKG+ VY + G ++ L+ + S + + +EV +L L H +II+
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM--SEKEREDALNEVKILKKLNHPNIIK 63
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDI----RAIKSWARQILQGLVYLHS 149
+Y S+ ++ + E G L + KK ++ I W Q+ L YLHS
Sbjct: 64 YYESFE--EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121
Query: 150 RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS-AHSVIGTPEFMAPELYEED 208
R ++HRD+K NIF+ G VK+GD G++ +L + A +V+GTP +++PEL +
Sbjct: 122 RK--ILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNK 178
Query: 209 -YNELVDVYSFGMCVL-EMFTCEYPYSECANPAQIYKKVTSGKLP--GAFYSIQDLEAQR 264
YN D++S G CVL E+ T ++P+ E N ++ K+ G+ P + YS +L +
Sbjct: 179 PYNYKSDIWSLG-CVLYELCTLKHPF-EGENLLELALKILKGQYPPIPSQYS-SEL--RN 233
Query: 265 FIGRCL-VNASKRLSAKELLLDPFL 288
+ L + +R S ++L PF+
Sbjct: 234 LVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-44
Identities = 88/262 (33%), Positives = 141/262 (53%), Gaps = 16/262 (6%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRL-NELMRSPDDLQRLYSEVHLLSTLKHDSII 92
E+LG G+ +VY+ ++ G A +V L ++ + +++L E+ LLS L+H +I+
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 93 RFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDP 152
++ + + ++ E+ G+L + KKY I+ + RQIL GL YLH R+
Sbjct: 66 QYLGT--EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN- 122
Query: 153 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELY--EEDYN 210
+HRD+K NI V+ + G VK+ D G+A + A S G+P +MAPE+ + Y
Sbjct: 123 -TVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180
Query: 211 ELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD---LEAQRFIG 267
D++S G VLEM T + P+S+ A ++K S +LP I D EA+ FI
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP----PIPDHLSDEAKDFIL 236
Query: 268 RCL-VNASKRLSAKELLLDPFL 288
+CL + S R +A ELL PF+
Sbjct: 237 KCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 6e-41
Identities = 87/267 (32%), Positives = 134/267 (50%), Gaps = 19/267 (7%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
E +GKG+ TV K + G + W ++ + + + Q+L SEV++L LKH +I+R
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVR 63
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTL----REYRKKYRRVDIRAIKSWARQILQGLVYLHS 149
+Y ID +T + E G L ++ +K+ + ++ I Q+L L H+
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 150 RDPP---VIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS-AHSVIGTPEFMAPE-L 204
R P V+HRDLK NIF++ + VK+GD GLA IL S A + +GTP +M+PE L
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL 182
Query: 205 YEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP--GAFYSIQDLEA 262
Y+E D++S G + E+ P+ N Q+ K+ GK YS +L
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPPF-TARNQLQLASKIKEGKFRRIPYRYS-SEL-- 238
Query: 263 QRFIGRCL-VNASKRLSAKELLLDPFL 288
I L V+ KR S +ELL P +
Sbjct: 239 NEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 5e-38
Identities = 87/279 (31%), Positives = 130/279 (46%), Gaps = 51/279 (18%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
E LG+G+ +VYKAI + G VA V + E DLQ + E+ +L I
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYI 60
Query: 92 IRFYTS-------WIDVDQKTFNFITEMF--TSGTLREYRKKYRRVDIRAIKSWARQILQ 142
+++Y S WI ++ ++++ T+ TL E +I AI Q L+
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTE-------EEIAAI---LYQTLK 110
Query: 143 GLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-KSAHSVIGTPEFMA 201
GL YLHS IHRD+K NI +N GQ K+ D G++ L + ++VIGTP +MA
Sbjct: 111 GLEYLHSNK--KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMA 167
Query: 202 PE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSEC----------ANPAQIYKKVTSGKL 250
PE + E YN D++S G+ +EM + PYS+ P
Sbjct: 168 PEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSD------ 221
Query: 251 PGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288
P + E F+ +CLV + +R SA +LL PF+
Sbjct: 222 PEKWSP----EFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 87/264 (32%), Positives = 140/264 (53%), Gaps = 18/264 (6%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95
+G G VY A++ G +A ++R+ + P ++ + E+ +L LKH +++++Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDN--DPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 96 TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVI 155
++V ++ E + GTL E + R +D I+ + Q+L+GL YLHS ++
Sbjct: 66 G--VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IV 121
Query: 156 HRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA-----HSVIGTPEFMAPELYEED-- 208
HRD+K NIF+ H G +K+GD G A L+ + + S+ GTP +MAPE+
Sbjct: 122 HRDIKPANIFL-DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 209 --YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQ-DLEAQRF 265
+ D++S G VLEM T + P+SE N QI V +G P S+Q E + F
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDF 240
Query: 266 IGRCLV-NASKRLSAKELLLDPFL 288
+ RCL + KR +A ELL PF+
Sbjct: 241 LDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 3e-37
Identities = 73/262 (27%), Positives = 131/262 (50%), Gaps = 18/262 (6%)
Query: 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRF 94
VLG+G+ VYK + G A ++ ++ + ++L E+ L + + +++
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDG---DEEFRKQLLRELKTLRSCESPYVVKC 64
Query: 95 YTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPV 154
Y ++ + + + E G+L + KK ++ + ARQIL+GL YLH +
Sbjct: 65 YGAFYK--EGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH-TKRHI 121
Query: 155 IHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-RGSKSAHSVIGTPEFMAPE-LYEEDYNEL 212
IHRD+K N+ +N G+VKI D G++ +L ++ +GT +M+PE + E Y+
Sbjct: 122 IHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYA 180
Query: 213 VDVYSFGMCVLEMFTCEYPYS--ECANPAQIYKKVTSG---KLPGAFYSIQDLEAQRFIG 267
D++S G+ +LE ++P+ + ++ + + G LP +S E + FI
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSP---EFRDFIS 237
Query: 268 RCLV-NASKRLSAKELLLDPFL 288
CL + KR SA ELL PF+
Sbjct: 238 ACLQKDPKKRPSAAELLQHPFI 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 7e-36
Identities = 90/260 (34%), Positives = 133/260 (51%), Gaps = 10/260 (3%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLN-ELMRSPDDLQRLYSEVHLLSTLKHDSII 92
++LG+GA VY D G E+A QV+ + E + ++ L E+ LL L+H+ I+
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 93 RFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDP 152
++Y D +KT E G++++ K Y + + + RQIL+G+ YLHS
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN-- 125
Query: 153 PVIHRDLKCDNIFVNGHLGQVKIGDLG----LAAILRGSKSAHSVIGTPEFMAPELYE-E 207
++HRD+K NI + G VK+GD G L I SV GTP +M+PE+ E
Sbjct: 126 MIVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 208 DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIG 267
Y DV+S G V+EM T + P++E A I+K T P I + A+ F+G
Sbjct: 185 GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE-HARDFLG 243
Query: 268 RCLVNASKRLSAKELLLDPF 287
V A R SA+ELL PF
Sbjct: 244 CIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 1e-35
Identities = 82/262 (31%), Positives = 140/262 (53%), Gaps = 18/262 (6%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
+GKG+ V+K + + A Q+ L+++ R + + E +L+ L IIR
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR--EREEAIDEARVLAKLDSSYIIR 63
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWAR--QILQGLVYLHSRD 151
+Y S++D K N + E +G L + K R + + W QIL GL +LHS+
Sbjct: 64 YYESFLD-KGK-LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 152 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS-AHSVIGTPEFMAPELYEED-Y 209
++HRD+K N+F++ + VKIGDLG+A +L + + A++++GTP +++PEL E+ Y
Sbjct: 122 --ILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPY 178
Query: 210 NELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP--GAFYSIQDLEAQRFIG 267
NE DV++ G+ + E T ++P+ + N + K+ G P YS Q L + I
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPF-DANNQGALILKIIRGVFPPVSQMYS-QQL--AQLID 234
Query: 268 RCL-VNASKRLSAKELLLDPFL 288
+CL + +R +LL +P L
Sbjct: 235 QCLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-35
Identities = 84/263 (31%), Positives = 138/263 (52%), Gaps = 22/263 (8%)
Query: 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSII 92
E+ +GKG VYKAI + G VA +V++ E+M Q E+ LL L H ++I
Sbjct: 7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-DAKARQDCLKEIDLLKQLDHPNVI 65
Query: 93 RFYTSWIDVDQKTFNFITEMFTSGTL----REYRKKYRRVDIRAIKSWARQILQGLVYLH 148
++ S+I+ ++ N + E+ +G L + ++K+ R + R I + Q+ L ++H
Sbjct: 66 KYLASFIENNE--LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123
Query: 149 SRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS--AHSVIGTPEFMAPE-LY 205
S+ ++HRD+K N+F+ G VK+GDLGL SK+ AHS++GTP +M+PE ++
Sbjct: 124 SKR--IMHRDIKPANVFITAT-GVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPERIH 179
Query: 206 EEDYNELVDVYSFGMCVLEMFTCEYP-YSECANPAQIYKKVTSGK---LPGAFYSIQDLE 261
E YN D++S G + EM + P Y + N + KK+ LP YS E
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS---EE 236
Query: 262 AQRFIGRCL-VNASKRLSAKELL 283
+ + RC+ + KR +L
Sbjct: 237 LRDLVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-35
Identities = 90/262 (34%), Positives = 133/262 (50%), Gaps = 19/262 (7%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRS-PDDLQRLYSEVHLLSTLKHDSIIRF 94
LG+GA VY D G E+A QV + ++ L E+ LL L+H+ I+++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 95 YTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPV 154
Y D +T + E G++++ K Y + + + RQIL+G+ YLHS +
Sbjct: 70 YG--CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--I 125
Query: 155 IHRDLKCDNIFVNGHLGQVKIGDLG----LAAILRGSKSAHSVIGTPEFMAPELYE-EDY 209
+HRD+K NI + G VK+GD G L I SV GTP +M+PE+ E Y
Sbjct: 126 VHRDIKGANILRDSA-GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY 184
Query: 210 NELVDVYSFGMCVLEMFTCEYPYSECANPAQIYK---KVTSGKLPGAFYSIQDLEAQRFI 266
DV+S G V+EM T + P++E A I+K + T+ +LP S +A+ F+
Sbjct: 185 GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLP----SHVSPDARNFL 240
Query: 267 GRCLV-NASKRLSAKELLLDPF 287
R V NA KR SA+ELL F
Sbjct: 241 RRTFVENAKKRPSAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 87/274 (31%), Positives = 134/274 (48%), Gaps = 25/274 (9%)
Query: 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH 88
Y L E + G GA VY AI +VA ++ +L + + L EV +S H
Sbjct: 3 YELIEVI-GVGATAVVYAAICLPNNEKVA---IKRIDLEKCQTSVDELRKEVQAMSQCNH 58
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRK-KYRR--VDIRAIKSWARQILQGLV 145
+++++YTS+ V + + G+L + K Y R +D I + +++L+GL
Sbjct: 59 PNVVKYYTSF--VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLE 116
Query: 146 YLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-----RGSKSAHSVIGTPEFM 200
YLHS IHRD+K NI + G VKI D G++A L R K + +GTP +M
Sbjct: 117 YLHSNG--QIHRDIKAGNILLGED-GSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM 173
Query: 201 APELYEED--YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP----GAF 254
APE+ E+ Y+ D++SFG+ +E+ T PYS+ P ++ P GA
Sbjct: 174 APEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP-PMKVLMLTLQNDPPSLETGAD 232
Query: 255 YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPF 287
Y ++ I CL + SKR +A+ELL F
Sbjct: 233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 79/262 (30%), Positives = 128/262 (48%), Gaps = 19/262 (7%)
Query: 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSII 92
E +GKG+ VYKAID+ VA + L E + D+++ + E+ LS + I
Sbjct: 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 93 RFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDP 152
++Y S+ + I E G+ + K ++D I R++L GL YLH
Sbjct: 63 KYYGSF--LKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEG- 118
Query: 153 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-RGSKSAHSVIGTPEFMAPELY-EEDYN 210
IHRD+K NI ++ G VK+ D G++ L ++ +GTP +MAPE+ + Y+
Sbjct: 119 -KIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYD 176
Query: 211 ELVDVYSFGMCVLEMFTCEYPYSECANPAQIY---KKVTSGKLPGAFYSIQDLEAQRFIG 267
E D++S G+ +E+ E P S+ +P ++ K L G +S + F+
Sbjct: 177 EKADIWSLGITAIELAKGEPPLSD-LHPMRVLFLIPKNNPPSLEGNKFS---KPFKDFVS 232
Query: 268 RCLV-NASKRLSAKELLLDPFL 288
CL + +R SAKELL F+
Sbjct: 233 LCLNKDPKERPSAKELLKHKFI 254
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-34
Identities = 89/269 (33%), Positives = 135/269 (50%), Gaps = 13/269 (4%)
Query: 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLN-ELMRSPDDLQRLYSEVHLLS 84
N R G ++LG+GA VY D G E+A QV+ + E + ++ L E+ LL
Sbjct: 3 NWRLG---KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLK 59
Query: 85 TLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGL 144
L H+ I+++Y D ++T + E G++++ K Y + + + RQIL+G+
Sbjct: 60 NLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGV 119
Query: 145 VYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG----LAAILRGSKSAHSVIGTPEFM 200
YLHS ++HRD+K NI + +G VK+GD G L I SV GTP +M
Sbjct: 120 SYLHSN--MIVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176
Query: 201 APELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259
+PE+ E Y D++S G V+EM T + P++E A I+K T P + D
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD 236
Query: 260 LEAQRFIGRCLVNASKRLSAKELLLDPFL 288
+ F+ R V A R SA ELL F+
Sbjct: 237 -HCRDFLKRIFVEAKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 9e-34
Identities = 93/275 (33%), Positives = 133/275 (48%), Gaps = 20/275 (7%)
Query: 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVH 81
E D NG VLGKG VY A D V +A ++ R +Q L+ E+
Sbjct: 6 EYDENGE----RVVLGKGTYGIVYAARDLSTQVRIAIKEIP----ERDSRYVQPLHEEIA 57
Query: 82 LLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIR--AIKSWAR 138
L S LKH +I+++ S D + F E G+L R K+ + I + +
Sbjct: 58 LHSYLKHRNIVQYLGS--DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK 115
Query: 139 QILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SKSAHSVIGTP 197
QIL+GL YLH ++HRD+K DN+ VN + G VKI D G + L G + + GT
Sbjct: 116 QILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTL 173
Query: 198 EFMAPELYEE---DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAF 254
++MAPE+ ++ Y D++S G ++EM T + P+ E P KV K+
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI 233
Query: 255 YSIQDLEAQRFIGRC-LVNASKRLSAKELLLDPFL 288
EA+ FI RC + KR SA +LL DPFL
Sbjct: 234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 7e-33
Identities = 93/269 (34%), Positives = 141/269 (52%), Gaps = 16/269 (5%)
Query: 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLL 83
DP +Y FE++ G+GA TVY AID G EVA Q+ L + + + + +E+ ++
Sbjct: 16 DPKKKYTRFEKI-GQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK----ELIINEILVM 70
Query: 84 STLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQG 143
KH +I+ + S++ D+ + E G+L + + +D I + R+ LQ
Sbjct: 71 RENKHPNIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 127
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS-VIGTPEFMAP 202
L +LHS VIHRD+K DNI + G G VK+ D G A + +S S ++GTP +MAP
Sbjct: 128 LEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 203 ELY-EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQ-IYKKVTSGKLPGAFYSIQDL 260
E+ + Y VD++S G+ +EM E PY NP + +Y T+G
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPEKLSA 243
Query: 261 EAQRFIGRCL-VNASKRLSAKELLLDPFL 288
+ F+ RCL ++ KR SAKELL PFL
Sbjct: 244 IFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 1e-32
Identities = 80/339 (23%), Positives = 132/339 (38%), Gaps = 36/339 (10%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH-DS 90
LG+G+ VY A D L +V +L +++R E+ +L++L H +
Sbjct: 4 ILRKLGEGSFGEVYLARDRKLVA----LKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRR---VDIRAIKSWARQILQGLVYL 147
I++ Y D+ + + E G+L + KK R + QIL L YL
Sbjct: 60 IVKLY--DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 148 HSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA-------HSVIGTPEFM 200
HS+ +IHRD+K +NI ++ VK+ D GLA +L S + +GTP +M
Sbjct: 118 HSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 201 APELY----EEDYNELVDVYSFGMCVLEMFTCEYPY---SECANPAQIYKKVTSGKLPGA 253
APE+ + D++S G+ + E+ T P+ + +Q K + P
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 254 FYSIQ-------DLEAQRFIGRCL-VNASKRLSAKELLLDPFLA--SDEVKLLSKTKLNQ 303
+ A + + L + RLS+ L LA + LS
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPD 295
Query: 304 KPFLNETELEKLQLSDDPPRTDMTITGKLNPEDDTIFLK 342
L + + I+G DD+ F K
Sbjct: 296 DSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSK 334
|
Length = 384 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-32
Identities = 86/268 (32%), Positives = 133/268 (49%), Gaps = 13/268 (4%)
Query: 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLN-ELMRSPDDLQRLYSEVHLLS 84
N R G ++LG+GA VY D G E+A QV + + + ++ L E+ LL
Sbjct: 3 NWRLG---KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLK 59
Query: 85 TLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGL 144
L+HD I+++Y D ++K + E G++++ K Y + + + RQILQG+
Sbjct: 60 NLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGV 119
Query: 145 VYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG----LAAILRGSKSAHSVIGTPEFM 200
YLHS ++HRD+K NI + G VK+GD G + I SV GTP +M
Sbjct: 120 SYLHSN--MIVHRDIKGANILRDSA-GNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176
Query: 201 APELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259
+PE+ E Y DV+S V+EM T + P++E A I+K T P + D
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD 236
Query: 260 LEAQRFIGRCLVNASKRLSAKELLLDPF 287
+ F+ + V +R +A+ LL PF
Sbjct: 237 -ACRDFLKQIFVEEKRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-32
Identities = 67/249 (26%), Positives = 119/249 (47%), Gaps = 12/249 (4%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95
LGKG+ V + G A ++ + + +++ +E ++LS + H I++ +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLK-KKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 96 TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVI 155
++ ++ + E G L + K R + +A +I+ L YLHS +I
Sbjct: 60 YAFQT--EEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--II 115
Query: 156 HRDLKCDNIFVNGHLGQVKIGDLGLAAIL-RGSKSAHSVIGTPEFMAPE-LYEEDYNELV 213
+RDLK +NI ++ G +K+ D GLA L ++ GTPE++APE L + Y + V
Sbjct: 116 YRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAV 174
Query: 214 DVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCL-VN 272
D +S G+ + EM T + P+ + +IY+K+ L F EA+ I L +
Sbjct: 175 DWWSLGVLLYEMLTGKPPF-YAEDRKEIYEKILKDPL--RFPEFLSPEARDLISGLLQKD 231
Query: 273 ASKRLSAKE 281
+KRL +
Sbjct: 232 PTKRLGSGG 240
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 9e-32
Identities = 73/271 (26%), Positives = 119/271 (43%), Gaps = 37/271 (13%)
Query: 32 FEEVLGKGAMKTVYKAI----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
+ LG+GA VYK + VEVA V+ + S ++ E ++ L
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVA---VKTLKEDASEQQIEEFLREARIMRKLD 59
Query: 88 HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK--SWARQILQGLV 145
H +I++ + +++ + E G L +Y +K R ++ S+A QI +G+
Sbjct: 60 HPNIVKLLG--VCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGME 117
Query: 146 YLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPE---FMAP 202
YL S+ IHRDL N V +L VKI D GL+ L + V G +MAP
Sbjct: 118 YLESK--NFIHRDLAARNCLVGENL-VVKISDFGLSRDL-YDDDYYKVKGGKLPIRWMAP 173
Query: 203 ELYEED-YNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKL-------PGA 253
E +E + DV+SFG+ + E+FT E PY +N A++ + + G P
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN-AEVLEYLKKGYRLPKPPNCPPE 232
Query: 254 FYSIQDLEAQRFIGRCLV-NASKRLSAKELL 283
Y + + +C + R + EL+
Sbjct: 233 LYKL--------MLQCWAEDPEDRPTFSELV 255
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 81/268 (30%), Positives = 133/268 (49%), Gaps = 21/268 (7%)
Query: 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQR-----LYSEVHLLSTLKHD 89
++G G+ +VY ++ G +A QV L + S D +R L E+ LL L+H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 90 SIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHS 149
+I+++ S +D N E G++ Y + ++++ RQIL+GL YLH+
Sbjct: 67 NIVQYLGS--SLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 150 RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL-----AAILRGSKSAH--SVIGTPEFMAP 202
R +IHRD+K NI V+ G +KI D G+ A L + S+ G+ +MAP
Sbjct: 125 RG--IIHRDIKGANILVDNK-GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 203 ELYEED-YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLE 261
E+ ++ Y D++S G V+EM T ++P+ +C I+K S E
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK--IGENASPEIPSNISSE 239
Query: 262 AQRFIGRCL-VNASKRLSAKELLLDPFL 288
A F+ + ++ +KR +A ELL PFL
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 78/276 (28%), Positives = 130/276 (47%), Gaps = 27/276 (9%)
Query: 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLS 84
P Y L + + G G VYKA D G VA ++L DD + + E+ +L
Sbjct: 1 PQEDYELIQRI-GSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLK 55
Query: 85 TLKHDSIIRFYTSWIDVDQKTFNFIT-EMFTSGTLRE-YRKKYRRVDIRAIKSWARQILQ 142
+H +I+ ++ S++ D+ +I E G+L++ Y+ + I R+ L+
Sbjct: 56 ECRHPNIVAYFGSYLRRDKL---WIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLK 112
Query: 143 GLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA-HSVIGTPEFMA 201
GL YLH IHRD+K NI + G VK+ D G++A L + + S IGTP +MA
Sbjct: 113 GLAYLHETG--KIHRDIKGANILLTED-GDVKLADFGVSAQLTATIAKRKSFIGTPYWMA 169
Query: 202 PELYEE----DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSI 257
PE+ Y+ D+++ G+ +E+ + P + +P + ++ P +
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD-LHPMRALFLISKSNFPPP--KL 226
Query: 258 QDLEA-----QRFIGRCLV-NASKRLSAKELLLDPF 287
+D E FI +CL + KR +A +LL PF
Sbjct: 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 7e-31
Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 36/270 (13%)
Query: 32 FEEVLGKGAMKTVYKAI----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
+ LG+GA VYK VEVA ++ + S ++ E ++ L
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKED---ASEQQIEEFLREARIMRKLD 59
Query: 88 HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVY 146
H ++++ + +++ + E G L Y +K R ++ + + S+A QI +G+ Y
Sbjct: 60 HPNVVKLLG--VCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPE---FMAPE 203
L S+ IHRDL N V +L VKI D GL+ L + G +MAPE
Sbjct: 118 LESK--NFIHRDLAARNCLVGENL-VVKISDFGLSRDL-YDDDYYRKRGGKLPIRWMAPE 173
Query: 204 LYEED-YNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKL-------PGAF 254
+E + DV+SFG+ + E+FT E PY +N ++ + + +G P
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLEYLKNGYRLPQPPNCPPEL 232
Query: 255 YSIQDLEAQRFIGRCLV-NASKRLSAKELL 283
Y + + +C + R + EL+
Sbjct: 233 YDL--------MLQCWAEDPEDRPTFSELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 74/264 (28%), Positives = 118/264 (44%), Gaps = 15/264 (5%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRL--NELMRSPDDLQRLYSEVHLLSTLKHDSI 91
+ LG GA + Y+A D G +A QV N + ++ L E+ L++ L H I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRD 151
IR + + FN E G++ KY I ++ Q+L+GL YLH
Sbjct: 66 IRMLGA--TCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ 123
Query: 152 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA-----ILRGSKSAHSVIGTPEFMAPE-LY 205
+IHRD+K N+ ++ +++I D G AA + ++GT FMAPE L
Sbjct: 124 --IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 206 EEDYNELVDVYSFGMCVLEMFTCEYPYS--ECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263
E Y DV+S G ++EM T + P++ + +N + K+ S + +
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLR 241
Query: 264 RFIGRCL-VNASKRLSAKELLLDP 286
RCL + R ++ELL P
Sbjct: 242 DVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 87/263 (33%), Positives = 127/263 (48%), Gaps = 29/263 (11%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPD----DLQRLYSEVHLLSTLKHD 89
E++G+GA VY+ G VA + L+ +PD D+QR EV LLS L+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLD----TPDDDVSDIQR---EVALLSQLRQS 59
Query: 90 ---SIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVY 146
+I ++Y S++ I E G++R K + + I R++L L Y
Sbjct: 60 QPPNITKYYGSYLK--GPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKY 116
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSV-IGTPEFMAPELY 205
+H VIHRD+K NI V G VK+ D G+AA+L + S S +GTP +MAPE+
Sbjct: 117 IHKV--GVIHRDIKAANILVTNT-GNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVI 173
Query: 206 EE--DYNELVDVYSFGMCVLEMFTCEYPYS--ECANPAQIYKKVTSGKLPGAFYSIQDLE 261
E Y+ D++S G+ + EM T PYS + + K +L YS
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSK---L 230
Query: 262 AQRFIGRCLVNASK-RLSAKELL 283
+ F+ CL K RLSA+ELL
Sbjct: 231 LREFVAACLDEEPKERLSAEELL 253
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-29
Identities = 83/263 (31%), Positives = 133/263 (50%), Gaps = 24/263 (9%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYS--EVHLLSTLKHDSIIR 93
LGKG+ +VYK A +V L S +R + E+ +L+++ H +II
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDL----GSMSQKEREDAVNEIRILASVNHPNIIS 63
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREY---RKKYRR-VDIRAIKSWARQILQGLVYLHS 149
+ +++D ++ + E G L + RKK R+ + + I Q+L+GL LH
Sbjct: 64 YKEAFLDGNK--LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121
Query: 150 RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE-ED 208
+ ++HRDLK NI + + VKIGDLG++ +L+ + A + IGTP +MAPE+++
Sbjct: 122 QK--ILHRDLKSANILLVAN-DLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGRP 177
Query: 209 YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP--GAFYSIQDLEAQRFI 266
Y+ D++S G + EM T P+ E + + KV GK P YS QDL Q FI
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYPPIPPIYS-QDL--QNFI 233
Query: 267 GRCL-VNASKRLSAKELLLDPFL 288
L V R + ++L P +
Sbjct: 234 RSMLQVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 90/273 (32%), Positives = 144/273 (52%), Gaps = 24/273 (8%)
Query: 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLL 83
DP +Y +E++ G+GA TV+ AID G EVA Q+ L + + + + +E+ ++
Sbjct: 16 DPKKKYTRYEKI-GQGASGTVFTAIDVATGQEVAIKQINLQKQPKK----ELIINEILVM 70
Query: 84 STLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQG 143
LK+ +I+ F S++ D+ + E G+L + + +D I + R+ LQ
Sbjct: 71 KELKNPNIVNFLDSFLVGDE--LFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQA 127
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS-VIGTPEFMAP 202
L +LH+ VIHRD+K DN+ + G G VK+ D G A + +S S ++GTP +MAP
Sbjct: 128 LEFLHANQ--VIHRDIKSDNVLL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 203 ELY-EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLE 261
E+ + Y VD++S G+ +EM E PY NP + + + P +Q+ E
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTP----ELQNPE 239
Query: 262 A-----QRFIGRCL-VNASKRLSAKELLLDPFL 288
+ F+ RCL ++ KR SAKELL PFL
Sbjct: 240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 84/277 (30%), Positives = 140/277 (50%), Gaps = 33/277 (11%)
Query: 28 RYGLFEEVLGKGAMKTVYKAID------EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVH 81
RY + ++ LGKG+ TVY D E L V ++ + EL +P++ + E
Sbjct: 1 RY-ILQQRLGKGSFGTVYLVKDKKAVAEERLKV---LKEIPVGEL--NPNETVQANQEAQ 54
Query: 82 LLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSG-----TLREYRKKYRRVDIRAIKSW 136
LLS L H +I++F+ S+ +++ F ITE + G L E + + + + W
Sbjct: 55 LLSKLDHPAIVKFHASF--LERDAFCIITE-YCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 137 ARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-KSAHSVIG 195
Q+L G+ Y+H R ++HRDLK NIF+ +L +KIGD G++ +L GS A + G
Sbjct: 112 FIQLLLGVHYMHQRR--ILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTFTG 167
Query: 196 TPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG---KLP 251
TP +M+PE L + Y+ D++S G + EM + + E N + ++ G LP
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF-EGQNFLSVVLRIVEGPTPSLP 226
Query: 252 GAFYSIQDLEAQRFIGRCLVNASKRLSAKELLLDPFL 288
+ + Q + + + S R SA E+L +PF+
Sbjct: 227 ETYSRQLNSIMQSMLNK---DPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 62/229 (27%), Positives = 101/229 (44%), Gaps = 21/229 (9%)
Query: 32 FEEVLGKGAMKTVYKAI----DEVLGVEVAWNQV-RLNELMRSPDDLQRLYSEVHLLSTL 86
+ LG+GA VYK E +VA V L E S ++ + E ++ L
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVA---VKTLKEGA-SEEEREEFLEEASIMKKL 58
Query: 87 KHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLV 145
H +I+R + + +TE G L ++ RK ++ ++ + A QI +G+
Sbjct: 59 SHPNIVRLLG--VCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116
Query: 146 YLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPE---FMAP 202
YL S+ +HRDL N V VKI D GL+ + G +MAP
Sbjct: 117 YLESK--NFVHRDLAARNCLV-TENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAP 173
Query: 203 ELYEED-YNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGK 249
E ++ + DV+SFG+ + E+FT E PY +N ++ + + G
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLELLEDGY 221
|
Length = 258 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 84/288 (29%), Positives = 136/288 (47%), Gaps = 41/288 (14%)
Query: 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHL 82
+PN + + E LG GA VYKA + G+ A +++ S ++L+ E+ +
Sbjct: 1 VNPNDIWEIIGE-LGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDI 55
Query: 83 LSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLR----EYRKKYRRVDIRAIKSWAR 138
LS KH +I+ Y ++ + K + I E G L E + IR + R
Sbjct: 56 LSECKHPNIVGLYEAYF-YENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYV---CR 110
Query: 139 QILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA-HSVIGTP 197
Q+L+ L +LHS VIHRDLK NI + G VK+ D G++A + + + IGTP
Sbjct: 111 QMLEALNFLHSHK--VIHRDLKAGNILLTLD-GDVKLADFGVSAKNKSTLQKRDTFIGTP 167
Query: 198 EFMAPELY------EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP 251
+MAPE+ + Y+ D++S G+ ++E+ E P+ E NP ++ K+ + P
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE-LNPMRVLLKILKSEPP 226
Query: 252 GAFYSIQDLEAQR--------FIGRCLV-NASKRLSAKELLLDPFLAS 290
L+ F+ CLV + R +A ELL PF++
Sbjct: 227 -------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 4e-28
Identities = 91/270 (33%), Positives = 143/270 (52%), Gaps = 18/270 (6%)
Query: 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLL 83
DP +Y FE++ G+GA TVY AID G EVA Q+ L + + + + +E+ ++
Sbjct: 16 DPKKKYTRFEKI-GQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK----ELIINEILVM 70
Query: 84 STLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQG 143
K+ +I+ + S++ D+ + E G+L + + +D I + R+ LQ
Sbjct: 71 RENKNPNIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 127
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS-VIGTPEFMAP 202
L +LHS VIHRD+K DNI + G G VK+ D G A + +S S ++GTP +MAP
Sbjct: 128 LDFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 203 ELY-EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLE 261
E+ + Y VD++S G+ +EM E PY NP + + + P + + L
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTP-ELQNPERLS 242
Query: 262 A--QRFIGRCL-VNASKRLSAKELLLDPFL 288
A + F+ RCL ++ +R SAKELL PFL
Sbjct: 243 AVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 1e-27
Identities = 90/270 (33%), Positives = 142/270 (52%), Gaps = 18/270 (6%)
Query: 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLL 83
DP +Y FE++ G+GA TVY A+D G EVA Q+ L + + + + +E+ ++
Sbjct: 17 DPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK----ELIINEILVM 71
Query: 84 STLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQG 143
K+ +I+ + S++ D+ + E G+L + + +D I + R+ LQ
Sbjct: 72 RENKNPNIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 128
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS-VIGTPEFMAP 202
L +LHS VIHRD+K DNI + G G VK+ D G A + +S S ++GTP +MAP
Sbjct: 129 LEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 203 ELY-EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLE 261
E+ + Y VD++S G+ +EM E PY NP + + + P + + L
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTP-ELQNPEKLS 243
Query: 262 A--QRFIGRCL-VNASKRLSAKELLLDPFL 288
A + F+ RCL ++ KR SAKELL FL
Sbjct: 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 78/270 (28%), Positives = 130/270 (48%), Gaps = 21/270 (7%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQR------LYSEVHLLSTLK 87
E++GKG VY A++ G +A QV L + D ++ L SE+ L L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 88 HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYL 147
H +I+++ + ++ + E G++ + Y R + + ++ + Q+L+GL YL
Sbjct: 67 HLNIVQYLG--FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 148 HSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA---AILRGSKSAHSVIGTPEFMAPE- 203
HS+ ++HRDLK DN+ V+ G KI D G++ + + S+ G+ +MAPE
Sbjct: 125 HSKG--ILHRDLKADNLLVDAD-GICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 204 --LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK---LPGAFYSIQ 258
Y + Y+ VD++S G VLEMF P+S+ A ++K +P
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241
Query: 259 DLEAQRFIGRC-LVNASKRLSAKELLLDPF 287
A F+ C +N R +A+ELL PF
Sbjct: 242 SPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 77/266 (28%), Positives = 132/266 (49%), Gaps = 25/266 (9%)
Query: 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRL--NELMRSPDDLQRLYSEVHLLSTLKHDSII 92
LG G V K + G +A +RL NE ++ +++ E+ +L I+
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQ-----KQILRELDILHKCNSPYIV 62
Query: 93 RFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRD 151
FY ++ + + E G+L + K+ + R+ R + A +L+GL YLH
Sbjct: 63 GFYGAFYN--NGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE-K 119
Query: 152 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE-LYEEDYN 210
+IHRD+K NI VN GQ+K+ D G++ L S A + +GT +MAPE + DY+
Sbjct: 120 HKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSL-AKTFVGTSSYMAPERIQGNDYS 177
Query: 211 ELVDVYSFGMCVLEMFTCEYPYSECANPA----QIYKKVTSG---KLPGAFYSIQDLEAQ 263
D++S G+ ++E+ T +PY +P ++ + + + +LP +S + Q
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFS---PDFQ 234
Query: 264 RFIGRCLV-NASKRLSAKELLLDPFL 288
F+ CL+ + +R S KELL PF+
Sbjct: 235 DFVNLCLIKDPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 78/260 (30%), Positives = 135/260 (51%), Gaps = 20/260 (7%)
Query: 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRF 94
V+G+GA V+ + V Q+ + ++ + D+ +E +L L H +II +
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK--DERLAAQNECQVLKLLSHPNIIEY 64
Query: 95 YTSWIDVDQKTFNFITEMFTSGTLREYRKKYRR--VDIRAIKSWARQILQGLVYLHSRDP 152
Y ++++ K + E GTL EY +K +D I + QIL L ++H++
Sbjct: 65 YENFLE--DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL- 121
Query: 153 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNE 211
++HRDLK NI ++ H VKIGD G++ IL A++V+GTP +++PEL E + YN+
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 212 LVDVYSFGMCVL-EMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL---EAQRFIG 267
D+++ G CVL E+ + + + E AN + K+ SG F I D + ++ I
Sbjct: 181 KSDIWALG-CVLYELASLKRAF-EAANLPALVLKIMSGT----FAPISDRYSPDLRQLIL 234
Query: 268 RCL-VNASKRLSAKELLLDP 286
L ++ SKR +++ P
Sbjct: 235 SMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 8e-27
Identities = 76/248 (30%), Positives = 133/248 (53%), Gaps = 19/248 (7%)
Query: 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSII 92
E+ +G+G VY+A + GV VA +V++ +LM + E+ LL L H ++I
Sbjct: 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR-ADCIKEIDLLKQLNHPNVI 65
Query: 93 RFYTSWIDVDQKTFNFITEMFTSGTL----REYRKKYRRVDIRAIKSWARQILQGLVYLH 148
++Y S+I+ ++ N + E+ +G L + ++K+ R + + + + Q+ L ++H
Sbjct: 66 KYYASFIEDNE--LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 149 SRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SKSAHSVIGTPEFMAPE-LYE 206
SR V+HRD+K N+F+ G VK+GDLGL + +AHS++GTP +M+PE ++E
Sbjct: 124 SRR--VMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 207 EDYNELVDVYSFGMCVLEMFTCEYP-YSECANPAQIYKKVTS---GKLPGAFYSIQDLEA 262
YN D++S G + EM + P Y + N + KK+ LP YS E
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS---EEL 237
Query: 263 QRFIGRCL 270
++ + C+
Sbjct: 238 RQLVNMCI 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 83/286 (29%), Positives = 143/286 (50%), Gaps = 22/286 (7%)
Query: 12 DEAKAHIGYI--ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRS 69
++ +A + + DP F ++ G+G+ V A D+ G +VA ++ L + R
Sbjct: 2 EQFRAALQLVVDPGDPRSYLDNFVKI-GEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRR 60
Query: 70 PDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVD 129
+ L++EV ++ +H +I+ Y+S++ D+ + E G L + + R++
Sbjct: 61 ----ELLFNEVVIMRDYQHPNIVEMYSSYLVGDE--LWVVMEFLEGGALTDI-VTHTRMN 113
Query: 130 IRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS 189
I + +L+ L +LH++ VIHRD+K D+I + G+VK+ D G A + SK
Sbjct: 114 EEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLT-SDGRVKLSDFGFCAQV--SKE 168
Query: 190 A---HSVIGTPEFMAPELY-EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKV 245
S++GTP +MAPE+ Y VD++S G+ V+EM E PY P Q K++
Sbjct: 169 VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRI 227
Query: 246 TSGKLPGAFYSIQ-DLEAQRFIGRCLV-NASKRLSAKELLLDPFLA 289
P + + F+ R LV + ++R +A ELL PFLA
Sbjct: 228 RDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 82/271 (30%), Positives = 135/271 (49%), Gaps = 27/271 (9%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRL--NELMRSPDDLQRLYSEVHLLSTLKHDSI 91
EVLGKGA TVY + G +A QV L + ++ + + ++L EV LL +LKH +I
Sbjct: 6 EVLGKGAYGTVYCGLTNQ-GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRD 151
+++ + +D T + E G++ ++ + + +QIL G+ YLH +
Sbjct: 65 VQYLGTCLD--DNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH--N 120
Query: 152 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-----AILRGSKSA--HSVIGTPEFMAPEL 204
V+HRD+K +N+ + + G +K+ D G A L G+ S S+ GTP +MAPE+
Sbjct: 121 NCVVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 205 YEED-YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK-----LPGAFYSIQ 258
E Y D++S G V EM T + P + A ++ + + + LP +F +
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF-YIGAHRGLMPRLPDSFSA-- 236
Query: 259 DLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288
A F+ CL + +R SA +LL FL
Sbjct: 237 --AAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 3e-26
Identities = 71/236 (30%), Positives = 125/236 (52%), Gaps = 16/236 (6%)
Query: 31 LFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDS 90
E+ +G+G VY+A + VA +V++ E+M + Q E+ LL L H +
Sbjct: 5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR-QDCVKEIDLLKQLNHPN 63
Query: 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLRE----YRKKYRRVDIRAIKSWARQILQGLVY 146
+I++ S+I+ ++ N + E+ +G L + ++K+ R + R + + Q+ + +
Sbjct: 64 VIKYLDSFIEDNE--LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SKSAHSVIGTPEFMAPE-L 204
+HSR V+HRD+K N+F+ G VK+GDLGL + +AHS++GTP +M+PE +
Sbjct: 122 MHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 205 YEEDYNELVDVYSFGMCVLEMFTCEYP-YSECANPAQIYKKVTSGK---LPGAFYS 256
+E YN D++S G + EM + P Y + N + +K+ LP YS
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS 234
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 71/302 (23%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNEL--------MRSPDDLQRLYSEVHLLST 85
E LG+G VYKA D+ G VA ++RL+ +R E+ LL
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR----------EISLLKE 54
Query: 86 LKHDSIIRFYTSWIDV---DQKT---FNFITEMFTSGTLREYRKKYRR-VDIRAIKSWAR 138
LKH +I++ DV ++K F + +M L++Y K + IKS
Sbjct: 55 LKHPNIVKLL----DVIHTERKLYLVFEYC-DM----DLKKYLDKRPGPLSPNLIKSIMY 105
Query: 139 QILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR--GSKSAHSVIGT 196
Q+L+GL Y HS ++HRDLK NI +N G +K+ D GLA H V+ T
Sbjct: 106 QLLRGLAYCHSHR--ILHRDLKPQNILIN-RDGVLKLADFGLARAFGIPLRTYTHEVV-T 161
Query: 197 PEFMAPELY--EEDYNELVDVYSFGMCVLEMFT--------CE----------------- 229
+ APE+ + Y+ VD++S G EM T E
Sbjct: 162 LWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEE 221
Query: 230 -YP-YSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDP 286
+P ++ + + K K D E + + L N +KR+SAKE L P
Sbjct: 222 SWPGVTKLPDYKPTFPKFP-PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHP 280
Query: 287 FL 288
+
Sbjct: 281 YF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 4e-26
Identities = 74/287 (25%), Positives = 132/287 (45%), Gaps = 43/287 (14%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVA---WNQVRLNELMRSPDDLQRLYSEVHLLSTLK- 87
F +++G+G+ TV A ++ E A ++ +L + + + E +L+ L
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKY----VKIEKEVLTRLNG 60
Query: 88 HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYL 147
H II+ Y ++ D++ F+ E +G L +Y +KY +D + + +A +IL L YL
Sbjct: 61 HPGIIKLYYTF--QDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYL 118
Query: 148 HSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH---------------- 191
HS+ +IHRDLK +NI ++ +KI D G A +L + S
Sbjct: 119 HSKG--IIHRDLKPENILLD-KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 192 -----SVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKV 245
S +GT E+++PEL E + D+++ G + +M T + P+ +N ++K+
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR-GSNEYLTFQKI 234
Query: 246 TSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAK----ELLLDPF 287
+ F +A+ I + LV + RL EL PF
Sbjct: 235 LKLEYS--FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 81/265 (30%), Positives = 133/265 (50%), Gaps = 26/265 (9%)
Query: 35 VLGKGAM--KTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSII 92
VLGKGA T+Y+ ++ V W +V L L S + + +E+ +LS L+H +II
Sbjct: 7 VLGKGAFGEATLYRRTED--DSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNII 62
Query: 93 RFYTSWIDVDQKTFNFITEMFTSGTLRE--YRKKYRRVDIRAIKSWARQILQGLVYLHSR 150
+Y ++ D T E GTL + R+K + + + + QI+ + Y+H
Sbjct: 63 AYYNHFM--DDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 151 DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS-AHSVIGTPEFMAPELYE-ED 208
++HRD+K NIF+ G +K+GD G++ IL S A +V+GTP +M+PEL +
Sbjct: 121 G--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK 177
Query: 209 YNELVDVYSFGMCVL-EMFTCEYPYSECANPAQIYKKVTSGK---LPGAFYSIQDLEAQR 264
YN D+++ G CVL E+ T + + + NP + K+ G + + S E
Sbjct: 178 YNFKSDIWALG-CVLYELLTLKRTF-DATNPLNLVVKIVQGNYTPVVSVYSS----ELIS 231
Query: 265 FIGRCL-VNASKRLSAKELLLDPFL 288
+ L + KR +A E+L P L
Sbjct: 232 LVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 26/232 (11%)
Query: 34 EVLGKGAMKTVYKAI--DEVLG-VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDS 90
+ LG+GA VYK + EVA ++ + S ++ + E ++ L H +
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA---SEEERKDFLKEARVMKKLGHPN 57
Query: 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK---------SWARQIL 141
++R ++ + + E G L +Y +K R V K S+A QI
Sbjct: 58 VVRLL-GVCTEEEPLY-LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 142 QGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPE--- 198
+G+ YL S+ +HRDL N V L VKI D GL+ + G
Sbjct: 116 KGMEYLASK--KFVHRDLAARNCLVGEDL-VVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
Query: 199 FMAPE-LYEEDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSG 248
+MAPE L + + DV+SFG+ + E+FT PY +N ++ + + G
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-EEVLEYLRKG 223
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 66/270 (24%), Positives = 126/270 (46%), Gaps = 25/270 (9%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95
+ KGA V+ A + G A ++ +++R + + ++ +E +LS + +++ Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRK-NQVDQVLTERDILSQAQSPYVVKLY 59
Query: 96 TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVI 155
S+ K + E G L + +D + + +I+ L YLHS +I
Sbjct: 60 YSFQGK--KNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--II 115
Query: 156 HRDLKCDNIFVNGHLGQVKIGDLGLA---------AILRGSKSAHSVIGTPEFMAPE-LY 205
HRDLK DNI ++ + G +K+ D GL+ + K ++GTP+++APE +
Sbjct: 116 HRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 206 EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL--EAQ 263
+ +++ VD +S G + E P+ P +I++ + +GK+ + ++ EA
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIE--WPEDVEVSDEAI 231
Query: 264 RFIGRCL-VNASKRL---SAKELLLDPFLA 289
I + L + KRL S +E+ PF
Sbjct: 232 DLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 81/288 (28%), Positives = 136/288 (47%), Gaps = 38/288 (13%)
Query: 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLL 83
DP G + L E V+G+G VYKA + G VA +++ +++ D+ + + E ++L
Sbjct: 3 DPTGIFELVE-VIGEGTYGKVYKARHKKTGQLVA---IKIMDII--EDEEEEIKEEYNIL 56
Query: 84 STL-KHDSIIRFYTSWI----DVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSW-- 136
H +I FY ++I + + E+ G++ + K R+ R + W
Sbjct: 57 RKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA 116
Query: 137 --ARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA-HSV 193
R+ L+GL YLH VIHRD+K NI + +VK+ D G++A L + ++
Sbjct: 117 YILRETLRGLAYLHENK--VIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTF 173
Query: 194 IGTPEFMAPEL------YEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS 247
IGTP +MAPE+ + Y+ DV+S G+ +E+ + P + +P + K+
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD-MHPMRALFKIPR 232
Query: 248 GKLPG----AFYS--IQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288
P +S D FI CL+ N +R +ELL PF+
Sbjct: 233 NPPPTLKSPENWSKKFND-----FISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 13/210 (6%)
Query: 74 QRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAI 133
+ + +E +L L H ++ + S+ D ++ + + ++ G LR + + + +
Sbjct: 45 RNVLNERRILQELNHPFLVNLWYSFQD-EENMY-LVVDLLLGGDLRYHLSQKVKFSEEQV 102
Query: 134 KSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSV 193
K W +I+ L YLHS+ +IHRD+K DNI ++ G V I D +A + S
Sbjct: 103 KFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQ-GHVHITDFNIATKVTPDTLTTST 159
Query: 194 IGTPEFMAPELY-EEDYNELVDVYSFGMCVLEMFTCEYPY---SECANPAQIYKKVTSGK 249
GTP +MAPE+ + Y+ VD +S G+ E + PY S K+ T+
Sbjct: 160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADV 219
Query: 250 LPGAFYSIQDLEAQRFIGRCL-VNASKRLS 278
L + + EA I + L + KRL
Sbjct: 220 L---YPATWSTEAIDAINKLLERDPQKRLG 246
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 2e-23
Identities = 63/246 (25%), Positives = 110/246 (44%), Gaps = 11/246 (4%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQR-LYSEVHLLSTLKHDSIIRF 94
LG G V + A V+ ++ + Q ++SE +L H I++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVET--GQQEHIFSEKEILEECNHPFIVKL 58
Query: 95 YTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPV 154
Y ++ D+K + E G L + D + + ++ YLH+R +
Sbjct: 59 YRTF--KDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--I 114
Query: 155 IHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELV 213
I+RDLK +N+ ++ G VK+ D G A L+ + + GTPE++APE+ + Y+ V
Sbjct: 115 IYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSV 173
Query: 214 DVYSFGMCVLEMFTCEYPYSECA-NPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGR-CLV 271
D +S G+ + E+ T P+ E +P +IY + G F + D A+ I +
Sbjct: 174 DYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR 233
Query: 272 NASKRL 277
N +RL
Sbjct: 234 NPEERL 239
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 4e-23
Identities = 64/204 (31%), Positives = 110/204 (53%), Gaps = 16/204 (7%)
Query: 78 SEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWA 137
+E +L +++H ++ Y S+ D D + + E G L + +K R + +A
Sbjct: 50 NEKRILQSIRHPFLVNLYGSFQD-DSNLY-LVMEYVPGGELFSHLRKSGRFPEPVARFYA 107
Query: 138 RQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTP 197
Q++ L YLHS D +++RDLK +N+ + G +KI D G A ++G +++ GTP
Sbjct: 108 AQVVLALEYLHSLD--IVYRDLKPENLLL-DSDGYIKITDFGFAKRVKGR--TYTLCGTP 162
Query: 198 EFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQIYKKVTSGKLPGAF 254
E++APE + + Y + VD ++ G+ + EM YP + + NP QIY+K+ GK+ F
Sbjct: 163 EYLAPEIILSKGYGKAVDWWALGILIYEML-AGYPPFFDD--NPIQIYEKILEGKV--RF 217
Query: 255 YSIQDLEAQRFIGRCL-VNASKRL 277
S +A+ I L V+ +KRL
Sbjct: 218 PSFFSPDAKDLIRNLLQVDLTKRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-22
Identities = 77/259 (29%), Positives = 131/259 (50%), Gaps = 17/259 (6%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95
+G+G+ V A + G VA ++ L + R + L++EV ++ +H++++ Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRR----ELLFNEVVIMRDYQHENVVEMY 83
Query: 96 TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVI 155
S++ D+ + E G L + + R++ I + +L+ L LH++ VI
Sbjct: 84 NSYLVGDE--LWVVMEFLEGGALTDI-VTHTRMNEEQIAAVCLAVLKALSVLHAQG--VI 138
Query: 156 HRDLKCDNIFVNGHLGQVKIGDLGLAA-ILRGSKSAHSVIGTPEFMAPELYEE-DYNELV 213
HRD+K D+I + H G+VK+ D G A + + S++GTP +MAPEL Y V
Sbjct: 139 HRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 214 DVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA--QRFIGRCLV 271
D++S G+ V+EM E PY P K+ LP ++ + + F+ R LV
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFN--EPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255
Query: 272 -NASKRLSAKELLLDPFLA 289
+ ++R +A ELL PFLA
Sbjct: 256 RDPAQRATAAELLKHPFLA 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 74/279 (26%), Positives = 135/279 (48%), Gaps = 32/279 (11%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSP-DDLQR-LYSEVHLLSTLKHDSIIR 93
LG+GA +V K + G+ A L + P DLQ+ + E+ + + K I++
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFA-----LKTITTDPNPDLQKQILRELEINKSCKSPYIVK 63
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTL----REYRKKYRRVDIRAIKSWARQILQGLVYLHS 149
+Y +++D + E G+L ++ +K+ R+ + + A +L+GL YLHS
Sbjct: 64 YYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS 123
Query: 150 RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE-LYEED 208
R +IHRD+K NI + GQVK+ D G++ L + A + GT +MAPE + +
Sbjct: 124 RK--IIHRDIKPSNILLTRK-GQVKLCDFGVSGEL-VNSLAGTFTGTSFYMAPERIQGKP 179
Query: 209 YNELVDVYSFGMCVLEMFTCEYPY----SECANPAQIYKKVTSGKLP--------GAFYS 256
Y+ DV+S G+ +LE+ +P+ P ++ + + P G +S
Sbjct: 180 YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWS 239
Query: 257 IQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVK 294
E + FI +CL + ++R + ++L P++ + K
Sbjct: 240 ---EEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 8e-22
Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRL-NELMRSPDDLQRLYSEVHLLSTLKHDSIIRF 94
+G+G VYKA ++ G VA ++R+ NE P R E+ LL L+H +I+R
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR---EIKLLQKLRHPNIVRL 63
Query: 95 YTSWIDVDQKTFNFITEMFT---SGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRD 151
+ + + E +G L K+ IK + +Q+L+GL YLHS
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKF---TESQIKCYMKQLLEGLQYLHSNG 120
Query: 152 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA---HSVIGTPEFMAPELY--E 206
++HRD+K NI +N G +K+ D GLA SA + VI T + PEL
Sbjct: 121 --ILHRDIKGSNILINND-GVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGA 176
Query: 207 EDYNELVDVYSFGMCVLEMFT 227
Y VD++S G + E+F
Sbjct: 177 TRYGPEVDMWSVGCILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 73/263 (27%), Positives = 129/263 (49%), Gaps = 19/263 (7%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
+ +G+G+ +Y A + ++ L ++ + + EV LL+ +KH +I+
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK--KEVILLAKMKHPNIVT 63
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIR--AIKSWARQILQGLVYLHSRD 151
F+ S+ + + + F + E G L + + R V I SW QI GL ++H R
Sbjct: 64 FFASFQE-NGRLF-IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK 121
Query: 152 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS-AHSVIGTPEFMAPELYE-EDY 209
++HRD+K NIF++ + K+GD G+A L S A++ +GTP +++PE+ + Y
Sbjct: 122 --ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPY 179
Query: 210 NELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL----PGAFYSIQDLEAQRF 265
N D++S G + E+ T ++P+ E N Q+ K+ G P ++ L +Q F
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPF-EGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLF 238
Query: 266 IGRCLVNASKRLSAKELLLDPFL 288
V+ R S +L PFL
Sbjct: 239 ----KVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 69/216 (31%), Positives = 107/216 (49%), Gaps = 13/216 (6%)
Query: 79 EVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDI---RAIKS 135
E LLS LKH +I+ + SW D + I F G ++ K ++ + +
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLY--IVMGFCEGGDLYHKLKEQKGKLLPENQVVE 106
Query: 136 WARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS-AHSVI 194
W QI L YLH + ++HRDLK N+F+ +K+GDLG+A +L A ++I
Sbjct: 107 WFVQIAMALQYLHEKH--ILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLI 163
Query: 195 GTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA 253
GTP +M+PEL+ + YN DV++ G CV EM T ++ ++ + +Y ++ GKLP
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY-RIIEGKLP-P 221
Query: 254 FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288
E I L KR S K +L P++
Sbjct: 222 MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 85/313 (27%), Positives = 127/313 (40%), Gaps = 69/313 (22%)
Query: 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
RY + +G GA V A+D+ G +VA +++ + D +R+ E+ LL L+
Sbjct: 1 RY-ELLKPIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDDLIDAKRILREIKLLRHLR 57
Query: 88 HDSIIRFYTSWIDVDQKTFN---FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGL 144
H++II + FN +TE+ + L + K + + I+ + QIL+GL
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGL 116
Query: 145 VYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFM---- 200
YLHS + VIHRDLK NI VN + +KI D GLA RG F+
Sbjct: 117 KYLHSAN--VIHRDLKPSNILVNSNC-DLKICDFGLA---RGVDPDED---EKGFLTEYV 167
Query: 201 ------APE--LYEEDYNELVDVYSFGMCVL-EMFT------------------------ 227
APE L Y + +D++S G C+ E+ T
Sbjct: 168 VTRWYRAPELLLSSSRYTKAIDIWSVG-CIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226
Query: 228 CEYPYSECANPA--------QIYKKVT-SGKLPGAFYSIQDLEAQRFIGRCLV-NASKRL 277
E + K S PGA EA + + LV + KR+
Sbjct: 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGA-----SPEAIDLLEKMLVFDPKKRI 281
Query: 278 SAKELLLDPFLAS 290
+A E L P+LA
Sbjct: 282 TADEALAHPYLAQ 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 5e-21
Identities = 83/285 (29%), Positives = 136/285 (47%), Gaps = 33/285 (11%)
Query: 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVH 81
+ DPN + + E LG GA VYKA ++ G A + +S ++L+ E+
Sbjct: 7 DLDPNEVWEIIGE-LGDGAFGKVYKAKNKETGALAAAKVIE----TKSEEELEDYMVEIE 61
Query: 82 LLSTLKHDSIIR----FYTS---WIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK 134
+L+T H I++ FY WI ++ F + E + I+ I
Sbjct: 62 ILATCNHPYIVKLLGAFYWDGKLWIMIE-----FCPGGAVDAIMLELDRGLTEPQIQVI- 115
Query: 135 SWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSKSAHSV 193
RQ+L+ L YLHS +IHRDLK N+ + G +K+ D G++A ++ + S
Sbjct: 116 --CRQMLEALQYLHSMK--IIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQRRDSF 170
Query: 194 IGTPEFMAPE------LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS 247
IGTP +MAPE + + Y+ D++S G+ ++EM E P+ E NP ++ K+
Sbjct: 171 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAK 229
Query: 248 GKLPGAFY-SIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLAS 290
+ P S +E + F+ L + R SA +LL PF++S
Sbjct: 230 SEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 9e-21
Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95
+G+G VYKA D++ G VA +++L S + E+ LL L H +II
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRF--ESEGIPKTALREIKLLKELNHPNII--- 61
Query: 96 TSWIDV--DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPP 153
+DV + + E + + + + R + IKS+ Q+LQGL + HS
Sbjct: 62 -KLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG-- 118
Query: 154 VIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS-VIGTPEFMAPELYEED--YN 210
++HRDLK +N+ +N G +K+ D GLA ++ + T + APEL D Y+
Sbjct: 119 ILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 211 ELVDVYSFGMCVL-EMFT 227
VD++S G C+ E+ +
Sbjct: 178 TPVDIWSVG-CIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 81/294 (27%), Positives = 133/294 (45%), Gaps = 35/294 (11%)
Query: 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLL 83
DP + E+ G G+ VY A D VA ++ + +S + Q + EV L
Sbjct: 12 DPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQDIIKEVRFL 69
Query: 84 STLKHDSIIRF-------YTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSW 136
L+H + I + +T+W+ ++ + S L ++K + V+I AI
Sbjct: 70 QQLRHPNTIEYKGCYLREHTAWLVMEYCLGS------ASDILEVHKKPLQEVEIAAICH- 122
Query: 137 ARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGT 196
LQGL YLHS + IHRD+K NI + G VK+ D G A+++ A+S +GT
Sbjct: 123 --GALQGLAYLHSHE--RIHRDIKAGNILLTEP-GTVKLADFGSASLV---SPANSFVGT 174
Query: 197 PEFMAPELY----EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG 252
P +MAPE+ E Y+ VDV+S G+ +E+ + P + +Y + P
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPT 233
Query: 253 AFYSIQDLEAQRFIGRCLVN-ASKRLSAKELLLDPFLASDE-----VKLLSKTK 300
+ + F+ CL R S++ELL F+ + + L+ +TK
Sbjct: 234 LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLIQRTK 287
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 74/258 (28%), Positives = 131/258 (50%), Gaps = 17/258 (6%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95
+G+G+ V A ++ G +VA ++ L + R + L++EV ++ H++++ Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR----ELLFNEVVIMRDYHHENVVDMY 85
Query: 96 TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVI 155
S++ D+ + E G L + + R++ I + +L+ L YLH++ VI
Sbjct: 86 NSYLVGDE--LWVVMEFLEGGALTDI-VTHTRMNEEQIATVCLSVLRALSYLHNQG--VI 140
Query: 156 HRDLKCDNIFVNGHLGQVKIGDLGLAA-ILRGSKSAHSVIGTPEFMAPELYEE-DYNELV 213
HRD+K D+I + G++K+ D G A + + S++GTP +MAPE+ Y V
Sbjct: 141 HRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 214 DVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA--QRFIGRCLV 271
D++S G+ V+EM E PY P Q +++ LP + + + F+ LV
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRD-NLPPRVKDSHKVSSVLRGFLDLMLV 257
Query: 272 -NASKRLSAKELLLDPFL 288
S+R +A+ELL PFL
Sbjct: 258 REPSQRATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 71/208 (34%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQR-LYSEVHLLSTL 86
RY + LG+G VYKA D+ G VA +++L E + D + E+ LL L
Sbjct: 1 RY-EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL 59
Query: 87 KHDSIIRFYTSWIDV-DQKTF-NFITEMFTSGTLREYRKKYRRVDIR----AIKSWARQI 140
KH +II +DV K+ N + E F L K + I IKS+
Sbjct: 60 KHPNIIGL----LDVFGHKSNINLVFE-FMETDL---EKVIKDKSIVLTPADIKSYMLMT 111
Query: 141 LQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---KSAHSVIGTP 197
L+GL YLHS ++HRDLK +N+ + G +K+ D GLA GS K H V+ T
Sbjct: 112 LRGLEYLHSNW--ILHRDLKPNNLLIASD-GVLKLADFGLARSF-GSPNRKMTHQVV-TR 166
Query: 198 EFMAPELY--EEDYNELVDVYSFGMCVL 223
+ APEL Y VD++S G C+
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVG-CIF 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 73/244 (29%), Positives = 125/244 (51%), Gaps = 13/244 (5%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95
+G G V+ D + A + + E++R + Q +++E +L + H IIR +
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQE-QHVHNEKRVLKEVSHPFIIRLF 67
Query: 96 TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVI 155
W + DQ+ + E G L Y + R +A +I+ L YLHS++ ++
Sbjct: 68 --WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IV 123
Query: 156 HRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE-LYEEDYNELVD 214
+RDLK +NI ++ G +K+ D G A LR ++ GTPE++APE + + +N+ VD
Sbjct: 124 YRDLKPENILLDKE-GHIKLTDFGFAKKLR--DRTWTLCGTPEYLAPEVIQSKGHNKAVD 180
Query: 215 VYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLVN-A 273
++ G+ + EM P+ + NP IY+K+ +GKL F DL A+ I + LV
Sbjct: 181 WWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKL--EFPRHLDLYAKDLIKKLLVVDR 237
Query: 274 SKRL 277
++RL
Sbjct: 238 TRRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 2e-20
Identities = 81/275 (29%), Positives = 129/275 (46%), Gaps = 32/275 (11%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR-- 93
LG GA VYKA ++ GV A + +S ++L+ E+ +L++ H +I++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVID----TKSEEELEDYMVEIDILASCDHPNIVKLL 68
Query: 94 --FYTS---WIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLH 148
FY WI ++ F + E + IR + +Q L+ L YLH
Sbjct: 69 DAFYYENNLWILIE-----FCAGGAVDAVMLELERPLTEPQIRVV---CKQTLEALNYLH 120
Query: 149 SRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSKSAHSVIGTPEFMAPELY-- 205
+ +IHRDLK NI G +K+ D G++A R + S IGTP +MAPE+
Sbjct: 121 --ENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 206 ----EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG-AFYSIQDL 260
+ Y+ DV+S G+ ++EM E P+ E NP ++ K+ + P A S
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLAQPSRWSS 236
Query: 261 EAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVK 294
E + F+ +CL N R + +LL PF+ + K
Sbjct: 237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNK 271
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 81/281 (28%), Positives = 142/281 (50%), Gaps = 15/281 (5%)
Query: 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLL 83
DP + E++ GKG+ V+K ID VA +++ +L + D+++ + E+ +L
Sbjct: 1 DPEELFTKLEKI-GKGSFGEVFKGIDNRTQKVVA---IKIIDLEEAEDEIEDIQQEITVL 56
Query: 84 STLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQG 143
S + ++Y S++ D K + I E G+ + + +D I + R+IL+G
Sbjct: 57 SQCDSPYVTKYYGSYLK-DTKLW-IIMEYLGGGSALDLLEP-GPLDETQIATILREILKG 113
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-SAHSVIGTPEFMAP 202
L YLHS IHRD+K N+ ++ H G+VK+ D G+A L ++ ++ +GTP +MAP
Sbjct: 114 LDYLHSEKK--IHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
Query: 203 ELYEED-YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLE 261
E+ ++ Y+ D++S G+ +E+ E P+SE +P ++ + P
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL-HPMKVLFLIPKNN-PPTLEGNYSKP 228
Query: 262 AQRFIGRCL-VNASKRLSAKELLLDPFLASDEVKLLSKTKL 301
+ F+ CL S R +AKELL F+ K T+L
Sbjct: 229 LKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKTSYLTEL 269
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 78/257 (30%), Positives = 131/257 (50%), Gaps = 15/257 (5%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95
+G+G+ V A ++ G +VA + L + R + L++EV ++ +H +++ Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRR----ELLFNEVVIMRDYQHQNVVEMY 84
Query: 96 TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVI 155
S++ V ++ + + E G L + + R ++ I + +LQ L YLHS+ VI
Sbjct: 85 KSYL-VGEELW-VLMEFLQGGALTDIVSQTR-LNEEQIATVCESVLQALCYLHSQG--VI 139
Query: 156 HRDLKCDNIFVNGHLGQVKIGDLGLAA-ILRGSKSAHSVIGTPEFMAPELYEED-YNELV 213
HRD+K D+I + G+VK+ D G A I + S++GTP +MAPE+ Y V
Sbjct: 140 HRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 214 DVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQR-FIGRCLV- 271
D++S G+ V+EM E PY +P Q K++ P + + R F+ R L
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTR 257
Query: 272 NASKRLSAKELLLDPFL 288
+R +A+ELL PFL
Sbjct: 258 EPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 60/179 (33%), Positives = 89/179 (49%), Gaps = 17/179 (9%)
Query: 121 YRKKY---RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGD 177
Y+K Y + + A I++ L YLHS+ VIHRD+K N+ +N GQVK+ D
Sbjct: 90 YKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK-LSVIHRDVKPSNVLIN-RNGQVKLCD 147
Query: 178 LGLAAILRGSKSAHSVIGTPEFMAPELYEED-----YNELVDVYSFGMCVLEMFTCEYPY 232
G++ L S + G +MAPE + Y+ DV+S G+ ++E+ T +PY
Sbjct: 148 FGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY 207
Query: 233 SECANPAQIYKKV---TSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPF 287
P Q K+V S +LP +S E Q F+ +CL N +R + ELL PF
Sbjct: 208 DSWKTPFQQLKQVVEEPSPQLPAEKFS---PEFQDFVNKCLKKNYKERPNYPELLQHPF 263
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 79/281 (28%), Positives = 135/281 (48%), Gaps = 34/281 (12%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
E +GKG+ V+K ID VA + L E + D+++ + E+ +LS + +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTK 66
Query: 94 FYTS-------WIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVY 146
+Y S WI ++ ++ +G E++ I + ++IL+GL Y
Sbjct: 67 YYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQ----------IATMLKEILKGLDY 116
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-SAHSVIGTPEFMAPELY 205
LHS IHRD+K N+ ++ G VK+ D G+A L ++ ++ +GTP +MAPE+
Sbjct: 117 LHSEKK--IHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 173
Query: 206 EED-YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIY---KKVTSGKLPGAFYSIQDLE 261
++ Y+ D++S G+ +E+ E P S+ +P ++ K L G F
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGEPPNSD-MHPMRVLFLIPKNNPPTLTGEFSK----P 228
Query: 262 AQRFIGRCL-VNASKRLSAKELLLDPFLASDEVKLLSKTKL 301
+ FI CL + S R +AKELL F+ + K T+L
Sbjct: 229 FKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTEL 269
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 17/215 (7%)
Query: 36 LGKGAMKTVYKAIDEVL----GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
LG+G V + L G +VA + + + D +R E+ +L TL H++I
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFER---EIEILRTLDHENI 68
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSR 150
+++ ++ I E SG+LR+Y +++R +++++ + ++ QI +G+ YL S+
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 151 DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF----MAPE-LY 205
IHRDL NI V VKI D GLA +L K + V E APE L
Sbjct: 129 R--YIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 206 EEDYNELVDVYSFGMCVLEMFT-CEYPYSECANPA 239
++ DV+SFG+ + E+FT + S A
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL 220
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 72/224 (32%), Positives = 118/224 (52%), Gaps = 23/224 (10%)
Query: 28 RYGLFEEVLGKGAMKTV----YKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLL 83
R+ F + LGKG +V Y + + G VA +++ + + + L+ E+ +L
Sbjct: 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEIL 59
Query: 84 STLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQ 142
+L+HD+I+++ ++ + E G+LR+Y +K+R R+D R + +A QI +
Sbjct: 60 KSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICK 119
Query: 143 GLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVI---GTPEF 199
G+ YL S+ +HRDL NI V +VKIGD GL +L K + V +P F
Sbjct: 120 GMEYLGSKR--YVHRDLATRNILVESE-NRVKIGDFGLTKVLPQDKEYYKVREPGESPIF 176
Query: 200 -MAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSE--CANPA 239
APE L E ++ DV+SFG+ + E+FT YS+ C+ PA
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFT----YSDKSCSPPA 216
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 81/268 (30%), Positives = 131/268 (48%), Gaps = 27/268 (10%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
++E+LG G TVYKA + +A V++ L + + +++ SE+ +L I
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILA---VKVIPLDITVELQKQIMSELEILYKCDSPYI 61
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRD 151
I FY ++ V+ + + TE G+L YRK V R A +++GL YL S
Sbjct: 62 IGFYGAFF-VENR-ISICTEFMDGGSLDVYRKIPEHVLGRI----AVAVVKGLTYLWSLK 115
Query: 152 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE-LYEEDYN 210
++HRD+K N+ VN GQVK+ D G++ L S A + +GT +MAPE + E Y
Sbjct: 116 --ILHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGEQYG 171
Query: 211 ELVDVYSFGMCVLEMFTCEYPYSECAN------PAQIYKKVT---SGKLPGAFYSIQDLE 261
DV+S G+ +E+ +PY + P Q+ + + LP +S + +
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH 231
Query: 262 AQRFIGRCLVNASKRLSAKELLLD-PFL 288
FI +C+ K A E L+D PF+
Sbjct: 232 ---FITQCMRKQPKERPAPENLMDHPFI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 35 VLGKGAMKTVYKAIDEVLG----VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDS 90
VLG GA TVYK + G + VA +R SP + + E ++++++ H
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVDHPH 70
Query: 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHS 149
++R + IT++ G L +Y + ++ + + + +W QI +G+ YL
Sbjct: 71 VVRLLGICL---SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE 127
Query: 150 RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-RGSKSAHSVIG-TP-EFMAPE-LY 205
+ ++HRDL N+ V VKI D GLA +L K H+ G P ++MA E +
Sbjct: 128 KR--LVHRDLAARNVLVKTP-QHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 206 EEDYNELVDVYSFGMCVLEMFT 227
Y DV+S+G+ V E+ T
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 5e-18
Identities = 75/277 (27%), Positives = 126/277 (45%), Gaps = 38/277 (13%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95
LGKG +VYK + GV +A ++RL EL S ++ E+ +L I+ FY
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRL-ELDES--KFNQIIMELDILHKAVSPYIVDFY 65
Query: 96 TSWIDVDQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQILQGLVYLHSRDP 152
++ ++ + E +G+L + + ++ +++GL +L +
Sbjct: 66 GAFF-IEGAVY-MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL-KEEH 122
Query: 153 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYEED---- 208
+IHRD+K N+ VNG+ GQVK+ D G++ L S A + IG +MAPE +
Sbjct: 123 NIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 209 ---YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG----------KLPGAFY 255
Y DV+S G+ +LEM YPY P + Y + + LP +
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYPY-----PPETYANIFAQLSAIVDGDPPTLPSGYS 235
Query: 256 SIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASD 291
+AQ F+ +CL ++R + +LL P+L
Sbjct: 236 D----DAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 62/206 (30%), Positives = 106/206 (51%), Gaps = 19/206 (9%)
Query: 35 VLGKGAMKTV----YKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHD 89
VLGKG+ V K DE+ V+V V L + DD++ +E +L+ KH
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQD-----DDVECTMTEKRVLALAGKHP 56
Query: 90 SIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHS 149
+ + ++ + D+ F+ E G L + ++ R D + +A +I+ GL +LH
Sbjct: 57 FLTQLHSCFQTKDR--LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE 114
Query: 150 RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA--AILRGSKSAHSVIGTPEFMAPE-LYE 206
R +I+RDLK DN+ ++ G +KI D G+ IL G ++ + GTP+++APE L
Sbjct: 115 RG--IIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTS-TFCGTPDYIAPEILSY 170
Query: 207 EDYNELVDVYSFGMCVLEMFTCEYPY 232
+ Y VD ++ G+ + EM + P+
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 5e-18
Identities = 75/259 (28%), Positives = 129/259 (49%), Gaps = 16/259 (6%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
E +GKG+ VYK ID VA +++ +L + D+++ + E+ +LS I R
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVA---IKIIDLEEAEDEIEDIQQEITVLSQCDSPYITR 66
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPP 153
+Y S++ + I E G+ + K ++ I + R+IL+GL YLHS
Sbjct: 67 YYGSYLKGTK--LWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERK- 122
Query: 154 VIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-SAHSVIGTPEFMAPELYEED-YNE 211
IHRD+K N+ ++ G VK+ D G+A L ++ ++ +GTP +MAPE+ ++ Y+
Sbjct: 123 -IHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180
Query: 212 LVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV 271
D++S G+ +E+ E P S+ +P ++ + P + F+ CL
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNS-PPTLEGQYSKPFKEFVEACL- 237
Query: 272 NASKRL--SAKELLLDPFL 288
N R +AKELL F+
Sbjct: 238 NKDPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 9e-18
Identities = 80/294 (27%), Positives = 125/294 (42%), Gaps = 54/294 (18%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSII 92
+ LG G +VY A ++ G VA ++ + S ++ L EV L L H +I+
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIK--KMKKKFYSWEECMNL-REVKSLRKLNEHPNIV 61
Query: 93 RFYTSWIDV--DQKTFNFITEMFTSGTLREY--RKKYRRVDIRAIKSWARQILQGLVYLH 148
+ +V + F+ E + G L + +K + I+S QILQGL ++H
Sbjct: 62 KLK----EVFRENDELYFVFE-YMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 149 SRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE--LYE 206
HRDLK +N+ V+G VKI D GLA +R + T + APE L
Sbjct: 117 KHG--FFHRDLKPENLLVSGP-EVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 207 EDYNELVDVYSFGMCVL-EMFTCE--YP-YSECANPAQIYKKVT---------------- 246
Y+ VD+++ G C++ E++T +P SE Q+YK +
Sbjct: 174 TSYSSPVDIWALG-CIMAELYTLRPLFPGSSEI---DQLYKICSVLGTPTKQDWPEGYKL 229
Query: 247 SGKL-----PGAFYSIQDL------EAQRFIGRCLV-NASKRLSAKELLLDPFL 288
+ KL A S+ L EA I L + KR +A + L P+
Sbjct: 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.6 bits (211), Expect = 1e-17
Identities = 60/206 (29%), Positives = 108/206 (52%), Gaps = 29/206 (14%)
Query: 75 RLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTL-REYRKKYR---RVDI 130
+L EV+++ LKH +I+R+ +++ + + E +G L R +K Y+ +++
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117
Query: 131 RAIKSWARQILQGLVYLHS-RDPP----VIHRDLKCDNIFVNG---HLGQV--------- 173
AI RQ+L L Y H+ +D P V+HRDLK NIF++ H+G++
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 174 ----KIGDLGLAAILRGSKSAHSVIGTPEFMAPELY---EEDYNELVDVYSFGMCVLEMF 226
KIGD GL+ + AHS +GTP + +PEL + Y++ D+++ G + E+
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 227 TCEYPYSECANPAQIYKKVTSG-KLP 251
+ + P+ + N +Q+ ++ G LP
Sbjct: 238 SGKTPFHKANNFSQLISELKRGPDLP 263
|
Length = 1021 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 74/282 (26%), Positives = 135/282 (47%), Gaps = 27/282 (9%)
Query: 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLL 83
DP + + E + GKG VYK ++ G A V++ + + D + + +E ++L
Sbjct: 19 DPTDTWEIIETI-GKGTYGKVYKVTNKKDGSLAA---VKILDPISDVD--EEIEAEYNIL 72
Query: 84 STL-KHDSIIRFYTSWIDVDQKT---FNFITEMFTSGTLREYRKKY----RRVDIRAIKS 135
+L H ++++FY + D+ + E+ G++ E K +R+D I
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 136 WARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-SAHSVI 194
L GL +LH+ +IHRD+K +NI + G VK+ D G++A L ++ ++ +
Sbjct: 133 ILYGALLGLQHLHNNR--IIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSV 189
Query: 195 GTPEFMAPEL------YEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG 248
GTP +MAPE+ Y+ Y+ DV+S G+ +E+ + P + +P + K+
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD-MHPVKTLFKIPRN 248
Query: 249 KLPGAFYSIQDLEA-QRFIGRCLV-NASKRLSAKELLLDPFL 288
P + + + FI +CL+ + R S LL PF+
Sbjct: 249 PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 74/297 (24%), Positives = 140/297 (47%), Gaps = 38/297 (12%)
Query: 34 EVLGKGAMKTVY----KAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLS-TLKH 88
++LGKG+ V+ K ++ ++ V L + DD++ E +LS +H
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMD-----DDVECTMVEKRVLSLAWEH 55
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLH 148
+ Y ++ ++ F+ E G L + + + D+ +A +I+ GL +LH
Sbjct: 56 PFLTHLYCTF--QTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH 113
Query: 149 SRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA-ILRGSKSAHSVIGTPEFMAPE-LYE 206
S+ +++RDLK DNI ++ G +KI D G+ + G + GTP+++APE L
Sbjct: 114 SKG--IVYRDLKLDNILLDTD-GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170
Query: 207 EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFI 266
+ YN VD +SFG+ + EM + P+ + ++++ + ++ Y R++
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPF-HGHDEEELFQSI---RMDNPCYP-------RWL 219
Query: 267 GRCLVNASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNETELEKLQLSD-DPP 322
R AK++L+ F+ E +L K + Q PF E + L+ + +PP
Sbjct: 220 TR---------EAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWSALEEREIEPP 267
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 74/267 (27%), Positives = 122/267 (45%), Gaps = 29/267 (10%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQR--LYSEVHLLSTLKHDSIIR 93
+G GA TVYK I G A L + + +D R + E+ +L + H ++++
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYA-----LKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 94 FYTSWIDVDQK-TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDP 152
+ + D + E G+L + D + + ARQIL G+ YLH R
Sbjct: 137 CHDMF---DHNGEIQVLLEFMDGGSL----EGTHIADEQFLADVARQILSGIAYLHRRH- 188
Query: 153 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-KSAHSVIGTPEFMAPELYEEDYNE 211
++HRD+K N+ +N VKI D G++ IL + +S +GT +M+PE D N
Sbjct: 189 -IVHRDIKPSNLLINSA-KNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNH 246
Query: 212 LV------DVYSFGMCVLEMFTCEYPY--SECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263
D++S G+ +LE + +P+ + A + + + P A + E +
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR-EFR 305
Query: 264 RFIGRCLV-NASKRLSAKELLLDPFLA 289
FI CL +KR SA +LL PF+
Sbjct: 306 HFISCCLQREPAKRWSAMQLLQHPFIL 332
|
Length = 353 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 69/208 (33%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRL-NELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
+G+G VYKA D+ G VA +VRL NE P R E+ +L L H +I+
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR---EIKILRQLNHRNIVN 70
Query: 94 FYTSWID--------VDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLV 145
D D+ F + E + IKS+ +Q+L+GL
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLN 130
Query: 146 YLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS---AHSVIGTPEFMAP 202
Y H ++ +HRD+KC NI +N GQ+K+ D GLA + +S + VI T + P
Sbjct: 131 YCHKKN--FLHRDIKCSNILLNNK-GQIKLADFGLARLYNSEESRPYTNKVI-TLWYRPP 186
Query: 203 ELY--EEDYNELVDVYSFGMCVL-EMFT 227
EL EE Y +DV+S G C+L E+FT
Sbjct: 187 ELLLGEERYGPAIDVWSCG-CILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-17
Identities = 64/228 (28%), Positives = 109/228 (47%), Gaps = 18/228 (7%)
Query: 69 SPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRV 128
SP + + EV +LS +KH +I+++ S+ + + + G L + R V
Sbjct: 39 SPKEREESRKEVAVLSNMKHPNIVQYQESF--EENGNLYIVMDYCEGGDLYKKINAQRGV 96
Query: 129 DI--RAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186
I W QI L ++H R ++HRD+K NIF+ G +K+GD G+A +L
Sbjct: 97 LFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNS 153
Query: 187 S-KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKK 244
+ + A + IGTP +++PE+ E YN D+++ G + EM T ++ + E N + K
Sbjct: 154 TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF-EAGNMKNLVLK 212
Query: 245 VTSGKLPGA----FYSIQDLEAQRFIGRCLVNASKRLSAKELLLDPFL 288
+ G P Y +++L +Q F N R S +L F+
Sbjct: 213 IIRGSYPPVSSHYSYDLRNLVSQLF----KRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 15/213 (7%)
Query: 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLL 83
+P Y L + V G G VYKA + G A ++L DD + E+ ++
Sbjct: 6 NPQHDYELIQRV-GSGTYGDVYKARNLHTGELAAVKIIKLEP----GDDFSLIQQEIFMV 60
Query: 84 STLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQG 143
KH +I+ ++ S++ ++ E G+L++ + I R+ LQG
Sbjct: 61 KECKHCNIVAYFGSYLS--REKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQG 118
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH-SVIGTPEFMAP 202
L YLHS+ +HRD+K NI + + G VK+ D G+AA + + + S IGTP +MAP
Sbjct: 119 LAYLHSKGK--MHRDIKGANILLTDN-GDVKLADFGVAAKITATIAKRKSFIGTPYWMAP 175
Query: 203 ELYEED----YNELVDVYSFGMCVLEMFTCEYP 231
E+ + YN+L D+++ G+ +E+ + P
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 5e-17
Identities = 55/237 (23%), Positives = 115/237 (48%), Gaps = 24/237 (10%)
Query: 74 QRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAI 133
+++ E+ ++ + I+ FY ++++ + E G+L KK + + +
Sbjct: 48 KQILRELQIMHECRSPYIVSFYGAFLN--ENNICMCMEFMDCGSLDRIYKKGGPIPVEIL 105
Query: 134 KSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSV 193
A +++GL YL++ ++HRD+K NI VN GQ+K+ D G++ L S A +
Sbjct: 106 GKIAVAVVEGLTYLYNVHR-IMHRDIKPSNILVNSR-GQIKLCDFGVSGELINS-IADTF 162
Query: 194 IGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSE-------CANPAQIYKKV 245
+GT +M+PE + Y DV+S G+ ++E+ ++P++ +P I +
Sbjct: 163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL 222
Query: 246 ------TSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELL-LDPFLASDEVK 294
+LP + + +DL F+ CL+ + ++R + ++L + PF+ +
Sbjct: 223 QQIVQEPPPRLPSSDFP-EDLR--DFVDACLLKDPTERPTPQQLCAMPPFIQALRAS 276
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 77/298 (25%), Positives = 131/298 (43%), Gaps = 42/298 (14%)
Query: 35 VLGKGAMKTVY----KAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLS-TLKHD 89
VLGKG+ V K +E ++ V L + DD++ E +L+ +H
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED-----DDVECTMVERRVLALAWEHP 56
Query: 90 SIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHS 149
+ + ++ + F F+ E G L + + R D + +A +I+ GL +LH
Sbjct: 57 FLTHLFCTF-QTKEHLF-FVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK 114
Query: 150 RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSKSAHSVIGTPEFMAPELYE-E 207
+ +I+RDLK DN+ ++ G +KI D G+ + G A + GTP+++APE+ + +
Sbjct: 115 KG--IIYRDLKLDNVLLDKD-GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ 171
Query: 208 DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIG 267
YNE VD +SFG+ + EM + P+ F SI L +
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-------------LFDSI--LNDRPHFP 216
Query: 268 RCLVNASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPF---LNETELEKLQLSDDPP 322
R + +K +K DP +L + Q PF ++ LEK ++ PP
Sbjct: 217 RWISKEAKDCLSKLFERDP-----TKRLGVDGDIRQHPFFRGIDWERLEKREI--PPP 267
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 68/222 (30%), Positives = 114/222 (51%), Gaps = 38/222 (17%)
Query: 20 YIETDPNGRYGLFEEVLGKGAMKTVYKAID----EVLGVE-VAWNQVRLNELMRSPDDLQ 74
+ + DP + E+ G G+ VY A D EV+ ++ ++++ + NE Q
Sbjct: 8 FFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE------KWQ 60
Query: 75 RLYSEVHLLSTLKHDSIIRF-------YTSWIDVDQKTFNFITEMFTSGTLREYRKKYRR 127
+ EV L L+H + I++ +T+W+ ++ + S L ++K +
Sbjct: 61 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGS------ASDLLEVHKKPLQE 114
Query: 128 VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187
V+I A+ A LQGL YLHS + +IHRD+K NI ++ G VK+GD G A+I+
Sbjct: 115 VEIAAVTHGA---LQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIM--- 165
Query: 188 KSAHSVIGTPEFMAPELY----EEDYNELVDVYSFGMCVLEM 225
A+ +GTP +MAPE+ E Y+ VDV+S G+ +E+
Sbjct: 166 APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 12/193 (6%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95
+G GA V A D++ G VA ++ + +P +R Y E+ LL L+H++II
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIK--KIMKPFSTPVLAKRTYRELKLLKHLRHENIISLS 75
Query: 96 TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVI 155
+I + + F+TE+ GT R ++ + I+ + QIL+GL Y+HS V+
Sbjct: 76 DIFISPLEDIY-FVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG--VV 130
Query: 156 HRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE--LYEEDYNELV 213
HRDLK NI +N + +KI D GLA I + + + T + APE L + Y+ V
Sbjct: 131 HRDLKPSNILINENC-DLKICDFGLARIQDPQMTGY--VSTRYYRAPEIMLTWQKYDVEV 187
Query: 214 DVYSFGMCVLEMF 226
D++S G EM
Sbjct: 188 DIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 56/183 (30%), Positives = 93/183 (50%), Gaps = 13/183 (7%)
Query: 76 LYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR-RVDIRAIK 134
L E+ +L L H++I+++ + I E SG+L+EY + + +++++
Sbjct: 53 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQL 112
Query: 135 SWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSV- 193
+A QI +G+ YL SR +HRDL N+ V QVKIGD GL + K ++V
Sbjct: 113 KYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEYYTVK 169
Query: 194 --IGTPEF-MAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKV--TS 247
+ +P F APE L + + DV+SFG+ + E+ T Y SE + K + T
Sbjct: 170 DDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT--YCDSESSPMTLFLKMIGPTH 227
Query: 248 GKL 250
G++
Sbjct: 228 GQM 230
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
E LG+G TVYK + G VA ++ L+ +P R E+ L+ LKH++I+R
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR---EISLMKELKHENIVR 62
Query: 94 FYTSWIDVDQKTFNFITEMF--TSGTLREYRKKY---RRVDIRAIKSWARQILQGLVYLH 148
+ DV T N + +F L++Y + +D +KS+ Q+L+G+ + H
Sbjct: 63 LH----DVIH-TENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 149 SRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRGSKSAHSVIGTPEFMAPE--LY 205
+ V+HRDLK N+ +N G++K+ D GLA A + + + T + AP+ L
Sbjct: 118 --ENRVLHRDLKPQNLLINKR-GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLG 174
Query: 206 EEDYNELVDVYSFGMCVLEMFT 227
Y+ +D++S G + EM T
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 21/199 (10%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRS-PDDLQRLYSEVHLLSTLKHDSIIRF 94
+G+GA V+KA D G VA +V L L P+ R E+ L +H +++
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR---EIKALQACQHPYVVKL 64
Query: 95 YTSWIDVDQKTFNFITEM-FTSGTLREYRKKYRR-VDIRAIKSWARQILQGLVYLHSRDP 152
+DV F+ M + L E + R + +KS+ R +L+G+ Y+H+
Sbjct: 65 ----LDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG- 119
Query: 153 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS---AHSVIGTPEFMAPELY--EE 207
++HRDLK N+ ++ G +KI D GLA + + +H V T + APEL
Sbjct: 120 -IMHRDLKPANLLISAD-GVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGAR 176
Query: 208 DYNELVDVYSFGMCVL-EM 225
Y+ VD+++ G C+ E+
Sbjct: 177 KYDPGVDLWAVG-CIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 85/304 (27%), Positives = 126/304 (41%), Gaps = 64/304 (21%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
+G GA V A D G +VA +L+ +S +R Y E+ LL + H+++
Sbjct: 19 NLSPVGSGAYGQVCSAFDTKTGRKVAIK--KLSRPFQSAIHAKRTYRELRLLKHMDHENV 76
Query: 92 IRFYTSWIDV--------DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQG 143
I +DV D + +T L K + D I+ QIL+G
Sbjct: 77 I----GLLDVFTPASSLEDFQDVYLVTH-LMGADLNNIVKCQKLSDDH-IQFLVYQILRG 130
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE 203
L Y+HS +IHRDLK NI VN ++KI D GLA + + + T + APE
Sbjct: 131 LKYIHSAG--IIHRDLKPSNIAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPE 185
Query: 204 --LYEEDYNELVDVYSFGMCVL-EMFTCE--YPYSE-----------CANP--------- 238
L YN+ VD++S G C++ E+ T + +P S+ P
Sbjct: 186 IMLNWMHYNQTVDIWSVG-CIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244
Query: 239 ---AQIY--------KKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDP 286
A+ Y KK GA DL + + LV + KR++A E L P
Sbjct: 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDL-----LEKMLVLDPDKRITAAEALAHP 299
Query: 287 FLAS 290
+LA
Sbjct: 300 YLAE 303
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 74/288 (25%), Positives = 135/288 (46%), Gaps = 30/288 (10%)
Query: 34 EVLGKGAMKTVY----KAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLS-TLKH 88
VLGKG+ V K + V+V V L + DD++ +E +LS H
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD-----DDVECTMTEKRILSLARNH 55
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLH 148
+ + Y + D+ F+ E G L + +K RR D + +A +I L++LH
Sbjct: 56 PFLTQLYCCFQTPDR--LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH 113
Query: 149 SRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSKSAHSVIGTPEFMAPE-LYE 206
+ +I+RDLK DN+ ++ H G K+ D G+ + K+ + GTP+++APE L E
Sbjct: 114 DKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE 170
Query: 207 EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA--QR 264
Y VD ++ G+ + EM P+ E N +++ + + ++ + QD +
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLSQDAVDILKA 229
Query: 265 FIGRCLVNASKRLSA------KELLLDPFLASDEVKLLSKTKLNQKPF 306
F+ + N + RL + + +L PF + + L++ ++ + PF
Sbjct: 230 FMTK---NPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQI-EPPF 273
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 88/304 (28%), Positives = 144/304 (47%), Gaps = 47/304 (15%)
Query: 20 YIETDPNGRY-GLFEEVLGKGAMKTVYKAID----EVLGVE-VAWNQVRLNELMRSPDDL 73
+ + DP + GL E +G G+ VY A + EV+ V+ ++++ + NE
Sbjct: 14 FYKDDPEEIFVGLHE--IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE------KW 65
Query: 74 QRLYSEVHLLSTLKHDSIIRF-------YTSWIDVDQKTFNFITEMFTSGTLREYRKKYR 126
Q + EV L LKH + I + +T+W+ V + +++ L ++K +
Sbjct: 66 QDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL-VMEYCLGSASDL-----LEVHKKPLQ 119
Query: 127 RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186
V+I AI A LQGL YLHS + +IHRD+K NI + GQVK+ D G A+
Sbjct: 120 EVEIAAITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASK--- 170
Query: 187 SKSAHSVIGTPEFMAPELY----EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIY 242
S A+S +GTP +MAPE+ E Y+ VDV+S G+ +E+ + P + +Y
Sbjct: 171 SSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 230
Query: 243 KKVTSGKLPGAFYSIQDLEAQRFIGRCLVN-ASKRLSAKELLLDPFLASDE-----VKLL 296
+ P + + F+ CL +R ++ ELL F+ D + L+
Sbjct: 231 -HIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLI 289
Query: 297 SKTK 300
+TK
Sbjct: 290 QRTK 293
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 83/304 (27%), Positives = 125/304 (41%), Gaps = 64/304 (21%)
Query: 32 FEEV--LGKGAMKTVYKAIDEVLGVEVAWNQVR--LNE------------LMRSPDDLQ- 74
+EE+ +G+GA TVYKA D G VA +VR L+E L++ + +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 75 ----RLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDI 130
RL H T D ++ + VDQ ++++ G +
Sbjct: 61 PNIVRLLDVCHGPRT---DRELKLTLVFEHVDQDLATYLSKCPKPG-----------LPP 106
Query: 131 RAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA 190
IK RQ+L+G+ +LHS ++HRDLK NI V GQVKI D GLA I +
Sbjct: 107 ETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSD-GQVKIADFGLARIYSFEMAL 163
Query: 191 HSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCE---YPYSECANPAQIYKK-- 244
SV+ T + APE L + Y VD++S G E+F SE +I+
Sbjct: 164 TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIG 223
Query: 245 --------VTSGKLPGAFYS---------IQDLEAQ--RFIGRCLV-NASKRLSAKELLL 284
+F S + ++ + + + L N KR+SA E L
Sbjct: 224 LPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283
Query: 285 DPFL 288
P+
Sbjct: 284 HPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 6e-16
Identities = 71/272 (26%), Positives = 125/272 (45%), Gaps = 18/272 (6%)
Query: 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLL 83
+P + L + + G G VYKA + G A ++L +D + E+ ++
Sbjct: 6 NPQEDFELIQRI-GSGTYGDVYKARNVNTGELAAIKVIKL----EPGEDFAVVQQEIIMM 60
Query: 84 STLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQG 143
KH +I+ ++ S++ D+ E G+L++ + I +R+ LQG
Sbjct: 61 KDCKHSNIVAYFGSYLRRDKLWICM--EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQG 118
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH-SVIGTPEFMAP 202
L YLHS+ +HRD+K NI + + G VK+ D G++A + + + S IGTP +MAP
Sbjct: 119 LYYLHSKGK--MHRDIKGANILLTDN-GHVKLADFGVSAQITATIAKRKSFIGTPYWMAP 175
Query: 203 ELYEED----YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258
E+ + YN+L D+++ G+ +E+ + P + ++ S P
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKM 235
Query: 259 DLEA--QRFIGRCLV-NASKRLSAKELLLDPF 287
F+ L N KR +A++LL PF
Sbjct: 236 KWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 6e-16
Identities = 69/217 (31%), Positives = 109/217 (50%), Gaps = 28/217 (12%)
Query: 20 YIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSE 79
+ + DP + E+ G G+ VY A D VA ++ + +S + Q + E
Sbjct: 18 FFKEDPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQDIIKE 75
Query: 80 VHLLSTLKHDSIIRF-------YTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRA 132
V L +KH + I + +T+W+ ++ + S L ++K + V+I A
Sbjct: 76 VKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGS------ASDLLEVHKKPLQEVEIAA 129
Query: 133 IKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS 192
I A LQGL YLHS + +IHRD+K NI + GQVK+ D G A+I + A+S
Sbjct: 130 ITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASI---ASPANS 180
Query: 193 VIGTPEFMAPELY----EEDYNELVDVYSFGMCVLEM 225
+GTP +MAPE+ E Y+ VDV+S G+ +E+
Sbjct: 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 7e-16
Identities = 79/294 (26%), Positives = 121/294 (41%), Gaps = 47/294 (15%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRL--NELMRSPDDLQRLYSEVHLLSTLKHDSI 91
E +G+G VYKA D+ G VA + RL +E P L+ E+ LL L
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR----EISLLQMLSESIY 62
Query: 92 IRFYTSWIDVDQKT--------FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQG 143
I V++K F ++ R R + + IKS+ Q+L+G
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL--AAILRGSKSAHSVIGTPEFMA 201
+ + H V+HRDLK N+ V+ G +KI DLGL A + H ++ T + A
Sbjct: 123 VAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYRA 179
Query: 202 PE--LYEEDYNELVDVYSFGMCVLEMFTCEYPY---SECANPAQIYKKV---TSGKLPGA 253
PE L Y+ VD++S G EM + + SE I+K + T PG
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239
Query: 254 F-----------------YSIQDLEAQ--RFIGRCLV-NASKRLSAKELLLDPF 287
++ DL + + + L + +KR+SAK L P+
Sbjct: 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 7e-16
Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 23/224 (10%)
Query: 34 EVLGKGAMKTVYKAI-DEVLG--VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDS 90
+ LG G+ V + G + VA ++ ++L DD + E ++ +L H++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLK---EAAIMHSLDHEN 57
Query: 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRR--VDIRAIKSWARQILQGLVYLH 148
+IR Y V +TE+ G+L + +K I + +A QI G+ YL
Sbjct: 58 LIRLYGV---VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114
Query: 149 SRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-----SAHSVIGTPEFMAPE 203
S+ IHRDL NI + +VKIGD GL L ++ H + + APE
Sbjct: 115 SKR--FIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA-WCAPE 170
Query: 204 -LYEEDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKV 245
L ++ DV+ FG+ + EMFT E P++ + +QI KK+
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 8e-16
Identities = 72/311 (23%), Positives = 132/311 (42%), Gaps = 70/311 (22%)
Query: 36 LGKGAMKTVY----KAIDEVLGVEVAWNQVRLN-ELMRSPDDLQRLYSEVHLLSTLKHDS 90
+G+G V+ K E++ ++ R+ L+ ++++ + +E +L+T K +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALK------RMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 91 IIRFYTSWIDVDQKTF---------NFITEMFTSGTLRE-YRKKYRRVDIRAIKSWARQI 140
+++ ++ D D+ + +F T + G L E + + Y A+ +
Sbjct: 63 LVKLLYAFQD-DEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDA----- 116
Query: 141 LQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFM 200
L L Y IHRDLK +N F+ G +K+ D GL+ A+SV+G+P++M
Sbjct: 117 LHELGY--------IHRDLKPEN-FLIDASGHIKLTDFGLSK--GIVTYANSVVGSPDYM 165
Query: 201 APE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIY------KKV---TSGKL 250
APE L + Y+ VD +S G C+L F C +P + P + + K+
Sbjct: 166 APEVLRGKGYDFTVDYWSLG-CMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD 224
Query: 251 PGAFYSIQDLEAQRFIGRCLVNASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNET 310
P S EA I + + + S+R + E ++K PF E
Sbjct: 225 PRFNLSD---EAWDLITKLINDPSRRFGSLE----------DIK--------NHPFFKEV 263
Query: 311 ELEKLQLSDDP 321
+ +L+ P
Sbjct: 264 DWNELRELKPP 274
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 85/307 (27%), Positives = 130/307 (42%), Gaps = 75/307 (24%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRF 94
LGKGA V+KAID VA ++ + R+ D QR + E+ L L H +I++
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIF--DAFRNATDAQRTFREIMFLQELGDHPNIVKL 72
Query: 95 YTSWIDVDQKTFNFITE-MFT-------SGTLREYRKKYRRVDIRAIKSWARQILQGLVY 146
+ K + E M T + L + K+Y I Q+L+ L Y
Sbjct: 73 LNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRY-------I---MYQLLKALKY 122
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSV------IGTPEFM 200
+HS + VIHRDLK NI +N +VK+ D GLA L + + T +
Sbjct: 123 IHSGN--VIHRDLKPSNILLNSDC-RVKLADFGLARSLSELEENPENPVLTDYVATRWYR 179
Query: 201 APE--LYEEDYNELVDVYSFGMCVL-EMFTCE--YPYSECANPAQIYKKVTSGKLPGAFY 255
APE L Y + VD++S G C+L EM + +P + N Q+ K + P
Sbjct: 180 APEILLGSTRYTKGVDMWSVG-CILGEMLLGKPLFPGTSTLN--QLEKIIEVIGPP---- 232
Query: 256 SIQDLEAQR--------------------------------FIGRCLV-NASKRLSAKEL 282
S +D+E+ + + + LV N +KRL+A+E
Sbjct: 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEA 292
Query: 283 LLDPFLA 289
L P++A
Sbjct: 293 LEHPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 67/205 (32%), Positives = 100/205 (48%), Gaps = 25/205 (12%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLN-ELMRSPDDLQRLYSEVHLLSTLKHDSII 92
E +G+G VYKA +++ G VA ++RL+ E P R E+ LL L H +I+
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 62
Query: 93 RFYTSWIDV--DQKTFNFITEMFTSGTLREYRKKYRRVDIRA--IKSWARQILQGLVYLH 148
+ +DV + + E F L+++ I IKS+ Q+LQGL + H
Sbjct: 63 KL----LDVIHTENKLYLVFE-FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 149 SRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI----LRGSKSAHSVIGTPEFMAPE- 203
S V+HRDLK N+ +N G +K+ D GLA +R H V+ T + APE
Sbjct: 118 SHR--VLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVR--TYTHEVV-TLWYRAPEI 171
Query: 204 -LYEEDYNELVDVYSFGMCVLEMFT 227
L + Y+ VD++S G EM T
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 41/98 (41%), Positives = 59/98 (60%), Gaps = 4/98 (4%)
Query: 136 WARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIG 195
+A QI+ GL +LH R +++RDLK +N+ ++ H G V+I DLGLA L+G K G
Sbjct: 100 YAAQIICGLEHLHQRR--IVYRDLKPENVLLDDH-GNVRISDLGLAVELKGGKKIKGRAG 156
Query: 196 TPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPY 232
TP +MAPE L E Y+ VD ++ G + EM P+
Sbjct: 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 23/203 (11%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
+ LG+G+ TVYK ++ G VA ++RL +P R E LL LKH +I+
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR---EASLLKDLKHANIVT 67
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRR-VDIRAIKSWARQILQGLVYLHSRDP 152
+ I +KT + E + L++Y + + ++ + Q+L+GL Y H R
Sbjct: 68 LHD--IIHTKKTLTLVFE-YLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR- 123
Query: 153 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS------AHSVIGTPEFMAPE--L 204
V+HRDLK N+ ++ G++K+ D GLA +KS ++ V+ T + P+ L
Sbjct: 124 -VLHRDLKPQNLLIS-ERGELKLADFGLAR----AKSVPSKTYSNEVV-TLWYRPPDVLL 176
Query: 205 YEEDYNELVDVYSFGMCVLEMFT 227
+Y+ +D++ G EM T
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95
LG G+ V+ A+D VA ++ ++ P ++ E+ ++ L HD+I++ Y
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKI----VLTDPQSVKHALREIKIIRRLDHDNIVKVY 68
Query: 96 TSWIDV---DQKTFNFITEMFTSGTLREYRKKYRRVDIRA-------IKSWARQILQGLV 145
+ +TE+ + ++EY + + + + Q+L+GL
Sbjct: 69 EVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLK 128
Query: 146 YLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG--SKSAHSVIG--TPEFMA 201
Y+HS + V+HRDLK N+F+N +KIGD GLA I+ S + G T + +
Sbjct: 129 YIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRS 186
Query: 202 PE--LYEEDYNELVDVYSFGMCVLEMFT 227
P L +Y + +D+++ G EM T
Sbjct: 187 PRLLLSPNNYTKAIDMWAAGCIFAEMLT 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 5e-15
Identities = 65/226 (28%), Positives = 112/226 (49%), Gaps = 18/226 (7%)
Query: 66 LMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRK-- 123
L +S ++ E LL+ +KH +I+ F S+ + D + + E G L + K
Sbjct: 35 LPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-EADGHLY-IVMEYCDGGDLMQKIKLQ 92
Query: 124 KYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183
+ + I W Q+ G+ ++H + V+HRD+K NIF+ + G+VK+GD G A +
Sbjct: 93 RGKLFPEDTILQWFVQMCLGVQHIH--EKRVLHRDIKSKNIFLTQN-GKVKLGDFGSARL 149
Query: 184 LRGSKS-AHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQI 241
L + A + +GTP ++ PE++E YN D++S G + E+ T ++P+ + + +
Sbjct: 150 LTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPF-QANSWKNL 208
Query: 242 YKKVTSGK---LPGAF-YSIQDLEAQRFIGRCLVNASKRLSAKELL 283
KV G LP + Y ++ L Q F N R SA +L
Sbjct: 209 ILKVCQGSYKPLPSHYSYELRSLIKQMF----KRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 5e-15
Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 34 EVLGKGAMKTVY----KAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLS-TLKH 88
+VLGKG+ V K DEV ++V V L + DD+ +E +L+ KH
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQD-----DDVDCTMTEKRILALAAKH 55
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLH 148
+ + + D+ F+ E G L ++ R+ D + +A ++ L++LH
Sbjct: 56 PFLTALHCCFQTKDR--LFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113
Query: 149 SRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA--AILRGSKSAHSVIGTPEFMAPE-LY 205
VI+RDLK DNI ++ G K+ D G+ IL G + + GTP+++APE L
Sbjct: 114 RHG--VIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNG-VTTTTFCGTPDYIAPEILQ 169
Query: 206 EEDYNELVDVYSFGMCVLEMFTCEYPY 232
E +Y VD ++ G+ + EM + P+
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 66/246 (26%), Positives = 121/246 (49%), Gaps = 13/246 (5%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
E LG G+ V A + G A ++ E+++ +Q + E +L L H I+
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKM-KQVQHVAQEKSILMELSHPFIVN 82
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPP 153
S+ D ++ F+ E G L + +K R K + +++ YLHS+D
Sbjct: 83 MMCSFQDENR--VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD-- 138
Query: 154 VIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNEL 212
+I+RDLK +N+ ++ G VK+ D G A + ++ GTPE++APE+ + + + +
Sbjct: 139 IIYRDLKPENLLLDNK-GHVKVTDFGFAK--KVPDRTFTLCGTPEYLAPEVIQSKGHGKA 195
Query: 213 VDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFI-GRCLV 271
VD ++ G+ + E P+ + P +IY+K+ +G+L F + D A+ + G
Sbjct: 196 VDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAGRL--KFPNWFDGRARDLVKGLLQT 252
Query: 272 NASKRL 277
+ +KRL
Sbjct: 253 DHTKRL 258
|
Length = 329 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 7e-15
Identities = 69/240 (28%), Positives = 109/240 (45%), Gaps = 44/240 (18%)
Query: 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRL----NELMRSPDDLQRLYSEVHL 82
RY + ++GKG M VY A D V VA ++R N L++ +R E +
Sbjct: 2 QRYDIIR-LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLK-----KRFLREAKI 55
Query: 83 LSTLKHDSIIRFYT--SWIDVDQKTFNFITEMFTSGT-LREYRKK-------YRRVDIRA 132
+ L H I+ Y+ S D T +I E +T + L+ +K + + A
Sbjct: 56 AADLIHPGIVPVYSICSDGDPVYYTMPYI-EGYTLKSLLKSVWQKESLSKELAEKTSVGA 114
Query: 133 IKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK---- 188
S +I + Y+HS+ V+HRDLK DNI + G G+V I D G A + +
Sbjct: 115 FLSIFHKICATIEYVHSKG--VLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLL 171
Query: 189 --------SAHS-------VIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPY 232
+S ++GTP++MAPE L +E D+Y+ G+ + +M T +PY
Sbjct: 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 8e-15
Identities = 76/281 (27%), Positives = 134/281 (47%), Gaps = 27/281 (9%)
Query: 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMR-SPDDLQRLYSEVHL 82
DP G + L E ++G G VYK G V Q+ ++M + D+ + + E+++
Sbjct: 3 DPAGIFELVE-LVGNGTYGQVYK------GRHVKTGQLAAIKVMDVTGDEEEEIKQEINM 55
Query: 83 LSTLKHD-SIIRFYTSWIDVDQKTFN----FITEMFTSGTLREYRKKYRRVDIRA--IKS 135
L H +I +Y ++I + + + E +G++ + K + ++ I
Sbjct: 56 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 115
Query: 136 WARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-RGSKSAHSVI 194
R+IL+GL +LH VIHRD+K N+ + + +VK+ D G++A L R ++ I
Sbjct: 116 ICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFI 172
Query: 195 GTPEFMAPELYEED------YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG 248
GTP +MAPE+ D Y+ D++S G+ +EM P + +P + +
Sbjct: 173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRN 231
Query: 249 KLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288
P + Q FI CLV N S+R + ++L+ PF+
Sbjct: 232 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 8e-15
Identities = 56/160 (35%), Positives = 80/160 (50%), Gaps = 16/160 (10%)
Query: 79 EVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEM----FTSGTLREYRKKYRRVDIRAIK 134
E LL + H S+IR D IT M ++S K+ R + I
Sbjct: 107 EAMLLQNVNHPSVIRM------KDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQAL 160
Query: 135 SWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVI 194
+QIL+GL YLH++ +IHRD+K +NIF+N + QV IGDLG A + + +
Sbjct: 161 IIEKQILEGLRYLHAQR--IIHRDVKTENIFIND-VDQVCIGDLGAAQFPVVAPAFLGLA 217
Query: 195 GTPEFMAPELYEED-YNELVDVYSFGMCVLEMFTCEYPYS 233
GT E APE+ D YN D++S G+ + EM YP +
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA--YPST 255
|
Length = 357 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 39/100 (39%), Positives = 53/100 (53%), Gaps = 5/100 (5%)
Query: 136 WARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVI- 194
+A ++ GL YLH +++RDLK DN+ ++ G VKI D GL G S
Sbjct: 106 YAACVVLGLQYLHENK--IVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGDRTSTFC 162
Query: 195 GTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYS 233
GTPEF+APE L E Y VD + G+ + EM E P+
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP 202
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 68/205 (33%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLN-ELMRSPDDLQRLYSEVHLLSTLKHDSII 92
E +G+G VYKA D++ G VA ++RL E P R E+ LL L H +I+
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR---EISLLKELNHPNIV 61
Query: 93 RFYTSWIDV--DQKTFNFITEMFTSGTLREY--RKKYRRVDIRAIKSWARQILQGLVYLH 148
R DV + + E F L++Y +D IKS+ Q+LQG+ Y H
Sbjct: 62 RLL----DVVHSENKLYLVFE-FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH 116
Query: 149 SRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI----LRGSKSAHSVIGTPEFMAPE- 203
S V+HRDLK N+ ++ G +K+ D GLA +R H V+ T + APE
Sbjct: 117 SHR--VLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEI 170
Query: 204 -LYEEDYNELVDVYSFGMCVLEMFT 227
L Y+ VD++S G EM
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 68/201 (33%), Positives = 92/201 (45%), Gaps = 17/201 (8%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRL-NELMRSPDDLQRLYSEVHLLSTLKHDSIIRF 94
+G GA TVYKA D G VA VR+ P R + + L H +I+R
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 95 YTSWIDV------DQKTFNFITEMFTSGTLREYRKKYRR--VDIRAIKSWARQILQGLVY 146
+DV D++T + LR Y K + IK RQ L+GL +
Sbjct: 68 ----MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE-LY 205
LH+ ++HRDLK +NI V GQVK+ D GLA I + V+ T + APE L
Sbjct: 124 LHAN--CIVHRDLKPENILVTSG-GQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLL 180
Query: 206 EEDYNELVDVYSFGMCVLEMF 226
+ Y VD++S G EMF
Sbjct: 181 QSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 49/168 (29%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 136 WARQ----ILQGLVYLHSRDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLAAILRGSKS 189
WA+Q ++ G+ LH R +IHRD+K +N+ + GHL K+ D GL+ +K
Sbjct: 98 WAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHL---KLTDFGLSRNGLENKK 152
Query: 190 AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG 248
+GTP+++APE +++ D +S G + E YP P ++ + S
Sbjct: 153 ---FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLF-GYPPFHAETPDAVFDNILSR 208
Query: 249 KL--PGAFYSIQDLEAQRFIGRCL-VNASKRLSAK---ELLLDPFLAS 290
++ P EA I R L ++ +KRL A E+ PF S
Sbjct: 209 RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRL-YSEVHLLSTLKHDSII 92
V+G+GA V K ++ G VA + + +E +D+++ EV +L L+H++I+
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESE---DDEDVKKTALREVKVLRQLRHENIV 63
Query: 93 RFYTSWIDV-DQKTFNFITEMFTSGTLREYRKKYRR-VDIRAIKSWARQILQGLVYLHSR 150
+ +K ++ + TL E + + A++S+ Q+LQ + Y HS
Sbjct: 64 NL----KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119
Query: 151 DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH--SVIGTPEFMAPELYEED 208
+ +IHRD+K +NI V+ G +K+ D G A LR ++ + T + APEL D
Sbjct: 120 N--IIHRDIKPENILVSES-GVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176
Query: 209 --YNELVDVYSFGMCVLEMFT 227
Y + VDV++ G + E+
Sbjct: 177 TNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 72/265 (27%), Positives = 121/265 (45%), Gaps = 26/265 (9%)
Query: 29 YGLFEEVLGKGAMKTVYKAIDEVLGV------EVAWNQVRLNELMRSPD-DLQRLYSEVH 81
Y + E LG GA VYK + G E+ + + R D + + SEV
Sbjct: 2 YAVLEH-LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 82 LL-STLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY----RKKYRRVDIRAIKSW 136
++ L+H +I+R+Y ++++ D+ + ++ L E+ ++K +R I +
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDR--LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118
Query: 137 ARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGT 196
Q++ L YLH ++ ++HRDL +NI + G +V I D GLA + SV+GT
Sbjct: 119 FVQMVLALRYLH-KEKRIVHRDLTPNNIML-GEDDKVTITDFGLAKQKQPESKLTSVVGT 176
Query: 197 PEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK---LPG 252
+ PE+ + E Y E DV++FG + +M T + P+ N + K+ LP
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPE 235
Query: 253 AFYSIQDLEAQRFIGRCL-VNASKR 276
YS I CL +A R
Sbjct: 236 GMYSED---VTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-14
Identities = 40/99 (40%), Positives = 59/99 (59%), Gaps = 5/99 (5%)
Query: 136 WARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSKSAHSVI 194
+ QI+ GL +LH R +I+RDLK +N+ ++ G V+I DLGLA L+ G
Sbjct: 102 YTAQIISGLEHLHQRR--IIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKTKGYA 158
Query: 195 GTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPY 232
GTP FMAPEL + E+Y+ VD ++ G+ + EM P+
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 64/244 (26%), Positives = 99/244 (40%), Gaps = 50/244 (20%)
Query: 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSR 150
I+ FY ++ + E G+L + KK R+ + + +L+GL YL R
Sbjct: 61 IVGFYGAF--YSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYL--R 116
Query: 151 DP-PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE-LYEED 208
+ ++HRD+K NI VN G++K+ D G++ L S A+S +GT +M+PE L
Sbjct: 117 EKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTH 174
Query: 209 YNELVDVYSFGMCVLEMFTCEYPY----------------SECANPAQIYKKVTSG---- 248
Y D++S G+ ++EM YP SE
Sbjct: 175 YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234
Query: 249 ------------------KLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLA 289
KLP +S E Q F+ +CL N +R KEL PF+
Sbjct: 235 RPMAIFELLDYIVNEPPPKLPSGAFS---DEFQDFVDKCLKKNPKERADLKELTKHPFIK 291
Query: 290 SDEV 293
E+
Sbjct: 292 RAEL 295
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 15/165 (9%)
Query: 140 ILQGLVYL---HSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGT 196
I++ L YL H VIHRD+K NI ++ G VK+ D G++ L SK+ G
Sbjct: 123 IVKALHYLKEKHG----VIHRDVKPSNILLDA-SGNVKLCDFGISGRLVDSKAKTRSAGC 177
Query: 197 PEFMAPELYE-----EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP 251
+MAPE + Y+ DV+S G+ ++E+ T ++PY C ++ K+ + P
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP 237
Query: 252 GAFYSIQ-DLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVK 294
+ + F+ CL + KR +ELL PF+ E
Sbjct: 238 SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETA 282
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 53/162 (32%), Positives = 78/162 (48%), Gaps = 23/162 (14%)
Query: 78 SEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKY-------RRVDI 130
+E H+L + H SII+ ++ T+N FT L Y+ R + I
Sbjct: 132 TEAHILRAINHPSIIQLKGTF------TYN----KFTCLILPRYKTDLYCYLAAKRNIAI 181
Query: 131 RAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA--ILRGSK 188
I + R +L+ + YLH +IHRD+K +NIF+N H G V +GD G A + +
Sbjct: 182 CDILAIERSVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINAN 238
Query: 189 SAHSVIGTPEFMAPELYEED-YNELVDVYSFGMCVLEMFTCE 229
+ GT APEL D Y VD++S G+ + EM TC
Sbjct: 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 53/155 (34%), Positives = 82/155 (52%), Gaps = 21/155 (13%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYS----EVHLLSTLKHD 89
E +G+G TV+KA + VA +VRL+ DD + + S E+ LL LKH
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLD------DDDEGVPSSALREICLLKELKHK 59
Query: 90 SIIRFYTSWIDV--DQKTFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVY 146
+I+R Y DV K + E + L++Y +D +KS+ Q+L+GL +
Sbjct: 60 NIVRLY----DVLHSDKKLTLVFE-YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181
HS + V+HRDLK N+ +N + G++K+ D GLA
Sbjct: 115 CHSHN--VLHRDLKPQNLLINKN-GELKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 8e-14
Identities = 71/282 (25%), Positives = 137/282 (48%), Gaps = 27/282 (9%)
Query: 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLL 83
DP+ + + E + GKG V+K +++ G + A V++ + + D + + +E ++L
Sbjct: 15 DPSDTWEIIETI-GKGTYGKVFKVLNKKNGSKAA---VKILDPIHDID--EEIEAEYNIL 68
Query: 84 STLK-HDSIIRFYTSWIDVDQKTFN---FITEMFTSGTLRE----YRKKYRRVDIRAIKS 135
L H ++++FY + D K + + E+ G++ + + K+ R++ I
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY 128
Query: 136 WARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-SAHSVI 194
+ L GL +LH IHRD+K +NI + G VK+ D G++A L ++ ++ +
Sbjct: 129 ILHEALMGLQHLHVNK--TIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSV 185
Query: 195 GTPEFMAPEL------YEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG 248
GTP +MAPE+ + Y+ DV+S G+ +E+ + P ++ +P + K+
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL-HPMRALFKIPRN 244
Query: 249 KLPGAFY-SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288
P + E FI +CL + KR + +LL F+
Sbjct: 245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 54/203 (26%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 34 EVLGKGAMKTVYKAI----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHD 89
+VLG GA TVYK I E + + VA +++ P E +++++ H
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVA---IKILNETTGPKANVEFMDEALIMASMDHP 69
Query: 90 SIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLH 148
++R + T +T++ G L +Y +++ + + + +W QI +G++YL
Sbjct: 70 HLVRLLGVCL---SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 149 SRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTP---EFMAPE-L 204
R ++HRDL N+ V VKI D GLA +L G + ++ G ++MA E +
Sbjct: 127 ERR--LVHRDLAARNVLVKSP-NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 205 YEEDYNELVDVYSFGMCVLEMFT 227
+ + DV+S+G+ + E+ T
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 34 EVLGKGAMKTVYKAI----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHD 89
+VLG GA TVYK + E + + VA ++R SP + + E ++++++ +
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNP 69
Query: 90 SIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVYLH 148
+ R + T IT++ G L +Y R+ + + + +W QI +G+ YL
Sbjct: 70 HVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 126
Query: 149 SRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTP---EFMAPE-L 204
R ++HRDL N+ V VKI D GLA +L + + G ++MA E +
Sbjct: 127 ERR--LVHRDLAARNVLVKTP-QHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183
Query: 205 YEEDYNELVDVYSFGMCVLEMFT 227
Y DV+S+G+ V E+ T
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 62/237 (26%), Positives = 109/237 (45%), Gaps = 23/237 (9%)
Query: 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSII 92
E LG G V++ + + V VA ++ ++ + D Q EV L L+H +I
Sbjct: 11 ERKLGSGYFGEVWEGLWKNR-VRVAIKILK-SDDLLKQQDFQ---KEVQALKRLRHKHLI 65
Query: 93 RFYTSWIDVDQKTFNFITEMFTSGTLREYRK--KYRRVDIRAIKSWARQILQGLVYLHSR 150
+ + + ITE+ G+L + + + + + + ++ A Q+ +G+ YL +
Sbjct: 66 SLFA--VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 151 DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-KSAHSVIGTPEFMAPE-LYEED 208
+ IHRDL NI V L K+ D GLA +++ + ++ APE
Sbjct: 124 N--SIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGT 180
Query: 209 YNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSG-------KLPGAFYSI 257
++ DV+SFG+ + EMFT + PY N ++Y ++T+G K P Y I
Sbjct: 181 FSTKSDVWSFGILLYEMFTYGQVPY-PGMNNHEVYDQITAGYRMPCPAKCPQEIYKI 236
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 36/212 (16%)
Query: 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRL-NELMRSPDDLQRLYSEVHLLSTLKHDSI 91
E +G+G VYKA D V +A ++RL E P R E+ LL ++H +I
Sbjct: 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR---EISLLKEMQHGNI 63
Query: 92 IRFYT------------SWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQ 139
+R ++D+D K + F + R IK++ Q
Sbjct: 64 VRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAK-------------NPRLIKTYLYQ 110
Query: 140 ILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA--HSVIGTP 197
IL+G+ Y HS V+HRDLK N+ ++ +K+ D GLA H V+ T
Sbjct: 111 ILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TL 167
Query: 198 EFMAPE--LYEEDYNELVDVYSFGMCVLEMFT 227
+ APE L Y+ VD++S G EM
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 61/225 (27%), Positives = 91/225 (40%), Gaps = 43/225 (19%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDL-----QRLYSEVHLLSTL 86
LG+G VYKA G VA ++ LM + D R E+ +L L
Sbjct: 12 ILGKLGEGTFGEVYKARQIKTGRVVALKKI----LMHNEKDGFPITALR---EIKILKKL 64
Query: 87 KHDSIIRFYTSWIDVDQKTFNFITEMFT---------SGTLREYRKKYRRVDIRAIKSWA 137
KH +++ ++ K+ ++ SG L K IK +
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQ---IKCYM 121
Query: 138 RQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH------ 191
Q+L+G+ YLH ++HRD+K NI ++ G +KI D GLA G
Sbjct: 122 LQLLEGINYLHENH--ILHRDIKAANILIDNQ-GILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 192 ------SVIGTPEFMAPELY--EEDYNELVDVYSFGMCVL-EMFT 227
+++ T + PEL E Y VD++ G CV EMFT
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG-CVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 42/127 (33%), Positives = 70/127 (55%), Gaps = 5/127 (3%)
Query: 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVN 167
F+ E G L + + R D+ +A +I+ GL +LHS+ +I+RDLK DN+ ++
Sbjct: 73 FVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLD 130
Query: 168 GHLGQVKIGDLGLAAI-LRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEM 225
G +KI D G+ + G A + GTP+++APE+ + Y VD +SFG+ + EM
Sbjct: 131 RD-GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEM 189
Query: 226 FTCEYPY 232
+ P+
Sbjct: 190 LIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 18/209 (8%)
Query: 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVN 167
+T+ + G L + +K R K + +++ L +LH D +++RDLK +NI ++
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD 130
Query: 168 GHLGQVKIGDLGLA-AILRGSKSAHSVIGTPEFMAPE--LYEEDYNELVDVYSFGMCVLE 224
G + + D GL+ A L +K+ ++ GT E++APE L E+ Y + VD +S G+ V E
Sbjct: 131 AT-GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFE 189
Query: 225 MFTCEYPYSECANPAQIYKKVTSGKL--PGAFYSIQDLEAQRFI-GRCLVNASKRLSA-- 279
M C + + Q+Y+ + GK+ P S E ++F+ G N RL A
Sbjct: 190 M-CCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLS---DEGRQFVKGLLNRNPQHRLGAHR 245
Query: 280 --KELLLDPFLASDEVKLLSKTKLNQKPF 306
EL PF A + LLSK K PF
Sbjct: 246 DAVELKEHPFFADIDWDLLSK-KQITPPF 273
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 59/239 (24%), Positives = 98/239 (41%), Gaps = 43/239 (17%)
Query: 21 IETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYS-- 78
+ + RY LG+G V KA D + G VA +V++ E+ ++L
Sbjct: 2 MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMC 61
Query: 79 --------EVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDI 130
E+ +++ +KH++I+ + V+ N + ++ + L++ + R+
Sbjct: 62 GIHFTTLRELKIMNEIKHENIMGLVDVY--VEGDFINLVMDIM-ASDLKKVVDRKIRLTE 118
Query: 131 RAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA 190
+K QIL GL LH +HRDL NIF+N G KI D GLA +
Sbjct: 119 SQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSK-GICKIADFGLA-----RRYG 170
Query: 191 HSVIG---------------TPE-----FMAPELY--EEDYNELVDVYSFGMCVLEMFT 227
+ T + + APEL E Y+ VD++S G E+ T
Sbjct: 171 YPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
|
Length = 335 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 18/215 (8%)
Query: 35 VLGKGAMKTVY----KAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDS 90
V+G+G+ V K + + ++V EL+ +D+ + +E H+ +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVV-----KKELVNDDEDIDWVQTEKHVFEQASNHP 56
Query: 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSR 150
+ S + + F F+ E G L + ++ R++ + ++ +I L YLH R
Sbjct: 57 FLVGLHSCFQTESRLF-FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 115
Query: 151 DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSKSAHSVIGTPEFMAPELYE-ED 208
+I+RDLK DN+ ++ G +K+ D G+ LR + + GTP ++APE+ ED
Sbjct: 116 G--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 209 YNELVDVYSFGMCVLEMFTCEYPYS---ECANPAQ 240
Y VD ++ G+ + EM P+ NP Q
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 67/203 (33%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 36 LGKGAMKTVYKAID-EVLGVEVAWNQVRLN-ELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
+G+GA V+KA D + G VA +VR+ P R + + L T +H +++R
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 94 FY----TSWIDVDQK---TFNFITEMFTSGTLREYRKKYRR--VDIRAIKSWARQILQGL 144
+ S D + K F + + T+ Y K V IK Q+L+GL
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTT-----YLDKVPEPGVPTETIKDMMFQLLRGL 123
Query: 145 VYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE- 203
+LHS V+HRDLK NI V GQ+K+ D GLA I + SV+ T + APE
Sbjct: 124 DFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 180
Query: 204 LYEEDYNELVDVYSFGMCVLEMF 226
L + Y VD++S G EMF
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 53/192 (27%), Positives = 91/192 (47%), Gaps = 23/192 (11%)
Query: 111 EMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHL 170
E+FT RE+ ++ + +I+ L +LH +I+RD+K +NI ++
Sbjct: 91 ELFTHLYQREH------FTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSE- 141
Query: 171 GQVKIGDLGLAAILRGSKS--AHSVIGTPEFMAPELY---EEDYNELVDVYSFGMCVLEM 225
G V + D GL+ + A+S GT E+MAPE+ +++ VD +S G+ E+
Sbjct: 142 GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201
Query: 226 FTCEYPYS---ECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRL---S 278
T P++ E + ++I +++ K P F EA+ FI + L + KRL
Sbjct: 202 LTGASPFTVDGEQNSQSEISRRILKSKPP--FPKTMSAEARDFIQKLLEKDPKKRLGANG 259
Query: 279 AKELLLDPFLAS 290
A E+ PF
Sbjct: 260 ADEIKNHPFFQG 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 45/119 (37%), Positives = 61/119 (51%), Gaps = 13/119 (10%)
Query: 121 YRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHL---GQVKIGD 177
+ K + +KS QIL G+ YLHS V+HRDLK NI V G G VKIGD
Sbjct: 98 RQAKRVSIPPSMVKSLLWQILNGVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGD 155
Query: 178 LGLAAI----LRGSKSAHSVIGTPEFMAPELY--EEDYNELVDVYSFGMCVL-EMFTCE 229
LGLA + L+ V+ T + APEL Y + +D+++ G C+ E+ T E
Sbjct: 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG-CIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 5e-13
Identities = 67/203 (33%), Positives = 102/203 (50%), Gaps = 20/203 (9%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRL-NELMRSPDDLQRLYSEVHLLSTLKHDSII 92
E +G+G VYK ++ G VA ++RL +E P R E+ LL L+H +I+
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR---EISLLKELQHPNIV 62
Query: 93 RFYTSWIDV-DQKTFNFITEMFTSGTLREYR---KKYRRVDIRAIKSWARQILQGLVYLH 148
DV Q++ ++ F S L++Y K + +D +KS+ QILQG+++ H
Sbjct: 63 CL----QDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 149 SRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA--HSVIGTPEFMAPE--L 204
SR V+HRDLK N+ ++ G +K+ D GLA H V+ T + APE L
Sbjct: 119 SRR--VLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLL 174
Query: 205 YEEDYNELVDVYSFGMCVLEMFT 227
Y+ VD++S G EM T
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 26/203 (12%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQ------RLYSEVHLLSTLKHD 89
+G+G+ V+K + G VA + + + S DD R E+ +L LKH
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVA-----IKKFVESEDDPVIKKIALR---EIRMLKQLKHP 60
Query: 90 SIIRFYTSWIDV--DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYL 147
+++ + I+V ++ + + E L E K R V IK Q LQ + +
Sbjct: 61 NLV----NLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 148 HSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS-VIGTPEFMAPELYE 206
H + IHRD+K +NI + GQ+K+ D G A IL G ++ + T + APEL
Sbjct: 117 HKHN--CIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLV 173
Query: 207 ED--YNELVDVYSFGMCVLEMFT 227
D Y VDV++ G E+ T
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 80/304 (26%), Positives = 127/304 (41%), Gaps = 59/304 (19%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDL---QRLYSEVHLLSTLKHDSII 92
+G GA V+ D G VA L ++ +L +R++ E+ +L KHD+++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVA-----LKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVL 62
Query: 93 RFYTSWIDVDQ-------KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLV 145
S +D+ Q + +TE+ S L + + + +K + QIL+GL
Sbjct: 63 ----SALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLK 117
Query: 146 YLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI--LRGSKSAHSVIGTPEFMAPE 203
YLHS ++HRD+K N+ VN + +KI D GLA + SK + T + APE
Sbjct: 118 YLHSAG--ILHRDIKPGNLLVNSNC-VLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174
Query: 204 LY--EEDYNELVDVYSFGMCVLEM------FTCEYP-------------------YSEC- 235
+ Y VD++S G E+ F + P S C
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234
Query: 236 ANPAQIYKKVTSGKLPGAFYSIQD---LEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291
A I + Y++ EA + R LV + KR+SA + L P+L D
Sbjct: 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL--D 292
Query: 292 EVKL 295
E +L
Sbjct: 293 EGRL 296
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 10/202 (4%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
++LGKG V ++ G A +R E++ + D++ +E +L +H +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPP 153
++ D+ F+ E G L + + R + + +I+ L YLHSRD
Sbjct: 60 LKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD-- 115
Query: 154 VIHRDLKCDNIFVNGHLGQVKIGDLGLA--AILRGSKSAHSVIGTPEFMAPELYEE-DYN 210
V++RD+K +N+ ++ G +KI D GL I G+ + + GTPE++APE+ E+ DY
Sbjct: 116 VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLEDNDYG 173
Query: 211 ELVDVYSFGMCVLEMFTCEYPY 232
VD + G+ + EM P+
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 52/155 (33%), Positives = 85/155 (54%), Gaps = 11/155 (7%)
Query: 79 EVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWAR 138
E+++L TL H++I+++ + K I E G+LR+Y K+ ++++ + +A+
Sbjct: 56 EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQ 114
Query: 139 QILQGLVYLHSRDPPVIHRDLKCDNIFV-NGHLGQVKIGDLGLAAILRGSKSAHSVI--- 194
QI +G+ YLHS+ IHRDL N+ + N L VKIGD GLA + + V
Sbjct: 115 QICEGMAYLHSQH--YIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDG 170
Query: 195 GTPEF-MAPE-LYEEDYNELVDVYSFGMCVLEMFT 227
+P F A E L E ++ DV+SFG+ + E+ T
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 7e-13
Identities = 80/288 (27%), Positives = 131/288 (45%), Gaps = 41/288 (14%)
Query: 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMR-SPDDLQRLYSEVHL 82
DP G + L E V+G G VYK G V Q+ ++M + D+ + + E+++
Sbjct: 13 DPAGIFELVE-VVGNGTYGQVYK------GRHVKTGQLAAIKVMDVTEDEEEEIKLEINM 65
Query: 83 LSTLKHD-SIIRFYTSWIDVDQKTFN----FITEMFTSGTLREYRKKYRRVDIRA--IKS 135
L H +I +Y ++I + + E +G++ + K + ++ I
Sbjct: 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY 125
Query: 136 WARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-RGSKSAHSVI 194
R+IL+GL +LH+ VIHRD+K N+ + + +VK+ D G++A L R ++ I
Sbjct: 126 ICREILRGLAHLHAHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFI 182
Query: 195 GTPEFMAPELYEED------YNELVDVYSFGMCVLEMFTCEYPYSECAN-------PAQI 241
GTP +MAPE+ D Y+ D++S G+ +EM P + P
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 242
Query: 242 YKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288
K+ S K F FI CLV N R S ++LL PF+
Sbjct: 243 PPKLKSKKWSKKFID--------FIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 63/234 (26%), Positives = 111/234 (47%), Gaps = 24/234 (10%)
Query: 4 NKQLAGAADEAKAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRL 63
N DE K I PN Y L ++G G+ VY+AI ++ + +V +
Sbjct: 43 NNNAGEDEDEEKMIDNDINRSPNKSYKL-GNIIGNGSFGVVYEAI----CIDTS-EKVAI 96
Query: 64 NELMRSPDDLQRLYSEVHLLSTLKHDSII----RFYTSWIDVDQKT--FNFITEMFTSGT 117
++++ P R E+ ++ L H +II +YT ++K N + E F T
Sbjct: 97 KKVLQDPQYKNR---ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVME-FIPQT 152
Query: 118 LREYRKKYRR----VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQV 173
+ +Y K Y R + + +K ++ Q+ + L Y+HS+ + HRDLK N+ ++ + +
Sbjct: 153 VHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTL 210
Query: 174 KIGDLGLAAILRGSKSAHSVIGTPEFMAPELY--EEDYNELVDVYSFGMCVLEM 225
K+ D G A L + + S I + + APEL +Y +D++S G + EM
Sbjct: 211 KLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEM 264
|
Length = 440 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 66/274 (24%), Positives = 117/274 (42%), Gaps = 32/274 (11%)
Query: 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVH-LLSTLKHDSI 91
+G+GA TV K + + G +A ++R + + +RL ++ ++ + I
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEK---EQKRLLMDLDVVMRSSDCPYI 65
Query: 92 IRFY-------TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGL 144
++FY WI ++ + + F Y + + A ++ L
Sbjct: 66 VKFYGALFREGDCWICMELMDISL--DKFYK---YVYEVLKSVIPEEILGKIAVATVKAL 120
Query: 145 VYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPEL 204
YL + +IHRD+K NI ++ + G +K+ D G++ L S + G +MAPE
Sbjct: 121 NYL-KEELKIIHRDVKPSNILLDRN-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPER 178
Query: 205 ----YEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP------GAF 254
+ Y+ DV+S G+ + E+ T ++PY + + +V G P
Sbjct: 179 IDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238
Query: 255 YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPF 287
+S FI CL+ + SKR KELL PF
Sbjct: 239 FSP---SFVNFINLCLIKDESKRPKYKELLEHPF 269
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 58/197 (29%), Positives = 100/197 (50%), Gaps = 13/197 (6%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
E LG+G+ TVYK I + G VA + + P R E LL LKH +I+
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR---EASLLKGLKHANIVL 67
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRDP 152
+ I ++T F+ E + L +Y ++ + ++ + Q+L+GL Y+H +
Sbjct: 68 LHD--IIHTKETLTFVFE-YMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH- 123
Query: 153 PVIHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRGSKSAHSVIGTPEFMAPE--LYEEDY 209
++HRDLK N+ ++ +LG++K+ D GLA A S++ S + T + P+ L DY
Sbjct: 124 -ILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDY 181
Query: 210 NELVDVYSFGMCVLEMF 226
+ +D++ G +EM
Sbjct: 182 SSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 63/229 (27%), Positives = 110/229 (48%), Gaps = 19/229 (8%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSP--DDLQRLYSEVHLLSTL-KH 88
F + LG GA V +A L A +V + L + + + L SE+ ++S L H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY--RKKYRRVDIRAIKSWARQILQGLVY 146
++I+ + ITE G L + RK+ + + + S++ Q+ +G+ +
Sbjct: 99 ENIVNLLGAC--TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 147 LHSRDPPVIHRDLKCDNIFV-NGHLGQVKIGDLGLAAILRGSKSAHSVIGTP----EFMA 201
L S++ IHRDL N+ + +G + VKI D GLA + + S + V G ++MA
Sbjct: 157 LASKN--CIHRDLAARNVLLTHGKI--VKICDFGLARDIM-NDSNYVVKGNARLPVKWMA 211
Query: 202 PE-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
PE ++ Y DV+S+G+ + E+F+ PY ++ YK + G
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG 260
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 29/211 (13%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDD----LQRLYSEVHLLSTLKHD 89
+G+GA V A + GV+VA ++ SP + QR E+ +L KH+
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKI-------SPFEHQTFCQRTLREIKILRRFKHE 63
Query: 90 SIIRFYTSWIDVDQKTFN--FITEMFTSGTLREYRK-KYRRVDIRAIKSWARQILQGLVY 146
+II ++FN +I + L Y+ K + + I+ + QIL+GL Y
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMETDL--YKLIKTQHLSNDHIQYFLYQILRGLKY 121
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS-----VIGTPEFMA 201
+HS + V+HRDLK N+ +N + +KI D GLA I + H+ + T + A
Sbjct: 122 IHSAN--VLHRDLKPSNLLLNTNC-DLKICDFGLARIA-DPEHDHTGFLTEYVATRWYRA 177
Query: 202 PE--LYEEDYNELVDVYSFGMCVL-EMFTCE 229
PE L + Y + +D++S G C+L EM +
Sbjct: 178 PEIMLNSKGYTKAIDIWSVG-CILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 36/110 (32%), Positives = 64/110 (58%), Gaps = 4/110 (3%)
Query: 126 RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185
R +++ + ++ QI G+++LHS D +++RD+K +N+ ++ G ++ DLGLA L+
Sbjct: 90 RGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLD-DQGNCRLSDLGLAVELK 146
Query: 186 GSKSAHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSE 234
K+ GT +MAPE L EE Y+ VD ++ G + EM P+ +
Sbjct: 147 DGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95
LG+G TVYK ++ VA ++RL +P R EV LL LKH +I+ +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVTLH 70
Query: 96 TSWIDVDQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPV 154
I +K+ + E + L++Y +++ +K + Q+L+GL Y H R V
Sbjct: 71 D--IIHTEKSLTLVFE-YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--V 125
Query: 155 IHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRGSKSAHSVIGTPEFMAPE--LYEEDYNE 211
+HRDLK N+ +N G++K+ D GLA A +K+ + + T + P+ L DY+
Sbjct: 126 LHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184
Query: 212 LVDVYSFGMCVLEMFT 227
+D++ G EM T
Sbjct: 185 QIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 4e-12
Identities = 48/202 (23%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 34 EVLGKGAMKTVYKAI-----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH 88
+G+G VY+ + +E + V V + N SP ++ E +++ H
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAV---KTCKNCT--SPSVREKFLQEAYIMRQFDH 66
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYL 147
I++ + + + + E+ G LR Y + + +D+ ++ ++ Q+ L YL
Sbjct: 67 PHIVKLIG--VITENPVW-IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL 123
Query: 148 HSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGT-P-EFMAPE-L 204
S+ +HRD+ N+ V+ VK+GD GL+ L + G P ++MAPE +
Sbjct: 124 ESKR--FVHRDIAARNVLVSSP-DCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESI 180
Query: 205 YEEDYNELVDVYSFGMCVLEMF 226
+ DV+ FG+C+ E+
Sbjct: 181 NFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 77/326 (23%), Positives = 136/326 (41%), Gaps = 62/326 (19%)
Query: 32 FEEV--LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHD 89
FE++ LG G V+K + G+ +A +L L P ++ E+ +L
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMA---RKLIHLEIKPAIRNQIIRELQVLHECNSP 63
Query: 90 SIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHS 149
I+ FY ++ + E G+L + KK R+ + + + +++GL YL
Sbjct: 64 YIVGFYGAF--YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 150 RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE-LYEED 208
+ ++HRD+K NI VN G++K+ D G++ L S A+S +GT +M+PE L
Sbjct: 122 KHK-IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTH 178
Query: 209 YNELVDVYSFGMCVLEMFTCEYPY--SECANPAQIYKKVTSG------------------ 248
Y+ D++S G+ ++EM YP + ++ G
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL 238
Query: 249 -------KLPGAFYSIQD----------------LEAQRFIGRCLV-NASKRLSAKELLL 284
+ P A + + D E Q F+ +CL+ N ++R K+L++
Sbjct: 239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298
Query: 285 DPFLASDEVK-------LLSKTKLNQ 303
F+ E + L S LNQ
Sbjct: 299 HAFIKRSEAEEVDFAGWLCSTIGLNQ 324
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 61/238 (25%), Positives = 94/238 (39%), Gaps = 37/238 (15%)
Query: 36 LGKGAMKTVYKAI-----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDS 90
LG+G+ VY+ + VA V N MR + +E ++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR---ERIEFLNEASVMKEFNCHH 70
Query: 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREY----RKKYRRVDIRAIKS------WARQI 140
++R + Q T + E+ G L+ Y R + + A +I
Sbjct: 71 VVRLL-GVVSTGQPTL-VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 141 LQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-------RGSKSAHSV 193
G+ YL ++ +HRDL N V L VKIGD G+ + +G K V
Sbjct: 129 ADGMAYLAAKK--FVHRDLAARNCMVAEDL-TVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 194 IGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGK 249
+MAPE L + + DV+SFG+ + EM T E PY +N ++ K V G
Sbjct: 186 ----RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EEVLKFVIDGG 238
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 66/246 (26%), Positives = 108/246 (43%), Gaps = 37/246 (15%)
Query: 31 LFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNEL--MRSPD---DLQRLYSEVHLLST 85
+ + LG+GA V+ L E V + L S D D +R E LL+
Sbjct: 8 VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFER---EAELLTN 64
Query: 86 LKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY--------------RKKYRRVDIR 131
+H++I++FY + D F E G L ++ + +
Sbjct: 65 FQHENIVKFYGVCTEGDPPIMVF--EYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122
Query: 132 AIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH 191
+ A QI G+VYL S+ +HRDL N V G+ VKIGD G++ + + +
Sbjct: 123 QLLQIAVQIASGMVYLASQH--FVHRDLATRNCLV-GYDLVVKIGDFGMSRDVY-TTDYY 178
Query: 192 SVIGTP----EFMAPE--LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKK 244
V G +M PE +Y + E DV+SFG+ + E+FT + P+ +N ++ +
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSN-EEVIEC 236
Query: 245 VTSGKL 250
+T G+L
Sbjct: 237 ITQGRL 242
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 24/194 (12%)
Query: 79 EVHLLSTLKHDSIIRFYTSWIDVDQ-KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWA 137
E +++ L H I+R I V + + + E+ G L +Y KK R + + +K A
Sbjct: 46 EASVMAQLDHPCIVRL----IGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELA 101
Query: 138 RQILQGLVYLHSRDPPVIHRDLKCDNIF-VNGHLGQVKIGDLGLAAILR-GSKSAHSVIG 195
Q+ G+ YL S+ +HRDL N+ VN H Q KI D G++ L GS +
Sbjct: 102 HQVAMGMAYLESKH--FVHRDLAARNVLLVNRH--QAKISDFGMSRALGAGSDYYRATTA 157
Query: 196 T--P-EFMAPE-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG-- 248
P ++ APE + ++ DV+S+G+ + E F+ PY E ++ + SG
Sbjct: 158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-EVIAMLESGER 216
Query: 249 -----KLPGAFYSI 257
+ P YSI
Sbjct: 217 LPRPEECPQEIYSI 230
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 63/197 (31%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRF- 94
+G GA TV A+D G +VA +L +S +R Y E+ LL +KH+++I
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 95 --YTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDP 152
+T + +D+ +F M GT K+ ++ I+ Q+L+GL Y+H+
Sbjct: 81 DVFTPDLSLDRFH-DFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG- 138
Query: 153 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE--LYEEDYN 210
+IHRDLK N+ VN ++KI D GLA + + V T + APE L Y
Sbjct: 139 -IIHRDLKPGNLAVNEDC-ELKILDFGLARQTDSEMTGYVV--TRWYRAPEVILNWMHYT 194
Query: 211 ELVDVYSFGMCVLEMFT 227
+ VD++S G + EM T
Sbjct: 195 QTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 35 VLGKGAMKTVYKAI----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDS 90
VLG GA TVYK I E + + VA +R N SP + + E ++++ +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGVGSPY 70
Query: 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHS 149
+ R + T +T++ G L +Y ++ + R+ + + +W QI +G+ YL
Sbjct: 71 VCRLLGICL---TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL-- 125
Query: 150 RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTP---EFMAPE-LY 205
+ ++HRDL N+ V VKI D GLA +L ++ + G ++MA E +
Sbjct: 126 EEVRLVHRDLAARNVLVKSP-NHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 206 EEDYNELVDVYSFGMCVLEMFT 227
+ DV+S+G+ V E+ T
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 67/289 (23%), Positives = 119/289 (41%), Gaps = 45/289 (15%)
Query: 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRF 94
V+G+GA V+ D+ G A +R +++++ + + +E +L+ I++
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIVKL 66
Query: 95 YTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPV 154
Y S+ D++ + E G L + + + +++ L +H
Sbjct: 67 YYSF--QDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--F 122
Query: 155 IHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS------------------------- 189
IHRD+K DNI ++ G +K+ D GL + +K
Sbjct: 123 IHRDIKPDNILIDAD-GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181
Query: 190 -----AHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQI 241
A+S +GTP+++APE L Y D +S G+ + EM +P YS+ +
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY-GFPPFYSD--TLQET 238
Query: 242 YKKVTSGKLPGAFYSIQDL--EAQRFIGRCLVNASKRL-SAKELLLDPF 287
Y K+ + K F + EA I R L + RL S +E+ PF
Sbjct: 239 YNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 8e-12
Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 8/201 (3%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
++LGKG V ++ G A ++ E++ + D++ +E +L +H +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILK-KEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPP 153
S+ D+ F+ E G L + + R + + +I+ L YLHS
Sbjct: 60 LKYSFQTKDR--LCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK-- 115
Query: 154 VIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSKSAHSVIGTPEFMAPELYEE-DYNE 211
+++RDLK +N+ ++ G +KI D GL + + + + GTPE++APE+ E+ DY
Sbjct: 116 IVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 212 LVDVYSFGMCVLEMFTCEYPY 232
VD + G+ + EM P+
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 8e-12
Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 40/210 (19%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95
+G GA +V AID+ G +VA +L+ +S +R Y E+ LL ++H+++I
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIK--KLSRPFQSEIFAKRAYRELTLLKHMQHENVIG-- 78
Query: 96 TSWIDVDQKTFNFITEMFTSGT-LREYRK-----KYRRVDIRAIKSW----------ARQ 139
+DV FTS E++ Y + D++ I Q
Sbjct: 79 --LLDV-----------FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQ 125
Query: 140 ILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF 199
+L GL Y+HS +IHRDLK N+ VN ++KI D GLA + + V T +
Sbjct: 126 MLCGLKYIHSAG--IIHRDLKPGNLAVNEDC-ELKILDFGLARHADAEMTGYVV--TRWY 180
Query: 200 MAPE--LYEEDYNELVDVYSFGMCVLEMFT 227
APE L YN+ VD++S G + EM T
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 7/201 (3%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
++LGKG V ++ G A ++ E++ + D++ +E +L +H +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILK-KEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPP 153
S+ D+ F+ E G L + + R + + +I+ L YLHS +
Sbjct: 60 LKYSFQTHDR--LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS-EKN 116
Query: 154 VIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSKSAHSVIGTPEFMAPELYEE-DYNE 211
V++RDLK +N+ ++ G +KI D GL ++ + + GTPE++APE+ E+ DY
Sbjct: 117 VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175
Query: 212 LVDVYSFGMCVLEMFTCEYPY 232
VD + G+ + EM P+
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 32 FEEV--LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHD 89
FE + LG G V K + G+ +A +L L P ++ E+ +L
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMA---RKLIHLEIKPAIRNQIIRELQVLHECNSP 63
Query: 90 SIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHS 149
I+ FY ++ + E G+L + K+ +R+ + + +L+GL YL
Sbjct: 64 YIVGFYGAF--YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE 121
Query: 150 RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE-LYEED 208
+ ++HRD+K NI VN G++K+ D G++ L S A+S +GT +M+PE L
Sbjct: 122 KHQ-IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTH 178
Query: 209 YNELVDVYSFGMCVLEMFTCEYP 231
Y+ D++S G+ ++E+ YP
Sbjct: 179 YSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 60/192 (31%), Positives = 96/192 (50%), Gaps = 22/192 (11%)
Query: 71 DDLQRLY--SEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRV 128
D+ Q Y SE+H L+ H I++ + + D+ I E + G L + + K R
Sbjct: 105 DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK--LLLIMEYGSGGDLNK-QIKQRLK 161
Query: 129 DIRAIKSWA-----RQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183
+ + + QI+ L +HSR ++HRDLK NIF+ G +K+GD G +
Sbjct: 162 EHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMP-TGIIKLGDFGFSKQ 218
Query: 184 LRGSKS---AHSVIGTPEFMAPELYEED-YNELVDVYSFGMCVLEMFTCEYPYSECANPA 239
S S A S GTP ++APEL+E Y++ D++S G+ + E+ T P+ P+
Sbjct: 219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK---GPS 275
Query: 240 Q--IYKKVTSGK 249
Q I ++V GK
Sbjct: 276 QREIMQQVLYGK 287
|
Length = 478 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 57/209 (27%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 32 FEEVLGKGAMKTVY----KAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL- 86
F VLGKG+ V K DE+ +++ V + + DD++ E +L+
Sbjct: 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQD-----DDVECTMVEKRVLALPG 58
Query: 87 KHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVY 146
K + + ++ + +D+ F+ E G L + ++ + +A +I GL +
Sbjct: 59 KPPFLTQLHSCFQTMDR--LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFF 116
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSKSAHSVIGTPEFMAPE-- 203
LHS+ +I+RDLK DN+ ++ G +KI D G+ + G K+ + GTP+++APE
Sbjct: 117 LHSKG--IIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII 173
Query: 204 LYEEDYNELVDVYSFGMCVLEMFTCEYPY 232
Y+ Y + VD ++FG+ + EM + P+
Sbjct: 174 AYQP-YGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 59/196 (30%), Positives = 96/196 (48%), Gaps = 13/196 (6%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
E LG+G TV+K ++ VA ++RL +P R EV LL LKH +I+
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVT 68
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRV-DIRAIKSWARQILQGLVYLHSRDP 152
+ I K+ + E + L++Y + + +K + QIL+GL Y H R
Sbjct: 69 LHD--IVHTDKSLTLVFE-YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK- 124
Query: 153 PVIHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRGSKSAHSVIGTPEFMAPE--LYEEDY 209
V+HRDLK N+ +N G++K+ D GLA A +K+ + + T + P+ L +Y
Sbjct: 125 -VLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 210 NELVDVYSFGMCVLEM 225
+ +D++ G EM
Sbjct: 183 STQIDMWGVGCIFFEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 64/238 (26%), Positives = 109/238 (45%), Gaps = 15/238 (6%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95
+G GA +V A D G+ VA +L+ +S +R Y E+ LL +KH+++I
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82
Query: 96 TSWIDVDQ-KTFN--FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDP 152
+ + FN ++ L K + D ++ QIL+GL Y+HS D
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD-DHVQFLIYQILRGLKYIHSAD- 140
Query: 153 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYEE--DYN 210
+IHRDLK N+ VN ++KI D GLA + + + T + APE+ YN
Sbjct: 141 -IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMTGY--VATRWYRAPEIMLNWMHYN 196
Query: 211 ELVDVYSFGMCVLEMFTCE--YPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFI 266
+ VD++S G + E+ T +P ++ + ++ ++ I A+ +I
Sbjct: 197 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 254
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 53/221 (23%)
Query: 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQ---RLYSEVHLLSTLKHD 89
E +G GA V AID G +VA + ++ + D R E+ +L KHD
Sbjct: 10 IENIGSGAYGVVCSAIDTRSGKKVA-----IKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 90 SIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDI------RAIKS-------- 135
+II I ++ +++ Y +D+ I S
Sbjct: 65 NIIA---------------IRDILRP-PGADFKDVYVVMDLMESDLHHIIHSDQPLTEEH 108
Query: 136 ---WARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS 192
+ Q+L+GL Y+HS + VIHRDLK N+ VN +++IGD G+A L S + H
Sbjct: 109 IRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNED-CELRIGDFGMARGLSSSPTEHK 165
Query: 193 V-----IGTPEFMAPELY--EEDYNELVDVYSFGMCVL-EM 225
+ T + APEL +Y +D++S G C+ EM
Sbjct: 166 YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVG-CIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 39/129 (30%), Positives = 71/129 (55%), Gaps = 6/129 (4%)
Query: 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVN 167
FI ++ G L + ++ + ++ +A +I+ GL ++H+R V++RDLK NI ++
Sbjct: 74 FILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLD 131
Query: 168 GHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYEED--YNELVDVYSFGMCVLEM 225
H G V+I DLGLA K H+ +GT +MAPE+ ++ Y+ D +S G + ++
Sbjct: 132 EH-GHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKL 189
Query: 226 FTCEYPYSE 234
P+ +
Sbjct: 190 LRGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 81/329 (24%), Positives = 146/329 (44%), Gaps = 30/329 (9%)
Query: 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVH-LLSTLKHDSIIR 93
V+GKG+ V A + G A +V + + + + + +E + LL +KH ++
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPP 153
+ S+ D+ F+ + G L + ++ R + +A +I L YLHS +
Sbjct: 61 LHYSFQTADK--LYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN-- 116
Query: 154 VIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSKSAHSVIGTPEFMAPE-LYEEDYNE 211
+I+RDLK +NI ++ G V + D GL + SK+ + GTPE++APE L ++ Y+
Sbjct: 117 IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDR 175
Query: 212 LVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL---PGAFYSIQDLEAQRFIGR 268
VD + G + EM P+ + A++Y + + L P S + L G
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFY-SRDTAEMYDNILNKPLRLKPNISVSARHL----LEGL 230
Query: 269 CLVNASKRLSAKELLLD----PFLASDEVKLLSKTKLNQK---PFLNETELEKLQLSD-D 320
+ +KRL AK+ L+ F +S ++ L K P N + L D
Sbjct: 231 LQKDRTKRLGAKDDFLEIKNHVFFSS-----INWDDLVNKKITPPFNPNVSGPMDLKHFD 285
Query: 321 PPRTDMTITGKLNPEDDTIFLKVQIADKD 349
P T+ + + D++ + + + D
Sbjct: 286 PEFTEEPVPNSVGKSPDSVLVSASVKEAD 314
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVN 167
+ G L + ++ R D+ + + ++L L LH + VI+RDLK +NI ++
Sbjct: 70 LVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD 127
Query: 168 GHLGQVKIGDLGLAAI-LRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEM 225
+ G + + D GL + ++ ++ GTPE++APEL Y + VD ++ G+ + EM
Sbjct: 128 -YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEM 186
Query: 226 FTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLVNA-SKRL---SAKE 281
T P+ + N ++Y+K+ P F D +A+ + L ++RL A+E
Sbjct: 187 LTGLPPFYD-ENVNEMYRKILQE--PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQE 243
Query: 282 LLLDPFLASDEVKLLSKTKLNQKPF 306
+ PF + K L + Q PF
Sbjct: 244 IKNHPFFSQLSWKKLLMKGI-QPPF 267
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 32 FEEVLGKGAMKTVY----KAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLS-TL 86
F VLGKG+ V K DE+ +++ V + + DD++ E +L+ +
Sbjct: 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD-----DDVECTMVEKRVLALSG 58
Query: 87 KHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVY 146
K + + ++ + +D+ F+ E G L ++ R +A +I GL +
Sbjct: 59 KPPFLTQLHSCFQTMDR--LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFF 116
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA--ILRGSKSAHSVIGTPEFMAPEL 204
LHS+ +I+RDLK DN+ ++ G +KI D G+ + G + + GTP+++APE+
Sbjct: 117 LHSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDGV-TTKTFCGTPDYIAPEI 172
Query: 205 YE-EDYNELVDVYSFGMCVLEMFTCEYPY 232
+ Y + VD ++FG+ + EM + P+
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 22/194 (11%)
Query: 78 SEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK--S 135
+E +L+ L+H ++R Y V Q+ ITE +G+L ++ K + + K
Sbjct: 50 AEANLMKQLQHPRLVRLYAV---VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLID 106
Query: 136 WARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-SAHSVI 194
A QI +G+ ++ ++ IHRDL+ NI V+ L KI D GLA ++ ++ +A
Sbjct: 107 MAAQIAEGMAFIERKN--YIHRDLRAANILVSETL-CCKIADFGLARLIEDNEYTAREGA 163
Query: 195 GTP-EFMAPELYEEDYNELV---DVYSFGMCVLEMFTC-EYPYSECANPAQI------YK 243
P ++ APE +Y DV+SFG+ + E+ T PY NP I Y+
Sbjct: 164 KFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR 221
Query: 244 KVTSGKLPGAFYSI 257
P Y +
Sbjct: 222 MPRPDNCPEELYEL 235
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 52/204 (25%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 35 VLGKGAMKTV----YKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDS 90
V+G+G+ V K + ++V EL+ +D+ + +E H+ T +
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVI-----KKELVNDDEDIDWVQTEKHVFETASNHP 56
Query: 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSR 150
+ S + + F F+ E + G L + ++ R++ + ++ +I L +LH R
Sbjct: 57 FLVGLHSCFQTESRLF-FVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER 115
Query: 151 DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSKSAHSVIGTPEFMAPE-LYEED 208
+I+RDLK DN+ ++ G +K+ D G+ +R + + GTP ++APE L ED
Sbjct: 116 G--IIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 209 YNELVDVYSFGMCVLEMFTCEYPY 232
Y VD ++ G+ + EM P+
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 50/204 (24%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 35 VLGKGAMKTVY----KAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDS 90
V+G+G+ V K D++ ++V EL+ +D+ + +E H+ +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVV-----KKELVHDDEDIDWVQTEKHVFEQASSNP 56
Query: 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSR 150
+ S + F + E G L + ++ R++ + +A +I L +LH R
Sbjct: 57 FLVGLHSCFQTTSRLF-LVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115
Query: 151 DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSKSAHSVIGTPEFMAPELYE-ED 208
+I+RDLK DN+ ++ G +K+ D G+ L + + GTP ++APE+ E+
Sbjct: 116 G--IIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 209 YNELVDVYSFGMCVLEMFTCEYPY 232
Y VD ++ G+ + EM P+
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 51/173 (29%), Positives = 85/173 (49%), Gaps = 20/173 (11%)
Query: 69 SPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRV 128
SP+ + E ++ L+HD +++ Y + +++ +TE + G+L ++ K
Sbjct: 44 SPEAFLQ---EAQIMKKLRHDKLVQLYA--VCSEEEPIYIVTEYMSKGSLLDFLKSGEGK 98
Query: 129 DIRAIK--SWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186
+R + A QI +G+ YL SR+ IHRDL NI V +L KI D GLA ++
Sbjct: 99 KLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENL-VCKIADFGLARLIED 155
Query: 187 SK-SAHSVIGTP-EFMAPELYEEDYNELV---DVYSFGMCVLEMFT---CEYP 231
+ +A P ++ APE +Y DV+SFG+ + E+ T YP
Sbjct: 156 DEYTAREGAKFPIKWTAPE--AANYGRFTIKSDVWSFGILLTEIVTYGRVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
RY + +EV+GKG+ V AID G +VA ++ N++ D R+ E+ LL L+
Sbjct: 1 RYKI-QEVIGKGSYGVVCSAIDTHTGEKVAIKKI--NDVFEHVSDATRILREIKLLRLLR 57
Query: 88 HDSIIRFYTSWIDVDQKTFNFITEMF--TSGTLREYRKKYRRVDIRAIKSWARQILQGLV 145
H I+ + ++ F I +F L + K + + + Q+L+ L
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALK 117
Query: 146 YLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSV-----IGTPEFM 200
Y+H+ + V HRDLK NI N ++KI D GLA + + + ++ + T +
Sbjct: 118 YIHTAN--VFHRDLKPKNILANADC-KLKICDFGLARVAF-NDTPTAIFWTDYVATRWYR 173
Query: 201 APEL---YEEDYNELVDVYSFGMCVLEMFT 227
APEL + Y +D++S G E+ T
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLT 203
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 5e-11
Identities = 47/180 (26%), Positives = 85/180 (47%), Gaps = 15/180 (8%)
Query: 116 GTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKI 175
G L + KK ++ +K RQ+++ L LH + +IH D+K +N+ + ++ +
Sbjct: 94 GDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYL 151
Query: 176 GDLGLAAILRGSKSAHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPY-- 232
D GL I G+ S + GT ++ +PE + +Y+ D ++ G+ E+ T ++P+
Sbjct: 152 CDYGLCKI-IGTPSCYD--GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE 208
Query: 233 --SECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCL-VNASKRLSA-KELLLDPFL 288
E + + K KLP F A F+ L N + RL+ E++ PFL
Sbjct: 209 DEDEELDLESL-LKRQQKKLP--FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 7/106 (6%)
Query: 123 KKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182
+ R + + + + ARQ+L + Y+H +IHRD+K +N+ VNG + +GD G A
Sbjct: 252 ARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGP-EDICLGDFGAAC 308
Query: 183 ILRGSKSA---HSVIGTPEFMAPELYEED-YNELVDVYSFGMCVLE 224
RGS S + + GT + APE+ D Y VD++S G+ + E
Sbjct: 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
++LGKG V ++ G A ++ E++ + D++ +E +L +H +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILK-KEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPP 153
S+ D+ F+ E G L + + R + + +I+ L YLHS D
Sbjct: 60 LKYSFQTHDR--LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD-- 115
Query: 154 VIHRDLKCDNIFVNGHLGQVKIGDLGLA--AILRGSKSAHSVIGTPEFMAPELYEE-DYN 210
V++RDLK +N+ ++ G +KI D GL I G+ + GTPE++APE+ E+ DY
Sbjct: 116 VVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMK-TFCGTPEYLAPEVLEDNDYG 173
Query: 211 ELVDVYSFGMCVLEMFTCEYPY 232
VD + G+ + EM P+
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 6e-11
Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 26/204 (12%)
Query: 69 SPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY--RKKYR 126
P D E ++ L+H +I+ Y + ++ +TE+ G+L EY R
Sbjct: 44 DPKDFLA---EAQIMKKLRHPKLIQLYA--VCTLEEPIYIVTELMKYGSLLEYLQGGAGR 98
Query: 127 RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186
+ + + A Q+ G+ YL +++ IHRDL N+ V + K+ D GLA +++
Sbjct: 99 ALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGEN-NICKVADFGLARVIKE 155
Query: 187 SK-SAHSVIGTP-EFMAPELYEEDYNELV---DVYSFGMCVLEMFT-CEYPYSECANPAQ 240
A P ++ APE YN DV+SFG+ + E+ T PY N A+
Sbjct: 156 DIYEAREGAKFPIKWTAPE--AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-AE 212
Query: 241 IYKKVTSG-------KLPGAFYSI 257
+ ++V G P Y I
Sbjct: 213 VLQQVDQGYRMPCPPGCPKELYDI 236
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 55/209 (26%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 32 FEEVLGKGAMKTVY----KAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL- 86
F VLGKG+ V K DE+ +++ V + + DD++ E +L+
Sbjct: 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD-----DDVECTMVEKRVLALQD 58
Query: 87 KHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVY 146
K + + ++ + VD+ F+ E G L + ++ + +A +I GL +
Sbjct: 59 KPPFLTQLHSCFQTVDR--LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFF 116
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA--AILRGSKSAHSVIGTPEFMAPEL 204
LH R +I+RDLK DN+ ++ G +KI D G+ ++ G + + GTP+++APE+
Sbjct: 117 LHRRG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKEHMVDGV-TTRTFCGTPDYIAPEI 172
Query: 205 YE-EDYNELVDVYSFGMCVLEMFTCEYPY 232
+ Y + VD +++G+ + EM + P+
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 8e-11
Identities = 47/156 (30%), Positives = 79/156 (50%), Gaps = 12/156 (7%)
Query: 79 EVHLLSTLKHDSIIRFYTSWIDV--DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSW 136
E+ +L L+H++++ + I+V +K + E L + K +D ++ +
Sbjct: 50 EIRMLKQLRHENLV----NLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKY 105
Query: 137 ARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS-VIG 195
QIL+G+ + HS + +IHRD+K +NI V+ G VK+ D G A L ++ +
Sbjct: 106 LFQILRGIEFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYTDYVA 162
Query: 196 TPEFMAPELYEED--YNELVDVYSFGMCVLEMFTCE 229
T + APEL D Y VD+++ G V EM T E
Sbjct: 163 TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 8e-11
Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 47/215 (21%)
Query: 32 FEEV--LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYS--EVHLLSTLK 87
FE++ +G+G VY+A D G VA +VR++ D + + S E+ LL L+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMD---NERDGIP-ISSLREITLLLNLR 64
Query: 88 HDSIIRFY--------TSWIDV----DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKS 135
H +I+ S V +Q + + M T + +K
Sbjct: 65 HPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFS------------ESQVKC 112
Query: 136 WARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIG 195
Q+L+GL YLH +IHRDLK N+ + G +KI D GLA A +
Sbjct: 113 LMLQLLRGLQYLHEN--FIIHRDLKVSNLLLTDK-GCLKIADFGLAR--TYGLPAKPM-- 165
Query: 196 TPE-----FMAPELY--EEDYNELVDVYSFGMCVL 223
TP+ + APEL Y +D+++ G C+L
Sbjct: 166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVG-CIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 39/129 (30%), Positives = 70/129 (54%), Gaps = 6/129 (4%)
Query: 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVN 167
FI ++ G L + ++ ++ +A +I+ GL ++H+R V++RDLK NI ++
Sbjct: 74 FILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD 131
Query: 168 GHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYEED--YNELVDVYSFGMCVLEM 225
H G V+I DLGLA K H+ +GT +MAPE+ ++ Y+ D +S G + ++
Sbjct: 132 EH-GHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 189
Query: 226 FTCEYPYSE 234
P+ +
Sbjct: 190 LRGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 13/196 (6%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95
LG+G TV+K ++ VA ++RL +P R EV LL LKH +I+ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKNLKHANIVTLH 69
Query: 96 TSWIDVDQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPV 154
I ++ + E S L++Y + + +K + Q+L+GL Y H R +
Sbjct: 70 D--IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--I 124
Query: 155 IHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRGSKSAHSVIGTPEFMAPE--LYEEDYNE 211
+HRDLK N+ +N G++K+ D GLA A +K+ + + T + P+ L +Y+
Sbjct: 125 LHRDLKPQNLLINEK-GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 212 LVDVYSFGMCVLEMFT 227
+D++ G + EM T
Sbjct: 184 PIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 48/171 (28%), Positives = 89/171 (52%), Gaps = 16/171 (9%)
Query: 79 EVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRK--KYRRVDIRAIKSW 136
E +++ TL+HD +++ + V ++ ITE G+L ++ K + + + + +
Sbjct: 51 EANVMKTLQHDKLVKLHAV---VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 107
Query: 137 ARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-SAHSVIG 195
+ QI +G+ ++ R+ IHRDL+ NI V+ L KI D GLA ++ ++ +A
Sbjct: 108 SAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGAK 164
Query: 196 TP-EFMAPELYEEDYNELV---DVYSFGMCVLEMFTC-EYPYSECANPAQI 241
P ++ APE ++ DV+SFG+ ++E+ T PY +NP I
Sbjct: 165 FPIKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 58/195 (29%), Positives = 96/195 (49%), Gaps = 11/195 (5%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
E LG+G+ TVYK +V G VA +RL E +P R E LL LKH +I+
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR---EASLLKGLKHANIVL 67
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPP 153
+ I ++T + E + + K + +K + Q+L+GL Y+H R
Sbjct: 68 LHD--IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR--Y 123
Query: 154 VIHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRGSKSAHSVIGTPEFMAPE--LYEEDYN 210
++HRDLK N+ ++ G++K+ D GLA A S + + + T + P+ L +Y+
Sbjct: 124 ILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 211 ELVDVYSFGMCVLEM 225
+D++ G +EM
Sbjct: 183 TCLDMWGVGCIFVEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 49/145 (33%), Positives = 75/145 (51%), Gaps = 11/145 (7%)
Query: 139 QILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA--AILRGSKSAHSVIGT 196
+I L +LH + +I+RDLK +NI ++ G VK+ D GL +I G+ + H+ GT
Sbjct: 108 EISLALEHLHQQG--IIYRDLKPENILLD-AQGHVKLTDFGLCKESIHEGTVT-HTFCGT 163
Query: 197 PEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFY 255
E+MAPE L + + VD +S G + +M T P++ N + K+ GKL Y
Sbjct: 164 IEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT-AENRKKTIDKILKGKLNLPPY 222
Query: 256 SIQDLEAQRFIGRCLV-NASKRLSA 279
EA+ + + L N S RL A
Sbjct: 223 LTP--EARDLLKKLLKRNPSSRLGA 245
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 66/281 (23%), Positives = 126/281 (44%), Gaps = 30/281 (10%)
Query: 73 LQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRA 132
+ ++SE +L+ + H + Y S+ D+ + E G + ++ +R
Sbjct: 75 VDHVFSERKILNYINHPFCVNLYGSF--KDESYLYLVLEFVIGGEFFTFLRRNKRFPNDV 132
Query: 133 IKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS 192
+A QI+ YL S + +++RDLK +N+ ++ G +K+ D G A ++ ++
Sbjct: 133 GCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKD-GFIKMTDFGFAKVV--DTRTYT 187
Query: 193 VIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP 251
+ GTPE++APE L + + D ++ G+ + E+ P+ P IY+K+ G +
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY-ANEPLLIYQKILEGII- 245
Query: 252 GAFYSIQDLEAQRFIGRCLV-NASKRL-----SAKELLLDPFLAS-DEVKLLSKT----- 299
F D + + + L + +KR A+ + P+ + D V LL K
Sbjct: 246 -YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPY 304
Query: 300 KLNQKPFLNETELEKLQLSDDPPRTDMTITGKLNPEDDTIF 340
K K + + E++Q D+TI K+ E+D F
Sbjct: 305 KPKYKNVFDSSNFERVQ-------EDLTIADKITNENDPFF 338
|
Length = 340 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 65/237 (27%), Positives = 100/237 (42%), Gaps = 34/237 (14%)
Query: 36 LGKGAMKTVYK--AIDEVLGVEVAWNQVRLNELMRSPDDLQR--LYSEVHLLSTLKHDSI 91
LG GA VY+ A D LG +V + L + D ++ E HL+S H +I
Sbjct: 3 LGSGAFGEVYEGTATDI-LGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRR----------VDIRAIKSWARQIL 141
++ + + + I E+ G L Y + R ++ I +
Sbjct: 62 VKLLG--VCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDI---CLDVA 116
Query: 142 QGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQ----VKIGDLGLAAILRGS----KSAHSV 193
+G VYL IHRDL N V+ VKIGD GLA + S K +
Sbjct: 117 KGCVYL--EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 194 IGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
+ +MAPE L + + DV+SFG+ + E+ T + PY N ++ + VT+G
Sbjct: 175 LPV-RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-QEVLQHVTAG 229
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 49/171 (28%), Positives = 88/171 (51%), Gaps = 11/171 (6%)
Query: 73 LQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR--RVDI 130
+Q E +L+ TL+HD ++R Y + ++ ITE G+L ++ K +V +
Sbjct: 45 VQAFLEEANLMKTLQHDKLVRLYA--VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLL 102
Query: 131 RAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-S 189
+ ++ QI +G+ Y+ ++ IHRDL+ N+ V+ L KI D GLA ++ ++ +
Sbjct: 103 PKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESL-MCKIADFGLARVIEDNEYT 159
Query: 190 AHSVIGTP-EFMAPELYE-EDYNELVDVYSFGMCVLEMFTC-EYPYSECAN 237
A P ++ APE + DV+SFG+ + E+ T + PY +N
Sbjct: 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 79/286 (27%), Positives = 135/286 (47%), Gaps = 36/286 (12%)
Query: 34 EVLGKGAMKTVYKAIDEVLG----VEVAWNQVRLNELMRSPDDLQRLYSEVH-LLSTLKH 88
+V+GKG+ V A ++ G V+V ++ LN + + + +E + LL +KH
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR-----KEQKHIMAERNVLLKNVKH 55
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLH 148
++ + S+ ++ F+ + G L + ++ R + +A +I L YLH
Sbjct: 56 PFLVGLHYSFQTTEK--LYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH 113
Query: 149 SRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSKSAHSVIGTPEFMAPE-LYE 206
S + +++RDLK +NI ++ G V + D GL + S + + GTPE++APE + +
Sbjct: 114 SIN--IVYRDLKPENILLDS-QGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK 170
Query: 207 EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL---PGAFYSIQDLEAQ 263
+ Y+ VD + G + EM P+ C + A++Y + L PGA L A
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLPPFY-CRDVAEMYDNILHKPLVLRPGA-----SLTAW 224
Query: 264 RFIGRCL-VNASKRLSAKELLLD----PFLASDEVKLLSKTKLNQK 304
+ L + +RL AKE L+ PF S LS T L QK
Sbjct: 225 SILEELLEKDRQRRLGAKEDFLEIQEHPFFES-----LSWTDLEQK 265
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 21/221 (9%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95
LG G VY+ + + + VA ++ + M ++ E ++ +KH ++++
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTME----VEEFLKEAAVMKEIKHPNLVQLL 68
Query: 96 TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK--SWARQILQGLVYLHSRDPP 153
+ + F ITE T G L +Y ++ R ++ A+ A QI + YL ++
Sbjct: 69 G--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 154 VIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SKSAHSVIGTP-EFMAPE-LYEEDYN 210
IHRDL N V + VK+ D GL+ ++ G + +AH+ P ++ APE L ++
Sbjct: 125 FIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 183
Query: 211 ELVDVYSFGMCVLEMFT---CEYPYSECANPAQIYKKVTSG 248
DV++FG+ + E+ T YP + +Q+Y+ + G
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKG 221
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 66/259 (25%), Positives = 117/259 (45%), Gaps = 37/259 (14%)
Query: 10 AADEAKAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAI----DEVLGVEVAWNQVRLNE 65
A DEA A + +Y + VLG GA TV A E V+V V +
Sbjct: 21 AKDEATAK------EQAKKYWI-SRVLGSGATGTVLCAKRVSDGEPFAVKV----VDMEG 69
Query: 66 LMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT------FNFITEMFTSGTLR 119
+ S D R +EV L SI++ + + D + + + +G LR
Sbjct: 70 M--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLR 127
Query: 120 EYRKKYRRVDIRAIKSWAR-----QILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVK 174
+ K + + R + Q+L + ++HS+ +IHRD+K NI + + G VK
Sbjct: 128 QEIKSRAKTN-RTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSN-GLVK 183
Query: 175 IGDLGLAAILRGSKS---AHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEY 230
+GD G + + + S + GTP ++APE++ Y++ D++S G+ + E+ T +
Sbjct: 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
Query: 231 PYSECANPAQIYKKVTSGK 249
P+ + N ++ K +G+
Sbjct: 244 PF-DGENMEEVMHKTLAGR 261
|
Length = 496 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 29/231 (12%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
E +GKG VYK + + EVA R PD ++ E +L H +I++
Sbjct: 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTL---PPDLKRKFLQEAEILKQYDHPNIVK 56
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVYLHSRDP 152
+ V ++ + E+ G+L + RKK R+ ++ + + G+ YL S++
Sbjct: 57 LIG--VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN- 113
Query: 153 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGT--------P-EFMAPE 203
IHRDL N V G +KI D G+ S+ I T P ++ APE
Sbjct: 114 -CIHRDLAARNCLV-GENNVLKISDFGM------SREEEGGIYTVSDGLKQIPIKWTAPE 165
Query: 204 -LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG-KLP 251
L Y DV+S+G+ + E F+ + PY +N Q +++ SG ++P
Sbjct: 166 ALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-QQTRERIESGYRMP 215
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 53/219 (24%), Positives = 105/219 (47%), Gaps = 8/219 (3%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
+V+GKG+ V A + A ++ +++ ++ + LL +KH ++
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPP 153
+ S+ D+ F+ + G L + ++ R + +A +I L YLHS +
Sbjct: 61 LHFSFQTADK--LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN-- 116
Query: 154 VIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSKSAHSVIGTPEFMAPE-LYEEDYNE 211
+++RDLK +NI ++ G + + D GL + + + + GTPE++APE L+++ Y+
Sbjct: 117 IVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175
Query: 212 LVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL 250
VD + G + EM P+ N A++Y + + L
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPL 213
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 8e-10
Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 4/98 (4%)
Query: 136 WARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIG 195
+A +I GL LH +++RDLK +NI ++ + G ++I DLGLA + ++ +G
Sbjct: 107 YAAEITCGLEDLHRER--IVYRDLKPENILLDDY-GHIRISDLGLAVEIPEGETIRGRVG 163
Query: 196 TPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPY 232
T +MAPE+ + E Y D + G + EM + P+
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 8e-10
Identities = 35/101 (34%), Positives = 55/101 (54%), Gaps = 12/101 (11%)
Query: 133 IKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR--GS--K 188
+K Q+L G+ +LH ++HRDLK N+ +N + G +KI D GLA R GS K
Sbjct: 108 VKCLMLQLLSGVAHLHDN--WILHRDLKTSNLLLN-NRGILKICDFGLA---REYGSPLK 161
Query: 189 SAHSVIGTPEFMAPELY--EEDYNELVDVYSFGMCVLEMFT 227
++ T + APEL ++Y+ +D++S G E+ T
Sbjct: 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 9e-10
Identities = 56/194 (28%), Positives = 89/194 (45%), Gaps = 11/194 (5%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95
+G GA V A D VLG+ VA +L+ ++ +R Y E+ LL + H +II
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVK--KLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 96 TSWIDVDQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQILQGLVYLHSRDP 152
+ QK+ +++ L + + + +D + Q+L G+ +LHS
Sbjct: 87 NVF--TPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG- 143
Query: 153 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE-LYEEDYNE 211
+IHRDLK NI V +KI D GLA + + T + APE + Y E
Sbjct: 144 -IIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKE 201
Query: 212 LVDVYSFGMCVLEM 225
VD++S G + E+
Sbjct: 202 NVDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 34/202 (16%)
Query: 72 DLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY---------- 121
D QR E LL+ L+H+ I++FY D D F E G L ++
Sbjct: 53 DFQR---EAELLTNLQHEHIVKFYGVCGDGDPLIMVF--EYMKHGDLNKFLRAHGPDAMI 107
Query: 122 ------RKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKI 175
R+ + + + A QI G+VYL S+ +HRDL N V +L VKI
Sbjct: 108 LVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANL-LVKI 164
Query: 176 GDLGLAAILRGSK----SAHSVIGTPEFMAPE--LYEEDYNELVDVYSFGMCVLEMFTC- 228
GD G++ + + H+++ +M PE +Y + E DV+SFG+ + E+FT
Sbjct: 165 GDFGMSRDVYSTDYYRVGGHTMLPI-RWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYG 222
Query: 229 EYPYSECANPAQIYKKVTSGKL 250
+ P+ + + ++ + +T G++
Sbjct: 223 KQPWFQLS-NTEVIECITQGRV 243
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 37/117 (31%), Positives = 58/117 (49%), Gaps = 14/117 (11%)
Query: 139 QILQGLVYLHSRDPPVIHRDLKCDNIFVN--GHLGQVKIGDLGLAAILRGSKSA------ 190
Q+L L H++ ++HRDLK NI V+ G K+ D G+ +L G + A
Sbjct: 87 QVLDALACAHNQG--IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT 144
Query: 191 --HSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKK 244
V+GTP + APE L E D+Y++G+ LE T + + A+ A+I +
Sbjct: 145 RTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ-RVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 38/101 (37%), Positives = 53/101 (52%), Gaps = 17/101 (16%)
Query: 133 IKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS 192
+S+ QIL GL Y+HS + V+HRDLK N+ VN ++KI D GLA RG
Sbjct: 107 FQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNAD-CELKICDFGLA---RGFSENPG 160
Query: 193 V--------IGTPEFMAPE--LYEEDYNELVDVYSFGMCVL 223
+ T + APE L + Y + +DV+S G C+L
Sbjct: 161 ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVG-CIL 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 42/223 (18%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQ------VRLNELMRSPDDLQRLYSEVHLLSTL-KH 88
LG+G V +A E G++ + V++ + + DL L SE+ L+ + KH
Sbjct: 20 LGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR----------------RVDIRA 132
+II + + I E G LRE+ + R ++ +
Sbjct: 78 KNIINLLG--VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 133 IKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG------ 186
+ S A Q+ +G+ YL SR IHRDL N+ V +KI D GLA RG
Sbjct: 136 LVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTED-NVMKIADFGLA---RGVHDIDY 189
Query: 187 -SKSAHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFT 227
K+++ + ++MAPE L++ Y DV+SFG+ + E+FT
Sbjct: 190 YKKTSNGRLPV-KWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 49/172 (28%), Positives = 86/172 (50%), Gaps = 10/172 (5%)
Query: 82 LLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQIL 141
LL LKH ++ + S+ +K + F+ + G L + ++ R + +A ++
Sbjct: 49 LLKNLKHPFLVGLHYSF-QTAEKLY-FVLDYVNGGELFFHLQRERCFLEPRARFYAAEVA 106
Query: 142 QGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSKSAHSVIGTPEFM 200
+ YLHS + +I+RDLK +NI ++ G V + D GL + ++ + GTPE++
Sbjct: 107 SAIGYLHSLN--IIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTSTFCGTPEYL 163
Query: 201 APE-LYEEDYNELVDVYSFGMCVLEMFTCEYP-YSECANPAQIYKKVTSGKL 250
APE L +E Y+ VD + G + EM P YS + +Q+Y + L
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR--DVSQMYDNILHKPL 213
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 57/228 (25%), Positives = 96/228 (42%), Gaps = 50/228 (21%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95
+G+GA V A + +VA ++ + D +R E+ LL L H+++I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKI--ANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70
Query: 96 TSWIDVDQKTFN---FITEMF---------TSGTLREYRKKYRRVDIRAIKSWARQILQG 143
++ FN + E+ +S TL + +Y + Q+L+G
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQY----------FLYQLLRG 120
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFM--- 200
L Y+HS + V+HRDLK N+ +N + +KI D GLA R + +FM
Sbjct: 121 LKYIHSAN--VLHRDLKPSNLLLNANC-DLKICDFGLA---RTTSEKG------DFMTEY 168
Query: 201 -------APELY--EEDYNELVDVYSFGMCVLEMFTCE--YPYSECAN 237
APEL +Y +DV+S G E+ + +P + +
Sbjct: 169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH 216
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 63/228 (27%), Positives = 100/228 (43%), Gaps = 45/228 (19%)
Query: 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMR--SPDDLQRLYSEVHLLSTLKHDSII 92
LG+G V KA L + V + L S +L+ L SE +LL + H +I
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 93 RFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRV-------------------DIRAI 133
+ Y + I E G+LR + ++ R+V D RA+
Sbjct: 67 KLYGAC--SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 134 K-----SWARQILQGLVYLHSRDPPVIHRDLKCDNIFV-NGHLGQVKIGDLGLA------ 181
S+A QI +G+ YL + ++HRDL N+ V G ++KI D GL+
Sbjct: 125 TMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGR--KMKISDFGLSRDVYEE 180
Query: 182 -AILRGSKSAHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFT 227
+ ++ SK V ++MA E L++ Y DV+SFG+ + E+ T
Sbjct: 181 DSYVKRSKGRIPV----KWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 60/266 (22%), Positives = 115/266 (43%), Gaps = 24/266 (9%)
Query: 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDD--LQRLYSEVHLLSTLKHDSII 92
LG+G V+ A + + E V + L ++ D+ E+ + L H +++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 93 RFYTSWIDVDQKTFNFITEMFTSGTLREY---------RKKYRRVDIRAIKSWARQILQG 143
R + + I E G L+++ + K + + + QI G
Sbjct: 72 RLLGLCREAE--PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 144 LVYLH-SRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH--SVIGTPEFM 200
+ +L +R +HRDL N V+ +VK+ L L+ + S+ + + ++
Sbjct: 130 MDHLSNAR---FVHRDLAARNCLVSSQR-EVKVSLLSLSKDVYNSEYYKLRNALIPLRWL 185
Query: 201 APE-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258
APE + E+D++ DV+SFG+ + E+FT E P+ ++ ++ ++ +GKL
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-EEVLNRLQAGKLELPVPEGC 244
Query: 259 DLEAQRFIGRC-LVNASKRLSAKELL 283
+ + RC VN R S EL+
Sbjct: 245 PSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 49/201 (24%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 31 LFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDS 90
+GKG V G +VA ++ + Q +E +++TL+H +
Sbjct: 9 KLGATIGKGEFGDVMLGD--YRGQKVAVKCLKDDSTA-----AQAFLAEASVMTTLRHPN 61
Query: 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRA-IKSWARQILQGLVYLH 148
+++ + + +TE G+L +Y R + R V A +A + +G+ YL
Sbjct: 62 LVQLLG--VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 149 SRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTP-EFMAPE-LYE 206
++ +HRDL N+ V+ L K+ D GLA + + P ++ APE L E
Sbjct: 120 EKN--FVHRDLAARNVLVSEDL-VAKVSDFGLA---KEASQGQDSGKLPVKWTAPEALRE 173
Query: 207 EDYNELVDVYSFGMCVLEMFT 227
+ ++ DV+SFG+ + E+++
Sbjct: 174 KKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 43/159 (27%), Positives = 69/159 (43%), Gaps = 24/159 (15%)
Query: 78 SEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKK-YRRVDIRA---- 132
E+ +L T+ H +II + + M + +Y+ + VD
Sbjct: 135 REIDILKTISHRAIINL------IHAYRWKSTVCM----VMPKYKCDLFTYVDRSGPLPL 184
Query: 133 --IKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA 190
+ R++L+ L YLH R +IHRD+K +NIF++ +GD G A L
Sbjct: 185 EQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEP-ENAVLGDFGAACKLDAHPDT 241
Query: 191 ---HSVIGTPEFMAPELYEED-YNELVDVYSFGMCVLEM 225
+ GT E +PEL D Y D++S G+ + EM
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 48/184 (26%), Positives = 76/184 (41%), Gaps = 59/184 (32%)
Query: 155 IHRDLKCDNIFV--NGHLGQVKIGDLGL------------AAILRGSKS----------- 189
IHRD+K DN+ + GH +K+ D GL IL +
Sbjct: 123 IHRDIKPDNLLLDAKGH---IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPM 179
Query: 190 ----------------AHSVIGTPEFMAPELYEED-YNELVDVYSFGMCVLEMFTCEYP- 231
A+S +GTP+++APE++ + YN+ D +S G+ + EM YP
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV-GYPP 238
Query: 232 -YSECANPAQIYKKVTSGKLPGAFYSIQDL----EAQRFIGRCLVNASKRL---SAKELL 283
S+ NP + Y+K+ + K ++ EA+ I R A +RL E+
Sbjct: 239 FCSD--NPQETYRKIINWK--ETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIK 294
Query: 284 LDPF 287
PF
Sbjct: 295 SHPF 298
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRL-NELMRSPDDLQRLYSEVHLLSTLKHDSIIRF 94
+G+G V+KA + VA +V + NE P R E+ +L LKH++++
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR---EIKILQLLKHENVVNL 76
Query: 95 Y------TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLH 148
+ + + +F + E K + + IK + +L GL Y+H
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 149 SRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH-----SVIGTPEFMAPE 203
++HRD+K NI + G +K+ D GLA SK++ + + T + PE
Sbjct: 137 RNK--ILHRDMKAANILITKD-GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193
Query: 204 LY--EEDYNELVDVYSFGMCVLEMFT 227
L E DY +D++ G + EM+T
Sbjct: 194 LLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 6e-09
Identities = 65/230 (28%), Positives = 104/230 (45%), Gaps = 20/230 (8%)
Query: 33 EEVLGKGAMKTVYKAIDEVLG-VEVAWNQVRLNELMRSPDDLQR--LYSEVHLLSTLKHD 89
++V+G G V++ I ++ G EVA V + L + QR SE ++ H
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVA---VAIKTLKPGYTEKQRQDFLSEASIMGQFSHH 66
Query: 90 SIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVYLH 148
+IIR + K ITE +G L +Y R + R I G+ YL
Sbjct: 67 NIIRL--EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL- 123
Query: 149 SRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA-HSVIGTP---EFMAPE- 203
D +HRDL NI VN +L + K+ D GL+ +L ++ G + APE
Sbjct: 124 -SDMNYVHRDLAARNILVNSNL-ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA 181
Query: 204 LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG-KLP 251
+ + DV+SFG+ + E+ + E PY + +N ++ K + G +LP
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAINDGFRLP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 6e-09
Identities = 35/102 (34%), Positives = 58/102 (56%), Gaps = 5/102 (4%)
Query: 133 IKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA-ILRGSKSAH 191
+K + ++ L +LHS +I+RDLK +NI ++ G +K+ D GL+ + K A+
Sbjct: 100 VKFYLAELALALDHLHSLG--IIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAY 156
Query: 192 SVIGTPEFMAPELY-EEDYNELVDVYSFGMCVLEMFTCEYPY 232
S GT E+MAPE+ + + D +SFG+ + EM T P+
Sbjct: 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 15/238 (6%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRF- 94
+G GA +V A D L +VA +L+ +S +R Y E+ LL +KH+++I
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVK--KLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 95 --YTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDP 152
+T ++ ++ L K + D ++ Q+L+GL Y+HS
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSD-EHVQFLIYQLLRGLKYIHSAG- 138
Query: 153 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE--LYEEDYN 210
+IHRDLK N+ VN +++I D GLA + + T + APE L YN
Sbjct: 139 -IIHRDLKPSNVAVNEDC-ELRILDFGLAR--QADDEMTGYVATRWYRAPEIMLNWMHYN 194
Query: 211 ELVDVYSFGMCVLEMFTCE--YPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFI 266
+ VD++S G + E+ + +P ++ + + +V P I A+++I
Sbjct: 195 QTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYI 252
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 8e-09
Identities = 31/96 (32%), Positives = 57/96 (59%), Gaps = 6/96 (6%)
Query: 138 RQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA--HSVIG 195
+Q+L + Y+H + +IHRD+K +NIF+N G++ +GD G A + A + +G
Sbjct: 274 KQLLCAVEYIHDK--KLIHRDIKLENIFLNCD-GKIVLGDFGTAMPFEKEREAFDYGWVG 330
Query: 196 TPEFMAPELYEED-YNELVDVYSFGMCVLEMFTCEY 230
T +PE+ D Y E+ D++S G+ +L+M + ++
Sbjct: 331 TVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366
|
Length = 501 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 9e-09
Identities = 53/194 (27%), Positives = 90/194 (46%), Gaps = 27/194 (13%)
Query: 136 WARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIG 195
+A +IL GL LH + ++RDLK +NI ++ + G ++I DLGLA + +S +G
Sbjct: 107 YAAEILCGLEDLHREN--TVYRDLKPENILLDDY-GHIRISDLGLAVKIPEGESIRGRVG 163
Query: 196 TPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPY---SECANPAQIYKKVTSGKLP 251
T +MAPE L + Y D + G + EM + P+ E ++ ++V +
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE-- 221
Query: 252 GAFYSIQDLEAQRFIGRCLV--NASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNE 309
YS + E + I + L+ + +RL +E + EVK + PF
Sbjct: 222 -EVYSAKFSEEAKSICKMLLTKDPKQRLGCQE------EGAGEVK--------RHPFFRN 266
Query: 310 TELEKLQLSD-DPP 322
++L+ DPP
Sbjct: 267 MNFKRLEAGMLDPP 280
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 54/209 (25%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 111 EMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHL 170
EMFT R+ + ++ ++ +I+ L +LH +++RD+K +NI ++
Sbjct: 91 EMFTHLYQRDNFSE------DEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSE- 141
Query: 171 GQVKIGDLGLAA--ILRGSKSAHSVIGTPEFMAPELY--EEDYNELVDVYSFGMCVLEMF 226
G V + D GL+ + + +S GT E+MAPE+ + + + VD +S G+ + E+
Sbjct: 142 GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201
Query: 227 TCEYPYS---ECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRL----- 277
T P++ E +++ +++ K F S EAQ + + L + KRL
Sbjct: 202 TGASPFTLEGERNTQSEVSRRIL--KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQ 259
Query: 278 SAKELLLDPFLASDEVKLLSKTKLNQKPF 306
A E+ PF + + L+ K+N PF
Sbjct: 260 GASEIKEHPFFKGLDWEALALRKVN-PPF 287
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 58/208 (27%), Positives = 86/208 (41%), Gaps = 37/208 (17%)
Query: 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRF 94
+G GA V A D V G VA +L+ ++ +R Y E+ L+ + H +II
Sbjct: 23 PIGSGAQGIVCAAYDTVTGQNVAIK--KLSRPFQNVTHAKRAYRELVLMKLVNHKNIIG- 79
Query: 95 YTSWIDVDQKTFNFITEMFT-SGTLREYRKKY---------------RRVDIRAIKSWAR 138
+ +FT +L E++ Y +D +
Sbjct: 80 --------------LLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLY 125
Query: 139 QILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPE 198
Q+L G+ +LHS +IHRDLK NI V +KI D GLA S + T
Sbjct: 126 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRY 182
Query: 199 FMAPE-LYEEDYNELVDVYSFGMCVLEM 225
+ APE + Y E VD++S G + EM
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEM 210
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 45/155 (29%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 79 EVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRK--KYRRVDIRAIKSW 136
E ++ L+HD +++ Y V ++ +TE + G+L ++ K + R + + +
Sbjct: 51 EAQIMKKLRHDKLVQLYAV---VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM 107
Query: 137 ARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-SAHSVIG 195
A Q+ G+ Y+ + IHRDL+ NI V L KI D GLA ++ ++ +A
Sbjct: 108 AAQVAAGMAYIERMN--YIHRDLRSANILVGDGL-VCKIADFGLARLIEDNEYTARQGAK 164
Query: 196 TP-EFMAPE--LYEEDYNELVDVYSFGMCVLEMFT 227
P ++ APE LY + DV+SFG+ + E+ T
Sbjct: 165 FPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 47/196 (23%), Positives = 94/196 (47%), Gaps = 19/196 (9%)
Query: 69 SPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRV 128
S +DL+ L E+ L+H +I+ + TS+I D + + ++ + G+ + K +
Sbjct: 39 SKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-DSELY-VVSPLMAYGSCEDLLKTHFPE 96
Query: 129 DIR--AIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-AILR 185
+ AI + +L L Y+HS+ IHR +K +I ++G G+V + L + ++++
Sbjct: 97 GLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGD-GKVVLSGLRYSVSMIK 153
Query: 186 GSKSAHSVIGTPEF-------MAPELYEED---YNELVDVYSFGMCVLEMFTCEYPYSEC 235
K V P+ ++PE+ +++ YNE D+YS G+ E+ P+ +
Sbjct: 154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD- 212
Query: 236 ANPAQIYKKVTSGKLP 251
Q+ + G +P
Sbjct: 213 MPATQMLLEKVRGTVP 228
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 47/176 (26%), Positives = 87/176 (49%), Gaps = 13/176 (7%)
Query: 79 EVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWA 137
E ++ L H+ +++ Y + Q+ +TE ++G L Y R+ +R +
Sbjct: 49 EAKVMMKLSHEKLVQLYG--VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMC 106
Query: 138 RQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTP 197
+ + +G+ YL S+ IHRDL N V+ G VK+ D GL+ + + SV G+
Sbjct: 107 KDVCEGMAYLESKQ--FIHRDLAARNCLVDDQ-GCVKVSDFGLSRYVLDDEYTSSV-GSK 162
Query: 198 ---EFMAPE-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
+ PE L ++ DV++FG+ + E+++ + PY E N ++ +KV+ G
Sbjct: 163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPY-ERFNNSETVEKVSQG 217
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 33/100 (33%), Positives = 56/100 (56%), Gaps = 4/100 (4%)
Query: 136 WARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIG 195
+A +I GL LH +++RDLK +NI ++ H G ++I DLGLA + ++ +G
Sbjct: 107 YAAEICCGLEDLHQER--IVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVG 163
Query: 196 TPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSE 234
T +MAPE+ + E Y D ++ G + EM + P+ +
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 49/191 (25%), Positives = 92/191 (48%), Gaps = 14/191 (7%)
Query: 63 LNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY- 121
+NE S +D E ++ L H +++ Y + QK +TE +G L Y
Sbjct: 36 INEGAMSEEDF---IEEAKVMMKLSHPKLVQLYG--VCTQQKPLYIVTEFMENGCLLNYL 90
Query: 122 RKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181
R++ ++ + S + + +G+ YL IHRDL N V+ G VK+ D G+
Sbjct: 91 RQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSS-TGVVKVSDFGMT 147
Query: 182 A-ILRGSKSAHSVIGTP-EFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECAN 237
+L ++ S P ++ PE++ Y+ DV+SFG+ + E+FT + P+ + +N
Sbjct: 148 RYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN 207
Query: 238 PAQIYKKVTSG 248
++ + ++ G
Sbjct: 208 -YEVVEMISRG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 36/220 (16%)
Query: 36 LGKGAMKTVYKAIDEVLGVE------VAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KH 88
LG+G V A E +G++ V V++ + + DL L SE+ ++ + KH
Sbjct: 26 LGEGCFGQVVMA--EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR----------------RVDIRA 132
+II + I E + G LREY + R ++ +
Sbjct: 84 KNIINLLGAC--TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 133 IKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA----ILRGSK 188
+ S A Q+ +G+ YL S+ IHRDL N+ V +KI D GLA I K
Sbjct: 142 LVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKK 198
Query: 189 SAHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFT 227
+ + + ++MAPE L++ Y DV+SFG+ + E+FT
Sbjct: 199 TTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 62/236 (26%), Positives = 112/236 (47%), Gaps = 29/236 (12%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQR-LYSEVHLLSTLKHDSIIRF 94
LG+GA V+ A L E V + L + D+ ++ + E LL+ L+H+ I++F
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 95 YTSWIDVDQKTFNFITEMFTSGTLREYRKKY-------------RRVDIRAIKSWARQIL 141
Y ++ D F E G L ++ + + + + A+QI
Sbjct: 73 YGVCVEGDPLIMVF--EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 142 QGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK----SAHSVIGTP 197
G+VYL S+ +HRDL N V +L VKIGD G++ + + H+++
Sbjct: 131 AGMVYLASQH--FVHRDLATRNCLVGENL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPI- 186
Query: 198 EFMAPE--LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSGKL 250
+M PE +Y + E DV+S G+ + E+FT + P+ + +N ++ + +T G++
Sbjct: 187 RWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSN-NEVIECITQGRV 240
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 38/147 (25%), Positives = 65/147 (44%), Gaps = 13/147 (8%)
Query: 155 IHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSV--IGTPEFMAPELYEE----- 207
+HRD+K +N+ ++ G +K+ D G AA L +K +S +GTP+++APE+
Sbjct: 124 VHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 208 --DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL--EAQ 263
Y D +S G+ EM P+ E A+ Y + + + F + +
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMNFQRFLKFPEDPKVSSDFL 241
Query: 264 RFIGRCLVNASKRLSAKELLLDPFLAS 290
I L +RL + L PF +
Sbjct: 242 DLIQSLLCGQKERLGYEGLCCHPFFSK 268
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 34 EVLGKGAMKTVYKAI----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHD 89
++LG G TV+K I + + + VA ++ + Q + + + +L H
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVA---IKTIQDRSGRQTFQEITDHMLAMGSLDHA 69
Query: 90 SIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLH 148
I+R + +T++ G+L ++ +++R +D + + +W QI +G+ YL
Sbjct: 70 YIVRLLGI---CPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126
Query: 149 SRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL--RGSKSAHSVIGTP-EFMAPE-L 204
++HR+L NI + V+I D G+A +L K +S TP ++MA E +
Sbjct: 127 EHR--MVHRNLAARNILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 205 YEEDYNELVDVYSFGMCVLEMFT 227
Y DV+S+G+ V EM +
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 67/240 (27%), Positives = 107/240 (44%), Gaps = 37/240 (15%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPD----DLQRLYSEVHLLSTLKHDSI 91
LG+GA V+ A L E V + L + + D QR E LL+ L+H I
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTVLQHQHI 69
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR---------------RVDIRAIKSW 136
+RFY + + + + E G L + + + ++ + + +
Sbjct: 70 VRFYG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 137 ARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGT 196
A QI G+VYL S +HRDL N V L VKIGD G++ + S + V G
Sbjct: 128 ASQIASGMVYLASLH--FVHRDLATRNCLVGQGL-VVKIGDFGMSRDIY-STDYYRVGGR 183
Query: 197 P----EFMAPE--LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSGK 249
+M PE LY + E D++SFG+ + E+FT + P+ + +N I + +T G+
Sbjct: 184 TMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAI-ECITQGR 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 5e-08
Identities = 51/216 (23%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
E++G+G V + E G +VA ++ + Q E +++ L H +++R
Sbjct: 12 EIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTA------QAFLEETAVMTKLHHKNLVR 63
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRR--VDIRAIKSWARQILQGLVYLHSRD 151
+ + E+ + G L + + R V + + ++ + +G+ YL S+
Sbjct: 64 LLGVIL---HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK 120
Query: 152 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE-LYEEDYN 210
++HRDL NI V+ G K+ D GLA + GS + ++ APE L + ++
Sbjct: 121 --LVHRDLAARNILVSED-GVAKVSDFGLARV--GSMGVDNSKLPVKWTAPEALKHKKFS 175
Query: 211 ELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVT 246
DV+S+G+ + E+F+ Y P K+V
Sbjct: 176 SKSDVWSYGVLLWEVFS----YGRAPYPKMSLKEVK 207
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 25/205 (12%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWN---QVRLNELMRSPDDLQRLYSEVHLLSTLKH 88
E LG+G V+ WN +V + L + E ++ L+H
Sbjct: 10 LEVKLGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH 60
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIR--AIKSWARQILQGLVY 146
+ +++ Y V ++ +TE + G+L ++ K +R + A QI G+ Y
Sbjct: 61 EKLVQLYAV---VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 117
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-SAHSVIGTP-EFMAPE- 203
+ + +HRDL+ NI V +L K+ D GLA ++ ++ +A P ++ APE
Sbjct: 118 VERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 204 -LYEEDYNELVDVYSFGMCVLEMFT 227
LY + DV+SFG+ + E+ T
Sbjct: 175 ALYGR-FTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 36/220 (16%)
Query: 36 LGKGAMKTVYKAIDEVLGV------EVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KH 88
LG+G V A E LG+ E V++ + + DL L SE+ ++ + KH
Sbjct: 23 LGEGCFGQVVMA--EALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR----------------RVDIRA 132
+II + I E + G LREY + R ++ +
Sbjct: 81 KNIINLLGAC--TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 133 IKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG----SK 188
+ S Q+ +G+ YL S+ IHRDL N+ V + +KI D GLA + K
Sbjct: 139 LVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKIADFGLARDVNNIDYYKK 195
Query: 189 SAHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFT 227
+ + + ++MAPE L++ Y DV+SFG+ + E+FT
Sbjct: 196 TTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 8e-08
Identities = 49/192 (25%), Positives = 91/192 (47%), Gaps = 16/192 (8%)
Query: 63 LNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY- 121
+ E S DD E ++ L H ++++ Y + Q+ +TE +G L Y
Sbjct: 36 IREGAMSEDDF---IEEAKVMMKLSHPNLVQLYG--VCTKQRPIFIVTEYMANGCLLNYL 90
Query: 122 RKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181
R++ ++ + + + + YL S IHRDL N V G VK+ D GLA
Sbjct: 91 RERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLV-GEDNVVKVSDFGLA 147
Query: 182 AILRGSKSAHSVIGTP---EFMAPELYE-EDYNELVDVYSFGMCVLEMFTC-EYPYSECA 236
+ + S GT ++ PE+++ ++ DV+SFG+ + E+F+ + PY +
Sbjct: 148 RYVLDDQYTSSQ-GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS 206
Query: 237 NPAQIYKKVTSG 248
N +++ + V++G
Sbjct: 207 N-SEVVESVSAG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 9e-08
Identities = 51/186 (27%), Positives = 70/186 (37%), Gaps = 52/186 (27%)
Query: 155 IHRDLKCDNIFVNGHLGQVKIGDLGLAAILR---GSK----------------------- 188
IHRD+K DNI ++ G +K+ D GL R SK
Sbjct: 123 IHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181
Query: 189 ------------------SAHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCE 229
AHS++GTP ++APE L Y +L D +S G+ + EM +
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
Query: 230 YPYSECANPAQIYKKVTSGKLPGAFYSIQDL--EAQRFIGRCLVNASKRL---SAKELLL 284
P+ PA+ KV + + S L EA I R A RL A E+
Sbjct: 242 PPFLA-DTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKA 300
Query: 285 DPFLAS 290
PF
Sbjct: 301 HPFFKG 306
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 53/174 (30%), Positives = 82/174 (47%), Gaps = 20/174 (11%)
Query: 79 EVHLLSTLKHDSIIRFYTSWID-VDQKT---FNF----ITEMFTSGTLREYRKKYRRVDI 130
E+ LL LKH ++I ++ D+K F++ + + + KK ++
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 107
Query: 131 RAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNG---HLGQVKIGDLGLAAI---- 183
+KS QIL G+ YLH+ V+HRDLK NI V G G+VKI D+G A +
Sbjct: 108 GMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 184 LRGSKSAHSVIGTPEFMAPELY--EEDYNELVDVYSFGMCVLEMFTCEYPYSEC 235
L+ V+ T + APEL Y + +D+++ G E+ T E P C
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHC 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 53/174 (30%), Positives = 82/174 (47%), Gaps = 20/174 (11%)
Query: 79 EVHLLSTLKHDSIIRFYTSWID-VDQKT---FNF----ITEMFTSGTLREYRKKYRRVDI 130
E+ LL LKH ++I ++ D+K F++ + + + KK ++
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPR 107
Query: 131 RAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNG---HLGQVKIGDLGLAAI---- 183
+KS QIL G+ YLH+ V+HRDLK NI V G G+VKI D+G A +
Sbjct: 108 SMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 184 LRGSKSAHSVIGTPEFMAPELY--EEDYNELVDVYSFGMCVLEMFTCEYPYSEC 235
L+ V+ T + APEL Y + +D+++ G E+ T E P C
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHC 218
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 66/236 (27%), Positives = 100/236 (42%), Gaps = 42/236 (17%)
Query: 31 LFEEVLGKGAMKTVY----KAIDEVLGVE----------VAWNQVRLNELMRSPDDLQRL 76
+E LG+G V+ + + E LG VA +R + + +D +
Sbjct: 8 RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLK- 66
Query: 77 YSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTL------REYRKKYRR--- 127
E+ ++S LK+ +IIR + V ITE +G L RE +
Sbjct: 67 --EIKIMSRLKNPNIIRLLG--VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN 122
Query: 128 ---VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184
V I + A QI G+ YL S + +HRDL N V H +KI D G++ L
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHY-TIKIADFGMSRNL 179
Query: 185 RGSKSAHSVIGTP----EFMAPE-LYEEDYNELVDVYSFGMCVLEMFT-C-EYPYS 233
S + + G +MA E + + DV++FG+ + EMFT C E PYS
Sbjct: 180 Y-SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 51/181 (28%), Positives = 90/181 (49%), Gaps = 16/181 (8%)
Query: 79 EVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSW 136
E ++ L+HD ++ Y V ++ +TE G+L ++ K+ + + + +
Sbjct: 51 EAQIMKKLRHDKLVPLYAV---VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM 107
Query: 137 ARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-SAHSVIG 195
A QI G+ Y+ + IHRDL+ NI V +L KI D GLA ++ ++ +A
Sbjct: 108 AAQIADGMAYIERMN--YIHRDLRAANILVGDNL-VCKIADFGLARLIEDNEYTARQGAK 164
Query: 196 TP-EFMAPE--LYEEDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSG-KL 250
P ++ APE LY + DV+SFG+ + E+ T PY N ++ ++V G ++
Sbjct: 165 FPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVN-REVLEQVERGYRM 222
Query: 251 P 251
P
Sbjct: 223 P 223
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 17/228 (7%)
Query: 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRL--YSEVHLLSTLKHDS 90
E+V+G G V + ++ G + V + L D QRL +E ++ H +
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEI--DVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVYLHS 149
IIR + + ITE +G+L ++ R+ + + + R I G+ YL
Sbjct: 67 IIRLEG--VVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE 124
Query: 150 RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIG--TP-EFMAPE-LY 205
+ +HRDL NI VN +L K+ D GL+ L S++ ++ G P + APE +
Sbjct: 125 MN--YVHRDLAARNILVNSNL-VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA 181
Query: 206 EEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG-KLP 251
+ DV+SFG+ + E+ + E PY + +N + K V G +LP
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDGYRLP 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 43/116 (37%), Positives = 61/116 (52%), Gaps = 10/116 (8%)
Query: 139 QILQGLVYLHSRDPPVIHRDLKCDNIFV-NGHLGQVKIGDLGLAA-ILRGSK--SAHSVI 194
Q+ G+ +L S++ +HRDL N+ + G L VKI D GLA I+R S S S
Sbjct: 247 QVANGMEFLASKN--CVHRDLAARNVLICEGKL--VKICDFGLARDIMRDSNYISKGSTF 302
Query: 195 GTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
++MAPE ++ Y L DV+SFG+ + E+FT PY E Q Y + G
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRG 358
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 38/128 (29%), Positives = 70/128 (54%), Gaps = 12/128 (9%)
Query: 128 VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFV-NGHLGQVKIGDLGLAAILRG 186
+D+ + ++ Q+ QG+ +L S++ IHRD+ N+ + +G + KI D GLA +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRV--AKICDFGLARDIM- 263
Query: 187 SKSAHSVIGTP----EFMAPE-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQ 240
+ S + V G ++MAPE +++ Y DV+S+G+ + E+F+ + PY ++
Sbjct: 264 NDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK 323
Query: 241 IYKKVTSG 248
YK V G
Sbjct: 324 FYKMVKRG 331
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 69/249 (27%), Positives = 103/249 (41%), Gaps = 34/249 (13%)
Query: 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRLNEL--MRSPDDLQRLYSEVHLLSTLKHDSII 92
LG GA VY+ + + QV + L S D E ++S H +I+
Sbjct: 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72
Query: 93 RFYTSWIDVD-QKTFNFIT-EMFTSGT----LREYRKKYRRVDIRAIKSW---ARQILQG 143
R I V ++ FI E+ G LRE R + R +K AR + +G
Sbjct: 73 RL----IGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVN--GHLGQVKIGDLGLAA-ILRGS---KSAHSVIGTP 197
YL IHRD+ N + G KI D G+A I R S K +++
Sbjct: 129 CKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI- 185
Query: 198 EFMAPELYEED-YNELVDVYSFGMCVLEMFTCEY-PYSECANPAQIYKKVTSG------- 248
++M PE + + + DV+SFG+ + E+F+ Y PY N ++ + VT G
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEVMEFVTGGGRLDPPK 244
Query: 249 KLPGAFYSI 257
PG Y I
Sbjct: 245 GCPGPVYRI 253
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 46/226 (20%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVE-------VAWNQVRLNELMRSPDDLQRLYSEVHLLSTL 86
+ LG+GA V KA E +G++ VA V++ + + DL L SE+ ++ +
Sbjct: 18 KPLGEGAFGQVVKA--EAVGLDNPNETSTVA---VKMLKDDATEKDLSDLVSEMEMMKMI 72
Query: 87 -KHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR----------------RVD 129
KH +II + + + E G LR++ + R +
Sbjct: 73 GKHKNIINLLG--VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 130 IRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFV-NGHLGQVKIGDLGLAAIL---- 184
+ + S+A Q+ +G+ +L S+ IHRDL N+ V H+ +KI D GLA +
Sbjct: 131 QKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDHV--MKIADFGLARDIHHID 186
Query: 185 --RGSKSAHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFT 227
R + + + ++MAPE L++ Y DV+SFG+ + E+FT
Sbjct: 187 YYRKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 28/178 (15%)
Query: 72 DLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR---- 126
DL L SE+ ++ + KH +II + + E + G LREY + R
Sbjct: 60 DLSDLVSEMEMMKMIGKHKNIINLLGAC--TQDGPLYVLVEYASKGNLREYLRARRPPGM 117
Query: 127 ------------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVK 174
++ + + S A Q+ +G+ YL S+ IHRDL N+ V +K
Sbjct: 118 DYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTED-NVMK 174
Query: 175 IGDLGLAAILRG----SKSAHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFT 227
I D GLA + K+ + + ++MAPE L++ Y DV+SFG+ + E+FT
Sbjct: 175 IADFGLARDVHNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 34 EVLGKGAMKTVYKA-IDEVLGVEVAWNQVRLNELMRSPDDLQ-RLYSEVHLLSTLKHDSI 91
E+LGKG V+K + + V V + L P +L+ + SE +L H +I
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL------PQELKIKFLSEARILKQYDHPNI 54
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVYLHSR 150
++ + ++ + E+ G + RKK + + + +A G+ YL S+
Sbjct: 55 VKLIG--VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112
Query: 151 DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSKSAHSVIGTP-EFMAPE-LYEE 207
+ IHRDL N V G +KI D G++ G S+ + P ++ APE L
Sbjct: 113 N--CIHRDLAARNCLV-GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYG 169
Query: 208 DYNELVDVYSFGMCVLEMFT---CEYP 231
Y+ DV+S+G+ + E F+ C YP
Sbjct: 170 RYSSESDVWSYGILLWETFSLGVCPYP 196
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 56/194 (28%), Positives = 86/194 (44%), Gaps = 11/194 (5%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95
+G GA V A D VL VA +L+ ++ +R Y E+ L+ + H +II
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 96 TSWIDVDQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQILQGLVYLHSRDP 152
+ QK+ +++ L + + +D + Q+L G+ +LHS
Sbjct: 83 NVF--TPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG- 139
Query: 153 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE-LYEEDYNE 211
+IHRDLK NI V +KI D GLA S + T + APE + Y E
Sbjct: 140 -IIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE 197
Query: 212 LVDVYSFGMCVLEM 225
VD++S G + EM
Sbjct: 198 NVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 39/136 (28%), Positives = 71/136 (52%), Gaps = 17/136 (12%)
Query: 155 IHRDLKCDNIFVNGHLGQVKIGDLGLAAILR--GSKSAHSVIGTPEFMAPELYE--ED-- 208
+HRD+K DN+ ++ + G +++ D G L G+ ++ +GTP++++PE+ + ED
Sbjct: 124 VHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182
Query: 209 --YNELVDVYSFGMCVLEMFTCEYP-YSECANPAQIYKKVTSGK----LPGAFYSIQDLE 261
Y D +S G+C+ EM E P Y+E + + Y K+ + K P + + E
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKEHFQFPPDVTDVSE-E 239
Query: 262 AQRFIGRCLVNASKRL 277
A+ I R + + RL
Sbjct: 240 AKDLIRRLICSPETRL 255
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 43/137 (31%), Positives = 73/137 (53%), Gaps = 19/137 (13%)
Query: 155 IHRDLKCDNIF--VNGHLGQVKIGDLG--LAAILRGSKSAHSVIGTPEFMAPELYE--ED 208
+HRD+K DN+ +NGH +++ D G L G+ + +GTP++++PE+ + ED
Sbjct: 124 VHRDIKPDNVLLDMNGH---IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 209 ----YNELVDVYSFGMCVLEMFTCEYP-YSECANPAQIYKKVTSGKLPGAFYS-IQDL-- 260
Y D +S G+C+ EM E P Y+E + + Y K+ + + F S I D+
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHEERFQFPSHITDVSE 238
Query: 261 EAQRFIGRCLVNASKRL 277
EA+ I R + + +RL
Sbjct: 239 EAKDLIQRLICSRERRL 255
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 5e-07
Identities = 60/280 (21%), Positives = 118/280 (42%), Gaps = 39/280 (13%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
++LGKG + V+ + G A +V + M + ++R+ +E +L+TL H +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFAL-KVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPT 65
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRD 151
Y S + + + G L ++ + + + +A ++L L YLH
Sbjct: 66 LYAS-FQTE-TYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG 123
Query: 152 PPVIHRDLKCDNIFV--NGHL--------------GQVKIGDLG-------LAAILRGSK 188
+++RDLK +NI + +GH+ L + +I +
Sbjct: 124 --IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181
Query: 189 SA------HSVIGTPEFMAPELYEED-YNELVDVYSFGMCVLEMFTCEYPYSECANPAQI 241
S +S +GT E++APE+ D + VD ++ G+ + EM P+ + +N +
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF-KGSNRDET 240
Query: 242 YKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAK 280
+ + ++ A+ I + LV + SKRL +K
Sbjct: 241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSK 280
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 37/132 (28%), Positives = 60/132 (45%), Gaps = 39/132 (29%)
Query: 155 IHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS--------------------------- 187
IHRD+K DN+ ++ G VK+ D GL L+ +
Sbjct: 123 IHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181
Query: 188 ---------KSAHSVIGTPEFMAPELY-EEDYNELVDVYSFGMCVLEMFTCEYPYSECAN 237
+ A+S +GTP+++APE++ + YN+L D +S G+ + EM YP
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI-GYPPFCSET 240
Query: 238 PAQIYKKVTSGK 249
P + Y+KV + K
Sbjct: 241 PQETYRKVMNWK 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 40/149 (26%), Positives = 80/149 (53%), Gaps = 17/149 (11%)
Query: 111 EMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHL 170
E+FT + RE R + ++ ++ +I+ L +LH +I+RD+K +NI ++ +
Sbjct: 91 ELFTHLSQRE------RFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSN- 141
Query: 171 GQVKIGDLGLAA--ILRGSKSAHSVIGTPEFMAPELY---EEDYNELVDVYSFGMCVLEM 225
G V + D GL+ + A+S GT E+MAP++ + +++ VD +S G+ + E+
Sbjct: 142 GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYEL 201
Query: 226 FTCEYPYS---ECANPAQIYKKVTSGKLP 251
T P++ E + A+I +++ + P
Sbjct: 202 LTGASPFTVDGEKNSQAEISRRILKSEPP 230
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 59/224 (26%), Positives = 93/224 (41%), Gaps = 39/224 (17%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLG-------VEVAWNQVRLNELMRSPDDLQRLYSEVHLLS 84
F E LG+GA VYK E+ G VA ++ N + + ++ E L+S
Sbjct: 9 FLEELGEGAFGKVYKG--ELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ---EAELMS 63
Query: 85 TLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY---RKKYRRV----DIRAIKS-- 135
L+H +I+ + ++ + E G L E+ + V +KS
Sbjct: 64 DLQHPNIVCLLG--VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121
Query: 136 -------WARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS- 187
A QI G+ YL S +HRDL N V L VKI D GL+ + +
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGL-TVKISDFGLSRDIYSAD 178
Query: 188 --KSAHSVIGTPEFMAPE--LYEEDYNELVDVYSFGMCVLEMFT 227
+ + +M PE LY + E D++SFG+ + E+F+
Sbjct: 179 YYRVQSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 38/132 (28%), Positives = 59/132 (44%), Gaps = 39/132 (29%)
Query: 155 IHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS--------------------------- 187
IHRD+K DN+ ++ G VK+ D GL L+ +
Sbjct: 123 IHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181
Query: 188 ---------KSAHSVIGTPEFMAPELYEED-YNELVDVYSFGMCVLEMFTCEYPYSECAN 237
+ A S +GTP+++APE++ + YN+L D +S G+ + EM YP
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI-GYPPFCSET 240
Query: 238 PAQIYKKVTSGK 249
P + YKKV + K
Sbjct: 241 PQETYKKVMNWK 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 39/136 (28%), Positives = 71/136 (52%), Gaps = 17/136 (12%)
Query: 155 IHRDLKCDNIFVNGHLGQVKIGDLG--LAAILRGSKSAHSVIGTPEFMAPELYE--ED-- 208
+HRD+K DNI ++ + G +++ D G L + G+ + +GTP++++PE+ + ED
Sbjct: 124 VHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 209 --YNELVDVYSFGMCVLEMFTCEYP-YSECANPAQIYKKVTSGK----LPGAFYSIQDLE 261
Y D +S G+C+ EM E P Y+E + + Y K+ + K P + + +
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKERFQFPAQVTDVSE-D 239
Query: 262 AQRFIGRCLVNASKRL 277
A+ I R + + RL
Sbjct: 240 AKDLIRRLICSREHRL 255
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 79 EVHLLSTLKHDSIIRFYTSWIDV--DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSW 136
E+ L + ++I++ Y ID+ D + I E T G LRE K + + +
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDM 127
Query: 137 ARQILQGLVYLHSRD--PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG--SKSAHS 192
A +GL L+ P +++L + V + ++KI GL IL K+ +
Sbjct: 128 AIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTEN-YKLKIICHGLEKILSSPPFKNVNF 183
Query: 193 VIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIY----KKVTSG 248
++ M +++ E Y D+YS G+ + E+FT + P+ E +IY K S
Sbjct: 184 MVYFSYKMLNDIFSE-YTIKDDIYSLGVVLWEIFTGKIPF-ENLTTKEIYDLIINKNNSL 241
Query: 249 KLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELL 283
KLP LE + + C ++ KR + KE+L
Sbjct: 242 KLPLD----CPLEIKCIVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 51/182 (28%), Positives = 85/182 (46%), Gaps = 14/182 (7%)
Query: 78 SEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR-RVDIRAIKSW 136
SE ++ H +II + K +TE +G+L + +K+ + + +
Sbjct: 54 SEASIMGQFDHPNIIHL--EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGM 111
Query: 137 ARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-KSAHSVIG 195
R I G+ YL D +HRDL NI VN +L K+ D GL+ +L ++A++ G
Sbjct: 112 LRGIASGMKYL--SDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTRG 168
Query: 196 TP---EFMAPE-LYEEDYNELVDVYSFGMCVLE-MFTCEYPYSECANPAQIYKKVTSG-K 249
+ APE + + DV+S+G+ + E M E PY E +N + K + G +
Sbjct: 169 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDVIKAIEEGYR 227
Query: 250 LP 251
LP
Sbjct: 228 LP 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 39/119 (32%), Positives = 63/119 (52%), Gaps = 8/119 (6%)
Query: 135 SWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA-ILRGSK--SAH 191
S+ Q+ +G+ +L S++ +HRDL N+ + VKI D GLA I+ S S
Sbjct: 241 SFTYQVARGMEFLASKN--CVHRDLAARNVLL-AQGKIVKICDFGLARDIMHDSNYVSKG 297
Query: 192 SVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
S ++MAPE +++ Y L DV+S+G+ + E+F+ PY + Y K+ SG
Sbjct: 298 STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSG 356
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 54/197 (27%), Positives = 86/197 (43%), Gaps = 12/197 (6%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95
+G GA V A D +L VA +L+ ++ +R Y E+ L+ + H +II
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 96 TSWIDVDQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQILQGLVYLHSRDP 152
+ QK+ +++ L + + +D + Q+L G+ +LHS
Sbjct: 90 NVF--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG- 146
Query: 153 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE-LYEEDYNE 211
+IHRDLK NI V +KI D GLA S + T + APE + Y E
Sbjct: 147 -IIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE 204
Query: 212 LVDVYSFGMCVLEMFTC 228
VD++S G C++
Sbjct: 205 NVDIWSVG-CIMGEMIK 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 40/127 (31%), Positives = 67/127 (52%), Gaps = 10/127 (7%)
Query: 128 VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187
+D + S++ Q+ +G+ +L S++ IHRDL NI + H KI D GLA +R +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLT-HGRITKICDFGLARDIR-N 266
Query: 188 KSAHSVIGTP----EFMAPE-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQI 241
S + V G ++MAPE ++ Y DV+S+G+ + E+F+ PY ++
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF 326
Query: 242 YKKVTSG 248
YK + G
Sbjct: 327 YKMIKEG 333
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 35/138 (25%), Positives = 64/138 (46%), Gaps = 11/138 (7%)
Query: 102 DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKC 161
D K + E G L Y V + K + +++ L +HS +IHRD+K
Sbjct: 114 DDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKP 170
Query: 162 DNIFVNGHLGQVKIGDLGLAAILRGSKSAH--SVIGTPEFMAPELYEED-----YNELVD 214
DN+ ++ H G +K+ D G + + + +GTP++++PE+ + Y D
Sbjct: 171 DNMLLDKH-GHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 229
Query: 215 VYSFGMCVLEMFTCEYPY 232
+S G+ + EM + P+
Sbjct: 230 WWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 32/219 (14%)
Query: 36 LGKG--AMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDD-LQRLYSEVHLLSTLKHDSII 92
+G+G + +VY A G V VR+ +L ++ L+ L +EV L +H +I+
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVT---VRITDLENCTEEHLKALQNEVVLSHFFRHPNIM 62
Query: 93 RFYTSWIDVDQKTFNFITEMFTS-GTLREYRKKY-----RRVDIRAIKSWARQILQGLVY 146
TSW ++ ++ F + G+ K Y I I A L+GL Y
Sbjct: 63 ---TSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGA---LRGLNY 116
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG-LAAILRGSKSAHSVIGTPEF------ 199
LH IHR++K +I ++G G V + L L +++R + A V P+F
Sbjct: 117 LHQNG--YIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP 173
Query: 200 -MAPELYEED---YNELVDVYSFGMCVLEMFTCEYPYSE 234
++PEL +D YN D+YS G+ E+ T P+ +
Sbjct: 174 WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 39/161 (24%), Positives = 80/161 (49%), Gaps = 17/161 (10%)
Query: 74 QRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRV-DIR 131
Q +E +++ L+H ++++ ++ ++ +TE G+L +Y R + R V
Sbjct: 44 QAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 102
Query: 132 AIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH 191
+ ++ + + + YL + + +HRDL N+ V+ K+ D GL +K A
Sbjct: 103 CLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSED-NVAKVSDFGL------TKEAS 153
Query: 192 SVIGTPE----FMAPE-LYEEDYNELVDVYSFGMCVLEMFT 227
S T + + APE L E+ ++ DV+SFG+ + E+++
Sbjct: 154 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 35/114 (30%), Positives = 55/114 (48%), Gaps = 14/114 (12%)
Query: 137 ARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL------AAILRGSKSA 190
A+Q+ G+ YL R +HRDL N V ++ VKI D GL A + S++
Sbjct: 136 AKQVAAGMAYLSERK--FVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKASEND 192
Query: 191 HSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEY-PYSECANPAQIY 242
I +M PE ++ Y DV+++G+ + E+F+ PY A+ IY
Sbjct: 193 AIPI---RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 50/182 (27%), Positives = 83/182 (45%), Gaps = 23/182 (12%)
Query: 69 SPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTS-GTLREYRKKYRR 127
S + L E LL L H +I+ + ++ F+ + + G L+ + ++ R
Sbjct: 48 SEIQVTLLLQESCLLYGLSHQNIL--PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRL 105
Query: 128 VDI--------RAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179
+ + + A QI G+ YLH R VIH+D+ N ++ L QVKI D
Sbjct: 106 GEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEEL-QVKITDNA 162
Query: 180 LAAILRGSKSAHSVIGTPE-----FMAPE-LYEEDYNELVDVYSFGMCVLEMFTC-EYPY 232
L+ L + +G E +MA E L ++Y+ DV+SFG+ + E+ T + PY
Sbjct: 163 LSRDL--FPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY 220
Query: 233 SE 234
E
Sbjct: 221 VE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 28/167 (16%)
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH------------ 191
L YLH+ ++HRDLK DN+ + +G +K+ D GL+ I S + +
Sbjct: 114 LEYLHNYG--IVHRDLKPDNLLITS-MGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 192 ----SVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVT 246
V GTPE++APE + + Y + VD ++ G+ + E P+ P +++ +V
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVI 229
Query: 247 SGKL--PGAFYSIQDLEAQRFIGRCL-VNASKRL---SAKELLLDPF 287
S + P ++ +AQ I R L N +RL A E+ F
Sbjct: 230 SDDIEWPEGDEALPA-DAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 4/98 (4%)
Query: 136 WARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIG 195
+A ++ GL L +++RDLK +NI ++ G ++I DLGLA + ++ +G
Sbjct: 107 YAAELCCGLEDLQRER--IVYRDLKPENILLDDR-GHIRISDLGLAVQIPEGETVRGRVG 163
Query: 196 TPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPY 232
T +MAPE + E Y D + G + EM + P+
Sbjct: 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 4e-06
Identities = 41/175 (23%), Positives = 82/175 (46%), Gaps = 11/175 (6%)
Query: 79 EVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWA 137
E ++ L H +++ Y + ++ + E G L +Y R + + +
Sbjct: 49 EAQVMMKLSHPKLVQLYG--VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMC 106
Query: 138 RQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK--SAHSVIG 195
+ +G+ YL S + VIHRDL N V G VK+ D G+ + + S+
Sbjct: 107 LDVCEGMAYLESSN--VIHRDLAARNCLV-GENQVVKVSDFGMTRFVLDDQYTSSTGTKF 163
Query: 196 TPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSG 248
++ +PE++ Y+ DV+SFG+ + E+F+ + PY +N +++ + + +G
Sbjct: 164 PVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-SEVVETINAG 217
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 45/193 (23%), Positives = 83/193 (43%), Gaps = 36/193 (18%)
Query: 41 MKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100
MK +K++++V N +R + +R H +I+R D
Sbjct: 32 MKKHFKSLEQV-------NNLREIQALRRLSP---------------HPNILRLIEVLFD 69
Query: 101 VDQKTFNFITEMFTSGTLREYRKKYRR-VDIRAIKSWARQILQGLVYLHSRDPPVIHRDL 159
+ E+ L E K +R + + +KS+ Q+L+ L ++H + HRD+
Sbjct: 70 RKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDI 126
Query: 160 KCDNIFVNGHLGQVKIGDLGLAAILRG--SKSAHSV-IGTPEFMAPE--LYEEDYNELVD 214
K +NI + + +K+ D G RG SK ++ I T + APE L + Y +D
Sbjct: 127 KPENILIKDDI--LKLADFGSC---RGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMD 181
Query: 215 VYSFGMCVLEMFT 227
+++ G E+ +
Sbjct: 182 IWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 7e-06
Identities = 64/253 (25%), Positives = 109/253 (43%), Gaps = 43/253 (16%)
Query: 60 QVRLNELMRS--PDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGT 117
+V + EL S PD+ EV L H ++++ I+ + + E G
Sbjct: 24 RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES--IPYLLVLEFCPLGD 81
Query: 118 LREYRKKYRRV-----DIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQ 172
L+ Y + R + ++ A ++ GL++LH D IH DL N + L
Sbjct: 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADL-S 138
Query: 173 VKIGDLGLAAILRGSKSAHSVIGTPE-------FMAPELYEEDYNELV--------DVYS 217
VKIGD GLA + T + ++APEL E +L+ +++S
Sbjct: 139 VKIGDYGLAL----EQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWS 194
Query: 218 FGMCVLEMFT-CEYPYSECANPAQIYKKVTSG---KLPGA----FYSIQDLEAQRFIGRC 269
G+ + E+FT + PY + ++ Q+ K+V KLP YS + E +F C
Sbjct: 195 LGVTMWELFTAADQPYPDLSD-EQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQF---C 250
Query: 270 LVNASKRLSAKEL 282
++ R +A+E+
Sbjct: 251 WLDPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 18/216 (8%)
Query: 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQR--LYSEVHLLSTLKHDS 90
EEV+G G V + ++ G V + L + QR SE ++ H +
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKRE--IFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVYLHS 149
II + + ITE +G L + R+ + + + R I G+ YL
Sbjct: 67 IIHL--EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL-- 122
Query: 150 RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGT-----P-EFMAPE 203
+ +HRDL NI VN +L K+ D GL+ L S + + P + APE
Sbjct: 123 SEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 204 -LYEEDYNELVDVYSFGMCVLE-MFTCEYPYSECAN 237
+ + DV+S+G+ + E M E PY + +N
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 49/185 (26%), Positives = 74/185 (40%), Gaps = 34/185 (18%)
Query: 73 LQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRA 132
+ EV +LS L +I R + I E +G L ++ +K+
Sbjct: 63 REDFLKEVKILSRLSDPNIARLLG--VCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 133 ---IKS--------WARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181
KS A QI G+ YL S + +HRDL N V G +KI D G+
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLV-GKNYTIKIADFGM- 176
Query: 182 AILRGSKSAHS-----VIGTP----EFMAPE-LYEEDYNELVDVYSFGMCVLEMFT-C-E 229
S++ +S V G +MA E + + DV++FG+ + E+ T C E
Sbjct: 177 -----SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231
Query: 230 YPYSE 234
PY
Sbjct: 232 QPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 30/77 (38%), Positives = 40/77 (51%), Gaps = 4/77 (5%)
Query: 131 RAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG--SK 188
+ I++ RQIL L LHS ++HRD+K NI + G KI DLG AA LR +
Sbjct: 255 KIIQTIMRQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY 312
Query: 189 SAHSVIGTPEFMAPELY 205
+ P + APE Y
Sbjct: 313 IPKEFLLDPRYAAPEQY 329
|
Length = 566 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 20/173 (11%)
Query: 136 WAR----QILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR--GSKS 189
WAR +++ L +HS IHRD+K DN+ ++ G +K+ D G + G
Sbjct: 143 WARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVR 199
Query: 190 AHSVIGTPEFMAPELYEED-----YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKK 244
+ +GTP++++PE+ + Y D +S G+ + EM + P+ + Y K
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSK 258
Query: 245 VTSGKLPGAFYSIQDL--EAQRFIGRCLVNASKRL---SAKELLLDPFLASDE 292
+ + K F D+ EA+ I L + RL +E+ F +D+
Sbjct: 259 IMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 33/100 (33%), Positives = 55/100 (55%), Gaps = 13/100 (13%)
Query: 135 SWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG------SK 188
S++ Q+ +G+ +L SR IHRDL NI ++ + VKI D GLA +
Sbjct: 177 SYSFQVARGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKG 233
Query: 189 SAHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFT 227
A + ++MAPE ++++ Y DV+SFG+ + E+F+
Sbjct: 234 DARLPL---KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 6e-05
Identities = 32/99 (32%), Positives = 47/99 (47%), Gaps = 14/99 (14%)
Query: 116 GTLREYRKKYRRV---------DIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFV 166
G L E+ +++ DI IK RQ+L GL LH ++HRD+K +N+ V
Sbjct: 285 GCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLV 342
Query: 167 NGHLGQVKIGDLGLAAILRGSKSAHSVIGT--PEFMAPE 203
GQVKI D G A + + + + G P + PE
Sbjct: 343 TVD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380
|
Length = 507 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 33/126 (26%), Positives = 58/126 (46%), Gaps = 10/126 (7%)
Query: 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNI-FV 166
+ E+ G L ++ +K + V + I Q+ G+ YL + +HRDL N+ V
Sbjct: 72 LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLV 129
Query: 167 NGHLGQVKIGDLGLAAILRGSKSAHSVIGTP----EFMAPE-LYEEDYNELVDVYSFGMC 221
H KI D GL+ L ++ + ++ APE + ++ DV+SFG+
Sbjct: 130 TQHYA--KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVL 187
Query: 222 VLEMFT 227
+ E F+
Sbjct: 188 MWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 47/191 (24%), Positives = 75/191 (39%), Gaps = 60/191 (31%)
Query: 155 IHRDLKCDNIFVNGHLGQVKIGDLGLAA------------ILRGSKS------------- 189
IHRD+K DNI ++ G +K+ D GL+ L KS
Sbjct: 123 IHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAV 181
Query: 190 -----------------------AHSVIGTPEFMAPELY-EEDYNELVDVYSFGMCVLEM 225
A+S +GTP+++APE++ ++ Y + D +S G + E
Sbjct: 182 DSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFEC 241
Query: 226 FTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL----EAQRFIGRCLVNASKRL---S 278
+P N + Y+K+ + + Y D+ EA+ I R + NA RL
Sbjct: 242 L-IGWPPFCSENSHETYRKIINWR--ETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGG 298
Query: 279 AKELLLDPFLA 289
A E+ PF
Sbjct: 299 AHEIKSHPFFR 309
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 58/283 (20%), Positives = 106/283 (37%), Gaps = 65/283 (22%)
Query: 67 MRSPDDLQR-----LYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY 121
+R D L R + +E +L+ ++ +++ Y S+ D D F+ + G +
Sbjct: 34 LRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD--NLYFVMDYIPGGDMMSL 91
Query: 122 RKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181
+ + + ++ + +H IHRD+K DNI ++ G +K+ D GL
Sbjct: 92 LIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLD-GHIKLTDFGLC 148
Query: 182 AILRGSKS------------------------------------------------AHSV 193
R + + AHS+
Sbjct: 149 TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSL 208
Query: 194 IGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG 252
+GTP ++APE L + Y +L D +S G+ + EM + P+ P + KV + +
Sbjct: 209 VGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFL-APTPTETQLKVINWENTL 267
Query: 253 AFYSIQDL--EAQRFIGRCLVNASKRL---SAKELLLDPFLAS 290
L EA I + +A +RL A ++ PF +
Sbjct: 268 HIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 31/110 (28%), Positives = 54/110 (49%), Gaps = 18/110 (16%)
Query: 136 WAR----QILQGLVYLHSRDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLAAILRGSKS 189
WAR +++ L +HS IHRD+K DN+ + +GHL K+ D G + +
Sbjct: 143 WARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHL---KLADFGTCMKMDANGM 197
Query: 190 AHS--VIGTPEFMAPELYEED-----YNELVDVYSFGMCVLEMFTCEYPY 232
+GTP++++PE+ + Y D +S G+ + EM + P+
Sbjct: 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 19/99 (19%)
Query: 139 QILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA--------ILRGSKSA 190
Q+ +G+ +L SR IHRDL NI ++ + VKI D GLA + +GS
Sbjct: 182 QVARGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGSAR- 237
Query: 191 HSVIGTP-EFMAPE-LYEEDYNELVDVYSFGMCVLEMFT 227
P ++MAPE ++++ Y DV+SFG+ + E+F+
Sbjct: 238 -----LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 38/170 (22%), Positives = 56/170 (32%), Gaps = 26/170 (15%)
Query: 136 WA--RQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSV 193
WA Q L L LH + L + + G A K+
Sbjct: 20 WAVCLQCLGALRELHRQAKS--GNILLTWDGLLKLD---------GSVAF----KTPEQS 64
Query: 194 IGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG 252
P FMAPE+ + Y E D+YS G+ + E E PY+E + I + + +G
Sbjct: 65 RPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD 124
Query: 253 AFYSIQDLEAQ-------RFIGRCLVNASK-RLSAKELLLDPFLASDEVK 294
+LE F+ C + R +A L E
Sbjct: 125 DPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAETL 174
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 54/258 (20%), Positives = 96/258 (37%), Gaps = 67/258 (25%)
Query: 31 LFEEV--LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQR-----LYSEVHLL 83
+F ++ LG GA V L +V + + +R D L R + +E +L
Sbjct: 2 MFVKIKTLGIGAFGEV------CLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDIL 55
Query: 84 STLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQG 143
+ ++ ++R Y S+ D D F+ + G + + + + ++
Sbjct: 56 AEADNEWVVRLYYSFQDKDN--LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCA 113
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS-------------- 189
+ +H IHRD+K DNI ++ G +K+ D GL R +
Sbjct: 114 VESVHKMG--FIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDS 170
Query: 190 ----------------------------------AHSVIGTPEFMAPE-LYEEDYNELVD 214
AHS++GTP ++APE L Y +L D
Sbjct: 171 MDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 230
Query: 215 VYSFGMCVLEMFTCEYPY 232
+S G+ + EM + P+
Sbjct: 231 WWSVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 50/182 (27%), Positives = 76/182 (41%), Gaps = 32/182 (17%)
Query: 79 EVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVD--------- 129
EV +LS LK +IIR +D D ITE +G L ++ + D
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 130 ----------IRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179
++ A QI G+ YL S + +HRDL N V +L +KI D G
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENL-TIKIADFG 183
Query: 180 LAAILRGSKSAHSVIGTP----EFMAPE-LYEEDYNELVDVYSFGMCVLEMFT-C-EYPY 232
++ L + + G +MA E + + DV++FG+ + E+ C E PY
Sbjct: 184 MSRNLYAG-DYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
Query: 233 SE 234
E
Sbjct: 243 GE 244
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 25/102 (24%)
Query: 139 QILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPE 198
Q+ +G+ +L SR IHRDL NI ++ + VKI D GLA + P+
Sbjct: 187 QVAKGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLA---------RDIYKDPD 234
Query: 199 F------------MAPE-LYEEDYNELVDVYSFGMCVLEMFT 227
+ MAPE +++ Y DV+SFG+ + E+F+
Sbjct: 235 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 30/238 (12%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDS 90
FE+V+G+G V +A+ + G+++ L E S +D + E+ +L L H +
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPN 64
Query: 91 IIRFYTS-------WIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQ- 142
II + +I ++ + + + + E + + A ++Q+LQ
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 143 ------GLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS-AHSVIG 195
G+ YL + IHRDL N+ V +L KI D GL+ RG + +G
Sbjct: 125 ASDVATGMQYL--SEKQFIHRDLAARNVLVGENLAS-KIADFGLS---RGEEVYVKKTMG 178
Query: 196 --TPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECA-NPAQIYKKVTSG 248
+MA E L Y DV+SFG+ + E+ + PY C A++Y+K+ G
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY--CGMTCAELYEKLPQG 234
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 39/158 (24%), Positives = 76/158 (48%), Gaps = 29/158 (18%)
Query: 79 EVHLLSTLKHDSII----------RFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRV 128
E+ +L TLK ++I+ + Y + V++ + EM +G E
Sbjct: 50 ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEM-PNGVPPE-------- 100
Query: 129 DIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK 188
++S+ Q+++ + + H D ++HRD+K +N+ ++ H +K+ D G A L
Sbjct: 101 ---KVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGS 154
Query: 189 SAH--SVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVL 223
+A+ + T + +PE L Y + VD++S G C+L
Sbjct: 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVG-CIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 29/219 (13%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNEL--MRSPDDLQRLYSEVHLLSTLKHD 89
F E LG+ A +YK + G++ A V + L + +P E L++ L H
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHA-QLVAIKTLKDINNPQQWGEFQQEASLMAELHHP 67
Query: 90 SIIRFYTSWIDVDQKTFNFITEMFTSGTLREY---RKKYRRVDIRA-----IKS------ 135
+I+ + ++ + E G L E+ R + V + +KS
Sbjct: 68 NIVCLLG--VVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD 125
Query: 136 ---WARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---KS 189
A QI G+ YL S +H+DL NI + L VKI DLGL+ + + +
Sbjct: 126 FLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGEQL-HVKISDLGLSREIYSADYYRV 182
Query: 190 AHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFT 227
+ +M PE + ++ D++SFG+ + E+F+
Sbjct: 183 QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 466 | |||
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.91 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.69 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.39 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.38 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.36 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.27 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.26 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.07 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.05 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.02 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.83 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.81 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.8 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.75 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.66 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.58 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.57 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.55 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.48 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.31 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.22 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.2 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.98 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.97 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.92 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.86 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.85 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.82 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.69 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.64 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.52 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.52 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.48 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.43 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.41 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.39 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.14 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.01 | |
| PF12202 | 38 | OSR1_C: Oxidative-stress-responsive kinase 1 C ter | 97.0 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.81 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.77 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.63 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.62 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.55 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.43 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.39 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.15 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.14 | |
| PLN02236 | 344 | choline kinase | 96.12 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.09 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.75 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.6 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.46 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.41 | |
| PF07914 | 414 | DUF1679: Protein of unknown function (DUF1679); In | 95.1 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.05 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 93.77 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.5 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 92.51 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.07 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 91.72 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 90.65 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 88.92 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-87 Score=682.53 Aligned_cols=391 Identities=63% Similarity=1.025 Sum_probs=350.5
Q ss_pred hhccceeeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEE
Q 012320 15 KAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRF 94 (466)
Q Consensus 15 ~~~~~~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l 94 (466)
.....+++++|+|||.++.++||+|+|.+||||+|..+|.+|||..++..++.+++...++++.|+++|+.|+|||||++
T Consensus 27 ~~~~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirf 106 (632)
T KOG0584|consen 27 PDESEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRF 106 (632)
T ss_pred cccccccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeee
Confidence 35677999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EeEEEeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEE
Q 012320 95 YTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVK 174 (466)
Q Consensus 95 ~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vK 174 (466)
|++|++..++++.+|+|++++|+|+.|++++++++.+.++.|++||++||.|||++.||||||||||+||||+++.|.||
T Consensus 107 y~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VK 186 (632)
T KOG0584|consen 107 YDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVK 186 (632)
T ss_pred eeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCcee
Confidence 99999998999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EeccchhhhhcCCCCCccccCCCCcCCccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 012320 175 IGDLGLAAILRGSKSAHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAF 254 (466)
Q Consensus 175 L~DFGla~~~~~~~~~~~~~GT~~y~APE~l~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~ 254 (466)
|+|+|||+.+..+.. .+++|||+|||||++.+.|++.+||||||||++||+|+.+||++|.|+++||++|.+|..|..+
T Consensus 187 IGDLGLAtl~r~s~a-ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl 265 (632)
T KOG0584|consen 187 IGDLGLATLLRKSHA-KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAAL 265 (632)
T ss_pred ecchhHHHHhhcccc-ceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHh
Confidence 999999998877554 4589999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhccCcCCCCCHHHHhcCCCCCchhh--------hh----cc------ccccCCCCCCC--------
Q 012320 255 YSIQDLEAQRFIGRCLVNASKRLSAKELLLDPFLASDEV--------KL----LS------KTKLNQKPFLN-------- 308 (466)
Q Consensus 255 ~~~~~~~~~~lI~~~L~dp~~Rpsa~elL~hpf~~~~~~--------~~----~~------~~~~~~~~~~~-------- 308 (466)
.++.++++++||++||...++||||.|||.||||+.+.. .. +. ......++..+
T Consensus 266 ~kV~dPevr~fIekCl~~~~~R~sa~eLL~d~Ff~~d~g~~~~~~e~d~~~~~~~~~~~~~~~~~~~~~~~n~i~~~~~~ 345 (632)
T KOG0584|consen 266 SKVKDPEVREFIEKCLATKSERLSAKELLKDPFFDEDGGIVELAPEDDMSDPALSLSLRDEDGKKNKRPKANAIQFDYNL 345 (632)
T ss_pred hccCCHHHHHHHHHHhcCchhccCHHHHhhChhhccccccccccchhhcccccccccccccchhhcCCcccccccceeec
Confidence 999999999999999988999999999999999988622 00 00 00000111111
Q ss_pred -h-------hHhhhcc-cCC--------CCCCCCcccccCCCCCCCceEEEEEeeCCCCCCcceeecCcCCCCChhHHHH
Q 012320 309 -E-------TELEKLQ-LSD--------DPPRTDMTITGKLNPEDDTIFLKVQIADKDGPGRNIYFPFDILNDTPLDVAR 371 (466)
Q Consensus 309 -~-------~~~~~~~-~~~--------~~~~~~~~i~~~~~~~~~~i~l~~~~~d~~~~~r~i~f~f~~~~dt~~~va~ 371 (466)
. .++.... .+. ......+.+.|+.+.+...++|.++|.+++|..|+|+|||++..|||.+||.
T Consensus 346 ~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~~~~~~~l~l~i~~~~g~~r~i~fpf~~~~dta~~Va~ 425 (632)
T KOG0584|consen 346 NTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRNDRQTEISLELRIADEDGLVRNIHFPFDLEGDTAPSVAH 425 (632)
T ss_pred CCCchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhhcccccceeEeeccCCCCCcccccCCCcCCCcchhHHHH
Confidence 0 0011111 111 1234567888998877779999999999999999999999999999999999
Q ss_pred HHHHcccCCCCCHHHHHHHHHHHHHHhCCCCccCC
Q 012320 372 EMVKELEITDWEPFEIAKMIDEEISVLVPHWKKRE 406 (466)
Q Consensus 372 Emv~~~~~~~~d~~~ia~~i~~~~~~~~~~~~~~~ 406 (466)
|||++++++++++..||+||+.++.+|+|.|+...
T Consensus 426 eMv~el~~~dq~v~~ia~mid~~i~~L~p~~~~~~ 460 (632)
T KOG0584|consen 426 EMVEELEITDQPVVNIAEMIDGEISALVPNWKAST 460 (632)
T ss_pred HHHhhcCCcccchhhHHHHHhchhhhcCCccCCCC
Confidence 99999999999999999999999999999998764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-59 Score=458.68 Aligned_cols=263 Identities=25% Similarity=0.367 Sum_probs=234.1
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCH---HHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSP---DDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
...|+++.+.||+|+||.|.+|.++.||+.||||++.+....... .....+.+|+++|++|+|||||++++.| +.
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f--~~ 247 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF--EV 247 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee--ec
Confidence 456667789999999999999999999999999999987654322 1234467999999999999999999988 44
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC--CCcEEEeccch
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGL 180 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~--~g~vKL~DFGl 180 (466)
....|+||||+.||+|++.+..++.+.+..-+.+++|++.||.|||++| |+||||||+|||++.+ .-.+||+|||+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccch
Confidence 6678999999999999999999999999999999999999999999999 9999999999999765 23789999999
Q ss_pred hhhhcCCCCCccccCCCCcCCccccccC----CCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC--CC
Q 012320 181 AAILRGSKSAHSVIGTPEFMAPELYEED----YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG--AF 254 (466)
Q Consensus 181 a~~~~~~~~~~~~~GT~~y~APE~l~~~----y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~--~~ 254 (466)
|+.......+.+.||||.|.|||++... |..++||||+||++|-+++|.+||++......+.++|.+|+++. ..
T Consensus 326 AK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 326 AKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred hhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 9998888889999999999999988642 55689999999999999999999999888777999999999864 35
Q ss_pred CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 255 YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 255 ~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
|...+.++++||..||+ ||++|||+.|+|+||||+...
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 67788999999999995 999999999999999998644
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-56 Score=457.94 Aligned_cols=266 Identities=31% Similarity=0.496 Sum_probs=243.5
Q ss_pred hccceeeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEE
Q 012320 16 AHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95 (466)
Q Consensus 16 ~~~~~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~ 95 (466)
.+++-+.+|+..+++..+++||+|||++||.+.+..+|+.||+|+|.++.+ .+....+++.+||+|.++|+|||||++|
T Consensus 6 ~~ip~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l-~k~~~reKv~~EIeIHr~L~HpnIV~f~ 84 (592)
T KOG0575|consen 6 PEIPEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLL-KKPKQREKVLNEIEIHRSLKHPNIVQFY 84 (592)
T ss_pred CCCCCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHh-cCcchHHHHHHHHHHHHhcCCCcEEeee
Confidence 456777788777777779999999999999999999999999999997765 4567889999999999999999999999
Q ss_pred eEEEeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEE
Q 012320 96 TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKI 175 (466)
Q Consensus 96 ~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL 175 (466)
++| ++.+++|+|+|+|..++|..++++.+.++|..++.+++||+.||.|||+++ |||||||..|+|++.+ -+|||
T Consensus 85 ~~F--EDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~-~~VKI 159 (592)
T KOG0575|consen 85 HFF--EDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNEN-MNVKI 159 (592)
T ss_pred eEe--ecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCc-CcEEe
Confidence 999 668899999999999999999999999999999999999999999999999 9999999999999988 59999
Q ss_pred eccchhhhhcCC-CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 012320 176 GDLGLAAILRGS-KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA 253 (466)
Q Consensus 176 ~DFGla~~~~~~-~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~ 253 (466)
+|||||+.+... ....+.||||.|+|||++. .+++..+||||+||+||-|++|.+||.. .+..++|.+|......
T Consensus 160 gDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~Y~-- 236 (592)
T KOG0575|consen 160 GDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNEYS-- 236 (592)
T ss_pred cccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcCcc--
Confidence 999999998744 6677899999999999887 5699999999999999999999999976 7899999999988763
Q ss_pred CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 254 FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 254 ~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
.+...+.++++||.+||. +|.+|||++++|.|+||..
T Consensus 237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 445788999999999996 9999999999999999954
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-56 Score=435.46 Aligned_cols=267 Identities=27% Similarity=0.477 Sum_probs=240.4
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
..|.+ .++||+|+||+||.++.+.|++.+|+|+++++.+... .+......|..+|.+++||+||+++.+| ++...+
T Consensus 25 ~dF~~-lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-~e~~~~~~Er~IL~~v~hPFiv~l~ysF--Qt~~kL 100 (357)
T KOG0598|consen 25 DDFEI-LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-KEVRHTKAERNILSKIKHPFIVKLIYSF--QTEEKL 100 (357)
T ss_pred hheee-eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-hhHHHHHHHHHHHHhCCCCcEeeeEEec--ccCCeE
Confidence 44555 5779999999999999999999999999998887544 5678899999999999999999999999 778899
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh-hc
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LR 185 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~-~~ 185 (466)
|+|+||+.||.|+.++++.+.++|..++.|+.+|+.||.|||+.| ||||||||+|||++.+ |+++|+||||++. +.
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~-GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQ-GHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCC-CcEEEeccccchhccc
Confidence 999999999999999999999999999999999999999999999 9999999999999987 9999999999985 45
Q ss_pred CCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 012320 186 GSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQR 264 (466)
Q Consensus 186 ~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~ 264 (466)
.+...+++|||++|||||++. ..|+..+|+||||+++|||++|.+||.. .+..+++++|..++.+. .+...+.++++
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~k~~~-~p~~ls~~ard 255 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKGKLPL-PPGYLSEEARD 255 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcCcCCC-CCccCCHHHHH
Confidence 556778899999999999765 6799999999999999999999999977 88999999999998543 34557889999
Q ss_pred HHHHhcc-CcCCCC----CHHHHhcCCCCCchhhhhccccccC
Q 012320 265 FIGRCLV-NASKRL----SAKELLLDPFLASDEVKLLSKTKLN 302 (466)
Q Consensus 265 lI~~~L~-dp~~Rp----sa~elL~hpf~~~~~~~~~~~~~~~ 302 (466)
+|+++|. +|.+|. ++.++-+||||....|+.+...+..
T Consensus 256 ll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~ 298 (357)
T KOG0598|consen 256 LLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLS 298 (357)
T ss_pred HHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCC
Confidence 9999995 999996 6889999999999999776554443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-56 Score=434.72 Aligned_cols=250 Identities=31% Similarity=0.508 Sum_probs=227.9
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecC
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMF 113 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~ 113 (466)
..||+|+.|+||||.|+.|++.+|+|.|... .++...+++.+|+++++.++|||||++|+.|+.... .++|+||||
T Consensus 85 ~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~---~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~mEYM 160 (364)
T KOG0581|consen 85 GVLGSGNGGTVYKVRHKPTGKIYALKVILLN---IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISICMEYM 160 (364)
T ss_pred hhcccCCCcEEEEEEEcCCCeEEEEEeeccc---CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEeehhhc
Confidence 4599999999999999999999999999533 356677899999999999999999999999976444 799999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCCcc
Q 012320 114 TSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHS-RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS 192 (466)
Q Consensus 114 ~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs-~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~~~ 192 (466)
.||||.+++++.++++|..+..++.+++.||.|||. ++ ||||||||+|||++.. |.|||||||.++.+..+ ...+
T Consensus 161 DgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNsk-GeVKicDFGVS~~lvnS-~a~t 236 (364)
T KOG0581|consen 161 DGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSK-GEVKICDFGVSGILVNS-IANT 236 (364)
T ss_pred CCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccC-CCEEeccccccHHhhhh-hccc
Confidence 999999999999999999999999999999999995 78 9999999999999987 99999999999998776 6789
Q ss_pred ccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCC----CCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 012320 193 VIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSE----CANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIG 267 (466)
Q Consensus 193 ~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~----~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~ 267 (466)
++||..|||||.+.+ .|+.++||||||+.++||++|++||.. ..+..+++..|..+..|.......++++++||.
T Consensus 237 fvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~ 316 (364)
T KOG0581|consen 237 FVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVS 316 (364)
T ss_pred ccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHH
Confidence 999999999998775 699999999999999999999999976 257888999999988766555569999999999
Q ss_pred Hhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 268 RCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 268 ~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.||. ||++|||++||+.|||+++.
T Consensus 317 ~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 317 CCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred HHhcCCcccCCCHHHHhcCHHHhhc
Confidence 9995 99999999999999999754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-54 Score=408.89 Aligned_cols=259 Identities=26% Similarity=0.489 Sum_probs=234.7
Q ss_pred eEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEE
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNF 108 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~l 108 (466)
|.+ .+.||.|+||.|.+++++.+|..+|+|++.+.++.+ -.+.+...+|..+|+.+.||++++++.+| .+...+|+
T Consensus 46 fe~-~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVk-lKQveH~~nEk~vL~~v~~PFlv~l~~t~--~d~~~lym 121 (355)
T KOG0616|consen 46 FER-LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVK-LKQVEHTHNEKRVLKAVSHPFLVKLYGTF--KDNSNLYM 121 (355)
T ss_pred hhh-eeeeccCccceEEEEEEccCCceeehhhcCHHHHHH-HHHHHHHhhHHHHHhhccCceeEEEEEee--ccCCeEEE
Confidence 455 467999999999999999999999999999887653 35678899999999999999999999988 56889999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCC
Q 012320 109 ITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK 188 (466)
Q Consensus 109 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~ 188 (466)
||||++||.|+.++++.+++++..+++|+.||+.||+|||+++ |++|||||+|||+|.+ |++||+|||+|+.....
T Consensus 122 vmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~-G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQN-GHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccC-CcEEEEeccceEEecCc-
Confidence 9999999999999999999999999999999999999999999 9999999999999987 99999999999887654
Q ss_pred CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 012320 189 SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIG 267 (466)
Q Consensus 189 ~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~ 267 (466)
..+.||||.|+|||++. .+|+.++|+|||||++|||++|.+||.. .++.++|.+|..|++. ++...++++++||+
T Consensus 198 -T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~-~~~~~iY~KI~~~~v~--fP~~fs~~~kdLl~ 273 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD-DNPIQIYEKILEGKVK--FPSYFSSDAKDLLK 273 (355)
T ss_pred -EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC-CChHHHHHHHHhCccc--CCcccCHHHHHHHH
Confidence 67899999999999776 6799999999999999999999999987 7889999999999874 55677889999999
Q ss_pred Hhcc-CcCCC-----CCHHHHhcCCCCCchhhhhcccc
Q 012320 268 RCLV-NASKR-----LSAKELLLDPFLASDEVKLLSKT 299 (466)
Q Consensus 268 ~~L~-dp~~R-----psa~elL~hpf~~~~~~~~~~~~ 299 (466)
++|+ |-++| ....++.+||||++..|..+...
T Consensus 274 ~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r 311 (355)
T KOG0616|consen 274 KLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQR 311 (355)
T ss_pred HHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhc
Confidence 9995 98888 45679999999999998654433
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-53 Score=429.36 Aligned_cols=268 Identities=24% Similarity=0.409 Sum_probs=236.1
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
..+.|..+ ++||+||||.||+|..+.||..+|+|+++++... ..++.+.++.|-.+|...++|+||++|.+| ++..
T Consensus 139 ~~~DFe~L-k~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~-~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF--QD~~ 214 (550)
T KOG0605|consen 139 SLDDFELL-KVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML-KKNQVEHVRAERDILAEVDSPWVVKLYYSF--QDKE 214 (550)
T ss_pred Ccccchhh-eeeccccceeEEEEEEccCCcEEeeecccHHHHH-hhhhHHHHHHHHHHhhhcCCCcEEEEEEEe--cCCC
Confidence 34556665 6699999999999999999999999999988754 556889999999999999999999999999 7789
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
++||||||++||++..+|.+.+.+++..+++|+.+++.||+-||++| +|||||||+|+|||.. |++||+||||++.+
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~-GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAK-GHIKLSDFGLSTGL 291 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCC-CCEeeccccccchh
Confidence 99999999999999999999999999999999999999999999999 9999999999999987 99999999998533
Q ss_pred cC---------------C---------C------------------------CCccccCCCCcCCccccc-cCCCChhhH
Q 012320 185 RG---------------S---------K------------------------SAHSVIGTPEFMAPELYE-EDYNELVDV 215 (466)
Q Consensus 185 ~~---------------~---------~------------------------~~~~~~GT~~y~APE~l~-~~y~~~~DI 215 (466)
.. . . ...+.+|||.|||||++. .+|+..||+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 11 0 0 013568999999999776 569999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCCCHHHHHHHHHhccCcCCCCC---HHHHhcCCCCCc
Q 012320 216 YSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK--LPGAFYSIQDLEAQRFIGRCLVNASKRLS---AKELLLDPFLAS 290 (466)
Q Consensus 216 wSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~--~p~~~~~~~~~~~~~lI~~~L~dp~~Rps---a~elL~hpf~~~ 290 (466)
||||||+||||.|.+||.. .++.+.|++|...+ +..+.....+.++++||.+||.||.+|+. ++||..||||+.
T Consensus 372 WSLG~ImyEmLvGyPPF~s-~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCS-ETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCcccc
Confidence 9999999999999999977 89999999999876 44444556678999999999999999985 889999999999
Q ss_pred hhhhhccccc
Q 012320 291 DEVKLLSKTK 300 (466)
Q Consensus 291 ~~~~~~~~~~ 300 (466)
.+|..+....
T Consensus 451 v~W~~l~~~~ 460 (550)
T KOG0605|consen 451 VDWDHLREMP 460 (550)
T ss_pred CCcchhhcCC
Confidence 9997654433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-53 Score=430.50 Aligned_cols=260 Identities=29% Similarity=0.489 Sum_probs=231.0
Q ss_pred eEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCCEEE
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~~~ 107 (466)
-.+|+++||.|+|++|++|+++.++++||||++.++-+.+ .....-+..|-..|.+| .||.|++||..| ++...+|
T Consensus 74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iik-e~KvkYV~~Ek~~l~~L~~hPgivkLy~TF--QD~~sLY 150 (604)
T KOG0592|consen 74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIK-EKKVKYVTREKEALTQLSGHPGIVKLYFTF--QDEESLY 150 (604)
T ss_pred hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHh-hcccchhhHHHHHHHHhhCCCCeEEEEEEe--ecccceE
Confidence 3578999999999999999999999999999998776542 33445677888899999 899999999999 6688899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~ 187 (466)
+|+||+++|+|.++|++.+.|++..++.++.||+.||+|||++| ||||||||+|||++++ |++||+|||.|+.+...
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~d-mhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKD-GHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCC-CcEEEeeccccccCChh
Confidence 99999999999999999999999999999999999999999999 9999999999999988 89999999999887532
Q ss_pred CC--------------CccccCCCCcCCccccccC-CCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC
Q 012320 188 KS--------------AHSVIGTPEFMAPELYEED-YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG 252 (466)
Q Consensus 188 ~~--------------~~~~~GT~~y~APE~l~~~-y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~ 252 (466)
.. ..+++||..|.+||+|... .+..+|||+||||+|+|+.|.+||.+ .|+-.++++|..-.+
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra-~NeyliFqkI~~l~y-- 304 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA-ANEYLIFQKIQALDY-- 304 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc-ccHHHHHHHHHHhcc--
Confidence 21 1468999999999998754 68899999999999999999999987 888899999987554
Q ss_pred CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhhhhcc
Q 012320 253 AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVKLLS 297 (466)
Q Consensus 253 ~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~~~~~ 297 (466)
.++...++.+++||+++|+ ||++|+|+.+|..||||.+.+|..+.
T Consensus 305 ~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw 350 (604)
T KOG0592|consen 305 EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLW 350 (604)
T ss_pred cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhh
Confidence 3445566899999999996 99999999999999999999987543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-53 Score=413.86 Aligned_cols=260 Identities=27% Similarity=0.482 Sum_probs=231.4
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
-.+.|....+ ||+|+||+||+|+++.++..||||.|.++.+ .+...+.+..||.+|+.++|||||.+++.. ..++
T Consensus 8 ~~~~y~~~~~-iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~--~~~~ 82 (429)
T KOG0595|consen 8 VVGDYELSRE-IGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCI--EDDD 82 (429)
T ss_pred ccccceehhh-ccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEE--ecCC
Confidence 3577877555 9999999999999999999999999998765 566778899999999999999999999976 5678
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC--C---CcEEEeccc
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH--L---GQVKIGDLG 179 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~--~---g~vKL~DFG 179 (466)
.+|+|||||.||+|.+|+.+.+.+++..++.++.||+.||++||+++ ||||||||+|||++.. . -.+||+|||
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 99999999999999999999999999999999999999999999999 9999999999999764 1 358999999
Q ss_pred hhhhhcCCCCCccccCCCCcCCcccc-ccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCCCCC
Q 012320 180 LAAILRGSKSAHSVIGTPEFMAPELY-EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK-LPGAFYSI 257 (466)
Q Consensus 180 la~~~~~~~~~~~~~GT~~y~APE~l-~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~-~p~~~~~~ 257 (466)
+|+.+.......+.||+|.|||||++ .++|+.|+|+||+|+|+|+|++|+.||.. .+..++...+..+. ..+.++..
T Consensus 161 fAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a-~t~~eL~~~~~k~~~~~~~~~~~ 239 (429)
T KOG0595|consen 161 FARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA-ETPKELLLYIKKGNEIVPVLPAE 239 (429)
T ss_pred hhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc-cCHHHHHHHHhccccccCchhhh
Confidence 99999988888999999999999988 57899999999999999999999999977 78888888888776 33344555
Q ss_pred CCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 258 QDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 258 ~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
.+....+++-..|. +|..|.+..+-+.||++....
T Consensus 240 ~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 240 LSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred ccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 56667778777775 999999999999999997654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-52 Score=421.97 Aligned_cols=262 Identities=27% Similarity=0.507 Sum_probs=231.1
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCH-HHHHHHHHHHHHHHhCC-CCceeEEEeEEEe
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSP-DDLQRLYSEVHLLSTLK-HDSIIRFYTSWID 100 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~-~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~ 100 (466)
....++|.+ ++.||+|+||+|++|.+..+|..||+|++.++...... ...+.+.+|+.+++.++ ||||+++++++
T Consensus 13 ~~~~g~y~~-~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~-- 89 (370)
T KOG0583|consen 13 QLSIGKYEL-GRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF-- 89 (370)
T ss_pred ccccCceee-eeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE--
Confidence 345678877 78899999999999999999999999988765433222 34466778999999998 99999999987
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
.....+|+|||||.||+|++++.+.+++.|..++.+++||+.|++|||++| |+||||||+|||++.+.+.+||+|||+
T Consensus 90 ~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 90 ATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred ecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 456669999999999999999999999999999999999999999999999 999999999999998757999999999
Q ss_pred hhhh-cCCCCCccccCCCCcCCcccccc-C-CC-ChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 012320 181 AAIL-RGSKSAHSVIGTPEFMAPELYEE-D-YN-ELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 181 a~~~-~~~~~~~~~~GT~~y~APE~l~~-~-y~-~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 256 (466)
+... ......++.+|||.|+|||++.+ . |+ .++||||+||+||.|++|.+||.. .+...++.+|..+.+....+-
T Consensus 168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~~~~~~p~~~ 246 (370)
T KOG0583|consen 168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRKGEFKIPSYL 246 (370)
T ss_pred ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhcCCccCCCCc
Confidence 9988 46667889999999999998875 4 65 789999999999999999999987 888889999999987543322
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
. +++++.||++||. +|.+|+|+.+++.||||+..
T Consensus 247 ~-S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 247 L-SPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred C-CHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 2 9999999999996 99999999999999999873
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-54 Score=401.02 Aligned_cols=254 Identities=28% Similarity=0.508 Sum_probs=223.8
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
..|.++ ++||+|+||+||||.+..+|..+|+|.|....+ +....+....||.+|++|+|||||++|+.-+.++...+
T Consensus 19 ~~y~Il-~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m--d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 19 ADYQIL-KKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM--DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred HHHHHH-HHHcCCcchheEEeeeccCcchhhhhhcchhhc--cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 346664 569999999999999999999999999986654 55677889999999999999999999984344556669
Q ss_pred EEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCC--eEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 107 NFITEMFTSGTLREYRKKY----RRVDIRAIKSWARQILQGLVYLHSRDPP--VIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qIl~gL~yLHs~~~~--IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
+||||+|.+|+|...++.. +.++|+.+++++.|++.||..||+.-+. |+||||||.|||++.+ |.|||+||||
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~-gvvKLGDfGL 174 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN-GVVKLGDFGL 174 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC-Cceeeccchh
Confidence 9999999999999988653 5699999999999999999999995455 9999999999999987 9999999999
Q ss_pred hhhhcCCC-CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 012320 181 AAILRGSK-SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258 (466)
Q Consensus 181 a~~~~~~~-~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 258 (466)
++.+.... .+++.+|||.||+||++. .+|+.++||||+||++|||+.-..||.+ .|..++.++|.+|.+|+.+....
T Consensus 175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g-~n~~~L~~KI~qgd~~~~p~~~Y 253 (375)
T KOG0591|consen 175 GRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG-DNLLSLCKKIEQGDYPPLPDEHY 253 (375)
T ss_pred HhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc-ccHHHHHHHHHcCCCCCCcHHHh
Confidence 99987544 467899999999999776 6799999999999999999999999988 69999999999999987776888
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
|.+++.+|..|+. ||..||+. +|+++.
T Consensus 254 S~~l~~li~~ci~vd~~~RP~t-----~~~v~d 281 (375)
T KOG0591|consen 254 STDLRELINMCIAVDPEQRPDT-----VPYVQD 281 (375)
T ss_pred hhHHHHHHHHHccCCcccCCCc-----chHHHH
Confidence 9999999999995 99999997 555544
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-52 Score=427.03 Aligned_cols=260 Identities=27% Similarity=0.467 Sum_probs=236.7
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
.+..|-|.+ ++.||+|+.|.|.+|.|..||+.+|||+|.+..- .+......+.+||-||+.+.||||+++|+.| ++
T Consensus 8 ~~tiGpwkL-gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~-~s~s~~~~IerEIviMkLi~HpnVl~LydVw--e~ 83 (786)
T KOG0588|consen 8 KNTIGPWKL-GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSE-LSSSQPAGIEREIVIMKLIEHPNVLRLYDVW--EN 83 (786)
T ss_pred cccccceec-cccccCCCCceehhhhcccccceeEEEeeccccc-cccccccchhhhhHHHHHhcCCCeeeeeeee--cc
Confidence 445677755 9999999999999999999999999999987642 2344567889999999999999999999999 66
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
+.++|+|.||++||.|++++.+.+++++..++++++||+.|+.|||..+ ||||||||+|+|++.+ +.|||+|||.|.
T Consensus 84 ~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~-~nIKIADFGMAs 160 (786)
T KOG0588|consen 84 KQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVK-NNIKIADFGMAS 160 (786)
T ss_pred CceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcc-cCEeeeccceee
Confidence 8899999999999999999999999999999999999999999999999 9999999999999988 679999999999
Q ss_pred hhcCCCCCccccCCCCcCCcccccc-CC-CChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 012320 183 ILRGSKSAHSVIGTPEFMAPELYEE-DY-NELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL 260 (466)
Q Consensus 183 ~~~~~~~~~~~~GT~~y~APE~l~~-~y-~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~ 260 (466)
.-.+++...+-||+|.|.|||++.+ .| +.++||||+|||||.|+||..||.+ .|...++.+|++|.+. .+...+.
T Consensus 161 Le~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f~--MPs~Is~ 237 (786)
T KOG0588|consen 161 LEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVFE--MPSNISS 237 (786)
T ss_pred cccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCccc--CCCcCCH
Confidence 8778888899999999999997764 56 4789999999999999999999986 8999999999999974 4577889
Q ss_pred HHHHHHHHhc-cCcCCCCCHHHHhcCCCCCchh
Q 012320 261 EAQRFIGRCL-VNASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 261 ~~~~lI~~~L-~dp~~Rpsa~elL~hpf~~~~~ 292 (466)
++++||++|| +||++|+|.+|+++|||+.+..
T Consensus 238 eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 238 EAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 9999999999 5999999999999999998643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-52 Score=393.70 Aligned_cols=256 Identities=24% Similarity=0.415 Sum_probs=218.0
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
+++|..+++ +|+|+||+||||+++.||+.||||++.-+. .++...+-.++||++|++|+|||+|.+.++| ..++.
T Consensus 1 MekYE~Lgk-vGEGSYGvV~KCrnk~TgqIVAIKkF~Ese--dd~~VkKIAlREIrmLKqLkH~NLVnLiEVF--rrkrk 75 (396)
T KOG0593|consen 1 MEKYEKLGK-VGEGSYGVVMKCRNKDTGQIVAIKKFVESE--DDPVVKKIALREIRMLKQLKHENLVNLIEVF--RRKRK 75 (396)
T ss_pred CcHHhhhhc-cccCcceEEEEeccCCcccEEEEEeeccCC--ccHHHHHHHHHHHHHHHhcccchHHHHHHHH--Hhcce
Confidence 357888877 899999999999999999999999876433 3455567789999999999999999999988 66889
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 106 FNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
+++|+|||... +.+-+.++ ..++...++.|++|++.|+.|||+++ +|||||||+|||++.+ |.+||||||+|+.+
T Consensus 76 lhLVFE~~dhT-vL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~-gvvKLCDFGFAR~L 151 (396)
T KOG0593|consen 76 LHLVFEYCDHT-VLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQN-GVVKLCDFGFARTL 151 (396)
T ss_pred eEEEeeecchH-HHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecC-CcEEeccchhhHhh
Confidence 99999999654 44455555 56999999999999999999999999 9999999999999987 89999999999998
Q ss_pred c-CCCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCC---------
Q 012320 185 R-GSKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-GKLP--------- 251 (466)
Q Consensus 185 ~-~~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-g~~p--------- 251 (466)
. ++......+-|.+|+|||++-+ +|+.++||||+||++.||++|++.|.+..+.+++|..... |.+.
T Consensus 152 ~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~ 231 (396)
T KOG0593|consen 152 SAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSS 231 (396)
T ss_pred cCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence 7 5556677899999999997764 6999999999999999999999999998888998875542 3221
Q ss_pred ----------CC--------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 252 ----------GA--------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 252 ----------~~--------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
.. -+...+..+.+|+++||. ||.+|++.+++|.||||..
T Consensus 232 N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 232 NPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred CCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 11 012234478899999996 9999999999999999954
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-53 Score=387.96 Aligned_cols=262 Identities=27% Similarity=0.485 Sum_probs=233.9
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
-.+..|.+ .++||+|+|+.||++.+..||+.+|+|+|..+.+... ..+.+.+|++|.+.|+||||+++.+++ .+.
T Consensus 8 ~f~d~y~l-~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~--~~e~l~rEarIC~~LqHP~IvrL~~ti--~~~ 82 (355)
T KOG0033|consen 8 KFSDNYDV-KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKLEREARICRKLQHPNIVRLHDSI--QEE 82 (355)
T ss_pred ccchhhhH-HHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc--cHHHHHHHHHHHHhcCCCcEeehhhhh--ccc
Confidence 34566777 4669999999999999999999999999988776433 678899999999999999999999987 567
Q ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCC--CcEEEeccchh
Q 012320 104 KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHL--GQVKIGDLGLA 181 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~--g~vKL~DFGla 181 (466)
...|+|+|+++|++|..-|.+.-.++|..+..+++||++||.|||.++ |+|||+||+|+++.+.. ..+||+|||+|
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred ceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceE
Confidence 889999999999999876666567899999999999999999999999 99999999999996542 36999999999
Q ss_pred hhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCC
Q 012320 182 AILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL--PGAFYSIQ 258 (466)
Q Consensus 182 ~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~ 258 (466)
..+..+......+|||.|||||++. ..|+..+|||+.||++|.|+.|.+||++ .+...+|+.|..|.. |...+...
T Consensus 161 i~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~-~~~~rlye~I~~g~yd~~~~~w~~i 239 (355)
T KOG0033|consen 161 IEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYEQIKAGAYDYPSPEWDTV 239 (355)
T ss_pred EEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhccccCCCCcccCcC
Confidence 9988777788899999999999887 5699999999999999999999999987 678899999999975 56678888
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
++++++||++||. ||++|+||.|+|+|||+.....
T Consensus 240 s~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~ 275 (355)
T KOG0033|consen 240 TPEAKSLIRRMLTVNPKKRITADEALKHPWICNRER 275 (355)
T ss_pred CHHHHHHHHHHhccChhhhccHHHHhCCchhcchHH
Confidence 9999999999995 9999999999999999987543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-51 Score=417.62 Aligned_cols=259 Identities=33% Similarity=0.543 Sum_probs=234.1
Q ss_pred eeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 21 IETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 21 ~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
...||..+|..+.+ ||+|+.|.||.|....+++.||||++.+... ...+-+++|+.+|+..+|+|||+++++|..
T Consensus 267 ~~~dP~~~y~~~~k-igqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q----~~keLilnEi~Vm~~~~H~NiVnfl~Sylv 341 (550)
T KOG0578|consen 267 SQGDPRSKYTDFKK-IGQGATGGVYVARKISTKQEVAIKRMDLRKQ----PKKELLLNEILVMRDLHHPNIVNFLDSYLV 341 (550)
T ss_pred cCCChhhhhcchhh-hccccccceeeeeeccCCceEEEEEEEeccC----CchhhhHHHHHHHHhccchHHHHHHHHhcc
Confidence 44899999999866 9999999999999999999999999986653 234678999999999999999999999965
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
...+|.||||+.||+|.|.+.. ..++|.+++.++++++.||+|||.+| |+|||||-+|||++.+ |.+||+|||+
T Consensus 342 --~deLWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~-g~vKltDFGF 415 (550)
T KOG0578|consen 342 --GDELWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMD-GSVKLTDFGF 415 (550)
T ss_pred --cceeEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccC-CcEEEeeeee
Confidence 4679999999999999998875 55999999999999999999999999 9999999999999877 8999999999
Q ss_pred hhhhcCCC-CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 012320 181 AAILRGSK-SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258 (466)
Q Consensus 181 a~~~~~~~-~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 258 (466)
+..+.... ...+.+|||+|||||+.. ..|++++||||||++++||+-|++||........+|..-..|......+...
T Consensus 416 caqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~kl 495 (550)
T KOG0578|consen 416 CAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKL 495 (550)
T ss_pred eeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCcccc
Confidence 99886554 677899999999999887 5699999999999999999999999987555666777778888877788889
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
++++++|+.+||+ |+.+|++|.|||.||||+.
T Consensus 496 S~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 496 SPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred CHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 9999999999995 9999999999999999943
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-51 Score=401.31 Aligned_cols=260 Identities=33% Similarity=0.567 Sum_probs=219.8
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
..+|.+ ++.||+|+||+||++.++.+|...|+|.+.... .+ ..+.+.+|+.+|++++|||||++++.........
T Consensus 16 ~~~~~~-~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 16 ISNWSK-GKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SP-TSESLEREIRILSRLNHPNIVQYYGSSSSRENDE 90 (313)
T ss_pred cchhhh-hccccCccceEEEEEEecCCCcceeeeeeeccc---ch-hHHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence 344555 788999999999999999999999999988652 22 2678999999999999999999999632222237
Q ss_pred EEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 106 FNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
+++.|||++||+|.+++++++ .+++..++.+.+||+.||.|||++| |+||||||+|||++...|.+||+|||+++..
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 899999999999999999987 7999999999999999999999999 9999999999999983389999999999876
Q ss_pred cC----CCCCccccCCCCcCCccccccCCC--ChhhHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHhcCCCCCCCCCC
Q 012320 185 RG----SKSAHSVIGTPEFMAPELYEEDYN--ELVDVYSFGMCVLEMFTCEYPYSE-CANPAQIYKKVTSGKLPGAFYSI 257 (466)
Q Consensus 185 ~~----~~~~~~~~GT~~y~APE~l~~~y~--~~~DIwSlGvil~elltg~~Pf~~-~~~~~~i~~~i~~g~~p~~~~~~ 257 (466)
.. ........|||.|||||++...+. .++|||||||++.||+||..||.+ ......+++....+..| .++..
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P-~ip~~ 247 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP-EIPDS 247 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC-CCCcc
Confidence 63 222446789999999998875433 499999999999999999999987 34455566666666555 66777
Q ss_pred CCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 258 QDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 258 ~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
.+.++++||.+|+. +|.+||||.+||.|||++....
T Consensus 248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 89999999999996 9999999999999999976443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-50 Score=416.51 Aligned_cols=260 Identities=24% Similarity=0.440 Sum_probs=233.5
Q ss_pred EeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCCEEEEE
Q 012320 31 LFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQKTFNFI 109 (466)
Q Consensus 31 ~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~~~lV 109 (466)
++-++||+|+||+|++|..+.+++.+|||.+++..+..+ ++.+..+.|.+|+... +||.++.+|.+| +.+.++|+|
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~-d~Ve~~~~EkrI~~la~~HPFL~~L~~~f--QT~~~l~fv 447 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQR-DEVESLMCEKRIFELANRHPFLVNLFSCF--QTKEHLFFV 447 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecc-ccHHHHHHHHHHHHHhccCCeEeeccccc--ccCCeEEEE
Confidence 456889999999999999999999999999998887654 6789999999999988 599999999999 778999999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc-CCC
Q 012320 110 TEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSK 188 (466)
Q Consensus 110 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~-~~~ 188 (466)
|||+.||++. ++...+.+++..++.|+..|+.||.|||++| ||+||||.+|||+|.. |++||+|||+++..- .+.
T Consensus 448 mey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~e-Gh~kiADFGlcKe~m~~g~ 523 (694)
T KOG0694|consen 448 MEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTE-GHVKIADFGLCKEGMGQGD 523 (694)
T ss_pred EEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEccc-CcEEecccccccccCCCCC
Confidence 9999999954 3445589999999999999999999999999 9999999999999987 999999999998743 556
Q ss_pred CCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 012320 189 SAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIG 267 (466)
Q Consensus 189 ~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~ 267 (466)
.+.++||||.|||||++.+ .|+.++|+|||||+||||+.|..||.+ .+.++++..|..... .++...+.++..+++
T Consensus 524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-ddEee~FdsI~~d~~--~yP~~ls~ea~~il~ 600 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-DDEEEVFDSIVNDEV--RYPRFLSKEAIAIMR 600 (694)
T ss_pred ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCC--CCCCcccHHHHHHHH
Confidence 7889999999999998875 699999999999999999999999987 889999999988764 356678899999999
Q ss_pred Hhcc-CcCCCCCH-----HHHhcCCCCCchhhhhccccc
Q 012320 268 RCLV-NASKRLSA-----KELLLDPFLASDEVKLLSKTK 300 (466)
Q Consensus 268 ~~L~-dp~~Rpsa-----~elL~hpf~~~~~~~~~~~~~ 300 (466)
++|. +|.+|+.+ .++..||||+...|..+....
T Consensus 601 ~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~ 639 (694)
T KOG0694|consen 601 RLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRR 639 (694)
T ss_pred HHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhcc
Confidence 9995 99999975 789999999999997655433
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=390.84 Aligned_cols=259 Identities=29% Similarity=0.463 Sum_probs=219.4
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
...|.+ .++||.|..++||+|++..+++.||||++...+.. .+...+.+|++.|+.++||||+++|.+|+. +..
T Consensus 25 ~~~YeL-~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~---~~ld~l~kE~~~msl~~HPNIv~~~~sFvv--~~~ 98 (516)
T KOG0582|consen 25 AKDYEL-QEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN---NDLDALRKEVQTMSLIDHPNIVTYHCSFVV--DSE 98 (516)
T ss_pred ccceeE-EEEEeccceeEeeeeeecccCCEEEEEEeehhhhh---hhHHHHHHHHHHhhhcCCCCcceEEEEEEe--cce
Confidence 345655 57799999999999999999999999999988752 347889999999999999999999999965 678
Q ss_pred EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 106 FNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
+|+||.||.+||+.++++.. ..++|..++.++++++.||.|||.+| .||||||+.||||+++ |.|||+|||.+..
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~d-G~VkLadFgvsa~ 175 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSD-GTVKLADFGVSAS 175 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCC-CcEEEcCceeeee
Confidence 99999999999999999875 45999999999999999999999999 9999999999999988 9999999998866
Q ss_pred hcCCCC-----CccccCCCCcCCccccc---cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC--
Q 012320 184 LRGSKS-----AHSVIGTPEFMAPELYE---EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA-- 253 (466)
Q Consensus 184 ~~~~~~-----~~~~~GT~~y~APE~l~---~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~-- 253 (466)
+..... .++++|||+|||||++. .+|+.|+||||||+++.||++|..||........+..++ ++..|..
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-qn~pp~~~t 254 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-QNDPPTLLT 254 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCCCCCccc
Confidence 543221 15679999999999854 359999999999999999999999998854444444444 4544422
Q ss_pred ------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhhh
Q 012320 254 ------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVK 294 (466)
Q Consensus 254 ------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~~ 294 (466)
..+..+..++.+|..||+ ||.+||||++||+|+||+..+.+
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 233445689999999996 99999999999999999875543
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=396.86 Aligned_cols=261 Identities=29% Similarity=0.489 Sum_probs=232.9
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEeEEEec
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYTSWIDV 101 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~ 101 (466)
.+-..+|.. .+.||+|+||+||+|.++.||+.+|+|.+.+..... ....+.+.+|+++|+++. |||||.+++.| +
T Consensus 31 ~~~~~~Y~l-~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~-~~~~~~v~~Ev~il~~l~~hpniv~l~~~~--e 106 (382)
T KOG0032|consen 31 EDIKEKYEL-GRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG-KEDREDVRREVAILQQLSGHPNIVQLKDAF--E 106 (382)
T ss_pred ccccccEEe-hhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc-cccHHHHHHHHHHHHhccCCCCEEEEEEEE--E
Confidence 334456655 677999999999999999999999999999777543 335678999999999998 99999999998 5
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCC---CcEEEecc
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHL---GQVKIGDL 178 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~---g~vKL~DF 178 (466)
+...+++|||+|.||+|++.+.+. .+++..+..+++||+.++.|||+.| |+||||||+|+|+.... +.+|++||
T Consensus 107 ~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 107 DPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred cCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 577999999999999999999876 5999999999999999999999999 99999999999997552 47999999
Q ss_pred chhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--CCCCC
Q 012320 179 GLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL--PGAFY 255 (466)
Q Consensus 179 Gla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~--p~~~~ 255 (466)
|++.........+..+|||.|+|||++. ..|+..+||||+||++|.|++|..||.. .+....+.+|..|++ +...+
T Consensus 184 Gla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~-~~~~~~~~~i~~~~~~f~~~~w 262 (382)
T KOG0032|consen 184 GLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWG-ETEFEIFLAILRGDFDFTSEPW 262 (382)
T ss_pred CCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcC-CChhHHHHHHHcCCCCCCCCCc
Confidence 9999988777788999999999999998 7899999999999999999999999987 677778889998876 45567
Q ss_pred CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 256 ~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
...+..+++||++||. ||.+|+||.++|+|||++..
T Consensus 263 ~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 263 DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred cccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 7779999999999996 99999999999999999764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=400.91 Aligned_cols=253 Identities=27% Similarity=0.462 Sum_probs=226.7
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
++|.++ +.||+|+||+||||+.|.|.+.||+|.+.+.. +...+...+.+|++|++.++|||||.++++| +...++
T Consensus 2 e~yhv~-e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g--r~~k~l~~l~~ev~i~r~lkHpniv~m~esf--Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVY-EMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG--RNEKELKNLRQEVRILRSLKHPNIVEMLESF--ETSAHL 76 (808)
T ss_pred cchhHH-HHhcCCccceeeecccccceeEEEEEEehhcC--CchHHHHHHHHHHHHHHhcCCcchhhHHHhh--cccceE
Confidence 577775 55999999999999999999999999998654 4667889999999999999999999999988 668899
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
++|+||+.| +|+.++...+.++|+.++.++.|++.||.|||+++ |+|||+||.|||+... |.+|+||||+|+.+..
T Consensus 77 ~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~-~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKG-GTLKLCDFGLARAMST 152 (808)
T ss_pred EEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCC-Cceeechhhhhhhccc
Confidence 999999977 99999999999999999999999999999999999 9999999999999988 8999999999998865
Q ss_pred CCC-CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 012320 187 SKS-AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQR 264 (466)
Q Consensus 187 ~~~-~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~ 264 (466)
.+. ..++-|||.|||||++. +.|+..+|+||+|||+|||.+|.+||.. ....++.+.|..... .++...+..+++
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~d~v--~~p~~~S~~f~n 229 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILKDPV--KPPSTASSSFVN 229 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhcCCC--CCcccccHHHHH
Confidence 443 45678999999999876 5699999999999999999999999976 667778888876543 344567889999
Q ss_pred HHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 265 FIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 265 lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
|+..+|. ||.+|+|..+|+.|||.++.
T Consensus 230 fl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 230 FLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 9999995 99999999999999999763
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-50 Score=397.39 Aligned_cols=261 Identities=29% Similarity=0.420 Sum_probs=222.8
Q ss_pred eeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEeEEEe
Q 012320 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYTSWID 100 (466)
Q Consensus 22 ~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~ 100 (466)
.+.-..||..+++ ||.|+||.||+|..+.+|..||||+++++- .+.++ ..-++|++.|++|+ |||||++++.+.+
T Consensus 5 ~~~~m~RY~~i~k-lGDGTfGsV~la~~~~~~~~VAIK~MK~Kf--~s~ee-~~nLREvksL~kln~hpniikL~Evi~d 80 (538)
T KOG0661|consen 5 QVIFMDRYTVIRK-LGDGTFGSVYLAKSKETGELVAIKKMKKKF--YSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRD 80 (538)
T ss_pred ehhHHHHHHHHHH-hcCCcceeEEEeeecCCCceeeHHHHHhhh--ccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhc
Confidence 4556789999766 999999999999999999999999887543 23333 34478999999998 9999999999866
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
.+. .+||||||| ..+|.++++.. +.|++..++.|+.||+.||+|+|.+| +.||||||||||+.++ ..|||+|||
T Consensus 81 ~~~-~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~-~~iKiaDFG 155 (538)
T KOG0661|consen 81 NDR-ILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGN-DVIKIADFG 155 (538)
T ss_pred cCc-eEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEeccc-ceeEecccc
Confidence 443 899999999 67999988754 56999999999999999999999999 9999999999999976 589999999
Q ss_pred hhhhhcCCCCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-C--------
Q 012320 180 LAAILRGSKSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-G-------- 248 (466)
Q Consensus 180 la~~~~~~~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-g-------- 248 (466)
||+...........+.|.+|+|||+|- +.|+.++|||++|||++|+.+-++.|.+....+++++...- |
T Consensus 156 LARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 156 LAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred cccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 999988888888899999999999764 45999999999999999999999999998888888876531 1
Q ss_pred -----------CCCCC-------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 249 -----------KLPGA-------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 249 -----------~~p~~-------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.+|.. +....+.++.++|.+||. ||.+||||.|+|+||||+..
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 11111 123367789999999998 99999999999999999864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=398.53 Aligned_cols=260 Identities=30% Similarity=0.497 Sum_probs=228.5
Q ss_pred eeeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEE
Q 012320 20 YIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWI 99 (466)
Q Consensus 20 ~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 99 (466)
....++...|..+ +.||+|+||.||||.+..+++.||+|++.+.. ..++.+.+.+|+.+|.+++++||.++|++|+
T Consensus 6 ~~~~~~~~~~~~~-~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~---~~deIediqqei~~Ls~~~~~~it~yygsyl 81 (467)
T KOG0201|consen 6 VLKIDPELLYTKL-ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE---AEDEIEDIQQEISVLSQCDSPNITEYYGSYL 81 (467)
T ss_pred hhcCCcccccccc-hhccccccceeeeeeeccccceEEEEEechhh---cchhhHHHHHHHHHHHhcCcchHHhhhhhee
Confidence 4557788899997 66999999999999999999999999998765 4567889999999999999999999999996
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
. +..++++||||.||++.+.++..+.+++..+..++++++.||.|||+.+ .+|||||+.|||+... |.+||+|||
T Consensus 82 ~--g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~-g~vkl~Dfg 156 (467)
T KOG0201|consen 82 K--GTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSES-GDVKLADFG 156 (467)
T ss_pred e--cccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEecc-CcEEEEecc
Confidence 5 6789999999999999999998777799999999999999999999999 9999999999999988 999999999
Q ss_pred hhhhhcCCC-CCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 012320 180 LAAILRGSK-SAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSI 257 (466)
Q Consensus 180 la~~~~~~~-~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 257 (466)
++.++.... ...+++|||.|||||++.+ .|+.++||||||++++||++|++|+..... ....-.|.+. .|+.+...
T Consensus 157 Va~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP-mrvlflIpk~-~PP~L~~~ 234 (467)
T KOG0201|consen 157 VAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP-MRVLFLIPKS-APPRLDGD 234 (467)
T ss_pred eeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc-ceEEEeccCC-CCCccccc
Confidence 998876543 3478999999999998875 799999999999999999999999988544 2222223222 34455557
Q ss_pred CCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 258 QDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 258 ~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
.++.+++||..||. +|+.||||.+||+|+|++.
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 78899999999996 9999999999999999976
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-49 Score=389.94 Aligned_cols=260 Identities=23% Similarity=0.430 Sum_probs=221.3
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCC----------HHHHHHHHHHHHHHHhCCCCceeEEEe
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRS----------PDDLQRLYSEVHLLSTLKHDSIIRFYT 96 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~----------~~~~~~~~~Ei~iL~~l~HpnIv~l~~ 96 (466)
+.|.+..+ ||+|+||.|.+|++..+++.||||++.+..+... ....++.++||.+|++|.|||||+|++
T Consensus 97 Nqy~l~~e-iG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 97 NQYELIKE-IGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hheehhhh-hcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 56777544 9999999999999999999999999988765321 113578999999999999999999999
Q ss_pred EEEeccCCEEEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEE
Q 012320 97 SWIDVDQKTFNFITEMFTSGTLREYRKKYRR-VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKI 175 (466)
Q Consensus 97 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL 175 (466)
+.-+.....+|+|+|||..|.+...- ..+. +++.++++|++.++.||+|||.+| ||||||||+|+|++++ |+|||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~-g~VKI 251 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSD-GTVKI 251 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCC-CcEEe
Confidence 87556678999999999999886432 2234 999999999999999999999999 9999999999999988 99999
Q ss_pred eccchhhhhcCCC------CCccccCCCCcCCccccccC-----CCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 012320 176 GDLGLAAILRGSK------SAHSVIGTPEFMAPELYEED-----YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKK 244 (466)
Q Consensus 176 ~DFGla~~~~~~~------~~~~~~GT~~y~APE~l~~~-----y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~ 244 (466)
+|||.+..+..+. .....+|||.|||||++... -+.+.||||+||+||.|+.|++||.+ ....+++.+
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-~~~~~l~~K 330 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-DFELELFDK 330 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-chHHHHHHH
Confidence 9999997663221 12346899999999977642 35789999999999999999999987 788899999
Q ss_pred HhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 245 VTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 245 i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
|....+...........++++|.+||. ||.+|++..++..|||.....
T Consensus 331 Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 331 IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 998877655555568899999999995 999999999999999997653
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=390.47 Aligned_cols=264 Identities=27% Similarity=0.368 Sum_probs=219.7
Q ss_pred eeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 21 IETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 21 ~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
........|..+++ ||+|+||.||+|++..||+.||+|+|++... .++......+||.||++|+|||||+|.+..++
T Consensus 111 w~~r~~~~feki~k-IGeGTyg~VYkAr~~~tgkivALKKvr~d~~--~~~~~~t~~REI~ILr~l~HpNIikL~eivt~ 187 (560)
T KOG0600|consen 111 WGPRRADSFEKIEK-IGEGTYGQVYKARDLETGKIVALKKVRFDNE--KEGFPITAIREIKILRRLDHPNIIKLEEIVTS 187 (560)
T ss_pred ccccchHHHHHHHH-hcCcchhheeEeeecccCcEEEEEEeecccC--CCcchHHHHHHHHHHHhcCCCcccceeeEEEe
Confidence 33444566777655 9999999999999999999999999997763 34455678899999999999999999998766
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
.....+|+|+||| ..+|.-++... -.|++.+++.|++||+.||+|||++| |+|||||+.|||||.+ |.+||+|||
T Consensus 188 ~~~~siYlVFeYM-dhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~-G~LKiaDFG 263 (560)
T KOG0600|consen 188 KLSGSIYLVFEYM-DHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNN-GVLKIADFG 263 (560)
T ss_pred cCCceEEEEEecc-cchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCC-CCEEecccc
Confidence 5568999999999 55777777653 47999999999999999999999999 9999999999999987 999999999
Q ss_pred hhhhhcCCC--CCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-C------
Q 012320 180 LAAILRGSK--SAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-G------ 248 (466)
Q Consensus 180 la~~~~~~~--~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-g------ 248 (466)
||+++.... ...+.+-|.+|.|||+|.+ .|+.++|+||+||||.||++|++.|.+....+|+.+.+.- |
T Consensus 264 LAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~ 343 (560)
T KOG0600|consen 264 LARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY 343 (560)
T ss_pred ceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc
Confidence 999876544 4667788999999997754 5999999999999999999999999986666666544431 1
Q ss_pred ----CCCCC---------------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 249 ----KLPGA---------------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 249 ----~~p~~---------------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
++|.. .....+..+.+|+..||. ||.+|.||.++|+++||...
T Consensus 344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 12200 023345678899999996 99999999999999999543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=369.54 Aligned_cols=258 Identities=24% Similarity=0.443 Sum_probs=228.2
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCH----HHHHHHHHHHHHHHhC-CCCceeEEEeEEEecc
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSP----DDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVD 102 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~----~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 102 (466)
.|.- .++||+|..++|.+|+++.+|.++|+|++.......+. .-.+.-.+|+.||+++ .||+|+++.++| +.
T Consensus 18 ~y~p-keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--es 94 (411)
T KOG0599|consen 18 KYEP-KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--ES 94 (411)
T ss_pred hcCh-HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec--cC
Confidence 3444 67899999999999999999999999999765433222 2345677899999998 799999999988 66
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
+..+++|+|+|+-|.|+||+...-.++++..++|++|+++|++|||..+ |+||||||+|||++.+ -.+||+|||+++
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn-~~i~isDFGFa~ 171 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDN-MNIKISDFGFAC 171 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccc-cceEEeccceee
Confidence 8889999999999999999999889999999999999999999999999 9999999999999988 599999999999
Q ss_pred hhcCCCCCccccCCCCcCCcccccc-------CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--CC
Q 012320 183 ILRGSKSAHSVIGTPEFMAPELYEE-------DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP--GA 253 (466)
Q Consensus 183 ~~~~~~~~~~~~GT~~y~APE~l~~-------~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p--~~ 253 (466)
.+..+......||||.|+|||.+.. +|+..+|+|++|||||-|+.|.+||.. ....-+.+.|..|++. .+
T Consensus 172 ~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH-RkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 172 QLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH-RKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred ccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH-HHHHHHHHHHHhcccccCCc
Confidence 9999999999999999999998752 488999999999999999999999975 4455678899999865 34
Q ss_pred CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 254 FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 254 ~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
.|...+...++||.+||+ ||.+|+|++|+|.||||....
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 566677899999999995 999999999999999996543
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=384.93 Aligned_cols=259 Identities=21% Similarity=0.350 Sum_probs=220.0
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
++|.+ .+.||+|+||.||+|.++.+|+.||+|++.+... ........+.+|+.+++.++||||+++++.+ .+...+
T Consensus 1 ~~y~~-~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~--~~~~~~ 76 (333)
T cd05600 1 KDFQI-LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL-FKLNEVRHVLTERDILTTTKSEWLVKLLYAF--QDDEYL 76 (333)
T ss_pred CCcEE-EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhCCCCCCccEEEEE--EcCCEE
Confidence 46777 4669999999999999999999999999986543 2234556788999999999999999999987 457789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++.....
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 77 YLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDAS-GHIKLTDFGLSKGIVT 153 (333)
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC-CCEEEEeCcCCccccc
Confidence 999999999999999998889999999999999999999999999 9999999999999876 8999999999976543
Q ss_pred CCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC------CCCC
Q 012320 187 SKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFY------SIQD 259 (466)
Q Consensus 187 ~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~------~~~~ 259 (466)
.....+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..+.+..+.........+ ...+
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s 230 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFNLS 230 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC-CCHHHHHHHHHhccccccCCCCCccccccC
Confidence 345668999999999876 4689999999999999999999999976 66677776665433211111 1347
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhhhh
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVKL 295 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~~~ 295 (466)
.++.++|.+||. +|.+||++.++++||||....+..
T Consensus 231 ~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~ 267 (333)
T cd05600 231 DEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNE 267 (333)
T ss_pred HHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHHH
Confidence 899999999996 889999999999999999866543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=360.71 Aligned_cols=255 Identities=28% Similarity=0.445 Sum_probs=213.6
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
.||.+. ++||+|+||+||+|++..||+.||||+|+..+... .......+||++|+.++||||+.+.++| .....+
T Consensus 2 ~rY~~~-~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd--Gi~~talREIK~Lqel~h~nIi~LiD~F--~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKL-EKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD--GINRTALREIKLLQELKHPNIIELIDVF--PHKSNL 76 (318)
T ss_pred chhhhh-hhhcCcceEEEEEEEecCCCcEEEEEEeecccccc--CccHHHHHHHHHHHHccCcchhhhhhhc--cCCCce
Confidence 588885 55999999999999999999999999999876432 2345789999999999999999999998 567789
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 107 NFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
.+|+||+ ..+|...++.. ..++...++.|+.+++.||+|||+++ |+||||||.|+|++++ |.+||+|||+|+.+.
T Consensus 77 ~lVfEfm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~-g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 77 SLVFEFM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSD-GQLKIADFGLARFFG 152 (318)
T ss_pred EEEEEec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCC-CcEEeecccchhccC
Confidence 9999999 56898888754 46899999999999999999999999 9999999999999987 999999999999876
Q ss_pred CCCC-CccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CC------------
Q 012320 186 GSKS-AHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-GK------------ 249 (466)
Q Consensus 186 ~~~~-~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-g~------------ 249 (466)
.... ....+-|.+|.|||++- +.|+..+||||.|||+.||+-+.+-|.+.++.+|+...+.. |.
T Consensus 153 ~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 153 SPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred CCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 4332 23347899999999775 46999999999999999999998778776776776544432 11
Q ss_pred --------CCC----CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 250 --------LPG----AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 250 --------~p~----~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
+|. ......+.++.+|+.+|+. ||.+|+|+.|+|+||||+.
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 111 1233455678999999997 9999999999999999975
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=387.42 Aligned_cols=262 Identities=23% Similarity=0.393 Sum_probs=219.3
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
.|.. .+.||+|+||+||+|.++.+|+.||+|++++.... .......+.+|+.+++.++||||+++++.+ .+...+|
T Consensus 2 ~y~~-~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~~~~~~iv~~~~~~--~~~~~~~ 77 (363)
T cd05628 2 DFES-LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-EKEQVGHIRAERDILVEADSLWVVKMFYSF--QDKLNLY 77 (363)
T ss_pred CceE-eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhhHHHHHHHHHHHHHhCCCCCcceEEEEE--ecCCeEE
Confidence 4666 46699999999999999999999999999865432 234556788999999999999999999988 4577899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~ 187 (466)
+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ |.+||+|||+++.+...
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~-~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKA 154 (363)
T ss_pred EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCC-CCEEEeeccCccccccc
Confidence 99999999999999998899999999999999999999999999 9999999999999876 89999999998754321
Q ss_pred C------------------------------------CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCC
Q 012320 188 K------------------------------------SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEY 230 (466)
Q Consensus 188 ~------------------------------------~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~ 230 (466)
. ...+.+||+.|+|||++. ..|+.++|||||||++|||++|..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 0 012458999999999875 569999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHhcCCCCCCC--CCCCCHHHHHHHHHhccCc---CCCCCHHHHhcCCCCCchhhhhcc
Q 012320 231 PYSECANPAQIYKKVTSGKLPGAF--YSIQDLEAQRFIGRCLVNA---SKRLSAKELLLDPFLASDEVKLLS 297 (466)
Q Consensus 231 Pf~~~~~~~~i~~~i~~g~~p~~~--~~~~~~~~~~lI~~~L~dp---~~Rpsa~elL~hpf~~~~~~~~~~ 297 (466)
||.. .+..+.++++........+ ....+.+++++|.+|+.+| ..||+++|+++||||+...+....
T Consensus 235 Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~~~ 305 (363)
T cd05628 235 PFCS-ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEHIR 305 (363)
T ss_pred CCCC-CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHHHH
Confidence 9976 6677888888764322111 2235789999999987644 456899999999999988776543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=384.09 Aligned_cols=254 Identities=25% Similarity=0.423 Sum_probs=220.1
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecC
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMF 113 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~ 113 (466)
++||+|+||+||+|.++.+|+.||+|++++... ........+.+|+.+|++++||||+++++.+ .....+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~--~~~~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI-IAKDEVAHTLTESRVLQNTRHPFLTALKYSF--QTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE--EcCCEEEEEEeCC
Confidence 369999999999999999999999999986543 2334556788999999999999999999987 4577899999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc-CCCCCcc
Q 012320 114 TSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSKSAHS 192 (466)
Q Consensus 114 ~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~-~~~~~~~ 192 (466)
.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+ |.+||+|||++.... .......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCC-CCEEEeeCCCCcccccCCCcccc
Confidence 99999999998889999999999999999999999999 9999999999999876 899999999987532 2233455
Q ss_pred ccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc
Q 012320 193 VIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV 271 (466)
Q Consensus 193 ~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~ 271 (466)
.+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+...+...+..+.. .++...+.++++||++||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHcc
Confidence 78999999999876 5599999999999999999999999976 667777777776654 2345578899999999996
Q ss_pred -CcCCCC-----CHHHHhcCCCCCchhhhhc
Q 012320 272 -NASKRL-----SAKELLLDPFLASDEVKLL 296 (466)
Q Consensus 272 -dp~~Rp-----sa~elL~hpf~~~~~~~~~ 296 (466)
||.+|| ++.++++||||....+...
T Consensus 232 ~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~ 262 (323)
T cd05571 232 KDPKQRLGGGPEDAKEIMEHRFFASINWQDV 262 (323)
T ss_pred CCHHHcCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence 999999 8999999999998766543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=377.66 Aligned_cols=255 Identities=29% Similarity=0.461 Sum_probs=221.9
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+|.. .+.||+|+||+||+|.++.+|+.||+|++...... .....+.+.+|+.+|++++||||+++++.+ .+...++
T Consensus 2 ~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~~~~ 77 (291)
T cd05612 2 DLER-IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQEQHVHNEKRVLKEVSHPFIIRLFWTE--HDQRFLY 77 (291)
T ss_pred Ccee-eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hhHHHHHHHHHHHHHHhCCCCcHhhhHhhh--ccCCeEE
Confidence 5666 46699999999999999999999999998765432 223456788999999999999999999876 4567899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~ 187 (466)
+||||+++|+|.+++.+.+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ |.+||+|||++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKE-GHIKLTDFGFAKKLRDR 154 (291)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC-CCEEEEecCcchhccCC
Confidence 99999999999999998889999999999999999999999999 9999999999999876 89999999999766432
Q ss_pred CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 012320 188 KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFI 266 (466)
Q Consensus 188 ~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI 266 (466)
....+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+...+++.+..+..+ ++...+..++++|
T Consensus 155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~--~~~~~~~~~~~li 229 (291)
T cd05612 155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKLE--FPRHLDLYAKDLI 229 (291)
T ss_pred --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcC--CCccCCHHHHHHH
Confidence 33567999999999876 4589999999999999999999999976 6778888888877643 3445588999999
Q ss_pred HHhcc-CcCCCCC-----HHHHhcCCCCCchhhh
Q 012320 267 GRCLV-NASKRLS-----AKELLLDPFLASDEVK 294 (466)
Q Consensus 267 ~~~L~-dp~~Rps-----a~elL~hpf~~~~~~~ 294 (466)
++||. ||.+|++ +.+++.||||+...+.
T Consensus 230 ~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 230 KKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred HHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 99996 9999995 9999999999876664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=375.22 Aligned_cols=263 Identities=28% Similarity=0.388 Sum_probs=223.8
Q ss_pred eeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEec
Q 012320 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
-+.||+|.-|+||+|..+.++..+|+|++.+..+. +.....++..|-+||+.++||.+.+||.+| +..+..++||||
T Consensus 82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~-~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f--et~~~~cl~mey 158 (459)
T KOG0610|consen 82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLA-SRKKLKRAQTEREILSLLDHPFLPTLYASF--ETDKYSCLVMEY 158 (459)
T ss_pred HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHh-hhhHHHHHHHHHHHHHhcCCCccchhhhee--eccceeEEEEec
Confidence 35599999999999999999999999999977653 456778999999999999999999999998 678899999999
Q ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC----
Q 012320 113 FTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG---- 186 (466)
Q Consensus 113 ~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~---- 186 (466)
|+||+|..++++. +.+++..+++|+.+++.||+|||-.| ||+|||||+||||-.+ |+|.|+||.|+.....
T Consensus 159 CpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvred-GHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVRED-GHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred CCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecC-CcEEeeeccccccCCCCCee
Confidence 9999999998875 56999999999999999999999999 9999999999999877 9999999998732210
Q ss_pred ------------------------------CC-----------------------CCccccCCCCcCCcccccc-CCCCh
Q 012320 187 ------------------------------SK-----------------------SAHSVIGTPEFMAPELYEE-DYNEL 212 (466)
Q Consensus 187 ------------------------------~~-----------------------~~~~~~GT~~y~APE~l~~-~y~~~ 212 (466)
.+ ...+++||-+|.|||++.+ +.+.+
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA 315 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA 315 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence 00 0135789999999999874 59999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCC----HHHHhcCCC
Q 012320 213 VDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLS----AKELLLDPF 287 (466)
Q Consensus 213 ~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rps----a~elL~hpf 287 (466)
+|||+|||++|||+.|..||.+..+. +.+.+|....+........+..+++||+++|+ ||++|+. |.||.+|||
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~-~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpF 394 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNK-ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPF 394 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCch-hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCcc
Confidence 99999999999999999999985554 44555554444333334567899999999996 9999998 999999999
Q ss_pred CCchhhhhccccccC
Q 012320 288 LASDEVKLLSKTKLN 302 (466)
Q Consensus 288 ~~~~~~~~~~~~~~~ 302 (466)
|+..+|.++....+.
T Consensus 395 F~gVnWaLir~~~PP 409 (459)
T KOG0610|consen 395 FEGVNWALIRCARPP 409 (459)
T ss_pred ccCCChhheeccCCC
Confidence 999999865544443
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=379.66 Aligned_cols=254 Identities=25% Similarity=0.478 Sum_probs=232.1
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
.-.||.+ .+.||+|+||+|-+|++...|+.||||.|++..+ .+..++-.+.+||+||..|+||||+.+|++| ++..
T Consensus 51 lkHRyE~-~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkI-kdeqDlvhIRREIeIMSsLNHPhII~IyEVF--ENkd 126 (668)
T KOG0611|consen 51 LKHRYEI-TETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKI-KDEQDLVHIRREIEIMSSLNHPHIIQIYEVF--ENKD 126 (668)
T ss_pred hhhHHHH-HHHhcCCcccceeehhhccCCcEeehhhhhhhhc-ccHHHHHHHHHHHHHHhhcCCCceeehhhhh--cCCc
Confidence 3568877 4669999999999999999999999999998876 4667888999999999999999999999998 6678
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.+.|||||..+|.|.||+...+.+++..++.+++||++|+.|||.++ ++|||||.+|||+|.+ +++||+||||+..+
T Consensus 127 KIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N-~NiKIADFGLSNly 203 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQN-NNIKIADFGLSNLY 203 (668)
T ss_pred eEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCC-CCeeeeccchhhhh
Confidence 89999999999999999999999999999999999999999999999 9999999999999988 89999999999999
Q ss_pred cCCCCCccccCCCCcCCccccccC-C-CChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 012320 185 RGSKSAHSVIGTPEFMAPELYEED-Y-NELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA 262 (466)
Q Consensus 185 ~~~~~~~~~~GT~~y~APE~l~~~-y-~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~ 262 (466)
...+...++||+|.|.+||+..+. | ++.+|-|||||+||-|+.|.+||.+ .+...+.++|.+|.+.++. ....+
T Consensus 204 ~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-~Dhk~lvrQIs~GaYrEP~---~PSdA 279 (668)
T KOG0611|consen 204 ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-RDHKRLVRQISRGAYREPE---TPSDA 279 (668)
T ss_pred ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-chHHHHHHHhhcccccCCC---CCchH
Confidence 988899999999999999988764 5 5889999999999999999999987 7788899999999874432 23478
Q ss_pred HHHHHHhc-cCcCCCCCHHHHhcCCCCC
Q 012320 263 QRFIGRCL-VNASKRLSAKELLLDPFLA 289 (466)
Q Consensus 263 ~~lI~~~L-~dp~~Rpsa~elL~hpf~~ 289 (466)
.-||+.|| ++|.+|.|..++-.|=|+.
T Consensus 280 ~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 280 SGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHHHHHHhcCcccchhHHHHhhhheee
Confidence 89999999 6999999999999999985
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=374.42 Aligned_cols=258 Identities=29% Similarity=0.433 Sum_probs=216.6
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe---ccC
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID---VDQ 103 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~---~~~ 103 (466)
.+|+...+.||+|+||.|..|.++.+|+.||||++. +..++.-..++.++|+++|+.++|+||+.+++.+.. ..-
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~--~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKIL--NPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhh--hhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 334343567999999999999999999999999876 344566788999999999999999999999998754 224
Q ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 104 KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
+.+|+|+|+| +.+|...++....+++..++.++.||+.||.|+||.+ |+||||||.|+|++.+ ..+||+|||+|+.
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~-c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNAD-CDLKICDFGLARY 174 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccC-CCEEeccccceee
Confidence 5799999999 7899999998778999999999999999999999999 9999999999999988 7999999999998
Q ss_pred hcC---CCCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--------------H
Q 012320 184 LRG---SKSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYK--------------K 244 (466)
Q Consensus 184 ~~~---~~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~--------------~ 244 (466)
... ....+..+-|.+|.|||++. ..|+.++||||+|||+.||++|++.|.+.....|+.. .
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 753 34456678899999999765 5699999999999999999999999987554444422 1
Q ss_pred Hh----------cCCCCC----CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 245 VT----------SGKLPG----AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 245 i~----------~g~~p~----~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
|. .+..|. ......++.+.+|+++||+ ||.+|+|++|+|.|||+..
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence 11 011111 1234678899999999998 9999999999999999975
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=382.49 Aligned_cols=257 Identities=26% Similarity=0.453 Sum_probs=223.9
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
+.|.+ .+.||+|+||+||+|.++.+|+.||+|.+...... .....+.+.+|+.+|++++||||+++++.+ .+.+.+
T Consensus 18 ~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~~~ 93 (329)
T PTZ00263 18 SDFEM-GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQVQHVAQEKSILMELSHPFIVNMMCSF--QDENRV 93 (329)
T ss_pred hheEE-EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCcEEEEE--EcCCEE
Confidence 55666 57799999999999999999999999999865432 233456789999999999999999999988 456789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++.....
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNK-GHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCC-CCEEEeeccCceEcCC
Confidence 999999999999999998889999999999999999999999999 9999999999999877 8999999999976543
Q ss_pred CCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 012320 187 SKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRF 265 (466)
Q Consensus 187 ~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~l 265 (466)
. ..+.+||+.|+|||++. ..++.++|||||||++|+|++|..||.+ .+..++++.+..+.++ ++...+..+++|
T Consensus 171 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~l 245 (329)
T PTZ00263 171 R--TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAGRLK--FPNWFDGRARDL 245 (329)
T ss_pred C--cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCcC--CCCCCCHHHHHH
Confidence 2 33567999999999876 4589999999999999999999999976 6778888888888754 345577899999
Q ss_pred HHHhcc-CcCCCCC-----HHHHhcCCCCCchhhhh
Q 012320 266 IGRCLV-NASKRLS-----AKELLLDPFLASDEVKL 295 (466)
Q Consensus 266 I~~~L~-dp~~Rps-----a~elL~hpf~~~~~~~~ 295 (466)
|.+||. ||.+|++ +++++.||||....+..
T Consensus 246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~ 281 (329)
T PTZ00263 246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDK 281 (329)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHH
Confidence 999995 9999997 79999999998866643
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=385.55 Aligned_cols=261 Identities=27% Similarity=0.427 Sum_probs=233.0
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
-.|-|.+ ++.||+|-|.+|.+|+|..||..||+|+|.+.++ +.-....+++|++.|+.++|||||++|++. ..+.
T Consensus 16 IAGLYDL-ekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl--D~~st~hlfqEVRCMKLVQHpNiVRLYEVi--DTQT 90 (864)
T KOG4717|consen 16 IAGLYDL-EKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL--DTLSTGHLFQEVRCMKLVQHPNIVRLYEVI--DTQT 90 (864)
T ss_pred eeeeehh-hhhhcCCceehhhhhhhhcccceeEEEEeccccc--chhhhhHHHHHHHHHHHhcCcCeeeeeehh--cccc
Confidence 3566655 8889999999999999999999999999998775 344557899999999999999999999965 5678
Q ss_pred EEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
.+|+|+|+-.+|+|++||.++ ..++|..+++|++||+.|+.|||+.. ++||||||+|+.+-...|.|||.|||++..
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNK 168 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeecccccc
Confidence 899999999999999999887 56999999999999999999999999 999999999998877889999999999999
Q ss_pred hcCCCCCccccCCCCcCCccccc-cCCC-ChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 012320 184 LRGSKSAHSVIGTPEFMAPELYE-EDYN-ELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLE 261 (466)
Q Consensus 184 ~~~~~~~~~~~GT~~y~APE~l~-~~y~-~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 261 (466)
+.+++...+.||+..|.|||++- ..|+ +++||||||||||.|+||..||.+ .|..+..-+|...++ ..+...+.+
T Consensus 169 f~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqe-ANDSETLTmImDCKY--tvPshvS~e 245 (864)
T KOG4717|consen 169 FQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQE-ANDSETLTMIMDCKY--TVPSHVSKE 245 (864)
T ss_pred CCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccc-ccchhhhhhhhcccc--cCchhhhHH
Confidence 99999999999999999999765 4576 779999999999999999999988 666777777877665 345677889
Q ss_pred HHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhhhh
Q 012320 262 AQRFIGRCLV-NASKRLSAKELLLDPFLASDEVKL 295 (466)
Q Consensus 262 ~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~~~ 295 (466)
+++||..||+ ||.+|.|.+||..++|++..+...
T Consensus 246 CrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 246 CRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred HHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 9999999997 999999999999999999866543
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-47 Score=385.10 Aligned_cols=260 Identities=25% Similarity=0.420 Sum_probs=219.8
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+|.+ .++||+|+||+||+|.++.+|+.||+|++.+.... .......+.+|+.+|+.++||||+++++.| .+...+|
T Consensus 2 ~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~--~~~~~~~ 77 (364)
T cd05599 2 DFES-IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWVVKLYYSF--QDENYLY 77 (364)
T ss_pred CceE-EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEE--EcCCeEE
Confidence 5666 46699999999999999999999999999865432 234556788999999999999999999988 4577899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~ 187 (466)
+||||++||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..+...
T Consensus 78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKS 154 (364)
T ss_pred EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-CCEEEeecccceecccc
Confidence 99999999999999998889999999999999999999999999 9999999999999877 89999999998654321
Q ss_pred C---------------------------------------CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh
Q 012320 188 K---------------------------------------SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT 227 (466)
Q Consensus 188 ~---------------------------------------~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt 227 (466)
. ...+.+||+.|+|||++. ..|+.++|||||||++|+|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1 112357999999999775 569999999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCCCHHHHHHHHHhccCcCCCCC---HHHHhcCCCCCchhhhh
Q 012320 228 CEYPYSECANPAQIYKKVTSGKLPGA--FYSIQDLEAQRFIGRCLVNASKRLS---AKELLLDPFLASDEVKL 295 (466)
Q Consensus 228 g~~Pf~~~~~~~~i~~~i~~g~~p~~--~~~~~~~~~~~lI~~~L~dp~~Rps---a~elL~hpf~~~~~~~~ 295 (466)
|..||.. .+..+.+..+........ .....+++++++|.+||.+|.+|++ +.+++.||||+...+..
T Consensus 235 G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~~~ 306 (364)
T cd05599 235 GYPPFCS-DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDWEH 306 (364)
T ss_pred CCCCCCC-CCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 9999976 566677777765443222 2224578999999999999999998 99999999999876654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=374.06 Aligned_cols=250 Identities=25% Similarity=0.411 Sum_probs=216.5
Q ss_pred eeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecCCC
Q 012320 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTS 115 (466)
Q Consensus 36 LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~~g 115 (466)
||+|+||+||+|.++.+++.||+|.+..... ........+.+|+.+|++++||||+++++.+ .+...+|+||||++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-VSRSEVTHTLAERTVLAQVNCPFIVPLKFSF--QSPEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCcEeceeeEE--ecCCeEEEEEcCCCC
Confidence 7999999999999999999999999875543 2334567788999999999999999999987 456789999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC-CCCCcccc
Q 012320 116 GTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SKSAHSVI 194 (466)
Q Consensus 116 gsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~-~~~~~~~~ 194 (466)
|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..... .......+
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCC-CcEEEEECcccccCccCCCcccccc
Confidence 999999998889999999999999999999999999 9999999999999877 8999999999875422 23344567
Q ss_pred CCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-C
Q 012320 195 GTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-N 272 (466)
Q Consensus 195 GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-d 272 (466)
||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+..++++.+..+.. .++...+.+++++|.+||. |
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~d 231 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQEPL--RFPDGFDRDAKDLLIGLLSRD 231 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHHcCCC
Confidence 999999999776 4589999999999999999999999976 667778888777654 3445677899999999996 9
Q ss_pred cCCCC---CHHHHhcCCCCCchhhh
Q 012320 273 ASKRL---SAKELLLDPFLASDEVK 294 (466)
Q Consensus 273 p~~Rp---sa~elL~hpf~~~~~~~ 294 (466)
|.+|| ++.++|.||||....+.
T Consensus 232 p~~R~~~~~~~e~l~hp~~~~~~~~ 256 (312)
T cd05585 232 PTRRLGYNGAQEIKNHPFFSQLSWK 256 (312)
T ss_pred HHHcCCCCCHHHHHcCCCcCCCCHH
Confidence 99997 58999999999876543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=384.10 Aligned_cols=260 Identities=25% Similarity=0.393 Sum_probs=215.8
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+|.+ .+.||+|+||+||+|.++.+|+.||+|++.+.... .....+.+.+|+.++++++||||++++++| .+...+|
T Consensus 2 ~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~--~~~~~~~ 77 (377)
T cd05629 2 DFHT-VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDSPWVVSLYYSF--QDAQYLY 77 (377)
T ss_pred CceE-eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhHHHHHHHHHHHHHHhCCCCCcceEEEEE--EcCCeeE
Confidence 5766 46699999999999999999999999998765432 334567788999999999999999999988 4577899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~ 187 (466)
+||||++||+|.+++.+.+.+++..++.|+.||+.||+|||+.| |+||||||+|||++.+ |.+||+|||+++.+...
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~-~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCC-CCEEEeecccccccccc
Confidence 99999999999999998889999999999999999999999999 9999999999999876 89999999998632110
Q ss_pred C------------------------------------------------CCccccCCCCcCCccccc-cCCCChhhHHHH
Q 012320 188 K------------------------------------------------SAHSVIGTPEFMAPELYE-EDYNELVDVYSF 218 (466)
Q Consensus 188 ~------------------------------------------------~~~~~~GT~~y~APE~l~-~~y~~~~DIwSl 218 (466)
. ...+.+||+.|+|||++. ..|+.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 0 001357999999999775 569999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCCCHHHHHHHHHhccCcCC---CCCHHHHhcCCCCCchhh
Q 012320 219 GMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA--FYSIQDLEAQRFIGRCLVNASK---RLSAKELLLDPFLASDEV 293 (466)
Q Consensus 219 Gvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~--~~~~~~~~~~~lI~~~L~dp~~---Rpsa~elL~hpf~~~~~~ 293 (466)
||++|||++|..||.. .+....++.+........ .....+.++++||.+||.+|.+ |+++.+++.||||+...+
T Consensus 235 Gvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 235 GAIMFECLIGWPPFCS-ENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred chhhhhhhcCCCCCCC-CCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 9999999999999976 556667777765332211 2224678999999999986665 569999999999987665
Q ss_pred hh
Q 012320 294 KL 295 (466)
Q Consensus 294 ~~ 295 (466)
..
T Consensus 314 ~~ 315 (377)
T cd05629 314 DT 315 (377)
T ss_pred HH
Confidence 43
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=380.35 Aligned_cols=261 Identities=24% Similarity=0.409 Sum_probs=222.2
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
++|.+ .+.||+|+||+||+|.++.+|+.||+|++.+.... .......+.+|+.+++.++||||+++++.+ .+...+
T Consensus 1 ~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~ 76 (350)
T cd05573 1 DDFEV-IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-KRNQIAHVRAERDILADADSPWIVKLYYSF--QDEEHL 76 (350)
T ss_pred CCceE-EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhcCCCCccchhhhe--ecCCeE
Confidence 46777 46699999999999999999999999999865532 224556788999999999999999999987 457789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
++||||+.|++|.+++.+.+.+++..++.++.||+.||.|||+.| |+||||||+|||++.+ |.+||+|||++..+..
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 77 YLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDAD-GHIKLADFGLCKKMNK 153 (350)
T ss_pred EEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEeecCCCCccCcc
Confidence 999999999999999998889999999999999999999999999 9999999999999877 8999999999976543
Q ss_pred CC------------------------------CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 012320 187 SK------------------------------SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSEC 235 (466)
Q Consensus 187 ~~------------------------------~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~ 235 (466)
.. ......||+.|+|||++. ..++.++|||||||++|+|++|..||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~- 232 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS- 232 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC-
Confidence 32 233567999999999776 4699999999999999999999999987
Q ss_pred CCHHHHHHHHhc--CCCCCCCCCCCCHHHHHHHHHhccCcCCCCC-HHHHhcCCCCCchhhhh
Q 012320 236 ANPAQIYKKVTS--GKLPGAFYSIQDLEAQRFIGRCLVNASKRLS-AKELLLDPFLASDEVKL 295 (466)
Q Consensus 236 ~~~~~i~~~i~~--g~~p~~~~~~~~~~~~~lI~~~L~dp~~Rps-a~elL~hpf~~~~~~~~ 295 (466)
.+....+..+.. ..+........++++++||.+||.+|.+|++ ++++++||||+...+..
T Consensus 233 ~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~~~~~ 295 (350)
T cd05573 233 DTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDWEN 295 (350)
T ss_pred CCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCCCHHH
Confidence 456666666665 2222222233588999999999999999999 99999999999876643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=384.69 Aligned_cols=259 Identities=24% Similarity=0.378 Sum_probs=216.1
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+|..+ ++||+|+||+||+|.++.+++.||+|++.+.... .......+.+|+.++++++||||+++++.|. +...+|
T Consensus 2 ~f~~~-~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~--~~~~~~ 77 (382)
T cd05625 2 MFVKI-KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL-LRNQVAHVKAERDILAEADNEWVVRLYYSFQ--DKDNLY 77 (382)
T ss_pred CcEEE-EEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE--eCCEEE
Confidence 57764 6699999999999999999999999999865432 2345678899999999999999999999884 567899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC-
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG- 186 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~- 186 (466)
+||||++||+|.+++.+.+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ |.+||+|||++..+..
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~-g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 78 FVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWT 154 (382)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEEeECCCCcccccc
Confidence 99999999999999988888999999999999999999999999 9999999999999876 8999999999753210
Q ss_pred -----------------------------------------------CCCCccccCCCCcCCccccc-cCCCChhhHHHH
Q 012320 187 -----------------------------------------------SKSAHSVIGTPEFMAPELYE-EDYNELVDVYSF 218 (466)
Q Consensus 187 -----------------------------------------------~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSl 218 (466)
.....+.+||+.|+|||++. ..|+.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 00112457999999999775 569999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCCCHHHHHHHHHhccCcCCCCC---HHHHhcCCCCCchhh
Q 012320 219 GMCVLEMFTCEYPYSECANPAQIYKKVTSGK--LPGAFYSIQDLEAQRFIGRCLVNASKRLS---AKELLLDPFLASDEV 293 (466)
Q Consensus 219 Gvil~elltg~~Pf~~~~~~~~i~~~i~~g~--~p~~~~~~~~~~~~~lI~~~L~dp~~Rps---a~elL~hpf~~~~~~ 293 (466)
||++|||++|..||.. .++.+....+.... ++.......+++++++|.+|+.+|.+|++ +.++++||||+...+
T Consensus 235 Gvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 235 GVILYEMLVGQPPFLA-QTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred hHHHHHHHhCCCCCCC-CCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence 9999999999999976 55555555555432 22222345678999999998889999987 999999999987655
Q ss_pred h
Q 012320 294 K 294 (466)
Q Consensus 294 ~ 294 (466)
.
T Consensus 314 ~ 314 (382)
T cd05625 314 S 314 (382)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=373.64 Aligned_cols=253 Identities=25% Similarity=0.425 Sum_probs=218.1
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecC
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMF 113 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~ 113 (466)
++||+|+||+||+|.++.+|..||+|+++.... ........+.+|+.+++.++||||+++++.| .....+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~--~~~~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAF--QTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCcceeeEE--ecCCEEEEEEeCC
Confidence 369999999999999999999999999986543 2334566788999999999999999999987 4467899999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc-CCCCCcc
Q 012320 114 TSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSKSAHS 192 (466)
Q Consensus 114 ~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~-~~~~~~~ 192 (466)
+||+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++.... .......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCC-CCEEecccHHhccccCCCCcccc
Confidence 99999999988889999999999999999999999999 9999999999999876 899999999987532 2233445
Q ss_pred ccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc
Q 012320 193 VIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV 271 (466)
Q Consensus 193 ~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~ 271 (466)
..||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+...+.+.+..+... ++...+++++++|.+||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~~~~~~~~--~p~~~~~~~~~li~~~L~ 231 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHHcc
Confidence 67999999999875 5689999999999999999999999976 5666777777655542 345568899999999996
Q ss_pred -CcCCCC-----CHHHHhcCCCCCchhhhh
Q 012320 272 -NASKRL-----SAKELLLDPFLASDEVKL 295 (466)
Q Consensus 272 -dp~~Rp-----sa~elL~hpf~~~~~~~~ 295 (466)
||.+|+ ++.++++||||.+..+..
T Consensus 232 ~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~ 261 (323)
T cd05595 232 KDPKQRLGGGPSDAKEVMEHRFFLSINWQD 261 (323)
T ss_pred CCHHHhCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 999998 899999999999876643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=381.63 Aligned_cols=259 Identities=22% Similarity=0.373 Sum_probs=213.4
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
.|..+ +.||+|+||+||+|.++.+++.||+|++.+.... .....+.+.+|+.+|+.++||||+++++.+. +...++
T Consensus 2 ~f~~~-~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~--~~~~~~ 77 (381)
T cd05626 2 MFVKI-KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-NRNQVAHVKAERDILAEADNEWVVKLYYSFQ--DKDNLY 77 (381)
T ss_pred CceEE-EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe--cCCEEE
Confidence 46664 5699999999999999999999999999865532 3345678899999999999999999999884 567899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~ 187 (466)
+||||++||+|.+++.+.+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ |.+||+|||++..+...
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~-~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 78 FVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWT 154 (381)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCC-CCEEEeeCcCCcccccc
Confidence 99999999999999998889999999999999999999999999 9999999999999876 89999999997533100
Q ss_pred ------------------------------------------------CCCccccCCCCcCCccccc-cCCCChhhHHHH
Q 012320 188 ------------------------------------------------KSAHSVIGTPEFMAPELYE-EDYNELVDVYSF 218 (466)
Q Consensus 188 ------------------------------------------------~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSl 218 (466)
....+.+||+.|+|||++. ..|+.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 0113467999999999775 569999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCCCHHHHHHHHHhcc---CcCCCCCHHHHhcCCCCCchhh
Q 012320 219 GMCVLEMFTCEYPYSECANPAQIYKKVTSG--KLPGAFYSIQDLEAQRFIGRCLV---NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 219 Gvil~elltg~~Pf~~~~~~~~i~~~i~~g--~~p~~~~~~~~~~~~~lI~~~L~---dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
||++|||++|..||.. .+.......+... .+........++++++||.+|+. ++..|+++.+++.||||+...+
T Consensus 235 G~il~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 235 GVILFEMLVGQPPFLA-PTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred hhHHHHHHhCCCCCcC-CCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence 9999999999999976 4444444444432 22222233467899999999763 5566999999999999987665
Q ss_pred h
Q 012320 294 K 294 (466)
Q Consensus 294 ~ 294 (466)
.
T Consensus 314 ~ 314 (381)
T cd05626 314 S 314 (381)
T ss_pred h
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=374.88 Aligned_cols=252 Identities=24% Similarity=0.437 Sum_probs=217.8
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecC
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMF 113 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~ 113 (466)
++||+|+||+||+|.++.+|..||+|++..... ........+.+|+.+|+.++||||+++++.+ .....+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI-IAKDEVAHTLTESRVLKNTRHPFLTSLKYSF--QTKDRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceEEEE--EcCCEEEEEEeCC
Confidence 369999999999999999999999999986543 2344567888999999999999999999887 4577899999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc-CCCCCcc
Q 012320 114 TSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSKSAHS 192 (466)
Q Consensus 114 ~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~-~~~~~~~ 192 (466)
++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++.... .......
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCC-CcEEEecCcCCccCCCccccccc
Confidence 99999999988889999999999999999999999999 9999999999999876 899999999987532 2233445
Q ss_pred ccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc
Q 012320 193 VIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV 271 (466)
Q Consensus 193 ~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~ 271 (466)
.+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..++.+.+..+.. .++...+.++++||++||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~ 231 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEDI--KFPRTLSADAKSLLSGLLI 231 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC-CCHHHHHHHhccCCc--cCCCCCCHHHHHHHHHHcC
Confidence 67999999999876 5689999999999999999999999976 566677777765544 2345578899999999996
Q ss_pred -CcCCCC-----CHHHHhcCCCCCchhhh
Q 012320 272 -NASKRL-----SAKELLLDPFLASDEVK 294 (466)
Q Consensus 272 -dp~~Rp-----sa~elL~hpf~~~~~~~ 294 (466)
||.+|+ ++.++++||||....+.
T Consensus 232 ~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 260 (328)
T cd05593 232 KDPNKRLGGGPDDAKEIMRHSFFTGVNWQ 260 (328)
T ss_pred CCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 999997 89999999999887664
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-47 Score=362.49 Aligned_cols=264 Identities=21% Similarity=0.316 Sum_probs=221.6
Q ss_pred eeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 21 IETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 21 ~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
--+.....|.++.+ |++|+||.||+|.++.|++.||+|+++...- ...-.-.-++||.+|.+++|||||.+-++.+.
T Consensus 70 ~gCrsv~efe~lnr-I~EGtyGiVYRakdk~t~eIVALKr~kmeke--k~GFPItsLREIniLl~~~H~NIV~vkEVVvG 146 (419)
T KOG0663|consen 70 GGCRSVEEFEKLNR-IEEGTYGVVYRAKDKKTDEIVALKRLKMEKE--KEGFPITSLREINILLKARHPNIVEVKEVVVG 146 (419)
T ss_pred cCcccHHHHHHHhh-cccCcceeEEEeccCCcceeEEeeecccccc--cCCCcchhHHHHHHHHhcCCCCeeeeEEEEec
Confidence 34566677888766 9999999999999999999999999987652 22233456899999999999999999998776
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
.+-+.+|+||||| ..+|..++...+ ++...+++.++.|++.||+|||.++ |+||||||+|+|++.. |.+||+|||
T Consensus 147 ~~~d~iy~VMe~~-EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~-G~lKiaDFG 222 (419)
T KOG0663|consen 147 SNMDKIYIVMEYV-EHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHK-GILKIADFG 222 (419)
T ss_pred cccceeeeeHHHH-HhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccC-CcEEecccc
Confidence 6677899999999 569999998775 8999999999999999999999999 9999999999999876 999999999
Q ss_pred hhhhhcCC-CCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CC------
Q 012320 180 LAAILRGS-KSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-GK------ 249 (466)
Q Consensus 180 la~~~~~~-~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-g~------ 249 (466)
||+.+... +.....+-|.+|.|||++- ..|+.++|+||+|||+.||+++++.|.+.....|+.+.+.. |.
T Consensus 223 LAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iw 302 (419)
T KOG0663|consen 223 LAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIW 302 (419)
T ss_pred hhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccC
Confidence 99988654 4456678899999999775 45999999999999999999999999987777777665542 11
Q ss_pred -------------CCCC--------CCCC-CCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 250 -------------LPGA--------FYSI-QDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 250 -------------~p~~--------~~~~-~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
++.. +... .+....+|+..+|. ||.+|.||+|.|+|+||...
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 1110 1111 44678899999996 99999999999999999764
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=376.66 Aligned_cols=259 Identities=22% Similarity=0.403 Sum_probs=222.6
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCC-eEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLG-VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g-~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
..+.|.+ .+.||+|+||.||+|.++.++ ..||+|.+.+.... .....+.+.+|+.+++.++||||+++++++ .+.
T Consensus 28 ~~~~y~~-~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~--~~~ 103 (340)
T PTZ00426 28 KYEDFNF-IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-KQKQVDHVFSERKILNYINHPFCVNLYGSF--KDE 103 (340)
T ss_pred ChhhcEE-EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCCcceEEEE--EeC
Confidence 3456777 466999999999999877655 78999998765432 334556788999999999999999999988 456
Q ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 104 KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
..+++||||+.||+|.+++.+.+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ |.+||+|||++..
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~-~~ikL~DFG~a~~ 180 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKD-GFIKMTDFGFAKV 180 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCC-CCEEEecCCCCee
Confidence 789999999999999999998889999999999999999999999999 9999999999999876 8999999999976
Q ss_pred hcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 012320 184 LRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA 262 (466)
Q Consensus 184 ~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~ 262 (466)
+.. ...+.+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+...+++.+..+... ++...+..+
T Consensus 181 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~ 255 (340)
T PTZ00426 181 VDT--RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA-NEPLLIYQKILEGIIY--FPKFLDNNC 255 (340)
T ss_pred cCC--CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCC--CCCCCCHHH
Confidence 543 234568999999999876 4589999999999999999999999976 6777888888877643 345567899
Q ss_pred HHHHHHhcc-CcCCCC-----CHHHHhcCCCCCchhhhh
Q 012320 263 QRFIGRCLV-NASKRL-----SAKELLLDPFLASDEVKL 295 (466)
Q Consensus 263 ~~lI~~~L~-dp~~Rp-----sa~elL~hpf~~~~~~~~ 295 (466)
+++|++||. +|.+|+ +++++++||||....|..
T Consensus 256 ~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~ 294 (340)
T PTZ00426 256 KHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVS 294 (340)
T ss_pred HHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 999999996 999995 899999999999876643
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-46 Score=364.96 Aligned_cols=260 Identities=20% Similarity=0.334 Sum_probs=214.9
Q ss_pred eEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEE
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNF 108 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~l 108 (466)
|.. .++||+|+||+||+|.++.+|+.||+|.+.+.... .......+.+|+.++++++|+||+++++.+ .+...+++
T Consensus 2 f~~-~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~iv~~~~~~--~~~~~~~l 77 (285)
T cd05631 2 FRH-YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKRILEKVNSRFVVSLAYAY--ETKDALCL 77 (285)
T ss_pred ceE-EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh-hhhhHHHHHHHHHHHHhcCCCcEEEEEEEE--ccCCeEEE
Confidence 444 56799999999999999999999999998865542 223345678999999999999999999987 44678999
Q ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 109 ITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 109 V~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
|+||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++.....
T Consensus 78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDR-GHIRISDLGLAVQIPE 154 (285)
T ss_pred EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCC-CCEEEeeCCCcEEcCC
Confidence 99999999999887643 36899999999999999999999999 9999999999999876 8999999999987654
Q ss_pred CCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHhcCCCCCCCCCCCCHHH
Q 012320 187 SKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECAN---PAQIYKKVTSGKLPGAFYSIQDLEA 262 (466)
Q Consensus 187 ~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~---~~~i~~~i~~g~~p~~~~~~~~~~~ 262 (466)
........||+.|+|||++. ..|+.++|||||||++|+|++|..||..... ...+...+..+. .......+.++
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~ 232 (285)
T cd05631 155 GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ--EEYSEKFSEDA 232 (285)
T ss_pred CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc--ccCCccCCHHH
Confidence 44445668999999999876 5699999999999999999999999976332 123333333322 23444567899
Q ss_pred HHHHHHhcc-CcCCCCC-----HHHHhcCCCCCchhhhhcc
Q 012320 263 QRFIGRCLV-NASKRLS-----AKELLLDPFLASDEVKLLS 297 (466)
Q Consensus 263 ~~lI~~~L~-dp~~Rps-----a~elL~hpf~~~~~~~~~~ 297 (466)
.+||++||. ||.+||+ ++++++||||....++.+.
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~ 273 (285)
T cd05631 233 KSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLE 273 (285)
T ss_pred HHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHH
Confidence 999999996 9999997 8999999999987775543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=379.35 Aligned_cols=262 Identities=23% Similarity=0.409 Sum_probs=219.7
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
.|.. .+.||+|+||+||+|.++.+|+.||+|+++..... .......+.+|+.++.+++||||+++++.| .+...+|
T Consensus 2 ~f~~-~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~--~~~~~~~ 77 (360)
T cd05627 2 DFES-LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAERDILVEADGAWVVKMFYSF--QDKRNLY 77 (360)
T ss_pred CceE-EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEE--EcCCEEE
Confidence 4555 46699999999999999999999999999865432 334567788999999999999999999987 4577899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~ 187 (466)
+||||++||+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++.+ |.+||+|||++..+...
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~-~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKA 154 (360)
T ss_pred EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCC-CCEEEeeccCCcccccc
Confidence 99999999999999998889999999999999999999999999 9999999999999876 89999999998654221
Q ss_pred C------------------------------------CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCC
Q 012320 188 K------------------------------------SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEY 230 (466)
Q Consensus 188 ~------------------------------------~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~ 230 (466)
. ...+.+||+.|+|||++. ..|+.++|||||||++|+|++|..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 0 012457999999999875 569999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHhcCCCCC--CCCCCCCHHHHHHHHHhccCcCCCC---CHHHHhcCCCCCchhhhhcc
Q 012320 231 PYSECANPAQIYKKVTSGKLPG--AFYSIQDLEAQRFIGRCLVNASKRL---SAKELLLDPFLASDEVKLLS 297 (466)
Q Consensus 231 Pf~~~~~~~~i~~~i~~g~~p~--~~~~~~~~~~~~lI~~~L~dp~~Rp---sa~elL~hpf~~~~~~~~~~ 297 (466)
||.. .++...+..+....... ......+.+++++|.+|+.+|.+|+ ++.+++.||||+...|..+.
T Consensus 235 Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~ 305 (360)
T cd05627 235 PFCS-ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGHIR 305 (360)
T ss_pred CCCC-CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHHHHh
Confidence 9976 66777777776543211 1122357899999999888999998 47999999999998876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=381.85 Aligned_cols=260 Identities=23% Similarity=0.376 Sum_probs=215.9
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
.|.++ +.||+|+||+||+|.++.+|+.||+|++.+.... .......+.+|+.+|+.++||||+++++.| .+++.++
T Consensus 2 ~y~~~-~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~--~~~~~~~ 77 (376)
T cd05598 2 MFVKI-KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-MRNQAAHVKAERDILAEADNEWVVKLYYSF--QDKDNLY 77 (376)
T ss_pred CceEE-EEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-hhhhHHHHHHHHHHHHhCCCCCcceEEEEE--EcCCEEE
Confidence 57664 5599999999999999999999999998755432 223456788999999999999999999988 4577899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~ 187 (466)
+||||++||+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..+...
T Consensus 78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~-~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWT 154 (376)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCC-CCEEEEeCCCCcccccc
Confidence 99999999999999998889999999999999999999999999 9999999999999876 89999999997532100
Q ss_pred --------------------------------------------CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHH
Q 012320 188 --------------------------------------------KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCV 222 (466)
Q Consensus 188 --------------------------------------------~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil 222 (466)
....+.+||+.|||||++. ..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0112457999999999876 4589999999999999
Q ss_pred HHHHhCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCCHHHHHHHHHhccCcCCCC---CHHHHhcCCCCCchhhhh
Q 012320 223 LEMFTCEYPYSECANPAQIYKKVTSGKL--PGAFYSIQDLEAQRFIGRCLVNASKRL---SAKELLLDPFLASDEVKL 295 (466)
Q Consensus 223 ~elltg~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~~~~~~~lI~~~L~dp~~Rp---sa~elL~hpf~~~~~~~~ 295 (466)
|+|++|..||.. .+.......+..... +.......+.+++++|.+|+.+|.+|+ ++.++++||||+...+..
T Consensus 235 yell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~~~ 311 (376)
T cd05598 235 YEMLVGQPPFLA-DTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDFAS 311 (376)
T ss_pred eehhhCCCCCCC-CCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCHHH
Confidence 999999999976 455555555554322 222233567899999999888999999 999999999998765543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=371.52 Aligned_cols=253 Identities=25% Similarity=0.438 Sum_probs=218.3
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCCEEEEEEec
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
++||+|+||+||+|.++.+|+.||+|++.+.... .....+.+..|+.+++.+ +||||+++++.+ .+...+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~--~~~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLYCCF--QTPDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhccCCCchhceeeEE--EcCCEEEEEEcC
Confidence 3699999999999999999999999998865432 234556778899999877 799999999987 456789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc-CCCCCc
Q 012320 113 FTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSKSAH 191 (466)
Q Consensus 113 ~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~-~~~~~~ 191 (466)
++||+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++.... ......
T Consensus 78 ~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~-~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 78 VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCC-CcEEEeeCCCCeecCcCCCccc
Confidence 999999999998889999999999999999999999999 9999999999999877 899999999987532 223344
Q ss_pred cccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhc
Q 012320 192 SVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCL 270 (466)
Q Consensus 192 ~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L 270 (466)
...||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..++++.+..+... .+...+.+++++|++||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~L 231 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVV--YPTWLSQDAVDILKAFM 231 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHHc
Confidence 567999999999876 4589999999999999999999999976 6778888888876643 34456789999999999
Q ss_pred c-CcCCCCCH------HHHhcCCCCCchhhhh
Q 012320 271 V-NASKRLSA------KELLLDPFLASDEVKL 295 (466)
Q Consensus 271 ~-dp~~Rpsa------~elL~hpf~~~~~~~~ 295 (466)
. ||.+||++ +++++||||....+..
T Consensus 232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~ 263 (320)
T cd05590 232 TKNPTMRLGSLTLGGEEAILRHPFFKELDWEK 263 (320)
T ss_pred ccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 6 99999998 8999999998866643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=373.45 Aligned_cols=242 Identities=35% Similarity=0.540 Sum_probs=207.2
Q ss_pred eeeeeeeCceEEEEEEEcCCCeE-EEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC-EEEEEE
Q 012320 33 EEVLGKGAMKTVYKAIDEVLGVE-VAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK-TFNFIT 110 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g~~-vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~-~~~lV~ 110 (466)
.+.||+|+||+||+|... |.. ||+|++..... +....+.+.+|+.+|++++|||||++++++.. .. .+.+||
T Consensus 46 ~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~--~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~--~~~~~~iVt 119 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDF--DDESRKAFRREASLLSRLRHPNIVQFYGACTS--PPGSLCIVT 119 (362)
T ss_pred hhhcccCCceeEEEEEeC--CceeEEEEEecchhc--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCceEEEE
Confidence 445999999999999766 566 99999886553 23337799999999999999999999998743 33 689999
Q ss_pred ecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCC-cEEEeccchhhhhcCC
Q 012320 111 EMFTSGTLREYRKK--YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLG-QVKIGDLGLAAILRGS 187 (466)
Q Consensus 111 E~~~ggsL~~~l~~--~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g-~vKL~DFGla~~~~~~ 187 (466)
||+++|+|.+++.+ .+.++...+..|+.||+.|+.|||+.++ ||||||||+|||++.+ + ++||+|||+++.....
T Consensus 120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~-~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLK-GKTLKIADFGLSREKVIS 197 (362)
T ss_pred EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCC-CCEEEECCCccceeeccc
Confidence 99999999999987 5889999999999999999999999987 9999999999999987 5 9999999999876654
Q ss_pred -CCCccccCCCCcCCcccccc---CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 188 -KSAHSVIGTPEFMAPELYEE---DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 188 -~~~~~~~GT~~y~APE~l~~---~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
.......||+.|||||++.+ .|+.++|||||||++|||+||+.||.+... .++...+..+...+..+....+.+.
T Consensus 198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~~p~~~~~~l~ 276 (362)
T KOG0192|consen 198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRPPIPKECPPHLS 276 (362)
T ss_pred cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCCCCCccCCHHHH
Confidence 33444789999999999984 399999999999999999999999998666 6665555544444455555888999
Q ss_pred HHHHHhcc-CcCCCCCHHHHh
Q 012320 264 RFIGRCLV-NASKRLSAKELL 283 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rpsa~elL 283 (466)
.++..|+. ||.+||+..+++
T Consensus 277 ~l~~~CW~~dp~~RP~f~ei~ 297 (362)
T KOG0192|consen 277 SLMERCWLVDPSRRPSFLEIV 297 (362)
T ss_pred HHHHHhCCCCCCcCCCHHHHH
Confidence 99999995 999999999986
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=350.04 Aligned_cols=249 Identities=27% Similarity=0.472 Sum_probs=224.9
Q ss_pred eeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEe
Q 012320 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITE 111 (466)
Q Consensus 32 ~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E 111 (466)
+++.||+|-||.||+|+.+.++-.||+|++.++.+. ......++.+|++|.+.|+||||+++|++|. +...+|+++|
T Consensus 26 igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~-~~~v~~qlrREiEIqs~L~hpnilrlY~~fh--d~~riyLilE 102 (281)
T KOG0580|consen 26 IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQIL-KTQVEHQLRREIEIQSHLRHPNILRLYGYFH--DSKRIYLILE 102 (281)
T ss_pred ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHH-HhcchhhhhheeEeecccCCccHHhhhhhee--ccceeEEEEE
Confidence 488999999999999999999999999999988754 3344578999999999999999999999995 4778999999
Q ss_pred cCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCC
Q 012320 112 MFTSGTLREYRK--KYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS 189 (466)
Q Consensus 112 ~~~ggsL~~~l~--~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~ 189 (466)
|.+.|+|+..+. +..++++.....+++|++.||.|||..+ ||||||||+|+|+... |.+||+|||-+.... ...
T Consensus 103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~-~~lkiAdfGwsV~~p-~~k 178 (281)
T KOG0580|consen 103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSA-GELKIADFGWSVHAP-SNK 178 (281)
T ss_pred ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCC-CCeeccCCCceeecC-CCC
Confidence 999999999998 6788999999999999999999999999 9999999999999987 899999999886544 567
Q ss_pred CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 012320 190 AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGR 268 (466)
Q Consensus 190 ~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~ 268 (466)
..+.|||..|.+||+.. ..++..+|+|++|++.||++.|..||.. .+..+.|+.|..-.+. ++...+.+++++|.+
T Consensus 179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes-~~~~etYkrI~k~~~~--~p~~is~~a~dlI~~ 255 (281)
T KOG0580|consen 179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFES-QSHSETYKRIRKVDLK--FPSTISGGAADLISR 255 (281)
T ss_pred ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhh-hhhHHHHHHHHHcccc--CCcccChhHHHHHHH
Confidence 78999999999999877 4699999999999999999999999976 5689999999887653 346778899999999
Q ss_pred hcc-CcCCCCCHHHHhcCCCCCc
Q 012320 269 CLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 269 ~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
||+ +|.+|.+..|++.|||+..
T Consensus 256 ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 256 LLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HhccCccccccHHHHhhhHHHHh
Confidence 996 9999999999999999864
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=372.01 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=216.8
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecC
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMF 113 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~ 113 (466)
++||+|+||+||+|.++.+|..||+|++.+... ........+.+|+++++.++||||+++++.+ .....+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~--~~~~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSF--QTHDRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCCceEEEE--EcCCEEEEEEeCC
Confidence 369999999999999999999999999986543 2334566788999999999999999999987 4567899999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc-CCCCCc
Q 012320 114 TSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHS-RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSKSAH 191 (466)
Q Consensus 114 ~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs-~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~-~~~~~~ 191 (466)
.||+|..++.+.+.+++..++.++.||+.||.|||+ .+ |+||||||+|||++.+ |.+||+|||++.... ......
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCC-CCEEEecCCCCeecCCCCcccc
Confidence 999999999888899999999999999999999997 68 9999999999999877 899999999987532 223344
Q ss_pred cccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhc
Q 012320 192 SVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCL 270 (466)
Q Consensus 192 ~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L 270 (466)
..+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+...+.+.+..+... ++...++++++||++||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~li~~~L 231 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIR--FPRTLSPEAKSLLSGLL 231 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC-CCHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHHh
Confidence 567999999999875 5689999999999999999999999976 5667777777665432 34556889999999999
Q ss_pred c-CcCCCC-----CHHHHhcCCCCCchhhh
Q 012320 271 V-NASKRL-----SAKELLLDPFLASDEVK 294 (466)
Q Consensus 271 ~-dp~~Rp-----sa~elL~hpf~~~~~~~ 294 (466)
. ||.+|+ ++.++++||||....+.
T Consensus 232 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 232 KKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred hcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 5 999997 89999999999876654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=366.07 Aligned_cols=247 Identities=28% Similarity=0.452 Sum_probs=210.1
Q ss_pred eeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC---EEEEE
Q 012320 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK---TFNFI 109 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~---~~~lV 109 (466)
.+++|.|+||+||+|....++++||||++-.....+ -+|+.+|+.++|||||++.-+|...... +.++|
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k--------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK--------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC--------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 688999999999999999999999999986544222 3599999999999999999888765444 56789
Q ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 110 TEMFTSGTLREYRKK----YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 110 ~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
|||+ ..+|..+++. ..+++.-.++-++.||++||.|||++| |+||||||.|+|||.+.|.+||||||.|+.+.
T Consensus 101 leym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 101 LEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 9999 5688888774 477999999999999999999999999 99999999999999999999999999999998
Q ss_pred CCCCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-C--------------
Q 012320 186 GSKSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-G-------------- 248 (466)
Q Consensus 186 ~~~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-g-------------- 248 (466)
.+....+.+.|..|+|||++- ..|+.+.||||.||++.||+-|.+.|.+.....|+...+.- |
T Consensus 178 ~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 178 KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY 257 (364)
T ss_pred cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence 888888899999999999765 45999999999999999999999999886665555433321 0
Q ss_pred ---CCC--------CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 249 ---KLP--------GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 249 ---~~p--------~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
++| ..+....++++.+|+.++|+ +|.+|.++.|+|.||||..
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE 311 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence 111 11345567899999999997 9999999999999999964
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=369.54 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=213.7
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHH-HHHhCCCCceeEEEeEEEeccCCEEEEEEec
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVH-LLSTLKHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
++||+|+||+||+|.++.+|+.||+|++.+...... .....+..|.. +++.++||||+++++.+ .+...+++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~e~~~~~~~l~hp~iv~~~~~~--~~~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK-KEQKHIMAERNVLLKNVKHPFLVGLHYSF--QTADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh-hHHHHHHHHHHHHHhhCCCCCCCCeeEEE--EeCCEEEEEEcC
Confidence 369999999999999999999999999986543222 23345555555 56789999999999987 456789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc-CCCCCc
Q 012320 113 FTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSKSAH 191 (466)
Q Consensus 113 ~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~-~~~~~~ 191 (466)
+.||+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ |.+||+|||++.... ......
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCC-CcEEEeccCCCcccccCCCccc
Confidence 999999999998889999999999999999999999999 9999999999999877 899999999987532 223344
Q ss_pred cccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhc
Q 012320 192 SVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCL 270 (466)
Q Consensus 192 ~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L 270 (466)
..+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..++++.+..+... .....+..+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~l 231 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDTAEMYDNILNKPLR--LKPNISVSARHLLEGLL 231 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHHh
Confidence 567999999999776 4589999999999999999999999976 6777888888776543 33445789999999999
Q ss_pred c-CcCCCCCH----HHHhcCCCCCchhhhh
Q 012320 271 V-NASKRLSA----KELLLDPFLASDEVKL 295 (466)
Q Consensus 271 ~-dp~~Rpsa----~elL~hpf~~~~~~~~ 295 (466)
. ||.+||++ .+++.||||....+..
T Consensus 232 ~~~p~~R~~~~~~~~~il~~~~~~~~~~~~ 261 (323)
T cd05575 232 QKDRTKRLGAKDDFLEIKNHVFFSSINWDD 261 (323)
T ss_pred hcCHHhCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 6 99999998 5999999998866643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=369.24 Aligned_cols=254 Identities=21% Similarity=0.406 Sum_probs=214.1
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCCEEEEEEec
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
++||+|+||+||+|.++.+++.||+|++++... ........+.+|+.+++.+ +||||+++++.+ .+...+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~--~~~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV-NDDEDIDWVQTEKHVFETASNHPFLVGLHSCF--QTESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCCCCceEEEE--EcCCEEEEEEeC
Confidence 369999999999999999999999999986543 2334556788999999998 799999999987 456789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh-cCCCCCc
Q 012320 113 FTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-RGSKSAH 191 (466)
Q Consensus 113 ~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~-~~~~~~~ 191 (466)
++||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.. .......
T Consensus 78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC-CCEEECcCccccccccCCCccc
Confidence 999999999988889999999999999999999999999 9999999999999876 89999999998753 2233345
Q ss_pred cccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCC--------CCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 012320 192 SVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSEC--------ANPAQIYKKVTSGKLPGAFYSIQDLEA 262 (466)
Q Consensus 192 ~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~--------~~~~~i~~~i~~g~~p~~~~~~~~~~~ 262 (466)
..+||+.|+|||++. ..++.++|||||||++|+|++|..||... .....+++.+..+..+ .+...+..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~p~~~~~~~ 232 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC--CCCCCCHHH
Confidence 678999999999876 45899999999999999999999999521 1223455666555432 344567899
Q ss_pred HHHHHHhcc-CcCCCCC------HHHHhcCCCCCchhhhh
Q 012320 263 QRFIGRCLV-NASKRLS------AKELLLDPFLASDEVKL 295 (466)
Q Consensus 263 ~~lI~~~L~-dp~~Rps------a~elL~hpf~~~~~~~~ 295 (466)
+++|.+||. ||.+|++ +.++++||||....+..
T Consensus 233 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~ 272 (329)
T cd05588 233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDL 272 (329)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHH
Confidence 999999996 9999997 78999999998766643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=368.99 Aligned_cols=254 Identities=24% Similarity=0.410 Sum_probs=219.0
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCCEEEEEEec
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
++||+|+||+||+|.++.+|+.||+|++.+.... .....+.+..|+.+++.+ +||||+++++.| .+...+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~--~~~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL-QDDDVDCTMTEKRILALAAKHPFLTALHCCF--QTKDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhccCCCCccceeeEE--EcCCeEEEEEeC
Confidence 3599999999999999999999999999865432 334556778899999876 899999999988 456789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc-CCCCCc
Q 012320 113 FTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSKSAH 191 (466)
Q Consensus 113 ~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~-~~~~~~ 191 (466)
++||+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++.... ......
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 78 VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEEeecccceecccCCcccc
Confidence 999999999998889999999999999999999999999 9999999999999877 899999999987543 223344
Q ss_pred cccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhc
Q 012320 192 SVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCL 270 (466)
Q Consensus 192 ~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L 270 (466)
..+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+...+++.+..+... .+...+.++.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~ll~~~L 231 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA-DNEDDLFESILHDDVL--YPVWLSKEAVSILKAFM 231 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHHh
Confidence 567999999999876 4699999999999999999999999976 6778888888877643 33456789999999999
Q ss_pred c-CcCCCC-------CHHHHhcCCCCCchhhhhc
Q 012320 271 V-NASKRL-------SAKELLLDPFLASDEVKLL 296 (466)
Q Consensus 271 ~-dp~~Rp-------sa~elL~hpf~~~~~~~~~ 296 (466)
. +|.+|+ ++.++++||||....+...
T Consensus 232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~ 265 (321)
T cd05591 232 TKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLL 265 (321)
T ss_pred ccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHH
Confidence 6 999999 9999999999988766543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=363.66 Aligned_cols=259 Identities=25% Similarity=0.371 Sum_probs=206.5
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
..++|.+. +.||+|+||+||+|.++.+|+.||+|++..... ......+.+|+.+++.++||||+++++++ .+..
T Consensus 3 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~--~~~~ 76 (303)
T cd07869 3 KADSYEKL-EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE---EGTPFTAIREASLLKGLKHANIVLLHDII--HTKE 76 (303)
T ss_pred ccccceEe-eeEEecCCEEEEEEEECCCCCEEEEEEeccccc---cccchhHHHHHHHHhhCCCCCcCeEEEEE--ecCC
Confidence 45788885 669999999999999999999999999875432 12234577899999999999999999987 4467
Q ss_pred EEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
.+++||||+. ++|.+++.+. +.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..
T Consensus 77 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~ 152 (303)
T cd07869 77 TLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDT-GELKLADFGLARA 152 (303)
T ss_pred eEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEECCCCccee
Confidence 8999999995 6777777654 67999999999999999999999999 9999999999999876 8999999999865
Q ss_pred hcC-CCCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--CCC--------
Q 012320 184 LRG-SKSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS--GKL-------- 250 (466)
Q Consensus 184 ~~~-~~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~--g~~-------- 250 (466)
... ........||+.|+|||++. ..++.++|||||||++|+|++|..||.+..+.....+.+.. +..
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 153 KSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred ccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccch
Confidence 432 22334567899999999875 34899999999999999999999999875554443333211 000
Q ss_pred -------CCCC-------------CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 251 -------PGAF-------------YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 251 -------p~~~-------------~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
+..+ ....+..+++||.+||. ||++|||++|+|.||||+....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 0000 00123578999999996 9999999999999999986543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=368.09 Aligned_cols=253 Identities=26% Similarity=0.381 Sum_probs=216.7
Q ss_pred eeeeeeCceEEEEEEEc---CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEE
Q 012320 34 EVLGKGAMKTVYKAIDE---VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFIT 110 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~ 110 (466)
+.||+|+||+||+|.+. .+|+.||+|.+..............+.+|+.+|+.++||||+++++.| ..++.+|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~--~~~~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF--QTGGKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE--ecCCeEEEEE
Confidence 46999999999999863 579999999998655433444556788999999999999999999987 4467899999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc-CCCC
Q 012320 111 EMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSKS 189 (466)
Q Consensus 111 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~-~~~~ 189 (466)
||+.|++|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++.... ....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CCEEEeeCcCCeecccCCCc
Confidence 99999999999998889999999999999999999999999 9999999999999877 899999999986532 2233
Q ss_pred CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 012320 190 AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGR 268 (466)
Q Consensus 190 ~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~ 268 (466)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+.......+..+..+ .+...+..+++||.+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~ 233 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILKGKLN--LPPYLTPEARDLLKK 233 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHH
Confidence 44567999999999876 4588999999999999999999999976 5666777777777643 344567899999999
Q ss_pred hcc-CcCCCC-----CHHHHhcCCCCCchhhh
Q 012320 269 CLV-NASKRL-----SAKELLLDPFLASDEVK 294 (466)
Q Consensus 269 ~L~-dp~~Rp-----sa~elL~hpf~~~~~~~ 294 (466)
||. +|.+|| ++.+++.||||....+.
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~ 265 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWD 265 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 996 999999 89999999999876553
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=370.96 Aligned_cols=261 Identities=21% Similarity=0.355 Sum_probs=219.2
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+|.+ .+.||+|+||+||+|.++.+|+.||+|.++.... ......+.+.+|+.+++.++||||+++++.+ .+...++
T Consensus 2 ~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~--~~~~~~~ 77 (330)
T cd05601 2 DFDV-KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-LAQETVSFFEEERDILSISNSPWIPQLQYAF--QDKDNLY 77 (330)
T ss_pred CceE-EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceeeEE--ecCCeEE
Confidence 5666 5679999999999999999999999999986543 2334556788999999999999999999987 4467899
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 108 FITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
+||||++||+|.+++.+. +.+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ |.+||+|||++..+..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRT-GHIKLADFGSAARLTA 154 (330)
T ss_pred EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCC-CCEEeccCCCCeECCC
Confidence 999999999999999886 68999999999999999999999999 9999999999999876 8999999999977643
Q ss_pred CCC--CccccCCCCcCCccccc-------cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC--C
Q 012320 187 SKS--AHSVIGTPEFMAPELYE-------EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAF--Y 255 (466)
Q Consensus 187 ~~~--~~~~~GT~~y~APE~l~-------~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~--~ 255 (466)
... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+....+..+........+ .
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~ 233 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMNFQRFLKFPED 233 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC-CCHHHHHHHHHcCCCccCCCCC
Confidence 322 23357999999999874 3478999999999999999999999976 5556666766654321111 2
Q ss_pred CCCCHHHHHHHHHhccCcCCCCCHHHHhcCCCCCchhhhhc
Q 012320 256 SIQDLEAQRFIGRCLVNASKRLSAKELLLDPFLASDEVKLL 296 (466)
Q Consensus 256 ~~~~~~~~~lI~~~L~dp~~Rpsa~elL~hpf~~~~~~~~~ 296 (466)
...+.++++||.+||.+|.+|||+.+++.||||....+...
T Consensus 234 ~~~~~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~~~~~~ 274 (330)
T cd05601 234 PKVSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNNI 274 (330)
T ss_pred CCCCHHHHHHHHHHccChhhCCCHHHHhCCCCcCCCCHHHH
Confidence 24578999999999999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=360.01 Aligned_cols=252 Identities=24% Similarity=0.403 Sum_probs=203.7
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|... +.||+|+||+||+|.++.++..||+|+++.... ......+.+|+.+++.++||||+++++.+ .....
T Consensus 4 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~--~~~~~ 77 (288)
T cd07871 4 LETYVKL-DKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKNLKHANIVTLHDII--HTERC 77 (288)
T ss_pred cccceEe-eEEecCCCEEEEEEEECCCCCEEEEEEeccccc---CCcchhHHHHHHHHHhCCCCCEeeEEEEE--cCCCe
Confidence 4678775 669999999999999999999999999875432 12235678899999999999999999987 45678
Q ss_pred EEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 106 FNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
+++||||+.+ +|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++...
T Consensus 78 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~-~~~kl~DfG~~~~~ 153 (288)
T cd07871 78 LTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEK-GELKLADFGLARAK 153 (288)
T ss_pred EEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEECcCcceeec
Confidence 9999999975 8999887654 5799999999999999999999999 9999999999999876 89999999998764
Q ss_pred cCC-CCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--CC----------
Q 012320 185 RGS-KSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS--GK---------- 249 (466)
Q Consensus 185 ~~~-~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~--g~---------- 249 (466)
... .......||+.|+|||++. ..++.++||||+||++|+|++|..||.... ..+....+.. +.
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST-VKEELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred cCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCChHHhhccc
Confidence 322 2234567899999999775 358999999999999999999999997743 3333322211 10
Q ss_pred ---------CCC-------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 250 ---------LPG-------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 250 ---------~p~-------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
+|. ......+.++++||.+||. ||.+|||++|+|+||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 000 0012346789999999996 99999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=374.41 Aligned_cols=260 Identities=20% Similarity=0.364 Sum_probs=218.3
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+ .++||+|+||+||+|.++.+|..||+|++.+.... .......+.+|+.+++.++||||+++++.+ .+...
T Consensus 42 ~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~h~~iv~~~~~~--~~~~~ 117 (370)
T cd05596 42 AEDFDV-IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDSAFFWEERDIMAHANSEWIVQLHYAF--QDDKY 117 (370)
T ss_pred HHHcEE-EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCcceEEEEE--ecCCE
Confidence 467877 46699999999999999999999999999754432 223445678899999999999999999987 45778
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+++||||++||+|.+++.+ ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~-~~~kL~DfG~~~~~~ 193 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCC-CCEEEEeccceeecc
Confidence 9999999999999998865 56899999999999999999999999 9999999999999877 899999999997654
Q ss_pred CCC--CCccccCCCCcCCcccccc-----CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC--C
Q 012320 186 GSK--SAHSVIGTPEFMAPELYEE-----DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFY--S 256 (466)
Q Consensus 186 ~~~--~~~~~~GT~~y~APE~l~~-----~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~--~ 256 (466)
... .....+||+.|+|||++.. .++.++|||||||++|+|++|..||.. .+....+.++..+.....++ .
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 272 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMDHKNSLTFPDDI 272 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCCcCCCCCcC
Confidence 322 2245679999999998753 378999999999999999999999976 66677788887654322222 2
Q ss_pred CCCHHHHHHHHHhcc-CcCC--CCCHHHHhcCCCCCchhhh
Q 012320 257 IQDLEAQRFIGRCLV-NASK--RLSAKELLLDPFLASDEVK 294 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~--Rpsa~elL~hpf~~~~~~~ 294 (466)
..+.++++||.+||. +|.+ |+|+.++++||||+...+.
T Consensus 273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred CCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 467899999999996 7776 9999999999999886653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=377.77 Aligned_cols=258 Identities=31% Similarity=0.501 Sum_probs=229.4
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|..+ +++|+|+||.+++++++..+..+++|.|..... +........+|+.+++++.|||||.++++|+. +...
T Consensus 3 m~~Ye~~-~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~--t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~-~~~~ 78 (426)
T KOG0589|consen 3 MDNYEVL-RQVGRGAFGSALLVRHKSDDKLYVLKKINLEKL--TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE-DGQL 78 (426)
T ss_pred cchhhhh-hhcCccccchhhhhhhccCCceEEEEEEecccc--CchhhHHHHHHHHHHHhccCCCeeeeccchhc-CCce
Confidence 4567664 669999999999999999999999999998775 33345578999999999999999999999964 3445
Q ss_pred EEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 106 FNFITEMFTSGTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
++|||+||.||+|.+.+++.+ .++++.+..|+.||+.|+.|||+.. |+|||||+.|||++.+ +.|||+|||+|+.
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~-~~VkLgDfGlaK~ 155 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKD-KKVKLGDFGLAKI 155 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhcccc-Cceeecchhhhhh
Confidence 999999999999999987654 5899999999999999999999998 9999999999999987 7889999999999
Q ss_pred hcCCC-CCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 012320 184 LRGSK-SAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLE 261 (466)
Q Consensus 184 ~~~~~-~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 261 (466)
+.... ...+.+|||.||.||++.+ .|+.++||||||||+|||++-+.+|.. .+...+..+|..+... +.+...+.+
T Consensus 156 l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-~~m~~Li~ki~~~~~~-Plp~~ys~e 233 (426)
T KOG0589|consen 156 LNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-SNMSELILKINRGLYS-PLPSMYSSE 233 (426)
T ss_pred cCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-cchHHHHHHHhhccCC-CCCccccHH
Confidence 88766 6788999999999999985 699999999999999999999999977 7888888888888743 456778889
Q ss_pred HHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 262 AQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 262 ~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
++.+|+.||. +|..||+|.+||.+|.++..-
T Consensus 234 l~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 234 LRSLVKSMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred HHHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence 9999999995 999999999999999987543
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=360.93 Aligned_cols=256 Identities=27% Similarity=0.457 Sum_probs=231.8
Q ss_pred eeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEe
Q 012320 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITE 111 (466)
Q Consensus 32 ~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E 111 (466)
+-++||+|.||+|.+|+.+.+|+.||||++++..+. ..++...-+.|-++|+..+||.+..+-.+| +.+..+++|||
T Consensus 172 fLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevii-akdEVAHTlTE~RVL~~~~HPFLt~LKYsF--Qt~drlCFVMe 248 (516)
T KOG0690|consen 172 FLKVLGKGTFGKVILCREKATGKLYAIKILKKEVII-AKDEVAHTLTENRVLQNCRHPFLTSLKYSF--QTQDRLCFVME 248 (516)
T ss_pred HHHHhcCCccceEEEEeecccCceeehhhhhhhhee-ehHHhhhhhhHHHHHHhccCcHHHHhhhhh--ccCceEEEEEE
Confidence 357899999999999999999999999999876654 556777889999999999999999998888 67889999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh-hcCCCCC
Q 012320 112 MFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-LRGSKSA 190 (466)
Q Consensus 112 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~-~~~~~~~ 190 (466)
|..||.|+-++.+.+.+++...+++-..|+.||.|||+.+ |+.||||.+|+|++.+ |++||+||||++. +..+...
T Consensus 249 yanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkD-GHIKitDFGLCKE~I~~g~t~ 325 (516)
T KOG0690|consen 249 YANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKD-GHIKITDFGLCKEEIKYGDTT 325 (516)
T ss_pred EccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccC-CceEeeecccchhccccccee
Confidence 9999999999999999999999999999999999999999 9999999999999987 9999999999976 3455678
Q ss_pred ccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 012320 191 HSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRC 269 (466)
Q Consensus 191 ~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~ 269 (466)
.++||||+|+|||++. ..|+.++|+|.+||++|||+||+.||.. .+...++..|..+.+ .++...+++++.|+..+
T Consensus 326 kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn-~dh~kLFeLIl~ed~--kFPr~ls~eAktLLsGL 402 (516)
T KOG0690|consen 326 KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN-KDHEKLFELILMEDL--KFPRTLSPEAKTLLSGL 402 (516)
T ss_pred ccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc-cchhHHHHHHHhhhc--cCCccCCHHHHHHHHHH
Confidence 8999999999999997 5699999999999999999999999977 777888998887765 35677889999999999
Q ss_pred cc-CcCCCCC-----HHHHhcCCCCCchhhhhc
Q 012320 270 LV-NASKRLS-----AKELLLDPFLASDEVKLL 296 (466)
Q Consensus 270 L~-dp~~Rps-----a~elL~hpf~~~~~~~~~ 296 (466)
|. ||.+|+. |+|+.+|+||....|...
T Consensus 403 L~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~ 435 (516)
T KOG0690|consen 403 LKKDPKKRLGGGPDDAKEIMRHRFFASVDWEAT 435 (516)
T ss_pred hhcChHhhcCCCchhHHHHHhhhhhccCCHHHH
Confidence 95 9999984 789999999999999653
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=382.02 Aligned_cols=259 Identities=27% Similarity=0.408 Sum_probs=208.0
Q ss_pred eeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 21 IETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 21 ~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
+...+.++|.+ .++||+|+||+||+|.+..+++.||+|++.... ....+|+.+|+.++|||||+++++|..
T Consensus 60 ~~~~~~~~y~~-~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~ 130 (440)
T PTZ00036 60 INRSPNKSYKL-GNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYT 130 (440)
T ss_pred hccCcCCeEEE-eEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEee
Confidence 33456778887 677999999999999999999999999885322 223469999999999999999887754
Q ss_pred c------cCCEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCC
Q 012320 101 V------DQKTFNFITEMFTSGTLREYRK----KYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHL 170 (466)
Q Consensus 101 ~------~~~~~~lV~E~~~ggsL~~~l~----~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~ 170 (466)
. ....+++||||+++ +|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.+.
T Consensus 131 ~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~ 207 (440)
T PTZ00036 131 ECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNT 207 (440)
T ss_pred cccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCC
Confidence 2 12357799999965 6766654 3467999999999999999999999999 99999999999998764
Q ss_pred CcEEEeccchhhhhcCCCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-
Q 012320 171 GQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS- 247 (466)
Q Consensus 171 g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~- 247 (466)
+.+||+|||+++.+.........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+......+.+.+..
T Consensus 208 ~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 287 (440)
T PTZ00036 208 HTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVL 287 (440)
T ss_pred CceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 5799999999987765555556789999999997653 5999999999999999999999999875554444443321
Q ss_pred CC-----------------CCC--------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 248 GK-----------------LPG--------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 248 g~-----------------~p~--------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
|. +|. .++...+.++++||.+||. ||.+|||+.|+|.||||...
T Consensus 288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 10 111 1122356789999999996 99999999999999999753
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=358.84 Aligned_cols=254 Identities=20% Similarity=0.333 Sum_probs=206.3
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
++|.+ .+.||+|+||+||+|.++.+++.||+|++..... .....+.+.+|+.+++.++||||+++++.+ .....+
T Consensus 1 ~~y~~-~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~ 75 (287)
T cd07848 1 NKFEV-LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEEVKETTLRELKMLRTLKQENIVELKEAF--RRRGKL 75 (287)
T ss_pred CCceE-EEEecccCCEEEEEEEECCCCcEEEEEEEecccc--cccchhhHHHHHHHHHhCCCccccchhhhE--ecCCEE
Confidence 46777 4669999999999999999999999999875432 233456788999999999999999999987 456789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
++||||++++.+..+......+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++.....
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHN-DVLKLCDFGFARNLSE 152 (287)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CcEEEeeccCcccccc
Confidence 999999999888766665667999999999999999999999999 9999999999999876 8999999999977643
Q ss_pred CC--CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCC-----------
Q 012320 187 SK--SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVT-SGKLP----------- 251 (466)
Q Consensus 187 ~~--~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~-~g~~p----------- 251 (466)
.. ......||+.|+|||++. ..++.++|||||||++|+|++|..||.............. .+.+|
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 22 233467999999999775 4689999999999999999999999976443333222111 01111
Q ss_pred --------CC---------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 252 --------GA---------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 252 --------~~---------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
.. .....+.++++||.+||. ||.+|||++++|+||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00 112356789999999996 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=364.04 Aligned_cols=256 Identities=25% Similarity=0.455 Sum_probs=212.5
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.++ +.||+|+||+||+|.++.+|..+|+|.+.... .....+++.+|+++|++++||||+++++.+. +...
T Consensus 4 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~ 77 (331)
T cd06649 4 DDDFERI-SELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFY--SDGE 77 (331)
T ss_pred cccceEE-EeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE--ECCE
Confidence 5678885 55999999999999999999999999987542 3445578999999999999999999999874 4668
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSR-DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~-~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
+++||||++|++|.+++.+.+.+++..+..++.|++.||.|||+. + |+||||||+|||++.+ |.+||+|||++..+
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~ 154 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQL 154 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCC-CcEEEccCcccccc
Confidence 999999999999999999888899999999999999999999985 6 9999999999999877 89999999998765
Q ss_pred cCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------------------
Q 012320 185 RGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKV------------------ 245 (466)
Q Consensus 185 ~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i------------------ 245 (466)
... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..++...+
T Consensus 155 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 155 IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP-PDAKELEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ccc-ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhcccccccccCCccccCcc
Confidence 432 334567999999999876 4589999999999999999999999965 3333332221
Q ss_pred ----------------------------hcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 246 ----------------------------TSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 246 ----------------------------~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
.....+.......+.++++||.+||. ||++|||+.+||+||||+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 11111222223456789999999996 999999999999999997543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=364.10 Aligned_cols=253 Identities=25% Similarity=0.440 Sum_probs=217.5
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCCEEEEEEec
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
++||+|+||+||+|.++.++..||+|++++.... .......+..|+.+++.+ +||||+++++.+ .+...+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~--~~~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL-QDDDVECTMTEKRVLALAGKHPFLTQLHSCF--QTKDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhccCCCCccceeeEE--EcCCEEEEEEcC
Confidence 3699999999999999999999999999865432 334556778899999988 799999999987 456789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc-CCCCCc
Q 012320 113 FTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSKSAH 191 (466)
Q Consensus 113 ~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~-~~~~~~ 191 (466)
++||+|..++.+.+.+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++.... ......
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 78 VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCC-CcEEecccCCCeecCcCCCccc
Confidence 999999999998889999999999999999999999999 9999999999999877 899999999986532 223334
Q ss_pred cccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhc
Q 012320 192 SVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCL 270 (466)
Q Consensus 192 ~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L 270 (466)
..+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+...++..+..+... .+...+.++++||.+||
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~-~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~l 231 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG-DDEDELFQSILEDEVR--YPRWLSKEAKSILKSFL 231 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCC--CCCcCCHHHHHHHHHHc
Confidence 567999999999876 4689999999999999999999999976 6677777777766542 34556789999999999
Q ss_pred c-CcCCCCCH-----HHHhcCCCCCchhhhh
Q 012320 271 V-NASKRLSA-----KELLLDPFLASDEVKL 295 (466)
Q Consensus 271 ~-dp~~Rpsa-----~elL~hpf~~~~~~~~ 295 (466)
. ||.+|||+ .+++.||||....+..
T Consensus 232 ~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~ 262 (318)
T cd05570 232 TKNPEKRLGCLPTGEQDIKGHPFFREIDWDK 262 (318)
T ss_pred cCCHHHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 5 99999999 9999999998876643
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=363.58 Aligned_cols=254 Identities=25% Similarity=0.452 Sum_probs=214.6
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCCEEEEEEec
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
++||+|+||+||+|.++.+++.||+|.++..... .....+.+..|..++..+ +||||+++++.+ .....+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~--~~~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-EDDDVECTMVERRVLALAWEHPFLTHLFCTF--QTKEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhccCCCCccceeeEE--EcCCEEEEEEcC
Confidence 3699999999999999999999999999865432 233455667777777755 899999999987 456789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC-CCCCc
Q 012320 113 FTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SKSAH 191 (466)
Q Consensus 113 ~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~-~~~~~ 191 (466)
++||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..... .....
T Consensus 78 ~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 78 LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKD-GHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCC-CCEEEccCcCCeECCCCCCccc
Confidence 999999999998889999999999999999999999999 9999999999999877 8999999999975432 23344
Q ss_pred cccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhc
Q 012320 192 SVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCL 270 (466)
Q Consensus 192 ~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L 270 (466)
..+||+.|+|||++. ..++.++|||||||++|+|++|..||.+ .+..+++..+..... .++...+.+++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~ll~~~l 231 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILNDRP--HFPRWISKEAKDCLSKLF 231 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHc
Confidence 568999999999876 4589999999999999999999999976 566777777765442 344557789999999999
Q ss_pred c-CcCCCCCH-HHHhcCCCCCchhhhhc
Q 012320 271 V-NASKRLSA-KELLLDPFLASDEVKLL 296 (466)
Q Consensus 271 ~-dp~~Rpsa-~elL~hpf~~~~~~~~~ 296 (466)
. +|.+||++ .+++.||||....+...
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~~~~~ 259 (316)
T cd05592 232 ERDPTKRLGVDGDIRQHPFFRGIDWERL 259 (316)
T ss_pred cCCHHHcCCChHHHHcCcccCCCCHHHH
Confidence 6 99999986 58999999998766543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=364.49 Aligned_cols=257 Identities=28% Similarity=0.411 Sum_probs=205.5
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC---C
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ---K 104 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~---~ 104 (466)
||.+ .++||+|+||.||+|.++.+|..||+|++.... .......++.+|+.+++.++||||+++++.+...+. .
T Consensus 1 ry~i-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 77 (338)
T cd07859 1 RYKI-QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 77 (338)
T ss_pred CeEE-EEEEeecCCeEEEEEEECCCCCEEEEEEechhh--ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence 5777 577999999999999999999999999886432 123344678899999999999999999998754332 3
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.+|+||||+ +++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++...
T Consensus 78 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~-~~~kL~Dfg~~~~~ 153 (338)
T cd07859 78 DIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANAD-CKLKICDFGLARVA 153 (338)
T ss_pred eEEEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CcEEEccCcccccc
Confidence 589999999 5799999988889999999999999999999999999 9999999999999877 89999999999754
Q ss_pred cCCC----CCccccCCCCcCCccccc---cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--------------HH
Q 012320 185 RGSK----SAHSVIGTPEFMAPELYE---EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQI--------------YK 243 (466)
Q Consensus 185 ~~~~----~~~~~~GT~~y~APE~l~---~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i--------------~~ 243 (466)
.... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+......+ ..
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 3211 123467999999999875 46899999999999999999999999763322111 11
Q ss_pred HHhcC-----------CCCCC---CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 244 KVTSG-----------KLPGA---FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 244 ~i~~g-----------~~p~~---~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.+... ..+.. .....++.+.++|.+||. +|.+|||++|+|+||||+..
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 11100 00100 112346788999999996 99999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=372.95 Aligned_cols=261 Identities=21% Similarity=0.377 Sum_probs=216.5
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
...++|.+. ++||+|+||+||+|.++.+++.+|+|.+.+.... .......+.+|+.+++.++||||+++++.+ .+.
T Consensus 40 ~~~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~--~~~ 115 (370)
T cd05621 40 MKAEDYDVV-KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFCAF--QDD 115 (370)
T ss_pred CCHHHCeEE-EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEE--EcC
Confidence 345788874 6699999999999999999999999998754432 223445688999999999999999999987 457
Q ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 104 KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
..+|+||||++||+|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++..
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~-~~~kL~DFG~a~~ 191 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKH-GHLKLADFGTCMK 191 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCC-CCEEEEeccccee
Confidence 789999999999999999875 46899999999999999999999999 9999999999999876 8999999999976
Q ss_pred hcCCC--CCccccCCCCcCCcccccc-----CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC--
Q 012320 184 LRGSK--SAHSVIGTPEFMAPELYEE-----DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAF-- 254 (466)
Q Consensus 184 ~~~~~--~~~~~~GT~~y~APE~l~~-----~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~-- 254 (466)
+.... ...+.+||+.|+|||++.. .++.++|||||||++|+|++|..||.. .+....+..+........+
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~ 270 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKNSLNFPE 270 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcccCCCC
Confidence 64322 2245679999999998753 278999999999999999999999976 5666777777654422222
Q ss_pred CCCCCHHHHHHHHHhccCc---CCCCCHHHHhcCCCCCchhh
Q 012320 255 YSIQDLEAQRFIGRCLVNA---SKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 255 ~~~~~~~~~~lI~~~L~dp---~~Rpsa~elL~hpf~~~~~~ 293 (466)
....+..++++|.+||.++ ..|+++.|+++||||+...+
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 271 DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 2245788999999999743 34889999999999987554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=385.80 Aligned_cols=262 Identities=29% Similarity=0.496 Sum_probs=228.3
Q ss_pred ceeeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEE
Q 012320 19 GYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSW 98 (466)
Q Consensus 19 ~~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 98 (466)
-|-..+|..-|.++++ ||.|+||.||+|.++.++...|.|.|.. .+.++++.++-||.||..++||+||++++.|
T Consensus 24 v~rdlnP~d~WeIiGE-LGDGAFGKVyKA~nket~~lAAaKvIet----kseEELEDylVEIeILa~CdHP~ivkLl~ay 98 (1187)
T KOG0579|consen 24 VYRDLNPRDHWEIIGE-LGDGAFGKVYKAVNKETKLLAAAKVIET----KSEEELEDYLVEIEILAECDHPVIVKLLSAY 98 (1187)
T ss_pred HhccCCHHHHHHHHhh-hcCccchhhhhhhcccchhhhhhhhhcc----cchhHHhhhhhhhhhhhcCCChHHHHHHHHH
Confidence 3556889999999999 9999999999999999999999998873 3567889999999999999999999999998
Q ss_pred EeccCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEec
Q 012320 99 IDVDQKTFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGD 177 (466)
Q Consensus 99 ~~~~~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~D 177 (466)
+. .+.+|++.|||.||-....+-. ...+++.++.-+++|++.||.|||+.+ |||||||..|||++-+ |.|+|+|
T Consensus 99 y~--enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~Tld-GdirLAD 173 (1187)
T KOG0579|consen 99 YF--ENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLD-GDIRLAD 173 (1187)
T ss_pred hc--cCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEec-CcEeeec
Confidence 65 5679999999999999877654 467999999999999999999999999 9999999999999987 9999999
Q ss_pred cchhhhh-cCCCCCccccCCCCcCCccccc------cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC
Q 012320 178 LGLAAIL-RGSKSAHSVIGTPEFMAPELYE------EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL 250 (466)
Q Consensus 178 FGla~~~-~~~~~~~~~~GT~~y~APE~l~------~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~ 250 (466)
||.+... .......+++|||+|||||+.. ..|+.++||||||++|.||+.+.+|..+ -++..+.-+|.....
T Consensus 174 FGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe-lnpMRVllKiaKSeP 252 (1187)
T KOG0579|consen 174 FGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSEP 252 (1187)
T ss_pred ccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc-cchHHHHHHHhhcCC
Confidence 9987543 2334567899999999999653 4699999999999999999999999987 667766666666554
Q ss_pred CC-CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 251 PG-AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 251 p~-~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
|- ..+...+..+++|+.+||+ ||..||++.+||+|||++..
T Consensus 253 PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 253 PTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred CcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 43 3456677899999999996 99999999999999999853
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=362.60 Aligned_cols=257 Identities=23% Similarity=0.403 Sum_probs=218.6
Q ss_pred eEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCC-ceeEEEeEEEeccCCEEE
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHD-SIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp-nIv~l~~~~~~~~~~~~~ 107 (466)
|.. .+.||+|+||+||+|.++.+++.||+|++.+.... .....+.+..|+.+++.++|+ +|+++++.+ .+...+|
T Consensus 2 y~~-~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~--~~~~~~~ 77 (324)
T cd05587 2 FNF-LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII-QDDDVECTMVEKRVLALPGKPPFLTQLHSCF--QTMDRLY 77 (324)
T ss_pred ceE-EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhcCCCCceeeeEEEE--EcCCEEE
Confidence 544 56799999999999999999999999999865432 334567788999999999765 588888877 4467899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc-C
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-G 186 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~-~ 186 (466)
+||||++||+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++.... .
T Consensus 78 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 78 FVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFG 154 (324)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCC-CCEEEeecCcceecCCC
Confidence 99999999999999998889999999999999999999999999 9999999999999876 899999999986532 2
Q ss_pred CCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 012320 187 SKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRF 265 (466)
Q Consensus 187 ~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~l 265 (466)
.......+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..+++..+..+.. .++...+.++.++
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~l 231 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNV--SYPKSLSKEAVSI 231 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHH
Confidence 23344567999999999876 4589999999999999999999999976 667778888877654 2345678899999
Q ss_pred HHHhcc-CcCCCCCH-----HHHhcCCCCCchhhhh
Q 012320 266 IGRCLV-NASKRLSA-----KELLLDPFLASDEVKL 295 (466)
Q Consensus 266 I~~~L~-dp~~Rpsa-----~elL~hpf~~~~~~~~ 295 (466)
+.+||. +|.+|+++ .++++||||....+..
T Consensus 232 i~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~ 267 (324)
T cd05587 232 CKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEK 267 (324)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 999995 99999986 8999999999876643
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=362.88 Aligned_cols=253 Identities=24% Similarity=0.432 Sum_probs=214.9
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCCEEEEEEec
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
++||+|+||+||+|.++.+|..||+|.+++.... .....+....|+.+++.+ +||||+++++.+ .+.+.+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~--~~~~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-IDDDVECTMVEKRVLALAWENPFLTHLYCTF--QTKEHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCCccCeeEEE--EeCCEEEEEECC
Confidence 3699999999999999999999999999865432 223456677888888765 899999999988 456789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc-CCCCCc
Q 012320 113 FTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSKSAH 191 (466)
Q Consensus 113 ~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~-~~~~~~ 191 (466)
+.||+|..++.+.+.+++..+..++.||+.||+|||++| |+||||||+|||++.+ |.+||+|||++.... ......
T Consensus 78 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 78 LNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRD-GHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC-CCEEeCccCCCeecccCCCcee
Confidence 999999999988889999999999999999999999999 9999999999999877 899999999986532 223344
Q ss_pred cccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhc
Q 012320 192 SVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCL 270 (466)
Q Consensus 192 ~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L 270 (466)
..+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..++.+.+..+.. ..+...+.+++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l 231 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIRVDTP--HYPRWITKESKDILEKLF 231 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHc
Confidence 577999999999876 4699999999999999999999999976 667777777776542 234457889999999999
Q ss_pred c-CcCCCCCH-HHHhcCCCCCchhhhh
Q 012320 271 V-NASKRLSA-KELLLDPFLASDEVKL 295 (466)
Q Consensus 271 ~-dp~~Rpsa-~elL~hpf~~~~~~~~ 295 (466)
. ||.+||++ .++++||||....+..
T Consensus 232 ~~dP~~R~~~~~~~~~h~~f~~~~~~~ 258 (316)
T cd05620 232 ERDPTRRLGVVGNIRGHPFFKTINWTA 258 (316)
T ss_pred cCCHHHcCCChHHHHcCCCcCCCCHHH
Confidence 5 99999998 5889999998876643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=365.38 Aligned_cols=254 Identities=21% Similarity=0.394 Sum_probs=213.3
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCCEEEEEEec
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
++||+|+||+||+|.++.+++.||+|++.+... ........+..|+.++.++ +||||+++++.+ .....+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~--~~~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF--QTESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHh-cchhHHHHHHHHHHHHHhcCCCCcCCceeeEE--EeCCEEEEEEeC
Confidence 369999999999999999999999999986543 2344556788899998877 899999999987 446789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc-CCCCCc
Q 012320 113 FTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSKSAH 191 (466)
Q Consensus 113 ~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~-~~~~~~ 191 (466)
+++|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++.... ......
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~-~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCC-CCEEEeeCCccccccCCCCccc
Confidence 999999999988889999999999999999999999999 9999999999999877 899999999987532 223344
Q ss_pred cccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCC--------CCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 012320 192 SVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSEC--------ANPAQIYKKVTSGKLPGAFYSIQDLEA 262 (466)
Q Consensus 192 ~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~--------~~~~~i~~~i~~g~~p~~~~~~~~~~~ 262 (466)
..+||+.|+|||++. ..++.++|||||||++|+|++|..||... .....+++.+..+.. ..+...+..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~~~~~~ 232 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC--CCCCCCCHHH
Confidence 578999999999776 45899999999999999999999999521 223345555655443 2445567899
Q ss_pred HHHHHHhcc-CcCCCCCH------HHHhcCCCCCchhhhh
Q 012320 263 QRFIGRCLV-NASKRLSA------KELLLDPFLASDEVKL 295 (466)
Q Consensus 263 ~~lI~~~L~-dp~~Rpsa------~elL~hpf~~~~~~~~ 295 (466)
+++|.+||. ||.+||++ .++++||||+...|..
T Consensus 233 ~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~ 272 (329)
T cd05618 233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDL 272 (329)
T ss_pred HHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHH
Confidence 999999996 99999984 7999999998876643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=355.93 Aligned_cols=261 Identities=28% Similarity=0.433 Sum_probs=214.9
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCc-eeEEEeEEEecc--
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDS-IIRFYTSWIDVD-- 102 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~-- 102 (466)
...|..+++ ||+|+||+||+|+++.+|+.||+|+++...-. +.......+|+.+|+.|+|+| |+++++++...+
T Consensus 10 ~~~~~~~ek-lGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~ 86 (323)
T KOG0594|consen 10 MFDYEKVEK-LGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNH 86 (323)
T ss_pred HHHHHHHHH-hCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence 445777655 99999999999999999999999999876421 223466789999999999999 999999875432
Q ss_pred --CCEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEe
Q 012320 103 --QKTFNFITEMFTSGTLREYRKKYR----RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIG 176 (466)
Q Consensus 103 --~~~~~lV~E~~~ggsL~~~l~~~~----~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~ 176 (466)
...+++|+||+ .-+|..++...+ .++...++.+++||+.||+|||+++ |+||||||.||||+.. |.+||+
T Consensus 87 ~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~-G~lKla 162 (323)
T KOG0594|consen 87 RGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSS-GVLKLA 162 (323)
T ss_pred cccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCC-CcEeee
Confidence 13899999999 779999998765 5888999999999999999999999 9999999999999986 999999
Q ss_pred ccchhhhhc-CCCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCC--
Q 012320 177 DLGLAAILR-GSKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-GKL-- 250 (466)
Q Consensus 177 DFGla~~~~-~~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-g~~-- 250 (466)
|||+|+.+. +.......++|.+|+|||++-+ .|+..+||||+|||++||+++...|.+..+..++.+.... |..
T Consensus 163 DFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 163 DFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNE 242 (323)
T ss_pred ccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCc
Confidence 999999776 3344667789999999997653 4999999999999999999999999887776666655432 110
Q ss_pred ---C---------CCCC------------CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 251 ---P---------GAFY------------SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 251 ---p---------~~~~------------~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
| ..++ ...++...+++.+||. +|.+|.||+.+|.||||.....
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 0 0011 1122478899999997 9999999999999999987543
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=365.03 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=212.3
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHH-HHHHhCCCCceeEEEeEEEeccCCEEEEEEec
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEV-HLLSTLKHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei-~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
+.||+|+||+||+|.++.+++.||+|++.+....... ....+..|. .+++.++||||+++++.+ .....+|+||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~~e~~~~l~~~~h~~Iv~~~~~~--~~~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKK-EEKHIMSERNVLLKNVKHPFLVGLHFSF--QTADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhh-HHHHHHHHHHHHHHhCCCCCCCceeEEE--EcCCeEEEEEeC
Confidence 3699999999999999999999999999865432222 223444444 457889999999999987 456789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc-CCCCCc
Q 012320 113 FTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSKSAH 191 (466)
Q Consensus 113 ~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~-~~~~~~ 191 (466)
+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ |.+||+|||++.... ......
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~-~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC-CCEEEccCCCCcccccCCCCcc
Confidence 999999999998888999999999999999999999999 9999999999999876 899999999987543 223344
Q ss_pred cccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhc
Q 012320 192 SVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCL 270 (466)
Q Consensus 192 ~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L 270 (466)
..+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..++++.+...... .....+..++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~l 231 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPLQ--LKPNITNSARHLLEGLL 231 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC-CCHHHHHHHHHhCCcC--CCCCCCHHHHHHHHHHc
Confidence 668999999999776 4589999999999999999999999976 6677777777765432 33456789999999999
Q ss_pred c-CcCCCCCHH----HHhcCCCCCchhhhh
Q 012320 271 V-NASKRLSAK----ELLLDPFLASDEVKL 295 (466)
Q Consensus 271 ~-dp~~Rpsa~----elL~hpf~~~~~~~~ 295 (466)
. +|.+|+++. ++++|+||....|..
T Consensus 232 ~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~ 261 (325)
T cd05602 232 QKDRTKRLGAKDDFMEIKNHIFFSPINWDD 261 (325)
T ss_pred ccCHHHCCCCCCCHHHHhcCcccCCCCHHH
Confidence 6 999999876 899999998876643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=369.90 Aligned_cols=260 Identities=20% Similarity=0.344 Sum_probs=218.2
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
..++|.+. +.||+|+||+||+|.++.+++.||+|.+.+.... .......+.+|+.+++.++||||+++++.+ .+..
T Consensus 41 ~~~~y~i~-~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~--~~~~ 116 (371)
T cd05622 41 KAEDYEVV-KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAF--QDDR 116 (371)
T ss_pred chhhcEEE-EEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCeEEEEE--EcCC
Confidence 34788885 6699999999999999999999999998764432 223446678999999999999999999988 4577
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.+++||||++||+|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..+
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~-~~ikL~DfG~a~~~ 192 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKM 192 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCC-CCEEEEeCCceeEc
Confidence 89999999999999999875 46899999999999999999999999 9999999999999876 89999999999766
Q ss_pred cCCC--CCccccCCCCcCCcccccc-----CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--CCCCC
Q 012320 185 RGSK--SAHSVIGTPEFMAPELYEE-----DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL--PGAFY 255 (466)
Q Consensus 185 ~~~~--~~~~~~GT~~y~APE~l~~-----~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~--p~~~~ 255 (466)
.... .....+||+.|+|||++.. .++.++|||||||++|+|++|..||.. .+....++.+..... +....
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~ 271 (371)
T cd05622 193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDD 271 (371)
T ss_pred CcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCcccCCCc
Confidence 4322 2345679999999998753 278999999999999999999999976 677778888876542 22223
Q ss_pred CCCCHHHHHHHHHhccCcCC---CCCHHHHhcCCCCCchhh
Q 012320 256 SIQDLEAQRFIGRCLVNASK---RLSAKELLLDPFLASDEV 293 (466)
Q Consensus 256 ~~~~~~~~~lI~~~L~dp~~---Rpsa~elL~hpf~~~~~~ 293 (466)
...+..++++|.+||.+|.. |+++.++++||||+...+
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 272 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 35678999999999975443 789999999999987654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=365.73 Aligned_cols=259 Identities=29% Similarity=0.513 Sum_probs=218.4
Q ss_pred eeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 21 IETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 21 ~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
+..-|..-|.++++ ||+|+||.||||+|+.+|..+|||++.... +++.+.+||.+|++++.|++|++|++|+.
T Consensus 27 L~K~PEEVFDi~~K-LGEGSYGSV~KAIH~EsG~v~AIK~VPV~s------DLQEIIKEISIMQQC~S~yVVKYYGSYFK 99 (502)
T KOG0574|consen 27 LNKPPEEVFDIVGK-LGEGSYGSVHKAIHRESGHVLAIKKVPVDT------DLQEIIKEISIMQQCKSKYVVKYYGSYFK 99 (502)
T ss_pred hcCChHHHHHHHHH-hcCCcchHHHHHHHhccCcEEEEEecCccc------hHHHHHHHHHHHHHcCCchhhhhhhhhcc
Confidence 34445555666655 999999999999999999999999987543 67889999999999999999999999864
Q ss_pred ccCCEEEEEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 101 VDQKTFNFITEMFTSGTLREYRK-KYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~-~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
+..+|+|||||..|++.+.++ +.+.++++.+..+++..+.||+|||... -||||||..|||++.+ |+.||+|||
T Consensus 100 --~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~-G~AKLADFG 174 (502)
T KOG0574|consen 100 --HSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTD-GIAKLADFG 174 (502)
T ss_pred --CCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEccc-chhhhhhcc
Confidence 556999999999999999876 4578999999999999999999999998 8999999999999987 999999999
Q ss_pred hhhhhcCC-CCCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC--CCC
Q 012320 180 LAAILRGS-KSAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG--AFY 255 (466)
Q Consensus 180 la~~~~~~-~~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~--~~~ 255 (466)
.|..+... .+.++++|||.|||||++.+ +|+.++||||||++..||+-|++||.+-.....++ .|-. +.|+ .-+
T Consensus 175 VAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF-MIPT-~PPPTF~KP 252 (502)
T KOG0574|consen 175 VAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF-MIPT-KPPPTFKKP 252 (502)
T ss_pred ccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-eccC-CCCCCCCCh
Confidence 99876532 34678999999999999985 69999999999999999999999998743333232 2222 1222 223
Q ss_pred CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 256 ~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
...+.++.+||++||+ +|++|.||.+|++|||+++.+.
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g 291 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPG 291 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence 4556789999999996 9999999999999999987543
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=361.59 Aligned_cols=258 Identities=22% Similarity=0.394 Sum_probs=219.4
Q ss_pred eEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCCEEE
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~~~ 107 (466)
|.. .+.||+|+||+||+|.++.+++.||+|++.+.... .....+....|+.++..+ .||+|+++++.+ .+...+|
T Consensus 2 f~~-~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~--~~~~~~~ 77 (323)
T cd05616 2 FNF-LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALSGKPPFLTQLHSCF--QTMDRLY 77 (323)
T ss_pred ceE-EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCeEeeEEEEE--ecCCEEE
Confidence 444 56799999999999999999999999999865432 233456677888888887 589999999887 4567899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc-C
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-G 186 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~-~ 186 (466)
+||||++||+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.... .
T Consensus 78 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~-~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 78 FVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWD 154 (323)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCC-CcEEEccCCCceecCCC
Confidence 99999999999999998889999999999999999999999999 9999999999999877 899999999987543 2
Q ss_pred CCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 012320 187 SKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRF 265 (466)
Q Consensus 187 ~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~l 265 (466)
.......+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+...+++.+..+... ++...+.+++++
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~l 231 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVA--YPKSMSKEAVAI 231 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCCcCCHHHHHH
Confidence 23344568999999999776 5699999999999999999999999976 6677888888776543 345578899999
Q ss_pred HHHhcc-CcCCCCCH-----HHHhcCCCCCchhhhhc
Q 012320 266 IGRCLV-NASKRLSA-----KELLLDPFLASDEVKLL 296 (466)
Q Consensus 266 I~~~L~-dp~~Rpsa-----~elL~hpf~~~~~~~~~ 296 (466)
+.+||. +|.+|+++ .++++||||+...|...
T Consensus 232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~ 268 (323)
T cd05616 232 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 268 (323)
T ss_pred HHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 999995 99999984 89999999998777543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=363.37 Aligned_cols=258 Identities=22% Similarity=0.369 Sum_probs=215.0
Q ss_pred eEEeeeeeeeeCceEEEEEEEc---CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCC
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDE---VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 104 (466)
|.+ .+.||+|+||+||+|.+. .+|..||+|++.+..........+.+..|+.+|+.+ +||||+++++.+ ....
T Consensus 2 y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~--~~~~ 78 (332)
T cd05614 2 FEL-LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF--QTEA 78 (332)
T ss_pred ceE-EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE--ecCC
Confidence 555 567999999999998764 579999999998655433444557788999999999 599999999887 4567
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.+++||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++...
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~-~~~kl~DfG~~~~~ 155 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSE-GHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCC-CCEEEeeCcCCccc
Confidence 89999999999999999988889999999999999999999999999 9999999999999877 89999999999765
Q ss_pred cCC--CCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCC---CCHHHHHHHHhcCCCCCCCCCC
Q 012320 185 RGS--KSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSEC---ANPAQIYKKVTSGKLPGAFYSI 257 (466)
Q Consensus 185 ~~~--~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~---~~~~~i~~~i~~g~~p~~~~~~ 257 (466)
... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||... .....+.+.+..... ..+..
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~ 233 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP--PFPSF 233 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC--CCCCC
Confidence 322 22335679999999998764 3788999999999999999999999632 334455555554432 34456
Q ss_pred CCHHHHHHHHHhcc-CcCCCC-----CHHHHhcCCCCCchhhh
Q 012320 258 QDLEAQRFIGRCLV-NASKRL-----SAKELLLDPFLASDEVK 294 (466)
Q Consensus 258 ~~~~~~~lI~~~L~-dp~~Rp-----sa~elL~hpf~~~~~~~ 294 (466)
.+..++++|.+||. ||++|| +++++++||||+...+.
T Consensus 234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 276 (332)
T cd05614 234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE 276 (332)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 78899999999996 999999 88899999999876554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=363.21 Aligned_cols=252 Identities=24% Similarity=0.381 Sum_probs=212.5
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHH-HHHhCCCCceeEEEeEEEeccCCEEEEEEec
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVH-LLSTLKHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
++||+|+||+||+|.++.+|+.||+|++.+...... .....+..|+. +++.++||||+++++.+ .+.+.+|+||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~iv~~~~~~--~~~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKK-KEQNHIMAERNVLLKNLKHPFLVGLHYSF--QTAEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHh-hHHHHHHHHHHHHHHhCCCCCccceeeEE--EcCCEEEEEEcC
Confidence 369999999999999999999999999986543222 23345555554 67889999999999887 456789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc-CCCCCc
Q 012320 113 FTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSKSAH 191 (466)
Q Consensus 113 ~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~-~~~~~~ 191 (466)
++||+|..++.+.+.+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ |.+||+|||++.... ......
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-CCEEEccCCCCccCCCCCCccc
Confidence 999999999988888999999999999999999999999 9999999999999877 899999999987532 223344
Q ss_pred cccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhc
Q 012320 192 SVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCL 270 (466)
Q Consensus 192 ~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L 270 (466)
..+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..+++..+..+.. ..+...+..+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l 231 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILHKPL--QLPGGKTVAACDLLVGLL 231 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHc
Confidence 567999999999876 4589999999999999999999999976 567778888876654 334456788999999999
Q ss_pred c-CcCCCCCH----HHHhcCCCCCchhhh
Q 012320 271 V-NASKRLSA----KELLLDPFLASDEVK 294 (466)
Q Consensus 271 ~-dp~~Rpsa----~elL~hpf~~~~~~~ 294 (466)
. +|.+|+++ .++++||||....+.
T Consensus 232 ~~~p~~R~~~~~~~~~~~~~~~~~~~~~~ 260 (321)
T cd05603 232 HKDQRRRLGAKADFLEIKNHVFFSPINWD 260 (321)
T ss_pred cCCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence 6 99999976 499999999876654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=361.78 Aligned_cols=253 Identities=25% Similarity=0.440 Sum_probs=212.9
Q ss_pred eeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHH---HhCCCCceeEEEeEEEeccCCEEEEE
Q 012320 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLL---STLKHDSIIRFYTSWIDVDQKTFNFI 109 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL---~~l~HpnIv~l~~~~~~~~~~~~~lV 109 (466)
.++||+|+||+||+|.++.+|+.||+|.++..... .....+.+.+|++++ +.++||||+++++.+ .....+|+|
T Consensus 4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~--~~~~~~~lv 80 (324)
T cd05589 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-ARDEVESLMCEKRIFETANSERHPFLVNLFACF--QTEDHVCFV 80 (324)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccccCCCChhceeeEE--EcCCEEEEE
Confidence 56799999999999999999999999999865432 233456677777665 456899999999987 457789999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC-CC
Q 012320 110 TEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SK 188 (466)
Q Consensus 110 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~-~~ 188 (466)
|||+.|++|..++.+ +.+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ |.+||+|||++..... ..
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCC-CcEEeCcccCCccCCCCCC
Confidence 999999999988764 67999999999999999999999999 9999999999999877 8999999999865332 23
Q ss_pred CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 012320 189 SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIG 267 (466)
Q Consensus 189 ~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~ 267 (466)
.....+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..++...+..+... .+...+..+.++|.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~li~ 233 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG-DDEEEVFDSIVNDEVR--YPRFLSREAISIMR 233 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCCCCCHHHHHHHH
Confidence 344578999999999776 4589999999999999999999999976 5667777777766542 33456789999999
Q ss_pred Hhcc-CcCCCC-----CHHHHhcCCCCCchhhhh
Q 012320 268 RCLV-NASKRL-----SAKELLLDPFLASDEVKL 295 (466)
Q Consensus 268 ~~L~-dp~~Rp-----sa~elL~hpf~~~~~~~~ 295 (466)
+||. ||.+|| ++.++++||||....+..
T Consensus 234 ~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~ 267 (324)
T cd05589 234 RLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDD 267 (324)
T ss_pred HHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHH
Confidence 9996 999999 699999999998766543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=362.46 Aligned_cols=255 Identities=20% Similarity=0.372 Sum_probs=215.4
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCCEEEEEEec
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
++||+|+||+||+|.++.+++.||+|++.+... ......+.+.+|+.++.++ +||||+++++.+ .+...+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~--~~~~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV-HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF--QTTSRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE--EeCCEEEEEEeC
Confidence 369999999999999999999999999986543 2334567788999999988 699999999987 446789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc-CCCCCc
Q 012320 113 FTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSKSAH 191 (466)
Q Consensus 113 ~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~-~~~~~~ 191 (466)
++||+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.... ......
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 78 VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCC-CCEEEeccccceeccCCCCcee
Confidence 999999999988889999999999999999999999999 9999999999999877 899999999987532 233345
Q ss_pred cccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCC------CCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 012320 192 SVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSEC------ANPAQIYKKVTSGKLPGAFYSIQDLEAQR 264 (466)
Q Consensus 192 ~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~------~~~~~i~~~i~~g~~p~~~~~~~~~~~~~ 264 (466)
..+||+.|+|||++. ..++.++|||||||++|+|++|..||... .....+++.+..... ..+...+..+++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~ 232 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI--RIPRFLSVKASH 232 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC--CCCCCCCHHHHH
Confidence 678999999999775 56899999999999999999999999531 233455666655433 345567789999
Q ss_pred HHHHhcc-CcCCCCCH------HHHhcCCCCCchhhhhc
Q 012320 265 FIGRCLV-NASKRLSA------KELLLDPFLASDEVKLL 296 (466)
Q Consensus 265 lI~~~L~-dp~~Rpsa------~elL~hpf~~~~~~~~~ 296 (466)
+|.+||. ||.+|+++ .+++.||||....+...
T Consensus 233 li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~ 271 (327)
T cd05617 233 VLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLL 271 (327)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHH
Confidence 9999996 99999984 69999999998877554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=381.86 Aligned_cols=252 Identities=34% Similarity=0.549 Sum_probs=221.3
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecC
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMF 113 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~ 113 (466)
-+||+|+||+||-|+|..|...+|||.|..+ +....+-+..||.+.++|+|.|||++.+++ ..++++-|.||-+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek----dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~--senGf~kIFMEqV 654 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK----DSREVQPLHEEIALHSTLRHKNIVRYLGSV--SENGFFKIFMEQV 654 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc----cchhhccHHHHHHHHHHHhhHhHHHHhhcc--CCCCeEEEEeecC
Confidence 3699999999999999999999999998744 345678899999999999999999999986 5577888999999
Q ss_pred CCCCHHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC-CC
Q 012320 114 TSGTLREYRKK-YRRV--DIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-KS 189 (466)
Q Consensus 114 ~ggsL~~~l~~-~~~l--~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~-~~ 189 (466)
+||||.++++. .+++ +|..+.+|.+||++||.|||.+. |+|||||-+|+||+.-.|.+||+|||-++.+.+- ..
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 99999998864 5888 89999999999999999999999 9999999999999988899999999999988653 34
Q ss_pred CccccCCCCcCCcccccc---CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 012320 190 AHSVIGTPEFMAPELYEE---DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFI 266 (466)
Q Consensus 190 ~~~~~GT~~y~APE~l~~---~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI 266 (466)
..++.||..|||||++.. +|+.++|||||||++.||+||++||-+..++....-++---+..+..+...+.+++.||
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fi 812 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFI 812 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHH
Confidence 567889999999999873 59999999999999999999999998877776554444333445566777788999999
Q ss_pred HHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 267 GRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 267 ~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
.+|+. +|.+||+|++||.+||++..+.
T Consensus 813 lrcFepd~~~R~sA~~LL~DpFlq~~~k 840 (1226)
T KOG4279|consen 813 LRCFEPDPCDRPSAKDLLQDPFLQHNNK 840 (1226)
T ss_pred HHHcCCCcccCccHHHhccCcccccCCC
Confidence 99995 9999999999999999987644
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=364.77 Aligned_cols=252 Identities=25% Similarity=0.398 Sum_probs=212.5
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHH-HHHhCCCCceeEEEeEEEeccCCEEEEEEec
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVH-LLSTLKHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
++||+|+||+||+|.++.+|+.||+|++.+.... .......+..|.. +++.++||||+++++.+ .....+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~--~~~~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-NRKEQKHIMAERNVLLKNVKHPFLVGLHYSF--QTTEKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHHhCCCCCCccEEEEE--ecCCEEEEEEcC
Confidence 3599999999999999999999999999865432 2233445566655 56789999999999987 456789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc-CCCCCc
Q 012320 113 FTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSKSAH 191 (466)
Q Consensus 113 ~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~-~~~~~~ 191 (466)
+.||+|..++.+.+.+++..++.++.||+.||.|||+.| |+||||||+|||++.+ |.+||+|||++.... ......
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQ-GHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC-CCEEEeecCCcccCCCCCCCcc
Confidence 999999999998889999999999999999999999999 9999999999999877 899999999987532 223344
Q ss_pred cccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhc
Q 012320 192 SVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCL 270 (466)
Q Consensus 192 ~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L 270 (466)
..+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..++++.+..+... .....+..+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~ll~~ll 231 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC-RDVAEMYDNILHKPLV--LRPGASLTAWSILEELL 231 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC-CCHHHHHHHHHcCCcc--CCCCCCHHHHHHHHHHh
Confidence 567999999999876 4589999999999999999999999976 6677788888776542 22346788999999999
Q ss_pred c-CcCCCCCH----HHHhcCCCCCchhhh
Q 012320 271 V-NASKRLSA----KELLLDPFLASDEVK 294 (466)
Q Consensus 271 ~-dp~~Rpsa----~elL~hpf~~~~~~~ 294 (466)
. +|.+||++ .+++.||||....+.
T Consensus 232 ~~~p~~R~~~~~~~~~i~~h~~f~~~~~~ 260 (325)
T cd05604 232 EKDRQRRLGAKEDFLEIQEHPFFESLSWT 260 (325)
T ss_pred ccCHHhcCCCCCCHHHHhcCCCcCCCCHH
Confidence 5 99999987 589999999876654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=360.57 Aligned_cols=253 Identities=25% Similarity=0.461 Sum_probs=214.7
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCCEEEEEEec
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
+.||+|+||+||+|.++.+++.||+|.++..... ..........|..+++.+ +||||+++++.+. +...+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~--~~~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ--TKENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCcCcceEEEEE--eCCEEEEEEeC
Confidence 3599999999999999999999999999865432 223445677788888864 9999999999874 46789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc-CCCCCc
Q 012320 113 FTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSKSAH 191 (466)
Q Consensus 113 ~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~-~~~~~~ 191 (466)
++||+|.+++.+...+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.... ......
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 78 LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTD-GHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCC-CCEEEccCCcceECCCCCCcee
Confidence 999999999988888999999999999999999999999 9999999999999877 899999999986532 223344
Q ss_pred cccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhc
Q 012320 192 SVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCL 270 (466)
Q Consensus 192 ~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L 270 (466)
..+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..++++.+..+.. .++...+.+++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l 231 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRMDNP--CYPRWLTREAKDILVKLF 231 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHHHHHh
Confidence 567999999999876 4689999999999999999999999976 567777777766543 233456789999999999
Q ss_pred c-CcCCCCCHH-HHhcCCCCCchhhhh
Q 012320 271 V-NASKRLSAK-ELLLDPFLASDEVKL 295 (466)
Q Consensus 271 ~-dp~~Rpsa~-elL~hpf~~~~~~~~ 295 (466)
. +|.+||++. +++.||||....+..
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~~~~ 258 (316)
T cd05619 232 VREPERRLGVKGDIRQHPFFREIDWSA 258 (316)
T ss_pred ccCHhhcCCChHHHHcCcccCCCCHHH
Confidence 5 999999997 999999999876643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=401.07 Aligned_cols=265 Identities=20% Similarity=0.367 Sum_probs=231.5
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
.|.+ .++||+|+||.|.+++++.|++.||+|++.+-.... ..+..-|..|-.+|...+.+.|+.++.+| ++.+++|
T Consensus 76 Dfei-lKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK-r~~tA~F~EERDimv~~ns~Wiv~LhyAF--QD~~~LY 151 (1317)
T KOG0612|consen 76 DFEI-LKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK-RAETACFREERDIMVFGNSEWIVQLHYAF--QDERYLY 151 (1317)
T ss_pred hhHH-HHHhcccccceeEEEEeeccccchhHHHhhHHHHhh-chhHHHHHHHhHHHHcCCcHHHHHHHHHh--cCccceE
Confidence 3444 588999999999999999999999999998655432 23556789999999999999999999999 7789999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~ 187 (466)
+||||++||+|..++.++.+++++.+++|+..|+.||.-||+.| +|||||||+|||++.. |++||+|||.+..+...
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~-GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKS-GHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEeccc-CcEeeccchhHHhcCCC
Confidence 99999999999999999999999999999999999999999999 9999999999999987 99999999999777643
Q ss_pred CC--CccccCCCCcCCccccc------cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC--CC
Q 012320 188 KS--AHSVIGTPEFMAPELYE------EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFY--SI 257 (466)
Q Consensus 188 ~~--~~~~~GT~~y~APE~l~------~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~--~~ 257 (466)
.. ....+|||.|++||++. +.|++.||+||+|||+|||+.|..||.. .+..+.|.+|..-+-...+| ..
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l~FP~~~~ 307 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESLSFPDETD 307 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhcCCCcccc
Confidence 33 34568999999999884 3599999999999999999999999976 78889999998764222222 44
Q ss_pred CCHHHHHHHHHhccCcCCCCC---HHHHhcCCCCCchhhhhccccc
Q 012320 258 QDLEAQRFIGRCLVNASKRLS---AKELLLDPFLASDEVKLLSKTK 300 (466)
Q Consensus 258 ~~~~~~~lI~~~L~dp~~Rps---a~elL~hpf~~~~~~~~~~~~~ 300 (466)
.|.++++||.+++.+|+.|.. ++++..||||.+.+|..+....
T Consensus 308 VSeeakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~ 353 (1317)
T KOG0612|consen 308 VSEEAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWDNIRESV 353 (1317)
T ss_pred cCHHHHHHHHHHhcChhhhcccccHHHHHhCccccCCChhhhhhcC
Confidence 789999999999999999998 9999999999999996544333
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=363.72 Aligned_cols=252 Identities=25% Similarity=0.373 Sum_probs=215.2
Q ss_pred eeeeeeCceEEEEEEE---cCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEE
Q 012320 34 EVLGKGAMKTVYKAID---EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFIT 110 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~---~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~ 110 (466)
+.||+|+||+||++.+ +.+|+.||+|++..... .......+.+|+.+|++++||||+++++.+ .+...+|+||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~--~~~~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDRVRTKMERDILAEVNHPFIVKLHYAF--QTEGKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhCCCCCcccEEEEE--EcCCEEEEEE
Confidence 4699999999999976 46899999999986543 223445678899999999999999999987 4567899999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC-CC
Q 012320 111 EMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-KS 189 (466)
Q Consensus 111 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~-~~ 189 (466)
||+.+|+|.+++.+...+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++...... ..
T Consensus 78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 78 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCC-CcEEEeeccCCcccCCCCCc
Confidence 99999999999988888999999999999999999999999 9999999999999877 89999999998765433 33
Q ss_pred CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 012320 190 AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGR 268 (466)
Q Consensus 190 ~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~ 268 (466)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..+....+..+... .+...+..++++|.+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~li~~ 231 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMILKAKLG--MPQFLSPEAQSLLRA 231 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHH
Confidence 44578999999999876 4588999999999999999999999976 5667777777766542 334567899999999
Q ss_pred hcc-CcCCCCC-----HHHHhcCCCCCchhhhh
Q 012320 269 CLV-NASKRLS-----AKELLLDPFLASDEVKL 295 (466)
Q Consensus 269 ~L~-dp~~Rps-----a~elL~hpf~~~~~~~~ 295 (466)
||. ||.+||+ ..+++.||||....+..
T Consensus 232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T cd05582 232 LFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNK 264 (318)
T ss_pred HhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHH
Confidence 995 9999999 67799999998876543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=351.89 Aligned_cols=260 Identities=22% Similarity=0.347 Sum_probs=213.9
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+|.+ .++||+|+||+||+|.+..++..||+|++...... .......+.+|+.+++.++||||+++++.+ ..+..++
T Consensus 1 ~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~ 76 (285)
T cd05605 1 TFRH-YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAY--ETKDALC 76 (285)
T ss_pred CceE-EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-hhhhHHHHHHHHHHHHhcCCCCEeeeeeee--cCCCeEE
Confidence 4666 46699999999999999999999999998755432 222345678899999999999999999987 4466899
Q ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 108 FITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+||||+.||+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDY-GHIRISDLGLAVEIP 153 (285)
T ss_pred EEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCC-CCEEEeeCCCceecC
Confidence 999999999999887653 46999999999999999999999999 9999999999999876 899999999997765
Q ss_pred CCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhcCCCCCCCCCCCCHH
Q 012320 186 GSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPA---QIYKKVTSGKLPGAFYSIQDLE 261 (466)
Q Consensus 186 ~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~---~i~~~i~~g~~p~~~~~~~~~~ 261 (466)
........+||+.|+|||++. ..++.++||||+||++|+|++|..||.+..... ++...+..+ +...+...+..
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 231 (285)
T cd05605 154 EGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED--QEEYSEKFSEA 231 (285)
T ss_pred CCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc--ccccCcccCHH
Confidence 444445568999999999775 558899999999999999999999997633221 223333322 22334456788
Q ss_pred HHHHHHHhcc-CcCCCC-----CHHHHhcCCCCCchhhhhc
Q 012320 262 AQRFIGRCLV-NASKRL-----SAKELLLDPFLASDEVKLL 296 (466)
Q Consensus 262 ~~~lI~~~L~-dp~~Rp-----sa~elL~hpf~~~~~~~~~ 296 (466)
+++||.+||. ||.+|| ++.++++||||....++..
T Consensus 232 ~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 272 (285)
T cd05605 232 ARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRL 272 (285)
T ss_pred HHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHH
Confidence 9999999996 999999 9999999999998777544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=364.68 Aligned_cols=252 Identities=25% Similarity=0.407 Sum_probs=213.6
Q ss_pred eeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC---CCCceeEEEeEEEeccCCEEEEEEec
Q 012320 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL---KHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 36 LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
||+|+||+||+|.++.+|+.||+|++.+.... ..........|..++..+ +||||++++..+ .....+|+||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~--~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV-AKKEVAHTIGERNILVRTLLDESPFIVGLKFSF--QTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh-hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE--ecCCeEEEEEcC
Confidence 79999999999999999999999999765432 223445566677777765 699999999987 456789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc-CCCCCc
Q 012320 113 FTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSKSAH 191 (466)
Q Consensus 113 ~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~-~~~~~~ 191 (466)
+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.... ......
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDAT-GHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-CCEEEecCCcCcCCCCCCCCcc
Confidence 999999999998899999999999999999999999999 9999999999999877 899999999987532 233345
Q ss_pred cccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 012320 192 SVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRC 269 (466)
Q Consensus 192 ~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~ 269 (466)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..++++.+..+..... ....+.++++||.+|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~-~~~~~~~~~~li~~~ 232 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA-EDTQQMYRNIAFGKVRFP-KNVLSDEGRQFVKGL 232 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC-CCHHHHHHHHHcCCCCCC-CccCCHHHHHHHHHH
Confidence 6789999999998753 489999999999999999999999976 677888888887765332 234578999999999
Q ss_pred cc-CcCCCC----CHHHHhcCCCCCchhhhh
Q 012320 270 LV-NASKRL----SAKELLLDPFLASDEVKL 295 (466)
Q Consensus 270 L~-dp~~Rp----sa~elL~hpf~~~~~~~~ 295 (466)
|. +|.+|| ++.++++||||....+..
T Consensus 233 L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~ 263 (330)
T cd05586 233 LNRNPQHRLGAHRDAVELKEHPFFADIDWDL 263 (330)
T ss_pred cCCCHHHCCCCCCCHHHHhcCccccCCCHHH
Confidence 96 999998 689999999998766544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=358.47 Aligned_cols=259 Identities=20% Similarity=0.367 Sum_probs=213.6
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+|.+ .+.||+|+||+||+|.++.+++.||+|++.+.... .....+.+.+|+.+++.++||||+++++.+ .+...+|
T Consensus 2 ~y~~-~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~~ 77 (331)
T cd05597 2 DFEI-LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML-KRAETACFREERDVLVNGDRRWITNLHYAF--QDENNLY 77 (331)
T ss_pred CceE-EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCceEEEE--ecCCeEE
Confidence 5766 46699999999999999999999999999754432 233456788999999999999999999987 4567899
Q ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 108 FITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
+||||++||+|.+++.+ ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..+..
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLA 154 (331)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCC-CCEEEEECCceeecCC
Confidence 99999999999999976 467999999999999999999999999 9999999999999876 8999999999876543
Q ss_pred CCC--CccccCCCCcCCccccc------cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----CCCCC
Q 012320 187 SKS--AHSVIGTPEFMAPELYE------EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK----LPGAF 254 (466)
Q Consensus 187 ~~~--~~~~~GT~~y~APE~l~------~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~----~p~~~ 254 (466)
... ....+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..+.+..+.... ++..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~- 232 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKEHFQFPPD- 232 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCcccCCCc-
Confidence 322 22356999999999875 3478899999999999999999999976 55666666665433 2221
Q ss_pred CCCCCHHHHHHHHHhcc---CcCCCCCHHHHhcCCCCCchhhhh
Q 012320 255 YSIQDLEAQRFIGRCLV---NASKRLSAKELLLDPFLASDEVKL 295 (466)
Q Consensus 255 ~~~~~~~~~~lI~~~L~---dp~~Rpsa~elL~hpf~~~~~~~~ 295 (466)
....+..++++|.+||. ++..|+++.++++||||....+..
T Consensus 233 ~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~ 276 (331)
T cd05597 233 VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDN 276 (331)
T ss_pred cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHH
Confidence 22357899999999985 334488999999999998876643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=350.85 Aligned_cols=265 Identities=22% Similarity=0.331 Sum_probs=229.5
Q ss_pred ccceeeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEE
Q 012320 17 HIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFY 95 (466)
Q Consensus 17 ~~~~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~ 95 (466)
.+.+-+..-+..|.+-.++||-|-.|.|..|.++.||+.+|+|++. +..+.++|+++.-.. .|||||.+.
T Consensus 51 ~m~~k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~---------Ds~KARrEVeLHw~~s~h~~iV~Ii 121 (400)
T KOG0604|consen 51 DMDFKEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL---------DSPKARREVELHWMASGHPHIVSII 121 (400)
T ss_pred hcchhcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh---------cCHHHHhHhhhhhhhcCCCceEEee
Confidence 3445566678889998899999999999999999999999999764 335678899887666 699999999
Q ss_pred eEEEec--cCCEEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC--
Q 012320 96 TSWIDV--DQKTFNFITEMFTSGTLREYRKKYRR--VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH-- 169 (466)
Q Consensus 96 ~~~~~~--~~~~~~lV~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~-- 169 (466)
++|... ..+.+.+|||.++||.|+..++..+. ++|+++..|++||..|+.|||+.+ |.||||||+|+|....
T Consensus 122 dVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~ 199 (400)
T KOG0604|consen 122 DVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSP 199 (400)
T ss_pred hhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCC
Confidence 987432 35678899999999999999988765 999999999999999999999999 9999999999999754
Q ss_pred CCcEEEeccchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHH
Q 012320 170 LGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECA---NPAQIYKKV 245 (466)
Q Consensus 170 ~g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~---~~~~i~~~i 245 (466)
+..+||+|||+|+.-.......+.+-||+|.|||++. ++|+..+|+||+||++|.|++|.+||.... -+..+..+|
T Consensus 200 na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI 279 (400)
T KOG0604|consen 200 NAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRI 279 (400)
T ss_pred CcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHh
Confidence 2478999999999877677788899999999999997 679999999999999999999999996432 234567788
Q ss_pred hcCC--CCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 246 TSGK--LPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 246 ~~g~--~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
..|. +|...|...|..++++|+++|. +|++|+|.++++.|||+....
T Consensus 280 ~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 280 RTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred hccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 8886 5667778889999999999995 999999999999999997644
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=350.46 Aligned_cols=252 Identities=24% Similarity=0.390 Sum_probs=207.7
Q ss_pred eeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecCCC
Q 012320 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTS 115 (466)
Q Consensus 36 LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~~g 115 (466)
||+|+||+||+|.++.+|+.||+|.+...... .....+.+..|+.+++.++||||+++++.+ .....+++||||++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~--~~~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-KRKGYEGAMVEKRILAKVHSRFIVSLAYAF--QTKTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-hhHHHHHHHHHHHHHHhCCCCcEeeeeEEE--cCCCeEEEEEeCCCC
Confidence 69999999999999999999999998765432 223446778899999999999999999877 456789999999999
Q ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCC-CC
Q 012320 116 GTLREYRKK----YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-SA 190 (466)
Q Consensus 116 gsL~~~l~~----~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~-~~ 190 (466)
|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++..+.... ..
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~ 154 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKT 154 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEeeCccceecCCCCccc
Confidence 999987743 356999999999999999999999999 9999999999999876 899999999997654332 23
Q ss_pred ccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 012320 191 HSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECAN---PAQIYKKVTSGKLPGAFYSIQDLEAQRFI 266 (466)
Q Consensus 191 ~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~---~~~i~~~i~~g~~p~~~~~~~~~~~~~lI 266 (466)
....||+.|+|||++. ..++.++|||||||++|+|++|..||..... ...+...+..+. ...+...+..+++++
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li 232 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS--VTYPDKFSPASKSFC 232 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC--CCCcccCCHHHHHHH
Confidence 4467999999999776 5689999999999999999999999975332 223333333332 233455678999999
Q ss_pred HHhcc-CcCCCC-----CHHHHhcCCCCCchhhhh
Q 012320 267 GRCLV-NASKRL-----SAKELLLDPFLASDEVKL 295 (466)
Q Consensus 267 ~~~L~-dp~~Rp-----sa~elL~hpf~~~~~~~~ 295 (466)
.+||. ||.+|| +++++++||||+...+..
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~ 267 (280)
T cd05608 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQ 267 (280)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhH
Confidence 99995 999999 889999999998766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=356.50 Aligned_cols=255 Identities=22% Similarity=0.378 Sum_probs=216.8
Q ss_pred eeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEeEEEeccCCEEEEEEe
Q 012320 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYTSWIDVDQKTFNFITE 111 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~~~lV~E 111 (466)
.++||+|+||+||+|.++.+|+.||+|++.+.... .....+.+..|+.+++.+. |++|+++++.+ .+...+|+|||
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~--~~~~~~~lv~E 81 (323)
T cd05615 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALQDKPPFLTQLHSCF--QTVDRLYFVME 81 (323)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCchhheeeEE--ecCCEEEEEEc
Confidence 57799999999999999999999999998865432 2345567888999999885 57788888877 44678999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC-CCCC
Q 012320 112 MFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SKSA 190 (466)
Q Consensus 112 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~-~~~~ 190 (466)
|++||+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..... ....
T Consensus 82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~-~~ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEEeccccccccCCCCccc
Confidence 9999999999998899999999999999999999999999 9999999999999977 8999999999875432 2233
Q ss_pred ccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 012320 191 HSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRC 269 (466)
Q Consensus 191 ~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~ 269 (466)
....||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+...+++.+..+... .+...+.++++++.+|
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~li~~~ 235 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNVS--YPKSLSKEAVSICKGL 235 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCccCCHHHHHHHHHH
Confidence 4567999999999876 4589999999999999999999999976 6677788888776542 3455678999999999
Q ss_pred cc-CcCCCCC-----HHHHhcCCCCCchhhhhc
Q 012320 270 LV-NASKRLS-----AKELLLDPFLASDEVKLL 296 (466)
Q Consensus 270 L~-dp~~Rps-----a~elL~hpf~~~~~~~~~ 296 (466)
|. +|.+|++ .+++++||||....+...
T Consensus 236 l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~ 268 (323)
T cd05615 236 MTKHPSKRLGCGPEGERDIREHAFFRRIDWDKL 268 (323)
T ss_pred cccCHhhCCCCCCCCHHHHhcCcccCCCCHHHH
Confidence 95 9999997 479999999998776543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=358.16 Aligned_cols=256 Identities=25% Similarity=0.470 Sum_probs=210.9
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
..++|.+. +.||+|+||+||+|.++.+|..+|+|.+.... .....+.+.+|+++|++++||||+++++.+.+ .+
T Consensus 3 ~~~~y~~~-~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 76 (333)
T cd06650 3 KDDDFEKI-SELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DG 76 (333)
T ss_pred chhhhhee-ccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--CC
Confidence 35788875 56999999999999999999999999887542 33455778999999999999999999998854 67
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSR-DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~-~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
.+++||||++|++|.+++.+.+.+++..+..++.||+.||.|||+. + |+||||||+|||++.+ |.+||+|||++..
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~ 153 (333)
T cd06650 77 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQ 153 (333)
T ss_pred EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCC-CCEEEeeCCcchh
Confidence 8999999999999999999888899999999999999999999974 6 9999999999999876 8999999999976
Q ss_pred hcCCCCCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH--------------------
Q 012320 184 LRGSKSAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIY-------------------- 242 (466)
Q Consensus 184 ~~~~~~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~-------------------- 242 (466)
+... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||... ...++.
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (333)
T cd06650 154 LIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP-DAKELELMFGCPVEGDPAESETSPRP 231 (333)
T ss_pred hhhh-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-chhHHHHHhcCcccCCccccccCccc
Confidence 5332 2345679999999998764 5899999999999999999999999652 222221
Q ss_pred ------------------------HHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 243 ------------------------KKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 243 ------------------------~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
..+.....+.......+.++++||.+||. ||.+|||+.|++.||||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 11112222222222356789999999996 99999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=349.43 Aligned_cols=254 Identities=31% Similarity=0.436 Sum_probs=200.9
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcC-CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC---CCCceeEEEeEEEec-
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEV-LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL---KHDSIIRFYTSWIDV- 101 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~~- 101 (466)
.+|.+ .+.||+|+||+||+|.+.. +|..||+|.++..... ......+.+|+.+++.+ +||||+++++.+...
T Consensus 1 ~~Y~~-~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~ 77 (290)
T cd07862 1 QQYEC-VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 77 (290)
T ss_pred CCcce-eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC--CCchHHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence 36777 4669999999999999854 5789999998754421 12234556677777765 699999999987432
Q ss_pred --cCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEec
Q 012320 102 --DQKTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGD 177 (466)
Q Consensus 102 --~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~D 177 (466)
....+++||||+. ++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|
T Consensus 78 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~-~~~kl~D 153 (290)
T cd07862 78 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLAD 153 (290)
T ss_pred CCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCC-CCEEEcc
Confidence 3457899999995 6899988764 45899999999999999999999999 9999999999999877 8999999
Q ss_pred cchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCC--C
Q 012320 178 LGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK-LPG--A 253 (466)
Q Consensus 178 FGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~-~p~--~ 253 (466)
||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||..... .+....+.... .|. .
T Consensus 154 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~-~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 154 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKILDVIGLPGEED 232 (290)
T ss_pred ccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHHHhCCCChhh
Confidence 99997765544455677999999999775 5689999999999999999999999987444 33433333211 000 0
Q ss_pred ----------------------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 254 ----------------------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 254 ----------------------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
.....+..++++|.+||. ||++|||+.|+|+||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 012346678999999996 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=360.37 Aligned_cols=257 Identities=27% Similarity=0.389 Sum_probs=204.6
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc--
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD-- 102 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-- 102 (466)
-.++|.+. +.||+|+||+||+|.++.+|..||+|++.... ........+.+|+.+++.++||||+++++.+...+
T Consensus 19 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 19 VLKRYQQL-KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF--QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhceEEE-EEeecCCCEEEEEEEEcCCCceeEEEEecccc--cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence 35789884 66999999999999999999999999986443 23345567889999999999999999999875432
Q ss_pred --CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 103 --QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 103 --~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
...+|+||||+.+ +|.+.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~-~~~kl~Dfg~ 169 (359)
T cd07876 96 EEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGL 169 (359)
T ss_pred cccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEEecCCC
Confidence 2357999999965 5666554 36899999999999999999999999 9999999999999877 8999999999
Q ss_pred hhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-------------
Q 012320 181 AAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVT------------- 246 (466)
Q Consensus 181 a~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~------------- 246 (466)
+.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+........+.+.
T Consensus 170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 97654444445668999999999876 4699999999999999999999999976433222111110
Q ss_pred --------cC--CCCC----------------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 247 --------SG--KLPG----------------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 247 --------~g--~~p~----------------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
.. ..+. ......+.++++||.+||. ||.+|||+.|+|+||||..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 00 0000 0112235678999999996 9999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=374.93 Aligned_cols=263 Identities=25% Similarity=0.389 Sum_probs=223.6
Q ss_pred eeeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEE
Q 012320 20 YIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWI 99 (466)
Q Consensus 20 ~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 99 (466)
.....+.+||.+ .++||+|+||+||+|.+..+|+.||+|.+..... +......+.+|+.+|..++|+||++++..+.
T Consensus 25 ~~~~~~~~rY~i-~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~ 101 (496)
T PTZ00283 25 ATAKEQAKKYWI-SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFA 101 (496)
T ss_pred ccccccCCCEEE-EEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHhcCCCCcEEEeeccee
Confidence 344567789988 5779999999999999999999999999876543 4456678899999999999999999988775
Q ss_pred eccC------CEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC
Q 012320 100 DVDQ------KTFNFITEMFTSGTLREYRKKY----RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH 169 (466)
Q Consensus 100 ~~~~------~~~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~ 169 (466)
..+. ..+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 102 ~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~ 179 (496)
T PTZ00283 102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSN 179 (496)
T ss_pred cccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCC
Confidence 4322 1478999999999999988643 46899999999999999999999999 9999999999999987
Q ss_pred CCcEEEeccchhhhhcCC---CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q 012320 170 LGQVKIGDLGLAAILRGS---KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKV 245 (466)
Q Consensus 170 ~g~vKL~DFGla~~~~~~---~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i 245 (466)
+.+||+|||+++.+... ......+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+...++..+
T Consensus 180 -~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~-~~~~~~~~~~ 257 (496)
T PTZ00283 180 -GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKT 257 (496)
T ss_pred -CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHH
Confidence 89999999999765432 2234568999999999876 4599999999999999999999999976 6777777877
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 246 TSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 246 ~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
..+..+. .+...++++++++.+||. +|.+||++.++++|||++.
T Consensus 258 ~~~~~~~-~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 258 LAGRYDP-LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred hcCCCCC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 7776543 345567899999999996 9999999999999999865
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=373.09 Aligned_cols=260 Identities=28% Similarity=0.467 Sum_probs=225.6
Q ss_pred eeeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEE
Q 012320 20 YIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWI 99 (466)
Q Consensus 20 ~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 99 (466)
|...||..+|.-+.+ ||.|+||.||-|++..+.+.||||++...- +++.+.++.+++|+.+|++++|||+|.+-++|.
T Consensus 19 F~k~DPEklf~dLrE-IGHGSFGAVYfArd~~n~evVAIKKMsySG-KQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL 96 (948)
T KOG0577|consen 19 FFKDDPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL 96 (948)
T ss_pred HccCCHHHHHHHHHH-hcCCccceeEEeeccCccceeeeeeccccc-cccHHHHHHHHHHHHHHHhccCCCcccccceee
Confidence 456789999998877 999999999999999999999999988665 467788999999999999999999999999985
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEecc
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDL 178 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DF 178 (466)
...+.|+||||| -||-.|++.-+ +++-+..++.|+.+.+.||.||||++ .||||||..|||++.. |.|||+||
T Consensus 97 --re~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~-g~VKLaDF 170 (948)
T KOG0577|consen 97 --REHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEP-GLVKLADF 170 (948)
T ss_pred --ccchHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCC-Ceeeeccc
Confidence 467899999999 56777777543 57999999999999999999999999 9999999999999987 99999999
Q ss_pred chhhhhcCCCCCccccCCCCcCCcccc----ccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 012320 179 GLAAILRGSKSAHSVIGTPEFMAPELY----EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAF 254 (466)
Q Consensus 179 Gla~~~~~~~~~~~~~GT~~y~APE~l----~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~ 254 (466)
|.|....+ .++++|||+|||||++ .+.|+-++||||||++-.||+-.++|+++.+-...+| .|....-|-..
T Consensus 171 GSAsi~~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY-HIAQNesPtLq 246 (948)
T KOG0577|consen 171 GSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPTLQ 246 (948)
T ss_pred cchhhcCc---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH-HHHhcCCCCCC
Confidence 99987644 5689999999999965 3679999999999999999999999998844444444 45555545444
Q ss_pred CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 255 YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 255 ~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
....+..++.||..||. -|.+|||++++|+|+|+...
T Consensus 247 s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 247 SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 55567899999999996 89999999999999999753
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=355.25 Aligned_cols=261 Identities=19% Similarity=0.333 Sum_probs=214.8
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
.|.+ .++||+|+||+||++.++.+++.+|+|.+.+.... .......+.+|+.++..++||||+++++.+ .+...++
T Consensus 2 ~y~~-~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~~ 77 (332)
T cd05623 2 DFEI-LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDNQWITTLHYAF--QDENNLY 77 (332)
T ss_pred CceE-EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-HhhHHHHHHHHHHHHhhCCCCCEeeEEEEE--ecCCEEE
Confidence 5666 46699999999999999999999999998754322 223445678899999999999999999987 4567899
Q ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 108 FITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
+||||+.||+|.+++.+ ...+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..+..
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~-~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMN-GHIRLADFGSCLKLME 154 (332)
T ss_pred EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCC-CCEEEeecchheeccc
Confidence 99999999999999987 467999999999999999999999999 9999999999999876 8999999999876533
Q ss_pred CCC--CccccCCCCcCCccccc------cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---CC
Q 012320 187 SKS--AHSVIGTPEFMAPELYE------EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA---FY 255 (466)
Q Consensus 187 ~~~--~~~~~GT~~y~APE~l~------~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~---~~ 255 (466)
... ....+||+.|+|||++. +.++.++|||||||++|+|++|..||.. .+..+.+.++........ ..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~ 233 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPAQV 233 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCccccCCCcc
Confidence 222 23457999999999874 3588999999999999999999999976 566777777765442211 12
Q ss_pred CCCCHHHHHHHHHhcc---CcCCCCCHHHHhcCCCCCchhhhhc
Q 012320 256 SIQDLEAQRFIGRCLV---NASKRLSAKELLLDPFLASDEVKLL 296 (466)
Q Consensus 256 ~~~~~~~~~lI~~~L~---dp~~Rpsa~elL~hpf~~~~~~~~~ 296 (466)
...+.++++||.+||. ++..|+++.++++||||+...+...
T Consensus 234 ~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~ 277 (332)
T cd05623 234 TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNI 277 (332)
T ss_pred ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHH
Confidence 3457899999999995 3344789999999999998766543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=357.02 Aligned_cols=261 Identities=18% Similarity=0.334 Sum_probs=214.7
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
++|.+ .+.||+|+||+||+|.++.+++.||+|.+.+.... .......+.+|+.++..++|+||+++++.+ .+.+.+
T Consensus 1 d~y~i-~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~--~~~~~~ 76 (331)
T cd05624 1 DDFEI-IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML-KRAETACFREERNVLVNGDCQWITTLHYAF--QDENYL 76 (331)
T ss_pred CCceE-EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-hhHHHHHHHHHHHHHHhCCCCCEeeEEEEE--EcCCEE
Confidence 35766 46699999999999999999999999998754322 233456688899999999999999999987 457789
Q ss_pred EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 107 NFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
|+||||+.||+|.+++.+ .+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++..+.
T Consensus 77 ~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~-~~~kl~DfG~a~~~~ 153 (331)
T cd05624 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMN-GHIRLADFGSCLKMN 153 (331)
T ss_pred EEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCC-CCEEEEeccceeecc
Confidence 999999999999999987 467999999999999999999999999 9999999999999876 899999999997654
Q ss_pred CCCC--CccccCCCCcCCccccc------cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC---
Q 012320 186 GSKS--AHSVIGTPEFMAPELYE------EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAF--- 254 (466)
Q Consensus 186 ~~~~--~~~~~GT~~y~APE~l~------~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~--- 254 (466)
.... ....+||+.|+|||++. +.++.++|||||||++|+|++|..||.. .+..+.+..+........+
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~ 232 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHEERFQFPSH 232 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC-CCHHHHHHHHHcCCCcccCCCc
Confidence 3322 22357999999999875 3578899999999999999999999976 5666677777654321111
Q ss_pred CCCCCHHHHHHHHHhccCcCC---CCCHHHHhcCCCCCchhhhh
Q 012320 255 YSIQDLEAQRFIGRCLVNASK---RLSAKELLLDPFLASDEVKL 295 (466)
Q Consensus 255 ~~~~~~~~~~lI~~~L~dp~~---Rpsa~elL~hpf~~~~~~~~ 295 (466)
....+.+++++|.+||..+.+ |++++++++||||+...|..
T Consensus 233 ~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~ 276 (331)
T cd05624 233 ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWEN 276 (331)
T ss_pred cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHH
Confidence 223578999999999963333 57899999999999876654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=345.99 Aligned_cols=254 Identities=31% Similarity=0.404 Sum_probs=199.7
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC---CCCceeEEEeEEEec---
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL---KHDSIIRFYTSWIDV--- 101 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~~--- 101 (466)
||... +.||+|+||+||+|.++.+|+.||+|.++...... .......+|+.+++.+ +||||+++++.+...
T Consensus 1 ~y~~~-~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QYEPV-AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED--GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred CceEe-eEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC--CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence 57674 66999999999999999999999999987543211 1123455677766655 799999999987542
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
....+++|+|++. ++|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||
T Consensus 78 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~-~~~kl~dfg 153 (288)
T cd07863 78 RETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG-GQVKLADFG 153 (288)
T ss_pred CCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEECccC
Confidence 2356899999996 5898888764 34899999999999999999999999 9999999999999877 899999999
Q ss_pred hhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC------CCC
Q 012320 180 LAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK------LPG 252 (466)
Q Consensus 180 la~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~------~p~ 252 (466)
++.............||+.|+|||++. ..++.++|||||||++|+|++|..||........+.+.+..-. .+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 154 LARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred ccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 998765544445567899999999775 5689999999999999999999999976444333322221100 000
Q ss_pred ------------------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 253 ------------------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 253 ------------------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
......+..++++|.+||. ||.+|||+.|++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0112345678999999996 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=344.74 Aligned_cols=252 Identities=20% Similarity=0.348 Sum_probs=207.2
Q ss_pred eeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecCCC
Q 012320 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTS 115 (466)
Q Consensus 36 LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~~g 115 (466)
||+|+||+||+|.++.+|+.||+|.+..+..... .....+..|+.++++++||||+++++.+ .+...+++||||++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-~~~~~~~~E~~il~~l~hp~i~~~~~~~--~~~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK-SGEKMALLEKEILEKVNSPFIVNLAYAF--ESKTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc-hhhHHHHHHHHHHHhcCCCcEEEEEEEE--ecCCeEEEEEecCCC
Confidence 6999999999999999999999999876543222 2234566799999999999999999987 456789999999999
Q ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCCccc
Q 012320 116 GTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSV 193 (466)
Q Consensus 116 gsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~~~~ 193 (466)
++|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++............
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~~~ 154 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQ-GNCRLSDLGLAVELKDGKTITQR 154 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCC-CCEEEeeceeeeecCCCceeecc
Confidence 99998886543 5889999999999999999999999 9999999999999876 89999999999776544444456
Q ss_pred cCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 012320 194 IGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECA---NPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRC 269 (466)
Q Consensus 194 ~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~---~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~ 269 (466)
.||+.|+|||++. ..++.++||||+||++|+|++|..||.... +..++.+....+..+.. ....+.+++++|.+|
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~ 233 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE-HQNFTEESKDICRLF 233 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc-cccCCHHHHHHHHHH
Confidence 7999999999775 458999999999999999999999996532 23344444444443322 234678999999999
Q ss_pred cc-CcCCCCCH----HHHhcCCCCCchhhh
Q 012320 270 LV-NASKRLSA----KELLLDPFLASDEVK 294 (466)
Q Consensus 270 L~-dp~~Rpsa----~elL~hpf~~~~~~~ 294 (466)
|. ||.+||++ ++++.||||+...+.
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~ 263 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKTINFP 263 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcCCCHH
Confidence 96 99999999 678899999876553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=337.18 Aligned_cols=254 Identities=34% Similarity=0.542 Sum_probs=213.0
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccC-CHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMR-SPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
.|.+ .++||+|++|.||+|.+..+|+.+|+|.+....... .......+.+|+.++++++||||+++++.+. +...+
T Consensus 3 ~~~~-~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~ 79 (263)
T cd06625 3 NWRR-GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR--DDETL 79 (263)
T ss_pred cccc-cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc--cCCeE
Confidence 4655 788999999999999999999999999987554221 1224567889999999999999999999884 46689
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
++|+||++|++|.+++.+.+.+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ +.++|+|||++.....
T Consensus 80 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~-~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeecccceeccc
Confidence 999999999999999998889999999999999999999999999 9999999999999876 8999999999876533
Q ss_pred CCC----CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 012320 187 SKS----AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLE 261 (466)
Q Consensus 187 ~~~----~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 261 (466)
... .....|++.|+|||++. ..++.++|||||||++|+|++|..||......... ..+.........+...+..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 235 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI-FKIATQPTNPQLPSHVSPD 235 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH-HHHhccCCCCCCCccCCHH
Confidence 211 13456889999999876 45889999999999999999999999764444333 3444444444455667889
Q ss_pred HHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 262 AQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 262 ~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
+.++|.+||. +|.+|||+.++++||||
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 236 ARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999996 99999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=386.85 Aligned_cols=261 Identities=25% Similarity=0.420 Sum_probs=220.8
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.++ +.||+|+||+||+|.++.++..+|+|.+..... .......+..|+.+|++|+|||||++++.|.+.....
T Consensus 12 l~~YeIl-~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l--~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 12 LNEYEVI-KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL--KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred cCCEEEE-EEEecCCCeEEEEEEECCCCeEEEEEEEecccc--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 4688875 569999999999999999999999999876543 3345678899999999999999999999998777788
Q ss_pred EEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----CCeEeccCCCCcEEEeCC-------
Q 012320 106 FNFITEMFTSGTLREYRKKY----RRVDIRAIKSWARQILQGLVYLHSRD-----PPVIHRDLKCDNIFVNGH------- 169 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qIl~gL~yLHs~~-----~~IiHrDLKp~NIlv~~~------- 169 (466)
+|+||||+.+|+|.+++... +.+++..++.|+.||+.||.|||+.+ .+|+||||||+||||+..
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 99999999999999998753 57999999999999999999999854 349999999999999642
Q ss_pred ---------CCcEEEeccchhhhhcCCCCCccccCCCCcCCccccc---cCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q 012320 170 ---------LGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE---EDYNELVDVYSFGMCVLEMFTCEYPYSECAN 237 (466)
Q Consensus 170 ---------~g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~---~~y~~~~DIwSlGvil~elltg~~Pf~~~~~ 237 (466)
.+.+||+|||++..+.........+||+.|+|||++. ..++.++|||||||++|+|++|..||....+
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 2358999999998765544455678999999999874 3488999999999999999999999987677
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 238 PAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 238 ~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
..++...+..+.. ......+.++.+||..||. +|.+||++.|+|.|||+...
T Consensus 249 ~~qli~~lk~~p~--lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 249 FSQLISELKRGPD--LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHHHHHhcCCC--CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 7777777665532 2223457899999999996 99999999999999999743
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=352.08 Aligned_cols=247 Identities=26% Similarity=0.369 Sum_probs=193.0
Q ss_pred eeeeeeeCceEEEEEEEc--CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEE
Q 012320 33 EEVLGKGAMKTVYKAIDE--VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFIT 110 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~ 110 (466)
++.||+|+||+||+|.++ .+++.||+|.+..... ...+.+|+.+|++++||||+++++.+.......+++|+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence 467999999999999976 4788999998864321 23467899999999999999999998766677899999
Q ss_pred ecCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEe---CCCCcEEEecc
Q 012320 111 EMFTSGTLREYRKKY---------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVN---GHLGQVKIGDL 178 (466)
Q Consensus 111 E~~~ggsL~~~l~~~---------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~---~~~g~vKL~DF 178 (466)
||+ +++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+. ...+.+||+||
T Consensus 80 e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 80 DYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 998 56888887532 25899999999999999999999999 99999999999994 23478999999
Q ss_pred chhhhhcCC----CCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCC---------HHHHHH
Q 012320 179 GLAAILRGS----KSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECAN---------PAQIYK 243 (466)
Q Consensus 179 Gla~~~~~~----~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~---------~~~i~~ 243 (466)
|++...... ......+||+.|+|||++.+ .|+.++||||+||++|+|++|..||....+ ..++.+
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 999765432 12345679999999997753 489999999999999999999999964221 111111
Q ss_pred HHhcCCC------------CC-----------------------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCC
Q 012320 244 KVTSGKL------------PG-----------------------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPF 287 (466)
Q Consensus 244 ~i~~g~~------------p~-----------------------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf 287 (466)
.+..... +. ......+..+.+||.+||. ||.+|||++|+|+|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 316 (317)
T ss_pred HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 1110000 00 0011234578899999996 9999999999999999
Q ss_pred C
Q 012320 288 L 288 (466)
Q Consensus 288 ~ 288 (466)
|
T Consensus 317 f 317 (317)
T cd07868 317 F 317 (317)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=369.15 Aligned_cols=251 Identities=27% Similarity=0.398 Sum_probs=213.7
Q ss_pred eEEeeeeeeeeCceEEEEEEEcCC-CeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEVL-GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~~-g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
|. +.++||+|+||+||+|.+..+ +..||+|.+... .......+.+|+.+|+.++|||||++++.+. ....+|
T Consensus 69 y~-~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~--~~~~~~ 141 (478)
T PTZ00267 69 YV-LTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYARSELHCLAACDHFGIVKHFDDFK--SDDKLL 141 (478)
T ss_pred EE-EEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE--ECCEEE
Confidence 54 478899999999999999888 888999976533 3345567788999999999999999999884 467899
Q ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 108 FITEMFTSGTLREYRKK----YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
+||||++||+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~-~~~kL~DFgla~~ 218 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPT-GIIKLGDFGFSKQ 218 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCC-CcEEEEeCcCcee
Confidence 99999999999987753 346899999999999999999999999 9999999999999976 8999999999987
Q ss_pred hcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 012320 184 LRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259 (466)
Q Consensus 184 ~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 259 (466)
+.... ...+.+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..++...+..+..+. .+...+
T Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~-~~~~~~~~~~~~~~~~~-~~~~~s 296 (478)
T PTZ00267 219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG-PSQREIMQQVLYGKYDP-FPCPVS 296 (478)
T ss_pred cCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCC-CCccCC
Confidence 64332 234567999999999876 4599999999999999999999999976 56677777777776543 344567
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.+++++|.+||. +|.+||++.+++.|||++..
T Consensus 297 ~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 297 SGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 899999999996 99999999999999999643
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=356.80 Aligned_cols=257 Identities=27% Similarity=0.374 Sum_probs=205.0
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc--
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD-- 102 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-- 102 (466)
-.+||.+. +.||+|+||+||+|.+..+++.||+|.+.... ........+.+|+.+++.++||||+++++.+....
T Consensus 15 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 15 VLKRYQNL-KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhceeEE-EEeeecCCEEEEEEEecCCCceEEEEEeCCcc--cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 35789885 66999999999999999999999999886432 23445577889999999999999999999875432
Q ss_pred --CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 103 --QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 103 --~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
...+++||||+.+ +|.+++.. .+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~-~~~kl~Dfg~ 165 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGL 165 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCC-CCEEEeeCcc
Confidence 2468999999965 67666653 6899999999999999999999999 9999999999999877 8999999999
Q ss_pred hhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc------------
Q 012320 181 AAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS------------ 247 (466)
Q Consensus 181 a~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~------------ 247 (466)
+.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+........+.+..
T Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 98765544455678999999999876 45899999999999999999999999763322222111110
Q ss_pred ---------C--C-----CCC-----------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 248 ---------G--K-----LPG-----------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 248 ---------g--~-----~p~-----------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
. . ++. ......+.++++||.+||. ||++|||+.|+|+||||..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 0 0 000 0112234578999999996 9999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=342.25 Aligned_cols=251 Identities=30% Similarity=0.547 Sum_probs=207.1
Q ss_pred EeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEE
Q 012320 31 LFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFIT 110 (466)
Q Consensus 31 ~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~ 110 (466)
++.+.||+|+||+||+|.++.+++.||+|.+..... .........+|+.++++++||||+++++.+.+ ...+++||
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~ 77 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI--EEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVM 77 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH--HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEE
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc--cccccchhhhhhhccccccccccccccccccc--cccccccc
Confidence 346789999999999999999999999999986543 22233345669999999999999999998744 77899999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh-cCCCC
Q 012320 111 EMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-RGSKS 189 (466)
Q Consensus 111 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~-~~~~~ 189 (466)
|++.+++|.+++.+.+.+++..+..++.||+.||.+||+.+ |+||||||+||+++.+ +.++|+|||++... .....
T Consensus 78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~-~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDEN-GEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTT-SEEEESSGTTTEESTSTTSE
T ss_pred ccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccc-cccccccccccccccccccc
Confidence 99999999999998899999999999999999999999999 9999999999999966 89999999998753 22334
Q ss_pred CccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCCCCCCCC--CCCCHHHH
Q 012320 190 AHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECA--NPAQIYKKVTSGKLPGAFY--SIQDLEAQ 263 (466)
Q Consensus 190 ~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~--~~~~i~~~i~~g~~p~~~~--~~~~~~~~ 263 (466)
.....+|+.|+|||++. ..++.++||||||+++++|++|..||.... +.............+.... .....+++
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELR 234 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHH
Confidence 45677899999999876 568999999999999999999999998741 2333333333222211111 11237899
Q ss_pred HHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 264 RFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
++|.+||. +|++|||+.++++||||
T Consensus 235 ~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 235 DLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHccCChhHCcCHHHHhcCCCC
Confidence 99999995 99999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=362.58 Aligned_cols=248 Identities=27% Similarity=0.383 Sum_probs=199.4
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.++ +.||+|+||.||+|.+..+++.||+|... ...+.+|+.+|++++||||+++++.|. ....
T Consensus 91 ~~~y~~~-~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----------~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~ 157 (391)
T PHA03212 91 KAGFSIL-ETFTPGAEGFAFACIDNKTCEHVVIKAGQ----------RGGTATEAHILRAINHPSIIQLKGTFT--YNKF 157 (391)
T ss_pred cCCcEEE-EEEcCCCCeEEEEEEECCCCCEEEEechh----------hhhhHHHHHHHHhCCCCCCCCEeEEEE--ECCe
Confidence 3678885 56999999999999999999999999643 134678999999999999999999884 4678
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
.++|+|++ +++|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++....
T Consensus 158 ~~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~-~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 158 TCLILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHP-GDVCLGDFGAACFPV 233 (391)
T ss_pred eEEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCC-CCEEEEeCCcccccc
Confidence 89999999 5789999988888999999999999999999999999 9999999999999877 899999999996543
Q ss_pred C--CCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHhc-CCCCCC-
Q 012320 186 G--SKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECAN-------PAQIYKKVTS-GKLPGA- 253 (466)
Q Consensus 186 ~--~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~-------~~~i~~~i~~-g~~p~~- 253 (466)
. .......+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+... ..++...+.. |..|..
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 2 12234568999999999876 4699999999999999999999988754221 1111111110 111100
Q ss_pred -------------------------CC-----CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 254 -------------------------FY-----SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 254 -------------------------~~-----~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
.+ ...+.++++||.+||. ||.+||||+|+|+||||+.
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 00 0124578899999996 9999999999999999975
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=344.16 Aligned_cols=259 Identities=20% Similarity=0.339 Sum_probs=211.0
Q ss_pred eEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEE
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNF 108 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~l 108 (466)
|.+ .++||+|+||+||+|.++.+++.||+|.+...... .......+.+|+.+++.++|+||+.+++.+. +...+++
T Consensus 2 f~~-~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~--~~~~~~l 77 (285)
T cd05630 2 FRQ-YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGESMALNEKQILEKVNSRFVVSLAYAYE--TKDALCL 77 (285)
T ss_pred cee-eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc-chHHHHHHHHHHHHHHhCCCCCeeeeeEEEe--cCCEEEE
Confidence 555 46699999999999999999999999998765432 2233456788999999999999999999874 4678999
Q ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 109 ITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 109 V~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
||||++|++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.+ +.++|+|||++.....
T Consensus 78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDH-GHIRISDLGLAVHVPE 154 (285)
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCC-CCEEEeeccceeecCC
Confidence 99999999999988654 35899999999999999999999999 9999999999999876 7999999999876544
Q ss_pred CCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 187 SKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANP--AQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 187 ~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~--~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
........||+.|+|||++. ..++.++||||+||++|+|++|..||....+. ......+.. ..+.......+.+++
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 233 (285)
T cd05630 155 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVQEEYSEKFSPDAR 233 (285)
T ss_pred CccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh-hhhhhcCccCCHHHH
Confidence 44444567999999999875 45899999999999999999999999763321 111222211 112233455678899
Q ss_pred HHHHHhcc-CcCCCCC-----HHHHhcCCCCCchhhhh
Q 012320 264 RFIGRCLV-NASKRLS-----AKELLLDPFLASDEVKL 295 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rps-----a~elL~hpf~~~~~~~~ 295 (466)
+|+.+||. ||.+||| ++|+++||||+...+..
T Consensus 234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~ 271 (285)
T cd05630 234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKR 271 (285)
T ss_pred HHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHH
Confidence 99999996 9999999 99999999998765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=368.97 Aligned_cols=252 Identities=21% Similarity=0.310 Sum_probs=197.3
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCC------CceeEEEeEEE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH------DSIIRFYTSWI 99 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~H------pnIv~l~~~~~ 99 (466)
.++|.+ .++||+|+||+||+|.+..+++.||+|+++... ........|+.+++.++| ++|++++++|.
T Consensus 128 ~~~y~i-~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 128 TQRFKI-LSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred CCcEEE-EEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 578887 466999999999999999999999999986321 122345567777776654 45888888764
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCCCCcEEEeCCC--------
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHS-RDPPVIHRDLKCDNIFVNGHL-------- 170 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs-~~~~IiHrDLKp~NIlv~~~~-------- 170 (466)
.+...+++|||++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .| ||||||||+|||++...
T Consensus 202 -~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 202 -NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred -cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccccc
Confidence 3456788999988 88999999888899999999999999999999998 58 99999999999997652
Q ss_pred -------CcEEEeccchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q 012320 171 -------GQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIY 242 (466)
Q Consensus 171 -------g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~ 242 (466)
+.+||+|||++.... ......+||+.|+|||++. ..|+.++|||||||++|||++|..||....+...+
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~- 354 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL- 354 (467)
T ss_pred cccCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-
Confidence 149999999885432 2344678999999999776 46999999999999999999999999764433322
Q ss_pred HHHhc--CCCCCCC--------------------------------------CCCCCHHHHHHHHHhcc-CcCCCCCHHH
Q 012320 243 KKVTS--GKLPGAF--------------------------------------YSIQDLEAQRFIGRCLV-NASKRLSAKE 281 (466)
Q Consensus 243 ~~i~~--g~~p~~~--------------------------------------~~~~~~~~~~lI~~~L~-dp~~Rpsa~e 281 (466)
..+.. |.+|..+ ....+..+.+||.+||+ ||.+|||++|
T Consensus 355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e 434 (467)
T PTZ00284 355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ 434 (467)
T ss_pred HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence 22211 1111100 01124567899999996 9999999999
Q ss_pred HhcCCCCCc
Q 012320 282 LLLDPFLAS 290 (466)
Q Consensus 282 lL~hpf~~~ 290 (466)
+|+||||..
T Consensus 435 ~L~Hp~~~~ 443 (467)
T PTZ00284 435 MTTHPYVLK 443 (467)
T ss_pred HhcCccccc
Confidence 999999975
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=356.31 Aligned_cols=255 Identities=27% Similarity=0.382 Sum_probs=205.5
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc---
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD--- 102 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--- 102 (466)
.+||... +.||+|+||+||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++.+...+
T Consensus 23 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 23 LKRYQNL-KPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hcceeEE-EEeecCCCeEEEEEEECCCCcEEEEEEeCccc--cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 5789885 66999999999999999999999999986432 23345567889999999999999999998774322
Q ss_pred -CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 103 -QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 103 -~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
...+|+||||+. ++|.+++.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 100 ~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~DfG~a 173 (364)
T cd07875 100 EFQDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA 173 (364)
T ss_pred ccCeEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCC-CcEEEEeCCCc
Confidence 246899999995 477777653 5889999999999999999999999 9999999999999877 89999999999
Q ss_pred hhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-C---------
Q 012320 182 AILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK-L--------- 250 (466)
Q Consensus 182 ~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~-~--------- 250 (466)
.............||+.|+|||++. ..++.++|||||||++|+|++|..||... +....+..+.... .
T Consensus 174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT-DHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred cccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCCHHHHHhh
Confidence 8765544445678999999999776 46899999999999999999999999763 3333333332110 0
Q ss_pred -----------C-------------------CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 251 -----------P-------------------GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 251 -----------p-------------------~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
| .......+..+++||.+||. ||.+|||+.++|+||||..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0 00011234578999999996 9999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=365.20 Aligned_cols=253 Identities=28% Similarity=0.428 Sum_probs=207.5
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-C-----CceeEEEeEEEe
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-H-----DSIIRFYTSWID 100 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-H-----pnIv~l~~~~~~ 100 (466)
.||.+ .++||+|+||.|.+|.+..|++.||||+|+.+ +.-..+...|+.+|..|+ | -|||+++++|.
T Consensus 186 ~rY~V-~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~- 258 (586)
T KOG0667|consen 186 YRYEV-LEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY- 258 (586)
T ss_pred EEEEE-EEEecccccceeEEEEecCCCcEEEEEeeccC-----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc-
Confidence 37777 68899999999999999999999999998733 345567788999999996 4 38999999994
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC-CCcEEEec
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH-LGQVKIGD 177 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~-~g~vKL~D 177 (466)
.++++|||+|++ +.+|.++++.+ ..++...++.++.||+.||..||+.+ |||+||||||||+... ...|||+|
T Consensus 259 -fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVID 334 (586)
T KOG0667|consen 259 -FRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVID 334 (586)
T ss_pred -cccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEe
Confidence 488999999999 88999999876 46899999999999999999999999 9999999999999643 34799999
Q ss_pred cchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCC-----
Q 012320 178 LGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-GKL----- 250 (466)
Q Consensus 178 FGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-g~~----- 250 (466)
||.++.... ...+.+.+..|+|||++- ..|+.+.||||||||++||++|.+.|.+....+++...+.- |..
T Consensus 335 FGSSc~~~q--~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL 412 (586)
T KOG0667|consen 335 FGSSCFESQ--RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML 412 (586)
T ss_pred cccccccCC--cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 999987543 334888999999999665 67999999999999999999998888875555555433320 100
Q ss_pred -----------------------------------------------CCC-------CCCCCCHHHHHHHHHhcc-CcCC
Q 012320 251 -----------------------------------------------PGA-------FYSIQDLEAQRFIGRCLV-NASK 275 (466)
Q Consensus 251 -----------------------------------------------p~~-------~~~~~~~~~~~lI~~~L~-dp~~ 275 (466)
|.. ........+.+||++||. ||.+
T Consensus 413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~ 492 (586)
T KOG0667|consen 413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE 492 (586)
T ss_pred HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence 000 001122467899999997 9999
Q ss_pred CCCHHHHhcCCCCCchh
Q 012320 276 RLSAKELLLDPFLASDE 292 (466)
Q Consensus 276 Rpsa~elL~hpf~~~~~ 292 (466)
|+|+.++|+||||....
T Consensus 493 R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 493 RITPAQALNHPFLTGTS 509 (586)
T ss_pred cCCHHHHhcCccccccc
Confidence 99999999999998543
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=344.14 Aligned_cols=255 Identities=26% Similarity=0.437 Sum_probs=220.8
Q ss_pred eEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCCEEE
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~~~ 107 (466)
|.+-+++||+|+|+.|-.|....+|.+||+|+|.+.. .....++++|++++.++ .|+||+.+.+.| +++..+|
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~----gHsR~RvfREVe~f~~Cqgh~nilqLiefF--Edd~~FY 152 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP----GHSRSRVFREVETFYQCQGHKNILQLIEFF--EDDTRFY 152 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC----chHHHHHHHHHHHHHHhcCCccHHHHHHHh--cccceEE
Confidence 5566789999999999999999999999999998553 34668999999999999 699999999988 5677899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCC--CcEEEeccchhhhhc
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHL--GQVKIGDLGLAAILR 185 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~--g~vKL~DFGla~~~~ 185 (466)
+|||-+.||+|..+|.+...+++..+..++++|+.||.+||.+| |.||||||+|||-.... ..||||||.|+..+.
T Consensus 153 LVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k 230 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIK 230 (463)
T ss_pred EEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccc
Confidence 99999999999999999999999999999999999999999999 99999999999986542 368999999886543
Q ss_pred CC--------CCCccccCCCCcCCccccc---c---CCCChhhHHHHHHHHHHHHhCCCCCCCCC--------------C
Q 012320 186 GS--------KSAHSVIGTPEFMAPELYE---E---DYNELVDVYSFGMCVLEMFTCEYPYSECA--------------N 237 (466)
Q Consensus 186 ~~--------~~~~~~~GT~~y~APE~l~---~---~y~~~~DIwSlGvil~elltg~~Pf~~~~--------------~ 237 (466)
.. ....+.+|+.+|||||+.. + .|+.++|.||||||+|.|++|.+||.+.- -
T Consensus 231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~C 310 (463)
T KOG0607|consen 231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVC 310 (463)
T ss_pred cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHH
Confidence 21 2244678999999999643 2 39999999999999999999999995421 1
Q ss_pred HHHHHHHHhcCCC--CCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 238 PAQIYKKVTSGKL--PGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 238 ~~~i~~~i~~g~~--p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
...++..|..|++ |...|...+.+++++|+.+|+ ++.+|.+|.++++|||++..
T Consensus 311 Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 311 QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 3457888999874 666788889999999999996 99999999999999999764
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=355.04 Aligned_cols=252 Identities=27% Similarity=0.443 Sum_probs=204.5
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
..|.. .+.||+|+||+||+|.++.+|+.||+|++.... .......+.+|+.+|+.++|+||+++++.+ ...+.+
T Consensus 74 ~~~~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~ 147 (353)
T PLN00034 74 SELER-VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMF--DHNGEI 147 (353)
T ss_pred HHHhh-hhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHHHHHHHHHHHHHHHhCCCCCcceeeeEe--ccCCeE
Confidence 34555 456999999999999999999999999986432 334456789999999999999999999987 457789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
++||||+.+|+|... ...++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..+..
T Consensus 148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSA-KNVKIADFGVSRILAQ 220 (353)
T ss_pred EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCC-CCEEEcccccceeccc
Confidence 999999999998652 35678889999999999999999999 9999999999999877 8999999999976643
Q ss_pred C-CCCccccCCCCcCCcccccc-----C-CCChhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCCCCCCCCCC
Q 012320 187 S-KSAHSVIGTPEFMAPELYEE-----D-YNELVDVYSFGMCVLEMFTCEYPYSECA--NPAQIYKKVTSGKLPGAFYSI 257 (466)
Q Consensus 187 ~-~~~~~~~GT~~y~APE~l~~-----~-y~~~~DIwSlGvil~elltg~~Pf~~~~--~~~~i~~~i~~g~~p~~~~~~ 257 (466)
. ......+||+.|+|||++.. . ++.++|||||||++|+|++|..||.... +...+...+..+.. ......
T Consensus 221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~ 299 (353)
T PLN00034 221 TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP-PEAPAT 299 (353)
T ss_pred ccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC-CCCCCc
Confidence 2 22345679999999998742 2 3468999999999999999999996422 22333333333332 233445
Q ss_pred CCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 258 QDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 258 ~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
.+.++++||.+||. +|.+|||+.|+|+||||....
T Consensus 300 ~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 300 ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 67899999999996 999999999999999998753
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=338.00 Aligned_cols=256 Identities=28% Similarity=0.492 Sum_probs=211.1
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEec
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDV 101 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 101 (466)
.+|+|+|... +.||+|+||+||+|.++.+++.||+|.+.... .....+.+|+.+++.+ +||||+++++.+...
T Consensus 2 ~~~~~~y~~~-~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (272)
T cd06637 2 RDPAGIFELV-ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 75 (272)
T ss_pred CChhhhhhHH-HheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence 4789999885 66999999999999999999999999986432 2235678899999998 799999999988654
Q ss_pred c----CCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEE
Q 012320 102 D----QKTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKI 175 (466)
Q Consensus 102 ~----~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL 175 (466)
. ...+++||||+.+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||
T Consensus 76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~-~~~~l 152 (272)
T cd06637 76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKL 152 (272)
T ss_pred CCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCC-CCEEE
Confidence 3 35789999999999999998864 46899999999999999999999999 9999999999999977 79999
Q ss_pred eccchhhhhcCC-CCCccccCCCCcCCccccc------cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q 012320 176 GDLGLAAILRGS-KSAHSVIGTPEFMAPELYE------EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG 248 (466)
Q Consensus 176 ~DFGla~~~~~~-~~~~~~~GT~~y~APE~l~------~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g 248 (466)
+|||++...... .......|++.|+|||++. ..|+.++|||||||++|+|++|..||.... .......+...
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~-~~~~~~~~~~~ 231 (272)
T cd06637 153 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRN 231 (272)
T ss_pred ccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC-HHHHHHHHhcC
Confidence 999998765432 2334567999999999874 348889999999999999999999997643 33333333333
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 249 KLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 249 ~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
..+.......+.++++|+.+||. +|.+|||+.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 232 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 33333334556799999999996 99999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=333.06 Aligned_cols=257 Identities=32% Similarity=0.540 Sum_probs=212.9
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEeccccc-CCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELM-RSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
.|.+ .++||+|+||+||+|.+..+|..||+|.+...... ......+.+.+|+.++++++||||+++++.+.+.....+
T Consensus 3 ~~~~-~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 3 NWRL-GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred cceE-eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4555 68899999999999999999999999998754321 123456788999999999999999999998765555688
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
++||||++|++|.+++.+.+.+++..+..++.|++.||.|||+.+ |+|+||||+||+++.+ +.+||+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSV-GNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCC-CCEEECcCcccccccc
Confidence 999999999999999988888999999999999999999999999 9999999999999876 8999999999876532
Q ss_pred C----CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 012320 187 S----KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLE 261 (466)
Q Consensus 187 ~----~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 261 (466)
. .......||..|+|||++. ..++.++|||||||++|+|++|..||........+. .+.........+...+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQPTNPVLPPHVSDH 237 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH-HHhcCCCCCCCchhhCHH
Confidence 1 1223456899999999775 458899999999999999999999997644444443 333332223344456678
Q ss_pred HHHHHHHhccCcCCCCCHHHHhcCCCCC
Q 012320 262 AQRFIGRCLVNASKRLSAKELLLDPFLA 289 (466)
Q Consensus 262 ~~~lI~~~L~dp~~Rpsa~elL~hpf~~ 289 (466)
+.++|.+|+.+|.+||+++++++|||+.
T Consensus 238 ~~~~i~~~l~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 238 CRDFLKRIFVEAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHHhcChhhCCCHHHHhcCcccC
Confidence 9999999999999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=350.36 Aligned_cols=252 Identities=24% Similarity=0.360 Sum_probs=204.3
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEE-----cCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeE
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAID-----EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTS 97 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~ 97 (466)
-+.+||.+ .++||+|+||+||+|.+ +.++..||+|+++... .......+.+|+.+|+.+ +||||++++++
T Consensus 4 ~~~~~~~~-~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 4 FPRDRLRL-GKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA---TASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred cchhHcee-eeEeccCCcceEEEEEEeccCCcccchhhheecccccc---chHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 45678877 67799999999999975 3456789999886332 234556789999999999 89999999998
Q ss_pred EEeccCCEEEEEEecCCCCCHHHHHHhc----------------------------------------------------
Q 012320 98 WIDVDQKTFNFITEMFTSGTLREYRKKY---------------------------------------------------- 125 (466)
Q Consensus 98 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~---------------------------------------------------- 125 (466)
+.. ....+++||||+++|+|.+++...
T Consensus 80 ~~~-~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (338)
T cd05102 80 CTK-PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTN 158 (338)
T ss_pred ecC-CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccc
Confidence 743 345689999999999999998753
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCC---CCcc
Q 012320 126 ----------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK---SAHS 192 (466)
Q Consensus 126 ----------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~---~~~~ 192 (466)
..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++....... ....
T Consensus 159 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~-~~~kl~DfG~a~~~~~~~~~~~~~~ 235 (338)
T cd05102 159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGS 235 (338)
T ss_pred cchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCC-CcEEEeecccccccccCcchhcccC
Confidence 23778889999999999999999999 9999999999999876 899999999997653221 1123
Q ss_pred ccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhc
Q 012320 193 VIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCL 270 (466)
Q Consensus 193 ~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L 270 (466)
..+|+.|+|||++. ..|+.++|||||||++|||++ |..||........+...+..+..+. .+...++.+++++.+||
T Consensus 236 ~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl 314 (338)
T cd05102 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR-APENATPEIYRIMLACW 314 (338)
T ss_pred CCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHc
Confidence 44678899999775 569999999999999999997 9999977555555666666655432 34566789999999999
Q ss_pred c-CcCCCCCHHHHhc
Q 012320 271 V-NASKRLSAKELLL 284 (466)
Q Consensus 271 ~-dp~~Rpsa~elL~ 284 (466)
. ||.+|||+.++++
T Consensus 315 ~~dp~~RPs~~el~~ 329 (338)
T cd05102 315 QGDPKERPTFSALVE 329 (338)
T ss_pred cCChhhCcCHHHHHH
Confidence 6 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=344.79 Aligned_cols=256 Identities=26% Similarity=0.403 Sum_probs=204.3
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
...+|.+. +.||+|+||+||+|.++.++..||+|.++.... ......+.+|+.++++++||||+++++.+. ...
T Consensus 4 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~ 77 (309)
T cd07872 4 KMETYIKL-EKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIVH--TDK 77 (309)
T ss_pred CCCceEEE-EEecccCCEEEEEEEecCCCCeEEEEEeecccc---CCcchhHHHHHHHHHhCCCCCcceEEEEEe--eCC
Confidence 34678774 569999999999999999999999999875432 122345778999999999999999999874 467
Q ss_pred EEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
.+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++..
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~ 153 (309)
T cd07872 78 SLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINER-GELKLADFGLARA 153 (309)
T ss_pred eEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEECcccccee
Confidence 89999999965 888887654 45899999999999999999999999 9999999999999877 8999999999875
Q ss_pred hcCC-CCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--C----------
Q 012320 184 LRGS-KSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS--G---------- 248 (466)
Q Consensus 184 ~~~~-~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~--g---------- 248 (466)
.... .......+|+.|+|||++. ..++.++|||||||++|+|++|..||...... .....+.. +
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 154 KSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-DELHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred cCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhhh
Confidence 4322 2233456899999999775 35899999999999999999999999764332 22222211 0
Q ss_pred ---------CCCCC-------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 249 ---------KLPGA-------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 249 ---------~~p~~-------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
..+.. .....+.+++++|.+||. ||.+|||+.|+|+||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred cchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 00100 112346789999999996 99999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=339.15 Aligned_cols=242 Identities=21% Similarity=0.283 Sum_probs=206.5
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe--ccCCEEEEEEe
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID--VDQKTFNFITE 111 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~~~lV~E 111 (466)
..||+|++|.||+|.. +|+.||+|.++.... ......+.+.+|+.+|++++||||+++++.+.+ .+...+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHK-GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEecccccc-ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 3589999999999976 699999999875432 233335778899999999999999999998866 44567899999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCC
Q 012320 112 MFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSR-DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA 190 (466)
Q Consensus 112 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~-~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~ 190 (466)
|++||+|.+++.+.+.+++.....++.|++.||.|||+. + ++||||||+||+++.+ +.+||+|||++..+... .
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~-~~~kl~dfg~~~~~~~~--~ 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTEN-YKLKIICHGLEKILSSP--P 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCC-CcEEEcccchHhhhccc--c
Confidence 999999999999888899999999999999999999984 7 8899999999999987 89999999999865432 2
Q ss_pred ccccCCCCcCCccccc---cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 012320 191 HSVIGTPEFMAPELYE---EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIG 267 (466)
Q Consensus 191 ~~~~GT~~y~APE~l~---~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~ 267 (466)
...+||+.|+|||++. +.|+.++|||||||++|||++|..||.. .+..+++..+..+..+...+...+.++++++.
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~ 256 (283)
T PHA02988 178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN-LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVE 256 (283)
T ss_pred ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHH
Confidence 3457899999999886 4689999999999999999999999986 56777788776554444444456789999999
Q ss_pred Hhcc-CcCCCCCHHHHhc
Q 012320 268 RCLV-NASKRLSAKELLL 284 (466)
Q Consensus 268 ~~L~-dp~~Rpsa~elL~ 284 (466)
+||. ||.+|||+.+++.
T Consensus 257 ~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 257 ACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHhcCCcccCcCHHHHHH
Confidence 9996 9999999999984
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=362.85 Aligned_cols=262 Identities=26% Similarity=0.453 Sum_probs=232.1
Q ss_pred eeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 21 IETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 21 ~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
.+..-.+.|.+ .+.||+|.|++|.+|++..||.+||||.|.+... +....+.+.+|+++|+.|+|||||++|.+.
T Consensus 50 ~~~~~vg~y~i-~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l--n~~~~~k~~rev~imk~l~HPnIvkl~~v~-- 124 (596)
T KOG0586|consen 50 DDSNSVGLYVI-IKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL--NPSKRQKLGREVDIMKSLNHPNIVKLFSVI-- 124 (596)
T ss_pred cccccccceee-eeeeccceeEEEEeeEecCCCceEEEEEehhccc--ChHHHHHHHHHHHHHHhcCCcceeeeeeee--
Confidence 34445566766 5669999999999999999999999999987764 445567799999999999999999999976
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
..+..+|+||||+.+|.+++|+.+++++.+..++.++.|+++|++|||+++ |+|||||++|||++.+ -.+||+|||+
T Consensus 125 ~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~-mnikIaDfgf 201 (596)
T KOG0586|consen 125 ETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDEN-MNIKIADFGF 201 (596)
T ss_pred eecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccc-cceeeecccc
Confidence 567899999999999999999999999999999999999999999999999 9999999999999988 4799999999
Q ss_pred hhhhcCCCCCccccCCCCcCCccccccC-C-CChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 012320 181 AAILRGSKSAHSVIGTPEFMAPELYEED-Y-NELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258 (466)
Q Consensus 181 a~~~~~~~~~~~~~GT~~y~APE~l~~~-y-~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 258 (466)
+..+.......+++|+|.|.|||++.+. | ++.+|+||+|+++|-|+.|.+||.+ .+..++...+..|++.- +...
T Consensus 202 S~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG-~~lk~Lr~rvl~gk~rI--p~~m 278 (596)
T KOG0586|consen 202 STFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG-QNLKELRPRVLRGKYRI--PFYM 278 (596)
T ss_pred ceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC-cccccccchheeeeecc--ccee
Confidence 9999988888999999999999998753 5 5889999999999999999999987 67777777788887643 3445
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
+.+++++|+++|+ +|.+|++.++++.|.|......
T Consensus 279 s~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 279 SCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred echhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence 6789999999996 9999999999999999975433
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=338.01 Aligned_cols=257 Identities=27% Similarity=0.485 Sum_probs=221.2
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
++|.+ .+.||+|+||.||+|.+..+++.+|+|.+...... .....+.+.+|++++++++||||+++++.+ .+...+
T Consensus 1 ~~y~~-~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~ 76 (290)
T cd05580 1 DDFEF-IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-KLKQVEHVLNEKRILQSIRHPFLVNLYGSF--QDDSNL 76 (290)
T ss_pred CceEE-EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCccceeeEE--EcCCeE
Confidence 35777 47799999999999999999999999998755432 234567889999999999999999999987 456789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
++||||+++++|.+++.+.+.+++..+..++.||+.||.|||+.+ |+||||+|.||+++.+ |.+||+|||++.....
T Consensus 77 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 77 YLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSD-GYIKITDFGFAKRVKG 153 (290)
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCC-CCEEEeeCCCccccCC
Confidence 999999999999999998899999999999999999999999999 9999999999999877 8999999999977654
Q ss_pred CCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 012320 187 SKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRF 265 (466)
Q Consensus 187 ~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~l 265 (466)
. .....|++.|+|||.+. ..++.++||||||+++|+|++|..||.. .+.....+.+..+..+ .+...+..++++
T Consensus 154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 228 (290)
T cd05580 154 R--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD-DNPIQIYEKILEGKVR--FPSFFSPDAKDL 228 (290)
T ss_pred C--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCcc--CCccCCHHHHHH
Confidence 3 34557899999999765 4578899999999999999999999976 4566777777766543 334457899999
Q ss_pred HHHhcc-CcCCCC-----CHHHHhcCCCCCchhhhh
Q 012320 266 IGRCLV-NASKRL-----SAKELLLDPFLASDEVKL 295 (466)
Q Consensus 266 I~~~L~-dp~~Rp-----sa~elL~hpf~~~~~~~~ 295 (466)
|.+||. +|.+|+ +++|+++||||....|..
T Consensus 229 i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 264 (290)
T cd05580 229 IRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIA 264 (290)
T ss_pred HHHHccCCHHHccCcccCCHHHHHcCcccccCCHHH
Confidence 999996 999999 999999999998876643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=333.44 Aligned_cols=257 Identities=34% Similarity=0.554 Sum_probs=212.0
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEeccccc-CCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELM-RSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
.|.. .++||+|+||.||+|.+..+|..||+|.+...... ........+.+|+.++++++||||+++++.+.......+
T Consensus 3 ~~~~-~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 3 NWRR-GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred Cccc-cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3555 67799999999999999999999999998755421 123355678999999999999999999998765556789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
++++||+++++|.+++.+.+.+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++..+..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~-~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC-CCEEEccCCCcccccc
Confidence 999999999999999988888999999999999999999999999 9999999999999876 7999999999876532
Q ss_pred C----CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 012320 187 S----KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLE 261 (466)
Q Consensus 187 ~----~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 261 (466)
. .......|+..|+|||.+. ..++.++||||+||++|+|++|..||........+.+....+. ....+...+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 237 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT-NPQLPSHISEH 237 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC-CCCCchhcCHH
Confidence 1 1123356889999999776 4588999999999999999999999987555554544433332 33444556788
Q ss_pred HHHHHHHhccCcCCCCCHHHHhcCCCCC
Q 012320 262 AQRFIGRCLVNASKRLSAKELLLDPFLA 289 (466)
Q Consensus 262 ~~~lI~~~L~dp~~Rpsa~elL~hpf~~ 289 (466)
++++|..|+.+|.+||+++|+++||||+
T Consensus 238 ~~~li~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 238 ARDFLGCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHHHHhcCChhhCcCHHHHhcCcccc
Confidence 9999965557999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=354.47 Aligned_cols=253 Identities=27% Similarity=0.414 Sum_probs=204.6
Q ss_pred eeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc---CCEEEEE
Q 012320 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD---QKTFNFI 109 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~---~~~~~lV 109 (466)
.+.||+|+||+||+|.+..+|+.||+|++.... .......++.+|+.+|+.++||||+++++.+...+ ...+|+|
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF--QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cceeeeCCCEEEEEEEECCCCCEEEEEeccccc--cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 567999999999999999999999999876332 23345578899999999999999999999874322 1278999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC--
Q 012320 110 TEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-- 187 (466)
Q Consensus 110 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~-- 187 (466)
+||+. ++|.+++...+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++......
T Consensus 83 ~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~-~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 83 TELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSN-CVLKICDFGLARVEEPDES 158 (372)
T ss_pred eeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCC-CCEEeccccceeecccCcc
Confidence 99995 688888888888999999999999999999999999 9999999999999877 89999999999765322
Q ss_pred CCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc------------------
Q 012320 188 KSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS------------------ 247 (466)
Q Consensus 188 ~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~------------------ 247 (466)
.......+|+.|+|||++.+ .|+.++|||||||++|+|++|..||... +..+....+..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ-SPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC-CHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 22334568999999998764 4899999999999999999999999763 33333333221
Q ss_pred -----CC-CCC------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 248 -----GK-LPG------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 248 -----g~-~p~------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
.. .+. ......+.++.+||.+||. ||.+|||+.|+|.||||....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 11 111 1122346789999999996 999999999999999997643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=337.63 Aligned_cols=258 Identities=22% Similarity=0.349 Sum_probs=211.6
Q ss_pred eEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEE
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNF 108 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~l 108 (466)
|.. .++||+|+||+||+|.+..+|+.+|+|.+...... .......+.+|+.+|+.++|+||+.+++.+ ..+..+++
T Consensus 2 ~~~-~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~--~~~~~~~l 77 (285)
T cd05632 2 FRQ-YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-KRKGESMALNEKQILEKVNSQFVVNLAYAY--ETKDALCL 77 (285)
T ss_pred ceE-EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-hhhHHHHHHHHHHHHHHcCCcCceeEEEEE--ecCCEEEE
Confidence 555 36699999999999999999999999998765432 223345678899999999999999999887 44678999
Q ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 109 ITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 109 V~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
||||+.+++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.+ +.+||+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~-~~~kl~Dfg~~~~~~~ 154 (285)
T cd05632 78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDY-GHIRISDLGLAVKIPE 154 (285)
T ss_pred EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCC-CCEEEecCCcceecCC
Confidence 99999999999888653 46999999999999999999999999 9999999999999877 7999999999876544
Q ss_pred CCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhcCCCCCCCCCCCCHHH
Q 012320 187 SKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPA---QIYKKVTSGKLPGAFYSIQDLEA 262 (466)
Q Consensus 187 ~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~---~i~~~i~~g~~p~~~~~~~~~~~ 262 (466)
........||+.|+|||++. ..++.++|+|||||++|+|++|..||....... .+...+..+. .......+.++
T Consensus 155 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 232 (285)
T cd05632 155 GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE--EVYSAKFSEEA 232 (285)
T ss_pred CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc--cccCccCCHHH
Confidence 33444567999999999775 568999999999999999999999997633322 2223333322 22334567789
Q ss_pred HHHHHHhcc-CcCCCCC-----HHHHhcCCCCCchhhhh
Q 012320 263 QRFIGRCLV-NASKRLS-----AKELLLDPFLASDEVKL 295 (466)
Q Consensus 263 ~~lI~~~L~-dp~~Rps-----a~elL~hpf~~~~~~~~ 295 (466)
.+|+.+||. +|.+||+ +.+++.||||....++.
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~ 271 (285)
T cd05632 233 KSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKR 271 (285)
T ss_pred HHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHH
Confidence 999999996 9999999 88999999998876643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=335.91 Aligned_cols=255 Identities=27% Similarity=0.477 Sum_probs=208.9
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
..+.++|.. .+.||+|+||.||+|.+..+++.||+|.++... ......+.+|+.+++.++||||+++++.+. .
T Consensus 5 ~~~~~~~~~-~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~--~ 77 (267)
T cd06645 5 RNPQEDFEL-IQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYL--R 77 (267)
T ss_pred cCcHHHHHH-HHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEE--e
Confidence 345567776 466999999999999999999999999987443 234456788999999999999999999874 4
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
...+++|+||+++++|.+++...+.+++..+..++.||+.||.|||+.| ++|+||||+||+++.+ +.+||+|||++.
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~-~~~~l~dfg~~~ 154 (267)
T cd06645 78 RDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDN-GHVKLADFGVSA 154 (267)
T ss_pred CCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEECcceeee
Confidence 6789999999999999999998889999999999999999999999999 9999999999999876 899999999986
Q ss_pred hhcCC-CCCccccCCCCcCCccccc----cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC--
Q 012320 183 ILRGS-KSAHSVIGTPEFMAPELYE----EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFY-- 255 (466)
Q Consensus 183 ~~~~~-~~~~~~~GT~~y~APE~l~----~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~-- 255 (466)
..... .......||+.|+|||++. ..++.++|+|||||++|+|++|..||........+.........+....
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06645 155 QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDK 234 (267)
T ss_pred EccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCccccc
Confidence 55322 2223457999999999763 4588999999999999999999999976443333333222222222111
Q ss_pred CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCC
Q 012320 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPF 287 (466)
Q Consensus 256 ~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf 287 (466)
...+..++++|.+||. +|.+|||+.+++.|||
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 235 MKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 1245689999999996 9999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=351.86 Aligned_cols=254 Identities=27% Similarity=0.429 Sum_probs=204.0
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc---
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD--- 102 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--- 102 (466)
.+||.++ +.||+|+||+||+|.+..++..||+|++..... .......+.+|+.+|++++||||+++++++....
T Consensus 14 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 14 PERYQNL-TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ--SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhh-eecccCCCeEEEEEEECCCCCEEEEEEeCchhh--hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 3688885 569999999999999999999999999864321 2234466789999999999999999998774322
Q ss_pred -CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 103 -QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 103 -~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
...+|++++++ |++|.++++ .+.+++..++.++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~-~~~kl~Dfg~~ 165 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNED-CELRILDFGLA 165 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCC-CCEEEcCCccc
Confidence 24578999988 889988775 467999999999999999999999999 9999999999999877 89999999999
Q ss_pred hhhcCCCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--CC--------
Q 012320 182 AILRGSKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS--GK-------- 249 (466)
Q Consensus 182 ~~~~~~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~--g~-------- 249 (466)
..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||... +..+....+.. +.
T Consensus 166 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 166 RQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN-DYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred eecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC-CHHHHHHHHHHHhCCCCHHHHHh
Confidence 76543 2345679999999998764 5899999999999999999999999763 33332222211 00
Q ss_pred ------------CC---C----CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 250 ------------LP---G----AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 250 ------------~p---~----~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
++ . ......++.+.+||.+||. ||.+|||+.|+|.||||..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 00 0 0012245678899999996 9999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=337.79 Aligned_cols=258 Identities=31% Similarity=0.545 Sum_probs=217.2
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
++|..+|.+.++ ||.|+||+||+|.+..++..+|+|.+... .....+.+.+|+.++++++||||+++++.+. .
T Consensus 1 ~~~~~~~~i~~~-l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~ 73 (280)
T cd06611 1 VNPNDIWEIIGE-LGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYF--Y 73 (280)
T ss_pred CCchhHHHHHHH-hcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEe--c
Confidence 368899988655 99999999999999999999999998643 3455678889999999999999999999874 4
Q ss_pred CCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
+..+++||||+++++|.+++.+. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.+ +.++|+|||++
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~-~~~~l~d~g~~ 150 (280)
T cd06611 74 ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLD-GDVKLADFGVS 150 (280)
T ss_pred CCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCC-CCEEEccCccc
Confidence 67899999999999999998764 56999999999999999999999999 9999999999999877 89999999988
Q ss_pred hhhcCC-CCCccccCCCCcCCccccc------cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC-C
Q 012320 182 AILRGS-KSAHSVIGTPEFMAPELYE------EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG-A 253 (466)
Q Consensus 182 ~~~~~~-~~~~~~~GT~~y~APE~l~------~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~-~ 253 (466)
...... .......||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..+....+..+..+. .
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~ 229 (280)
T cd06611 151 AKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE-LNPMRVLLKILKSEPPTLD 229 (280)
T ss_pred hhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCccc-CCHHHHHHHHhcCCCCCcC
Confidence 664322 2234467899999999763 2377899999999999999999999976 44555555666554332 2
Q ss_pred CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 254 FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 254 ~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.+...+.++.++|.+||. +|.+||++.++++||||...
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred CcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 234567799999999995 99999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=328.37 Aligned_cols=253 Identities=32% Similarity=0.529 Sum_probs=218.1
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+|.+. +.||.|+||+||+|.+..+|..+|+|.+..... .....+++..|+.+++.++||||+++++.+.......++
T Consensus 1 ~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (265)
T cd08217 1 DYEVL-ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY 77 (265)
T ss_pred Cceee-eeeccCCCeEEEEeeecCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence 36664 669999999999999999999999999875543 345567889999999999999999999988766677899
Q ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCeEeccCCCCcEEEeCCCCcEEEecc
Q 012320 108 FITEMFTSGTLREYRKK----YRRVDIRAIKSWARQILQGLVYLH-----SRDPPVIHRDLKCDNIFVNGHLGQVKIGDL 178 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qIl~gL~yLH-----s~~~~IiHrDLKp~NIlv~~~~g~vKL~DF 178 (466)
+++||+++++|.+++.+ ...+++..+..++.||+.||.||| +.+ ++|+||||+||+++.+ +.+||+||
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~-~~~kl~d~ 154 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDAN-NNVKLGDF 154 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecC-CCEEEecc
Confidence 99999999999999876 367899999999999999999999 777 9999999999999976 89999999
Q ss_pred chhhhhcCCCC-CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 012320 179 GLAAILRGSKS-AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 179 Gla~~~~~~~~-~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 256 (466)
|++........ .....|++.|+|||++. ..++.++|+||||+++++|++|..||.. .+...+.+.+..+..+. .+.
T Consensus 155 g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~ 232 (265)
T cd08217 155 GLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA-RNQLQLASKIKEGKFRR-IPY 232 (265)
T ss_pred cccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccC-cCHHHHHHHHhcCCCCC-Ccc
Confidence 99987654332 34567999999999876 4588999999999999999999999976 45777788888776543 344
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
..+..+.+++.+||. +|.+||++.++++|||+
T Consensus 233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 567899999999996 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=328.13 Aligned_cols=250 Identities=30% Similarity=0.543 Sum_probs=214.7
Q ss_pred eEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEE
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNF 108 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~l 108 (466)
|.. .+.||+|++|.||+|.++.+|..||+|.+..... .......+.+|+.+++.++||||+++++.+. +...+++
T Consensus 2 ~~~-~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~l 76 (256)
T cd08529 2 FEI-LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYIIRYYESFL--DKGKLNI 76 (256)
T ss_pred ceE-eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC--CHHHHHHHHHHHHHHHhcCCCCeehheeeec--cCCEEEE
Confidence 444 5779999999999999999999999999876543 3445678899999999999999999999874 4678999
Q ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 109 ITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 109 V~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
|+||++|++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.+ +.+||+|||++..+..
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~-~~~~l~df~~~~~~~~ 153 (256)
T cd08529 77 VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAY-DNVKIGDLGVAKLLSD 153 (256)
T ss_pred EEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCC-CCEEEcccccceeccC
Confidence 99999999999999774 57899999999999999999999999 9999999999999977 8999999999876543
Q ss_pred CC-CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 012320 187 SK-SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQR 264 (466)
Q Consensus 187 ~~-~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~ 264 (466)
.. ......|++.|+|||++. ..++.++|||||||++++|++|..||.. .+.......+..+..+.. ....+..+.+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 231 (256)
T cd08529 154 NTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA-NNQGALILKIIRGVFPPV-SQMYSQQLAQ 231 (256)
T ss_pred ccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCC-ccccCHHHHH
Confidence 32 233457899999999776 4588999999999999999999999976 556677777777765543 3356789999
Q ss_pred HHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 265 FIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 265 lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
+|.+|+. +|++||++.+++.|||+
T Consensus 232 ~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 232 LIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHccCCcccCcCHHHHhhCCCC
Confidence 9999996 99999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=338.37 Aligned_cols=261 Identities=32% Similarity=0.500 Sum_probs=217.2
Q ss_pred eeeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEE
Q 012320 20 YIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWI 99 (466)
Q Consensus 20 ~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 99 (466)
....++..+|..+ +.||+|+||+||+|.+..+|..||+|.+..... ...+.+.+|+.+++.++||||+++++.+.
T Consensus 13 ~~~~~~~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~v~~~~~~~~ 87 (296)
T cd06654 13 VSVGDPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYL 87 (296)
T ss_pred cccCCcccceeeE-EEecCCCCeEEEEEEECCCCcEEEEEEEecCCc----chHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4557888999996 559999999999999999999999999875442 23467889999999999999999999885
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
. ...+++||||++|++|.+++.+ ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.+ +.+||+|||
T Consensus 88 ~--~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~-~~~kl~dfg 161 (296)
T cd06654 88 V--GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFG 161 (296)
T ss_pred e--CCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCC-CCEEECccc
Confidence 4 6689999999999999999865 56899999999999999999999999 9999999999999876 799999999
Q ss_pred hhhhhcCCC-CCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 012320 180 LAAILRGSK-SAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSI 257 (466)
Q Consensus 180 la~~~~~~~-~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 257 (466)
++....... ......|++.|+|||.+.+ .++.++|||||||++|+|++|..||........++.....+..+...+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06654 162 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241 (296)
T ss_pred cchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccc
Confidence 987654322 2234578999999997764 48899999999999999999999997644434444444333322233445
Q ss_pred CCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 258 QDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 258 ~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.+..+.++|.+||. +|.+||++.+++.||||...
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 66789999999996 99999999999999999653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=326.56 Aligned_cols=252 Identities=30% Similarity=0.511 Sum_probs=212.3
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+|.. .+.||+|++|.||+|.++.+++.||+|.+..... .....+.+.+|+.++++++||||+++++.+. .....++
T Consensus 1 ~y~~-~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~ 76 (257)
T cd08223 1 AYCF-VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--SRRERKAAEQEAQLLSQLKHPNIVAYRESWE-GEDGLLY 76 (257)
T ss_pred CceE-EEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeec-CCCCEEE
Confidence 3555 5679999999999999999999999999875443 3345567889999999999999999998763 2345789
Q ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 108 FITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.. +.++|+|||++..+.
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~-~~~~l~df~~~~~~~ 153 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRT-NIIKVGDLGIARVLE 153 (257)
T ss_pred EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecC-CcEEEecccceEEec
Confidence 999999999999998763 45899999999999999999999999 9999999999999876 899999999997664
Q ss_pred CC-CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 186 GS-KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 186 ~~-~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
.. .......|++.|+|||++. ..++.++|||||||++++|++|..||.. .+.......+..+..+. .....+.++.
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 231 (257)
T cd08223 154 NQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA-KDMNSLVYRIIEGKLPP-MPKDYSPELG 231 (257)
T ss_pred ccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCC-CccccCHHHH
Confidence 32 2234457899999999776 4588999999999999999999999976 45555656666666543 3455678999
Q ss_pred HHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 264 RFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
++|.+|+. +|.+||++.++++||||
T Consensus 232 ~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 232 ELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHhccCcccCCCHHHHhcCCCC
Confidence 99999996 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=339.49 Aligned_cols=261 Identities=23% Similarity=0.399 Sum_probs=216.0
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+|... +.||+|+||+||+|.+..+++.||+|.+.+.... .......+..|+.+|+.++||||+++++.+ .+...++
T Consensus 2 ~y~~~-~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~ 77 (316)
T cd05574 2 HFKKI-KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLDHPFLPTLYASF--QTETYLC 77 (316)
T ss_pred ceEEe-eeecCCccEEEEEEEEcCCCcEEEEEEEeccccc-hHHHHHHHHHHHHHHHhCCCCCchhheeee--ecCCEEE
Confidence 57674 6699999999999999999999999999865432 223567789999999999999999999987 4567899
Q ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 108 FITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+||||+.|++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.+ |.++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~ 154 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHES-GHIMLSDFDLSKQSD 154 (316)
T ss_pred EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCC-CCEEEeecchhhccc
Confidence 999999999999998764 56999999999999999999999999 9999999999999876 899999999986542
Q ss_pred CCC------------------------------CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 012320 186 GSK------------------------------SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSE 234 (466)
Q Consensus 186 ~~~------------------------------~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~ 234 (466)
... .....+||..|+|||++. ..++.++|||||||++|+|++|..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 211 112347899999999775 4588999999999999999999999976
Q ss_pred CCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCC----HHHHhcCCCCCchhhhhc
Q 012320 235 CANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLS----AKELLLDPFLASDEVKLL 296 (466)
Q Consensus 235 ~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rps----a~elL~hpf~~~~~~~~~ 296 (466)
.+....+..+.....+.......+..++++|.+||. +|.+||| ++++|.||||+...+...
T Consensus 235 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~ 300 (316)
T cd05574 235 -SNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALI 300 (316)
T ss_pred -CchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhc
Confidence 444444555554443322233367899999999995 9999999 999999999998776544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=344.50 Aligned_cols=251 Identities=20% Similarity=0.359 Sum_probs=200.6
Q ss_pred eeeeeee--CceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEE
Q 012320 33 EEVLGKG--AMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFIT 110 (466)
Q Consensus 33 ~~~LG~G--~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~ 110 (466)
.++||+| +|++||++.++.+|+.||+|++..... .....+.+.+|+.+++.++||||+++++.|. .++.+++|+
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~--~~~~~~lv~ 78 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYRATFI--ADNELWVVT 78 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhc--cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE--ECCEEEEEE
Confidence 4679999 789999999999999999999875532 2334567788999999999999999999884 467899999
Q ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC-
Q 012320 111 EMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS- 187 (466)
Q Consensus 111 E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~- 187 (466)
||+++|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.++++||+.+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~-~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLRSNLSMINHG 155 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecC-CcEEEcccchhhcccccc
Confidence 999999999998753 45899999999999999999999999 9999999999999877 79999999865433211
Q ss_pred C-------CCccccCCCCcCCcccccc---CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC----
Q 012320 188 K-------SAHSVIGTPEFMAPELYEE---DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA---- 253 (466)
Q Consensus 188 ~-------~~~~~~GT~~y~APE~l~~---~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~---- 253 (466)
. ......++..|+|||++.+ .|+.++|||||||++|+|++|..||....... .......+..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKLNGTVPCLLDTT 234 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH-HHHHHhcCCcccccccc
Confidence 1 0122357788999998763 48999999999999999999999997643333 2222222222110
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 254 ----------------------------------------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 254 ----------------------------------------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.....++++++||.+||. ||++|||+.++++||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 111235689999999996 99999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=335.82 Aligned_cols=261 Identities=30% Similarity=0.477 Sum_probs=216.7
Q ss_pred eeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 22 ~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
..+|.++|.++ +.||+|+||.||+|.+..+|..+|+|.+... +....+.+.+|+.+++.++||||+++++.+.
T Consensus 7 ~~~~~~~y~i~-~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-- 79 (292)
T cd06644 7 DLDPNEVWEII-GELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFY-- 79 (292)
T ss_pred ccCcchhhhhh-heecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE--
Confidence 35678889885 5599999999999999999999999998643 4456778899999999999999999999874
Q ss_pred cCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 102 DQKTFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
....+++||||++|++|..++.+ ...+++..+..++.||+.||.|||+++ ++||||||+||+++.+ |.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~dfg~ 156 (292)
T cd06644 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLD-GDIKLADFGV 156 (292)
T ss_pred eCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCC-CCEEEccCcc
Confidence 45689999999999999887754 457899999999999999999999999 9999999999999876 8999999998
Q ss_pred hhhhcCC-CCCccccCCCCcCCccccc------cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC-
Q 012320 181 AAILRGS-KSAHSVIGTPEFMAPELYE------EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG- 252 (466)
Q Consensus 181 a~~~~~~-~~~~~~~GT~~y~APE~l~------~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~- 252 (466)
+...... .......+++.|+|||++. ..++.++|||||||++|+|++|..||.. .+......++..+..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~ 235 (292)
T cd06644 157 SAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSEPPTL 235 (292)
T ss_pred ceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc-ccHHHHHHHHhcCCCccC
Confidence 8654322 2234557899999999773 2378899999999999999999999976 44555555555544332
Q ss_pred CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 253 AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 253 ~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
......+.++.++|.+||. +|.+||++.++++||||....+
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 277 (292)
T cd06644 236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS 277 (292)
T ss_pred CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 2234456789999999996 9999999999999999976544
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=338.42 Aligned_cols=252 Identities=27% Similarity=0.424 Sum_probs=203.1
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
||... +.||+|+||+||+|.++.+|..||+|.++.... .......+.+|+.++++++||||+++++.+ .+...++
T Consensus 1 ~y~~~-~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~--~~~~~~~ 75 (284)
T cd07839 1 KYEKL-EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLYDVL--HSDKKLT 75 (284)
T ss_pred CceeE-EEecccCCeEEEEEEECCCCcEEEEEEeecccc--cccCccchhHHHHHHHhcCCCCeeeHHHHh--ccCCceE
Confidence 57774 669999999999999999999999999875432 222335677899999999999999999987 4567899
Q ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 108 FITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
+|+||+. ++|.+++.+ .+.+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++..+..
T Consensus 76 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKN-GELKLADFGLARAFGI 151 (284)
T ss_pred EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCC-CcEEECccchhhccCC
Confidence 9999996 578777765 467999999999999999999999999 9999999999999877 8999999999976543
Q ss_pred C-CCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--------------
Q 012320 187 S-KSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK-------------- 249 (466)
Q Consensus 187 ~-~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~-------------- 249 (466)
. .......+++.|+|||++.+ .++.++|||||||++|+|++|..||....+....++.+....
T Consensus 152 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 152 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 2 22334568899999997754 378999999999999999999999765555544444332110
Q ss_pred -----CCC--------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 250 -----LPG--------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 250 -----~p~--------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
.+. ......+.+++++|.+||. ||.+|||+++++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 000 0012346789999999996 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=329.75 Aligned_cols=253 Identities=31% Similarity=0.477 Sum_probs=207.3
Q ss_pred eEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEeccccc--CCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELM--RSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~--~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
|.. .+.||+|+||+||+|.+ .+|..+|+|.+...... ........+.+|+.+|++++|+||+++++.+. +...+
T Consensus 2 ~~~-~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~ 77 (265)
T cd06631 2 WTK-GEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL--DDNTI 77 (265)
T ss_pred ccc-cceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee--cCCeE
Confidence 444 67799999999999986 47899999998754321 12334567899999999999999999999874 46789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
++|+||++|++|.+++.+.+.+++..+..++.||+.||.|||+.+ |+|+||||+||+++.+ +.+||+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 78 SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAW 154 (265)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCC-CeEEeccchhhHhhhh
Confidence 999999999999999988888999999999999999999999999 9999999999999876 8999999999876421
Q ss_pred -------CCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 012320 187 -------SKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258 (466)
Q Consensus 187 -------~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 258 (466)
........||+.|+|||++. ..++.++|+|||||++|+|++|..||..........................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSF 234 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCC
Confidence 11123456899999999876 4588999999999999999999999976444443333222211222344556
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
+.++.++|.+||. +|.+||++.+++.||||
T Consensus 235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 7899999999995 99999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=331.53 Aligned_cols=252 Identities=25% Similarity=0.431 Sum_probs=215.8
Q ss_pred eeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecCCC
Q 012320 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTS 115 (466)
Q Consensus 36 LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~~g 115 (466)
||.|++|.||+|.+..+++.+|+|.+.+.... .....+.+.+|+.+++.++||||+++++.+ .+...+++|+||+++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV-ETGQQEHIFSEKEILEECNHPFIVKLYRTF--KDKKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcch-hhhHHHHHHHHHHHHHhCCCCCEeeeeeeE--EcCCccEEEEecCCC
Confidence 69999999999999999999999998765432 234457899999999999999999999977 456789999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCCccccC
Q 012320 116 GTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIG 195 (466)
Q Consensus 116 gsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~~~~~G 195 (466)
++|.+++.+...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.+ +.+||+|||++.............|
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~-~~~~l~df~~~~~~~~~~~~~~~~~ 154 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTWTFCG 154 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCC-CCEEEeeCCcccccCcccccccccC
Confidence 999999998888999999999999999999999999 9999999999999876 8999999999987655433445678
Q ss_pred CCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-C
Q 012320 196 TPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECA-NPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-N 272 (466)
Q Consensus 196 T~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~-~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-d 272 (466)
++.|+|||.+. ..++.++|+||||+++|+|++|..||.... +...+++.+..+......+...+.+++++|.+||. +
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCC
Confidence 99999999765 458999999999999999999999997643 36667777775444344444457899999999995 9
Q ss_pred cCCCCC-----HHHHhcCCCCCchhh
Q 012320 273 ASKRLS-----AKELLLDPFLASDEV 293 (466)
Q Consensus 273 p~~Rps-----a~elL~hpf~~~~~~ 293 (466)
|.+||+ ++|+++||||.+..|
T Consensus 235 p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred hhhCcCCcccCHHHHhcChhhhCCCC
Confidence 999999 999999999986543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=340.24 Aligned_cols=248 Identities=26% Similarity=0.366 Sum_probs=191.8
Q ss_pred eeeeeeeeCceEEEEEEEcC--CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEE
Q 012320 32 FEEVLGKGAMKTVYKAIDEV--LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFI 109 (466)
Q Consensus 32 ~~~~LG~G~fg~Vyka~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV 109 (466)
.+.+||+|+||+||+|.++. ++..||+|.+.... ....+.+|+.+|+.++||||+++++.+....+..+++|
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCC------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence 35679999999999999654 67899999886432 12356789999999999999999999877677889999
Q ss_pred EecCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEe---CCCCcEEEec
Q 012320 110 TEMFTSGTLREYRKKY---------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVN---GHLGQVKIGD 177 (466)
Q Consensus 110 ~E~~~ggsL~~~l~~~---------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~---~~~g~vKL~D 177 (466)
+||+. ++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+. ...+.+||+|
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 79 FDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred EeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 99985 5787776532 24889999999999999999999999 99999999999994 2337899999
Q ss_pred cchhhhhcCCC----CCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCH---------HHHH
Q 012320 178 LGLAAILRGSK----SAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANP---------AQIY 242 (466)
Q Consensus 178 FGla~~~~~~~----~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~---------~~i~ 242 (466)
||++....... ......||+.|+|||++.+ .++.++|||||||++|+|+||..||...... .++.
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD 235 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHH
Confidence 99997654321 2334678999999998753 4899999999999999999999999642211 1111
Q ss_pred HHHhc-C--------------CCC--------------------CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCC
Q 012320 243 KKVTS-G--------------KLP--------------------GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDP 286 (466)
Q Consensus 243 ~~i~~-g--------------~~p--------------------~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hp 286 (466)
+.+.. | ..+ .......+..++++|.+||. ||.+|||+.|+|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp 315 (317)
T cd07867 236 RIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDP 315 (317)
T ss_pred HHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCC
Confidence 11100 0 000 00011234568899999996 999999999999999
Q ss_pred CC
Q 012320 287 FL 288 (466)
Q Consensus 287 f~ 288 (466)
||
T Consensus 316 ~f 317 (317)
T cd07867 316 YF 317 (317)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=332.42 Aligned_cols=257 Identities=27% Similarity=0.462 Sum_probs=209.9
Q ss_pred eeeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEE
Q 012320 20 YIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWI 99 (466)
Q Consensus 20 ~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 99 (466)
++...+.++|.+. +.||+|+||+||+|.++.+|+.||+|++.... ......+.+|+.++++++||||+++++.+.
T Consensus 2 ~~~~~~~~~y~~~-~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~ 76 (267)
T cd06646 2 ILRRNPQHDYELI-QRVGSGTYGDVYKARNLHTGELAAVKIIKLEP----GDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76 (267)
T ss_pred ccccCchhhcchh-heeecCCCeEEEEEEECCCCeEEEEEEEecCc----cchHHHHHHHHHHHHhcCCCCeeeeeEEEE
Confidence 3456777888885 55999999999999999999999999987442 123456788999999999999999999884
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
....+++||||+++++|.+++.+.+.+++..+..++.|++.||.|||+.+ |+||||||+||+++.+ +.+||+|||
T Consensus 77 --~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~-~~~~l~dfg 151 (267)
T cd06646 77 --SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDN-GDVKLADFG 151 (267)
T ss_pred --eCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC-CCEEECcCc
Confidence 46789999999999999999988888999999999999999999999999 9999999999999876 799999999
Q ss_pred hhhhhcCC-CCCccccCCCCcCCccccc----cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC-
Q 012320 180 LAAILRGS-KSAHSVIGTPEFMAPELYE----EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA- 253 (466)
Q Consensus 180 la~~~~~~-~~~~~~~GT~~y~APE~l~----~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~- 253 (466)
++...... .......|++.|+|||.+. ..++.++||||+||++|+|++|..||......... ..+....+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~ 230 (267)
T cd06646 152 VAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMSKSNFQPPK 230 (267)
T ss_pred cceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eeeecCCCCCCC
Confidence 99765432 2234457899999999763 34788999999999999999999999653322222 22222222211
Q ss_pred C--CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCC
Q 012320 254 F--YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPF 287 (466)
Q Consensus 254 ~--~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf 287 (466)
. ....+..+++||.+||. +|.+|||++++|+|+|
T Consensus 231 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 231 LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 1 12346789999999995 9999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=328.02 Aligned_cols=256 Identities=31% Similarity=0.545 Sum_probs=214.9
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccc-cCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNEL-MRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
.|.+ .++||+|+||.||+|.++.+|..||+|.+..... .........+.+|+.++++++||||+++++.+.+.....+
T Consensus 3 ~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 3 NWRL-GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred ceee-eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4655 7789999999999999999999999998864321 1233456788999999999999999999998866556788
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
++|+||+++++|.+++.+.+.+++..+..++.||+.||.|||+.+ ++|+||||+||+++.+ +.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC-CCEEECcccccccccc
Confidence 999999999999999988788999999999999999999999999 9999999999999876 7999999999976532
Q ss_pred C----CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 012320 187 S----KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLE 261 (466)
Q Consensus 187 ~----~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 261 (466)
. .......|+..|+|||++. ..++.++|+|||||++|+|++|..||........+.+ +.....+...+...+.+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~p~~~~~~ 237 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK-IATQPTKPMLPDGVSDA 237 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHH-HHcCCCCCCCCcccCHH
Confidence 1 1123456899999999776 4588999999999999999999999987544444443 44333344456667789
Q ss_pred HHHHHHHhccCcCCCCCHHHHhcCCCC
Q 012320 262 AQRFIGRCLVNASKRLSAKELLLDPFL 288 (466)
Q Consensus 262 ~~~lI~~~L~dp~~Rpsa~elL~hpf~ 288 (466)
++++|.+|+.+|.+||++.+++.|||.
T Consensus 238 ~~~~i~~~l~~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 238 CRDFLKQIFVEEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHhcCcccCccHHHHhcCCCC
Confidence 999999999989999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=337.59 Aligned_cols=252 Identities=27% Similarity=0.444 Sum_probs=207.3
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
.|.+ .+.||+|+||.||+|.+..+|..+|+|.+.... .......+.+|++++++++||||+++++.+. +.+.++
T Consensus 2 ~~~~-~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~ 75 (308)
T cd06615 2 DFEK-LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI---KPAIRNQIIRELKVLHECNSPYIVGFYGAFY--SDGEIS 75 (308)
T ss_pred CceE-EeeccCCCCeEEEEEEEcCCCeEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--eCCEEE
Confidence 4656 566999999999999999999999999886432 3345567899999999999999999999884 467899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHS-RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs-~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
+|+||++|++|.+++.+.+.+++..+..++.||+.||.|||+ .+ ++||||||+|||++.+ +.+||+|||++.....
T Consensus 76 lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLID 152 (308)
T ss_pred EEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecC-CcEEEccCCCcccccc
Confidence 999999999999999988899999999999999999999997 57 9999999999999876 8999999999876533
Q ss_pred CCCCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc------------------
Q 012320 187 SKSAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS------------------ 247 (466)
Q Consensus 187 ~~~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~------------------ 247 (466)
. .....+|++.|+|||++.+ .++.++|||||||++|+|++|..||.. .+.......+..
T Consensus 153 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 153 S-MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP-PDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred c-ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC-cchhhHHHhhcCccccccccCCcccccCCC
Confidence 2 2345678999999998764 588999999999999999999999964 233333222211
Q ss_pred ------------------CCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 248 ------------------GKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 248 ------------------g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
...|.......+.++++||.+||. +|++|||+.++++||||..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 111111112356789999999995 9999999999999999965
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=356.89 Aligned_cols=261 Identities=28% Similarity=0.444 Sum_probs=225.2
Q ss_pred CCCCceEEe-eeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 24 DPNGRYGLF-EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 24 ~~~~rY~~~-~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
+-..-|++| .++||.|.||+||-|.++.+|+.||||+|.+.+.- ......+++|+.||+++.||.||.+-.-| +.
T Consensus 559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp--~kqesqlR~EVaILq~l~HPGiV~le~M~--ET 634 (888)
T KOG4236|consen 559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFP--TKQESQLRNEVAILQNLHHPGIVNLECMF--ET 634 (888)
T ss_pred hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCC--CchHHHHHHHHHHHHhcCCCCeeEEEEee--cC
Confidence 334567777 67899999999999999999999999999977653 33447899999999999999999998766 66
Q ss_pred CCEEEEEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC--CCcEEEeccc
Q 012320 103 QKTFNFITEMFTSGTLREYRK-KYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH--LGQVKIGDLG 179 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~-~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~--~g~vKL~DFG 179 (466)
...++.|||-+.|--|..++. ..+++++...++++.||+.||.|||-.| |+|.||||+|||+.+. ...+||||||
T Consensus 635 ~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFG 712 (888)
T KOG4236|consen 635 PERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFG 712 (888)
T ss_pred CceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeecccc
Confidence 888999999995544444443 3589999999999999999999999999 9999999999999765 3479999999
Q ss_pred hhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--CCCCCCC
Q 012320 180 LAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK--LPGAFYS 256 (466)
Q Consensus 180 la~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~--~p~~~~~ 256 (466)
+|+++.......+++|||.|+|||++. ++|+...|+||+|||+|--+.|..||.+. +++..+|..-. +|...|+
T Consensus 713 fARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd---EdIndQIQNAaFMyPp~PW~ 789 (888)
T KOG4236|consen 713 FARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED---EDINDQIQNAAFMYPPNPWS 789 (888)
T ss_pred ceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc---cchhHHhhccccccCCCchh
Confidence 999998878888999999999999887 56999999999999999999999999653 44556665544 5777888
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
..++++.+||..+|+ .-.+|.|..+.|.|||++....
T Consensus 790 eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~ 827 (888)
T KOG4236|consen 790 EISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQT 827 (888)
T ss_pred hcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchH
Confidence 899999999999995 9999999999999999987543
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=330.19 Aligned_cols=256 Identities=29% Similarity=0.459 Sum_probs=210.8
Q ss_pred eEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCC--HHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRS--PDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
|.. +++||+|+||.||+|.++.+|+.||+|.+........ ....+.+.+|+++++.++||||+++++.+ .+...+
T Consensus 2 ~~~-~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~~ 78 (268)
T cd06630 2 WLK-GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT--CEDSHF 78 (268)
T ss_pred ccc-cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee--ccCCeE
Confidence 555 5779999999999999999999999999875442111 22457889999999999999999999987 456789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
++|+||+.|++|.+++.+.+.+++..+..++.||+.||.|||+.+ ++||||||+||+++.+...+||+|||++..+..
T Consensus 79 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999999999999998889999999999999999999999999 999999999999987634699999999876543
Q ss_pred CC-----CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCCCCCCCCCCC
Q 012320 187 SK-----SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECA--NPAQIYKKVTSGKLPGAFYSIQ 258 (466)
Q Consensus 187 ~~-----~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~--~~~~i~~~i~~g~~p~~~~~~~ 258 (466)
.. ......||..|+|||++. ..++.++|+||+||++|+|++|..||.... +.......+.....+...+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL 236 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhh
Confidence 21 112356889999999775 458899999999999999999999996432 2223333333333334445566
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCC
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLLDPFLA 289 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~ 289 (466)
+.++++++.+||. +|.+||++.++++||||+
T Consensus 237 ~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 237 SPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 7899999999996 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=338.05 Aligned_cols=261 Identities=33% Similarity=0.511 Sum_probs=216.4
Q ss_pred eeeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEE
Q 012320 20 YIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWI 99 (466)
Q Consensus 20 ~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 99 (466)
....++..+|... +.||+|+||.||+|.++.+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++.+.
T Consensus 12 ~~~~~~~~~y~~~-~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 86 (297)
T cd06656 12 VSVGDPKKKYTRF-EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYL 86 (297)
T ss_pred cccCChhhhceee-eeeccCCCeEEEEEEECCCCCEEEEEEEecCcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3447888999985 559999999999999999999999999875432 23467889999999999999999999884
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
....+++||||++|++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.+ |.+||+|||
T Consensus 87 --~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~-~~~~l~Dfg 160 (297)
T cd06656 87 --VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFG 160 (297)
T ss_pred --cCCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEECcCc
Confidence 46789999999999999999865 56899999999999999999999999 9999999999999876 899999999
Q ss_pred hhhhhcCCC-CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 012320 180 LAAILRGSK-SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSI 257 (466)
Q Consensus 180 la~~~~~~~-~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 257 (466)
++....... ......|++.|+|||.+. ..++.++|+|||||++|+|++|..||........++.....+..+...+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (297)
T cd06656 161 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPER 240 (297)
T ss_pred cceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccc
Confidence 987654332 223457899999999776 458899999999999999999999997644333333333333333334455
Q ss_pred CCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 258 QDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 258 ~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.+..+++||.+||. +|.+||++.++++||||...
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 67789999999996 99999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=336.96 Aligned_cols=256 Identities=25% Similarity=0.398 Sum_probs=204.9
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
-++|... +.||+|+||+||+|.++.+++.||+|.++.... ......+.+|+.+++.++||||+++++.+ .....
T Consensus 5 ~~~y~~~-~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~nI~~~~~~~--~~~~~ 78 (301)
T cd07873 5 LETYIKL-DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDII--HTEKS 78 (301)
T ss_pred ccceEEe-eEeccCcCEEEEEEEEcCCCcEEEEEEEecccc---cCchhHHHHHHHHHHhcCCCCcceEEEEE--ecCCe
Confidence 4578775 569999999999999999999999999875432 12234577899999999999999999987 45678
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 106 FNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
+++|+||+. ++|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++...
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~ 154 (301)
T cd07873 79 LTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINER-GELKLADFGLARAK 154 (301)
T ss_pred EEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCC-CcEEECcCcchhcc
Confidence 999999996 5888887654 56899999999999999999999999 9999999999999877 89999999998764
Q ss_pred cCC-CCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-------------
Q 012320 185 RGS-KSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG------------- 248 (466)
Q Consensus 185 ~~~-~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g------------- 248 (466)
... .......+++.|+|||++.+ .++.++|||||||++|+|++|..||.... ..+....+...
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST-VEEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHcCCCChhhchhhh
Confidence 322 22334567999999997753 47889999999999999999999997643 33332222110
Q ss_pred --------CCCC-------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 249 --------KLPG-------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 249 --------~~p~-------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
..|. ......+..+++||.+||. ||.+|||++|+|+||||+.-.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0010 0112346788999999996 999999999999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=330.56 Aligned_cols=256 Identities=31% Similarity=0.522 Sum_probs=210.6
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEec
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDV 101 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 101 (466)
.++++||.+. +.||+|++|+||+|.++.+++.+|+|.+.... ...+.+.+|+.+++++ +||||+++++.+...
T Consensus 2 ~~~~~~y~~~-~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (275)
T cd06608 2 PDPTGIFELV-EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKK 75 (275)
T ss_pred CCchhheehe-eeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCChheEEEEEEec
Confidence 4688999985 66999999999999999999999999887443 2346788999999999 799999999998653
Q ss_pred c----CCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcE
Q 012320 102 D----QKTFNFITEMFTSGTLREYRKK----YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQV 173 (466)
Q Consensus 102 ~----~~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~v 173 (466)
. ...+++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.+ +.+
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~-~~~ 152 (275)
T cd06608 76 NPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKN-AEV 152 (275)
T ss_pred CCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccC-CeE
Confidence 3 4568999999999999998865 357999999999999999999999999 9999999999999876 899
Q ss_pred EEeccchhhhhcCC-CCCccccCCCCcCCccccc------cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q 012320 174 KIGDLGLAAILRGS-KSAHSVIGTPEFMAPELYE------EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVT 246 (466)
Q Consensus 174 KL~DFGla~~~~~~-~~~~~~~GT~~y~APE~l~------~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~ 246 (466)
||+|||++...... .......|++.|+|||++. ..++.++|||||||++|+|++|..||.... .......+.
T Consensus 153 ~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~ 231 (275)
T cd06608 153 KLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH-PMRALFKIP 231 (275)
T ss_pred EECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc-hHHHHHHhh
Confidence 99999998764322 2234466899999999764 237789999999999999999999997643 333344444
Q ss_pred cCCCCCCC-CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 247 SGKLPGAF-YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 247 ~g~~p~~~-~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
.+..+... ....+..+++||.+||. ||.+|||+.+++.|||+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 232 RNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 44332222 12246789999999995 99999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=332.84 Aligned_cols=256 Identities=29% Similarity=0.484 Sum_probs=211.0
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEec
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDV 101 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 101 (466)
..|.++|... +.||.|+||+||+|.++.+++.+|+|.+.... .....+..|+.+++.+ +||||+++++.|+..
T Consensus 12 ~~~~~~~~~~-~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 12 RDPAGIFELV-EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred cChhhhhhhh-eeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3578899885 66999999999999999999999999876432 3445688899999998 799999999988643
Q ss_pred ----cCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEE
Q 012320 102 ----DQKTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKI 175 (466)
Q Consensus 102 ----~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL 175 (466)
....++++|||+.+|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~-~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTEN-AEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEE
Confidence 246889999999999999998764 45889999999999999999999999 9999999999999876 89999
Q ss_pred eccchhhhhcCC-CCCccccCCCCcCCccccc------cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q 012320 176 GDLGLAAILRGS-KSAHSVIGTPEFMAPELYE------EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG 248 (466)
Q Consensus 176 ~DFGla~~~~~~-~~~~~~~GT~~y~APE~l~------~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g 248 (466)
+|||++...... .......|++.|+|||++. ..++.++|||||||++|+|++|..||........+. .+...
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-~~~~~ 241 (282)
T cd06636 163 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRN 241 (282)
T ss_pred eeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-hHhhC
Confidence 999998765422 2234567999999999764 348889999999999999999999997644333333 33333
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 249 KLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 249 ~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
..+.......+.++.+||.+||. +|.+||++.|||+||||
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 242 PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 33333344567899999999996 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=328.57 Aligned_cols=253 Identities=31% Similarity=0.542 Sum_probs=209.8
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCC-----HHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRS-----PDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~-----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
||.+ .+.||+|++|.||+|.+..++..+|+|.+........ ....+.+.+|+.++++++||||+++++.+. +
T Consensus 1 ~~~~-~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~ 77 (267)
T cd06628 1 KWIK-GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL--D 77 (267)
T ss_pred Cccc-cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE--e
Confidence 4544 6789999999999999999999999998875543211 123467889999999999999999999874 4
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
....++|+||+++++|.+++.+.+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.+ +.+||+|||++.
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~-~~~~l~dfg~~~ 154 (267)
T cd06628 78 ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNK-GGIKISDFGISK 154 (267)
T ss_pred CCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCC-CCEEecccCCCc
Confidence 6688899999999999999998889999999999999999999999999 9999999999999876 899999999987
Q ss_pred hhcCCC-------CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 012320 183 ILRGSK-------SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAF 254 (466)
Q Consensus 183 ~~~~~~-------~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~ 254 (466)
.+.... ......|++.|+|||.+. ..++.++|+|||||++|+|++|..||....... ....+..+..+ ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~-~~ 232 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AIFKIGENASP-EI 232 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HHHHHhccCCC-cC
Confidence 664211 112346889999999776 458899999999999999999999998754433 33344443332 23
Q ss_pred CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 255 YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 255 ~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
+...+..++++|.+||. +|.+||++.++++||||
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 233 PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 44567899999999996 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=335.12 Aligned_cols=258 Identities=33% Similarity=0.529 Sum_probs=213.8
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
.++..+|... +.||.|+||+||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++.+. .
T Consensus 15 ~~~~~~y~~~-~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~ 87 (296)
T cd06655 15 GDPKKKYTRY-EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ----PKKELIINEILVMKELKNPNIVNFLDSFL--V 87 (296)
T ss_pred CCCcceEEEE-EEEecCCCeEEEEEEEcCCCcEEEEEEEecccC----chHHHHHHHHHHHHhcCCCceeeeeeeEe--c
Confidence 4567789885 559999999999999999999999999875432 23467889999999999999999999874 4
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
...+++|+||+.+++|..++.+ ..+++..+..++.|++.||.|||+++ ++||||||+||+++.+ +.+||+|||++.
T Consensus 88 ~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~-~~~kl~dfg~~~ 163 (296)
T cd06655 88 GDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMD-GSVKLTDFGFCA 163 (296)
T ss_pred CceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEccCccch
Confidence 6789999999999999998875 56899999999999999999999999 9999999999999876 899999999987
Q ss_pred hhcCCC-CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 012320 183 ILRGSK-SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL 260 (466)
Q Consensus 183 ~~~~~~-~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~ 260 (466)
...... ......|++.|+|||.+. ..++.++|||||||++|+|++|..||........+......+..+...+...+.
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T cd06655 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSP 243 (296)
T ss_pred hcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCH
Confidence 654332 223457899999999776 458899999999999999999999997744433333332223222233445677
Q ss_pred HHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 261 EAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 261 ~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.++++|++||. +|.+||++.+++.||||+..
T Consensus 244 ~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 244 IFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 89999999996 99999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=331.82 Aligned_cols=249 Identities=29% Similarity=0.481 Sum_probs=205.5
Q ss_pred eEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEE
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNF 108 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~l 108 (466)
|.. .++||+|+||+||+|.+..+++.||+|.+.... .......+.+|+.++++++||||+++++.+.. .+..++
T Consensus 3 ~~~-~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 76 (279)
T cd06619 3 IQY-QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCDSPYIIGFYGAFFV--ENRISI 76 (279)
T ss_pred chh-eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--CCEEEE
Confidence 444 567999999999999999999999999987542 33455678999999999999999999998844 677899
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCC
Q 012320 109 ITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK 188 (466)
Q Consensus 109 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~ 188 (466)
|+||+++++|..+ ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.+ +.+||+|||++..+...
T Consensus 77 v~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~-~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 77 CTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred EEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCC-CCEEEeeCCcceecccc-
Confidence 9999999999754 46789999999999999999999999 9999999999999877 89999999999765432
Q ss_pred CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHhcCCCCCCCCCCCCHH
Q 012320 189 SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECAN------PAQIYKKVTSGKLPGAFYSIQDLE 261 (466)
Q Consensus 189 ~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~------~~~i~~~i~~g~~p~~~~~~~~~~ 261 (466)
.....+||+.|+|||++. ..++.++|+|||||++|+|++|..||..... .....+.+.....+.......+.+
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEK 228 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHH
Confidence 234567999999999776 4589999999999999999999999964221 223334443333333333446778
Q ss_pred HHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 262 AQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 262 ~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
++++|.+||. +|.+||++++++.||||+..
T Consensus 229 ~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 229 FVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 9999999995 99999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=324.10 Aligned_cols=251 Identities=29% Similarity=0.494 Sum_probs=216.7
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
||..+ ++||.|+||.||.+.+..+|..+++|.+..... +......+.+|+.++++++|+||+++++.+. +...++
T Consensus 1 ~y~~~-~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~ 75 (256)
T cd08221 1 HYIPI-RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFM--DDNTLL 75 (256)
T ss_pred CceEe-eEecccCCceEEEEEEcCCCcEEEEEEEeeccc--chhHHHHHHHHHHHHHhCCCCCeeEEEeEEe--cCCeEE
Confidence 57774 669999999999999999999999999876543 3445677889999999999999999999884 467899
Q ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 108 FITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
++|||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.+ +.+||+|||++....
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~-~~~kl~d~~~~~~~~ 152 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKA-GLIKLGDFGISKILG 152 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCC-CCEEECcCcceEEcc
Confidence 999999999999999775 46899999999999999999999999 9999999999999977 799999999987654
Q ss_pred CCC-CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 186 GSK-SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 186 ~~~-~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
... ......|++.|+|||++. ..++.++|||||||++++|++|..||.. .+..+....+..+..+.. ....+.++.
T Consensus 153 ~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 230 (256)
T cd08221 153 SEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQGNYTPV-VSVYSSELI 230 (256)
T ss_pred cccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCC-ccccCHHHH
Confidence 332 334567999999999775 4588899999999999999999999976 667777777777776543 355678999
Q ss_pred HHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 264 RFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
++|.+||. +|.+||++.++|+|||+
T Consensus 231 ~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 231 SLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHcccCcccCCCHHHHhhCcCC
Confidence 99999995 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=331.93 Aligned_cols=255 Identities=30% Similarity=0.518 Sum_probs=215.6
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
+||... +.||.|++|.||+|.+..+|..||+|.+.... .......+.+|+.+++.++||||+++++.+.+ ...+
T Consensus 1 ~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 74 (274)
T cd06609 1 ELFTLL-ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--GSKL 74 (274)
T ss_pred Chhhhh-hhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--CCeE
Confidence 467664 56999999999999999999999999987543 23445678899999999999999999998754 5789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
++|+||+++++|.+++... ++++..+..++.||+.||.|||+.+ ++||||+|+||+++.+ +.++|+|||++..+..
T Consensus 75 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEE-GDVKLADFGVSGQLTS 150 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEEcccccceeecc
Confidence 9999999999999998764 8999999999999999999999999 9999999999999987 8999999999977654
Q ss_pred C-CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 012320 187 S-KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQR 264 (466)
Q Consensus 187 ~-~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~ 264 (466)
. .......|++.|+|||.+. ..++.++|||||||++|+|++|..||.. .++......+..+..+.......+.++.+
T Consensus 151 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (274)
T cd06609 151 TMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD-LHPMRVLFLIPKNNPPSLEGNKFSKPFKD 229 (274)
T ss_pred cccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc-CchHHHHHHhhhcCCCCCcccccCHHHHH
Confidence 3 2334567899999999776 4589999999999999999999999976 44555656666555443332226778999
Q ss_pred HHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 265 FIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 265 lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
++.+||. +|.+|||++++++||||+...
T Consensus 230 ~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 230 FVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred HHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 9999995 999999999999999997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=325.98 Aligned_cols=252 Identities=29% Similarity=0.502 Sum_probs=210.2
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
|..+|.. .+.||.|+||.||+|.+..++..+|+|.+.... ....+.+.+|+.++++++||||+++++.+. +..
T Consensus 1 ~~~~~~~-~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~ 73 (262)
T cd06613 1 PQEDYEL-IQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYFGSYL--RRD 73 (262)
T ss_pred CccceEE-EEEecCCCceEEEEeEecCCCCEEEEEEEEcCc----hhhHHHHHHHHHHHHhCCCCChhceEEEEE--eCC
Confidence 5678887 466999999999999999999999999987543 235678899999999999999999999874 467
Q ss_pred EEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
.++++|||+.+++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.+ +.+||+|||++..
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~ 150 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTED-GDVKLADFGVSAQ 150 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCC-CCEEECccccchh
Confidence 899999999999999998876 78999999999999999999999999 9999999999999976 8999999999876
Q ss_pred hcCCC-CCccccCCCCcCCccccc-c---CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---CC
Q 012320 184 LRGSK-SAHSVIGTPEFMAPELYE-E---DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA---FY 255 (466)
Q Consensus 184 ~~~~~-~~~~~~GT~~y~APE~l~-~---~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~---~~ 255 (466)
..... ......|+..|+|||++. . .++.++|||||||++|+|++|..||......... ..+....++.. ..
T Consensus 151 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~ 229 (262)
T cd06613 151 LTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL-FLISKSNFPPPKLKDK 229 (262)
T ss_pred hhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhccCCCccccch
Confidence 54322 234567899999999775 3 5889999999999999999999999874433333 33333322211 12
Q ss_pred CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCC
Q 012320 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPF 287 (466)
Q Consensus 256 ~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf 287 (466)
...+.++++|+++||. +|.+|||+.+++.|||
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 2335689999999995 9999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=324.61 Aligned_cols=254 Identities=34% Similarity=0.537 Sum_probs=213.6
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEeccccc-CCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELM-RSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
||.. .+.||+|+||+||+|.++.++..||+|.+...... ...+..+.+.+|+.+++.++||||+++++.+ .+...+
T Consensus 1 ~~~~-~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~--~~~~~~ 77 (258)
T cd06632 1 RWRK-GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE--REEDNL 77 (258)
T ss_pred Cccc-cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE--ecCCeE
Confidence 4654 68899999999999999999999999998764422 2234567889999999999999999999976 456789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
++|+||+++++|.+++.+.+.+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.+ +.+||+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~-~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 78 YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTN-GVVKLADFGMAKQVVE 154 (258)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEccCccceeccc
Confidence 999999999999999998888999999999999999999999999 9999999999999876 8999999999877654
Q ss_pred CCCCccccCCCCcCCccccc-cC-CCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 012320 187 SKSAHSVIGTPEFMAPELYE-ED-YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQR 264 (466)
Q Consensus 187 ~~~~~~~~GT~~y~APE~l~-~~-y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~ 264 (466)
........|++.|+|||.+. .. ++.++|+|||||++|+|++|..||..........+....+..+ ..+...+..+++
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 233 (258)
T cd06632 155 FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP-PIPDHLSDEAKD 233 (258)
T ss_pred cccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCC-CcCCCcCHHHHH
Confidence 44345567899999999765 34 8899999999999999999999997755444444433323332 344556789999
Q ss_pred HHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 265 FIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 265 lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
++.+||. +|.+||++.+++.|||+
T Consensus 234 li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 234 FILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHhhcCcccCcCHHHHhcCCCC
Confidence 9999996 99999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=323.85 Aligned_cols=252 Identities=29% Similarity=0.473 Sum_probs=213.6
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+|.. .+.||+|+||.||+|.++.+++.+|+|.+..... +......+.+|+.+|+.++||||+++++.+. ....++
T Consensus 1 ~y~~-~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~ 75 (256)
T cd08220 1 KYEK-IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM--TKDERLAAQNECQVLKLLSHPNIIEYYENFL--EDKALM 75 (256)
T ss_pred CceE-EEEecccCceEEEEEEEcCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHhhCCCCchhheeeeEe--cCCEEE
Confidence 4666 4669999999999999999999999999886543 3345678999999999999999999999874 467899
Q ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 108 FITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+|+||++|++|.+++.+. ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.+.+.+||+|||++....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence 999999999999999764 34899999999999999999999999 99999999999998665678999999998765
Q ss_pred CCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 012320 186 GSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQR 264 (466)
Q Consensus 186 ~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~ 264 (466)
.........|++.|+|||.+. ..++.++||||||+++|+|++|..||.. .+.......+..+..+ ......+.++++
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 231 (256)
T cd08220 154 SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA-ANLPALVLKIMSGTFA-PISDRYSPDLRQ 231 (256)
T ss_pred CCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCccc-CchHHHHHHHHhcCCC-CCCCCcCHHHHH
Confidence 544444567899999999876 4578899999999999999999999976 4445555555555433 233456789999
Q ss_pred HHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 265 FIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 265 lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
+|.+||. +|.+|||+.|++.||||
T Consensus 232 li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 232 LILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHccCChhhCCCHHHHhhCCCC
Confidence 9999995 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=323.52 Aligned_cols=268 Identities=26% Similarity=0.414 Sum_probs=227.9
Q ss_pred hccceeeeCCCCceEE------eeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CC
Q 012320 16 AHIGYIETDPNGRYGL------FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KH 88 (466)
Q Consensus 16 ~~~~~~~~~~~~rY~~------~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~H 88 (466)
...+|++.+...||.. +-..||.|+-|+|++++.+.+|...|+|++.... +.++.+++++.+.++... +.
T Consensus 74 ~~tg~lti~~g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~---Nkee~kRILmDldvv~~s~dc 150 (391)
T KOG0983|consen 74 KQTGYLTIGGGQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG---NKEENKRILMDLDVVLKSHDC 150 (391)
T ss_pred CCceeEEecCCcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC---CHHHHHHHHHhhhHHhhccCC
Confidence 3478888888888853 1233999999999999999999999999998654 567889999999987766 59
Q ss_pred CceeEEEeEEEeccCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCCCCcEEE
Q 012320 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHS-RDPPVIHRDLKCDNIFV 166 (466)
Q Consensus 89 pnIv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs-~~~~IiHrDLKp~NIlv 166 (466)
|+||+.|++|+. +..+++.||.| +.-+..++++ .++++|..+-++..-++.||.||-. ++ |||||+||+|||+
T Consensus 151 pyIV~c~GyFi~--n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILl 225 (391)
T KOG0983|consen 151 PYIVQCFGYFIT--NTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILL 225 (391)
T ss_pred CeeeeeeeEEee--CchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEE
Confidence 999999999965 44577889988 4455555554 4789999999999999999999975 46 9999999999999
Q ss_pred eCCCCcEEEeccchhhhhcCCCCCccccCCCCcCCccccc----cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q 012320 167 NGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE----EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIY 242 (466)
Q Consensus 167 ~~~~g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~----~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~ 242 (466)
|.. |.+||||||++..+..+.....-.|-+.|||||.+. .+|+.++||||||+.++||+||.+||.++....++.
T Consensus 226 De~-GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~l 304 (391)
T KOG0983|consen 226 DER-GNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVL 304 (391)
T ss_pred ccC-CCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHH
Confidence 977 999999999999887776666678999999999875 359999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCC-CCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 243 KKVTSGKLPGAFYS-IQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 243 ~~i~~g~~p~~~~~-~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
.+|.....|..... ..++.+++|+..||. |+.+||...+||+|||+...+
T Consensus 305 tkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 305 TKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 99988655433332 378999999999995 999999999999999997543
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=347.22 Aligned_cols=248 Identities=28% Similarity=0.394 Sum_probs=195.0
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
..+|.+. +.||+|+||+||+|.+..++..||+|..... ....|+.++++++||||+++++.+. ....
T Consensus 65 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~ 131 (357)
T PHA03209 65 SLGYTVI-KTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLV--SGAI 131 (357)
T ss_pred hcCcEEE-EEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEE--eCCe
Confidence 3468774 6699999999999999999999999974322 2346999999999999999999884 4667
Q ss_pred EEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 106 FNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.++|+|++. ++|.+++.+ ...+++..+..|+.||+.||.|||+++ |+||||||+|||++.. +.+||+|||++...
T Consensus 132 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~ 207 (357)
T PHA03209 132 TCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDV-DQVCIGDLGAAQFP 207 (357)
T ss_pred eEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEEecCcccccc
Confidence 889999994 678877754 467999999999999999999999999 9999999999999877 79999999999764
Q ss_pred cCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCC----------HHHHHHHHhc-CCCCC
Q 012320 185 RGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECAN----------PAQIYKKVTS-GKLPG 252 (466)
Q Consensus 185 ~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~----------~~~i~~~i~~-g~~p~ 252 (466)
..........||+.|+|||++. ..|+.++|||||||++|||+++..|+..... ...+.+.+.. +..|.
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 287 (357)
T PHA03209 208 VVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287 (357)
T ss_pred ccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence 4433445567999999999775 5699999999999999999986655533211 1122222221 11111
Q ss_pred CCC------------------------------CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 253 AFY------------------------------SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 253 ~~~------------------------------~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
.++ ...+.++.+||.+||. ||.+||||.|+|+||||+.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 111 1234567789999996 9999999999999999974
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=332.04 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=200.9
Q ss_pred eeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHH---hCCCCceeEEEeEEEeccCCEEEEEEe
Q 012320 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLS---TLKHDSIIRFYTSWIDVDQKTFNFITE 111 (466)
Q Consensus 35 ~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~---~l~HpnIv~l~~~~~~~~~~~~~lV~E 111 (466)
+||+|+||.||+|.+..+|..+|+|.+........ .......+|..+++ ..+||||+.+++.+. ..+.+++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMTYAFH--TPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc-hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe--cCCeEEEEEe
Confidence 48999999999999999999999999876543222 22223344544433 447999999999874 4568899999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCCc
Q 012320 112 MFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH 191 (466)
Q Consensus 112 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~~ 191 (466)
|++|++|.+++.+.+.+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++...... ...
T Consensus 78 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~-~~~~l~dfg~~~~~~~~-~~~ 153 (279)
T cd05633 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPH 153 (279)
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCC-CCEEEccCCcceecccc-Ccc
Confidence 9999999999988889999999999999999999999999 9999999999999877 89999999998655432 223
Q ss_pred cccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 012320 192 SVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECA--NPAQIYKKVTSGKLPGAFYSIQDLEAQRFIG 267 (466)
Q Consensus 192 ~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~--~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~ 267 (466)
...||+.|+|||.+. ..++.++||||+||++|+|++|..||.... +...+.+... ..+...+...+.+++++|.
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~ 231 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TVNVELPDSFSPELKSLLE 231 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh--cCCcCCccccCHHHHHHHH
Confidence 457999999999875 348899999999999999999999996532 2222222221 1223344556789999999
Q ss_pred Hhcc-CcCCCC-----CHHHHhcCCCCCchhhh
Q 012320 268 RCLV-NASKRL-----SAKELLLDPFLASDEVK 294 (466)
Q Consensus 268 ~~L~-dp~~Rp-----sa~elL~hpf~~~~~~~ 294 (466)
+||. ||++|+ |++++++||||+...+.
T Consensus 232 ~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~ 264 (279)
T cd05633 232 GLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQ 264 (279)
T ss_pred HHhcCCHHHhcCCCCCCHHHHHhCccccCCCHh
Confidence 9995 999999 69999999999886654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=330.25 Aligned_cols=256 Identities=28% Similarity=0.468 Sum_probs=208.2
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEecc
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVD 102 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 102 (466)
++.++|... +.||+|+||.||+|.++.+|+.+|+|.+.... .....+.+|+.+++.+ +||||+++++.+...+
T Consensus 19 ~~~~~y~~~-~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 19 DPTDTWEII-ETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCCCeEEE-EEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 568999885 56999999999999999999999999886432 2335677899999999 8999999999886543
Q ss_pred ---CCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEE
Q 012320 103 ---QKTFNFITEMFTSGTLREYRKK----YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKI 175 (466)
Q Consensus 103 ---~~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL 175 (466)
...+++|+||++|++|.++++. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.+ +.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~-~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTE-GGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCC-CCEEE
Confidence 2578999999999999998763 357899999999999999999999999 9999999999999876 79999
Q ss_pred eccchhhhhcCCC-CCccccCCCCcCCcccccc------CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q 012320 176 GDLGLAAILRGSK-SAHSVIGTPEFMAPELYEE------DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG 248 (466)
Q Consensus 176 ~DFGla~~~~~~~-~~~~~~GT~~y~APE~l~~------~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g 248 (466)
+|||++....... ......|++.|+|||++.. .++.++|||||||++|+|++|..||.... .......+..+
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~-~~~~~~~~~~~ 248 (291)
T cd06639 170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH-PVKTLFKIPRN 248 (291)
T ss_pred eecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc-HHHHHHHHhcC
Confidence 9999987654322 2234568999999998742 26789999999999999999999997643 33333344444
Q ss_pred CCCC-CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCC
Q 012320 249 KLPG-AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLA 289 (466)
Q Consensus 249 ~~p~-~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~ 289 (466)
..+. .........++++|.+||. +|.+||++.+++.||||+
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 249 PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 3221 1223345689999999996 999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=330.10 Aligned_cols=254 Identities=28% Similarity=0.448 Sum_probs=207.2
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
++|... +.||+|+||.||+|.++.+|+.||+|.+..... .....+.+.+|+.++++++||||+++++.+. ....+
T Consensus 1 ~~y~~~-~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~ 75 (286)
T cd07847 1 EKYEKL-SKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVNLIEVFR--RKRKL 75 (286)
T ss_pred Cceeee-eeecccCCeEEEEEEECCCCcEEEEEEEeeccc--CccccHHHHHHHHHHHhCCCCCEeeeeeEEe--eCCEE
Confidence 467775 569999999999999999999999998875432 2223356788999999999999999999874 46789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
++||||+++++|..++.+...+++..++.++.||+.||.|||+.+ ++||||||+||+++.+ |.+||+|||++.....
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQ-GQIKLCDFGFARILTG 152 (286)
T ss_pred EEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCC-CcEEECccccceecCC
Confidence 999999999999888877778999999999999999999999999 9999999999999877 8999999999977644
Q ss_pred CC-CCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CC-------------
Q 012320 187 SK-SAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-GK------------- 249 (466)
Q Consensus 187 ~~-~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-g~------------- 249 (466)
.. ......++..|+|||++.+ .++.++|||||||++|+|++|..||.+..+...++..... +.
T Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 153 PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred CcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 33 2334568899999997753 4889999999999999999999999875554444332211 00
Q ss_pred ------CCCC--------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 250 ------LPGA--------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 250 ------~p~~--------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
.|.. .....+..+.+||.+||. +|.+||++.|++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0100 012346788999999996 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=330.46 Aligned_cols=256 Identities=26% Similarity=0.460 Sum_probs=207.6
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEec
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDV 101 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 101 (466)
.++.++|... +.||+|+||+||+|.++.+|..+|+|.+.... .....+..|+.+++.+ +||||+++++.+...
T Consensus 14 ~~~~~~~~~~-~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 14 PDPSDTWEII-ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred CCcccceeee-eeeccCCCcEEEEEEECCCCceeEEEeecccc-----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 4578899885 56999999999999999999999999875322 1235677899999999 799999999987542
Q ss_pred ---cCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEE
Q 012320 102 ---DQKTFNFITEMFTSGTLREYRKK----YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVK 174 (466)
Q Consensus 102 ---~~~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vK 174 (466)
+...+++||||++|++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.+ +.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~-~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTE-GGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCC-CCEE
Confidence 34679999999999999988753 356899999999999999999999999 9999999999999877 7899
Q ss_pred EeccchhhhhcCCC-CCccccCCCCcCCccccc------cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q 012320 175 IGDLGLAAILRGSK-SAHSVIGTPEFMAPELYE------EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS 247 (466)
Q Consensus 175 L~DFGla~~~~~~~-~~~~~~GT~~y~APE~l~------~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~ 247 (466)
|+|||++..+.... ......||+.|+|||++. ..++.++||||+||++|+|++|..||........+. .+..
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~-~~~~ 243 (286)
T cd06638 165 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-KIPR 243 (286)
T ss_pred EccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh-hccc
Confidence 99999987654322 233457999999999764 348899999999999999999999997644333333 3323
Q ss_pred CCC-CCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 248 GKL-PGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 248 g~~-p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
+.. +...+...+..++++|.+||. +|.+|||+.|+++||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 244 NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 222 122334456789999999995 99999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=346.95 Aligned_cols=272 Identities=24% Similarity=0.372 Sum_probs=230.1
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
..+.+.-++||+|+||.|+-|.-+.||+-||.|.+.++.++... .....+.|-.||.+++.+.||.+-.+| +.+..+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~-ge~maLnEk~iL~kV~s~FiVslaYAf--eTkd~L 260 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRK-GETMALNEKQILEKVSSPFIVSLAYAF--ETKDAL 260 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhh-hhHHhhHHHHHHHHhccCcEEEEeeee--cCCCce
Confidence 34445567899999999999999999999999999888764333 335678899999999999999998888 668889
Q ss_pred EEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 107 NFITEMFTSGTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
++|+..|.||+|.-+|.+.+ .+++..+.+|+.+|+.||++||..+ |++|||||+|||+|.. |+|+|+|+|||..+
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~-GhvRISDLGLAvei 337 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDH-GHVRISDLGLAVEI 337 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccC-CCeEeeccceEEec
Confidence 99999999999999888776 7999999999999999999999999 9999999999999987 99999999999999
Q ss_pred cCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHhcCCCCCCCCCCCCH
Q 012320 185 RGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECA---NPAQIYKKVTSGKLPGAFYSIQDL 260 (466)
Q Consensus 185 ~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~---~~~~i~~~i~~g~~p~~~~~~~~~ 260 (466)
..++.....+||..|||||++. +.|+..+|+|||||++|||+.|..||..-. ..+++-+.+... +..++...++
T Consensus 338 ~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~--~~ey~~kFS~ 415 (591)
T KOG0986|consen 338 PEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED--PEEYSDKFSE 415 (591)
T ss_pred CCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc--hhhcccccCH
Confidence 8888777889999999999887 459999999999999999999999996422 223444444433 3345677889
Q ss_pred HHHHHHHHhcc-CcCCCCC-----HHHHhcCCCCCchhhhhccccccCCCCCC
Q 012320 261 EAQRFIGRCLV-NASKRLS-----AKELLLDPFLASDEVKLLSKTKLNQKPFL 307 (466)
Q Consensus 261 ~~~~lI~~~L~-dp~~Rps-----a~elL~hpf~~~~~~~~~~~~~~~~~~~~ 307 (466)
+++++.+.+|. ||++|+. +.++..||||+..+|+.+.. ....+||.
T Consensus 416 eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rlea-gml~PPfi 467 (591)
T KOG0986|consen 416 EAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEA-GMLEPPFI 467 (591)
T ss_pred HHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhc-cCCCCCCC
Confidence 99999999995 9999874 67999999999999876432 33344554
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=329.66 Aligned_cols=253 Identities=28% Similarity=0.478 Sum_probs=212.6
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
.|.. .+.||.|+||.||+|.++.+++.+|+|.+.... .......+.+|+.++++++||||+++++.+.. ...++
T Consensus 2 ~~~~-~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~ 75 (265)
T cd06605 2 DLEY-LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYN--NGDIS 75 (265)
T ss_pred cchH-HHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeec--CCEEE
Confidence 3444 466999999999999999999999999987543 23455778999999999999999999998744 57899
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 108 FITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHS-RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs-~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+|+||+.+++|.+++... ..+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.+ +.+||+|||++..+.
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~-~~~~l~d~g~~~~~~ 152 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSR-GQIKLCDFGVSGQLV 152 (265)
T ss_pred EEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCC-CCEEEeecccchhhH
Confidence 999999999999999876 789999999999999999999999 88 9999999999999986 899999999987654
Q ss_pred CCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCC----CCHHHHHHHHhcCCCCCCCCCCCCH
Q 012320 186 GSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSEC----ANPAQIYKKVTSGKLPGAFYSIQDL 260 (466)
Q Consensus 186 ~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~----~~~~~i~~~i~~g~~p~~~~~~~~~ 260 (466)
.... ....|++.|+|||.+. ..++.++|||||||++|+|++|..||... ....+..+.+..+..+.......+.
T Consensus 153 ~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (265)
T cd06605 153 NSLA-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSP 231 (265)
T ss_pred HHHh-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCH
Confidence 3222 2267899999999775 45889999999999999999999999764 2344455555555444333333678
Q ss_pred HHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 261 EAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 261 ~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
+++++|.+||. +|.+|||+.+++.||||+.
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 232 DFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 89999999996 9999999999999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=328.70 Aligned_cols=252 Identities=27% Similarity=0.433 Sum_probs=214.2
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+|.. .+.||.|+||.||+|.++.+|..||+|.+.+... ......+.+.+|++++++++||||+++++.+ .+...++
T Consensus 1 ~y~~-~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~ 76 (258)
T cd05578 1 HFEL-LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVRNVLNERRILQELNHPFLVNLWYSF--QDEENMY 76 (258)
T ss_pred CceE-EEEeccCCCceEEEEEEccCCcEEEEEEEehhhh-cchhHHHHHHHHHHHHHhCCCCChHHHHHhh--cCCCeEE
Confidence 3655 5779999999999999999999999999986543 2334567899999999999999999999877 5577899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~ 187 (466)
+|+||+.|++|.+++.+...+++..+..|+.||+.||.|||+++ ++|+||||+||+++.+ +.++|+|||++......
T Consensus 77 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 77 LVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQ-GHVHITDFNIATKVTPD 153 (258)
T ss_pred EEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCC-CCEEEeecccccccCCC
Confidence 99999999999999988778999999999999999999999999 9999999999999977 89999999999776554
Q ss_pred CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 012320 188 KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECAN--PAQIYKKVTSGKLPGAFYSIQDLEAQR 264 (466)
Q Consensus 188 ~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~--~~~i~~~i~~g~~p~~~~~~~~~~~~~ 264 (466)
.......|+..|+|||++. ..++.++|+|||||++|+|++|..||..... ...+.+.... .....+...+..+.+
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 231 (258)
T cd05578 154 TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAID 231 (258)
T ss_pred ccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHH
Confidence 4445567899999999776 4589999999999999999999999976443 4444444332 222334456689999
Q ss_pred HHHHhcc-CcCCCCCH--HHHhcCCCC
Q 012320 265 FIGRCLV-NASKRLSA--KELLLDPFL 288 (466)
Q Consensus 265 lI~~~L~-dp~~Rpsa--~elL~hpf~ 288 (466)
+|.+||. +|.+||++ +|++.||||
T Consensus 232 ~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 232 AINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHccCChhHcCCccHHHHhcCCCC
Confidence 9999995 99999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=325.85 Aligned_cols=247 Identities=34% Similarity=0.525 Sum_probs=203.5
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecC
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMF 113 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~ 113 (466)
.+||+|+||+||+|.+..++..||+|.+... .....+.+.+|+.+++.++||||+++++.+ .....+++|+||+
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~~~lv~e~~ 87 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPER----DSRYVQPLHEEIALHSYLKHRNIVQYLGSD--SENGFFKIFMEQV 87 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCC----CHHHHHHHHHHHHHHHhcCCCCeeeeeeee--ccCCEEEEEEecC
Confidence 4599999999999999999999999987643 234567889999999999999999999977 4467899999999
Q ss_pred CCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCC-C
Q 012320 114 TSGTLREYRKKY-RRV--DIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-S 189 (466)
Q Consensus 114 ~ggsL~~~l~~~-~~l--~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~-~ 189 (466)
++++|.+++... ..+ ++..+..++.||+.||.|||+.+ |+||||||+||+++...+.+||+|||++....... .
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165 (268)
T ss_pred CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence 999999998764 455 88999999999999999999999 99999999999998755799999999987654322 2
Q ss_pred CccccCCCCcCCcccccc---CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 012320 190 AHSVIGTPEFMAPELYEE---DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFI 266 (466)
Q Consensus 190 ~~~~~GT~~y~APE~l~~---~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI 266 (466)
.....|++.|+|||++.. .++.++||||||+++|+|++|..||............+.........+...+.++++|+
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFI 245 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHH
Confidence 334568999999998753 38899999999999999999999997644433332222211222234455678999999
Q ss_pred HHhcc-CcCCCCCHHHHhcCCCC
Q 012320 267 GRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 267 ~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
.+||. +|.+|||+.+++.||||
T Consensus 246 ~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 246 LRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHcCCCchhCCCHHHHHhCCCC
Confidence 99996 99999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=330.47 Aligned_cols=251 Identities=27% Similarity=0.430 Sum_probs=201.5
Q ss_pred eEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEE
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNF 108 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~l 108 (466)
|.+ .+.||.|++|+||+|.++.+|..||+|.++.... .......+.+|+.++++++||||+++++.+. ++..+++
T Consensus 2 y~~-~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~ 76 (285)
T cd07861 2 YTK-IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHPNIVCLQDVLM--QESRLYL 76 (285)
T ss_pred ceE-eeEecccCceEEEEEEECCCCcEEEEEEeccccc--cCCchHHHHHHHHHHHhcCCCCEeeeEEEEe--eCCeEEE
Confidence 555 4669999999999999999999999999875432 2223456788999999999999999999874 4678999
Q ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 109 ITEMFTSGTLREYRKKY---RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 109 V~E~~~ggsL~~~l~~~---~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
||||+. ++|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ |.+||+|||++....
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~ 152 (285)
T cd07861 77 IFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNK-GVIKLADFGLARAFG 152 (285)
T ss_pred EEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCC-CcEEECcccceeecC
Confidence 999996 6888887653 46899999999999999999999999 9999999999999876 899999999987553
Q ss_pred CCC-CCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-------------
Q 012320 186 GSK-SAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK------------- 249 (466)
Q Consensus 186 ~~~-~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~------------- 249 (466)
... ......+++.|+|||++.+ .++.++|||||||++|+|+||..||.+...............
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence 222 2233467899999997753 478999999999999999999999976544444433222110
Q ss_pred ------CC-------CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 250 ------LP-------GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 250 ------~p-------~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
.+ .......+.+++++|.+||. ||.+|||+.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00 00122356789999999996 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=329.95 Aligned_cols=252 Identities=23% Similarity=0.374 Sum_probs=203.8
Q ss_pred eeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHH---HHHHhCCCCceeEEEeEEEeccCCEEEEEEe
Q 012320 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEV---HLLSTLKHDSIIRFYTSWIDVDQKTFNFITE 111 (466)
Q Consensus 35 ~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei---~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E 111 (466)
+||+|+||+||+|.+..+|+.||+|.+.++...... .......|. .+++...||||+++++.+ .+...+++|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ-GETLALNERIMLSLVSTGDCPFIVCMSYAF--HTPDKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccch-hHHHHHHHHHHHHHHHhCCCCcEeeeeeee--ecCCEEEEEEe
Confidence 489999999999999999999999998865433222 112233343 445556899999999887 45678999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCCc
Q 012320 112 MFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH 191 (466)
Q Consensus 112 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~~ 191 (466)
|+.|++|.+++.+.+.+++..++.|+.|++.||.|||+.+ |+||||||+||+++.+ +.+||+|||++..+... ...
T Consensus 78 ~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~-~~~kl~dfg~~~~~~~~-~~~ 153 (278)
T cd05606 78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPH 153 (278)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCC-CCEEEccCcCccccCcc-CCc
Confidence 9999999999988888999999999999999999999999 9999999999999877 79999999998765432 234
Q ss_pred cccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 012320 192 SVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECA--NPAQIYKKVTSGKLPGAFYSIQDLEAQRFIG 267 (466)
Q Consensus 192 ~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~--~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~ 267 (466)
...||+.|+|||++.+ .++.++||||+||++|+|++|..||.... ......+.+... +...+...+.++.+++.
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~li~ 231 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AVELPDSFSPELRSLLE 231 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc--CCCCCCcCCHHHHHHHH
Confidence 5579999999998763 48999999999999999999999997642 233333333322 22334456789999999
Q ss_pred Hhcc-CcCCCC-----CHHHHhcCCCCCchhhhh
Q 012320 268 RCLV-NASKRL-----SAKELLLDPFLASDEVKL 295 (466)
Q Consensus 268 ~~L~-dp~~Rp-----sa~elL~hpf~~~~~~~~ 295 (466)
+||. +|.+|| ++.++++||||....+..
T Consensus 232 ~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~ 265 (278)
T cd05606 232 GLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM 265 (278)
T ss_pred HHhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence 9996 999999 999999999998876643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=324.35 Aligned_cols=251 Identities=33% Similarity=0.545 Sum_probs=208.2
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
|.++|.. .+.||.|+||.||+|.++.++..+|+|.+.... ..+.+.+|+.++++++||||+++++.+. ...
T Consensus 1 ~~~~y~~-~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~ 71 (256)
T cd06612 1 PEEVFDI-LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYIVKYYGSYF--KNT 71 (256)
T ss_pred Ccccchh-hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHHHHHHHHHHHHhCCCCcEeeeeeeee--cCC
Confidence 5678877 456999999999999999999999999886332 2578899999999999999999999884 457
Q ss_pred EEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 105 TFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
.+|+++||+.+++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||+|+||+++.+ +.+||+|||++..
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~-~~~~l~dfg~~~~ 148 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEE-GQAKLADFGVSGQ 148 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCC-CcEEEcccccchh
Confidence 89999999999999999875 456899999999999999999999999 9999999999999877 8999999999987
Q ss_pred hcCCC-CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-CCCCCCCCH
Q 012320 184 LRGSK-SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP-GAFYSIQDL 260 (466)
Q Consensus 184 ~~~~~-~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p-~~~~~~~~~ 260 (466)
..... ......|+..|+|||++. ..++.++|||||||++|+|++|..||.... .......+.....+ .......+.
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd06612 149 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH-PMRAIFMIPNKPPPTLSDPEKWSP 227 (256)
T ss_pred cccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-hhhhhhhhccCCCCCCCchhhcCH
Confidence 65433 334456899999999876 458899999999999999999999997633 33333333222211 112234567
Q ss_pred HHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 261 EAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 261 ~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
.+.++|.+|+. +|.+|||+.++|.||||
T Consensus 228 ~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 228 EFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 89999999995 99999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=342.03 Aligned_cols=257 Identities=23% Similarity=0.412 Sum_probs=229.5
Q ss_pred eeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCCEEEEEE
Q 012320 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQKTFNFIT 110 (466)
Q Consensus 32 ~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~~~lV~ 110 (466)
|-.+||+|+||+|.+|..+.+.+.+|||++++..+.++ ++.+--+.|-++|... +-|.++.++..| +.-..+|+||
T Consensus 353 Fl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd-DDvectm~EKrvLAL~~kppFL~qlHScF--QTmDRLyFVM 429 (683)
T KOG0696|consen 353 FLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD-DDVECTMVEKRVLALPGKPPFLVQLHSCF--QTMDRLYFVM 429 (683)
T ss_pred eEEEeccCccceeeeecccCcchhhhhhhhccceeeec-CcccceehhhhheecCCCCchHHHHHHHh--hhhhheeeEE
Confidence 46789999999999999999999999999998776655 4566777888889877 568899999888 5667899999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh-cCCCC
Q 012320 111 EMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-RGSKS 189 (466)
Q Consensus 111 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~-~~~~~ 189 (466)
||+.||+|.-++++.+++.+..+.+|+.+|+-||-+||+.| ||+||||.+||+++++ |++||+|||+++.- -....
T Consensus 430 EyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~e-GHiKi~DFGmcKEni~~~~T 506 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIFDGVT 506 (683)
T ss_pred EEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccC-CceEeeecccccccccCCcc
Confidence 99999999999999999999999999999999999999999 9999999999999988 99999999999763 35567
Q ss_pred CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 012320 190 AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGR 268 (466)
Q Consensus 190 ~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~ 268 (466)
..+++|||.|+|||++. +.|+.++|+||+||+||||+.|..||.+ .+..++++.|...+. .+++..|.++..+.+.
T Consensus 507 TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG-eDE~elF~aI~ehnv--syPKslSkEAv~ickg 583 (683)
T KOG0696|consen 507 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQAIMEHNV--SYPKSLSKEAVAICKG 583 (683)
T ss_pred eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHccC--cCcccccHHHHHHHHH
Confidence 78999999999999765 7899999999999999999999999987 889999999987764 4667788999999999
Q ss_pred hcc-CcCCCCCH-----HHHhcCCCCCchhhhhcc
Q 012320 269 CLV-NASKRLSA-----KELLLDPFLASDEVKLLS 297 (466)
Q Consensus 269 ~L~-dp~~Rpsa-----~elL~hpf~~~~~~~~~~ 297 (466)
+|. .|.+|+.+ .++-.||||+..+|..+.
T Consensus 584 ~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E 618 (683)
T KOG0696|consen 584 LLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLE 618 (683)
T ss_pred HhhcCCccccCCCCccccchhhCcchhhccHHHHh
Confidence 995 99999865 589999999999986543
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=329.37 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=209.8
Q ss_pred eeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecCCC
Q 012320 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTS 115 (466)
Q Consensus 36 LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~~g 115 (466)
||+|+||+||+|.+..+|+.||+|.+..+... .......+..|+.+|+.++||||+++++.+ .....+|+||||++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK-KRKGEQMALNEKKILEKVSSRFIVSLAYAF--ETKDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh-hhhhhHHHHHHHHHHHhCCCCCEeeeeeEE--ecCCeEEEEEecCCC
Confidence 69999999999999999999999998765432 223455678899999999999999999987 446789999999999
Q ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCCccc
Q 012320 116 GTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSV 193 (466)
Q Consensus 116 gsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~~~~ 193 (466)
++|.+++.+.+ .+++..+..++.|++.||.|||+.+ ++||||+|+||+++.+ +.+||+|||++............
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~ 154 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDH-GNVRISDLGLAVELKGGKKIKGR 154 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEEccCcchhhhccCCccccc
Confidence 99999997765 7999999999999999999999999 9999999999999876 89999999999776544444456
Q ss_pred cCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 012320 194 IGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECAN---PAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRC 269 (466)
Q Consensus 194 ~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~---~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~ 269 (466)
.++..|+|||.+. +.++.++|||||||++|+|++|..||..... ..++.+.+... +...+...++.++++|++|
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~ 232 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM--AVEYPDKFSPEAKDLCEAL 232 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccc--cccCCccCCHHHHHHHHHH
Confidence 7889999999765 4588999999999999999999999965332 23333333222 2234445688999999999
Q ss_pred cc-CcCCCC-----CHHHHhcCCCCCchhhhh
Q 012320 270 LV-NASKRL-----SAKELLLDPFLASDEVKL 295 (466)
Q Consensus 270 L~-dp~~Rp-----sa~elL~hpf~~~~~~~~ 295 (466)
|. +|.+|| ++.+++.||||....+..
T Consensus 233 l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~ 264 (277)
T cd05577 233 LQKDPEKRLGCRGGSADEVREHPLFKDLNWRR 264 (277)
T ss_pred ccCChhHccCCCcccHHHHHhChhhhcCChhh
Confidence 95 999999 889999999998766644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=348.91 Aligned_cols=254 Identities=22% Similarity=0.354 Sum_probs=201.5
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEc--CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDE--VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
..+|.++ +.||+|+||+||+|... .++..||+|.+... ....+|+.+|++++||||+++++.| ...
T Consensus 91 ~~~y~i~-~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~~~~E~~il~~l~h~~iv~~~~~~--~~~ 158 (392)
T PHA03207 91 RMQYNIL-SSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KTPGREIDILKTISHRAIINLIHAY--RWK 158 (392)
T ss_pred cCceEEE-EeecCCCCeEEEEEEEcCCccceeEEEEecccc---------ccHHHHHHHHHhcCCCCccceeeeE--eeC
Confidence 3568775 66999999999999754 46788999987532 1245799999999999999999987 446
Q ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 104 KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
..+++|||++ +++|.+++.+.+.+++..+..|+.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++..
T Consensus 159 ~~~~lv~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~-~~~~l~DfG~a~~ 234 (392)
T PHA03207 159 STVCMVMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEP-ENAVLGDFGAACK 234 (392)
T ss_pred CEEEEEehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCC-CCEEEccCccccc
Confidence 7899999999 4789999987789999999999999999999999999 9999999999999877 8999999999976
Q ss_pred hcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHhc-CC----CC
Q 012320 184 LRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECAN---PAQIYKKVTS-GK----LP 251 (466)
Q Consensus 184 ~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~---~~~i~~~i~~-g~----~p 251 (466)
+.... ......||+.|+|||++. ..|+.++|||||||++|+|++|..||.+... ..++...+.. +. ++
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 54322 223567999999999876 4699999999999999999999999965332 1112111110 00 00
Q ss_pred ---------------------CCC-----CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhhhh
Q 012320 252 ---------------------GAF-----YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVKL 295 (466)
Q Consensus 252 ---------------------~~~-----~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~~~ 295 (466)
... ....+.++++||.+||. ||.+|||+.|+|.||||....+..
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~ 385 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINL 385 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhh
Confidence 000 01235678899999996 999999999999999998766543
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=323.61 Aligned_cols=251 Identities=32% Similarity=0.541 Sum_probs=208.7
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+|.. .+.||.|+||+||+|.+..++..+|+|++..... ......+.+|+.+|+.++||||+++++.+. ....++
T Consensus 2 ~y~~-~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~ 75 (267)
T cd06610 2 DYEL-IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVKYYTSFV--VGDELW 75 (267)
T ss_pred ccee-eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcCCCCEEEEEEEEe--eCCEEE
Confidence 4666 5679999999999999999999999998875442 225678899999999999999999999874 467899
Q ss_pred EEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 108 FITEMFTSGTLREYRKKY---RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~---~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
+|+|++.|++|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++..+
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~-~~~~l~df~~~~~~ 152 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGED-GSVKIADFGVSASL 152 (267)
T ss_pred EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCC-CCEEEcccchHHHh
Confidence 999999999999999764 45899999999999999999999999 9999999999999986 89999999999776
Q ss_pred cCCCC-----CccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC---
Q 012320 185 RGSKS-----AHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAF--- 254 (466)
Q Consensus 185 ~~~~~-----~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~--- 254 (466)
..... .....|++.|+|||++.. .++.++|+|||||++++|++|..||... +..+.+..+..+..+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd06610 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY-PPMKVLMLTLQNDPPSLETGA 231 (267)
T ss_pred ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc-ChhhhHHHHhcCCCCCcCCcc
Confidence 54322 234578999999997764 4889999999999999999999999764 444444444443322111
Q ss_pred -CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 255 -YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 255 -~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
+...+..+++++.+||. +|.+||++.+|+.||||
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 232 DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 12446789999999996 99999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=329.03 Aligned_cols=252 Identities=30% Similarity=0.497 Sum_probs=208.4
Q ss_pred eEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEE
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNF 108 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~l 108 (466)
|.+ .+.||.|+||.||+|.+..++..+|+|.+... .....+.+.+|+.+++.++||||+++++.+.. ....++
T Consensus 7 ~~i-~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~~ 79 (282)
T cd06643 7 WEI-IGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWI 79 (282)
T ss_pred HHH-HhhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCEEEE
Confidence 544 45699999999999999999999999988633 34456788999999999999999999998844 678999
Q ss_pred EEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC
Q 012320 109 ITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187 (466)
Q Consensus 109 V~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~ 187 (466)
|+||+.+++|..++.+ .+.+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~ 156 (282)
T cd06643 80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRT 156 (282)
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccC-CCEEEcccccccccccc
Confidence 9999999999988764 467999999999999999999999999 9999999999999876 89999999998654322
Q ss_pred -CCCccccCCCCcCCccccc------cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-CCCCCCCC
Q 012320 188 -KSAHSVIGTPEFMAPELYE------EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP-GAFYSIQD 259 (466)
Q Consensus 188 -~~~~~~~GT~~y~APE~l~------~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p-~~~~~~~~ 259 (466)
.......||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..+....+..+..+ ...+...+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd06643 157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSEPPTLAQPSRWS 235 (282)
T ss_pred ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc-cCHHHHHHHHhhcCCCCCCCccccC
Confidence 2234467899999999873 2377899999999999999999999976 4444444444444332 22334467
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.++++||.+||. +|.+||++.++++||||...
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 236 SEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 799999999995 99999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=328.77 Aligned_cols=255 Identities=29% Similarity=0.439 Sum_probs=204.4
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHH-HHhCCCCceeEEEeEEEeccCCEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHL-LSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~i-L~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
.|... +.||+|+||.||+|.++.+|..||+|+++.... . ....++..|+.+ ++.++||||+++++.+. ....+
T Consensus 2 ~~~~~-~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~-~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~--~~~~~ 75 (283)
T cd06617 2 DLEVI-EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--S-QEQKRLLMDLDISMRSVDCPYTVTFYGALF--REGDV 75 (283)
T ss_pred CceEE-EEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--c-HHHHHHHHHHHHHHHHcCCCCeeeeeEEEe--cCCcE
Confidence 46664 669999999999999999999999999875432 2 223455666665 66679999999999874 46679
Q ss_pred EEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 107 NFITEMFTSGTLREYRKK----YRRVDIRAIKSWARQILQGLVYLHSR-DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qIl~gL~yLHs~-~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
|+||||++ |+|.+++.. ...+++..+..++.||+.||.|||++ + ++||||||+||+++.+ +.+||+|||++
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~-~~~kl~dfg~~ 151 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRN-GQVKLCDFGIS 151 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCC-CCEEEeecccc
Confidence 99999995 688777654 24689999999999999999999997 7 9999999999999877 89999999999
Q ss_pred hhhcCCCCCccccCCCCcCCccccc-----cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 012320 182 AILRGSKSAHSVIGTPEFMAPELYE-----EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 182 ~~~~~~~~~~~~~GT~~y~APE~l~-----~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 256 (466)
..+..........|+..|+|||++. ..++.++|+|||||++|+|++|..||....+..+....+..+..+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd06617 152 GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAE 231 (283)
T ss_pred cccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcc
Confidence 7764433334467899999999774 34788999999999999999999999754444444444444443333333
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
..+.+++++|.+||. +|.+||++.+++.||||....
T Consensus 232 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 232 KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 467889999999995 999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=352.34 Aligned_cols=256 Identities=22% Similarity=0.388 Sum_probs=233.8
Q ss_pred eeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecCC
Q 012320 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFT 114 (466)
Q Consensus 35 ~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~~ 114 (466)
.||-|+||.|=++.-+.....+|+|++++..+. +..+.+.++.|-++|..++.|.||++|-.| .+.+++|++||-|-
T Consensus 427 TLGvGgFGRVELV~~~~~~~~fAlKilkK~hIV-dtkQqeHv~sEr~Im~~~~s~fIvrLYrTf--rd~kyvYmLmEaCl 503 (732)
T KOG0614|consen 427 TLGVGGFGRVELVKVNSQKATFALKILKKKHIV-DTKQQEHVFSERNIMMECRSDFIVRLYRTF--RDSKYVYMLMEACL 503 (732)
T ss_pred hcccCccceEEEEEecccchHHHHHHHhHhhcc-chhHHHHHHhHHHHHHhcCchHHHHHHHHh--ccchhhhhhHHhhc
Confidence 499999999999876665556999999988875 445678999999999999999999999998 66889999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCCcccc
Q 012320 115 SGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVI 194 (466)
Q Consensus 115 ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~~~~~ 194 (466)
||.|+..++..+.+++..+++++.-+++|++|||++| ||+|||||+|.+++.+ |.+||.|||+|+.+..+..+.++|
T Consensus 504 GGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~-Gy~KLVDFGFAKki~~g~KTwTFc 580 (732)
T KOG0614|consen 504 GGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNR-GYLKLVDFGFAKKIGSGRKTWTFC 580 (732)
T ss_pred CchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccC-CceEEeehhhHHHhccCCceeeec
Confidence 9999999999999999999999999999999999999 9999999999999977 999999999999999999999999
Q ss_pred CCCCcCCccc-cccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-C
Q 012320 195 GTPEFMAPEL-YEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-N 272 (466)
Q Consensus 195 GT~~y~APE~-l~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-d 272 (466)
|||+|.|||+ +..+.+.++|.||||+++|||++|.+||++ .++...|..|.+|.-.-.++......+.++|+++-. +
T Consensus 581 GTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~-~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~ 659 (732)
T KOG0614|consen 581 GTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG-VDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDN 659 (732)
T ss_pred CCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC-CchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcC
Confidence 9999999995 567799999999999999999999999988 899999999999986666777788899999988775 8
Q ss_pred cCCCCC-----HHHHhcCCCCCchhhhhcc
Q 012320 273 ASKRLS-----AKELLLDPFLASDEVKLLS 297 (466)
Q Consensus 273 p~~Rps-----a~elL~hpf~~~~~~~~~~ 297 (466)
|.+|+. ..++-+|.||.+-+|.-+.
T Consensus 660 P~ERLG~~~~gI~DIkkH~Wf~gfdweglr 689 (732)
T KOG0614|consen 660 PTERLGYQKGGINDIKKHRWFEGFDWEGLR 689 (732)
T ss_pred cHhhhccccCChHHHHhhhhhhcCChhhhh
Confidence 999987 6899999999998886543
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=325.56 Aligned_cols=250 Identities=23% Similarity=0.420 Sum_probs=206.4
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHH-HhCCCCceeEEEeEEEeccCCEEEEEEec
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLL-STLKHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL-~~l~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
+.||.|+||.||+|.+..+|+.||+|.+.+.... .......+..|..++ ...+||||+++++.+ .....+|+|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~--~~~~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI-AKNQVTNVKAERAIMMIQGESPYVAKLYYSF--QSKDYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh-HHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE--EcCCeEEEEEec
Confidence 4589999999999999999999999998754432 122233445555544 455899999999988 446789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCCcc
Q 012320 113 FTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS 192 (466)
Q Consensus 113 ~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~~~ 192 (466)
+.|++|.+++...+.+++..+..++.||+.||.|||+.+ ++||||+|+||+++.+ +.+||+|||++..... ...
T Consensus 79 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~---~~~ 152 (260)
T cd05611 79 LNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQT-GHLKLTDFGLSRNGLE---NKK 152 (260)
T ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CcEEEeecccceeccc---ccc
Confidence 999999999998889999999999999999999999999 9999999999999876 8999999998875432 234
Q ss_pred ccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCCHHHHHHHHHh
Q 012320 193 VIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL--PGAFYSIQDLEAQRFIGRC 269 (466)
Q Consensus 193 ~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~~~~~~~lI~~~ 269 (466)
..|++.|+|||.+.+ .++.++||||||+++|+|++|..||.. .+..+++..+..+.. +.......+.++.++|.+|
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 231 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA-ETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHH
Confidence 568999999997764 478999999999999999999999976 566677777665543 3333445678999999999
Q ss_pred cc-CcCCCCCH---HHHhcCCCCCchhh
Q 012320 270 LV-NASKRLSA---KELLLDPFLASDEV 293 (466)
Q Consensus 270 L~-dp~~Rpsa---~elL~hpf~~~~~~ 293 (466)
|. +|.+||++ +|+|.||||+..+|
T Consensus 232 l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 232 LCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred ccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 95 99999955 79999999977554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=333.03 Aligned_cols=262 Identities=23% Similarity=0.330 Sum_probs=209.5
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
+++..+|.+. +.||+|+||+||+|.++.+|+.||+|.++..... ........+|+.++++++|+||+++++.+....
T Consensus 3 ~~~~~~y~~~-~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (309)
T cd07845 3 CRSVTEFEKL-NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER--DGIPISSLREITLLLNLRHPNIVELKEVVVGKH 79 (309)
T ss_pred cccccceeEe-eeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC--CCCcchhhHHHHHHHhCCCCCCcceEEEEecCC
Confidence 3567788885 5699999999999999999999999998755421 112234567999999999999999999886655
Q ss_pred CCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
...+++||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.+ +.+||+|||++
T Consensus 80 ~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~kL~dfg~~ 155 (309)
T cd07845 80 LDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDK-GCLKIADFGLA 155 (309)
T ss_pred CCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEECcccee
Confidence 567899999996 5888887753 67999999999999999999999999 9999999999999876 89999999999
Q ss_pred hhhcCC-CCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---------
Q 012320 182 AILRGS-KSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK--------- 249 (466)
Q Consensus 182 ~~~~~~-~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~--------- 249 (466)
...... .......+++.|+|||++. ..++.++|||||||++|+|++|..||.. .+..+.+..+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 156 RTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG-KSEIEQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred eecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHhcCCCChhhch
Confidence 766432 2223345688999999875 3488999999999999999999999976 44444444433210
Q ss_pred ----------C--CCCC-------CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 250 ----------L--PGAF-------YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 250 ----------~--p~~~-------~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
+ +... ....++.++++|.+||. ||++|||+++++.||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 0 0000 01246788999999996 999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=353.59 Aligned_cols=248 Identities=25% Similarity=0.404 Sum_probs=199.5
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
..+|.+ .+.||+|+||.||+|.+..+++.||+|.... ..+.+|+++|++++|||||++++.+. ....
T Consensus 168 ~~gy~i-~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~--~~~~ 234 (461)
T PHA03211 168 GLGFAI-HRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRV--VGGL 234 (461)
T ss_pred cCCeEE-EEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEE--ECCE
Confidence 557877 5669999999999999999999999995321 23567999999999999999999774 4667
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 106 FNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.++|+|++ .++|.+++.+. +.+++..+..|+.||+.||.|||+.| |+||||||+|||++.+ +.+||+|||+++.+
T Consensus 235 ~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~-~~vkL~DFGla~~~ 310 (461)
T PHA03211 235 TCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGP-EDICLGDFGAACFA 310 (461)
T ss_pred EEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCC-CCEEEcccCCceec
Confidence 88999999 46888887654 56999999999999999999999999 9999999999999877 79999999999765
Q ss_pred cCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCC-------CCHHHHHHHHhcCCCCCC
Q 012320 185 RGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSEC-------ANPAQIYKKVTSGKLPGA 253 (466)
Q Consensus 185 ~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~-------~~~~~i~~~i~~g~~p~~ 253 (466)
..... ....+||+.|+|||++. ..++.++|||||||++|||++|..|+... ....++.+.+........
T Consensus 311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 43221 23467999999999776 45999999999999999999988765331 123455555544322100
Q ss_pred -C-------------------------------CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 254 -F-------------------------------YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 254 -~-------------------------------~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
+ ....+..+++||.+||. ||.+|||+.|+|+||||++
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0 01234578999999996 9999999999999999964
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=321.36 Aligned_cols=251 Identities=25% Similarity=0.474 Sum_probs=213.2
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
||.. .+.||+|+||+||++.+..+|+.||+|.+..... .......+.+|+.++++++||||+++++.+ .....++
T Consensus 1 ~y~~-~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~ 75 (256)
T cd08218 1 KYVK-VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESF--EENGNLY 75 (256)
T ss_pred CceE-EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCCCCCeeeeEeee--cCCCeEE
Confidence 5777 4669999999999999999999999999876543 334556889999999999999999999987 4567899
Q ss_pred EEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 108 FITEMFTSGTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+|+||+++++|.+++.... .+++..+..|+.|++.||.|||+.+ ++|+||+|+||+++.+ +.++|+|||++....
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~-~~~~l~d~~~~~~~~ 152 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKD-GTIKLGDFGIARVLN 152 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC-CCEEEeeccceeecC
Confidence 9999999999999987643 5899999999999999999999999 9999999999999876 799999999987654
Q ss_pred CCC-CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 186 GSK-SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 186 ~~~-~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
... ......|++.|+|||++. ..++.++|+|||||++++|++|..||.. .+...+...+..+..+.. +...+.+++
T Consensus 153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 230 (256)
T cd08218 153 STVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA-GNMKNLVLKIIRGSYPPV-SSHYSYDLR 230 (256)
T ss_pred cchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC-CCHHHHHHHHhcCCCCCC-cccCCHHHH
Confidence 322 123456899999999876 4578899999999999999999999976 566666777777765433 345677899
Q ss_pred HHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 264 RFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
++|.+||. +|.+||++.+++.||||
T Consensus 231 ~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 231 NLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 99999995 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=326.25 Aligned_cols=258 Identities=27% Similarity=0.447 Sum_probs=210.7
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
++|... +.||.|++|.||+|.++.+++.+|+|.+.... ......++.+|++++++++||||+++++.+.+.....+
T Consensus 1 ~~~~~~-~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 76 (287)
T cd06621 1 EKIVEL-SRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI 76 (287)
T ss_pred CceEEE-EEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence 356664 55999999999999999999999999887442 22455778999999999999999999998877667789
Q ss_pred EEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 107 NFITEMFTSGTLREYRKK----YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
++||||++|++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.+ +.++|+|||++.
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~-~~~~l~dfg~~~ 153 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRK-GQVKLCDFGVSG 153 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecC-CeEEEeeccccc
Confidence 999999999999988653 355899999999999999999999999 9999999999999876 799999999986
Q ss_pred hhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCC----CCHHHHHHHHhcCCCCCC---C
Q 012320 183 ILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSEC----ANPAQIYKKVTSGKLPGA---F 254 (466)
Q Consensus 183 ~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~----~~~~~i~~~i~~g~~p~~---~ 254 (466)
...... .....++..|+|||.+. ..++.++|||||||++|+|++|..||... ....++...+.....+.. .
T Consensus 154 ~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd06621 154 ELVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP 232 (287)
T ss_pred cccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCC
Confidence 543322 22456788999999775 56899999999999999999999999764 234455555544332211 1
Q ss_pred C--CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 255 Y--SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 255 ~--~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
. ...+..+++||.+||. +|++|||+.|++.||||....
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 1 1235689999999996 999999999999999996543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=328.94 Aligned_cols=260 Identities=23% Similarity=0.380 Sum_probs=215.8
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
.|.. .+.||+|+||.||+|.++.+++.||+|.+..... ........+.+|+.+++.++||||+++++.+ ..+..++
T Consensus 2 ~y~~-~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~~ 77 (305)
T cd05609 2 DFET-IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-ILRNQIQQVFVERDILTFAENPFVVSMFCSF--ETKRHLC 77 (305)
T ss_pred CceE-eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE--ecCCEEE
Confidence 4656 4669999999999999999999999999875532 2233456788999999999999999999987 4567899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~ 187 (466)
+||||++|++|.+++...+.+++..+..++.|++.||.|||+++ ++||||||+||+++.. |.+||+|||++......
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~-~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSM-GHIKLTDFGLSKIGLMS 154 (305)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCC-CCEEEeeCCCccccCcC
Confidence 99999999999999988888999999999999999999999999 9999999999999876 89999999988632110
Q ss_pred ----------------CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC
Q 012320 188 ----------------KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL 250 (466)
Q Consensus 188 ----------------~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~ 250 (466)
.......|++.|+|||.+. ..++.++|||||||++|+|++|..||.+ .+..++...+..+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~-~~~~~~~~~~~~~~~ 233 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDI 233 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccc
Confidence 0111346788999999765 5689999999999999999999999976 566777777766643
Q ss_pred CCC-CCCCCCHHHHHHHHHhcc-CcCCCCC---HHHHhcCCCCCchhhhh
Q 012320 251 PGA-FYSIQDLEAQRFIGRCLV-NASKRLS---AKELLLDPFLASDEVKL 295 (466)
Q Consensus 251 p~~-~~~~~~~~~~~lI~~~L~-dp~~Rps---a~elL~hpf~~~~~~~~ 295 (466)
+.. .....+.+++++|.+||. +|.+||+ +.++|.||||....+..
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 234 EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 322 122457789999999996 9999998 78999999998766643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=326.18 Aligned_cols=253 Identities=27% Similarity=0.432 Sum_probs=204.6
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+|.+ .+.||.|+||.||+|.++.+|..||+|++..... .......+.+|+.++++++||||+++++.+. ....++
T Consensus 1 ~y~~-~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~ 75 (286)
T cd07832 1 RYKI-LGRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQALREIKALQACQHPYVVKLLDVFP--HGSGFV 75 (286)
T ss_pred CceE-EeecccCCCcEEEEEEECCCCceEEEEEEEcccc--cchhhHHHHHHHHHHHhCCCCCCcceeeEEe--cCCeeE
Confidence 4666 5669999999999999999999999999876543 2234567899999999999999999999874 477899
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 108 FITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
+|+||+ +++|.+++... ..+++..++.++.||+.||.|||+.+ ++|+||||+||+++.+ +.++|+|||++.....
T Consensus 76 ~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~-~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISAD-GVLKIADFGLARLFSE 151 (286)
T ss_pred EEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCC-CcEEEeeeeecccccC
Confidence 999999 99999998653 56999999999999999999999999 9999999999999986 8999999999977644
Q ss_pred CC--CCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-------------
Q 012320 187 SK--SAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK------------- 249 (466)
Q Consensus 187 ~~--~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~------------- 249 (466)
.. ......|++.|+|||++. ..++.++||||+||++|+|++|..||....+...+...+..-.
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 152 EEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc
Confidence 32 233457899999999775 3478999999999999999999877765443333222221100
Q ss_pred -------CCC-------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCC
Q 012320 250 -------LPG-------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLA 289 (466)
Q Consensus 250 -------~p~-------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~ 289 (466)
.+. ......+..+.++|.+||. +|.+|||++++|.||||.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 000 0112345789999999996 999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=317.34 Aligned_cols=255 Identities=38% Similarity=0.614 Sum_probs=218.4
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+|.. .+.||+|++|.||+|.+..+|..|++|++..... .....+.+.+|+.++++++||||+++++.+.......++
T Consensus 1 ~~~~-~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (260)
T cd06606 1 EWTR-GELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN 77 (260)
T ss_pred Ccee-eeEeeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence 3555 5779999999999999999999999999875543 245668899999999999999999999987543337899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~ 187 (466)
+|+|++.+++|.+++.+...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.+ +.+||+|||.+......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSD-GVVKLADFGCAKRLGDI 154 (260)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCC-CCEEEcccccEEecccc
Confidence 99999999999999998889999999999999999999999999 9999999999999986 89999999999876554
Q ss_pred CC---CccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 188 KS---AHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 188 ~~---~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
.. .....++..|+|||.+.. .++.++||||||+++|+|++|..||....+.......+..+......+...+..++
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAK 234 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHH
Confidence 32 345678999999997764 48999999999999999999999998766555555555544444445556688999
Q ss_pred HHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 264 RFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
+||.+||. +|.+||++.+++.||||
T Consensus 235 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 235 DFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 99999996 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=320.40 Aligned_cols=252 Identities=34% Similarity=0.594 Sum_probs=212.8
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
||.. .+.||+|+||.||+|.+..++..||+|.+..... .......+..|+.+++.++|+||+++++.+ .+...++
T Consensus 1 ~y~~-~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~--~~~~~~~ 75 (264)
T cd06626 1 RWQR-GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN--DPKTIKEIADEMKVLELLKHPNLVKYYGVE--VHREKVY 75 (264)
T ss_pred Ccee-eeEeecCCCcEEEEEEECCCCcEEEEEEEECccc--chHHHHHHHHHHHHHHhCCCCChhheeeeE--ecCCEEE
Confidence 6777 4669999999999999999999999999886653 245678899999999999999999999975 4577899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~ 187 (466)
+|+||+++++|.+++.+.+.+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.. +.+||+|||++......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~-~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNN 152 (264)
T ss_pred EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEcccccccccCCC
Confidence 99999999999999988778999999999999999999999999 9999999999999886 89999999999776432
Q ss_pred CC-----CccccCCCCcCCcccccc-C---CCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC-
Q 012320 188 KS-----AHSVIGTPEFMAPELYEE-D---YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSI- 257 (466)
Q Consensus 188 ~~-----~~~~~GT~~y~APE~l~~-~---y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~- 257 (466)
.. .....+++.|+|||++.. . ++.++||||||+++++|++|..||....+.......+..+..+ ..+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~ 231 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP-PIPDSL 231 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCC-CCCccc
Confidence 22 123568899999998763 2 7889999999999999999999997655555554445444332 22222
Q ss_pred -CCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 258 -QDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 258 -~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
.+..+.++|.+||. +|.+|||+.+++.|||+
T Consensus 232 ~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 232 QLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 37889999999995 99999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=386.22 Aligned_cols=256 Identities=28% Similarity=0.492 Sum_probs=227.1
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
+-||++ +..||.|.||.||.|.+..||+..|+|-|+..... ......+.+|+.+|..|+|||+|++|+ ++.++..
T Consensus 1234 ~~rWqr-g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyG--VEvHRek 1308 (1509)
T KOG4645|consen 1234 TFRWQR-GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYG--VEVHREK 1308 (1509)
T ss_pred eeeecc-ccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCc--eeecHHH
Confidence 346777 67799999999999999999999999998877653 334467889999999999999999999 5566778
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
++|.||||.||+|.+.+...+..++...+.+..|++.|+.|||++| |+||||||+|||++.+ |.+|++|||.|..+.
T Consensus 1309 v~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~-g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFN-GLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecC-CcEEeecccceeEec
Confidence 8999999999999999998888999999999999999999999999 9999999999999988 899999999997765
Q ss_pred CCC-----CCccccCCCCcCCcccccc----CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 012320 186 GSK-----SAHSVIGTPEFMAPELYEE----DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 186 ~~~-----~~~~~~GT~~y~APE~l~~----~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 256 (466)
+.. ..+..+|||.|||||++.+ +...++|||||||++.||+||+.||.+..+.-+|.-.+..|..|.....
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ 1465 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER 1465 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh
Confidence 432 2456789999999998864 3567899999999999999999999999999999999999998865544
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
.+.+.++||+.||. ||++|.++.|||.|.|-+.
T Consensus 1466 -ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1466 -LSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred -hhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 88999999999995 9999999999999999754
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=371.64 Aligned_cols=248 Identities=33% Similarity=0.591 Sum_probs=210.0
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe-------------
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID------------- 100 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------------- 100 (466)
++||+||||.||||+++-+|+.||||+|..+- +.....++.+|+.+|++|+|||||++|.+|++
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~ 561 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVAS 561 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccccc
Confidence 46999999999999999999999999998654 44566889999999999999999999999970
Q ss_pred ---------------------------------------------------------------c----------------
Q 012320 101 ---------------------------------------------------------------V---------------- 101 (466)
Q Consensus 101 ---------------------------------------------------------------~---------------- 101 (466)
+
T Consensus 562 ~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~ 641 (1351)
T KOG1035|consen 562 DSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVI 641 (1351)
T ss_pred chhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccc
Confidence 0
Q ss_pred ------------------c-------CCEEEEEEecCCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 012320 102 ------------------D-------QKTFNFITEMFTSGTLREYRKKYRRV-DIRAIKSWARQILQGLVYLHSRDPPVI 155 (466)
Q Consensus 102 ------------------~-------~~~~~lV~E~~~ggsL~~~l~~~~~l-~~~~~~~i~~qIl~gL~yLHs~~~~Ii 155 (466)
+ ...+||-||||+...|++++.++... ....++++++||++||.|+|+.| ||
T Consensus 642 ~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g--iI 719 (1351)
T KOG1035|consen 642 LDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG--II 719 (1351)
T ss_pred cCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc--ee
Confidence 0 03578889999988888888775544 57889999999999999999999 99
Q ss_pred eccCCCCcEEEeCCCCcEEEeccchhhhhc-------------------CCCCCccccCCCCcCCcccccc----CCCCh
Q 012320 156 HRDLKCDNIFVNGHLGQVKIGDLGLAAILR-------------------GSKSAHSVIGTPEFMAPELYEE----DYNEL 212 (466)
Q Consensus 156 HrDLKp~NIlv~~~~g~vKL~DFGla~~~~-------------------~~~~~~~~~GT~~y~APE~l~~----~y~~~ 212 (466)
||||||.|||++.+ +.|||+|||+|+... .....++.+||..|+|||++.+ .|+.|
T Consensus 720 HRDLKP~NIFLd~~-~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K 798 (1351)
T KOG1035|consen 720 HRDLKPRNIFLDSR-NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK 798 (1351)
T ss_pred eccCCcceeEEcCC-CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence 99999999999977 799999999997621 0112356789999999998862 59999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCC
Q 012320 213 VDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA--FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLA 289 (466)
Q Consensus 213 ~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~--~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~ 289 (466)
+|||||||+++||+ +||........+...++.|.+|.. ++...-+....+|+.||. ||++||||.|||++.||.
T Consensus 799 iDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 799 IDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred hhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 99999999999998 589877788888999999998876 222233466779999996 999999999999999997
Q ss_pred c
Q 012320 290 S 290 (466)
Q Consensus 290 ~ 290 (466)
.
T Consensus 876 p 876 (1351)
T KOG1035|consen 876 P 876 (1351)
T ss_pred c
Confidence 3
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=329.08 Aligned_cols=252 Identities=29% Similarity=0.515 Sum_probs=208.2
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+|..+ +.||+|+||+||+|.+..+|..||+|.+.... .......+.+|+.++++++||||+++++.+. ..+.++
T Consensus 2 ~~~~~-~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~ 75 (286)
T cd06622 2 EIEVL-DELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQIIMELDILHKAVSPYIVDFYGAFF--IEGAVY 75 (286)
T ss_pred hhhhh-hhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHhcCCCcHHhhhhhee--cCCeEE
Confidence 45554 55999999999999999999999999886432 3445578899999999999999999999874 467899
Q ss_pred EEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 108 FITEMFTSGTLREYRKKY---RRVDIRAIKSWARQILQGLVYLHS-RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~---~~l~~~~~~~i~~qIl~gL~yLHs-~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
+||||++|++|..++... ..+++..+..++.||+.||.|||+ .+ |+||||||+||+++.+ +.+||+|||++..
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~ 152 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGN-GQVKLCDFGVSGN 152 (286)
T ss_pred EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCC-CCEEEeecCCccc
Confidence 999999999999988763 379999999999999999999996 57 9999999999999886 8999999999876
Q ss_pred hcCCCCCccccCCCCcCCcccccc-------CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHhcCCCCCC
Q 012320 184 LRGSKSAHSVIGTPEFMAPELYEE-------DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIY---KKVTSGKLPGA 253 (466)
Q Consensus 184 ~~~~~~~~~~~GT~~y~APE~l~~-------~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~---~~i~~g~~p~~ 253 (466)
+... ......|++.|+|||.+.. .++.++|||||||++|+|++|..||... +....+ ..+..+..+ .
T Consensus 153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~-~ 229 (286)
T cd06622 153 LVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE-TYANIFAQLSAIVDGDPP-T 229 (286)
T ss_pred ccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc-chhhHHHHHHHHhhcCCC-C
Confidence 5332 2345578999999998742 2578999999999999999999999653 333333 334444433 3
Q ss_pred CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 254 FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 254 ~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.+...+.++++||.+||. +|.+||++.+++.||||...
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 230 LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred CCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 344478899999999996 99999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=359.34 Aligned_cols=256 Identities=23% Similarity=0.357 Sum_probs=212.7
Q ss_pred cceeeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEe
Q 012320 18 IGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYT 96 (466)
Q Consensus 18 ~~~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~ 96 (466)
.|.+.+-...++++ +++|-+|||+.||+|.+...|.+||+|++-.. ++...+.+.+||.+|++|+ |||||.|++
T Consensus 28 ~G~~~~Vg~~~v~V-~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~nIV~yid 102 (738)
T KOG1989|consen 28 VGQTFTVGSHRVTV-EKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAVKREIDIMKLLSGHKNIVSYID 102 (738)
T ss_pred CceEEEECCEEEEE-EEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCceeeEec
Confidence 44566666677766 89999999999999999998899999987633 5678889999999999995 999999999
Q ss_pred E-EEec-c---CCEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC
Q 012320 97 S-WIDV-D---QKTFNFITEMFTSGTLREYRKK--YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH 169 (466)
Q Consensus 97 ~-~~~~-~---~~~~~lV~E~~~ggsL~~~l~~--~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~ 169 (466)
+ .... . .-.+.|.||||.||+|-|++.+ ..+|++..+.+|+.|+++|+.+||...|||||||||-||||++.+
T Consensus 103 ss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~ 182 (738)
T KOG1989|consen 103 SSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSAD 182 (738)
T ss_pred cccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCC
Confidence 4 3222 1 2367899999999999999874 356999999999999999999999999999999999999999987
Q ss_pred CCcEEEeccchhhhhcCCC-CCc---------cccCCCCcCCccccc----cCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 012320 170 LGQVKIGDLGLAAILRGSK-SAH---------SVIGTPEFMAPELYE----EDYNELVDVYSFGMCVLEMFTCEYPYSEC 235 (466)
Q Consensus 170 ~g~vKL~DFGla~~~~~~~-~~~---------~~~GT~~y~APE~l~----~~y~~~~DIwSlGvil~elltg~~Pf~~~ 235 (466)
|+.||||||.++-..... ... ...-|+.|+|||++. ...++|+|||+|||+||-|+....||.+.
T Consensus 183 -g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 183 -GNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred -CCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 899999999986532221 111 123589999999764 35899999999999999999999999774
Q ss_pred CCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 236 ANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 236 ~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.. -+|..|++..+.....+..+++||+.||. +|.+||++.+++.
T Consensus 262 g~-----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~ 306 (738)
T KOG1989|consen 262 GK-----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLE 306 (738)
T ss_pred cc-----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence 33 24677877666666788899999999996 9999999998874
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=319.84 Aligned_cols=254 Identities=28% Similarity=0.501 Sum_probs=217.5
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
.|.+ .+.||+|++|.||+|.++.+|+.||+|++..... ......+.+|+..+++++||||+++++.+. ....++
T Consensus 2 ~~~~-~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~ 75 (264)
T cd06623 2 DLER-VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRKQLLRELKTLRSCESPYVVKCYGAFY--KEGEIS 75 (264)
T ss_pred ccee-eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEc--cCCeEE
Confidence 3545 5779999999999999999999999999875432 245678999999999999999999999874 467899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHS-RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs-~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
+|+||+++++|.+++.+...+++..+..++.||+.||.|||+ .+ ++||||+|+||+++.+ +.++|+|||++.....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~-~~~~l~df~~~~~~~~ 152 (264)
T cd06623 76 IVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSK-GEVKIADFGISKVLEN 152 (264)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCC-CCEEEccCccceeccc
Confidence 999999999999999988899999999999999999999999 99 9999999999999887 8999999999977644
Q ss_pred CCCC-ccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCCCCCCCCCCCCHHH
Q 012320 187 SKSA-HSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECA--NPAQIYKKVTSGKLPGAFYSIQDLEA 262 (466)
Q Consensus 187 ~~~~-~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~--~~~~i~~~i~~g~~p~~~~~~~~~~~ 262 (466)
.... ....++..|+|||.+. ..++.++|+||||+++|+|++|..||.... ...+..+.+..+..+.......+..+
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (264)
T cd06623 153 TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232 (264)
T ss_pred CCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence 3322 2567899999999776 458889999999999999999999997754 66677777776555443333367899
Q ss_pred HHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 263 QRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 263 ~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
.++|.+||. +|++|||+.+++.|||++.
T Consensus 233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 233 RDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 999999995 9999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=325.98 Aligned_cols=258 Identities=29% Similarity=0.511 Sum_probs=214.9
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
++.+.|..+ +.||.|+||.||+|.++.++..||+|.+.... .....+.+.+|+.++++++||||+++++.+. +.
T Consensus 1 ~~~~~y~~~-~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~ 74 (277)
T cd06640 1 DPEELFTKL-ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYL--KG 74 (277)
T ss_pred ChHHhhhhh-hhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--EC
Confidence 355678775 44999999999999999999999999987543 2345678899999999999999999999874 46
Q ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 104 KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
..+++||||+.|++|.+++.. +++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.+ +.++|+|||++..
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~-~~~~l~dfg~~~~ 150 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQ-GDVKLADFGVAGQ 150 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCC-CCEEEccccccee
Confidence 789999999999999999875 67899999999999999999999999 9999999999999876 8999999999976
Q ss_pred hcCCC-CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 012320 184 LRGSK-SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLE 261 (466)
Q Consensus 184 ~~~~~-~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 261 (466)
..... ......++..|+|||++. ..++.++|+|||||++|+|++|..||.. .++......+..+.. .......+..
T Consensus 151 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~ 228 (277)
T cd06640 151 LTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD-MHPMRVLFLIPKNNP-PTLTGEFSKP 228 (277)
T ss_pred ccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCC-cChHhHhhhhhcCCC-CCCchhhhHH
Confidence 54322 223456889999999775 4588999999999999999999999976 444555444444433 3334455678
Q ss_pred HHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 262 AQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 262 ~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
+.++|.+||. +|.+||++.+++.||||.....
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 229 FKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred HHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 9999999995 9999999999999999976443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=327.05 Aligned_cols=251 Identities=26% Similarity=0.400 Sum_probs=202.8
Q ss_pred eeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEeEEEeccCCEEEEEEe
Q 012320 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYTSWIDVDQKTFNFITE 111 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~~~lV~E 111 (466)
.+.||+|+||+||++.+..+|+.+|+|.+.+... ......+.+|+.++.++. ||||+++++.+.. ....+++||
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~~~e 83 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWICME 83 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccC---hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEEEEe
Confidence 3569999999999999999999999999875432 245567889999999995 9999999998743 567889999
Q ss_pred cCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 112 MFTSGTLREYRK-----KYRRVDIRAIKSWARQILQGLVYLHSR-DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 112 ~~~ggsL~~~l~-----~~~~l~~~~~~~i~~qIl~gL~yLHs~-~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
|+. +++.++.. ..+.+++..+..++.|++.||+|||+. + |+||||||+||+++.+ +.+||+|||++..+.
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRN-GNIKLCDFGISGQLV 159 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccC-CcEEEeecchhHHhc
Confidence 985 45554322 246799999999999999999999974 7 9999999999999876 899999999998765
Q ss_pred CCCCCccccCCCCcCCcccccc----CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC---CCCC
Q 012320 186 GSKSAHSVIGTPEFMAPELYEE----DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAF---YSIQ 258 (466)
Q Consensus 186 ~~~~~~~~~GT~~y~APE~l~~----~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~---~~~~ 258 (466)
.........||+.|+|||++.. .++.++|||||||++|+|++|..||.......+....+..+..|... ....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd06616 160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREF 239 (288)
T ss_pred cCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCcc
Confidence 4444445578999999998763 48899999999999999999999997654433444444444333222 2236
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
+.++.+||.+||. +|++|||+++++.||||+...
T Consensus 240 ~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 240 SPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 7789999999996 999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=342.40 Aligned_cols=249 Identities=26% Similarity=0.360 Sum_probs=202.9
Q ss_pred CCceEEeeeeeeeeCceEEEEEEE-----cCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAID-----EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWI 99 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 99 (466)
.++|.. .+.||+|+||+||+|.+ ..++..||+|+++... .....+.+.+|+.+|+.+ +||||+++++.+
T Consensus 34 ~~~~~~-~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~- 108 (375)
T cd05104 34 RNRLSF-GKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHINIVNLLGAC- 108 (375)
T ss_pred hHHeeh-hheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHHHHHHHhcCCcceeeeeeee-
Confidence 446766 78899999999999963 4567899999886432 233456789999999999 899999999987
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhcC-----------------------------------------------------
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKYR----------------------------------------------------- 126 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------------------------------------- 126 (466)
.+....++||||++||+|.+++....
T Consensus 109 -~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 109 -TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred -ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 44667899999999999999986432
Q ss_pred ----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 127 ----------------------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 127 ----------------------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++...
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~-~~~kl~DfG~a~~~ 264 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHG-RITKICDFGLARDI 264 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECC-CcEEEecCccceec
Confidence 3678889999999999999999999 9999999999999876 79999999999765
Q ss_pred cCCCCC---ccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 012320 185 RGSKSA---HSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259 (466)
Q Consensus 185 ~~~~~~---~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 259 (466)
...... ....+++.|+|||++. ..++.++|||||||++|+|++ |..||........+++.+..+..+ ..+...+
T Consensus 265 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 343 (375)
T cd05104 265 RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM-LSPECAP 343 (375)
T ss_pred cCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC-CCCCCCC
Confidence 432211 1233456799999775 569999999999999999998 889998766666777777766433 2334567
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.+++++|.+||. ||++|||+.++++
T Consensus 344 ~~l~~li~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 344 SEMYDIMKSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHH
Confidence 799999999996 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=321.93 Aligned_cols=250 Identities=26% Similarity=0.467 Sum_probs=213.2
Q ss_pred eeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecCCC
Q 012320 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTS 115 (466)
Q Consensus 36 LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~~g 115 (466)
||.|+||+||+|.+..+|+.+|+|.+..... ......+.+.+|+.++++++||||+++++.+ .....+++|+||+.|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~--~~~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-IRKNQVDQVLTERDILSQAQSPYVVKLYYSF--QGKKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh-hhhhHHHHHHHHHHHHHhCCCcchhHHHHhe--ecCcEEEEEEecCCC
Confidence 6899999999999999999999999875543 2234567899999999999999999999877 457789999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCC-------
Q 012320 116 GTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK------- 188 (466)
Q Consensus 116 gsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~------- 188 (466)
++|.+++.+.+.+++..+..++.||+.||.|||+.+ ++||||+|+||+++.+ +.+||+|||++.......
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCC-CCEEEEecccchhcccCcccccccc
Confidence 999999998889999999999999999999999999 9999999999999987 899999999987643321
Q ss_pred --CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 012320 189 --SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRF 265 (466)
Q Consensus 189 --~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~l 265 (466)
......+++.|+|||... ..++.++||||||+++|+|++|..||.. ....+.+..+..+..+.......+..+.++
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSDEAIDL 233 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCcCCCccccCCHHHHHH
Confidence 223456889999999765 4588899999999999999999999976 566777777777665433332347899999
Q ss_pred HHHhcc-CcCCCCCH---HHHhcCCCCCchh
Q 012320 266 IGRCLV-NASKRLSA---KELLLDPFLASDE 292 (466)
Q Consensus 266 I~~~L~-dp~~Rpsa---~elL~hpf~~~~~ 292 (466)
+.+||. +|.+|||+ .++|+||||.+..
T Consensus 234 i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 234 ISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred HHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 999996 99999999 9999999997654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=325.74 Aligned_cols=251 Identities=27% Similarity=0.437 Sum_probs=202.9
Q ss_pred eEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEE
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNF 108 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~l 108 (466)
|.. .+.||.|++|+||+|.++.+|..||+|.+..... .......+.+|++++++++||||+++++++ .+...+++
T Consensus 2 y~~-~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~~ 76 (284)
T cd07860 2 FQK-VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVI--HTENKLYL 76 (284)
T ss_pred cee-eeeecCCCceEEEEEEECCCCCEEEEEEcccccc--ccccchHHHHHHHHHHhcCCCCCcchhhhc--ccCCcEEE
Confidence 555 4569999999999999999999999998875432 223345788999999999999999999987 45678999
Q ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 109 ITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 109 V~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
||||+. ++|..++... ..+++..+..++.||+.||.|||+.+ ++||||+|+||+++.+ +.+||+|||++..+..
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~-~~~~l~dfg~~~~~~~ 152 (284)
T cd07860 77 VFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFGV 152 (284)
T ss_pred Eeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEEeeccchhhccc
Confidence 999995 6898888653 56899999999999999999999999 9999999999999977 8999999999876543
Q ss_pred CC-CCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC-----------
Q 012320 187 SK-SAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG----------- 252 (466)
Q Consensus 187 ~~-~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~----------- 252 (466)
.. ......+++.|+|||++.+ .++.++|||||||++|+|+||..||..........+.+.....+.
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 153 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred CccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence 22 2234467899999997753 368899999999999999999999977555444444333211110
Q ss_pred ---------------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 253 ---------------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 253 ---------------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
......+.+++++|.+||. ||.+|||+++++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0112346788999999996 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=342.63 Aligned_cols=250 Identities=25% Similarity=0.385 Sum_probs=201.0
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCC-----eEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEE
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLG-----VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSW 98 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~ 98 (466)
|.++|.+ .+.||+|+||.||+|.+..+| ..||+|.++... ..+..+.+.+|+.+++.+ +||||+++++++
T Consensus 36 ~~~~~~~-~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 36 PRDNLQF-GKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cHHHcee-hheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 4456766 677999999999999865444 579999987443 334567789999999999 899999999987
Q ss_pred EeccCCEEEEEEecCCCCCHHHHHHhc-----------------------------------------------------
Q 012320 99 IDVDQKTFNFITEMFTSGTLREYRKKY----------------------------------------------------- 125 (466)
Q Consensus 99 ~~~~~~~~~lV~E~~~ggsL~~~l~~~----------------------------------------------------- 125 (466)
.....+++||||+++|+|.+++.+.
T Consensus 112 --~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 112 --THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred --cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 4466899999999999999998642
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCC
Q 012320 126 -----------------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK 188 (466)
Q Consensus 126 -----------------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~ 188 (466)
.++++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~-~~~kL~DfGla~~~~~~~ 266 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDS 266 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCC-CeEEEeeceeeeeccCCc
Confidence 24778889999999999999999999 9999999999999876 799999999997654322
Q ss_pred C---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 189 S---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 189 ~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
. .....+++.|||||++. ..|+.++|||||||++|+|++ |..||.........++.+..+. +...+...+.+++
T Consensus 267 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 345 (374)
T cd05106 267 NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY-QMSRPDFAPPEIY 345 (374)
T ss_pred ceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc-CccCCCCCCHHHH
Confidence 1 11223566899999765 569999999999999999997 9999976544444555554442 3334445678999
Q ss_pred HHHHHhcc-CcCCCCCHHHHhc
Q 012320 264 RFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
++|.+||. +|.+|||+.++++
T Consensus 346 ~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 346 SIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 99999996 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=337.68 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=204.0
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc---
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD--- 102 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--- 102 (466)
.++|..+ +.||+|+||+||+|.++.+|..||+|.+.+.. ........+.+|+.+++.++||||+++++.|....
T Consensus 15 ~~~y~~~-~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 15 LKRYQNL-KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF--QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hcceEEE-EEeccCCCEEEEEEEECCCCCEEEEEecCccc--cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 4789885 66999999999999999999999999876432 23345567889999999999999999999875332
Q ss_pred -CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 103 -QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 103 -~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
...+|+||||+. ++|.+++... +++..+..++.||+.||.|||+.| |+||||||+||+++.+ +.+||+|||++
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~-~~~kL~Dfg~~ 165 (353)
T cd07850 92 EFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA 165 (353)
T ss_pred ccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC-CCEEEccCccc
Confidence 235799999995 5888887653 999999999999999999999999 9999999999999987 89999999999
Q ss_pred hhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--CCC--------
Q 012320 182 AILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS--GKL-------- 250 (466)
Q Consensus 182 ~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~--g~~-------- 250 (466)
.............||+.|+|||++. ..++.++|||||||++|+|++|..||..... ...+..+.. +..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 166 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH-IDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred eeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHHHh
Confidence 7765444444567899999999775 5699999999999999999999999976433 222222211 000
Q ss_pred -----------------------CCC--------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCC
Q 012320 251 -----------------------PGA--------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLA 289 (466)
Q Consensus 251 -----------------------p~~--------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~ 289 (466)
+.. .....+..++++|.+||. ||++|||+.|+|.||||.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 000 011234578999999996 999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=328.70 Aligned_cols=258 Identities=28% Similarity=0.434 Sum_probs=212.6
Q ss_pred eeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 22 ~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
..+|..+|... +.||+|+||+||+|.+..+|+.||+|.+..... ......+.+.+|+.+++.++||||+++++.+.
T Consensus 10 ~~~~~~~y~~~-~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~-- 85 (307)
T cd06607 10 KDDPEKLFTDL-REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL-- 85 (307)
T ss_pred CCCcchhhhhh-eeecCCCCeEEEEEEEcCCCcEEEEEEEecccc-CcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE--
Confidence 36778889875 669999999999999999999999999865432 23445577899999999999999999999885
Q ss_pred cCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 102 DQKTFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
+....++|+||+. |+|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||+|+||+++.+ +.+||+|||+
T Consensus 86 ~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~-~~~kL~dfg~ 161 (307)
T cd06607 86 REHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEP-GTVKLADFGS 161 (307)
T ss_pred eCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCC-CCEEEeecCc
Confidence 4667899999996 577666654 467999999999999999999999999 9999999999999877 8999999999
Q ss_pred hhhhcCCCCCccccCCCCcCCccccc----cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 012320 181 AAILRGSKSAHSVIGTPEFMAPELYE----EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 181 a~~~~~~~~~~~~~GT~~y~APE~l~----~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 256 (466)
+..... .....|++.|+|||++. +.++.++||||||+++|+|++|..||... +.......+..+..+.....
T Consensus 162 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~ 237 (307)
T cd06607 162 ASLVSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNDSPTLSSN 237 (307)
T ss_pred ceecCC---CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc-cHHHHHHHHhcCCCCCCCch
Confidence 865432 23457899999999763 45889999999999999999999999763 44444444444444433334
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
..+..++++|.+||. +|.+||++.+++.||||...
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 238 DWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred hhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 456789999999996 99999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=327.72 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=195.7
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEc----------------CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDE----------------VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH 88 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~----------------~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~H 88 (466)
|.++|.+ .+.||+|+||+||+|.+. .++..||+|.+.... .......+.+|+.+|++++|
T Consensus 3 ~~~~~~~-~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h 78 (304)
T cd05096 3 PRGHLLF-KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARNDFLKEVKILSRLKD 78 (304)
T ss_pred chhhCee-eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHHHHHHHHHHHhhcCC
Confidence 4578876 667999999999999753 245679999886432 34455678999999999999
Q ss_pred CceeEEEeEEEeccCCEEEEEEecCCCCCHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHh
Q 012320 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR-------------------RVDIRAIKSWARQILQGLVYLHS 149 (466)
Q Consensus 89 pnIv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-------------------~l~~~~~~~i~~qIl~gL~yLHs 149 (466)
|||+++++.+.+ ...+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+
T Consensus 79 ~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 156 (304)
T cd05096 79 PNIIRLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156 (304)
T ss_pred CCeeEEEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 999999998854 567899999999999999986532 36778899999999999999999
Q ss_pred CCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHH
Q 012320 150 RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEM 225 (466)
Q Consensus 150 ~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~el 225 (466)
.+ |+||||||+|||++.+ +.+||+|||++..+..... .....+++.|+|||++. +.++.++|||||||++|+|
T Consensus 157 ~~--ivH~dlkp~Nill~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 233 (304)
T cd05096 157 LN--FVHRDLATRNCLVGEN-LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233 (304)
T ss_pred CC--ccccCcchhheEEcCC-ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHH
Confidence 99 9999999999999976 8999999999976543221 22344678999999765 5699999999999999999
Q ss_pred Hh--CCCCCCCCCCHHHHHHHHhc----C--CCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHh
Q 012320 226 FT--CEYPYSECANPAQIYKKVTS----G--KLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELL 283 (466)
Q Consensus 226 lt--g~~Pf~~~~~~~~i~~~i~~----g--~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL 283 (466)
++ +..||... +..++...+.. . ......+...+..+.+++.+|+. +|.+|||+.++.
T Consensus 234 ~~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 234 LMLCKEQPYGEL-TDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred HHccCCCCCCcC-CHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 86 66788763 34444333321 1 11111233456789999999996 999999999995
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=321.58 Aligned_cols=255 Identities=30% Similarity=0.520 Sum_probs=207.4
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccC------CHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMR------SPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~------~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
+|.+ .+.||.|+||.||+|.++.+|+.+|+|.++...... .....+.+.+|+.+++.++||||+++++.+ .
T Consensus 2 ~~~~-~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~ 78 (272)
T cd06629 2 KWVK-GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE--T 78 (272)
T ss_pred ceee-cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe--c
Confidence 4555 678999999999999999999999999886432111 112345688899999999999999999976 4
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
....+++|+||++|++|.+++.+.+.+++..++.++.||+.||.|||+.+ ++||||||+||+++.+ +.++|+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~-~~~~l~d~~~~ 155 (272)
T cd06629 79 TEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDAD-GICKISDFGIS 155 (272)
T ss_pred cCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCC-CeEEEeecccc
Confidence 56789999999999999999988889999999999999999999999999 9999999999999876 89999999998
Q ss_pred hhhcCC---CCCccccCCCCcCCcccccc---CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC---CCCC
Q 012320 182 AILRGS---KSAHSVIGTPEFMAPELYEE---DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG---KLPG 252 (466)
Q Consensus 182 ~~~~~~---~~~~~~~GT~~y~APE~l~~---~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g---~~p~ 252 (466)
...... .......|+..|+|||.+.. .++.++|+||||+++++|++|..||........+.+..... .++.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP 235 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCc
Confidence 764321 11234568899999997753 37899999999999999999999997644444443332222 1222
Q ss_pred CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 253 AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 253 ~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
......+.+++++|.+||. +|.+|||+.++|+|||+
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 2333456799999999995 99999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=326.08 Aligned_cols=254 Identities=23% Similarity=0.410 Sum_probs=209.1
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
.+|.+ .+.||+|+||+||+|.+..+|..||+|++.... .......+.+|+.+++.++||||+++++.+. ....+
T Consensus 5 ~~~~~-~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~ 78 (284)
T cd06620 5 EDLET-ISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSVRKQILRELQIMHECRSPYIVSFYGAFL--NENNI 78 (284)
T ss_pred HHHHH-HHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchHHHHHHHHHHHHHHcCCCCcceEeeeEe--cCCEE
Confidence 34555 456999999999999999999999999886432 2344578899999999999999999999884 45789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHS-RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs-~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
++|+||+++++|.+++.+.+.+++..+..++.|++.||.|||+ ++ ++||||||+||+++.+ +.++|+|||++....
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~-~~~~l~d~gl~~~~~ 155 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSR-GQIKLCDFGVSGELI 155 (284)
T ss_pred EEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCC-CcEEEccCCcccchh
Confidence 9999999999999999888889999999999999999999997 57 9999999999999876 899999999986543
Q ss_pred CCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCH----------HHHHHHHhcCCCCCCC
Q 012320 186 GSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANP----------AQIYKKVTSGKLPGAF 254 (466)
Q Consensus 186 ~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~----------~~i~~~i~~g~~p~~~ 254 (466)
.. ......||..|+|||++. ..++.++|||||||++|+|++|..||...... ....+.+.....+...
T Consensus 156 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd06620 156 NS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP 234 (284)
T ss_pred hh-ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC
Confidence 32 233567999999999764 56889999999999999999999999753321 1233444433333222
Q ss_pred CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 255 YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 255 ~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
....+..+.+||.+|+. ||.+|||+.|+++||||..
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 22356789999999996 9999999999999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=319.53 Aligned_cols=252 Identities=27% Similarity=0.456 Sum_probs=210.4
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
++|.+ .+.||+|+||.||+|.++.+|..||+|.+..... ........+.+|+.+++.++||||+++++.+.+ .+..
T Consensus 2 ~~~~i-~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 77 (267)
T cd08228 2 ANFQI-EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--DNEL 77 (267)
T ss_pred cceee-eeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--CCeE
Confidence 46766 6779999999999999999999999998875443 234455678999999999999999999998854 5688
Q ss_pred EEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 107 NFITEMFTSGTLREYRKK----YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
++|+||+++++|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++.+ +.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~-~~~~l~d~g~~~ 154 (267)
T cd08228 78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCC-CCEEECccccce
Confidence 999999999999988753 345899999999999999999999999 9999999999999876 899999999987
Q ss_pred hhcCCC-CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhcCCCCCCCCCCCC
Q 012320 183 ILRGSK-SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECA-NPAQIYKKVTSGKLPGAFYSIQD 259 (466)
Q Consensus 183 ~~~~~~-~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~-~~~~i~~~i~~g~~p~~~~~~~~ 259 (466)
...... ......|++.|+|||.+. ..++.++|+||+|+++|+|++|..||.... +...+...+..+..+.......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08228 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS 234 (267)
T ss_pred eccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcC
Confidence 654322 223456899999999775 558899999999999999999999986432 44566677766666655555567
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
..+++++.+||. +|++||++.++++.
T Consensus 235 ~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 235 EKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 889999999996 99999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=326.59 Aligned_cols=257 Identities=28% Similarity=0.407 Sum_probs=206.5
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCC-HHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRS-PDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
||.+ .+.||+|+||.||+|.++.+|+.||+|.++....... ......+..|+.+++.++||||+++++.+. +...+
T Consensus 1 ~y~~-~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~ 77 (298)
T cd07841 1 RYEK-GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG--HKSNI 77 (298)
T ss_pred Ccee-eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee--cCCEE
Confidence 5666 4669999999999999999999999999986553211 223456778999999999999999999884 46789
Q ss_pred EEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 107 NFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
++||||+ +++|.+++.+.. .+++..+..++.||+.||.|||+++ |+|+||||+||+++.+ |.+||+|||++....
T Consensus 78 ~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~ 153 (298)
T cd07841 78 NLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASD-GVLKLADFGLARSFG 153 (298)
T ss_pred EEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCC-CCEEEccceeeeecc
Confidence 9999999 999999998766 7999999999999999999999999 9999999999999977 899999999997664
Q ss_pred CC-CCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CC----------
Q 012320 186 GS-KSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK-LP---------- 251 (466)
Q Consensus 186 ~~-~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~-~p---------- 251 (466)
.. .......+++.|+|||.+. ..++.++|||||||++|+|++|..||..... ...+.++.... .+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 154 SPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred CCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-HHHHHHHHHHcCCCchhhhhhccc
Confidence 33 2233346788999999774 3578999999999999999999777765333 33333332110 00
Q ss_pred ---------------CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 252 ---------------GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 252 ---------------~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
.......+..+.++|.+||. +|.+|||+.|++.||||++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 00112345688999999996 999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=323.82 Aligned_cols=254 Identities=26% Similarity=0.405 Sum_probs=199.7
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
..++|.. .+.||+|+||+||+|.++.+|..||+|.+..+.. ......+.+|+.+++.++|+||+++++.+ .+..
T Consensus 3 ~~~~y~~-~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~--~~~~ 76 (291)
T cd07870 3 AATSYLN-LEKLGEGSYATVYKGISRINGQLVALKVISMKTE---EGVPFTAIREASLLKGLKHANIVLLHDII--HTKE 76 (291)
T ss_pred ccceeEE-EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc---CCCcHHHHHHHHHHHhcCCCCEeEEEEEE--ecCC
Confidence 3567877 4669999999999999999999999999875432 12224567899999999999999999987 4467
Q ss_pred EEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 105 TFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
..++|+||+. ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++..
T Consensus 77 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~ 152 (291)
T cd07870 77 TLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYL-GELKLADFGLARA 152 (291)
T ss_pred eEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCC-CcEEEeccccccc
Confidence 8999999995 677666654 356888999999999999999999999 9999999999999876 8999999999875
Q ss_pred hcC-CCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--CC---------
Q 012320 184 LRG-SKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS--GK--------- 249 (466)
Q Consensus 184 ~~~-~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~--g~--------- 249 (466)
... ........+++.|+|||++.+ .++.++|||||||++|+|++|..||.......+....+.. +.
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 153 KSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred cCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhh
Confidence 432 122334567999999998753 4788999999999999999999999764443333222211 00
Q ss_pred --C------------CCCC-----CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 250 --L------------PGAF-----YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 250 --~------------p~~~-----~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
. +... ....+..+.+++.+||. ||++|||+.|++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 0000 01124688999999996 99999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=325.56 Aligned_cols=254 Identities=28% Similarity=0.456 Sum_probs=208.1
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
++|.. .+.||+|+||+||+|.++.+++.||+|.++.... .....+.+.+|++++++++||||+++++.+.. .+.+
T Consensus 1 ~~y~~-~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 75 (288)
T cd07833 1 NKYEV-LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRL 75 (288)
T ss_pred CceeE-EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--cccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEE
Confidence 46777 5669999999999999999999999998875432 23345778999999999999999999998854 6789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
++|+||+.++.+..+..+...+++..+..++.||+.||.|||+.+ ++||||+|+||+++.+ +.+||+|||++.....
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~-~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSES-GVLKLCDFGFARALRA 152 (288)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CCEEEEeeecccccCC
Confidence 999999998888777776677999999999999999999999999 9999999999999976 8999999999977654
Q ss_pred CC--CCccccCCCCcCCccccc-c-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCC-----------
Q 012320 187 SK--SAHSVIGTPEFMAPELYE-E-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-GKL----------- 250 (466)
Q Consensus 187 ~~--~~~~~~GT~~y~APE~l~-~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-g~~----------- 250 (466)
.. ......+++.|+|||++. . .++.++|||||||++|+|++|..||........+...... +.+
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 33 334567899999999775 4 5889999999999999999999999765444443332110 000
Q ss_pred --------CC---------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 251 --------PG---------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 251 --------p~---------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
+. .+....+.++++||.+||. +|.+|||++++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 1122336789999999995 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=329.91 Aligned_cols=257 Identities=29% Similarity=0.509 Sum_probs=210.8
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
..+...|..+ ..||+|+||.||++.+..++..||+|.+... .....+.+.+|+.+++.++||||+++++.+. .
T Consensus 18 ~~~~~~~~~~-~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~--~ 90 (292)
T cd06658 18 GDPREYLDSF-IKIGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRRELLFNEVVIMRDYHHENVVDMYNSYL--V 90 (292)
T ss_pred CchHHHHhhh-hcccCCCCeEEEEEEECCCCCEEEEEEEecc----hHHHHHHHHHHHHHHHhCCCCcHHHHHHhee--c
Confidence 3445566664 4499999999999999999999999988643 2345567899999999999999999999874 4
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
....++||||+++++|.+++.. +.+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++.
T Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~-~~~kL~dfg~~~ 166 (292)
T cd06658 91 GDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSD-GRIKLSDFGFCA 166 (292)
T ss_pred CCeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCC-CCEEEccCcchh
Confidence 6788999999999999998854 57999999999999999999999999 9999999999999877 899999999987
Q ss_pred hhcCC-CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC-CCCCCCC
Q 012320 183 ILRGS-KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG-AFYSIQD 259 (466)
Q Consensus 183 ~~~~~-~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~-~~~~~~~ 259 (466)
..... .......||+.|+|||.+. ..++.++|||||||++|+|++|..||.. .+..+....+.....+. ......+
T Consensus 167 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (292)
T cd06658 167 QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPPRVKDSHKVS 245 (292)
T ss_pred hcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCccccccccC
Confidence 65322 2233457899999999876 4588999999999999999999999976 44444445444332111 1122456
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
..+++++.+|+. +|.+|||++++++||||...
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence 789999999996 99999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=341.57 Aligned_cols=255 Identities=26% Similarity=0.400 Sum_probs=204.9
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCC
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 104 (466)
+.-|.++ +.||+||.+.||++.....+ .||+|++.... .+...+..+.+||.+|.+| .|.+||++|++- ..++
T Consensus 360 g~~Yeil-k~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~--~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE--v~d~ 433 (677)
T KOG0596|consen 360 GREYEIL-KQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLE--ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE--VTDG 433 (677)
T ss_pred cchhhHH-HhhcCCCcceeeeeecCCCc-chhhhHHHHhh--cCHHHHHHHHHHHHHHHHhcCCceEEEEeeee--ccCc
Confidence 4557775 55999999999999876644 56666554333 3666778899999999999 599999999954 5688
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRV-DIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l-~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
++|+|||+- ..+|..++++.... +.-.+++|..|+|.|+.++|.+| |||.||||.|+|+-. |.+||+|||+|..
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlVk--G~LKLIDFGIA~a 508 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLVK--GRLKLIDFGIANA 508 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEEe--eeEEeeeechhcc
Confidence 999999986 67999999887554 33689999999999999999999 999999999999864 7999999999988
Q ss_pred hcCCCC---CccccCCCCcCCcccccc------------CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q 012320 184 LRGSKS---AHSVIGTPEFMAPELYEE------------DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG 248 (466)
Q Consensus 184 ~~~~~~---~~~~~GT~~y~APE~l~~------------~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g 248 (466)
+..... ..+-+||+.||+||.+.. +.+.++||||||||||+|+.|+.||....|...-+..|...
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P 588 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDP 588 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCC
Confidence 765432 345689999999997631 15678999999999999999999997766555555666554
Q ss_pred CCCCCCCCCCCH-HHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 249 KLPGAFYSIQDL-EAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 249 ~~p~~~~~~~~~-~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.-.-.++...+. ++.++++.||. ||.+|||..|||+|||++..
T Consensus 589 ~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 589 NHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred CccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 222233333333 49999999996 99999999999999999763
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=322.81 Aligned_cols=257 Identities=30% Similarity=0.529 Sum_probs=214.2
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
.++..+|..+ ++||+|++|+||+|.++.++..+|+|.+.... ....+.+.+|+.+++.++||||+++++.+. .
T Consensus 15 ~~~~~~~~~~-~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~--~ 87 (285)
T cd06648 15 GDPRSYLDNF-VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRRELLFNEVVIMRDYQHPNIVEMYSSYL--V 87 (285)
T ss_pred CcchHhhhcc-eEeccCCCeEEEEEEECCCCCEEEEEEEeccc----hhHHHHHHHHHHHHHHcCCCChheEEEEEE--c
Confidence 4555566664 56999999999999999999999999876432 234466889999999999999999999874 4
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
....++|+||++|++|.+++.. +++++..+..++.||+.||.|||+++ |+||||+|+||+++.+ +.++|+|||++.
T Consensus 88 ~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~l~d~g~~~ 163 (285)
T cd06648 88 GDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSD-GRVKLSDFGFCA 163 (285)
T ss_pred CCeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCC-CcEEEcccccch
Confidence 6778999999999999999887 78999999999999999999999999 9999999999999876 899999999886
Q ss_pred hhcCC-CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC-CCCCC
Q 012320 183 ILRGS-KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAF-YSIQD 259 (466)
Q Consensus 183 ~~~~~-~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~-~~~~~ 259 (466)
..... .......|++.|+|||.+. ..++.++|||||||++|+|++|..||.. .+.......+..+..+... ....+
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (285)
T cd06648 164 QVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVS 242 (285)
T ss_pred hhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHhcCCCCCcccccCC
Confidence 55332 2223456899999999876 4589999999999999999999999976 5566666667665432221 22256
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
..+.+||.+||. +|.+||++.+++.||||+..
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHccCcccccC
Confidence 789999999995 99999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=331.98 Aligned_cols=264 Identities=27% Similarity=0.366 Sum_probs=210.5
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHH----------HHHHHHHHHHHHHhCCCCcee
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPD----------DLQRLYSEVHLLSTLKHDSII 92 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~----------~~~~~~~Ei~iL~~l~HpnIv 92 (466)
.+..+||..+.++||.|+||+||+|.++.+|+.||+|.++......... ....+.+|+.++++++||||+
T Consensus 4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 83 (335)
T PTZ00024 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM 83 (335)
T ss_pred cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence 4567899988899999999999999999999999999987554321100 012477899999999999999
Q ss_pred EEEeEEEeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCc
Q 012320 93 RFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQ 172 (466)
Q Consensus 93 ~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~ 172 (466)
++++++. ....+++||||+. |+|.+++.....+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.
T Consensus 84 ~~~~~~~--~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~-~~ 157 (335)
T PTZ00024 84 GLVDVYV--EGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSK-GI 157 (335)
T ss_pred eeeEEEe--cCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCC-CC
Confidence 9999874 4678999999996 699999988888999999999999999999999999 9999999999999877 89
Q ss_pred EEEeccchhhhhcC---------------CCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 012320 173 VKIGDLGLAAILRG---------------SKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSEC 235 (466)
Q Consensus 173 vKL~DFGla~~~~~---------------~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~ 235 (466)
+||+|||++..... ........+++.|+|||.+.+ .++.++|||||||++|+|++|..||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999875541 111223457889999997754 4789999999999999999999999764
Q ss_pred CCHHHHHHHHhc--CCC-----CC-------------------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 236 ANPAQIYKKVTS--GKL-----PG-------------------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 236 ~~~~~i~~~i~~--g~~-----p~-------------------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
.... ....+.. +.. +. ......+.++.++|.+||. +|++|||++++|.||||
T Consensus 238 ~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 238 NEID-QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred CHHH-HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 4333 3332221 000 00 0012335688999999996 99999999999999999
Q ss_pred Cchhh
Q 012320 289 ASDEV 293 (466)
Q Consensus 289 ~~~~~ 293 (466)
+....
T Consensus 317 ~~~~~ 321 (335)
T PTZ00024 317 KSDPL 321 (335)
T ss_pred CCCCC
Confidence 86543
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=316.55 Aligned_cols=252 Identities=27% Similarity=0.466 Sum_probs=210.2
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
||.. .+.||+|+||.||+|.++.+|..+|+|.+..... .....+.+.+|+.+++.++||||+++++.+ .....++
T Consensus 1 ~~~~-~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~--~~~~~~~ 75 (257)
T cd08225 1 RYEI-IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKEASKKEVILLAKMKHPNIVTFFASF--QENGRLF 75 (257)
T ss_pred CceE-EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc--cchhhHHHHHHHHHHHhCCCCChhhhhhee--ccCCeEE
Confidence 4655 5679999999999999999999999999876543 223456788999999999999999999977 4567899
Q ss_pred EEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 108 FITEMFTSGTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+|+||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.+...+||+|||.+....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence 9999999999999987643 4799999999999999999999999 99999999999998774457999999987664
Q ss_pred CCC-CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 186 GSK-SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 186 ~~~-~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
... ......|++.|+|||++. ..++.++|+|||||++++|++|..||.. .+..+....+..+..+.. ....+.+++
T Consensus 154 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (257)
T cd08225 154 DSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG-NNLHQLVLKICQGYFAPI-SPNFSRDLR 231 (257)
T ss_pred CCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHhcccCCCC-CCCCCHHHH
Confidence 332 223356899999999775 4588999999999999999999999976 455555555655554432 334567899
Q ss_pred HHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 264 RFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
++|.+|+. +|++|||+.++++||||
T Consensus 232 ~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 232 SLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHhccChhhCcCHHHHhhCCCC
Confidence 99999996 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=321.86 Aligned_cols=247 Identities=22% Similarity=0.346 Sum_probs=197.5
Q ss_pred eeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCCEEEEEEe
Q 012320 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQKTFNFITE 111 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~~~lV~E 111 (466)
.+.||+|+||+||+|.++.++..||+|+++.... .. ......+|+.+++++ +||||+++++.+.+...+.+++|+|
T Consensus 4 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred EeeccccccceEEEEEEcCCCcEEEEEEehhccC--Cc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 4669999999999999999999999998864421 22 223446799999988 4999999999886554478999999
Q ss_pred cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCC
Q 012320 112 MFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA 190 (466)
Q Consensus 112 ~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~ 190 (466)
|+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++. +.+||+|||++.........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD--DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC--CCeEEEecccccccccCCCc
Confidence 996 577777765 357899999999999999999999999 999999999999987 89999999999876544444
Q ss_pred ccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--CC-----------------
Q 012320 191 HSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS--GK----------------- 249 (466)
Q Consensus 191 ~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~--g~----------------- 249 (466)
....+|+.|+|||++. +.++.++|||||||++|+|++|..||.. .+.......+.. +.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPG-TNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCC-CCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 4567899999999653 3478899999999999999999999976 343333332221 10
Q ss_pred -CCCC-------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 250 -LPGA-------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 250 -~p~~-------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
.+.. .....+.+++++|.+||. +|.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0000 012346789999999996 99999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=325.23 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=204.5
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
+.|.. .+.||.|+||+||+|.++.++..+|+|.++..... ......+.+|+.++++++||||+++++.+...+...+
T Consensus 5 ~~y~~-~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 5 DEYEK-LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred hhhhh-hhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 45666 46699999999999999999999999998755432 2233467789999999999999999998866555889
Q ss_pred EEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 107 NFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
++|+||+. ++|.+++.... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.+ |.+||+|||++....
T Consensus 82 ~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~-~~~~l~d~g~~~~~~ 157 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNR-GILKICDFGLAREYG 157 (293)
T ss_pred EEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCC-CcEEEeecCceeecc
Confidence 99999996 59999887654 5899999999999999999999999 9999999999999977 899999999987664
Q ss_pred CC-CCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC--------------
Q 012320 186 GS-KSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG-------------- 248 (466)
Q Consensus 186 ~~-~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g-------------- 248 (466)
.. .......+++.|+|||.+.+ .++.++|||||||++|+|++|..||........ ...+...
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchHHHHHhhc
Confidence 43 23344568899999997753 368899999999999999999999976443332 2222110
Q ss_pred -------C--------CCCCCCCC-CCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 249 -------K--------LPGAFYSI-QDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 249 -------~--------~p~~~~~~-~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
. +...+... .+..++++|.+||. +|++|||+.|+|.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0 00111122 46789999999996 99999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=318.79 Aligned_cols=247 Identities=19% Similarity=0.260 Sum_probs=202.7
Q ss_pred CceEEeeeeeeeeCceEEEEEEEc---CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDE---VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
.+|.+ .++||+|+||.||+|.++ ..+..||+|.++... +......+.+|+.++++++||||+++++.+ ..+
T Consensus 5 ~~~~~-~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~ 78 (266)
T cd05064 5 KSIKI-ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC---SDKQRRGFLAEALTLGQFDHSNIVRLEGVI--TRG 78 (266)
T ss_pred HHeEE-eeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEE--ecC
Confidence 45655 678999999999999865 457789999887432 334456789999999999999999999987 446
Q ss_pred CEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 104 KTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
..+++||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+.+ ++||||||+|||++.+ +.+|++|||.+.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~-~~~~l~dfg~~~ 155 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSD-LVCKISGFRRLQ 155 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCC-CcEEECCCcccc
Confidence 7899999999999999999874 57899999999999999999999999 9999999999999876 899999999876
Q ss_pred hhcCCCCC--ccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 012320 183 ILRGSKSA--HSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258 (466)
Q Consensus 183 ~~~~~~~~--~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 258 (466)
........ ....+++.|+|||++. ..++.++|||||||++|+|++ |..||.. .+...+.+.+..+..+. .+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~ 233 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD-MSGQDVIKAVEDGFRLP-APRNC 233 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc-CCHHHHHHHHHCCCCCC-CCCCC
Confidence 54322111 1234567899999765 568999999999999999775 9999976 55666777777664432 34556
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+..+.+++.+|+. +|.+||++.+|++
T Consensus 234 ~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 234 PNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 7889999999996 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=315.60 Aligned_cols=247 Identities=27% Similarity=0.446 Sum_probs=209.4
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+|.. .+.||+|+||.||++.++.++..+|+|.++... .....+.+.+|+.+++.++||||+++++.+ .+...++
T Consensus 1 ~y~~-~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~ 74 (255)
T cd08219 1 QYNV-LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESF--EADGHLY 74 (255)
T ss_pred CceE-EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEE--EECCEEE
Confidence 3555 577999999999999999999999999987543 234567888999999999999999999988 4567899
Q ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 108 FITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+|+||+++++|.+++... ..+++..+..|+.||+.||.|||+++ |+|+||||+||+++.+ +.++|+|||++....
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~ 151 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQN-GKVKLGDFGSARLLT 151 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCC-CcEEEcccCcceeec
Confidence 999999999999988653 45899999999999999999999999 9999999999999876 899999999987654
Q ss_pred CCC-CCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 186 GSK-SAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 186 ~~~-~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
... ......|++.|+|||++.+ .++.++|+||||+++|+|++|..||.. .+.......+..+..+. .+...+..++
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 229 (255)
T cd08219 152 SPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA-NSWKNLILKVCQGSYKP-LPSHYSYELR 229 (255)
T ss_pred ccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC-CCHHHHHHHHhcCCCCC-CCcccCHHHH
Confidence 322 2334678999999998764 588999999999999999999999976 56666777777766543 3345677899
Q ss_pred HHHHHhcc-CcCCCCCHHHHhcC
Q 012320 264 RFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
++|.+||. +|.+|||+.+++.-
T Consensus 230 ~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 230 SLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHhCCcccCCCHHHHhhc
Confidence 99999995 99999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=322.33 Aligned_cols=252 Identities=25% Similarity=0.412 Sum_probs=199.2
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
++|.. .+.||+|++|+||+|.++.+|+.||+|.+...... .....+.+|+.+++.++||||+++++++ .+....
T Consensus 5 ~~y~~-~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~ 78 (291)
T cd07844 5 ETYKK-LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE---GAPFTAIREASLLKDLKHANIVTLHDII--HTKKTL 78 (291)
T ss_pred cceeE-EEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc---CCchhHHHHHHHHhhCCCcceeeEEEEE--ecCCeE
Confidence 56776 56799999999999999999999999998754321 1223467899999999999999999987 456789
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 107 NFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
++||||+.+ +|.+++.+. +.+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ |.+||+|||++....
T Consensus 79 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~ 154 (291)
T cd07844 79 TLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISER-GELKLADFGLARAKS 154 (291)
T ss_pred EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCC-CCEEECccccccccC
Confidence 999999974 999988764 46899999999999999999999999 9999999999999877 899999999986543
Q ss_pred CC-CCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC--C-----------
Q 012320 186 GS-KSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG--K----------- 249 (466)
Q Consensus 186 ~~-~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g--~----------- 249 (466)
.. .......+++.|+|||++. ..++.++||||+||++|+|++|..||.......+..+.+... .
T Consensus 155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 21 1122345788999999775 348899999999999999999999997654333322222110 0
Q ss_pred --------CC----CC---CCCCCC--HHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 250 --------LP----GA---FYSIQD--LEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 250 --------~p----~~---~~~~~~--~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
.+ .. .....+ .++.++|.+||. +|.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 00 001122 678899999996 99999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=321.12 Aligned_cols=247 Identities=24% Similarity=0.333 Sum_probs=205.8
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCC-----eEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLG-----VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
.|.. .+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.++++++||||+++++.+. +
T Consensus 6 ~~~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~--~ 79 (283)
T cd05048 6 AVRF-LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA---EPKVQQEFRQEAELMSDLQHPNIVCLLGVCT--K 79 (283)
T ss_pred Hcch-hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC---CHHHHHHHHHHHHHHHhcCCcccceEEEEEc--C
Confidence 4555 455999999999999876655 789999876332 3445567899999999999999999999874 4
Q ss_pred CCEEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEE
Q 012320 103 QKTFNFITEMFTSGTLREYRKKY----------------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFV 166 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv 166 (466)
....++++||+.+++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++||||||+||++
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~ 157 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLV 157 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEE
Confidence 56789999999999999999765 45788999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeccchhhhhcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHH
Q 012320 167 NGHLGQVKIGDLGLAAILRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQI 241 (466)
Q Consensus 167 ~~~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i 241 (466)
+.+ +.+||+|||++....... ......+|+.|+|||.+. ..++.++|||||||++|||++ |..||.+ .+..++
T Consensus 158 ~~~-~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~-~~~~~~ 235 (283)
T cd05048 158 GEG-LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG-FSNQEV 235 (283)
T ss_pred cCC-CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC-CCHHHH
Confidence 876 799999999987543221 123345788999999765 569999999999999999998 9999976 566778
Q ss_pred HHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 242 YKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 242 ~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
...+..+..+. .+...+.++.+++.+|+. +|.+||++.+++++
T Consensus 236 ~~~i~~~~~~~-~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 236 IEMIRSRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHcCCcCC-CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 88888776543 345567899999999996 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=314.55 Aligned_cols=256 Identities=22% Similarity=0.287 Sum_probs=206.9
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec--
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV-- 101 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-- 101 (466)
-.+.||.+ .+.||.|+|+-||++.+..++..||+|+|... +.++.+..++||+..++++|||+++++++.+..
T Consensus 18 In~~Ryri-~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~----~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 18 INNKRYRI-QRLLGEGGFSFVDLVKGLSTGHLYALKKILCH----SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred EcCceEEE-eeeecCCCceeeeeecccCcccchhhheeecc----chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 34678877 56699999999999999999999999998754 346788999999999999999999999876543
Q ss_pred -cCCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEe
Q 012320 102 -DQKTFNFITEMFTSGTLREYRKKY----RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIG 176 (466)
Q Consensus 102 -~~~~~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~ 176 (466)
.....|+++.|+..|+|.+.+... ..+++.++..|+.+|++||++||+..||.+||||||.|||+.+. +.++|.
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~-~~~vl~ 171 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS-GLPVLM 171 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC-CceEEE
Confidence 245799999999999999988653 35999999999999999999999999999999999999999876 899999
Q ss_pred ccchhhhhcC----CCC------CccccCCCCcCCcccccc----CCCChhhHHHHHHHHHHHHhCCCCCCCCCC-HHHH
Q 012320 177 DLGLAAILRG----SKS------AHSVIGTPEFMAPELYEE----DYNELVDVYSFGMCVLEMFTCEYPYSECAN-PAQI 241 (466)
Q Consensus 177 DFGla~~~~~----~~~------~~~~~GT~~y~APE~l~~----~y~~~~DIwSlGvil~elltg~~Pf~~~~~-~~~i 241 (466)
|||.++...- ... ...-..|..|.|||++.- ..++++|||||||++|.|+.|..||...-. -..+
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl 251 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL 251 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence 9999876421 111 112246899999998863 378999999999999999999999943100 0011
Q ss_pred HHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 242 YKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 242 ~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
--++.++.+..+-....+..+.++|+.||+ ||.+||++.+|+.+
T Consensus 252 aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 252 ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 123334444333344578899999999995 99999999999853
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=326.25 Aligned_cols=260 Identities=33% Similarity=0.529 Sum_probs=213.0
Q ss_pred eeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 22 ~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
..++.++|... +.||+|+||+||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++.+.
T Consensus 14 ~~~~~~~~~~~-~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-- 86 (293)
T cd06647 14 VGDPKKKYTRF-EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKHPNIVNYLDSYL-- 86 (293)
T ss_pred ccCchhhceee-eEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHHHHHHHHHHhhcCCCCeeehhheee--
Confidence 46677899885 66999999999999999999999999886432 223467899999999999999999999884
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
.....|+|+||+++++|.+++.+ ..+++..+..++.|++.||.|||+++ ++||||||+||+++.+ +.+||+|||++
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~-~~~kL~dfg~~ 162 (293)
T cd06647 87 VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFC 162 (293)
T ss_pred eCCcEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCC-CCEEEccCcce
Confidence 46678999999999999999875 46889999999999999999999999 9999999999999876 79999999988
Q ss_pred hhhcCCC-CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 012320 182 AILRGSK-SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259 (466)
Q Consensus 182 ~~~~~~~-~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 259 (466)
....... ......|++.|+|||.+. ..++.++|+|||||++|+|++|..||........+......+..+.......+
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd06647 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242 (293)
T ss_pred ecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccC
Confidence 6554322 233456899999999775 45889999999999999999999999764443333332222322222333456
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
..++++|.+||. +|.+||++.+++.||||+...
T Consensus 243 ~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 243 AIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 789999999996 999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=323.64 Aligned_cols=259 Identities=24% Similarity=0.360 Sum_probs=202.5
Q ss_pred eeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 22 ~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
-.+..++|... +.||+|+||+||+|.++.+|+.||+|.+..... .......+.+|+.++++++||||+++++.+...
T Consensus 7 ~~~~~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (310)
T cd07865 7 FCDEVSKYEKL-AKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTK 83 (310)
T ss_pred ccchhhheEEE-EEeecCCCEEEEEEEECCCCcEEEEEEEeccCC--cCCchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence 45566789885 559999999999999999999999999875432 122234567899999999999999999977543
Q ss_pred c------CCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEE
Q 012320 102 D------QKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVK 174 (466)
Q Consensus 102 ~------~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vK 174 (466)
. ...+++|+||+. ++|.+++.+. ..+++..+..++.||+.||.|||+++ ++|+||||+||+++.+ +.+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~k 159 (310)
T cd07865 84 ATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKD-GILK 159 (310)
T ss_pred cccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCC-CcEE
Confidence 2 246799999995 5788777654 37899999999999999999999999 9999999999999877 8999
Q ss_pred EeccchhhhhcCCC-----CCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q 012320 175 IGDLGLAAILRGSK-----SAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS 247 (466)
Q Consensus 175 L~DFGla~~~~~~~-----~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~ 247 (466)
|+|||++..+.... ......++..|+|||.+.+ .++.++||||||+++|+|++|..||.. .+.......+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~-~~~~~~~~~~~~ 238 (310)
T cd07865 160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG-NTEQHQLTLISQ 238 (310)
T ss_pred ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHH
Confidence 99999997654322 1223467889999997754 378899999999999999999999966 333332222211
Q ss_pred --CCCCCC----------------------------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 248 --GKLPGA----------------------------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 248 --g~~p~~----------------------------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
|..+.. .....+..+++||.+||. ||.+|||+.++|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred HhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 111110 011235678899999996 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=332.24 Aligned_cols=257 Identities=25% Similarity=0.399 Sum_probs=204.2
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc-
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD- 102 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~- 102 (466)
+..+||.. .+.||.|+||+||+|.++.+|..||+|++..... ...+.+.+|+.+++.++||||+++++.+....
T Consensus 2 ~~~~~y~~-~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 2 DLGSRYMD-LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred CcCcceEE-EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence 45789988 4669999999999999999999999999875542 34567889999999999999999998764322
Q ss_pred -----------CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCC
Q 012320 103 -----------QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLG 171 (466)
Q Consensus 103 -----------~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g 171 (466)
...+++|+||+. ++|.+++.. +.+++..++.++.||+.||.|||+.| |+||||||+||+++...+
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~ 152 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCc
Confidence 135789999996 589888764 57999999999999999999999999 999999999999986656
Q ss_pred cEEEeccchhhhhcCCC----CCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q 012320 172 QVKIGDLGLAAILRGSK----SAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKV 245 (466)
Q Consensus 172 ~vKL~DFGla~~~~~~~----~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i 245 (466)
.+||+|||++..+.... ......||+.|+|||++. ..++.++|||||||++|+|++|..||..... ......+
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~-~~~~~~~ 231 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE-LEQMQLI 231 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH
Confidence 89999999987653221 112346889999999764 3588999999999999999999999976433 3322222
Q ss_pred hcCC------------------------CCC----CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 246 TSGK------------------------LPG----AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 246 ~~g~------------------------~p~----~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
.... .+. ......+.++++||.+||. ||.+|||+.++|.||||+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 1110 000 0112356789999999996 9999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=321.99 Aligned_cols=257 Identities=28% Similarity=0.354 Sum_probs=201.5
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEeEEEeccC--
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYTSWIDVDQ-- 103 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~-- 103 (466)
++|.+ .+.||+|+||+||+|.+..+|+.||+|.+..... .......+.+|+.+++.+. ||||+++++.+...+.
T Consensus 1 ~~y~~-~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 77 (295)
T cd07837 1 DAYEK-LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD--EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG 77 (295)
T ss_pred CCceE-eeEecccCCeEEEEEEECCCCcEEEEEeehhhcc--ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence 46777 4669999999999999999999999998765432 2223456788999999995 6999999998754322
Q ss_pred -CEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEec
Q 012320 104 -KTFNFITEMFTSGTLREYRKKY-----RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGD 177 (466)
Q Consensus 104 -~~~~lV~E~~~ggsL~~~l~~~-----~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~D 177 (466)
..+|+||||+.+ +|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+.+.+||+|
T Consensus 78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~d 154 (295)
T cd07837 78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIAD 154 (295)
T ss_pred CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEee
Confidence 248899999975 788887543 35799999999999999999999999 999999999999998448999999
Q ss_pred cchhhhhcCC-CCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC---
Q 012320 178 LGLAAILRGS-KSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP--- 251 (466)
Q Consensus 178 FGla~~~~~~-~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p--- 251 (466)
||++..+... .......+++.|+|||++. ..++.++|||||||++|+|++|..||.......+..+....-..|
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 155 LGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred cccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9998765322 2223346789999999775 347899999999999999999999998755544443332210000
Q ss_pred ---------------C-------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCC
Q 012320 252 ---------------G-------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLA 289 (466)
Q Consensus 252 ---------------~-------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~ 289 (466)
. ......+.++.+||.+||. +|.+||++.|++.||||+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0 0012356789999999996 999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=318.47 Aligned_cols=244 Identities=21% Similarity=0.341 Sum_probs=196.0
Q ss_pred CceEEeeee-eeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCC
Q 012320 27 GRYGLFEEV-LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 27 ~rY~~~~~~-LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 104 (466)
+.|..+..+ ||.|+||+||++.++.+|..+|+|.+....... . |+.....+ +||||+++++.+.. .+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~-----e~~~~~~~~~h~~iv~~~~~~~~--~~ 82 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----I-----EPMVHQLMKDNPNFIKLYYSVTT--LK 82 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----h-----hHHHHHHhhcCCCEEEEEEEEec--CC
Confidence 355555443 699999999999999999999999987543211 1 22222222 79999999998844 56
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.+++||||++|++|.+++.+...+++..+..++.||+.||.|||+.+ ++||||||+||+++.+.+.++|+|||++...
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 89999999999999999988889999999999999999999999999 9999999999999987339999999998765
Q ss_pred cCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHhcCCCCCCCCCCCC
Q 012320 185 RGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANP----AQIYKKVTSGKLPGAFYSIQD 259 (466)
Q Consensus 185 ~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~----~~i~~~i~~g~~p~~~~~~~~ 259 (466)
... ....||+.|+|||++. ..++.++||||+||++|+|++|..||...... ..+.... . .+.......+
T Consensus 161 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~ 234 (267)
T PHA03390 161 GTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-Q--KKLPFIKNVS 234 (267)
T ss_pred CCC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-c--ccCCcccccC
Confidence 432 2346899999999876 46899999999999999999999999753321 1122222 1 1223445678
Q ss_pred HHHHHHHHHhcc-CcCCCCC-HHHHhcCCCCC
Q 012320 260 LEAQRFIGRCLV-NASKRLS-AKELLLDPFLA 289 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rps-a~elL~hpf~~ 289 (466)
..+++||.+||. +|.+||+ ++++|+||||.
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 235 KNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 899999999996 9999996 59999999996
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=313.97 Aligned_cols=251 Identities=31% Similarity=0.523 Sum_probs=210.8
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
++|.. .+.||+|+||.||+|.+..+|+.||+|.++.... ......+.+.+|+.++++++|+||+++++.+.. .+.+
T Consensus 2 ~~y~~-~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~~~~ 77 (267)
T cd08224 2 GNFKI-EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM-MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NNEL 77 (267)
T ss_pred Cceee-eeeeccCCceEEEEEEEcCCCCEEEEEEeecccc-cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeE
Confidence 57877 6779999999999999999999999999875443 233456789999999999999999999998844 5788
Q ss_pred EEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 107 NFITEMFTSGTLREYRKKY----RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
++||||+++++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.++|+|||++.
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~-~~~~l~d~~~~~ 154 (267)
T cd08224 78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITAT-GVVKLGDLGLGR 154 (267)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCC-CcEEEeccceee
Confidence 9999999999999988642 45899999999999999999999999 9999999999999876 899999999987
Q ss_pred hhcCCC-CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCCCCCCCCCC
Q 012320 183 ILRGSK-SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSEC-ANPAQIYKKVTSGKLPGAFYSIQD 259 (466)
Q Consensus 183 ~~~~~~-~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~-~~~~~i~~~i~~g~~p~~~~~~~~ 259 (466)
.+.... ......|++.|+|||.+. ..++.++|||||||++|+|++|..||... .+...+.+.+..+..+.......+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08224 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS 234 (267)
T ss_pred eccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcC
Confidence 654322 233457899999999765 45899999999999999999999999543 344556667777766554444667
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..++++|.+||. +|.+|||+.+++.
T Consensus 235 ~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 235 EELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 799999999996 9999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=320.51 Aligned_cols=253 Identities=32% Similarity=0.519 Sum_probs=208.2
Q ss_pred eEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC---CCceeEEEeEEEeccCCE
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK---HDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~ 105 (466)
|.. .+.||+|+||.||+|.+..+|..||+|.+.... .....+.+.+|+.+++.++ ||||+++++.+. +...
T Consensus 3 y~~-~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~--~~~~ 76 (277)
T cd06917 3 YQR-LELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL--KGPR 76 (277)
T ss_pred hhh-hhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee--eCCE
Confidence 444 466999999999999999999999999887542 2345567889999999996 999999999874 4678
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+++||||+.|++|.+++.. +.+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.. +.++|+|||++..+.
T Consensus 77 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~ 152 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNT-GNVKLCDFGVAALLN 152 (277)
T ss_pred EEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCC-CCEEEccCCceeecC
Confidence 9999999999999999866 58999999999999999999999999 9999999999999976 899999999997664
Q ss_pred CCC-CCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 012320 186 GSK-SAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA 262 (466)
Q Consensus 186 ~~~-~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~ 262 (466)
... ......|++.|+|||.+.+ .++.++|+|||||++|+|++|..||... +.......+.....+.......+.++
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (277)
T cd06917 153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV-DAFRAMMLIPKSKPPRLEDNGYSKLL 231 (277)
T ss_pred CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC-ChhhhhhccccCCCCCCCcccCCHHH
Confidence 332 2344579999999997753 4788999999999999999999999763 33333333333333322222366799
Q ss_pred HHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 263 QRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 263 ~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
.+++.+||. +|.+||++.+++.||||+...
T Consensus 232 ~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 232 REFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 999999996 999999999999999996543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=342.71 Aligned_cols=260 Identities=23% Similarity=0.402 Sum_probs=217.8
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecC
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMF 113 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~ 113 (466)
+.||-|+||.|-++....|...||+|.++++++. ...+......|-.||...+.+.||+||.+| +++..+||||+|+
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl-~rnQvaHVKAERDILAEADn~WVVrLyySF--QDkdnLYFVMdYI 711 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVL-MRNQVAHVKAERDILAEADNEWVVRLYYSF--QDKDNLYFVMDYI 711 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHH-hhhhhhhhhhhhhhHhhcCCcceEEEEEEe--ccCCceEEEEecc
Confidence 4599999999999999999999999999988865 345667889999999999999999999999 6788999999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc--------
Q 012320 114 TSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-------- 185 (466)
Q Consensus 114 ~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~-------- 185 (466)
+||++..+|.+.+.|.|..+++|+.++..|+++.|..| +|||||||+|||||.+ |+|||+||||++-+.
T Consensus 712 PGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrd-GHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 712 PGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred CCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccC-Cceeeeeccccccceeccccccc
Confidence 99999999999999999999999999999999999999 9999999999999988 999999999986431
Q ss_pred -CC----------------------------------CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCC
Q 012320 186 -GS----------------------------------KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCE 229 (466)
Q Consensus 186 -~~----------------------------------~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~ 229 (466)
.+ ...++.+||+.|+|||++. .+|+..||+||.|||||||+.|.
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence 00 0124678999999999876 57999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHhcC--CCCCCCCCCCCHHHHHHHHHhccCcCCCCC---HHHHhcCCCCCchhhhhccccc
Q 012320 230 YPYSECANPAQIYKKVTSG--KLPGAFYSIQDLEAQRFIGRCLVNASKRLS---AKELLLDPFLASDEVKLLSKTK 300 (466)
Q Consensus 230 ~Pf~~~~~~~~i~~~i~~g--~~p~~~~~~~~~~~~~lI~~~L~dp~~Rps---a~elL~hpf~~~~~~~~~~~~~ 300 (466)
.||... ++.+...+|..- -+....-...+.++.++|.++..+++.|+. +.++..||||+..++..+.+.+
T Consensus 869 ~pf~~~-tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfsslRkq~ 943 (1034)
T KOG0608|consen 869 PPFLAD-TPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSSLRKQR 943 (1034)
T ss_pred CCccCC-CCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHhhhhcc
Confidence 999763 333322222221 122233455788999999999988888874 6789999999998876544333
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=318.99 Aligned_cols=251 Identities=26% Similarity=0.433 Sum_probs=200.4
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+|.. .+.||.|++|+||+|.++.+|..||+|.++.... ....+.+.+|+.++++++||||+++++.+.+ ...++
T Consensus 1 ~y~~-~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 74 (284)
T cd07836 1 NFKQ-LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHENIVRLHDVIHT--ENKLM 74 (284)
T ss_pred CceE-eeeeccCCceEEEEEEECCCCeEEEEEEeccccc---ccchHHHHHHHHHHHhhcCCCEeeeeeeEee--CCcEE
Confidence 3666 4569999999999999999999999999875532 2234567789999999999999999998844 56789
Q ss_pred EEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 108 FITEMFTSGTLREYRKKY---RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~---~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
+||||+.+ +|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.+ +.+||+|||++...
T Consensus 75 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~-~~~~l~d~g~~~~~ 150 (284)
T cd07836 75 LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKR-GELKLADFGLARAF 150 (284)
T ss_pred EEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCC-CcEEEeecchhhhh
Confidence 99999975 888887654 35899999999999999999999999 9999999999999876 89999999999765
Q ss_pred cCC-CCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC------------
Q 012320 185 RGS-KSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK------------ 249 (466)
Q Consensus 185 ~~~-~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~------------ 249 (466)
... .......+|+.|+|||++.+ .++.++|||||||++|+|++|..||..........+.+....
T Consensus 151 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 151 GIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred cCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 432 22234567899999997753 478999999999999999999999987544333222211100
Q ss_pred -------CCCC-------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 250 -------LPGA-------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 250 -------~p~~-------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
.+.. .....+..++++|.+||. +|.+||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0000 012345688999999995 99999999999999997
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=310.96 Aligned_cols=251 Identities=29% Similarity=0.542 Sum_probs=214.6
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+|.. .+.||+|+||.||+|.+..++..+|+|.+..... .......+.+|+++++.++|||++++++.+.. ...++
T Consensus 1 ~y~~-~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~ 75 (258)
T cd08215 1 KYEI-IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM--SEKEREDALNEVKILKKLNHPNIIKYYESFEE--KGKLC 75 (258)
T ss_pred CceE-EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC--ChHHHHHHHHHHHHHHhcCCCChhheEEEEec--CCEEE
Confidence 4666 4669999999999999999999999999875543 33456778999999999999999999998844 57899
Q ss_pred EEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 108 FITEMFTSGTLREYRKKY----RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
+|+|++++++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.+ +.++|+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~-~~~~l~d~~~~~~ 152 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSN-GLVKLGDFGISKV 152 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCC-CcEEECCccceee
Confidence 999999999999998764 67999999999999999999999999 9999999999999876 8999999999976
Q ss_pred hcCCC-CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 012320 184 LRGSK-SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLE 261 (466)
Q Consensus 184 ~~~~~-~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 261 (466)
..... ......|++.|+|||.+. ..++.++|+||+|+++++|++|..||.. .+..++...+..+..+. .+...+..
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~ 230 (258)
T cd08215 153 LSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG-ENLLELALKILKGQYPP-IPSQYSSE 230 (258)
T ss_pred cccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCC-CcHHHHHHHHhcCCCCC-CCCCCCHH
Confidence 54432 334457899999999765 4588999999999999999999999976 45667777766665433 34466789
Q ss_pred HHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 262 AQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 262 ~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
+.+++.+||. +|.+|||+.++|.||||
T Consensus 231 ~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 231 LRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 9999999996 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=326.47 Aligned_cols=256 Identities=30% Similarity=0.513 Sum_probs=209.9
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
++..-|..+ ..||+|+||.||+|.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++.+. ..
T Consensus 18 ~~~~~~~~~-~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~--~~ 90 (297)
T cd06659 18 DPRSLLENY-IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHQNVVEMYKSYL--VG 90 (297)
T ss_pred cchhhHHhh-hhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc----chHHHHHHHHHHHHhCCCCchhhhhhhee--eC
Confidence 444444443 459999999999999999999999999875432 23456889999999999999999999874 46
Q ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 104 KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
..+++|+||+++++|..++.. ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.+ +.+||+|||++..
T Consensus 91 ~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~-~~~kL~dfg~~~~ 166 (297)
T cd06659 91 EELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQ 166 (297)
T ss_pred CeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccC-CcEEEeechhHhh
Confidence 789999999999999997755 67899999999999999999999999 9999999999999877 8999999999876
Q ss_pred hcCC-CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC-CCCCCCCH
Q 012320 184 LRGS-KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG-AFYSIQDL 260 (466)
Q Consensus 184 ~~~~-~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~-~~~~~~~~ 260 (466)
+... .......|++.|+|||++. ..++.++|||||||++|+|++|..||.. .+..+....+.....+. ......+.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (297)
T cd06659 167 ISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNAHKISP 245 (297)
T ss_pred cccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCCCccccCCCCH
Confidence 5432 2234567999999999876 4588999999999999999999999976 44455555554433221 12234567
Q ss_pred HHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 261 EAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 261 ~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.+.++|.+||. +|.+||++.++++||||...
T Consensus 246 ~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 246 VLRDFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 89999999996 99999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=324.92 Aligned_cols=255 Identities=30% Similarity=0.518 Sum_probs=210.4
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
+...|..+ +.||+|+||.||+|.+..+|..||+|.+.... .....+.+.+|+.++++++||||+++++.+. ...
T Consensus 2 ~~~~y~~~-~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~ 75 (277)
T cd06642 2 PEELFTKL-ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYL--KGT 75 (277)
T ss_pred hHHHHHHH-HHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhcccc--cCC
Confidence 34456664 55999999999999999999999999886443 2345578899999999999999999999874 467
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.+++|+||+++++|.+++.. +.+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.+ +.+||+|||++..+
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~-~~~~l~dfg~~~~~ 151 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQ-GDVKLADFGVAGQL 151 (277)
T ss_pred ceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCC-CCEEEccccccccc
Confidence 89999999999999998864 67899999999999999999999999 9999999999999876 89999999999765
Q ss_pred cCCC-CCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 012320 185 RGSK-SAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA 262 (466)
Q Consensus 185 ~~~~-~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~ 262 (466)
.... ......|+..|+|||.+.+ .++.++|+|||||++|+|++|..||.. .++......+..+..+ ......+.++
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 229 (277)
T cd06642 152 TDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD-LHPMRVLFLIPKNSPP-TLEGQYSKPF 229 (277)
T ss_pred cCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc-cchhhHHhhhhcCCCC-CCCcccCHHH
Confidence 4322 2233568899999998764 588999999999999999999999965 3444444444444332 2334456789
Q ss_pred HHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 263 QRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 263 ~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.++|.+|+. +|.+||++.++++||||..-
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 230 KEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred HHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 999999996 99999999999999999653
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=321.13 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=203.5
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
++|... +.||+|++|+||+|.++.+|+.||+|.+..... .......+.+|+.++++++||||+++++.+. +....
T Consensus 2 ~~y~~~-~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 76 (294)
T PLN00009 2 DQYEKV-EKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVH--SEKRL 76 (294)
T ss_pred CceEEE-EEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchHHHHHHHHHHHhccCCCEeeEEEEEe--cCCeE
Confidence 467775 569999999999999999999999998865432 2223456788999999999999999999874 46789
Q ss_pred EEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 107 NFITEMFTSGTLREYRKKYRR--VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
++||||+. ++|.+++..... +++..++.++.||+.||.|||+++ ++||||||+||+++...+.+||+|||++...
T Consensus 77 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred EEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 99999995 578887765433 588899999999999999999999 9999999999999865468999999999754
Q ss_pred cCC-CCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCC----------
Q 012320 185 RGS-KSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-GKL---------- 250 (466)
Q Consensus 185 ~~~-~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-g~~---------- 250 (466)
... .......|++.|+|||.+.+ .++.++||||+||++|+|+||..||........+.+.+.. +..
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 322 22234567899999997753 4789999999999999999999999764444444433211 000
Q ss_pred --------C---CC----CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 251 --------P---GA----FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 251 --------p---~~----~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
+ .. .....+.++.++|.+||. +|.+||++.+++.||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0 00 112346788999999996 99999999999999999754
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=324.65 Aligned_cols=255 Identities=28% Similarity=0.417 Sum_probs=198.7
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcC--CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEV--LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
+|.+. +.||+|+||.||+|.++. +|..||+|.+..... ......+.+.+|+.+++.++||||+++++.+.+.....
T Consensus 1 ~y~~~-~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KYEIE-GCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS 78 (316)
T ss_pred CceEE-EEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence 46664 559999999999999998 899999999886432 12233466788999999999999999999986655578
Q ss_pred EEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeC----CCCcEEEe
Q 012320 106 FNFITEMFTSGTLREYRKKY-----RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNG----HLGQVKIG 176 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~-----~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~----~~g~vKL~ 176 (466)
+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++. . |.+||+
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~-~~~kl~ 154 (316)
T cd07842 79 VYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPER-GVVKIG 154 (316)
T ss_pred EEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCcc-ceEEEC
Confidence 999999996 4677766432 36899999999999999999999999 999999999999987 5 899999
Q ss_pred ccchhhhhcCCC----CCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHH---------HH
Q 012320 177 DLGLAAILRGSK----SAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPA---------QI 241 (466)
Q Consensus 177 DFGla~~~~~~~----~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~---------~i 241 (466)
|||++....... .....++|+.|+|||++.+ .++.++|||||||++|+|++|..||....... .+
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL 234 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence 999997654322 1234578999999997653 48899999999999999999999996532211 00
Q ss_pred HHHHh---------------------------cCCCCC-C------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCC
Q 012320 242 YKKVT---------------------------SGKLPG-A------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDP 286 (466)
Q Consensus 242 ~~~i~---------------------------~g~~p~-~------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hp 286 (466)
.+.+. ....+. . .....+..+.++|.+||. ||++|||+.|++.||
T Consensus 235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~ 314 (316)
T cd07842 235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHP 314 (316)
T ss_pred HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCC
Confidence 00000 000000 0 001455688999999996 999999999999999
Q ss_pred CC
Q 012320 287 FL 288 (466)
Q Consensus 287 f~ 288 (466)
||
T Consensus 315 ~f 316 (316)
T cd07842 315 YF 316 (316)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=321.78 Aligned_cols=254 Identities=26% Similarity=0.414 Sum_probs=205.3
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
++|... ++||+|+||.||+|.++.+|+.||+|.+..... .....+.+.+|+++++.++||||+++++.+ .+...+
T Consensus 1 ~~y~~~-~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~ 75 (286)
T cd07846 1 EKYENL-GLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLRHENLVNLIEVF--RRKKRL 75 (286)
T ss_pred CceeEe-eeeccCCCeEEEEEEECCCCCEEEEEeHhhccC--cchhhHHHHHHHHHHHhcCCcchhhHHHhc--ccCCeE
Confidence 367764 669999999999999999999999998765432 223446788899999999999999999987 457789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
++|+||+.+++|..+......+++..+..++.||+.||.|||+.+ ++||||+|+||+++.+ +.+||+|||++.....
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~-~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTLAA 152 (286)
T ss_pred EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC-CcEEEEeeeeeeeccC
Confidence 999999999999988877677999999999999999999999999 9999999999999876 8999999999876543
Q ss_pred C-CCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CC-------------
Q 012320 187 S-KSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-GK------------- 249 (466)
Q Consensus 187 ~-~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-g~------------- 249 (466)
. .......++..|+|||++.+ .++.++|||||||++|+|++|..||..........+.... +.
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 153 PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred CccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 2 22334568999999997753 4788999999999999999999999764433322222110 00
Q ss_pred ------CCCC--------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 250 ------LPGA--------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 250 ------~p~~--------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
.+.. .....+..+.+|+.+||. +|.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0000 012346689999999996 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=318.25 Aligned_cols=254 Identities=30% Similarity=0.520 Sum_probs=211.4
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
..-|..+ +.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.++++++||||+++++.+. +...
T Consensus 3 ~~~~~~~-~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~ 76 (277)
T cd06641 3 EELFTKL-EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYL--KDTK 76 (277)
T ss_pred HHhhhhh-eeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHHHhcCCCCEeEEEEEEE--eCCe
Confidence 3445554 55999999999999999999999999876443 2334567889999999999999999999884 4678
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+++|+||+.+++|.+++.+ +.+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.+ +.++|+|||++..+.
T Consensus 77 ~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~-~~~~l~dfg~~~~~~ 152 (277)
T cd06641 77 LWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEH-GEVKLADFGVAGQLT 152 (277)
T ss_pred EEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCC-CCEEEeecccceecc
Confidence 9999999999999999865 57899999999999999999999999 9999999999999876 899999999986654
Q ss_pred CCC-CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 186 GSK-SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 186 ~~~-~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
... ......|+..|+|||.+. ..++.++|+|||||++|+|++|..||.. .+.......+..+..+ ......+.++.
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 230 (277)
T cd06641 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE-LHPMKVLFLIPKNNPP-TLEGNYSKPLK 230 (277)
T ss_pred cchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc-cchHHHHHHHhcCCCC-CCCcccCHHHH
Confidence 322 223456899999999775 4578899999999999999999999976 4555555555544433 33445678899
Q ss_pred HHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 264 RFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
++|.+||. +|.+||++.++++||||...
T Consensus 231 ~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 231 EFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 99999995 99999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=327.98 Aligned_cols=257 Identities=27% Similarity=0.394 Sum_probs=202.1
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc--
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD-- 102 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-- 102 (466)
-+++|.+ .++||+|+||+||+|.++.+|+.||+|.+.... ......++.+|+.+++.++||||+++++.+...+
T Consensus 3 ~~~~y~i-~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (336)
T cd07849 3 VGPRYQN-LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE---HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFE 78 (336)
T ss_pred cccceEE-EEEEEecCCeEEEEEEEcCCCCeEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccc
Confidence 4578887 567999999999999999999999999886322 2234567888999999999999999998764332
Q ss_pred -CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 103 -QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 103 -~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
...+++|+||+. ++|..++. .+.+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~-~~~kl~dfg~~ 153 (336)
T cd07849 79 SFNDVYIVQELME-TDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTN-CDLKICDFGLA 153 (336)
T ss_pred ccceEEEEehhcc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCC-CCEEECcccce
Confidence 246899999995 58887775 367999999999999999999999999 9999999999999877 89999999998
Q ss_pred hhhcCCC----CCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----------
Q 012320 182 AILRGSK----SAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKV---------- 245 (466)
Q Consensus 182 ~~~~~~~----~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i---------- 245 (466)
....... ......||+.|+|||.+. ..++.++|||||||++|+|++|..||.+.. .......+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~-~~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD-YLHQLNLILGVLGTPSQE 232 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHcCCCCHH
Confidence 7653221 123357899999999754 358999999999999999999999997532 22211111
Q ss_pred -----hcCC-------CCCC-------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 246 -----TSGK-------LPGA-------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 246 -----~~g~-------~p~~-------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.... .+.. .....+.++.+++.+||. +|.+|||+.+++.||||...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 1000 0000 012246679999999996 99999999999999999754
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=294.99 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=203.2
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
.|..+++ ||+|+||+||+|+++.+++.||+|.++..+- +........+||-+|+.++|.|||++++.. ..++.+-
T Consensus 3 ~ydkmek-igegtygtvfkarn~~t~eivalkrvrlddd--degvpssalreicllkelkhknivrl~dvl--hsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEK-IGEGTYGTVFKARNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVL--HSDKKLT 77 (292)
T ss_pred chHHHHh-hcCCcceeeEecccCCccceEEEEEEeccCC--CCCCcHHHHHHHHHHHHhhhcceeehhhhh--ccCceeE
Confidence 4666544 9999999999999999999999999997763 344557789999999999999999999965 5677899
Q ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 108 FITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
+|+||| ...|..|... ++.++...++.++.|++.||.+||+++ +.||||||.|+|++.+ |.+||+|||+++.+.-
T Consensus 78 lvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~n-gelkladfglarafgi 153 (292)
T KOG0662|consen 78 LVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRN-GELKLADFGLARAFGI 153 (292)
T ss_pred EeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccC-CcEEecccchhhhcCC
Confidence 999999 6678777755 478999999999999999999999999 9999999999999988 9999999999987654
Q ss_pred CC-CCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhc--CCCCCC-------
Q 012320 187 SK-SAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTS--GKLPGA------- 253 (466)
Q Consensus 187 ~~-~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~--g~~p~~------- 253 (466)
.- -.+.-+-|.+|.+|.++-+ -|+...|+||.|||+.|+.. |.+.|.+ .+.....+.|.. |...+.
T Consensus 154 pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg-~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG-NDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC-CcHHHHHHHHHHHhCCCccccCCcccc
Confidence 32 2333467999999998764 39999999999999999997 5555655 444443343321 211110
Q ss_pred ---------CC---------CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 254 ---------FY---------SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 254 ---------~~---------~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
++ ...+..-++++.++|. +|.+|++|+++|+||||..
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 00 1112356889999996 9999999999999999964
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=330.47 Aligned_cols=258 Identities=26% Similarity=0.378 Sum_probs=206.5
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC--
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ-- 103 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~-- 103 (466)
..+|.+. +.||+|+||+||+|.+..+|..||+|.+..... .......+.+|+.+++.++||||+++++.+.....
T Consensus 4 ~~~y~~~-~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 4 DTKYVPI-KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD--NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA 80 (337)
T ss_pred ccceeEE-EEeccCCCeEEEEEEecCCCCeEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence 4678885 569999999999999999999999999874321 22344567889999999999999999987754322
Q ss_pred -CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 104 -KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 104 -~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
..+++|+||+ +++|.+++.+.+.+++..+..++.||+.||.|||+++ ++||||||+||+++.+ +.+||+|||++.
T Consensus 81 ~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~ 156 (337)
T cd07858 81 FNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNAN-CDLKICDFGLAR 156 (337)
T ss_pred cCcEEEEEeCC-CCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC-CCEEECcCcccc
Confidence 4589999999 4789999988889999999999999999999999999 9999999999999877 899999999997
Q ss_pred hhcCC-CCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--C---------
Q 012320 183 ILRGS-KSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS--G--------- 248 (466)
Q Consensus 183 ~~~~~-~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~--g--------- 248 (466)
..... .......||..|+|||.+. ..++.++|||||||++|+|++|..||.+. +.......+.. |
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK-DYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHHHHHhCCCChHHhhh
Confidence 65432 2234457899999999765 35889999999999999999999999653 22221111110 0
Q ss_pred --------------CCC----CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 249 --------------KLP----GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 249 --------------~~p----~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
..+ .......+.+++++|.+||. +|.+|||++++++||||...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000 00123456789999999996 99999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=311.12 Aligned_cols=250 Identities=29% Similarity=0.471 Sum_probs=214.3
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+|.+ .+.||+|+||.||+|.++.+|+.+|+|.+..... .......+.+|+.+++.++||||+++++.+. +....+
T Consensus 1 ~y~~-~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~ 75 (256)
T cd08530 1 DFKV-LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM--SQKEREDAVNEIRILASVNHPNIISYKEAFL--DGNKLC 75 (256)
T ss_pred CceE-eeeecCCCceeEEEEEECCCCCEEEEEEEehhhc--cHHHHHHHHHHHHHHHhCCCCCchhhhhhhc--cCCEEE
Confidence 4666 4669999999999999999999999999875543 3345677889999999999999999999874 457899
Q ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 108 FITEMFTSGTLREYRKK----YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
+|+||+++++|.+++.+ ...+++..+..++.|++.||.|||+.| ++|+||+|+||+++.+ +.+||+|||++..
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~-~~~kl~d~g~~~~ 152 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVAN-DLVKIGDLGISKV 152 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecC-CcEEEeeccchhh
Confidence 99999999999998866 356899999999999999999999999 9999999999999986 7999999999977
Q ss_pred hcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 012320 184 LRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA 262 (466)
Q Consensus 184 ~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~ 262 (466)
.... ......|++.|+|||.+. ..++.++|+||||+++++|++|..||.. .+...+...+..+..+... ...+.++
T Consensus 153 ~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~ 229 (256)
T cd08530 153 LKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA-RSMQDLRYKVQRGKYPPIP-PIYSQDL 229 (256)
T ss_pred hccC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCCCc-hhhCHHH
Confidence 6544 334456899999999775 4588899999999999999999999976 5566677777777665433 3567889
Q ss_pred HHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 263 QRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 263 ~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
++++.+||. +|.+||++.++++||++
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 230 QNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 999999996 99999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=322.93 Aligned_cols=258 Identities=28% Similarity=0.437 Sum_probs=212.1
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
.++..+|..+.+ ||+|+||+||+|.+..+|..||+|.+..... ........+.+|+.+++.++|||++++++.+. +
T Consensus 17 ~~~~~~~~~~~~-lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~ 92 (313)
T cd06633 17 DDPEEIFVGLHE-IGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL--K 92 (313)
T ss_pred CCHHHHhhccee-eccCCCeEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHHhCCCCCCccEEEEEE--e
Confidence 666777877544 9999999999999999999999999875542 23345567889999999999999999999874 4
Q ss_pred CCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 103 QKTFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
....|+||||+. |+|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.+ +.+||+|||++
T Consensus 93 ~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~-~~~kL~dfg~~ 168 (313)
T cd06633 93 EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEP-GQVKLADFGSA 168 (313)
T ss_pred CCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCC-CCEEEeecCCC
Confidence 678999999995 577776654 457899999999999999999999999 9999999999999876 89999999988
Q ss_pred hhhcCCCCCccccCCCCcCCccccc----cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 012320 182 AILRGSKSAHSVIGTPEFMAPELYE----EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSI 257 (466)
Q Consensus 182 ~~~~~~~~~~~~~GT~~y~APE~l~----~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 257 (466)
.... ......|++.|+|||++. +.++.++|||||||++|+|++|..||........+ ..+..+..+......
T Consensus 169 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~ 244 (313)
T cd06633 169 SKSS---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQNDSPTLQSNE 244 (313)
T ss_pred cccC---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhcCCCCCCccc
Confidence 5432 233567899999999763 45888999999999999999999999774443444 344444444444445
Q ss_pred CCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 258 QDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 258 ~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
.+..+++|+.+||. +|.+||++.+++.||||....
T Consensus 245 ~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 245 WTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 56789999999995 999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=311.83 Aligned_cols=241 Identities=22% Similarity=0.355 Sum_probs=197.1
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecC
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMF 113 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~ 113 (466)
+.||+|+||+||+|.++.+|..+|+|.+.... ..+....+.+|+.+++.++||||+++++.+ .....+++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL---PPDLKAKFLQEARILKQYSHPNIVRLIGVC--TQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEE--cCCCCeEEEEeec
Confidence 35999999999999999999999999875322 344557899999999999999999999987 4467899999999
Q ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCC--
Q 012320 114 TSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA-- 190 (466)
Q Consensus 114 ~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~-- 190 (466)
.+++|.+++.+. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.+ +.+||+|||++.........
T Consensus 76 ~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 76 QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEK-NVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred cCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCC-CcEEECccccCccccccccccc
Confidence 999999998764 46899999999999999999999999 9999999999999876 79999999998754332111
Q ss_pred -ccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 012320 191 -HSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIG 267 (466)
Q Consensus 191 -~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~ 267 (466)
....++..|+|||.+. +.++.++|||||||++|+|++ |..||.. .+.......+..+.. ...+...+..+.+++.
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~ 230 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN-LSNQQTREAIEQGVR-LPCPELCPDAVYRLME 230 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc-cCHHHHHHHHHcCCC-CCCcccCCHHHHHHHH
Confidence 1112345799999775 458999999999999999998 8888865 444555555554432 2344556789999999
Q ss_pred Hhcc-CcCCCCCHHHHhc
Q 012320 268 RCLV-NASKRLSAKELLL 284 (466)
Q Consensus 268 ~~L~-dp~~Rpsa~elL~ 284 (466)
+||. +|.+|||+.++++
T Consensus 231 ~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 231 RCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 9996 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=317.73 Aligned_cols=248 Identities=24% Similarity=0.362 Sum_probs=205.2
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEc-----CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDE-----VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
.++|.. .+.||+|+||+||+|.+. .++..||+|.+.... ..+..+.+.+|+++|+.++||||+++++.+.
T Consensus 4 ~~~~~~-~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~- 78 (280)
T cd05049 4 RDTIVL-KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA---SNDARKDFEREAELLTNFQHENIVKFYGVCT- 78 (280)
T ss_pred hHHhhH-HhhccccCCceEeeeeeccccCcCCcceEEEEeecccC---CHHHHHHHHHHHHHHHhcCCCCchheeeEEe-
Confidence 345666 466999999999999874 446889999886432 2334578899999999999999999999874
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEE
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKKYR--------------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFV 166 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv 166 (466)
.....++||||++|++|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+||++
T Consensus 79 -~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili 155 (280)
T cd05049 79 -EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLV 155 (280)
T ss_pred -cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEE
Confidence 4578999999999999999997643 3788999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeccchhhhhcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHH
Q 012320 167 NGHLGQVKIGDLGLAAILRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQI 241 (466)
Q Consensus 167 ~~~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i 241 (466)
+.+ +.+||+|||++....... ......+++.|+|||++. ..++.++|||||||++|+|++ |..||.. .+....
T Consensus 156 ~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~-~~~~~~ 233 (280)
T cd05049 156 GYD-LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG-LSNEEV 233 (280)
T ss_pred cCC-CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCC-CCHHHH
Confidence 877 899999999987543221 122345678999999776 568999999999999999998 9999976 556677
Q ss_pred HHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 242 YKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 242 ~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
...+..+..+.. ....+..+++++.+||. +|.+||++.|++.
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 234 IECITQGRLLQR-PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHHcCCcCCC-CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 777877776543 34567899999999996 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=340.74 Aligned_cols=239 Identities=32% Similarity=0.455 Sum_probs=202.9
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecC
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMF 113 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~ 113 (466)
+-||.|+.|.||+|..+ ++.||||+|+ +.-..+|+-|++|+|||||.|.+++ .....++||||||
T Consensus 130 eWlGSGaQGAVF~Grl~--netVAVKKV~-----------elkETdIKHLRkLkH~NII~FkGVC--tqsPcyCIiMEfC 194 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLH--NETVAVKKVR-----------ELKETDIKHLRKLKHPNIITFKGVC--TQSPCYCIIMEFC 194 (904)
T ss_pred hhhccCcccceeeeecc--CceehhHHHh-----------hhhhhhHHHHHhccCcceeeEeeee--cCCceeEEeeecc
Confidence 44999999999999654 8999999875 1223488999999999999999976 5567899999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCCccc
Q 012320 114 TSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSV 193 (466)
Q Consensus 114 ~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~~~~ 193 (466)
..|-|...++....+.......|.++|+.|+.|||.+. |||||||.-||||..+ ..|||+|||-++......+.-++
T Consensus 195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~-d~VKIsDFGTS~e~~~~STkMSF 271 (904)
T KOG4721|consen 195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYD-DVVKISDFGTSKELSDKSTKMSF 271 (904)
T ss_pred ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeecc-ceEEeccccchHhhhhhhhhhhh
Confidence 99999999999999999999999999999999999999 9999999999999987 59999999999887766666789
Q ss_pred cCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-
Q 012320 194 IGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV- 271 (466)
Q Consensus 194 ~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~- 271 (466)
+||..|||||++. +..++|+|||||||+||||+||+.||.+-...+-|| -+-...+.-..+......++-|+++|+.
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw-GVGsNsL~LpvPstcP~GfklL~Kqcw~s 350 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW-GVGSNSLHLPVPSTCPDGFKLLLKQCWNS 350 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE-eccCCcccccCcccCchHHHHHHHHHHhc
Confidence 9999999999887 568999999999999999999999997643333222 1222333344556677789999999996
Q ss_pred CcCCCCCHHHHhcCCCCCch
Q 012320 272 NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 272 dp~~Rpsa~elL~hpf~~~~ 291 (466)
.|..|||+.++|.|-=+.+.
T Consensus 351 KpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 351 KPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred CCCCCccHHHHHHHHhhcCH
Confidence 99999999999998655543
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=315.94 Aligned_cols=250 Identities=23% Similarity=0.356 Sum_probs=202.0
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEc-----CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEE
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDE-----VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWI 99 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 99 (466)
.+++|.. .+.||+|+||+||+|.++ .++..||+|.+.... .......+.+|+.+++.++||||+++++.+
T Consensus 4 ~~~~~~~-~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~- 78 (277)
T cd05062 4 AREKITM-SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVV- 78 (277)
T ss_pred cHHHcee-eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-
Confidence 3467877 466999999999999865 346789999875332 233456788999999999999999999977
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKYR----------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH 169 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~~----------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~ 169 (466)
......++||||+++++|.+++.+.. .++...+..++.|++.||.|||+.+ ++||||||+||+++.+
T Consensus 79 -~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 79 -SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED 155 (277)
T ss_pred -cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCC
Confidence 45677899999999999999987532 2567889999999999999999999 9999999999999976
Q ss_pred CCcEEEeccchhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHH
Q 012320 170 LGQVKIGDLGLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKK 244 (466)
Q Consensus 170 ~g~vKL~DFGla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~ 244 (466)
+.+||+|||++........ .....+++.|+|||++. +.++.++|||||||++|+|++ |..||.+ .+.....+.
T Consensus 156 -~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~-~~~~~~~~~ 233 (277)
T cd05062 156 -FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-MSNEQVLRF 233 (277)
T ss_pred -CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHH
Confidence 8999999999875432211 11234578899999876 468999999999999999999 7888876 566677776
Q ss_pred HhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 245 VTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 245 i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
+..+..+. .....+..++++|.+||. +|.+|||+.|++.+
T Consensus 234 ~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 234 VMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHcCCcCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 66665433 334566789999999996 99999999999854
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=317.75 Aligned_cols=258 Identities=22% Similarity=0.377 Sum_probs=211.5
Q ss_pred eEEeeeeeeeeCceEEEEEEEc---CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCC
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDE---VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 104 (466)
|.+ .+.||.|+||.||+|.+. .+|..||+|.++...........+.+.+|+.+|+++ +||||+++++.+ ....
T Consensus 2 y~~-~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~--~~~~ 78 (290)
T cd05613 2 FEL-LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF--QTDT 78 (290)
T ss_pred cee-eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe--ecCC
Confidence 555 566999999999999875 489999999987554333333456788999999999 699999999887 4467
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.+++|+||+++++|.+++.+.+.+++..+..++.||+.||.|||+.+ ++||||||+|||++.+ +.+||+|||++...
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~ 155 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSN-GHVVLTDFGLSKEF 155 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCC-CCEEEeeCccceec
Confidence 89999999999999999998888999999999999999999999999 9999999999999876 89999999998765
Q ss_pred cCCC--CCccccCCCCcCCcccccc---CCCChhhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHhcCCCCCCCCC
Q 012320 185 RGSK--SAHSVIGTPEFMAPELYEE---DYNELVDVYSFGMCVLEMFTCEYPYSECA---NPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 185 ~~~~--~~~~~~GT~~y~APE~l~~---~y~~~~DIwSlGvil~elltg~~Pf~~~~---~~~~i~~~i~~g~~p~~~~~ 256 (466)
.... ......|+..|+|||.+.. .++.++||||||+++|+|++|..||.... ....+.+.+..+.. ..+.
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~ 233 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQ 233 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC--CCCc
Confidence 4322 2234678999999997753 47889999999999999999999996422 23344444444332 2344
Q ss_pred CCCHHHHHHHHHhcc-CcCCCC-----CHHHHhcCCCCCchhhh
Q 012320 257 IQDLEAQRFIGRCLV-NASKRL-----SAKELLLDPFLASDEVK 294 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rp-----sa~elL~hpf~~~~~~~ 294 (466)
..+..+.+++.+||. +|.+|| ++.+++.||||+...|.
T Consensus 234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 277 (290)
T cd05613 234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWD 277 (290)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHH
Confidence 567889999999996 999997 88999999999887664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=318.35 Aligned_cols=248 Identities=28% Similarity=0.444 Sum_probs=200.8
Q ss_pred eeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEec
Q 012320 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
.+.||.|++|+||+|.++.+|..||+|++..... .......+.+|+.+++.++||||+++++.+ .+....++|+||
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~--~~~~~~~iv~e~ 79 (283)
T cd07835 4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELNHPNIVRLLDVV--HSENKLYLVFEF 79 (283)
T ss_pred heEecCCCCeEEEEEEEcCCCCEEEEEEeecccc--cccchhHHHHHHHHHHhcCCCCccCHhhee--ccCCeEEEEEec
Confidence 4669999999999999999999999999876542 222335678899999999999999999987 446789999999
Q ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCC-C
Q 012320 113 FTSGTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-S 189 (466)
Q Consensus 113 ~~ggsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~-~ 189 (466)
+ +++|.+++.+.. .+++..+..++.||+.||.|||+++ ++||||+|+||+++.+ +.++|+|||++..+.... .
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 80 L-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRT 155 (283)
T ss_pred c-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCC-CcEEEeecccccccCCCccc
Confidence 9 568999988765 7999999999999999999999999 9999999999999986 899999999987653222 2
Q ss_pred CccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC------------------
Q 012320 190 AHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK------------------ 249 (466)
Q Consensus 190 ~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~------------------ 249 (466)
.....+++.|+|||++.+ .++.++|||||||++|+|++|..||.......++.+.+....
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 233467899999997753 478999999999999999999999976444343333222100
Q ss_pred -CC-------CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 250 -LP-------GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 250 -~p-------~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
++ .......+..+.++|.+||. +|.+|||+++++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 00 01123345789999999996 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=329.77 Aligned_cols=253 Identities=24% Similarity=0.351 Sum_probs=203.7
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEc-----CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeE
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDE-----VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTS 97 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~ 97 (466)
-|..||.+ .++||+|+||.||+|.+. .+++.||+|+++... .....+.+.+|+.+++++ +||||+++++.
T Consensus 4 ~~~~~~~i-~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 4 FPRDRLKL-GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cCHHHhhh-hcccccCcCceEEeccccccccccccceeeeeeccCCC---CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 35678877 577999999999999743 356889999886432 234456788999999999 89999999997
Q ss_pred EEeccCCEEEEEEecCCCCCHHHHHHhc----------------------------------------------------
Q 012320 98 WIDVDQKTFNFITEMFTSGTLREYRKKY---------------------------------------------------- 125 (466)
Q Consensus 98 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~---------------------------------------------------- 125 (466)
+.. ....+++++||+++++|.+++...
T Consensus 80 ~~~-~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (337)
T cd05054 80 CTK-PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEE 158 (337)
T ss_pred Eec-CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhccc
Confidence 753 356788999999999999988642
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCC---CCccc
Q 012320 126 ---------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK---SAHSV 193 (466)
Q Consensus 126 ---------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~---~~~~~ 193 (466)
..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++..+.... .....
T Consensus 159 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~-~~vkL~DfG~a~~~~~~~~~~~~~~~ 235 (337)
T cd05054 159 DEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDA 235 (337)
T ss_pred chhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCC-CcEEEeccccchhcccCcchhhccCC
Confidence 25788999999999999999999999 9999999999999976 899999999998753321 12234
Q ss_pred cCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc
Q 012320 194 IGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV 271 (466)
Q Consensus 194 ~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~ 271 (466)
.++..|+|||++. ..++.++|||||||++|+|++ |..||........+.+.+..+..+ ..+...+.++.+++.+||.
T Consensus 236 ~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~ 314 (337)
T cd05054 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-RAPEYATPEIYSIMLDCWH 314 (337)
T ss_pred CCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-CCCccCCHHHHHHHHHHcc
Confidence 5677899999765 569999999999999999998 999997644444455555555432 2344567889999999996
Q ss_pred -CcCCCCCHHHHhcC
Q 012320 272 -NASKRLSAKELLLD 285 (466)
Q Consensus 272 -dp~~Rpsa~elL~h 285 (466)
+|.+||++.|+++|
T Consensus 315 ~~p~~RPs~~ell~~ 329 (337)
T cd05054 315 NNPEDRPTFSELVEI 329 (337)
T ss_pred CChhhCcCHHHHHHH
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=316.88 Aligned_cols=256 Identities=21% Similarity=0.343 Sum_probs=205.8
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcC-----CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEV-----LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
.+||.+. +.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.++||||+++++.+
T Consensus 5 ~~~~~i~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-- 78 (288)
T cd05061 5 REKITLL-RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA---SLRERIEFLNEASVMKGFTCHHVVRLLGVV-- 78 (288)
T ss_pred HHHceee-eeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEE--
Confidence 4688885 669999999999997652 35689999876332 233445688999999999999999999987
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCC
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKKYR----------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHL 170 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~~~----------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~ 170 (466)
.+....++||||+++|+|.+++.+.+ ..+...+..++.||+.||.|||+++ |+||||||+||+++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~- 155 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHD- 155 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCC-
Confidence 34567899999999999999997532 3466788999999999999999999 9999999999999976
Q ss_pred CcEEEeccchhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHH
Q 012320 171 GQVKIGDLGLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKV 245 (466)
Q Consensus 171 g~vKL~DFGla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i 245 (466)
+.+||+|||++........ .....++..|+|||.+. +.++.++|||||||++|+|++ |..||.. .+..++.+.+
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-~~~~~~~~~~ 234 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-LSNEQVLKFV 234 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHH
Confidence 8999999999875432211 12234577899999775 568999999999999999998 7888876 5666677777
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc------CCCCCchh
Q 012320 246 TSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL------DPFLASDE 292 (466)
Q Consensus 246 ~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~------hpf~~~~~ 292 (466)
..+..+.. ....+..+++++.+||. +|.+|||+.++++ ||||....
T Consensus 235 ~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 235 MDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred HcCCCCCC-CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 66654332 33456789999999995 9999999999976 89987643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=317.71 Aligned_cols=257 Identities=36% Similarity=0.588 Sum_probs=214.6
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
.++...|.. .+.||.|++|.||+|.+..++..+|+|.+..... ..+.+.+|+.+++.++|+||+++++.+..
T Consensus 15 ~~~~~~~~~-~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 86 (286)
T cd06614 15 GDPRELYKN-LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLV-- 86 (286)
T ss_pred CCccccchH-hHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEE--
Confidence 467777766 4679999999999999999999999999874432 45678899999999999999999998854
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
....++|+||+.|++|.+++...+ .++...+..++.||+.||.|||+.| ++|+||||+||+++.+ +.++|+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~-~~~~l~d~~~~ 163 (286)
T cd06614 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKD-GSVKLADFGFA 163 (286)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCC-CCEEECccchh
Confidence 578999999999999999998876 8999999999999999999999999 9999999999999976 89999999998
Q ss_pred hhhcCC-CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC-CCCCCC
Q 012320 182 AILRGS-KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG-AFYSIQ 258 (466)
Q Consensus 182 ~~~~~~-~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~-~~~~~~ 258 (466)
...... .......+++.|+|||++. ..++.++|+|||||++|+|++|..||... +.......+.....+. ......
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 242 (286)
T cd06614 164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE-PPLRALFLITTKGIPPLKNPEKW 242 (286)
T ss_pred hhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCcchhhC
Confidence 765432 1223456889999999775 45899999999999999999999999763 4444444444333322 222335
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
+..++++|.+||. +|.+||++.+++.||||...
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 243 SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 6789999999996 99999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=327.69 Aligned_cols=253 Identities=24% Similarity=0.366 Sum_probs=199.4
Q ss_pred eeeeee--CceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEe
Q 012320 34 EVLGKG--AMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITE 111 (466)
Q Consensus 34 ~~LG~G--~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E 111 (466)
+.||+| +||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||++++++|. ....+++|+|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~--~~~~~~~v~e 79 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMTSWTVFT--TGSWLWVISP 79 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcceEeeeEe--cCCceEEEEe
Confidence 447777 999999999999999999999875432 3345678899999999999999999999884 4667899999
Q ss_pred cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC-C
Q 012320 112 MFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-K 188 (466)
Q Consensus 112 ~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~-~ 188 (466)
|+.+++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+|++||+.+...... .
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~-~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCC-CcEEEechHHHhhhhccCc
Confidence 99999999998865 35899999999999999999999999 9999999999999876 89999999865433211 1
Q ss_pred CC-------ccccCCCCcCCcccccc---CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--------
Q 012320 189 SA-------HSVIGTPEFMAPELYEE---DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL-------- 250 (466)
Q Consensus 189 ~~-------~~~~GT~~y~APE~l~~---~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~-------- 250 (466)
.. ....++..|+|||++.+ .++.++|||||||++|+|++|..||........+...+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccccc
Confidence 11 11234667999998754 3789999999999999999999999775444433333221100
Q ss_pred ------------------------------------CCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 251 ------------------------------------PGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 251 ------------------------------------p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
........+..+++||.+||. ||.+|||+.|+|+||||.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 000112234578999999996 9999999999999999975443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=314.43 Aligned_cols=251 Identities=29% Similarity=0.499 Sum_probs=209.3
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
++|.+ .+.||+|+||.||+|.++.+|..+|+|.+..... ........+.+|+.+++.++||||+++++.+.. .+.+
T Consensus 2 ~~y~~-~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~ 77 (267)
T cd08229 2 ANFRI-EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNEL 77 (267)
T ss_pred chhhh-hhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-hhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--CCeE
Confidence 35655 5679999999999999999999999998875442 233455688999999999999999999998854 6688
Q ss_pred EEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 107 NFITEMFTSGTLREYRKK----YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
++|+||+.|++|.+++.. ...+++..+..++.||+.||.|||+++ ++|+||||+||+++.+ +.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~-~~~~l~dfg~~~ 154 (267)
T cd08229 78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CCEEECcchhhh
Confidence 999999999999998864 346899999999999999999999999 9999999999999876 899999999987
Q ss_pred hhcCCC-CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhcCCCCCCCCCCCC
Q 012320 183 ILRGSK-SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECA-NPAQIYKKVTSGKLPGAFYSIQD 259 (466)
Q Consensus 183 ~~~~~~-~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~-~~~~i~~~i~~g~~p~~~~~~~~ 259 (466)
.+.... ......|++.|+|||.+. ..++.++|+||||+++|+|++|..||.... +.....+.+..+..+.......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08229 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 234 (267)
T ss_pred ccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCccccc
Confidence 664322 233457899999999775 458899999999999999999999996533 33455666666666555556677
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..++++|.+||. +|.+|||+.++++
T Consensus 235 ~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 235 EELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 899999999996 9999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=305.14 Aligned_cols=248 Identities=32% Similarity=0.593 Sum_probs=206.8
Q ss_pred eEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEE
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNF 108 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~l 108 (466)
|.. .+.||+|++|.||+|.+..+|..+++|++..... .....+.+|+.+++.++||||+++++.+. .....++
T Consensus 2 y~~-~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~l 74 (253)
T cd05122 2 FEI-LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYL--KKDELWI 74 (253)
T ss_pred cee-eeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEe--cCCeEEE
Confidence 444 5679999999999999999999999999875432 35678899999999999999999999874 3578899
Q ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC
Q 012320 109 ITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187 (466)
Q Consensus 109 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~ 187 (466)
++||++|++|.+++... +.+++..+..++.|++.||.|||+.+ ++||||+|+||+++.+ +.++|+|||.+......
T Consensus 75 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 75 VMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDT 151 (253)
T ss_pred EEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccC-CeEEEeecccccccccc
Confidence 99999999999998876 68999999999999999999999999 9999999999999876 89999999999776544
Q ss_pred CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC-CCHHHHHH
Q 012320 188 KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSI-QDLEAQRF 265 (466)
Q Consensus 188 ~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~-~~~~~~~l 265 (466)
.......|+..|+|||.+. ..++.++|+||||+++|+|++|..||........+.... ....+...... .+..+.++
T Consensus 152 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 230 (253)
T cd05122 152 KARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA-TNGPPGLRNPEKWSDEFKDF 230 (253)
T ss_pred ccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH-hcCCCCcCcccccCHHHHHH
Confidence 3244567899999999776 457889999999999999999999997644434333333 23222222222 26789999
Q ss_pred HHHhcc-CcCCCCCHHHHhcCCC
Q 012320 266 IGRCLV-NASKRLSAKELLLDPF 287 (466)
Q Consensus 266 I~~~L~-dp~~Rpsa~elL~hpf 287 (466)
|.+||. +|++|||+.+++.|||
T Consensus 231 i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 231 LKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHccCChhhCCCHHHHhcCCC
Confidence 999996 9999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=309.98 Aligned_cols=242 Identities=24% Similarity=0.380 Sum_probs=206.7
Q ss_pred eeeeeeCceEEEEEEEcCC---CeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEE
Q 012320 34 EVLGKGAMKTVYKAIDEVL---GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFIT 110 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~ 110 (466)
++||+|+||.||+|.+... +..||+|.+..... ....+.+.+|+.+++.++|+||+++++.+. ....+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS---EEERKDFLKEARVMKKLGHPNVVRLLGVCT--EEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc---hhHHHHHHHHHHHHhhcCCCChheeeeeec--CCCceEEEE
Confidence 3699999999999999866 99999999875432 224678899999999999999999999874 477899999
Q ss_pred ecCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 111 EMFTSGTLREYRKKY---------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 111 E~~~ggsL~~~l~~~---------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
||+++++|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++.+ +.+||+|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~-~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGED-LVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCC-CcEEEcccccc
Confidence 999999999999875 77999999999999999999999999 9999999999999987 89999999999
Q ss_pred hhhcCC---CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 012320 182 AILRGS---KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 182 ~~~~~~---~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 256 (466)
...... .......+++.|+|||.+. ..++.++|||||||++|+|++ |..||.. ....++.+.+..+... ..+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~ 230 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG-LSNEEVLEYLRKGYRL-PKPE 230 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCc
Confidence 776543 2233456789999999776 468999999999999999999 6889876 5677788888765433 2344
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
..+.++.+++.+||. +|.+|||+.+++++
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 231 YCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred cCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 557899999999996 99999999999864
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=310.51 Aligned_cols=240 Identities=22% Similarity=0.344 Sum_probs=200.9
Q ss_pred eeeeeCceEEEEEEE--cCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEec
Q 012320 35 VLGKGAMKTVYKAID--EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 35 ~LG~G~fg~Vyka~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
.||+|+||+||+|.. +.++..+|+|+++... ......+.+.+|+.+++.++||||+++++.+ . ...+++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~-~~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVRMIGIC--E-AESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC--CcHHHHHHHHHHHHHHHhCCCCCcceEEEEE--c-CCCcEEEEec
Confidence 489999999999964 5678999999886443 2344567889999999999999999999865 2 3457899999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCC---
Q 012320 113 FTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS--- 189 (466)
Q Consensus 113 ~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~--- 189 (466)
+++|+|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||.||+++.+ +.+||+|||++..+.....
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~-~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCC-CeEEECCCccccccCCCCCeee
Confidence 999999999988888999999999999999999999999 9999999999999876 7999999999976543221
Q ss_pred -CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 012320 190 -AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFI 266 (466)
Q Consensus 190 -~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI 266 (466)
.....+++.|+|||.+. ..++.++|||||||++|||++ |..||.. .+...+.+.+..+..+. .+...+.+++++|
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~l~~li 231 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG-MKGNEVTQMIESGERME-CPQRCPPEMYDLM 231 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCCCHHHHHHH
Confidence 12233467899999776 458889999999999999998 9999976 56677788888776433 4455778999999
Q ss_pred HHhcc-CcCCCCCHHHHhc
Q 012320 267 GRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 267 ~~~L~-dp~~Rpsa~elL~ 284 (466)
.+|+. +|.+||++.++..
T Consensus 232 ~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 232 KLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHhccCchhCcCHHHHHH
Confidence 99996 9999999998853
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=313.52 Aligned_cols=246 Identities=20% Similarity=0.300 Sum_probs=201.0
Q ss_pred eeeeeeeeCceEEEEEEEcCCCe--EEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc----CCE
Q 012320 32 FEEVLGKGAMKTVYKAIDEVLGV--EVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD----QKT 105 (466)
Q Consensus 32 ~~~~LG~G~fg~Vyka~~~~~g~--~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----~~~ 105 (466)
++++||+|+||+||+|.+..++. .+|+|.++... .+....+.+.+|+.+++.++||||+++++.+.... ...
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI--CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 46789999999999999887775 68999876543 24456778899999999999999999998764322 235
Q ss_pred EEEEEecCCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 106 FNFITEMFTSGTLREYRKK------YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~------~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
.++|+||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNEN-MNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCC-CCEEECCCC
Confidence 7899999999999988742 134889999999999999999999999 9999999999999876 799999999
Q ss_pred hhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 012320 180 LAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAF 254 (466)
Q Consensus 180 la~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~ 254 (466)
++..+..... .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.. ....++++.+..+..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~~- 235 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG-VENSEIYDYLRQGNRLKQ- 235 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCCCC-
Confidence 9987643221 12234677899999776 458999999999999999999 7889876 566778888887764332
Q ss_pred CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 255 YSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 255 ~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
....+..++++|.+||. +|.+|||+.+|++
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 266 (272)
T cd05075 236 PPDCLDGLYSLMSSCWLLNPKDRPSFETLRC 266 (272)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 33456789999999996 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=306.63 Aligned_cols=251 Identities=32% Similarity=0.562 Sum_probs=212.3
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+|.. .+.||+|++|.||+|.+..+++.||+|.+..... .....+.+.+|++++++++|||++++++.+. +...++
T Consensus 1 ~y~~-~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~ 75 (254)
T cd06627 1 NYQL-GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVKYIGSIE--TSDSLY 75 (254)
T ss_pred Ccee-eeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc--CHHHHHHHHHHHHHHHhCCCCCccEEEEEEE--eCCEEE
Confidence 4666 5779999999999999999999999999876543 2346678999999999999999999999774 467899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~ 187 (466)
+|+|++.+++|.+++.+.+.+++..+..++.|++.||.|||+.+ |+||||||+||+++.+ +.++|+|||++......
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 76 IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKD-GVVKLADFGVATKLNDV 152 (254)
T ss_pred EEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCC-CCEEEeccccceecCCC
Confidence 99999999999999998889999999999999999999999999 9999999999999876 89999999999776543
Q ss_pred CC-CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 012320 188 KS-AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRF 265 (466)
Q Consensus 188 ~~-~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~l 265 (466)
.. .....|++.|+|||.+. ..++.++||||+|+++|+|++|..||..........+. .....+ ..+...+..++++
T Consensus 153 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~ 230 (254)
T cd06627 153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI-VQDDHP-PLPEGISPELKDF 230 (254)
T ss_pred cccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH-hccCCC-CCCCCCCHHHHHH
Confidence 22 23456899999999765 34788999999999999999999999764443334443 333332 3445567899999
Q ss_pred HHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 266 IGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 266 I~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
+.+||. +|++|||+.+++.||||
T Consensus 231 i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 231 LMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHhCChhhCcCHHHHhcCCCC
Confidence 999996 99999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=315.57 Aligned_cols=251 Identities=28% Similarity=0.508 Sum_probs=211.6
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEeEEEeccCCEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~~ 106 (466)
+|.. .+.||+|+||.||+|.++.+|..||+|.+.+.... .......+.+|+.++++++ ||||+++++.+ .+...+
T Consensus 2 ~y~~-~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~--~~~~~~ 77 (280)
T cd05581 2 DFKF-GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF--QDEENL 77 (280)
T ss_pred CceE-eeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc-chHHHHHHHHHHHHHHhcccCCCchhHHHHh--cCCceE
Confidence 5666 56699999999999999999999999998765432 3334567889999999998 99999999977 456789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
++|||++.+++|.+++.+.+.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.+ |.++|+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~-~~~~l~df~~~~~~~~ 154 (280)
T cd05581 78 YFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKD-MHIKITDFGTAKVLDP 154 (280)
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC-CCEEecCCccccccCC
Confidence 999999999999999999889999999999999999999999999 9999999999999876 8999999999876543
Q ss_pred CC---------------------CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 012320 187 SK---------------------SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKK 244 (466)
Q Consensus 187 ~~---------------------~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~ 244 (466)
.. ......|++.|+|||++. ..++.++||||||+++++|++|..||.. .+....++.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~ 233 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG-SNEYLTFQK 233 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC-ccHHHHHHH
Confidence 22 123456889999999765 4588899999999999999999999976 344555555
Q ss_pred HhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCH----HHHhcCCCC
Q 012320 245 VTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSA----KELLLDPFL 288 (466)
Q Consensus 245 i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa----~elL~hpf~ 288 (466)
+..... .++...+..+.+||.+||. +|.+||++ +++++||||
T Consensus 234 ~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKLEY--SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHhcCC--CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 554433 2334457789999999995 99999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=332.63 Aligned_cols=249 Identities=27% Similarity=0.355 Sum_probs=201.4
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcC-----CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEeEEE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEV-----LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYTSWI 99 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~ 99 (466)
.++|.+ .++||+|+||+||+|.+.. ++..||+|.+.... .....+.+.+|+++|++++ ||||++++++|
T Consensus 36 ~~~~~~-~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~- 110 (400)
T cd05105 36 RDGLVL-GRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEKQALMSELKIMTHLGPHLNIVNLLGAC- 110 (400)
T ss_pred ccceeh-hheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE-
Confidence 455555 6779999999999998643 34579999886432 2344578999999999996 99999999988
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhc------------------------------------------------------
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKY------------------------------------------------------ 125 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~------------------------------------------------------ 125 (466)
.+...+|+|||||++|+|.+++.+.
T Consensus 111 -~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 111 -TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred -ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 4567899999999999999988642
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCc
Q 012320 126 ------------------------------------------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDN 163 (466)
Q Consensus 126 ------------------------------------------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~N 163 (466)
..+++..+..++.||+.||.|||+.+ |+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~N 267 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHh
Confidence 23677888999999999999999999 9999999999
Q ss_pred EEEeCCCCcEEEeccchhhhhcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCH
Q 012320 164 IFVNGHLGQVKIGDLGLAAILRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANP 238 (466)
Q Consensus 164 Ilv~~~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~ 238 (466)
||++.+ +.+||+|||++....... ......+++.|+|||++. ..++.++|||||||++|+|++ |..||......
T Consensus 268 ill~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 268 VLLAQG-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred EEEeCC-CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 999977 799999999997653322 122345778899999765 568999999999999999997 99999775555
Q ss_pred HHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 239 AQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 239 ~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..++..+..+..+ ......+.++++++.+||. +|++||++.++.+
T Consensus 347 ~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 347 STFYNKIKSGYRM-AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHHhcCCCC-CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 6666777666432 2344567789999999996 9999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=315.45 Aligned_cols=243 Identities=25% Similarity=0.393 Sum_probs=201.6
Q ss_pred EeeeeeeeeCceEEEEEEE-----cCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 31 LFEEVLGKGAMKTVYKAID-----EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 31 ~~~~~LG~G~fg~Vyka~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.+.+.||+|+||+||+|.+ ..++..+|+|.+... .....+.+.+|+.++++++||||+++++.+. ....
T Consensus 8 ~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~ 81 (288)
T cd05093 8 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCV--EGDP 81 (288)
T ss_pred eeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCc
Confidence 3467799999999999985 345677999987632 3345677899999999999999999999874 4678
Q ss_pred EEEEEecCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCc
Q 012320 106 FNFITEMFTSGTLREYRKKYR-------------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQ 172 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~-------------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~ 172 (466)
+++|+||+++++|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+||+++.+ +.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~-~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN-LL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccC-Cc
Confidence 899999999999999997543 4899999999999999999999999 9999999999999877 89
Q ss_pred EEEeccchhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhc
Q 012320 173 VKIGDLGLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTS 247 (466)
Q Consensus 173 vKL~DFGla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~ 247 (466)
+||+|||++........ .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.. .+...+...+..
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~-~~~~~~~~~i~~ 237 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ-LSNNEVIECITQ 237 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHc
Confidence 99999999976532211 12334577899999776 558999999999999999998 8888876 556677788888
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 248 GKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 248 g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+..+. .....+.++.+++.+||. +|.+|||+.+++.
T Consensus 238 ~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 238 GRVLQ-RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCcCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 76543 334567899999999996 9999999999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=321.58 Aligned_cols=248 Identities=26% Similarity=0.442 Sum_probs=201.2
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeE----EEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVE----VAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~----vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
..+|... +.||+|+||+||+|.+..+|.. ||+|.++.. ......+.+.+|+.+++.++||||+++++.+..
T Consensus 6 ~~~f~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~- 80 (316)
T cd05108 6 ETEFKKI-KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLT- 80 (316)
T ss_pred hhhceee-eeeecCCCceEEEEEEecCCCccceeEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-
Confidence 4567764 6699999999999998666654 899987632 234456788999999999999999999998743
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
...++|+||+.+|+|.+++.+. ..++...+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||+
T Consensus 81 --~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~-~~~kl~DfG~ 155 (316)
T cd05108 81 --STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTP-QHVKITDFGL 155 (316)
T ss_pred --CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCC-CcEEEccccc
Confidence 3467999999999999999875 46899999999999999999999999 9999999999999877 7999999999
Q ss_pred hhhhcCCCCC---ccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 012320 181 AAILRGSKSA---HSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFY 255 (466)
Q Consensus 181 a~~~~~~~~~---~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~ 255 (466)
+..+...... ....++..|+|||++. ..++.++|||||||++|||++ |..||.+ ....++...+..+..+. .+
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~ 233 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-QP 233 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhCCCCCC-CC
Confidence 9876533221 1223467899999775 568999999999999999998 9999975 45556665555544322 33
Q ss_pred CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 256 ~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
...+.++.+++.+|+. +|.+||++.+++.+
T Consensus 234 ~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 234 PICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 4567789999999996 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=353.86 Aligned_cols=252 Identities=27% Similarity=0.406 Sum_probs=198.6
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.+||.+. ++||+|+||+||+|.++.+|+.||+|+++... .......+++.+|+.++++++||||+++++.+ .+.+.
T Consensus 1 igrYeIi-~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l-~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~--~d~~~ 76 (932)
T PRK13184 1 MQRYDII-RLIGKGGMGEVYLAYDPVCSRRVALKKIREDL-SENPLLKKRFLREAKIAADLIHPGIVPVYSIC--SDGDP 76 (932)
T ss_pred CCCeEEE-EEEecCCCEEEEEEEECCCCcEEEEEEECccc-ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE--eeCCE
Confidence 3789884 66999999999999999999999999987433 23344557899999999999999999999977 44678
Q ss_pred EEEEEecCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEE
Q 012320 106 FNFITEMFTSGTLREYRKKY-----------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVK 174 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~-----------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vK 174 (466)
.++||||++||+|.+++.+. ..++...+..++.||+.||.|||+.+ |+||||||+||+++.+ |.+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~d-g~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLF-GEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCC-CCEE
Confidence 99999999999999988642 23556778899999999999999999 9999999999999876 8999
Q ss_pred EeccchhhhhcCC-------------------CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 012320 175 IGDLGLAAILRGS-------------------KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSE 234 (466)
Q Consensus 175 L~DFGla~~~~~~-------------------~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~ 234 (466)
|+|||++...... ......+||+.|||||++. ..++.++|||||||++|+|+||..||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999765210 0112357999999999775 5689999999999999999999999976
Q ss_pred CCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 235 CANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 235 ~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
........................++.+.+++.+||. ||.+|++..+.+.
T Consensus 234 ~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 234 KKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred cchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 3332222222111111111223456789999999996 9999987765543
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=316.46 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=199.1
Q ss_pred CCceEEeeeeeeeeCceEEEEEE----EcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAI----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
.+||+.+.+.||+|+||+||++. ...++..||+|.++... .......+.+|+.+|+.++||||+++++.+...
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 46886667889999999998764 44678899999886442 223456788999999999999999999987655
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
....+++||||+.+++|.+++.+ ..+++..+..++.|++.||.|||+++ |+||||||+||+++.+ +.+||+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~~ 154 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDND-RLVKIGDFGLA 154 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCC-CcEEEeecccc
Confidence 56689999999999999999876 46999999999999999999999999 9999999999999877 79999999999
Q ss_pred hhhcCCCC----CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHH--------------HHH
Q 012320 182 AILRGSKS----AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPA--------------QIY 242 (466)
Q Consensus 182 ~~~~~~~~----~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~--------------~i~ 242 (466)
..+..... .....++..|+|||.+. ..++.++|||||||++|+|++|..||....... .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence 76643221 12234567799999775 568999999999999999999999985432211 111
Q ss_pred HHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 243 KKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 243 ~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..+..+.. ...+...+.++++++.+|+. +|++|||+++++.
T Consensus 235 ~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 235 ELLERGMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11111211 11234456799999999996 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=309.99 Aligned_cols=243 Identities=23% Similarity=0.383 Sum_probs=202.7
Q ss_pred eEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEE
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNF 108 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~l 108 (466)
|.. .+.||+|+||+||+|.++.++..||+|.+... ......+.+|+.+++.++||||+++++.+ .....+++
T Consensus 8 ~~~-~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~l 79 (263)
T cd05052 8 ITM-KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVC--TREPPFYI 79 (263)
T ss_pred eEE-eeecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHHHHHHHHHHHhCCCCChhheEEEE--cCCCCcEE
Confidence 444 67799999999999999999999999987632 22456788999999999999999999977 44667899
Q ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 109 ITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 109 V~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.+ +.+||+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~-~~~kl~df~~~~~~~~ 156 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGLSRLMTG 156 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCC-CcEEeCCCcccccccc
Confidence 99999999999998764 35899999999999999999999999 9999999999999876 8999999999976543
Q ss_pred CCCC--ccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 012320 187 SKSA--HSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA 262 (466)
Q Consensus 187 ~~~~--~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~ 262 (466)
.... ....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.. .+....++.+..+.. ...+...+.++
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKGYR-MERPEGCPPKV 234 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCC-CCCCCCCCHHH
Confidence 2211 1223466899999765 568899999999999999998 8899876 566777777776543 23445567899
Q ss_pred HHHHHHhcc-CcCCCCCHHHHhc
Q 012320 263 QRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 263 ~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.++|.+||. +|++|||+.++++
T Consensus 235 ~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 235 YELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHccCCcccCCCHHHHHH
Confidence 999999996 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=313.40 Aligned_cols=250 Identities=22% Similarity=0.337 Sum_probs=201.7
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcC-----CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEV-----LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
.++|.+ .+.||+|+||.||+|.++. ++..||+|.+.... .......+.+|+.+++.++||||+++++.+.
T Consensus 5 ~~~~~~-~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~- 79 (277)
T cd05036 5 RDSITL-LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC---SEQDESDFLMEALIMSKFNHQNIVRLIGVSF- 79 (277)
T ss_pred HHHcEe-eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-
Confidence 456766 4669999999999999987 78999999875332 3334467899999999999999999999774
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC--CC
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKKYR-------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH--LG 171 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~~~-------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~--~g 171 (466)
+....++||||+.|++|.+++.+.+ .+++..+..++.||+.||.|||+.+ ++||||||+||+++.+ ..
T Consensus 80 -~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~ 156 (277)
T cd05036 80 -ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGR 156 (277)
T ss_pred -cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCc
Confidence 4566789999999999999997653 4899999999999999999999999 9999999999999864 13
Q ss_pred cEEEeccchhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHh
Q 012320 172 QVKIGDLGLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVT 246 (466)
Q Consensus 172 ~vKL~DFGla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~ 246 (466)
.+||+|||++..+..... .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.. .+...+.+.+.
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~-~~~~~~~~~~~ 235 (277)
T cd05036 157 VAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG-RTNQEVMEFVT 235 (277)
T ss_pred ceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHH
Confidence 699999999976532211 11223456899999875 569999999999999999997 9999976 45556666665
Q ss_pred cCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 247 SGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 247 ~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
.+..+ ..+...+..+.+++.+||. +|.+|||+.++++|
T Consensus 236 ~~~~~-~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 236 GGGRL-DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred cCCcC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 54322 2334556789999999996 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=319.73 Aligned_cols=255 Identities=25% Similarity=0.409 Sum_probs=199.5
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc---
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD--- 102 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--- 102 (466)
.++|.+. +.||.|+||.||+|.++.+|+.+|+|++...... ......+.+|+++++.++||||+++++.+.+..
T Consensus 7 ~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 7 LRDYEIL-GKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccEEEE-EEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC--CCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 6889884 5599999999999999999999999998755421 112345678999999999999999998775433
Q ss_pred ---CCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEecc
Q 012320 103 ---QKTFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDL 178 (466)
Q Consensus 103 ---~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DF 178 (466)
...+++|+||+.+ +|...+.. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+||
T Consensus 84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~df 159 (311)
T cd07866 84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQ-GILKIADF 159 (311)
T ss_pred cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEECcC
Confidence 2368999999964 67666654 457999999999999999999999999 9999999999999987 89999999
Q ss_pred chhhhhcCCCC------------CccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 012320 179 GLAAILRGSKS------------AHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKK 244 (466)
Q Consensus 179 Gla~~~~~~~~------------~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~ 244 (466)
|++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+.......
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~-~~~~~~~~~ 238 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG-KSDIDQLHL 238 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC-CCHHHHHHH
Confidence 99976532211 123467899999997653 488999999999999999999999976 333333333
Q ss_pred Hhc--CCC-----------CC------------C---CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 245 VTS--GKL-----------PG------------A---FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 245 i~~--g~~-----------p~------------~---~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
+.. +.. +. . .....+..+.+||.+||. +|.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 221 000 00 0 011233578899999996 99999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=317.33 Aligned_cols=247 Identities=23% Similarity=0.337 Sum_probs=199.3
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCe--EEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCC
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGV--EVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~--~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 104 (466)
+|.. .++||+|+||+||+|..+.+|. .+|+|.++.. ......+.+.+|+.+++++ +||||+++++.+ ....
T Consensus 3 ~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~--~~~~ 76 (297)
T cd05089 3 DIKF-EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF---ASENDHRDFAGELEVLCKLGHHPNIINLLGAC--ENRG 76 (297)
T ss_pred ccee-eeeecCCCcceEEEEEecCCCCcceeEEEEcccc---CCHHHHHHHHHHHHHHHhhcCCCchhheEEEE--ccCC
Confidence 4555 6789999999999999988775 4677776521 2334557789999999999 799999999987 4466
Q ss_pred EEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeC
Q 012320 105 TFNFITEMFTSGTLREYRKKYR----------------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNG 168 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~ 168 (466)
.+++|+||+++++|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~ 154 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGE 154 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECC
Confidence 7899999999999999997542 4788999999999999999999999 999999999999987
Q ss_pred CCCcEEEeccchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHh
Q 012320 169 HLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVT 246 (466)
Q Consensus 169 ~~g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~ 246 (466)
+ +.+||+|||++..............+..|+|||++. ..++.++|||||||++|+|++ |..||.. .+...+..++.
T Consensus 155 ~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~-~~~~~~~~~~~ 232 (297)
T cd05089 155 N-LASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG-MTCAELYEKLP 232 (297)
T ss_pred C-CeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHh
Confidence 6 799999999986432211111222345799999775 458999999999999999997 9999976 56667777776
Q ss_pred cCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 247 SGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 247 ~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
.+..+ ..+...+..+++||.+||. +|.+|||+.++++.
T Consensus 233 ~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 233 QGYRM-EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred cCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 66433 2344567899999999996 99999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=320.63 Aligned_cols=257 Identities=27% Similarity=0.437 Sum_probs=211.0
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
.++..+|... +.||+|+||+||+|.++.++..+|+|.+..... .......++.+|+.+++.++|||++++++++..
T Consensus 11 ~~~~~~~~~~-~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 86 (308)
T cd06634 11 DDPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-- 86 (308)
T ss_pred CCcHHHHHHH-HheeeCCCEEEEEEEEcCCCcEEEEEEEecccc-cChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--
Confidence 4577778775 459999999999999999999999999875432 233455678899999999999999999998754
Q ss_pred CCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 103 QKTFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
....++|+||+. |+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.+ +.+||+|||++
T Consensus 87 ~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~ 162 (308)
T cd06634 87 EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGSA 162 (308)
T ss_pred CCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCC-CcEEECCcccc
Confidence 677899999996 577776643 456899999999999999999999999 9999999999999876 89999999998
Q ss_pred hhhcCCCCCccccCCCCcCCccccc----cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 012320 182 AILRGSKSAHSVIGTPEFMAPELYE----EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSI 257 (466)
Q Consensus 182 ~~~~~~~~~~~~~GT~~y~APE~l~----~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 257 (466)
..... .....|++.|+|||.+. +.++.++|||||||++|+|++|..||..... ......+..+..+......
T Consensus 163 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~ 238 (308)
T cd06634 163 SIMAP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNESPALQSGH 238 (308)
T ss_pred eeecC---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-HHHHHHHhhcCCCCcCccc
Confidence 76543 23456899999999763 4588899999999999999999999976433 3333344445555444456
Q ss_pred CCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 258 QDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 258 ~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.+..++++|++||. +|.+||++.++++|||+...
T Consensus 239 ~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 67889999999995 99999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=327.05 Aligned_cols=260 Identities=28% Similarity=0.416 Sum_probs=207.0
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec--cC
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV--DQ 103 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~ 103 (466)
..+|.. .+.||+|+||.||+|.++.+|..||+|.+..... .......+.+|+.+|+.++||||+++++.+... ..
T Consensus 4 ~~~y~~-~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (334)
T cd07855 4 GSRYKP-IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD--VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADF 80 (334)
T ss_pred hhceee-eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc--cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence 467877 5679999999999999999999999999875432 223456778899999999999999999876432 34
Q ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 104 KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
..+++|+||+. ++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++..
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~-~~~kl~dfg~~~~ 156 (334)
T cd07855 81 KDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNED-CELRIGDFGMARG 156 (334)
T ss_pred ceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CcEEeccccccee
Confidence 57899999995 689999987788999999999999999999999999 9999999999999976 8999999999876
Q ss_pred hcCCC-----CCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CC------
Q 012320 184 LRGSK-----SAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-GK------ 249 (466)
Q Consensus 184 ~~~~~-----~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-g~------ 249 (466)
..... .....+|+..|+|||++.+ .++.++|||||||++|+|++|..||.......++...+.. |.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 53221 1234578999999998753 4889999999999999999999999764332222111110 10
Q ss_pred --------------CCCC-------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 250 --------------LPGA-------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 250 --------------~p~~-------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
++.. .....+.+++++|.+||. +|.+|||+.+++.||||....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 0000 112356789999999996 999999999999999997543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=319.25 Aligned_cols=247 Identities=24% Similarity=0.347 Sum_probs=197.8
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEE--EEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCC
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEV--AWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~v--AiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 104 (466)
.|.. .+.||+|+||+||+|.++.+|..+ |+|.+... ........+.+|+.++.++ +||||+++++.+ ....
T Consensus 8 ~~~~-~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~--~~~~ 81 (303)
T cd05088 8 DIKF-QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGAC--EHRG 81 (303)
T ss_pred hcee-eeeecCCCCceEEEEEEccCCceeeEEEEEeccc---CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE--CCCC
Confidence 4544 677999999999999998888654 66654421 2344557788999999999 899999999987 4567
Q ss_pred EEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeC
Q 012320 105 TFNFITEMFTSGTLREYRKKYR----------------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNG 168 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~ 168 (466)
.+|+|+||+++++|.+++.+.+ .+++..+..++.||+.||.|||++| |+||||||+|||++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~ 159 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE 159 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecC
Confidence 7999999999999999997543 4789999999999999999999999 999999999999987
Q ss_pred CCCcEEEeccchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHh
Q 012320 169 HLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVT 246 (466)
Q Consensus 169 ~~g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~ 246 (466)
+ +.+||+|||++.............++..|+|||.+. ..++.++|||||||++|+|+| |..||.. .+..+..+.+.
T Consensus 160 ~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~ 237 (303)
T cd05088 160 N-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLP 237 (303)
T ss_pred C-CcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc-CChHHHHHHHh
Confidence 6 799999999986432211111223466799999776 458899999999999999998 9999965 55566676665
Q ss_pred cCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 247 SGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 247 ~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
.+..+ ..+...+.++.++|.+||. +|.+||++.+++.+
T Consensus 238 ~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 238 QGYRL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCCcC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 54322 2233456789999999996 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=315.20 Aligned_cols=258 Identities=25% Similarity=0.407 Sum_probs=206.9
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 103 (466)
.-+.|.. .+.||+|+||+||+|.++.+|+.||+|.++... .......+..|+.++..+ .||||+++++++. +.
T Consensus 13 ~~~~~~~-~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~ 86 (296)
T cd06618 13 DLNDLEN-LGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVKCYGYFI--TD 86 (296)
T ss_pred Ccchhee-eeEeeccCCeEEEEEEECCCCeEEEEEEEeccC---ChHHHHHHHHHHHHHHhccCCCchHhhheeee--cC
Confidence 3455665 567999999999999999999999999987543 223445667788777666 5999999999874 46
Q ss_pred CEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 104 KTFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHS-RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs-~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
..+++||||+ +++|.+++.. .+.+++..+..++.||+.||.|||+ .+ |+||||+|+||+++.+ +.+||+|||++
T Consensus 87 ~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~-~~~kL~dfg~~ 162 (296)
T cd06618 87 SDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDAS-GNVKLCDFGIS 162 (296)
T ss_pred CeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCC-CCEEECccccc
Confidence 7899999998 5578777765 4578999999999999999999997 57 9999999999999876 89999999999
Q ss_pred hhhcCCCCCccccCCCCcCCcccccc-----CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC-
Q 012320 182 AILRGSKSAHSVIGTPEFMAPELYEE-----DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFY- 255 (466)
Q Consensus 182 ~~~~~~~~~~~~~GT~~y~APE~l~~-----~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~- 255 (466)
..+..........+++.|+|||.+.. .++.++||||||+++|+|++|..||.......+....+..+..+....
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T cd06618 163 GRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPN 242 (296)
T ss_pred hhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCC
Confidence 77654433344568889999998753 378899999999999999999999976444455555555544332221
Q ss_pred CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 256 ~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
...+.++++||.+||. +|.+||++.+++.||||+...
T Consensus 243 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 243 EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 2356789999999995 999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=310.96 Aligned_cols=242 Identities=23% Similarity=0.360 Sum_probs=190.1
Q ss_pred eeeeeCceEEEEEEEc--CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEec
Q 012320 35 VLGKGAMKTVYKAIDE--VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 35 ~LG~G~fg~Vyka~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
.||+|+||.||+|... .++..+|+|.++... .......+.+|+.+++.++||||+++++.+ .+...+++||||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~lv~e~ 76 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLLQCLGQC--TEVTPYLLVMEF 76 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEE--cCCCCcEEEEEC
Confidence 4899999999999754 466789999876443 223345788899999999999999999977 445678999999
Q ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC
Q 012320 113 FTSGTLREYRKKYR-----RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187 (466)
Q Consensus 113 ~~ggsL~~~l~~~~-----~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~ 187 (466)
+++|+|.+++.... ..++..+..++.|++.||.|||+.+ ++||||||+||+++.+ +.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCC-CcEEECCccccccccCc
Confidence 99999999987532 3567788899999999999999999 9999999999999876 79999999998654322
Q ss_pred C---CCccccCCCCcCCcccccc--------CCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCC--C-C
Q 012320 188 K---SAHSVIGTPEFMAPELYEE--------DYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKL--P-G 252 (466)
Q Consensus 188 ~---~~~~~~GT~~y~APE~l~~--------~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~--p-~ 252 (466)
. ......|++.|+|||++.+ .++.++|||||||++|+|++ |..||....+.......+..... + +
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence 1 1223457889999998753 25789999999999999996 99999764444433333333222 1 1
Q ss_pred CCCCCCCHHHHHHHHHhccCcCCCCCHHHHhc
Q 012320 253 AFYSIQDLEAQRFIGRCLVNASKRLSAKELLL 284 (466)
Q Consensus 253 ~~~~~~~~~~~~lI~~~L~dp~~Rpsa~elL~ 284 (466)
......+..+++++++|+.+|.+|||+.+|+.
T Consensus 234 ~~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~ 265 (269)
T cd05087 234 RLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHL 265 (269)
T ss_pred ccCCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence 12234567899999999989999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=310.97 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=204.1
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCC-----CeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEE
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVL-----GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWI 99 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 99 (466)
+..+|.+ .+.||+|+||.||+|.++.. +..||+|.+.... .......+.+|+.+|+.++||||+++++.+
T Consensus 4 ~~~~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~- 78 (277)
T cd05032 4 PREKITL-IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA---SMRERIEFLNEASVMKEFNCHHVVRLLGVV- 78 (277)
T ss_pred chHHeeE-EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc---CHHHHHHHHHHHHHHHhCCCCceeEEEEEE-
Confidence 3457776 46699999999999998654 4899999875332 334456788999999999999999999987
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKYR----------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH 169 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~~----------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~ 169 (466)
......++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.+
T Consensus 79 -~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~ 155 (277)
T cd05032 79 -STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAED 155 (277)
T ss_pred -cCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCC
Confidence 44677899999999999999986532 3678899999999999999999999 9999999999999987
Q ss_pred CCcEEEeccchhhhhcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHH
Q 012320 170 LGQVKIGDLGLAAILRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKK 244 (466)
Q Consensus 170 ~g~vKL~DFGla~~~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~ 244 (466)
+.+||+|||++....... ......+|..|+|||.+. +.++.++|||||||++|+|++ |..||.. .+..+..+.
T Consensus 156 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~ 233 (277)
T cd05032 156 -LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG-LSNEEVLKF 233 (277)
T ss_pred -CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc-CCHHHHHHH
Confidence 899999999987654322 123345688999999775 568999999999999999998 8999976 566777777
Q ss_pred HhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 245 VTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 245 i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+..+..+. .+...+.++.++|.+||. +|++|||+.+++.
T Consensus 234 ~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 234 VIDGGHLD-LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HhcCCCCC-CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 77654432 334457899999999996 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=318.52 Aligned_cols=259 Identities=27% Similarity=0.422 Sum_probs=212.0
Q ss_pred eeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 21 IETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 21 ~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
-..+|...|.. .+.||+|+||+||+|.+..+|..+|+|.+..... ...+....+.+|+.+++.++|||++++++.+.
T Consensus 19 ~~~~~~~~f~~-~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 95 (317)
T cd06635 19 FKEDPEKLFTD-LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL- 95 (317)
T ss_pred cCCCchhhhhh-hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-
Confidence 34566666766 4559999999999999999999999999875433 23445578899999999999999999999874
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
+....++||||+.| +|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||+|+||+++.+ +.+||+|||
T Consensus 96 -~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~-~~~kl~dfg 170 (317)
T cd06635 96 -REHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEP-GQVKLADFG 170 (317)
T ss_pred -eCCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCC-CCEEEecCC
Confidence 46678999999965 77776654 467899999999999999999999999 9999999999999876 899999999
Q ss_pred hhhhhcCCCCCccccCCCCcCCccccc----cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 012320 180 LAAILRGSKSAHSVIGTPEFMAPELYE----EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFY 255 (466)
Q Consensus 180 la~~~~~~~~~~~~~GT~~y~APE~l~----~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~ 255 (466)
++..... .....|++.|+|||.+. +.++.++|||||||++|+|++|..||... +.......+..+..+....
T Consensus 171 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~ 246 (317)
T cd06635 171 SASIASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPTLQS 246 (317)
T ss_pred CccccCC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHhccCCCCCC
Confidence 8865432 23456899999999763 45889999999999999999999999774 4444444555544444444
Q ss_pred CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 256 ~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
...+..++++|.+||. +|.+||++.++++|||+...
T Consensus 247 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 247 NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred ccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 4567789999999996 99999999999999999653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=312.54 Aligned_cols=246 Identities=22% Similarity=0.314 Sum_probs=201.6
Q ss_pred eEEeeeeeeeeCceEEEEEEE----cCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 29 YGLFEEVLGKGAMKTVYKAID----EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
|.. .+.||+|+||+||+|.. ..++..+|+|.+.... .......+.+|+.+++.++||||+++++.+ ....
T Consensus 7 ~~~-~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~--~~~~ 80 (283)
T cd05090 7 VRF-MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN---NPQQWGEFQQEASLMAELHHPNIVCLLGVV--TQEQ 80 (283)
T ss_pred cee-eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCCeeeEEEEE--ecCC
Confidence 444 56699999999999985 3466889999886432 344557788999999999999999999977 4466
Q ss_pred EEEEEEecCCCCCHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEe
Q 012320 105 TFNFITEMFTSGTLREYRKKY-----------------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVN 167 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~-----------------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~ 167 (466)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~ 158 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIG 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEc
Confidence 789999999999999998532 24788899999999999999999999 99999999999999
Q ss_pred CCCCcEEEeccchhhhhcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHH
Q 012320 168 GHLGQVKIGDLGLAAILRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIY 242 (466)
Q Consensus 168 ~~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~ 242 (466)
.+ +.+||+|||+++...... ......++..|+|||.+. ..++.++|||||||++|+|++ |..||.+ .+...+.
T Consensus 159 ~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~-~~~~~~~ 236 (283)
T cd05090 159 EQ-LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG-FSNQEVI 236 (283)
T ss_pred CC-CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHH
Confidence 76 799999999997654322 123344677899999775 568999999999999999998 8889876 5566777
Q ss_pred HHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 243 KKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 243 ~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
+.+..+..+. .+...+..+++++.+|+. +|.+||++.+++++
T Consensus 237 ~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 237 EMVRKRQLLP-CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 7777665443 345567899999999996 99999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=307.13 Aligned_cols=244 Identities=28% Similarity=0.479 Sum_probs=210.9
Q ss_pred eeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecCCC
Q 012320 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTS 115 (466)
Q Consensus 36 LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~~g 115 (466)
||.|+||.||+|.++.+|+.+|+|.+..... ........+..|+.+++.++||||+++++.+ .....+++|||++.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-IKRKEVEHTLTERNILSRINHPFIVKLHYAF--QTEEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh-cchHHHHHHHHHHHHHHHcCCCcHHHHHHHe--ecCCeeEEEEecCCC
Confidence 6999999999999999999999999886653 2334567889999999999999999999877 457789999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC-CCCcccc
Q 012320 116 GTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-KSAHSVI 194 (466)
Q Consensus 116 gsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~-~~~~~~~ 194 (466)
++|.+++.+.+.+++..+..++.||+.||.|||+.+ ++|+||||+||+++.+ +.++|+|||++...... .......
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCC-CcEEEeecCcceecccCCCcccCCc
Confidence 999999998888999999999999999999999999 9999999999999877 89999999998765443 2344567
Q ss_pred CCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-C
Q 012320 195 GTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-N 272 (466)
Q Consensus 195 GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-d 272 (466)
|+..|+|||... ..++.++|+||||+++|+|++|..||.. .+...+.+.+..+.++ .+...+..+.++|.+||. |
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~--~~~~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKDPLR--FPEFLSPEARDLISGLLQKD 231 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHHhcCC
Confidence 899999999775 4478899999999999999999999965 4556677777665442 444557899999999995 9
Q ss_pred cCCCCCH---HHHhcCCCC
Q 012320 273 ASKRLSA---KELLLDPFL 288 (466)
Q Consensus 273 p~~Rpsa---~elL~hpf~ 288 (466)
|.+||++ ++++.||||
T Consensus 232 p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 232 PTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HhhCCCcccHHHHHhCCCC
Confidence 9999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=312.19 Aligned_cols=243 Identities=28% Similarity=0.471 Sum_probs=198.3
Q ss_pred eeeeeeeeCceEEEEEEEc----CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 32 FEEVLGKGAMKTVYKAIDE----VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 32 ~~~~LG~G~fg~Vyka~~~----~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+.+.||.|+||.||+|... ..+..|++|.++.. ......+.+.+|++++++++||||+++++.+. ....++
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~--~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS---SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI--ENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT---SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE--SSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc---cccccceeeeeccccccccccccccccccccc--cccccc
Confidence 4677999999999999987 56788999998532 24456789999999999999999999999886 445589
Q ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 108 FITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+|+||+++|+|.+++... ..++...+..|+.||+.||.|||+.+ ++|++|+|.|||++.+ +.+||+|||++....
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~-~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSN-GQVKLSDFGLSRPIS 154 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETT-TEEEEESTTTGEETT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccc-ccccccccccccccc
Confidence 999999999999999886 67999999999999999999999999 9999999999999987 799999999997763
Q ss_pred CCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 012320 186 GSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL 260 (466)
Q Consensus 186 ~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~ 260 (466)
.... .....+...|+|||.+. ..++.++||||||+++|||++ |..||.+ .+..++...+..+..+. .+...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 232 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSD-YDNEEIIEKLKQGQRLP-IPDNCPK 232 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTT-SCHHHHHHHHHTTEETT-SBTTSBH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccce-eccchhH
Confidence 2211 22344677899999876 458999999999999999999 7899977 47777778887765433 3455678
Q ss_pred HHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 261 EAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 261 ~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.+.++|.+|+. +|.+|||+.++++
T Consensus 233 ~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 233 DIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHh
Confidence 89999999995 9999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=322.82 Aligned_cols=258 Identities=27% Similarity=0.391 Sum_probs=206.9
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
....+||.++ +.||+|+||+||+|.+..+|..||+|++.... ......+.+.+|+.+|+.++||||+++++.+....
T Consensus 11 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 11 WEVPDRYRDL-KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred hccccceEEE-EEeeecCCeEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 3457889885 56999999999999999999999999886432 23334567889999999999999999999875432
Q ss_pred C----CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEecc
Q 012320 103 Q----KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDL 178 (466)
Q Consensus 103 ~----~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DF 178 (466)
. ..+++|+||+ |++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+||
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~-~~~kl~df 162 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNED-CELKILDF 162 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeec
Confidence 1 3568999998 8899988764 67999999999999999999999999 9999999999999876 89999999
Q ss_pred chhhhhcCCCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-------
Q 012320 179 GLAAILRGSKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK------- 249 (466)
Q Consensus 179 Gla~~~~~~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~------- 249 (466)
|++..... ......+++.|+|||.+.+ .++.++|+|||||++|+|++|..||........ +..+....
T Consensus 163 g~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~ 239 (343)
T cd07880 163 GLARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LMEIMKVTGTPSKEF 239 (343)
T ss_pred cccccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHH
Confidence 99876543 2334568999999998764 488999999999999999999999976443322 22221100
Q ss_pred ---------------CCC-------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 250 ---------------LPG-------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 250 ---------------~p~-------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
++. ......+..+.++|.+||. ||.+|||+.+++.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 000 0123456689999999996 99999999999999999754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=324.86 Aligned_cols=258 Identities=28% Similarity=0.373 Sum_probs=207.1
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCC
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 104 (466)
.++|.. .+.||+|+||.||+|.+..+|..+|+|.+.... ........+.+|+.+++++ +||||+++++.+...+..
T Consensus 6 ~~~y~~-~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 6 LRKYEI-LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF--RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhHHHH-hHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc--CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 467776 567999999999999999999999999886432 2333456778899999999 999999999987655566
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.+++||||+. ++|..++.+. .+++..+..++.||+.||.|||+.| |+||||||+||+++.+ |.+||+|||++..+
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~-~~~kl~d~g~~~~~ 157 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSD-CRVKLADFGLARSL 157 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CcEEEeeccchhcc
Confidence 8899999996 5999988765 8889999999999999999999999 9999999999999877 89999999999765
Q ss_pred cCCC------CCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC------
Q 012320 185 RGSK------SAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL------ 250 (466)
Q Consensus 185 ~~~~------~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~------ 250 (466)
.... ......||+.|+|||++. ..++.++|||||||++|+|++|..||....+.....+.+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 4321 223457899999999764 34789999999999999999999999764444333222111100
Q ss_pred ----------------------CCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 251 ----------------------PGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 251 ----------------------p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
........+.++.++|.+||. +|.+|||+.++++|||++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 001112256789999999996 99999999999999999763
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=311.45 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=202.5
Q ss_pred eEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEE
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNF 108 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~l 108 (466)
|.+ .+.||.|+||.||+|.+..+|+.+|+|.+.... ........+.+|+.+++.++|||++++++.+.+......++
T Consensus 1 y~~-~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 77 (287)
T cd07840 1 YEK-IAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM 77 (287)
T ss_pred Cee-eEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence 444 456999999999999999999999999998654 12334467889999999999999999999885433478999
Q ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC
Q 012320 109 ITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187 (466)
Q Consensus 109 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~ 187 (466)
|+||++ ++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.+ +.+||+|||++......
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~-~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 78 VFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINND-GVLKLADFGLARPYTKR 153 (287)
T ss_pred Eecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCC-CCEEEccccceeeccCC
Confidence 999996 5898888765 57999999999999999999999999 9999999999999987 89999999999776543
Q ss_pred C--CCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CC--C--------
Q 012320 188 K--SAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK-LP--G-------- 252 (466)
Q Consensus 188 ~--~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~-~p--~-------- 252 (466)
. ......++..|+|||.+.+ .++.++||||||+++|+|++|..||.... .......+.... .+ .
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST-ELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCchhhccccccc
Confidence 2 2334567889999996653 47899999999999999999999997644 333333332210 00 0
Q ss_pred ------------------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 253 ------------------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 253 ------------------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
.+....+..+.++|.+||. +|.+||++++++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0111126788999999996 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=343.61 Aligned_cols=260 Identities=22% Similarity=0.341 Sum_probs=189.5
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCe-EEEEEEEe-------------cccccCCHHHHHHHHHHHHHHHhCCCCcee
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGV-EVAWNQVR-------------LNELMRSPDDLQRLYSEVHLLSTLKHDSII 92 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~-~vAiK~i~-------------~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv 92 (466)
++|.++ +.||+|+||+||+|..+.... ..+.|.+. .+...........+.+|+.+|++++||||+
T Consensus 148 ~~Y~ii-~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 148 AHFRVI-DDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hccEEE-eEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 578775 559999999999987654322 22222110 011112233456788999999999999999
Q ss_pred EEEeEEEeccCCEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEe
Q 012320 93 RFYTSWIDVDQKTFNFITEMFTSGTLREYRKKY-----RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVN 167 (466)
Q Consensus 93 ~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~-----~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~ 167 (466)
++++++. .....|+|++++ +++|..++... .......++.|+.||+.||.|||+++ |+||||||+|||++
T Consensus 227 ~l~~~~~--~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~ 301 (501)
T PHA03210 227 KIEEILR--SEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLN 301 (501)
T ss_pred cEeEEEE--ECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC
Confidence 9999874 466789999998 56777766432 23456778899999999999999999 99999999999998
Q ss_pred CCCCcEEEeccchhhhhcCCC--CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCC-CC-CC-HHHH
Q 012320 168 GHLGQVKIGDLGLAAILRGSK--SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYS-EC-AN-PAQI 241 (466)
Q Consensus 168 ~~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~-~~-~~-~~~i 241 (466)
.+ |.+||+|||++..+.... .....+||+.|+|||++. ..|+.++|||||||++|||++|..|+. .. .+ ..++
T Consensus 302 ~~-~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CD-GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CC-CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 77 899999999998765432 223467999999999876 469999999999999999999886543 22 12 2333
Q ss_pred HHHHhcCC-----CCCC------------------------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 242 YKKVTSGK-----LPGA------------------------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 242 ~~~i~~g~-----~p~~------------------------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.+.+.... +|.. .....+..+.++|.+||. ||.+|||+.|+|.||||...
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 33322111 1110 001133467788999996 99999999999999999764
Q ss_pred hh
Q 012320 292 EV 293 (466)
Q Consensus 292 ~~ 293 (466)
..
T Consensus 461 ~~ 462 (501)
T PHA03210 461 EE 462 (501)
T ss_pred Cc
Confidence 43
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=309.45 Aligned_cols=247 Identities=19% Similarity=0.297 Sum_probs=200.9
Q ss_pred eeeeeeeeCceEEEEEEEcC---CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC----C
Q 012320 32 FEEVLGKGAMKTVYKAIDEV---LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ----K 104 (466)
Q Consensus 32 ~~~~LG~G~fg~Vyka~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~----~ 104 (466)
+.++||+|+||+||+|.+.. ++..||+|.++.... .......+.+|+.+++.++||||+++++.+..... .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH--TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 36779999999999998765 348899999875432 34456788999999999999999999987654322 3
Q ss_pred EEEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEecc
Q 012320 105 TFNFITEMFTSGTLREYRKKY------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDL 178 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DF 178 (466)
..++|+||+++|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.+ +.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLRED-MTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCC-CeEEECCc
Confidence 578999999999999988543 35899999999999999999999999 9999999999999876 79999999
Q ss_pred chhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCC
Q 012320 179 GLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGA 253 (466)
Q Consensus 179 Gla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~ 253 (466)
|++........ .....++..|+|||.+. ..++.++|||||||++|||++ |..||.. .+..++++.+..+..+.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~- 235 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG-VENHEIYDYLRHGNRLK- 235 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-
Confidence 99876543221 11223567899999776 458999999999999999999 8888866 55667777777665433
Q ss_pred CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 254 FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 254 ~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
.+...+..+.+++.+||. +|.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 236 QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 345567899999999996 99999999999753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=337.60 Aligned_cols=243 Identities=23% Similarity=0.379 Sum_probs=208.8
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCC
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 104 (466)
...|.. ...+|.|+|++|..+.+..+++..|+|++.+... ...+|+.++... +||||+++++.+ .+..
T Consensus 321 ~~~y~~-~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~--------~~~~e~~~~~~~~~h~niv~~~~v~--~~~~ 389 (612)
T KOG0603|consen 321 TESYEF-REELGEGSFSAVKYCESSPTDQEPAVKIISKRAD--------DNQDEIPISLLVRDHPNIVKSHDVY--EDGK 389 (612)
T ss_pred chhhcc-ccccCCCCccceeeeeccccccchhheecccccc--------ccccccchhhhhcCCCcceeeccee--cCCc
Confidence 455555 4559999999999999999999999999985521 223467566555 899999999977 6788
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
..|+|||.+.|+.|.+.+.+.+.+. ..+..|++||+.|+.|||++| |+||||||+|||++++.|+++|+|||.++..
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred eeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 9999999999999998887766555 888899999999999999999 9999999999999644489999999999876
Q ss_pred cCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 185 RGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 185 ~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
... ..+.+-|..|.|||++. ..|+++|||||||++||+|++|..||....+..++...+..|++. ...|.+++
T Consensus 467 ~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s----~~vS~~AK 540 (612)
T KOG0603|consen 467 ERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS----ECVSDEAK 540 (612)
T ss_pred chh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc----cccCHHHH
Confidence 654 33456688999999887 569999999999999999999999998767777899998887654 66789999
Q ss_pred HHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 264 RFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
+||.+||+ ||.+||++.+++.||||
T Consensus 541 dLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 541 DLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHHhccCChhhCcChhhhccCcch
Confidence 99999996 99999999999999999
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=315.70 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=202.7
Q ss_pred CCceEEeeeeeeeeCceEEEEEEE-----cCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAID-----EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWI 99 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 99 (466)
.++|.. .+.||+|+||.||+|.+ ..++..+|+|.++... .....+.+.+|+.+++++ +||||+++++.+
T Consensus 34 ~~~~~~-~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~- 108 (302)
T cd05055 34 RNNLSF-GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHENIVNLLGAC- 108 (302)
T ss_pred HHHeEE-cceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCCcceEEEEE-
Confidence 345655 67799999999999975 4467789999876432 234557889999999999 799999999987
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEec
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGD 177 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~D 177 (466)
.....+++||||+++|+|.+++.+.. .+++.++..++.||+.||.|||+++ |+|+||||+||+++.+ +.+||+|
T Consensus 109 -~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~~l~d 184 (302)
T cd05055 109 -TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHG-KIVKICD 184 (302)
T ss_pred -ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCC-CeEEECC
Confidence 44667899999999999999997643 3899999999999999999999999 9999999999999876 7999999
Q ss_pred cchhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCC
Q 012320 178 LGLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPG 252 (466)
Q Consensus 178 FGla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~ 252 (466)
||++..+..... .....+++.|+|||.+. ..++.++||||+||++|+|++ |..||..........+.+..+..+
T Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~- 263 (302)
T cd05055 185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM- 263 (302)
T ss_pred CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC-
Confidence 999976543221 12234678899999765 568999999999999999998 999998755555566666555432
Q ss_pred CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 253 AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 253 ~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..+...+.++.+++.+||. +|.+|||+.+++.
T Consensus 264 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 264 AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 3344567899999999996 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=307.05 Aligned_cols=240 Identities=25% Similarity=0.389 Sum_probs=198.7
Q ss_pred eeeeeeCceEEEEEEEcCCC---eEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEE
Q 012320 34 EVLGKGAMKTVYKAIDEVLG---VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFIT 110 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~ 110 (466)
++||+|+||.||+|....++ ..+|+|.+..... ....+.+.+|+.+++.++||||+++++.+. ...+++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI---AAGKKEFLREASVMAQLDHPCIVRLIGVCK---GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEc---CCceEEEE
Confidence 35999999999999876655 8999998875542 134567899999999999999999998652 34578999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCC
Q 012320 111 EMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA 190 (466)
Q Consensus 111 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~ 190 (466)
||+.+++|.+++.+.+.+++..+..++.|++.||.|||..+ ++||||||+|||++.+ +.+||+|||++..+......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~-~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 75 ELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred EeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCC-CcEEeccccccceeecCCcc
Confidence 99999999999998888999999999999999999999999 9999999999999877 89999999999766432221
Q ss_pred ----ccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 012320 191 ----HSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQR 264 (466)
Q Consensus 191 ----~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~ 264 (466)
....++..|+|||.+. ..++.++|||||||++|+|++ |..||.. .+..++.+.+..+... ..+...+..+++
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 229 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE-MKGAEVIAMLESGERL-PRPEECPQEIYS 229 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHcCCcC-CCCCCCCHHHHH
Confidence 1112346799999775 558999999999999999998 9999976 4566777777766532 334456788999
Q ss_pred HHHHhcc-CcCCCCCHHHHhc
Q 012320 265 FIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 265 lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+|.+||. +|.+||++.+++.
T Consensus 230 li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 230 IMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 9999996 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=306.73 Aligned_cols=243 Identities=21% Similarity=0.381 Sum_probs=199.7
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
.|.. .+.||+|+||.||+|..+. +..+|+|.+..... ....+.+|+.+|+.++||||+++++.+ .....++
T Consensus 5 ~~~~-~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~ 75 (256)
T cd05114 5 ELTF-MKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM-----SEEDFIEEAKVMMKLSHPKLVQLYGVC--TQQKPLY 75 (256)
T ss_pred HcEE-eeEecCCcCceEEEEEecc-CceEEEEecccCCc-----cHHHHHHHHHHHHHCCCCCceeEEEEE--ccCCCEE
Confidence 4555 4669999999999998764 56799998764332 235688899999999999999999977 4466799
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 108 FITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
+||||+++|+|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+||+++.+ +.+||+|||++.....
T Consensus 76 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~-~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 76 IVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSST-GVVKVSDFGMTRYVLD 152 (256)
T ss_pred EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCC-CeEEECCCCCccccCC
Confidence 999999999999998753 56899999999999999999999999 9999999999999876 7999999999876533
Q ss_pred CCCC--ccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 012320 187 SKSA--HSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA 262 (466)
Q Consensus 187 ~~~~--~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~ 262 (466)
.... ....++..|+|||++. ..++.++|||||||++|+|++ |..||.. .+..++...+..+..+. .+...+.++
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~ 230 (256)
T cd05114 153 DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK-KSNYEVVEMISRGFRLY-RPKLASMTV 230 (256)
T ss_pred CceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCCCHHH
Confidence 2211 1223556899999876 568999999999999999999 8999976 56667777777765432 234567789
Q ss_pred HHHHHHhcc-CcCCCCCHHHHhc
Q 012320 263 QRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 263 ~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.+++.+|+. +|.+|||+.++++
T Consensus 231 ~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 231 YEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHHccCCcccCcCHHHHHH
Confidence 999999996 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=320.14 Aligned_cols=244 Identities=24% Similarity=0.396 Sum_probs=195.6
Q ss_pred CceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecCCCCCHH
Q 012320 40 AMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLR 119 (466)
Q Consensus 40 ~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~~ggsL~ 119 (466)
++|.||++.++.+|+.||+|++..... .......+.+|+.+++.++||||+++++.|. +...++++|||+++++|.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~--~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILPYVTSFI--VDSELYVVSPLMAYGSCE 87 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc--chhHHHHHHHHHHHHHhcCCcchhhhhheee--cCCeEEEEEeccCCCCHH
Confidence 566777777788999999999886532 3456678999999999999999999999884 467789999999999999
Q ss_pred HHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCC--------C
Q 012320 120 EYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK--------S 189 (466)
Q Consensus 120 ~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~--------~ 189 (466)
+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||.+..+.... .
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecC-CceEEecCccceeeccccccccccccc
Confidence 999764 46899999999999999999999999 9999999999999976 899999999886543211 1
Q ss_pred CccccCCCCcCCcccccc---CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--------CCC------
Q 012320 190 AHSVIGTPEFMAPELYEE---DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK--------LPG------ 252 (466)
Q Consensus 190 ~~~~~GT~~y~APE~l~~---~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~--------~p~------ 252 (466)
.....++..|+|||++.. .|+.++||||+||++++|++|..||............+.... .+.
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcC
Confidence 233457889999998754 488999999999999999999999987554444444332110 000
Q ss_pred -----------------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 253 -----------------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 253 -----------------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
......+.++.+|+.+||. +|++|||+.++|.||||+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence 0011123578899999996 9999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=308.28 Aligned_cols=248 Identities=22% Similarity=0.355 Sum_probs=202.9
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCC---CeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVL---GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
++|.. .+.||+|+||+||+|.++.+ ...||+|.++... .......+.+|+.+++.++||||+++++.+ ...
T Consensus 4 ~~~~~-~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~ 77 (266)
T cd05033 4 SYVTI-EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFDHPNIIRLEGVV--TKS 77 (266)
T ss_pred HHcee-eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCcceEeEEE--ecC
Confidence 45665 67799999999999998654 5679999876432 334556788999999999999999999977 446
Q ss_pred CEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 104 KTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
..+++||||+++++|.+++.+. +.+++..+..++.|++.||.|||+++ |+||||||+||+++.+ +.+||+|||++.
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~-~~~~l~dfg~~~ 154 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSN-LVCKVSDFGLSR 154 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC-CCEEECccchhh
Confidence 6789999999999999998764 47899999999999999999999999 9999999999999877 899999999998
Q ss_pred hhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 012320 183 ILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSI 257 (466)
Q Consensus 183 ~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 257 (466)
.+..... .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||.. ....++.+.+..+..++ ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~ 232 (266)
T cd05033 155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD-MSNQDVIKAVEDGYRLP-PPMD 232 (266)
T ss_pred cccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCCCCC-CCCC
Confidence 7642111 11223467899999776 568999999999999999998 9999976 45566667776653322 2345
Q ss_pred CCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 258 QDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 258 ~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
.+..+.+++.+|+. +|.+||++.+++++
T Consensus 233 ~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 233 CPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 67899999999996 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=309.82 Aligned_cols=242 Identities=22% Similarity=0.361 Sum_probs=189.7
Q ss_pred eeeeeCceEEEEEEEc--CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEec
Q 012320 35 VLGKGAMKTVYKAIDE--VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 35 ~LG~G~fg~Vyka~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
.||+|+||+||+|... .....+|+|.+.... .......+.+|+.+++.++||||+++++.+ .....+++||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~nii~~~~~~--~~~~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA---TPDEQLLFLQEVQPYRELNHPNVLQCLGQC--IESIPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC---ChHHHHHHHHHHHHHHhCCCCCcceEEEEE--CCCCceEEEEEe
Confidence 4899999999999643 245678888765322 333456788999999999999999999987 446678999999
Q ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC
Q 012320 113 FTSGTLREYRKKYR-----RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187 (466)
Q Consensus 113 ~~ggsL~~~l~~~~-----~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~ 187 (466)
+++|+|.+++.+.. ..++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTAD-LSVKIGDYGLALEQYPE 153 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCC-CcEEEeccccccccccc
Confidence 99999999997643 2467888999999999999999999 9999999999999987 89999999998653222
Q ss_pred C---CCccccCCCCcCCccccc--------cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCC---C
Q 012320 188 K---SAHSVIGTPEFMAPELYE--------EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLP---G 252 (466)
Q Consensus 188 ~---~~~~~~GT~~y~APE~l~--------~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p---~ 252 (466)
. ......+++.|+|||++. ..++.++|||||||++|+|++ |..||....+...+...+..+..+ +
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence 1 112334677899999763 246789999999999999999 788887654444444444444322 1
Q ss_pred CCCCCCCHHHHHHHHHhccCcCCCCCHHHHhc
Q 012320 253 AFYSIQDLEAQRFIGRCLVNASKRLSAKELLL 284 (466)
Q Consensus 253 ~~~~~~~~~~~~lI~~~L~dp~~Rpsa~elL~ 284 (466)
......+...++++.+|+.||.+|||+++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~ 265 (269)
T cd05042 234 QLDLKYSDRWYEVMQFCWLDPETRPTAEEVHE 265 (269)
T ss_pred cccccCCHHHHHHHHHHhcCcccccCHHHHHH
Confidence 22345667889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=314.78 Aligned_cols=250 Identities=28% Similarity=0.404 Sum_probs=205.2
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCC-----CeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEE
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVL-----GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSW 98 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~ 98 (466)
..++|.. .+.||+|+||.||+|.++.. ...+|+|.+.... .......+.+|+.+++.+ +||||+++++++
T Consensus 10 ~~~~~~~-~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 10 PRDRLTL-GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred CHhHeEE-eeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4467877 46799999999999987654 3789999886432 334556789999999999 899999999987
Q ss_pred EeccCCEEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCC
Q 012320 99 IDVDQKTFNFITEMFTSGTLREYRKKY----------------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCD 162 (466)
Q Consensus 99 ~~~~~~~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~ 162 (466)
.....+++||||+++|+|..++... +.+++..+..++.||+.||.|||+.+ |+||||||+
T Consensus 86 --~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~ 161 (293)
T cd05053 86 --TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAAR 161 (293)
T ss_pred --cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--cccccccee
Confidence 4466799999999999999998642 45889999999999999999999999 999999999
Q ss_pred cEEEeCCCCcEEEeccchhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 012320 163 NIFVNGHLGQVKIGDLGLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECAN 237 (466)
Q Consensus 163 NIlv~~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~ 237 (466)
|||++.+ +.+||+|||++..+..... .....++..|+|||++. ..++.++|||||||++|+|++ |..||.. .+
T Consensus 162 Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~ 239 (293)
T cd05053 162 NVLVTED-HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IP 239 (293)
T ss_pred eEEEcCC-CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC-CC
Confidence 9999876 8999999999986543221 11223467899999765 568999999999999999997 9999976 56
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 238 PAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 238 ~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
..++++.+..+..+. .+...+..+.+|+.+|+. +|.+|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 240 VEELFKLLKEGYRME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 677778777765443 334557789999999996 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=322.81 Aligned_cols=257 Identities=29% Similarity=0.401 Sum_probs=209.5
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc---CC
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD---QK 104 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~---~~ 104 (466)
||.+ .+.||.|++|.||+|.+..+|..||+|.+.... ......+.+.+|+.+++.++||||+++++.+.... ..
T Consensus 1 ~y~i-~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (330)
T cd07834 1 RYEL-LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN 77 (330)
T ss_pred Ccee-eeeecCCCCeEEEEEEeCCCCcEEEEEeecccc--ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence 5766 577999999999999999999999999887432 22445578899999999999999999999875432 24
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.+|+||||+. ++|.+++.+...+++..+..++.||+.||.|||+.| |+||||||+|||++.+ +.++|+|||++...
T Consensus 78 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~-~~~~L~dfg~~~~~ 153 (330)
T cd07834 78 DVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSN-CDLKICDFGLARGV 153 (330)
T ss_pred ceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEcccCceEee
Confidence 7899999996 589999988789999999999999999999999999 9999999999999987 89999999999876
Q ss_pred cCCC----CCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC--CCCCC---
Q 012320 185 RGSK----SAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG--KLPGA--- 253 (466)
Q Consensus 185 ~~~~----~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g--~~p~~--- 253 (466)
.... ......+|+.|+|||++.+ .++.++|||||||++|+|++|..||... +..+.++.+... ..+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR-DYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC-CHHHHHHHHHHhcCCCChhHhh
Confidence 5432 2345578999999998763 5889999999999999999999999763 444444443321 10000
Q ss_pred ------------------------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 254 ------------------------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 254 ------------------------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
.....+.++.++|.+||. +|.+|||+.+++.||||+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 012246688999999996 999999999999999997643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=306.65 Aligned_cols=244 Identities=24% Similarity=0.390 Sum_probs=199.5
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
.+|.++ +.||+|+||+||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++.+ .+....
T Consensus 6 ~~~~~~-~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~ 76 (261)
T cd05072 6 ESIKLV-KKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVV--TKEEPI 76 (261)
T ss_pred HHeEEe-eecCCcCCceEEEEEec-CCceEEEEEccCCc-----hhHHHHHHHHHHHHhCCCCCeeeEEEEE--cCCCCc
Confidence 456664 55999999999999875 46779999876432 2356789999999999999999999877 456778
Q ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 107 NFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
++|+||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.+ +.+||+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~-~~~~l~dfg~~~~~ 153 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSES-LMCKIADFGLARVI 153 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCC-CcEEECCCccceec
Confidence 9999999999999998753 56889999999999999999999999 9999999999999876 89999999999765
Q ss_pred cCCCC--CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 012320 185 RGSKS--AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL 260 (466)
Q Consensus 185 ~~~~~--~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~ 260 (466)
..... .....++..|+|||.+. ..++.++|||||||++|+|++ |..||.. .+.......+..+... ......+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (261)
T cd05072 154 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG-MSNSDVMSALQRGYRM-PRMENCPD 231 (261)
T ss_pred CCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCH
Confidence 43221 12234567899999775 558899999999999999998 9999976 5556666666655332 23344677
Q ss_pred HHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 261 EAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 261 ~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
++.+++.+|+. +|.+||++++++.
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 232 ELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 89999999996 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=315.98 Aligned_cols=248 Identities=28% Similarity=0.396 Sum_probs=201.9
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcC-------CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEV-------LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTS 97 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~ 97 (466)
.++|.+ .+.||+|+||+||+|.+.. ++..+|+|.+.... .......+.+|+.+++.+ +||||+++++.
T Consensus 17 ~~~~~i-~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 17 RDRLVL-GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred hHHeEE-eeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC---ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 467866 6779999999999998643 34579999886432 334556788999999999 79999999998
Q ss_pred EEeccCCEEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCC
Q 012320 98 WIDVDQKTFNFITEMFTSGTLREYRKKYR----------------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKC 161 (466)
Q Consensus 98 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp 161 (466)
+ .....+|+||||+.+|+|.+++.+.+ .++...+..++.||+.||.|||+++ ++||||||
T Consensus 93 ~--~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 168 (307)
T cd05098 93 C--TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAA 168 (307)
T ss_pred E--ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccH
Confidence 7 44567899999999999999997642 4788999999999999999999999 99999999
Q ss_pred CcEEEeCCCCcEEEeccchhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 012320 162 DNIFVNGHLGQVKIGDLGLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECA 236 (466)
Q Consensus 162 ~NIlv~~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~ 236 (466)
+||+++.+ +.+||+|||++........ .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.. .
T Consensus 169 ~Nill~~~-~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~-~ 246 (307)
T cd05098 169 RNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-V 246 (307)
T ss_pred HheEEcCC-CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc-C
Confidence 99999877 8999999999876532211 11223457899999775 558999999999999999998 8888865 6
Q ss_pred CHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 237 NPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 237 ~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+..++.+.+..+..+ ..+...+.+++++|.+||. +|.+|||+.+++.
T Consensus 247 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 247 PVEELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred CHHHHHHHHHcCCCC-CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 677777777766533 2344567899999999996 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=327.89 Aligned_cols=238 Identities=24% Similarity=0.416 Sum_probs=199.1
Q ss_pred eeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEe
Q 012320 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITE 111 (466)
Q Consensus 32 ~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E 111 (466)
+.+.||+|.||.||+|.... ...||+|.++.... ..+.+.+|+++|++|+|+|||++|+++ ..++.+|||||
T Consensus 210 l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m-----~~~~f~~Ea~iMk~L~H~~lV~l~gV~--~~~~piyIVtE 281 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM-----SPEAFLREAQIMKKLRHEKLVKLYGVC--TKQEPIYIVTE 281 (468)
T ss_pred HHHHhcCCccceEEEEEEcC-CCcccceEEecccc-----ChhHHHHHHHHHHhCcccCeEEEEEEE--ecCCceEEEEE
Confidence 45569999999999998764 34799999875432 235678999999999999999999976 44557999999
Q ss_pred cCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCC
Q 012320 112 MFTSGTLREYRKK--YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS 189 (466)
Q Consensus 112 ~~~ggsL~~~l~~--~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~ 189 (466)
|++.|+|.+|++. .+.+...+...++.||++|++||++++ +|||||-..||||+.+ +.+||+|||||+.......
T Consensus 282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~-~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDED-LVVKISDFGLARLIGDDEY 358 (468)
T ss_pred ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccC-ceEEEcccccccccCCCce
Confidence 9999999999987 467999999999999999999999999 9999999999999987 7999999999995433221
Q ss_pred CccccC---CCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 012320 190 AHSVIG---TPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQR 264 (466)
Q Consensus 190 ~~~~~G---T~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~ 264 (466)
....| ..-|.|||.+. +.|+.++|||||||+|+||+| |..||.+ .+..++.+.+.+|.- -.-+..++.++-+
T Consensus 359 -~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~-msn~ev~~~le~GyR-lp~P~~CP~~vY~ 435 (468)
T KOG0197|consen 359 -TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG-MSNEEVLELLERGYR-LPRPEGCPDEVYE 435 (468)
T ss_pred -eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC-CCHHHHHHHHhccCc-CCCCCCCCHHHHH
Confidence 11112 34699999776 779999999999999999999 9999987 666778888888752 1234568889999
Q ss_pred HHHHhcc-CcCCCCCHHHHh
Q 012320 265 FIGRCLV-NASKRLSAKELL 283 (466)
Q Consensus 265 lI~~~L~-dp~~Rpsa~elL 283 (466)
++..|+. +|++|||++.|.
T Consensus 436 lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 436 LMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHHhhCCcccCCCHHHHH
Confidence 9999996 999999999664
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=312.85 Aligned_cols=259 Identities=23% Similarity=0.373 Sum_probs=209.8
Q ss_pred eEEeeeeeeeeCceEEEEEEEc---CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCC
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDE---VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 104 (466)
|.+ .+.||+|++|.||+|.+. .++..||+|.+++..........+.+.+|+.+++++ +||||+++++.+ ....
T Consensus 2 ~~~-~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~--~~~~ 78 (288)
T cd05583 2 FEL-LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF--QTDT 78 (288)
T ss_pred ceE-EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee--ecCC
Confidence 555 567999999999999853 578899999987654333334456788999999999 699999999887 4567
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.+++||||+.+++|.+++.+...+++..++.++.|++.||.|||+.+ ++||||||+||+++.+ +.++|+|||++..+
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~-~~~~l~dfg~~~~~ 155 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSE-GHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEEEECcccccc
Confidence 89999999999999999988788999999999999999999999999 9999999999999876 89999999998765
Q ss_pred cCCCC--CccccCCCCcCCccccccC---CCChhhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHhcCCCCCCCCC
Q 012320 185 RGSKS--AHSVIGTPEFMAPELYEED---YNELVDVYSFGMCVLEMFTCEYPYSECA---NPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 185 ~~~~~--~~~~~GT~~y~APE~l~~~---y~~~~DIwSlGvil~elltg~~Pf~~~~---~~~~i~~~i~~g~~p~~~~~ 256 (466)
..... .....|++.|+|||.+.+. ++.++||||||+++|+|++|..||.... ....+.+.+..... ..+.
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~ 233 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PFPK 233 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CCCc
Confidence 43221 2335689999999977532 6889999999999999999999995322 23344444444432 2334
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCC---HHHHhcCCCCCchhhhh
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLS---AKELLLDPFLASDEVKL 295 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rps---a~elL~hpf~~~~~~~~ 295 (466)
..+..++++|.+||. +|++||| +.++|+||||+...|..
T Consensus 234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~ 276 (288)
T cd05583 234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDD 276 (288)
T ss_pred ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHH
Confidence 467789999999996 9999998 56789999998877743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=312.89 Aligned_cols=250 Identities=24% Similarity=0.315 Sum_probs=201.2
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCC----------------eEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLG----------------VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH 88 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g----------------~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~H 88 (466)
+.++|.+ .+.||+|+||.||+|.+..++ ..||+|.+.... .....+.+.+|+.++++++|
T Consensus 3 ~~~~~~~-~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~~ 78 (296)
T cd05051 3 PRQPLNF-VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNAREDFLKEVKILSRLSD 78 (296)
T ss_pred chhhCcc-cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhcCC
Confidence 3467877 466999999999999877644 568999877443 23456788999999999999
Q ss_pred CceeEEEeEEEeccCCEEEEEEecCCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEec
Q 012320 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR-----------RVDIRAIKSWARQILQGLVYLHSRDPPVIHR 157 (466)
Q Consensus 89 pnIv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHr 157 (466)
|||+++++.+. ....+++|+|++.+++|.+++.+.. .+++..+..++.|++.||.|||+++ |+||
T Consensus 79 ~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~ 154 (296)
T cd05051 79 PNIARLLGVCT--VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHR 154 (296)
T ss_pred CCEeEEEEEEe--cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccc
Confidence 99999999874 4567899999999999999998765 6899999999999999999999999 9999
Q ss_pred cCCCCcEEEeCCCCcEEEeccchhhhhcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh--CCCC
Q 012320 158 DLKCDNIFVNGHLGQVKIGDLGLAAILRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT--CEYP 231 (466)
Q Consensus 158 DLKp~NIlv~~~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt--g~~P 231 (466)
||||+||+++.+ +.++|+|||++....... ......+|+.|+|||.+. ..++.++|||||||++|+|++ +..|
T Consensus 155 dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 233 (296)
T cd05051 155 DLATRNCLVGKN-YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233 (296)
T ss_pred ccchhceeecCC-CceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCC
Confidence 999999999887 899999999987653322 122345678899999766 468999999999999999998 7788
Q ss_pred CCCCCCHHHHHHHHhcC------CCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 232 YSECANPAQIYKKVTSG------KLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 232 f~~~~~~~~i~~~i~~g------~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
|.. .+..++++.+... ..........+.++.+++.+||. +|.+|||+.+++.
T Consensus 234 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 234 YEH-LTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CCC-cChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 865 4445555544432 11112233456789999999996 9999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=321.86 Aligned_cols=254 Identities=27% Similarity=0.409 Sum_probs=202.9
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc---
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD--- 102 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--- 102 (466)
.+||.+. +.||+|+||.||+|.+..+|+.||+|++.... .+....+.+.+|+.++++++||||+++++.+....
T Consensus 16 ~~~y~~~-~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 16 PERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred cCceEEE-EEeeecCCeEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 4788875 66999999999999999999999999886432 23334567889999999999999999999875322
Q ss_pred -CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 103 -QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 103 -~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
...++++++++ |++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ |.+||+|||++
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~-~~~kl~dfg~~ 167 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLA 167 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCC-CCEEEeccccc
Confidence 23477888876 8899888764 57999999999999999999999999 9999999999999877 89999999998
Q ss_pred hhhcCCCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----------
Q 012320 182 AILRGSKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK---------- 249 (466)
Q Consensus 182 ~~~~~~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~---------- 249 (466)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||... +.......+....
T Consensus 168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 168 RHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT-DHIDQLKLILRLVGTPGAELLKK 244 (345)
T ss_pred ccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCCHHHHhh
Confidence 76432 2344578999999997754 5889999999999999999999999653 3333222221110
Q ss_pred ---------------CCC----CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 250 ---------------LPG----AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 250 ---------------~p~----~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
.+. ......+.++++||.+||. +|.+||++.+++.||||+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence 000 0112346789999999996 9999999999999999975
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=322.95 Aligned_cols=253 Identities=24% Similarity=0.353 Sum_probs=203.0
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEE-----cCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeE
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAID-----EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTS 97 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~ 97 (466)
-|.+||.+ .+.||+|+||+||+|.+ ..+++.||+|+++... .......+.+|+.+|.++ +||||+++++.
T Consensus 4 ~~~~~~~~-~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (343)
T cd05103 4 FPRDRLKL-GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGA 79 (343)
T ss_pred cchhHhcc-cccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence 45678877 67799999999999984 4578899999987432 233456788999999999 68999999997
Q ss_pred EEeccCCEEEEEEecCCCCCHHHHHHhc----------------------------------------------------
Q 012320 98 WIDVDQKTFNFITEMFTSGTLREYRKKY---------------------------------------------------- 125 (466)
Q Consensus 98 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~---------------------------------------------------- 125 (466)
+.. ....+++||||+++|+|.+++...
T Consensus 80 ~~~-~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (343)
T cd05103 80 CTK-PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSL 158 (343)
T ss_pred eec-CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcc
Confidence 743 345788999999999999998642
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCC-
Q 012320 126 ---------------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS- 189 (466)
Q Consensus 126 ---------------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~- 189 (466)
..++...+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~ 235 (343)
T cd05103 159 SDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDY 235 (343)
T ss_pred ccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCC-CcEEEEecccccccccCcch
Confidence 23677888999999999999999999 9999999999999876 7999999999876532211
Q ss_pred --CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 012320 190 --AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRF 265 (466)
Q Consensus 190 --~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~l 265 (466)
.....+++.|+|||++. ..++.++|||||||++|+|++ |..||........+...+..+..+. .+...++++.++
T Consensus 236 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 314 (343)
T cd05103 236 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-APDYTTPEMYQT 314 (343)
T ss_pred hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCC-CCCCCCHHHHHH
Confidence 12234567899999765 568999999999999999997 9999977555555666666554332 234467789999
Q ss_pred HHHhcc-CcCCCCCHHHHhcC
Q 012320 266 IGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 266 I~~~L~-dp~~Rpsa~elL~h 285 (466)
+..|+. +|.+|||+.++++|
T Consensus 315 ~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 315 MLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999995 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=326.50 Aligned_cols=266 Identities=27% Similarity=0.432 Sum_probs=220.3
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHH---HHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPD---DLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
+.||.++ .+||+|+|+.||||++....+.||+|+-.+++-.+++. ..+...+|.+|.+.|+||-||++|++|- -+
T Consensus 462 n~RYLlL-hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs-lD 539 (775)
T KOG1151|consen 462 NDRYLLL-HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS-LD 539 (775)
T ss_pred HHHHHHH-HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee-ec
Confidence 4688764 77999999999999999999999999876655333221 2356788999999999999999999874 46
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC--CCcEEEeccch
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGL 180 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~--~g~vKL~DFGl 180 (466)
...++-|+|||+|.+|.-|++.++-++++.++.|+.||+.||.||....|||||-||||.|||+... -|.+||+||||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 7789999999999999999999999999999999999999999999999999999999999998543 36899999999
Q ss_pred hhhhcCCCC--------CccccCCCCcCCccccc-----cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--
Q 012320 181 AAILRGSKS--------AHSVIGTPEFMAPELYE-----EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKV-- 245 (466)
Q Consensus 181 a~~~~~~~~--------~~~~~GT~~y~APE~l~-----~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i-- 245 (466)
++++..... .....||.+|++||.+- .+.+.++||||+|||+|.++.|+-||........+.+.-
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 999865322 34567999999999653 237889999999999999999999997655544444322
Q ss_pred -hcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 246 -TSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 246 -~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
.......+.....+.++++||++||. ...+|....+|-.||+|.....
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~r 749 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIR 749 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhh
Confidence 12223334445678899999999997 7889999999999999987443
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=323.73 Aligned_cols=256 Identities=28% Similarity=0.407 Sum_probs=206.5
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC-
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ- 103 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~- 103 (466)
-.++|.. .+.||+|++|+||+|.++.++..||+|.+.... .+....+.+.+|+.+++.++||||+++++.+...+.
T Consensus 13 ~~~~y~~-~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 13 VPDRYQN-LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF--QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred ccCceEE-EEEeccCCceEEEEEEECCCCcEEEEEeccccc--chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 4668887 466999999999999999999999999876432 233455678889999999999999999887643222
Q ss_pred ---CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 104 ---KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 104 ---~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
..+++|+||+ |++|.+++.. ..+++..+..++.||+.||.|||+.| |+||||||+||+++.+ +.+||+|||+
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~-~~~kL~dfg~ 164 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNED-CELKILDFGL 164 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CCEEEccccc
Confidence 3589999998 7799998875 67999999999999999999999999 9999999999999876 8999999999
Q ss_pred hhhhcCCCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--CC-----
Q 012320 181 AAILRGSKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK--LP----- 251 (466)
Q Consensus 181 a~~~~~~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~--~p----- 251 (466)
+...... .....+|+.|+|||++.+ .++.++|||||||++|+|++|..||..... ...+..+.... .+
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 165 ARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-IDQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred ccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCHHHHh
Confidence 9765432 345578999999997753 578999999999999999999999976433 33333332211 00
Q ss_pred ---------------C-------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 252 ---------------G-------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 252 ---------------~-------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
. ..+...+..+.+||.+||. +|.+|||+.+|+.||||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~ 304 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence 0 0112347789999999996 99999999999999999754
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=309.36 Aligned_cols=246 Identities=26% Similarity=0.401 Sum_probs=200.6
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCe----EEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGV----EVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
.+|.. .++||+|+||+||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++.+..
T Consensus 7 ~~~~~-~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-- 80 (279)
T cd05109 7 TELKK-VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-- 80 (279)
T ss_pred hheee-eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC---CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC--
Confidence 44555 4679999999999999877776 48999876432 34455778899999999999999999997742
Q ss_pred CCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
...++++||+++|+|.+++... +.+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~-~~~kL~dfG~~ 156 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSP-NHVKITDFGLA 156 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCC-CcEEECCCCce
Confidence 3467899999999999998764 56999999999999999999999999 9999999999999876 79999999999
Q ss_pred hhhcCCCCC---ccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 012320 182 AILRGSKSA---HSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 182 ~~~~~~~~~---~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 256 (466)
+.+...... ....+++.|+|||.+. ..++.++|||||||++|||++ |..||.. .....+...+..+..+. .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~ 234 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG-IPAREIPDLLEKGERLP-QPP 234 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcCC-CCc
Confidence 776432221 1223467899999765 569999999999999999998 8888865 45566666676665433 234
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..+.++.++|.+||. ||.+||++.+++.
T Consensus 235 ~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 235 ICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 567899999999996 9999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=314.14 Aligned_cols=248 Identities=29% Similarity=0.495 Sum_probs=205.0
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecC
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMF 113 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~ 113 (466)
.+||+|+||.||++.++.+|..||+|++... .......+.+|+.+++.++||||+++++.+. .....++||||+
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~ 99 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMYNSYL--VGDELWVVMEFL 99 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc----chhHHHHHHHHHHHHHhcCCcchhheeeEEE--eCCEEEEEEecC
Confidence 4599999999999999999999999987533 2334567899999999999999999999884 467899999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC-CCCcc
Q 012320 114 TSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-KSAHS 192 (466)
Q Consensus 114 ~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~-~~~~~ 192 (466)
++++|.+++.. +.+++..+..++.|++.||.|||+.+ ++||||||+||+++.+ +.++|+|||++...... .....
T Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~-~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 100 EGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEEcccccceecccccccccc
Confidence 99999998754 67899999999999999999999999 9999999999999877 89999999988655332 12234
Q ss_pred ccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC-CCCCCCCHHHHHHHHHhc
Q 012320 193 VIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG-AFYSIQDLEAQRFIGRCL 270 (466)
Q Consensus 193 ~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~-~~~~~~~~~~~~lI~~~L 270 (466)
..||+.|+|||.+. ..++.++|+||+||++|+|++|..||.. .+.......+..+..+. ......+..+.+++.+||
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 254 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLL 254 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHH
Confidence 56899999999775 4588999999999999999999999976 44444444444332211 112345678999999999
Q ss_pred c-CcCCCCCHHHHhcCCCCCchh
Q 012320 271 V-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 271 ~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
. +|.+||++.+++.||||....
T Consensus 255 ~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 255 VRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred hCCcccCcCHHHHhcChHHhccC
Confidence 5 999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=305.78 Aligned_cols=245 Identities=21% Similarity=0.382 Sum_probs=200.5
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
..|... +.||+|+||+||+|..+. +..+|+|.+..... ..+.+.+|+.++++++||||+++++.+ .....+
T Consensus 4 ~~~~~~-~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~ 74 (256)
T cd05113 4 KDLTFL-KELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLSHEKLVQLYGVC--TKQRPI 74 (256)
T ss_pred HHeEEe-eEecCcccceEEEEEecC-CCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCCCCCeeeEEEEE--ccCCCc
Confidence 346664 569999999999997764 45699998764332 235688999999999999999999987 445678
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 107 NFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
++||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.+ +.+||+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~-~~~kl~d~g~~~~~~ 151 (256)
T cd05113 75 YIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQ-GCVKVSDFGLSRYVL 151 (256)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCC-CCEEECCCccceecC
Confidence 9999999999999999764 46899999999999999999999999 9999999999999876 799999999987654
Q ss_pred CCCCC--ccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 012320 186 GSKSA--HSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLE 261 (466)
Q Consensus 186 ~~~~~--~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 261 (466)
..... ....++..|+|||.+. ..++.++|||||||++|+|++ |..||.. .+...+...+..+..+. .....+..
T Consensus 152 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~ 229 (256)
T cd05113 152 DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER-FNNSETVEKVSQGLRLY-RPHLASEK 229 (256)
T ss_pred CCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCc-CCHHHHHHHHhcCCCCC-CCCCCCHH
Confidence 32211 1223556799999876 568999999999999999998 9999976 45566777777665432 33456789
Q ss_pred HHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 262 AQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 262 ~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
+++++.+||. +|.+||++.+|+.+
T Consensus 230 ~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 230 VYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHh
Confidence 9999999996 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=310.83 Aligned_cols=246 Identities=25% Similarity=0.382 Sum_probs=201.7
Q ss_pred CceEEeeeeeeeeCceEEEEEEEc-----CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDE-----VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
++|.+ .+.||+|+||.||+|.+. .++..+|+|.+... .....+.+.+|+.++++++||||+++++.+ .
T Consensus 5 ~~~~~-~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~ 77 (291)
T cd05094 5 RDIVL-KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAELLTNLQHEHIVKFYGVC--G 77 (291)
T ss_pred HHeEE-eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc----cHHHHHHHHHHHHHHhcCCCCCcceEEEEE--c
Confidence 45655 577999999999999753 35677899887532 233456788999999999999999999977 4
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEE
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKYR----------------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIF 165 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIl 165 (466)
....+++||||+++++|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+||+
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil 155 (291)
T cd05094 78 DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCL 155 (291)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEE
Confidence 5667899999999999999997643 3789999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEeccchhhhhcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHH
Q 012320 166 VNGHLGQVKIGDLGLAAILRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQ 240 (466)
Q Consensus 166 v~~~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~ 240 (466)
++.+ +.+||+|||++....... ......|++.|+|||.+. ..++.++|||||||++|+|+| |..||.. .+...
T Consensus 156 ~~~~-~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~ 233 (291)
T cd05094 156 VGAN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ-LSNTE 233 (291)
T ss_pred EccC-CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHH
Confidence 9977 799999999997543321 122345788999999765 568899999999999999999 9999876 55666
Q ss_pred HHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 241 IYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 241 i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..+.+..+..+. .....+..+.+++.+||. +|.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 234 VIECITQGRVLE-RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHHhCCCCCC-CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 777777776543 334567789999999996 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=308.66 Aligned_cols=241 Identities=25% Similarity=0.351 Sum_probs=194.3
Q ss_pred eeeeeeCceEEEEEEEcCCCeE--EEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCCEEEEEE
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVE--VAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQKTFNFIT 110 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~--vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~~~lV~ 110 (466)
++||+|+||.||+|.++.+|.. +|+|.+... ......+.+.+|+.+++++ +||||+++++.+ .....+++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--~~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGAC--EHRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc---CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE--ecCCCceEEE
Confidence 3689999999999999888764 577776522 1334556889999999999 899999999987 4456789999
Q ss_pred ecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEE
Q 012320 111 EMFTSGTLREYRKKYR----------------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVK 174 (466)
Q Consensus 111 E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vK 174 (466)
||+++|+|.+++.+.+ .+++..+..++.|++.||+|||+.+ ++||||||+||+++.+ +.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~-~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN-YVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCC-CeEE
Confidence 9999999999987543 4788999999999999999999999 9999999999999877 8999
Q ss_pred EeccchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCC
Q 012320 175 IGDLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPG 252 (466)
Q Consensus 175 L~DFGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~ 252 (466)
|+|||++..............++.|+|||++. ..++.++|||||||++|+|++ |..||.. .+....++.+..+...
T Consensus 153 l~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~-~~~~~~~~~~~~~~~~- 230 (270)
T cd05047 153 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRL- 230 (270)
T ss_pred ECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc-cCHHHHHHHHhCCCCC-
Confidence 99999985332111111223356799999775 568899999999999999997 9999966 5566667777655332
Q ss_pred CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 253 AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 253 ~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..+...+.++.+++.+|+. +|.+|||+.+++.
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 231 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 2334466789999999996 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=313.90 Aligned_cols=254 Identities=28% Similarity=0.432 Sum_probs=200.1
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc----
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD---- 102 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~---- 102 (466)
++|.+ .+.||+|+||+||+|.++.+|+.||+|.++.... .......+.+|+.++++++||||+++++.+.+..
T Consensus 7 ~~~~~-~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 7 DKFDI-IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE--KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhe-eeeecccCCEEEEEEEECCCCcEEEEEEEeeccc--ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45666 5679999999999999999999999999875532 1223356778999999999999999999875432
Q ss_pred ----CCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEec
Q 012320 103 ----QKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGD 177 (466)
Q Consensus 103 ----~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~D 177 (466)
...+++|+||+++ ++..++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~-~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNK-GQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CcEEeCc
Confidence 3478999999976 676666643 57999999999999999999999999 9999999999999877 8999999
Q ss_pred cchhhhhcCCC--CCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc---CCC
Q 012320 178 LGLAAILRGSK--SAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS---GKL 250 (466)
Q Consensus 178 FGla~~~~~~~--~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~---g~~ 250 (466)
||++..+.... ......+++.|+|||.+.+ .++.++|||||||++++|++|..||.... .......+.. +..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~-~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ-ELAQLELISRLCGSPC 238 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCC
Confidence 99997654322 1223456889999997753 47899999999999999999999997633 3332222221 111
Q ss_pred CCC-------------------------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 251 PGA-------------------------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 251 p~~-------------------------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
+.. .....+..+.++|.+||. +|.+||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 110 112346789999999996 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=308.37 Aligned_cols=247 Identities=26% Similarity=0.413 Sum_probs=204.6
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
+...|.+ .++||.|+||+||+|.++. +..+|+|.+.... ......+.+|+.+++.++||||+++++.+ .+..
T Consensus 4 ~~~~y~~-~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~ 75 (261)
T cd05148 4 PREEFTL-ERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD----LLKQQDFQKEVQALKRLRHKHLISLFAVC--SVGE 75 (261)
T ss_pred cHHHHHH-hhhhccCCCccEEEeEecC-CCcEEEEeccccc----hhhHHHHHHHHHHHhcCCCcchhheeeeE--ecCC
Confidence 4455766 5669999999999999988 8999999987443 22456788999999999999999999976 4566
Q ss_pred EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 105 TFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
.+++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~-~~~kl~d~g~~~ 152 (261)
T cd05148 76 PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGED-LVCKVADFGLAR 152 (261)
T ss_pred CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCC-ceEEEccccchh
Confidence 789999999999999999763 46899999999999999999999999 9999999999999877 899999999997
Q ss_pred hhcCCC-CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 012320 183 ILRGSK-SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259 (466)
Q Consensus 183 ~~~~~~-~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 259 (466)
...... ......+++.|+|||.+. ..++.++||||||+++|+|++ |..||.. .+..+++..+..+..+ ..+...+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 230 (261)
T cd05148 153 LIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG-MNNHEVYDQITAGYRM-PCPAKCP 230 (261)
T ss_pred hcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHHhCCcC-CCCCCCC
Confidence 654321 122334567899999775 568899999999999999998 8999976 5566677777655332 3345667
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..+.++|.+||. +|.+|||+.+|+.
T Consensus 231 ~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 231 QEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 899999999996 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=314.00 Aligned_cols=251 Identities=29% Similarity=0.404 Sum_probs=203.4
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEc-------CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEE
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDE-------VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRF 94 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~-------~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l 94 (466)
..+.+||.+ .+.||+|+||.||+|.+. ..+..+|+|.++... .......+.+|+.+++++ +||||+++
T Consensus 8 ~~~~~~~~~-~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (314)
T cd05099 8 EFPRDRLVL-GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA---TDKDLADLISEMELMKLIGKHKNIINL 83 (314)
T ss_pred cccHHHeee-eeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC---ChHHHHHHHHHHHHHHhccCCCCeeeE
Confidence 445678876 677999999999999763 345679999876332 334567789999999999 69999999
Q ss_pred EeEEEeccCCEEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecc
Q 012320 95 YTSWIDVDQKTFNFITEMFTSGTLREYRKKY----------------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRD 158 (466)
Q Consensus 95 ~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrD 158 (466)
++++ .+...+++||||+++|+|.+++... ..++...+..++.||+.||.|||++| |+|||
T Consensus 84 ~~~~--~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~d 159 (314)
T cd05099 84 LGVC--TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRD 159 (314)
T ss_pred EEEE--ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecc
Confidence 9977 4466789999999999999999763 24788899999999999999999999 99999
Q ss_pred CCCCcEEEeCCCCcEEEeccchhhhhcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCC
Q 012320 159 LKCDNIFVNGHLGQVKIGDLGLAAILRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYS 233 (466)
Q Consensus 159 LKp~NIlv~~~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~ 233 (466)
|||+|||++.+ +.+||+|||++....... ......+++.|+|||++. ..++.++|||||||++|+|++ |..||.
T Consensus 160 lkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~ 238 (314)
T cd05099 160 LAARNVLVTED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP 238 (314)
T ss_pred ccceeEEEcCC-CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCC
Confidence 99999999876 899999999997654321 112223456899999765 558999999999999999999 888996
Q ss_pred CCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 234 ECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 234 ~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
. .+..++++.+..+..+. .+...+.+++++|.+||. +|.+|||+.+++.
T Consensus 239 ~-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 239 G-IPVEELFKLLREGHRMD-KPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred C-CCHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 5 56677777777665332 234456789999999996 9999999999984
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=344.67 Aligned_cols=150 Identities=22% Similarity=0.376 Sum_probs=134.5
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+. +.||+|+||+||+|.+..+++.||+|+++.... ........+..|+.+++.++||||++++..+ .....
T Consensus 3 ~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~--~~~~~ 78 (669)
T cd05610 3 IEEFVIV-KPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-INKNMVHQVQAERDALALSKSPFIVHLYYSL--QSANN 78 (669)
T ss_pred cCCEEEE-EEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE--EECCE
Confidence 3578775 669999999999999999999999999986553 2445567889999999999999999999877 44678
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
+|+||||+.|++|.+++...+.+++..++.|+.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++
T Consensus 79 ~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~-g~vkL~DFGls~ 152 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNE-GHIKLTDFGLSK 152 (669)
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCC-CCEEEEeCCCCc
Confidence 9999999999999999998889999999999999999999999999 9999999999999876 899999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=310.74 Aligned_cols=248 Identities=27% Similarity=0.429 Sum_probs=201.3
Q ss_pred eeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEec
Q 012320 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
.+.||.|++|.||+|.+..+|+.+|+|.+..... .......+.+|+.+|+.++||||+++++.+. +...+++|+||
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e~ 79 (283)
T cd05118 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE--SEGIPKTALREIKLLKELNHPNIIKLLDVFR--HKGDLYLVFEF 79 (283)
T ss_pred ceeeecCCCceEEEEEcCCCCcEEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCcchHHHhhc--cCCCEEEEEec
Confidence 3569999999999999999999999999875442 2234567889999999999999999999874 46789999999
Q ss_pred CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCC-CC
Q 012320 113 FTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-SA 190 (466)
Q Consensus 113 ~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~-~~ 190 (466)
+.+ +|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.+ +.+||+|||.+....... ..
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~-~~~~l~df~~~~~~~~~~~~~ 155 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPY 155 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCC-CcEEEeeeeeeEecCCCcccc
Confidence 965 88877765 468999999999999999999999999 9999999999999976 899999999987665433 23
Q ss_pred ccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--C--------------
Q 012320 191 HSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP--G-------------- 252 (466)
Q Consensus 191 ~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p--~-------------- 252 (466)
....++..|+|||.+.+ .++.++|||||||++|+|++|..||....+..++.+.......+ .
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence 34568899999997753 58899999999999999999999997755444433332211100 0
Q ss_pred -----------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 253 -----------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 253 -----------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
......+.++++||.+||. +|.+||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0112246789999999996 99999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=304.09 Aligned_cols=238 Identities=20% Similarity=0.346 Sum_probs=196.0
Q ss_pred eeeeCceEEEEEEEc--CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecC
Q 012320 36 LGKGAMKTVYKAIDE--VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMF 113 (466)
Q Consensus 36 LG~G~fg~Vyka~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~ 113 (466)
||+|+||+||+|.++ ..+..||+|++.... .....+.+.+|+.++++++||||+++++.+ . ...+++||||+
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~--~-~~~~~lv~e~~ 76 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIVRMIGVC--E-AEALMLVMEMA 76 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEccccc---ChHHHHHHHHHHHHHHhcCCCCeEEEEEEE--c-CCCeEEEEEeC
Confidence 899999999999765 456789999876432 334456789999999999999999999976 2 34688999999
Q ss_pred CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCC---
Q 012320 114 TSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS--- 189 (466)
Q Consensus 114 ~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~--- 189 (466)
++++|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++.+ +.+||+|||++..+.....
T Consensus 77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQ-HYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCC-CcEEeccCCccccccCCcccee
Confidence 99999999875 457999999999999999999999999 9999999999999876 7999999999876533221
Q ss_pred -CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 012320 190 -AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFI 266 (466)
Q Consensus 190 -~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI 266 (466)
.....+++.|+|||.+. +.++.++|||||||++|+|++ |..||.. .+...+...+..+..+ ..+...+.++.++|
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li 231 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKK-MKGPEVMSFIEQGKRL-DCPAECPPEMYALM 231 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCc-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHHH
Confidence 11122357899999775 568999999999999999996 9999976 4556677777776643 34455678999999
Q ss_pred HHhcc-CcCCCCCHHHHhc
Q 012320 267 GRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 267 ~~~L~-dp~~Rpsa~elL~ 284 (466)
.+|+. +|.+||++.++.+
T Consensus 232 ~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 232 KDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 99996 9999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=310.11 Aligned_cols=247 Identities=28% Similarity=0.406 Sum_probs=201.1
Q ss_pred eeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEeEEEeccCCEEEEEEe
Q 012320 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYTSWIDVDQKTFNFITE 111 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~~~lV~E 111 (466)
.+.||+|++|+||+|....+++.||+|.+..... . .......+|+..+++++ ||||+++++.+. ++...++|||
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~--~~~~~~lv~e 78 (283)
T cd07830 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--S-WEECMNLREVKSLRKLNEHPNIVKLKEVFR--ENDELYFVFE 78 (283)
T ss_pred heeeccCCceEEEEEEECCCCcEEEEEEehhhcc--c-hhHHHHHHHHHHHHhccCCCCchhHHHHhh--cCCcEEEEEe
Confidence 5679999999999999999999999998864432 1 12234567999999998 999999999874 4778999999
Q ss_pred cCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCC
Q 012320 112 MFTSGTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS 189 (466)
Q Consensus 112 ~~~ggsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~ 189 (466)
|+ +|+|.+++.... .+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.+ +.++|+|||++........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~-~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGP-EVVKIADFGLAREIRSRPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCC-CCEEEeecccceeccCCCC
Confidence 99 889999887754 7899999999999999999999999 9999999999999976 8999999999987655444
Q ss_pred CccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-----------------
Q 012320 190 AHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL----------------- 250 (466)
Q Consensus 190 ~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~----------------- 250 (466)
.....|+..|+|||++. ..++.++|+||||+++++|++|..||..........+.......
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 44567899999999774 34789999999999999999999999775544444333221100
Q ss_pred ---CC-------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 251 ---PG-------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 251 ---p~-------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
+. ......+..+++||.+||. +|.+|||++|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 0011225689999999996 99999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=306.10 Aligned_cols=246 Identities=21% Similarity=0.353 Sum_probs=199.5
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
-+.++|.+ .+.||+|+||+||+|.+..++ .||+|.++.... ..+.+.+|+.+++.++||||+++++.+ . .
T Consensus 3 ~~~~~~~~-~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~--~-~ 72 (262)
T cd05071 3 IPRESLRL-EVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVV--S-E 72 (262)
T ss_pred CChHHeeE-eeecCCCCCCcEEEEEecCCc-eEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCcceEEEEE--C-C
Confidence 35678887 456999999999999987664 599998874332 225688899999999999999999865 2 3
Q ss_pred CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 104 KTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
...++||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.+ +.+||+|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~-~~~~L~dfg~~ 149 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLA 149 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCC-CcEEeccCCce
Confidence 4578999999999999999764 45899999999999999999999999 9999999999999876 89999999999
Q ss_pred hhhcCCCC--CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 012320 182 AILRGSKS--AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSI 257 (466)
Q Consensus 182 ~~~~~~~~--~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 257 (466)
..+..... .....++..|+|||+.. ..++.++|||||||++|+|++ |..||.. .+..++...+..+... .....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~ 227 (262)
T cd05071 150 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRM-PCPPE 227 (262)
T ss_pred eeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CChHHHHHHHhcCCCC-CCccc
Confidence 76543221 12334667899999765 568999999999999999999 7888866 4556666666655322 22344
Q ss_pred CCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 258 QDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 258 ~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.+..+.++|.+|+. +|.+||++.+++.
T Consensus 228 ~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 228 CPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 66789999999996 9999999998863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=311.36 Aligned_cols=248 Identities=26% Similarity=0.421 Sum_probs=210.5
Q ss_pred eeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHh-CCCCceeEEEeEEEeccCCEEEEEEecCC
Q 012320 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLST-LKHDSIIRFYTSWIDVDQKTFNFITEMFT 114 (466)
Q Consensus 36 LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~~~~~~~~lV~E~~~ 114 (466)
||.|+||+|+|..|+.+|+..|+|+|+.... ..+.++++.|.....+ -+.||||++|++.+. ++..|+.||+|
T Consensus 72 iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~---~keq~rll~e~d~~mks~~cp~IVkfyGa~F~--EGdcWiCMELM- 145 (361)
T KOG1006|consen 72 IGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI---EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS--EGDCWICMELM- 145 (361)
T ss_pred hcCCcchhhhhhhcCccCcEEEEEEeeeccc---hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc--CCceeeeHHHH-
Confidence 9999999999999999999999999986653 4566788888876554 489999999998754 55689999999
Q ss_pred CCCHHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCC
Q 012320 115 SGTLREYR-----KKYRRVDIRAIKSWARQILQGLVYLHSR-DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK 188 (466)
Q Consensus 115 ggsL~~~l-----~~~~~l~~~~~~~i~~qIl~gL~yLHs~-~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~ 188 (466)
..||..+- .+..+++|+.+..|..-.+.||.||-.. . |||||+||+|||++.. |.|||||||++..+..+-
T Consensus 146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~-G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRH-GDVKLCDFGICGQLVDSI 222 (361)
T ss_pred hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecC-CCEeeecccchHhHHHHH
Confidence 66776543 2457899999999999999999999754 5 9999999999999987 999999999998887765
Q ss_pred CCccccCCCCcCCccccc---cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC----CCHH
Q 012320 189 SAHSVIGTPEFMAPELYE---EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSI----QDLE 261 (466)
Q Consensus 189 ~~~~~~GT~~y~APE~l~---~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~----~~~~ 261 (466)
......|-..|||||.+. .+|+.++|+||||++|||++||.+||.+-.+..+...++..|..|...... .+..
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~ 302 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFS 302 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHH
Confidence 555667999999999775 349999999999999999999999998877777777778888877544332 4678
Q ss_pred HHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 262 AQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 262 ~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
+..||..||. |.+.||+..+|+++||++...
T Consensus 303 ~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 303 MVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred HHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 9999999995 999999999999999997543
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=304.21 Aligned_cols=241 Identities=26% Similarity=0.388 Sum_probs=198.5
Q ss_pred eeeeeeCceEEEEEEEcC-C--CeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEE
Q 012320 34 EVLGKGAMKTVYKAIDEV-L--GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFIT 110 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~-~--g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~ 110 (466)
++||+|++|+||+|.+.. . ...||+|.+...... ...+.+.+|+.++++++||||+++++.+.. ..+++|+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEE
Confidence 358999999999998765 3 336999998755432 566789999999999999999999998753 7889999
Q ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCC
Q 012320 111 EMFTSGTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK 188 (466)
Q Consensus 111 E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~ 188 (466)
||+++++|.+++.+.. .+++..+..++.||+.||.|||+.+ ++||||||+||+++.+ +.+||+|||++..+....
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~-~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASD-DKVKIGDFGLMRALPQNE 151 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecC-CEEEeccccccccccccc
Confidence 9999999999997754 6899999999999999999999999 9999999999999987 899999999997764321
Q ss_pred C----CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 012320 189 S----AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA 262 (466)
Q Consensus 189 ~----~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~ 262 (466)
. .....++..|+|||.+. ..++.++|||||||++|+|++ |..||.. .+..++.+.+.........+...+..+
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG-LSGSQILKKIDKEGERLERPEACPQDI 230 (257)
T ss_pred cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHhcCCcCCCCccCCHHH
Confidence 1 12345778899999776 568999999999999999998 9999976 455566666553222222334456789
Q ss_pred HHHHHHhcc-CcCCCCCHHHHhc
Q 012320 263 QRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 263 ~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.+++.+||. +|++|||+.+++.
T Consensus 231 ~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 231 YNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHCCCCcccCCCHHHHHH
Confidence 999999996 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=301.56 Aligned_cols=242 Identities=27% Similarity=0.429 Sum_probs=203.6
Q ss_pred eeeeeeeCceEEEEEEEcCCC----eEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEE
Q 012320 33 EEVLGKGAMKTVYKAIDEVLG----VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNF 108 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~l 108 (466)
.+.||.|+||.||+|.+..++ ..||+|.+.... .....+.+.+|+.+++.++||||+++++.+. +...+++
T Consensus 4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~ 78 (258)
T smart00219 4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA---DEQQIEEFLREARIMRKLDHPNIVKLLGVCT--EEEPLMI 78 (258)
T ss_pred cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC---ChHHHHHHHHHHHHHHhcCCCchheEEEEEc--CCCeeEE
Confidence 567999999999999998877 999999986432 2235678999999999999999999999874 4578999
Q ss_pred EEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 109 ITEMFTSGTLREYRKKYRR--VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 109 V~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
|||++++++|.+++..... +++..+..++.||+.||.|||+.+ ++||||||+||+++.+ +.++|+|||++.....
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~-~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGEN-LVVKISDFGLSRDLYD 155 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccC-CeEEEcccCCceeccc
Confidence 9999999999999976554 999999999999999999999999 9999999999999877 7999999999976543
Q ss_pred CCCCc--cccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 012320 187 SKSAH--SVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA 262 (466)
Q Consensus 187 ~~~~~--~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~ 262 (466)
..... ...+++.|+|||.+. ..++.++|||||||++|+|++ |..||.. .+...+.+.+..+..+.. ....+.++
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~ 233 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLKKGYRLPK-PENCPPEI 233 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCCCC-CCcCCHHH
Confidence 32111 123678999999775 458999999999999999998 7777765 677777778877765433 34467899
Q ss_pred HHHHHHhcc-CcCCCCCHHHHhc
Q 012320 263 QRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 263 ~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.+++.+||. +|.+|||+.++++
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 234 YKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHCcCChhhCcCHHHHHh
Confidence 999999996 9999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=305.31 Aligned_cols=247 Identities=21% Similarity=0.356 Sum_probs=201.5
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCC---eEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLG---VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
++|.+ .+.||+|+||.||+|.++.++ ..+|+|.++... .....+.+.+|+.++++++||||+++++.+ ...
T Consensus 4 ~~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~ 77 (267)
T cd05066 4 SCIKI-EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVV--TKS 77 (267)
T ss_pred HHeEe-eeeecccCCCceEEEEEecCCCCceEEEEEECCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEE--ecC
Confidence 56765 678999999999999987554 379999876432 234557889999999999999999999987 346
Q ss_pred CEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 104 KTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
..+++||||+++++|.+++.+. +.+++..+..++.|++.||.|||+.+ ++||||||+||+++.+ +.+||+|||++.
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~-~~~~l~dfg~~~ 154 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSN-LVCKVSDFGLSR 154 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCC-CeEEeCCCCccc
Confidence 6889999999999999999765 56899999999999999999999999 9999999999999876 799999999997
Q ss_pred hhcCCCC----CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 012320 183 ILRGSKS----AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 183 ~~~~~~~----~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 256 (466)
.+..... .....++..|+|||.+. +.++.++|+|||||++|+|++ |..||.. .+..+..+.+..+..+ ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~ 232 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWE-MSNQDVIKAIEEGYRL-PAPM 232 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCccc-CCHHHHHHHHhCCCcC-CCCC
Confidence 6543221 11222356899999876 568999999999999999886 9999976 4455667777665322 2234
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..+..+++++.+|+. +|.+||++.+++.
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 233 DCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 456789999999996 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=303.40 Aligned_cols=245 Identities=22% Similarity=0.369 Sum_probs=199.3
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.. .+.||+|++|.||+|.+.. +..||+|.++.... ..+.+.+|+.++++++||||+++++.+ ...+.
T Consensus 5 ~~~~~~-~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~ 75 (261)
T cd05068 5 RTSIQL-LRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM-----DPKDFLAEAQIMKKLRHPKLIQLYAVC--TLEEP 75 (261)
T ss_pred hhheee-EEEecccCCccEEEEEecC-CeEEEEEeeCCCcc-----cHHHHHHHHHHHHHCCCCCccceeEEE--ecCCC
Confidence 355655 5779999999999999764 57899999864432 235688899999999999999999977 44667
Q ss_pred EEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 106 FNFITEMFTSGTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
+++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.+ +.+||+|||++..
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~ 152 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGEN-NICKVADFGLARV 152 (261)
T ss_pred eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCC-CCEEECCcceEEE
Confidence 899999999999999997654 6899999999999999999999999 9999999999999977 8999999999977
Q ss_pred hcCCCCC--ccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 012320 184 LRGSKSA--HSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259 (466)
Q Consensus 184 ~~~~~~~--~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 259 (466)
....... ....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+ .+...+...+..+.. .......+
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~ 230 (261)
T cd05068 153 IKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG-MTNAEVLQQVDQGYR-MPCPPGCP 230 (261)
T ss_pred ccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC-CCCCCcCC
Confidence 6432111 1112235799999776 568999999999999999999 9999976 556666666665432 22334567
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..+.+++.+|+. +|.+||++.+|+.
T Consensus 231 ~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 231 KELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 889999999995 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=338.57 Aligned_cols=260 Identities=28% Similarity=0.440 Sum_probs=219.1
Q ss_pred eeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEe
Q 012320 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWID 100 (466)
Q Consensus 22 ~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~ 100 (466)
.-||++.+.+ .++||+|.+|.||++.++.+|+..|+|+..... +.-+.+..|.++|+.+ .|||++.+|++|.-
T Consensus 14 lpdp~d~~ei-~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-----d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 14 LPDPADIFEI-IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-----DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred CCCCCCccEE-EEEEeeccceeEEEEeeeecCceeeeEeecCCc-----cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3688899987 577999999999999999999999999876443 2335667799999987 79999999999875
Q ss_pred cc---CCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEE
Q 012320 101 VD---QKTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKI 175 (466)
Q Consensus 101 ~~---~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL 175 (466)
.+ ++.+|||||||.|||.-|+++.. .++.|..+..|++.++.||.+||.+. +||||||-.|||++.+ |.|||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e-~~VKL 164 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTEN-AEVKL 164 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEecc-CcEEE
Confidence 43 56899999999999999998764 67999999999999999999999999 9999999999999988 89999
Q ss_pred eccchhhhhcCC-CCCccccCCCCcCCcccccc------CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q 012320 176 GDLGLAAILRGS-KSAHSVIGTPEFMAPELYEE------DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG 248 (466)
Q Consensus 176 ~DFGla~~~~~~-~~~~~~~GT~~y~APE~l~~------~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g 248 (466)
+|||++..+... ....+.+|||+|||||++.. .|+..+|+||||++..||.-|.+|+.......-+++.....
T Consensus 165 vDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP 244 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 244 (953)
T ss_pred eeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCC
Confidence 999999887543 44678899999999998753 38889999999999999999999998744444444433332
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 249 KLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 249 ~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
.....-++..+.++.+||..||. |-.+||+..++|+|||++.
T Consensus 245 PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 245 PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred CccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 22222356667899999999995 9999999999999999984
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=316.91 Aligned_cols=255 Identities=26% Similarity=0.368 Sum_probs=200.7
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCC--CeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEec--c
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVL--GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDV--D 102 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~--g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~--~ 102 (466)
+|.. .+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+.+|+.+++++ +||||+++++.+... .
T Consensus 1 ~y~~-~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 77 (332)
T cd07857 1 RYEL-IKELGQGAYGIVCSARNAETSEEETVAIKKITNVF--SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN 77 (332)
T ss_pred CceE-EEEccccCCeEEEEEEeCCCCcCceEEEEEecccc--ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence 4555 57799999999999999988 9999999886432 1223456788999999999 599999999865432 2
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
...+++++|++ +++|.+++.....+++..++.++.||+.||.|||+.| |+||||||+|||++.+ +.+||+|||++.
T Consensus 78 ~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~-~~~kl~Dfg~a~ 153 (332)
T cd07857 78 FNELYLYEELM-EADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNAD-CELKICDFGLAR 153 (332)
T ss_pred CCcEEEEEecc-cCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCC-CCEEeCcCCCce
Confidence 35678888988 4799999988888999999999999999999999999 9999999999999877 899999999997
Q ss_pred hhcCCC-----CCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--------
Q 012320 183 ILRGSK-----SAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-------- 247 (466)
Q Consensus 183 ~~~~~~-----~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-------- 247 (466)
.+.... ......||+.|+|||++. ..++.++||||+||++|+|++|..||.... .......+..
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD-YVDQLNQILQVLGTPDEE 232 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC-HHHHHHHHHHHhCCCCHH
Confidence 654221 123457899999999765 358999999999999999999999997533 2222211110
Q ss_pred -----------------CCCC----CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 248 -----------------GKLP----GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 248 -----------------g~~p----~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
+..+ .......+..+++|+.+||. +|.+|||+.+++.|||++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~ 297 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhh
Confidence 0000 01122346789999999996 9999999999999999953
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=304.03 Aligned_cols=247 Identities=23% Similarity=0.363 Sum_probs=201.2
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCe---EEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGV---EVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
.+|.. .+.||+|+||.||+|.++.++. .+|+|.+.... .....+.+.+|+.++++++||||+++++.+ .+.
T Consensus 5 ~~~~~-~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~ 78 (268)
T cd05063 5 SHITK-QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEASIMGQFSHHNIIRLEGVV--TKF 78 (268)
T ss_pred HHceE-eeEecCCCCccEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCCCeeEEEEEE--ccC
Confidence 35665 6779999999999999887665 68999876432 334557789999999999999999999987 446
Q ss_pred CEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 104 KTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
..+++||||+++++|.+++.+. +.+++..+..++.|++.||.|||+.+ ++||||||+||+++.+ +.+||+|||++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~dfg~~~ 155 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSN-LECKVSDFGLSR 155 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCC-CcEEECCCccce
Confidence 6789999999999999998764 67899999999999999999999999 9999999999999876 799999999987
Q ss_pred hhcCCCCC----ccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 012320 183 ILRGSKSA----HSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 183 ~~~~~~~~----~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 256 (466)
........ .....++.|+|||++. ..++.++|||||||++|+|++ |..||.. .+...+.+.+..+... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~ 233 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD-MSNHEVMKAINDGFRL-PAPM 233 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCc-CCHHHHHHHHhcCCCC-CCCC
Confidence 65432111 1122345799999776 568999999999999999997 9999976 4556677777665322 2233
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..+..+.+++.+|+. +|.+||++.++++
T Consensus 234 ~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 234 DCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 456789999999996 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=306.77 Aligned_cols=252 Identities=30% Similarity=0.505 Sum_probs=206.1
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccC-CHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMR-SPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
||.+ .+.||+|+||+||+|.+..++..+++|.++...... .......+..|+.+++.++||||+++++.+. +....
T Consensus 1 ~y~i-~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 77 (260)
T cd08222 1 RYIL-QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL--ERDAF 77 (260)
T ss_pred Ccee-eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh--cCCce
Confidence 6777 566999999999999998888877777665432211 2234456778999999999999999999874 45678
Q ss_pred EEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 107 NFITEMFTSGTLREYRKK----YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
++|+||+++++|.+++.+ ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++. +.+||+|||++.
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~--~~~~l~d~g~~~ 153 (260)
T cd08222 78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN--NLLKIGDFGVSR 153 (260)
T ss_pred EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec--CCEeecccCcee
Confidence 999999999999988754 356999999999999999999999999 999999999999975 579999999987
Q ss_pred hhcCCC-CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 012320 183 ILRGSK-SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL 260 (466)
Q Consensus 183 ~~~~~~-~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~ 260 (466)
...... ......|++.|+|||.+. ..++.++|+||||+++|+|++|..||.. .+.......+..+..+. .+...+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (260)
T cd08222 154 LLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIVEGPTPS-LPETYSR 231 (260)
T ss_pred ecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCCCCC-CcchhcH
Confidence 654322 233456899999999765 4588899999999999999999999965 45555666666665443 3455678
Q ss_pred HHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 261 EAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 261 ~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
++.++|.+||. +|.+||++.++++||||
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 232 QLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 99999999996 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=319.69 Aligned_cols=254 Identities=27% Similarity=0.375 Sum_probs=201.5
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc---
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD--- 102 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--- 102 (466)
..+|.. .+.||+|+||+||+|.++.+|..||+|.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~-~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 14 PERYTS-LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ--SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred ccceEE-EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc--cccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 468887 5679999999999999999999999998875431 2223456789999999999999999999875432
Q ss_pred -CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 103 -QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 103 -~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
...+++|+||+. .+|..++ ...+++..+..++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~-~~~kL~dfg~~ 164 (342)
T cd07879 91 EFQDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNED-CELKILDFGLA 164 (342)
T ss_pred CCceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEeeCCCC
Confidence 235789999995 4777665 347899999999999999999999999 9999999999999977 89999999998
Q ss_pred hhhcCCCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CC--------
Q 012320 182 AILRGSKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG-KL-------- 250 (466)
Q Consensus 182 ~~~~~~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g-~~-------- 250 (466)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||... +.......+... ..
T Consensus 165 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 165 RHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK-DYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred cCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCCHHHHHH
Confidence 75432 2334578999999998754 4889999999999999999999999763 333333322210 00
Q ss_pred -------------CCC-------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 251 -------------PGA-------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 251 -------------p~~-------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
+.. .....+..+.+||.+||. ||.+||++.+++.||||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000 012345678999999996 99999999999999999764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=309.27 Aligned_cols=259 Identities=29% Similarity=0.426 Sum_probs=200.9
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCe----EEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGV----EVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
.|...++ ||+|+||.||||..+.+.. .+|||+++-.+- ........-+||.+++.++|||||.+..+|+.. +
T Consensus 25 ~ye~ig~-Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd--~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d 100 (438)
T KOG0666|consen 25 EYEGIGK-IGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD--GTGISMSACREIALLRELKHPNVISLVKVFLSH-D 100 (438)
T ss_pred Hhhccce-ecccccceeeEeeeccCCcccchhhHHHHHhccCC--CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-C
Confidence 4555544 9999999999997665543 789998864421 223446788999999999999999999988654 7
Q ss_pred CEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC---CCcEEE
Q 012320 104 KTFNFITEMFTSGTLREYRKKY-----RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH---LGQVKI 175 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~-----~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~---~g~vKL 175 (466)
..+++++||. .-+|...|+-+ +.++...++.++.||+.|+.|||++. |+||||||.||||.++ .|.|||
T Consensus 101 ~~v~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 101 KKVWLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred ceEEEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEe
Confidence 7899999998 56888887643 45899999999999999999999999 9999999999999765 479999
Q ss_pred eccchhhhhcCCC----CCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCC------CH---HH
Q 012320 176 GDLGLAAILRGSK----SAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECA------NP---AQ 240 (466)
Q Consensus 176 ~DFGla~~~~~~~----~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~------~~---~~ 240 (466)
+|||+++.+...- ....++-|.+|.|||++-+ .|+.++|||++|||+.||+|-++.|.+.. ++ .+
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 9999999876432 2345678999999997754 59999999999999999999888875421 11 12
Q ss_pred HHHHHhc-CC-----------CCCC----------------------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 241 IYKKVTS-GK-----------LPGA----------------------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 241 i~~~i~~-g~-----------~p~~----------------------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
+.+...- |. .|.. ..+..++.+.+|+.+||. ||.+|+|++++|+|
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 2111110 11 1110 013345568899999996 99999999999999
Q ss_pred CCCCchhh
Q 012320 286 PFLASDEV 293 (466)
Q Consensus 286 pf~~~~~~ 293 (466)
+||..++.
T Consensus 338 ~yF~~d~l 345 (438)
T KOG0666|consen 338 PYFTEDPL 345 (438)
T ss_pred cccccCCC
Confidence 99987643
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=302.96 Aligned_cols=245 Identities=22% Similarity=0.357 Sum_probs=198.1
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
+.++|.+ .+.||+|++|+||+|.++.++ .+|+|.+..... ..+.+.+|+.+++.++||||+++++.+ . ..
T Consensus 4 ~~~~~~~-~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~--~-~~ 73 (260)
T cd05069 4 PRESLRL-DVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM-----MPEAFLQEAQIMKKLRHDKLVPLYAVV--S-EE 73 (260)
T ss_pred ChHHeee-eeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc-----cHHHHHHHHHHHHhCCCCCeeeEEEEE--c-CC
Confidence 4567777 566999999999999887654 599998764332 235678899999999999999999875 2 34
Q ss_pred EEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
..++||||+.+++|.+++.+.. .+++..+..++.||+.||.|||+.+ ++||||||+||+++.+ +.+||+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~-~~~~l~dfg~~~ 150 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDN-LVCKIADFGLAR 150 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCC-CeEEECCCccce
Confidence 5789999999999999997643 4789999999999999999999999 9999999999999876 899999999997
Q ss_pred hhcCCCC--CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 012320 183 ILRGSKS--AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258 (466)
Q Consensus 183 ~~~~~~~--~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 258 (466)
....... .....++..|+|||... ..++.++|||||||++|+|++ |..||.+ .+.......+..+..+ ..+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~ 228 (260)
T cd05069 151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG-MVNREVLEQVERGYRM-PCPQGC 228 (260)
T ss_pred EccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCccc
Confidence 6543221 12234567899999765 568999999999999999999 8999976 4555666666655322 233456
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+..+++++++||. +|.+||+++++++
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 229 PESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 7899999999996 9999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=306.78 Aligned_cols=246 Identities=23% Similarity=0.361 Sum_probs=198.3
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeE----EEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVE----VAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~----vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
+.|.+ .+.||+|+||+||+|....+|.. +|+|.+... ........+..|+.++++++||||+++++.+.
T Consensus 7 ~~~~~-~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~--- 79 (279)
T cd05111 7 TELRK-LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR---SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP--- 79 (279)
T ss_pred hhcee-ccccCccCCcceEEEEEcCCCCceeeEEEEeecccc---cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC---
Confidence 45555 46699999999999998877764 666665321 12334467888999999999999999999762
Q ss_pred CCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
....++|+||+++|+|.+++... +.+++..+..|+.||+.||.|||+.+ ++||||||+||+++.+ +.+||+|||++
T Consensus 80 ~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~-~~~kl~Dfg~~ 156 (279)
T cd05111 80 GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSD-SIVQIADFGVA 156 (279)
T ss_pred CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCC-CcEEEcCCccc
Confidence 34577899999999999999764 57899999999999999999999999 9999999999999876 79999999999
Q ss_pred hhhcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 012320 182 AILRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 182 ~~~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 256 (466)
+...... ......++..|+|||.+. +.++.++|||||||++|||++ |..||.+ .....+.+.+..+..+. .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~ 234 (279)
T cd05111 157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG-MRPHEVPDLLEKGERLA-QPQ 234 (279)
T ss_pred eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcCC-CCC
Confidence 7653322 122345677899999775 569999999999999999998 9999976 45666666666665443 334
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..+..+.+++.+|+. +|.+|||+.|+++
T Consensus 235 ~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 235 ICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 566788999999995 9999999999865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=303.96 Aligned_cols=241 Identities=22% Similarity=0.380 Sum_probs=197.5
Q ss_pred eeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEe
Q 012320 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITE 111 (466)
Q Consensus 32 ~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E 111 (466)
+.+.||+|+||.||+|.++ ++..+|+|.+..... ....+.+|+.+++.++||||+++++.+ .....+++|||
T Consensus 8 ~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~lv~e 79 (256)
T cd05059 8 FLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-----SEDDFIEEAKVMMKLSHPNLVQLYGVC--TKQRPIFIVTE 79 (256)
T ss_pred hhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEEEEEEEE--cCCCceEEEEe
Confidence 4677999999999999886 467899998764332 224578899999999999999999976 45678899999
Q ss_pred cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCC
Q 012320 112 MFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA 190 (466)
Q Consensus 112 ~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~ 190 (466)
|++|++|.+++.+. +.+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ |.+||+|||++.........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~-~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGED-NVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCC-CcEEECCcccceeccccccc
Confidence 99999999998764 56899999999999999999999999 9999999999999876 89999999998765322111
Q ss_pred --ccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 012320 191 --HSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFI 266 (466)
Q Consensus 191 --~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI 266 (466)
....++..|+|||.+. ..++.++|||||||++|+|++ |..||.. .+..++...+..+.. ...+...+.++.+++
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li 234 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER-FSNSEVVESVSAGYR-LYRPKLAPTEVYTIM 234 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHHcCCc-CCCCCCCCHHHHHHH
Confidence 1112345799999776 568999999999999999999 7889965 456667777766532 233455788999999
Q ss_pred HHhcc-CcCCCCCHHHHhcC
Q 012320 267 GRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 267 ~~~L~-dp~~Rpsa~elL~h 285 (466)
.+||. +|.+|||+.++++.
T Consensus 235 ~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 235 YSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHhcCChhhCcCHHHHHHH
Confidence 99995 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=307.42 Aligned_cols=241 Identities=25% Similarity=0.377 Sum_probs=197.1
Q ss_pred eeeeeeeCceEEEEEEE-----cCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 33 EEVLGKGAMKTVYKAID-----EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
.+.||+|+||+||+|.. ..++..+|+|.+... .....+.+.+|+.+++.++||||+++++.+. +...++
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 83 (280)
T cd05092 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTVLQHQHIVRFYGVCT--EGRPLL 83 (280)
T ss_pred ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEe--cCCceE
Confidence 56699999999999964 346778999987632 3445678999999999999999999999874 466789
Q ss_pred EEEecCCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCc
Q 012320 108 FITEMFTSGTLREYRKKYR---------------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQ 172 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~---------------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~ 172 (466)
+|+||+++++|.+++.+.+ .+++..+..++.||+.||.|||+.+ ++||||||+|||++.+ +.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~~-~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQG-LV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcCC-CC
Confidence 9999999999999987653 4789999999999999999999999 9999999999999876 79
Q ss_pred EEEeccchhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhc
Q 012320 173 VKIGDLGLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTS 247 (466)
Q Consensus 173 vKL~DFGla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~ 247 (466)
+||+|||++........ .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.. .+.......+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ-LSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc-CCHHHHHHHHHc
Confidence 99999999865432211 12234578899999765 568999999999999999998 8899866 445556666666
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 248 GKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 248 g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+..+. .+...+..+.++|.+||. +|.+||++.+++.
T Consensus 240 ~~~~~-~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GRELE-RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 54332 334567789999999996 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=309.09 Aligned_cols=242 Identities=20% Similarity=0.251 Sum_probs=199.3
Q ss_pred eeeeeeeCceEEEEEEEcC-----CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 33 EEVLGKGAMKTVYKAIDEV-----LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
.+.||+|+||+||+|.+.. .+..||+|.++... .....+.+.+|+.+++.++||||+++++.+ ......+
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~--~~~~~~~ 84 (283)
T cd05091 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPNIVCLLGVV--TKEQPLS 84 (283)
T ss_pred HHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEE--cCCCceE
Confidence 4569999999999998754 36889999887432 233456788999999999999999999977 4456789
Q ss_pred EEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCC
Q 012320 108 FITEMFTSGTLREYRKKY----------------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLG 171 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g 171 (466)
+++||+.+++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.+ +
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~~~-~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDK-L 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEecCC-C
Confidence 999999999999998532 34788899999999999999999999 9999999999999876 7
Q ss_pred cEEEeccchhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHh
Q 012320 172 QVKIGDLGLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVT 246 (466)
Q Consensus 172 ~vKL~DFGla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~ 246 (466)
.+||+|||++........ .....+++.|+|||.+. +.++.++|||||||++|||++ |..||.+ .+..++...+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~i~ 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDVIEMIR 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHH
Confidence 999999999876533221 22345678999999765 568999999999999999998 7788866 56677888888
Q ss_pred cCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 247 SGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 247 ~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.+..+. .....+..+.+++..||. +|.+||++++++.
T Consensus 241 ~~~~~~-~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 241 NRQVLP-CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred cCCcCC-CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 776532 334567789999999995 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=324.96 Aligned_cols=249 Identities=27% Similarity=0.370 Sum_probs=201.4
Q ss_pred CceEEeeeeeeeeCceEEEEEEE-----cCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEeEEEe
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAID-----EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYTSWID 100 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~ 100 (466)
.+|.+ .+.||+|+||.||+|.+ ..++..||+|+++... .....+.+.+|+++|.++. ||||+++++.+.
T Consensus 37 ~~~~~-~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~- 111 (401)
T cd05107 37 DNLVL-GRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQALMSELKIMSHLGPHLNIVNLLGACT- 111 (401)
T ss_pred HHeeh-hhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc-
Confidence 44544 67799999999999985 3456789999987432 2334467889999999997 999999999884
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHhcC------------------------------------------------------
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKKYR------------------------------------------------------ 126 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~~~------------------------------------------------------ 126 (466)
....+++|+||+.+|+|.+++.+.+
T Consensus 112 -~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 112 -KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred -cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 4567999999999999999986532
Q ss_pred --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCC
Q 012320 127 --------------------------------------------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCD 162 (466)
Q Consensus 127 --------------------------------------------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~ 162 (466)
.+++..+..++.||+.||.|||+.+ |+||||||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~ 268 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAAR 268 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcc
Confidence 2566778889999999999999998 999999999
Q ss_pred cEEEeCCCCcEEEeccchhhhhcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 012320 163 NIFVNGHLGQVKIGDLGLAAILRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECAN 237 (466)
Q Consensus 163 NIlv~~~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~ 237 (466)
|||++.. +.+||+|||++..+.... ......+++.|+|||.+. ..++.++|||||||++|||++ |..||.....
T Consensus 269 NiLl~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 269 NVLICEG-KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred eEEEeCC-CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 9999876 799999999997653221 122345788999999776 458999999999999999998 8999977566
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 238 PAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 238 ~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
.......+..+..+ ..+...+.++.+++.+|+. +|.+||++.+|++.
T Consensus 348 ~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 348 NEQFYNAIKRGYRM-AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred hHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 66666666665432 3344567899999999996 99999999999853
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=302.57 Aligned_cols=243 Identities=19% Similarity=0.278 Sum_probs=194.2
Q ss_pred eeeeeeCceEEEEEEEcC---CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEE
Q 012320 34 EVLGKGAMKTVYKAIDEV---LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFIT 110 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~ 110 (466)
++||+|+||+||+|.+.. .+..+|+|.+... ......+.+.+|+.+++.++||||+++++.+.. .+...++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI---TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP-SEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc---CCHHHHHHHHHHHHHHccCCCCCcceEEEEeec-CCCCcEEEE
Confidence 358999999999998653 4567999987532 134456788999999999999999999997643 345678999
Q ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCC-
Q 012320 111 EMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK- 188 (466)
Q Consensus 111 E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~- 188 (466)
||+.+|+|.+++.+. ...++..+..++.||+.||.|||+.+ ++||||||+|||++.+ +.+||+|||++.......
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~-~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDES-FTVKVADFGLARDIYDKEY 153 (262)
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCC-CcEEECCccccccccCCcc
Confidence 999999999998764 45678888999999999999999999 9999999999999876 799999999987543211
Q ss_pred ----CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 189 ----SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 189 ----~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
......+++.|+|||.+. ..++.++|||||||++|||++|..|+....+...+.+.+..+..+. .....+..+.
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 232 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLL-QPEYCPDPLY 232 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC-CCCcCCHHHH
Confidence 112334677899999765 5689999999999999999996544333366667777777665433 2344567899
Q ss_pred HHHHHhcc-CcCCCCCHHHHhc
Q 012320 264 RFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+++.+||. +|++||++.+++.
T Consensus 233 ~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 233 EVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHHH
Confidence 99999996 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=310.09 Aligned_cols=249 Identities=27% Similarity=0.397 Sum_probs=202.5
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEc-------CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDE-------VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTS 97 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~-------~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~ 97 (466)
..+|.+ .+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.+ +||||+++++.
T Consensus 14 ~~~~~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 14 RDKLTL-GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred HHHeee-cceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc---chHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 456665 677999999999999752 345689999876332 234557889999999999 89999999998
Q ss_pred EEeccCCEEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCC
Q 012320 98 WIDVDQKTFNFITEMFTSGTLREYRKKY----------------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKC 161 (466)
Q Consensus 98 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp 161 (466)
+ .....+++||||+.+|+|.+++.+. ..++...+..++.||+.||.|||++| |+||||||
T Consensus 90 ~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp 165 (304)
T cd05101 90 C--TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAA 165 (304)
T ss_pred E--ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence 7 4466889999999999999999764 24678889999999999999999999 99999999
Q ss_pred CcEEEeCCCCcEEEeccchhhhhcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 012320 162 DNIFVNGHLGQVKIGDLGLAAILRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECA 236 (466)
Q Consensus 162 ~NIlv~~~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~ 236 (466)
+||+++.+ +.+||+|||++....... ......+++.|+|||++. ..++.++||||||+++|+|++ |..||.. .
T Consensus 166 ~Nili~~~-~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~ 243 (304)
T cd05101 166 RNVLVTEN-NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-I 243 (304)
T ss_pred ceEEEcCC-CcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc-C
Confidence 99999876 899999999997654321 122334677899999775 558999999999999999998 7888866 5
Q ss_pred CHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 237 NPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 237 ~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
+..++.+.+..+..+ ..+...+.+++++|.+||. +|.+|||+.++++.
T Consensus 244 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 244 PVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 677788877766532 2334567899999999995 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=306.60 Aligned_cols=249 Identities=32% Similarity=0.415 Sum_probs=197.5
Q ss_pred eeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC---CCCceeEEEeEEEeccC---CEE
Q 012320 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL---KHDSIIRFYTSWIDVDQ---KTF 106 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~~~~---~~~ 106 (466)
.++||+|+||.||+|.++.+|..||+|.++.... .......+.+|+.+++++ +||||+++++.+...+. ..+
T Consensus 4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred EEEecccCceEEEEEEECCCCCEEEEEEeccccc--cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 5679999999999999999999999999875542 222334566788877766 69999999998865332 248
Q ss_pred EEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 107 NFITEMFTSGTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
++++|++. ++|.+++.+.. .+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.+ +.+||+|||++..+
T Consensus 82 ~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~-~~~~l~dfg~~~~~ 157 (287)
T cd07838 82 TLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSD-GQVKIADFGLARIY 157 (287)
T ss_pred EEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccC-CCEEEeccCcceec
Confidence 99999996 48988887643 5899999999999999999999999 9999999999999987 89999999999776
Q ss_pred cCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCC------------
Q 012320 185 RGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-GKL------------ 250 (466)
Q Consensus 185 ~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-g~~------------ 250 (466)
..........+++.|+|||++. ..++.++|||||||++|+|++|..||.. .+..+....+.. -..
T Consensus 158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 158 SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRG-TSEADQLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred cCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccC-CChHHHHHHHHHHcCCCChHhcCCCccc
Confidence 5444444556899999999775 4588999999999999999999999876 344443333322 000
Q ss_pred -----CCC-------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 251 -----PGA-------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 251 -----p~~-------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
+.. .....+..+.++|.+||. ||.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 000 001234678899999995 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=301.40 Aligned_cols=240 Identities=20% Similarity=0.350 Sum_probs=198.6
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+|.. .++||+|+||.||+|... |..+|+|.++.. ...+.+.+|+.++++++||||+++++.+.. ....++
T Consensus 7 ~~~~-~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~ 76 (256)
T cd05082 7 ELKL-LQTIGKGEFGDVMLGDYR--GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLY 76 (256)
T ss_pred hCee-eeeecccCCCeEEEEEEc--CCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEc-CCCceE
Confidence 4555 577999999999999654 888999987532 234578899999999999999999987643 455789
Q ss_pred EEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 108 FITEMFTSGTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+|+||+++++|.+++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~ 153 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEAS 153 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCC-CcEEecCCccceecc
Confidence 9999999999999987653 4889999999999999999999999 9999999999999876 899999999987543
Q ss_pred CCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 186 GSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 186 ~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
... ....++..|+|||++. ..++.++|||||||++|+|++ |..||.. .+..++...+..+..+ ......+..++
T Consensus 154 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 229 (256)
T cd05082 154 STQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCPPVVY 229 (256)
T ss_pred ccC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCCHHHH
Confidence 322 2334567899999776 458899999999999999998 9999975 5667777777665433 34456678999
Q ss_pred HHHHHhcc-CcCCCCCHHHHhc
Q 012320 264 RFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
++|.+|+. +|.+|||+.++++
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHH
Confidence 99999995 9999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=308.33 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=199.0
Q ss_pred CceEEeeeeeeeeCceEEEEEEE----cCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAID----EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
+|++...+.||+|+||+||+|.. +.++..||+|.++... .......+.+|+.+++.++||||+++++.+...+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 79 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 34444456699999999999973 5678999999876432 3345567899999999999999999999886554
Q ss_pred CCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
...+++||||++|++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~-~~~~l~dfg~~ 156 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE-HQVKIGDFGLT 156 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCC-CCEEECCCccc
Confidence 57789999999999999998765 46899999999999999999999999 9999999999999876 89999999999
Q ss_pred hhhcCCCC----CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCC--------------CCHHHHH
Q 012320 182 AILRGSKS----AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSEC--------------ANPAQIY 242 (466)
Q Consensus 182 ~~~~~~~~----~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~--------------~~~~~i~ 242 (466)
..+..... .....|+..|+|||++. ..++.++|||||||++|+|+++..|+... .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 87643321 22345677899999765 56889999999999999999977664321 1112222
Q ss_pred HHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 243 KKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 243 ~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
+.+..+... ..+...+..+.+||.+||. +|.+|||+.++++.
T Consensus 237 ~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 237 RVLEEGKRL-PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHcCccC-CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 233333322 2234467899999999996 99999999999853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=307.53 Aligned_cols=242 Identities=26% Similarity=0.371 Sum_probs=197.3
Q ss_pred eeeeeeeCceEEEEEEEcC-----CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 33 EEVLGKGAMKTVYKAIDEV-----LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
.++||+|+||+||+|.+.. ....+|+|.+.... .......+.+|+.+++.++||||+++++.+ ......+
T Consensus 5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~ 79 (290)
T cd05045 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQVNHPHVIKLYGAC--SQDGPLL 79 (290)
T ss_pred cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCCEeeEEEEE--ecCCCcE
Confidence 5779999999999998753 33678888775332 334567889999999999999999999987 4456788
Q ss_pred EEEecCCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCc
Q 012320 108 FITEMFTSGTLREYRKKY------------------------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDN 163 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~------------------------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~N 163 (466)
+|+||+.+++|.+++.+. ..+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~n 157 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARN 157 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhhe
Confidence 999999999999998653 24788899999999999999999999 9999999999
Q ss_pred EEEeCCCCcEEEeccchhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCH
Q 012320 164 IFVNGHLGQVKIGDLGLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANP 238 (466)
Q Consensus 164 Ilv~~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~ 238 (466)
||++.+ +.+||+|||++........ .....++..|+|||.+. ..++.++|||||||++|+|++ |..||.+ .++
T Consensus 158 ill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~ 235 (290)
T cd05045 158 VLVAEG-RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG-IAP 235 (290)
T ss_pred EEEcCC-CcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC-CCH
Confidence 999876 7999999999876532211 12334567899999664 558999999999999999998 9999965 667
Q ss_pred HHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 239 AQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 239 ~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.++.+.+..+..+ ..+...+.++.+|+.+||. +|.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 236 ERLFNLLKTGYRM-ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHhCCCCC-CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 7777777665432 2344567899999999995 9999999999974
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=300.19 Aligned_cols=240 Identities=22% Similarity=0.368 Sum_probs=200.4
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
.|.. .+.||.|+||.||+|... |+.||+|.+.... ...+++.+|+.+++.++|+||+++++.+. +....+
T Consensus 7 ~~~~-~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~ 76 (256)
T cd05039 7 ELKL-GATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS-----TAAQAFLAEASVMTTLRHPNLVQLLGVVL--QGNPLY 76 (256)
T ss_pred hccc-eeeeecCCCceEEEEEec--CcEEEEEEeccch-----hHHHHHHHHHHHHHhcCCcceeeeEEEEc--CCCCeE
Confidence 4444 677999999999999765 8999999986432 24578899999999999999999999874 367789
Q ss_pred EEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 108 FITEMFTSGTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+||||+++++|.+++.+.. .+++..+..++.|++.||.|||+++ ++||||||+||+++.+ +.+||+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~-~~~~l~d~g~~~~~~ 153 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSED-LVAKVSDFGLAKEAS 153 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCC-CCEEEcccccccccc
Confidence 9999999999999998765 6999999999999999999999999 9999999999999876 899999999997763
Q ss_pred CCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 186 GSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 186 ~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
.... ...++..|+|||.+. +.++.++|||||||++|+|++ |..||.. .+...+...+..+..+ ..+...+..+.
T Consensus 154 ~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 229 (256)
T cd05039 154 QGQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPHVEKGYRM-EAPEGCPPEVY 229 (256)
T ss_pred cccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCC-CCccCCCHHHH
Confidence 3222 333466799999765 568899999999999999997 9999976 5666666666655322 33445678999
Q ss_pred HHHHHhcc-CcCCCCCHHHHhc
Q 012320 264 RFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
++|.+||. +|.+|||+.+++.
T Consensus 230 ~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 230 KVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHhccChhhCcCHHHHHH
Confidence 99999996 9999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=302.81 Aligned_cols=244 Identities=21% Similarity=0.339 Sum_probs=199.0
Q ss_pred EeeeeeeeeCceEEEEEEEcCCCe---EEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 31 LFEEVLGKGAMKTVYKAIDEVLGV---EVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 31 ~~~~~LG~G~fg~Vyka~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
.+.+.||+|+||.||+|.++.+|. .||+|.+.... .....+.+..|+.+++.++||||+++++.+ .+...++
T Consensus 7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~--~~~~~~~ 81 (269)
T cd05065 7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVV--TKSRPVM 81 (269)
T ss_pred EEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCcCcceEEEEE--CCCCceE
Confidence 447889999999999999887765 59999876432 445667899999999999999999999987 4566789
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 108 FITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
+||||+++++|.+++... +.+++..+..++.|++.||.|||+++ ++||||||+||+++.+ +.+||+|||++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRFLED 158 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCC-CcEEECCCcccccccc
Confidence 999999999999998764 56899999999999999999999999 9999999999999876 7999999999876543
Q ss_pred CCCCc----ccc--CCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 012320 187 SKSAH----SVI--GTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258 (466)
Q Consensus 187 ~~~~~----~~~--GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 258 (466)
..... ... ++..|+|||.+. ..++.++|||||||++|||++ |..||.. .+...+.+.+.... +...+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~-~~~~~~~~~i~~~~-~~~~~~~~ 236 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MSNQDVINAIEQDY-RLPPPMDC 236 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC-CCHHHHHHHHHcCC-cCCCcccC
Confidence 22111 111 235799999776 568999999999999999886 9999976 45566666665442 22223345
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+..+.+++.+||. +|.+||++.+++.
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 237 PTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 6789999999996 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=307.19 Aligned_cols=248 Identities=22% Similarity=0.318 Sum_probs=201.8
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEc-----CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDE-----VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
.++|... +.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.++++++||||+++++.+
T Consensus 4 ~~~~~~~-~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~-- 77 (288)
T cd05050 4 RNNIEYV-RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDHPNIVKLLGVC-- 77 (288)
T ss_pred hHhceec-ccccccccccEEEEEEcccCCCCcceeEEEEecCCCc---CHHHHHHHHHHHHHHHhcCCCchheEEEEE--
Confidence 4567664 55999999999999875 368899999886432 334456788999999999999999999977
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecc
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKKYR----------------------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRD 158 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrD 158 (466)
.....+++|+||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ ++|||
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~d 155 (288)
T cd05050 78 AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRD 155 (288)
T ss_pred cCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eeccc
Confidence 44567899999999999999987532 3678889999999999999999999 99999
Q ss_pred CCCCcEEEeCCCCcEEEeccchhhhhcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCC
Q 012320 159 LKCDNIFVNGHLGQVKIGDLGLAAILRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYS 233 (466)
Q Consensus 159 LKp~NIlv~~~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~ 233 (466)
|||+||+++.+ +.+||+|||++..+.... ......+++.|+|||.+. ..++.++|||||||++|+|++ |..||.
T Consensus 156 l~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 156 LATRNCLVGEN-MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred ccHhheEecCC-CceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999876 899999999987543221 112233567799999765 569999999999999999998 888986
Q ss_pred CCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 234 ECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 234 ~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+ .+..++...+..+..+. .+...+.++.+||.+||. +|.+|||+.|+++
T Consensus 235 ~-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 235 G-MAHEEVIYYVRDGNVLS-CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred C-CCHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 5 56677777787776543 233456789999999996 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=308.57 Aligned_cols=262 Identities=20% Similarity=0.388 Sum_probs=221.5
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCCE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~ 105 (466)
..|.+ -.+||+|+|.+|.++.++.|.+.||+|++++.-+ +..+++.-...|-.+..+. +||.+|-++..| +....
T Consensus 250 ~df~l-l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~-nddedidwvqtek~vfe~asn~pflvglhscf--qtesr 325 (593)
T KOG0695|consen 250 QDFDL-LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF--QTESR 325 (593)
T ss_pred cccee-eeeecCcchhhhhheehcccceeeehhhHHHHhc-CCcccchhHHhhHHHHHhccCCCeEEehhhhh--cccce
Confidence 34444 5789999999999999999999999999886554 4555667778888888877 799999999988 66778
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh-h
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI-L 184 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~-~ 184 (466)
+++|.||++||+|.-++++.++++++.++++...|..||.|||+.| ||.||||.+|+|++.. |++||+|+|.++. +
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldae-ghikltdygmcke~l 402 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccC-CceeecccchhhcCC
Confidence 9999999999999989999999999999999999999999999999 9999999999999988 9999999999976 4
Q ss_pred cCCCCCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCC-------CCCCHHHHHHHHhcCCCCCCCCC
Q 012320 185 RGSKSAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYS-------ECANPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 185 ~~~~~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~-------~~~~~~~i~~~i~~g~~p~~~~~ 256 (466)
..+...+++||||.|+|||++.+ .|+..+|+|+|||+++||+.|+.||. +.++..-+++.|....+ ..+.
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--ripr 480 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--RIPR 480 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--cccc
Confidence 56677889999999999999985 59999999999999999999999993 22334446666655433 2334
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCC------HHHHhcCCCCCchhhhhcc
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLS------AKELLLDPFLASDEVKLLS 297 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rps------a~elL~hpf~~~~~~~~~~ 297 (466)
..+..+..+++..|. ||.+|+. ..++..||||+..+|..+.
T Consensus 481 slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~le 528 (593)
T KOG0695|consen 481 SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLE 528 (593)
T ss_pred eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHh
Confidence 455567778888885 9999874 5799999999999987654
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=313.61 Aligned_cols=256 Identities=31% Similarity=0.458 Sum_probs=203.6
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
.-+++|... +.||.|+||+||+|.++.+|..||+|.+.+... .....+.+.+|+.+++.++||||++++++|.. ..
T Consensus 7 ~~~~~y~~~-~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~ 82 (328)
T cd07856 7 EITNRYVDL-QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS--TPVLAKRTYRELKLLKHLRHENIISLSDIFIS-PL 82 (328)
T ss_pred ccccceEEE-EeecccCCeEEEEEEECCCCCEEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCeeeEeeeEec-CC
Confidence 356788884 669999999999999999999999998864321 22345678899999999999999999998753 34
Q ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 104 KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
..+++|+||+ +++|..+++. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++..
T Consensus 83 ~~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~-~~~~l~dfg~~~~ 157 (328)
T cd07856 83 EDIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINEN-CDLKICDFGLARI 157 (328)
T ss_pred CcEEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCC-CCEEeCccccccc
Confidence 5788999998 6789888764 56889999999999999999999999 9999999999999876 8999999999875
Q ss_pred hcCCCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---------------
Q 012320 184 LRGSKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVT--------------- 246 (466)
Q Consensus 184 ~~~~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~--------------- 246 (466)
... ......+++.|+|||.+.+ .++.++|||||||++|+|++|..||... +....+..+.
T Consensus 158 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 158 QDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK-DHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred cCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 432 2234568899999997653 5899999999999999999999999653 2221111110
Q ss_pred cC---------C----CCC-CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 247 SG---------K----LPG-AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 247 ~g---------~----~p~-~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.+ . .|. ......+..++++|.+||. +|.+||++.+++.||||...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 00 0 000 0112346789999999996 99999999999999999643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=302.55 Aligned_cols=244 Identities=23% Similarity=0.392 Sum_probs=197.9
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
+.++|.+. +.||+|+||+||+|.++ .+..+|+|.+..... . .+.+.+|+.++++++||||+++++.+ . ..
T Consensus 4 ~~~~~~~~-~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~---~~~~~~E~~~l~~l~~~~i~~~~~~~--~-~~ 73 (260)
T cd05070 4 PRESLQLI-KKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--S---PESFLEEAQIMKKLRHDKLVQLYAVV--S-EE 73 (260)
T ss_pred chHHhhhh-heeccccCceEEEEEec-CCceeEEEEecCCCC--C---HHHHHHHHHHHHhcCCCceEEEEeEE--C-CC
Confidence 34577774 56999999999999876 567799998875432 2 24688999999999999999999865 2 34
Q ss_pred EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 105 TFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
..++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.+ +.+||+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~-~~~~l~dfg~~~ 150 (260)
T cd05070 74 PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDG-LVCKIADFGLAR 150 (260)
T ss_pred CcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCC-ceEEeCCceeee
Confidence 578999999999999998763 45899999999999999999999999 9999999999999876 799999999997
Q ss_pred hhcCCCC--CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 012320 183 ILRGSKS--AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258 (466)
Q Consensus 183 ~~~~~~~--~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 258 (466)
.+..... .....++..|+|||.+. ..++.++||||||+++|+|++ |..||.. .+..++...+..+.. ...+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~ 228 (260)
T cd05070 151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG-MNNREVLEQVERGYR-MPCPQDC 228 (260)
T ss_pred eccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC-CCCCCcC
Confidence 6543221 12233566799999765 568899999999999999999 8889976 455566666665432 2334556
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHh
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELL 283 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL 283 (466)
+..+++++.+||. +|.+|||+.+++
T Consensus 229 ~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 229 PISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHH
Confidence 7899999999995 999999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=303.86 Aligned_cols=249 Identities=24% Similarity=0.311 Sum_probs=204.3
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcC----CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEV----LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~----~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
..+|.. .++||+|+||+||+|.++. ++..||+|.+... ......+.+.+|+.+++.++||||+++++.+..
T Consensus 5 ~~~~~~-~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~- 79 (280)
T cd05043 5 RDRVTL-SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH---ASEIQVTLLLQESCLLYGLSHQNILPILHVCIE- 79 (280)
T ss_pred hhheEE-eeeecccCCceEEEEEEecCCCCceeEEEEEEccCC---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-
Confidence 356765 6889999999999999876 3688999987532 244566788999999999999999999997653
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcE
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKY--------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQV 173 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~--------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~v 173 (466)
++...++++||+++++|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++.+ +.+
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~-~~~ 156 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEE-LQV 156 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCC-CcE
Confidence 356788999999999999998764 45889999999999999999999999 9999999999999877 899
Q ss_pred EEeccchhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcC
Q 012320 174 KIGDLGLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSG 248 (466)
Q Consensus 174 KL~DFGla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g 248 (466)
||+|||+++.+..... .....++..|+|||++. ..++.++|||||||++|+|++ |..||.. .++.++...+..+
T Consensus 157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~ 235 (280)
T cd05043 157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE-IDPFEMAAYLKDG 235 (280)
T ss_pred EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc-CCHHHHHHHHHcC
Confidence 9999999976543221 12234567899999775 458999999999999999999 9999976 5677777777665
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 249 KLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 249 ~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..+. .....+.++.+++.+|+. +|++|||+.+++.
T Consensus 236 ~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 236 YRLA-QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 4322 334457789999999996 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=308.79 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=196.2
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCC--------------CeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCc
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVL--------------GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDS 90 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~--------------g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn 90 (466)
|.+||.+ .+.||+|+||.||+|.+..+ ...||+|.++... .......+.+|++++++++|||
T Consensus 3 ~~~~~~~-~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~ 78 (295)
T cd05097 3 PRQQLRL-KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV---TKTARNDFLKEIKIMSRLKNPN 78 (295)
T ss_pred chHhCee-hhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCC
Confidence 5678877 46699999999999987643 3358999886432 3445567899999999999999
Q ss_pred eeEEEeEEEeccCCEEEEEEecCCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecc
Q 012320 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR------------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRD 158 (466)
Q Consensus 91 Iv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrD 158 (466)
|+++++.+. .....++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ ++|||
T Consensus 79 i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~d 154 (295)
T cd05097 79 IIRLLGVCV--SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRD 154 (295)
T ss_pred cCeEEEEEc--CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccc
Confidence 999999874 4667899999999999999986532 3688899999999999999999999 99999
Q ss_pred CCCCcEEEeCCCCcEEEeccchhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh--CCCCC
Q 012320 159 LKCDNIFVNGHLGQVKIGDLGLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT--CEYPY 232 (466)
Q Consensus 159 LKp~NIlv~~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt--g~~Pf 232 (466)
|||+||+++.+ +.+||+|||++........ .....+++.|+|||++. +.++.++|||||||++|+|++ +..||
T Consensus 155 lkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~ 233 (295)
T cd05097 155 LATRNCLVGNH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233 (295)
T ss_pred cChhhEEEcCC-CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 99999999876 7999999999876533221 12234567899999765 568999999999999999988 67788
Q ss_pred CCCCCHHHHHHHHhc-----CC-CCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 233 SECANPAQIYKKVTS-----GK-LPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 233 ~~~~~~~~i~~~i~~-----g~-~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.. .+..++...+.. +. .........+..+++||.+|+. +|.+|||+.++++
T Consensus 234 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 234 SL-LSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cc-cChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 65 344444333321 11 1112233456789999999996 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=305.63 Aligned_cols=249 Identities=21% Similarity=0.346 Sum_probs=204.3
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCC-----CeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVL-----GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
.+|..+ +.||+|+||+||+|..+.+ ...+|+|.+.... .....+.+.+|+++|++++||||+++++.+ .
T Consensus 5 ~~~~~~-~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~ 78 (275)
T cd05046 5 SNLQEI-TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK---DENLQSEFRRELDMFRKLSHKNVVRLLGLC--R 78 (275)
T ss_pred Hhceee-eeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc---chHHHHHHHHHHHHHHhcCCcceeeeEEEE--C
Confidence 567765 5599999999999997643 4678888765322 223457889999999999999999999977 4
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCc
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKYR---------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQ 172 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~~---------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~ 172 (466)
+....++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~-~~ 155 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQ-RE 155 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCC-Cc
Confidence 5667899999999999999998766 6899999999999999999999999 9999999999999876 89
Q ss_pred EEEeccchhhhhcCC--CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcC
Q 012320 173 VKIGDLGLAAILRGS--KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSG 248 (466)
Q Consensus 173 vKL~DFGla~~~~~~--~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g 248 (466)
++|+|||++...... .......+++.|+|||.+. ..++.++||||||+++|+|++ |..||.. .+...+...+..+
T Consensus 156 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~-~~~~~~~~~~~~~ 234 (275)
T cd05046 156 VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG-LSDEEVLNRLQAG 234 (275)
T ss_pred EEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc-cchHHHHHHHHcC
Confidence 999999998654321 1223445678899999765 558899999999999999998 7889865 4556677777766
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 249 KLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 249 ~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
..+.......+..+.+++.+||. +|.+|||+.+++..
T Consensus 235 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 235 KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 66544455667899999999996 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=299.32 Aligned_cols=240 Identities=25% Similarity=0.407 Sum_probs=197.2
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecC
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMF 113 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~ 113 (466)
++||+|+||.||+|.+.. ++.||+|.+..... ....+.+.+|+.++++++||||+++++.+ .+....++|+||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIGVC--VQKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCeEEEEEEE--ecCCCeEEEEEcC
Confidence 359999999999999988 99999998875432 24567889999999999999999999977 4466789999999
Q ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCC--
Q 012320 114 TSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA-- 190 (466)
Q Consensus 114 ~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~-- 190 (466)
.|++|.+++.+. ..+++..+..++.|++.||.|||+++ ++||||||+||+++.+ +.+||+|||++.........
T Consensus 75 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~ 151 (251)
T cd05041 75 PGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGEN-NVLKISDFGMSREEEGGIYTVS 151 (251)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCC-CcEEEeeccccccccCCcceec
Confidence 999999998663 56899999999999999999999999 9999999999999877 89999999998765321111
Q ss_pred -ccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 012320 191 -HSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIG 267 (466)
Q Consensus 191 -~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~ 267 (466)
....++..|+|||.+. +.++.++|||||||++|+|++ |..||.. .+.......+..+. ....+...+.++.+++.
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~ 229 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG-MSNQQTRERIESGY-RMPAPQLCPEEIYRLML 229 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc-CCHHHHHHHHhcCC-CCCCCccCCHHHHHHHH
Confidence 1122356799999765 568999999999999999999 7888866 44555666665542 22334556789999999
Q ss_pred Hhcc-CcCCCCCHHHHhc
Q 012320 268 RCLV-NASKRLSAKELLL 284 (466)
Q Consensus 268 ~~L~-dp~~Rpsa~elL~ 284 (466)
+||. +|.+|||+.|+++
T Consensus 230 ~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 230 QCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHhccChhhCcCHHHHHH
Confidence 9995 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=304.04 Aligned_cols=249 Identities=27% Similarity=0.410 Sum_probs=195.7
Q ss_pred CceEEeeeeeeeeCceEEEEEE----EcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAI----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
.+|.. .+.||+|+||+||+|. +..++..||+|.+... .....+.+.+|+++++.++||||+++++.+...+
T Consensus 4 ~~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKF-IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred cccee-eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 35666 4679999999999997 4567999999987633 3445678899999999999999999999876556
Q ss_pred CCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
...+++|+||+++++|.+++.+. ..+++..+..++.||+.||.|||++| |+||||||+||+++.+ +.+||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~-~~~~l~dfg~~ 155 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESE-NRVKIGDFGLT 155 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCC-CeEEECCCccc
Confidence 67789999999999999999765 46899999999999999999999999 9999999999999876 79999999999
Q ss_pred hhhcCCCCC----ccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCH---------------HHH
Q 012320 182 AILRGSKSA----HSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANP---------------AQI 241 (466)
Q Consensus 182 ~~~~~~~~~----~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~---------------~~i 241 (466)
..+...... ....++..|+|||++. ..++.++|||||||++|||++|..|+...... ..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 866432211 1122345699999776 45899999999999999999987765431110 011
Q ss_pred HHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 242 YKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 242 ~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
...+..+.. .......+.++.++|.+|+. +|++|||+.+++.
T Consensus 236 ~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 236 IELLKNNGR-LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHhcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 122222221 12234456789999999996 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=329.55 Aligned_cols=250 Identities=31% Similarity=0.467 Sum_probs=210.1
Q ss_pred eeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 22 ~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
+.-|.+...+ .+.||+|+||+||+|.+- ..||||.+..... +++..+.|.+|+..|++-+|.||+-+.+++.
T Consensus 387 WeIp~~ev~l-~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~p--t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~-- 458 (678)
T KOG0193|consen 387 WEIPPEEVLL-GERIGSGSFGTVYRGRWH---GDVAVKLLNVDDP--TPEQLQAFKNEVAVLKKTRHENILLFMGACM-- 458 (678)
T ss_pred cccCHHHhhc-cceeccccccceeecccc---cceEEEEEecCCC--CHHHHHHHHHHHHHHhhcchhhheeeehhhc--
Confidence 3334444444 677999999999999764 4699999987765 6678999999999999999999999999873
Q ss_pred cCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 102 DQKTFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
... +.||+-+|+|.+|..++.- ..+|+......|++||+.|+.|||.++ |||||||..|||+..+ +.|||+||||
T Consensus 459 ~p~-~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~-~kVkIgDFGL 534 (678)
T KOG0193|consen 459 NPP-LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHED-LKVKIGDFGL 534 (678)
T ss_pred CCc-eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccC-CcEEEecccc
Confidence 333 4899999999999998753 357999999999999999999999999 9999999999999987 8999999999
Q ss_pred hhhh---cCCCCCccccCCCCcCCccccc----cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 012320 181 AAIL---RGSKSAHSVIGTPEFMAPELYE----EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA 253 (466)
Q Consensus 181 a~~~---~~~~~~~~~~GT~~y~APE~l~----~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~ 253 (466)
+... .........-|...|||||++. ..|++.+|||||||++|||+||..||. ..+.+++.=++-+|.+.+.
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd 613 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPD 613 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCcc
Confidence 9653 2333444556888999999875 359999999999999999999999999 6899999988988855333
Q ss_pred ---CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 254 ---FYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 254 ---~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.......++++|+..|+. ++.+||...+||.
T Consensus 614 ~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 614 LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 333445599999999996 9999999999984
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=302.93 Aligned_cols=247 Identities=26% Similarity=0.424 Sum_probs=203.5
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCe----EEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGV----EVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
..++|.. .+.||+|+||+||+|.++.+|. .+|+|.+.... .......+.+|+.++++++||||+++++.+..
T Consensus 5 ~~~~~~~-~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 5 KETELEK-IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVDHPHVVRLLGICLS 80 (279)
T ss_pred CHHHcEE-cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 3467766 5679999999999999877765 58888765443 24456788999999999999999999998753
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
...++|+||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.+ +.+||+|||
T Consensus 81 ---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~-~~~kL~dfg 154 (279)
T cd05057 81 ---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTP-QHVKITDFG 154 (279)
T ss_pred ---CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCC-CeEEECCCc
Confidence 5788999999999999998764 56999999999999999999999999 9999999999999876 799999999
Q ss_pred hhhhhcCCCCC---ccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 012320 180 LAAILRGSKSA---HSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAF 254 (466)
Q Consensus 180 la~~~~~~~~~---~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~ 254 (466)
++......... ....++..|+|||.+. ..++.++|||||||++|+|++ |..||.. .+..++...+..+... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~ 232 (279)
T cd05057 155 LAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG-IPAVEIPDLLEKGERL-PQ 232 (279)
T ss_pred ccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhCCCCC-CC
Confidence 99766432221 1122356899999775 568999999999999999998 9999976 5667777777766532 23
Q ss_pred CCCCCHHHHHHHHHhcc-CcCCCCCHHHHh
Q 012320 255 YSIQDLEAQRFIGRCLV-NASKRLSAKELL 283 (466)
Q Consensus 255 ~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL 283 (466)
+...+..+.+++.+|+. +|.+||++.+++
T Consensus 233 ~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~ 262 (279)
T cd05057 233 PPICTIDVYMVLVKCWMIDAESRPTFKELI 262 (279)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 34567889999999995 999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=296.95 Aligned_cols=240 Identities=22% Similarity=0.347 Sum_probs=195.6
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecC
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMF 113 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~ 113 (466)
++||+|+||.||+|... ++..+|+|.+.... .......+.+|+.+++.++||||+++++.+ ......++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL---PQELKIKFLSEARILKQYDHPNIVKLIGVC--TQRQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCCcCeEEEEE--ecCCccEEEEECC
Confidence 36999999999999865 68899999876332 233445788999999999999999999977 4456789999999
Q ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCC--
Q 012320 114 TSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA-- 190 (466)
Q Consensus 114 ~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~-- 190 (466)
++++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.+ +.+||+|||++.........
T Consensus 75 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~ 151 (250)
T cd05085 75 PGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGEN-NVLKISDFGMSRQEDDGIYSSS 151 (250)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCC-CeEEECCCccceeccccccccC
Confidence 999999998754 46899999999999999999999999 9999999999999876 89999999998654322111
Q ss_pred ccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 012320 191 HSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGR 268 (466)
Q Consensus 191 ~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~ 268 (466)
....+++.|+|||++. ..++.++|||||||++|+|++ |..||.. .+.......+..+... ..+...+..+.+++.+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ 229 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPG-MTNQQAREQVEKGYRM-SCPQKCPDDVYKVMQR 229 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHH
Confidence 1123456799999776 558899999999999999998 9999976 4555666666655432 2334467899999999
Q ss_pred hcc-CcCCCCCHHHHhc
Q 012320 269 CLV-NASKRLSAKELLL 284 (466)
Q Consensus 269 ~L~-dp~~Rpsa~elL~ 284 (466)
|+. +|.+||++.++++
T Consensus 230 ~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 230 CWDYKPENRPKFSELQK 246 (250)
T ss_pred HcccCcccCCCHHHHHH
Confidence 996 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=306.94 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=194.6
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcC----------------CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEV----------------LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH 88 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~----------------~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~H 88 (466)
|.+||.. .+.||+|+||+||+|.++. ++..+|+|.+.... .......+.+|+.+|+.++|
T Consensus 3 ~~~~~~~-~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~E~~~l~~l~~ 78 (296)
T cd05095 3 PRKRLTF-KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFLKEIKIMSRLKD 78 (296)
T ss_pred Chhhcee-eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCC
Confidence 5678877 5669999999999986443 35579999876432 33455688999999999999
Q ss_pred CceeEEEeEEEeccCCEEEEEEecCCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEec
Q 012320 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR-----------RVDIRAIKSWARQILQGLVYLHSRDPPVIHR 157 (466)
Q Consensus 89 pnIv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHr 157 (466)
|||+++++.+. ....+++||||+++++|.+++.+.. .+++..+..++.||+.||.|||+.+ ++||
T Consensus 79 ~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~ 154 (296)
T cd05095 79 PNIIRLLAVCI--TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHR 154 (296)
T ss_pred CCcceEEEEEe--cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecc
Confidence 99999999874 4567899999999999999987643 3667889999999999999999999 9999
Q ss_pred cCCCCcEEEeCCCCcEEEeccchhhhhcCCCC---CccccCCCCcCCcccc-ccCCCChhhHHHHHHHHHHHHh--CCCC
Q 012320 158 DLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS---AHSVIGTPEFMAPELY-EEDYNELVDVYSFGMCVLEMFT--CEYP 231 (466)
Q Consensus 158 DLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~y~APE~l-~~~y~~~~DIwSlGvil~ellt--g~~P 231 (466)
||||+|||++.+ +.+||+|||++..+..... .....+++.|+|||.. .+.++.++|||||||++|||++ |..|
T Consensus 155 dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p 233 (296)
T cd05095 155 DLATRNCLVGKN-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233 (296)
T ss_pred cCChheEEEcCC-CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCC
Confidence 999999999876 8999999999876533221 1223346789999954 4679999999999999999998 7789
Q ss_pred CCCCCCHHHHHHHHhc-----C-CCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 232 YSECANPAQIYKKVTS-----G-KLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 232 f~~~~~~~~i~~~i~~-----g-~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
|.. .+..++...... + ......+...+..+++|+.+||. ||.+||++.++++
T Consensus 234 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 234 YSQ-LSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ccc-cChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 865 333343332211 0 01111223456789999999996 9999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=305.50 Aligned_cols=237 Identities=19% Similarity=0.319 Sum_probs=187.2
Q ss_pred eeeeeeCceEEEEEEEcCCCeE-------EEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVE-------VAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~-------vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
+.||+|+||+||+|.++.++.. +|+|.+... .....+.+.+|+.+++.++||||+++++.+.. ....
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLSHKHLVLNYGVCVC--GDES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch----hHHHHHHHHHHHHHHHhCCCCChhheeeEEEe--CCCc
Confidence 3599999999999998765544 777776532 23345678899999999999999999998854 4568
Q ss_pred EEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCC-------cEEEecc
Q 012320 107 NFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLG-------QVKIGDL 178 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g-------~vKL~DF 178 (466)
++||||+.+|+|.+++.+.+ .+++..+..++.||+.||.|||+.+ |+||||||+||+++.+.. .++++||
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccc
Confidence 89999999999999997654 5899999999999999999999999 999999999999976521 3799999
Q ss_pred chhhhhcCCCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCC-CCCCCCCCHHHHHHHHhcCCCCCCCC
Q 012320 179 GLAAILRGSKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCE-YPYSECANPAQIYKKVTSGKLPGAFY 255 (466)
Q Consensus 179 Gla~~~~~~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~-~Pf~~~~~~~~i~~~i~~g~~p~~~~ 255 (466)
|++..... .....+++.|+|||++.+ .++.++|||||||++|+|++|. .||.. .+........ .... ..+
T Consensus 153 g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~-~~~~~~~~~~-~~~~--~~~ 225 (258)
T cd05078 153 GISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA-LDSQKKLQFY-EDRH--QLP 225 (258)
T ss_pred ccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh-ccHHHHHHHH-Hccc--cCC
Confidence 98865432 234568899999998864 4789999999999999999985 55544 3333322222 2211 223
Q ss_pred CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 256 ~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
...+.++.++|.+||. +|.+|||++++++.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 226 APKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 3345789999999996 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=299.50 Aligned_cols=245 Identities=24% Similarity=0.399 Sum_probs=200.0
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
+.++|.+ .++||+|+||+||+|.++. +..+|+|.+..... ..+.+.+|+.++++++||||+++++.+ ....
T Consensus 4 ~~~~~~i-~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~ 74 (261)
T cd05034 4 PRESLKL-ERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM-----SPEAFLQEAQIMKKLRHDKLVQLYAVC--SEEE 74 (261)
T ss_pred chhheee-eeeeccCcceEEEEEEEcC-CceEEEEEecCCcc-----CHHHHHHHHHHHhhCCCCCEeeeeeee--ecCC
Confidence 4567777 5779999999999999764 57899998874432 235688999999999999999999976 4456
Q ss_pred EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 105 TFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
.+++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+++ ++|+||||+||+++.+ +.+||+|||++.
T Consensus 75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~-~~~~l~d~g~~~ 151 (261)
T cd05034 75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGEN-LVCKIADFGLAR 151 (261)
T ss_pred ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCC-CCEEECccccce
Confidence 789999999999999999765 36899999999999999999999999 9999999999999877 899999999987
Q ss_pred hhcCCCC--CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 012320 183 ILRGSKS--AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258 (466)
Q Consensus 183 ~~~~~~~--~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 258 (466)
.+..... .....++..|+|||.+. ..++.++|||||||++|+|++ |..||.+ .+.....+.+..+... ..+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~ 229 (261)
T cd05034 152 LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG-MTNREVLEQVERGYRM-PRPPNC 229 (261)
T ss_pred eccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCC
Confidence 6542111 11223457899999776 458899999999999999998 9999976 4556666666654322 223334
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHh
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELL 283 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL 283 (466)
+.++++++.+||. +|.+||++++++
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rp~~~~l~ 255 (261)
T cd05034 230 PEELYDLMLQCWDKDPEERPTFEYLQ 255 (261)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHH
Confidence 6789999999995 999999999986
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=300.45 Aligned_cols=227 Identities=18% Similarity=0.260 Sum_probs=186.6
Q ss_pred eCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecCCCCCH
Q 012320 39 GAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTL 118 (466)
Q Consensus 39 G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~~ggsL 118 (466)
|++|+||+|.++.+|+.||+|.+.... ...+|...+....||||+++++.+ .+...+++||||++||+|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYI--VSEDSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhhe--ecCCeEEEEEecCCCCCH
Confidence 899999999999999999999987432 122345555666799999999987 446789999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCCccccCCCC
Q 012320 119 REYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPE 198 (466)
Q Consensus 119 ~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~~~~~GT~~ 198 (466)
.+++.+...+++..+..++.|++.||.|||+.+ |+||||||+||+++.+ +.++|+|||++...... .....+++.
T Consensus 73 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~~l~df~~~~~~~~~--~~~~~~~~~ 147 (237)
T cd05576 73 WSHISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDR-GHIQLTYFSRWSEVEDS--CDGEAVENM 147 (237)
T ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCC-CCEEEecccchhccccc--cccCCcCcc
Confidence 999988888999999999999999999999999 9999999999999987 89999999987655432 233456788
Q ss_pred cCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCC
Q 012320 199 FMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKR 276 (466)
Q Consensus 199 y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~R 276 (466)
|+|||.+. ..++.++|+||+||++|+|++|..|+..... .+. .......+...+..++++|.+||. ||++|
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~--~~~-----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 220 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPS--GIN-----THTTLNIPEWVSEEARSLLQQLLQFNPTER 220 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCch--hcc-----cccccCCcccCCHHHHHHHHHHccCCHHHh
Confidence 99999876 5589999999999999999999988754221 110 011112334567889999999995 99999
Q ss_pred CCH-----HHHhcCCCC
Q 012320 277 LSA-----KELLLDPFL 288 (466)
Q Consensus 277 psa-----~elL~hpf~ 288 (466)
|++ +++++||||
T Consensus 221 ~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 221 LGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cCCCccchHHHHcCCCC
Confidence 996 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=299.99 Aligned_cols=245 Identities=23% Similarity=0.377 Sum_probs=199.9
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
+..+|.. .++||+|+||+||+|..+ +++.||+|.+..... ..+.+.+|+.++++++||||+++++.+ ...
T Consensus 4 ~~~~~~~-~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~---~~~ 73 (260)
T cd05067 4 PRETLKL-VKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-----SPEAFLAEANLMKQLQHPRLVRLYAVV---TQE 73 (260)
T ss_pred chHHcee-eeeeccCccceEEeeecC-CCceEEEEEecCCCC-----cHHHHHHHHHHHHhcCCcCeeeEEEEE---ccC
Confidence 4566776 466999999999999865 578899998874432 235788999999999999999999875 234
Q ss_pred EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 105 TFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
.+++|+||+.+++|.+++.+. ..++...+..++.|++.||+|||+.+ ++||||||+||+++.+ +.++|+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~-~~~~l~dfg~~~ 150 (260)
T cd05067 74 PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSET-LCCKIADFGLAR 150 (260)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCC-CCEEEccCccee
Confidence 688999999999999998754 46899999999999999999999999 9999999999999876 899999999997
Q ss_pred hhcCCCC--CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 012320 183 ILRGSKS--AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258 (466)
Q Consensus 183 ~~~~~~~--~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 258 (466)
....... .....++..|+|||++. ..++.++||||||+++|+|++ |..||.. .+...+.+.+..+..+ ..+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~ 228 (260)
T cd05067 151 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPG-MTNPEVIQNLERGYRM-PRPDNC 228 (260)
T ss_pred ecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCC-CChHHHHHHHHcCCCC-CCCCCC
Confidence 6542211 12334567899999775 558899999999999999999 9999976 4556666666655432 334456
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+.+++++|.+||. +|.+||++++++.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 229 PEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 7799999999995 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=302.41 Aligned_cols=241 Identities=19% Similarity=0.310 Sum_probs=186.9
Q ss_pred eeeeeCceEEEEEEEcCC--CeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEec
Q 012320 35 VLGKGAMKTVYKAIDEVL--GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 35 ~LG~G~fg~Vyka~~~~~--g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
.||+|+||+||+|..... ...+++|.+.... .....+.+.+|+.+++.++||||+++++.+. +...+++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~--~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA---SSKEQNEFLQQGDPYRILQHPNILQCLGQCV--EAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC---ChHHHHHHHHHHHHHhccCCcchhheEEEec--CCCccEEEEec
Confidence 499999999999975432 2345566554322 3345678999999999999999999999874 46678999999
Q ss_pred CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC-
Q 012320 113 FTSGTLREYRKKY----RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS- 187 (466)
Q Consensus 113 ~~ggsL~~~l~~~----~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~- 187 (466)
+++|+|.+++.+. ...++..++.++.||+.||.|||+.+ ++||||||+|||++.+ +.+||+|||++......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~-~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSD-LTVKVGDYGIGPSRYKED 153 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCC-ccEEecccccccccCcch
Confidence 9999999998753 34677888999999999999999999 9999999999999877 89999999988543211
Q ss_pred --CCCccccCCCCcCCcccccc--------CCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCC----CC
Q 012320 188 --KSAHSVIGTPEFMAPELYEE--------DYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKL----PG 252 (466)
Q Consensus 188 --~~~~~~~GT~~y~APE~l~~--------~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~----p~ 252 (466)
.......|++.|+|||++.. .++.++|||||||++|+|++ |..||... +....+..+..+.. .+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL-SDREVLNHVIKDQQVKLFKP 232 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhhcccccCCC
Confidence 11234568899999998642 35788999999999999997 56688664 44444444433321 12
Q ss_pred CCCCCCCHHHHHHHHHhccCcCCCCCHHHHhc
Q 012320 253 AFYSIQDLEAQRFIGRCLVNASKRLSAKELLL 284 (466)
Q Consensus 253 ~~~~~~~~~~~~lI~~~L~dp~~Rpsa~elL~ 284 (466)
......+..+++++.+|+.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~ 264 (268)
T cd05086 233 QLELPYSERWYEVLQFCWLSPEKRATAEEVHR 264 (268)
T ss_pred ccCCCCcHHHHHHHHHHhhCcccCCCHHHHHH
Confidence 23334577889999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=311.54 Aligned_cols=248 Identities=28% Similarity=0.403 Sum_probs=200.8
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcC-------CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEV-------LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSW 98 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~ 98 (466)
.||.+ .+.||+|+||.||+|.+.. .+..||+|.+.... .....+.+.+|+.+++++ +||||+++++.+
T Consensus 12 ~~~~i-~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 12 TRLTL-GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA---TDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred hHeee-cceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 46765 6779999999999998643 23478999776322 334567889999999999 899999999987
Q ss_pred EeccCCEEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCC
Q 012320 99 IDVDQKTFNFITEMFTSGTLREYRKKYR----------------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCD 162 (466)
Q Consensus 99 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~ 162 (466)
.....+++|+||+++|+|.+++.+.. .++...+..++.||+.||.|||+++ |+||||||+
T Consensus 88 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~ 163 (334)
T cd05100 88 --TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAAR 163 (334)
T ss_pred --ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccc
Confidence 44667899999999999999987532 3677888999999999999999999 999999999
Q ss_pred cEEEeCCCCcEEEeccchhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 012320 163 NIFVNGHLGQVKIGDLGLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECAN 237 (466)
Q Consensus 163 NIlv~~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~ 237 (466)
|||++.+ +.+||+|||+++....... .....++..|+|||++. ..++.++|||||||++|+|++ |..||.. .+
T Consensus 164 Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~ 241 (334)
T cd05100 164 NVLVTED-NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IP 241 (334)
T ss_pred eEEEcCC-CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC-CC
Confidence 9999877 7999999999876543221 12233456799999775 568999999999999999998 8888876 56
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 238 PAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 238 ~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
...+.+.+..+..+. .+...+.++.++|.+|+. +|.+|||+.+++.+
T Consensus 242 ~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 242 VEELFKLLKEGHRMD-KPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 777777777664332 334456789999999996 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=300.00 Aligned_cols=233 Identities=22% Similarity=0.368 Sum_probs=187.5
Q ss_pred eeeeeeCceEEEEEEEcCCC----------eEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 34 EVLGKGAMKTVYKAIDEVLG----------VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g----------~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
+.||+|+||.||+|.++.++ ..+++|.+.... .....+.+|+.+++.++||||+++++.+..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDSLAFFETASLMSQLSHKHLVKLYGVCVR--- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhHHHHHHHHHHHHcCCCcchhheeeEEec---
Confidence 35999999999999998877 457777665332 125778899999999999999999998754
Q ss_pred CEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCC-------cEEE
Q 012320 104 KTFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLG-------QVKI 175 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g-------~vKL 175 (466)
...++|+||+++|+|.+++.+.+ .++...+..++.||+.||.|||+.+ |+||||||+||+++.. + .+||
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~-~~~~~~~~~~kl 149 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARY-GLNEGYVPFIKL 149 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecC-ccccCCceeEEe
Confidence 45789999999999999998766 7999999999999999999999999 9999999999999866 4 6999
Q ss_pred eccchhhhhcCCCCCccccCCCCcCCcccccc---CCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCC
Q 012320 176 GDLGLAAILRGSKSAHSVIGTPEFMAPELYEE---DYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLP 251 (466)
Q Consensus 176 ~DFGla~~~~~~~~~~~~~GT~~y~APE~l~~---~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p 251 (466)
+|||++..... .....++..|+|||++.. .++.++|||||||++|+|++ |..||.... ............
T Consensus 150 ~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~~~~-- 223 (259)
T cd05037 150 SDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQDQH-- 223 (259)
T ss_pred CCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHhcCC--
Confidence 99999876543 223457788999998764 48899999999999999999 577886543 333333222211
Q ss_pred CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 252 GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 252 ~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..+......+.++|.+||. +|.+|||+.++++
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 224 -RLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1112223789999999996 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=300.10 Aligned_cols=246 Identities=22% Similarity=0.388 Sum_probs=198.9
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCC---CeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVL---GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
.+|.+ .+.||+|+||.||+|.+... ...||+|...... .....+.+.+|+.+++.++||||+++++.+. .
T Consensus 6 ~~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~---~ 78 (270)
T cd05056 6 EDITL-GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPHIVKLIGVIT---E 78 (270)
T ss_pred hhcee-eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCchhceeEEEc---C
Confidence 34665 67799999999999987654 4568899775332 2445678999999999999999999999763 2
Q ss_pred CEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 104 KTFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
...++||||+++|+|.+++.+.. .+++..+..++.||+.||.|||+.+ ++||||||+||+++.+ +.+||+|||++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~-~~~~l~d~g~~~ 155 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSP-DCVKLGDFGLSR 155 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecC-CCeEEccCceee
Confidence 45779999999999999998754 5899999999999999999999999 9999999999999877 799999999987
Q ss_pred hhcCCCC--CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 012320 183 ILRGSKS--AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258 (466)
Q Consensus 183 ~~~~~~~--~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 258 (466)
....... .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.... ..+....+..+..+. .+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-~~~~~~~~~~~~~~~-~~~~~ 233 (270)
T cd05056 156 YLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK-NNDVIGRIENGERLP-MPPNC 233 (270)
T ss_pred ecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcCCcCC-CCCCC
Confidence 6544321 11223456899999775 558899999999999999986 999997744 445556666655332 33456
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+.+++++|.+|+. +|.+|||+.+++.
T Consensus 234 ~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 234 PPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7899999999995 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=304.91 Aligned_cols=248 Identities=31% Similarity=0.441 Sum_probs=200.0
Q ss_pred eeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEec
Q 012320 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
.+.||+|++|.||+|.+..+++.+|+|.+..... .....+.+..|+.+++.++||||+++++.+. +...+++|+||
T Consensus 4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~~v~e~ 79 (282)
T cd07829 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE--EEGIPSTALREISLLKELKHPNIVKLLDVIH--TERKLYLVFEY 79 (282)
T ss_pred ehcccccCcceEEEeeecCCCcEEEEEEeccccc--cccccHHHHHHHHHHHhcCCCCHHHHHhhhh--cCCceEEEecC
Confidence 4669999999999999999999999999876541 2233467788999999999999999999874 45789999999
Q ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCC-CC
Q 012320 113 FTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-SA 190 (466)
Q Consensus 113 ~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~-~~ 190 (466)
+. ++|.+++.+. ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.+ +.+||+|||++....... ..
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~~~ 155 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTY 155 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCC-CCEEEecCCcccccCCCcccc
Confidence 97 5899999876 58999999999999999999999999 9999999999999886 899999999987654322 23
Q ss_pred ccccCCCCcCCccccc-c-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-------------------cCC
Q 012320 191 HSVIGTPEFMAPELYE-E-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVT-------------------SGK 249 (466)
Q Consensus 191 ~~~~GT~~y~APE~l~-~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~-------------------~g~ 249 (466)
....++..|+|||.+. . .++.++|||||||++++|++|..||........+.+... ...
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 3445688899999765 3 588999999999999999999999976433332222111 001
Q ss_pred CCCC-------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 250 LPGA-------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 250 ~p~~-------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
++.. .....+..+.++|++||. +|++||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1100 011235689999999996 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=299.32 Aligned_cols=249 Identities=25% Similarity=0.417 Sum_probs=205.2
Q ss_pred eEEeeeeeeeeCceEEEEEEEcC-CCeEEEEEEEeccccc------CCHHHHHHHHHHHHHHHh-CCCCceeEEEeEEEe
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEV-LGVEVAWNQVRLNELM------RSPDDLQRLYSEVHLLST-LKHDSIIRFYTSWID 100 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~-~g~~vAiK~i~~~~~~------~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~ 100 (466)
|.. .+.||+|+||+||+|.++. ++..+|+|.+...... .......++.+|+.++.+ ++||||+++++.+
T Consensus 2 y~~-~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-- 78 (269)
T cd08528 2 YAV-LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF-- 78 (269)
T ss_pred chh-hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence 444 4669999999999999988 7899999988754321 233455678889998875 7999999999987
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCCCCcEEEeCCCCcEEE
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKK----YRRVDIRAIKSWARQILQGLVYLHS-RDPPVIHRDLKCDNIFVNGHLGQVKI 175 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qIl~gL~yLHs-~~~~IiHrDLKp~NIlv~~~~g~vKL 175 (466)
.....+++||||++|++|.+++.. ...+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.+ +.+||
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~-~~~~l 155 (269)
T cd08528 79 LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGED-DKVTI 155 (269)
T ss_pred ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCC-CcEEE
Confidence 446789999999999999988743 3568999999999999999999996 67 9999999999999877 89999
Q ss_pred eccchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 012320 176 GDLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAF 254 (466)
Q Consensus 176 ~DFGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~ 254 (466)
+|||++.............|+..|+|||.+. ..++.++||||||+++|+|++|..||.. .+.......+..+..++..
T Consensus 156 ~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd08528 156 TDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLP 234 (269)
T ss_pred ecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc-cCHHHHHHHHhhccCCcCC
Confidence 9999997765444445567899999999776 4588999999999999999999999965 5555566666666554444
Q ss_pred CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 255 YSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 255 ~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
....+..+.++|.+||. ||.+||++.|+..
T Consensus 235 ~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 235 EGMYSEDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred cccCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 44567899999999996 9999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=292.34 Aligned_cols=259 Identities=23% Similarity=0.386 Sum_probs=217.7
Q ss_pred eeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEeEEE
Q 012320 21 IETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYTSWI 99 (466)
Q Consensus 21 ~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~ 99 (466)
+.......|+++.+ +|+|.|+.||.|++..+.++++||+++ +-..+.+.+||.||+.|. |||||++++...
T Consensus 32 i~wg~~ddYeivrk-~GRGKYSEVFeg~~~~~~eK~ViKiLK-------PVkkkKIkREikIL~nL~gg~NIi~L~DiV~ 103 (338)
T KOG0668|consen 32 IDWGNQDDYEIVRK-VGRGKYSEVFEGINITNNEKCVIKILK-------PVKKKKIKREIKILQNLRGGPNIIKLLDIVK 103 (338)
T ss_pred eeccccchHHHHHH-HcCccHhhHhcccccCCCceEEEeeec-------hHHHHHHHHHHHHHHhccCCCCeeehhhhhc
Confidence 55667788988766 999999999999999999999999875 334578999999999995 999999999887
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
+...++..+|+||+.+.+...+ .+.++...++.++.|++.||.||||.| |+|||+||.|++++.....++|+|+|
T Consensus 104 Dp~SktpaLiFE~v~n~Dfk~l---y~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWG 178 (338)
T KOG0668|consen 104 DPESKTPSLIFEYVNNTDFKQL---YPTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
T ss_pred CccccCchhHhhhhccccHHHH---hhhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecc
Confidence 7777888999999988766544 567888999999999999999999999 99999999999999877789999999
Q ss_pred hhhhhcCCCCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHh----------
Q 012320 180 LAAILRGSKSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSE-CANPAQIYKKVT---------- 246 (466)
Q Consensus 180 la~~~~~~~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~-~~~~~~i~~~i~---------- 246 (466)
||.++.++...+-.+.+..|.-||++- +.|+.+.|+|||||++..|+..+-||.. ..|.+|+.+..+
T Consensus 179 LAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Y 258 (338)
T KOG0668|consen 179 LAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAY 258 (338)
T ss_pred hHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHH
Confidence 999998888777778899999999775 5699999999999999999999999854 456666544221
Q ss_pred --c--CCCC--------------------CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 247 --S--GKLP--------------------GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 247 --~--g~~p--------------------~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
. -.++ ..-....++++.+|+.++|. |..+|+||+|++.||||....
T Consensus 259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 0 0011 11123346899999999997 999999999999999997643
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=323.51 Aligned_cols=246 Identities=23% Similarity=0.371 Sum_probs=204.9
Q ss_pred eeeeeeeeCceEEEEEEEcCCCe---E-EEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 32 FEEVLGKGAMKTVYKAIDEVLGV---E-VAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 32 ~~~~LG~G~fg~Vyka~~~~~g~---~-vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+.++||+|+||.||+|..+..+. . ||+|..+.+. ....+....+++|+++|++++|||||++|++. ..+..++
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa--~~~~Pl~ 237 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA--VLEEPLM 237 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE--cCCCccE
Confidence 35789999999999998766432 3 8999877422 23567788999999999999999999999966 5577899
Q ss_pred EEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 108 FITEMFTSGTLREYRKKYRR-VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~-l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
+|||+|.||+|.+|+++.+. ++..+...++.+.+.||+|||+++ +|||||=..|+|++.+ +.+||+|||+++.-..
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~-~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKK-GVVKISDFGLSRAGSQ 314 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCC-CeEEeCccccccCCcc
Confidence 99999999999999999874 999999999999999999999999 9999999999999876 6789999999876431
Q ss_pred CCCCccc-cCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 187 SKSAHSV-IGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 187 ~~~~~~~-~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
....... --...|+|||.+. ..|+.++|||||||++||+.+ |..||.+ .+..++..+|.....+...+.....++.
T Consensus 315 ~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g-~~~~~v~~kI~~~~~r~~~~~~~p~~~~ 393 (474)
T KOG0194|consen 315 YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG-MKNYEVKAKIVKNGYRMPIPSKTPKELA 393 (474)
T ss_pred eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC-CCHHHHHHHHHhcCccCCCCCCCHHHHH
Confidence 1111111 1235799999887 569999999999999999998 8889988 6777888888665555556667778899
Q ss_pred HHHHHhcc-CcCCCCCHHHHhc
Q 012320 264 RFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.++.+|+. +|++||++.++.+
T Consensus 394 ~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 394 KVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHhccCChhhccCHHHHHH
Confidence 99999995 9999999998863
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=295.34 Aligned_cols=244 Identities=20% Similarity=0.378 Sum_probs=199.8
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
.|.. .+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|++++++++||||+++++.+ .....++
T Consensus 5 ~~~~-~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~ 75 (256)
T cd05112 5 ELTL-VQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-----SEEDFIEEAQVMMKLSHPKLVQLYGVC--TERSPIC 75 (256)
T ss_pred HeEE-EeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-----CHHHHHHHHHHHHhCCCCCeeeEEEEE--ccCCceE
Confidence 5666 466999999999999876 477899998764432 224678899999999999999999987 4466789
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 108 FITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
+|+||+++++|.+++... +.+++..+..++.|++.||.|||+.+ ++||||||+||+++.+ +.+||+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 76 LVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGEN-QVVKVSDFGMTRFVLD 152 (256)
T ss_pred EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCC-CeEEECCCcceeeccc
Confidence 999999999999998764 56899999999999999999999999 9999999999999876 7999999999875432
Q ss_pred CCC--CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 012320 187 SKS--AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA 262 (466)
Q Consensus 187 ~~~--~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~ 262 (466)
... .....++..|+|||.+. +.++.++|||||||++|+|++ |..||.. .+...+.+.+..+..+ ..+...+..+
T Consensus 153 ~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (256)
T cd05112 153 DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN-RSNSEVVETINAGFRL-YKPRLASQSV 230 (256)
T ss_pred CcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHhCCCCC-CCCCCCCHHH
Confidence 211 11233567899999776 568899999999999999998 8999976 5566777777665332 2234567899
Q ss_pred HHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 263 QRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 263 ~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
.+|+.+||. +|.+|||+.++++.
T Consensus 231 ~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 231 YELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHHcccChhhCCCHHHHHHh
Confidence 999999996 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=299.12 Aligned_cols=235 Identities=18% Similarity=0.325 Sum_probs=184.8
Q ss_pred eeeeeCceEEEEEEEcC------------CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 35 VLGKGAMKTVYKAIDEV------------LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 35 ~LG~G~fg~Vyka~~~~------------~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
.||+|+||+||+|.... ....+|+|.+... .......+.+|+.+++.++||||+++++++. +
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~--~ 75 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS----HRDISLAFFETASMMRQVSHKHIVLLYGVCV--R 75 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe--c
Confidence 58999999999997432 2345888876532 2234567888999999999999999999874 4
Q ss_pred CCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCC-------cEE
Q 012320 103 QKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLG-------QVK 174 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g-------~vK 174 (466)
+...++||||+++|+|..++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ + .+|
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~-~~~~~~~~~~~ 152 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLARE-GIDGECGPFIK 152 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecC-CccCCCCceeE
Confidence 56678999999999999988754 56999999999999999999999999 9999999999999754 3 389
Q ss_pred EeccchhhhhcCCCCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHH-hCCCCCCCCCCHHHHHHHHhcCCCC
Q 012320 175 IGDLGLAAILRGSKSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMF-TCEYPYSECANPAQIYKKVTSGKLP 251 (466)
Q Consensus 175 L~DFGla~~~~~~~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~ell-tg~~Pf~~~~~~~~i~~~i~~g~~p 251 (466)
++|||++..... .....|+..|+|||.+. ..++.++|||||||++|+|+ +|..||.. ....+..+ ...+..+
T Consensus 153 l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~-~~~~~~~~-~~~~~~~ 227 (262)
T cd05077 153 LSDPGIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD-KTLAEKER-FYEGQCM 227 (262)
T ss_pred eCCCCCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-cchhHHHH-HHhcCcc
Confidence 999998865432 23456888999999775 45899999999999999998 58888865 33333322 2223222
Q ss_pred CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 252 GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 252 ~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
.......+++++|.+||. ||.+||++.+|+++
T Consensus 228 --~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 228 --LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred --CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 122234689999999996 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=299.94 Aligned_cols=240 Identities=25% Similarity=0.407 Sum_probs=195.1
Q ss_pred eeeeeCceEEEEEEEcCCC------eEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEE
Q 012320 35 VLGKGAMKTVYKAIDEVLG------VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNF 108 (466)
Q Consensus 35 ~LG~G~fg~Vyka~~~~~g------~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~l 108 (466)
.||+|+||.||+|.++... +.+|+|.+.... .......+.+|+.+++.++||||+++++.+. .....++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~ 76 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA---TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL--LNEPQYI 76 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc---chhhHHHHHHHHHHHHhcCCCCeeeEeeeec--CCCCeEE
Confidence 5899999999999886544 789999876432 2234567889999999999999999999874 4567899
Q ss_pred EEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCC-----cEEEe
Q 012320 109 ITEMFTSGTLREYRKKY-------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLG-----QVKIG 176 (466)
Q Consensus 109 V~E~~~ggsL~~~l~~~-------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g-----~vKL~ 176 (466)
||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.+ + .+||+
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~~~~~~~l~ 153 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEK-GYDADRVVKIG 153 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecC-CCCCCcceEEC
Confidence 99999999999998642 34788999999999999999999999 9999999999999876 4 79999
Q ss_pred ccchhhhhcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCC
Q 012320 177 DLGLAAILRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLP 251 (466)
Q Consensus 177 DFGla~~~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p 251 (466)
|||++....... ......++..|+|||.+. +.++.++|||||||++|+|++ |..||.. .+..+....+..+..+
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~ 232 (269)
T cd05044 154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA-LNNQEVLQHVTAGGRL 232 (269)
T ss_pred CcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcc-cCHHHHHHHHhcCCcc
Confidence 999987653321 112334678899999776 568999999999999999998 9999976 4556666666655432
Q ss_pred CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 252 GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 252 ~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
. .+...+..+.++|.+||. +|.+||++.++++
T Consensus 233 ~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 233 Q-KPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred C-CcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2 234456789999999996 9999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=295.18 Aligned_cols=245 Identities=23% Similarity=0.391 Sum_probs=198.4
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
+.++|.. .+.||+|+||.||+|.+. .+..+|+|.+... ....+.+.+|+.+++.++|+||+++++.+.. .
T Consensus 4 ~~~~~~~-~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~ 73 (260)
T cd05073 4 PRESLKL-EKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---E 73 (260)
T ss_pred cccceeE-EeEecCccceEEEEEEec-CCccEEEEecCCC-----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---C
Confidence 4567776 567999999999999865 4567999987632 2345678899999999999999999987643 5
Q ss_pred EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 105 TFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
.++++|||+++++|.+++.+. ..++...+..++.||+.||.|||+.+ ++||||||+||+++.. +.+||+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~-~~~~l~d~~~~~ 150 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSAS-LVCKIADFGLAR 150 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCC-CcEEECCCccee
Confidence 688999999999999999763 45788899999999999999999999 9999999999999876 899999999987
Q ss_pred hhcCCCC--CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 012320 183 ILRGSKS--AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258 (466)
Q Consensus 183 ~~~~~~~--~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 258 (466)
.+..... .....++..|+|||++. ..++.++|+|||||++|+|++ |..||.. .+...+...+..+... ......
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~ 228 (260)
T cd05073 151 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG-MSNPEVIRALERGYRM-PRPENC 228 (260)
T ss_pred eccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCCC-CCcccC
Confidence 6543221 11234567799999776 458889999999999999999 8999976 4555666666655432 233456
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+.++.+++.+|+. +|.+||++.+++.
T Consensus 229 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 229 PEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 6789999999995 9999999998863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=313.90 Aligned_cols=244 Identities=26% Similarity=0.411 Sum_probs=189.3
Q ss_pred eeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEec
Q 012320 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
..+||+|+||+||+|.... |..||||++....... ...+.+|+.+|.+++|||+|+|+++|.+.+. ...+|+||
T Consensus 80 ~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~----~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~LVYEy 153 (361)
T KOG1187|consen 80 SNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG----EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HRLLVYEY 153 (361)
T ss_pred hcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc----hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eEEEEEEc
Confidence 3679999999999998765 4899999766433110 3449999999999999999999998854332 68899999
Q ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC-CC
Q 012320 113 FTSGTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSR-DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-SK 188 (466)
Q Consensus 113 ~~ggsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~-~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~-~~ 188 (466)
+++|+|.+++.... .+++....+|+.+++.||+|||.. .||||||||||.|||+|.+ ...||+|||+|+.... ..
T Consensus 154 m~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~-~~aKlsDFGLa~~~~~~~~ 232 (361)
T KOG1187|consen 154 MPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED-FNAKLSDFGLAKLGPEGDT 232 (361)
T ss_pred cCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC-CCEEccCccCcccCCcccc
Confidence 99999999987654 889999999999999999999985 4589999999999999977 6999999999966543 33
Q ss_pred CCccc-cCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCC-----C-HHHHHHHHhcCCCCCCC----C-
Q 012320 189 SAHSV-IGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECA-----N-PAQIYKKVTSGKLPGAF----Y- 255 (466)
Q Consensus 189 ~~~~~-~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~-----~-~~~i~~~i~~g~~p~~~----~- 255 (466)
...+. .||..|+|||.+. +..+.++|||||||+++||+||+.|..... + .......+..+.+.... .
T Consensus 233 ~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~ 312 (361)
T KOG1187|consen 233 SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKE 312 (361)
T ss_pred ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccC
Confidence 33333 8999999999775 679999999999999999999998776422 1 12223444444432211 1
Q ss_pred CCCC--HH---HHHHHHHhcc-CcCCCCCHHHHh
Q 012320 256 SIQD--LE---AQRFIGRCLV-NASKRLSAKELL 283 (466)
Q Consensus 256 ~~~~--~~---~~~lI~~~L~-dp~~Rpsa~elL 283 (466)
.... .+ +..+..+|+. +|.+||++.|++
T Consensus 313 ~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv 346 (361)
T KOG1187|consen 313 GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVV 346 (361)
T ss_pred CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence 1112 23 3445678986 899999999974
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=300.79 Aligned_cols=236 Identities=20% Similarity=0.291 Sum_probs=184.5
Q ss_pred eeeeeCceEEEEEEEcCC------------------------CeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCc
Q 012320 35 VLGKGAMKTVYKAIDEVL------------------------GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDS 90 (466)
Q Consensus 35 ~LG~G~fg~Vyka~~~~~------------------------g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn 90 (466)
.||+|+||.||+|....+ ...||+|.+.... ......+.+|+.+++.++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH----RDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH----HHHHHHHHHHHHHHhcCCCCC
Confidence 499999999999975332 2457888775332 234467888999999999999
Q ss_pred eeEEEeEEEeccCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC
Q 012320 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH 169 (466)
Q Consensus 91 Iv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~ 169 (466)
|+++++++. +....++||||+++|+|..++.+ .+.+++..+..++.||+.||.|||+.+ |+||||||+||+++..
T Consensus 78 iv~~~~~~~--~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~ 153 (274)
T cd05076 78 LAFVHGVCV--RGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARL 153 (274)
T ss_pred eeeEEEEEE--eCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEecc
Confidence 999999874 45678899999999999999875 467899999999999999999999999 9999999999999753
Q ss_pred ------CCcEEEeccchhhhhcCCCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHH-hCCCCCCCCCCHHH
Q 012320 170 ------LGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMF-TCEYPYSECANPAQ 240 (466)
Q Consensus 170 ------~g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~ell-tg~~Pf~~~~~~~~ 240 (466)
.+.+|++|||++..... .....+++.|+|||.+.+ .++.++|||||||++|||+ +|..||... ...+
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~ 229 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER-TPSE 229 (274)
T ss_pred CcccCccceeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc-ChHH
Confidence 12489999998754322 123457889999997753 5899999999999999985 689999763 3333
Q ss_pred HHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 241 IYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 241 i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
....+.... ..+......+.++|.+||. +|.+|||+.++|++
T Consensus 230 ~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 230 KERFYEKKH---RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHHhcc---CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 322222211 1122345689999999996 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=330.50 Aligned_cols=212 Identities=27% Similarity=0.419 Sum_probs=179.6
Q ss_pred eeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 21 IETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 21 ~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
+....++.|.. .+.||+||||.||+++++.+|+.||||.++... .....++.-+|+++|++++|||||+++++=..
T Consensus 7 l~~~~~y~W~~-~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee~ 82 (732)
T KOG4250|consen 7 LTSGENYLWEM-DERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEET 82 (732)
T ss_pred cccCCCcceee-hhhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCCc
Confidence 33444566666 678999999999999999999999999987544 33456788999999999999999999984311
Q ss_pred cc----CCEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC-CC-
Q 012320 101 VD----QKTFNFITEMFTSGTLREYRKKY---RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH-LG- 171 (466)
Q Consensus 101 ~~----~~~~~lV~E~~~ggsL~~~l~~~---~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~-~g- 171 (466)
.. ...-.+|||||+||||+..+.+- ..+++.++..++..+..||.|||.+| |+||||||+||++-.. .|
T Consensus 83 ~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq 160 (732)
T KOG4250|consen 83 KFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQ 160 (732)
T ss_pred cccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCc
Confidence 11 23456899999999999999753 45999999999999999999999999 9999999999987432 23
Q ss_pred -cEEEeccchhhhhcCCCCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCH
Q 012320 172 -QVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANP 238 (466)
Q Consensus 172 -~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~ 238 (466)
..||+|||.|+.+..+....+++||+.|.+||++. +.|+..+|.|||||++|+++||..||-....+
T Consensus 161 ~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 161 SIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred eEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 46999999999999888899999999999999998 56999999999999999999999999654444
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=294.16 Aligned_cols=239 Identities=22% Similarity=0.391 Sum_probs=196.7
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
..|.+ .+.||+|+||.||++. .++..||+|.++... ..+.+.+|+.+++.++||||+++++.+.. ...
T Consensus 6 ~~~~~-~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~ 73 (254)
T cd05083 6 QKLTL-GEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV------TAQAFLEETAVMTKLHHKNLVRLLGVILH---NGL 73 (254)
T ss_pred HHcee-eeeeccCCCCceEecc--cCCCceEEEeecCcc------hHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCc
Confidence 45666 6779999999999985 578899999876322 33578899999999999999999998742 347
Q ss_pred EEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 107 NFITEMFTSGTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
++||||+.+++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.+ +.+||+|||++...
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~-~~~kl~Dfg~~~~~ 150 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSED-GVAKVSDFGLARVG 150 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCC-CcEEECCCccceec
Confidence 89999999999999997653 4899999999999999999999999 9999999999999876 89999999998654
Q ss_pred cCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 012320 185 RGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA 262 (466)
Q Consensus 185 ~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~ 262 (466)
... ......+..|+|||.+. ..++.++|+|||||++|+|++ |..||.. .+..+....+..+..+. .....+..+
T Consensus 151 ~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~ 226 (254)
T cd05083 151 SMG--VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK-MSLKEVKECVEKGYRME-PPEGCPADV 226 (254)
T ss_pred ccc--CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhCCCCCC-CCCcCCHHH
Confidence 322 12233467899999775 568999999999999999998 8999976 55666677776664332 334567789
Q ss_pred HHHHHHhcc-CcCCCCCHHHHhc
Q 012320 263 QRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 263 ~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.+++.+||. +|.+||++.+++.
T Consensus 227 ~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 227 YVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 999999996 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=295.96 Aligned_cols=246 Identities=21% Similarity=0.296 Sum_probs=197.2
Q ss_pred eeeeeeeeCceEEEEEEEc---CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC----
Q 012320 32 FEEVLGKGAMKTVYKAIDE---VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK---- 104 (466)
Q Consensus 32 ~~~~LG~G~fg~Vyka~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~---- 104 (466)
+.++||+|+||+||+|..+ .+|+.||+|++..+. ......+.+.+|+.+++.++||||+++++.+......
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI--FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc--CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 3677999999999999864 468999999986443 2344567889999999999999999999987543322
Q ss_pred EEEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEecc
Q 012320 105 TFNFITEMFTSGTLREYRKKY------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDL 178 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DF 178 (466)
..+++++|+.+|+|.+++... ..++...+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~-~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNEN-MTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCC-CCEEECcc
Confidence 346889999999998886432 24789999999999999999999999 9999999999999876 79999999
Q ss_pred chhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCC
Q 012320 179 GLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGA 253 (466)
Q Consensus 179 Gla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~ 253 (466)
|++........ .....+++.|++||.+. ..++.++|||||||++|+|++ |..||.. .+...+++.+..+....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~- 235 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG-VENSEIYNYLIKGNRLK- 235 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC-CCHHHHHHHHHcCCcCC-
Confidence 99876543221 12234567899999775 458899999999999999999 8888865 55667777776654332
Q ss_pred CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 254 FYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 254 ~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.....+..+.+++.+||. +|.+|||+.+++.
T Consensus 236 ~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 223456789999999995 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=300.17 Aligned_cols=253 Identities=17% Similarity=0.200 Sum_probs=188.3
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCC---CeEEEEEEEecccccCCHHH-------HHHHHHHHHHHHhCCCCceeE
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVL---GVEVAWNQVRLNELMRSPDD-------LQRLYSEVHLLSTLKHDSIIR 93 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~---g~~vAiK~i~~~~~~~~~~~-------~~~~~~Ei~iL~~l~HpnIv~ 93 (466)
...++|.+ .++||+|+||+||+|.+..+ +..+|+|...........+. ......+...+..++|+||++
T Consensus 9 i~~~~y~i-~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 9 ITGKEWKI-DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred cCCCceEE-eeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 34467766 67899999999999998887 67778776443321100000 011223344556679999999
Q ss_pred EEeEEEeccCC--EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCC
Q 012320 94 FYTSWIDVDQK--TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLG 171 (466)
Q Consensus 94 l~~~~~~~~~~--~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g 171 (466)
+++.+...... ..++++|++ ..++.+.++.....++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~-~ 163 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGN-N 163 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-C
Confidence 99876443322 446778877 4577777777666889999999999999999999999 9999999999999876 7
Q ss_pred cEEEeccchhhhhcCC--------CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHH--
Q 012320 172 QVKIGDLGLAAILRGS--------KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQ-- 240 (466)
Q Consensus 172 ~vKL~DFGla~~~~~~--------~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~-- 240 (466)
.+||+|||+++.+... .......||+.|+|||+.. ..|+.++|||||||++|+|++|..||........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999999765321 1122356999999999776 4599999999999999999999999976533222
Q ss_pred ------HHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 241 ------IYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 241 ------i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..+.+..++.. ....+.++.+++..|+. +|.+||++.+|++
T Consensus 244 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 244 HAAKCDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHhHHHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 23444444432 23346789999999995 9999999999874
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=301.23 Aligned_cols=247 Identities=26% Similarity=0.448 Sum_probs=197.7
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCe----EEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGV----EVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
+.|.. .+.||+|+||.||+|.+..+|. .+|+|.+.... .......+.+|+.+++.++||||+++++.+..
T Consensus 7 ~~~~~-~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-- 80 (303)
T cd05110 7 TELKR-VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT---GPKANVEFMDEALIMASMDHPHLVRLLGVCLS-- 80 (303)
T ss_pred hhcee-ccccccCCCccEEEEEEecCCCcceeeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC--
Confidence 44555 4669999999999999887776 46888765332 23344568899999999999999999997742
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
...++++||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++
T Consensus 81 -~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~-~~~kL~Dfg~~ 156 (303)
T cd05110 81 -PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSP-NHVKITDFGLA 156 (303)
T ss_pred -CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCC-CceEEcccccc
Confidence 24678999999999999987654 6899999999999999999999999 9999999999999876 79999999999
Q ss_pred hhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 012320 182 AILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 182 ~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 256 (466)
..+..... .....++..|+|||.+. ..++.++|||||||++|+|++ |..||.+ .....+.+.+..+..+. .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~ 234 (303)
T cd05110 157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG-IPTREIPDLLEKGERLP-QPP 234 (303)
T ss_pred ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCCCCCC-CCC
Confidence 86643222 22234577899999776 568999999999999999997 8899965 44555555555554332 234
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
..+..+.+++.+|+. +|.+||++.+++..
T Consensus 235 ~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 235 ICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 567789999999995 99999999998763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=297.14 Aligned_cols=248 Identities=26% Similarity=0.394 Sum_probs=197.0
Q ss_pred EEeeeeeeeeCceEEEEEEEc----CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 30 GLFEEVLGKGAMKTVYKAIDE----VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 30 ~~~~~~LG~G~fg~Vyka~~~----~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
..+.+.||+|+||+||+|... .++..+|+|.+..... ....+.+.+|+.+++.++||||+++++++...+...
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE---EQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc---hHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 334577999999999999854 4589999999875432 135678999999999999999999999876555678
Q ss_pred EEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 106 FNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.++||||+++++|.+++.+.. .+++..+..++.||+.||.|||+.+ ++||||||+||+++.+ +.+||+|||++...
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~ 159 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESE-DLVKISDFGLAKVL 159 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCC-CCEEEccccccccc
Confidence 999999999999999997754 6999999999999999999999999 9999999999999987 89999999999776
Q ss_pred cCCCCC----ccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCC--------------HHHHHHHH
Q 012320 185 RGSKSA----HSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECAN--------------PAQIYKKV 245 (466)
Q Consensus 185 ~~~~~~----~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~--------------~~~i~~~i 245 (466)
...... ....++..|+|||.+. ..++.++|||||||++++|++|..|+..... ...+...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 532211 1223456799999765 5688999999999999999999999864321 11122233
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 246 TSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 246 ~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..+. ....+...+.++.+++.+||. +|.+|||+.|++.
T Consensus 240 ~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 240 KEGE-RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HcCC-cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 3222 122233455789999999996 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=309.32 Aligned_cols=265 Identities=21% Similarity=0.377 Sum_probs=207.3
Q ss_pred hhhhhccceeeeCC-CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-C-
Q 012320 12 DEAKAHIGYIETDP-NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-H- 88 (466)
Q Consensus 12 ~~~~~~~~~~~~~~-~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-H- 88 (466)
||+-...-|...|- .+||.++ .+||+|+||.|-.|.+..++..||+|+++-- ....+..+-||++|+++. +
T Consensus 73 dD~dGH~v~~~gD~l~~Ry~i~-~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-----~kYreAa~iEi~vLqki~~~D 146 (415)
T KOG0671|consen 73 DDKDGHYVYQVGDILTNRYEIV-DLLGEGTFGKVVECWDRETKEHVALKIIKNV-----DKYREAALIEIEVLQKINESD 146 (415)
T ss_pred CCCCceEEEEeccccccceehh-hhhcCCcccceEEEeecCCCceehHHHHHHH-----HHHhhHHHHHHHHHHHHHhcC
Confidence 44445455666666 8999996 5599999999999999999999999987621 234466778999999993 2
Q ss_pred Cc----eeEEEeEEEeccCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCC
Q 012320 89 DS----IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCD 162 (466)
Q Consensus 89 pn----Iv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~ 162 (466)
|+ +|.+.+.| +-.+++++|+|.+ |-|++++++.+ .+++...++.+.+||+.++++||+.+ ++|.||||+
T Consensus 147 P~g~~rcv~m~~wF--dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPE 221 (415)
T KOG0671|consen 147 PNGKFRCVQMRDWF--DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPE 221 (415)
T ss_pred CCCceEEEeeehhh--hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChh
Confidence 32 56666655 3478899999999 88999999875 56999999999999999999999999 999999999
Q ss_pred cEEEeCC-------------------CCcEEEeccchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHH
Q 012320 163 NIFVNGH-------------------LGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCV 222 (466)
Q Consensus 163 NIlv~~~-------------------~g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil 222 (466)
|||+.+. .-.||++|||.|+.-.... ++++.|..|.|||++- -+++.++||||+||||
T Consensus 222 NILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL 299 (415)
T KOG0671|consen 222 NILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCIL 299 (415)
T ss_pred eEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEE
Confidence 9998221 1368999999998754433 6788999999999665 5799999999999999
Q ss_pred HHHHhCCCCCCCCCCHHHH--HHHHhcCCCCCCC---------------------------------------C---CCC
Q 012320 223 LEMFTCEYPYSECANPAQI--YKKVTSGKLPGAF---------------------------------------Y---SIQ 258 (466)
Q Consensus 223 ~elltg~~Pf~~~~~~~~i--~~~i~~g~~p~~~---------------------------------------~---~~~ 258 (466)
+|+.||...|..-.|.+.+ .+.|. |.+|... . ...
T Consensus 300 ~ElytG~~LFqtHen~EHLaMMerIl-Gp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e 378 (415)
T KOG0671|consen 300 VELYTGETLFQTHENLEHLAMMERIL-GPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLE 378 (415)
T ss_pred EEeeccceecccCCcHHHHHHHHHhh-CCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHH
Confidence 9999999999875555543 22222 1211100 0 011
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
..++.+|+++||. ||++|+|+.|+|.||||+.
T Consensus 379 ~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 379 HVQLFDLLRRMLEFDPARRITLREALSHPFFAR 411 (415)
T ss_pred HhHHHHHHHHHHccCccccccHHHHhcCHHhhc
Confidence 1367889999996 9999999999999999964
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=301.66 Aligned_cols=267 Identities=24% Similarity=0.372 Sum_probs=210.0
Q ss_pred ceeeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEE
Q 012320 19 GYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSW 98 (466)
Q Consensus 19 ~~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 98 (466)
.+--++..+.|.++.+ ||+|.||.||+|+.+.+|+.||+|++-...- .........+|+++|..|+|+|++.+.+.+
T Consensus 9 ~~P~~~~~~~yek~~k-igqGtfgeVFkAr~~n~~kkvalkkvlmene--KeGfpitalreikiL~~lkHenv~nliEic 85 (376)
T KOG0669|consen 9 YEPFCDEVSKYEKLAK-IGQGTFGEVFKARSKNTGKKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEIC 85 (376)
T ss_pred cCCceecchHHHHHHh-cCCchHHHHHHHhhcCccchhHHHHHHHhcc--ccCCcHHHHHHHHHHHHhcchhHHHHHHHH
Confidence 3445677889988655 9999999999999999999999987654332 222345678999999999999999887654
Q ss_pred Ee------ccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCC
Q 012320 99 ID------VDQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLG 171 (466)
Q Consensus 99 ~~------~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g 171 (466)
-. .++.++|+|+.+| ..+|.-++... .+++...+++++++++.||.|+|+.. |+|||+||+|+|++.+ |
T Consensus 86 ~tk~Tp~~r~r~t~ylVf~~c-ehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~d-g 161 (376)
T KOG0669|consen 86 RTKATPTNRDRATFYLVFDFC-EHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKD-G 161 (376)
T ss_pred hhccCCcccccceeeeeHHHh-hhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCC-c
Confidence 21 2355799999999 55788777654 67999999999999999999999999 9999999999999987 8
Q ss_pred cEEEeccchhhhhcCCCC-----CccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 012320 172 QVKIGDLGLAAILRGSKS-----AHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKK 244 (466)
Q Consensus 172 ~vKL~DFGla~~~~~~~~-----~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~ 244 (466)
.+||+|||+++.+..... ....+-|.+|.+||.+- ..|+++.|||..|||+.||+|+.+-+.+..+..+ ...
T Consensus 162 ilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqq-l~~ 240 (376)
T KOG0669|consen 162 ILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQ-LHL 240 (376)
T ss_pred eEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHH-HHH
Confidence 999999999976643322 23445699999999664 4699999999999999999999988877443332 222
Q ss_pred Hh------------------------cCCCCCC---------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 245 VT------------------------SGKLPGA---------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 245 i~------------------------~g~~p~~---------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
|. ...+|.. -+-..++++.++++++|. ||.+|+.+.++|+|.||.+
T Consensus 241 Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 241 ISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred HHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 22 1111111 012335688999999997 9999999999999999987
Q ss_pred hhh
Q 012320 291 DEV 293 (466)
Q Consensus 291 ~~~ 293 (466)
+..
T Consensus 321 dp~ 323 (376)
T KOG0669|consen 321 DPM 323 (376)
T ss_pred CCc
Confidence 654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=328.65 Aligned_cols=257 Identities=23% Similarity=0.289 Sum_probs=179.2
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCC----CeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEE-
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVL----GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWI- 99 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~----g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~- 99 (466)
..++|.. .+.||+|+||+||+|.+..+ +..||+|++.... ..+....| .++...+.++..+...+.
T Consensus 130 ~~~~y~l-~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 130 KKDDFVL-GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVEIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred ccCCeEE-eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhHHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 3456766 67799999999999999999 9999999875321 11111111 122222333333222211
Q ss_pred ---eccCCEEEEEEecCCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCCeEe
Q 012320 100 ---DVDQKTFNFITEMFTSGTLREYRKKYRR--------------------VDIRAIKSWARQILQGLVYLHSRDPPVIH 156 (466)
Q Consensus 100 ---~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------------l~~~~~~~i~~qIl~gL~yLHs~~~~IiH 156 (466)
......+++|+||+.+++|.+++..... .....+..++.||+.||.|||+++ |+|
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiH 278 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVH 278 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEe
Confidence 1345678999999999999998865321 123457789999999999999999 999
Q ss_pred ccCCCCcEEEeCCCCcEEEeccchhhhhcCC--CCCccccCCCCcCCcccccc-----------------------CCCC
Q 012320 157 RDLKCDNIFVNGHLGQVKIGDLGLAAILRGS--KSAHSVIGTPEFMAPELYEE-----------------------DYNE 211 (466)
Q Consensus 157 rDLKp~NIlv~~~~g~vKL~DFGla~~~~~~--~~~~~~~GT~~y~APE~l~~-----------------------~y~~ 211 (466)
|||||+|||++.+.+.+||+|||+++.+... ......+||+.|||||.+.. .++.
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~ 358 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 358 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence 9999999999875579999999999865432 22346789999999995421 2445
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC---------C----C------CCCCCCHHHHHHHHHhcc-
Q 012320 212 LVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP---------G----A------FYSIQDLEAQRFIGRCLV- 271 (466)
Q Consensus 212 ~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p---------~----~------~~~~~~~~~~~lI~~~L~- 271 (466)
++|||||||++|||+++..|+. .+..+..+.+...... . . .....+....+||.+||.
T Consensus 359 k~DVwSlGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 359 RFDIYSAGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred CcccHHHHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 6799999999999999776653 2333333333221110 0 0 011122345689999996
Q ss_pred CcCCCCCHHHHhcCCCCCchhhh
Q 012320 272 NASKRLSAKELLLDPFLASDEVK 294 (466)
Q Consensus 272 dp~~Rpsa~elL~hpf~~~~~~~ 294 (466)
||.+|||+.++|+||||+.....
T Consensus 437 dP~kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 437 KGRQRISAKAALAHPYFDREGLL 459 (566)
T ss_pred CcccCCCHHHHhCCcCcCCCCcc
Confidence 99999999999999999876553
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=303.43 Aligned_cols=270 Identities=24% Similarity=0.347 Sum_probs=208.8
Q ss_pred hhhhccceeeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-----
Q 012320 13 EAKAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK----- 87 (466)
Q Consensus 13 ~~~~~~~~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~----- 87 (466)
++.+...+-++-.++||-++++ ||+|-|+|||+|.|....+.||+|+++-. ....+..+.||++|++++
T Consensus 64 GGYHpV~IGD~F~~gRY~v~rK-LGWGHFSTVWLawDtq~~r~VAlKVvKSA-----qhYtEaAlDEIklL~~v~~~Dp~ 137 (590)
T KOG1290|consen 64 GGYHPVRIGDVFNGGRYHVQRK-LGWGHFSTVWLAWDTQNKRYVALKVVKSA-----QHYTEAALDEIKLLQQVREGDPN 137 (590)
T ss_pred CCCceeeccccccCceEEEEEe-ccccccceeEEEeeccCCeEEEEEEEehh-----hHHHHHHHHHHHHHHHHHhcCCC
Confidence 4445555566666799998655 99999999999999999999999998732 245678899999999982
Q ss_pred C---CceeEEEeEEEecc--CCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCC
Q 012320 88 H---DSIIRFYTSWIDVD--QKTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLK 160 (466)
Q Consensus 88 H---pnIv~l~~~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLK 160 (466)
| ..||+|++.|.... ..++++|+|++ |-+|..+|++. +.++...++.|++|||.||.|||.. ++|||.|||
T Consensus 138 ~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlK 215 (590)
T KOG1290|consen 138 DPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLK 215 (590)
T ss_pred CCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCC
Confidence 3 36999999997654 56899999999 88888888764 6799999999999999999999987 569999999
Q ss_pred CCcEEE--------------------------------------------------------------------------
Q 012320 161 CDNIFV-------------------------------------------------------------------------- 166 (466)
Q Consensus 161 p~NIlv-------------------------------------------------------------------------- 166 (466)
|+|||+
T Consensus 216 PENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~ 295 (590)
T KOG1290|consen 216 PENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIE 295 (590)
T ss_pred cceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccc
Confidence 999998
Q ss_pred ------------------------------------------eC------------------------------------
Q 012320 167 ------------------------------------------NG------------------------------------ 168 (466)
Q Consensus 167 ------------------------------------------~~------------------------------------ 168 (466)
+.
T Consensus 296 ~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~ 375 (590)
T KOG1290|consen 296 EEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIA 375 (590)
T ss_pred ccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccc
Confidence 00
Q ss_pred -----------C--CCcEEEeccchhhhhcCCCCCccccCCCCcCCcccc-ccCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 012320 169 -----------H--LGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELY-EEDYNELVDVYSFGMCVLEMFTCEYPYSE 234 (466)
Q Consensus 169 -----------~--~g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l-~~~y~~~~DIwSlGvil~elltg~~Pf~~ 234 (466)
+ .-.|||+|||.|+.... .....+.|..|+|||++ ..+|+..+||||++|+++||+||.+.|..
T Consensus 376 ~n~~v~p~~~~~~~di~vKIaDlGNACW~~k--hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFeP 453 (590)
T KOG1290|consen 376 SNPLVNPDIPLPECDIRVKIADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEP 453 (590)
T ss_pred cccccCCCCCCCccceeEEEeeccchhhhhh--hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecC
Confidence 0 01478899998887543 34456789999999966 46799999999999999999999999842
Q ss_pred ------CCCHHHHHHH-----------HhcCCCCCCC---------------C----------C---CCCHHHHHHHHHh
Q 012320 235 ------CANPAQIYKK-----------VTSGKLPGAF---------------Y----------S---IQDLEAQRFIGRC 269 (466)
Q Consensus 235 ------~~~~~~i~~~-----------i~~g~~p~~~---------------~----------~---~~~~~~~~lI~~~ 269 (466)
..+...+... +..|+....+ | . ....++.+|+.-|
T Consensus 454 hsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~Pm 533 (590)
T KOG1290|consen 454 HSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPM 533 (590)
T ss_pred CCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHH
Confidence 1222223222 2223321111 1 1 1123677899999
Q ss_pred cc-CcCCCCCHHHHhcCCCCCchh
Q 012320 270 LV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 270 L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
|. +|.+||||.++|+|||+....
T Consensus 534 Lef~PeKR~tA~~cl~hPwLn~~~ 557 (590)
T KOG1290|consen 534 LEFDPEKRPTAAQCLKHPWLNPVA 557 (590)
T ss_pred HhcCccccccHHHHhcCccccCCC
Confidence 96 999999999999999997644
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=279.63 Aligned_cols=241 Identities=34% Similarity=0.555 Sum_probs=207.5
Q ss_pred CceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecCCCCCHH
Q 012320 40 AMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLR 119 (466)
Q Consensus 40 ~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~~ggsL~ 119 (466)
+||.||+|.+..+|+.+|+|++...... ...+.+.+|+..+++++|+||+++++.+. .....++++|++.+++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK---KKRERILREISILKKLKHPNIVRLYDVFE--DEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc---cHHHHHHHHHHHHHhCCCCcHHHHHhhee--eCCEEEEEEeCCCCCCHH
Confidence 5899999999999999999998754421 11578899999999999999999999874 357889999999999999
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCCccccCCCCc
Q 012320 120 EYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF 199 (466)
Q Consensus 120 ~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~~~~~GT~~y 199 (466)
.++.....++...+..++.+++.+|.|||+.+ ++|+||+|.||+++.+ +.++|+|||.+.............+++.|
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 152 (244)
T smart00220 76 DLLKKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDED-GHVKLADFGLARQLDPGGLLTTFVGTPEY 152 (244)
T ss_pred HHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCC-CcEEEccccceeeeccccccccccCCcCC
Confidence 99987767999999999999999999999999 9999999999999987 89999999999876654445566789999
Q ss_pred CCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC-CCHHHHHHHHHhcc-CcCCC
Q 012320 200 MAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSI-QDLEAQRFIGRCLV-NASKR 276 (466)
Q Consensus 200 ~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~-~~~~~~~lI~~~L~-dp~~R 276 (466)
++||.+. ..++.++||||||+++++|++|..||....+...+.+.+..+..+...... .+.++.+++.+|+. +|.+|
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR 232 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence 9999775 568899999999999999999999997756777777777766654333222 56789999999996 99999
Q ss_pred CCHHHHhcCCCC
Q 012320 277 LSAKELLLDPFL 288 (466)
Q Consensus 277 psa~elL~hpf~ 288 (466)
|++.++++||||
T Consensus 233 p~~~~~~~~~~~ 244 (244)
T smart00220 233 LTAEEALQHPFF 244 (244)
T ss_pred cCHHHHhhCCCC
Confidence 999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=308.57 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=207.9
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC------CCceeEEEe
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK------HDSIIRFYT 96 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~------HpnIv~l~~ 96 (466)
+--++||.+++- .|+|-|++|..|.+...|.+||||+|+.+.++. +.-+.|++||++|+ --++++|+.
T Consensus 428 E~LD~RY~V~~~-~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-----KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 428 ELLDSRYEVQGY-TGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-----KTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred hhhcceeEEEec-cccceeeeeeeccccCCCCeeEEEEeecchHHh-----hhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 445788888655 899999999999999999999999998666543 44577999999994 237899999
Q ss_pred EEEeccCCEEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcE
Q 012320 97 SWIDVDQKTFNFITEMFTSGTLREYRKKYRR---VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQV 173 (466)
Q Consensus 97 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~v 173 (466)
+| ...+++|+|+|.+ ..+|++.+++++. +...+++.|+.|++.||..|-..| |+|.||||+||||+.....+
T Consensus 502 ~F--~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 502 HF--KHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNIL 576 (752)
T ss_pred Hh--hhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCccee
Confidence 88 4578999999998 7899999999875 889999999999999999999988 99999999999999887789
Q ss_pred EEeccchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHhcCCCC
Q 012320 174 KIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIY-KKVTSGKLP 251 (466)
Q Consensus 174 KL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~-~~i~~g~~p 251 (466)
||||||.|....... ...+.-+..|.|||++- -.|+...|+||+||+||||.||+..|.+.+|...+. -+-..|++|
T Consensus 577 KLCDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 577 KLCDFGSASFASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred eeccCcccccccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 999999997765443 33445577899999665 579999999999999999999999999866544331 122234433
Q ss_pred CCC--------------------------------------C------------CCCC------HHHHHHHHHhcc-CcC
Q 012320 252 GAF--------------------------------------Y------------SIQD------LEAQRFIGRCLV-NAS 274 (466)
Q Consensus 252 ~~~--------------------------------------~------------~~~~------~~~~~lI~~~L~-dp~ 274 (466)
... + ...+ .++++|+.+||. ||+
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 110 0 0000 268899999996 999
Q ss_pred CCCCHHHHhcCCCCCc
Q 012320 275 KRLSAKELLLDPFLAS 290 (466)
Q Consensus 275 ~Rpsa~elL~hpf~~~ 290 (466)
+|.|..++|.||||+.
T Consensus 736 KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 736 KRITVNQALKHPFITE 751 (752)
T ss_pred hcCCHHHHhcCCcccC
Confidence 9999999999999974
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=317.31 Aligned_cols=242 Identities=26% Similarity=0.376 Sum_probs=203.2
Q ss_pred eeeeeeeeCceEEEEEEEc-----CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 32 FEEVLGKGAMKTVYKAIDE-----VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 32 ~~~~LG~G~fg~Vyka~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
+.+.||+|+||+||+|... .....||||.++... +.+..+.|.+|+++|..++|||||+|++.+ ..++.+
T Consensus 490 ~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a---~~~~~~dF~REaeLla~l~H~nIVrLlGVC--~~~~P~ 564 (774)
T KOG1026|consen 490 FKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA---ENQARQDFRREAELLAELQHPNIVRLLGVC--REGDPL 564 (774)
T ss_pred ehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc---cHHHHHHHHHHHHHHHhccCCCeEEEEEEE--ccCCee
Confidence 3566999999999999743 345779999887433 444678999999999999999999999977 567789
Q ss_pred EEEEecCCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCc
Q 012320 107 NFITEMFTSGTLREYRKKYR--------------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQ 172 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~--------------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~ 172 (466)
++|+|||..|+|.+++...+ +++..+...|+.||+.|++||-++. ++||||-..|+||..+ -.
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVge~-l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVGEN-LV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceeccc-eE
Confidence 99999999999999987532 2788899999999999999999999 9999999999999887 59
Q ss_pred EEEeccchhhhhcCCCCCc---cccCCCCcCCcc-ccccCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhc
Q 012320 173 VKIGDLGLAAILRGSKSAH---SVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTS 247 (466)
Q Consensus 173 vKL~DFGla~~~~~~~~~~---~~~GT~~y~APE-~l~~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~ 247 (466)
|||+||||++..-...-.+ ...-...||||| ++.++|+.++||||+||+|||+++ |..||.+ -..+++.+.|+.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~g-lSn~EVIe~i~~ 720 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYG-LSNQEVIECIRA 720 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccc-cchHHHHHHHHc
Confidence 9999999997643221111 111245899999 667899999999999999999998 9999988 556788899999
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHh
Q 012320 248 GKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELL 283 (466)
Q Consensus 248 g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL 283 (466)
|.+ -.-+...+.++..|+..|+. .|++|||++||-
T Consensus 721 g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 721 GQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred CCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 997 45667788999999999996 999999999983
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=306.95 Aligned_cols=262 Identities=21% Similarity=0.297 Sum_probs=189.8
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEc----------------CCCeEEEEEEEecccccCC----------HHHHHHHHH
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDE----------------VLGVEVAWNQVRLNELMRS----------PDDLQRLYS 78 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~----------------~~g~~vAiK~i~~~~~~~~----------~~~~~~~~~ 78 (466)
..++|.+ .++||+|+||+||+|... ..++.||+|++........ ....+....
T Consensus 143 ~~d~F~i-~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 143 SSDDFQL-RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred cccCceE-eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3567777 577999999999999752 3457899999864321000 001123445
Q ss_pred HHHHHHhCCCCce-----eEEEeEEEec------cCCEEEEEEecCCCCCHHHHHHhc----------------------
Q 012320 79 EVHLLSTLKHDSI-----IRFYTSWIDV------DQKTFNFITEMFTSGTLREYRKKY---------------------- 125 (466)
Q Consensus 79 Ei~iL~~l~HpnI-----v~l~~~~~~~------~~~~~~lV~E~~~ggsL~~~l~~~---------------------- 125 (466)
|+.++.+++|.++ ++++++|... .....++|+||+.+++|.+++...
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7778888876654 5566655321 235689999999999999988642
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCCcc--ccCCCCcCC
Q 012320 126 --RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS--VIGTPEFMA 201 (466)
Q Consensus 126 --~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~~~--~~GT~~y~A 201 (466)
..+++..++.++.|++.||.|||+.+ |+||||||+|||++.+ +.+||+|||++..+........ ..+||.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCC-CcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 12356788999999999999999999 9999999999999877 7999999999976543322222 335899999
Q ss_pred ccccccC---------------------CC--ChhhHHHHHHHHHHHHhCCC-CCCCC----------CCHHHHHHHHhc
Q 012320 202 PELYEED---------------------YN--ELVDVYSFGMCVLEMFTCEY-PYSEC----------ANPAQIYKKVTS 247 (466)
Q Consensus 202 PE~l~~~---------------------y~--~~~DIwSlGvil~elltg~~-Pf~~~----------~~~~~i~~~i~~ 247 (466)
||++... |+ .++||||+||++|+|++|.. ||... .+....++.+..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 9976421 22 34799999999999999886 66431 122233444445
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcc-Cc---CCCCCHHHHhcCCCCCc
Q 012320 248 GKLPGAFYSIQDLEAQRFIGRCLV-NA---SKRLSAKELLLDPFLAS 290 (466)
Q Consensus 248 g~~p~~~~~~~~~~~~~lI~~~L~-dp---~~Rpsa~elL~hpf~~~ 290 (466)
+......+...+..+++|+.+||. +| .+|+|++|+|.||||..
T Consensus 459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 555445556678899999999995 44 68999999999999964
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.70 Aligned_cols=246 Identities=30% Similarity=0.431 Sum_probs=195.4
Q ss_pred eeeeeeeCceE-EEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCCEEEEEE
Q 012320 33 EEVLGKGAMKT-VYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQKTFNFIT 110 (466)
Q Consensus 33 ~~~LG~G~fg~-Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~~~lV~ 110 (466)
.+++|.|+-|+ ||+|... |++||+|.+- .+......+||.+|+.. +|||||++|+ .+.++...||..
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll-------~e~~~~A~rEi~lL~eSD~H~NviRyyc--~E~d~qF~YIal 582 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE--GREVAVKRLL-------EEFFDFAQREIQLLQESDEHPNVIRYYC--SEQDRQFLYIAL 582 (903)
T ss_pred HHHcccCCCCcEEEEEeeC--CceehHHHHh-------hHhHHHHHHHHHHHHhccCCCceEEEEe--eccCCceEEEEe
Confidence 67899999987 7999654 8899999764 22335678899999998 6999999998 557889999999
Q ss_pred ecCCCCCHHHHHHhcCC-C---CHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC----CCcEEEeccchhh
Q 012320 111 EMFTSGTLREYRKKYRR-V---DIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH----LGQVKIGDLGLAA 182 (466)
Q Consensus 111 E~~~ggsL~~~l~~~~~-l---~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~----~g~vKL~DFGla~ 182 (466)
|+| ..+|.++++..+. + ..-.....+.|++.||++||+.+ |+||||||.||||+.. ...++|+|||+++
T Consensus 583 ELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 583 ELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred hHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 999 6799999987411 1 11234678999999999999999 9999999999999863 2478999999999
Q ss_pred hhcCCCC----CccccCCCCcCCccccccC-CCChhhHHHHHHHHHHHHhC-CCCCCCCCCHHHHHHHHhcCCCCCC-CC
Q 012320 183 ILRGSKS----AHSVIGTPEFMAPELYEED-YNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSGKLPGA-FY 255 (466)
Q Consensus 183 ~~~~~~~----~~~~~GT~~y~APE~l~~~-y~~~~DIwSlGvil~elltg-~~Pf~~~~~~~~i~~~i~~g~~p~~-~~ 255 (466)
.+..++. ..+..||-.|+|||++.+. -..++||+||||++|+.++| ..||.. .-+.-.+|..|...-. +.
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd---~~~R~~NIl~~~~~L~~L~ 736 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD---SLERQANILTGNYTLVHLE 736 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc---hHHhhhhhhcCccceeeec
Confidence 8875543 4456799999999988754 56689999999999999985 889954 3344445666664321 22
Q ss_pred CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhhhh
Q 012320 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVKL 295 (466)
Q Consensus 256 ~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~~~ 295 (466)
...+.++++||.+||. +|..||+|.++|.||||.....++
T Consensus 737 ~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL 777 (903)
T KOG1027|consen 737 PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRL 777 (903)
T ss_pred cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHH
Confidence 2223389999999996 999999999999999998766543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=320.34 Aligned_cols=243 Identities=24% Similarity=0.403 Sum_probs=200.2
Q ss_pred eeeeeeeeCceEEEEEEEcCC-C----eEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 32 FEEVLGKGAMKTVYKAIDEVL-G----VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 32 ~~~~LG~G~fg~Vyka~~~~~-g----~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
+.+.||+|+||.||.|..... | ..||+|.+++. .+..+...|++|..+|+.++|||||++.+..++ ....
T Consensus 696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~---~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~--~~~~ 770 (1025)
T KOG1095|consen 696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL---SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD--SGPP 770 (1025)
T ss_pred eeeeeccccccceEEEEEecCCCCccceEEEEEecccc---CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC--CCCc
Confidence 367899999999999986543 2 34888877643 366788899999999999999999999998765 6678
Q ss_pred EEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 107 NFITEMFTSGTLREYRKKY-------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~-------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
++++|||.||+|..+|++. ..++......++.||+.|..||+++. +|||||-+.|+|++.. ..|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~-r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDER-RVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeeccc-CcEEEcccc
Confidence 8999999999999999876 34889999999999999999999999 9999999999999988 799999999
Q ss_pred hhhhhcCCCCCc-cc--cCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 012320 180 LAAILRGSKSAH-SV--IGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAF 254 (466)
Q Consensus 180 la~~~~~~~~~~-~~--~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~ 254 (466)
+|+.+-...... .. .-...|||||.+. +.|+.++|||||||++||++| |..||.+-.|.+.+......|+++.
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~-- 925 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDP-- 925 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCC--
Confidence 998543222111 11 1124799999776 779999999999999999999 8999988555444444666676653
Q ss_pred CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 255 YSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 255 ~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+......+.+++..|+. +|++||++..|++
T Consensus 926 P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 926 PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 45566778899999996 9999999999987
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=286.50 Aligned_cols=253 Identities=27% Similarity=0.396 Sum_probs=206.0
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc----
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD---- 102 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~---- 102 (466)
.||.-+ +.+|.|+- .|--|.|..+++.||+|++... ..+.....+..+|..++..++|+||++++..|.-..
T Consensus 17 ~Ry~nL-~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p--f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 17 KRYVNL-KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP--FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeee-cccCCCCc-eEEecchhhccCceehhhhcCc--cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 577775 55899998 8889999999999999988755 334456678999999999999999999999885322
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
-..+|+|||++ ..+|...+. -.++-..++.++.|++.|+.|||+.| |+||||||+||+++.+ +.+||.|||+|.
T Consensus 93 ~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~-~~lKi~dfg~ar 166 (369)
T KOG0665|consen 93 FQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSD-CTLKILDFGLAR 166 (369)
T ss_pred HHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecch-hheeeccchhhc
Confidence 23689999999 678888776 47788999999999999999999999 9999999999999987 899999999998
Q ss_pred hhcCCCCCccccCCCCcCCcccc-ccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-C------------
Q 012320 183 ILRGSKSAHSVIGTPEFMAPELY-EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-G------------ 248 (466)
Q Consensus 183 ~~~~~~~~~~~~GT~~y~APE~l-~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-g------------ 248 (466)
.....-..+..+.|..|.|||++ .-.|.+.+||||+||++.||++|+..|.+....++..+.+.. |
T Consensus 167 ~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 167 TEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred ccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 76655456678899999999965 445999999999999999999999999864444443332221 0
Q ss_pred -------------------CCCCCC-------CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCC
Q 012320 249 -------------------KLPGAF-------YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLA 289 (466)
Q Consensus 249 -------------------~~p~~~-------~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~ 289 (466)
.+|... .......+++++.+||+ +|++|.|++++|+|||++
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 111111 12334579999999996 999999999999999996
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.96 Aligned_cols=261 Identities=30% Similarity=0.503 Sum_probs=221.9
Q ss_pred eeeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEE
Q 012320 20 YIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWI 99 (466)
Q Consensus 20 ~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 99 (466)
+...+|...|+.+.+ +|.|+||.||||+++.+|+..|+|.|+... .++..-+.+||-+++.++|||||.+++++.
T Consensus 8 isrrnP~ddyellqr-vgsgTygdvyKaRd~~s~elaavkvVkLep----~dd~~~iqqei~~~~dc~h~nivay~gsyl 82 (829)
T KOG0576|consen 8 ISRRNPQDDYELLQR-VGSGTYGDVYKARDKRSGELAAVKVVKLEP----GDDFSGIQQEIGMLRDCRHPNIVAYFGSYL 82 (829)
T ss_pred hhhcCCccchhheee-ecCCcccchhhhcccccCchhhheeeeccC----CccccccccceeeeecCCCcChHHHHhhhh
Confidence 344599999999866 999999999999999999999999998653 346677888999999999999999999985
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
....+|++||||.||+|.+.-.-.+.+++.++...++..+.||+|||+.| -+|||||-.||+++.. |.+|++|||
T Consensus 83 --r~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~-gDvklaDfg 157 (829)
T KOG0576|consen 83 --RRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDE-GDVKLADFG 157 (829)
T ss_pred --hhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeeccc-CceeecccC
Confidence 46679999999999999997766789999999999999999999999999 8999999999999987 999999999
Q ss_pred hhhhhcCC-CCCccccCCCCcCCcccc----ccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCC
Q 012320 180 LAAILRGS-KSAHSVIGTPEFMAPELY----EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVT-SGKLPGA 253 (466)
Q Consensus 180 la~~~~~~-~~~~~~~GT~~y~APE~l----~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~-~g~~p~~ 253 (466)
.+..+... .+..+++|||+|||||+- .+.|+..+|||++|+...|+.-...|-.. ..+.+.....+ ++--|+.
T Consensus 158 vsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd-lhpmr~l~LmTkS~~qpp~ 236 (829)
T KOG0576|consen 158 VSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD-LHPMRALFLMTKSGFQPPT 236 (829)
T ss_pred chhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc-cchHHHHHHhhccCCCCCc
Confidence 99776532 346789999999999964 36799999999999999999888888766 44444444444 4443433
Q ss_pred C--CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 254 F--YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 254 ~--~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
. ....++.+.+|++.+|. +|++||+++.+|.|||+...
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 2 23446789999999995 99999999999999999765
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=265.28 Aligned_cols=209 Identities=28% Similarity=0.441 Sum_probs=179.5
Q ss_pred eeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCCEEEEEEecC
Q 012320 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQKTFNFITEMF 113 (466)
Q Consensus 35 ~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~~~lV~E~~ 113 (466)
-||+|+||.|=+.+|..+|...|+|.++... +.....++++|+.+..+. ..|.+|.+|+.+.. ...+|+.||.+
T Consensus 53 elGrGayG~vekmrh~~sg~imAvKri~~tv---n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r--egdvwIcME~M 127 (282)
T KOG0984|consen 53 ELGRGAYGVVEKMRHIQSGTIMAVKRIRATV---NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR--EGDVWICMELM 127 (282)
T ss_pred hhcCCccchhhheeeccCCeEEEEeeehhhc---ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc--cccEEEeHHHh
Confidence 3999999999999999999999999998554 345667889999887766 79999999998854 56799999999
Q ss_pred CCCCHHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCC
Q 012320 114 TSGTLREY----RKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS 189 (466)
Q Consensus 114 ~ggsL~~~----l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~ 189 (466)
..||..+ +++.+.++|..+-+|+..++.||.|||++ ..|||||+||.|||+|.+ |.||+||||++..+..+-.
T Consensus 128 -~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~-GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 128 -DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYD-GQVKICDFGISGYLVDSIA 204 (282)
T ss_pred -hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccC-CcEEEcccccceeehhhhH
Confidence 5677654 45668899999999999999999999987 349999999999999987 9999999999988766544
Q ss_pred CccccCCCCcCCccccc-----cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC
Q 012320 190 AHSVIGTPEFMAPELYE-----EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP 251 (466)
Q Consensus 190 ~~~~~GT~~y~APE~l~-----~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p 251 (466)
.+...|...|||||.+. ..|+.++||||||+.++||+++++||....++.+..+++....-|
T Consensus 205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P 271 (282)
T KOG0984|consen 205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSP 271 (282)
T ss_pred HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCC
Confidence 44467888999999764 259999999999999999999999999889999999988876544
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=292.68 Aligned_cols=241 Identities=24% Similarity=0.459 Sum_probs=199.0
Q ss_pred eeeeeeeeCceEEEEEEEcC----CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 32 FEEVLGKGAMKTVYKAIDEV----LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 32 ~~~~LG~G~fg~Vyka~~~~----~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
++++||.|.||.||+|+... ...-||||.-+.. ..+++.+.|+.|.-+|++++|||||++.+.+. ....|
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d---~t~d~tekflqEa~iMrnfdHphIikLIGv~~---e~P~W 466 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD---CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV---EQPMW 466 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccC---CChhhHHHHHHHHHHHHhCCCcchhheeeeee---cccee
Confidence 35679999999999998532 3445777765432 36677899999999999999999999999874 34689
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 108 FITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
+|||+++-|.|+.|++.. ..++......++.||..||.||||.. ++||||-..||||.+. ..|||+||||++.+..
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp-~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSP-QCVKLADFGLSRYLED 543 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCc-ceeeecccchhhhccc
Confidence 999999999999999876 46999999999999999999999999 9999999999999988 5999999999998876
Q ss_pred CCCCccccC--CCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 012320 187 SKSAHSVIG--TPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA 262 (466)
Q Consensus 187 ~~~~~~~~G--T~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~ 262 (466)
....+...| ..-|||||-+. ..++.++|||-||||+||++. |.-||.+-.|.+.+ -.+.+|.-+ +.+..+.+.+
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-~~iEnGeRl-P~P~nCPp~L 621 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-GHIENGERL-PCPPNCPPAL 621 (974)
T ss_pred cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-EEecCCCCC-CCCCCCChHH
Confidence 544333333 34699999665 789999999999999999887 99999986665444 445555532 2455678889
Q ss_pred HHHHHHhcc-CcCCCCCHHHHh
Q 012320 263 QRFIGRCLV-NASKRLSAKELL 283 (466)
Q Consensus 263 ~~lI~~~L~-dp~~Rpsa~elL 283 (466)
..+..+|+. +|++||...+|.
T Consensus 622 YslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 622 YSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHHHHHhccCcccCCcHHHHH
Confidence 999999996 999999998774
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=276.72 Aligned_cols=249 Identities=26% Similarity=0.449 Sum_probs=199.4
Q ss_pred eeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC-----CEEE
Q 012320 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ-----KTFN 107 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~-----~~~~ 107 (466)
.+-||.|+||+||.+.|..+|+.||.|++. .+.++-...+++++|+++|..++|.|+....+.. +.. ..+|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~p--nvfq~L~s~krvFre~kmLcfFkHdNVLSaLDIL--QPph~dfFqEiY 133 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMP--NVFQNLASCKRVFREIKMLSSFRHDNVLSLLDIL--QPANPSFFQELY 133 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcc--hHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhc--CCCCchHHHHHH
Confidence 466999999999999999999999999865 4445555678999999999999999999988754 322 1367
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~ 187 (466)
.|+|++ ..+|..+|..-..++.+.++-++.||++||.|||+.+ |.||||||.|+|++++ ..+||||||+++.....
T Consensus 134 V~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSN-CvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 134 VLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSN-CILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccC-ceEEecccccccccchh
Confidence 788888 5688888888888999999999999999999999999 9999999999999998 78999999999875433
Q ss_pred C--CCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-----------------
Q 012320 188 K--SAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVT----------------- 246 (466)
Q Consensus 188 ~--~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~----------------- 246 (466)
. .+..-+-|-+|.|||++.+ .|+.++||||+|||+.||+..+..|.. .++.+..+.|+
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA-q~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA-AGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc-cChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 2 3334466899999998864 599999999999999999998888876 45544444332
Q ss_pred ------c-CCCCCC---CCCCCC-----HHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 247 ------S-GKLPGA---FYSIQD-----LEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 247 ------~-g~~p~~---~~~~~~-----~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
+ +..++. ++...+ .+...++.++|. ||.+|.+.++++.|+++..
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 1 111221 222222 366677777775 9999999999999999854
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=317.41 Aligned_cols=235 Identities=21% Similarity=0.330 Sum_probs=176.8
Q ss_pred eeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEec
Q 012320 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
.++||+|+||+||+|.++.+|..||+|.+..... ....|++.+++++|||||++++++. +....++||||
T Consensus 695 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~l~~l~HpnIv~~~~~~~--~~~~~~lv~Ey 764 (968)
T PLN00113 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--------IPSSEIADMGKLQHPNIVKLIGLCR--SEKGAYLIHEY 764 (968)
T ss_pred ccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--------ccHHHHHHHhhCCCCCcceEEEEEE--cCCCCEEEEeC
Confidence 4679999999999999999999999998763221 1134688999999999999999884 45678999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCCc
Q 012320 113 FTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSR-DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH 191 (466)
Q Consensus 113 ~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~-~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~~ 191 (466)
+++|+|.++++ .+++..+..++.||+.||+|||.. .++|+||||||+||+++.+ +..++. ||....... ..
T Consensus 765 ~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~-~~~~~~-~~~~~~~~~---~~ 836 (968)
T PLN00113 765 IEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK-DEPHLR-LSLPGLLCT---DT 836 (968)
T ss_pred CCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-CceEEE-ecccccccc---CC
Confidence 99999999985 488999999999999999999944 2349999999999999876 566665 655433222 12
Q ss_pred cccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHhc---------CCCCCC--CC
Q 012320 192 SVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECA----NPAQIYKKVTS---------GKLPGA--FY 255 (466)
Q Consensus 192 ~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~----~~~~i~~~i~~---------g~~p~~--~~ 255 (466)
...||+.|||||++. ..|+.++|||||||++|||+||+.||.... ......+.... ..++.. ..
T Consensus 837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (968)
T PLN00113 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916 (968)
T ss_pred CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence 346899999999776 469999999999999999999999985321 11111111110 011000 00
Q ss_pred CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 256 ~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
.....++.+++.+|+. +|.+|||+.|+++.
T Consensus 917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 917 QNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred HHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 1111256788999996 99999999999853
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=282.98 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=198.4
Q ss_pred eeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 21 IETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 21 ~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
+..-|-.+- ++++.||+|.||.|.+|.-.. +..||+|.++-.. .......|.+||++|.+|+|||||+++++++.
T Consensus 532 l~EfPRs~L-~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a---~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~ 606 (807)
T KOG1094|consen 532 LVEFPRSRL-RFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA---TKNARNDFLKEIKILSRLKHPNIVELLGVCVQ 606 (807)
T ss_pred hhhcchhhe-ehhhhhcCcccceeEEEEecC-ceEEEEeecCccc---chhHHHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence 334444444 457889999999999997554 6999999987543 33456789999999999999999999998854
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEecc
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDL 178 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DF 178 (466)
++.+++|+||+..|+|.+++.++ .........+++.||+.|++||.+.+ ++||||-+.|+|++++ +++||+||
T Consensus 607 --DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e-~~iKiadf 681 (807)
T KOG1094|consen 607 --DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGE-FTIKIADF 681 (807)
T ss_pred --CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCc-ccEEecCc
Confidence 66799999999999999999987 33345556679999999999999999 9999999999999988 79999999
Q ss_pred chhhhhcCCCCC---ccccCCCCcCCcc-ccccCCCChhhHHHHHHHHHHHHh--CCCCCCCCCCHHHHHHHHh---cCC
Q 012320 179 GLAAILRGSKSA---HSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFT--CEYPYSECANPAQIYKKVT---SGK 249 (466)
Q Consensus 179 Gla~~~~~~~~~---~~~~GT~~y~APE-~l~~~y~~~~DIwSlGvil~ellt--g~~Pf~~~~~~~~i~~~i~---~g~ 249 (466)
|.++.+-.+... ...+-...||||| ++.++++.++|+|+||+++||+++ .+-||+...+ +++.+... .+.
T Consensus 682 gmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-e~vven~~~~~~~~ 760 (807)
T KOG1094|consen 682 GMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-EQVVENAGEFFRDQ 760 (807)
T ss_pred ccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-HHHHHhhhhhcCCC
Confidence 999865433221 1223456899999 667999999999999999999764 7889987444 44433322 111
Q ss_pred CC---CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 250 LP---GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 250 ~p---~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
-+ ...+......+.+++.+|+. +.++|||.++|-.
T Consensus 761 ~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 761 GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 11 12345566788899999995 9999999999853
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=279.41 Aligned_cols=238 Identities=24% Similarity=0.401 Sum_probs=205.2
Q ss_pred eeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEe
Q 012320 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITE 111 (466)
Q Consensus 32 ~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E 111 (466)
+..+||-|.||.||.|+.+.-.-.||+|.++ .+.-..+.|+.|..+|+.++|||+|+|.++| .....+|||+|
T Consensus 271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-----EDtMeveEFLkEAAvMKeikHpNLVqLLGVC--T~EpPFYIiTE 343 (1157)
T KOG4278|consen 271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC--THEPPFYIITE 343 (1157)
T ss_pred eeeccCCCcccceeeeeeeccceeeehhhhh-----hcchhHHHHHHHHHHHHhhcCccHHHHhhhh--ccCCCeEEEEe
Confidence 5678999999999999999999999999875 2345778999999999999999999999977 55667999999
Q ss_pred cCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCC
Q 012320 112 MFTSGTLREYRKKYRR--VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS 189 (466)
Q Consensus 112 ~~~ggsL~~~l~~~~~--l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~ 189 (466)
||+.|+|.+|+++..+ ++.-.+..++.||..|++||...+ +|||||-..|.||..+ ..||++||||++.+.+...
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEn-hiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhcccccc-ceEEeeccchhhhhcCCce
Confidence 9999999999987643 677778888999999999999999 9999999999999877 6899999999998876432
Q ss_pred CccccC---CCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 012320 190 AHSVIG---TPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQR 264 (466)
Q Consensus 190 ~~~~~G---T~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~ 264 (466)
....| ..-|.|||-+- +.++.++|||+|||+|||++| |-.||.+ -+..++|..+..|- .-.-+..+.+.+..
T Consensus 421 -TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-idlSqVY~LLEkgy-RM~~PeGCPpkVYe 497 (1157)
T KOG4278|consen 421 -TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYGLLEKGY-RMDGPEGCPPKVYE 497 (1157)
T ss_pred -ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHhccc-cccCCCCCCHHHHH
Confidence 12223 34699999665 779999999999999999999 8889987 78899999888764 33445677888999
Q ss_pred HHHHhcc-CcCCCCCHHHH
Q 012320 265 FIGRCLV-NASKRLSAKEL 282 (466)
Q Consensus 265 lI~~~L~-dp~~Rpsa~el 282 (466)
|++.|+. .|++||++.|+
T Consensus 498 LMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 498 LMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred HHHHHhcCCcccCccHHHH
Confidence 9999998 99999999876
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=269.48 Aligned_cols=247 Identities=27% Similarity=0.452 Sum_probs=192.9
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC--CCCceeEEEeEEEecc-
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL--KHDSIIRFYTSWIDVD- 102 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l--~HpnIv~l~~~~~~~~- 102 (466)
..|-..+.+.||+|.||.||+|... |+.||+|++.-. +....++|.+|.++. +|+||..|..+=....
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr-------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR-------DERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred hhheeEEEEEecCccccceeecccc--CCceEEEEeccc-------chhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 4566677899999999999999765 999999997622 335788899999874 9999999987532211
Q ss_pred -CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------CCCCeEeccCCCCcEEEeCCCCcEEE
Q 012320 103 -QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHS------RDPPVIHRDLKCDNIFVNGHLGQVKI 175 (466)
Q Consensus 103 -~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs------~~~~IiHrDLKp~NIlv~~~~g~vKL 175 (466)
-..+|+|++|.+.|||+||+.+ ..++.+.+.+++.-++.||++||- ..|.|.|||||..||||..+ |.+.|
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn-~~C~I 357 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCI 357 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC-CcEEE
Confidence 1369999999999999999998 789999999999999999999993 23569999999999999988 89999
Q ss_pred eccchhhhhcCCC-----CCccccCCCCcCCccccccCCC-------ChhhHHHHHHHHHHHHh----------CCCCCC
Q 012320 176 GDLGLAAILRGSK-----SAHSVIGTPEFMAPELYEEDYN-------ELVDVYSFGMCVLEMFT----------CEYPYS 233 (466)
Q Consensus 176 ~DFGla~~~~~~~-----~~~~~~GT~~y~APE~l~~~y~-------~~~DIwSlGvil~ellt----------g~~Pf~ 233 (466)
+|+|||....... ..+..+||..|||||++.+..+ ..+||||||.++||++. -..||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 9999997654332 2356789999999999987543 35899999999999974 246774
Q ss_pred C----CCCHHHHHHHHhcCCCCCCCCCC--CCH---HHHHHHHHhc-cCcCCCCCHHHHh
Q 012320 234 E----CANPAQIYKKVTSGKLPGAFYSI--QDL---EAQRFIGRCL-VNASKRLSAKELL 283 (466)
Q Consensus 234 ~----~~~~~~i~~~i~~g~~p~~~~~~--~~~---~~~~lI~~~L-~dp~~Rpsa~elL 283 (466)
+ ..+.+++.+.+...++.+..+.. .++ .+-.+++-|+ .+|+-|.||--+.
T Consensus 438 d~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 438 DVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred cCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 3 35567777777666654433322 223 3455778888 4999999986553
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=284.10 Aligned_cols=262 Identities=24% Similarity=0.357 Sum_probs=215.1
Q ss_pred hhccceeeeCCCCceEEeeeeeeeeCceEEEEEEEcCC---CeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCce
Q 012320 15 KAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVL---GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91 (466)
Q Consensus 15 ~~~~~~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI 91 (466)
.++.+..+..|.+.-.+. |+||+|.||+|++|..+.. -..||+|.++..... .....|++|+.+|.+|+|||+
T Consensus 98 ~p~~~lkclIpee~i~l~-e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~---~~mddflrEas~M~~L~H~hl 173 (1039)
T KOG0199|consen 98 NPSIDLKCLIPEEQIKLY-ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN---AIMDDFLREASHMLKLQHPHL 173 (1039)
T ss_pred CcCCCcceeccHHHHHHH-HHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc---hhHHHHHHHHHHHHhccCcce
Confidence 345555666677666664 6699999999999987653 355899998865542 266789999999999999999
Q ss_pred eEEEeEEEeccCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC
Q 012320 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH 169 (466)
Q Consensus 92 v~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~ 169 (466)
|+||+...+ ..+.+|+|+++.|||.+.+.+. ..|....+..|+.||+.|+.||.+++ +|||||-..|+|+-..
T Consensus 174 iRLyGvVl~---qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasp 248 (1039)
T KOG0199|consen 174 IRLYGVVLD---QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASP 248 (1039)
T ss_pred eEEeeeecc---chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheeccc
Confidence 999997543 4577999999999999988773 45888999999999999999999999 9999999999999886
Q ss_pred CCcEEEeccchhhhhcCCCCCccccC----CCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHH
Q 012320 170 LGQVKIGDLGLAAILRGSKSAHSVIG----TPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYK 243 (466)
Q Consensus 170 ~g~vKL~DFGla~~~~~~~~~~~~~G----T~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~ 243 (466)
..|||+||||.+.+........+.+ ...|+|||.+. ..++.++|+|++||++|||++ |+.||.+ -+..+|.+
T Consensus 249 -rtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G-~~g~qIL~ 326 (1039)
T KOG0199|consen 249 -RTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG-CRGIQILK 326 (1039)
T ss_pred -ceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC-CCHHHHHH
Confidence 6999999999998876555443322 23699999776 789999999999999999999 8899988 67788999
Q ss_pred HHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 244 KVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 244 ~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
.|..|..- .-++.++..+.+++..|+. +|.+|||+..|...-++
T Consensus 327 ~iD~~erL-pRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 327 NIDAGERL-PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred hccccccC-CCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 99876532 2345678899999999997 99999999988654443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=283.77 Aligned_cols=201 Identities=26% Similarity=0.444 Sum_probs=176.3
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHH----HHHHHHHHHHHHHhCC---CCceeEEEeEEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPD----DLQRLYSEVHLLSTLK---HDSIIRFYTSWI 99 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~----~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~ 99 (466)
..|+.+++ ||.|+||.|++|+++.+..+|++|.|.+.++..+.- .+-.+-.||+||..++ |+||+++.+.|
T Consensus 561 s~yttlq~-lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF- 638 (772)
T KOG1152|consen 561 SDYTTLQP-LGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF- 638 (772)
T ss_pred ccceeeee-ccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee-
Confidence 44777655 999999999999999999999999999877643321 2344667999999997 99999999988
Q ss_pred eccCCEEEEEEecC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEecc
Q 012320 100 DVDQKTFNFITEMF-TSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDL 178 (466)
Q Consensus 100 ~~~~~~~~lV~E~~-~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DF 178 (466)
++++++|++||-- +|.+|+++|..+++++|..++-|++|++.|+++||+.| |+|||||-+|+.++++ |.+||+||
T Consensus 639 -Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~-g~~klidf 714 (772)
T KOG1152|consen 639 -EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSN-GFVKLIDF 714 (772)
T ss_pred -ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecC-CeEEEeec
Confidence 6688999999985 57799999999999999999999999999999999999 9999999999999998 99999999
Q ss_pred chhhhhcCCCCCccccCCCCcCCccccccC-C-CChhhHHHHHHHHHHHHhCCCCCCC
Q 012320 179 GLAAILRGSKSAHSVIGTPEFMAPELYEED-Y-NELVDVYSFGMCVLEMFTCEYPYSE 234 (466)
Q Consensus 179 Gla~~~~~~~~~~~~~GT~~y~APE~l~~~-y-~~~~DIwSlGvil~elltg~~Pf~~ 234 (466)
|.+..... .....++||..|.|||++.+. | +..-|||++|+++|-++..+.||.+
T Consensus 715 gsaa~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 715 GSAAYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cchhhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 98876544 456788999999999999854 4 6789999999999999999999853
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=287.29 Aligned_cols=247 Identities=23% Similarity=0.394 Sum_probs=208.3
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCC---eEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLG---VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
-.|-.++++||.|.||.|++|..+..| ..||||.++..- ...+...|+.|+.||-+++||||++|-++. ...
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy---tekqrrdFL~EAsIMGQFdHPNIIrLEGVV--Tks 702 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIRLEGVV--TKS 702 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc---cHHHHhhhhhhhhhcccCCCCcEEEEEEEE--ecC
Confidence 346667999999999999999998877 569999887432 456678899999999999999999999954 667
Q ss_pred CEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 104 KTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
+.+.||+|||++|+|..+++++ +.|+.-++-.+++.|+.|+.||-++| .+||||-..|||||.+ -.+|++||||++
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsn-LvCKVsDFGLSR 779 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSN-LVCKVSDFGLSR 779 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccc-eEEEecccccee
Confidence 8899999999999999999865 67998999999999999999999999 9999999999999998 589999999999
Q ss_pred hhcCCC-CCcc-ccC--CCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCC-CCCCCC
Q 012320 183 ILRGSK-SAHS-VIG--TPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGK-LPGAFY 255 (466)
Q Consensus 183 ~~~~~~-~~~~-~~G--T~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~-~p~~~~ 255 (466)
.+.... ...+ .-| ...|.|||.+. .+++.++||||+|++|||.++ |+.||.+ .+..++.+.|..|- +|+ +
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd-mSNQdVIkaIe~gyRLPp--P 856 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MSNQDVIKAIEQGYRLPP--P 856 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc-cchHHHHHHHHhccCCCC--C
Confidence 885433 2222 222 35799999775 889999999999999999776 9999998 45566778887764 443 3
Q ss_pred CCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 256 ~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
-.....+..|...|++ |..+||.+.+|+.
T Consensus 857 mDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 857 MDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 4566789999999996 9999999999974
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=266.69 Aligned_cols=240 Identities=28% Similarity=0.452 Sum_probs=184.6
Q ss_pred eeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHh--CCCCceeEEEeEEEec--cCCEEE
Q 012320 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLST--LKHDSIIRFYTSWIDV--DQKTFN 107 (466)
Q Consensus 32 ~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~~--~~~~~~ 107 (466)
+-++||+|.||+||||. -+++.||||++. ..+.+.+..|-+|.+. ++|+||++|++.-... +...++
T Consensus 214 l~eli~~Grfg~V~Kaq--L~~~~VAVKifp-------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQ--LDNRLVAVKIFP-------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred hHHHhhcCccceeehhh--ccCceeEEEecC-------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 34679999999999995 457999999876 3455677888888775 5899999999742111 134799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSR-------DPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~-------~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
+|+||.+.|+|.+|++. ..++.....+++.-++.||+|||+- .|+|+|||||..||||..+ ++..|+||||
T Consensus 285 LVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D-lTccIaDFGL 362 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND-LTCCIADFGL 362 (534)
T ss_pred EEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC-CcEEeeccce
Confidence 99999999999999986 6789999999999999999999953 3679999999999999877 8999999999
Q ss_pred hhhhcCCC---CCccccCCCCcCCccccccCCC-------ChhhHHHHHHHHHHHHhCC------------CCCC----C
Q 012320 181 AAILRGSK---SAHSVIGTPEFMAPELYEEDYN-------ELVDVYSFGMCVLEMFTCE------------YPYS----E 234 (466)
Q Consensus 181 a~~~~~~~---~~~~~~GT~~y~APE~l~~~y~-------~~~DIwSlGvil~elltg~------------~Pf~----~ 234 (466)
|..+.... ....-+||..|||||+|.+..+ ...||||+|.+++||++.. .||. .
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 98876433 3445789999999999986533 3489999999999999721 2232 1
Q ss_pred CCCHHHHHHHHhcCCC----CCCCCCCCC-HHHHHHHHHhcc-CcCCCCCHHHH
Q 012320 235 CANPAQIYKKVTSGKL----PGAFYSIQD-LEAQRFIGRCLV-NASKRLSAKEL 282 (466)
Q Consensus 235 ~~~~~~i~~~i~~g~~----p~~~~~~~~-~~~~~lI~~~L~-dp~~Rpsa~el 282 (466)
-...+++...+.+.+. |..+..... ..+++.++-|+. ||.-|+||.-+
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 1334555555554443 333323322 367889999995 99999999644
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=267.39 Aligned_cols=253 Identities=24% Similarity=0.421 Sum_probs=199.8
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcC---CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEecc
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEV---LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVD 102 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 102 (466)
..+++..++||.|+|++||+|++.. ....||+|.+.... ...++..|+++|..+ .+.||+++.+.+ ..
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts------~p~ri~~El~~L~~~gG~~ni~~~~~~~--rn 106 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS------SPSRILNELEMLYRLGGSDNIIKLNGCF--RN 106 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc------CchHHHHHHHHHHHhccchhhhcchhhh--cc
Confidence 3455567789999999999999887 89999999887443 336789999999999 689999999987 55
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
++.+.+|+||++.-...++.. .++...++.+++.++.||.++|.+| ||||||||.|+|.+...+.-.|+|||||.
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred CCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHH
Confidence 778999999999988888765 5678999999999999999999999 99999999999999998999999999996
Q ss_pred hhcCCC--------------C-------------------------------CccccCCCCcCCccccc--cCCCChhhH
Q 012320 183 ILRGSK--------------S-------------------------------AHSVIGTPEFMAPELYE--EDYNELVDV 215 (466)
Q Consensus 183 ~~~~~~--------------~-------------------------------~~~~~GT~~y~APE~l~--~~y~~~~DI 215 (466)
..+... . .....|||.|.|||++. ..-+.++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 211000 0 01235999999999876 346788999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------------hcCC--C-----------------------------
Q 012320 216 YSFGMCVLEMFTCEYPYSECANPAQIYKKV--------------TSGK--L----------------------------- 250 (466)
Q Consensus 216 wSlGvil~elltg~~Pf~~~~~~~~i~~~i--------------~~g~--~----------------------------- 250 (466)
||.|||+.-++++.+||..+.+.......+ ..|. +
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 999999999999999997654432211111 1122 0
Q ss_pred ----CCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 251 ----PGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 251 ----p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
+.......+..+.+|+.+||. ||.+|+||+++|+||||....
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 001112233478899999995 999999999999999998543
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=281.31 Aligned_cols=243 Identities=28% Similarity=0.398 Sum_probs=202.2
Q ss_pred eeeeeeeeCceEEEEEEEc----C---CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccC
Q 012320 32 FEEVLGKGAMKTVYKAIDE----V---LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 32 ~~~~LG~G~fg~Vyka~~~----~---~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 103 (466)
+.+.||.|+||.|++|.-+ . ....||+|..+... ...+.+.+..|+++|+.+ .||||+.+.+.+.. +
T Consensus 300 ~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~---~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~--~ 374 (609)
T KOG0200|consen 300 LGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA---SSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ--D 374 (609)
T ss_pred ccceeecccccceEeEEEeecccccccceEEEEEEeccccc---CcHHHHHHHHHHHHHHHhcCCcchhhheeeecc--C
Confidence 4568999999999999732 1 25679999876443 235778999999999999 69999999998743 7
Q ss_pred CEEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEe
Q 012320 104 KTFNFITEMFTSGTLREYRKKYR----------------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVN 167 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~ 167 (466)
..+++|+||+..|+|..+++..+ .++......++.||+.|++||++.. ++||||-..|||+.
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAARNVLIT 452 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhhhEEec
Confidence 78999999999999999998765 3888999999999999999999998 99999999999999
Q ss_pred CCCCcEEEeccchhhhhcCCCCC--ccccCCC--CcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHH
Q 012320 168 GHLGQVKIGDLGLAAILRGSKSA--HSVIGTP--EFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQI 241 (466)
Q Consensus 168 ~~~g~vKL~DFGla~~~~~~~~~--~~~~GT~--~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i 241 (466)
.+ ..+||+|||+|+........ ....||. .|||||.+. ..|+.++||||+||++|||++ |..||.+......+
T Consensus 453 ~~-~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l 531 (609)
T KOG0200|consen 453 KN-KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL 531 (609)
T ss_pred CC-CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence 87 69999999999854332222 2222333 499999776 579999999999999999998 89999876657778
Q ss_pred HHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHh
Q 012320 242 YKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELL 283 (466)
Q Consensus 242 ~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL 283 (466)
++.+..|.... .+...+.++.++++.|+. +|.+||+..++.
T Consensus 532 ~~~l~~G~r~~-~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~ 573 (609)
T KOG0200|consen 532 LEFLKEGNRME-QPEHCSDEIYDLMKSCWNADPEDRPTFSECV 573 (609)
T ss_pred HHHHhcCCCCC-CCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence 88899887543 345568899999999996 999999999886
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=234.68 Aligned_cols=210 Identities=35% Similarity=0.587 Sum_probs=182.2
Q ss_pred eeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecCCC
Q 012320 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTS 115 (466)
Q Consensus 36 LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~~g 115 (466)
||.|++|.||++.+..+|+.+++|.+...... ...+.+.+|+..++.++|++|+++++.+. .....++++|++.|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS---SLLEELLREIEILKKLNHPNIVKLYGVFE--DENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccch---hHHHHHHHHHHHHHhcCCCCeeeEeeeee--cCCeEEEEEecCCC
Confidence 68999999999999988999999998744321 13578999999999999999999999874 45789999999999
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCC-CCccc
Q 012320 116 GTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-SAHSV 193 (466)
Q Consensus 116 gsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~-~~~~~ 193 (466)
++|.+++... ..++...+..++.+++.+|.+||+.+ ++|+||+|.||+++...+.++|+|||.+....... .....
T Consensus 76 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (215)
T cd00180 76 GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI 153 (215)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence 9999999876 57999999999999999999999999 99999999999999723799999999997654432 13345
Q ss_pred cCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc
Q 012320 194 IGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV 271 (466)
Q Consensus 194 ~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~ 271 (466)
.++..|++||.+.. .++.+.|+|++|+++++| ..+.+++.+|+.
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~~l~ 199 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELKDLIRKMLQ 199 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHHHHhh
Confidence 67889999998865 688999999999999998 578999999995
Q ss_pred -CcCCCCCHHHHhcCC
Q 012320 272 -NASKRLSAKELLLDP 286 (466)
Q Consensus 272 -dp~~Rpsa~elL~hp 286 (466)
+|.+||++.++++++
T Consensus 200 ~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 200 KDPEKRPSAKEILEHL 215 (215)
T ss_pred CCcccCcCHHHHhhCC
Confidence 999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=238.14 Aligned_cols=211 Identities=30% Similarity=0.496 Sum_probs=182.4
Q ss_pred eeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEe
Q 012320 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITE 111 (466)
Q Consensus 32 ~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E 111 (466)
+.+.||.|++|+||+|.+..+++.+|+|.+...... ...+.+.+|+..++.++|+|++++++.+. .....++++|
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~--~~~~~~~v~e 77 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFE--DPEPLYLVME 77 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeee--cCCceEEEEe
Confidence 357799999999999999999999999998755421 25678899999999999999999999773 3567889999
Q ss_pred cCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCC--
Q 012320 112 MFTSGTLREYRKKYRR-VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-- 188 (466)
Q Consensus 112 ~~~ggsL~~~l~~~~~-l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~-- 188 (466)
++.+++|.+++..... +++..+..++.|++.+|.+||+.+ ++|+||+|.||+++.+ +.++|+|||++.......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMD-GLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeeCceeeEecCcccc
Confidence 9999999999988776 899999999999999999999998 9999999999999987 899999999998765432
Q ss_pred CCccccCCCCcCCcccc-c-cCCCChhhHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHhcCCC
Q 012320 189 SAHSVIGTPEFMAPELY-E-EDYNELVDVYSFGMCVLEMFTCEYPYSE-CANPAQIYKKVTSGKL 250 (466)
Q Consensus 189 ~~~~~~GT~~y~APE~l-~-~~y~~~~DIwSlGvil~elltg~~Pf~~-~~~~~~i~~~i~~g~~ 250 (466)
......++..|++||.+ . ..++.++|+||||+++++|++|..||.. ..+..++.+.+..|..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence 33456788999999987 3 4577899999999999999999999966 5666688888888763
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=275.07 Aligned_cols=240 Identities=28% Similarity=0.450 Sum_probs=200.8
Q ss_pred eeeeeeeCceEEEEEEEcCCC----eEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEE
Q 012320 33 EEVLGKGAMKTVYKAIDEVLG----VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNF 108 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~l 108 (466)
.++||.|+||+||+|.....| .+||||++.... .......+++|+-+|.+++|||++++.+.+.. ..+-|
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t---~~~~s~e~LdeAl~masldHpnl~RLLgvc~~---s~~ql 774 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT---SPKASIELLDEALRMASLDHPNLLRLLGVCML---STLQL 774 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccC---CchhhHHHHHHHHHHhcCCCchHHHHhhhccc---chHHH
Confidence 577999999999999875544 457888765332 34456789999999999999999999997642 23779
Q ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC
Q 012320 109 ITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187 (466)
Q Consensus 109 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~ 187 (466)
|++|+++|.|.+|++.+ .++..+....|+.||++|+.|||.+. ++||||-..||||... .++||.|||+++.+...
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP-~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSP-NHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCC-CeEEEEecchhhccCcc
Confidence 99999999999999875 57999999999999999999999999 9999999999999887 69999999999987654
Q ss_pred CCCccc-c--CCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 012320 188 KSAHSV-I--GTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA 262 (466)
Q Consensus 188 ~~~~~~-~--GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~ 262 (466)
....+. . -.+.|||-|.+. ..|+..+|||||||++||++| |.-||.+ ...++|-+.+..|.- -..+...+.++
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-i~~~eI~dlle~geR-LsqPpiCtiDV 929 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-IPAEEIPDLLEKGER-LSQPPICTIDV 929 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-CCHHHhhHHHhcccc-CCCCCCccHHH
Confidence 433222 1 245788888665 679999999999999999999 8899987 677888888888764 44567788899
Q ss_pred HHHHHHhcc-CcCCCCCHHHHh
Q 012320 263 QRFIGRCLV-NASKRLSAKELL 283 (466)
Q Consensus 263 ~~lI~~~L~-dp~~Rpsa~elL 283 (466)
-.++.+|+. |+..||+++++.
T Consensus 930 y~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 930 YMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred HHHHHHHhccCcccCccHHHHH
Confidence 999999995 999999999874
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=284.41 Aligned_cols=201 Identities=19% Similarity=0.190 Sum_probs=148.2
Q ss_pred HhCCC-CceeEEEeEEEe----c-cCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEe
Q 012320 84 STLKH-DSIIRFYTSWID----V-DQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIH 156 (466)
Q Consensus 84 ~~l~H-pnIv~l~~~~~~----~-~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiH 156 (466)
+.++| +||++++++|-. . ....+++++|++ +++|.+++... +.+++..++.+++||+.||.|||++| |+|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvH 103 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVV 103 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence 34556 577777777611 1 134677888887 77999999753 56999999999999999999999999 999
Q ss_pred ccCCCCcEEEeCC------------------CCcEEEeccchhhhhcCC-----------------CCCccccCCCCcCC
Q 012320 157 RDLKCDNIFVNGH------------------LGQVKIGDLGLAAILRGS-----------------KSAHSVIGTPEFMA 201 (466)
Q Consensus 157 rDLKp~NIlv~~~------------------~g~vKL~DFGla~~~~~~-----------------~~~~~~~GT~~y~A 201 (466)
|||||+||||+.. .+.+||+|||+++..... ......+||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 9999999999532 246677777777542110 00112468999999
Q ss_pred ccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCH
Q 012320 202 PELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSA 279 (466)
Q Consensus 202 PE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa 279 (466)
||++. ..|+.++|||||||++|||++|..|+.. .......+....+|... ....+....++.+||. +|.+||++
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~ 259 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE---KSRTMSSLRHRVLPPQI-LLNWPKEASFCLWLLHPEPSCRPSM 259 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh---HHHHHHHHHHhhcChhh-hhcCHHHHHHHHHhCCCChhhCcCh
Confidence 99765 5699999999999999999998888743 22233333333333222 1234567789999995 99999999
Q ss_pred HHHhcCCCCCch
Q 012320 280 KELLLDPFLASD 291 (466)
Q Consensus 280 ~elL~hpf~~~~ 291 (466)
.|+|+||||...
T Consensus 260 ~eil~h~~~~~~ 271 (793)
T PLN00181 260 SELLQSEFINEP 271 (793)
T ss_pred HHHhhchhhhhh
Confidence 999999999763
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=221.36 Aligned_cols=160 Identities=24% Similarity=0.314 Sum_probs=128.3
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCCcccc
Q 012320 116 GTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVI 194 (466)
Q Consensus 116 gsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~~~~~ 194 (466)
|+|.+++.+. +.+++..++.|+.||+.||.|||+.+ ||+|||++.+ +.+|+ ||++....... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~-~~~~~--fG~~~~~~~~~----~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWD-GLLKL--DGSVAFKTPEQ----SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCc-cceee--ccceEeecccc----CC
Confidence 7899999874 56999999999999999999999886 9999999877 79999 99987654322 26
Q ss_pred CCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC-----CCCCCH--HHHHHH
Q 012320 195 GTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAF-----YSIQDL--EAQRFI 266 (466)
Q Consensus 195 GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~-----~~~~~~--~~~~lI 266 (466)
||+.|||||++. ..|+.++|||||||++|||++|..||..........+.+..+..+... ....+. +++++|
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 899999999876 569999999999999999999999997655444555555443322211 111122 689999
Q ss_pred HHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 267 GRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 267 ~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
.+||. +|.+||++.+++.|+|+..
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHH
Confidence 99995 9999999999999999753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=231.48 Aligned_cols=255 Identities=22% Similarity=0.358 Sum_probs=193.0
Q ss_pred eeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEe
Q 012320 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWID 100 (466)
Q Consensus 22 ~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~ 100 (466)
..+-...|.+ .+.||+|.||.+.+|.|+.+...+++|.+.... .....+.+|.+---.| .|.||+.-|+.-+
T Consensus 19 kv~l~d~y~I-~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF- 91 (378)
T KOG1345|consen 19 KVDLEDVYTI-NKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-----TTQADFVREFHYSFFLSPHQHIIDTYEVAF- 91 (378)
T ss_pred ccchhhhhhH-HHHhcccceeeEEeeeccCCceEEEeeccCcch-----hhHHHHHHHhccceeeccchhhhHHHHHHh-
Confidence 3455667877 677999999999999999999999999987443 2456789999877777 5899999887644
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEe-CCCCcEEEeccc
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVN-GHLGQVKIGDLG 179 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~-~~~g~vKL~DFG 179 (466)
+..+.+.+++||++-|+|..-+.. ..+-|...+.++.|+++||.|||+.+ ++|||||.+||||- .+.-.|||||||
T Consensus 92 qt~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 92 QTSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred hcCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecc
Confidence 445688899999999999987654 56889999999999999999999999 99999999999984 444589999999
Q ss_pred hhhhhcCCCCCccccCCCCcCCccccc----cC--CCChhhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHhcCCC
Q 012320 180 LAAILRGSKSAHSVIGTPEFMAPELYE----ED--YNELVDVYSFGMCVLEMFTCEYPYSECA---NPAQIYKKVTSGKL 250 (466)
Q Consensus 180 la~~~~~~~~~~~~~GT~~y~APE~l~----~~--y~~~~DIwSlGvil~elltg~~Pf~~~~---~~~~i~~~i~~g~~ 250 (466)
+..... ......--+..|.+||++. +. .++.+|||.||+++|.++||..||.... .+-.-+.+...++-
T Consensus 169 ~t~k~g--~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 169 LTRKVG--TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN 246 (378)
T ss_pred cccccC--ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC
Confidence 885422 2222233456799999654 22 4688999999999999999999996432 23334455555543
Q ss_pred CC--CCCCCCCHHHHHHHHHhcc-CcCCC---CCHHHHhcCCCC
Q 012320 251 PG--AFYSIQDLEAQRFIGRCLV-NASKR---LSAKELLLDPFL 288 (466)
Q Consensus 251 p~--~~~~~~~~~~~~lI~~~L~-dp~~R---psa~elL~hpf~ 288 (466)
+. ......++.+..+.++-|. ++.+| -+++.....-|.
T Consensus 247 ~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 247 PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 32 2234456677777788885 78888 455555555554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-28 Score=261.77 Aligned_cols=261 Identities=25% Similarity=0.357 Sum_probs=201.6
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecc--cccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLN--ELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~--~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
..|...+.++|.|++|.|+.+........+++|..+.. ...........+..|+-+-.++.|||++...... .+..
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~--~~~~ 394 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIV--QEID 394 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHH--hhcc
Confidence 55888889999999999999888877777787765532 1111112223367788888889999998776644 3334
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
..+.+||||++ +|+.++.+.+.+....+..+++|++.|+.|||+.| |.||||||+|++++.+ |.+||+|||.+..+
T Consensus 395 ~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~-g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 395 GILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTEN-GILKIIDFGAASVF 470 (601)
T ss_pred cchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecC-CceEEeecCcceee
Confidence 44455999999 99999998889999999999999999999999999 9999999999999987 89999999999776
Q ss_pred cCC-----CCCccccCCCCcCCcccccc-CCCC-hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CC-----CC
Q 012320 185 RGS-----KSAHSVIGTPEFMAPELYEE-DYNE-LVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-GK-----LP 251 (466)
Q Consensus 185 ~~~-----~~~~~~~GT~~y~APE~l~~-~y~~-~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-g~-----~p 251 (466)
... ......+|+..|+|||++.+ .|++ .+||||.|++++.|.+|+.||.......+.+..... +. -+
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~ 550 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP 550 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccCh
Confidence 432 22456789999999998874 5775 599999999999999999999654433332211111 10 12
Q ss_pred CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 252 GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 252 ~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
..+........+.+|.+||. +|.+|.|+++|++++||+....
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 22344455688999999995 9999999999999999987654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-25 Score=214.45 Aligned_cols=253 Identities=28% Similarity=0.418 Sum_probs=204.2
Q ss_pred eEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCC-ceeEEEeEEEeccCCEEE
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHD-SIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp-nIv~l~~~~~~~~~~~~~ 107 (466)
|.. .+.||.|+||.||++.+. ..+|+|.+...... .......+.+|+.+++.+.|+ +|+++++.+ ......+
T Consensus 2 ~~~-~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~--~~~~~~~ 74 (384)
T COG0515 2 YRI-LRKLGEGSFGEVYLARDR---KLVALKVLAKKLES-KSKEVERFLREIQILASLNHPPNIVKLYDFF--QDEGSLY 74 (384)
T ss_pred cee-EEeecCCCCeEEEEEEec---cEEEEEeechhhcc-chhHHHHHHHHHHHHHHccCCcceeeEEEEE--ecCCEEE
Confidence 444 566999999999999888 78899988765532 223467899999999999988 799999988 4455689
Q ss_pred EEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 108 FITEMFTSGTLREYRKKYR---RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~---~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
++++++.++++.+++.... .++...+..++.|++.++.|+|+.+ ++|||+||+||+++.....++++|||++..+
T Consensus 75 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 75 LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152 (384)
T ss_pred EEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence 9999999999998887765 7999999999999999999999999 9999999999999977227999999999755
Q ss_pred cCCC-------CCccccCCCCcCCcccccc----CCCChhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHhcCCC
Q 012320 185 RGSK-------SAHSVIGTPEFMAPELYEE----DYNELVDVYSFGMCVLEMFTCEYPYSECAN---PAQIYKKVTSGKL 250 (466)
Q Consensus 185 ~~~~-------~~~~~~GT~~y~APE~l~~----~y~~~~DIwSlGvil~elltg~~Pf~~~~~---~~~i~~~i~~g~~ 250 (466)
.... .....+||+.|+|||.+.. .+....|+||+|++++++++|..||..... ..+..+.+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (384)
T COG0515 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232 (384)
T ss_pred CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence 4332 2456789999999997764 688899999999999999999999876543 5666666665554
Q ss_pred C-CCCCCCC------CHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 251 P-GAFYSIQ------DLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 251 p-~~~~~~~------~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
+ ....... ...+.+++..|+. +|..|.++.+...+++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 3 1111111 1478899999995 9999999999988866543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-28 Score=247.91 Aligned_cols=243 Identities=22% Similarity=0.297 Sum_probs=207.8
Q ss_pred eeeeeCceEEEEEE---EcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEeEEEeccCCEEEEEE
Q 012320 35 VLGKGAMKTVYKAI---DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYTSWIDVDQKTFNFIT 110 (466)
Q Consensus 35 ~LG~G~fg~Vyka~---~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~~~lV~ 110 (466)
++|.|+||.|+++. -...|.-+|+|..++......... ....|..++..++ ||.+|+++..| +.+...++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyaf--qt~~kl~l~l 76 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAF--QTDGKLYLIL 76 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeee--ccccchhHhh
Confidence 47999999998764 455688899998887765443322 6677888999886 99999999988 6677899999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCC
Q 012320 111 EMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA 190 (466)
Q Consensus 111 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~ 190 (466)
++..||.|...+.+...+++...+.+...++.+++.+|+.+ |+|||+|++||+++.+ |++|+.|||+++.....+..
T Consensus 77 d~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~-Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLE-GHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred hhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeeccc-CccccCCchhhhHhHhhhhc
Confidence 99999999999999899999999999999999999999999 9999999999999988 99999999999887654433
Q ss_pred ccccCCCCcCCccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhc
Q 012320 191 HSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCL 270 (466)
Q Consensus 191 ~~~~GT~~y~APE~l~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L 270 (466)
|||..|||||+.. .....+|+||+|+++++|+||..||.. ++.+.|..-+++ .+...+..+++++..++
T Consensus 154 ---cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~~~--~p~~l~~~a~~~~~~l~ 222 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAELE--MPRELSAEARSLFRQLF 222 (612)
T ss_pred ---ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhccC--CchhhhHHHHHHHHHHH
Confidence 9999999999988 778899999999999999999999976 556666554443 44556779999999999
Q ss_pred c-CcCCCCCH-----HHHhcCCCCCchhhhh
Q 012320 271 V-NASKRLSA-----KELLLDPFLASDEVKL 295 (466)
Q Consensus 271 ~-dp~~Rpsa-----~elL~hpf~~~~~~~~ 295 (466)
. +|..|..+ .|+++|+||+...|..
T Consensus 223 ~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~ 253 (612)
T KOG0603|consen 223 KRNPENRLGAGPDGVDEIKQHEFFQSIDWNE 253 (612)
T ss_pred hhCHHHHhccCcchhHHHhccchheeeeHhh
Confidence 5 99999865 6999999999988863
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=226.47 Aligned_cols=174 Identities=17% Similarity=0.185 Sum_probs=132.7
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcC-CCeEEEEEEEecccc-cCCHHHHHHHHHHHHHHHhCCCCceeE-EEeEEEecc
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEV-LGVEVAWNQVRLNEL-MRSPDDLQRLYSEVHLLSTLKHDSIIR-FYTSWIDVD 102 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~-~g~~vAiK~i~~~~~-~~~~~~~~~~~~Ei~iL~~l~HpnIv~-l~~~~~~~~ 102 (466)
.++|.+ .++||+|+||+||+|.++. +|+.+|+|++..... .......+.+.+|+++|++++|+||+. ++. +
T Consensus 17 ~~~Y~~-~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-~---- 90 (365)
T PRK09188 17 SARFVE-TAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-T---- 90 (365)
T ss_pred cCCceE-ccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-c----
Confidence 467877 6779999999999999876 788889998652211 112334567899999999999999985 543 1
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccC-CCCcEEEeCCCCcEEEeccchh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDL-KCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDL-Kp~NIlv~~~~g~vKL~DFGla 181 (466)
...|+||||+.|++|... . ... ...++.|++.||.|||++| |+|||| ||+|||++.+ +.+||+|||+|
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~-~~ikLiDFGlA 159 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPD-GEAAVIDFQLA 159 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCC-CCEEEEECccc
Confidence 347899999999999732 1 111 1467899999999999999 999999 9999999766 79999999999
Q ss_pred hhhcCCC---------CCccccCCCCcCCccccccC-------CCChhhHH
Q 012320 182 AILRGSK---------SAHSVIGTPEFMAPELYEED-------YNELVDVY 216 (466)
Q Consensus 182 ~~~~~~~---------~~~~~~GT~~y~APE~l~~~-------y~~~~DIw 216 (466)
..+.... ...+..+++.|+|||.+... .+..+|-|
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 8654322 12356789999999988632 33446666
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.2e-25 Score=236.06 Aligned_cols=223 Identities=26% Similarity=0.402 Sum_probs=171.7
Q ss_pred eeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEec
Q 012320 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
-++|..|+||.||.+.|+.+.+.+|+| +.++.+. +++ +|.....|.+|
T Consensus 88 IklisngAygavylvrh~~trqrfa~k-iNkq~li--------lRn---ilt~a~npfvv-------------------- 135 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI--------LRN---ILTFAGNPFVV-------------------- 135 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhc-ccccchh--------hhc---cccccCCccee--------------------
Confidence 377999999999999999999999994 4433321 000 22223333333
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC-----
Q 012320 113 FTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS----- 187 (466)
Q Consensus 113 ~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~----- 187 (466)
|+-...++..+.++... +.+++|+|+.+ |+|||+||+|.+|+.- |++|++|||+++..-..
T Consensus 136 ---gDc~tllk~~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT~m-GhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLITSM-GHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred ---chhhhhcccCCCCcchh--------hHHhHhhccCC--eecCCCCCCcceeeec-ccccccchhhhhhhhhhccchh
Confidence 66677777777777555 78999999999 9999999999999876 99999999998653111
Q ss_pred -----------CCCccccCCCCcCCcccc-ccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--CCCC
Q 012320 188 -----------KSAHSVIGTPEFMAPELY-EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK--LPGA 253 (466)
Q Consensus 188 -----------~~~~~~~GT~~y~APE~l-~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~--~p~~ 253 (466)
-....++|||+|+|||++ .++|+..+|||++|+|+|+.+.|..||++ .++++++..+.... +|+.
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG-dtpeelfg~visd~i~wpE~ 280 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEWPEE 280 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC-CCHHHHHhhhhhhhcccccc
Confidence 012356899999999965 47799999999999999999999999988 88899988887643 4544
Q ss_pred CCCCCCHHHHHHHHHhcc-CcCCCC---CHHHHhcCCCCCchhhhhccccccCC
Q 012320 254 FYSIQDLEAQRFIGRCLV-NASKRL---SAKELLLDPFLASDEVKLLSKTKLNQ 303 (466)
Q Consensus 254 ~~~~~~~~~~~lI~~~L~-dp~~Rp---sa~elL~hpf~~~~~~~~~~~~~~~~ 303 (466)
..-..++++++|.++|. +|..|. .+-++.+|+||+.-+|+-+..++...
T Consensus 281 -dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqkaef 333 (1205)
T KOG0606|consen 281 -DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKAEF 333 (1205)
T ss_pred -CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhccc
Confidence 33455799999999995 998885 56789999999998887544444433
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-24 Score=207.17 Aligned_cols=247 Identities=23% Similarity=0.280 Sum_probs=194.0
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCC-----eEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLG-----VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
.|.+ +.-++-+|.||.||.|+..+.. +.|-+|.++. ..++-+...++.|--+|..+.|||+....+..+.
T Consensus 284 ~Rv~-l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~---~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie- 358 (563)
T KOG1024|consen 284 CRVR-LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ---HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE- 358 (563)
T ss_pred hhee-chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh---cccHHHHHHHHHHHHHHhcCcCCCccceeEEEee-
Confidence 3433 3567889999999999755432 2233443331 1244466788999999999999999999988765
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcE
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKY--------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQV 173 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~--------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~v 173 (466)
+..+.+.++.+..-|+|..++... +.++..++-.++.|+..|++|||+++ |||.||-..|.+++.. -.|
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd~-LqV 435 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDDQ-LQV 435 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehhh-eeE
Confidence 445566778999889999998732 23566677788999999999999999 9999999999999977 699
Q ss_pred EEeccchhhhhcCCCCCcc----ccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhc
Q 012320 174 KIGDLGLAAILRGSKSAHS----VIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTS 247 (466)
Q Consensus 174 KL~DFGla~~~~~~~~~~~----~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~ 247 (466)
||+|=.+++.+-+.. .+. --....||+||.+. +.|+.++|+|||||++|||+| |+.||.+ -++.+++..++.
T Consensus 436 kltDsaLSRDLFP~D-YhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae-IDPfEm~~ylkd 513 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGD-YHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE-IDPFEMEHYLKD 513 (563)
T ss_pred EeccchhccccCccc-ccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc-cCHHHHHHHHhc
Confidence 999999998764322 111 11234799999776 569999999999999999998 9999987 889999999998
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 248 GKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 248 g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
|.- -..+...+.++..++--|+. .|++||+.+|+..
T Consensus 514 GyR-laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 514 GYR-LAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cce-ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 863 23455677899999999996 9999999999863
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-22 Score=204.01 Aligned_cols=249 Identities=20% Similarity=0.218 Sum_probs=181.5
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCC-eEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCC----CceeEEEeEEEecc
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLG-VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH----DSIIRFYTSWIDVD 102 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g-~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~H----pnIv~l~~~~~~~~ 102 (466)
+|.+ .+.||+|+||.||+|.+..++ ..+|+|......... . ..+..|+.+|..+.. +++..+++... ..
T Consensus 19 ~~~i-~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~ 92 (322)
T KOG1164|consen 19 RYKL-GKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---P-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-ST 92 (322)
T ss_pred ceEE-eeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---C-ccchhHHHHHHHHhhhcCCCCCCEEEEecc-CC
Confidence 7887 566999999999999998875 688888766432211 1 156778888888862 57888887653 34
Q ss_pred CCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCC----CcEEEe
Q 012320 103 QKTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHL----GQVKIG 176 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~----g~vKL~ 176 (466)
...-++||+.+ |.+|.++.+.. +.++...+..++.|++.+|++||+.| ++||||||+|+++.... -.+.|.
T Consensus 93 ~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 93 EDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred CceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEE
Confidence 66788999998 99999988665 57999999999999999999999999 99999999999997542 369999
Q ss_pred ccchhh--hhcCCC--------C-CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HH
Q 012320 177 DLGLAA--ILRGSK--------S-AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQ--IY 242 (466)
Q Consensus 177 DFGla~--~~~~~~--------~-~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~--i~ 242 (466)
|||+++ .+.... . .....||..|+++.+.. ...+.+-|+||++.++.+|..|..||........ .+
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~ 249 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF 249 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence 999998 321111 1 12356999999999665 4588999999999999999999999966443222 22
Q ss_pred HHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 243 KKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 243 ~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
+.................++..+...+-. +...+|....+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 250 EKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 22222221111222233455555544443 67778877766543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.7e-23 Score=196.52 Aligned_cols=207 Identities=19% Similarity=0.318 Sum_probs=169.6
Q ss_pred EEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCCEEEE
Q 012320 30 GLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQKTFNF 108 (466)
Q Consensus 30 ~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~~~l 108 (466)
++++++||+|+||+.+.|.+-.+++.||||.-..+. +..++..|.+..+.| ..++|...|. +.+...+-.+
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS------~APQLrdEYr~YKlL~g~~GIP~vYY--FGqeG~~NiL 101 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS------EAPQLRDEYRTYKLLGGTEGIPQVYY--FGQEGKYNIL 101 (449)
T ss_pred ceeccccccCcceeeecccccccCceEEEEeccccC------CcchHHHHHHHHHHHcCCCCCCceee--eccccchhhh
Confidence 355899999999999999999999999999755332 345678899999888 4688888775 3355666678
Q ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC----CCcEEEeccchhhh
Q 012320 109 ITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH----LGQVKIGDLGLAAI 183 (466)
Q Consensus 109 V~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~----~g~vKL~DFGla~~ 183 (466)
|+|++ |.||.|+..-. ++|+.+.+..++.|++.-++|+|+++ +|.|||||+|+||... ...|.|+|||+|+.
T Consensus 102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 99998 99999988765 56999999999999999999999999 9999999999999532 23689999999999
Q ss_pred hcCCCC--------CccccCCCCcCCcc-ccccCCCChhhHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHhc
Q 012320 184 LRGSKS--------AHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSEC--ANPAQIYKKVTS 247 (466)
Q Consensus 184 ~~~~~~--------~~~~~GT~~y~APE-~l~~~y~~~~DIwSlGvil~elltg~~Pf~~~--~~~~~i~~~i~~ 247 (466)
+....+ ..+..||..||+-. -+...-+.+-|+=|||-++++.+-|.+||.+. .+..+-|++|-.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence 865433 24567999999987 44556788899999999999999999999763 456677777743
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=186.82 Aligned_cols=143 Identities=17% Similarity=0.134 Sum_probs=111.2
Q ss_pred eeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHH----------------------HHHHHHHHHHHHHhCCCCc
Q 012320 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPD----------------------DLQRLYSEVHLLSTLKHDS 90 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~----------------------~~~~~~~Ei~iL~~l~Hpn 90 (466)
...||+|+||+||+|.+. +|+.||+|+++......... .......|+++|+++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 356999999999999997 89999999997643211100 0123345999999998777
Q ss_pred eeEEEeEEEeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeEeccCCCCcEEEeCC
Q 012320 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYL-HSRDPPVIHRDLKCDNIFVNGH 169 (466)
Q Consensus 91 Iv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yL-Hs~~~~IiHrDLKp~NIlv~~~ 169 (466)
+...+... ... .++||||++|+++...+.+.+.+++..+..++.||+.+|.|+ |+.| |+||||||+|||++.
T Consensus 81 v~~p~~~~--~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~~- 153 (190)
T cd05147 81 IPCPEPIL--LKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYHD- 153 (190)
T ss_pred CCCCcEEE--ecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEEC-
Confidence 64333211 112 379999999988776655567899999999999999999999 7999 999999999999983
Q ss_pred CCcEEEeccchhhhh
Q 012320 170 LGQVKIGDLGLAAIL 184 (466)
Q Consensus 170 ~g~vKL~DFGla~~~ 184 (466)
+.++|+|||+|...
T Consensus 154 -~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 -GKLYIIDVSQSVEH 167 (190)
T ss_pred -CcEEEEEccccccC
Confidence 68999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=187.03 Aligned_cols=233 Identities=21% Similarity=0.322 Sum_probs=175.2
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCC-CceeEEEeEEEeccCC
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH-DSIIRFYTSWIDVDQK 104 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~ 104 (466)
.|.|.++.+ ||.|+||.+|.|.+..+|.+||||.-+.+. .-..+..|.++...|++ ..|..+..+. .++.
T Consensus 14 ~gky~lvrk-iGsGSFGdIy~~~~i~~ge~VAiK~Es~~a------~hpqL~yEskvY~iL~~g~GiP~i~~y~--~e~~ 84 (341)
T KOG1163|consen 14 GGKYKLVRK-IGSGSFGDIYLGISITSGEEVAIKLESSKA------KHPQLLYESKVYRILQGGVGIPHIRHYG--TEKD 84 (341)
T ss_pred ccceEEEEe-ecCCchhheeeeeeccCCceEEEEeecccC------CCcchhHHHHHHHHhccCCCCchhhhhc--cccc
Confidence 578887655 999999999999999999999999754222 12356778888888864 5565555433 4466
Q ss_pred EEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC--CCcEEEeccchh
Q 012320 105 TFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLA 181 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~--~g~vKL~DFGla 181 (466)
+-.+||+++ |.||.++..- .++++.+.+.-++-|++.-++|+|.++ +|||||||+|+|+.-+ ...+.|+|||||
T Consensus 85 ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred cceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccch
Confidence 677999999 9999998764 367999999999999999999999999 9999999999998532 347899999999
Q ss_pred hhhcCCCC--------CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHhcCCC
Q 012320 182 AILRGSKS--------AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSEC--ANPAQIYKKVTSGKL 250 (466)
Q Consensus 182 ~~~~~~~~--------~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~--~~~~~i~~~i~~g~~ 250 (466)
+.+..... .....||..|.+-...- -.-+..-|+=|+|.++.++.-|..||.+. .+..+-|++|..-+.
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~ 241 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM 241 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence 88754322 23467999998866433 33567789999999999999999999764 345666777776554
Q ss_pred CCC---CCCCCCHHHHHHHHHhc
Q 012320 251 PGA---FYSIQDLEAQRFIGRCL 270 (466)
Q Consensus 251 p~~---~~~~~~~~~~~lI~~~L 270 (466)
.-. +=+..+.++...+.-|-
T Consensus 242 s~~ie~LC~G~P~EF~myl~Y~R 264 (341)
T KOG1163|consen 242 STPIEVLCKGFPAEFAMYLNYCR 264 (341)
T ss_pred CCCHHHHhCCCcHHHHHHHHHHh
Confidence 322 22233445666666554
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.2e-22 Score=189.71 Aligned_cols=175 Identities=13% Similarity=0.087 Sum_probs=134.2
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHH------HHHHHHHHHhCCCCceeEEEeEEE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQR------LYSEVHLLSTLKHDSIIRFYTSWI 99 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~------~~~Ei~iL~~l~HpnIv~l~~~~~ 99 (466)
.+||.. .++||.|+||.||++.. ++..+|+|.++.... ..+...++ +.+|+..+.++.||+|....+.++
T Consensus 30 ~~~y~~-~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~-~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 30 SYNIKT-IKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVK-RTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred hCceEE-EEEecCCCceEEEEEec--CCCcEEEEEechhcC-chHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 789987 57899999999999644 477899998874432 33333344 578999999999999999998876
Q ss_pred ecc------CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcE
Q 012320 100 DVD------QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQV 173 (466)
Q Consensus 100 ~~~------~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~v 173 (466)
+.. ....++||||++|.+|.++. .+++. ...+++.+|..||..| ++|||+||+||+++.+ | +
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~-g-i 173 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHG--MVSGDPHKGNFIVSKN-G-L 173 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcC--CccCCCChHHEEEeCC-C-E
Confidence 543 23578999999999998873 23333 4569999999999999 9999999999999876 7 9
Q ss_pred EEeccchhhhhcCCCCCccccCCCCcCCccccccCCCChhhHHHHHHHHHHHH
Q 012320 174 KIGDLGLAAILRGSKSAHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMF 226 (466)
Q Consensus 174 KL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~~~y~~~~DIwSlGvil~ell 226 (466)
+|+|||............. =++...|+.++||||||+++....
T Consensus 174 ~liDfg~~~~~~e~~a~d~----------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAKDR----------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhHHH----------HHHHhHhcccccccceeEeehHHH
Confidence 9999998765432221110 134456888999999999887653
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-23 Score=211.81 Aligned_cols=175 Identities=27% Similarity=0.466 Sum_probs=140.2
Q ss_pred EEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 105 TFNFITEMFTSGTLREYRKKYR---RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~---~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
++||.|++|.-.+|.+|+.+.. ..+...++.|+.|+..|++| ++ .+|||+||.||++..+ ..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d-~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDD-DQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccc-hhhhhhhhhhe
Confidence 4778899999999999997543 35677889999999999999 77 9999999999999766 68999999999
Q ss_pred hhhcCCC-------CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 012320 182 AILRGSK-------SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA 253 (466)
Q Consensus 182 ~~~~~~~-------~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~ 253 (466)
....... .....+||..||+||.+. +.|+.++||||||+|++|++. +|............+..|.+|+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~g~ip~~ 480 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDIRDGIIPPE 480 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhcCCCChH
Confidence 7765443 344568999999999776 679999999999999999997 33222233445566778888865
Q ss_pred CCCCCCHHHHHHHHHhc-cCcCCCCCHHHHhcCCCCC
Q 012320 254 FYSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLA 289 (466)
Q Consensus 254 ~~~~~~~~~~~lI~~~L-~dp~~Rpsa~elL~hpf~~ 289 (466)
+.. ..+.-..|+..|| ..|.+||++.+.-.|+|++
T Consensus 481 ~~~-d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 481 FLQ-DYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred Hhh-cCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 443 3456678888888 5999999888888888763
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=181.35 Aligned_cols=145 Identities=19% Similarity=0.167 Sum_probs=113.2
Q ss_pred eeeeeeeCceEEEEEEEcCCCeEEEEEEEeccccc--------------------CCHH--HHHHHHHHHHHHHhCCCCc
Q 012320 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELM--------------------RSPD--DLQRLYSEVHLLSTLKHDS 90 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~--------------------~~~~--~~~~~~~Ei~iL~~l~Hpn 90 (466)
...||+|++|+||+|.+. +|+.||+|+++..... .+.. ....+..|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 356999999999999988 8999999998865311 0000 1233468999999999998
Q ss_pred eeEEEeEEEeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCCCCcEEEeCC
Q 012320 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHS-RDPPVIHRDLKCDNIFVNGH 169 (466)
Q Consensus 91 Iv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs-~~~~IiHrDLKp~NIlv~~~ 169 (466)
|......+.. . .++||||++|+++.........+++..+..++.|++.++.++|+ .| |+||||||+||+++ +
T Consensus 81 i~~p~~~~~~--~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~ 153 (190)
T cd05145 81 VPVPEPILLK--K--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-D 153 (190)
T ss_pred CCCceEEEec--C--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-C
Confidence 7544433221 2 37999999988654443344678899999999999999999999 99 99999999999998 4
Q ss_pred CCcEEEeccchhhhhcC
Q 012320 170 LGQVKIGDLGLAAILRG 186 (466)
Q Consensus 170 ~g~vKL~DFGla~~~~~ 186 (466)
+.++|+|||++..+..
T Consensus 154 -~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 -GKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCEEEEEcccceecCC
Confidence 7999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-21 Score=179.10 Aligned_cols=184 Identities=15% Similarity=0.043 Sum_probs=137.0
Q ss_pred eeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEeEEEeccCCEEEEEEe
Q 012320 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYTSWIDVDQKTFNFITE 111 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~~~lV~E 111 (466)
...|++|+||+||.+.. .+.+++.+.+.........-....+.+|+++|++|. |++|.++++. ...+++||
T Consensus 7 ~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvme 78 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDRS 78 (218)
T ss_pred ceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEEe
Confidence 56799999999997754 678888776653332111112235789999999995 5889998873 23689999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccC-CCCcEEEeCCCCcEEEeccchhhhhcCCCCC
Q 012320 112 MFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDL-KCDNIFVNGHLGQVKIGDLGLAAILRGSKSA 190 (466)
Q Consensus 112 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDL-Kp~NIlv~~~~g~vKL~DFGla~~~~~~~~~ 190 (466)
|+.|.+|...+.. . ...++.|++.+|.+||++| |+|||| ||+|||++.+ |.++|+|||++.........
T Consensus 79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~-g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQED-GSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCC-CCEEEEECCCceecCCcchH
Confidence 9999999754321 1 1357889999999999999 999999 7999999866 89999999999754432211
Q ss_pred --------------ccccCCCCcCCcccc--ccCCC-ChhhHHHHHHHHHHHHhCCCCCCC
Q 012320 191 --------------HSVIGTPEFMAPELY--EEDYN-ELVDVYSFGMCVLEMFTCEYPYSE 234 (466)
Q Consensus 191 --------------~~~~GT~~y~APE~l--~~~y~-~~~DIwSlGvil~elltg~~Pf~~ 234 (466)
.-...++.|++|+.- ....+ ...++++.|+-+|.++|+..|+.+
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 012268889999732 23334 567888999999999999998765
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=177.18 Aligned_cols=137 Identities=20% Similarity=0.195 Sum_probs=107.9
Q ss_pred eeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-----CCCceeEEEeEEEeccC-CE-
Q 012320 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-----KHDSIIRFYTSWIDVDQ-KT- 105 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-----~HpnIv~l~~~~~~~~~-~~- 105 (466)
.++||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++++ +||||+++|+++..... +.
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 35799999999995 7777776 6998875432 2346789999999999 67999999998854321 34
Q ss_pred EEEEEec--CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCCCeEeccCCCCcEEEeCC---CCcEEEeccc
Q 012320 106 FNFITEM--FTSGTLREYRKKYRRVDIRAIKSWARQILQGL-VYLHSRDPPVIHRDLKCDNIFVNGH---LGQVKIGDLG 179 (466)
Q Consensus 106 ~~lV~E~--~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL-~yLHs~~~~IiHrDLKp~NIlv~~~---~g~vKL~DFG 179 (466)
+.+|+|| +.+|+|.+++++ +.+++. ..+++|++.++ +|||+++ |+||||||+|||++.. .+.++|+||+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 3378999 558999999976 457666 36688999888 9999999 9999999999999742 2379999954
Q ss_pred hh
Q 012320 180 LA 181 (466)
Q Consensus 180 la 181 (466)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 34
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-22 Score=195.54 Aligned_cols=274 Identities=30% Similarity=0.546 Sum_probs=199.7
Q ss_pred hhhhccceeeeCCCCceEEeeeeeeee---CceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCC
Q 012320 13 EAKAHIGYIETDPNGRYGLFEEVLGKG---AMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHD 89 (466)
Q Consensus 13 ~~~~~~~~~~~~~~~rY~~~~~~LG~G---~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp 89 (466)
+.-...++.+..|.+||.+-++..|+- +.-.||++.+...|.+|.|..|.....+.-....+....-...|-++.|-
T Consensus 48 ~s~~~~eIleesp~~rw~krreqv~qrdvPgid~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHs 127 (458)
T KOG1266|consen 48 DSEDESEILEESPCGRWGKRREQVGQRDVPGIDDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHS 127 (458)
T ss_pred cccchhhhhccCchhhhhhhhhhccCCCCCchHHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHH
Confidence 444667889999999999877767653 34468999999999999999887655433333334444455566777899
Q ss_pred ceeEEEeEEEec---cCCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCC
Q 012320 90 SIIRFYTSWIDV---DQKTFNFITEMFTSGTLREYRKKY----RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCD 162 (466)
Q Consensus 90 nIv~l~~~~~~~---~~~~~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~ 162 (466)
|||+++.+|-+. +...+.|++||+..|+|..++++. ..+.....++|+-||+.||.|||+..|||+|+++.++
T Consensus 128 nlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~ 207 (458)
T KOG1266|consen 128 NLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCD 207 (458)
T ss_pred HHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchh
Confidence 999999988543 234688999999999999999764 4588999999999999999999999999999999999
Q ss_pred cEEEeCCCCcEEEeccchhhhh---cCC--CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 012320 163 NIFVNGHLGQVKIGDLGLAAIL---RGS--KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECA 236 (466)
Q Consensus 163 NIlv~~~~g~vKL~DFGla~~~---~~~--~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~ 236 (466)
.|++..+ |.+|++--.....- ... .......|-+.|.|||.-. -+-+-++|||+||++..+|..++.--.++.
T Consensus 208 tifiq~n-gLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnse 286 (458)
T KOG1266|consen 208 TIFIQHN-GLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSE 286 (458)
T ss_pred heeecCC-ceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCc
Confidence 9999855 88888643221110 000 0011223668899998543 346678999999999999999887654433
Q ss_pred CHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 237 NPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 237 ~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
.....-..+.+-.+ ...+.--+.+|.+||. .|..||+|.+++.||.+-...
T Consensus 287 S~~~~ee~ia~~i~-----~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh 338 (458)
T KOG1266|consen 287 SKVEVEENIANVII-----GLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH 338 (458)
T ss_pred ceeehhhhhhhhee-----eccCccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence 33322222322111 1222334678999997 999999999999999875543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=182.91 Aligned_cols=239 Identities=18% Similarity=0.206 Sum_probs=147.8
Q ss_pred CCCCceE--EeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCC----------Cce
Q 012320 24 DPNGRYG--LFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH----------DSI 91 (466)
Q Consensus 24 ~~~~rY~--~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~H----------pnI 91 (466)
.+++++. +.++.||.|+++.||.+.|..||+++|+|+..... ......++.+.+|.-....+.+ -.+
T Consensus 6 ~~~~~~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~ 84 (288)
T PF14531_consen 6 ELGQRPRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRF 84 (288)
T ss_dssp SSS--EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B
T ss_pred cCCCCceEEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceE
Confidence 3444443 44778999999999999999999999999987665 3344567777777755555322 112
Q ss_pred eEEEeEEE--------ecc-C-CE-----EEEEEecCCCCCHHHHHH---hcCCC----CHHHHHHHHHHHHHHHHHHHh
Q 012320 92 IRFYTSWI--------DVD-Q-KT-----FNFITEMFTSGTLREYRK---KYRRV----DIRAIKSWARQILQGLVYLHS 149 (466)
Q Consensus 92 v~l~~~~~--------~~~-~-~~-----~~lV~E~~~ggsL~~~l~---~~~~l----~~~~~~~i~~qIl~gL~yLHs 149 (466)
+.-++... ... + .. .+++|.-+ .++|.+++. ..... .......+..|++..+++||+
T Consensus 85 l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~ 163 (288)
T PF14531_consen 85 LVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS 163 (288)
T ss_dssp ---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh
Confidence 22222111 111 1 11 24566666 678877754 22222 222334556999999999999
Q ss_pred CCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCCccccCCCCcCCcccccc---------CCCChhhHHHHHH
Q 012320 150 RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYEE---------DYNELVDVYSFGM 220 (466)
Q Consensus 150 ~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~~---------~y~~~~DIwSlGv 220 (466)
.| ++|+||||+|+|++.+ |.+.|+||+...... ........+..|.+||+... .++.+.|.|+||+
T Consensus 164 ~G--lVHgdi~~~nfll~~~-G~v~Lg~F~~~~r~g--~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~ 238 (288)
T PF14531_consen 164 YG--LVHGDIKPENFLLDQD-GGVFLGDFSSLVRAG--TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI 238 (288)
T ss_dssp TT--EEEST-SGGGEEE-TT-S-EEE--GGGEEETT--EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred cc--eEecccceeeEEEcCC-CCEEEcChHHHeecC--ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence 99 9999999999999987 999999998764432 22222345678999996643 3788999999999
Q ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCC
Q 012320 221 CVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKR 276 (466)
Q Consensus 221 il~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~R 276 (466)
++|.|+|+..||............+. .-. ..+..++.+|..+|. +|.+|
T Consensus 239 ~ly~lWC~~lPf~~~~~~~~~~~~f~------~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 239 TLYSLWCGRLPFGLSSPEADPEWDFS------RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHSS-STCCCGGGSTSGGGGT------TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHccCCCCCCCccccccccch------hcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999999964221110000010 011 345689999999996 89887
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-21 Score=210.83 Aligned_cols=240 Identities=21% Similarity=0.265 Sum_probs=176.9
Q ss_pred eeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEe
Q 012320 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITE 111 (466)
Q Consensus 32 ~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E 111 (466)
+.+.||.+.|=+|.+|.+.+ |. |.+|++-+....-+-....+...|++ .+.++|||.+.+.-. ....+.-|+|-+
T Consensus 27 ~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~--~~t~kAAylvRq 101 (1431)
T KOG1240|consen 27 YVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV--LVTDKAAYLVRQ 101 (1431)
T ss_pred eecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH--HHhhHHHHHHHH
Confidence 36779999999999997764 55 88998877664444445556666777 667799999987653 245667778888
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh--cC--C
Q 012320 112 MFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL--RG--S 187 (466)
Q Consensus 112 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~--~~--~ 187 (466)
|+ -.+|.|.+...+-+..-+.+.|+.||+.||.-||..| |+|+|||.+||||++= +.+.|+||..-+-. .. +
T Consensus 102 yv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSW-NW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSW-NWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeee-chhhhhcccccCCccCCCCCc
Confidence 88 5689998887666788888999999999999999999 9999999999999976 69999999754321 11 1
Q ss_pred CCCccccCC----CCcCCcccccc-----------C-CCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcC-C
Q 012320 188 KSAHSVIGT----PEFMAPELYEE-----------D-YNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSG-K 249 (466)
Q Consensus 188 ~~~~~~~GT----~~y~APE~l~~-----------~-y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g-~ 249 (466)
....-+..| .+|+|||.+-. . ..++-||||+||+++||++ |.+||. ..|++.- ++| .
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aY-r~~~~ 252 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAY-RSGNA 252 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhH-hccCc
Confidence 111122233 48999995521 1 4678899999999999998 677773 2333322 222 1
Q ss_pred C-C-CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 250 L-P-GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 250 ~-p-~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
. + ..+..+.+...+.+|..|+. ||++|.||++.|+-
T Consensus 253 ~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 253 DDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1 0 11234456688999999996 99999999999864
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.8e-19 Score=174.29 Aligned_cols=189 Identities=28% Similarity=0.381 Sum_probs=140.4
Q ss_pred CCCceeEEEeEEEec-------------------------cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHH
Q 012320 87 KHDSIIRFYTSWIDV-------------------------DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQIL 141 (466)
Q Consensus 87 ~HpnIv~l~~~~~~~-------------------------~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl 141 (466)
+|||||+++..|++. ...++|+||.-+ ..+|+.|+-. ...+....+-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~-~~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT-RHRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc-CCCchHHHHHHHHHHH
Confidence 699999999888642 346799999988 5689999865 5567778888999999
Q ss_pred HHHHHHHhCCCCeEeccCCCCcEEEeCCC---CcEEEeccchhhhhcC-------CCCCccccCCCCcCCcccccc---C
Q 012320 142 QGLVYLHSRDPPVIHRDLKCDNIFVNGHL---GQVKIGDLGLAAILRG-------SKSAHSVIGTPEFMAPELYEE---D 208 (466)
Q Consensus 142 ~gL~yLHs~~~~IiHrDLKp~NIlv~~~~---g~vKL~DFGla~~~~~-------~~~~~~~~GT~~y~APE~l~~---~ 208 (466)
+|+.|||.+| |.|||||.+|||+.-++ ..+.|+|||.+-.-.. ....-..-|...-||||+... .
T Consensus 352 Eav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 352 EAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 9999999999 99999999999995332 2679999997632211 011123457888999998763 2
Q ss_pred ---C-CChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHH
Q 012320 209 ---Y-NELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAK 280 (466)
Q Consensus 209 ---y-~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~ 280 (466)
. -.++|.|+.|.+.||+++...||.......--.+...+..+|. .+....+.+++++..+|+ ||++|+|+.
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPa-lp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPA-LPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCC-CcccCChHHHHHHHHHhcCCccccCCcc
Confidence 1 2579999999999999999999965221111111233334443 456677899999999996 999999965
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-20 Score=203.19 Aligned_cols=258 Identities=26% Similarity=0.379 Sum_probs=206.2
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEc-CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEeEEEecc
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDE-VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYTSWIDVD 102 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~-~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~ 102 (466)
|...|..+.. ||+|+|+.|-.+... .+...+|.|.+.... .+.....++..|..+-+.+. |+|++.+++.+ .+
T Consensus 18 ~~~~~~~~~~-ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~--~~ 92 (601)
T KOG0590|consen 18 PNSQYKLSRS-IGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS--SS 92 (601)
T ss_pred cccccccccc-ccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCcc--CC
Confidence 6777877544 999999999988763 345556666665443 34455677788999999986 99999999966 56
Q ss_pred CCEEEEEEecCCCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCCCeEeccCCCCcEEEeCCCC-cEEEecc
Q 012320 103 QKTFNFITEMFTSGTLREYR-KKYR-RVDIRAIKSWARQILQGLVYLH-SRDPPVIHRDLKCDNIFVNGHLG-QVKIGDL 178 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l-~~~~-~l~~~~~~~i~~qIl~gL~yLH-s~~~~IiHrDLKp~NIlv~~~~g-~vKL~DF 178 (466)
....++++++..|+++++.+ .... ..+...+..++.|+..++.|+| ..+ +.|||+||+|.+++.. + .+|+.||
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s-~~~l~~~df 169 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDES-GSALKIADF 169 (601)
T ss_pred CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccC-CCcccCCCc
Confidence 77888999999999999988 5544 6788889999999999999999 888 9999999999999877 7 8999999
Q ss_pred chhhhhcC-CC---CCccccC-CCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC--C
Q 012320 179 GLAAILRG-SK---SAHSVIG-TPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG--K 249 (466)
Q Consensus 179 Gla~~~~~-~~---~~~~~~G-T~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g--~ 249 (466)
|+|+.+.. .. .....+| ++.|+|||.+.+ ...+..|+||.|+++.-|++|..|+.......+.+...... .
T Consensus 170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~ 249 (601)
T KOG0590|consen 170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR 249 (601)
T ss_pred hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccc
Confidence 99988755 22 2344678 999999998876 35688999999999999999999996544433333333322 2
Q ss_pred CCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 250 LPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 250 ~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
+....+...+....+++.++|. +|+.|.+.+++..+||+..
T Consensus 250 ~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 250 FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 2244566677889999999994 9999999999999999987
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.9e-19 Score=170.30 Aligned_cols=151 Identities=21% Similarity=0.170 Sum_probs=116.0
Q ss_pred CCceEEeeeeeeeeCceEEEEEE-EcCCCeEEEEEEEecccccC------------------CHH--HHHHHHHHHHHHH
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAI-DEVLGVEVAWNQVRLNELMR------------------SPD--DLQRLYSEVHLLS 84 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~-~~~~g~~vAiK~i~~~~~~~------------------~~~--~~~~~~~Ei~iL~ 84 (466)
-|+-+.+.+.||+|+||.||+|. +..+|+.||+|+++...... .+. ....+..|+.+++
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 45555667889999999999999 77899999999987543210 000 1134678999999
Q ss_pred hCCCC--ceeEEEeEEEeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCC
Q 012320 85 TLKHD--SIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCD 162 (466)
Q Consensus 85 ~l~Hp--nIv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~ 162 (466)
++.+. .+.+.+.. . ..++||||+.|++|..+......+....+..++.||+.+|.+||+.| .|+||||||+
T Consensus 106 ~L~~~~i~~p~~~~~----~--~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~ 178 (237)
T smart00090 106 RLYEAGVPVPKPIAW----R--RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEY 178 (237)
T ss_pred HHHhcCCCCCeeeEe----c--CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChh
Confidence 99753 34444431 1 24799999999888776544456777778899999999999999886 4999999999
Q ss_pred cEEEeCCCCcEEEeccchhhhhc
Q 012320 163 NIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 163 NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
||+++ + +.++|+|||.+....
T Consensus 179 NIli~-~-~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILVH-D-GKVVIIDVSQSVELD 199 (237)
T ss_pred hEEEE-C-CCEEEEEChhhhccC
Confidence 99998 4 799999999987543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.3e-19 Score=168.74 Aligned_cols=235 Identities=17% Similarity=0.258 Sum_probs=180.1
Q ss_pred eeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecCC
Q 012320 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFT 114 (466)
Q Consensus 35 ~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~~ 114 (466)
+|...-.|..|+|+.. |..++.|++...++ +......|..|.-.|+-+.||||..+.+.+ .....+.+|..|++
T Consensus 197 kl~e~hsgelwrgrwq--gndivakil~vr~~--t~risrdfneefp~lrifshpnilpvlgac--nsppnlv~isq~mp 270 (448)
T KOG0195|consen 197 KLAESHSGELWRGRWQ--GNDIVAKILNVREV--TARISRDFNEEFPALRIFSHPNILPVLGAC--NSPPNLVIISQYMP 270 (448)
T ss_pred hhccCCCccccccccc--Ccchhhhhhhhhhc--chhhcchhhhhCcceeeecCCchhhhhhhc--cCCCCceEeeeecc
Confidence 4777888999999776 55677787776654 333445678888899999999999999987 55677889999999
Q ss_pred CCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEE--eccchhhhhcCCCCC
Q 012320 115 SGTLREYRKKYRR--VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKI--GDLGLAAILRGSKSA 190 (466)
Q Consensus 115 ggsL~~~l~~~~~--l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL--~DFGla~~~~~~~~~ 190 (466)
-|||+..+..... ++..++.+++.+|+.|+.|||+..|-|.---|....++++.+ -+.+| +|--++-+ .
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmided-ltarismad~kfsfq--e---- 343 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDED-LTARISMADTKFSFQ--E---- 343 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecch-hhhheecccceeeee--c----
Confidence 9999999876543 688899999999999999999998767777788889999876 24443 44333311 1
Q ss_pred ccccCCCCcCCccccccC----CCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 012320 191 HSVIGTPEFMAPELYEED----YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFI 266 (466)
Q Consensus 191 ~~~~GT~~y~APE~l~~~----y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI 266 (466)
....-.|.||+||.++.+ --.++|+|||+++++||.|.+.||.+..+.+.-.+....| +....+...+..+..++
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeg-lrv~ippgis~hm~klm 422 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEG-LRVHIPPGISRHMNKLM 422 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcc-ccccCCCCccHHHHHHH
Confidence 122347899999988754 2367999999999999999999998855444434444444 44455667788999999
Q ss_pred HHhcc-CcCCCCCHHHHh
Q 012320 267 GRCLV-NASKRLSAKELL 283 (466)
Q Consensus 267 ~~~L~-dp~~Rpsa~elL 283 (466)
+-|+. ||.+||....++
T Consensus 423 ~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 423 NICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHhcCCCCcCCCcceeh
Confidence 99996 999999987654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1e-18 Score=192.45 Aligned_cols=193 Identities=21% Similarity=0.282 Sum_probs=151.3
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC---CCceeEEEeEEEec
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK---HDSIIRFYTSWIDV 101 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~ 101 (466)
.+..|.+ .+.||+|+||+||+|.+.. |+.||+|+-+..... .++--.+++.+|+ -+.|+.++..++-
T Consensus 696 ~~~~~~I-~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W-------EfYI~~q~~~RLk~~~~~~~~~~~~a~~~- 765 (974)
T KOG1166|consen 696 GGEKFCI-SKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW-------EFYICLQVMERLKPQMLPSIMHISSAHVF- 765 (974)
T ss_pred cceeEEE-EeeeccccceEEEEeecCC-CcEEEEEeecCCCce-------eeeehHHHHHhhchhhhcchHHHHHHHcc-
Confidence 3456666 6779999999999999887 999999975533321 0111222333333 2445555554433
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC------CCcEEE
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH------LGQVKI 175 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~------~g~vKL 175 (466)
.+.-++|+||.+-|+|.+++...+.+++..+..++.|++..++.||..+ |||+||||+|+|+... .--++|
T Consensus 766 -~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 766 -QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred -CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEE
Confidence 4556799999999999999998899999999999999999999999999 9999999999998321 236899
Q ss_pred eccchhhhh---cCCCCCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCC
Q 012320 176 GDLGLAAIL---RGSKSAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEY 230 (466)
Q Consensus 176 ~DFGla~~~---~~~~~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~ 230 (466)
+|||.+--+ .........++|-.+-.+|+..+ .++..+|.|.|+-+++-||.|++
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999988544 33445677889999999998875 59999999999999999999875
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.2e-18 Score=158.19 Aligned_cols=138 Identities=20% Similarity=0.276 Sum_probs=110.6
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCC----HHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEE
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRS----PDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFI 109 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV 109 (466)
+.||+|++|.||+|.+ .|..+++|+......... .....++.+|+.++..+.|++|......+.+ ....++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--PENFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--CCCCEEE
Confidence 4699999999999986 688899997653322111 1123467889999999999988765554433 4457799
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 110 TEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 110 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
|||++|++|.+++..... ....++.+++.+|.++|+.+ ++|||++|.|||++ + +.++|+|||++..
T Consensus 78 ~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~-~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-G-GKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-C-CCEEEEECCcccC
Confidence 999999999999875432 77889999999999999999 99999999999998 4 7899999998865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=154.97 Aligned_cols=134 Identities=20% Similarity=0.261 Sum_probs=104.2
Q ss_pred eeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCH----HHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEE
Q 012320 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSP----DDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFIT 110 (466)
Q Consensus 35 ~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~ 110 (466)
+||+|+||+||+|. .+|..+++|........... ....++.+|+++++.+.|+++....-.+.. ....++||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD--PDNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE--CCCCEEEE
Confidence 48999999999997 46788999985543221111 123677899999999988765433332332 34567999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 111 EMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 111 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
||++|++|.+++..... .++.|++.+|.+||+.+ ++|+|++|.||+++ + +.++++|||++..
T Consensus 77 e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~-~~~~liDfg~a~~ 138 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-D-DKLYLIDFGLGKY 138 (199)
T ss_pred EEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-C-CcEEEEECCCCcC
Confidence 99999999998765321 78999999999999999 99999999999998 4 7999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-17 Score=155.46 Aligned_cols=139 Identities=22% Similarity=0.191 Sum_probs=106.3
Q ss_pred EeeeeeeeeCceEEEEEEEcCCCeEEEEEEEeccccc-----CCH-------------HHHHHHHHHHHHHHhCCCCc--
Q 012320 31 LFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELM-----RSP-------------DDLQRLYSEVHLLSTLKHDS-- 90 (466)
Q Consensus 31 ~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~-----~~~-------------~~~~~~~~Ei~iL~~l~Hpn-- 90 (466)
.+.+.||+|+||.||+|.+. +|+.||+|+++..... ... ........|+.++..+.|++
T Consensus 18 ~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 18 SLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 34678999999999999875 7999999987754310 000 01123677999999997774
Q ss_pred eeEEEeEEEeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCC
Q 012320 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHL 170 (466)
Q Consensus 91 Iv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~ 170 (466)
+.+.+. ....++||||++|++|..+... .....++.+|+.++.++|+.+ |+||||||+||+++.+
T Consensus 97 v~~~~~------~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~~- 161 (198)
T cd05144 97 VPKPID------WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDDD- 161 (198)
T ss_pred CCceee------cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcCC-
Confidence 444443 2235799999999999765431 345678899999999999999 9999999999999876
Q ss_pred CcEEEeccchhhhhc
Q 012320 171 GQVKIGDLGLAAILR 185 (466)
Q Consensus 171 g~vKL~DFGla~~~~ 185 (466)
+.++|+|||++....
T Consensus 162 ~~~~liDfg~~~~~~ 176 (198)
T cd05144 162 EKIYIIDWPQMVSTD 176 (198)
T ss_pred CcEEEEECCccccCC
Confidence 899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.4e-17 Score=174.86 Aligned_cols=138 Identities=18% Similarity=0.230 Sum_probs=107.6
Q ss_pred EeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccC----CHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 31 LFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMR----SPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 31 ~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
...++||+|+||+||+|... +..+++|+...+.... .....+++.+|+++++.++|++|+..+..+.+ ....
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~ 411 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--PEEK 411 (535)
T ss_pred CccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--CCCC
Confidence 44788999999999999764 4445555433222111 11234678899999999999999887655433 4456
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
++||||++|++|.+++. ....++.|++.+|.|||+.+ ++||||||+||+++ + +.++|+|||+++..
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl~-~-~~~~liDFGla~~~ 477 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIVR-D-DRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEEE-C-CcEEEEeCcccccC
Confidence 79999999999999875 35678999999999999999 99999999999994 3 68999999999653
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=8e-17 Score=166.86 Aligned_cols=197 Identities=27% Similarity=0.409 Sum_probs=150.9
Q ss_pred HHhCCCCceeEEEeEEEeccCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCC
Q 012320 83 LSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKC 161 (466)
Q Consensus 83 L~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp 161 (466)
|+.+.|.|+.++++..++ ...++.|.+||.-|+|.|.+.. .-.++..-...++++|+.||.|+|+.- --.|+.|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~--~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVD--GPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP-IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEec--CCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeeecc
Confidence 467899999999998865 4788899999999999999987 356788888889999999999999875 239999999
Q ss_pred CcEEEeCCCCcEEEeccchhhhhcC--C-CCCccccCCCCcCCccccccC--------CCChhhHHHHHHHHHHHHhCCC
Q 012320 162 DNIFVNGHLGQVKIGDLGLAAILRG--S-KSAHSVIGTPEFMAPELYEED--------YNELVDVYSFGMCVLEMFTCEY 230 (466)
Q Consensus 162 ~NIlv~~~~g~vKL~DFGla~~~~~--~-~~~~~~~GT~~y~APE~l~~~--------y~~~~DIwSlGvil~elltg~~ 230 (466)
.|.+++... .+||+|||+...... . .......-...|.|||++... .+.+.||||+|++++|+++...
T Consensus 78 ~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 78 SNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred ccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999874 899999999876532 0 111111223569999988643 4677999999999999999999
Q ss_pred CCCCC---CCHHHHHHHHhc-CCCC--CCCC-C-CCCHHHHHHHHHhcc-CcCCCCCHHHHh
Q 012320 231 PYSEC---ANPAQIYKKVTS-GKLP--GAFY-S-IQDLEAQRFIGRCLV-NASKRLSAKELL 283 (466)
Q Consensus 231 Pf~~~---~~~~~i~~~i~~-g~~p--~~~~-~-~~~~~~~~lI~~~L~-dp~~Rpsa~elL 283 (466)
||... ..+.++...+.. +..+ +..+ . ...+++..++..|+. +|.+||+++++-
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 99652 233566666766 3321 1111 1 223368889999996 999999998773
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.2e-16 Score=145.64 Aligned_cols=140 Identities=22% Similarity=0.196 Sum_probs=99.1
Q ss_pred eeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHH---------------------HHHHHHHHHHhCCCC--
Q 012320 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQ---------------------RLYSEVHLLSTLKHD-- 89 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~---------------------~~~~Ei~iL~~l~Hp-- 89 (466)
.+.||+|+||+||+|.+. +|+.||+|+++....... .... ....|...+..+.+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFK-KRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchh-hhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 467999999999999987 899999998875432111 1111 113566677776443
Q ss_pred ceeEEEeEEEeccCCEEEEEEecCCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCCCCcEEEe
Q 012320 90 SIIRFYTSWIDVDQKTFNFITEMFTSGTLRE-YRKKYRRVDIRAIKSWARQILQGLVYLHS-RDPPVIHRDLKCDNIFVN 167 (466)
Q Consensus 90 nIv~l~~~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~l~~~~~~~i~~qIl~gL~yLHs-~~~~IiHrDLKp~NIlv~ 167 (466)
.+.+.+.. ...++||||++|+.+.. .+... ... ..++.++.+++.++.++|+ .+ |+||||||+||+++
T Consensus 80 ~~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~ 149 (187)
T cd05119 80 PVPKPIDL------NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD 149 (187)
T ss_pred CCCceEec------CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE
Confidence 34445442 12579999999854321 11111 111 6778899999999999999 88 99999999999999
Q ss_pred CCCCcEEEeccchhhhhcC
Q 012320 168 GHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 168 ~~~g~vKL~DFGla~~~~~ 186 (466)
+ +.++|+|||.+.....
T Consensus 150 -~-~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -D-GKVYIIDVPQAVEIDH 166 (187)
T ss_pred -C-CcEEEEECcccccccC
Confidence 4 7999999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.4e-15 Score=146.49 Aligned_cols=145 Identities=18% Similarity=0.219 Sum_probs=108.9
Q ss_pred eEEeeeeee-eeCceEEEEEEEcCCCeEEEEEEEecccc----cC-----CHHHHHHHHHHHHHHHhCCCCce--eEEEe
Q 012320 29 YGLFEEVLG-KGAMKTVYKAIDEVLGVEVAWNQVRLNEL----MR-----SPDDLQRLYSEVHLLSTLKHDSI--IRFYT 96 (466)
Q Consensus 29 Y~~~~~~LG-~G~fg~Vyka~~~~~g~~vAiK~i~~~~~----~~-----~~~~~~~~~~Ei~iL~~l~HpnI--v~l~~ 96 (466)
+..-+.+|| .|+.|+||++... +..+++|......+ .. +.....++.+|+.++.+|.|++| ++.+.
T Consensus 32 ~~~~~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~ 109 (239)
T PRK01723 32 WQQQARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIA 109 (239)
T ss_pred HhhcCceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEe
Confidence 333356788 8999999999664 78899998864321 11 11234678899999999988775 66665
Q ss_pred EEEeccCC--EEEEEEecCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcE
Q 012320 97 SWIDVDQK--TFNFITEMFTS-GTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQV 173 (466)
Q Consensus 97 ~~~~~~~~--~~~lV~E~~~g-gsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~v 173 (466)
........ ..++|||+++| .+|.+++.. ..+++.. +.||+.+|.+||+.| |+||||||+|||++.+ +.+
T Consensus 110 ~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~-~~v 181 (239)
T PRK01723 110 ARVVRHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLDPD-GKF 181 (239)
T ss_pred eeeeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEcCC-CCE
Confidence 43322221 23599999997 699988865 4566554 578999999999999 9999999999999876 799
Q ss_pred EEeccchhhh
Q 012320 174 KIGDLGLAAI 183 (466)
Q Consensus 174 KL~DFGla~~ 183 (466)
+|+|||.+..
T Consensus 182 ~LIDfg~~~~ 191 (239)
T PRK01723 182 WLIDFDRGEL 191 (239)
T ss_pred EEEECCCccc
Confidence 9999998865
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.3e-16 Score=163.63 Aligned_cols=255 Identities=21% Similarity=0.263 Sum_probs=198.7
Q ss_pred CceEEeeeeeee--eCceEEEEEEE--cCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEec
Q 012320 27 GRYGLFEEVLGK--GAMKTVYKAID--EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDV 101 (466)
Q Consensus 27 ~rY~~~~~~LG~--G~fg~Vyka~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 101 (466)
.++... +-+|. |.+|.||.+.. ..++..+|+|.-+.. ...+....+-++|+...+.+ .|+|.++.+..| .
T Consensus 114 ~~~~~~-~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p--~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~--e 188 (524)
T KOG0601|consen 114 QRFPIS-SRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP--FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW--E 188 (524)
T ss_pred hhcccc-cccccCCCCCceeecccCCcccCCcccccccccCC--CCCccccccccchhhcccccCccccccccCccc--c
Confidence 334443 44899 99999999988 899999999863211 22233344556677777777 599999999988 5
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEe
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKYRR-VDIRAIKSWARQILQ----GLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIG 176 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~~~-l~~~~~~~i~~qIl~----gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~ 176 (466)
+.+..++-+|+| |.+|..+...... +++..++.++.+... ||..+|+.+ ++|-|+||+||++..+....+++
T Consensus 189 ~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 189 GSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred cCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecC
Confidence 567777888888 6889888876555 899999999999999 999999999 99999999999998774588999
Q ss_pred ccchhhhhcCCCCC------ccccCCCCcCCccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC
Q 012320 177 DLGLAAILRGSKSA------HSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL 250 (466)
Q Consensus 177 DFGla~~~~~~~~~------~~~~GT~~y~APE~l~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~ 250 (466)
|||+...+...... ....|..-|++||++++-++...||+|+|.++.+-.++-.++....+. -|..+..+.+
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--~W~~~r~~~i 343 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS--SWSQLRQGYI 343 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC--CccccccccC
Confidence 99998877544321 122577889999999999999999999999999999887776543221 2334445556
Q ss_pred CCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 251 PGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 251 p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
|..+-...+..+...+.+|+. +|..|++++.++.|+++...
T Consensus 344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 666655666677778888885 89999999999999999743
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.5e-16 Score=171.01 Aligned_cols=260 Identities=24% Similarity=0.362 Sum_probs=206.9
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecC
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMF 113 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~ 113 (466)
+-+-+|+++.++.+.-..+|...++|...+...... .+.+.+..+-.++-...+|-+++.+-.+ ......+++++|+
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~-~~~~s~r~~s~~~i~p~~P~v~~~~~s~--~~rsP~~L~~~~~ 886 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT-NDYESIRSKSNILITPRSPAVVRSFPSF--PCRSPLPLVGHYL 886 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhcc-ccccccCCccCccccCCCCceecccCCC--CCCCCcchhhHHh
Confidence 357889999999998888888888887655443222 2345555566666666778888877765 3356788999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc------CC
Q 012320 114 TSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR------GS 187 (466)
Q Consensus 114 ~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~------~~ 187 (466)
.|++|...+.+.+..+...++.++..+..+++|||+.. +.|||++|.|++.... |+.++.|||...... ..
T Consensus 887 ~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~-gh~~l~~~~t~~~vg~~~p~~~~ 963 (1205)
T KOG0606|consen 887 NGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYD-GHRPLTDFGTLSKVGLIPPTTDL 963 (1205)
T ss_pred ccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhccc-CCcccCccccccccccccCcCCc
Confidence 99999999988888999999999999999999999988 9999999999999866 899999998432110 00
Q ss_pred --------------------------CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q 012320 188 --------------------------KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQ 240 (466)
Q Consensus 188 --------------------------~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~ 240 (466)
.......||+.|.+||.+. ......+|+|++|++++|.++|..||.. ..+.+
T Consensus 964 sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na-~tpq~ 1042 (1205)
T KOG0606|consen 964 SGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA-ETPQQ 1042 (1205)
T ss_pred ccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC-cchhh
Confidence 0123467999999999665 5578889999999999999999999976 88899
Q ss_pred HHHHHhcCCCCCC-CCCCCCHHHHHHHHHhcc-CcCCCCCHH---HHhcCCCCCchhhhhccccc
Q 012320 241 IYKKVTSGKLPGA-FYSIQDLEAQRFIGRCLV-NASKRLSAK---ELLLDPFLASDEVKLLSKTK 300 (466)
Q Consensus 241 i~~~i~~g~~p~~-~~~~~~~~~~~lI~~~L~-dp~~Rpsa~---elL~hpf~~~~~~~~~~~~~ 300 (466)
+++.+..+..|-. -....+.++++++.++|. +|.+|..+. ++-.||||+...|..+....
T Consensus 1043 ~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q~ 1107 (1205)
T KOG0606|consen 1043 IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQK 1107 (1205)
T ss_pred hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccccccc
Confidence 9999988876533 234557799999999996 999999988 99999999999886554433
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.2e-14 Score=127.37 Aligned_cols=132 Identities=21% Similarity=0.134 Sum_probs=106.9
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCC--CceeEEEeEEEeccCCEEEEEEe
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH--DSIIRFYTSWIDVDQKTFNFITE 111 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~~~~lV~E 111 (466)
+.||+|.++.||++.... ..+++|....... ...+.+|+.+++.+.| .++.+++... ...+..++++|
T Consensus 4 ~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~--~~~~~~~~v~e 73 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD--EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASG--ESDGWSYLLME 73 (155)
T ss_pred eecccccccceEEEEecC--CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEc--CCCCccEEEEE
Confidence 569999999999998754 7899998753321 3568889999999976 5888888755 34567899999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-CCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 112 MFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRD-PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 112 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~-~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
|+.|+++..+ +......++.+++.+|.++|... .+++|+||+|+||+++.. +.++++|||.+..
T Consensus 74 ~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~-~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG-KILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC-cEEEEEecccccC
Confidence 9999887654 55677788999999999999852 239999999999999875 7999999998854
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.6e-13 Score=141.03 Aligned_cols=249 Identities=22% Similarity=0.184 Sum_probs=181.5
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEc-CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEecc
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDE-VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVD 102 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~-~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 102 (466)
+.+++..+.+ ||.|.|+.|+++.-. .++..|++|.+..... .......-..|+.+...+ .|.+++.++..|..
T Consensus 263 ~~~df~~v~~-i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-- 337 (524)
T KOG0601|consen 263 KLTDFGLVSK-ISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-- 337 (524)
T ss_pred ecCCcceeEE-ccCCccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccCCCCCCccc--
Confidence 4566666544 999999999988754 6788999997764332 222223446778777777 69999999999954
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
....|+=.|||.++++...+.-...+++...+....|++.++.++|+.. ++|+|+||+||++..+.+..+++|||.++
T Consensus 338 ~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 338 LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcccccccc
Confidence 3445588899999999877766677899999999999999999999999 99999999999998754688999999987
Q ss_pred hhcCCCCCccccCCCCcC-Ccccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 012320 183 ILRGSKSAHSVIGTPEFM-APELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259 (466)
Q Consensus 183 ~~~~~~~~~~~~GT~~y~-APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 259 (466)
.+.... ....++-.++ .+|++.+ .+..++|++|||.-+.+.+++.. +.. ....+..|..|..|..... .
T Consensus 416 ~~~~~~--~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~-ls~---~~~~~~~i~~~~~p~~~~~--~ 487 (524)
T KOG0601|consen 416 RLAFSS--GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP-LSE---SGVQSLTIRSGDTPNLPGL--K 487 (524)
T ss_pred ccceec--ccccccccccccchhhccccccccccccccccccccccccCcc-cCc---ccccceeeecccccCCCch--H
Confidence 532211 1122333444 3555543 47789999999999999988763 322 1223444566665543221 2
Q ss_pred HHHHHHHHHhc-cCcCCCCCHHHHhcCCCC
Q 012320 260 LEAQRFIGRCL-VNASKRLSAKELLLDPFL 288 (466)
Q Consensus 260 ~~~~~lI~~~L-~dp~~Rpsa~elL~hpf~ 288 (466)
.++..+.+.++ .++..|+++.++..|+-|
T Consensus 488 ~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 488 LQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 56777777776 489999999999888755
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.4e-12 Score=138.41 Aligned_cols=141 Identities=18% Similarity=0.181 Sum_probs=94.6
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccC-------------------------CH-----HHHHH------HH
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMR-------------------------SP-----DDLQR------LY 77 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~-------------------------~~-----~~~~~------~~ 77 (466)
+.||.|++|+||+|+.+.+|++||+|+++...... +. +..+. +.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 46999999999999999889999999987432000 00 11122 33
Q ss_pred HHHHHHHhC----CCCceeEEEeEEEeccCCEEEEEEecCCCCCHHHH--HHhcC----CCCHHHHHHHHHHHHHHHHHH
Q 012320 78 SEVHLLSTL----KHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY--RKKYR----RVDIRAIKSWARQILQGLVYL 147 (466)
Q Consensus 78 ~Ei~iL~~l----~HpnIv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~--l~~~~----~l~~~~~~~i~~qIl~gL~yL 147 (466)
+|+..+.++ .+.+.+.+-..+.+- ...-++||||+.|+.+.++ +.+.+ .+.+..+..++.|++
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------ 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------ 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH------
Confidence 444444444 233334333333221 2345699999999999874 33333 255556666677765
Q ss_pred HhCCCCeEeccCCCCcEEEeCCCC----cEEEeccchhhhhc
Q 012320 148 HSRDPPVIHRDLKCDNIFVNGHLG----QVKIGDLGLAAILR 185 (466)
Q Consensus 148 Hs~~~~IiHrDLKp~NIlv~~~~g----~vKL~DFGla~~~~ 185 (466)
..| ++|+|+||.||+++.+ | .++++|||++..+.
T Consensus 278 -~~G--ffHaDpHPGNIlv~~~-g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -RDG--FFHADMHPGNIFVSYD-PPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -hCC--eeeCCCChHHeEEecC-CCCCCeEEEEecceEEECC
Confidence 368 9999999999999876 5 89999999987654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.36 E-value=3.4e-12 Score=133.40 Aligned_cols=144 Identities=23% Similarity=0.171 Sum_probs=95.0
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHH------------------------------------HHHHH
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDD------------------------------------LQRLY 77 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~------------------------------------~~~~~ 77 (466)
+.||.|++|.||+|+.+ +|+.||||+.+......-..+ .-.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 46999999999999875 699999998754311000000 00244
Q ss_pred HHHHHHHhC----CCCceeEEEeEEEeccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 012320 78 SEVHLLSTL----KHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQ-GLVYLHSRD 151 (466)
Q Consensus 78 ~Ei~iL~~l----~HpnIv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~-gL~yLHs~~ 151 (466)
+|.+.+.++ +|.+-+.+-..+.+. ....++||||+.|++|.++.... ...+ ...++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 566655555 233223322222211 23357999999999998876532 1222 2344555555 467889999
Q ss_pred CCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 152 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 152 ~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
++|+|+||.||+++.+ |.++|+|||++..+.
T Consensus 278 --~~H~D~hPgNilv~~~-g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 --FFHADLHPGNIFVLKD-GKIIALDFGIVGRLS 308 (437)
T ss_pred --ceeCCCCcccEEECCC-CcEEEEeCCCeeECC
Confidence 9999999999999876 899999999986643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=5.9e-12 Score=113.85 Aligned_cols=128 Identities=20% Similarity=0.095 Sum_probs=92.9
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCcee-EEEeEEEeccCCEEEEEEec
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSII-RFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv-~l~~~~~~~~~~~~~lV~E~ 112 (466)
+.|+.|.++.||++... |..|++|....... .......|+.+++.+.+.+++ +++.. +.+ .-++|||+
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~--~~~lv~e~ 72 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYF--DPE--TGVLITEF 72 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEE--eCC--CCeEEEEe
Confidence 45899999999999764 88999998653221 123457799999988654443 44442 222 24689999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC---CeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 113 FTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDP---PVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 113 ~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~---~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
++|.++... . .....++.+++.+|..||+.+. .++|+|++|.||+++ + +.++++|||.+.
T Consensus 73 i~G~~l~~~-----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~-~~~~liDf~~a~ 135 (170)
T cd05151 73 IEGSELLTE-----D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D-GRLWLIDWEYAG 135 (170)
T ss_pred cCCCccccc-----c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C-CeEEEEeccccc
Confidence 999887643 1 1123457899999999999872 159999999999998 3 689999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.5e-11 Score=110.11 Aligned_cols=142 Identities=15% Similarity=0.132 Sum_probs=100.9
Q ss_pred eeeeeeCceEEEEEEEcC------CCeEEEEEEEecccc--cC----------------CHHHHHHH----HHHHHHHHh
Q 012320 34 EVLGKGAMKTVYKAIDEV------LGVEVAWNQVRLNEL--MR----------------SPDDLQRL----YSEVHLLST 85 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~------~g~~vAiK~i~~~~~--~~----------------~~~~~~~~----~~Ei~iL~~ 85 (466)
-.||.|-=+.||.|.... .+..+|+|+.+.... .. .......+ .+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 358999999999998653 358999998764221 00 01112223 389999999
Q ss_pred CC--CCceeEEEeEEEeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeEeccCCCC
Q 012320 86 LK--HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYL-HSRDPPVIHRDLKCD 162 (466)
Q Consensus 86 l~--HpnIv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yL-Hs~~~~IiHrDLKp~ 162 (466)
+. .-++.+.+.. ..-++||||+.+..+....-+...+++..+..+..|++.+|..| |..| |+|+||+|.
T Consensus 83 l~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence 84 3455555542 12458999997754432222234566677788899999999999 8999 999999999
Q ss_pred cEEEeCCCCcEEEeccchhhhhc
Q 012320 163 NIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 163 NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
||++.. |.+.|+|||.+....
T Consensus 155 NIL~~~--~~v~iIDF~qav~~~ 175 (197)
T cd05146 155 NMLWHD--GKVWFIDVSQSVEPT 175 (197)
T ss_pred HEEEEC--CcEEEEECCCceeCC
Confidence 999974 689999999886544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=6e-11 Score=124.93 Aligned_cols=169 Identities=22% Similarity=0.294 Sum_probs=126.3
Q ss_pred EEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecCCCCCHHHHHHhc
Q 012320 46 KAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKY 125 (466)
Q Consensus 46 ka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~ 125 (466)
.|..+.++.+|.+...+... ....+...+-++.|+.++||||+++++.+ +..+++|+|+|-+. .|..++++.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~----~~~~~~~~~A~k~lKtlRHP~Il~yL~t~--e~~~~~ylvTErV~--Pl~~~lk~l 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSN----GEVTELAKRAVKRLKTLRHPNILSYLDTT--EEEGTLYLVTERVR--PLETVLKEL 101 (690)
T ss_pred ccceeccCCceEEEEEeCCC----chhhHHHHHHHHHhhhccCchhhhhhhhh--cccCceEEEeeccc--cHHHHHHHh
Confidence 57778899999998776432 23456678889999999999999999988 44668999999874 566777654
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCC-CccccCCCCcCCccc
Q 012320 126 RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS-AHSVIGTPEFMAPEL 204 (466)
Q Consensus 126 ~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~-~~~~~GT~~y~APE~ 204 (466)
+ ...+.--+.||+.||.+||.. +.++|++|.-+.|+|+.. |..||++|.++....+... .....---.|..|+.
T Consensus 102 ~---~~~v~~Gl~qIl~AL~FL~~d-~~lvHgNv~~~SVfVn~~-GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 102 G---KEEVCLGLFQILAALSFLNDD-CNLVHGNVCKDSVFVNES-GEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEE 176 (690)
T ss_pred H---HHHHHHHHHHHHHHHHHHhcc-CCeeeccEeeeeEEEcCC-CcEEEeeeEEEeccccCCcccccchhhhcccChhh
Confidence 4 666777799999999999844 239999999999999987 9999999998865433221 111111123455554
Q ss_pred cccCCCChhhHHHHHHHHHHHHhC
Q 012320 205 YEEDYNELVDVYSFGMCVLEMFTC 228 (466)
Q Consensus 205 l~~~y~~~~DIwSlGvil~elltg 228 (466)
+... .-..|.|-|||++++++.|
T Consensus 177 ~~~s-~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPS-EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCcc-ccchhhhhHHHHHHHHhCc
Confidence 3321 1346999999999999988
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2e-09 Score=97.67 Aligned_cols=131 Identities=21% Similarity=0.339 Sum_probs=96.0
Q ss_pred eeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHH-----HHHHHHHHHHHHHhCCC--CceeEEEeEEEeccCCEEE
Q 012320 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPD-----DLQRLYSEVHLLSTLKH--DSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 35 ~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~-----~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~~~~ 107 (466)
.+++|+=+.+|.+.. -|..+.+|. +..+.-+.+. ..++..+|.++|.++.- -+...+|+ ++ .....
T Consensus 3 ~i~~GAEa~i~~~~~--~g~~av~K~-Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~d--vD--~~~~~ 75 (204)
T COG3642 3 LIKQGAEAIIYLTDF--LGLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYD--VD--PDNGL 75 (204)
T ss_pred hhhCCcceeEEeeec--cCcceEEEe-ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEE--Ec--CCCCE
Confidence 578999999999844 355555553 3333333332 23567789999998843 33444554 33 44456
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
++|||++|..|.+++... ...+++.+=.-+.-||..| |+|+||.++||++.+. .+.++||||+..
T Consensus 76 I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~--~i~~IDfGLg~~ 140 (204)
T COG3642 76 IVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGG--RIYFIDFGLGEF 140 (204)
T ss_pred EEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCC--cEEEEECCcccc
Confidence 899999999999998865 2456777777788999999 9999999999999864 599999999964
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=6.9e-10 Score=104.43 Aligned_cols=145 Identities=19% Similarity=0.236 Sum_probs=104.7
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCC--CceeEEEeEEEecc-CCEEEEEE
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH--DSIIRFYTSWIDVD-QKTFNFIT 110 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~-~~~~~lV~ 110 (466)
+.||.|.++.||++.... |..+++|........ .....+..|+.+++.+.+ .++.+++....... .+..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 458999999999997653 688999986543321 123567889999999865 34555665431111 13568999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 012320 111 EMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRD--------------------------------------- 151 (466)
Q Consensus 111 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~--------------------------------------- 151 (466)
|+++|.++.+.+.. ..+++.....++.+++.+|..||+..
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999988765432 45777788888888888888888531
Q ss_pred ---------------CCeEeccCCCCcEEEeCC-CCcEEEeccchhhh
Q 012320 152 ---------------PPVIHRDLKCDNIFVNGH-LGQVKIGDLGLAAI 183 (466)
Q Consensus 152 ---------------~~IiHrDLKp~NIlv~~~-~g~vKL~DFGla~~ 183 (466)
..++|+|+.|.||+++.+ .+.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 237999999999999873 25789999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.05 E-value=6.6e-09 Score=106.71 Aligned_cols=214 Identities=17% Similarity=0.229 Sum_probs=152.5
Q ss_pred CceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec--cCCEEEEEEecCCC-C
Q 012320 40 AMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV--DQKTFNFITEMFTS-G 116 (466)
Q Consensus 40 ~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~~~lV~E~~~g-g 116 (466)
.-.+.|||....+|..|+.|++.-.+. +++ .....-+++++++.|+|||.+.++|... +...+.+|++|+++ +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~-~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRD-QST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccc-cCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 445789999999999999999843332 122 1234467789999999999999988632 35678999999875 6
Q ss_pred CHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 117 TLREYRK---------------KYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 117 sL~~~l~---------------~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
+|.++-- .....+|..++.|+.||..||.++|+.| +.-+-|.|.+|+++++ -.++|...|..
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~-~RIriS~C~i~ 440 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGK-MRIRISGCGIM 440 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCc-ceEEEecccce
Confidence 7776531 1234788999999999999999999999 8889999999999987 38888888877
Q ss_pred hhhcCCCCCccccCCCCcCCccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHhcCCCCCCCCCCCCH
Q 012320 182 AILRGSKSAHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQI-YKKVTSGKLPGAFYSIQDL 260 (466)
Q Consensus 182 ~~~~~~~~~~~~~GT~~y~APE~l~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i-~~~i~~g~~p~~~~~~~~~ 260 (466)
..+.... . |.+++ ..+-|.=-||.+++.|+||..--.......+. .+.| ....+.
T Consensus 441 Dvl~~d~-----------~--~~le~--~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I---------~~~yS~ 496 (655)
T KOG3741|consen 441 DVLQEDP-----------T--EPLES--QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI---------TTTYST 496 (655)
T ss_pred eeecCCC-----------C--cchhH--HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh---------hhhhhH
Confidence 6554433 0 11111 13457888999999999985432111222222 2222 234567
Q ss_pred HHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 261 EAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 261 ~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
+++++|.-+.. ++.+ .+..+++.+
T Consensus 497 D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 497 DLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 89999988885 5655 778888743
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.5e-09 Score=95.16 Aligned_cols=143 Identities=22% Similarity=0.268 Sum_probs=101.9
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCH-----HHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEE
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSP-----DDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNF 108 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~l 108 (466)
.+|-+|+-+.|+++. ..|+.+.||.=..+.. +.+ -...+..+|+++|.++.--.|.----.|++...+. +
T Consensus 13 ~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~Y-RHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~--i 87 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGS--FSGEAAIIKERFSKRY-RHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQ--I 87 (229)
T ss_pred eeeeccceeeEeeec--cCCceeEEeecccccc-cchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCe--E
Confidence 568899999999995 4588888885333332 222 13467889999999985333322222234444444 6
Q ss_pred EEecCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCc--EEEeccchhhh
Q 012320 109 ITEMFTS-GTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQ--VKIGDLGLAAI 183 (466)
Q Consensus 109 V~E~~~g-gsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~--vKL~DFGla~~ 183 (466)
+|||+.| .++.+++.... .........++++|=..+.-||..+ |||+||..+||++.++.+. +-++|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhc
Confidence 7899977 47888887642 2333334788999999999999999 9999999999999877444 48999999854
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.4e-10 Score=121.24 Aligned_cols=244 Identities=18% Similarity=0.197 Sum_probs=168.0
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCc-eeEEEeEEEec
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDS-IIRFYTSWIDV 101 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~ 101 (466)
.|++--|.-|.+ +++|++++++|.+...+...+ .+.+... ....-++++|.+++||| .+..++.+ +
T Consensus 238 kDk~kws~~fh~-fvK~altknpKkRptaeklL~-h~fvs~~---------l~~rl~~eLLdK~n~P~~~v~~~~d~--~ 304 (829)
T KOG0576|consen 238 KDKTKWSEFFHN-FVKGALTKNPKKRPTAEKLLQ-HPFVSQT---------LSRRLAIELLDKVNNPNPVVRYLEDY--D 304 (829)
T ss_pred cCCccchHHHHH-HHHHHhcCCCccCCChhhhee-ceeeccc---------hhhHHHHHHHHHccCCCCcccccccC--C
Confidence 556666666666 899999999999877665555 5655422 34566899999999999 66666644 4
Q ss_pred cCCEEEEEEecCCCC-CHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 102 DQKTFNFITEMFTSG-TLREYR-KKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 102 ~~~~~~lV~E~~~gg-sL~~~l-~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
.+.+.+++++++.++ +-.... ...-.+.+-+...+++.-.++|+|+|+.. -+||| ||+... +..|.+||+
T Consensus 305 ~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~--~~~~~~~~~ 376 (829)
T KOG0576|consen 305 GEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE--EEVKLLDFA 376 (829)
T ss_pred cccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc--ccccccccc
Confidence 467888999999877 222111 11122444556667788889999999885 58888 887764 689999999
Q ss_pred hhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC--C
Q 012320 180 LAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFY--S 256 (466)
Q Consensus 180 la~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~--~ 256 (466)
....+...-...+..+|+.++|||+.. +.+....|.|++|+-..+|.-|..|-.. +......+-.|.-.+.+. .
T Consensus 377 v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~---P~~~~~~~g~~p~s~~L~~~~ 453 (829)
T KOG0576|consen 377 VPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS---PPAVLPMIGNGPNSPMLTDKS 453 (829)
T ss_pred CCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC---CccccCCCCCCCCccccchhh
Confidence 998887665677889999999999665 5699999999999888888877777543 111111111111000000 0
Q ss_pred CCCH-HHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 257 IQDL-EAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 257 ~~~~-~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
..++ .-+++...|+. -|..|+.+..++.|.+|..
T Consensus 454 aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 454 AWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred hcCcccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 0111 22347778885 7889999999998888864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=7.9e-08 Score=96.77 Aligned_cols=233 Identities=16% Similarity=0.218 Sum_probs=153.3
Q ss_pred eeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeE--------EEeEEEecc
Q 012320 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIR--------FYTSWIDVD 102 (466)
Q Consensus 32 ~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~--------l~~~~~~~~ 102 (466)
.+.-||+|+-+.+|-.- +-+..| .|+...... .. ..+.+..|... .||-+-. +|+. ..
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~V-AKIYh~Ppp----a~---~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~---~~ 81 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQV-AKIYHAPPP----AA---QAQKVAELAATPDAPLLNYRVAWPQATLHGG---RR 81 (637)
T ss_pred CCccccCCccceeeecc--hhhchh-heeecCCCc----hH---HHHHHHHhccCCCCcchhhhhcccHHHhhCC---Cc
Confidence 45569999999999762 223333 355542221 11 12233344443 6664433 2221 12
Q ss_pred CCEEEEEEecCCCCC-HHHHH------HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEE
Q 012320 103 QKTFNFITEMFTSGT-LREYR------KKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKI 175 (466)
Q Consensus 103 ~~~~~lV~E~~~ggs-L~~~l------~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL 175 (466)
...+-|+|..+.|.. +.++. +.+...+...+.+..+.|+.+..-||.+| ..-+|+.++|+||... +.|.|
T Consensus 82 ~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~-~~V~L 158 (637)
T COG4248 82 GKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDD-SKVVL 158 (637)
T ss_pred cceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecC-ceEEE
Confidence 334778898887752 22222 23355788889999999999999999999 8889999999999876 89999
Q ss_pred eccchhhhhcCCCCCccccCCCCcCCccccc-c-----CCCChhhHHHHHHHHHHHHhC-CCCCCCCC----CHHHHHHH
Q 012320 176 GDLGLAAILRGSKSAHSVIGTPEFMAPELYE-E-----DYNELVDVYSFGMCVLEMFTC-EYPYSECA----NPAQIYKK 244 (466)
Q Consensus 176 ~DFGla~~~~~~~~~~~~~GT~~y~APE~l~-~-----~y~~~~DIwSlGvil~elltg-~~Pf~~~~----~~~~i~~~ 244 (466)
.|-..-....++......+|.++|.+||.-. . .-+...|-|.||+++++++.| ..||++-. .+......
T Consensus 159 VdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 159 VDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred EcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 9865443334445556778999999999654 2 245779999999999999986 89997521 11111123
Q ss_pred HhcCCC-----------C---CCCCCCCCHHHHHHHHHhcc---CcCCCCCHH
Q 012320 245 VTSGKL-----------P---GAFYSIQDLEAQRFIGRCLV---NASKRLSAK 280 (466)
Q Consensus 245 i~~g~~-----------p---~~~~~~~~~~~~~lI~~~L~---dp~~Rpsa~ 280 (466)
|..|.+ | ...+....+.++.+..+|+. .+.-|||++
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 333332 2 12345567789999999995 466899986
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.2e-07 Score=91.00 Aligned_cols=107 Identities=18% Similarity=0.136 Sum_probs=79.4
Q ss_pred HHHHHHHHHHhCC-----CCceeEEEeEEEeccCCEEEEEEecCCCC-CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHH
Q 012320 75 RLYSEVHLLSTLK-----HDSIIRFYTSWIDVDQKTFNFITEMFTSG-TLREYRKK--YRRVDIRAIKSWARQILQGLVY 146 (466)
Q Consensus 75 ~~~~Ei~iL~~l~-----HpnIv~l~~~~~~~~~~~~~lV~E~~~gg-sL~~~l~~--~~~l~~~~~~~i~~qIl~gL~y 146 (466)
.+.+|...+..|. -|.+|-+...-.......-+||||++++. +|.+++.. ....+......++.++...+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 3678888887773 34444443211111123567999999886 89998864 2456677888999999999999
Q ss_pred HHhCCCCeEeccCCCCcEEEeC------CCCcEEEeccchhhh
Q 012320 147 LHSRDPPVIHRDLKCDNIFVNG------HLGQVKIGDLGLAAI 183 (466)
Q Consensus 147 LHs~~~~IiHrDLKp~NIlv~~------~~g~vKL~DFGla~~ 183 (466)
||..| |+|+||++.|||++. +.+.+.|+||+.+..
T Consensus 154 LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 154 MHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99999 999999999999974 235899999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=8.6e-08 Score=88.79 Aligned_cols=129 Identities=25% Similarity=0.253 Sum_probs=82.3
Q ss_pred EEEEEEEcCCCeEEEEEEEeccccc----------------------CCHHHHHHHHHHHHHHHhCCCC--ceeEEEeEE
Q 012320 43 TVYKAIDEVLGVEVAWNQVRLNELM----------------------RSPDDLQRLYSEVHLLSTLKHD--SIIRFYTSW 98 (466)
Q Consensus 43 ~Vyka~~~~~g~~vAiK~i~~~~~~----------------------~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~~ 98 (466)
.||.|... .|..+|+|+.+..... ...-......+|.+.|+.+..- ++.+.+..
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 38888764 5889999987653110 0011235678899999999654 45666642
Q ss_pred EeccCCEEEEEEecCC--CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCCCeEeccCCCCcEEEeCCCCcEEE
Q 012320 99 IDVDQKTFNFITEMFT--SGTLREYRKKYRRVDIRAIKSWARQILQGLVY-LHSRDPPVIHRDLKCDNIFVNGHLGQVKI 175 (466)
Q Consensus 99 ~~~~~~~~~lV~E~~~--ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~y-LHs~~~~IiHrDLKp~NIlv~~~~g~vKL 175 (466)
. ++ .+||||+. |..+..+... .++......++.+++..+.. +|..| |+|+||.+.||+++.+ .+.|
T Consensus 79 -~--~~--~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~--~~~i 147 (188)
T PF01163_consen 79 -N--RN--VIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG--KVYI 147 (188)
T ss_dssp -E--TT--EEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT--CEEE
T ss_pred -e--CC--EEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc--eEEE
Confidence 1 22 49999998 6666543332 22245566778888886655 57889 9999999999999864 8999
Q ss_pred eccchhhhh
Q 012320 176 GDLGLAAIL 184 (466)
Q Consensus 176 ~DFGla~~~ 184 (466)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.1e-07 Score=105.86 Aligned_cols=206 Identities=24% Similarity=0.349 Sum_probs=148.5
Q ss_pred HHHHHHHHHHHHHhCCCCceeEEEeEEEeccC-C-EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 012320 72 DLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ-K-TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHS 149 (466)
Q Consensus 72 ~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~-~-~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs 149 (466)
++.....|...+..+.|+|++.++.+-..... + ...+..|+|+.-++...+..-+.++...++.+..++++||.|+|+
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 44455667777888899999999876543221 2 233456889999999999999999999999999999999999999
Q ss_pred CCCCeEeccCCCC---cEEEeCCCCcEEEe--ccchhhhhcCCCCCccccCCCCcCCccccccC-C--CChhhHHHHHHH
Q 012320 150 RDPPVIHRDLKCD---NIFVNGHLGQVKIG--DLGLAAILRGSKSAHSVIGTPEFMAPELYEED-Y--NELVDVYSFGMC 221 (466)
Q Consensus 150 ~~~~IiHrDLKp~---NIlv~~~~g~vKL~--DFGla~~~~~~~~~~~~~GT~~y~APE~l~~~-y--~~~~DIwSlGvi 221 (466)
.. ..|.-|... +.-+++. +.+.+. ||+....+..........-+..+.|||.+..+ + ....|+|++|..
T Consensus 305 ~~--l~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 305 LS--LEHVVLSASSSKESTVDGE-GVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred hc--cceeEEecccccccccCcc-ceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 86 666655554 3334444 566666 88888776655555555667778889877644 3 344699999999
Q ss_pred HHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC-HHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 222 VLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD-LEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 222 l~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~-~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
...+..|..+-.....+. .+....+ .+..++..+|+. ++++|+++.+++.|||......
T Consensus 382 ~~~~~~~~~i~~~~~~~~-------------~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~ 442 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAVPV-------------SLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTD 442 (1351)
T ss_pred HhhhhhcCcccccccchh-------------hhhccccchhhhhhhhhhcchhhhhccchhhhhhchhcccccc
Confidence 999998876543211111 1111111 167788889995 8999999999999999976443
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.3e-08 Score=104.91 Aligned_cols=151 Identities=19% Similarity=0.291 Sum_probs=105.8
Q ss_pred HHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCC----------ccccCCCCcCCcccccc-C
Q 012320 140 ILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA----------HSVIGTPEFMAPELYEE-D 208 (466)
Q Consensus 140 Il~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~----------~~~~GT~~y~APE~l~~-~ 208 (466)
...|+.|+|.+ +.++|+.|.|++|.++.. |..||+.|+.+....+.... ....-...|.|||++.. .
T Consensus 108 v~dgl~flh~s-Ak~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 108 VADGLAFLHRS-AKVVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred ccchhhhhccC-cceeecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 33899999987 459999999999999987 89999999988655442110 11124568999997764 4
Q ss_pred CCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcC--CCC-CCCCCCCCHHHHHHHHHhc-cCcCCCCCHHHHh
Q 012320 209 YNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSG--KLP-GAFYSIQDLEAQRFIGRCL-VNASKRLSAKELL 283 (466)
Q Consensus 209 y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g--~~p-~~~~~~~~~~~~~lI~~~L-~dp~~Rpsa~elL 283 (466)
-+.++|++|+||++|-+.. |..-+.. .+.... .....+ ..+ .........++++=+.++| .++..||++.+++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a-~~~~~~-~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAA-NGGLLS-YSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhc-cCCcch-hhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 6788999999999998884 4444433 221212 222211 111 1122445668888888888 4999999999999
Q ss_pred cCCCCCchhhh
Q 012320 284 LDPFLASDEVK 294 (466)
Q Consensus 284 ~hpf~~~~~~~ 294 (466)
..|||.....+
T Consensus 264 ~~~ff~D~~~~ 274 (700)
T KOG2137|consen 264 SIPFFSDPGLK 274 (700)
T ss_pred cccccCCchhh
Confidence 99999875443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.5e-06 Score=81.81 Aligned_cols=108 Identities=19% Similarity=0.218 Sum_probs=82.3
Q ss_pred HHHHHHHHHHHHhCC-----CCceeEEEeEEEeccCCEEEEEEecCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 012320 73 LQRLYSEVHLLSTLK-----HDSIIRFYTSWIDVDQKTFNFITEMFTSG-TLREYRKKYRRVDIRAIKSWARQILQGLVY 146 (466)
Q Consensus 73 ~~~~~~Ei~iL~~l~-----HpnIv~l~~~~~~~~~~~~~lV~E~~~gg-sL~~~l~~~~~l~~~~~~~i~~qIl~gL~y 146 (466)
..+..+|...+..|. -|..+-+...- .......++|+|+++|. +|.+++......+......++.++...+.-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r-~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERR-KGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEc-CCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence 356778888777763 34444433210 01123457999999884 899999876668888889999999999999
Q ss_pred HHhCCCCeEeccCCCCcEEEeCCC--CcEEEeccchhhh
Q 012320 147 LHSRDPPVIHRDLKCDNIFVNGHL--GQVKIGDLGLAAI 183 (466)
Q Consensus 147 LHs~~~~IiHrDLKp~NIlv~~~~--g~vKL~DFGla~~ 183 (466)
||..| |+|+|++|.|||++.+. ..+.++||+.+..
T Consensus 134 lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999 99999999999998762 1689999997754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=3.3e-07 Score=88.12 Aligned_cols=142 Identities=23% Similarity=0.248 Sum_probs=100.5
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEeccc-----ccCCH-------------HHHHHHHHHHHHHHhCCC
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNE-----LMRSP-------------DDLQRLYSEVHLLSTLKH 88 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~-----~~~~~-------------~~~~~~~~Ei~iL~~l~H 88 (466)
+-+..++..||-|-=+.||.|.+. .|.++|+|.-+.-. +.... -......+|.++|..|.-
T Consensus 90 ~~ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~ 168 (304)
T COG0478 90 GIVEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP 168 (304)
T ss_pred ChHHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence 334557888999999999999887 59999999654321 11111 123456789999999954
Q ss_pred C--ceeEEEeEEEeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEE
Q 012320 89 D--SIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFV 166 (466)
Q Consensus 89 p--nIv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv 166 (466)
. .|.+-++ .+.-.+|||++.|-.|.... ++...+..++..|+.-+.-+-..| |+|+|+++-||++
T Consensus 169 ~G~~VP~P~~------~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV 235 (304)
T COG0478 169 EGVKVPKPIA------WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILV 235 (304)
T ss_pred cCCCCCCccc------cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEE
Confidence 3 5655554 23456899999998876532 234445555556665555555677 9999999999999
Q ss_pred eCCCCcEEEeccchhhh
Q 012320 167 NGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 167 ~~~~g~vKL~DFGla~~ 183 (466)
+.+ |.+.++||-.+..
T Consensus 236 ~~d-g~~~vIDwPQ~v~ 251 (304)
T COG0478 236 TED-GDIVVIDWPQAVP 251 (304)
T ss_pred ecC-CCEEEEeCccccc
Confidence 987 8999999987644
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.48 E-value=3.1e-06 Score=79.39 Aligned_cols=140 Identities=14% Similarity=0.136 Sum_probs=98.1
Q ss_pred eeeCceEEEEEEEcCCCeEEEEEEEec--ccccCCHHHHHHHHHHHHHHHhCCC-----CceeEEEeEEEeccCCEEEEE
Q 012320 37 GKGAMKTVYKAIDEVLGVEVAWNQVRL--NELMRSPDDLQRLYSEVHLLSTLKH-----DSIIRFYTSWIDVDQKTFNFI 109 (466)
Q Consensus 37 G~G~fg~Vyka~~~~~g~~vAiK~i~~--~~~~~~~~~~~~~~~Ei~iL~~l~H-----pnIv~l~~~~~~~~~~~~~lV 109 (466)
|+||-+.|+..... |..+=+|+-.. .....-+--...+.+|+..|++|.. |-++ +.+.--....-.-+||
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 56888889887543 44677776431 1111113345789999999998842 3333 2221111112346789
Q ss_pred EecCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCc--EEEeccchhh
Q 012320 110 TEMFTS-GTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQ--VKIGDLGLAA 182 (466)
Q Consensus 110 ~E~~~g-gsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~--vKL~DFGla~ 182 (466)
+|-+.| .+|.+++... .+.+......++.++...|.-||+.| +.|+|+-+.|||++.+ |. ++++||.-+.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~-g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTE-GKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCC-CCeeEEEEEhhccc
Confidence 997754 6898888663 45678888899999999999999999 9999999999999855 55 9999998654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.31 E-value=2.3e-05 Score=73.76 Aligned_cols=141 Identities=21% Similarity=0.232 Sum_probs=80.3
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCC--ceeEEEeEEEe-ccCCEEEEEE
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHD--SIIRFYTSWID-VDQKTFNFIT 110 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~~~~-~~~~~~~lV~ 110 (466)
+.|+.|..+.||++.... ..+++|.... ......+.+|+.+++.+... .+.+++..... ......+++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~~------~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD--GRYVLKFYRP------PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEESSSSEEEEEEETT--SEEEEEEESS------HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC--cEEEEEEeCC------CCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 458999999999998765 4888897542 23456778899998888422 34455542222 2244678999
Q ss_pred ecCCCCCHHH----------------HHHh---c--C--CCCHH------HHHH---H------------HHHHHH-HHH
Q 012320 111 EMFTSGTLRE----------------YRKK---Y--R--RVDIR------AIKS---W------------ARQILQ-GLV 145 (466)
Q Consensus 111 E~~~ggsL~~----------------~l~~---~--~--~l~~~------~~~~---i------------~~qIl~-gL~ 145 (466)
++++|..+.. .+.+ . . .+... .... . ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999998877 1111 1 0 00000 0000 0 111122 233
Q ss_pred HHHh-----CCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 146 YLHS-----RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 146 yLHs-----~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
.++. ....++|+|+.|.||+++...+.+.|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3332 223499999999999999333677899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.1e-05 Score=77.04 Aligned_cols=134 Identities=13% Similarity=0.120 Sum_probs=77.3
Q ss_pred eeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCc--eeEEEeEEEeccCCEEEEEEec
Q 012320 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDS--IIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 35 ~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~~~~~~~~~~lV~E~ 112 (466)
.||+|..+.||+. .|..+++|...... ....+.+|.++++.+..-. +.+.+... .+.+...+|||+
T Consensus 8 ~i~~G~t~~~y~~----~~~~~VlR~~~~~~------~~~~i~~E~~~l~~l~~~glpvP~~~~~~--~~~~~~glv~e~ 75 (226)
T TIGR02172 8 QTGEGGNGESYTH----KTGKWMLKLYNPGF------DKETIKREFDASRKVFSLGIPTPHPFDLV--EDGGRLGLIYEL 75 (226)
T ss_pred eecCCCCcceeEe----cCCCEEEEeCCCCC------CHHHHHHHHHHHHHHHHcCCCCCceEEEE--ecCCeeeeeeee
Confidence 4899999999984 25567788754211 2245688999998874322 34444432 345567889999
Q ss_pred CCCCC-HH--------------HHHHh----cC-----CCCHH-HHHHHHHHH----------HHH-HHHH--HhCCCCe
Q 012320 113 FTSGT-LR--------------EYRKK----YR-----RVDIR-AIKSWARQI----------LQG-LVYL--HSRDPPV 154 (466)
Q Consensus 113 ~~ggs-L~--------------~~l~~----~~-----~l~~~-~~~~i~~qI----------l~g-L~yL--Hs~~~~I 154 (466)
+.|.. +. ..+.+ -. ..+.. ....+..++ ... ..+| +...+.+
T Consensus 76 i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~ 155 (226)
T TIGR02172 76 IVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC 155 (226)
T ss_pred cCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence 99863 11 11110 00 11111 011111111 111 1122 2223448
Q ss_pred EeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 155 IHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 155 iHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
+|+|+.|.||+++.+ + +.|+||+.+.
T Consensus 156 ~HgD~~~~Nii~~~~-~-~~iIDwe~a~ 181 (226)
T TIGR02172 156 LHGDFQIGNLITSGK-G-TYWIDLGDFG 181 (226)
T ss_pred EecCCCCCcEEEcCC-C-cEEEechhcC
Confidence 999999999999875 5 9999999774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.20 E-value=5.9e-06 Score=87.68 Aligned_cols=151 Identities=17% Similarity=0.187 Sum_probs=93.5
Q ss_pred CCceEEee-eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccC-------------------------CH-H----HHH
Q 012320 26 NGRYGLFE-EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMR-------------------------SP-D----DLQ 74 (466)
Q Consensus 26 ~~rY~~~~-~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~-------------------------~~-~----~~~ 74 (466)
...|..|+ +-|+.++-|.||+|+.+. |++||||+.+...... +. . -.+
T Consensus 122 ee~F~eF~~~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 122 EELFSEFEPEPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred HHHHHHcCCCchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 34455555 669999999999999876 9999999875421100 00 0 011
Q ss_pred ------HHHHHHHHHHhC-----CCCceeEEEeEEEeccCCEEEEEEecCCCCCHHHH--HHhcCCCCHHHHHHHHHHHH
Q 012320 75 ------RLYSEVHLLSTL-----KHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY--RKKYRRVDIRAIKSWARQIL 141 (466)
Q Consensus 75 ------~~~~Ei~iL~~l-----~HpnIv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~--l~~~~~l~~~~~~~i~~qIl 141 (466)
.+.+|...+.++ +.|+|. +=..+.+-. ..-.++|||+.|-.+.+. ++. ..++.+.+.....++.
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~-VP~V~we~t-~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f 277 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVY-VPKVYWEYT-TRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF 277 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeE-eceeehhcc-CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH
Confidence 234455555544 234332 222222212 234589999999999887 444 4556444433333332
Q ss_pred HHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 142 QGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 142 ~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
. .-+=..| +.|.|..|.||+++.+ |.+.+.|||+...+.
T Consensus 278 ~--~q~~~dg--ffHaDpHpGNi~v~~~-g~i~~lDfGi~g~l~ 316 (517)
T COG0661 278 L--RQLLRDG--FFHADPHPGNILVRSD-GRIVLLDFGIVGRLD 316 (517)
T ss_pred H--HHHHhcC--ccccCCCccceEEecC-CcEEEEcCcceecCC
Confidence 2 1111257 9999999999999988 999999999886654
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.98 E-value=7.2e-07 Score=101.43 Aligned_cols=161 Identities=14% Similarity=0.022 Sum_probs=124.3
Q ss_pred HHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH
Q 012320 72 DLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKY----RRVDIRAIKSWARQILQGLVYL 147 (466)
Q Consensus 72 ~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qIl~gL~yL 147 (466)
..+....|...++...|+++...+..........-|.+++++.+|.+++.+.+. ..++..-+.....+.+.+..-+
T Consensus 1272 lkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ 1351 (2724)
T KOG1826|consen 1272 LKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVI 1351 (2724)
T ss_pred HHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchh
Confidence 345566777777788999999998876555566788999999999999988654 3455555655566657777777
Q ss_pred HhC---CCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC-CCCccccCCCCcCCcccccc-CCCChhhHHHHHHHH
Q 012320 148 HSR---DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-KSAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCV 222 (466)
Q Consensus 148 Hs~---~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil 222 (466)
|+. |--.+|++||+-|.++..+ -.+|++++|+.+...+. ......+++|.|++|++..+ .++.++|+|+.|+.+
T Consensus 1352 ls~tnlg~T~v~~~Lkf~lpmIVtn-y~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1352 LSLTNLGNTNVSKSLKFTLPMIVTN-YNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSL 1430 (2724)
T ss_pred hhcccCCccchhhhhhhhccceecC-CcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHH
Confidence 754 2337999999999999988 48999999999844332 22345678899999998775 588889999999999
Q ss_pred HHHHhCCCCCC
Q 012320 223 LEMFTCEYPYS 233 (466)
Q Consensus 223 ~elltg~~Pf~ 233 (466)
|...-|..+|-
T Consensus 1431 y~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1431 YLRSDGNAYFI 1441 (2724)
T ss_pred HHHhcccHHHH
Confidence 99988877763
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.97 E-value=7.9e-05 Score=71.65 Aligned_cols=74 Identities=14% Similarity=0.035 Sum_probs=47.4
Q ss_pred eeeeCc-eEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEeEEEeccCCEEEEEEecC
Q 012320 36 LGKGAM-KTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYTSWIDVDQKTFNFITEMF 113 (466)
Q Consensus 36 LG~G~f-g~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~~~lV~E~~ 113 (466)
|-.|.+ ..||++... +..+.+|+..... ...+.+|+++++.+. +--+.+++... ...+.-++|||++
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~--~~~~~~~lv~e~i 74 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYG--SDDGRAWLLTSAV 74 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEE--ecCCccEEEEEee
Confidence 344544 789999653 4577777654221 235677999988873 33455666544 2334577899999
Q ss_pred CCCCHHH
Q 012320 114 TSGTLRE 120 (466)
Q Consensus 114 ~ggsL~~ 120 (466)
+|.+|..
T Consensus 75 ~G~~l~~ 81 (244)
T cd05150 75 PGVPAAA 81 (244)
T ss_pred CCccHhH
Confidence 9987764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.92 E-value=7.9e-05 Score=71.19 Aligned_cols=140 Identities=17% Similarity=0.121 Sum_probs=90.8
Q ss_pred eeeeeCceEEEEEEEcCCCeEEEEEEEecccccC------------------CHHH--HHHHHHHHHHHHhCC--CCcee
Q 012320 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMR------------------SPDD--LQRLYSEVHLLSTLK--HDSII 92 (466)
Q Consensus 35 ~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~------------------~~~~--~~~~~~Ei~iL~~l~--HpnIv 92 (466)
.|+.|--+.||+|.. ..+..+|+|+.+...... +... ..-..+|...|+++. +-.+.
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 456666678999865 458999999876532210 1111 122457888888873 33344
Q ss_pred EEEeEEEeccCCEEEEEEecCCCCCHH-HHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCCCCcEEEeCCC
Q 012320 93 RFYTSWIDVDQKTFNFITEMFTSGTLR-EYRKKYRRVDIRAIKSWARQILQGLVYLHS-RDPPVIHRDLKCDNIFVNGHL 170 (466)
Q Consensus 93 ~l~~~~~~~~~~~~~lV~E~~~ggsL~-~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs-~~~~IiHrDLKp~NIlv~~~~ 170 (466)
+-+... .-.+||||+...... -.++. -.+....+..+..+++..+.-|-. .+ ++|+||+.-|||+. +
T Consensus 134 ~Pi~~~------~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-~- 202 (268)
T COG1718 134 EPIAFR------NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-D- 202 (268)
T ss_pred Cceeec------CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-C-
Confidence 444322 134899998554211 11111 122333677888888888888876 67 99999999999998 3
Q ss_pred CcEEEeccchhhhhcC
Q 012320 171 GQVKIGDLGLAAILRG 186 (466)
Q Consensus 171 g~vKL~DFGla~~~~~ 186 (466)
|.+.|+|||.|....+
T Consensus 203 ~~p~iID~~QaV~~~h 218 (268)
T COG1718 203 GEPYIIDVSQAVTIDH 218 (268)
T ss_pred CeEEEEECccccccCC
Confidence 7999999998876543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00018 Score=81.50 Aligned_cols=147 Identities=18% Similarity=0.291 Sum_probs=88.1
Q ss_pred eeeeeeCceEEEEEEEcCCC--eEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCce--eEEEeEEEecc-CCEEE
Q 012320 34 EVLGKGAMKTVYKAIDEVLG--VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSI--IRFYTSWIDVD-QKTFN 107 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g--~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnI--v~l~~~~~~~~-~~~~~ 107 (466)
+.|+.|.+..+|+......+ ..+++|+........ ....+.+|+++|+.+. |++| .+.+..+.+.. -+..|
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~---~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ---SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc---cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 44899999999998765432 467777654322211 2346788999999995 6665 66665442211 14567
Q ss_pred EEEecCCCCCHHH--------------------HHHhcCC----------------CCHHHHHHHHHHH-----------
Q 012320 108 FITEMFTSGTLRE--------------------YRKKYRR----------------VDIRAIKSWARQI----------- 140 (466)
Q Consensus 108 lV~E~~~ggsL~~--------------------~l~~~~~----------------l~~~~~~~i~~qI----------- 140 (466)
+|||+++|..+.+ .+.+-.. ....++..|..|.
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 9999998864321 1111000 1123444443332
Q ss_pred ----HHHHHHHHhCCC---------CeEeccCCCCcEEEeCCCCc-EEEeccchhhh
Q 012320 141 ----LQGLVYLHSRDP---------PVIHRDLKCDNIFVNGHLGQ-VKIGDLGLAAI 183 (466)
Q Consensus 141 ----l~gL~yLHs~~~---------~IiHrDLKp~NIlv~~~~g~-vKL~DFGla~~ 183 (466)
...+.+|..+-| .+||+|++++||+++...+. +-|.||+++..
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 223556644322 39999999999999854233 57999998754
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00013 Score=68.82 Aligned_cols=66 Identities=20% Similarity=0.307 Sum_probs=52.1
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
..++||||++|..|.++. .+++. +...|..++.-+|+.| +.|+|..|.|++++. +.++++||+-.+
T Consensus 117 ~~~ll~EYIeG~~l~d~~----~i~e~----~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~--~~i~iID~~~k~ 182 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIE----DIDED----LAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSN--NGIRIIDTQGKR 182 (229)
T ss_pred EEEEEEEEecCeecccch----hcCHH----HHHHHHHHHHHHHHcC--CccCCCCcCcEEEEC--CcEEEEECcccc
Confidence 456899999999887653 23332 3456777899999999 999999999999985 469999997553
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.82 E-value=8.1e-05 Score=67.56 Aligned_cols=131 Identities=23% Similarity=0.223 Sum_probs=90.2
Q ss_pred EeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCcee-EEEeEEEeccCCEEEEE
Q 012320 31 LFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSII-RFYTSWIDVDQKTFNFI 109 (466)
Q Consensus 31 ~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv-~l~~~~~~~~~~~~~lV 109 (466)
...+.||+|.+|.||+|... |.++|+|+=+ .......+..|+++|..+...++. ++|.+ +. -++.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr------~ds~r~~l~kEakiLeil~g~~~~p~vy~y--g~----~~i~ 90 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRR------RDSPRRNLEKEAKILEILAGEGVTPEVYFY--GE----DFIR 90 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEec------CCcchhhHHHHHHHHHHhhhcCCCceEEEe--ch----hhhh
Confidence 44567999999999999654 7799999643 223456788999999999877664 34432 11 2355
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCC--CcEEEeCCCCcEEEeccchhhhhcC
Q 012320 110 TEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKC--DNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 110 ~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp--~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
|||+.|-+|.+.-... +.++ +..+++.-.-|-..| |-|..|.- .||+++. +.+.|+||..|++...
T Consensus 91 me~i~G~~L~~~~~~~---~rk~----l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~--~~~~iIDFd~At~k~~ 158 (201)
T COG2112 91 MEYIDGRPLGKLEIGG---DRKH----LLRVLEKAYKLDRLG--IEHGELSRPWKNVLVND--RDVYIIDFDSATFKKK 158 (201)
T ss_pred hhhhcCcchhhhhhcc---cHHH----HHHHHHHHHHHHHhc--cchhhhcCCceeEEecC--CcEEEEEccchhhccC
Confidence 9999998887754321 2222 445556655566667 88988874 4666653 5899999999975443
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.0002 Score=76.11 Aligned_cols=147 Identities=17% Similarity=0.166 Sum_probs=89.0
Q ss_pred eEEee-eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCC----------------------------HHHHHHHHHH
Q 012320 29 YGLFE-EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRS----------------------------PDDLQRLYSE 79 (466)
Q Consensus 29 Y~~~~-~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~----------------------------~~~~~~~~~E 79 (466)
|..|. +-||.-+.|.||+|+.+. |+.||+|+-+.. +... .+-.+.+..|
T Consensus 161 f~~f~~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~-l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~E 238 (538)
T KOG1235|consen 161 FSEFDEEPIAAASLAQVHRARLKN-GEDVAVKVQHPG-LEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQE 238 (538)
T ss_pred HHhcCcchhhhcchhheEEEEecC-CCEEEEEecCcC-hHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhh
Confidence 44443 569999999999999887 999999964321 1100 0111223333
Q ss_pred HHH------HHh----CCCCc------eeEEEeEEEeccCCEEEEEEecCCCCCHHH--HHHhcCCCCHHHHHHHHHHHH
Q 012320 80 VHL------LST----LKHDS------IIRFYTSWIDVDQKTFNFITEMFTSGTLRE--YRKKYRRVDIRAIKSWARQIL 141 (466)
Q Consensus 80 i~i------L~~----l~Hpn------Iv~l~~~~~~~~~~~~~lV~E~~~ggsL~~--~l~~~~~l~~~~~~~i~~qIl 141 (466)
+.. ..+ +.|-+ |.++|-.+ ...-.++||||.|..+.| .+.+. .++...+..-+.+..
T Consensus 239 LDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~ 313 (538)
T KOG1235|consen 239 LDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAY 313 (538)
T ss_pred cchHHHHHhHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHH
Confidence 332 222 34545 44444322 234569999999987755 45543 344444433333332
Q ss_pred HHHHHHHhCCCCeEeccCCCCcEEEeC---CCCcEEEeccchhhhhcC
Q 012320 142 QGLVYLHSRDPPVIHRDLKCDNIFVNG---HLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 142 ~gL~yLHs~~~~IiHrDLKp~NIlv~~---~~g~vKL~DFGla~~~~~ 186 (466)
.- -+=..| ++|.|-.|.||++.. ..+.+.+.|||+...+..
T Consensus 314 ~~--qIf~~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 314 LE--QIFKTG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HH--HHHhcC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 21 122347 999999999999983 346899999999876543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00025 Score=67.93 Aligned_cols=29 Identities=24% Similarity=0.334 Sum_probs=24.2
Q ss_pred eEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 154 VIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 154 IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
++|+|+.|.||+++.+ +..-|+||+.+..
T Consensus 166 l~HGD~~~~Nvlv~~~-~i~giIDw~~a~~ 194 (235)
T cd05155 166 WFHGDLAPGNLLVQDG-RLSAVIDFGCLGV 194 (235)
T ss_pred EEeCCCCCCcEEEECC-CEEEEEeCcccCc
Confidence 8999999999999864 4457999997743
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00033 Score=64.97 Aligned_cols=99 Identities=22% Similarity=0.199 Sum_probs=77.0
Q ss_pred HHHHHHHhCCC-CceeEEEeEEEeccCCEEEEEEecCCCCCHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-C
Q 012320 78 SEVHLLSTLKH-DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQILQGLVYLHSRD-P 152 (466)
Q Consensus 78 ~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~---l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~-~ 152 (466)
.|.-+|+.+.+ +++.++++++ + -++|+||...+++... +...-.-++....+++.+++..+++++..- .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C----G--~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC----G--RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC----C--CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 47888999965 6999999987 2 2468899987766421 222234688999999999999999998631 1
Q ss_pred CeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 153 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 153 ~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
++.-.|++|+|+-++.+ |.+|++|...+..
T Consensus 82 ~~~lcDv~~~nfgv~~~-~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDD-GRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCC-CcEEEEechhcch
Confidence 28889999999999976 8999999987644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0024 Score=65.99 Aligned_cols=80 Identities=21% Similarity=0.236 Sum_probs=53.9
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEeccccc--CC-HHHHHHHHHHHHHHHhCC---CCceeEEEeEEEeccCCEEE
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELM--RS-PDDLQRLYSEVHLLSTLK---HDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~--~~-~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~~~ 107 (466)
+.||.|.+..||++.....++.+.+|+-...... .+ +-..++...|.+.|+.+. -.++.++|.+ + ....+
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D--~~~~~ 107 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--D--EELAV 107 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--C--CCCCE
Confidence 3489999999999998754468999985311100 11 224567788888898862 2456777753 2 34567
Q ss_pred EEEecCCCCC
Q 012320 108 FITEMFTSGT 117 (466)
Q Consensus 108 lV~E~~~ggs 117 (466)
+|||++++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0024 Score=59.75 Aligned_cols=132 Identities=19% Similarity=0.290 Sum_probs=86.5
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEeccccc------------CCHHHHHHHHHHHHHHHhCC------CCceeEEE
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELM------------RSPDDLQRLYSEVHLLSTLK------HDSIIRFY 95 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~------------~~~~~~~~~~~Ei~iL~~l~------HpnIv~l~ 95 (466)
..||+|+.-.||.- ......+||+....... ..........+|+.-..++. +.+|.++|
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46899999999985 23445678877655400 00112344555665555554 78899999
Q ss_pred eEEEeccCCEEEEEEecCCC------CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC
Q 012320 96 TSWIDVDQKTFNFITEMFTS------GTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH 169 (466)
Q Consensus 96 ~~~~~~~~~~~~lV~E~~~g------gsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~ 169 (466)
+.. +.+...-+|+|.+.+ .+|.++++. +.+++ .++. .+-.-..||-.++ |+.+||+|.||++...
T Consensus 84 G~v--eT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~---~L~~f~~~l~~~~--Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 84 GFV--ETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQ---ALDEFKRYLLDHH--IVIRDLNPHNIVVQRR 154 (199)
T ss_pred EEE--ecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHH---HHHHHHHHHHHcC--CeecCCCcccEEEEec
Confidence 954 556677888888643 468888854 55666 4433 3334455777778 9999999999999644
Q ss_pred C-C--cEEEec
Q 012320 170 L-G--QVKIGD 177 (466)
Q Consensus 170 ~-g--~vKL~D 177 (466)
. | .+.|+|
T Consensus 155 ~~~~~~lvlID 165 (199)
T PF10707_consen 155 DSGEFRLVLID 165 (199)
T ss_pred CCCceEEEEEe
Confidence 2 2 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.002 Score=61.33 Aligned_cols=74 Identities=14% Similarity=0.109 Sum_probs=45.3
Q ss_pred eeeeeeCceEEEEEEEcC-CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCC-CceeEEEeEEEeccCCEEEEEEe
Q 012320 34 EVLGKGAMKTVYKAIDEV-LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH-DSIIRFYTSWIDVDQKTFNFITE 111 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~~~lV~E 111 (466)
+.|..|-...||++.... .+..|.+|+...... ......+|+.+++.+.. .-..+++..+ . . .+|+|
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-----~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~--~--~~l~e 72 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-----LIIDRERELRIHKLLSKHGLAPKLYATF--Q--N--GLIYE 72 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-----ceecHHHHHHHHHHHHhCCCCCeEEEEe--C--C--cEEEE
Confidence 347889999999986443 356788886542211 11123468888888843 2234444432 1 1 27999
Q ss_pred cCCCCCH
Q 012320 112 MFTSGTL 118 (466)
Q Consensus 112 ~~~ggsL 118 (466)
|++|.++
T Consensus 73 ~i~G~~l 79 (235)
T cd05157 73 FIPGRTL 79 (235)
T ss_pred eeCCCcC
Confidence 9988765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0023 Score=59.79 Aligned_cols=130 Identities=19% Similarity=0.253 Sum_probs=86.2
Q ss_pred ceEEeeeeeeeeCc-eEEEEEEEcCCCeEEEEEEEec---ccc-------cCCH-------HHHHHHHHHHHHHHhC---
Q 012320 28 RYGLFEEVLGKGAM-KTVYKAIDEVLGVEVAWNQVRL---NEL-------MRSP-------DDLQRLYSEVHLLSTL--- 86 (466)
Q Consensus 28 rY~~~~~~LG~G~f-g~Vyka~~~~~g~~vAiK~i~~---~~~-------~~~~-------~~~~~~~~Ei~iL~~l--- 86 (466)
...- -+.||.|+- |.||++. ..|..||+|..+. ... .... .....+..|.+...+|
T Consensus 38 ~I~f-lefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 38 DIEF-LEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred cEee-eeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 3433 466999999 9999995 5689999998322 111 0000 1234567777766655
Q ss_pred CCCce--eEEEeEEEecc----------------CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 012320 87 KHDSI--IRFYTSWIDVD----------------QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLH 148 (466)
Q Consensus 87 ~HpnI--v~l~~~~~~~~----------------~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLH 148 (466)
.+.++ |++|++..-.. ....-||.||.+... .+..+. +.+|++-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence 45566 99998764321 112357788776544 233333 567888889999
Q ss_pred hCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 149 SRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 149 s~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
..| |+-+|+++.|.. + =||+|||.+
T Consensus 182 k~g--I~~~Dv~~~ny~-~-----G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLG--IVPRDVKPRNYR-G-----GKLVDFSSS 206 (207)
T ss_pred HCC--eeeccCcccccc-C-----CEEEecccC
Confidence 999 999999999976 1 278999854
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.002 Score=64.19 Aligned_cols=77 Identities=14% Similarity=0.073 Sum_probs=49.8
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCC---CceeEEEeEEEec-cCCEEEEE
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH---DSIIRFYTSWIDV-DQKTFNFI 109 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~H---pnIv~l~~~~~~~-~~~~~~lV 109 (466)
+-||.|..+.||+..... | .+.+|..+ .. . ....+..|...|+.|.- -.+.+.++.+.+. ..+.-++|
T Consensus 20 ~~i~~G~~~~vy~~~~~~-~-~~~~k~~~-~~---~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 20 ECISEQPYAALWALYDSQ-G-NPMPLMAR-SF---S--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred eecCCccceeEEEEEcCC-C-CEEEEEec-cc---c--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 349999999999985332 3 45566532 21 0 12467889999988742 3566677644222 23557899
Q ss_pred EecCCCCCH
Q 012320 110 TEMFTSGTL 118 (466)
Q Consensus 110 ~E~~~ggsL 118 (466)
||++.|+++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998764
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0015 Score=63.40 Aligned_cols=134 Identities=16% Similarity=0.166 Sum_probs=74.0
Q ss_pred eeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCce-eEEEeEEEeccCCEEEEEEecCC
Q 012320 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI-IRFYTSWIDVDQKTFNFITEMFT 114 (466)
Q Consensus 36 LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~~~lV~E~~~ 114 (466)
+..|-.+.+|+.. .+|..+.+|....... ...-...+|..+++.+....+ .+++.. + .+ ++|+||++
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~----~~~~~r~~E~~~l~~l~~~g~~P~~i~~--~--~~--~~v~e~i~ 71 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCK----ALGVDRQREYQILQALSALGLAPKPILV--N--EH--WLLVEWLE 71 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccc----cccCcHHHHHHHHHHHHhcCCCCceEEE--e--CC--EEEEEecc
Confidence 5668888999886 4577888886432211 000124668888888853222 233322 2 22 58999999
Q ss_pred CCCHHH--------------HHHhcC-------CCCH-HHHHHHHHHH---------HHHHHHHHhC------CCCeEec
Q 012320 115 SGTLRE--------------YRKKYR-------RVDI-RAIKSWARQI---------LQGLVYLHSR------DPPVIHR 157 (466)
Q Consensus 115 ggsL~~--------------~l~~~~-------~l~~-~~~~~i~~qI---------l~gL~yLHs~------~~~IiHr 157 (466)
|..+.. .+.+-. +++. ..+..+..++ ...+..+-.. .+.++|+
T Consensus 72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~ 151 (256)
T TIGR02721 72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM 151 (256)
T ss_pred CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence 876531 111110 1111 1222222222 1112222111 1238999
Q ss_pred cCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 158 DLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 158 DLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
|+.|.||+++.+ + +.|+||..+..
T Consensus 152 Dl~~~Nil~~~~-~-~~lIDwE~a~~ 175 (256)
T TIGR02721 152 DVHAYNLVVTPQ-G-LKLIDWEYASD 175 (256)
T ss_pred CCCcCcEEEeCC-C-CEEEeccccCc
Confidence 999999999875 4 78999987743
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0024 Score=66.75 Aligned_cols=164 Identities=17% Similarity=0.208 Sum_probs=101.5
Q ss_pred HHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 012320 74 QRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPP 153 (466)
Q Consensus 74 ~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~ 153 (466)
..+.-...+++++.|+|...+.+.- .....+..+|+|++ +.||.++++... +-... ++ .++
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~-r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s-------~~-------~~~-- 87 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFS-RGKHERVIVVMEHY-TMSLEDILKTGN-LKDES-------LL-------AHG-- 87 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeee-cCccceEEEEehhh-ccchHHHHHhcc-cchhh-------hc-------ccc--
Confidence 4567778899999999999888643 23345688899999 889999887644 21111 11 223
Q ss_pred eEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCCccccCCCCcCCccccccCCCChhhHHHHHHHHHHHHhCCCCCC
Q 012320 154 VIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYS 233 (466)
Q Consensus 154 IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~~~y~~~~DIwSlGvil~elltg~~Pf~ 233 (466)
+.|- +.++++| -++. .. .+..| +++||||+|.++.++..|...+.
T Consensus 88 ~~~~-------------~~~~~td-~~~t---~~---~~~~~---------------pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 88 VLHL-------------NIIYITD-HFLT---KY---PSPIG---------------PKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred ccee-------------hhhhccc-cccc---cC---CCCCC---------------cchhhhhHHHHHHHHHHhhHHHH
Confidence 3332 2334444 1111 00 11112 48999999999999998887775
Q ss_pred CCCCHHHHHHHHhcCCCCCCC---------CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 234 ECANPAQIYKKVTSGKLPGAF---------YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 234 ~~~~~~~i~~~i~~g~~p~~~---------~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.-.+........+-+..+... ....+.-...+..+|+. .|+.||...++++++-|...
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 533333333222222222211 12233456677888984 89999999999999988653
|
|
| >PF12202 OSR1_C: Oxidative-stress-responsive kinase 1 C terminal; InterPro: IPR024678 Oxidative-stress-responsive kinase 1 (OSR1) is involved in the signalling cascade which activates Na/K/2Cl co-transporter during osmotic stress | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.00082 Score=44.49 Aligned_cols=32 Identities=34% Similarity=0.509 Sum_probs=26.3
Q ss_pred eEEEEEeeCCCC------CCcceeecCcCCCCChhHHH
Q 012320 339 IFLKVQIADKDG------PGRNIYFPFDILNDTPLDVA 370 (466)
Q Consensus 339 i~l~~~~~d~~~------~~r~i~f~f~~~~dt~~~va 370 (466)
|.|+||+.|+.+ .+..|.|.|++.+|+|.+||
T Consensus 1 i~l~Lrv~d~kK~~~k~ken~aI~F~F~~~~D~~e~VA 38 (38)
T PF12202_consen 1 INLRLRVRDPKKRKGKHKENEAIEFEFDLGKDTAEEVA 38 (38)
T ss_dssp EEEEEEEC-TTSSSSS--TCEEEEEEEETTT--HHHHH
T ss_pred CcEEEEEeccccccCccccCccEEEEEecCCCcccccC
Confidence 568899999988 78899999999999999997
|
This entry represents the CCT domain found in OSR1, STE20/SPS1-related kinase and in WNK activators []. This domain is found in eukaryotes, and is approximately 40 amino acids in length. There is a single completely conserved residue F that may be functionally important. ; PDB: 2V3S_A 2LRU_A. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0072 Score=59.69 Aligned_cols=138 Identities=17% Similarity=0.106 Sum_probs=77.5
Q ss_pred eeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCC--ceeEEEeE----EEeccCCEEEE
Q 012320 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHD--SIIRFYTS----WIDVDQKTFNF 108 (466)
Q Consensus 35 ~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~----~~~~~~~~~~l 108 (466)
.|..|....+|++.. .+..+++|+... .+ ...+..|+.++..+.+- .+.+.+.. ++....+..++
T Consensus 21 ~i~~G~~n~~y~v~~--~~~~~vLr~~~~----~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~ 91 (296)
T cd05153 21 GISAGIENTNYFVTT--DSGRYVLTLFEK----VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA 91 (296)
T ss_pred cccCccccceEEEEe--CCCcEEEEEcCC----CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence 477888889999853 345788887642 12 24566788888877322 24444321 11112345678
Q ss_pred EEecCCCCCHHH--------H---HHh----cCCCCH--------HHHH------------HHHHHHHHHHHHHHh----
Q 012320 109 ITEMFTSGTLRE--------Y---RKK----YRRVDI--------RAIK------------SWARQILQGLVYLHS---- 149 (466)
Q Consensus 109 V~E~~~ggsL~~--------~---l~~----~~~l~~--------~~~~------------~i~~qIl~gL~yLHs---- 149 (466)
|+++++|..+.. . +.+ ...+.. .... .....+..++.++..
T Consensus 92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~ 171 (296)
T cd05153 92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS 171 (296)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999998876421 0 110 000000 0000 011112233444443
Q ss_pred -CCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 150 -RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 150 -~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
....+||+|+.|.||+++.+ +.+.|+||+.+.
T Consensus 172 ~~~~~l~HgD~~~~Nil~~~~-~~~~iIDfe~a~ 204 (296)
T cd05153 172 DLPRGVIHADLFRDNVLFDGD-ELSGVIDFYFAC 204 (296)
T ss_pred cCCCcCCccCcCcccEEEeCC-ceEEEeehhhhc
Confidence 11239999999999999875 566899998774
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.014 Score=59.29 Aligned_cols=83 Identities=17% Similarity=0.126 Sum_probs=54.0
Q ss_pred eeeeCceEEEEEEEcCCCeEEEEEEEeccccc---CCHHHHHHHHHHHHHHHhCC--CC-ceeEEEeEEEeccCCEEEEE
Q 012320 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELM---RSPDDLQRLYSEVHLLSTLK--HD-SIIRFYTSWIDVDQKTFNFI 109 (466)
Q Consensus 36 LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~---~~~~~~~~~~~Ei~iL~~l~--Hp-nIv~l~~~~~~~~~~~~~lV 109 (466)
||.|....||++.+...++.++||+-...... ..+-..++..-|...|+... -| .+.++|. + ++....+|
T Consensus 3 igdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~--D~e~~~~v 78 (370)
T TIGR01767 3 VGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--F--DTEMAVTV 78 (370)
T ss_pred CCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--E--ccccceeh
Confidence 79999999999998644478999974421111 12345567778888888763 24 4566665 2 34556689
Q ss_pred EecCCCCC-HHHHH
Q 012320 110 TEMFTSGT-LREYR 122 (466)
Q Consensus 110 ~E~~~ggs-L~~~l 122 (466)
||+++... |+..+
T Consensus 79 MEdL~~~~ilR~~L 92 (370)
T TIGR01767 79 MEDLSHHKIARKGL 92 (370)
T ss_pred HhhCccchHHHHHH
Confidence 99986533 44444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.042 Score=54.95 Aligned_cols=29 Identities=34% Similarity=0.408 Sum_probs=24.2
Q ss_pred CeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 153 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 153 ~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
.+||+|+.|.||+++++ ...-|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~~-~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFEGD-RLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEECC-ceEEEEeccccc
Confidence 49999999999999854 345899999774
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.023 Score=56.29 Aligned_cols=74 Identities=19% Similarity=0.180 Sum_probs=45.1
Q ss_pred eeeeeCceEEEEEEEcC------CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCce-eEEEeEEEeccCCEEE
Q 012320 35 VLGKGAMKTVYKAIDEV------LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI-IRFYTSWIDVDQKTFN 107 (466)
Q Consensus 35 ~LG~G~fg~Vyka~~~~------~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~~~ 107 (466)
.|..|-...||++.... .+..+++|+..... .......+|.++++.+....+ .+++..+ .+ .
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~--~~----~ 73 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-----ELLIDRERELVVFARLSERNLGPKLYGIF--PN----G 73 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-----cceechHHHHHHHHHHHhCCCCCceEEEe--CC----C
Confidence 36678888999987543 35788888754321 122345678888888743222 3444433 21 2
Q ss_pred EEEecCCCCCHH
Q 012320 108 FITEMFTSGTLR 119 (466)
Q Consensus 108 lV~E~~~ggsL~ 119 (466)
+|+||++|..+.
T Consensus 74 ~v~e~i~G~~l~ 85 (302)
T cd05156 74 RIEEFIPSRTLT 85 (302)
T ss_pred chhheeCCCcCC
Confidence 578998887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.018 Score=57.38 Aligned_cols=140 Identities=16% Similarity=0.129 Sum_probs=75.9
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCC--CceeEEEeE----EEeccCCEEE
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH--DSIIRFYTS----WIDVDQKTFN 107 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~----~~~~~~~~~~ 107 (466)
+.++.|....+|++.. .+| .+.+|+.... .+. ..+..|+.++..|.. -.+.+.+.. ++....+..+
T Consensus 28 ~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~---~~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 28 KGIAEGVENSNYLLTT-DVG-RYILTLYEKR---VKA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred cccCCccccceEEEEe-CCC-cEEEEEecCC---CCH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 3477888889998853 334 5778875431 122 234556777777632 123343321 1112245678
Q ss_pred EEEecCCCCCHH-----H------HHHh----cCCC--------CHHHH-----H----------HHHHHHHHHHHHHHh
Q 012320 108 FITEMFTSGTLR-----E------YRKK----YRRV--------DIRAI-----K----------SWARQILQGLVYLHS 149 (466)
Q Consensus 108 lV~E~~~ggsL~-----~------~l~~----~~~l--------~~~~~-----~----------~i~~qIl~gL~yLHs 149 (466)
++++|++|.++. + .+.+ ...+ ..... . .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999885431 1 1110 0001 00100 0 001122334555532
Q ss_pred -----CCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 150 -----RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 150 -----~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
....+||+|+.+.||+++.+ +.+.|+||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGD-SVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECC-ceEEEeeccccc
Confidence 12349999999999999876 566899999774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.0029 Score=62.85 Aligned_cols=138 Identities=18% Similarity=0.209 Sum_probs=93.4
Q ss_pred EeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccc-----cCCH-----------HHH--HHHHHHHHHHHhCC-CC-c
Q 012320 31 LFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNEL-----MRSP-----------DDL--QRLYSEVHLLSTLK-HD-S 90 (466)
Q Consensus 31 ~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~-----~~~~-----------~~~--~~~~~Ei~iL~~l~-Hp-n 90 (466)
-++..||-|--+-||.+-+.. |.+.++|.-++-.. ..+. -.+ -...+|...|+.|. |- -
T Consensus 95 svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 95 SVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 357779999999999998764 88889886443221 1111 111 23467888998883 32 2
Q ss_pred eeEEEeEEEeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCC
Q 012320 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHL 170 (466)
Q Consensus 91 Iv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~ 170 (466)
+.+-++ .+..++|||++.|-.|..... ..+ +..+...++.-+.-|-.+| +||+|..-=||++..+
T Consensus 174 VPkpiD------~~RH~Vvmelv~g~Pl~~v~~---v~d---~~~ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~dd- 238 (465)
T KOG2268|consen 174 VPKPID------HNRHCVVMELVDGYPLRQVRH---VED---PPTLYDDLMGLIVRLANHG--LIHGDFNEFNIMVKDD- 238 (465)
T ss_pred CCCccc------ccceeeHHHhhcccceeeeee---cCC---hHHHHHHHHHHHHHHHHcC--ceecccchheeEEecC-
Confidence 333333 344678999999988875431 222 3334555556667778889 9999999999999876
Q ss_pred CcEEEeccchhhhh
Q 012320 171 GQVKIGDLGLAAIL 184 (466)
Q Consensus 171 g~vKL~DFGla~~~ 184 (466)
+.++++||-.....
T Consensus 239 ~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 239 DKIVVIDFPQMVST 252 (465)
T ss_pred CCEEEeechHhhcc
Confidence 79999999766443
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.037 Score=56.09 Aligned_cols=147 Identities=17% Similarity=0.194 Sum_probs=93.8
Q ss_pred eeeeeeeeCceEEEEEEEcCCCeEEEEEEEeccccc--------------------CCHHHH--HHHHHHHHHHHhCCCC
Q 012320 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELM--------------------RSPDDL--QRLYSEVHLLSTLKHD 89 (466)
Q Consensus 32 ~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~--------------------~~~~~~--~~~~~Ei~iL~~l~Hp 89 (466)
+.-.|..|--+.||.|... +|..+|||+.+-+.+. .++... --..+|++.|++|...
T Consensus 148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3445777778889998754 5888999987543211 122221 1245788889988654
Q ss_pred ceeEEEeEEEeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC
Q 012320 90 SIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH 169 (466)
Q Consensus 90 nIv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~ 169 (466)
.|..---..+ . .-.|||+++....--.-.-+.-.++...+..+-.|++.-+.-|-+. |.++|.||.--|+|+..
T Consensus 227 GIP~PePIlL---k-~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~-c~LVHADLSEfN~Lyhd- 300 (520)
T KOG2270|consen 227 GIPCPEPILL---K-NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQK-CRLVHADLSEFNLLYHD- 300 (520)
T ss_pred CCCCCCceee---e-cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHH-hceeccchhhhhheEEC-
Confidence 4322111111 1 2348999995322111111234577778888888888877777544 45999999999999964
Q ss_pred CCcEEEeccchhhhhcC
Q 012320 170 LGQVKIGDLGLAAILRG 186 (466)
Q Consensus 170 ~g~vKL~DFGla~~~~~ 186 (466)
|.+.|+|.+.+.....
T Consensus 301 -G~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 301 -GKLYIIDVSQSVEHDH 316 (520)
T ss_pred -CEEEEEEccccccCCC
Confidence 7999999998765433
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.059 Score=55.86 Aligned_cols=76 Identities=16% Similarity=0.110 Sum_probs=49.9
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCC---HHHHHHHHHHHHHHHhCC---CCceeEEEeEEEeccCCEEE
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRS---PDDLQRLYSEVHLLSTLK---HDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~---~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~~~ 107 (466)
+.||.|....||+..+. +..+.+|+-........ +....+...|...|+.+. ..++.++|.+. . ..-.
T Consensus 38 ~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d--e--d~~v 111 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD--R--TMAL 111 (418)
T ss_pred EEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC--C--CCCE
Confidence 34899999999998863 45688997542211111 124566677788887763 24677777633 3 3456
Q ss_pred EEEecCCC
Q 012320 108 FITEMFTS 115 (466)
Q Consensus 108 lV~E~~~g 115 (466)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999977
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.041 Score=54.16 Aligned_cols=30 Identities=20% Similarity=0.345 Sum_probs=24.8
Q ss_pred CeEeccCCCCcEEEeCCCCc-EEEeccchhhh
Q 012320 153 PVIHRDLKCDNIFVNGHLGQ-VKIGDLGLAAI 183 (466)
Q Consensus 153 ~IiHrDLKp~NIlv~~~~g~-vKL~DFGla~~ 183 (466)
.++|+|++|.|||++.+ +. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~-~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDED-ARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCC-CCEEEEECcHhccc
Confidence 38999999999999864 44 57999997754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.039 Score=56.18 Aligned_cols=136 Identities=15% Similarity=0.204 Sum_probs=75.9
Q ss_pred eeeeCceEEEEEEEcC----CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCce-eEEEeEEEeccCCEEEEEE
Q 012320 36 LGKGAMKTVYKAIDEV----LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI-IRFYTSWIDVDQKTFNFIT 110 (466)
Q Consensus 36 LG~G~fg~Vyka~~~~----~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~~~lV~ 110 (466)
|-.|-...+|++.... .++.|.+|+..... ..... -.+|..+++.+..-++ .++++.+ .+ . .|+
T Consensus 44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t----~~~id-R~~E~~~~~~l~~~gl~P~~~~~~--~~-g---~v~ 112 (344)
T PLN02236 44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV----ELFFD-RDDEIRTFECMSRHGQGPRLLGRF--PN-G---RVE 112 (344)
T ss_pred cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC----Ceeec-hHHHHHHHHHHHHcCCCCceEEEE--CC-c---eEE
Confidence 5558889999986432 34678888764321 11112 2568888888843333 3444443 22 1 478
Q ss_pred ecCCCCCHHHH--------------HHhc---C----C--CCHHHHHHHHHHHH--------------------HHHHH-
Q 012320 111 EMFTSGTLREY--------------RKKY---R----R--VDIRAIKSWARQIL--------------------QGLVY- 146 (466)
Q Consensus 111 E~~~ggsL~~~--------------l~~~---~----~--l~~~~~~~i~~qIl--------------------~gL~y- 146 (466)
+|+.|.+|... +.+. . . ...+.+..|..++. ..|.-
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 88877665311 1110 0 0 11233434433221 11111
Q ss_pred HHh--CCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 147 LHS--RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 147 LHs--~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
+.. ....++|+|+++.||+++...+.+.++||..+.
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 221 112389999999999998654689999998774
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.055 Score=54.27 Aligned_cols=141 Identities=13% Similarity=0.137 Sum_probs=76.3
Q ss_pred eeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCC--CceeEEEeEEEeccCCEEEEEEecCCC
Q 012320 38 KGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH--DSIIRFYTSWIDVDQKTFNFITEMFTS 115 (466)
Q Consensus 38 ~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~~~~lV~E~~~g 115 (466)
.|..-.+|..... ++.+.+. ... .........+..+|..+++.+.- .-+-+-+..+.+......++||+++.|
T Consensus 35 ~G~sn~t~~~~~~--~~~~vlR-~P~--~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG 109 (321)
T COG3173 35 GGWSNDTFRLGDT--GQKYVLR-KPP--RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG 109 (321)
T ss_pred CCcccceEEEecC--CceEEEe-cCC--ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence 3444445555443 7777776 221 11122345667778888887732 223334443322222467899999988
Q ss_pred CCHHHH------------------HHhc--------------CCCCHHHHHHHHHHH--------------HHHHHHHHh
Q 012320 116 GTLREY------------------RKKY--------------RRVDIRAIKSWARQI--------------LQGLVYLHS 149 (466)
Q Consensus 116 gsL~~~------------------l~~~--------------~~l~~~~~~~i~~qI--------------l~gL~yLHs 149 (466)
..+.+. +..- +.....++..|..+. ..-..+++.
T Consensus 110 e~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~ 189 (321)
T COG3173 110 EVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEA 189 (321)
T ss_pred eeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHh
Confidence 433221 1100 001112222222222 112334444
Q ss_pred CCC------CeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 150 RDP------PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 150 ~~~------~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
+.+ .++|+|+.+.|++++.. +.+-++||+++..-
T Consensus 190 ~~p~~~~~~~lvHGD~~~gNlii~~~-~~~gVlDwe~~~lG 229 (321)
T COG3173 190 NRPPWAGPPVLVHGDYRPGNLIIDPG-RPTGVLDWELATLG 229 (321)
T ss_pred cCCCcCCCceeeeCCcccCCEEEeCC-CeeEEEeccccccC
Confidence 333 49999999999999987 56999999988653
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.058 Score=55.65 Aligned_cols=86 Identities=17% Similarity=0.189 Sum_probs=56.2
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEeccc-c-cCCHHHHHHHHHHHHHHHhCC--CC-ceeEEEeEEEeccCCEEEE
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNE-L-MRSPDDLQRLYSEVHLLSTLK--HD-SIIRFYTSWIDVDQKTFNF 108 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~-~-~~~~~~~~~~~~Ei~iL~~l~--Hp-nIv~l~~~~~~~~~~~~~l 108 (466)
+.||.|.-.-||++.+...+..|+||+-.... + ...+-..++..-|.+.|+.+. -| .+.++|. . ++....+
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~--D~e~~~~ 110 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--F--DSVMNCC 110 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--E--CcHHhhH
Confidence 34899999999999885446679999743211 1 112345677888999998773 34 4666765 2 3455668
Q ss_pred EEecCCCC-CHHHHHH
Q 012320 109 ITEMFTSG-TLREYRK 123 (466)
Q Consensus 109 V~E~~~gg-sL~~~l~ 123 (466)
|||+++.. .|++.+.
T Consensus 111 vMEdL~~~~ilR~~Li 126 (409)
T PRK12396 111 VMEDLSDHTILRTALI 126 (409)
T ss_pred HHHhCcccHHHHHHHH
Confidence 99999653 2444443
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.081 Score=53.46 Aligned_cols=29 Identities=24% Similarity=0.401 Sum_probs=25.4
Q ss_pred eEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 154 VIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 154 IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
.+|.||.+.||+++.+.+.++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 79999999999997554689999999774
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.18 Score=50.26 Aligned_cols=30 Identities=10% Similarity=0.122 Sum_probs=26.0
Q ss_pred CeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 153 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 153 ~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
.+||+|+.+.|++++++ +.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~-~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDET-RGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCC-CCEEEEEhhhccc
Confidence 39999999999999876 7899999987743
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.092 Score=49.76 Aligned_cols=88 Identities=17% Similarity=0.212 Sum_probs=62.4
Q ss_pred HHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 012320 74 QRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPP 153 (466)
Q Consensus 74 ~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~ 153 (466)
.-++.+.++++++. .|+++.. .+...+-+|.|.|--.. ... .-+ +.-=+.+|.-.|+..+.
T Consensus 103 ~~y~nky~v~Armh--GilrL~N----Dn~~~yGvIlE~Cy~~~---------i~~---~N~-i~agi~~L~~fH~~~~~ 163 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKN----DNNYKYGVILERCYKIK---------INF---SNF-ITAGIKDLMDFHSENQH 163 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeec----CCCceeEEEEeeccCcc---------cch---hHH-HHHhHHHHHHhhccCCC
Confidence 34577888998875 5888874 35567788999983211 111 111 11124678888977777
Q ss_pred eEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 154 VIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 154 IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
.+|+|-.|+||+-+.. |.+||.|=+..
T Consensus 164 ~lHGD~np~NiM~D~~-G~lKlVDP~~L 190 (308)
T PF07387_consen 164 CLHGDCNPDNIMCDKF-GYLKLVDPVCL 190 (308)
T ss_pred eecCCCChhheeecCC-CCEEecChhhh
Confidence 9999999999999987 99999998743
|
The function of this family is unknown. |
| >PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat | Back alignment and domain information |
|---|
Probab=95.10 E-value=0.052 Score=56.59 Aligned_cols=30 Identities=27% Similarity=0.286 Sum_probs=22.8
Q ss_pred CCeEeccCCCCcEEEeCCCC----cEEEeccchh
Q 012320 152 PPVIHRDLKCDNIFVNGHLG----QVKIGDLGLA 181 (466)
Q Consensus 152 ~~IiHrDLKp~NIlv~~~~g----~vKL~DFGla 181 (466)
+-++|+||...|||.+.+.+ -..|+||-.+
T Consensus 268 ~VL~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~v 301 (414)
T PF07914_consen 268 PVLVHGDLWSSNILWDKDSDGKLKLKAIIDWQCV 301 (414)
T ss_pred cceecCCccHHheeeecCCchhHHHHHHHHHHHh
Confidence 34899999999999987533 3467888655
|
In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO). |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.05 E-value=0.29 Score=49.77 Aligned_cols=103 Identities=18% Similarity=0.254 Sum_probs=65.8
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
..+.|++|++- |++|.- ......+++..++.+-+..+.-+... -+.-||++..+|||++ + |.|.|+||-+++
T Consensus 298 ~~y~yl~~kdh-gt~is~----ik~~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId-~-GnvtLIDfklsR 369 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI----IKADRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID-E-GNVTLIDFKLSR 369 (488)
T ss_pred ceEEEEEEecC-Cceeee----eecccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee-c-CceEEEEeeeee
Confidence 45677778876 555532 12334567777777777766666554 5799999999999998 5 899999999997
Q ss_pred hhcCCCCCccccCCCCcCCccccccCCCChhhHHH
Q 012320 183 ILRGSKSAHSVIGTPEFMAPELYEEDYNELVDVYS 217 (466)
Q Consensus 183 ~~~~~~~~~~~~GT~~y~APE~l~~~y~~~~DIwS 217 (466)
. ..++. .+-....--|-.+.+.-+..-+||-
T Consensus 370 l-~~~q~---~isy~rldhp~lF~G~dd~QFeIYr 400 (488)
T COG5072 370 L-SYSQG---IISYNRLDHPDLFNGVDDYQFEIYR 400 (488)
T ss_pred c-ccCCc---eeeccccCchhhhcCccceeeeHHH
Confidence 3 32211 1111223344445544455566766
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=93.77 E-value=0.41 Score=47.43 Aligned_cols=72 Identities=13% Similarity=0.066 Sum_probs=40.4
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC--C-CceeEEEeEEEeccCCEEEEEE
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK--H-DSIIRFYTSWIDVDQKTFNFIT 110 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~--H-pnIv~l~~~~~~~~~~~~~lV~ 110 (466)
+-+|.|....+|+.. .+++.+-+|.-. .. ....+..|..-|+.|. . -.+.+.+..... ...-+||+
T Consensus 23 ~~v~GG~i~~a~~~~--~~~~~~FvK~~~-~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~--~~~~fLll 91 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD--TDGGSYFVKVNS-ES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEY--DDDAFLLL 91 (288)
T ss_dssp EEE--SSSSEEEEEE--TTS-EEEEEEEE-GG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE---SSCCEEEE
T ss_pred EecCCCChhheEEEE--CCCccEEEEecC-hh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee--cCCceEEE
Confidence 348889999999986 668888888755 11 2245677888888773 2 334555554322 33347999
Q ss_pred ecCCCC
Q 012320 111 EMFTSG 116 (466)
Q Consensus 111 E~~~gg 116 (466)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 998766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.50 E-value=0.46 Score=49.06 Aligned_cols=27 Identities=26% Similarity=0.265 Sum_probs=23.1
Q ss_pred eEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 154 VIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 154 IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
.+|.||-+.||+.+. +.+.++||.-|.
T Consensus 229 fCHNDL~~gNIL~~~--~~l~lID~EYA~ 255 (383)
T PTZ00384 229 FCHNDLFFTNILDFN--QGIYFIDFDFAG 255 (383)
T ss_pred eeeccCCcccEEecC--CCEEEEEecccc
Confidence 899999999999864 479999998663
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.51 E-value=0.2 Score=51.53 Aligned_cols=61 Identities=13% Similarity=0.171 Sum_probs=42.4
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCCeEeccCCCCcEEEeCC
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLH-SRDPPVIHRDLKCDNIFVNGH 169 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLH-s~~~~IiHrDLKp~NIlv~~~ 169 (466)
..++-+|..|.++..+++. ...++...+.++.--+.||--+- --+ ++|.|+.|.||++--+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEEec
Confidence 3467778889899888864 44556666666655555554332 235 9999999999999544
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.07 E-value=4 Score=47.71 Aligned_cols=30 Identities=33% Similarity=0.424 Sum_probs=24.2
Q ss_pred CeEeccCCCCcEEEeCCC-CcEE-Eeccchhh
Q 012320 153 PVIHRDLKCDNIFVNGHL-GQVK-IGDLGLAA 182 (466)
Q Consensus 153 ~IiHrDLKp~NIlv~~~~-g~vK-L~DFGla~ 182 (466)
.+||.|+.+.|||++.+. +.+. |+|||-+.
T Consensus 204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 204 QVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred ceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 499999999999998762 1454 99999774
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.72 E-value=3.7 Score=41.32 Aligned_cols=84 Identities=15% Similarity=0.039 Sum_probs=44.9
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCC--CceeE---EEeE
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH--DSIIR---FYTS 97 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~---l~~~ 97 (466)
..++++... | .+.-..||++.. .+|..+++|+.+... . ....+..|+.++..|.. -.++. .-+.
T Consensus 25 ~~~~~~~~~----l-~s~eN~vy~v~~-~~~~~~vlKv~r~~~--~---~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~ 93 (325)
T PRK11768 25 LRVDGRLLA----L-NSYENRVYQFGD-EDGRRVVAKFYRPER--W---SDAQILEEHAFALELAEAEIPVVAPLAFNGQ 93 (325)
T ss_pred CCCccceEe----e-ccccceEEEEec-CCCCEEEEEEcCccc--C---CHHHHHHHHHHHHHHHHCCCCCCCCccCCCC
Confidence 345555433 2 345567898854 346678888764222 1 23456678888777621 11222 1111
Q ss_pred EEeccCCEEEEEEecCCCCC
Q 012320 98 WIDVDQKTFNFITEMFTSGT 117 (466)
Q Consensus 98 ~~~~~~~~~~lV~E~~~ggs 117 (466)
.+..-++..+.++++++|..
T Consensus 94 ~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 94 TLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred EEEEECCEEEEEEeeeCCCC
Confidence 11112346677899988764
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=90.65 E-value=0.52 Score=46.68 Aligned_cols=28 Identities=21% Similarity=0.358 Sum_probs=24.1
Q ss_pred CCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 152 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 152 ~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
..+||+|+.+.||+++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~--~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD--NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC--CcEEEEECccc
Confidence 34999999999999986 47899999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=88.92 E-value=0.29 Score=45.77 Aligned_cols=29 Identities=38% Similarity=0.547 Sum_probs=19.4
Q ss_pred eEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 154 VIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 154 IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
++|.||.|.||+++...+.++|+||..|.
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHh
Confidence 89999999999994444899999998774
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 466 | ||||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-69 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-25 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-25 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-25 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-25 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-25 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-24 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-24 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-22 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-21 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-21 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-21 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-21 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-21 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-21 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-21 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-21 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-21 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-20 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-20 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-20 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-20 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-20 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-20 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-20 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-20 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-20 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-20 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-20 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-20 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-20 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-20 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-19 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-19 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-19 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-19 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-19 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-19 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-19 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-19 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-19 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-19 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-19 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-19 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-19 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-19 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-19 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-18 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-18 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-18 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-18 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-18 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-17 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-17 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-16 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-15 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-15 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-15 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-15 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-14 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-14 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-14 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-14 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-14 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-14 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-14 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-14 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-14 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-14 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-14 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-14 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-14 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-14 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-14 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-14 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-14 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-14 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-14 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-14 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-14 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-14 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-14 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-14 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-14 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-14 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-14 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-14 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-14 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-14 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-14 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-14 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-14 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-14 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-14 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-14 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-14 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-14 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-14 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-14 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-14 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-13 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-12 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-12 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-12 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-12 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-11 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-11 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-11 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-11 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-10 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-10 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-10 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-10 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-10 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-10 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-10 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-07 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-07 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-07 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-06 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-06 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-06 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-06 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 9e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 9e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-05 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-05 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-05 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 9e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-04 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 6e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-04 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-04 |
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 412 bits (1060), Expect = e-144
Identities = 135/283 (47%), Positives = 185/283 (65%), Gaps = 6/283 (2%)
Query: 12 DEAKAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPD 71
D + + +GR+ F+ +G+G+ KTVYK +D VEVAW +++ +L +
Sbjct: 10 DIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKS 67
Query: 72 DLQRLYSEVHLLSTLKHDSIIRFYTSWIDV--DQKTFNFITEMFTSGTLREYRKKYRRVD 129
+ QR E +L L+H +I+RFY SW +K +TE+ TSGTL+ Y K+++ +
Sbjct: 68 ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMK 127
Query: 130 IRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS 189
I+ ++SW RQIL+GL +LH+R PP+IHRDLKCDNIF+ G G VKIGDLGLA + R S
Sbjct: 128 IKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF- 186
Query: 190 AHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK 249
A +VIGTPEFMAPE+YEE Y+E VDVY+FGMC+LEM T EYPYSEC N AQIY++VTSG
Sbjct: 187 AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV 246
Query: 250 LPGAFYSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASD 291
P +F + E + I C+ N +R S K+LL F +
Sbjct: 247 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 6e-64
Identities = 84/280 (30%), Positives = 127/280 (45%), Gaps = 24/280 (8%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
VLGKG VY D V +A ++ R Q L+ E+ L LKH +I++
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPE----RDSRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLRE-YRKKYRRVDIR--AIKSWARQILQGLVYLHSR 150
+ S + E G+L R K+ + I + +QIL+GL YLH
Sbjct: 84 YLGS--FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 151 DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS-AHSVIGTPEFMAPE---LYE 206
++HRD+K DN+ +N + G +KI D G + L G + GT ++MAPE
Sbjct: 142 Q--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 207 EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK----LPGAFYSIQDLEA 262
Y + D++S G ++EM T + P+ E P KV K +P + EA
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESM----SAEA 255
Query: 263 QRFIGRCL-VNASKRLSAKELLLDPFLASDEVKLLSKTKL 301
+ FI +C + KR A +LL+D FL K ++ KL
Sbjct: 256 KAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKL 295
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-62
Identities = 70/286 (24%), Positives = 116/286 (40%), Gaps = 18/286 (6%)
Query: 9 GAADEAKAHIGYIETDPNGRYG-LFE--EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNE 65
G A E GY + P + F+ LG G+ V+K + G A +
Sbjct: 35 GEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF 94
Query: 66 LMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKK 124
R P D R +EV + +H +R +W + TE +L+++ +
Sbjct: 95 --RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI--LYLQTE-LCGPSLQQHCEA 149
Query: 125 Y-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183
+ + + + R L L +LHS+ ++H D+K NIF+ G+ K+GD GL
Sbjct: 150 WGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPR-GRCKLGDFGLLVE 206
Query: 184 LRGSKSAHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYK 243
L + + G P +MAPEL + Y DV+S G+ +LE+ Q+ +
Sbjct: 207 LGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ 266
Query: 244 KVTSGKLPGAFYSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFL 288
+ A S E + + L + R +A+ LL P L
Sbjct: 267 GYLPPEFT-AGLS---SELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 3e-62
Identities = 80/268 (29%), Positives = 123/268 (45%), Gaps = 21/268 (7%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
+G G+ K + G + W ++ + + + Q L SEV+LL LKH +I+R
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVR 69
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTL----REYRKKYRRVDIRAIKSWARQILQGLVYLHS 149
+Y ID T + E G L + K+ + +D + Q+ L H
Sbjct: 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 150 RDPP---VIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS-AHSVIGTPEFMAPELY 205
R V+HRDLK N+F++G VK+GD GLA IL S A + +GTP +M+PE
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 206 EED-YNELVDVYSFGMCVL-EMFTCEYPYSECANPAQIYKKVTSGKLP--GAFYSIQDLE 261
YNE D++S G C+L E+ P+ + ++ K+ GK YS E
Sbjct: 189 NRMSYNEKSDIWSLG-CLLYELCALMPPF-TAFSQKELAGKIREGKFRRIPYRYS---DE 243
Query: 262 AQRFIGRCL-VNASKRLSAKELLLDPFL 288
I R L + R S +E+L +P +
Sbjct: 244 LNEIITRMLNLKDYHRPSVEEILENPLI 271
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 9e-62
Identities = 67/297 (22%), Positives = 130/297 (43%), Gaps = 20/297 (6%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
+ +G+G+ G + ++ ++ + S + + EV +L+ +KH +I++
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRM--SSKEREESRREVAVLANMKHPNIVQ 87
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDI--RAIKSWARQILQGLVYLHSRD 151
+ S+ + + + + G L + + V I W QI L ++H R
Sbjct: 88 YRESFE--ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK 145
Query: 152 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS-AHSVIGTPEFMAPELYEED-Y 209
++HRD+K NIF+ G V++GD G+A +L + A + IGTP +++PE+ E Y
Sbjct: 146 --ILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPY 202
Query: 210 NELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP--GAFYSIQDLEAQRFIG 267
N D+++ G + E+ T ++ + E + + K+ SG P YS + + +
Sbjct: 203 NNKSDIWALGCVLYELCTLKHAF-EAGSMKNLVLKIISGSFPPVSLHYS---YDLRSLVS 258
Query: 268 RCL-VNASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNETELEKLQLSDDPPR 323
+ N R S +L F+A K LS + ++ K P +
Sbjct: 259 QLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEE--FCLKTFSKFGSQPIPAK 313
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 6e-61
Identities = 77/266 (28%), Positives = 131/266 (49%), Gaps = 20/266 (7%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
+ +G+G VY+A + GV VA +V++ +LM E+ LL L H ++I+
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM-DAKARADCIKEIDLLKQLNHPNVIK 96
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTL----REYRKKYRRVDIRAIKSWARQILQGLVYLHS 149
+Y S+I + N + E+ +G L + ++K+ R + R + + Q+ L ++HS
Sbjct: 97 YYASFI--EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154
Query: 150 RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS-AHSVIGTPEFMAPELYEED 208
R V+HRD+K N+F+ G VK+GDLGL + AHS++GTP +M+PE E+
Sbjct: 155 RR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 211
Query: 209 -YNELVDVYSFGMCVLEMFTCEYPY-SECANPAQIYKKVTSGK---LPGAFYSIQDLEAQ 263
YN D++S G + EM + P+ + N + KK+ LP YS E +
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS---EELR 268
Query: 264 RFIGRCL-VNASKRLSAKELLLDPFL 288
+ + C+ + KR +
Sbjct: 269 QLVNMCINPDPEKRPDVTYVYDVAKR 294
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 4e-60
Identities = 64/273 (23%), Positives = 107/273 (39%), Gaps = 36/273 (13%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
E++G G V+KA + G +V+ N ++ EV L+ L H +I+
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVH 68
Query: 94 FYTSWIDVDQKTFNF--------------ITEMFTSGTLREYRKKYRRVDI--RAIKSWA 137
+ W D E GTL ++ +K R +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 138 RQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTP 197
QI +G+ Y+HS+ +I+RDLK NIF+ QVKIGD GL L+ GT
Sbjct: 129 EQITKGVDYIHSKK--LINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 198 EFMAPELYEED-YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYS 256
+M+PE Y + VD+Y+ G+ + E+ E + + + G + F
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK---FFTDLRDGIISDIFDK 242
Query: 257 IQDLEAQRFIGRCL-VNASKRLSAKELLLDPFL 288
+ + + + L R + E+L +
Sbjct: 243 ----KEKTLLQKLLSKKPEDRPNTSEILRTLTV 271
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 8e-58
Identities = 69/309 (22%), Positives = 128/309 (41%), Gaps = 43/309 (13%)
Query: 27 GRY-GLFE--EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLL 83
GRY FE + LG+G V++A ++V A ++RL +++ EV L
Sbjct: 1 GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP---NRELAREKVMREVKAL 57
Query: 84 STLKHDSIIRFYTSWIDVDQKTFNFITEMFTS----------GTLREY---RKKYRRVDI 130
+ L+H I+R++ +W++ + + L+++ R +
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 131 RAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA 190
QI + + +LHS+ ++HRDLK NIF VK+GD GL + +
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEE 174
Query: 191 HSV-------------IGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECA 236
+V +GT +M+PE Y+ VD++S G+ + E+ YP+S
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQM 231
Query: 237 NPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVKL 295
+ V + K P F + + + L + +R A ++ + +++
Sbjct: 232 ERVRTLTDVRNLKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF--EDLDF 288
Query: 296 LSKTKLNQK 304
KT L Q+
Sbjct: 289 PGKTVLRQR 297
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 3e-57
Identities = 83/289 (28%), Positives = 126/289 (43%), Gaps = 43/289 (14%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
VLG+GA V KA + + A ++R E + L + SEV LL++L H +
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-----EKLSTILSEVMLLASLNHQYV 64
Query: 92 IRFYTSWIDVDQKTFN-----------FITEMFTSGTLREY-RKKYRRVDIRAIKSWARQ 139
+R+Y +W++ E +GTL + + RQ
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 140 ILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL--------------- 184
IL+ L Y+HS+ +IHRDLK NIF++ VKIGD GLA +
Sbjct: 125 ILEALSYIHSQG--IIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 185 RGSKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIY 242
S + S IGT ++A E+ + YNE +D+YS G+ EM YP+S I
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNIL 238
Query: 243 KKVTSGK--LPGAFYSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFL 288
KK+ S P F + ++ I + + +KR A+ LL +L
Sbjct: 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 4e-56
Identities = 60/277 (21%), Positives = 105/277 (37%), Gaps = 29/277 (10%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
+G+G+ V++ D+ G + A +VRL E+ + L I+
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE---------ELVACAGLSSPRIVP 114
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPP 153
Y + + N E+ G+L + K+ + + Q L+GL YLH+R
Sbjct: 115 LYGA--VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR-- 170
Query: 154 VIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL------RGSKSAHSVIGTPEFMAPELYEE 207
++H D+K DN+ ++ + + D G A L + + + GT MAPE+
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 208 D-YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK----LPGAFYSIQDLEA 262
+ VD++S +L M +P+++ K + +P +
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAP----LT 286
Query: 263 QRFIGRCLV-NASKRLSAKELLLDPFLASDEVKLLSK 298
+ I L R SA EL A EV L
Sbjct: 287 AQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKS 323
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 3e-53
Identities = 59/285 (20%), Positives = 109/285 (38%), Gaps = 44/285 (15%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSII 92
E +G G +V+K + + G A + + + D Q EV+ + L +H ++
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKP--LAGSVDEQNALREVYAHAVLGQHSHVV 74
Query: 93 RFYTSWIDVDQKTFNFITEMFTSGTL----REYRKKYRRVDIRAIKSWARQILQGLVYLH 148
R++++W + D E G+L E + +K Q+ +GL Y+H
Sbjct: 75 RYFSAWAEDDH--MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 149 SRDPPVIHRDLKCDNIFVN------------------GHLGQVKIGDLGLAAILRGSKSA 190
S ++H D+K NIF++ + KIGDLG + S
Sbjct: 133 SMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---SSP 187
Query: 191 HSVIGTPEFMAPELYEED--YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG 248
G F+A E+ +E+ + D+++ + V+ E + ++ G
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN----GDQWHEIRQG 243
Query: 249 KLPG--AFYSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLAS 290
+LP S E + + + +R SA L+ L S
Sbjct: 244 RLPRIPQVLS---QEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-51
Identities = 71/225 (31%), Positives = 113/225 (50%), Gaps = 15/225 (6%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQV-RLNELMRSPDDLQRLYSEVHLLSTLKHDS 90
+E +G G+ TV++A G +VA V L E + + EV ++ L+H +
Sbjct: 41 IKEKIGAGSFGTVHRAE--WHGSDVA---VKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQILQGLVYL 147
I+ F + + +TE + G+L ++D R S A + +G+ YL
Sbjct: 96 IVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153
Query: 148 HSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-RGSKSAHSVIGTPEFMAPELYE 206
H+R+PP++HR+LK N+ V+ VK+ D GL+ + S+ S GTPE+MAPE+
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 207 -EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL 250
E NE DVYSFG+ + E+ T + P+ NPAQ+ V
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKCK 256
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-50
Identities = 66/294 (22%), Positives = 115/294 (39%), Gaps = 30/294 (10%)
Query: 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLST 85
GR + +G G V++ ++E A V L E L +E+ L+
Sbjct: 7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNK 63
Query: 86 LKH--DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQG 143
L+ D IIR Y I + + E + L + KK + +D KS+ + +L+
Sbjct: 64 LQQHSDKIIRLYDYEIT--DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEA 120
Query: 144 LVYLHSRDPPVIHRDLKCDNI-FVNGHLGQVKIGDLGLAAILRG---SKSAHSVIGTPEF 199
+ +H ++H DLK N V+G +K+ D G+A ++ S S +GT +
Sbjct: 121 VHTIHQHG--IVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 175
Query: 200 MAPEL------------YEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS 247
M PE + + DV+S G + M + P+ + N +
Sbjct: 176 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235
Query: 248 GKLPGAFYSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVKLLSKTK 300
F I + + Q + CL + +R+S ELL P++ + K
Sbjct: 236 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 289
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 175 bits (444), Expect = 3e-50
Identities = 65/298 (21%), Positives = 115/298 (38%), Gaps = 30/298 (10%)
Query: 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLS 84
GR + +G G V++ ++E A V L E L +E+ L+
Sbjct: 53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA--DNQTLDSYRNEIAYLN 109
Query: 85 TLKH--DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQ 142
L+ D IIR Y I + + E + L + KK + +D KS+ + +L+
Sbjct: 110 KLQQHSDKIIRLYDYEIT--DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLE 166
Query: 143 GLVYLHSRDPPVIHRDLKCDNI-FVNGHLGQVKIGDLGLAAILRG---SKSAHSVIGTPE 198
+ +H ++H DLK N V+G +K+ D G+A ++ S S +G
Sbjct: 167 AVHTIHQHG--IVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGAVN 221
Query: 199 FMAPELYEED------------YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVT 246
+M PE ++ + DV+S G + M + P+ + N +
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 281
Query: 247 SGKLPGAFYSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVKLLSKTKLNQ 303
F I + + Q + CL + +R+S ELL P++ + K
Sbjct: 282 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 339
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 4e-50
Identities = 64/286 (22%), Positives = 114/286 (39%), Gaps = 30/286 (10%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH--DSI 91
+ +G G V++ ++E A V L E L +E+ L+ L+ D I
Sbjct: 34 KQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKI 90
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRD 151
IR Y I + + E + L + KK + +D KS+ + +L+ + +H
Sbjct: 91 IRLYDYEIT--DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 147
Query: 152 PPVIHRDLKCDNI-FVNGHLGQVKIGDLGLAAILRG---SKSAHSVIGTPEFMAPELYEE 207
++H DLK N V+G +K+ D G+A ++ S S +GT +M PE ++
Sbjct: 148 --IVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 208 D------------YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFY 255
+ DV+S G + M + P+ + N + F
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 262
Query: 256 SIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVKLLSKTK 300
I + + Q + CL + +R+S ELL P++ + K
Sbjct: 263 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 308
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-49
Identities = 57/221 (25%), Positives = 89/221 (40%), Gaps = 18/221 (8%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVA---WNQVRLNELMRSPDDLQRLYSEVHLLSTLKH 88
+E+ +GKG V+K VA + Q EV ++S L H
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVYL 147
+I++ Y + E G L K + I G+ Y+
Sbjct: 83 PNIVKLYGLMH----NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 148 HSRDPPVIHRDLKCDNIFVNGHLGQ----VKIGDLGLAAILRGSKSAHSVIGTPEFMAPE 203
+++PP++HRDL+ NIF+ K+ D GL+ S S ++G ++MAPE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS--GLLGNFQWMAPE 196
Query: 204 LY---EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQI 241
EE Y E D YSF M + + T E P+ E + +I
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY-SYGKI 236
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-49
Identities = 65/226 (28%), Positives = 105/226 (46%), Gaps = 20/226 (8%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
EEV+G+GA V KA +VA ++ + S + + E+ LS + H +I
Sbjct: 12 VEEVVGRGAFGVVCKAK--WRAKDVA---IKQ---IESESERKAFIVELRQLSRVNHPNI 63
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQILQGLVYLH 148
++ Y + + + E G+L + SW Q QG+ YLH
Sbjct: 64 VKLYGACL----NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 149 SRDP-PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE- 206
S P +IHRDLK N+ + +KI D G A ++ + + G+ +MAPE++E
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT--NNKGSAAWMAPEVFEG 177
Query: 207 EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQ-IYKKVTSGKLP 251
+Y+E DV+S+G+ + E+ T P+ E PA I V +G P
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP 223
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-46
Identities = 69/232 (29%), Positives = 109/232 (46%), Gaps = 27/232 (11%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWN-QV---RLNELMRSPDDLQRLYSEVHLLSTLK 87
+ +G G+ TVYK W+ V LN +P LQ +EV +L +
Sbjct: 28 VGQRIGSGSFGTVYKGK---------WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78
Query: 88 HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVY 146
H +I+ F +T+ +L + + +++ + ARQ +G+ Y
Sbjct: 79 HVNILLFMGY---STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR---GSKSAHSVIGTPEFMAPE 203
LH++ +IHRDLK +NIF++ VKIGD GLA GS + G+ +MAPE
Sbjct: 136 LHAK--SIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 204 L--YEED--YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP 251
+ ++ Y+ DVY+FG+ + E+ T + PYS N QI + V G L
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS 244
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-46
Identities = 37/225 (16%), Positives = 83/225 (36%), Gaps = 16/225 (7%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
F L + ++K G ++ +++ + S + E L H ++
Sbjct: 14 FLTKLNENHSGELWKGR--WQGNDIVVKVLKVRDW--STRKSRDFNEECPRLRIFSHPNV 69
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREY--RKKYRRVDIRAIKSWARQILQGLVYLHS 149
+ + IT G+L VD +A + +G+ +LH+
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 150 RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE--- 206
+P + L ++ ++ + +I + S + + P ++APE +
Sbjct: 130 LEPLIPRHALNSRSVMIDEDM-TARISMADVKF----SFQSPGRMYAPAWVAPEALQKKP 184
Query: 207 -EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL 250
+ D++SF + + E+ T E P+++ + +I KV L
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPFADL-SNMEIGMKVALEGL 228
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 8e-46
Identities = 51/241 (21%), Positives = 100/241 (41%), Gaps = 37/241 (15%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWN-QV---RLNELMRSPDDLQRLYSEVHLLSTLK 87
E++GKG VY W+ +V ++ + D L+ EV +
Sbjct: 37 IGELIGKGRFGQVYHGR---------WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTR 87
Query: 88 HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVY 146
H++++ F + + IT + TL R +D+ + A++I++G+ Y
Sbjct: 88 HENVVLFMGACMS--PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH------SVIGTPEFM 200
LH++ ++H+DLK N+F + +V I D GL +I ++ G +
Sbjct: 146 LHAK--GILHKDLKSKNVFYDNG--KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHL 201
Query: 201 APEL----------YEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL 250
APE+ + +++ DV++ G E+ E+P+ I ++ +G
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ-PAEAIIWQMGTGMK 260
Query: 251 P 251
P
Sbjct: 261 P 261
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-45
Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 16/228 (7%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
EE++G G VY+A +G EVA R + ++ + E L + LKH +I
Sbjct: 11 LEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRD 151
I + + + E G L +R+ + +WA QI +G+ YLH
Sbjct: 69 IALRGVCLK--EPNLCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 152 P-PVIHRDLKCDNIFVNGHLGQ-------VKIGDLGLAAILRGSKSAHSVIGTPEFMAPE 203
P+IHRDLK NI + + +KI D GLA + + S G +MAPE
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-TKMSAAGAYAWMAPE 184
Query: 204 LYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL 250
+ +++ DV+S+G+ + E+ T E P+ + + V KL
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI-DGLAVAYGVAMNKL 231
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 6e-45
Identities = 81/287 (28%), Positives = 138/287 (48%), Gaps = 35/287 (12%)
Query: 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVH 81
+ DP + E++ GKG+ V+K ID VA + L E + D+++ + E+
Sbjct: 17 KADPEELFTKLEKI-GKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEIT 72
Query: 82 LLSTLKHDSIIRFYTS-------WIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK 134
+LS + ++Y S WI ++ ++ G L E I I
Sbjct: 73 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE-------TQIATI- 124
Query: 135 SWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS-AHSV 193
R+IL+GL YLHS IHRD+K N+ ++ H G+VK+ D G+A L ++ ++
Sbjct: 125 --LREILKGLDYLHSEK--KIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTF 179
Query: 194 IGTPEFMAPELYEED-YNELVDVYSFGMCVLEMFTCEYPYSECANPAQ-IYKKVTSG--K 249
+GTP +MAPE+ ++ Y+ D++S G+ +E+ E P+SE +P + ++ +
Sbjct: 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLIPKNNPPT 238
Query: 250 LPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVKL 295
L G + + F+ CL S R +AKELL F+ + K
Sbjct: 239 LEGNYSK----PLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKT 281
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 7e-45
Identities = 76/282 (26%), Positives = 132/282 (46%), Gaps = 38/282 (13%)
Query: 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVH 81
+ DP + + +G+G+ V A ++ G +VA + L R + L++EV
Sbjct: 40 QGDPRLLLDSYVK-IGEGSTGIVCLAREKHSGRQVAVKMMDL----RKQQRRELLFNEVV 94
Query: 82 LLSTLKHDSIIRFYTS-------WIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK 134
++ +H +++ Y S W+ ++ +T++ + L E I +
Sbjct: 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEE-------QIATV- 146
Query: 135 SWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS-AHSV 193
+LQ L YLH++ VIHRD+K D+I + G+VK+ D G A + S+
Sbjct: 147 --CEAVLQALAYLHAQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSL 201
Query: 194 IGTPEFMAPEL-YEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG 252
+GTP +MAPE+ Y VD++S G+ V+EM E PY +P Q K++ P
Sbjct: 202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPP- 259
Query: 253 AFYSIQDLEA-----QRFIGRCL-VNASKRLSAKELLLDPFL 288
+++ + F+ R L + +R +A+ELL PFL
Sbjct: 260 ---KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFL 298
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 8e-45
Identities = 88/282 (31%), Positives = 139/282 (49%), Gaps = 38/282 (13%)
Query: 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVH 81
DP +Y FE+ +G+GA TVY A+D G EVA Q+ L + + + +E+
Sbjct: 15 VGDPKKKYTRFEK-IGQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEIL 69
Query: 82 LLSTLKHDSIIRFYTS-------WIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK 134
++ K+ +I+ + S W+ ++ +T++ T + E I A+
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE-------GQIAAV- 121
Query: 135 SWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS-AHSV 193
R+ LQ L +LHS VIHRD+K DNI + G VK+ D G A + +S ++
Sbjct: 122 --CRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTM 176
Query: 194 IGTPEFMAPEL-YEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG 252
+GTP +MAPE+ + Y VD++S G+ +EM E PY NP + + + P
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTP- 234
Query: 253 AFYSIQDLEA-----QRFIGRCL-VNASKRLSAKELLLDPFL 288
+Q+ E + F+ RCL ++ KR SAKELL FL
Sbjct: 235 ---ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-44
Identities = 75/281 (26%), Positives = 123/281 (43%), Gaps = 37/281 (13%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVH-LLSTLKHDSII 92
LG+GA V K G +A ++R + + +RL ++ + T+ +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATV---NSQEQKRLLMDLDISMRTVDCPFTV 69
Query: 93 RFYTS-------WIDVDQKTFNFITE-MFTSGT--LREYRKKYRRVDIRAIKSWARQILQ 142
FY + WI E M TS ++ K + + + A I++
Sbjct: 70 TFYGALFREGDVWI---------CMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 143 GLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAP 202
L +LHS+ VIHRD+K N+ +N LGQVK+ D G++ L + G +MAP
Sbjct: 121 ALEHLHSKLS-VIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAP 178
Query: 203 E-----LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG---KLPGAF 254
E L ++ Y+ D++S G+ ++E+ +PY P Q K+V +LP
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK 238
Query: 255 YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVK 294
+S E F +CL N+ +R + EL+ PF E K
Sbjct: 239 FS---AEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESK 276
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 5e-44
Identities = 63/280 (22%), Positives = 119/280 (42%), Gaps = 36/280 (12%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVH-LLSTLKHDSII 92
+G G V+K G +A Q+R + + ++ +R+ ++ +L + I+
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG---NKEENKRILMDLDVVLKSHDCPYIV 87
Query: 93 RFYTS-------WIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLV 145
+ + + +I E+ + + ++ + R + I++ L
Sbjct: 88 QCFGTFITNTDVFI---------AMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALY 138
Query: 146 YLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE-- 203
YL + VIHRD+K NI ++ GQ+K+ D G++ L K+ G +MAPE
Sbjct: 139 YLKEKHG-VIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERI 196
Query: 204 ----LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP----GAFY 255
+ DY+ DV+S G+ ++E+ T ++PY C ++ KV + P +
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF 256
Query: 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVK 294
S + Q F+ CL + KR +LL F+ E
Sbjct: 257 S---GDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETL 293
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-43
Identities = 77/302 (25%), Positives = 118/302 (39%), Gaps = 57/302 (18%)
Query: 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHL 82
+ Y L E + G GA V A +VA ++ L + + L E+
Sbjct: 11 SINRDDYELQEVI-GSGATAVVQAAYCAPKKEKVAIKRINLEK---CQTSMDELLKEIQA 66
Query: 83 LSTLKHDSIIRFYTSWIDVDQK-----------------TFNFITEMFTSGTLREYRKKY 125
+S H +I+ +YTS++ V + SG L E
Sbjct: 67 MSQCHHPNIVSYYTSFV-VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE----- 120
Query: 126 RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185
I + R++L+GL YLH IHRD+K NI + G V+I D G++A L
Sbjct: 121 -----STIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGED-GSVQIADFGVSAFLA 172
Query: 186 GS------KSAHSVIGTPEFMAPELYEED--YNELVDVYSFGMCVLEMFTCEYPYSECA- 236
K + +GTP +MAPE+ E+ Y+ D++SFG+ +E+ T PY +
Sbjct: 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP 232
Query: 237 ---------NPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDP 286
N + K Y ++ I CL + KR +A ELL
Sbjct: 233 MKVLMLTLQNDPPSLETGVQDKEMLKKYG---KSFRKMISLCLQKDPEKRPTAAELLRHK 289
Query: 287 FL 288
F
Sbjct: 290 FF 291
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-43
Identities = 79/281 (28%), Positives = 131/281 (46%), Gaps = 29/281 (10%)
Query: 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVH 81
+ DPN + + E LG GA VYKA ++ G A + S ++L+ E+
Sbjct: 14 DLDPNEVWEIVGE-LGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYIVEIE 68
Query: 82 LLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLRE-YRKKYRRVDIRAIKSWARQI 140
+L+T H I++ ++ D K + + E G + + R + I+ RQ+
Sbjct: 69 ILATCDHPYIVKLLGAYY-HDGKLW-IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQM 126
Query: 141 LQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS-AHSVIGTPEF 199
L+ L +LHS+ +IHRDLK N+ + G +++ D G++A + S IGTP +
Sbjct: 127 LEALNFLHSKR--IIHRDLKAGNVLMTLE-GDIRLADFGVSAKNLKTLQKRDSFIGTPYW 183
Query: 200 MAPE------LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQ-IYKKVTSG---- 248
MAPE + + Y+ D++S G+ ++EM E P+ E NP + + K S
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSDPPTL 242
Query: 249 KLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288
P + E + F+ L N R SA +LL PF+
Sbjct: 243 LTPSKWSV----EFRDFLKIALDKNPETRPSAAQLLEHPFV 279
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-42
Identities = 74/285 (25%), Positives = 132/285 (46%), Gaps = 31/285 (10%)
Query: 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLL 83
DP G + L E +G G VYK G A + + D+ + + E+++L
Sbjct: 21 DPAGIFELVEL-VGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINML 74
Query: 84 STL-KHDSIIRFYTSWIDVDQKTFN----FITEMFTSGTLREYRK--KYRRVDIRAIKSW 136
H +I +Y ++I + + + E +G++ + K K + I
Sbjct: 75 KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 134
Query: 137 ARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS-AHSVIG 195
R+IL+GL +LH VIHRD+K N+ + + +VK+ D G++A L + ++ IG
Sbjct: 135 CREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIG 191
Query: 196 TPEFMAPE------LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQ-IYKKVTSG 248
TP +MAPE + Y+ D++S G+ +EM P + +P + ++ +
Sbjct: 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRNP 250
Query: 249 --KLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290
+L +S + Q FI CLV N S+R + ++L+ PF+
Sbjct: 251 APRLKSKKWS---KKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-42
Identities = 47/252 (18%), Positives = 96/252 (38%), Gaps = 29/252 (11%)
Query: 58 WNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFI-TEMFTSG 116
+ + SP + ++ + + + K + +I ++
Sbjct: 90 LKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS---SPKVYLYIQMQLCRKE 146
Query: 117 TLREY---RKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQV 173
L+++ R + QI + + +LHS+ ++HRDLK NIF V
Sbjct: 147 NLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVV 203
Query: 174 KIGDLGLAAILRGSKSAHSV-------------IGTPEFMAPELYEED-YNELVDVYSFG 219
K+GD GL + + +V +GT +M+PE + Y+ VD++S G
Sbjct: 204 KVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLG 263
Query: 220 MCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCL-VNASKRLS 278
+ + E+ Y +S +I V + K P F + + L + ++R
Sbjct: 264 LILFELL---YSFSTQMERVRIITDVRNLKFPLLFTQKYP-QEHMMVQDMLSPSPTERPE 319
Query: 279 AKELLLDPFLAS 290
A +++ + +
Sbjct: 320 ATDIIENAIFEN 331
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 6e-07
Identities = 16/83 (19%), Positives = 39/83 (46%), Gaps = 3/83 (3%)
Query: 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSII 92
+ +G+G V++A ++V A ++RL +++ EV L+ L+H I+
Sbjct: 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLP---NRELAREKVMREVKALAKLEHPGIV 67
Query: 93 RFYTSWIDVDQKTFNFITEMFTS 115
R++ +W++ + + +
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWL 90
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-42
Identities = 79/318 (24%), Positives = 136/318 (42%), Gaps = 43/318 (13%)
Query: 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLL 83
DP + E +G G+ VY A D VA ++ + +S + Q + EV L
Sbjct: 51 DPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKEVRFL 108
Query: 84 STLKHDSIIRFYTS-------WIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSW 136
L+H + I++ W+ + E + + I +
Sbjct: 109 QKLRHPNTIQYRGCYLREHTAWL---------VMEYCLGSASDLLEVHKKPLQEVEIAAV 159
Query: 137 ARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGT 196
LQGL YLHS + +IHRD+K NI ++ G VK+GD G A+I+ + A+S +GT
Sbjct: 160 THGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGSASIM--AP-ANSFVGT 213
Query: 197 PEFMAPE----LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQ-IYKKVTSG--K 249
P +MAPE + E Y+ VDV+S G+ +E+ + P N +Y +
Sbjct: 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPA 272
Query: 250 LPGAFYSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDE-----VKLLSKTK--L 301
L +S + F+ CL R +++ LL F+ + + L+ +TK +
Sbjct: 273 LQSGHWS---EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAV 329
Query: 302 NQKPFLNETELEKLQLSD 319
+ L +++K+ +
Sbjct: 330 RELDNLQYRKMKKILFQE 347
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-42
Identities = 55/274 (20%), Positives = 84/274 (30%), Gaps = 30/274 (10%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
F + LG+G V G A ++ + D + E + H +I
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNHPNI 88
Query: 92 IRFYTSWIDVDQKTFNF--ITEMFTSGTLREYRKKYRRVDIR----AIKSWARQILQGLV 145
+R + + F GTL ++ + I I +GL
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 146 YLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVI----------G 195
+H+ HRDLK NI + GQ + DLG
Sbjct: 149 AIHA--KGYAHRDLKPTNILLGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 196 TPEFMAPELYE----EDYNELVDVYSFGMCVL-EMFTCEYPYSECANPAQIYKKVTSGKL 250
T + APEL+ +E DV+S G CVL M E PY +L
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLG-CVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264
Query: 251 PGAFYSIQDLEAQRFIGRCL-VNASKRLSAKELL 283
+ + + V+ +R LL
Sbjct: 265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLL 298
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-41
Identities = 62/282 (21%), Positives = 118/282 (41%), Gaps = 35/282 (12%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVH-LLSTLKHDSII 92
+G+GA +V K + + G +A ++R + ++L ++ ++ + I+
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIV 84
Query: 93 RFYTS-------WIDVDQKTFNFITEMFTSGTLREYRKKY----RRVDIRAIKSWARQIL 141
+FY + WI E+ ++ + Y+ Y + + +
Sbjct: 85 QFYGALFREGDCWI---------CMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATV 135
Query: 142 QGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMA 201
+ L +L + +IHRD+K NI ++ G +K+ D G++ L S + G +MA
Sbjct: 136 KALNHLKE-NLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMA 193
Query: 202 PE-----LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG---KLPGA 253
PE + Y+ DV+S G+ + E+ T +PY + + +V G +L +
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNS 253
Query: 254 FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVK 294
F+ CL + SKR KELL PF+ E +
Sbjct: 254 EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER 295
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-41
Identities = 81/320 (25%), Positives = 148/320 (46%), Gaps = 46/320 (14%)
Query: 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVH 81
P + + E++ G+G+ +VYKAI + G VA QV + ++ + E+
Sbjct: 24 TKQPEEVFDVLEKL-GEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIK---EIS 76
Query: 82 LLSTLKHDSIIRFYTS-------WIDVDQKTFNFITEMFTSGTLRE-YRKKYRRVDIRAI 133
++ ++++Y S WI + E +G++ + R + + + I
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWI---------VMEYCGAGSVSDIIRLRNKTLTEDEI 127
Query: 134 KSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS-AHS 192
+ + L+GL YLH IHRD+K NI +N G K+ D G+A L + + ++
Sbjct: 128 ATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTE-GHAKLADFGVAGQLTDTMAKRNT 184
Query: 193 VIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP 251
VIGTP +MAPE + E YN + D++S G+ +EM + PY++ +P + + + P
Sbjct: 185 VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD-IHPMRAIFMIPTNPPP 243
Query: 252 GAFYSIQDLEA-----QRFIGRCL-VNASKRLSAKELLLDPFLASDEVKLLSKTKLNQKP 305
+ + E F+ +CL + +R +A +LL PF+ S +K +
Sbjct: 244 ----TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS------AKGVSILRD 293
Query: 306 FLNETELEKLQLSDDPPRTD 325
+NE KL+ + R +
Sbjct: 294 LINEAMDVKLKRQESQQREE 313
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-40
Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 22/292 (7%)
Query: 23 TDPN--GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEV 80
DP RY LGKG ++ D A ++ L+ P +++ E+
Sbjct: 9 VDPRSRRRYVR-GRFLGKGGFAKCFEISDADTKEVFAG-KIVPKSLLLKPHQREKMSMEI 66
Query: 81 HLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQI 140
+ +L H ++ F+ + + + F + E+ +L E K+ + + + + RQI
Sbjct: 67 SIHRSLAHQHVVGFHG-FFEDNDFVF-VVLELCRRRSLLELHKRRKALTEPEARYYLRQI 124
Query: 141 LQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVI-GTPEF 199
+ G YLH VIHRDLK N+F+N +VKIGD GLA + V+ GTP +
Sbjct: 125 VLGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPNY 181
Query: 200 MAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258
+APE L ++ ++ VDV+S G C++ P E + + Y ++ + YSI
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKNE-----YSIP 235
Query: 259 D---LEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEV-KLLSKTKLNQKP 305
A I + L + + R + ELL D F S + L T L P
Sbjct: 236 KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPP 287
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-40
Identities = 79/286 (27%), Positives = 127/286 (44%), Gaps = 20/286 (6%)
Query: 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL 86
RY LGKG ++ D A V L+ P +++ E+ + +L
Sbjct: 41 RRYVR-GRFLGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQREKMSMEISIHRSL 98
Query: 87 KHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVY 146
H ++ F+ + + + F + E+ +L E K+ + + + + RQI+ G Y
Sbjct: 99 AHQHVVGFHG-FFEDNDFVF-VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 156
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVI-GTPEFMAPE-L 204
LH VIHRDLK N+F+N +VKIGD GLA + V+ GTP ++APE L
Sbjct: 157 LHRNR--VIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL 213
Query: 205 YEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD---LE 261
++ ++ VDV+S G C++ P E + + Y ++ + YSI
Sbjct: 214 SKKGHSFEVDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKNE-----YSIPKHINPV 267
Query: 262 AQRFIGRCL-VNASKRLSAKELLLDPFLASDEV-KLLSKTKLNQKP 305
A I + L + + R + ELL D F S + L T L P
Sbjct: 268 AASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPP 313
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-39
Identities = 94/342 (27%), Positives = 149/342 (43%), Gaps = 42/342 (12%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
+ VLGKG+ V D++ G E A + ++ + D + L EV LL L H +I
Sbjct: 30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQV-KQKTDKESLLREVQLLKQLDHPNI 88
Query: 92 IRFYTSWIDV--DQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQILQGLVY 146
++ Y + D+ F + E++T G L + RK++ VD I RQ+L G+ Y
Sbjct: 89 MKLY----EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI---IRQVLSGITY 141
Query: 147 LHSRDPPVIHRDLKCDNI-FVNGHLG-QVKIGDLGLAAILRGSKSAHSVIGTPEFMAPEL 204
+H ++HRDLK +N+ + ++I D GL+ SK IGT ++APE+
Sbjct: 142 MHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV 199
Query: 205 YEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQIYKKVTSGKL--PGAFYSIQDL 260
Y+E DV+S G +L + P N I KKV GK +
Sbjct: 200 LHGTYDEKCDVWSTG-VILYILLSGCPPFNGA--NEYDILKKVEKGKYTFELPQWKKVSE 256
Query: 261 EAQRFIGRCL-VNASKRLSAKELLLDPFLASDE-------VKLLSKTKLNQKPFLNETEL 312
A+ I + L S R+SA++ L ++ + V L LN + F +L
Sbjct: 257 SAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKL 316
Query: 313 EKLQLSDDPPRTDMTITGKLNPEDDTIFLKV--QIADKDGPG 352
+ L + + KL +D+T L DK+G G
Sbjct: 317 AQAAL--------LYMGSKLTSQDETKELTAIFHKMDKNGDG 350
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-39
Identities = 63/301 (20%), Positives = 120/301 (39%), Gaps = 39/301 (12%)
Query: 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSI 91
VL +G VY+A D G E A ++ L + + + EV + L H +I
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRL----LSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 92 IRFYTSWIDVDQKTFN-----FITEMFTSGTLREYRKKYR---RVDIRAIKSWARQILQG 143
++F ++ +++ + G L E+ KK + + Q +
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR----GSKSAHSV------ 193
+ ++H + PP+IHRDLK +N+ ++ G +K+ D G A + S SA
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 194 ---IGTPEFMAPELYE----EDYNELVDVYSFGMCVL-EMFTCEYPYSECANPAQIYKKV 245
TP + PE+ + E D+++ G C+L + ++P+ + ++
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG-CILYLLCFRQHPFED-----GAKLRI 261
Query: 246 TSGKLPGAFYSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVKLLSKTKLNQK 304
+GK + Q I L VN +RLS E++ + + K+ + +
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITEL 321
Query: 305 P 305
Sbjct: 322 L 322
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-39
Identities = 68/307 (22%), Positives = 124/307 (40%), Gaps = 53/307 (17%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLY-SEVHLLSTLKHDS 90
+E +GKG V++ G EVA V++ S ++ +E++ L+H++
Sbjct: 46 LQESIGKGRFGEVWRGK--WRGEEVA---VKI---FSSREERSWFREAEIYQTVMLRHEN 97
Query: 91 IIRFYTSWIDVDQKTFNF--ITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLH 148
I+ F + + +++ G+L +Y +Y V + + A GL +LH
Sbjct: 98 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLH 156
Query: 149 SRD------PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS-----AHSVIGTP 197
P + HRDLK NI V + G I DLGLA + + +GT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 198 EFMAPELYEE-------DYNELVDVYSFGMCVLEMFTC----------EYPYSEC----A 236
+MAPE+ ++ + + D+Y+ G+ E+ + PY +
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 275
Query: 237 NPAQIYKKVTSGKL----PGAFYSIQDLEA-QRFIGRCL-VNASKRLSAKELL--LDPFL 288
+ ++ K V KL P + S + L + + C N + RL+A + L
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335
Query: 289 ASDEVKL 295
+ +K+
Sbjct: 336 QQEGIKM 342
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-39
Identities = 70/307 (22%), Positives = 125/307 (40%), Gaps = 53/307 (17%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLY-SEVHLLSTLKHDS 90
+ +GKG V+ G +VA V++ + ++ +E++ ++H++
Sbjct: 41 MVKQIGKGRYGEVWMGK--WRGEKVA---VKV---FFTTEEASWFRETEIYQTVLMRHEN 92
Query: 91 IIRFYTSWIDVDQKTFNF--ITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLH 148
I+ F + I IT+ +G+L +Y K +D +++ A + GL +LH
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLH 151
Query: 149 SRD------PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-----SAHSVIGTP 197
+ P + HRDLK NI V + G I DLGLA ++ +GT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 198 EFMAPELYEE-------DYNELVDVYSFGMCVLEMFTC----------EYPYSECANP-- 238
+M PE+ +E + D+YSFG+ + E+ + PY +
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270
Query: 239 --AQIYKKVTSGKL----PGAFYSIQDLEA-QRFIGRCL-VNASKRLSAKELL--LDPFL 288
+ + V KL P + S + L + + C N + RL+A + L
Sbjct: 271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330
Query: 289 ASDEVKL 295
S ++KL
Sbjct: 331 ESQDIKL 337
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 7e-39
Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 28/219 (12%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLY-SEVHLLSTLKHDS 90
EVLGKG K G + + EL+R ++ QR + EV ++ L+H +
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMV-----MKELIRFDEETQRTFLKEVKVMRCLEHPN 68
Query: 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVYLHS 149
+++F K NFITE GTLR + + S+A+ I G+ YLHS
Sbjct: 69 VLKFIGVL--YKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 150 RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---------------KSAHSVI 194
+ +IHRDL N V + V + D GLA ++ K ++V+
Sbjct: 127 MN--IIHRDLNSHNCLVRENK-NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 195 GTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPY 232
G P +MAPE + Y+E VDV+SFG+ + E+
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 63/377 (16%), Positives = 122/377 (32%), Gaps = 67/377 (17%)
Query: 23 TDPNGRYGLFEEVLGKGAMK--TVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEV 80
G Y L + GKG TV A + G V ++ L S + + L E+
Sbjct: 21 LPEGGCYELLTVI-GKGFEDLMTVNLARYKPTGEYVTVRRINLEAC--SNEMVTFLQGEL 77
Query: 81 HLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDI--RAIKSWAR 138
H+ H +I+ + ++I ++ +T G+ ++ + + AI +
Sbjct: 78 HVSKLFNHPNIVPYRATFIADNE--LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 135
Query: 139 QILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS--------A 190
+L+ L Y+H +HR +K +I ++ G+V + L +
Sbjct: 136 GVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 191 HSVIGTPEFMAPELYEED---YNELVDVYSFGMCVLEMFTCEYPYSE------------- 234
+ +++PE+ +++ Y+ D+YS G+ E+ P+ +
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 252
Query: 235 ----------------------CANPAQIYKKVTSGKLPGAFYSIQDLEAQR-------- 264
+ + +T+ + R
Sbjct: 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHH 312
Query: 265 FIGRCLV-NASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNETELEKLQLSDDPPR 323
F+ +CL N R SA LL F + + +P T E Q D
Sbjct: 313 FVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGI 372
Query: 324 TDMTITGKLNPEDDTIF 340
+ + DD F
Sbjct: 373 FGLVTNLEELEVDDWEF 389
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-38
Identities = 66/311 (21%), Positives = 118/311 (37%), Gaps = 65/311 (20%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
LG G V+K + G+ +A + L P ++ E+ +L I+
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVG 95
Query: 94 FYTS-------WIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVY 146
FY + I E G+L + KK R+ + + + +++GL Y
Sbjct: 96 FYGAFYSDGEISI---------CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 146
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE-LY 205
L + ++HRD+K NI VN G++K+ D G++ L S A+S +GT +M+PE L
Sbjct: 147 LREKHK-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQ 203
Query: 206 EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL----- 260
Y+ D++S G+ ++EM YP + A +
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263
Query: 261 ------------------------------------EAQRFIGRCLV-NASKRLSAKELL 283
E Q F+ +CL+ N ++R K+L+
Sbjct: 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 323
Query: 284 LDPFLASDEVK 294
+ F+ + +
Sbjct: 324 VHAFIKRSDAE 334
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 89/341 (26%), Positives = 152/341 (44%), Gaps = 40/341 (11%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
+ LG GA V D+V VE A +R + S +L EV +L L H +I
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV--STSSNSKLLEEVAVLKLLDHPNI 98
Query: 92 IRFYTSWIDV--DQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQILQGLVY 146
++ Y D D++ + + E + G L + R K+ VD I +Q+L G+ Y
Sbjct: 99 MKLY----DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI---IKQVLSGVTY 151
Query: 147 LHSRDPPVIHRDLKCDNI-FVNGHLG-QVKIGDLGLAAILRGSKSAHSVIGTPEFMAPEL 204
LH + ++HRDLK +N+ + +KI D GL+A+ K +GT ++APE+
Sbjct: 152 LHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV 209
Query: 205 YEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL--PGAFYSIQDLEA 262
+ Y+E DV+S G+ + + P+ +I +KV GK + A
Sbjct: 210 LRKKYDEKCDVWSIGVILFILLAGYPPFG-GQTDQEILRKVEKGKYTFDSPEWKNVSEGA 268
Query: 263 QRFIGRCL-VNASKRLSAKELLLDPFLASDEVK--------LLSKTKLNQKPFLNETELE 313
+ I + L ++ +R+SA++ L P++ K L+ N + F N +L
Sbjct: 269 KDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLA 328
Query: 314 KLQLSDDPPRTDMTITGKLNPEDDTIFLKV--QIADKDGPG 352
+ L + + KL +++T L + DK+G G
Sbjct: 329 QAAL--------LYMASKLTSQEETKELTDIFRHIDKNGDG 361
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-38
Identities = 72/293 (24%), Positives = 123/293 (41%), Gaps = 51/293 (17%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLY-SEVHLLSTLKHDS 90
E +GKG V++ G VA V++ S D+ +E++ L+H++
Sbjct: 12 LLECVGKGRYGEVWRGS--WQGENVA---VKI---FSSRDEKSWFRETELYNTVMLRHEN 63
Query: 91 IIRFYTSWIDVDQKTFNF--ITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLH 148
I+ F S + + IT G+L +Y + +D + I GL +LH
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLH 122
Query: 149 SR------DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS-----AHSVIGTP 197
P + HRDLK NI V + GQ I DLGLA + S + + +GT
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 198 EFMAPELYEE-------DYNELVDVYSFGMCVLEMFTC----------EYPYSE--CANP 238
+MAPE+ +E D + VD+++FG+ + E+ + P+ + +P
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241
Query: 239 A--QIYKKVTSGKL----PGAFYSIQDLEA-QRFIGRCL-VNASKRLSAKELL 283
+ + K V + P ++S L + + + C N S RL+A +
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-38
Identities = 57/307 (18%), Positives = 106/307 (34%), Gaps = 48/307 (15%)
Query: 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVH 81
++ N + L ++LG+GA V++ + G A +R D R E
Sbjct: 4 QSTSNHLW-LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR---EFE 59
Query: 82 LLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDI---RAIKSWAR 138
+L L H +I++ + + + I E G+L ++ R
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 139 QILQGLVYLHSRDPPVIHRDLKCDNIFVNG---HLGQVKIGDLGLAAILRGSKSAHSVIG 195
++ G+ +L ++HR++K NI K+ D G A L + S+ G
Sbjct: 120 DVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYG 177
Query: 196 TPEFMAPELYE---------EDYNELVDVYSFGMCVLEMFTCE---YPYSECANPAQIYK 243
T E++ P++YE + Y VD++S G+ T P+ ++
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
Query: 244 KVTSGKLPGAFYSIQDLE-----------------------AQRFIGRCL-VNASKRLSA 279
K+ +GK GA +Q E + L + K
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297
Query: 280 KELLLDP 286
+ +
Sbjct: 298 DQFFAET 304
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 85/343 (24%), Positives = 145/343 (42%), Gaps = 44/343 (12%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
+LGKG+ V K D + E A + D + EV LL L H +I
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREVELLKKLDHPNI 83
Query: 92 IRFYTSWIDV--DQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQILQGLVY 146
++ + ++ D +F + E++T G L + RK++ D I +Q+ G+ Y
Sbjct: 84 MKLF----EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI---IKQVFSGITY 136
Query: 147 LHSRDPPVIHRDLKCDNI-FVN-GHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPEL 204
+H + ++HRDLK +NI + +KI D GL+ + + IGT ++APE+
Sbjct: 137 MHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194
Query: 205 YEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQIYKKVTSGKL--PGAFYSIQDL 260
Y+E DV+S G +L + P Y + N I K+V +GK +
Sbjct: 195 LRGTYDEKCDVWSAG-VILYILLSGTPPFYGK--NEYDILKRVETGKYAFDLPQWRTISD 251
Query: 261 EAQRFIGRCL-VNASKRLSAKELLLDPFLASD--------EVKLLSKTKLNQKPFLNETE 311
+A+ I + L + S R++A + L P++ ++ L N + F E +
Sbjct: 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKK 311
Query: 312 LEKLQLSDDPPRTDMTITGKLNPEDDTIFLKVQIA--DKDGPG 352
L + L + + KL D+T L D + G
Sbjct: 312 LAQAAL--------LYMASKLTTLDETKQLTEIFRKLDTNNDG 346
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 93/353 (26%), Positives = 147/353 (41%), Gaps = 54/353 (15%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVA---------WNQVRLNELMRSPDDLQRLYSEVHL 82
LG GA V ++ E A ++ + +Y+E+ L
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 83 LSTLKHDSIIRFYTSWIDV--DQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWA 137
L +L H +II+ + DV D+K F +TE + G L E R K+ D I
Sbjct: 100 LKSLDHPNIIKLF----DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI---M 152
Query: 138 RQILQGLVYLHSRDPPVIHRDLKCDNI-FVNGHLG-QVKIGDLGLAAILRGSKSAHSVIG 195
+QIL G+ YLH + ++HRD+K +NI N + +KI D GL++ +G
Sbjct: 153 KQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLG 210
Query: 196 TPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQIYKKVTSGKLPGA 253
T ++APE+ ++ YNE DV+S G ++ + C YP + N I KKV GK
Sbjct: 211 TAYYIAPEVLKKKYNEKCDVWSCG-VIMYILLCGYPPFGGQ--NDQDIIKKVEKGKYY-- 265
Query: 254 FYSIQ----DLEAQRFIGRCL-VNASKRLSAKELLLDPFLASD-------EVKLLSKTKL 301
F EA+ I L + +KR +A+E L ++ + K L
Sbjct: 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALS 325
Query: 302 NQKPFLNETELEKLQLSDDPPRTDMTITGKLNPEDDTIFLKVQIA--DKDGPG 352
N + F +L + + + I KL ++ L DK+G G
Sbjct: 326 NMRKFEGSQKLAQAAI--------LFIGSKLTTLEERKELTDIFKKLDKNGDG 370
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-37
Identities = 65/289 (22%), Positives = 125/289 (43%), Gaps = 31/289 (10%)
Query: 19 GYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYS 78
G + D N Y E +G+G+ V A+ + + A ++ + +D+ R
Sbjct: 1 GSTKGDINQYY-TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV----EDVDRFKQ 55
Query: 79 EVHLLSTLKHDSIIRFYTSWIDV--DQKTFNFITEMFTSGTLREY---RKKYRRVDIRAI 133
E+ ++ +L H +IIR Y + D + E+ T G L E ++ +R D I
Sbjct: 56 EIEIMKSLDHPNIIRLY----ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI 111
Query: 134 KSWARQILQGLVYLHSRDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLAAILRGSKSAH 191
+ +L + Y H + V HRDLK +N + +K+ D GLAA + K
Sbjct: 112 ---MKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR 166
Query: 192 SVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQIYKKVTSGK 249
+ +GTP +++P++ E Y D +S G ++ + C YP + +++ K+ G
Sbjct: 167 TKVGTPYYVSPQVLEGLYGPECDEWSAG-VMMYVLLCGYPPFSAP--TDSEVMLKIREGT 223
Query: 250 L---PGAFYSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVK 294
+ ++ +A+ I R L + +R+++ + L +
Sbjct: 224 FTFPEKDWLNVSP-QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-37
Identities = 71/291 (24%), Positives = 128/291 (43%), Gaps = 28/291 (9%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELM----RSPDDLQRLYSEVHLLSTLK 87
+ LG GA V A + +VA + + R D + +E+ +L L
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 88 HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQILQGL 144
H II+ D + + + E+ G L + K+ + + Q+L +
Sbjct: 199 HPCIIKIKNF---FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY---FYQMLLAV 252
Query: 145 VYLHSRDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAP 202
YLH +IHRDLK +N+ ++ +KI D G + IL + ++ GTP ++AP
Sbjct: 253 QYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 310
Query: 203 E----LYEEDYNELVDVYSFGMCVLEMFTCEY-PYSECANPAQIYKKVTSGKL---PGAF 254
E + YN VD +S G +L + Y P+SE + ++TSGK P +
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLG-VILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369
Query: 255 YSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVKLLSKTKLNQK 304
+ + +A + + L V+ R + +E L P+L +++K + L+++
Sbjct: 370 AEVSE-KALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEE 419
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 72/275 (26%), Positives = 124/275 (45%), Gaps = 26/275 (9%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
+LGKG+ V K D + E A + D + EV LL L H +I
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREVELLKKLDHPNI 83
Query: 92 IRFYTSWIDV--DQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQILQGLVY 146
++ + ++ D +F + E++T G L + RK++ D I +Q+ G+ Y
Sbjct: 84 MKLF----EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI---IKQVFSGITY 136
Query: 147 LHSRDPPVIHRDLKCDNI-FVN-GHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPEL 204
+H + ++HRDLK +NI + +KI D GL+ + + IGT ++APE+
Sbjct: 137 MHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194
Query: 205 YEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQIYKKVTSGKL--PGAFYSIQDL 260
Y+E DV+S G +L + P Y + N I K+V +GK +
Sbjct: 195 LRGTYDEKCDVWSAG-VILYILLSGTPPFYGK--NEYDILKRVETGKYAFDLPQWRTISD 251
Query: 261 EAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVK 294
+A+ I + L + S R++A + L P++ +
Sbjct: 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 142 bits (358), Expect = 1e-36
Identities = 69/299 (23%), Positives = 107/299 (35%), Gaps = 21/299 (7%)
Query: 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL 86
G + +E LG G V + I + G +VA Q R SP + +R E+ ++ L
Sbjct: 14 GPW-EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE---LSPKNRERWCLEIQIMKKL 69
Query: 87 KHDSIIRFY----TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDI---RAIKSWARQ 139
H +++ E G LR+Y ++ I++
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 140 ILQGLVYLHSRDPPVIHRDLKCDNI--FVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTP 197
I L YLH +IHRDLK +NI KI DLG A L + +GT
Sbjct: 130 ISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTL 187
Query: 198 EFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYS 256
+++APEL E + Y VD +SFG E T P+ P Q + KV
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247
Query: 257 IQDLEAQRFIGRCLVNASKRLSAKELLLDPFLAS----DEVKLLSKTKLNQKPFLNETE 311
A +F L + L+ +L + + + + +
Sbjct: 248 DDLTGAVKFS-SVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-36
Identities = 59/270 (21%), Positives = 118/270 (43%), Gaps = 26/270 (9%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
F+ LG GA V+ + G+E + + RS ++++ +E+ +L +L H +I
Sbjct: 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKD---RSQVPMEQIEAEIEVLKSLDHPNI 82
Query: 92 IRFYTSWIDV--DQKTFNFITEMFTSGTL----REYRKKYRRVDIRAIKSWARQILQGLV 145
I+ + +V D + E G L + + + + + +Q++ L
Sbjct: 83 IKIF----EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 146 YLHSRDPPVIHRDLKCDNI-FVN-GHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE 203
Y HS+ V+H+DLK +NI F + +KI D GLA + + + + + GT +MAPE
Sbjct: 139 YFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE 196
Query: 204 LYEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQIYKKVTSGKL--PGAFYSIQD 259
+++ D D++S G V+ + ++ +K T + +
Sbjct: 197 VFKRDVTFKCDIWSAG-VVMYFLLTGCLPFTGT--SLEEVQQKATYKEPNYAVECRPLTP 253
Query: 260 LEAQRFIGRCL-VNASKRLSAKELLLDPFL 288
+A + + L + +R SA ++L +
Sbjct: 254 -QAVDLLKQMLTKDPERRPSAAQVLHHEWF 282
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-36
Identities = 77/277 (27%), Positives = 137/277 (49%), Gaps = 33/277 (11%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
+E LGKGA V + + + G+E A + +L S D Q+L E + L+H +I
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNI 67
Query: 92 IRFYTSWIDV--DQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQILQGLVY 146
+R + D ++ + ++ T G L E R+ Y D +QIL+ + Y
Sbjct: 68 VRLH----DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC---IQQILESIAY 120
Query: 147 LHSRDPPVIHRDLKCDNI-FVNGHLG-QVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE- 203
HS ++HR+LK +N+ + G VK+ D GLA + S++ H GTP +++PE
Sbjct: 121 CHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV 178
Query: 204 LYEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQIYKKVTSGKLPGAFYS----- 256
L ++ Y++ VD+++ G +L + YP + E + ++Y ++ +G + S
Sbjct: 179 LKKDPYSKPVDIWACG-VILYILLVGYPPFWDE--DQHRLYAQIKAGAY--DYPSPEWDT 233
Query: 257 IQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDE 292
+ EA+ I L VN KR++A + L P++ + E
Sbjct: 234 VTP-EAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-36
Identities = 60/341 (17%), Positives = 111/341 (32%), Gaps = 55/341 (16%)
Query: 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVH 81
++ N + L ++LG+GA V++ + G A +R D R E
Sbjct: 4 QSTSNHLW-LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR---EFE 59
Query: 82 LLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWAR 138
+L L H +I++ + + + I E G+L + R
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 139 QILQGLVYLHSRDPPVIHRDLKCDNIFVNG---HLGQVKIGDLGLAAILRGSKSAHSVIG 195
++ G+ +L ++HR++K NI K+ D G A L + S+ G
Sbjct: 120 DVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYG 177
Query: 196 TPEFMAPELYEED---------YNELVDVYSFGMCVLEMFTCE---YPYSECANPAQIYK 243
T E++ P++YE Y VD++S G+ T P+ ++
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
Query: 244 KVTSGKLPGAFYSIQDLE-----------------------AQRFIGRCL-VNASKRLSA 279
K+ +GK GA +Q E + L + K
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297
Query: 280 KELLLDPFLASDEVKLLSKTKLNQKPFLNETELEKLQLSDD 320
+ E + + L + K+ +
Sbjct: 298 DQFF-------AETSDILHRMVIHVFSLQQMTAHKIYIHSY 331
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 7e-36
Identities = 41/312 (13%), Positives = 91/312 (29%), Gaps = 60/312 (19%)
Query: 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVA---------------------WNQ 60
E R + VLG+ +A D+ G +
Sbjct: 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLR 126
Query: 61 VRLNELMRSPDDLQ---RLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTS-- 115
+RL +++ + R L+ + +IR D+ + F+ S
Sbjct: 127 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 186
Query: 116 ----GTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLG 171
L + ++ + A Q+++ L LH ++H L+ +I ++ G
Sbjct: 187 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQR-G 243
Query: 172 QVKIGDLGLAAILRGSKSAHSVIGTPEFMAPEL------------YEEDYNELVDVYSFG 219
V + + + F PEL D ++ G
Sbjct: 244 GVFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300
Query: 220 MCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL--EAQRFIGRCL-VNASKR 276
+ + ++ + P ++ + + F S +++ + + L R
Sbjct: 301 LVIYWIWCADLPITK-DAALGGSEWI--------FRSCKNIPQPVRALLEGFLRYPKEDR 351
Query: 277 LSAKELLLDPFL 288
L + + P
Sbjct: 352 LLPLQAMETPEY 363
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-36
Identities = 69/257 (26%), Positives = 121/257 (47%), Gaps = 16/257 (6%)
Query: 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRF 94
LGKG VY A ++ +A + +L ++ +L EV + S L+H +I+R
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA-GVEHQLRREVEIQSHLRHPNILRL 74
Query: 95 YTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPV 154
Y + D + + I E GT+ +K + D + ++ ++ L Y HS+ V
Sbjct: 75 YGYFHD-ATRVY-LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--V 130
Query: 155 IHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYEE-DYNELV 213
IHRD+K +N+ + G G++KI D G + S+ + GT +++ PE+ E ++E V
Sbjct: 131 IHRDIKPENLLL-GSAGELKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEGRMHDEKV 188
Query: 214 DVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL--PGAFYSIQDLEAQRFIGRCLV 271
D++S G + F P E + YK+++ + P A+ I R L
Sbjct: 189 DLWSLG-VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV----TEGARDLISRLLK 243
Query: 272 -NASKRLSAKELLLDPF 287
N S+R +E+L P+
Sbjct: 244 HNPSQRPMLREVLEHPW 260
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 73/305 (23%), Positives = 128/305 (41%), Gaps = 30/305 (9%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNEL----MRSPDDLQRLYSEVHLLSTLK 87
+ LG GA V A + +VA + + R D + +E+ +L L
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 88 HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQILQGL 144
H II+ D + + + E+ G L + K+ + + Q+L +
Sbjct: 74 HPCIIKIKNF---FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY---FYQMLLAV 127
Query: 145 VYLHSRDPPVIHRDLKCDNI-FVNGHLG-QVKIGDLGLAAILRGSKSAHSVIGTPEFMAP 202
YLH +IHRDLK +N+ + +KI D G + IL + ++ GTP ++AP
Sbjct: 128 QYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 203 E----LYEEDYNELVDVYSFGMCVLEMFTCEY-PYSECANPAQIYKKVTSGKL---PGAF 254
E + YN VD +S G +L + Y P+SE + ++TSGK P +
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLG-VILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244
Query: 255 YSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNETELE 313
+ + +A + + L V+ R + +E L P+L +++K K + T L
Sbjct: 245 AEVSE-KALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK--RKFQDLLSEENESTALP 301
Query: 314 KLQLS 318
++
Sbjct: 302 QVLAQ 306
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-35
Identities = 49/307 (15%), Positives = 91/307 (29%), Gaps = 46/307 (14%)
Query: 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVH 81
R E L G V+ D + A +V S +L+RL+
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFAL-KVFTMGAENSRSELERLHEATF 114
Query: 82 LLSTLKHDSIIRFYTSW-----IDV-----------------DQKTFN-FITEMFTSGTL 118
+ L +S D D N + S L
Sbjct: 115 AAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDL 174
Query: 119 REYRKKYRRVDIR-------AIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLG 171
V + A+ Q+++ L S+ ++H DN+F+ G
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPD-G 231
Query: 172 QVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELY---EEDYNELVDVYSFGMCVLEMFTC 228
++ +GD+ + + + E + ++ + G+ + ++
Sbjct: 232 RLMLGDVSALW--KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289
Query: 229 EYPYSECANPAQIYKKVTSGKLPGA----FYSIQDL--EAQRFIGRCLV-NASKRLSAKE 281
P+ + K S ++PG F S L + IGR L + +RL E
Sbjct: 290 FLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLE 349
Query: 282 LLLDPFL 288
+ P
Sbjct: 350 AMETPEF 356
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 2e-35
Identities = 36/311 (11%), Positives = 85/311 (27%), Gaps = 55/311 (17%)
Query: 21 IETDPNGRYGLFE--EVLGKGAMKTVYKAIDEVLGVEVA--------------------- 57
+E++ R VLG+ +A D+ G
Sbjct: 69 VESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEE 128
Query: 58 WNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN--FITEMFTS 115
++RL +++ + + +K + +D F
Sbjct: 129 VLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ 188
Query: 116 G-------TLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNG 168
L + ++ + A Q+++ L LH ++H L+ +I ++
Sbjct: 189 SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQ 246
Query: 169 HLGQVKIGDLGLAAIL--RGSKSAHSVIGTPEFMAPELYEED------YNELVDVYSFGM 220
G V + PE A + D ++ G+
Sbjct: 247 R-GGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305
Query: 221 CVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL--EAQRFIGRCL-VNASKRL 277
+ ++ + P ++ + + F S +++ + + L RL
Sbjct: 306 AIYWIWCADLPNTD-DAALGGSEWI--------FRSCKNIPQPVRALLEGFLRYPKEDRL 356
Query: 278 SAKELLLDPFL 288
+ + P
Sbjct: 357 LPLQAMETPEY 367
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 82/307 (26%), Positives = 145/307 (47%), Gaps = 37/307 (12%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
+E LGKGA V + + + G+E A + +L S D Q+L E + L+H +I
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNI 90
Query: 92 IRFYTSWIDV--DQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQILQGLVY 146
+R + D ++ + ++ T G L E R+ Y D +QIL+ + Y
Sbjct: 91 VRLH----DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC---IQQILESIAY 143
Query: 147 LHSRDPPVIHRDLKCDNI-FVNGHLG-QVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE- 203
HS ++HR+LK +N+ + G VK+ D GLA + S++ H GTP +++PE
Sbjct: 144 CHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV 201
Query: 204 LYEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQIYKKVTSGKLPGAFYS----- 256
L ++ Y++ VD+++ G +L + YP + E + ++Y ++ +G + S
Sbjct: 202 LKKDPYSKPVDIWACG-VILYILLVGYPPFWDE--DQHRLYAQIKAGAY--DYPSPEWDT 256
Query: 257 IQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVK----LLSKTKLNQKPFLNETE 311
+ EA+ I L VN KR++A + L P++ + E T K F +
Sbjct: 257 VTP-EAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRK 315
Query: 312 LEKLQLS 318
L+ L+
Sbjct: 316 LKGAILT 322
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 5e-35
Identities = 66/280 (23%), Positives = 120/280 (42%), Gaps = 30/280 (10%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELM--RSPDDLQRLYSEVHLLSTLKHD 89
E LG G V K ++ G+E A ++ + R + + EV +L + H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 90 SIIRFYTSWIDV--DQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQILQGL 144
++I + DV ++ I E+ + G L ++ ++ + + +QIL G+
Sbjct: 76 NVITLH----DVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF---IKQILDGV 128
Query: 145 VYLHSRDPPVIHRDLKCDNIFV---NGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMA 201
YLH++ + H DLK +NI + N + +K+ D GLA + ++ GTPEF+A
Sbjct: 129 NYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 202 PE-LYEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQIYKKVTSGKL---PGAFY 255
PE + E D++S G + + + + +TS F
Sbjct: 187 PEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANITSVSYDFDEEFFS 243
Query: 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVK 294
+ A+ FI + LV KRL+ +E L P++ + +
Sbjct: 244 HTSE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQ 282
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 70/282 (24%), Positives = 122/282 (43%), Gaps = 33/282 (11%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDS 90
++VLG GA T+ +VA ++ P+ EV LL +H +
Sbjct: 28 PKDVLGHGAEGTIVYR-GMFDNRDVAVKRI-------LPECFSFADREVQLLRESDEHPN 79
Query: 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREY--RKKYRRVDIRAIKSWARQILQGLVYLH 148
+IR++ + + D++ E + TL+EY +K + + + + +Q GL +LH
Sbjct: 80 VIRYFCT--EKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEP-ITLLQQTTSGLAHLH 135
Query: 149 SRDPPVIHRDLKCDNIFV----NGHLGQVKIGDLGLAAILRGSKSA----HSVIGTPEFM 200
S + ++HRDLK NI + + I D GL L + + V GT ++
Sbjct: 136 SLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 201 APELYEED----YNELVDVYSFGMCVLEMFTCEY-PYSECANPAQIYKKVTSGKLPG-AF 254
APE+ ED VD++S G + + P+ + Q + + L
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS-LQRQANILLGACSLDCLHP 252
Query: 255 YSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVKL 295
+D+ A+ I + + ++ KR SAK +L PF S E +L
Sbjct: 253 EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQL 294
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 66/303 (21%), Positives = 124/303 (40%), Gaps = 33/303 (10%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNEL--MRSPDDLQRLYSEVHLLSTLKHD 89
E LG G V K ++ G++ A ++ R + + EV +L ++H
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 90 SIIRFYTSWIDV--DQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQILQGL 144
++I + +V ++ I E+ G L ++ ++ + +QIL G+
Sbjct: 75 NVITLH----EVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF---LKQILNGV 127
Query: 145 VYLHSRDPPVIHRDLKCDNIFV---NGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMA 201
YLHS + H DLK +NI + N ++KI D GLA + ++ GTPEF+A
Sbjct: 128 YYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185
Query: 202 PE-LYEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQIYKKVTSGKL---PGAFY 255
PE + E D++S G + + + + V++ F
Sbjct: 186 PEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANVSAVNYEFEDEYFS 242
Query: 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNETELEK 314
+ A+ FI R LV + KR++ ++ L P++ + + + +N + +K
Sbjct: 243 NTSA-LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT---QQALSRKASAVNMEKFKK 298
Query: 315 LQL 317
Sbjct: 299 FAA 301
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 67/283 (23%), Positives = 109/283 (38%), Gaps = 35/283 (12%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
E LG GA V++ +++ G + P D + +E+ +++ L H +
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINT----PYPLDKYTVKNEISIMNQLHHPKL 110
Query: 92 IRFYTSWIDV--DQKTFNFITEMFTSGTL------REYRKKYRRVDIRAIKSWARQILQG 143
I + D D+ I E + G L +Y K ++ RQ +G
Sbjct: 111 INLH----DAFEDKYEMVLILEFLSGGELFDRIAAEDY--KMSEAEVINY---MRQACEG 161
Query: 144 LVYLHSRDPPVIHRDLKCDNI-FVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAP 202
L ++H ++H D+K +NI VKI D GLA L + T EF AP
Sbjct: 162 LKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 219
Query: 203 E-LYEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQIYKKVTSGKL---PGAFYS 256
E + E D+++ G + + E + + + V AF S
Sbjct: 220 EIVDREPVGFYTDMWAIG-VLGYVLLSGLSPFAGE--DDLETLQNVKRCDWEFDEDAFSS 276
Query: 257 IQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVKLLSK 298
+ EA+ FI L KRL+ + L P+L D L S+
Sbjct: 277 VSP-EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 318
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 71/258 (27%), Positives = 117/258 (45%), Gaps = 17/258 (6%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95
LGKG+ VY+A G+EVA ++ + M +QR+ +EV + LKH SI+ Y
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAI-KMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 96 TSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVYLHSRDPPV 154
+ + + + EM +G + Y + + + + + QI+ G++YLHS +
Sbjct: 78 N-YFEDSNYVY-LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--I 133
Query: 155 IHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVI-GTPEFMAPE-LYEEDYNEL 212
+HRDL N+ + + +KI D GLA L+ H + GTP +++PE +
Sbjct: 134 LHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLE 192
Query: 213 VDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG--KLPGAFYSIQDLEAQRFIGRCL 270
DV+S G C+ P + KV ++P EA+ I + L
Sbjct: 193 SDVWSLG-CMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSI----EAKDLIHQLL 247
Query: 271 V-NASKRLSAKELLLDPF 287
N + RLS +L PF
Sbjct: 248 RRNPADRLSLSSVLDHPF 265
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 70/307 (22%), Positives = 132/307 (42%), Gaps = 33/307 (10%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELM--RSPDDLQRLYSEVHLLSTLKHD 89
E LG G V K ++ G+E A ++ + R + + EV +L + H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 90 SIIRFYTSWIDV--DQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQILQGL 144
+II + DV ++ I E+ + G L ++ ++ + + +QIL G+
Sbjct: 76 NIITLH----DVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF---IKQILDGV 128
Query: 145 VYLHSRDPPVIHRDLKCDNIFV---NGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMA 201
YLH++ + H DLK +NI + N + +K+ D GLA + ++ GTPEF+A
Sbjct: 129 NYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 202 PE-LYEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQIYKKVTSGKL---PGAFY 255
PE + E D++S G + + + + +T+ F
Sbjct: 187 PEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANITAVSYDFDEEFFS 243
Query: 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVK---LLSKTKLNQKPFLNETE 311
+ A+ FI + LV KRL+ +E L P++ + + + ++ +N + F +
Sbjct: 244 QTSE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYV 302
Query: 312 LEKLQLS 318
+ +LS
Sbjct: 303 RRRWKLS 309
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-34
Identities = 63/280 (22%), Positives = 119/280 (42%), Gaps = 30/280 (10%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELM--RSPDDLQRLYSEVHLLSTLKHD 89
E LG G V K + G E A ++ L R + + EV++L ++H
Sbjct: 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68
Query: 90 SIIRFYTSWIDV--DQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQILQGL 144
+II + D+ ++ I E+ + G L ++ ++ + +QIL G+
Sbjct: 69 NIITLH----DIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF---LKQILDGV 121
Query: 145 VYLHSRDPPVIHRDLKCDNIFV---NGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMA 201
YLHS+ + H DLK +NI + N ++K+ D G+A + ++ GTPEF+A
Sbjct: 122 HYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 179
Query: 202 PE-LYEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQIYKKVTSGKL---PGAFY 255
PE + E D++S G + + E + +++ F
Sbjct: 180 PEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGE--TKQETLTNISAVNYDFDEEYFS 236
Query: 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVK 294
+ + A+ FI R LV + +R++ + L ++ + +
Sbjct: 237 NTSE-LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 66/291 (22%), Positives = 113/291 (38%), Gaps = 35/291 (12%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
E LG GA V++ + G A V D + + E+ +S L+H ++
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMT----PHESDKETVRKEIQTMSVLRHPTL 216
Query: 92 IRFYTSWIDV--DQKTFNFITEMFTSGTLREY----RKKYRRVDIRAIKSWARQILQGLV 145
+ + D D I E + G L E K + RQ+ +GL
Sbjct: 217 VNLH----DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY---MRQVCKGLC 269
Query: 146 YLHSRDPPVIHRDLKCDNI-FVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE- 203
++H + +H DLK +NI F ++K+ D GL A L +S GT EF APE
Sbjct: 270 HMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 327
Query: 204 LYEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQIYKKVTSGKL---PGAFYSIQ 258
+ D++S G + + E N + + V S AF I
Sbjct: 328 AEGKPVGYYTDMWSVG-VLSYILLSGLSPFGGE--NDDETLRNVKSCDWNMDDSAFSGIS 384
Query: 259 DLEAQRFIGRCLV-NASKRLSAKELLLDPFL----ASDEVKLLSKTKLNQK 304
+ + + FI + L+ + + R++ + L P+L A + ++ +
Sbjct: 385 E-DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKI 434
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 84/310 (27%), Positives = 145/310 (46%), Gaps = 42/310 (13%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
E LGKGA V + + + G E A + +L S D Q+L E + LKH +I
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKHPNI 72
Query: 92 IRFYTSWIDV--DQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQILQGLVY 146
+R + D ++ I ++ T G L E R+ Y D +QIL+ +++
Sbjct: 73 VRLH----DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC---IQQILEAVLH 125
Query: 147 LHSRDPPVIHRDLKCDNI-FVNGHLG-QVKIGDLGLAAILRGSKSA-HSVIGTPEFMAPE 203
H V+HR+LK +N+ + G VK+ D GLA + G + A GTP +++PE
Sbjct: 126 CHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE 183
Query: 204 -LYEEDYNELVDVYSFGMCVLEMFT--CEYP--YSECANPAQIYKKVTSGKLPGAFYS-- 256
L ++ Y + VD+++ G V+ ++ YP + E + ++Y+++ +G F S
Sbjct: 184 VLRKDPYGKPVDLWACG--VI-LYILLVGYPPFWDE--DQHRLYQQIKAGAY--DFPSPE 236
Query: 257 ---IQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASD----EVKLLSKTKLNQKPFLN 308
+ EA+ I + L +N SKR++A E L P+++ +T K F
Sbjct: 237 WDTVTP-EAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNA 295
Query: 309 ETELEKLQLS 318
+L+ L+
Sbjct: 296 RRKLKGAILT 305
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 59/302 (19%), Positives = 115/302 (38%), Gaps = 36/302 (11%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
E LG+G V++ ++ V+ D + E+ +L+ +H +I
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-----VKGTDQVLVKKEISILNIARHRNI 63
Query: 92 IRFYTSWIDV--DQKTFNFITEMFTSGTL------REYRKKYRRVDIRAIKSWARQILQG 143
+ + + + I E + + + + +I + Q+ +
Sbjct: 64 LHLH----ESFESMEELVMIFEFISGLDIFERINTSAF--ELNEREIVSY---VHQVCEA 114
Query: 144 LVYLHSRDPPVIHRDLKCDNI-FVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAP 202
L +LHS + + H D++ +NI + +KI + G A L+ + + PE+ AP
Sbjct: 115 LQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172
Query: 203 E-LYEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQIYKKVTSGKL---PGAFYS 256
E + + D++S G ++ + +E QI + + + + AF
Sbjct: 173 EVHQHDVVSTATDMWSLG-TLVYVLLSGINPFLAE--TNQQIIENIMNAEYTFDEEAFKE 229
Query: 257 IQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNETELEKL 315
I EA F+ R LV R++A E L P+L ++ +K K L K
Sbjct: 230 ISI-EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKK 288
Query: 316 QL 317
L
Sbjct: 289 DL 290
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 67/277 (24%), Positives = 128/277 (46%), Gaps = 36/277 (12%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
F EVLG GA V+ + G A ++ + R L +E+ +L +KH++I
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD----SSLENEIAVLKKIKHENI 68
Query: 92 IRFYTSWIDV--DQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQILQGLVY 146
+ D+ + + ++ + G L + R Y D + +Q+L + Y
Sbjct: 69 VTLE----DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV---IQQVLSAVKY 121
Query: 147 LHSRDPPVIHRDLKCDNI-FVNGHLG-QVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE- 203
LH ++HRDLK +N+ ++ ++ I D GL+ + + + GTP ++APE
Sbjct: 122 LHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-MSTACGTPGYVAPEV 178
Query: 204 LYEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQIYKKVTSGKLPGAFYS----- 256
L ++ Y++ VD +S G + + C YP Y E +++++K+ G F S
Sbjct: 179 LAQKPYSKAVDCWSIG-VITYILLCGYPPFYEE--TESKLFEKIKEGYY--EFESPFWDD 233
Query: 257 IQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDE 292
I + A+ FI L + ++R + ++ L P++ +
Sbjct: 234 ISE-SAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 58/257 (22%), Positives = 121/257 (47%), Gaps = 16/257 (6%)
Query: 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRF 94
LGKG VY A ++ +A + ++L + +L E+ + S L+H +I+R
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKE-GVEHQLRREIEIQSHLRHPNILRM 79
Query: 95 YTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPV 154
Y + ++ + + E G L + +K+ R D + ++ ++ L Y H R V
Sbjct: 80 YN-YFHDRKRIY-LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--V 135
Query: 155 IHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELV 213
IHRD+K +N+ + G++KI D G + + ++ GT +++ PE+ E + ++E V
Sbjct: 136 IHRDIKPENLLMGYK-GELKIADFGWSVHAPSLR-RRTMCGTLDYLPPEMIEGKTHDEKV 193
Query: 214 DVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL--PGAFYSIQDLEAQRFIGRCLV 271
D++ G+ E P+ + + + ++++ + L P ++ I + L
Sbjct: 194 DLWCAGVLCYEFLVGMPPF-DSPSHTETHRRIVNVDLKFPPFL----SDGSKDLISKLLR 248
Query: 272 -NASKRLSAKELLLDPF 287
+ +RL K ++ P+
Sbjct: 249 YHPPQRLPLKGVMEHPW 265
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 4e-33
Identities = 68/311 (21%), Positives = 122/311 (39%), Gaps = 26/311 (8%)
Query: 2 YSNKQLAGAADEAKAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQV 61
+ + +G + + N Y L + LG+G V + I + G E A +
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFL 62
Query: 62 RLNELMRSPDDLQRLYSEVHLLSTLKHD-SIIRFYTSWIDV--DQKTFNFITEMFTSGTL 118
+ D + E+ +L K +I + +V + I E G +
Sbjct: 63 KKRRR--GQDCRAEILHEIAVLELAKSCPRVINLH----EVYENTSEIILILEYAAGGEI 116
Query: 119 --REYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNI-FVN-GHLGQVK 174
+ V + +QIL+G+ YLH + ++H DLK NI + LG +K
Sbjct: 117 FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIK 174
Query: 175 IGDLGLAAILRGSKSAHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYP-- 231
I D G++ + + ++GTPE++APE L + D+++ G+ + M
Sbjct: 175 IVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGI-IAYMLLTHTSPF 233
Query: 232 YSECANPAQIYKKVTSGKL---PGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPF 287
E + + Y ++ + F S+ A FI LV N KR +A+ L +
Sbjct: 234 VGE--DNQETYLNISQVNVDYSEETFSSVSQ-LATDFIQSLLVKNPEKRPTAEICLSHSW 290
Query: 288 LASDEVKLLSK 298
L + + L
Sbjct: 291 LQQWDFENLFH 301
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 69/292 (23%), Positives = 126/292 (43%), Gaps = 35/292 (11%)
Query: 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSII 92
E+LG G V+K + G+++A ++ R D + + +E+ +++ L H ++I
Sbjct: 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKT----RGMKDKEEVKNEISVMNQLDHANLI 149
Query: 93 RFYTSWIDV--DQKTFNFITEMFTSGTL------REYRKKYRRVDIRAIKSWARQILQGL 144
+ Y D + + E G L Y +D +QI +G+
Sbjct: 150 QLY----DAFESKNDIVLVMEYVDGGELFDRIIDESY--NLTELDTILF---MKQICEGI 200
Query: 145 VYLHSRDPPVIHRDLKCDNI-FVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE 203
++H ++H DLK +NI VN Q+KI D GLA + + GTPEF+APE
Sbjct: 201 RHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPE 258
Query: 204 -LYEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQIYKKVTSGKL---PGAFYSI 257
+ + + D++S G+ + M + N A+ + + + F I
Sbjct: 259 VVNYDFVSFPTDMWSVGV-IAYMLLSGLSPFLGD--NDAETLNNILACRWDLEDEEFQDI 315
Query: 258 QDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLN 308
+ EA+ FI + L+ S R+SA E L P+L+ ++ + + +
Sbjct: 316 SE-EAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKNRGSD 366
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-33
Identities = 65/295 (22%), Positives = 124/295 (42%), Gaps = 42/295 (14%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
E LG+GA VY+ + A ++++ D + + +E+ +L L H +I
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYAL------KVLKKTVDKKIVRTEIGVLLRLSHPNI 110
Query: 92 IRFYTSWIDV--DQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQILQGLVY 146
I+ ++ + + E+ T G L + + Y D +QIL+ + Y
Sbjct: 111 IKLK----EIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA---VKQILEAVAY 163
Query: 147 LHSRDPPVIHRDLKCDNI-FVNGHLG-QVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE- 203
LH ++HRDLK +N+ + +KI D GL+ I+ +V GTP + APE
Sbjct: 164 LHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEI 221
Query: 204 LYEEDYNELVDVYSFG--MCVLEMFTCEYP--YSECANPAQIYKKVTSGKLPGAFYS--- 256
L Y VD++S G +L C + Y E +++++ + + F S
Sbjct: 222 LRGCAYGPEVDMWSVGIITYIL---LCGFEPFYDE-RGDQFMFRRILNCEY--YFISPWW 275
Query: 257 --IQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASD--EVKLLSKTKLNQKPF 306
+ A+ + + + ++ KRL+ + L P++ + + + F
Sbjct: 276 DEVSL-NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQKKLQEF 329
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-32
Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 30/230 (13%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQV-RLNELMRSPDDLQRLYSEVHLLSTLKHDS 90
EV +G V+KA ++L VA V ++ Q EV+ L +KH++
Sbjct: 28 LLEVKARGRFGCVWKA--QLLNEYVA---VKIFP--IQDKQSWQNE-YEVYSLPGMKHEN 79
Query: 91 IIRFYTSWIDVDQKTFNF--ITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLH 148
I++F + + IT G+L ++ K V + A + +GL YLH
Sbjct: 80 ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLH 138
Query: 149 S--------RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA---HSVIGTP 197
P + HRD+K N+ + + I D GLA KSA H +GT
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKFEAGKSAGDTHGQVGTR 197
Query: 198 EFMAPEL------YEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQI 241
+MAPE+ ++ D +D+Y+ G+ + E+ + + +
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-32
Identities = 63/291 (21%), Positives = 123/291 (42%), Gaps = 36/291 (12%)
Query: 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVA----------------------WNQVRLN 64
+Y L +E +GKG+ V A +E A +
Sbjct: 13 NQYTLKDE-IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71
Query: 65 ELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKK 124
++ ++++Y E+ +L L H ++++ D ++ + E+ G + E
Sbjct: 72 GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL 131
Query: 125 YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184
+ +A + + +++G+ YLH + +IHRD+K N+ V G +KI D G++
Sbjct: 132 KPLSEDQARF-YFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGED-GHIKIADFGVSNEF 187
Query: 185 RGSKS-AHSVIGTPEFMAPEL---YEEDYN-ELVDVYSFGMCVLEMFTCEY-PYSECANP 238
+GS + + +GTP FMAPE + ++ + +DV++ G L F P+ +
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMG-VTLYCFVFGQCPFMD-ERI 245
Query: 239 AQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFL 288
++ K+ S L + + I R L N R+ E+ L P++
Sbjct: 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-32
Identities = 63/287 (21%), Positives = 111/287 (38%), Gaps = 38/287 (13%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVA-----WNQVRLNELMRSPDDLQRLYSEVHLLSTL 86
+E+LG+G V + I + E A + + EV +L +
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 87 K-HDSIIRFYTSWIDV--DQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQI 140
H +II+ D F + ++ G L +Y + + R I R +
Sbjct: 81 SGHPNIIQLK----DTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI---MRAL 133
Query: 141 LQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFM 200
L+ + LH + ++HRDLK +NI ++ + +K+ D G + L + V GTP ++
Sbjct: 134 LEVICALHKLN--IVHRDLKPENILLDDDM-NIKLTDFGFSCQLDPGEKLREVCGTPSYL 190
Query: 201 APE-------LYEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQIYKKVTSGKL- 250
APE Y + VD++S G ++ P + + + + SG
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTG-VIMYTLLAGSPPFWHR--KQMLMLRMIMSGNYQ 247
Query: 251 --PGAFYSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVK 294
+ D + + R L V KR +A+E L PF V+
Sbjct: 248 FGSPEWDDYSD-TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE 293
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-32
Identities = 72/349 (20%), Positives = 126/349 (36%), Gaps = 67/349 (19%)
Query: 4 NKQLAGAADEAKAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRL 63
+ + E G + +Y L +G+G+ V AI+ A +
Sbjct: 3 HHHHHSSGRENLYFQGGSLLELQKKYHLKGA-IGQGSYGVVRVAIENQTRAIRAIKIMNK 61
Query: 64 NEL-MRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV--DQKTFNFITEMFTSGTLRE 120
N++ +P D++R+ +EV L+ L H +I R Y +V D++ + E+ G L +
Sbjct: 62 NKIRQINPKDVERIKTEVRLMKKLHHPNIARLY----EVYEDEQYICLVMELCHGGHLLD 117
Query: 121 YRKKYRRVDI----------------------------------------RAIKSWARQI 140
+ + I + RQI
Sbjct: 118 KLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177
Query: 141 LQGLVYLHSRDPPVIHRDLKCDNI-FVNGHLGQVKIGDLGLAAILRGSKSA-----HSVI 194
L YLH++ + HRD+K +N F ++K+ D GL+ + +
Sbjct: 178 FSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA 235
Query: 195 GTPEFMAPEL---YEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQIYKKVTSGK 249
GTP F+APE+ E Y D +S G +L + N A +V + K
Sbjct: 236 GTPYFVAPEVLNTTNESYGPKCDAWSAG-VLLHLLLMGAVPFPGV--NDADTISQVLNKK 292
Query: 250 L--PGAFYSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVKL 295
L Y++ A+ + L N +R A L P+++ K+
Sbjct: 293 LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKI 341
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 71/311 (22%), Positives = 119/311 (38%), Gaps = 38/311 (12%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNEL-MRSPDDLQRLYSEVHLLSTLKHDS 90
EV+GKG V + I+ G + A V + + + L E + LKH
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 91 IIRFYTSWIDV--DQKTFNFITEMFTSGTL-------REYRKKYRRVDIRAIKSWARQIL 141
I+ + + E L + Y RQIL
Sbjct: 88 IVELL----ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY---MRQIL 140
Query: 142 QGLVYLHSRDPPVIHRDLKCDNI-FVNGHLG-QVKIGDLGLAAIL-RGSKSAHSVIGTPE 198
+ L Y H + +IHRD+K + + VK+G G+A L A +GTP
Sbjct: 141 EALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPH 198
Query: 199 FMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQIYKKVTSGKL---PG 252
FMAPE + E Y + VDV+ G +L + Y ++++ + GK P
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCG-VILFILLSGCLPFYGT---KERLFEGIIKGKYKMNPR 254
Query: 253 AFYSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEV----KLLSKTKLNQKPFL 307
+ I + A+ + R L ++ ++R++ E L P+L + L +T + F
Sbjct: 255 QWSHISE-SAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFN 313
Query: 308 NETELEKLQLS 318
+L+ L+
Sbjct: 314 ARRKLKGAVLA 324
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 60/283 (21%), Positives = 111/283 (39%), Gaps = 31/283 (10%)
Query: 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL- 86
Y + +VLG G V + ++ + A ++ D + EV L
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFA---------LKMLQDCPKARREVELHWRAS 112
Query: 87 KHDSIIRFYTSWIDVDQKTFNF--ITEMFTSGTL--REYRKKYRRVDIRAIKSWARQILQ 142
+ I+R + ++ + E G L R + + R + I +
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 143 GLVYLHSRDPPVIHRDLKCDNI-FVN-GHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFM 200
+ YLHS + + HRD+K +N+ + + +K+ D G A S + TP ++
Sbjct: 173 AIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYV 230
Query: 201 APE-LYEEDYNELVDVYSFGMCVLEMFT--CEYP--YSECANPAQ--IYKKVTSGKL--P 251
APE L E Y++ D++S G V+ M+ C YP YS + ++ G+ P
Sbjct: 231 APEVLGPEKYDKSCDMWSLG--VI-MYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 287
Query: 252 GAFYSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEV 293
+S E + I L ++R++ E + P++
Sbjct: 288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 66/214 (30%), Positives = 107/214 (50%), Gaps = 16/214 (7%)
Query: 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLST 85
N RY + + LG G M TVY A D +L ++VA + + + L+R EVH S
Sbjct: 10 NERYKI-VDKLGGGGMSTVYLAEDTILNIKVAIKAIFI-PPREKEETLKRFEREVHNSSQ 67
Query: 86 LKHDSIIRFYTSWIDVDQ-KTFNFIT-EMFTSGTLREYRKKYRRVDIRAIKSWARQILQG 143
L H +I+ DVD+ ++ E TL EY + + + + ++ QIL G
Sbjct: 68 LSHQNIVSMI----DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDG 123
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK--SAHSVIGTPEFMA 201
+ + H ++HRD+K NI ++ + +KI D G+A L + + V+GT ++ +
Sbjct: 124 IKHAHDMR--IVHRDIKPQNILIDSN-KTLKIFDFGIAKALSETSLTQTNHVLGTVQYFS 180
Query: 202 PELYE-EDYNELVDVYSFGMCVL-EMFTCEYPYS 233
PE + E +E D+YS G VL EM E P++
Sbjct: 181 PEQAKGEATDECTDIYSIG-IVLYEMLVGEPPFN 213
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 64/271 (23%), Positives = 106/271 (39%), Gaps = 27/271 (9%)
Query: 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDD--LQRLYSEVHLLS 84
Y L +LGKG TV+ ++VA + N ++ EV LL
Sbjct: 31 AEYRL-GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW 89
Query: 85 TL----KHDSIIRFYTSWIDVDQKTFNFITEMFTSGT-LREYRKKYRRVDIRAIKSWARQ 139
+ H +IR W + + + E L +Y + + + + Q
Sbjct: 90 KVGAGGGHPGVIRLLD-WFETQEGFM-LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQ 147
Query: 140 ILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF 199
++ + + HSR V+HRD+K +NI ++ G K+ D G A+L GT +
Sbjct: 148 VVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-GTRVY 204
Query: 200 MAPELYE-EDYN-ELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFY-S 256
PE Y+ V+S G+ +L C P + +++ +L + S
Sbjct: 205 SPPEWISRHQYHALPATVWSLGI-LLYDMVCGD------IPFERDQEILEAELHFPAHVS 257
Query: 257 IQDLEAQRFIGRCL-VNASKRLSAKELLLDP 286
+ I RCL S R S +E+LLDP
Sbjct: 258 P---DCCALIRRCLAPKPSSRPSLEEILLDP 285
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 62/282 (21%), Positives = 117/282 (41%), Gaps = 41/282 (14%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQ----RLYSEVHLLSTLK 87
++V+G+G V + + G E A + + SP+ L+ E H+L +
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 88 -HDSIIRFYTSWIDV--DQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQIL 141
H II D + ++ G L +Y + + R+I R +L
Sbjct: 158 GHPHIITLI----DSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI---MRSLL 210
Query: 142 QGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMA 201
+ + +LH+ + ++HRDLK +NI ++ ++ Q+++ D G + L + + GTP ++A
Sbjct: 211 EAVSFLHANN--IVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTPGYLA 267
Query: 202 PE-------LYEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQIYKKVTSGKLPG 252
PE Y + VD+++ G +L P + + + + G+
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACG-VILFTLLAGSPPFWHR--RQILMLRMIMEGQY-- 322
Query: 253 AFYS-----IQDLEAQRFIGRCL-VNASKRLSAKELLLDPFL 288
F S + I R L V+ RL+A++ L PF
Sbjct: 323 QFSSPEWDDRSS-TVKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 69/305 (22%), Positives = 124/305 (40%), Gaps = 45/305 (14%)
Query: 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK- 87
L ++ LG+G+ K + + A + R + Q+ E+ L +
Sbjct: 12 LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS----KRMEANTQK---EITALKLCEG 64
Query: 88 HDSIIRFYTSWIDV--DQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQILQ 142
H +I++ + +V DQ + E+ G L E +K + + I R+++
Sbjct: 65 HPNIVKLH----EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI---MRKLVS 117
Query: 143 GLVYLHSRDPPVIHRDLKCDNI-FVN-GHLGQVKIGDLGLAAILRGSKSA-HSVIGTPEF 199
+ ++H V+HRDLK +N+ F + ++KI D G A + + T +
Sbjct: 118 AVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHY 175
Query: 200 MAPE-LYEEDYNELVDVYSFGMCVLEMFT--CEYP--YSE-----CANPAQIYKKVTSGK 249
APE L + Y+E D++S G V+ ++T S C + +I KK+ G
Sbjct: 176 AAPELLNQNGYDESCDLWSLG--VI-LYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232
Query: 250 L---PGAFYSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVKLLSKTKLNQKP 305
A+ ++ EA+ I L V+ +KRL L + +L LS L
Sbjct: 233 FSFEGEAWKNVSQ-EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ--LSSNPLMTPD 289
Query: 306 FLNET 310
L +
Sbjct: 290 ILGSS 294
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 52/288 (18%), Positives = 115/288 (39%), Gaps = 38/288 (13%)
Query: 40 AMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWI 99
A+K K++ E N N+ + +E+ +++ +K++ +
Sbjct: 58 ALKKYEKSLLEKKRDFTKSN----NDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIIT 113
Query: 100 DVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSW--------ARQILQGLVYLHSRD 151
+ + + I E + ++ ++ + + +D + +L Y+H+
Sbjct: 114 N-YDEVY-IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK 171
Query: 152 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE---ED 208
+ HRD+K NI ++ + G+VK+ D G + + K GT EFM PE +
Sbjct: 172 N-ICHRDVKPSNILMDKN-GRVKLSDFGESEYMVDKK-IKGSRGTYEFMPPEFFSNESSY 228
Query: 209 YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL--PGAFYSIQDL------ 260
VD++S G+C+ MF P+S + +++ + + + P
Sbjct: 229 NGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKS 288
Query: 261 ---------EAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVKLLSK 298
E F+ L N ++R+++++ L +LA ++ L +
Sbjct: 289 TCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLRE 336
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 75/293 (25%), Positives = 131/293 (44%), Gaps = 43/293 (14%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDS 90
+E +G G+ + I + +E A + +S D E+ +L +H +
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIID-----KSKRDPTE---EIEILLRYGQHPN 77
Query: 91 IIRFYTSWIDV--DQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQILQGLV 145
II DV D K +TE+ G L + +K + + A+ I + +
Sbjct: 78 IITLK----DVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV---LFTITKTVE 130
Query: 146 YLHSRDPPVIHRDLKCDNIFV---NGHLGQVKIGDLGLAAILRGSKSA-HSVIGTPEFMA 201
YLH++ V+HRDLK NI +G+ ++I D G A LR + T F+A
Sbjct: 131 YLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVA 188
Query: 202 PE-LYEEDYNELVDVYSFGMCVLEMFT--CEYP--YSEC-ANPAQIYKKVTSGKL---PG 252
PE L + Y+ D++S G VL ++T Y + P +I ++ SGK G
Sbjct: 189 PEVLERQGYDAACDIWSLG--VL-LYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG 245
Query: 253 AFYSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVKLLSKTKLNQK 304
+ S+ D A+ + + L V+ +RL+A +L P++ + L + +LN++
Sbjct: 246 YWNSVSD-TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ--LPQYQLNRQ 295
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-30
Identities = 68/335 (20%), Positives = 130/335 (38%), Gaps = 36/335 (10%)
Query: 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVR----LNELMRSPDDLQRLYSEVHL 82
+Y LG GA V+ A+D+ EV ++ L + L ++ E+ +
Sbjct: 24 QKYST-MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 83 LSTLKHDSIIRFYTSWIDV--DQKTFNFITEMFTSGT-LREYRKKYRRVDIRAIKSWARQ 139
LS ++H +II+ D+ +Q F + E SG L + ++ R+D RQ
Sbjct: 83 LSRVEHANIIKVL----DIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 140 ILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF 199
++ + YL +D +IHRD+K +NI + +K+ D G AA L K ++ GT E+
Sbjct: 139 LVSAVGYLRLKD--IIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKLFYTFCGTIEY 195
Query: 200 MAPELYE-EDYN-ELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSI 257
APE+ Y ++++S G+ L E NP ++ + +
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGV-TLYTLVFEE------NPFCELEETVEAAIHPPYLVS 248
Query: 258 QDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNETELEKLQ 316
++ + L +R + ++L+ DP++ +N + E +
Sbjct: 249 KE--LMSLVSGLLQPVPERRTTLEKLVTDPWV---------TQPVNLADYTWEEVFRVNK 297
Query: 317 LSDDPPRTDMTITGKLNPEDDTIFLKVQIADKDGP 351
G + D ++ +
Sbjct: 298 PESGVLSAASLEMGNRSLSDVAQAQELCGGEGHHH 332
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-30
Identities = 73/317 (23%), Positives = 146/317 (46%), Gaps = 33/317 (10%)
Query: 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVR-LNELMRSPDDLQRLYSEVHLLST 85
G Y L + +GKG V A + G EVA ++ +++ +P LQ+L+ EV ++
Sbjct: 15 GNYRL-LKTIGKGNFAKVKLARHILTGREVA---IKIIDKTQLNPTSLQKLFREVRIMKI 70
Query: 86 LKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLV 145
L H +I++ + I+ ++ + I E + G + +Y + R+ + +S RQI+ +
Sbjct: 71 LNHPNIVKLFEV-IETEKTLY-LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ 128
Query: 146 YLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELY 205
Y H + ++HRDLK +N+ ++ +KI D G + + G P + APEL+
Sbjct: 129 YCHQKR--IVHRDLKAENLLLDAD-MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELF 185
Query: 206 E-EDYN-ELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD---L 260
+ + Y+ VDV+S G+ + + + P+ N ++ ++V GK Y I
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGK-----YRIPFYMST 239
Query: 261 EAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNETELEKLQLSD 319
+ + + R L +N KR + ++++ D ++ + + +E
Sbjct: 240 DCENLLKRFLVLNPIKRGTLEQIMKDRWI-----------NAGHEEDELKPFVEPELDIS 288
Query: 320 DPPRTDMTITGKLNPED 336
D R D+ + + E+
Sbjct: 289 DQKRIDIMVGMGYSQEE 305
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 60/271 (22%), Positives = 112/271 (41%), Gaps = 25/271 (9%)
Query: 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRS--PDDLQRLYSEVHLLS 84
+Y + +LG G +VY I + VA V + + + R+ EV LL
Sbjct: 43 SQYQV-GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 101
Query: 85 TLKHDS--IIRFYTSWIDVDQKTFNFITEMFT-SGTLREYRKKYRRVDIRAIKSWARQIL 141
+ +IR W + I E L ++ + + +S+ Q+L
Sbjct: 102 KVSSGFSGVIRLLD-WFERPDSFV-LILERPEPVQDLFDFITERGALQEELARSFFWQVL 159
Query: 142 QGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMA 201
+ + + H+ V+HRD+K +NI ++ + G++K+ D G A+L+ + GT +
Sbjct: 160 EAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSP 216
Query: 202 PELYE-EDYN-ELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFY-SIQ 258
PE Y+ V+S G+ +L C P + +++ G++ S
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGI-LLYDMVCGD------IPFEHDEEIIRGQVFFRQRVSS- 268
Query: 259 DLEAQRFIGRCL-VNASKRLSAKELLLDPFL 288
E Q I CL + S R + +E+ P++
Sbjct: 269 --ECQHLIRWCLALRPSDRPTFEEIQNHPWM 297
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 65/299 (21%), Positives = 120/299 (40%), Gaps = 34/299 (11%)
Query: 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL- 86
Y L ++VLG G V + G + A ++ D + EV
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCA---------LKLLYDSPKARQEVDHHWQAS 79
Query: 87 KHDSIIRFYTSWIDVDQKTFNF--ITEMFTSGTL--REYRKKYRRVDIRAIKSWARQILQ 142
I+ + ++ I E G L R + + R R I
Sbjct: 80 GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139
Query: 143 GLVYLHSRDPPVIHRDLKCDNI-FVN-GHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFM 200
+ +LHS + + HRD+K +N+ + + +K+ D G A + + TP ++
Sbjct: 140 AIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYTPYYV 196
Query: 201 APE-LYEEDYNELVDVYSFGMCVLEMFT--CEYP--YSEC--ANPAQIYKKVTSGKL--P 251
APE L E Y++ D++S G V+ M+ C +P YS A + +++ G+ P
Sbjct: 197 APEVLGPEKYDKSCDMWSLG--VI-MYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP 253
Query: 252 GAFYSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNE 309
+S +A++ I L + ++RL+ + + P++ V + +T L+ L E
Sbjct: 254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV--VPQTPLHTARVLQE 310
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 46/213 (21%), Positives = 87/213 (40%), Gaps = 19/213 (8%)
Query: 26 NGRYGLFEEVLGKGAMKTVYKAIDEVL-GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLS 84
G+Y + + + G + +Y A+D + G V ++ + +E L+
Sbjct: 79 AGQYEV-KGCIAHGGLGWIYLALDRNVNGRPVV---LKGLVHSGDAEAQAMAMAERQFLA 134
Query: 85 TLKHDSIIRFYT--SWIDVDQKTFNFIT-EMFTSGTLREYRKKYRRVDIRAIKSWARQIL 141
+ H SI++ + D +I E +L+ + +++ + ++ +IL
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEIL 192
Query: 142 QGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMA 201
L YLHS +++ DLK +NI + Q+K+ DLG S + GTP F A
Sbjct: 193 PALSYLHSI--GLVYNDLKPENIMLTE--EQLKLIDLGAV---SRINSFGYLYGTPGFQA 245
Query: 202 PELYEEDYNELVDVYSFGMCVL-EMFTCEYPYS 233
PE+ D+Y+ G L + +
Sbjct: 246 PEIVRTGPTVATDIYTVG-RTLAALTLDLPTRN 277
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 4e-29
Identities = 58/230 (25%), Positives = 92/230 (40%), Gaps = 50/230 (21%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVA-------WNQVRLNELMRSPDDLQRLYSEVHLLS 84
E++G+G VYK + VA Q +NE ++ +
Sbjct: 17 LLELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQNFINEK------------NIYRVP 62
Query: 85 TLKHDSIIRFYTSWIDVDQKTFNF---ITEMFTSGTLREYRKKYRRVDIRAIKSWARQIL 141
++HD+I RF V + E + +G+L +Y D + A +
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVT 121
Query: 142 QGLVYLHS-------RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK------ 188
+GL YLH+ P + HRDL N+ V G I D GL+ L G++
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND-GTCVISDFGLSMRLTGNRLVRPGE 180
Query: 189 ---SAHSVIGTPEFMAPELYE--------EDYNELVDVYSFGMCVLEMFT 227
+A S +GT +MAPE+ E E + VD+Y+ G+ E+F
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 68/318 (21%), Positives = 112/318 (35%), Gaps = 57/318 (17%)
Query: 18 IGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQV-RLNELMRSPDDLQRL 76
I E + E++LG G+ TV G VA V R+ D
Sbjct: 6 IPNFEQSLKNLV-VSEKILGYGSSGTVVFQ-GSFQGRPVA---VKRML-----IDFCDIA 55
Query: 77 YSEVHLLSTLK-HDSIIRFYTSWIDV--DQKTFNFITEMFTSGTLREY---RKKYRRVDI 130
E+ LL+ H ++IR+Y + E + L++ +
Sbjct: 56 LMEIKLLTESDDHPNVIRYY----CSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLK 110
Query: 131 RAIKSWA----RQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLG------------QVK 174
+ RQI G+ +LHS +IHRDLK NI V+ ++
Sbjct: 111 LQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168
Query: 175 IGDLGLAAILRGSKSA-----HSVIGTPEFMAPELYEED--------YNELVDVYSFGMC 221
I D GL L +S+ ++ GT + APEL EE +D++S G
Sbjct: 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228
Query: 222 VLEMFTCEYP--YSECANPAQIYKKVTSGK-LPGAFYSIQDLEAQRFIGRCL-VNASKRL 277
+ + + + + I + + S + EA I + + + KR
Sbjct: 229 FYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP 288
Query: 278 SAKELLLDPFLASDEVKL 295
+A ++L P KL
Sbjct: 289 TAMKVLRHPLFWPKSKKL 306
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLST 85
+ RY L E+LG G M V+ A D +VA +R +L R P R E +
Sbjct: 11 SDRYEL-GEILGFGGMSEVHLARDLRDHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAA 68
Query: 86 LKHDSIIRFY-TSWIDVDQKTFNFIT-EMFTSGTLREYRKKYRRVDIRAIKSWARQILQG 143
L H +I+ Y T + +I E TLR+ + + Q
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA----HSVIGTPEF 199
L + H +IHRD+K NI ++ VK+ D G+A + S ++ +VIGT ++
Sbjct: 129 LNFSHQNG--IIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 200 MAPELYE-EDYNELVDVYSFGMCVL-EMFTCEYPYS 233
++PE + + DVYS G CVL E+ T E P++
Sbjct: 186 LSPEQARGDSVDARSDVYSLG-CVLYEVLTGEPPFT 220
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 51/304 (16%), Positives = 101/304 (33%), Gaps = 33/304 (10%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRL-NELMRSPDDLQRLYSEVHLLSTLKHDS 90
+LG+GA VY+A L + L + +P + + L
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAI-----KSWARQILQGLV 145
++FY++ + Q + E+++ GTL Y+ + + S+A ++L +
Sbjct: 129 FMKFYSAH--LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIE 186
Query: 146 YLHSRDPPVIHRDLKCDNIFVNGHL----------GQVKIGDLGLAAILRG---SKSAHS 192
+H + +IH D+K DN + + + DLG + ++ +
Sbjct: 187 QVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244
Query: 193 VIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP 251
T F E L + +N +D + V M Y + + +
Sbjct: 245 KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR--- 301
Query: 252 GAFYSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNET 310
D+ F L + L + +LL + +K + + L
Sbjct: 302 ---LPHLDM-WNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNR-LIVL 356
Query: 311 ELEK 314
LE
Sbjct: 357 LLEC 360
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 64/306 (20%), Positives = 124/306 (40%), Gaps = 58/306 (18%)
Query: 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
Y L E+VLG+GA V I+ + E A + + R EV +L +
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-HIRSRVFR---EVEMLYQCQ 68
Query: 88 -HDSIIRFYTSWIDV--DQKTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQIL 141
H +++ + ++ F + E G++ + R+ + ++ + + +
Sbjct: 69 GHRNVLELI----EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV---VQDVA 121
Query: 142 QGLVYLHSRDPPVIHRDLKCDNI-FVN-GHLGQVKIGDLGLAAILRGSKSAHSV------ 193
L +LH++ + HRDLK +NI + + VKI D L + ++ + +
Sbjct: 122 SALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 194 --IGTPEFMAPE------LYEEDYNELVDVYSFGMCVLEMFT--CEYP--YSEC------ 235
G+ E+MAPE Y++ D++S G V+ ++ YP C
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG--VI-LYILLSGYPPFVGRCGSDCGW 236
Query: 236 -------ANPAQIYKKVTSGKL--PGAFYSIQDLEAQRFIGRCL-VNASKRLSAKELLLD 285
A +++ + GK P ++ A+ I + L +A +RLSA ++L
Sbjct: 237 DRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296
Query: 286 PFLASD 291
P++
Sbjct: 297 PWVQGC 302
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 66/317 (20%), Positives = 135/317 (42%), Gaps = 33/317 (10%)
Query: 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL 86
G+Y L ++LG+G+ V + +D A ++ +L R P+ + E+ LL L
Sbjct: 5 GKY-LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 87 KHDSIIRFYTSWIDVDQKTFNFITEMFTSGT--LREYRKKYRRVDIRAIKSWARQILQGL 144
+H ++I+ + +++ + E G + + + +R + + Q++ GL
Sbjct: 64 RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGL 122
Query: 145 VYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA---HSVIGTPEFMA 201
YLHS+ ++H+D+K N+ + G +KI LG+A L + + G+P F
Sbjct: 123 EYLHSQG--IVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 202 PELY--EEDYN-ELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK--LPGAFYS 256
PE+ + ++ VD++S G+ + + T YP+ E N ++++ + G +PG
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKGSYAIPGDC-- 236
Query: 257 IQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNETELEKL 315
+ L +KR S +++ + + P +
Sbjct: 237 --GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF-----------RKKHPPAEAPVPIPPS 283
Query: 316 QLSDDPPRTDMTITGKL 332
+ D R+ MT+ L
Sbjct: 284 PDTKDRWRS-MTVVPYL 299
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 63/267 (23%), Positives = 123/267 (46%), Gaps = 15/267 (5%)
Query: 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL 86
+ L + LG+GA V A++ V VA V++ ++ R+ D + + E+ + L
Sbjct: 7 EDWDL-VQTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKML 62
Query: 87 KHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVY 146
H+++++FY + E + G L + + + + + Q++ G+VY
Sbjct: 63 NHENVVKFYGHR--REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA---HSVIGTPEFMAPE 203
LH + HRD+K +N+ ++ +KI D GLA + R + + + GT ++APE
Sbjct: 121 LHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 204 -LYEEDYN-ELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLE 261
L +++ E VDV+S G+ + M E P+ + ++ Q Y K + D
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 237
Query: 262 AQRFIGRCL-VNASKRLSAKELLLDPF 287
+ + L N S R++ ++ D +
Sbjct: 238 PLALLHKILVENPSARITIPDIKKDRW 264
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-27
Identities = 72/274 (26%), Positives = 124/274 (45%), Gaps = 25/274 (9%)
Query: 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVR-LN-ELMRSPDDLQRLYSEVHLLS 84
G Y L + LG G V ++ G +VA V+ LN + +RS D + ++ E+ L
Sbjct: 11 GHYVL-GDTLGVGTFGKVKIGEHQLTGHKVA---VKILNRQKIRSLDVVGKIKREIQNLK 66
Query: 85 TLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGL 144
+H II+ Y I F + E + G L +Y K+ RV+ + +QIL +
Sbjct: 67 LFRHPHIIKLYQV-ISTPTDFF-MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAV 124
Query: 145 VYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPEL 204
Y H V+HRDLK +N+ ++ H KI D GL+ ++ + + G+P + APE+
Sbjct: 125 DYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 181
Query: 205 YE-EDYN-ELVDVYSFGMCVLEMFTCEY-PYSECANPAQIYKKVTSGKLPGAFYSIQD-- 259
Y VD++S G+ +L C P+ + + ++KK+ G + I +
Sbjct: 182 ISGRLYAGPEVDIWSCGV-ILYALLCGTLPFDD-EHVPTLFKKIRGGV-----FYIPEYL 234
Query: 260 -LEAQRFIGRCL-VNASKRLSAKELLLDPFLASD 291
+ L V+ KR + K++ + D
Sbjct: 235 NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 76/296 (25%), Positives = 132/296 (44%), Gaps = 22/296 (7%)
Query: 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL 86
G Y + E LG+G+ V A +VA + L +S D R+ E+ L L
Sbjct: 9 GPYII-RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKS-DMHMRVEREISYLKLL 66
Query: 87 KHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVY 146
+H II+ Y I + E + G L +Y + +R+ + + +QI+ + Y
Sbjct: 67 RHPHIIKLYDV-ITTPTDIV-MVIE-YAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEY 123
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE 206
H ++HRDLK +N+ ++ + VKI D GL+ I+ + G+P + APE+
Sbjct: 124 CHRHK--IVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN 180
Query: 207 -EDYN-ELVDVYSFGMCVLEMFTCEY-PYSECANPAQIYKKVTSGKLPGAFYSIQD---L 260
+ Y VDV+S G+ VL + P+ + ++KKV S Y + D
Sbjct: 181 GKLYAGPEVDVWSCGI-VLYVMLVGRLPFDD-EFIPNLFKKVNSCV-----YVMPDFLSP 233
Query: 261 EAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNETELEKL 315
AQ I R + + +R++ +E+ DP+ + L + Q + + + KL
Sbjct: 234 GAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKL 289
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 72/339 (21%), Positives = 132/339 (38%), Gaps = 70/339 (20%)
Query: 24 DPNGRYGL--FE--EVLGKG-----------------AMKTVYKAIDEVLGVEVAWNQVR 62
D N FE +GKG AMK + K V N+VR
Sbjct: 7 DENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQ------KCVERNEVR 60
Query: 63 LNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYR 122
++ E+ ++ L+H ++ + S+ D ++ F + ++ G LR +
Sbjct: 61 ------------NVFKELQIMQGLEHPFLVNLWYSFQD-EEDMF-MVVDLLLGGDLRYHL 106
Query: 123 KKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGL 180
++ +K + +++ L YL ++ +IHRD+K DNI + +GH V I D +
Sbjct: 107 QQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGH---VHITDFNI 161
Query: 181 AAILRGSKSAHSVIGTPEFMAPELYEED----YNELVDVYSFGMCVLEMFTCEYPY--SE 234
AA+L ++ GT +MAPE++ Y+ VD +S G+ E+ PY
Sbjct: 162 AAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221
Query: 235 CANPAQIYKKVTSGKL--PGAFYSIQDLEAQRFIGRCL-VNASKRL-SAKELLLDPFLAS 290
+ +I + + P A+ E + + L N +R ++ P++
Sbjct: 222 STSSKEIVHTFETTVVTYPSAW----SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277
Query: 291 -DEVKLLSKT-------KLNQKPFLNETELEKLQLSDDP 321
+ + K + ELE++ L P
Sbjct: 278 INWDAVFQKRLIPGFIPNKGRLNCDPTFELEEMILESKP 316
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-27
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 18/228 (7%)
Query: 32 FEEVLGKGAMKTVYKAI----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
+ LGKG +V + G VA Q++ + D QR E+ +L L
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD-QQRDFQR---EIQILKALH 82
Query: 88 HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVY 146
D I+++ +++ + E SG LR++ ++ R+D + ++ QI +G+ Y
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 142
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF----MAP 202
L SR +HRDL NI V VKI D GLA +L K + V + AP
Sbjct: 143 LGSRR--CVHRDLAARNILVESEA-HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199
Query: 203 E-LYEEDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSG 248
E L + ++ DV+SFG+ + E+FT C+ S A ++
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 68/325 (20%), Positives = 134/325 (41%), Gaps = 30/325 (9%)
Query: 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL 86
+ L + LG+GA V A++ V VA V++ ++ R+ D + + E+ + L
Sbjct: 7 EDWDL-VQTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKML 62
Query: 87 KHDSIIRFYTSWIDV--DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGL 144
H+++++FY + E + G L + + + + + Q++ G+
Sbjct: 63 NHENVVKFY----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 145 VYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA---HSVIGTPEFMA 201
VYLH + HRD+K +N+ ++ +KI D GLA + R + + + GT ++A
Sbjct: 119 VYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 202 PELYE-EDYN-ELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259
PEL + +++ E VDV+S G+ + M E P+ + ++ Q Y K + D
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235
Query: 260 LEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNETELEKLQLS 318
+ + L N S R++ ++ D + K + +S
Sbjct: 236 SAPLALLHKILVENPSARITIPDIKKDRWY-----------NKPLKKGAKRPRVTSGGVS 284
Query: 319 DDPPRTDMTITGKLNPEDDTIFLKV 343
+ P I L+ +
Sbjct: 285 ESPSGFSKHIQSNLDFSPVNSASRT 309
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 79/330 (23%), Positives = 131/330 (39%), Gaps = 56/330 (16%)
Query: 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSII 92
+V+G G+ VY+A G VA +V D + E+ ++ L H +I+
Sbjct: 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--------DKRFKNRELQIMRKLDHCNIV 110
Query: 93 R----FYTSWIDVDQKTFNFITEMFTSGTL----REYRKKYRRVDIRAIKSWARQILQGL 144
R FY+S D+ N + + + T+ R Y + + + + +K + Q+ + L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 145 VYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPEL 204
Y+HS + HRD+K N+ ++ +K+ D G A L + S I + + APEL
Sbjct: 170 AYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 227
Query: 205 Y--EEDYNELVDVYSFGMCVL-EMFTCE--YPYSECANPAQIYK--KV------------ 245
DY +DV+S G CVL E+ + +P + Q+ + KV
Sbjct: 228 IFGATDYTSSIDVWSAG-CVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIREM 284
Query: 246 ----TSGKLP--------GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292
T K P F EA R L + RL+ E F DE
Sbjct: 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DE 342
Query: 293 VKLLSKTKLNQKPFLNETELEKLQLSDDPP 322
++ + N + +LS +PP
Sbjct: 343 LRDPNVKLPNGRDTPALFNFTTQELSSNPP 372
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 65/230 (28%), Positives = 105/230 (45%), Gaps = 21/230 (9%)
Query: 32 FEEVLGKGAMKTVYKA----IDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
F + LGKG +V + + G VA +++ + + + L+ E+ +L +L+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQ 69
Query: 88 HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVY 146
HD+I+++ ++ I E G+LR+Y +K R+D + + QI +G+ Y
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF----MAP 202
L ++ IHRDL NI V +VKIGD GL +L K V E AP
Sbjct: 130 LGTKR--YIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186
Query: 203 E-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP 251
E L E ++ DV+SFG+ + E+FT Y E + G
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDK 232
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 73/299 (24%), Positives = 122/299 (40%), Gaps = 57/299 (19%)
Query: 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSII 92
+V+G G+ V++A EVA +V D + E+ ++ +KH +++
Sbjct: 45 CKVIGNGSFGVVFQAKLVESD-EVAIKKVLQ--------DKRFKNRELQIMRIVKHPNVV 95
Query: 93 R----FYTSWIDVDQKTFNFITEMFTSGTL----REYRKKYRRVDIRAIKSWARQILQGL 144
FY++ D+ N + E + T+ R Y K + + + IK + Q+L+ L
Sbjct: 96 DLKAFFYSNGDKKDEVFLNLVLE-YVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 145 VYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPEL 204
Y+HS + HRD+K N+ ++ G +K+ D G A IL + S I + + APEL
Sbjct: 155 AYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPEL 212
Query: 205 Y--EEDYNELVDVYSFGMCVL-EMFTCE--------------------YPYSE---CANP 238
+Y +D++S G CV+ E+ + P E NP
Sbjct: 213 IFGATNYTTNIDIWSTG-CVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271
Query: 239 AQI------YKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290
+ + K+ F +A I R L S RL+A E L PF
Sbjct: 272 NYMEHKFPQIRPHPFSKV---FRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 52/215 (24%), Positives = 84/215 (39%), Gaps = 20/215 (9%)
Query: 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRL--NELMRSPDDLQRLYSEVHLLS 84
G Y L ++G+G M VY+A D V VA ++L L P R+ E
Sbjct: 34 GPYRL-RRLVGRGGMGDVYEAEDTVRERIVA---LKLMSETLSSDPVFRTRMQREARTAG 89
Query: 85 TLKHDSIIRFYTSWIDVDQK-TFNFIT-EMFTSGTLREYRKKYRRVDIRAIKSWARQILQ 142
L+ ++ + D + ++ + L ++ + + RQI
Sbjct: 90 RLQEPHVVPIH----DFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGS 145
Query: 143 GLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK--SAHSVIGTPEFM 200
L H+ HRD+K +NI V+ + D G+A+ K + +GT +M
Sbjct: 146 ALDAAHAAG--ATHRDVKPENILVSAD-DFAYLVDFGIASATTDEKLTQLGNTVGTLYYM 202
Query: 201 APELYE-EDYNELVDVYSFGMCVL-EMFTCEYPYS 233
APE + D+Y+ CVL E T PY
Sbjct: 203 APERFSESHATYRADIYALT-CVLYECLTGSPPYQ 236
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 32 FEEVLGKGAMKTVYKAI----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
LG+G V ++ G VA ++ + + ++ E+ +L TL
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQ---EIDILRTLY 91
Query: 88 HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYL 147
H+ II++ D + + E G+LR+Y + + + + +A+QI +G+ YL
Sbjct: 92 HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYL 150
Query: 148 HSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF----MAPE 203
H++ IHRDL N+ ++ VKIGD GLA + + V + APE
Sbjct: 151 HAQH--YIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 207
Query: 204 -LYEEDYNELVDVYSFGMCVLEMFT 227
L E + DV+SFG+ + E+ T
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLT 232
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 65/230 (28%), Positives = 106/230 (46%), Gaps = 21/230 (9%)
Query: 32 FEEVLGKGAMKTVYKA----IDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
F + LGKG +V + + G VA +++ + + + L+ E+ +L +L+
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQ 100
Query: 88 HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVY 146
HD+I+++ ++ I E G+LR+Y +K R+D + + QI +G+ Y
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 160
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF----MAP 202
L ++ IHRDL NI V +VKIGD GL +L K + V E AP
Sbjct: 161 LGTKR--YIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAP 217
Query: 203 E-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP 251
E L E ++ DV+SFG+ + E+FT Y E + G
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDK 263
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 82/340 (24%), Positives = 142/340 (41%), Gaps = 37/340 (10%)
Query: 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVR-LN-ELMRSPDDLQRLYSEVHLLS 84
G Y L + LG G V E+ G +VA V+ LN + +RS D + ++ E+ L
Sbjct: 16 GHYIL-GDTLGVGTFGKVKVGKHELTGHKVA---VKILNRQKIRSLDVVGKIRREIQNLK 71
Query: 85 TLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGL 144
+H II+ Y I F + E + G L +Y K R+D + + +QIL G+
Sbjct: 72 LFRHPHIIKLYQV-ISTPSDIF-MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGV 129
Query: 145 VYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPEL 204
Y H V+HRDLK +N+ ++ H KI D GL+ ++ + + G+P + APE+
Sbjct: 130 DYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 186
Query: 205 YE-EDYN-ELVDVYSFGMCVLEMFTCEY-PYSECANPAQIYKKVTSGKLPGAFYSIQD-- 259
Y VD++S G +L C P+ + + ++KK+ G +
Sbjct: 187 ISGRLYAGPEVDIWSSG-VILYALLCGTLPFDD-DHVPTLFKKICDGI-----FYTPQYL 239
Query: 260 -LEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNETELEKLQL 317
+ L V+ KR + K++ + D L K + P + T +
Sbjct: 240 NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD----LPKYLFPEDPSYSSTMI----- 290
Query: 318 SDDPPRTDMTITGKLNPEDDTIFLKVQIADKDGPGRNIYF 357
DD ++ + + E+ + + + P Y
Sbjct: 291 -DDEALKEVCEKFECSEEE--VLSCLYNRNHQDPLAVAYH 327
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 68/299 (22%), Positives = 114/299 (38%), Gaps = 49/299 (16%)
Query: 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSII 92
E + G+G TV ++ G+ VA +V + P R + L+ L H +I+
Sbjct: 28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-----PRFRNRELQIMQDLAVLHHPNIV 82
Query: 93 R----FYTSWIDVDQKTF-NFITEMFTSGTL----REYRKKYRRVDIRAIKSWARQILQG 143
+ FYT + + N + E + TL R Y ++ IK + Q+++
Sbjct: 83 QLQSYFYTLGERDRRDIYLNVVME-YVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRS 141
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE 203
+ LH V HRD+K N+ VN G +K+ D G A L S+ + I + + APE
Sbjct: 142 IGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPE 201
Query: 204 LY--EEDYNELVDVYSFGMCVL-EMFTCE--YPYSECAN------------PAQIYKKVT 246
L + Y VD++S G C+ EM E + A ++ +K+
Sbjct: 202 LIFGNQHYTTAVDIWSVG-CIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN 260
Query: 247 SGKLPGAFYSIQ---------------DLEAQRFIGRCLV-NASKRLSAKELLLDPFLA 289
Y+ + EA + L +R+ E L P+
Sbjct: 261 PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD 319
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 32 FEEVLGKGAMKTVYKAI----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
LG+G V + G +VA ++ DL++ E+ +L L
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK---EIEILRNLY 81
Query: 88 HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVY 146
H++I+++ + I E SG+L+EY K +++++ +A QI +G+ Y
Sbjct: 82 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY 141
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF----MAP 202
L SR +HRDL N+ V QVKIGD GL + K ++V + AP
Sbjct: 142 LGSRQ--YVHRDLAARNVLVESEH-QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAP 198
Query: 203 E-LYEEDYNELVDVYSFGMCVLEMFT 227
E L + + DV+SFG+ + E+ T
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 72/331 (21%), Positives = 123/331 (37%), Gaps = 90/331 (27%)
Query: 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
RY + LG G V+ A+D VA ++ ++ P ++ E+ ++ L
Sbjct: 12 RYMDLK-PLGCGGNGLVFSAVDNDCDKRVAIKKI----VLTDPQSVKHALREIKIIRRLD 66
Query: 88 HDSIIRFY---------TSWIDVDQKTFN---FITE-MFT-------SGTLREYRKKYRR 127
HD+I++ + + N + E M T G L E +
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-- 124
Query: 128 VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187
+ Q+L+GL Y+HS + V+HRDLK N+F+N +KIGD GLA R
Sbjct: 125 --------FMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLA---RIM 171
Query: 188 KSAHSVIGTPEFM----------APE--LYEEDYNELVDVYSFGMCVL-EMFT------- 227
+S + +P L +Y + +D+++ G C+ EM T
Sbjct: 172 DPHYS---HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLTGKTLFAG 227
Query: 228 -----------------CEYPYSECANPAQIYKKVTSGKLPGAFYSI---QDLEAQRFIG 267
E E + +Y + + + EA F+
Sbjct: 228 AHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLE 287
Query: 268 RCLV-NASKRLSAKELLLDPFLA-----SDE 292
+ L + RL+A+E L P+++ DE
Sbjct: 288 QILTFSPMDRLTAEEALSHPYMSIYSFPMDE 318
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 20/227 (8%)
Query: 32 FEEVLGKGAMKTVYKAI----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
+VLG GA TVYK + E + + VA ++R ++ ++ E ++++++
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD---EAYVMASVD 75
Query: 88 HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVY 146
+ + R T IT++ G L +Y R+ + + + +W QI +G+ Y
Sbjct: 76 NPHVCRLLGI---CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGT--P-EFMAPE 203
L R ++HRDL N+ V VKI D GLA +L + + G P ++MA E
Sbjct: 133 LEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 204 -LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
+ Y DV+S+G+ V E+ T PY ++I + G
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKG 235
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 68/274 (24%), Positives = 117/274 (42%), Gaps = 21/274 (7%)
Query: 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL 86
RY + +G G D++ VA + + R + + E+ +L
Sbjct: 20 DRYDF-VKDIGSGNFGVARLMRDKLTKELVA-----VKYIERGAAIDENVQREIINHRSL 73
Query: 87 KHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVY 146
+H +I+RF I I E + G L E R + + +Q+L G+ Y
Sbjct: 74 RHPNIVRFKEV-ILTPTHLA-IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSY 131
Query: 147 LHSRDPPVIHRDLKCDNIFVNGH-LGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELY 205
HS + HRDLK +N ++G ++KI D G + S +GTP ++APE+
Sbjct: 132 CHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 189
Query: 206 E-EDYN-ELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL--- 260
++Y+ ++ DV+S G+ + M YP+ E + Y+K T ++ YSI D
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRK-TIQRILSVKYSIPDDIRI 247
Query: 261 --EAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291
E I R V + + R+S E+ + +
Sbjct: 248 SPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 69/286 (24%), Positives = 134/286 (46%), Gaps = 26/286 (9%)
Query: 7 LAGAADEAKAHIGYIETD----PNGRYGL--FE--EVLGKGAMKTVYKAIDEVLGVEVAW 58
+ G A E + G ++ + F+ ++LG+G+ TV A + E A
Sbjct: 1 MDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAI 60
Query: 59 NQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTL 118
+ +++ + + + E ++S L H ++ Y ++ D D+K + F +G L
Sbjct: 61 KILEKRHIIKE-NKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLY-FGLSYAKNGEL 117
Query: 119 REYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDL 178
+Y +K D + + +I+ L YLH + +IHRDLK +NI +N ++I D
Sbjct: 118 LKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNED-MHIQITDF 174
Query: 179 GLAAILRGSKS---AHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSE 234
G A +L A+S +GT ++++PE L E+ + D+++ G + ++ P+
Sbjct: 175 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-R 233
Query: 235 CANPAQIYKKVTSGKL--PGAFYSIQDLEAQRFIGRCLV-NASKRL 277
N I++K+ + P F +A+ + + LV +A+KRL
Sbjct: 234 AGNEYLIFQKIIKLEYDFPEKF----FPKARDLVEKLLVLDATKRL 275
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 83/357 (23%), Positives = 129/357 (36%), Gaps = 91/357 (25%)
Query: 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
+ L + +LG+GA V A + G VA ++ P R E+ +L K
Sbjct: 12 DFQL-KSLLGEGAYGVVCSATHKPTGEIVAIKKIEP---FDKPLFALRTLREIKILKHFK 67
Query: 88 HDSIIRFYTSWIDVDQKTFN---FITE-MFT-------SGTLREYRKKYRRVDIRAIKSW 136
H++II + + FN I E M T + L + +Y +
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY----------F 117
Query: 137 ARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRGSKSAHSVIG 195
Q L+ + LH + VIHRDLK N+ +N + +K+ D GLA I + G
Sbjct: 118 IYQTLRAVKVLHGSN--VIHRDLKPSNLLINSN-CDLKVCDFGLARIIDESAADNSEPTG 174
Query: 196 TPEFM----------APE--LYEEDYNELVDVYSFGMCVL-EMFTCE------------- 229
M APE L Y+ +DV+S G C+L E+F
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCG-CILAELFLRRPIFPGRDYRHQLL 233
Query: 230 -------YPYSE-----CANP-AQIY--------KKVTSGKLPGAFYSIQDLEAQRFIGR 268
P+S+ +P A+ Y P + + + R
Sbjct: 234 LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRV-----NPKGIDLLQR 288
Query: 269 CLV-NASKRLSAKELLLDPFLA-----SDEVKLLSKTKLNQKPFLNETELEKLQLSD 319
LV + +KR++AKE L P+L +DE + F + E L D
Sbjct: 289 MLVFDPAKRITAKEALEHPYLQTYHDPNDEP---EGEPIPPSFFEFDHYKEALTTKD 342
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 52/225 (23%), Positives = 84/225 (37%), Gaps = 19/225 (8%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
E +G+G V+ VA R + E +L H +I
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQ---EARILKQYSHPNI 174
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVYLHSR 150
+R + ++ + E+ G + R + R+ ++ + G+ YL S+
Sbjct: 175 VRLIG--VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 151 DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRGSKSAHSVIGTPEF----MAPE-L 204
IHRDL N V +KI D G++ G +A G + APE L
Sbjct: 233 --CCIHRDLAARNCLVTEKN-VLKISDFGMSREEADGVYAASG--GLRQVPVKWTAPEAL 287
Query: 205 YEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
Y+ DV+SFG+ + E F+ PY +N Q + V G
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-QQTREFVEKG 331
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-23
Identities = 72/327 (22%), Positives = 127/327 (38%), Gaps = 74/327 (22%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNEL--------MRSPDDLQRLYSEVHLLST 85
+G+G+ V+K + G VA + +E +R E+ +L
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----------EIRMLKQ 58
Query: 86 LKHDSIIRFYTSWIDV--DQKTFNFITEMFTSGTLREYRKKYRR-VDIRAIKSWARQILQ 142
LKH +++ +V ++ + + E + T+ +Y+R V +KS Q LQ
Sbjct: 59 LKHPNLVNLL----EVFRRKRRLHLVFE-YCDHTVLHELDRYQRGVPEHLVKSITWQTLQ 113
Query: 143 GLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA--HSVIGTPEFM 200
+ + H + IHRD+K +NI + H +K+ D G A +L G V T +
Sbjct: 114 AVNFCHKHN--CIHRDVKPENILITKH-SVIKLCDFGFARLLTGPSDYYDDEVA-TRWYR 169
Query: 201 APELY--EEDYNELVDVYSFGMCVL-EMFTCEYPY----SECANPAQIYK--KV----TS 247
+PEL + Y VDV++ G CV E+ + P S+ Q+Y K
Sbjct: 170 SPELLVGDTQYGPPVDVWAIG-CVFAELLSGV-PLWPGKSD---VDQLYLIRKTLGDLIP 224
Query: 248 GKLPG-------------AFYSIQDLE---------AQRFIGRCLV-NASKRLSAKELLL 284
++ LE A + CL + ++RL+ ++LL
Sbjct: 225 RHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284
Query: 285 DPFLASDEVKLLSKTKLNQKPFLNETE 311
P+ + ++ K + KP N
Sbjct: 285 HPYFENIR-EIEDLAKEHDKPAENLYF 310
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-23
Identities = 77/309 (24%), Positives = 120/309 (38%), Gaps = 68/309 (22%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNEL--------MRSPDDLQRLYSEVHLLST 85
LG+G VYKAID V VA ++RL +R EV LL
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----------EVSLLKE 89
Query: 86 LKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLV 145
L+H +II + + + I E + L++Y K V +R IKS+ Q++ G+
Sbjct: 90 LQHRNIIELKS--VIHHNHRLHLIFE-YAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 146 YLHSRDPPVIHRDLKCDNIFVN----GHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFM- 200
+ HSR +HRDLK N+ ++ +KIGD GLA R + T E +
Sbjct: 147 FCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA---R-AFGIPIRQFTHEIIT 200
Query: 201 ----APELY--EEDYNELVDVYSFGMCVL-EMFTCE------------------------ 229
PE+ Y+ VD++S C+ EM
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIA-CIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD 259
Query: 230 --YP-YSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285
+P + + Q + K L ++ D E + L + KR+SAK L
Sbjct: 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319
Query: 286 PFLASDEVK 294
P+ + ++
Sbjct: 320 PYFSHNDFD 328
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 9e-23
Identities = 73/308 (23%), Positives = 126/308 (40%), Gaps = 76/308 (24%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNEL--------MRSPDDLQRLYSEVHLLST 85
E +G+G TV+KA + VA +VRL++ +R E+ LL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----------EICLLKE 57
Query: 86 LKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRV-DIRAIKSWARQILQGL 144
LKH +I+R + + K + E F L++Y D +KS+ Q+L+GL
Sbjct: 58 LKHKNIVRLHD--VLHSDKKLTLVFE-FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 145 VYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFM---- 200
+ HSR+ V+HRDLK N+ +N G++K+ + GLA R + + E +
Sbjct: 115 GFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLA---R-AFGIPVRCYSAEVVTLWY 167
Query: 201 -APELY--EEDYNELVDVYSFGMCVL-EMFTCEYPY----SECANPAQIYK--------- 243
P++ + Y+ +D++S G C+ E+ P Q+ +
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAG-CIFAELANAGRPLFPGNDV---DDQLKRIFRLLGTPT 223
Query: 244 -----KVTSGKLPGA-----FYSIQDL---------EAQRFIGRCLV-NASKRLSAKELL 283
+T KLP + + L + + L N +R+SA+E L
Sbjct: 224 EEQWPSMT--KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281
Query: 284 LDPFLASD 291
P+ +
Sbjct: 282 QHPYFSDF 289
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 73/309 (23%), Positives = 122/309 (39%), Gaps = 77/309 (24%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNEL--------MRSPDDLQRLYSEVHLLST 85
++G+G+ V K ++ G VA + ++ MR E+ LL
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----------EIKLLKQ 80
Query: 86 LKHDSIIRFYTSWIDV--DQKTFNFITEMFTSGTLREYRKKYRR-VDIRAIKSWARQILQ 142
L+H++++ +V +K + + E F T+ + + + +D + ++ + QI+
Sbjct: 81 LRHENLVNLL----EVCKKKKRWYLVFE-FVDHTILDDLELFPNGLDYQVVQKYLFQIIN 135
Query: 143 GLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA--HSVIGTPEFM 200
G+ + HS + +IHRD+K +NI V+ G VK+ D G A L V T +
Sbjct: 136 GIGFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYDDEVA-TRWYR 191
Query: 201 APELY--EEDYNELVDVYSFGMCVL-EMFTCEYPY----SECANPAQIYK---------- 243
APEL + Y + VDV++ G C++ EMF E P S+ Q+Y
Sbjct: 192 APELLVGDVKYGKAVDVWAIG-CLVTEMFMGE-PLFPGDSD---IDQLYHIMMCLGNLIP 246
Query: 244 ----KVTSGKLPGA-------FYSIQDLE---------AQRFIGRCLV-NASKRLSAKEL 282
K P + LE +CL + KR EL
Sbjct: 247 RHQELFN--KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAEL 304
Query: 283 LLDPFLASD 291
L F D
Sbjct: 305 LHHDFFQMD 313
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 18/224 (8%)
Query: 32 FEEVLGKGAMKTVYKAI---DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH 88
E LG G+ V + V VA ++ +++ P+ + EV+ + +L H
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK-PDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVYL 147
++IR Y V +TE+ G+L + RK + + +A Q+ +G+ YL
Sbjct: 81 RNLIRLYGV---VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 137
Query: 148 HSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF----MAPE 203
S+ IHRDL N+ + VKIGD GL L + + + + APE
Sbjct: 138 ESKR--FIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 204 -LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKV 245
L ++ D + FG+ + EMFT + P+ +QI K+
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILHKI 237
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 3e-22
Identities = 46/227 (20%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 32 FEEVLGKGAMKTVYKAI---DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH 88
+LG+G VY+ + + + VA + + + + + E ++ L H
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS---EAVIMKNLDH 72
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVYL 147
I++ ++++ I E++ G L Y + + + + ++ QI + + YL
Sbjct: 73 PHIVKLIGI---IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 129
Query: 148 HSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---KSAHSVIGTP-EFMAPE 203
S + +HRD+ NI V VK+GD GL+ + K++ + + P ++M+PE
Sbjct: 130 ESIN--CVHRDIAVRNILVASPE-CVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPE 184
Query: 204 -LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
+ + DV+ F +C+ E+ + + P+ N + + G
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKG 230
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 50/227 (22%), Positives = 96/227 (42%), Gaps = 20/227 (8%)
Query: 32 FEEVLGKGAMKTVYKAI----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
+VLG G TV+K + E + + V + +S + + + +L
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD---HMLAIGSLD 73
Query: 88 HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVY 146
H I+R + +T+ G+L ++ R+ + + + +W QI +G+ Y
Sbjct: 74 HAHIVRLLGL---CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 130
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGT--P-EFMAPE 203
L ++HR+L N+ + QV++ D G+A +L P ++MA E
Sbjct: 131 LEEHG--MVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187
Query: 204 -LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
++ Y DV+S+G+ V E+ T PY+ A++ + G
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-AEVPDLLEKG 233
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 4e-22
Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 20/227 (8%)
Query: 32 FEEVLGKGAMKTVYKAI----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
+VLG GA TVYK + E + + VA ++R ++ ++ E ++++++
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD---EAYVMASVD 75
Query: 88 HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVY 146
+ + R T IT++ G L +Y R+ + + + +W QI +G+ Y
Sbjct: 76 NPHVCRLLGI---CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGT--P-EFMAPE 203
L R ++HRDL N+ V VKI D GLA +L + + G P ++MA E
Sbjct: 133 LEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 204 -LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
+ Y DV+S+G+ V E+ T PY ++I + G
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKG 235
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 76/342 (22%), Positives = 124/342 (36%), Gaps = 77/342 (22%)
Query: 2 YSNKQLAGAADEAKAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQV 61
+ + +A AA + D RY +G+GA V A D + V VA ++
Sbjct: 2 HHHHHMAAAAAAGPEMVRGQVFDVGPRYTNLS-YIGEGAYGMVCSAYDNLNKVRVAIKKI 60
Query: 62 RLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN---FITE-MFT--- 114
QR E+ +L +H++II + + + M T
Sbjct: 61 SP---FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY 117
Query: 115 ----SGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHL 170
+ L Y + QIL+GL Y+HS + V+HRDLK N+ +N
Sbjct: 118 KLLKTQHLSNDHICY----------FLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTT- 164
Query: 171 GQVKIGDLGLAAILRGSKSAHSVIGTPEFM----------APE--LYEEDYNELVDVYSF 218
+KI D GLA R + H F+ APE L + Y + +D++S
Sbjct: 165 CDLKICDFGLA---RVADPDH---DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 218
Query: 219 GMCVL-EMFTCE--YPYSECAN------------PAQIYKKVTSGK-------LP----- 251
G C+L EM + +P + + + + K LP
Sbjct: 219 G-CILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 277
Query: 252 --GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290
+ D +A + + L N KR+ ++ L P+L
Sbjct: 278 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 5e-22
Identities = 54/223 (24%), Positives = 105/223 (47%), Gaps = 17/223 (7%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
+ LG G VY+ + + + VA ++ + + +++ E ++ +KH ++
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNL 278
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK--SWARQILQGLVYLHS 149
++ + + F ITE T G L +Y ++ R ++ A+ A QI + YL
Sbjct: 279 VQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 150 RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-SAHSVIGTP-EFMAPE-LYE 206
++ IHR+L N V + VK+ D GL+ ++ G +AH+ P ++ APE L
Sbjct: 337 KN--FIHRNLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 393
Query: 207 EDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
++ DV++FG+ + E+ T PY +Q+Y+ +
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKD 435
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 6e-22
Identities = 50/223 (22%), Positives = 96/223 (43%), Gaps = 22/223 (9%)
Query: 67 MRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR 126
M D + E +++ +++ + ++ D D+ + + E G L Y
Sbjct: 107 MIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-DRYLY-MVMEYMPGGDLVNLMSNYD 164
Query: 127 RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLAA-- 182
+ A + + +++ L +HS IHRD+K DN+ + +GH +K+ D G
Sbjct: 165 VPEKWA-RFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGH---LKLADFGTCMKM 218
Query: 183 ILRGSKSAHSVIGTPEFMAPEL-----YEEDYNELVDVYSFGMCVLEMFTCEYP-YSECA 236
G + +GTP++++PE+ + Y D +S G+ + EM + P Y++
Sbjct: 219 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-- 276
Query: 237 NPAQIYKKVTSGKLPGAFYSIQDL--EAQRFIGRCLVNASKRL 277
+ Y K+ + K F D+ EA+ I L + RL
Sbjct: 277 SLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRL 319
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 8e-22
Identities = 52/226 (23%), Positives = 96/226 (42%), Gaps = 17/226 (7%)
Query: 31 LFEEVLGKGAMKTVYKAI--DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH 88
L ++ LG G TV K + + VA ++ P L +E +++ L +
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDN 77
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLH 148
I+R + +++ + EM G L +Y ++ R V + I Q+ G+ YL
Sbjct: 78 PYIVRMIGI---CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE 134
Query: 149 SRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF----MAPE- 203
+ +HRDL N+ + KI D GL+ LR ++ + ++ APE
Sbjct: 135 ESN--FVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 191
Query: 204 LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
+ ++ DV+SFG+ + E F+ + PY ++ + G
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAMLEKG 236
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 9e-22
Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 23/237 (9%)
Query: 118 LREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGD 177
+ + + QI+ GL +LH R+ +I+RDLK +N+ ++ G V+I D
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDD-GNVRISD 332
Query: 178 LGLA-AILRGSKSAHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPY--- 232
LGLA + G GTP FMAPE L E+Y+ VD ++ G+ + EM P+
Sbjct: 333 LGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392
Query: 233 SECANPAQIYKKVTSGKL--PGAFYSIQDLEAQRFIGRCLV-NASKRL-----SAKELLL 284
E ++ ++V + P F ++ F L + KRL S L
Sbjct: 393 GEKVENKELKQRVLEQAVTYPDKF----SPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448
Query: 285 DPFLAS-DEVKLLSKTKLNQKPFLNETELEKLQLSDDPPRTDMTITGKLNPEDDTIF 340
P +L + L PF+ ++ + D D F
Sbjct: 449 HPLFRDISWRQLEAG-ML-TPPFVPDSRTVYAKNIQDVGAFSTVKGVAFEKADTEFF 503
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 66/266 (24%), Positives = 126/266 (47%), Gaps = 25/266 (9%)
Query: 22 ETDPNGRYGL--FE--EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLY 77
ET L F+ + LG G+ V + G A + ++++ ++
Sbjct: 31 ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTL 89
Query: 78 SEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWA 137
+E +L + +++ S+ D + + + E G + + ++ R + +A
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKD-NSNLY-MVMEYVAGGEMFSHLRRIGRFSEPHARFYA 147
Query: 138 RQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTP 197
QI+ YLHS D +I+RDLK +N+ ++ G +++ D G A ++G ++ GTP
Sbjct: 148 AQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGR--TWTLCGTP 202
Query: 198 EFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQIYKKVTSGKL--PG 252
E +APE + + YN+ VD ++ G+ + EM YP +++ P QIY+K+ SGK+ P
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEM-AAGYPPFFAD--QPIQIYEKIVSGKVRFPS 259
Query: 253 AFYSIQDLEAQRFIGRCL-VNASKRL 277
F + + + L V+ +KR
Sbjct: 260 HF----SSDLKDLLRNLLQVDLTKRF 281
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-21
Identities = 43/227 (18%), Positives = 91/227 (40%), Gaps = 19/227 (8%)
Query: 31 LFEEVLGKGAMKTVYKAI--DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH 88
+ + LG G +V + + ++VA ++ +++ R E ++ L +
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR---EAQIMHQLDN 69
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVYL 147
I+R + + EM G L ++ K + + + Q+ G+ YL
Sbjct: 70 PYIVRLIGV---CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 126
Query: 148 HSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF----MAPE 203
++ +HRDL N+ + KI D GL+ L S ++ ++ APE
Sbjct: 127 EEKN--FVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 183
Query: 204 -LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
+ ++ DV+S+G+ + E + + PY + ++ + G
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQG 229
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 56/296 (18%), Positives = 108/296 (36%), Gaps = 48/296 (16%)
Query: 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL- 86
Y + +VLG G V + ++ + A ++ D + EV L
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFA---------LKMLQDCPKARREVELHWRAS 68
Query: 87 KHDSIIRFYTSWIDVDQKTFNF--ITEMFTSGTL--REYRKKYRRVDIRAIKSWARQILQ 142
+ I+R + ++ + E G L R + + R + I +
Sbjct: 69 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 143 GLVYLHSRDPPVIHRDLKCDNI-FVNGHLG-QVKIGDLGLAAILRGSKSAHSVIGTPEFM 200
+ YLHS + + HRD+K +N+ + + +K+ D G
Sbjct: 129 AIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF-------------------- 166
Query: 201 APELYEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQ--IYKKVTSGKL--PGAF 254
A E E Y++ D++S G ++ + C YP YS + ++ G+ P
Sbjct: 167 AKETTGEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225
Query: 255 YSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNE 309
+S E + I L ++R++ E + P++ + +T L+ L E
Sbjct: 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK--VPQTPLHTSRVLKE 279
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 2e-21
Identities = 49/227 (21%), Positives = 97/227 (42%), Gaps = 22/227 (9%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLG---VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH 88
+G+G V++ I + VA + + + E + H
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ---EALTMRQFDH 450
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVYL 147
I++ + + I E+ T G LR + + + +D+ ++ +A Q+ L YL
Sbjct: 451 PHIVKLIGV---ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL 507
Query: 148 HSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---KSAHSVIGTP-EFMAPE 203
S+ +HRD+ N+ V+ + VK+GD GL+ + S K++ + P ++MAPE
Sbjct: 508 ESKR--FVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPE 562
Query: 204 -LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
+ + DV+ FG+C+ E+ P+ N + ++ +G
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENG 608
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 76/312 (24%), Positives = 123/312 (39%), Gaps = 76/312 (24%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNE-------LMRSPDDLQRLYSEVHLLSTL 86
E LG G TVYK +++ GV VA +V+L+ +R E+ L+ L
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----------EISLMKEL 60
Query: 87 KHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY------RKKYRRVDIRAIKSWARQI 140
KH++I+R Y + + + E F L++Y R +++ +K + Q+
Sbjct: 61 KHENIVRLYD--VIHTENKLTLVFE-FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 141 LQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFM 200
LQGL + H ++HRDLK N+ +N GQ+K+GD GLA + + E +
Sbjct: 118 LQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGLA----RAFGIPVNTFSSEVV 170
Query: 201 -----APELY--EEDYNELVDVYSFGMCVL-EMFT------------------------- 227
AP++ Y+ +D++S G C+L EM T
Sbjct: 171 TLWYRAPDVLMGSRTYSTSIDIWSCG-CILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN 229
Query: 228 -------CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSA 279
+ P + + + L D F+ L N RLSA
Sbjct: 230 ESLWPSVTKLPKYNPNIQQRPPRDLRQ-VLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA 288
Query: 280 KELLLDPFLASD 291
K+ L P+ A
Sbjct: 289 KQALHHPWFAEY 300
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-21
Identities = 55/226 (24%), Positives = 98/226 (43%), Gaps = 25/226 (11%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWN---QVRLNELMRSPDDLQRLYSEVHLLSTLKH 88
E LG+G V+ WN +V + L + E ++ L+H
Sbjct: 271 LEVKLGQGCFGEVWMGT---------WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH 321
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK--SWARQILQGLVY 146
+ +++ Y V ++ +TE + G+L ++ K +R + A QI G+ Y
Sbjct: 322 EKLVQLYAV---VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-SAHSVIGTP-EFMAPE- 203
+ + +HRDL+ NI V +L K+ D GLA ++ ++ +A P ++ APE
Sbjct: 379 VERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 435
Query: 204 LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
+ DV+SFG+ + E+ T PY N ++ +V G
Sbjct: 436 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERG 480
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-21
Identities = 49/227 (21%), Positives = 97/227 (42%), Gaps = 22/227 (9%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLG---VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH 88
+G+G V++ I + VA + + + E + H
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ---EALTMRQFDH 75
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVYL 147
I++ + + I E+ T G LR + + + +D+ ++ +A Q+ L YL
Sbjct: 76 PHIVKLIGV---ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132
Query: 148 HSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---KSAHSVIGTP-EFMAPE 203
S+ +HRD+ N+ V+ + VK+GD GL+ + S K++ + P ++MAPE
Sbjct: 133 ESKR--FVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPE 187
Query: 204 -LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
+ + DV+ FG+C+ E+ P+ N + ++ +G
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENG 233
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 5e-21
Identities = 55/226 (24%), Positives = 98/226 (43%), Gaps = 25/226 (11%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWN---QVRLNELMRSPDDLQRLYSEVHLLSTLKH 88
E LG+G V+ WN +V + L + E ++ L+H
Sbjct: 188 LEVKLGQGCFGEVWMGT---------WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH 238
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK--SWARQILQGLVY 146
+ +++ Y V ++ +TE + G+L ++ K +R + A QI G+ Y
Sbjct: 239 EKLVQLYAV---VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-SAHSVIGTP-EFMAPE- 203
+ + +HRDL+ NI V +L K+ D GLA ++ ++ +A P ++ APE
Sbjct: 296 VERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 352
Query: 204 LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
+ DV+SFG+ + E+ T PY N ++ +V G
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERG 397
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 5e-21
Identities = 41/233 (17%), Positives = 89/233 (38%), Gaps = 26/233 (11%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVR-----LNELMRSPDDLQRLYSEVHLLSTL 86
F E LG+G ++K + +G ++ L++ + + + ++S L
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKL 69
Query: 87 KHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLV 145
H ++ Y + V + E G+L Y +K ++I A+Q+ +
Sbjct: 70 SHKHLVLNYG--VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127
Query: 146 YLHSRDPPVIHRDLKCDNIFVN-------GHLGQVKIGDLGLAAILRGSKSAHSVIGTPE 198
+L +IH ++ NI + G+ +K+ D G++ + I
Sbjct: 128 FLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI---P 182
Query: 199 FMAPE--LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
++ PE ++ N D +SFG + E+ + + P S + + +
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQFYEDR 234
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 8e-21
Identities = 72/348 (20%), Positives = 118/348 (33%), Gaps = 93/348 (26%)
Query: 15 KAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQ 74
A G E + RY L LG G TV+ A D V VA VR +++ +
Sbjct: 9 PAFKG--EPYKDARYILVR-KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-----E 60
Query: 75 RLYSEVHLLSTLKHDS-----------IIRFYTSWIDVDQKTFNFITEMFT--------- 114
E+ LL + I++ FN
Sbjct: 61 AAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH--------FNHKGPNGVHVVMVFEVL 112
Query: 115 SGTLREYRKK--YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFV-----N 167
L KK +R + + +K ++Q+L GL Y+H R +IH D+K +N+ +
Sbjct: 113 GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSP 171
Query: 168 GHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMF 226
+L Q+KI DLG A + + I T E+ +PE L + D++S + E+
Sbjct: 172 ENLIQIKIADLGNAC--WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELI 229
Query: 227 TCEY------PYSECANPAQI------------------------------YKKVTSGKL 250
T ++ +S + I + ++ K
Sbjct: 230 TGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKF 289
Query: 251 PG------AFYSIQDLEAQRF---IGRCLV-NASKRLSAKELLLDPFL 288
Y EA+ + L + KR A L+ P+L
Sbjct: 290 WPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 8e-21
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNEL--------MRSPDDLQRLYSEVHLLST 85
E +G+G VYKA D G VA ++RL+ +R E+ LL
Sbjct: 27 EKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIR----------EISLLKE 75
Query: 86 LKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRV-DIRAIKSWARQILQGL 144
L H +I+ + ++ + E F L++ + + IK + Q+L+G+
Sbjct: 76 LHHPNIVSLID--VIHSERCLTLVFE-FMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 145 VYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFM---- 200
+ H ++HRDLK N+ +N G +K+ D GLA R + T E +
Sbjct: 133 AHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGLA---R-AFGIPVRSYTHEVVTLWY 185
Query: 201 -APELY--EEDYNELVDVYSFGMCVL-EMFT 227
AP++ + Y+ VD++S G C+ EM T
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIG-CIFAEMIT 215
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 9e-21
Identities = 64/215 (29%), Positives = 109/215 (50%), Gaps = 24/215 (11%)
Query: 71 DDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDI 130
++ E +LS + H IIR + ++ D Q+ F I + G L +K +R
Sbjct: 48 KQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIF-MIMDYIEGGELFSLLRKSQRFPN 105
Query: 131 RAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLAAILRGSK 188
K +A ++ L YLHS+D +I+RDLK +NI + NGH +KI D G A
Sbjct: 106 PVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGH---IKITDFGFAK--YVPD 158
Query: 189 SAHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYP--YSECANPAQIYKKV 245
+++ GTP+++APE + + YN+ +D +SFG+ + EM Y Y N + Y+K+
Sbjct: 159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEM-LAGYTPFYDS--NTMKTYEKI 215
Query: 246 TSGKL--PGAFYSIQDLEAQRFIGRCLV-NASKRL 277
+ +L P F + + + + R + + S+RL
Sbjct: 216 LNAELRFPPFF----NEDVKDLLSRLITRDLSQRL 246
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 35/219 (15%), Positives = 58/219 (26%), Gaps = 40/219 (18%)
Query: 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLST 85
NGRY L G ++A+D L +VA V + + D LQ S LS
Sbjct: 30 NGRYRL-LIFHGGVPPLQFWQALDTALDRQVALTFVDP-QGVLPDDVLQETLSRTLRLSR 87
Query: 86 LKHDSIIRFYTSWIDV-DQKTFNFI-TEMFTSGTLREYRKKYRRVDIRAIKSWARQILQG 143
+ + R DV + + E G+L+E + +
Sbjct: 88 IDKPGVARVL----DVVHTRAGGLVVAEWIRGGSLQEVAD--TSPSPVGAIRAMQSLAAA 141
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE 203
H V + V+ G V + +
Sbjct: 142 ADAAHRAG--VALSIDHPSRVRVSID-GDVVLAYPATMP----DANPQD----------- 183
Query: 204 LYEEDYNELVDVYSFGMCVL-EMFTCEYPYSECANPAQI 241
D+ G L + +P E + +
Sbjct: 184 ----------DIRGIG-ASLYALLVNRWPLPEAGVRSGL 211
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 44/176 (25%), Positives = 76/176 (43%), Gaps = 30/176 (17%)
Query: 135 SWAR----QILQGLVYLHSRDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLAA--ILRG 186
AR +I+ + +H +HRD+K DNI + GH +++ D G G
Sbjct: 162 EMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGH---IRLADFGSCLKLRADG 216
Query: 187 SKSAHSVIGTPEFMAPEL--------YEEDYNELVDVYSFGMCVLEMFTCEYP-YSECAN 237
+ + +GTP++++PE+ Y D ++ G+ EMF + P Y++ +
Sbjct: 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD--S 274
Query: 238 PAQIYKKVTSGKLPGAFYSIQDL---EAQRFIGRCLVNASKRL---SAKELLLDPF 287
A+ Y K+ K + + + EA+ FI R L RL A + PF
Sbjct: 275 TAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPF 330
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 19/153 (12%)
Query: 137 ARQILQGLVYLHSRDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLA-AILRGSKSAHSV 193
A +I L YLHS + +++RDLK +NI + GH + + D GL + + + +
Sbjct: 145 AAEIASALGYLHSLN--IVYRDLKPENILLDSQGH---IVLTDFGLCKENIEHNSTTSTF 199
Query: 194 IGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYP-YSECANPAQIYKKVTSGKL- 250
GTPE++APE L+++ Y+ VD + G + EM P YS N A++Y + + L
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--NTAEMYDNILNKPLQ 257
Query: 251 -PGAFYSIQDLEAQRFIGRCLV-NASKRLSAKE 281
A+ + L + +KRL AK+
Sbjct: 258 LKPNI----TNSARHLLEGLLQKDRTKRLGAKD 286
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 42/170 (24%), Positives = 78/170 (45%), Gaps = 25/170 (14%)
Query: 126 RRVDIRAIKSWAR----QILQGLVYLHSRDPPVIHRDLKCDNIFV--NGHLGQVKIGDLG 179
+ + R + AR +++ + +H +HRD+K DNI + NGH +++ D G
Sbjct: 166 SKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGH---IRLADFG 220
Query: 180 LAA--ILRGSKSAHSVIGTPEFMAPEL------YEEDYNELVDVYSFGMCVLEMFTCEYP 231
+ G+ + +GTP++++PE+ + Y D +S G+C+ EM E P
Sbjct: 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
Query: 232 -YSECANPAQIYKKVTSGKLPGAFYSIQDL---EAQRFIGRCLVNASKRL 277
Y+E + + Y K+ + K F + A+ I R + + RL
Sbjct: 281 FYAE--SLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRL 328
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 2e-20
Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 43/213 (20%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNEL--------MRSPDDLQRLYSEVHLLST 85
E +G+G VYKA + G A ++RL + +R E+ +L
Sbjct: 8 EKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIR----------EISILKE 56
Query: 86 LKHDSIIRFYTSWIDV--DQKTFNFITEMFTSGTLREYRKKYRRV-DIRAIKSWARQILQ 142
LKH +I++ Y DV +K + E L++ + KS+ Q+L
Sbjct: 57 LKHSNIVKLY----DVIHTKKRLVLVFE-HLDQDLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 143 GLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFM-- 200
G+ Y H R V+HRDLK N+ +N G++KI D GLA R + T E +
Sbjct: 112 GIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLA---R-AFGIPVRKYTHEIVTL 164
Query: 201 ---APELY--EEDYNELVDVYSFGMCVL-EMFT 227
AP++ + Y+ +D++S G C+ EM
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVG-CIFAEMVN 196
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 67/312 (21%), Positives = 118/312 (37%), Gaps = 70/312 (22%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRL-NELMRSPDDLQRLYSEVHLLSTLKHDSII 92
+G+G V+KA G +VA +V + NE P R E+ +L LKH++++
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EIKILQLLKHENVV 79
Query: 93 RFY---TSWIDVDQKTFNFITEMFTSGTLREY---------RKKYRRVDIRAIKSWARQI 140
+ + I +F ++ + + IK + +
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVF------DFCEHDLAGLLSNVLVKFTLSEIKRVMQML 133
Query: 141 LQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPE-- 198
L GL Y+H ++HRD+K N+ + G +K+ D GLA +K++ T
Sbjct: 134 LNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 190
Query: 199 ---FMAPELY--EEDYNELVDVYSFGMCVL-EMFT--------------------C---- 228
+ PEL E DY +D++ G C++ EM+T C
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAG-CIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249
Query: 229 --------EYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSA 279
Y E + K+ +L ++D A I + LV + ++R+ +
Sbjct: 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAY---VRDPYALDLIDKLLVLDPAQRIDS 306
Query: 280 KELLLDPFLASD 291
+ L F SD
Sbjct: 307 DDALNHDFFWSD 318
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 37/210 (17%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNE-------LMRSPDDLQRLYSEVHLLSTL 86
+ LG+G TVYK ++ VA ++RL +R EV LL L
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----------EVSLLKDL 57
Query: 87 KHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRV-DIRAIKSWARQILQGLV 145
KH +I+ + I +K+ + E + L++Y + ++ +K + Q+L+GL
Sbjct: 58 KHANIVTLHD--IIHTEKSLTLVFE-YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 146 YLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFM----- 200
Y H + V+HRDLK N+ +N G++K+ D GLA R +KS + E +
Sbjct: 115 YCHRQK--VLHRDLKPQNLLIN-ERGELKLADFGLA---R-AKSIPTKTYDNEVVTLWYR 167
Query: 201 APELY--EEDYNELVDVYSFGMCVL-EMFT 227
P++ DY+ +D++ G C+ EM T
Sbjct: 168 PPDILLGSTDYSTQIDMWGVG-CIFYEMAT 196
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 3e-20
Identities = 44/231 (19%), Positives = 94/231 (40%), Gaps = 20/231 (8%)
Query: 31 LFEEVLGKGAMKTVYKAI--DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH 88
+ + LG G +V + + ++VA ++ +++ R E ++ L +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR---EAQIMHQLDN 395
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVYL 147
I+R + + EM G L ++ K + + + Q+ G+ YL
Sbjct: 396 PYIVRLIGV---CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 452
Query: 148 HSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF----MAPE 203
++ +HR+L N+ + KI D GL+ L S ++ ++ APE
Sbjct: 453 EEKN--FVHRNLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 509
Query: 204 -LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSGK-LP 251
+ ++ DV+S+G+ + E + + PY + P ++ + GK +
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIEQGKRME 559
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 78/302 (25%), Positives = 130/302 (43%), Gaps = 64/302 (21%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
+ +G GA V A+D G +VA +L +S +R Y E+ LL ++H+++I
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHMRHENVIG 88
Query: 94 FYTSWI-DVDQKTFN---FITE-MFT-------SGTLREYRKKYRRVDIRAIKSWARQIL 141
+ D F + M T L E R ++ Q+L
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF----------LVYQML 138
Query: 142 QGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSV-IGTPEFM 200
+GL Y+H+ +IHRDLK N+ VN ++KI D GLA R + S + + T +
Sbjct: 139 KGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGLA---RQADSEMTGYVVTRWYR 192
Query: 201 APE--LYEEDYNELVDVYSFGMCVL-EMFTCE--YPYSECAN------------PAQIYK 243
APE L Y + VD++S G C++ EM T + + S+ + PA+ +
Sbjct: 193 APEVILNWMRYTQTVDIWSVG-CIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251
Query: 244 KVTSGK-------LP-------GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288
++ S + LP + + A + + LV +A +R++A E L P+
Sbjct: 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311
Query: 289 AS 290
S
Sbjct: 312 ES 313
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 4e-20
Identities = 49/228 (21%), Positives = 95/228 (41%), Gaps = 29/228 (12%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVR------LNELMRSPDDLQRLYSEVHLLST 85
F + +G G V+ W + E S +D E ++
Sbjct: 12 FVQEIGSGQFGLVHLGY---------WLNKDKVAIKTIREGAMSEEDFIE---EAEVMMK 59
Query: 86 LKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGL 144
L H +++ Y + ++Q +TE G L +Y R + + + +G+
Sbjct: 60 LSHPKLVQLYG--VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM 117
Query: 145 VYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRGSKSAHSVIGTP-EFMAP 202
YL VIHRDL N V + +K+ D G+ +L ++ + P ++ +P
Sbjct: 118 AYLEEAC--VIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 174
Query: 203 E-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
E Y+ DV+SFG+ + E+F+ + PY +N +++ + +++G
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTG 221
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 74/306 (24%), Positives = 123/306 (40%), Gaps = 62/306 (20%)
Query: 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
Y +G GA +V AID+ G +VA +L+ +S +R Y E+ LL ++
Sbjct: 25 TYVSPT-HVGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQSEIFAKRAYRELLLLKHMQ 81
Query: 88 HDSIIRFYTSWI-DVDQKTFN---FITE-MFT------SGTLREYRKKYRRVDIRAIKSW 136
H+++I + + F + M T E + +Y
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY----------L 131
Query: 137 ARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGT 196
Q+L+GL Y+HS V+HRDLK N+ VN ++KI D GLA + + + T
Sbjct: 132 VYQMLKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILDFGLARHADAEMTGY--VVT 186
Query: 197 PEFMAPE--LYEEDYNELVDVYSFGMCVL-EMFTCE--YPYSECAN------------PA 239
+ APE L YN+ VD++S G C++ EM T + + + +
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVG-CIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 245
Query: 240 QIYKKVTSGK-------LP-------GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284
+ +K+ LP + +A + + L + KRL+A + L
Sbjct: 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305
Query: 285 DPFLAS 290
PF
Sbjct: 306 HPFFEP 311
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 5e-20
Identities = 48/172 (27%), Positives = 78/172 (45%), Gaps = 21/172 (12%)
Query: 139 QILQGLVYLHSRDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLA-AILRGSKSAHSVIG 195
++ L +LHS +I+RDLK +NI + GH +K+ D GL+ + K A+S G
Sbjct: 134 ELALALDHLHSLG--IIYRDLKPENILLDEEGH---IKLTDFGLSKESIDHEKKAYSFCG 188
Query: 196 TPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYP-YSECANPAQIYKKVTSGKLPGA 253
T E+MAPE + + + D +SFG+ + EM T P + + + + KL
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK--DRKETMTMILKAKLG-- 244
Query: 254 FYSIQDLEAQRFIGRCLV-NASKRL-----SAKELLLDPFLAS-DEVKLLSK 298
EAQ + N + RL +E+ F ++ D KL +
Sbjct: 245 MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRR 296
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 54/227 (23%), Positives = 88/227 (38%), Gaps = 19/227 (8%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLG---VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH 88
E+++G G V V G V VA ++ R D E ++ H
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLS---EASIMGQFDH 109
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVYL 147
+IIR + + +TE +G+L + R + I + R + G+ YL
Sbjct: 110 PNIIRLEG--VVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 148 HSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF----MAPE 203
+HRDL N+ V+ +L K+ D GL+ +L A + APE
Sbjct: 168 SDLG--YVHRDLAARNVLVDSNL-VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE 224
Query: 204 -LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
+ ++ DV+SFG+ + E+ E PY N + V G
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RDVISSVEEG 270
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 65/326 (19%), Positives = 111/326 (34%), Gaps = 89/326 (27%)
Query: 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVA-------WNQVRLNELMRSPDDLQRLYSEV 80
Y + + + G+ V +D G+ VA + R ++ +R+ E+
Sbjct: 23 PYTV-QRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 81 HLLSTLKHDSIIRFYTSWIDVDQKTFN---FITE-MFT---------SGTLREYRKKYRR 127
LL+ H +I+ ++ ++ + +TE M T + +Y
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY-- 138
Query: 128 VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187
+ IL GL LH V+HRDL NI + + + I D LA R
Sbjct: 139 --------FMYHILLGLHVLHEAG--VVHRDLHPGNILLADN-NDITICDFNLA---RE- 183
Query: 188 KSAHSVIGTPEFM----------APE--LYEEDYNELVDVYSFGMCVL-EMFTC------ 228
APE + + + +LVD++S G CV+ EMF
Sbjct: 184 ------DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAG-CVMAEMFNRKALFRG 236
Query: 229 -------------------EYPYSECANPAQIYKKVTSGKLPG----AFYSIQDLEAQRF 265
E + A+ Y + + +P A D A
Sbjct: 237 STFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDL 296
Query: 266 IGRCLV-NASKRLSAKELLLDPFLAS 290
I + L N +R+S ++ L P+ S
Sbjct: 297 IAKMLEFNPQRRISTEQALRHPYFES 322
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 7e-20
Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 21/172 (12%)
Query: 139 QILQGLVYLHSRDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLA-AILRGSKSAHSVIG 195
+I L +LH + +I+RDLK +NI + GH VK+ D GL + H+ G
Sbjct: 129 EISMALGHLHQKG--IIYRDLKPENIMLNHQGH---VKLTDFGLCKESIHDGTVTHTFCG 183
Query: 196 TPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYP-YSECANPAQIYKKVTSGKLPGA 253
T E+MAPE L +N VD +S G + +M T P E N + K+ KL
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE--NRKKTIDKILKCKLN-- 239
Query: 254 FYSIQDLEAQRFIGRCLV-NASKRL-----SAKELLLDPFLAS-DEVKLLSK 298
EA+ + + L NA+ RL A E+ PF + +LL++
Sbjct: 240 LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLAR 291
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 8e-20
Identities = 57/226 (25%), Positives = 107/226 (47%), Gaps = 25/226 (11%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWN---QVRLNELMRSPDDLQRLYSEVHLLSTLKH 88
E+ LG G V+ A +N +V + + ++ +E +++ TL+H
Sbjct: 192 LEKKLGAGQFGEVWMAT---------YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQH 242
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK--SWARQILQGLVY 146
D +++ + V ++ ITE G+L ++ K K ++ QI +G+ +
Sbjct: 243 DKLVKLHAV---VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-SAHSVIGTP-EFMAPE- 203
+ R+ IHRDL+ NI V+ L KI D GLA ++ ++ +A P ++ APE
Sbjct: 300 IEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 356
Query: 204 LYEEDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSG 248
+ + DV+SFG+ ++E+ T PY +NP ++ + + G
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRALERG 401
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 49/174 (28%), Positives = 87/174 (50%), Gaps = 21/174 (12%)
Query: 137 ARQILQGLVYLHSRDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLA-AILRGSKSAHSV 193
+I+ L YLHSRD V++RD+K +N+ + +GH +KI D GL + + +
Sbjct: 111 GAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGH---IKITDFGLCKEGISDGATMKTF 165
Query: 194 IGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYP-YSECANPAQIYKKVTSGKLP 251
GTPE++APE L + DY VD + G+ + EM P Y++ + ++++ + ++
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILMEEIR 223
Query: 252 GAFYSIQDLEAQRFIGRCLV-NASKRL-----SAKELLLDPFLAS-DEVKLLSK 298
F EA+ + L + +RL AKE++ F S + ++ K
Sbjct: 224 --FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQK 275
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 23/226 (10%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVR-LNELMRSPDDLQRLYSEVHLLSTLKHDS 90
+ LG G VY+ + + + VA V+ L E ++ E ++ +KH +
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVA---VKTLKEDTMEVEEFL---KEAAVMKEIKHPN 70
Query: 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK--SWARQILQGLVYLH 148
+++ + + F ITE T G L +Y ++ R ++ A+ A QI + YL
Sbjct: 71 LVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 149 SRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF----MAPE- 203
++ IHRDL N V + VK+ D GL+ ++ G +F APE
Sbjct: 129 KKN--FIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGA--KFPIKWTAPES 183
Query: 204 LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
L ++ DV++FG+ + E+ T PY +Q+Y+ +
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKD 228
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 58/327 (17%), Positives = 108/327 (33%), Gaps = 80/327 (24%)
Query: 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSII 92
+ LG G+ V + D G A +V D + E+ ++ L H +II
Sbjct: 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQ--------DPRYKNRELDIMKVLDHVNII 63
Query: 93 R----FYTSWIDVDQKTFNFITEMFTSGT------------------------------- 117
+ FYT+ + + G
Sbjct: 64 KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123
Query: 118 ----LREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQV 173
L+ + + R + + I + Q+ + + ++HS + HRD+K N+ VN +
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTL 181
Query: 174 KIGDLGLAAILRGSKSAHSVIGTPEFMAPELY--EEDYNELVDVYSFGMCVL-EMFTCE- 229
K+ D G A L S+ + + I + + APEL +Y +D++S G CV E+ +
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG-CVFGELILGKP 240
Query: 230 -YPYSECAN-------------PAQIYK---KVTSGKLPG--------AFYSIQDLEAQR 264
+ + Q+ + T + P A
Sbjct: 241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAID 300
Query: 265 FIGRCLV-NASKRLSAKELLLDPFLAS 290
+ + L R++ E + PF
Sbjct: 301 LLEQILRYEPDLRINPYEAMAHPFFDH 327
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 47/177 (26%), Positives = 85/177 (48%), Gaps = 24/177 (13%)
Query: 139 QILQGLVYLHSRDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLA--AILRGSKSAHSVI 194
+I+ L +LH +I+RD+K +NI + NGH V + D GL+ + ++ A+
Sbjct: 167 EIVLALEHLHKLG--IIYRDIKLENILLDSNGH---VVLTDFGLSKEFVADETERAYDFC 221
Query: 195 GTPEFMAPELYEED---YNELVDVYSFGMCVLEMFTCEYPY---SECANPAQIYKKVTSG 248
GT E+MAP++ +++ VD +S G+ + E+ T P+ E + A+I +++
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 281
Query: 249 KLPGAFYSIQDLEAQRFIGRCLV-NASKRL-----SAKELLLDPFLAS-DEVKLLSK 298
+ P + A+ I R L+ + KRL A E+ F + L +K
Sbjct: 282 EPP--YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAK 336
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 2e-19
Identities = 51/195 (26%), Positives = 92/195 (47%), Gaps = 20/195 (10%)
Query: 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVN 167
FI ++ G L + ++ ++ +A +I+ GL ++H+R V++RDLK NI ++
Sbjct: 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD 326
Query: 168 GHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE--LYEEDYNELVDVYSFGMCVLEM 225
H G V+I DLGLA K H+ +GT +MAPE Y+ D +S G + ++
Sbjct: 327 EH-GHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 384
Query: 226 FTCEYPY--SECANPAQIYKKVTSGKL--PGAFYSIQDLEAQRFIGRCLV-NASKRL--- 277
P+ + + +I + + + P +F E + + L + ++RL
Sbjct: 385 LRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF----SPELRSLLEGLLQRDVNRRLGCL 440
Query: 278 --SAKELLLDPFLAS 290
A+E+ PF S
Sbjct: 441 GRGAQEVKESPFFRS 455
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 52/228 (22%), Positives = 93/228 (40%), Gaps = 29/228 (12%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVR------LNELMRSPDDLQRLYSEVHLLST 85
+ LG G V W + E S D+ + E +
Sbjct: 12 LLKELGSGQFGVVKLGK---------WKGQYDVAVKMIKEGSMSEDEFFQ---EAQTMMK 59
Query: 86 LKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGL 144
L H +++FY + + +TE ++G L Y R + ++ + + +G+
Sbjct: 60 LSHPKLVKFYG--VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGM 117
Query: 145 VYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRGSKSAHSVIGTP-EFMAP 202
+L S IHRDL N V+ L VK+ D G+ +L + P ++ AP
Sbjct: 118 AFLESHQ--FIHRDLAARNCLVDRDL-CVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAP 174
Query: 203 E-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
E + Y+ DV++FG+ + E+F+ + PY N +++ KV+ G
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-SEVVLKVSQG 221
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 2e-19
Identities = 54/242 (22%), Positives = 95/242 (39%), Gaps = 44/242 (18%)
Query: 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
RY + ++G G+ V +A D++ VA ++ + D +R+ E+ +L+ L
Sbjct: 54 RYEI-RHLIGTGSYGHVCEAYDKLEKRVVAIK--KILRVFEDLIDCKRILREIAILNRLN 110
Query: 88 HDSIIRFYTSWIDVDQKTFN---FITE-MFTSGTLREYRKKYRRVDIRAIKSWARQILQG 143
HD +++ I D + F+ + E + ++ + + IK+ +L G
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA------------------AILR 185
+ Y+HS ++HRDLK N VN VK+ D GLA
Sbjct: 169 VKYVHSAG--ILHRDLKPANCLVNQD-CSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 186 GSKSAHSVIGTPEFM----------APE--LYEEDYNELVDVYSFGMCVL-EMFTCEYPY 232
+ + APE L +E+Y E +DV+S G C+ E+
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG-CIFAELLNMIKEN 284
Query: 233 SE 234
Sbjct: 285 VA 286
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 50/228 (21%), Positives = 92/228 (40%), Gaps = 29/228 (12%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVR------LNELMRSPDDLQRLYSEVHLLST 85
F + LG G V W + E S D+ E ++
Sbjct: 28 FLKELGTGQFGVVKYGK---------WRGQYDVAIKMIKEGSMSEDEFIE---EAKVMMN 75
Query: 86 LKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGL 144
L H+ +++ Y + Q+ ITE +G L Y R+ R + + + + + +
Sbjct: 76 LSHEKLVQLYG--VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 133
Query: 145 VYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRGSKSAHSVIGTP-EFMAP 202
YL S+ +HRDL N VN VK+ D GL+ +L ++ P + P
Sbjct: 134 EYLESKQ--FLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 190
Query: 203 E-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
E L ++ D+++FG+ + E+++ + PY N ++ + + G
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHIAQG 237
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 46/168 (27%), Positives = 84/168 (50%), Gaps = 17/168 (10%)
Query: 139 QILQGLVYLHSRDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLA-AILRGSKSAHSVIG 195
+I+ GL +LHS+ +++RDLK DNI + +GH +KI D G+ + G ++ G
Sbjct: 126 EIILGLQFLHSKG--IVYRDLKLDNILLDKDGH---IKIADFGMCKENMLGDAKTNTFCG 180
Query: 196 TPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYP-YSECANPAQIYKKVTSGKLPGA 253
TP+++APE L + YN VD +SFG+ + EM + P + + + +++ +
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--DEEELFHSIRMDNPF-- 236
Query: 254 FYSIQDLEAQRFIGRCLV-NASKRL-SAKELLLDPFLAS-DEVKLLSK 298
+ + EA+ + + V KRL ++ P + +L K
Sbjct: 237 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERK 284
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 77/307 (25%), Positives = 129/307 (42%), Gaps = 63/307 (20%)
Query: 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
RY +G GA +V A D G+ VA ++ +S +R Y E+ LL +K
Sbjct: 30 RYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMK 86
Query: 88 HDSIIRFYTSWI-DVDQKTFN---FITE-MFT-------SGTLREYRKKYRRVDIRAIKS 135
H+++I + + FN +T M L + ++
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---------- 136
Query: 136 WARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIG 195
QIL+GL Y+HS D +IHRDLK N+ VN ++KI D GLA + + +
Sbjct: 137 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLARHTADEMTGY--VA 191
Query: 196 TPEFMAPE--LYEEDYNELVDVYSFGMCVL-EMFTCE--YPYSECAN------------P 238
T + APE L YN+ VD++S G C++ E+ T +P ++ +
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVG-CIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 250
Query: 239 AQIYKKVTSGK-------LP-------GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELL 283
A++ KK++S L + + A + + LV ++ KR++A + L
Sbjct: 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310
Query: 284 LDPFLAS 290
+ A
Sbjct: 311 AHAYFAQ 317
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 50/252 (19%), Positives = 94/252 (37%), Gaps = 33/252 (13%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQV---RLNELMRSPDDLQRLYSEVHLLSTLKH 88
+LGKG +V +A ++ + ++ +V L + + D++ E + H
Sbjct: 27 LGRMLGKGEFGSVREA--QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 89 DSIIRFY---TSWIDVDQKTFNF-ITEMFTSGTLREYRKKYR------RVDIRAIKSWAR 138
+ + + I G L + R + ++ + +
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 139 QILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPE 198
I G+ YL SR+ IHRDL N + + V + D GL+ + S + +
Sbjct: 145 DIACGMEYLSSRN--FIHRDLAARNCMLAEDM-TVCVADFGLSRKIY-SGDYYRQGCASK 200
Query: 199 F----MAPE-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSGKL-- 250
+A E L + Y DV++FG+ + E+ T + PY+ N A+IY + G
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-AEIYNYLIGGNRLK 259
Query: 251 -----PGAFYSI 257
Y +
Sbjct: 260 QPPECMEEVYDL 271
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 48/251 (19%), Positives = 89/251 (35%), Gaps = 32/251 (12%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQV---RLNELMRSPDDLQRLYSEVHLLSTLKH 88
++LG+G +V + + + +V + S +++ SE + H
Sbjct: 38 LGKILGEGEFGSVMEG--NLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH 95
Query: 89 DSIIRFY---TSWIDVDQKTFNFITEMFTSGTLREYRKKYR------RVDIRAIKSWARQ 139
++IR I G L Y R + ++ + +
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 140 ILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF 199
I G+ YL +R+ +HRDL N + + V + D GL+ + S + +
Sbjct: 156 IALGMEYLSNRN--FLHRDLAARNCMLRDDM-TVCVADFGLSKKIY-SGDYYRQGRIAKM 211
Query: 200 ----MAPE-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSGKL--- 250
+A E L + Y DV++FG+ + E+ T PY N ++Y + G
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-HEMYDYLLHGHRLKQ 270
Query: 251 ----PGAFYSI 257
Y I
Sbjct: 271 PEDCLDELYEI 281
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 3e-19
Identities = 80/337 (23%), Positives = 130/337 (38%), Gaps = 70/337 (20%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDL----QRLYSEVHLLSTLKHD 89
+ LG+G TVYKA D+ VA +++L + D + R E+ LL L H
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR---EIKLLQELSHP 72
Query: 90 SIIRFYTSWIDV--DQKTFNFITEMFTSGTLREYRKKYRRV-DIRAIKSWARQILQGLVY 146
+II D + + + + F L K V IK++ LQGL Y
Sbjct: 73 NIIGLL----DAFGHKSNISLVFD-FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR--GSKSA---HSVIGTPEFMA 201
LH ++HRDLK +N+ ++ G +K+ D GLA + GS + H V+ T + A
Sbjct: 128 LHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLA---KSFGSPNRAYTHQVV-TRWYRA 180
Query: 202 PELY--EEDYNELVDVYSFGMCVL-EMFTCEYPY----SECANPAQIYK----------- 243
PEL Y VD+++ G C+L E+ P+ S+ Q+ +
Sbjct: 181 PELLFGARMYGVGVDMWAVG-CILAELLLRV-PFLPGDSD---LDQLTRIFETLGTPTEE 235
Query: 244 ---KVTSGKLPGA----FYSIQDL---------EAQRFIGRCLV-NASKRLSAKELLLDP 286
+ LP + L + I + N R++A + L
Sbjct: 236 QWPDMC--SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293
Query: 287 FLASDEVKLLSKTKLNQKPFLNETELEKLQLSDDPPR 323
+ S+ +L + ET E+ + R
Sbjct: 294 YF-SNRPGPTPGCQLPRPNCPVETLKEQSNPALAIKR 329
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 54/227 (23%), Positives = 97/227 (42%), Gaps = 19/227 (8%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLG---VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH 88
++V+G G V ++ + VA +++ + D E ++ H
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EASIMGQFDH 105
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVYL 147
+IIR + K +TE +G+L + RK + + + R I G+ YL
Sbjct: 106 PNIIRLEG--VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 148 HSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRGSKSAHSVIGT--P-EFMAPE 203
+HRDL NI +N +L K+ D GL + ++A++ G P + +PE
Sbjct: 164 SDMG--YVHRDLAARNILINSNL-VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 204 -LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
+ + DV+S+G+ + E+ + E PY E +N + K V G
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEG 266
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 56/303 (18%), Positives = 115/303 (37%), Gaps = 54/303 (17%)
Query: 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
Y L ++ G+G V++AI+ +V ++ P +++ E+ +L L+
Sbjct: 37 DYQLVRKL-GRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLR 88
Query: 88 -HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVY 146
+II D +T + E + ++ + DIR + +IL+ L Y
Sbjct: 89 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR---FYMYEILKALDY 145
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE--L 204
HS ++HRD+K N+ ++ ++++ D GLA + + + + F PE +
Sbjct: 146 CHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 203
Query: 205 YEEDYNELVDVYSFGMCVL-EMFT---------------------------CEYPYSECA 236
+ Y+ +D++S G C+L M +Y
Sbjct: 204 DYQMYDYSLDMWSLG-CMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262
Query: 237 NPAQIY--------KKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPF 287
+ +K + + EA F+ + L + RL+A+E + P+
Sbjct: 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322
Query: 288 LAS 290
+
Sbjct: 323 FYT 325
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 56/238 (23%), Positives = 92/238 (38%), Gaps = 55/238 (23%)
Query: 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
Y + + ++G+G+ VY A D+ VA ++N + D +R+ E+ +L+ LK
Sbjct: 27 NYII-KHLIGRGSYGYVYLAYDKNTEKNVAIK--KVNRMFEDLIDCKRILREITILNRLK 83
Query: 88 HDSIIRFYTSWIDVDQKTFN---FITE-MFT--------SGTLREYRKKYRRVDIRAIKS 135
D IIR Y I D F+ + E + L E K
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKT---------- 133
Query: 136 WARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-------------A 182
+L G ++H +IHRDLK N +N VK+ D GLA
Sbjct: 134 ILYNLLLGENFIHESG--IIHRDLKPANCLLNQD-CSVKVCDFGLARTINSEKDTNIVND 190
Query: 183 ILRGSKSAHSVIGTPEFM----------APE--LYEEDYNELVDVYSFGMCVL-EMFT 227
+ + + + APE L +E+Y + +D++S G C+ E+
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG-CIFAELLN 247
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 29/220 (13%)
Query: 28 RYGLFEEVLGKGAMKTVYKAI--DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLST 85
+ +G+G VYKA D + A Q+ + R E+ LL
Sbjct: 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACR---EIALLRE 74
Query: 86 LKHDSIIRFYTSWIDVDQKTFNFITE--------MFTSGTLREYRKKYRRVDIRAIKSWA 137
LKH ++I ++ + + + + + KK ++ +KS
Sbjct: 75 LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134
Query: 138 RQILQGLVYLHSRDPPVIHRDLKCDNIFVNG---HLGQVKIGDLGLA----AILRGSKSA 190
QIL G+ YLH+ V+HRDLK NI V G G+VKI D+G A + L+
Sbjct: 135 YQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192
Query: 191 HSVIGTPEFMAPELY--EEDYNELVDVYSFGMCVL-EMFT 227
V+ T + APEL Y + +D+++ G C+ E+ T
Sbjct: 193 DPVVVTFWYRAPELLLGARHYTKAIDIWAIG-CIFAELLT 231
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 5e-19
Identities = 69/312 (22%), Positives = 124/312 (39%), Gaps = 62/312 (19%)
Query: 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
RY + +G GA V A D VL VA +L+ ++ +R Y E+ L+ +
Sbjct: 63 RYQNLK-PIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVN 119
Query: 88 HDSIIRFYTSWI-DVDQKTFN---FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQG 143
H +II + + F + E+ + + + + + + Q+L G
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY---QMLCG 176
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSV---IGTPEFM 200
+ +LHS +IHRDLK NI V +KI D GLA R + ++ + + T +
Sbjct: 177 IKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA---RTAGTSFMMTPYVVTRYYR 230
Query: 201 APE-LYEEDYNELVDVYSFGMCVL-EMFTCE--YPYSECAN------------PAQIYKK 244
APE + Y E VD++S G C++ EM + +P + + + KK
Sbjct: 231 APEVILGMGYKENVDIWSVG-CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 245 VTSG------------------KLPGAFYSIQDL-------EAQRFIGRCLV-NASKRLS 278
+ P + + +A+ + + LV + +KR+S
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349
Query: 279 AKELLLDPFLAS 290
+ L P++
Sbjct: 350 VDDALQHPYINV 361
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-19
Identities = 53/246 (21%), Positives = 98/246 (39%), Gaps = 30/246 (12%)
Query: 32 FEEVLGKGAMKTVYKAI---DEVLGVEVAWNQVR-LNELMRSPDDLQRLYSEVHLLSTLK 87
F EV+G+G VY ++ + A V+ LN + ++ + +E ++
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCA---VKSLNR-ITDIGEVSQFLTEGIIMKDFS 84
Query: 88 HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVY 146
H +++ + + + G LR + R + ++ + + Q+ +G+ Y
Sbjct: 85 HPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 143
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF------M 200
L S+ +HRDL N ++ VK+ D GLA + K +SV M
Sbjct: 144 LASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMY-DKEYYSVHNKTGAKLPVKWM 199
Query: 201 APE-LYEEDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKL-------P 251
A E L + + DV+SFG+ + E+ T PY + I + G+ P
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRLLQPEYCP 258
Query: 252 GAFYSI 257
Y +
Sbjct: 259 DPLYEV 264
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 6e-19
Identities = 60/228 (26%), Positives = 96/228 (42%), Gaps = 20/228 (8%)
Query: 32 FEEVLGKGAMKTVYKAI----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
++V+G G VYK + V VA ++ + D E ++
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG---EAGIMGQFS 104
Query: 88 HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVY 146
H +IIR + K ITE +G L ++ R+K + + R I G+ Y
Sbjct: 105 HHNIIRLEG--VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 162
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF----MAP 202
L + + +HRDL NI VN +L K+ D GL+ +L A + AP
Sbjct: 163 LANMN--YVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219
Query: 203 E-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
E + + DV+SFG+ + E+ T E PY E +N ++ K + G
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDG 266
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 71/314 (22%), Positives = 117/314 (37%), Gaps = 77/314 (24%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
+ +G GA V A D +L VA +L+ ++ +R Y E+ L+ + H +II
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 88
Query: 94 FYTSWI-DVDQKTFN---FITE-MFTS------GTLREYRKKYRRVDIRAIKSWARQILQ 142
+ + F + E M + L R Y Q+L
Sbjct: 89 LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY----------LLYQMLC 138
Query: 143 GLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSV---IGTPEF 199
G+ +LHS +IHRDLK NI V +KI D GLA R + ++ + + T +
Sbjct: 139 GIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA---RTAGTSFMMTPYVVTRYY 192
Query: 200 MAPE-LYEEDYNELVDVYSFGMCVL-EMFTCE---------------------------- 229
APE + Y E VD++S G C++ EM
Sbjct: 193 RAPEVILGMGYKENVDIWSVG-CIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251
Query: 230 ------------YPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKR 276
P + +++ V ++ +A+ + + LV +ASKR
Sbjct: 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSE-HNKLKASQARDLLSKMLVIDASKR 310
Query: 277 LSAKELLLDPFLAS 290
+S E L P++
Sbjct: 311 ISVDEALQHPYINV 324
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 9e-19
Identities = 66/315 (20%), Positives = 118/315 (37%), Gaps = 54/315 (17%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQV---RLNELMRSPDDLQRLYSEVHLLSTLKH 88
LG+G+ VY+ + + + + +V +NE S + +E ++
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE-AASMRERIEFLNEASVMKEFNC 87
Query: 89 DSIIRFY---TSWIDVDQKTFNFITEMFTSGTLREY----------RKKYRRVDIRAIKS 135
++R + Q T I E+ T G L+ Y + +
Sbjct: 88 HHVVRLLGVVS----QGQPTL-VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 136 WARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS----KSAH 191
A +I G+ YL++ +HRDL N V VKIGD G+ + + K
Sbjct: 143 MAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGK 199
Query: 192 SVIGTP-EFMAPE-LYEEDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSG 248
++ P +M+PE L + + DV+SFG+ + E+ T E PY +N Q+ + V G
Sbjct: 200 GLL--PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-EQVLRFVMEG 256
Query: 249 KL-------PGAFYSIQDLEAQRFIGRC-LVNASKRLSAKELL--LDPFLASDEVKLLSK 298
L P + + + C N R S E++ + + + +S
Sbjct: 257 GLLDKPDNCPDMLFEL--------MRMCWQYNPKMRPSFLEIISSIKEEM-EPGFREVSF 307
Query: 299 TKLNQKPFLNETELE 313
+ EL+
Sbjct: 308 YYSEENKLPEPEELD 322
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 9e-19
Identities = 36/159 (22%), Positives = 74/159 (46%), Gaps = 14/159 (8%)
Query: 139 QILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRGSKSAHSVIGTP 197
+I+ L++LH + +I+RDLK DN+ ++ G K+ D G+ + + + GTP
Sbjct: 132 EIISALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTP 188
Query: 198 EFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYS 256
+++APE L E Y VD ++ G+ + EM P+ E N +++ + + ++ + +
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVV--YPT 245
Query: 257 IQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVK 294
+A + + N + RL + +
Sbjct: 246 WLHEDATGILKSFMTKNPTMRLGSL-----TQGGEHAIL 279
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 9e-19
Identities = 48/236 (20%), Positives = 83/236 (35%), Gaps = 35/236 (14%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLG---VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH 88
+ V+GKG VY ++ A + M+ + R E L+ L H
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLR---EGLLMRGLNH 81
Query: 89 DSIIRFY--------TSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQ 139
+++ + + G L ++ R R ++ + S+ Q
Sbjct: 82 PNVLALIGIMLPPEGLPHV---------LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 140 ILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRGSKSAHSVIGTPE 198
+ +G+ YL + +HRDL N ++ VK+ D GLA IL +
Sbjct: 133 VARGMEYLAEQK--FVHRDLAARNCMLDESF-TVKVADFGLARDILDREYYSVQQHRHAR 189
Query: 199 F----MAPE-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
A E L + DV+SFG+ + E+ T PY + + G
Sbjct: 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFLAQG 244
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 9e-19
Identities = 44/176 (25%), Positives = 80/176 (45%), Gaps = 20/176 (11%)
Query: 136 WARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIG 195
+A +I GL LH +++RDLK +NI ++ H G ++I DLGLA + ++ +G
Sbjct: 291 YAAEICCGLEDLHRER--IVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVG 347
Query: 196 TPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPY---SECANPAQIYKKVTSGKL- 250
T +MAPE + E Y D ++ G + EM + P+ + ++ + V
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE 407
Query: 251 -PGAFYSIQDLEAQRFIGRCLV-NASKRL-----SAKELLLDPFLAS-DEVKLLSK 298
F +A+ + L + ++RL SA+E+ P + +L +
Sbjct: 408 YSERF----SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAG 459
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 33/218 (15%)
Query: 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLST 85
RY + ++GKG+ V KA D V VA ++ + + Q EV LL
Sbjct: 53 MDRYEIDS-LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN----QAQ-IEVRLLEL 106
Query: 86 L-KHD-----SIIRFYTSWIDVDQKTFNF------ITEMFTSGTLREYRKK--YRRVDIR 131
+ KHD I+ + F F + EM S L + + +R V +
Sbjct: 107 MNKHDTEMKYYIVHLK--------RHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLN 157
Query: 132 AIKSWARQILQGLVYLHSRDPPVIHRDLKCDNI-FVNGHLGQVKIGDLGLAAILRGSKSA 190
+ +A+Q+ L++L + + +IH DLK +NI N +KI D G + L +
Sbjct: 158 LTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRI 215
Query: 191 HSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFT 227
+ I + + +PE L Y+ +D++S G ++EM T
Sbjct: 216 YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 62/261 (23%), Positives = 105/261 (40%), Gaps = 47/261 (18%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQV---RLNELMRSPDDLQRLYSEVHLLSTLKH 88
+ LG+GA V+ A L V L + + + E LL+ L+H
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQH 76
Query: 89 DSIIRFY---TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK----------- 134
+ I++FY D + E G L ++ + + + +
Sbjct: 77 EHIVKFYGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 135 -----SWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS 189
A QI G+VYL S+ +HRDL N V +L VKIGD G++ + S
Sbjct: 132 LSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANL-LVKIGDFGMSRDVY-STD 187
Query: 190 AHSVIGTPEF----MAPE-LYEEDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYK 243
+ V G M PE + + DV+SFG+ + E+FT + P+ + +N ++ +
Sbjct: 188 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-TEVIE 246
Query: 244 KVTSGKL-------PGAFYSI 257
+T G++ P Y +
Sbjct: 247 CITQGRVLERPRVCPKEVYDV 267
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 88.2 bits (218), Expect = 1e-18
Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 15/200 (7%)
Query: 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVN 167
F+ E G L + ++ R +A +I GL +L S+ +I+RDLK DN+ ++
Sbjct: 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD 476
Query: 168 GHLGQVKIGDLGLA-AILRGSKSAHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEM 225
G +KI D G+ + + + GTP+++APE + + Y + VD ++FG+ + EM
Sbjct: 477 SE-GHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 535
Query: 226 FTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRL-----SA 279
+ P+ E + ++++ + + + EA + + KRL
Sbjct: 536 LAGQAPF-EGEDEDELFQSIMEHNVA--YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGE 592
Query: 280 KELLLDPFLAS-DEVKLLSK 298
+++ F D KL K
Sbjct: 593 RDIKEHAFFRYIDWEKLERK 612
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 1e-18
Identities = 69/210 (32%), Positives = 92/210 (43%), Gaps = 26/210 (12%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYS----EVHLLSTLK-- 87
+G GA TVYKA D G VA VR+ L EV LL L+
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVP---NGGGGGGGLPISTVREVALLRRLEAF 71
Query: 88 -HDSIIR----FYTSWIDVDQKTFNFITEMFTSGTLREY--RKKYRRVDIRAIKSWARQI 140
H +++R TS D + K + E LR Y + + IK RQ
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVT-LVFE-HVDQDLRTYLDKAPPPGLPAETIKDLMRQF 129
Query: 141 LQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRGSKSAHSVIGTPEF 199
L+GL +LH+ ++HRDLK +NI V G VK+ D GLA V+ T +
Sbjct: 130 LRGLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVV-TLWY 185
Query: 200 MAPE-LYEEDYNELVDVYSFGMCVL-EMFT 227
APE L + Y VD++S G C+ EMF
Sbjct: 186 RAPEVLLQSTYATPVDMWSVG-CIFAEMFR 214
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 42/169 (24%), Positives = 80/169 (47%), Gaps = 15/169 (8%)
Query: 139 QILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRGSKSAHSVIGTP 197
+I GL +L S+ +I+RDLK DN+ ++ G +KI D G+ + + + GTP
Sbjct: 129 EIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVTTKTFCGTP 185
Query: 198 EFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYS 256
+++APE + + Y + VD ++FG+ + EM + P+ E + ++++ + + +
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVA--YPK 242
Query: 257 IQDLEAQRFIGRCLV-NASKRL-----SAKELLLDPFLAS-DEVKLLSK 298
EA + + KRL +++ F D KL K
Sbjct: 243 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERK 291
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 49/245 (20%), Positives = 96/245 (39%), Gaps = 28/245 (11%)
Query: 32 FEEVLGKGAMKTVYKAI---DEVLGVEVAWNQVR-LNELMRSPDDLQRLYSEVHLLSTLK 87
F EV+G+G VY ++ + A V+ LN + ++ + +E ++
Sbjct: 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCA---VKSLNR-ITDIGEVSQFLTEGIIMKDFS 148
Query: 88 HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVY 146
H +++ + + + G LR + R + ++ + + Q+ +G+ +
Sbjct: 149 HPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 207
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRGSKSAHSVIGTPEF----MA 201
L S+ +HRDL N ++ VK+ D GLA + + + MA
Sbjct: 208 LASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 202 PE-LYEEDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKL-------PG 252
E L + + DV+SFG+ + E+ T PY + I + G+ P
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRLLQPEYCPD 323
Query: 253 AFYSI 257
Y +
Sbjct: 324 PLYEV 328
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 69/297 (23%), Positives = 112/297 (37%), Gaps = 53/297 (17%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQV---RLNELMRSPDDLQRLYSEVHLLSTLKH 88
+ LG+GA V+ A L E V L E S Q E LL+ L+H
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTMLQH 102
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK-------------- 134
I+RF+ + + + + E G L + + +
Sbjct: 103 QHIVRFFG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 135 -SWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRG---SKS 189
+ A Q+ G+VYL +HRDL N V L VKIGD G++ I
Sbjct: 161 LAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVG 217
Query: 190 AHSVIGTP-EFMAPE-LYEEDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVT 246
+++ P +M PE + + DV+SFG+ + E+FT + P+ + +N + +T
Sbjct: 218 GRTML--PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-TEAIDCIT 274
Query: 247 SGKL-------PGAFYSIQDLEAQRFIGRC-LVNASKRLSAKELL--LDPFLASDEV 293
G+ P Y+I + C +R S K++ L + V
Sbjct: 275 QGRELERPRACPPEVYAI--------MRGCWQREPQQRHSIKDVHARLQALAQAPPV 323
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 5e-18
Identities = 61/231 (26%), Positives = 99/231 (42%), Gaps = 35/231 (15%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVR------LNELMRSPDDLQRLYSEVHLLST 85
E LG G V+ +N L + SPD +E +L+
Sbjct: 17 LVERLGAGQFGEVWMGY---------YNGHTKVAVKSLKQGSMSPDAFL---AEANLMKQ 64
Query: 86 LKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK--SWARQILQG 143
L+H ++R Y V Q+ ITE +G+L ++ K + + K A QI +G
Sbjct: 65 LQHQRLVRLYAV---VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF---- 199
+ ++ R+ IHRDL+ NI V+ L KI D GLA ++ ++ +F
Sbjct: 122 MAFIEERN--YIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYTAREGA--KFPIKW 176
Query: 200 MAPE-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
APE + + DV+SFG+ + E+ T PY NP ++ + + G
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERG 226
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 71/310 (22%), Positives = 133/310 (42%), Gaps = 36/310 (11%)
Query: 1 MYSNKQLAGAADEAKAHIGYIETDPNGRYGL--FE--EVLGKGAMKTVY----KAIDEVL 52
+ + + + + P R + FE ++LGKG V KA
Sbjct: 117 EMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYY 176
Query: 53 GVEVAWNQVRLN-ELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITE 111
+++ L E++ + D++ +E +L +H + S+ D + F+ E
Sbjct: 177 AMKI------LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD-RLC-FVME 228
Query: 112 MFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFV--NGH 169
G L + + R + + +I+ L YLHS V++RDLK +N+ + +GH
Sbjct: 229 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLDKDGH 287
Query: 170 LGQVKIGDLGLA-AILRGSKSAHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFT 227
+KI D GL ++ + + GTPE++APE L + DY VD + G+ + EM
Sbjct: 288 ---IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 344
Query: 228 CEYP-YSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRL-----SAK 280
P Y++ + ++++ + ++ F EA+ + L + +RL AK
Sbjct: 345 GRLPFYNQ--DHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAK 400
Query: 281 ELLLDPFLAS 290
E++ F A
Sbjct: 401 EIMQHRFFAG 410
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 6e-18
Identities = 41/171 (23%), Positives = 73/171 (42%), Gaps = 25/171 (14%)
Query: 137 ARQILQGLVYLHSRDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLA-AILRGSKSAHSV 193
+ +I L YLH R +I+RDLK DN+ + GH +K+ D G+ LR + +
Sbjct: 116 SAEISLALNYLHERG--IIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTF 170
Query: 194 IGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECA--------NPAQIYKK 244
GTP ++APE L EDY VD ++ G+ + EM P+ +++
Sbjct: 171 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 230
Query: 245 VTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVK 294
+ ++ ++A + L + +RL P +++
Sbjct: 231 ILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGC-----HPQTGFADIQ 274
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 7e-18
Identities = 66/215 (30%), Positives = 91/215 (42%), Gaps = 38/215 (17%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVE-VAWNQVRLNEL--------MRSPDDLQRLYSEVHLLS 84
+G+GA V+KA D G VA +VR+ +R EV +L
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR----------EVAVLR 66
Query: 85 TLK---HDSIIR----FYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRV--DIRAIKS 135
L+ H +++R S D + K + E L Y K IK
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETK-LTLVFE-HVDQDLTTYLDKVPEPGVPTETIKD 124
Query: 136 WARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA-AILRGSKSAHSVI 194
Q+L+GL +LHS V+HRDLK NI V GQ+K+ D GLA V+
Sbjct: 125 MMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 195 GTPEFMAPE-LYEEDYNELVDVYSFGMCVL-EMFT 227
T + APE L + Y VD++S G C+ EMF
Sbjct: 182 -TLWYRAPEVLLQSSYATPVDLWSVG-CIFAEMFR 214
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 8e-18
Identities = 45/225 (20%), Positives = 94/225 (41%), Gaps = 27/225 (12%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
+ +GKG V + G +VA ++ + + +E +++ L+H ++
Sbjct: 25 LLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDA---TAQAFL---AEASVMTQLRHSNL 76
Query: 92 IRFY---TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK--SWARQILQGLVY 146
++ ++ +TE G+L +Y + R + ++ + + + Y
Sbjct: 77 VQLLGVIVE----EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTP-EFMAPE-L 204
L + +HRDL N+ V+ K+ D GL + + S P ++ APE L
Sbjct: 133 LEGNN--FVHRDLAARNVLVSEDN-VAKVSDFGLT---KEASSTQDTGKLPVKWTAPEAL 186
Query: 205 YEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
E+ ++ DV+SFG+ + E+++ PY + +V G
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKG 230
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 8e-18
Identities = 56/234 (23%), Positives = 99/234 (42%), Gaps = 51/234 (21%)
Query: 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
+Y L + LGKGA V+K+ID G VA ++ + ++ D QR + E+ +L+ L
Sbjct: 10 KYEL-VKKLGKGAYGIVWKSIDRRTGEVVAVK--KIFDAFQNSTDAQRTFREIMILTELS 66
Query: 88 -HDSIIRFYTSWIDVDQKTFNFITE-MFT-------SGTLREYRKKYRRVDIRAIKSWAR 138
H++I+ + + + + M T + L K+Y
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQY----------VVY 116
Query: 139 QILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA------------AILRG 186
Q+++ + YLHS ++HRD+K NI +N VK+ D GL+ L
Sbjct: 117 QLIKVIKYLHSGG--LLHRDMKPSNILLNAE-CHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 187 SKSAHSVIGTPEFM----------APE--LYEEDYNELVDVYSFGMCVL-EMFT 227
+++ + + APE L Y + +D++S G C+L E+
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG-CILGEILC 226
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 64/252 (25%), Positives = 102/252 (40%), Gaps = 34/252 (13%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQV---RLNELMRSPDDLQRLYSEVHLLSTLKH 88
LG GA VY+ + + + QV L E+ S D E ++S H
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNH 92
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR-------RVDIRAIKSWARQIL 141
+I+R + + + E+ G L+ + ++ R + + + AR I
Sbjct: 93 QNIVRCIG--VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 142 QGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQ--VKIGDLGLA-AILRGS---KSAHSVIG 195
G YL IHRD+ N + KIGD G+A I R S K +++
Sbjct: 151 CGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML- 207
Query: 196 TP-EFMAPE-LYEEDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKL-- 250
P ++M PE E + D +SFG+ + E+F+ PY +N ++ + VTSG
Sbjct: 208 -PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSGGRMD 265
Query: 251 -----PGAFYSI 257
PG Y I
Sbjct: 266 PPKNCPGPVYRI 277
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 41/171 (23%), Positives = 73/171 (42%), Gaps = 25/171 (14%)
Query: 137 ARQILQGLVYLHSRDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLA-AILRGSKSAHSV 193
+ +I L YLH R +I+RDLK DN+ + GH +K+ D G+ LR + +
Sbjct: 159 SAEISLALNYLHERG--IIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTF 213
Query: 194 IGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECA--------NPAQIYKK 244
GTP ++APE L EDY VD ++ G+ + EM P+ +++
Sbjct: 214 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273
Query: 245 VTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVK 294
+ ++ ++A + L + +RL P +++
Sbjct: 274 ILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGC-----HPQTGFADIQ 317
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 45/225 (20%), Positives = 94/225 (41%), Gaps = 27/225 (12%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
+ +GKG V + G +VA ++ + + +E +++ L+H ++
Sbjct: 197 LLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDA---TAQAFL---AEASVMTQLRHSNL 248
Query: 92 IRFY---TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK--SWARQILQGLVY 146
++ ++ +TE G+L +Y + R + ++ + + + Y
Sbjct: 249 VQLLGVIVE----EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTP-EFMAPE-L 204
L + +HRDL N+ V+ K+ D GL + + S P ++ APE L
Sbjct: 305 LEGNN--FVHRDLAARNVLVSEDN-VAKVSDFGLT---KEASSTQDTGKLPVKWTAPEAL 358
Query: 205 YEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
E+ ++ DV+SFG+ + E+++ PY + +V G
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKG 402
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 63/252 (25%), Positives = 101/252 (40%), Gaps = 34/252 (13%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQV---RLNELMRSPDDLQRLYSEVHLLSTLKH 88
LG GA VY+ + + + QV L E+ S D E ++S H
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNH 133
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR-------RVDIRAIKSWARQIL 141
+I+R + + + E+ G L+ + ++ R + + + AR I
Sbjct: 134 QNIVRCIG--VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 142 QGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQ--VKIGDLGLA-AILRGS---KSAHSVIG 195
G YL IHRD+ N + KIGD G+A I R K +++
Sbjct: 192 CGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML- 248
Query: 196 TP-EFMAPE-LYEEDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKL-- 250
P ++M PE E + D +SFG+ + E+F+ PY +N ++ + VTSG
Sbjct: 249 -PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSGGRMD 306
Query: 251 -----PGAFYSI 257
PG Y I
Sbjct: 307 PPKNCPGPVYRI 318
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 35/218 (16%)
Query: 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLST 85
RY +V+GKG+ V KA D + VA VR + ++ E+ +L
Sbjct: 96 AYRY-EVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH-----RQAAEEIRILEH 149
Query: 86 L-KHDS-----IIRFYTSWIDVDQKTFNF------ITEMFTSGTLREYRKK--YRRVDIR 131
L K D +I + F F E+ S L E KK ++ +
Sbjct: 150 LRKQDKDNTMNVIHML--------ENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLP 200
Query: 132 AIKSWARQILQGLVYLHSRDPPVIHRDLKCDNI-FVNGHLGQVKIGDLGLAAILRGSKSA 190
++ +A ILQ L LH +IH DLK +NI +K+ D G + +
Sbjct: 201 LVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRV 256
Query: 191 HSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFT 227
++ I + + APE + Y +D++S G + E+ T
Sbjct: 257 YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLT 294
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 4e-17
Identities = 54/262 (20%), Positives = 95/262 (36%), Gaps = 48/262 (18%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQV---RLNELMRSPDDLQRLYSEVHLLSTLKH 88
F E LG+ VYK V L + + E L + L+H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQH 71
Query: 89 DSIIRFY---TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK----------- 134
+++ T + + I + G L E+
Sbjct: 72 PNVVCLLGVVT-----KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 135 -----SWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-- 187
QI G+ YL S V+H+DL N+ V L VKI DLGL + +
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKL-NVKISDLGLFREVYAADY 183
Query: 188 --KSAHSVIGTP-EFMAPE-LYEEDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIY 242
+S++ P +MAPE + ++ D++S+G+ + E+F+ PY +N +
Sbjct: 184 YKLLGNSLL--PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVV 240
Query: 243 KKVTSGKL-------PGAFYSI 257
+ + + ++ P Y++
Sbjct: 241 EMIRNRQVLPCPDDCPAWVYAL 262
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 55/247 (22%), Positives = 96/247 (38%), Gaps = 40/247 (16%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVR-----LNELMRSPDDLQRLYSEVHLLSTL 86
+ LG+GA V +A + G++ L E + + + L SE+ +L +
Sbjct: 31 LGKPLGRGAFGQVIEA--DAFGIDKTATCRTVAVKMLKE-GATHSEHRALMSELKILIHI 87
Query: 87 -KHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK----------- 134
H +++ + I E G L Y + R +
Sbjct: 88 GHHLNVVNLLGACTKPGGPLM-VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 135 -----SWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS 189
++ Q+ +G+ +L SR IHRDL NI ++ VKI D GLA R
Sbjct: 147 LEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKN-VVKICDFGLA---RDIYK 200
Query: 190 AHSVIGTPE------FMAPE-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQI 241
+ + +MAPE +++ Y DV+SFG+ + E+F+ PY +
Sbjct: 201 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260
Query: 242 YKKVTSG 248
+++ G
Sbjct: 261 CRRLKEG 267
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 64/251 (25%), Positives = 101/251 (40%), Gaps = 47/251 (18%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQV---RLNELMRSPDDLQRLYSEVHLLSTL-K 87
F + LG GA V +A L A V L + + L SE+ +LS L
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSELKVLSYLGN 85
Query: 88 HDSIIRFY---TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK---------- 134
H +I+ T + T ITE G L + ++ R I +
Sbjct: 86 HMNIVNLLGACT----IGGPTL-VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 135 --------SWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA----- 181
S++ Q+ +G+ +L S++ IHRDL NI + H KI D GLA
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILL-THGRITKICDFGLARDIKN 197
Query: 182 --AILRGSKSAHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECAN 237
+ + V ++MAPE ++ Y DV+S+G+ + E+F+ PY
Sbjct: 198 DSNYVVKGNARLPV----KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 238 PAQIYKKVTSG 248
++ YK + G
Sbjct: 254 DSKFYKMIKEG 264
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 64/252 (25%), Positives = 104/252 (41%), Gaps = 53/252 (21%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQV---RLNELMRSPDDLQRLYSEVHLLSTL-K 87
F + LG GA V +A LG E A +V L D+ + L SE+ ++S L +
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS-TAHADEKEALMSELKIMSHLGQ 108
Query: 88 HDSIIRFY---TSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIK--------- 134
H++I+ T ITE G L + R+K R ++
Sbjct: 109 HENIVNLLGACT----HGGPVL-VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 135 ----SWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSA 190
++ Q+ QG+ +L S++ IHRD+ N+ + KIGD GLA
Sbjct: 164 RDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGH-VAKIGDFGLA--------- 211
Query: 191 HSVIGTPEF------------MAPE-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECA 236
++ + MAPE +++ Y DV+S+G+ + E+F+ PY
Sbjct: 212 RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271
Query: 237 NPAQIYKKVTSG 248
++ YK V G
Sbjct: 272 VNSKFYKLVKDG 283
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 57/270 (21%), Positives = 98/270 (36%), Gaps = 56/270 (20%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQV---RLNELMRSPDDLQRLYSEVHLLSTLKH 88
+ +G+GA V++A L + V L E S D E L++ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQREAALMAEFDN 109
Query: 89 DSIIRFY---TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK----------- 134
+I++ K + E G L E+ + + ++
Sbjct: 110 PNIVKLLGVCA-----VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 135 -------------SWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181
ARQ+ G+ YL R +HRDL N V ++ VKI D GL+
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENM-VVKIADFGLS 221
Query: 182 -AILRGS---KSAHSVIGTP-EFMAPE-LYEEDYNELVDVYSFGMCVLEMFT-CEYPYSE 234
I + I P +M PE ++ Y DV+++G+ + E+F+ PY
Sbjct: 222 RNIYSADYYKADGNDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279
Query: 235 CANPAQIYKKVTSGKL-------PGAFYSI 257
A+ ++ V G + P Y++
Sbjct: 280 MAH-EEVIYYVRDGNILACPENCPLELYNL 308
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 63/261 (24%), Positives = 99/261 (37%), Gaps = 63/261 (24%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQV---RLNELMRSPDDLQRLYSEVHLLSTLKH 88
+ LG+G V KA L + V L E SP +L+ L SE ++L + H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE-NASPSELRDLLSEFNVLKQVNH 85
Query: 89 DSIIRFY---TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK----------- 134
+I+ Y + I E G+LR + ++ R+V +
Sbjct: 86 PHVIKLYGACS-----QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 135 -------------SWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181
S+A QI QG+ YL ++HRDL NI V ++KI D GL
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGR-KMKISDFGL- 196
Query: 182 AILRGSKSAHSVIGTPEF------------MAPE-LYEEDYNELVDVYSFGMCVLEMFTC 228
+ V + MA E L++ Y DV+SFG+ + E+ T
Sbjct: 197 --------SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248
Query: 229 -EYPYSECANPAQIYKKVTSG 248
PY +++ + +G
Sbjct: 249 GGNPYPGIPP-ERLFNLLKTG 268
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 61/258 (23%), Positives = 98/258 (37%), Gaps = 56/258 (21%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVR-----LNELMRSPDDLQRLYSEVHLLSTL 86
F +VLG GA V A G+ ++ L E + + L SE+ +++ L
Sbjct: 49 FGKVLGSGAFGKVMNA--TAYGISKTGVSIQVAVKMLKE-KADSSEREALMSELKMMTQL 105
Query: 87 -KHDSIIRFY---TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK-------- 134
H++I+ T + + I E G L Y + R
Sbjct: 106 GSHENIVNLLGACT----LSGPIY-LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 135 ---------------SWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179
+A Q+ +G+ +L + +HRDL N+ V VKI D G
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGK-VVKICDFG 217
Query: 180 LA-------AILRGSKSAHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTC-EY 230
LA + + V ++MAPE L+E Y DV+S+G+ + E+F+
Sbjct: 218 LARDIMSDSNYVVRGNARLPV----KWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273
Query: 231 PYSECANPAQIYKKVTSG 248
PY A YK + +G
Sbjct: 274 PYPGIPVDANFYKLIQNG 291
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 62/247 (25%), Positives = 100/247 (40%), Gaps = 48/247 (19%)
Query: 32 FEEVLGKGAMKTVYKAI--DEVLGVEVAWNQV-RLNELMRSPDDLQRLYSEVHLLSTL-K 87
F++V+G+G V KA + L ++ A + R+ E S DD + E+ +L L
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAA---IKRMKE-YASKDDHRDFAGELEVLCKLGH 84
Query: 88 HDSIIRFY---TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK---------- 134
H +II + E G L ++ +K R ++
Sbjct: 85 HPNIINLLGACE-----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 135 ------SWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS- 187
+A + +G+ YL + IHRDL NI V + KI D GL+ RG
Sbjct: 140 SSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY-VAKIADFGLS---RGQE 193
Query: 188 ---KSAHSVIGTP-EFMAPE-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQI 241
K + P +MA E L Y DV+S+G+ + E+ + PY A++
Sbjct: 194 VYVKKTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AEL 250
Query: 242 YKKVTSG 248
Y+K+ G
Sbjct: 251 YEKLPQG 257
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 35 VLGKGAMKTVYK-AIDEVLGVEVAWNQVRLNELMRSPDDLQRL---YSEVHLLSTLKHDS 90
++G G VYK + + G +VA ++ R+P+ Q + +E+ LS +H
Sbjct: 46 LIGHGVFGKVYKGVLRD--GAKVA---LK----RRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWAR--QIL----QGL 144
++ + ++ I + +G L+ + Y SW + +I +GL
Sbjct: 97 LVSLIGFCDERNEMIL--IYKYMENGNLKRHL--YGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 145 VYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH---SVIGTPEFMA 201
YLH+ +IHRD+K NI ++ + KI D G++ H V GT ++
Sbjct: 153 HYLHT--RAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQTHLSTVVKGTLGYID 209
Query: 202 PELYEEDY-NELVDVYSFGMCVLEMFT 227
PE + + E DVYSFG+ + E+
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLC 236
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 78/328 (23%), Positives = 125/328 (38%), Gaps = 62/328 (18%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVR-----LNELMRSPDDLQRLYSEVHLLSTL 86
+ LG+GA V A L + + L + DL L SE+ ++ +
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-DATEKDLSDLISEMEMMKMI 131
Query: 87 -KHDSIIRFY---TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK-------- 134
KH +II T D + I E + G LREY + R +
Sbjct: 132 GKHKNIINLLGACT----QDGPLY-VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 135 --------SWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186
S A Q+ +G+ YL S+ IHRDL N+ V +KI D GLA +
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHH 243
Query: 187 S----KSAHSVIGTP-EFMAPE-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPA 239
K+ + + P ++MAPE L++ Y DV+SFG+ + E+FT PY
Sbjct: 244 IDYYKKTTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-E 300
Query: 240 QIYKKVTSGKL-------PGAFYSIQDLEAQRFIGRC-LVNASKRLSAKELL--LDPFLA 289
+++K + G Y + + C S+R + K+L+ LD +A
Sbjct: 301 ELFKLLKEGHRMDKPSNCTNELYMM--------MRDCWHAVPSQRPTFKQLVEDLDRIVA 352
Query: 290 SDEVKLLSKTKLNQKPFLNETELEKLQL 317
+ + + + E L
Sbjct: 353 LTSNQEMGYYHHHHHHDYDIPTTENLYF 380
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 74/304 (24%), Positives = 114/304 (37%), Gaps = 64/304 (21%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVR-----LNELMRSPDDLQRLYSEVHLLSTL 86
+ LG+G V A + + V L + + DL L SE+ ++ +
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMI 143
Query: 87 -KHDSIIRFY---TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK-------- 134
KH +II T D + I E + G LREY + R +
Sbjct: 144 GKHKNIINLLGACT----QDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 135 --------SWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186
S Q+ +G+ YL S+ IHRDL N+ V + +KI D GLA R
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLA---RD 252
Query: 187 SKSAHSVIGTPE------FMAPE-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANP 238
+ T +MAPE L++ Y DV+SFG+ + E+FT PY
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV- 311
Query: 239 AQIYKKVTSGKL-------PGAFYSIQDLEAQRFIGRC-LVNASKRLSAKELL--LDPFL 288
+++K + G Y + + C S+R + K+L+ LD L
Sbjct: 312 EELFKLLKEGHRMDKPANCTNELYMM--------MRDCWHAVPSQRPTFKQLVEDLDRIL 363
Query: 289 ASDE 292
Sbjct: 364 TLTT 367
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 67/265 (25%), Positives = 106/265 (40%), Gaps = 51/265 (19%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVR-----LNELMRSPDDLQRLYSEVHLLSTL 86
+ LG+GA V A + + V L + + DL L SE+ ++ +
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEMMKMI 97
Query: 87 -KHDSIIRFY---TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIK-------- 134
KH +II T D + I E + G LREY + R +
Sbjct: 98 GKHKNIINLLGACT----QDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 135 --------SWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186
S Q+ +G+ YL S+ IHRDL N+ V + +KI D GLA +
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDINN 209
Query: 187 S----KSAHSVIGTP-EFMAPE-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPA 239
K+ + + P ++MAPE L++ Y DV+SFG+ + E+FT PY
Sbjct: 210 IDYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-E 266
Query: 240 QIYKKVTSGKL-------PGAFYSI 257
+++K + G Y +
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMM 291
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 6e-14
Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 6/89 (6%)
Query: 142 QGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-RGSKSAHS--VIGTPE 198
G+ +LH + IHRD+K NI ++ KI D GLA + +++ + ++GT
Sbjct: 144 NGINFLH--ENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTA 200
Query: 199 FMAPELYEEDYNELVDVYSFGMCVLEMFT 227
+MAPE + D+YSFG+ +LE+ T
Sbjct: 201 YMAPEALRGEITPKSDIYSFGVVLLEIIT 229
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 7e-14
Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 17/95 (17%)
Query: 143 GLVYLHSR-DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH---SVIGTPE 198
GL YLH DP +IHRD+K NI ++ + +GD GLA ++ + H +V GT
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDT-HVTTAVRGTIG 200
Query: 199 FMAPELYEEDY------NELVDVYSFGMCVLEMFT 227
+APE Y +E DV+ +G+ +LE+ T
Sbjct: 201 HIAPE-----YLSTGKSSEKTDVFGYGVMLLELIT 230
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 8/119 (6%)
Query: 135 SWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVI 194
++ Q+ +G+ +L SR IHRDL NI ++ VKI D GLA +
Sbjct: 197 CYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKG 253
Query: 195 GTP---EFMAPE-LYEEDYNELVDVYSFGMCVLEMFTC-EYPYSECANPAQIYKKVTSG 248
++MAPE +++ Y DV+SFG+ + E+F+ PY + +++ G
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 312
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 67/348 (19%), Positives = 108/348 (31%), Gaps = 107/348 (30%)
Query: 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLST 85
N + L +G G V A VR + E +L
Sbjct: 34 NNAF-LVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTR----SAK-IEADILKK 87
Query: 86 LKHD-----SIIRFYTSWIDVDQKTFNF------ITEMFTSGTLREYRKK--YRRVDIRA 132
+++D +I++++ F + I E +L E + Y I
Sbjct: 88 IQNDDINNNNIVKYHGK--------FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIED 138
Query: 133 IKSWARQILQGLVYLHSRDPPVIHRDLKCDNI-FVNGHLG-------------------- 171
IK + +IL+ L YL + H DLK +NI + +
Sbjct: 139 IKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196
Query: 172 ---QVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVL-EMF 226
+K+ D G A S S+I T ++ APE + ++ D++SFG CVL E++
Sbjct: 197 KSTGIKLIDFGCATFK--SDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFG-CVLAELY 253
Query: 227 T---------------------------------------------CEYPYSECANPAQI 241
T + + E A+
Sbjct: 254 TGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINS 313
Query: 242 YKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288
K V P I+ F+ L + + R S ELL FL
Sbjct: 314 IKHVKKCL-PLYKI-IKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 8e-11
Identities = 51/237 (21%), Positives = 91/237 (38%), Gaps = 55/237 (23%)
Query: 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVE-VAWNQVRLNELMRSPDDLQRLYSEVHLLS 84
+ RY + + LG+GA V + ID G VA V+ + SE+ +L
Sbjct: 13 SARYEIVD-TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCE----AAR-SEIQVLE 66
Query: 85 TL-KHD-----SIIRFYTSWIDVDQKTFNF------ITEMFTSGTLREYRKK--YRRVDI 130
L D ++ F + E+ + ++ K+ + +
Sbjct: 67 HLNTTDPNSTFRCVQMLEW--------FEHHGHICIVFELL-GLSTYDFIKENGFLPFRL 117
Query: 131 RAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNI-FVNGHLGQ----------------- 172
I+ A QI + + +LHS + H DLK +NI FV +
Sbjct: 118 DHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 173 VKIGDLGLAAILRGSKSAHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVL-EMFT 227
+K+ D G A + +++ T + APE + +++ DV+S G C+L E +
Sbjct: 176 IKVVDFGSATYD--DEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIG-CILIEYYL 229
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 8e-11
Identities = 72/503 (14%), Positives = 154/503 (30%), Gaps = 116/503 (23%)
Query: 17 HIGYIETDP-NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQR 75
HI + D +G LF +L K + V K ++EVL + + + R P + R
Sbjct: 53 HI-IMSKDAVSGTLRLFWTLLSKQE-EMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTR 110
Query: 76 LYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFIT--EMFTSGTLREYRKKYRRVDIRAI 133
+Y E + D + + D ++ + + LR+ + R I
Sbjct: 111 MYIE-------QRDRL------YNDNQVFAKYNVSRLQPYL--KLRQALLELRPAKNVLI 155
Query: 134 -------KSWARQILQGLVYLHSRDPPVIHRDLKCDNIF-VNGHLGQVKIGDLGLAAILR 185
K+W + V + IF +N L + L + +
Sbjct: 156 DGVLGSGKTW-------VALDVCLSYKVQCK--MDFKIFWLN--LKNCNSPETVLEMLQK 204
Query: 186 -----------GSKSAHSVIGTPEFMAPEL----YEEDYNE--LV--DVYSFGMCVLEMF 226
S + ++ + EL + Y LV +V + F
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK--AWNAF 262
Query: 227 --TCEY----PYSECAN--PAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLVNASKRLS 278
+C+ + + + A ++ E + + + L + L
Sbjct: 263 NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT---PDEVKSLLLKYLDCRPQDLP 319
Query: 279 AKELLLDPFLASDEVKLLSKTKLNQKPFLNETELEKLQLSDDPPRT-DMTITGKLNPEDD 337
+ L +P S + + + L +KL + ++ L P +
Sbjct: 320 REVLTTNPRRLSIIAESI-RDGLATWDNWKHVNCDKLT------TIIESSLN-VLEPAEY 371
Query: 338 -TIFLKVQIADKDGPGRNIYFPFDIL----NDTPLDVAREMVKELE-----ITDWEP--- 384
+F ++ + +I P +L D +V +L +
Sbjct: 372 RKMFDRLSVFPPS---AHI--PTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI 426
Query: 385 ------FEIAKMIDEEISV---LVPHWKKREWPHPEAYHTFNYEED-EDGY--HHPLYSF 432
E+ ++ E ++ +V H+ P+ + + + D Y H +
Sbjct: 427 SIPSIYLELKVKLENEYALHRSIVDHYNI-----PKTFDSDDLIPPYLDQYFYSHIGHHL 481
Query: 433 PSCSSSQ-ASLPGLVTYDHDWLK 454
+ + +L +V D +L+
Sbjct: 482 KNIEHPERMTLFRMVFLDFRFLE 504
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 46/237 (19%), Positives = 84/237 (35%), Gaps = 55/237 (23%)
Query: 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVE-VAWNQVRLNELMRSPDDLQRLYSEVHLLS 84
RY + LG+G V + +D G VA +R R E+++L
Sbjct: 18 QERYEIVG-NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYRE----AAR-LEINVLK 71
Query: 85 TL-KHD-----SIIRFYTSWIDVDQKTFNF------ITEMFTSGTLREYRKK--YRRVDI 130
+ + D + FNF E+ E+ K+ ++ +
Sbjct: 72 KIKEKDKENKFLCVLMSDW--------FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPL 122
Query: 131 RAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQ------------------ 172
++ A Q+ L +LH + H DLK +NI +
Sbjct: 123 PHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 173 VKIGDLGLAAILRGSKSAHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVL-EMFT 227
+++ D G A + +++ T + PE + E + + DV+S G C+L E +
Sbjct: 181 IRVADFGSATFD--HEHHTTIVATRHYRPPEVILELGWAQPCDVWSIG-CILFEYYR 234
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 56/273 (20%), Positives = 84/273 (30%), Gaps = 104/273 (38%)
Query: 117 TLREYRKK--YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFV-------- 166
L ++ K Y+ + + +K +Q+LQGL YLH+ +IH D+K +NI +
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIR 188
Query: 167 ----------------------------------------NGHLGQVKIGDLGLAAILRG 186
N +VKI DLG A
Sbjct: 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC--WV 246
Query: 187 SKSAHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANP------- 238
K I T ++ + E L YN D++S E+ T +Y + +
Sbjct: 247 HKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDED 306
Query: 239 --AQIYKKVTSGKLPGAF-----------------------------------YSIQDLE 261
A I + GK+P Y E
Sbjct: 307 HIALIIE--LLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEE 364
Query: 262 AQ---RFIGRCLV-NASKRLSAKELLLDPFLAS 290
A F+ L KR +A E L P+L S
Sbjct: 365 AAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} Length = 98 | Back alignment and structure |
|---|
Score = 56.2 bits (135), Expect = 3e-10
Identities = 25/100 (25%), Positives = 49/100 (49%), Gaps = 27/100 (27%)
Query: 330 GKLNPEDDTIFLKVQIADKDGPGRN-----------------------IYFPFDILNDTP 366
G ++P+++T ++V++A++D + I F FD+ D P
Sbjct: 1 GAMDPQEET-GVRVELAEEDDGEKIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVP 59
Query: 367 LDVAREMVKELEITDWEPFEIAKMIDEEISVLVPHWKKRE 406
DVA+EMV+ + + + +AK I + +S++ +KRE
Sbjct: 60 EDVAQEMVESGYVCEGDHKTMAKAIKDRVSLI---KRKRE 96
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 33/202 (16%), Positives = 69/202 (34%), Gaps = 37/202 (18%)
Query: 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLST 85
++ L + +G G +Y A + A + V++ + L+SE+
Sbjct: 36 GNQWVL-GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVE-----YQENGPLFSELKFYQR 89
Query: 86 LKHDSIIRFYTSWIDVD----------------QKTFNF-ITEMFTSGT-LREYRKKYRR 127
+ I+ + +D +++ F + E G L++ +
Sbjct: 90 VAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGT 147
Query: 128 VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVN-GHLGQVKIGDLGLAAILRG 186
+ ++L L Y+H + +H D+K N+ + + QV + D GL+
Sbjct: 148 FKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCP 205
Query: 187 SK--------SAHSVIGTPEFM 200
+ GT EF
Sbjct: 206 NGNHKQYQENPRKGHNGTIEFT 227
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 40/187 (21%), Positives = 75/187 (40%), Gaps = 24/187 (12%)
Query: 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLST 85
RY L + +G G+ +Y D G EVA E +++ +L+ E +
Sbjct: 8 GNRYRLGRK-IGSGSFGDIYLGTDIAAGEEVAIKL----ECVKTKH--PQLHIESKIYKM 60
Query: 86 LKHDS-IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQG 143
++ I W + +N + +L + R+ ++ + A Q++
Sbjct: 61 MQGGVGIPTIR--WCGAEGD-YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISR 117
Query: 144 LVYLHSRDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLAAILRGSKS--------AHSV 193
+ Y+HS++ IHRD+K DN + V I D GLA R +++ ++
Sbjct: 118 IEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 175
Query: 194 IGTPEFM 200
GT +
Sbjct: 176 TGTARYA 182
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 37/187 (19%), Positives = 75/187 (40%), Gaps = 24/187 (12%)
Query: 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLST 85
++ L + +G G+ +Y + EVA E +++ +L E +
Sbjct: 6 GNKFRLGRK-IGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKH--PQLLYESKIYRI 58
Query: 86 LKHDS-IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQG 143
L+ + I W V+ +N + +L + R++ ++ + A Q++
Sbjct: 59 LQGGTGIPNVR--WFGVEGD-YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
Query: 144 LVYLHSRDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLAAILRGSKS--------AHSV 193
+ ++HS+ +HRD+K DN + QV I D GLA R + + ++
Sbjct: 116 VEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
Query: 194 IGTPEFM 200
GT +
Sbjct: 174 TGTARYA 180
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 3e-07
Identities = 46/313 (14%), Positives = 88/313 (28%), Gaps = 66/313 (21%)
Query: 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQR----LYSEVHLLSTL----- 86
+G+G V++ I + VA + + Q+ + E+ + L
Sbjct: 28 IGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 87 ----KHDSIIRFY--------------TSWIDVDQK--------------TFNFITEMFT 114
+ + I +W + + E
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 115 SGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQ-- 172
G E + + + KS Q+ L + HRDL N+ + +
Sbjct: 146 GGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEAS-LRFEHRDLHWGNVLLKKTSLKKL 203
Query: 173 --------VKIGDLGL-AAILRGSKSAHSVIGTPEFM----APELYEEDYNELVDVYSFG 219
I GL +I+ + S G F +L+ D + D+Y
Sbjct: 204 HYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYR-- 261
Query: 220 MCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLVNASKRL-- 277
+ E Y +N ++ F + + A + I R + + +
Sbjct: 262 LMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLN 321
Query: 278 --SAKELLLDPFL 288
SA +LL L
Sbjct: 322 FSSATDLLCQHSL 334
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 41/206 (19%), Positives = 73/206 (35%), Gaps = 42/206 (20%)
Query: 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLST 85
+ + +G+G +Y A D V + + ++ P D L++E+
Sbjct: 34 AAAWKV-GLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVE--PSDNGPLFTELKFYQR 89
Query: 86 LKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKY-------------------- 125
I+ WI + + + + + SG + K Y
Sbjct: 90 AAKPEQIQ---KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA 146
Query: 126 RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVN-GHLGQVKIGDLGLA--- 181
+R + + + +IL L Y+H + +H D+K N+ +N + QV + D GLA
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
Query: 182 -------AILRGSKSAHSVIGTPEFM 200
A K H GT EF
Sbjct: 205 CPEGVHKAYAADPKRCH--DGTIEFT 228
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 29/189 (15%), Positives = 67/189 (35%), Gaps = 26/189 (13%)
Query: 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLST 85
Y + +G+G+ +++ + + +VA D +L E
Sbjct: 9 GVHYKV-GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR------SDAPQLRDEYRTYKL 61
Query: 86 LKHDS-IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQG 143
L + I Y + + N + +L + R+ ++ + A+Q+L
Sbjct: 62 LAGCTGIPNVY--YFGQEGL-HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLAR 118
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVNGHLG----QVKIGDLGLAAILRGSKS--------AH 191
+ +H + +++RD+K DN + + + D G+ R +
Sbjct: 119 VQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 176
Query: 192 SVIGTPEFM 200
++ GT +M
Sbjct: 177 NLSGTARYM 185
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 36/189 (19%), Positives = 72/189 (38%), Gaps = 26/189 (13%)
Query: 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLST 85
+ + + +G G + + VA ++L E M+S +L+ E
Sbjct: 8 GPNFRV-GKKIGCGNFGELRLGKNLYTNEYVA---IKL-EPMKS--RAPQLHLEYRFYKQ 60
Query: 86 LKHDS-IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQG 143
L I + Y + K +N + +L + R ++ + A Q++
Sbjct: 61 LGSGDGIPQVY--YFGPCGK-YNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISR 117
Query: 144 LVYLHSRDPPVIHRDLKCDNIFV----NGHLGQVKIGDLGLAAILRGSKS--------AH 191
+ Y+HS++ +I+RD+K +N + N + I D LA ++
Sbjct: 118 MEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHK 175
Query: 192 SVIGTPEFM 200
S+ GT +M
Sbjct: 176 SLTGTARYM 184
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 22/75 (29%), Positives = 35/75 (46%), Gaps = 15/75 (20%)
Query: 137 ARQILQGLVYLHSRDPPVIHRDLKCDNIFVN-GHLGQVKIGDLGLA----------AILR 185
A ++L L +LH + +H ++ +NIFV+ QV + G A A +
Sbjct: 165 ACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222
Query: 186 GSKSAHSVIGTPEFM 200
GS+S H G EF+
Sbjct: 223 GSRSPH--EGDLEFI 235
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 466 | |||
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.68 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 2lru_A | 98 | Serine/threonine-protein kinase WNK1; autoinhibito | 98.74 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.97 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.94 | |
| 2v3s_A | 96 | Serine/threonine-protein kinase OSR1; ATP-binding, | 98.81 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.66 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.45 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.4 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.16 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.03 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.96 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.9 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.55 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.34 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.33 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.15 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.97 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.73 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.69 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.56 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.44 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.33 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.28 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.12 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.92 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.85 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.39 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 91.07 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.05 |
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-66 Score=510.84 Aligned_cols=270 Identities=49% Similarity=0.896 Sum_probs=244.8
Q ss_pred cceeeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeE
Q 012320 18 IGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTS 97 (466)
Q Consensus 18 ~~~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 97 (466)
...+...+++||+++++.||+|+||+||+|.++.+|..||+|++..... .....+++.+|+.+|++|+|||||++|++
T Consensus 16 ~~~~~~~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~ 93 (290)
T 3fpq_A 16 TKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDS 93 (290)
T ss_dssp -CEEEECTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhcCcCCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 4456778899999999999999999999999999999999999986653 45567889999999999999999999999
Q ss_pred EEec--cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEE
Q 012320 98 WIDV--DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKI 175 (466)
Q Consensus 98 ~~~~--~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL 175 (466)
|.+. .+..+|+|||||+||+|.+++.+.+.+++..++.|++||+.||.|||+++++|+||||||+|||+++..|.+||
T Consensus 94 ~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl 173 (290)
T 3fpq_A 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKI 173 (290)
T ss_dssp EEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEE
T ss_pred EeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEE
Confidence 8653 24578999999999999999999999999999999999999999999999899999999999999865589999
Q ss_pred eccchhhhhcCCCCCccccCCCCcCCccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 012320 176 GDLGLAAILRGSKSAHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFY 255 (466)
Q Consensus 176 ~DFGla~~~~~~~~~~~~~GT~~y~APE~l~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~ 255 (466)
+|||+|+... .....+.+|||.|||||++.+.|+.++|||||||++|||+||..||.+..+..++++.+..+..|..++
T Consensus 174 ~DFGla~~~~-~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 252 (290)
T 3fpq_A 174 GDLGLATLKR-ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 252 (290)
T ss_dssp CCTTGGGGCC-TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred EeCcCCEeCC-CCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCC
Confidence 9999998643 345667899999999999998999999999999999999999999988888999999999998877777
Q ss_pred CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 256 ~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
...++++++||.+||. ||.+|||+.|+|+||||+.
T Consensus 253 ~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 7888999999999996 9999999999999999975
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-63 Score=491.65 Aligned_cols=260 Identities=25% Similarity=0.436 Sum_probs=231.1
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
.|.+ .++||+|+||+||+|.++.+|+.||+|++.+.... .....+.+.+|+++|++++|||||++|++| ++++.+|
T Consensus 33 dy~i-~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~--~~~~~~y 108 (311)
T 4aw0_A 33 DFKF-GKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTF--QDDEKLY 108 (311)
T ss_dssp GEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSEEE
T ss_pred ccEE-EEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE--EeCCEEE
Confidence 4766 67799999999999999999999999999876542 223457899999999999999999999998 5578899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~ 187 (466)
+|||||+||+|.+++++.+.+++..++.|++||+.||+|||++| |+||||||+|||++.+ |.+||+|||+|+.+...
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~-g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNED-MHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEECCTT
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCC-CCEEEEEcCCceecCCC
Confidence 99999999999999999999999999999999999999999999 9999999999999877 89999999999877532
Q ss_pred ---CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 188 ---KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 188 ---~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
....+.+|||.|||||++. +.|+.++|||||||++|+|+||..||.+ .+..+++++|..+.+. ++...+++++
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~ 262 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEGLIFAKIIKLEYD--FPEKFFPKAR 262 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC--CCTTCCHHHH
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCC--CCcccCHHHH
Confidence 2356789999999999887 4699999999999999999999999976 7889999999988753 4456789999
Q ss_pred HHHHHhcc-CcCCCCCHHH------HhcCCCCCchhhhhcc
Q 012320 264 RFIGRCLV-NASKRLSAKE------LLLDPFLASDEVKLLS 297 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rpsa~e------lL~hpf~~~~~~~~~~ 297 (466)
+||.+||. ||.+|||++| +++||||++.+|..+.
T Consensus 263 dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~ 303 (311)
T 4aw0_A 263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 303 (311)
T ss_dssp HHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred HHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhc
Confidence 99999996 9999999988 5899999988876543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-62 Score=476.13 Aligned_cols=254 Identities=26% Similarity=0.461 Sum_probs=209.7
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
-|+|.+. +.||+|+||+||+|.++.+|+.||+|++.+.... .....+++.+|+.+|++++|||||+++++| .+++.
T Consensus 12 ig~Y~i~-~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~--~~~~~ 87 (275)
T 3hyh_A 12 IGNYQIV-KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA-KSDMQGRIEREISYLRLLRHPHIIKLYDVI--KSKDE 87 (275)
T ss_dssp --CCEEE-EEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSSE
T ss_pred eeCeEEE-EEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEE--EECCE
Confidence 3789884 6699999999999999999999999999866542 333456899999999999999999999988 45788
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+|+||||| +|+|.+++.+.+++++..++.|++||+.||+|||++| |+||||||+|||++.+ |.+||+|||+|+...
T Consensus 88 ~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 88 IIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEH-LNVKIADFGLSNIMT 163 (275)
T ss_dssp EEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTT-CCEEECCSSCC----
T ss_pred EEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCC-CCEEEeecCCCeecC
Confidence 99999999 7899999999999999999999999999999999999 9999999999999877 899999999998877
Q ss_pred CCCCCccccCCCCcCCcccccc-CC-CChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 186 GSKSAHSVIGTPEFMAPELYEE-DY-NELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 186 ~~~~~~~~~GT~~y~APE~l~~-~y-~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
......+.+|||.|||||++.+ .| +.++|||||||++|+|+||..||.+ .+..++++.+..+..+ ++...+++++
T Consensus 164 ~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~ 240 (275)
T 3hyh_A 164 DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYT--LPKFLSPGAA 240 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC--CCTTSCHHHH
T ss_pred CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHH
Confidence 6666678899999999998875 44 6899999999999999999999976 7888899999988754 4456789999
Q ss_pred HHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 264 RFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
+||.+||. ||.+|||++|+|+||||+.
T Consensus 241 ~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 241 GLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHHHHccCChhHCcCHHHHHcCccccc
Confidence 99999996 9999999999999999964
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-61 Score=488.46 Aligned_cols=257 Identities=30% Similarity=0.499 Sum_probs=226.4
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
.||..+|.++++ ||+|+||+||+|.++.+|+.||||++.+.... ..+.+.+|+.+|++++|||||++|++|. +
T Consensus 70 ~dp~~~y~~~~~-iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~----~~~~~~~Ei~il~~l~HpnIV~l~~~~~--~ 142 (346)
T 4fih_A 70 GDPRSYLDNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ----RRELLFNEVVIMRDYQHENVVEMYNSYL--V 142 (346)
T ss_dssp SCGGGTEEEEEE-EEECSSCEEEEEEETTTCCEEEEEEEEGGGCS----SGGGGHHHHHHHHHCCCTTBCCEEEEEE--E
T ss_pred CChhHhcEEeEE-eecCcCeEEEEEEECCCCCEEEEEEEecCchh----HHHHHHHHHHHHHhCCCCCCCcEEEEEE--E
Confidence 456678988755 99999999999999999999999999866532 2356889999999999999999999984 4
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
.+.+|+|||||+||+|.+++.+ +++++..++.|++||+.||.|||++| ||||||||+|||++.+ |.+||+|||+|+
T Consensus 143 ~~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~-g~vKl~DFGla~ 218 (346)
T 4fih_A 143 GDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHD-GRVKLSDFGFCA 218 (346)
T ss_dssp TTEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCE
T ss_pred CCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCC-CCEEEecCcCce
Confidence 7789999999999999999876 67999999999999999999999999 9999999999999877 899999999998
Q ss_pred hhcCC-CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC-CCCCCCC
Q 012320 183 ILRGS-KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG-AFYSIQD 259 (466)
Q Consensus 183 ~~~~~-~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~-~~~~~~~ 259 (466)
.+... ....+.+|||.|||||++. ..|+.++|||||||++|||++|..||.+ .+..++++.|..+..+. ..+...+
T Consensus 219 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s 297 (346)
T 4fih_A 219 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVS 297 (346)
T ss_dssp ECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCSCGGGSC
T ss_pred ecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCCccccCC
Confidence 77543 4456789999999999886 5699999999999999999999999987 67788888887765432 2345678
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
+++++||.+||. ||.+|||+.|+|+||||+..
T Consensus 298 ~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 298 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 899999999996 99999999999999999753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-62 Score=490.70 Aligned_cols=258 Identities=23% Similarity=0.441 Sum_probs=222.7
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
...+||.++ +.||+|+||+||+|.++.+|+.||||++.+... +....+++.+|+.+|++|+|||||+++++|. ++
T Consensus 21 ~sme~Y~~~-~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~--~~ 95 (350)
T 4b9d_A 21 QSMEKYVRL-QKIGEGSFGKAILVKSTEDGRQYVIKEINISRM--SSKEREESRREVAVLANMKHPNIVQYRESFE--EN 95 (350)
T ss_dssp SCCCCEEEE-EEC------CEEEEEETTTCCEEEEEEEECTTS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--ET
T ss_pred CcccceEEe-EEEecCCCeEEEEEEECCCCCEEEEEEEehHHC--CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE--EC
Confidence 456799886 559999999999999999999999999987653 4556788999999999999999999999884 57
Q ss_pred CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 104 KTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
+.+|+|||||+||+|.+++.+. ..+++..++.|++||+.||.|||++| |+||||||+|||++.+ |.+||+|||+|
T Consensus 96 ~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~-g~vKl~DFGla 172 (350)
T 4b9d_A 96 GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKD-GTVQLGDFGIA 172 (350)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTT-CCEEECSTTEE
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCC-CCEEEcccccc
Confidence 8899999999999999999754 35799999999999999999999999 9999999999999877 89999999999
Q ss_pred hhhcCC-CCCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 012320 182 AILRGS-KSAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259 (466)
Q Consensus 182 ~~~~~~-~~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 259 (466)
+.+... ....+.+||+.|||||++.+ .|+.++|||||||++|||+||..||.+ .+..+++.+|..+.+|. .+...+
T Consensus 173 ~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~~-~~~~~s 250 (350)
T 4b9d_A 173 RVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-GSMKNLVLKIISGSFPP-VSLHYS 250 (350)
T ss_dssp SCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCC-CCTTSC
T ss_pred eeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCC-CCccCC
Confidence 876432 22356789999999998874 699999999999999999999999976 78888999999888764 345578
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.++++||.+||. ||.+|||+.|+|+||||+..
T Consensus 251 ~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 251 YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 899999999996 99999999999999999754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-60 Score=491.42 Aligned_cols=258 Identities=30% Similarity=0.499 Sum_probs=226.9
Q ss_pred eeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 22 ~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
..||..+|.++++ ||+|+||+||+|.++.+|+.||||++.+... ...+.+.+|+.+|++++|||||++|++|.
T Consensus 146 ~~dp~~~y~~~~~-iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-- 218 (423)
T 4fie_A 146 PGDPRSYLDNFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYL-- 218 (423)
T ss_dssp SSCGGGTEEEEEE-EEECSSCEEEEEEETTTCCEEEEEEEESTTC----SSGGGHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred CCChhHhcEeeeE-eccCcCcEEEEEEECCCCCEEEEEEEeccch----hHHHHHHHHHHHHHhCCCCCCCceEEEEE--
Confidence 3567788988655 9999999999999999999999999986543 23356889999999999999999999985
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
+.+.+|||||||.||+|.++++. +++++..++.|++||+.||+|||++| ||||||||+|||++.+ |.+||+|||+|
T Consensus 219 ~~~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~-g~vKl~DFGla 294 (423)
T 4fie_A 219 VGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHD-GRVKLSDFGFC 294 (423)
T ss_dssp ETTEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTT-CCEEECCCTTC
T ss_pred ECCEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCC-CCEEEecCccc
Confidence 46789999999999999999875 67999999999999999999999999 9999999999999977 89999999999
Q ss_pred hhhcCC-CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC-CCCCCC
Q 012320 182 AILRGS-KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG-AFYSIQ 258 (466)
Q Consensus 182 ~~~~~~-~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~-~~~~~~ 258 (466)
+.+... ....+.+||+.|||||++. ..|+.++|||||||++|||++|..||.+ .+..+++..|..+..+. ..+...
T Consensus 295 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~ 373 (423)
T 4fie_A 295 AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKV 373 (423)
T ss_dssp EECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCCCCSCTTSS
T ss_pred eECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCcccccC
Confidence 876543 4456789999999999887 5699999999999999999999999977 67788888887765432 334567
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
++++++||.+||. ||.+|||+.|||+||||+..
T Consensus 374 s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 374 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 8999999999996 99999999999999999753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-61 Score=476.43 Aligned_cols=262 Identities=26% Similarity=0.371 Sum_probs=222.0
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEE---cCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAID---EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~---~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
+| .+|.++ +.||+|+||+||+|.+ +.+++.||+|++++..... ....++.+|+.+|++++|||||+++++|.
T Consensus 22 ~p-~~Y~i~-~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~- 96 (304)
T 3ubd_A 22 DP-SQFELL-KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV--RDRVRTKMERDILVEVNHPFIVKLHYAFQ- 96 (304)
T ss_dssp CG-GGEEEE-EEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE--EECC------CCCCCCCCTTEECEEEEEE-
T ss_pred Cc-cccEEE-EEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh--HHHHHHHHHHHHHHHCCCCCCCeEEEEEE-
Confidence 44 468774 6699999999999987 4578999999998655321 12346788999999999999999999884
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
+.+.+|+|||||+||+|.+++.+.+.+++..++.|++||+.||.|||++| |+||||||+|||++.+ |.+||+|||+
T Consensus 97 -~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~-g~vKl~DFGl 172 (304)
T 3ubd_A 97 -TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEE-GHIKLTDFGL 172 (304)
T ss_dssp -ETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTT-SCEEEESSEE
T ss_pred -ECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCC-CCEEeccccc
Confidence 57789999999999999999999999999999999999999999999999 9999999999999977 8999999999
Q ss_pred hhhhcC-CCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 012320 181 AAILRG-SKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258 (466)
Q Consensus 181 a~~~~~-~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 258 (466)
|+.... .....+.+|||.|||||++. +.|+.++|||||||++|||+||..||.+ .+..+++.+|.++.++ ++...
T Consensus 173 a~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~--~p~~~ 249 (304)
T 3ubd_A 173 SKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKLG--MPQFL 249 (304)
T ss_dssp EEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTS
T ss_pred ceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC-cCHHHHHHHHHcCCCC--CCCcC
Confidence 986543 34456789999999999886 5699999999999999999999999976 7888899999888754 45567
Q ss_pred CHHHHHHHHHhcc-CcCCCCCH-----HHHhcCCCCCchhhhhcc
Q 012320 259 DLEAQRFIGRCLV-NASKRLSA-----KELLLDPFLASDEVKLLS 297 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa-----~elL~hpf~~~~~~~~~~ 297 (466)
++++++||.+||. ||++|||| +|+++||||+..+|..+.
T Consensus 250 s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~ 294 (304)
T 3ubd_A 250 SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLY 294 (304)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHH
T ss_pred CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHH
Confidence 8999999999996 99999995 799999999998876543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=465.14 Aligned_cols=247 Identities=24% Similarity=0.347 Sum_probs=211.5
Q ss_pred eEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEE
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNF 108 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~l 108 (466)
++.+.+.||+|+||+||+|.++.+|+.||||++++.... .+|+.+|++++|||||++|++|. +...+||
T Consensus 59 ~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~---------~~E~~il~~l~HpnIV~l~~~~~--~~~~~~i 127 (336)
T 4g3f_A 59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR---------VEELVACAGLSSPRIVPLYGAVR--EGPWVNI 127 (336)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---------THHHHTTTTCCCTTBCCEEEEEE--ETTEEEE
T ss_pred heEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH---------HHHHHHHHhCCCCCCCcEEEEEE--ECCEEEE
Confidence 444467799999999999999999999999999865431 36999999999999999999884 5778999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCC-cEEEeccchhhhhcCC
Q 012320 109 ITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLG-QVKIGDLGLAAILRGS 187 (466)
Q Consensus 109 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g-~vKL~DFGla~~~~~~ 187 (466)
|||||+||+|.+++++.+.+++..++.|+.||+.||.|||+++ ||||||||+|||++.+ | .+||+|||+|+.+...
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~-g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSD-GSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTT-SCCEEECCCTTCEEC---
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCC-CCEEEEeeCCCCeEccCC
Confidence 9999999999999999999999999999999999999999999 9999999999999877 5 6999999999876532
Q ss_pred C------CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC-CCCCCCC
Q 012320 188 K------SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG-AFYSIQD 259 (466)
Q Consensus 188 ~------~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~-~~~~~~~ 259 (466)
. ...+++|||.|||||++. ..|+.++|||||||++|||+||..||.+ .+..++..+|..+..+. ..+...+
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~s 283 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ-YFRGPLCLKIASEPPPIREIPPSCA 283 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTT-TCCSCCHHHHHHSCCGGGGSCTTSC
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHHcCCCCchhcCccCC
Confidence 2 123468999999999876 5699999999999999999999999976 45555666777665442 3456678
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHH-------------hcCCCCCc
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKEL-------------LLDPFLAS 290 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~el-------------L~hpf~~~ 290 (466)
+++++||.+||. ||.+|||+.|| |+|||+..
T Consensus 284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 999999999996 99999999998 46888754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-58 Score=453.89 Aligned_cols=254 Identities=22% Similarity=0.419 Sum_probs=203.0
Q ss_pred eEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC-----
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ----- 103 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~----- 103 (466)
|.+ .+.||+|+||+||+|.++.+|+.||+|++++.. .....+++.+|+.+|++|+|||||++|++|.+.+.
T Consensus 7 y~~-~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 7 FEP-IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp EEE-EEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred CEE-eeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 455 567999999999999999999999999997543 44556789999999999999999999999976442
Q ss_pred -----CEEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEE
Q 012320 104 -----KTFNFITEMFTSGTLREYRKKYRR---VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKI 175 (466)
Q Consensus 104 -----~~~~lV~E~~~ggsL~~~l~~~~~---l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL 175 (466)
..+|+|||||.||+|.+++.+.+. .++..++.|+.||+.||+|||++| |+||||||+|||++.+ |.+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~-~~vKl 159 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKV 159 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEE
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCC-CcEEE
Confidence 258999999999999999987655 455678999999999999999999 9999999999999987 89999
Q ss_pred eccchhhhhcCCCC-------------CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q 012320 176 GDLGLAAILRGSKS-------------AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQI 241 (466)
Q Consensus 176 ~DFGla~~~~~~~~-------------~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i 241 (466)
+|||+|+.+..... ..+.+|||.|||||++. ..|+.++|||||||++|||++ ||....+....
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~ 236 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT 236 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence 99999987654321 23468999999999876 469999999999999999996 88653344455
Q ss_pred HHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 242 YKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 242 ~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
...+..+.+|+.+ ...++.+++||.+||. ||.+|||+.|+|+||||+..++
T Consensus 237 ~~~~~~~~~p~~~-~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 237 LTDVRNLKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HHHHHTTCCCHHH-HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred HHHHhcCCCCCCC-cccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 6667777765432 3345678899999996 9999999999999999987544
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-57 Score=463.52 Aligned_cols=258 Identities=28% Similarity=0.424 Sum_probs=216.7
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec----
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV---- 101 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~---- 101 (466)
.++|.++ +.||+|+||+||+|.++.+|+.||||++++.. ......+++.+|+++|++|+|||||++++++...
T Consensus 53 ~~~Y~~~-~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 53 GDEYEII-ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF--DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp CSSEEEE-EEEEECSSCEEEEEEETTTCCEEEEEEETTTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred CCCeEEE-EEEecccCeEEEEEEECCCCCEEEEEEECccc--cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence 4689885 66999999999999999999999999997543 2455667899999999999999999999987432
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
+.+.+|+|||||. |+|.+++.+.+.+++..++.|++||+.||.|||++| ||||||||+|||++.+ |.+||+|||+|
T Consensus 130 ~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~-~~~Ki~DFGla 205 (398)
T 4b99_A 130 EFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNEN-CELKIGDFGMA 205 (398)
T ss_dssp TCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-CCEEECCCTTC
T ss_pred cCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCC-CCEEEeeccee
Confidence 3468999999995 689999998899999999999999999999999999 9999999999999977 89999999999
Q ss_pred hhhcC-----CCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--CCCCC
Q 012320 182 AILRG-----SKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS--GKLPG 252 (466)
Q Consensus 182 ~~~~~-----~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~--g~~p~ 252 (466)
+.+.. .....+.+||+.|||||++.+ .|+.++||||+||++|||++|..||.+ .+.......|.. |..+.
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g-~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG-KNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC-SSHHHHHHHHHHHHCCCCG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC-CCHHHHHHHHHHhcCCCCh
Confidence 86532 233457899999999998753 479999999999999999999999987 555555555543 21111
Q ss_pred C---------------------------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 253 A---------------------------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 253 ~---------------------------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
. .....+.++++||.+||. ||.+||||.|+|+||||+..
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 0 012357899999999996 99999999999999999753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-55 Score=474.02 Aligned_cols=262 Identities=22% Similarity=0.359 Sum_probs=225.9
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCC--HHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRS--PDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
+.|.+ .++||+|+||+||+|.++.+|+.||+|++.+..+... .........++.+++.++|||||+++++| ++..
T Consensus 189 ddf~i-~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f--~~~~ 265 (689)
T 3v5w_A 189 NDFSV-HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF--HTPD 265 (689)
T ss_dssp GGEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE--ECSS
T ss_pred HHeEE-EEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE--EECC
Confidence 56776 5779999999999999999999999999987654222 22223344556777888999999999998 5678
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.+|||||||.||+|.+++.+.+.+++..++.|++||+.||+|||++| ||||||||+|||++.+ |++||+|||+|+.+
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~-G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDF 342 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTT-SCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCC-CCEEecccceeeec
Confidence 99999999999999999999999999999999999999999999999 9999999999999987 99999999999876
Q ss_pred cCCCCCccccCCCCcCCccccc-c-CCCChhhHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHhcCCCCCCCCCCCCH
Q 012320 185 RGSKSAHSVIGTPEFMAPELYE-E-DYNELVDVYSFGMCVLEMFTCEYPYSEC--ANPAQIYKKVTSGKLPGAFYSIQDL 260 (466)
Q Consensus 185 ~~~~~~~~~~GT~~y~APE~l~-~-~y~~~~DIwSlGvil~elltg~~Pf~~~--~~~~~i~~~i~~g~~p~~~~~~~~~ 260 (466)
... ...+.+|||.|||||++. + .|+.++|||||||++|||++|..||.+. .+..++++.+..+..+ ++...++
T Consensus 343 ~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~--~p~~~S~ 419 (689)
T 3v5w_A 343 SKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE--LPDSFSP 419 (689)
T ss_dssp SSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCC--CCTTSCH
T ss_pred CCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCC--CCccCCH
Confidence 543 456789999999999885 3 5999999999999999999999999642 3556777777776543 4566789
Q ss_pred HHHHHHHHhcc-CcCCCCC-----HHHHhcCCCCCchhhhhcc
Q 012320 261 EAQRFIGRCLV-NASKRLS-----AKELLLDPFLASDEVKLLS 297 (466)
Q Consensus 261 ~~~~lI~~~L~-dp~~Rps-----a~elL~hpf~~~~~~~~~~ 297 (466)
++++||.+||. ||.+|++ |+|+++||||+..+|..+.
T Consensus 420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~ 462 (689)
T 3v5w_A 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVF 462 (689)
T ss_dssp HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHH
T ss_pred HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHH
Confidence 99999999996 9999998 7999999999999997654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=448.24 Aligned_cols=252 Identities=20% Similarity=0.382 Sum_probs=206.5
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEc---CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEec
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDE---VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDV 101 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 101 (466)
.++|.+ .+.||+|+||+||+|.++ .+++.||+|++.... ...++.+|+++|+.+ +|||||+++++| .
T Consensus 20 ~~~Y~i-~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~------~~~~~~~E~~~l~~~~~h~nIv~l~~~~--~ 90 (361)
T 4f9c_A 20 SNVFKI-EDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS------HPIRIAAELQCLTVAGGQDNVMGVKYCF--R 90 (361)
T ss_dssp GGTCEE-EEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS------CHHHHHHHHHHHHHTCSBTTBCCCSEEE--E
T ss_pred cCcEEE-EEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc------CHHHHHHHHHHHHHhcCCCCCceEEEEE--E
Confidence 578877 566999999999999875 468999999886432 235678999999998 699999999988 4
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
+.+++|+|||||+||+|.+++ +.+++..++.|++||+.||+|||++| |+||||||+|||++.+.|.+||+|||+|
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ECCEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 578899999999999999988 46999999999999999999999999 9999999999999987689999999999
Q ss_pred hhhcCC-----------------------------CCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCC
Q 012320 182 AILRGS-----------------------------KSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEY 230 (466)
Q Consensus 182 ~~~~~~-----------------------------~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~ 230 (466)
+..... ....+.+||+.|||||++.+ .|+.++||||+||++|||++|..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 754321 12345689999999998754 48999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHhc--C-------------------CCC-------------------------------CCCCCCC
Q 012320 231 PYSECANPAQIYKKVTS--G-------------------KLP-------------------------------GAFYSIQ 258 (466)
Q Consensus 231 Pf~~~~~~~~i~~~i~~--g-------------------~~p-------------------------------~~~~~~~ 258 (466)
||....+..+....|.. | ..| ...+...
T Consensus 246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i 325 (361)
T 4f9c_A 246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV 325 (361)
T ss_dssp SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence 99776665544433321 0 000 1123456
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
++++++||.+||+ ||++||||+|+|+||||+..
T Consensus 326 s~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 326 PDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 7899999999996 99999999999999999753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-55 Score=469.49 Aligned_cols=257 Identities=24% Similarity=0.403 Sum_probs=228.8
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
++|.+. +.||+|+||+||+|.++.+|+.||+|++.+. .....+.+.+|+.+|+.|+|||||+++++| .+...+
T Consensus 157 ~~Y~i~-~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~--~~~~~~ 229 (573)
T 3uto_A 157 DHYDIH-EELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAF--EDDNEM 229 (573)
T ss_dssp GTEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEE--ECSSEE
T ss_pred cccEEE-EEEeeccCeEEEEEEECCCCCEEEEEEEecc----chhhHHHHHHHHHHHHhCCCCCCCeEEEEE--EECCEE
Confidence 678874 6699999999999999999999999998754 334567889999999999999999999998 557899
Q ss_pred EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC-CCcEEEeccchhhhh
Q 012320 107 NFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH-LGQVKIGDLGLAAIL 184 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~-~g~vKL~DFGla~~~ 184 (466)
|+|||||.||+|.+++.+ .+.+++..++.|++||+.||.|||+++ |+||||||+|||++.+ .|.+||+|||+|+.+
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 999999999999999864 468999999999999999999999999 9999999999999854 479999999999988
Q ss_pred cCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCCHH
Q 012320 185 RGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL--PGAFYSIQDLE 261 (466)
Q Consensus 185 ~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~~~~ 261 (466)
.......+.+||+.|||||++. ..|+.++|||||||++|+|++|..||.+ .+..+++..|..+.. +...+...+.+
T Consensus 308 ~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 386 (573)
T 3uto_A 308 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISED 386 (573)
T ss_dssp CTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred cCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 7777777889999999999876 4599999999999999999999999977 778888888888764 34445667899
Q ss_pred HHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 262 AQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 262 ~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
+++||.+||. ||.+|||+.|+|+||||+...+
T Consensus 387 ~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 387 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 9999999996 9999999999999999987544
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-54 Score=428.31 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=212.1
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEc-----CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEE
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDE-----VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWI 99 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 99 (466)
+-.+|.+ .+.||+|+||+||+|.+. .+|..||||+++.. +....+.+.+|+++|++++|||||++++++
T Consensus 11 ~r~~~~l-~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~- 84 (299)
T 4asz_A 11 KRHNIVL-KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVC- 84 (299)
T ss_dssp CGGGEEE-EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred CHHHeEE-eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC----ChHHHHHHHHHHHHHHhCCCCCCccEEEEE-
Confidence 3355655 677999999999999864 46899999998632 455668899999999999999999999987
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEE
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKY-------------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFV 166 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~-------------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv 166 (466)
.+.+.+++|||||+||+|.+++.+. ..+++..+..|+.||+.||.|||+++ |+||||||+|||+
T Consensus 85 -~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl 161 (299)
T 4asz_A 85 -VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLV 161 (299)
T ss_dssp -CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred -eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEE
Confidence 4567799999999999999999764 36999999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeccchhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHH
Q 012320 167 NGHLGQVKIGDLGLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQI 241 (466)
Q Consensus 167 ~~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i 241 (466)
+.+ +.+||+|||+|+....... ....+||+.|||||++. +.|+.++|||||||++|||+| |..||.+ .+..++
T Consensus 162 ~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~-~~~~~~ 239 (299)
T 4asz_A 162 GEN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ-LSNNEV 239 (299)
T ss_dssp CGG-GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHH
T ss_pred CCC-CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHH
Confidence 987 8999999999987643322 23457999999999876 679999999999999999999 8999987 677888
Q ss_pred HHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCC
Q 012320 242 YKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLA 289 (466)
Q Consensus 242 ~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~ 289 (466)
...+..|..+. .+...+.++.+|+.+||. ||++|||+.+++ +|++
T Consensus 240 ~~~i~~~~~~~-~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 240 IECITQGRVLQ-RPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp HHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred HHHHHcCCCCC-CCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence 99999887643 345678899999999996 999999999994 4543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-54 Score=428.19 Aligned_cols=248 Identities=28% Similarity=0.448 Sum_probs=206.1
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
+-..+.+ .+.||+|+||+||+|.++. .||||+++... .+....+.+.+|+.+|++++|||||++++++. +.
T Consensus 34 ~~~~l~l-~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~--~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~---~~ 104 (307)
T 3omv_A 34 EASEVML-STRIGSGSFGTVYKGKWHG---DVAVKILKVVD--PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT---KD 104 (307)
T ss_dssp CTTSCCE-EEECCCCSSSEEEEEESSS---EEEEEECCCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SS
T ss_pred cHHHeEE-eeEEeeCCCcEEEEEEECC---cEEEEEEEecC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE---CC
Confidence 3345554 6779999999999997643 59999986443 35667789999999999999999999999752 34
Q ss_pred EEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
.+++|||||+||+|.+++... +++++..+..|+.||+.||.|||+++ ||||||||+|||++.+ +.+||+|||+|+.
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~-~~~Ki~DFGla~~ 181 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEG-LTVKIGDFGLATV 181 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETT-EEEEECCCSSCBC
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCC-CcEEEeeccCcee
Confidence 588999999999999999764 57999999999999999999999999 9999999999999987 8999999999986
Q ss_pred hcC---CCCCccccCCCCcCCccccc----cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC---C
Q 012320 184 LRG---SKSAHSVIGTPEFMAPELYE----EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG---A 253 (466)
Q Consensus 184 ~~~---~~~~~~~~GT~~y~APE~l~----~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~---~ 253 (466)
... .....+.+||+.|||||++. +.|+.++|||||||++|||+||..||.+..+...+...+..+..++ .
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~ 261 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSK 261 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTT
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccc
Confidence 543 22345678999999999874 3489999999999999999999999988778888888887775443 2
Q ss_pred CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 254 FYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 254 ~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.+...+.++++||.+||. ||++|||+.|++.
T Consensus 262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 345567899999999996 9999999998753
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=428.03 Aligned_cols=244 Identities=24% Similarity=0.360 Sum_probs=203.0
Q ss_pred EeeeeeeeeCceEEEEEEEc-----CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 31 LFEEVLGKGAMKTVYKAIDE-----VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 31 ~~~~~LG~G~fg~Vyka~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.+.+.||+|+||+||+|..+ .+|..||||+++.. +....+.+.+|+++|++++|||||++++++ .+...
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~--~~~~~ 117 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTMLQHQHIVRFFGVC--TEGRP 117 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE--CSSSS
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE--EECCE
Confidence 44778999999999999864 47899999998632 455678899999999999999999999987 45677
Q ss_pred EEEEEecCCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCC
Q 012320 106 FNFITEMFTSGTLREYRKKY---------------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHL 170 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~---------------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~ 170 (466)
+++|||||++|+|.+++.+. +++++..+..|+.||+.||.|||+++ |+||||||+|||++.+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~~~- 194 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQG- 194 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT-
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEECCC-
Confidence 99999999999999999764 35899999999999999999999999 9999999999999987
Q ss_pred CcEEEeccchhhhhcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHH
Q 012320 171 GQVKIGDLGLAAILRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKV 245 (466)
Q Consensus 171 g~vKL~DFGla~~~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i 245 (466)
+.+||+|||+++.+.... .....+||+.|||||++. ..|+.++|||||||++|||+| |..||.+ .+..++...+
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~-~~~~~~~~~i 273 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ-LSNTEAIDCI 273 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-SCHHHHHHHH
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC-CCHHHHHHHH
Confidence 899999999998764332 234567999999999876 569999999999999999999 8999987 6677888888
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 246 TSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 246 ~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
..|..+. .+...++++.+|+.+||. ||++|||+.|++.+
T Consensus 274 ~~g~~~~-~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 274 TQGRELE-RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHTCCCC-CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HcCCCCC-CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 8886433 455678899999999996 99999999999753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=422.54 Aligned_cols=249 Identities=20% Similarity=0.261 Sum_probs=209.3
Q ss_pred CCceEEeeeeeeeeCceEEEEEEE-----cCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAID-----EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
-+.+.. .+.||+|+||+||+|.. ..+++.||||+++... .....+.+.+|+.+|++++|||||++++++
T Consensus 25 ~~~~~~-~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~g~~-- 98 (308)
T 4gt4_A 25 LSAVRF-MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA---EGPLREEFRHEAMLRARLQHPNVVCLLGVV-- 98 (308)
T ss_dssp GGGEEE-EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C---CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred HHHCeE-eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc---ChHHHHHHHHHHHHHHhCCCCCCCCcceEE--
Confidence 344544 56699999999999985 3578999999986432 223457899999999999999999999987
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcE
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKKY----------------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNI 164 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NI 164 (466)
.+...+++|||||++|+|.+++... ..+++..+..|+.||+.||+|||+++ ||||||||+||
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NI 176 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNV 176 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccce
Confidence 4466789999999999999999653 35899999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEeccchhhhhcCC---CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHH
Q 012320 165 FVNGHLGQVKIGDLGLAAILRGS---KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPA 239 (466)
Q Consensus 165 lv~~~~g~vKL~DFGla~~~~~~---~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~ 239 (466)
|++.+ +.+||+|||+++.+... ....+.+||+.|||||++. +.|+.++|||||||++|||+| |..||.+ .+..
T Consensus 177 Ll~~~-~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~-~~~~ 254 (308)
T 4gt4_A 177 LVYDK-LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQ 254 (308)
T ss_dssp EECGG-GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-CCHH
T ss_pred EECCC-CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC-CCHH
Confidence 99987 89999999999876432 2344568999999999775 679999999999999999998 8999987 6778
Q ss_pred HHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 240 QIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 240 ~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
++...+..+..++ .+...+.++.+|+.+|+. ||.+|||+.||+.+
T Consensus 255 ~~~~~i~~~~~~~-~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 255 DVVEMIRNRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8889998887544 345678899999999995 99999999999754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=425.12 Aligned_cols=253 Identities=24% Similarity=0.338 Sum_probs=214.1
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCC-----CeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCC-CceeEEEeE
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVL-----GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH-DSIIRFYTS 97 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~ 97 (466)
-|-++|.+ .+.||+|+||+||+|.+..+ ++.||+|.+.... .....+.+.+|+.+|++++| ||||+++++
T Consensus 61 i~~~~~~l-~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~---~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 61 FPRDRLKL-GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp CCGGGEEE-EEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ecHHHeEE-eeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---ChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 34567877 67799999999999987653 4789999886432 34556789999999999965 999999998
Q ss_pred EEeccCCEEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCC
Q 012320 98 WIDVDQKTFNFITEMFTSGTLREYRKKY----------------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKC 161 (466)
Q Consensus 98 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp 161 (466)
+.. +...+++|||||++|+|.+++++. ..+++..+..|+.||+.||+|||+++ ||||||||
T Consensus 137 ~~~-~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~ 213 (353)
T 4ase_A 137 CTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA 213 (353)
T ss_dssp ECC-TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EEe-cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCc
Confidence 743 345689999999999999999763 34899999999999999999999999 99999999
Q ss_pred CcEEEeCCCCcEEEeccchhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 012320 162 DNIFVNGHLGQVKIGDLGLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECA 236 (466)
Q Consensus 162 ~NIlv~~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~ 236 (466)
+|||++.+ +.+||+|||+|+.+..... ..+.+||+.|||||++. +.|+.++|||||||++|||+| |..||.+..
T Consensus 214 ~NILl~~~-~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 214 RNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGEEECGG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cceeeCCC-CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 99999987 8999999999987654332 23567999999999776 679999999999999999998 899998877
Q ss_pred CHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 237 NPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 237 ~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
....+.+.+..|..+. .+...++++.+++.+||. ||.+|||+.||++|
T Consensus 293 ~~~~~~~~i~~g~~~~-~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 293 IDEEFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CSHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 6778888888876443 445678899999999996 99999999999986
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=410.87 Aligned_cols=255 Identities=27% Similarity=0.491 Sum_probs=228.5
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+ .+.||+|+||+||+|.+..+|+.||+|++..... +....+++.+|+.+|+.++||||+++++++ .+.+.
T Consensus 14 ~~~y~~-~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~--~~~~~ 88 (328)
T 3fe3_A 14 IGNYRL-LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLFREVRIMKILNHPNIVKLFEVI--ETEKT 88 (328)
T ss_dssp ETTEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSSE
T ss_pred cCCEEE-EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE--EECCE
Confidence 478887 4669999999999999999999999999986543 556678899999999999999999999987 45778
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+|+||||++||+|.+++.+.+++++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDAD-MNIKIADFGFSNEFT 165 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECSTTCCGGGS
T ss_pred EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCC-CCEEEeeccCceecC
Confidence 9999999999999999998899999999999999999999999999 9999999999999877 899999999998877
Q ss_pred CCCCCccccCCCCcCCcccccc-CC-CChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 186 GSKSAHSVIGTPEFMAPELYEE-DY-NELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 186 ~~~~~~~~~GT~~y~APE~l~~-~y-~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
........+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+ .+..++...+..+..+. +...+.++.
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~--p~~~s~~~~ 242 (328)
T 3fe3_A 166 VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYRI--PFYMSTDCE 242 (328)
T ss_dssp SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCC--CTTSCHHHH
T ss_pred CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCC--CCCCCHHHH
Confidence 6666677899999999998764 45 4789999999999999999999976 77888888888887643 345688999
Q ss_pred HHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 264 RFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
+||.+||. ||.+|||++|+++||||+..
T Consensus 243 ~li~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 243 NLLKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp HHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred HHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 99999996 99999999999999999753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=396.44 Aligned_cols=271 Identities=49% Similarity=0.896 Sum_probs=240.7
Q ss_pred cceeeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeE
Q 012320 18 IGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTS 97 (466)
Q Consensus 18 ~~~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 97 (466)
...+..+.+++|+++.+.||+|+||+||+|.+..++..||+|.+..... +....+.+.+|+.+|++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 93 (290)
T 1t4h_A 16 TKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDS 93 (290)
T ss_dssp --CCEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhhhhcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh--CHHHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence 3456677889999999999999999999999999999999999886543 45667889999999999999999999998
Q ss_pred EEec--cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEE
Q 012320 98 WIDV--DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKI 175 (466)
Q Consensus 98 ~~~~--~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL 175 (466)
|... +...+++||||+++++|.+++.+.+.+++..++.|+.||+.||.|||+.+++|+||||||+|||++...+.+||
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl 173 (290)
T 1t4h_A 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKI 173 (290)
T ss_dssp EEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred eccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEE
Confidence 8653 35678999999999999999998899999999999999999999999998889999999999999855589999
Q ss_pred eccchhhhhcCCCCCccccCCCCcCCccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 012320 176 GDLGLAAILRGSKSAHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFY 255 (466)
Q Consensus 176 ~DFGla~~~~~~~~~~~~~GT~~y~APE~l~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~ 255 (466)
+|||++..... .......||+.|+|||++.+.++.++|||||||++|+|++|..||....+...++..+..+..+....
T Consensus 174 ~Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (290)
T 1t4h_A 174 GDLGLATLKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 252 (290)
T ss_dssp CCTTGGGGCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred eeCCCcccccc-cccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccC
Confidence 99999975443 33456679999999999998899999999999999999999999998889999999999888777777
Q ss_pred CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 256 ~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
...+++++++|.+||. ||.+|||+.++|+||||+..
T Consensus 253 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 7778899999999996 99999999999999999753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=411.49 Aligned_cols=265 Identities=25% Similarity=0.401 Sum_probs=230.5
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCH--HHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSP--DDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
.+-.++|.+ .+.||+|+||+||+|.++.+|+.||+|.+.+....... ...+.+.+|+.+|++++||||++++++|
T Consensus 8 ~~~~~~y~~-~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-- 84 (361)
T 2yab_A 8 QKVEDFYDI-GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-- 84 (361)
T ss_dssp SCGGGTEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE--
T ss_pred CChhhceEE-eeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE--
Confidence 344567877 67799999999999999999999999999876542221 1346789999999999999999999988
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCC---cEEEec
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLG---QVKIGD 177 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g---~vKL~D 177 (466)
.+...+++||||++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+.+ .+||+|
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 85 ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 457789999999999999999988889999999999999999999999999 999999999999986622 799999
Q ss_pred cchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC--CC
Q 012320 178 LGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG--AF 254 (466)
Q Consensus 178 FGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~--~~ 254 (466)
||++..+.........+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .+..+++..+..+.... ..
T Consensus 163 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~ 241 (361)
T 2yab_A 163 FGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITAVSYDFDEEF 241 (361)
T ss_dssp CSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCHHH
T ss_pred cCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCchh
Confidence 99998876666667788999999999876 4699999999999999999999999977 67788888888876533 23
Q ss_pred CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 255 YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 255 ~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
+...+.++++||.+||. ||.+|||+.|+|+||||+...+
T Consensus 242 ~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 281 (361)
T 2yab_A 242 FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT 281 (361)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence 45678899999999996 9999999999999999987554
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-51 Score=412.74 Aligned_cols=261 Identities=23% Similarity=0.426 Sum_probs=223.7
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCC
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 104 (466)
.++|.+ .++||+|+||+||+|.++.+|+.||+|++++.... .....+.+.+|+.+|+.+ +||||++++++| .+..
T Consensus 22 ~~~y~~-~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~--~~~~ 97 (353)
T 3txo_A 22 IDNFEF-IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLFCCF--QTPD 97 (353)
T ss_dssp -CCEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE--ECSS
T ss_pred hhheEE-EEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc-chhHHHHHHHHHHHHHhccCCCceeeEEEEE--EeCC
Confidence 467877 56799999999999999999999999999865421 223456788999999998 799999999988 5577
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.+|+||||+.||+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++.+ |.+||+|||+++..
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~-g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEG 174 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCS
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCC-CCEEEccccceeec
Confidence 89999999999999999999899999999999999999999999999 9999999999999877 89999999999764
Q ss_pred c-CCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 012320 185 R-GSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA 262 (466)
Q Consensus 185 ~-~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~ 262 (466)
. ......+.+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+..+++..+..+... ++...+.++
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~ 251 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVV--YPTWLHEDA 251 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHH
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHH
Confidence 3 333455678999999999876 4599999999999999999999999976 7888899999888754 345578899
Q ss_pred HHHHHHhcc-CcCCCCCH------HHHhcCCCCCchhhhhc
Q 012320 263 QRFIGRCLV-NASKRLSA------KELLLDPFLASDEVKLL 296 (466)
Q Consensus 263 ~~lI~~~L~-dp~~Rpsa------~elL~hpf~~~~~~~~~ 296 (466)
++||.+||. ||.+||++ .|+++||||+...|..+
T Consensus 252 ~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l 292 (353)
T 3txo_A 252 TGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQL 292 (353)
T ss_dssp HHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHH
T ss_pred HHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHH
Confidence 999999996 99999999 89999999999888654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=416.14 Aligned_cols=263 Identities=21% Similarity=0.391 Sum_probs=225.6
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCC
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 104 (466)
..+|.+ .++||+|+||+||+|.++.+|+.||+|++++.... .....+.+.+|+.+|+++ +||||++++++| .+..
T Consensus 51 ~~~y~~-~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~--~~~~ 126 (396)
T 4dc2_A 51 LQDFDL-LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCF--QTES 126 (396)
T ss_dssp GGGEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----CCHHHHHHHHHHHHTTCTTBCCEEEEE--ECSS
T ss_pred hhHcEE-EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE--EECC
Confidence 357877 56799999999999999999999999999876542 334556788999999887 899999999988 4577
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.+|+||||+.||+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ |.+||+|||+++..
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~-g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCC
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCC-CCEEEeecceeeec
Confidence 89999999999999999999899999999999999999999999999 9999999999999987 89999999999763
Q ss_pred -cCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCC--------CCHHHHHHHHhcCCCCCCC
Q 012320 185 -RGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSEC--------ANPAQIYKKVTSGKLPGAF 254 (466)
Q Consensus 185 -~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~--------~~~~~i~~~i~~g~~p~~~ 254 (466)
.......+.+||+.|+|||++. ..|+.++|||||||++|+|++|..||... .....+++.+..+.+. +
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--~ 281 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--I 281 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC--C
T ss_pred ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC--C
Confidence 3445566789999999999876 56999999999999999999999999532 2345577777776643 4
Q ss_pred CCCCCHHHHHHHHHhcc-CcCCCCCH------HHHhcCCCCCchhhhhcc
Q 012320 255 YSIQDLEAQRFIGRCLV-NASKRLSA------KELLLDPFLASDEVKLLS 297 (466)
Q Consensus 255 ~~~~~~~~~~lI~~~L~-dp~~Rpsa------~elL~hpf~~~~~~~~~~ 297 (466)
+...+.++++||.+||. ||.+||++ .|+++||||+..+|..+.
T Consensus 282 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~ 331 (396)
T 4dc2_A 282 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMME 331 (396)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHH
T ss_pred CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHH
Confidence 45678899999999996 99999995 799999999998886544
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-51 Score=404.46 Aligned_cols=248 Identities=24% Similarity=0.337 Sum_probs=193.7
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC--CE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ--KT 105 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~--~~ 105 (466)
|...+++.||+|+||+||+|.+ +|+.||||+++... ........|+..+.+++|||||++++++.+.+. ..
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 4456688899999999999976 59999999986432 122233456667778999999999999876543 36
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSR------DPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~------~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
+|+|||||+||+|.+++.+ ..+++..+..++.|++.||.|||++ .++|+||||||+|||++.+ +.+||+|||
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~-~~~Ki~DFG 153 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLG 153 (303)
T ss_dssp EEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT-SCEEECCCT
T ss_pred EEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC-CCEEEEeCC
Confidence 8999999999999999976 5789999999999999999999987 2349999999999999987 899999999
Q ss_pred hhhhhcCCC-----CCccccCCCCcCCcccccc-------CCCChhhHHHHHHHHHHHHhCCCCCCC-------------
Q 012320 180 LAAILRGSK-----SAHSVIGTPEFMAPELYEE-------DYNELVDVYSFGMCVLEMFTCEYPYSE------------- 234 (466)
Q Consensus 180 la~~~~~~~-----~~~~~~GT~~y~APE~l~~-------~y~~~~DIwSlGvil~elltg~~Pf~~------------- 234 (466)
+|+...... ...+.+||+.|||||++.+ .|+.++|||||||++|||+||..||..
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 998765432 2234689999999998864 367899999999999999999766532
Q ss_pred -CCCHHHHHHHHhcCCCCCCCCCCC-----CHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 235 -CANPAQIYKKVTSGKLPGAFYSIQ-----DLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 235 -~~~~~~i~~~i~~g~~p~~~~~~~-----~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.....++.+.+..+.+.+..+... ...+.+|+.+||. ||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 123456666666655543333221 2367899999996 9999999999985
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=407.38 Aligned_cols=261 Identities=24% Similarity=0.421 Sum_probs=228.4
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+ .++||+|+||+||+|.++.+|+.||+|++++.... .......+.+|+.+|+.++||||+++++++ .+...
T Consensus 4 ~~~y~~-~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~--~~~~~ 79 (337)
T 1o6l_A 4 MNDFDY-LKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAF--QTHDR 79 (337)
T ss_dssp GGGEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEE--ECSSE
T ss_pred hHHeEE-EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhCCCCcCcceEEEE--EeCCE
Confidence 357877 46799999999999999999999999999865431 122456788999999999999999999988 45778
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ |.+||+|||+++...
T Consensus 80 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCC-CCEEEeeccchhhcc
Confidence 9999999999999999998899999999999999999999999999 9999999999999877 899999999997643
Q ss_pred -CCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 186 -GSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 186 -~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
......+.+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+...+++.+..+... ++...+.+++
T Consensus 157 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~ 233 (337)
T 1o6l_A 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIR--FPRTLSPEAK 233 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHH
T ss_pred cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHH
Confidence 334456788999999999876 4699999999999999999999999976 6778888888877643 3456788999
Q ss_pred HHHHHhcc-CcCCCC-----CHHHHhcCCCCCchhhhhc
Q 012320 264 RFIGRCLV-NASKRL-----SAKELLLDPFLASDEVKLL 296 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rp-----sa~elL~hpf~~~~~~~~~ 296 (466)
+||.+||. ||.+|| +++|+++||||+...|..+
T Consensus 234 ~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~ 272 (337)
T 1o6l_A 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272 (337)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHH
Confidence 99999996 999999 8999999999999887654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=400.88 Aligned_cols=257 Identities=23% Similarity=0.361 Sum_probs=224.1
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
-.++|.+ .+.||+|+||+||+|.++.+|+.||+|.+... ......+.+|+.+|+.++||||+++++++ .+..
T Consensus 3 ~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~--~~~~ 74 (321)
T 1tki_A 3 LYEKYMI-AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESF--ESME 74 (321)
T ss_dssp CTTTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEE--EETT
T ss_pred hhhceEe-eeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHHHHHHHHHHHhCCCCCCCeEeEEE--ecCC
Confidence 3578887 56699999999999999999999999998633 23456789999999999999999999988 4467
Q ss_pred EEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC-CCcEEEeccchhh
Q 012320 105 TFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH-LGQVKIGDLGLAA 182 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~-~g~vKL~DFGla~ 182 (466)
.+++||||++||+|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++.. .+.+||+|||++.
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence 899999999999999999765 47999999999999999999999999 9999999999999863 4799999999998
Q ss_pred hhcCCCCCccccCCCCcCCccccccC-CCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCCC
Q 012320 183 ILRGSKSAHSVIGTPEFMAPELYEED-YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA--FYSIQD 259 (466)
Q Consensus 183 ~~~~~~~~~~~~GT~~y~APE~l~~~-y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~--~~~~~~ 259 (466)
.+..........||+.|+|||++.+. ++.++|||||||++|+|++|..||.. .+..++...+..+..+.. .+...+
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s 231 (321)
T 1tki_A 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEIS 231 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred ECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHcCCCCCChhhhccCC
Confidence 87666556677899999999988754 79999999999999999999999977 677788888887765432 234567
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
.++++||.+||. ||.+|||+.|+|+||||+...
T Consensus 232 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 899999999996 999999999999999997643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=400.18 Aligned_cols=262 Identities=21% Similarity=0.388 Sum_probs=226.9
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCC
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 104 (466)
.++|.+ .++||+|+||+||+|.++.+|+.||+|++.+... ......+.+.+|+.+++++ +||||++++++| .+..
T Consensus 8 ~~~y~~-~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~--~~~~ 83 (345)
T 3a8x_A 8 LQDFDL-LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF--QTES 83 (345)
T ss_dssp GGGEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS-CSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE--ECSS
T ss_pred hhheEE-EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh-cchHHHHHHHHHHHHHHhcCCCCccCeEEEEE--EeCC
Confidence 467877 5679999999999999999999999999986653 3455677889999999988 899999999988 4577
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ |.+||+|||+++..
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEG 160 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCGGGCBCS
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCC-CCEEEEeccccccc
Confidence 89999999999999999998899999999999999999999999999 9999999999999877 89999999999764
Q ss_pred c-CCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCC--------CCHHHHHHHHhcCCCCCCC
Q 012320 185 R-GSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSEC--------ANPAQIYKKVTSGKLPGAF 254 (466)
Q Consensus 185 ~-~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~--------~~~~~i~~~i~~g~~p~~~ 254 (466)
. ......+.+||+.|+|||++. ..|+.++|||||||++|+|++|..||... .+...+++.+..+..+ +
T Consensus 161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--~ 238 (345)
T 3a8x_A 161 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--I 238 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC--C
T ss_pred cCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC--C
Confidence 3 334456778999999999876 46999999999999999999999999642 3445667777766543 3
Q ss_pred CCCCCHHHHHHHHHhcc-CcCCCCCH------HHHhcCCCCCchhhhhc
Q 012320 255 YSIQDLEAQRFIGRCLV-NASKRLSA------KELLLDPFLASDEVKLL 296 (466)
Q Consensus 255 ~~~~~~~~~~lI~~~L~-dp~~Rpsa------~elL~hpf~~~~~~~~~ 296 (466)
+...+.++++||.+||. ||.+||++ .++++||||+...|..+
T Consensus 239 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~ 287 (345)
T 3a8x_A 239 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM 287 (345)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHH
T ss_pred CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHH
Confidence 45678899999999996 99999996 79999999998887544
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-50 Score=394.40 Aligned_cols=259 Identities=32% Similarity=0.508 Sum_probs=221.4
Q ss_pred eeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 22 ~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
..++.++|.++ +.||+|+||+||+|.+..+|+.||+|++..... ...+.+.+|+.++++++||||+++++.+.
T Consensus 15 ~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-- 87 (297)
T 3fxz_A 15 VGDPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYL-- 87 (297)
T ss_dssp SSCGGGTBCCC-EEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred cCChhhceeee-eeeccCCCeEEEEEEECCCCcEEEEEEeecccc----cHHHHHHHHHHHHhcCCCCCCCeEeEEEE--
Confidence 34678899885 569999999999999999999999999876543 12456889999999999999999999885
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
....+++||||+.||+|.+++.+ ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ |.+||+|||++
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~ 163 (297)
T 3fxz_A 88 VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFC 163 (297)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTC
T ss_pred ECCEEEEEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCC-CCEEEeeCCCc
Confidence 46789999999999999999976 47999999999999999999999999 9999999999999877 89999999998
Q ss_pred hhhcCC-CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 012320 182 AILRGS-KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259 (466)
Q Consensus 182 ~~~~~~-~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 259 (466)
...... ......+||+.|+|||++. ..|+.++|||||||++|+|++|..||........+......+......+...+
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (297)
T 3fxz_A 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243 (297)
T ss_dssp EECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSC
T ss_pred eecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccC
Confidence 776533 2345568999999999876 56999999999999999999999999875444445544444544444556678
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
..+++||.+||. ||.+|||+.|+|+||||+..
T Consensus 244 ~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 244 AIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 899999999996 99999999999999999753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=405.51 Aligned_cols=263 Identities=24% Similarity=0.444 Sum_probs=228.5
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 103 (466)
..++|.+ .++||+|+||+||+|.++.+|+.||+|++++..... ....+.+..|..+|+.+ +||||+++++++ .+.
T Consensus 15 ~~~~y~~-~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~iv~l~~~~--~~~ 90 (345)
T 1xjd_A 15 KIEDFIL-HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTF--QTK 90 (345)
T ss_dssp -CTTEEE-EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEE--ECS
T ss_pred ChHHeEE-EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh-hhhHHHHHHHHHHHHhcCCCCCCCcEEEEE--EeC
Confidence 3577877 577999999999999999999999999998654321 12346678899999987 999999999988 457
Q ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 104 KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
..+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ |.+||+|||+++.
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKD-GHIKIADFGMCKE 167 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCC-CCEEEeEChhhhh
Confidence 789999999999999999998899999999999999999999999999 9999999999999877 8999999999976
Q ss_pred hc-CCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 012320 184 LR-GSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLE 261 (466)
Q Consensus 184 ~~-~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 261 (466)
.. ......+.+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+..+++..+..+... ++...+.+
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~ 244 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNPF--YPRWLEKE 244 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHH
T ss_pred cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhCCCC--CCcccCHH
Confidence 43 233456788999999999876 4699999999999999999999999976 6788888888877643 34567889
Q ss_pred HHHHHHHhcc-CcCCCCCHH-HHhcCCCCCchhhhhcc
Q 012320 262 AQRFIGRCLV-NASKRLSAK-ELLLDPFLASDEVKLLS 297 (466)
Q Consensus 262 ~~~lI~~~L~-dp~~Rpsa~-elL~hpf~~~~~~~~~~ 297 (466)
+++||.+||. ||.+||++. ++++||||+...|..+.
T Consensus 245 ~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~ 282 (345)
T 1xjd_A 245 AKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELE 282 (345)
T ss_dssp HHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHH
T ss_pred HHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHHh
Confidence 9999999996 999999998 99999999998886543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=397.88 Aligned_cols=259 Identities=26% Similarity=0.453 Sum_probs=226.7
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+ .++||+|+||+||+|.++.+|+.||+|++.+..... ....+.+.+|+.+|+.++||||+++++++ .+...
T Consensus 5 ~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~--~~~~~ 80 (318)
T 1fot_A 5 LQDFQI-LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMWGTF--QDAQQ 80 (318)
T ss_dssp GGGEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCBTTBCCEEEEE--ECSSE
T ss_pred hHHcEE-EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhhCCCCCCceEeEEE--EeCCE
Confidence 357877 466999999999999999999999999998654321 12346788999999999999999999988 45778
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ |.+||+|||+++...
T Consensus 81 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN-GHIKITDFGFAKYVP 157 (318)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTT-SCEEECCCSSCEECS
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCC-CCEEEeecCcceecC
Confidence 9999999999999999999899999999999999999999999999 9999999999999877 899999999997654
Q ss_pred CCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 012320 186 GSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQR 264 (466)
Q Consensus 186 ~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~ 264 (466)
. ...+.+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+...++..+..+... ++...+.++++
T Consensus 158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~ 232 (318)
T 1fot_A 158 D--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAELR--FPPFFNEDVKD 232 (318)
T ss_dssp S--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHH
T ss_pred C--ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCCCCCHHHHH
Confidence 3 345678999999999876 5699999999999999999999999976 6777888888877653 34567889999
Q ss_pred HHHHhcc-CcCCCC-----CHHHHhcCCCCCchhhhhc
Q 012320 265 FIGRCLV-NASKRL-----SAKELLLDPFLASDEVKLL 296 (466)
Q Consensus 265 lI~~~L~-dp~~Rp-----sa~elL~hpf~~~~~~~~~ 296 (466)
+|.+||. ||.+|| +++++++||||+...|..+
T Consensus 233 li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~ 270 (318)
T 1fot_A 233 LLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 270 (318)
T ss_dssp HHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHH
T ss_pred HHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHH
Confidence 9999996 999999 9999999999998887554
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=404.70 Aligned_cols=258 Identities=26% Similarity=0.468 Sum_probs=227.6
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+ .+.||+|+||+||+|.++.+|+.||+|++..... .....+.+.+|+.+|++++||||+++++++ .+...
T Consensus 28 ~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~--~~~~~ 102 (362)
T 2bdw_A 28 SDNYDV-KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSI--QEESF 102 (362)
T ss_dssp HHHEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSSE
T ss_pred ccCeEE-eeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE--EeCCE
Confidence 357877 5679999999999999999999999999986543 455678899999999999999999999987 45778
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC--CCcEEEeccchhhh
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAAI 183 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~--~g~vKL~DFGla~~ 183 (466)
+|+||||+.||+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ .+.+||+|||++..
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 9999999999999999988888999999999999999999999999 9999999999999764 24699999999987
Q ss_pred hcCCCCCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCCH
Q 012320 184 LRGSKSAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP--GAFYSIQDL 260 (466)
Q Consensus 184 ~~~~~~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~~~~ 260 (466)
..........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+...++..+..+... ...+...+.
T Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~ 259 (362)
T 2bdw_A 181 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTP 259 (362)
T ss_dssp CTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTGGGGSCH
T ss_pred ecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 766555667889999999998764 699999999999999999999999976 6778888888887653 333456788
Q ss_pred HHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 261 EAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 261 ~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
++++||.+||. ||.+|||+.++|+||||+..
T Consensus 260 ~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 260 EAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 99999999996 99999999999999999754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=412.17 Aligned_cols=258 Identities=27% Similarity=0.442 Sum_probs=225.1
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+ .+.||+|+||+||+|.++.+|+.||+|++..... .....+.+.+|+.+|+.++||||+++++.+ .+...
T Consensus 10 ~~~Y~i-~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~--~~~~~ 84 (444)
T 3soa_A 10 TEEYQL-FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKHPNIVRLHDSI--SEEGH 84 (444)
T ss_dssp HHHEEE-EEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC--HHHHHHHHHHHHHHHHHCCBTTBCCEEEEE--ECSSE
T ss_pred cCCeEE-EEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCcCCCeEEEEE--EECCE
Confidence 467877 5669999999999999999999999999986553 344567899999999999999999999987 45788
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC--CCcEEEeccchhhh
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAAI 183 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~--~g~vKL~DFGla~~ 183 (466)
+|+||||+.||+|.+++...+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ .+.+||+|||++..
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 9999999999999999999899999999999999999999999999 9999999999999852 37899999999977
Q ss_pred hcCCC-CCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCC
Q 012320 184 LRGSK-SAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP--GAFYSIQD 259 (466)
Q Consensus 184 ~~~~~-~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~~~ 259 (466)
..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+...++..+..+... ...+...+
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s 241 (444)
T 3soa_A 163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVT 241 (444)
T ss_dssp CCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred ecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHhCCCCCCccccccCC
Confidence 65432 3456789999999998875 699999999999999999999999976 7788888888887653 34445678
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
+++++||.+||. ||.+|||+.|+|+||||+..
T Consensus 242 ~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 242 PEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 999999999996 99999999999999999754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=401.56 Aligned_cols=260 Identities=23% Similarity=0.418 Sum_probs=229.0
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
..++|.+ .+.||+|+||+||+|.++.+|+.||+|++.+.... .....+.+.+|+.+|+.++||||+++++++ .+..
T Consensus 39 ~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~ 114 (350)
T 1rdq_E 39 QLDQFDR-IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSF--KDNS 114 (350)
T ss_dssp CGGGEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSS
T ss_pred CHHHCEE-EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhc-cHHHHHHHHHHHHHHHhCCCCCCCeEEEEE--EcCC
Confidence 3478887 46699999999999999999999999999765432 112456788999999999999999999988 4577
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ |.+||+|||+++..
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCC-CCEEEcccccceec
Confidence 89999999999999999999899999999999999999999999999 9999999999999877 89999999999865
Q ss_pred cCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 185 RGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 185 ~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
.. ...+.+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+..+++..+..+..+ ++...+.+++
T Consensus 192 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~ 266 (350)
T 1rdq_E 192 KG--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKVR--FPSHFSSDLK 266 (350)
T ss_dssp SS--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTCCHHHH
T ss_pred cC--CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHH
Confidence 43 234678999999999775 5699999999999999999999999976 6788899999888753 3456788999
Q ss_pred HHHHHhcc-CcCCCCC-----HHHHhcCCCCCchhhhhc
Q 012320 264 RFIGRCLV-NASKRLS-----AKELLLDPFLASDEVKLL 296 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rps-----a~elL~hpf~~~~~~~~~ 296 (466)
++|.+||. ||.+||+ ++++++||||+..+|..+
T Consensus 267 ~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~ 305 (350)
T 1rdq_E 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHH
T ss_pred HHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHH
Confidence 99999996 9999998 999999999999888554
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=402.62 Aligned_cols=261 Identities=21% Similarity=0.374 Sum_probs=228.1
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCC
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 104 (466)
.++|.+ .++||+|+||+||+|.++.+|+.||+|++++..... ....+.+..|..+|+.+ +||||++++++| .+..
T Consensus 19 ~~~y~~-~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~--~~~~ 94 (353)
T 2i0e_A 19 LTDFNF-LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCF--QTMD 94 (353)
T ss_dssp CTTEEE-EEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTCTTCCTTBCCEEEEE--ECSS
T ss_pred hHHcEE-EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc-chHHHHHHHHHHHHHhcCCCCEEeeEEEEE--EcCC
Confidence 467877 567999999999999999999999999998654321 22456788999999988 899999999988 4577
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ |.+||+|||+++..
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKEN 171 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCC-CcEEEEeCCccccc
Confidence 89999999999999999998899999999999999999999999999 9999999999999877 89999999999764
Q ss_pred c-CCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 012320 185 R-GSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA 262 (466)
Q Consensus 185 ~-~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~ 262 (466)
. ......+.+||+.|+|||++. ..|+.++|||||||++|||++|..||.. .+..++++.+..+... ++...+.++
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~ 248 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVA--YPKSMSKEA 248 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHH
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCCC--CCCCCCHHH
Confidence 3 334456788999999999876 5699999999999999999999999976 7788888888887653 345678899
Q ss_pred HHHHHHhcc-CcCCCCC-----HHHHhcCCCCCchhhhhc
Q 012320 263 QRFIGRCLV-NASKRLS-----AKELLLDPFLASDEVKLL 296 (466)
Q Consensus 263 ~~lI~~~L~-dp~~Rps-----a~elL~hpf~~~~~~~~~ 296 (466)
++||.+||. ||.+||+ ++++++||||+...|..+
T Consensus 249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l 288 (353)
T 2i0e_A 249 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 288 (353)
T ss_dssp HHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHH
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHH
Confidence 999999996 9999995 699999999998888654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=394.71 Aligned_cols=262 Identities=24% Similarity=0.412 Sum_probs=225.0
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCH--HHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSP--DDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
..++|.+ .+.||+|+||+||+|.++.+|..||+|.+......... ...+.+.+|+.+|++++||||+++++++ .+
T Consensus 9 ~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~ 85 (326)
T 2y0a_A 9 VDDYYDT-GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY--EN 85 (326)
T ss_dssp HHHHEEE-EEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE--EC
T ss_pred cccceEe-ceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE--Ee
Confidence 3456766 67799999999999999999999999999866532211 1356789999999999999999999988 45
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCC----cEEEecc
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLG----QVKIGDL 178 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g----~vKL~DF 178 (466)
...+++||||+.|++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ + .+||+||
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~-~~~~~~~kl~Df 162 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDR-NVPKPRIKIIDF 162 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCS-SSSSCCEEECCC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecC-CCCCCCEEEEEC
Confidence 7789999999999999999988889999999999999999999999999 9999999999999866 4 7999999
Q ss_pred chhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC--CCC
Q 012320 179 GLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG--AFY 255 (466)
Q Consensus 179 Gla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~--~~~ 255 (466)
|++............+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+..+....+....... ..+
T Consensus 163 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~ 241 (326)
T 2y0a_A 163 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYF 241 (326)
T ss_dssp TTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHTCCCCCHHHH
T ss_pred CCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHHhcCCCcCcccc
Confidence 9998776555566778999999999876 5699999999999999999999999976 56666777776654432 223
Q ss_pred CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 256 ~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
...+..+++||.+||. ||.+|||+.|+|+||||+....
T Consensus 242 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 280 (326)
T 2y0a_A 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280 (326)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence 4567899999999996 9999999999999999987554
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=427.85 Aligned_cols=258 Identities=26% Similarity=0.448 Sum_probs=223.3
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
++|.+ .+.||+|+||+||+|.++.+|..||+|++.+.... ......+.+|+.+|+.++||||++++++| .+...+
T Consensus 37 ~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~--~~~~~~ 111 (494)
T 3lij_A 37 EMYQR-VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS--TSSNSKLLEEVAVLKLLDHPNIMKLYDFF--EDKRNY 111 (494)
T ss_dssp HHEEE-EEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSEE
T ss_pred cCeEE-eeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC--chHHHHHHHHHHHHHhCCCCCCCeEEEEE--EeCCEE
Confidence 47877 56699999999999999999999999999865432 22346789999999999999999999988 457789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC--CCcEEEeccchhhhh
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAAIL 184 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~--~g~vKL~DFGla~~~ 184 (466)
|+|||||.||+|.+++.+...+++..++.+++||+.||.|||++| |+||||||+|||++.. .+.+||+|||++...
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999999999999988899999999999999999999999999 9999999999999754 356999999999887
Q ss_pred cCCCCCccccCCCCcCCccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCCCHHH
Q 012320 185 RGSKSAHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA--FYSIQDLEA 262 (466)
Q Consensus 185 ~~~~~~~~~~GT~~y~APE~l~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~--~~~~~~~~~ 262 (466)
.........+||+.|+|||++.+.|+.++|||||||++|+|++|..||.. .+..++...+..+..+.. .+...+.++
T Consensus 190 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 268 (494)
T 3lij_A 190 ENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGG-QTDQEILRKVEKGKYTFDSPEWKNVSEGA 268 (494)
T ss_dssp BTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCSGGGTTSCHHH
T ss_pred CCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCchhcccCCHHH
Confidence 76666667889999999999988899999999999999999999999977 677888888888876433 345678899
Q ss_pred HHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 263 QRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 263 ~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
++||.+||. ||.+|||+.|+|+||||+...
T Consensus 269 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 269 KDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred HHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 999999996 999999999999999997643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=403.57 Aligned_cols=263 Identities=21% Similarity=0.401 Sum_probs=228.7
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+ .++||+|+||+||+|.++.+|+.||+|.+.+.... .......+.+|+.+|+.++||||++++++| .+...
T Consensus 14 ~~~y~i-~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~--~~~~~ 89 (384)
T 4fr4_A 14 FDHFEI-LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV-ERNEVRNVFKELQIMQGLEHPFLVNLWYSF--QDEED 89 (384)
T ss_dssp GGGEEE-EEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEE--ECSSE
T ss_pred hHHeEE-EEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcc-cHHHHHHHHHHHHHHHhCCCCCCCcEEEEE--EeCCE
Confidence 467877 56699999999999999999999999999865432 122456788999999999999999999988 45778
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+|+||||+.||+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++.+ |.+||+|||++..+.
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEH-GHVHITDFNIAAMLP 166 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCC-CCEEEeccceeeecc
Confidence 9999999999999999999889999999999999999999999999 9999999999999877 899999999998876
Q ss_pred CCCCCccccCCCCcCCccccc----cCCCChhhHHHHHHHHHHHHhCCCCCCC--CCCHHHHHHHHhcCCCCCCCCCCCC
Q 012320 186 GSKSAHSVIGTPEFMAPELYE----EDYNELVDVYSFGMCVLEMFTCEYPYSE--CANPAQIYKKVTSGKLPGAFYSIQD 259 (466)
Q Consensus 186 ~~~~~~~~~GT~~y~APE~l~----~~y~~~~DIwSlGvil~elltg~~Pf~~--~~~~~~i~~~i~~g~~p~~~~~~~~ 259 (466)
......+.+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. ......+...+.....+ ++...+
T Consensus 167 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~p~~~s 244 (384)
T 4fr4_A 167 RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT--YPSAWS 244 (384)
T ss_dssp TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC--CCTTSC
T ss_pred CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccC--CCCcCC
Confidence 666677889999999999875 3489999999999999999999999964 24556666766665543 345578
Q ss_pred HHHHHHHHHhcc-CcCCCCC-HHHHhcCCCCCchhhhhcc
Q 012320 260 LEAQRFIGRCLV-NASKRLS-AKELLLDPFLASDEVKLLS 297 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rps-a~elL~hpf~~~~~~~~~~ 297 (466)
.++++||.+||. ||.+||+ ++++++||||....|..+.
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~ 284 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVF 284 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHH
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHH
Confidence 899999999996 9999998 8999999999998886543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=412.03 Aligned_cols=262 Identities=20% Similarity=0.356 Sum_probs=222.6
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
..++|.+ .++||+|+||+||+|.++.+|+.||+|++.+..... ....+.+.+|+.+|+.++||||++++++| .+..
T Consensus 67 ~~~~y~~-~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~--~~~~ 142 (410)
T 3v8s_A 67 KAEDYEV-VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAF--QDDR 142 (410)
T ss_dssp CGGGEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TCCCSTHHHHHHHHHHCCCTTBCCEEEEE--ECSS
T ss_pred CccccEE-EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEE--EECC
Confidence 3567877 567999999999999999999999999997643211 11224578899999999999999999988 4578
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.+|+||||++||+|.+++.+ ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ |.+||+|||+++..
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~-g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKM 218 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCC-CCEEEeccceeEee
Confidence 89999999999999999876 57999999999999999999999999 9999999999999877 89999999999776
Q ss_pred cCCC--CCccccCCCCcCCcccccc-C----CCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--CCCCCC
Q 012320 185 RGSK--SAHSVIGTPEFMAPELYEE-D----YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK--LPGAFY 255 (466)
Q Consensus 185 ~~~~--~~~~~~GT~~y~APE~l~~-~----y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~--~p~~~~ 255 (466)
.... ...+.+||+.|+|||++.+ . |+.++|||||||++|+|++|..||.. .+...++.+|..+. ++....
T Consensus 219 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~ 297 (410)
T 3v8s_A 219 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDD 297 (410)
T ss_dssp CTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCTT
T ss_pred ccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC-CChhhHHHHHHhccccccCCCc
Confidence 5433 2346789999999998753 2 78999999999999999999999976 77888888887653 222333
Q ss_pred CCCCHHHHHHHHHhcc-CcCC--CCCHHHHhcCCCCCchhhhh
Q 012320 256 SIQDLEAQRFIGRCLV-NASK--RLSAKELLLDPFLASDEVKL 295 (466)
Q Consensus 256 ~~~~~~~~~lI~~~L~-dp~~--Rpsa~elL~hpf~~~~~~~~ 295 (466)
...+.++++||.+||. +|.+ |++++|+++||||+...|..
T Consensus 298 ~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~ 340 (410)
T 3v8s_A 298 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAW 340 (410)
T ss_dssp CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCS
T ss_pred ccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHH
Confidence 4578899999999997 6777 99999999999999887753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=411.67 Aligned_cols=263 Identities=22% Similarity=0.376 Sum_probs=222.2
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+ .++||+|+||+||+|.++.+|+.||+|++.+.... .....+.+.+|+.+|+.++||||++++++| .+...
T Consensus 60 ~~~f~~-~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~-~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~--~~~~~ 135 (412)
T 2vd5_A 60 RDDFEI-LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML-KRGEVSCFREERDVLVNGDRRWITQLHFAF--QDENY 135 (412)
T ss_dssp GGGEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HHGGGCCHHHHHHHHHHSCTTTBCCEEEEE--ECSSE
T ss_pred hhhEEE-EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhcCCCCeeeEEEEE--eeCCE
Confidence 467877 56799999999999999999999999999754321 122334578899999999999999999988 55778
Q ss_pred EEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 106 FNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
+|+||||++||+|.+++.+.+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |++||+|||+++.+
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~-g~vkL~DFGla~~~ 212 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRC-GHIRLADFGSCLKL 212 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEEC
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCC-CCEEEeechhheec
Confidence 999999999999999998764 7999999999999999999999999 9999999999999977 89999999999876
Q ss_pred cCCCC--CccccCCCCcCCccccc--------cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--CC-
Q 012320 185 RGSKS--AHSVIGTPEFMAPELYE--------EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK--LP- 251 (466)
Q Consensus 185 ~~~~~--~~~~~GT~~y~APE~l~--------~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~--~p- 251 (466)
..... ....+||+.|+|||++. ..|+.++|||||||++|||++|..||.. .+..+++.+|.... +.
T Consensus 213 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~ 291 (412)
T 2vd5_A 213 RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSL 291 (412)
T ss_dssp CTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCC
T ss_pred cCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCcCC
Confidence 54332 33568999999999875 3589999999999999999999999976 67777887776532 11
Q ss_pred CCCCCCCCHHHHHHHHHhccCcCCC---CCHHHHhcCCCCCchhhhhc
Q 012320 252 GAFYSIQDLEAQRFIGRCLVNASKR---LSAKELLLDPFLASDEVKLL 296 (466)
Q Consensus 252 ~~~~~~~~~~~~~lI~~~L~dp~~R---psa~elL~hpf~~~~~~~~~ 296 (466)
+......+.++++||.+||.+|.+| ++++|+++||||+..+|..+
T Consensus 292 p~~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 292 PLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp C----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred CccccCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 1123457889999999999988887 59999999999998888654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=414.38 Aligned_cols=262 Identities=19% Similarity=0.358 Sum_probs=222.0
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+ .++||+|+||+||+|.++.+|+.||+|++.+..... ......+.+|+.+|+.++||||++++++| .+...
T Consensus 73 ~~~y~~-~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~--~~~~~ 148 (437)
T 4aw2_A 73 REDFEI-LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDSKWITTLHYAF--QDDNN 148 (437)
T ss_dssp GGGEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTTTCCHHHHHHHHHHSCTTTBCCEEEEE--ECSSE
T ss_pred hhheEE-EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh-HHHHHHHHHHHHHHHhCCCCCEEEEEEEE--eeCCE
Confidence 467877 577999999999999999999999999997543211 11223478899999999999999999988 45778
Q ss_pred EEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 106 FNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
+|+||||+.||+|.+++.+ .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+++..
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~-g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMN-GHIRLADFGSCLKL 225 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCC-CCEEEcchhhhhhc
Confidence 9999999999999999987 478999999999999999999999999 9999999999999977 89999999999766
Q ss_pred cCCCC--CccccCCCCcCCccccc------cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----CCC
Q 012320 185 RGSKS--AHSVIGTPEFMAPELYE------EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK----LPG 252 (466)
Q Consensus 185 ~~~~~--~~~~~GT~~y~APE~l~------~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~----~p~ 252 (466)
..... ....+||+.|+|||++. +.|+.++|||||||++|||++|..||.. .+..+++.++.... +|.
T Consensus 226 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~ 304 (437)
T 4aw2_A 226 MEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPT 304 (437)
T ss_dssp CTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCS
T ss_pred ccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC-CChhHHHHhhhhccccccCCc
Confidence 44332 33468999999999875 3589999999999999999999999976 67777887776532 232
Q ss_pred CCCCCCCHHHHHHHHHhcc-CcCC--CCCHHHHhcCCCCCchhhhhc
Q 012320 253 AFYSIQDLEAQRFIGRCLV-NASK--RLSAKELLLDPFLASDEVKLL 296 (466)
Q Consensus 253 ~~~~~~~~~~~~lI~~~L~-dp~~--Rpsa~elL~hpf~~~~~~~~~ 296 (466)
.....+.++++||++||. +|.+ |++++|+++||||+..+|..+
T Consensus 305 -~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 305 -QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp -SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred -ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence 223468899999999996 6666 999999999999999888654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=403.68 Aligned_cols=255 Identities=27% Similarity=0.445 Sum_probs=217.7
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+ .+.||+|+||+||+|.+..+|+.||+|++...... ......++.+|+.+|+.++||||+++++++ .....
T Consensus 8 i~~Y~i-~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~--~~~~~ 83 (336)
T 3h4j_B 8 IGPYII-RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK-KSDMHMRVEREISYLKLLRHPHIIKLYDVI--TTPTD 83 (336)
T ss_dssp ETTEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCSHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSE
T ss_pred cCCEEE-EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc-chhHHHHHHHHHHHHHhCCCCCCCeEEEEE--EeCCE
Confidence 478987 57799999999999999999999999998754321 112235788999999999999999999987 45678
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+++||||+ +|+|.+++.+.+.+++..++.++.||+.||.|||+.| |+||||||+|||++.+ +.+||+|||++....
T Consensus 84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~-~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDN-LNVKIADFGLSNIMT 159 (336)
T ss_dssp EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTT-CCEEECCSSCTBTTT
T ss_pred EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCC-CCEEEEEeccceecc
Confidence 99999999 8899999988899999999999999999999999999 9999999999999977 899999999998877
Q ss_pred CCCCCccccCCCCcCCccccccC-C-CChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 186 GSKSAHSVIGTPEFMAPELYEED-Y-NELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 186 ~~~~~~~~~GT~~y~APE~l~~~-y-~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
......+.+||+.|+|||++.+. + +.++|||||||++|+|++|..||.. .+...+++.+..+.. ..+...+++++
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~ 236 (336)
T 3h4j_B 160 DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSCVY--VMPDFLSPGAQ 236 (336)
T ss_dssp TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBC-SSSTTCBCCCCSSCC--CCCTTSCHHHH
T ss_pred CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCCC--CCcccCCHHHH
Confidence 66666778899999999988754 4 7899999999999999999999976 333334444443332 23455788999
Q ss_pred HHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 264 RFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
+||.+||. ||.+|||+.|+++||||+..
T Consensus 237 ~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 237 SLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 99999996 99999999999999999753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=383.56 Aligned_cols=256 Identities=25% Similarity=0.394 Sum_probs=212.7
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
++|.+. +.||+|+||+||+|.++.+|+.||+|++..... .......+.+|+.++++++||||+++++++. +...+
T Consensus 2 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~ 76 (292)
T 3o0g_A 2 QKYEKL-EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLH--SDKKL 76 (292)
T ss_dssp CSEEEE-EEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEE--ETTEE
T ss_pred CCceee-eEecCCCCeEEEEEEECCCCceEEEEeeeccCC--cCCcchHHHHHHHHHhcCCCCCEeeEEeEEE--eCCEE
Confidence 578874 669999999999999999999999999986553 3345577889999999999999999999884 47789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
++||||+.++.+..+....+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ |.+||+|||++.....
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRN-GELKLANFGLARAFGI 153 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCS
T ss_pred EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeecccceecCC
Confidence 999999976544444455678999999999999999999999999 9999999999999977 8999999999987643
Q ss_pred C-CCCccccCCCCcCCcccccc-C-CCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--CCCCC---------
Q 012320 187 S-KSAHSVIGTPEFMAPELYEE-D-YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS--GKLPG--------- 252 (466)
Q Consensus 187 ~-~~~~~~~GT~~y~APE~l~~-~-y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~--g~~p~--------- 252 (466)
. ......+||+.|+|||++.+ . |+.++|||||||++|+|++|..||....+.......+.. +..+.
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence 2 33445689999999998753 3 899999999999999999999997666777666665543 11110
Q ss_pred ----------------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 253 ----------------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 253 ----------------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
......+.++++||.+||. ||.+|||++|+|+||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 0112356789999999996 9999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=401.65 Aligned_cols=261 Identities=24% Similarity=0.372 Sum_probs=219.4
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHH-HHhCCCCceeEEEeEEEeccCCE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHL-LSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~i-L~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
++|.+ .++||+|+||+||+|.++.+++.||+|++.+.... .......+.+|..+ ++.++||||++++++| .+...
T Consensus 38 ~~y~~-~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~--~~~~~ 113 (373)
T 2r5t_A 38 SDFHF-LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL-KKKEEKHIMSERNVLLKNVKHPFLVGLHFSF--QTADK 113 (373)
T ss_dssp GGEEE-EEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEE--ECSSE
T ss_pred hheEE-EEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE--EeCCE
Confidence 57777 57799999999999999999999999999876643 23345567778776 5778999999999988 45778
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ |.+||+|||+++...
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCCBCGGGB
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCC-CCEEEeeCccccccc
Confidence 9999999999999999999899999999999999999999999999 9999999999999977 899999999998643
Q ss_pred -CCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 186 -GSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 186 -~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
......+.+||+.|+|||++. ..|+.++|||||||++|||++|..||.. .+..++++.+..+.+. ++...+.+++
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~~--~~~~~~~~~~ 267 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPLQ--LKPNITNSAR 267 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SBHHHHHHHHHHSCCC--CCSSSCHHHH
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcccC--CCCCCCHHHH
Confidence 334556789999999999876 4599999999999999999999999976 7788888888877543 3455788999
Q ss_pred HHHHHhcc-CcCCCCCH----HHHhcCCCCCchhhhhcc
Q 012320 264 RFIGRCLV-NASKRLSA----KELLLDPFLASDEVKLLS 297 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rpsa----~elL~hpf~~~~~~~~~~ 297 (466)
+||.+||. ||.+||++ .++++||||+..+|..+.
T Consensus 268 ~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~ 306 (373)
T 2r5t_A 268 HLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLI 306 (373)
T ss_dssp HHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHH
T ss_pred HHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHH
Confidence 99999996 99999997 699999999998886543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=391.27 Aligned_cols=262 Identities=27% Similarity=0.361 Sum_probs=213.9
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEc---CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDE---VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
.++|.+ .++||+|+||+||+|.+. .+|+.||+|++++............+.+|+.+|+.++||||+++++.+ ..
T Consensus 16 ~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~ 92 (327)
T 3a62_A 16 PECFEL-LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF--QT 92 (327)
T ss_dssp GGGEEE-EEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE--EC
T ss_pred HHHeEE-EEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE--Ec
Confidence 467877 567999999999999985 689999999998665444444566788999999999999999999988 44
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
...+|+||||+.|++|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ |.+||+|||++.
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~ 169 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQ-GHVKLTDFGLCK 169 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTT-SCEEECCCSCC-
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCC-CcEEEEeCCccc
Confidence 6789999999999999999998899999999999999999999999999 9999999999999877 899999999997
Q ss_pred hhcC-CCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 012320 183 ILRG-SKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL 260 (466)
Q Consensus 183 ~~~~-~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~ 260 (466)
.... .......+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+...+...+..+..+ ++...+.
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~~--~p~~~~~ 246 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCKLN--LPPYLTQ 246 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCC--CCTTSCH
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCC--CCCCCCH
Confidence 6432 23345678999999999775 5699999999999999999999999976 6677777777776543 3345678
Q ss_pred HHHHHHHHhcc-CcCCCC-----CHHHHhcCCCCCchhhhhc
Q 012320 261 EAQRFIGRCLV-NASKRL-----SAKELLLDPFLASDEVKLL 296 (466)
Q Consensus 261 ~~~~lI~~~L~-dp~~Rp-----sa~elL~hpf~~~~~~~~~ 296 (466)
++++||.+||. ||.+|| ++.|+++||||+...|...
T Consensus 247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~ 288 (327)
T 3a62_A 247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEEL 288 (327)
T ss_dssp HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHH
T ss_pred HHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHH
Confidence 99999999996 999999 8899999999998777543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=377.15 Aligned_cols=262 Identities=26% Similarity=0.460 Sum_probs=228.5
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
.-.++|.+ .+.||+|+||+||+|.++.+|..||+|++..... +....+.+.+|+.++++++||||+++++.+ .+.
T Consensus 3 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~ 77 (284)
T 3kk8_A 3 KFSDNYDV-KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSI--QEE 77 (284)
T ss_dssp TTTTTEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--ECS
T ss_pred hhhhhhhh-hhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEE--EcC
Confidence 34688988 5669999999999999999999999999986553 555678899999999999999999999987 457
Q ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC--CCcEEEeccchh
Q 012320 104 KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLA 181 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~--~g~vKL~DFGla 181 (466)
...++||||+.|++|.+++...+.+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ .+.+||+|||++
T Consensus 78 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 78 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 788999999999999999988899999999999999999999999999 9999999999999755 234999999999
Q ss_pred hhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCC
Q 012320 182 AILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP--GAFYSIQ 258 (466)
Q Consensus 182 ~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~~ 258 (466)
.............||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+...+...+..+... ...+...
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T 3kk8_A 156 IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTV 234 (284)
T ss_dssp EECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred EEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC-CchhHHHHHHHhccccCCchhhccc
Confidence 8776655556678999999999876 4589999999999999999999999977 6777788888776643 3334567
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
++++++||.+||. ||.+|||+.|+|+||||+....
T Consensus 235 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 235 TPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 8899999999996 9999999999999999976443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=387.56 Aligned_cols=258 Identities=24% Similarity=0.440 Sum_probs=215.4
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCC----------------------HHHHHHHHHHHHHH
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRS----------------------PDDLQRLYSEVHLL 83 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~----------------------~~~~~~~~~Ei~iL 83 (466)
.++|.+ .+.||+|+||+||+|.++.+|+.||+|++........ ....+.+.+|+.+|
T Consensus 12 ~~~y~~-~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 12 LNQYTL-KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp ETTEEE-EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred ecceEE-EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 468887 5669999999999999999999999999986543211 12346789999999
Q ss_pred HhCCCCceeEEEeEEEeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCc
Q 012320 84 STLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDN 163 (466)
Q Consensus 84 ~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~N 163 (466)
++++||||+++++.+.+.....+++||||+.+++|.+++. .+.+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~N 167 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSN 167 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHH
Confidence 9999999999999886655778999999999999987653 467999999999999999999999999 9999999999
Q ss_pred EEEeCCCCcEEEeccchhhhhcCCC-CCccccCCCCcCCccccccC----CCChhhHHHHHHHHHHHHhCCCCCCCCCCH
Q 012320 164 IFVNGHLGQVKIGDLGLAAILRGSK-SAHSVIGTPEFMAPELYEED----YNELVDVYSFGMCVLEMFTCEYPYSECANP 238 (466)
Q Consensus 164 Ilv~~~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~y~APE~l~~~----y~~~~DIwSlGvil~elltg~~Pf~~~~~~ 238 (466)
||++.+ |.+||+|||++....... ......||+.|+|||++.+. ++.++|||||||++|+|++|..||.. .+.
T Consensus 168 il~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~ 245 (298)
T 2zv2_A 168 LLVGED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERI 245 (298)
T ss_dssp EEECTT-SCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC-SSH
T ss_pred EEECCC-CCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC-ccH
Confidence 999877 899999999998765432 23456899999999988643 37789999999999999999999976 566
Q ss_pred HHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCC
Q 012320 239 AQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLA 289 (466)
Q Consensus 239 ~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~ 289 (466)
..+...+..+..+.......+.++++||.+||. ||.+|||+.|+|+||||+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 777777777766544455678899999999996 999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=414.91 Aligned_cols=259 Identities=29% Similarity=0.474 Sum_probs=230.1
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+ .++||+|+||+||+|.++.+|+.||+|++.+.... .....+.+.+|+.+|++++||||+++++++ .+...
T Consensus 25 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~--~~~~~ 100 (484)
T 3nyv_A 25 SDRYKG-QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK-QKTDKESLLREVQLLKQLDHPNIMKLYEFF--EDKGY 100 (484)
T ss_dssp HHHEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-BSSCHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSE
T ss_pred cCceEE-eeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcc-cchHHHHHHHHHHHHHhCCCCCCCcEEEEE--EeCCE
Confidence 467877 57799999999999999999999999999866532 223457889999999999999999999987 45788
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeC--CCCcEEEeccchhhh
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNG--HLGQVKIGDLGLAAI 183 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~--~~g~vKL~DFGla~~ 183 (466)
+++||||+.||+|.+++...+.+++..++.+++||+.||.|||++| |+||||||+|||++. ..+.+||+|||++..
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 9999999999999999998899999999999999999999999999 999999999999952 347899999999988
Q ss_pred hcCCCCCccccCCCCcCCccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCCCHH
Q 012320 184 LRGSKSAHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA--FYSIQDLE 261 (466)
Q Consensus 184 ~~~~~~~~~~~GT~~y~APE~l~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~--~~~~~~~~ 261 (466)
+.........+||+.|+|||++.+.|+.++|||||||++|+|++|..||.. .+..++.+.+..+..+.. .+...+.+
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 257 (484)
T 3nyv_A 179 FEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEKGKYTFELPQWKKVSES 257 (484)
T ss_dssp BCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGGGSCHH
T ss_pred cccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCCcccccCCHH
Confidence 876666667889999999999988999999999999999999999999977 778888888888876543 34567889
Q ss_pred HHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 262 AQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 262 ~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 258 ~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 258 AKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred HHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 9999999996 99999999999999999754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=414.50 Aligned_cols=258 Identities=27% Similarity=0.463 Sum_probs=225.9
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
-.+||.+ .++||+|+||+||+|.++.+|+.||+|++.+..... .....+.+|+.+|++++||||+++++++ .+..
T Consensus 20 ~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~--~~~~ 94 (486)
T 3mwu_A 20 FAERYNI-VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTSTILREVELLKKLDHPNIMKLFEIL--EDSS 94 (486)
T ss_dssp HHHHEEE-EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC--SCHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSS
T ss_pred hhcceEE-eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc--hHHHHHHHHHHHHHhCCCCCcCeEEEEE--EcCC
Confidence 3578887 567999999999999999999999999997654322 2346789999999999999999999987 4578
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC--CCcEEEeccchhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAA 182 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~--~g~vKL~DFGla~ 182 (466)
.+|+|||||.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.. .+.+||+|||++.
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 89999999999999999988899999999999999999999999999 9999999999999643 3579999999998
Q ss_pred hhcCCCCCccccCCCCcCCccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCCCH
Q 012320 183 ILRGSKSAHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA--FYSIQDL 260 (466)
Q Consensus 183 ~~~~~~~~~~~~GT~~y~APE~l~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~--~~~~~~~ 260 (466)
.+.........+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .+..++.+.+..+..+.. .+...+.
T Consensus 173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~ 251 (486)
T 3mwu_A 173 CFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISD 251 (486)
T ss_dssp TBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCSGGGGGSCH
T ss_pred ECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCCcccCCCCH
Confidence 8776666667789999999999998999999999999999999999999977 677888888888876543 3355788
Q ss_pred HHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 261 EAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 261 ~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
++++||.+||. ||.+|||+.++|+||||+.
T Consensus 252 ~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 99999999996 9999999999999999965
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=409.13 Aligned_cols=261 Identities=24% Similarity=0.410 Sum_probs=216.6
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+ .++||+|+||+||+|.++.+|+.||+|++..... ........+.+|+.+|+.++||||+++++++. +...
T Consensus 147 ~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~--~~~~ 222 (446)
T 4ejn_A 147 MNEFEY-LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ--THDR 222 (446)
T ss_dssp GGGEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-C-------------CCCCCSCTTSCCEEEEEE--ETTE
T ss_pred hHHcEE-eEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh-hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe--eCCE
Confidence 467877 5679999999999999999999999999986543 23345567889999999999999999999884 4678
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHS-RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs-~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
+++||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+ .| |+||||||+|||++.+ |.+||+|||++...
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~-~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKD-GHIKITDFGLCKEG 299 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSS-SCEEECCCCCCCTT
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCC-CCEEEccCCCceec
Confidence 99999999999999999988999999999999999999999998 88 9999999999999877 89999999999764
Q ss_pred c-CCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 012320 185 R-GSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA 262 (466)
Q Consensus 185 ~-~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~ 262 (466)
. ........+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+...+...+..+..+ ++...++++
T Consensus 300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~ 376 (446)
T 4ejn_A 300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIR--FPRTLGPEA 376 (446)
T ss_dssp CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHH
T ss_pred cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHHhCCCC--CCccCCHHH
Confidence 3 333455678999999999876 5699999999999999999999999976 6777888888776643 345578899
Q ss_pred HHHHHHhcc-CcCCCC-----CHHHHhcCCCCCchhhhhc
Q 012320 263 QRFIGRCLV-NASKRL-----SAKELLLDPFLASDEVKLL 296 (466)
Q Consensus 263 ~~lI~~~L~-dp~~Rp-----sa~elL~hpf~~~~~~~~~ 296 (466)
++||.+||. ||.+|| +++|+++||||+...|...
T Consensus 377 ~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~ 416 (446)
T 4ejn_A 377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHV 416 (446)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred HHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHH
Confidence 999999996 999999 9999999999998877544
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=392.64 Aligned_cols=258 Identities=24% Similarity=0.390 Sum_probs=217.8
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
-.++|.+ .+.||+|+||+||+|.++.+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++ .+..
T Consensus 5 ~~~~y~i-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~--~~~~ 78 (323)
T 3tki_A 5 FVEDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHR--REGN 78 (323)
T ss_dssp TTTCEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEE--ECSS
T ss_pred Hhhhcee-eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc---cchHHHHHHHHHHHHhCCCCCCCeEEEEE--ecCC
Confidence 3578888 5669999999999999999999999999875542 22346788999999999999999999987 4577
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.+++||||+.||+|.+++...+.+++..++.++.||+.||.|||+.| |+||||||+|||++.+ +.+||+|||++..+
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVF 155 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEEC
T ss_pred eEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCC-CCEEEEEeecccee
Confidence 89999999999999999988888999999999999999999999999 9999999999999877 89999999999765
Q ss_pred cCC---CCCccccCCCCcCCcccccc-C-CCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 012320 185 RGS---KSAHSVIGTPEFMAPELYEE-D-YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259 (466)
Q Consensus 185 ~~~---~~~~~~~GT~~y~APE~l~~-~-y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 259 (466)
... ......+||+.|+|||++.+ . ++.++|||||||++|+|++|..||.........+............+...+
T Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (323)
T 3tki_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235 (323)
T ss_dssp EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSC
T ss_pred ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCC
Confidence 322 22346789999999998764 3 477899999999999999999999876655555555555554444456678
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
..+++||.+||. ||.+|||+.|+++||||+..
T Consensus 236 ~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 236 SAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 899999999996 99999999999999999754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=397.75 Aligned_cols=261 Identities=21% Similarity=0.368 Sum_probs=213.3
Q ss_pred CCCCceEEeeeeeeee--CceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 24 DPNGRYGLFEEVLGKG--AMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G--~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
...++|.+ .++||+| +||+||+|.++.+|+.||+|++..... .....+.+.+|+.+|+.++|||||+++++|.
T Consensus 22 ~~~~~y~~-~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-- 96 (389)
T 3gni_B 22 PEGGCYEL-LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC--SNEMVTFLQGELHVSKLFNHPNIVPYRATFI-- 96 (389)
T ss_dssp CCGGGEEE-EEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred CCCCcEEE-EecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE--
Confidence 45678887 5669999 999999999999999999999986643 4556778899999999999999999999884
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
+.+.+++||||+.+|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~dfg 173 (389)
T 3gni_B 97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLR 173 (389)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCGG
T ss_pred ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEcccc
Confidence 467899999999999999999876 67999999999999999999999999 9999999999999877 899999999
Q ss_pred hhhhhcCC--------CCCccccCCCCcCCcccccc---CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q 012320 180 LAAILRGS--------KSAHSVIGTPEFMAPELYEE---DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG 248 (466)
Q Consensus 180 la~~~~~~--------~~~~~~~GT~~y~APE~l~~---~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g 248 (466)
++...... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+......+.+ +..+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-~~~~ 252 (389)
T 3gni_B 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE-KLNG 252 (389)
T ss_dssp GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH-C---
T ss_pred cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HhcC
Confidence 88543211 12233579999999998764 589999999999999999999999977444433332 2222
Q ss_pred CCC--------------------------------------------CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHh
Q 012320 249 KLP--------------------------------------------GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELL 283 (466)
Q Consensus 249 ~~p--------------------------------------------~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL 283 (466)
..+ ...+...+.++++||.+||. ||.+|||+.|+|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 111 11234467789999999996 999999999999
Q ss_pred cCCCCCchhh
Q 012320 284 LDPFLASDEV 293 (466)
Q Consensus 284 ~hpf~~~~~~ 293 (466)
+||||+....
T Consensus 333 ~hp~f~~~~~ 342 (389)
T 3gni_B 333 NHSFFKQIKR 342 (389)
T ss_dssp TSGGGGGC--
T ss_pred cCHHHHHHhh
Confidence 9999986543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=391.79 Aligned_cols=256 Identities=23% Similarity=0.405 Sum_probs=206.5
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+ .+.||+|+||+||+|.++.+++.||+|++.... ..+.+.+|+.+|++++||||+++++.+ .+...
T Consensus 52 ~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~--~~~~~ 122 (349)
T 2w4o_A 52 SDFFEV-ESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLSHPNIIKLKEIF--ETPTE 122 (349)
T ss_dssp GGTEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEE--ECSSE
T ss_pred cCcEEE-eeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHHHHHHHHHHHhCCCCCCcceeeeE--ecCCe
Confidence 456776 677999999999999999999999999987432 335678899999999999999999988 45678
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeC--CCCcEEEeccchhhh
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNG--HLGQVKIGDLGLAAI 183 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~--~~g~vKL~DFGla~~ 183 (466)
+++||||+.||+|.+++...+.+++..++.++.||+.||.|||+.+ |+||||||+|||++. ..+.+||+|||++..
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 9999999999999999988888999999999999999999999999 999999999999974 237999999999987
Q ss_pred hcCCCCCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCCH
Q 012320 184 LRGSKSAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP--GAFYSIQDL 260 (466)
Q Consensus 184 ~~~~~~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~~~~ 260 (466)
..........+||+.|+|||++.+ .++.++|||||||++|+|++|..||........+++.+..+..+ ...+...+.
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 201 VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred cCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 765555566789999999998764 69999999999999999999999998877777788888776643 234456788
Q ss_pred HHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 261 EAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 261 ~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
++++||.+||. ||.+|||+.|+|+||||+...
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 99999999996 999999999999999997643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=412.89 Aligned_cols=261 Identities=28% Similarity=0.421 Sum_probs=225.4
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCC---------HHHHHHHHHHHHHHHhCCCCceeEE
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRS---------PDDLQRLYSEVHLLSTLKHDSIIRF 94 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~---------~~~~~~~~~Ei~iL~~l~HpnIv~l 94 (466)
.-.++|.+ .+.||+|+||+||+|.++.+|..||+|++........ ....+.+.+|+.+|++++||||+++
T Consensus 33 ~i~~~Y~~-~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 33 KIGESYFK-VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp CGGGTEEE-EEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CcccceEE-EeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 34578887 5669999999999999999999999999986543211 1234678999999999999999999
Q ss_pred EeEEEeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCC--Cc
Q 012320 95 YTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHL--GQ 172 (466)
Q Consensus 95 ~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~--g~ 172 (466)
++++ .+...+++|||||.||+|.+++.+.+.+++..++.+++||+.||.|||+.| |+||||||+|||++.+. ..
T Consensus 112 ~~~~--~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 112 FDVF--EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEEE--ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSS
T ss_pred EEEE--EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCcc
Confidence 9988 457889999999999999999998899999999999999999999999999 99999999999998662 26
Q ss_pred EEEeccchhhhhcCCCCCccccCCCCcCCccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC
Q 012320 173 VKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG 252 (466)
Q Consensus 173 vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~ 252 (466)
+||+|||++............+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .+..++...+..+....
T Consensus 188 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~ 266 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGG-QNDQDIIKKVEKGKYYF 266 (504)
T ss_dssp EEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCC
T ss_pred EEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCC
Confidence 99999999988776666677889999999999998899999999999999999999999977 77888889998887643
Q ss_pred C--CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 253 A--FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 253 ~--~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
. .+...+.++++||.+||. ||.+|||+.|+|+||||+.
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 3 235578899999999996 9999999999999999964
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=379.83 Aligned_cols=258 Identities=22% Similarity=0.376 Sum_probs=213.3
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
.-.++|.+ .+.||+|+||+||+|.++.+|..+|+|.+..... ....+.+.+|+.+|++++||||+++++.+ .+.
T Consensus 19 ~i~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~ 92 (285)
T 3is5_A 19 TIDDLFIF-KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS---QVPMEQIEAEIEVLKSLDHPNIIKIFEVF--EDY 92 (285)
T ss_dssp CHHHHEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---CSCHHHHHHHHHHHHTCCCTTBCCEEEEE--ECS
T ss_pred Chhhheee-cceeccCCCeEEEEEEEccCCceEEEEEeecccc---chhHHHHHHHHHHHHhCCCchHHhHHHhe--ecC
Confidence 34577877 6779999999999999999999999999986542 22356788999999999999999999987 457
Q ss_pred CEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC--CCcEEEec
Q 012320 104 KTFNFITEMFTSGTLREYRKKY----RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH--LGQVKIGD 177 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~--~g~vKL~D 177 (466)
..+++||||+.||+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.. .+.+||+|
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~D 170 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIID 170 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEe
Confidence 7899999999999999988543 67999999999999999999999999 9999999999999532 36899999
Q ss_pred cchhhhhcCCCCCccccCCCCcCCccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC-CCC
Q 012320 178 LGLAAILRGSKSAHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA-FYS 256 (466)
Q Consensus 178 FGla~~~~~~~~~~~~~GT~~y~APE~l~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~-~~~ 256 (466)
||++..+..........||+.|+|||++.+.++.++|||||||++|+|++|..||.+ .+...+...+........ ...
T Consensus 171 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~ 249 (285)
T 3is5_A 171 FGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTG-TSLEEVQQKATYKEPNYAVECR 249 (285)
T ss_dssp CCCCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCC--C
T ss_pred eecceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCC-CCHHHHHhhhccCCcccccccC
Confidence 999987665555567789999999999988899999999999999999999999977 566666666655443222 223
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
..++++++||.+||. ||.+|||+.|+|+||||+.
T Consensus 250 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 250 PLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 357899999999996 9999999999999999964
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=399.07 Aligned_cols=257 Identities=24% Similarity=0.380 Sum_probs=203.3
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEeEEEeccCC
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~ 104 (466)
.+||.+. +.||+|+||+||+|.++.+|+.||+|++... .......+++.+|+.+|+++. ||||+++++++...+..
T Consensus 8 ~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 8 LRKYELV-KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA--FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HTTEEEE-EC-------CEEEEEETTTCCEEEEEEECC----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cCceEEE-EEeeeCCCeEEEEEEECCCCCEEEEEEeccc--ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 4688884 6699999999999999999999999998643 235567788999999999996 99999999998766666
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.+|+||||+. ++|..++.. +.+++..++.++.||+.||.|||+.| |+||||||+|||++.+ +.+||+|||+++.+
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAE-CHVKVADFGLSRSF 159 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEES
T ss_pred EEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCC-CCEEecCCcccccc
Confidence 8999999996 689998876 68999999999999999999999999 9999999999999987 89999999999765
Q ss_pred cC----------------------CCCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q 012320 185 RG----------------------SKSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQ 240 (466)
Q Consensus 185 ~~----------------------~~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~ 240 (466)
.. .......+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 32 11234568999999999875 4599999999999999999999999987444443
Q ss_pred HHHHHhcCCCCCC--------------------------------------------CCCCCCHHHHHHHHHhcc-CcCC
Q 012320 241 IYKKVTSGKLPGA--------------------------------------------FYSIQDLEAQRFIGRCLV-NASK 275 (466)
Q Consensus 241 i~~~i~~g~~p~~--------------------------------------------~~~~~~~~~~~lI~~~L~-dp~~ 275 (466)
+.+.+.....|.. .....++++++||.+||. ||.+
T Consensus 240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 3332221111110 011457799999999996 9999
Q ss_pred CCCHHHHhcCCCCCc
Q 012320 276 RLSAKELLLDPFLAS 290 (466)
Q Consensus 276 Rpsa~elL~hpf~~~ 290 (466)
|||+.|+|+||||+.
T Consensus 320 R~t~~e~l~Hp~~~~ 334 (388)
T 3oz6_A 320 RISANDALKHPFVSI 334 (388)
T ss_dssp SCCHHHHTTSTTTTT
T ss_pred CCCHHHHhCCHHHHH
Confidence 999999999999964
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=377.33 Aligned_cols=256 Identities=24% Similarity=0.401 Sum_probs=224.5
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
-.++|.+ .+.||+|+||+||+|.++.++..+|+|.+..... ...+.+.+|+.++++++||||+++++.+ .+..
T Consensus 7 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~ 79 (277)
T 3f3z_A 7 INQYYTL-ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV----EDVDRFKQEIEIMKSLDHPNIIRLYETF--EDNT 79 (277)
T ss_dssp HHHHEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHTCCCTTBCCEEEEE--ECSS
T ss_pred hhhhEEe-eeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc----chHHHHHHHHHHHHhCCCCCEeeEEEEE--ecCC
Confidence 3467766 5779999999999999999999999999875542 2346788999999999999999999987 4577
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEE---eCCCCcEEEeccchh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFV---NGHLGQVKIGDLGLA 181 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv---~~~~g~vKL~DFGla 181 (466)
.+++||||+.|++|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+||++ +.+ +.+||+|||++
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~-~~~~l~Dfg~~ 156 (277)
T 3f3z_A 80 DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPD-SPLKLIDFGLA 156 (277)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTT-CCEEECCCTTC
T ss_pred eEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCC-CcEEEEecccc
Confidence 89999999999999999998899999999999999999999999999 9999999999999 444 79999999999
Q ss_pred hhhcCCCCCccccCCCCcCCccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCCC
Q 012320 182 AILRGSKSAHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAF--YSIQD 259 (466)
Q Consensus 182 ~~~~~~~~~~~~~GT~~y~APE~l~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~--~~~~~ 259 (466)
.............||+.|+|||++.+.++.++|||||||++|+|++|..||.. .+..++...+..+..+... +...+
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (277)
T 3f3z_A 157 ARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSA-PTDSEVMLKIREGTFTFPEKDWLNVS 235 (277)
T ss_dssp EECCTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCHHHHTTSC
T ss_pred eeccCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCchhhhcCC
Confidence 87766666667789999999999988899999999999999999999999977 6677777778777654322 23567
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
..++++|.+||. ||.+|||+.++|+||||+..
T Consensus 236 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 236 PQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 899999999996 99999999999999999653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=395.83 Aligned_cols=260 Identities=23% Similarity=0.373 Sum_probs=223.4
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
+-.++|.+ .+.||+|+||+||+|.++.+|+.||+|.+... .......+.+|+.+|++++||||+++++++ .+.
T Consensus 48 ~~~~~y~i-~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~--~~~ 120 (387)
T 1kob_A 48 SVYDYYDI-LEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLHDAF--EDK 120 (387)
T ss_dssp CGGGTEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEE--ECS
T ss_pred ccccceEE-EEEEecCCCEEEEEEEECCCCCEEEEEEeccc----chhhHHHHHHHHHHHHhCCCcCCCeEEEEE--EeC
Confidence 34467877 56699999999999999999999999998743 234556789999999999999999999988 457
Q ss_pred CEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC-CCcEEEeccchh
Q 012320 104 KTFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH-LGQVKIGDLGLA 181 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~-~g~vKL~DFGla 181 (466)
..+++||||+.||+|.+++...+ .+++..+..++.||+.||.|||++| |+||||||+|||++.+ .+.+||+|||++
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a 198 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLA 198 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccc
Confidence 78999999999999999987653 7999999999999999999999999 9999999999999743 368999999999
Q ss_pred hhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCC
Q 012320 182 AILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL--PGAFYSIQ 258 (466)
Q Consensus 182 ~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~ 258 (466)
..+.........+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..+....+..+.. +...+...
T Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 277 (387)
T 1kob_A 199 TKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSV 277 (387)
T ss_dssp EECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTS
T ss_pred eecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCccccccC
Confidence 8776555555678999999999876 4589999999999999999999999977 566677777776654 33344567
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
+.++++||.+||. ||.+|||+.|+|+||||+....
T Consensus 278 s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 278 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 8899999999996 9999999999999999986543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=393.52 Aligned_cols=258 Identities=23% Similarity=0.356 Sum_probs=207.5
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
....+||.+. +.||+|+||+||+|.++.+|+.||+|++..... ..+.+.+|+.+++.++||||+++++++. +
T Consensus 16 ~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~--~ 87 (361)
T 3uc3_A 16 MHDSDRYDFV-KDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-----IDENVQREIINHRSLRHPNIVRFKEVIL--T 87 (361)
T ss_dssp CCCTTTEEEE-EEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-----SCHHHHHHHHHHHHCCCTTBCCEEEEEE--C
T ss_pred CCCCCcEEEE-EEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-----ccHHHHHHHHHHHhCCCCCCCcEEEEEe--e
Confidence 4456899884 669999999999999999999999999875432 1246789999999999999999999884 5
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC-CCcEEEeccchh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH-LGQVKIGDLGLA 181 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~-~g~vKL~DFGla 181 (466)
...+++||||+.||+|.+++.+.+++++..++.++.||+.||.|||++| |+||||||+|||++.+ .+.+||+|||++
T Consensus 88 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a 165 (361)
T 3uc3_A 88 PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYS 165 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred CCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence 7789999999999999999998899999999999999999999999999 9999999999999865 134999999999
Q ss_pred hhhcCCCCCccccCCCCcCCccccc-cCCCCh-hhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHhcCCCCCCCCC
Q 012320 182 AILRGSKSAHSVIGTPEFMAPELYE-EDYNEL-VDVYSFGMCVLEMFTCEYPYSECA---NPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 182 ~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~-~DIwSlGvil~elltg~~Pf~~~~---~~~~i~~~i~~g~~p~~~~~ 256 (466)
+...........+||+.|+|||++. ..++.+ +|||||||++|+|++|..||.... ....+.+.+...........
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (361)
T 3uc3_A 166 KSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDI 245 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTS
T ss_pred ccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcC
Confidence 7655444456678999999999875 456544 899999999999999999997532 33455566666655444444
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
..+.++++||.+||. ||.+|||+.|+++||||..
T Consensus 246 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 246 RISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp CCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 578899999999996 9999999999999999954
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=394.56 Aligned_cols=260 Identities=26% Similarity=0.423 Sum_probs=218.9
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCC-HHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRS-PDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
.++|.+ .+.||+|+||+||+|.++.+|+.||+|++........ ....+.+.+|+.+++.++||||+++++++. +..
T Consensus 23 ~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~~ 99 (351)
T 3c0i_A 23 EDVYEL-CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS--SDG 99 (351)
T ss_dssp HHHEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE--ETT
T ss_pred ccceEE-eeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE--eCC
Confidence 467877 5679999999999999999999999999976543221 113467899999999999999999999884 467
Q ss_pred EEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC--CCcEEEecc
Q 012320 105 TFNFITEMFTSGTLREYRKKY----RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH--LGQVKIGDL 178 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~--~g~vKL~DF 178 (466)
.+|+||||+.|++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+.+||+||
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecC
Confidence 899999999999998887543 35899999999999999999999999 9999999999999765 234999999
Q ss_pred chhhhhcCCC-CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC--C
Q 012320 179 GLAAILRGSK-SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA--F 254 (466)
Q Consensus 179 Gla~~~~~~~-~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~--~ 254 (466)
|++....... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. ....++..+..+..... .
T Consensus 178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~i~~~~~~~~~~~ 255 (351)
T 3c0i_A 178 GVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG--TKERLFEGIIKGKYKMNPRQ 255 (351)
T ss_dssp TTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS--SHHHHHHHHHHTCCCCCHHH
T ss_pred cceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC--cHHHHHHHHHcCCCCCCccc
Confidence 9998765433 244568999999999876 4599999999999999999999999975 45677778877765432 2
Q ss_pred CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 255 YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 255 ~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
+...+.++++||.+||. ||.+|||+.|+|+||||+...
T Consensus 256 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 256 WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294 (351)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence 24567899999999996 999999999999999997654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=384.41 Aligned_cols=260 Identities=24% Similarity=0.382 Sum_probs=213.3
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 103 (466)
-.++|.+.+++||+|+||+||+|.++.+|+.||+|++.... ....+.+.+|+.+|+++ +||||+++++.+. +.
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~--~~ 83 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP----GHIRSRVFREVEMLYQCQGHRNVLELIEFFE--EE 83 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS----SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE--ET
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc----chhHHHHHHHHHHHHHhcCCCCeeeEEEEEe--eC
Confidence 35789887788999999999999999999999999987543 22346789999999995 7999999999884 46
Q ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCC--CcEEEeccchh
Q 012320 104 KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHL--GQVKIGDLGLA 181 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~--g~vKL~DFGla 181 (466)
..+++||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+. +.+||+|||++
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 789999999999999999998889999999999999999999999999 99999999999998652 23999999998
Q ss_pred hhhcCC--------CCCccccCCCCcCCccccc------cCCCChhhHHHHHHHHHHHHhCCCCCCCCCC----------
Q 012320 182 AILRGS--------KSAHSVIGTPEFMAPELYE------EDYNELVDVYSFGMCVLEMFTCEYPYSECAN---------- 237 (466)
Q Consensus 182 ~~~~~~--------~~~~~~~GT~~y~APE~l~------~~y~~~~DIwSlGvil~elltg~~Pf~~~~~---------- 237 (466)
...... ......+||+.|+|||++. ..|+.++|||||||++|+|++|..||.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 241 (316)
T 2ac3_A 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241 (316)
T ss_dssp C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence 765321 1223456999999999875 3489999999999999999999999976432
Q ss_pred ----HHHHHHHHhcCCCCCC--CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 238 ----PAQIYKKVTSGKLPGA--FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 238 ----~~~i~~~i~~g~~p~~--~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
...++..+..+..... .+...+.++++||.+||. ||.+|||+.|+|+||||+...
T Consensus 242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 242 CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp CHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred chhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 3456777777765322 123467899999999996 999999999999999998643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=382.48 Aligned_cols=261 Identities=26% Similarity=0.422 Sum_probs=225.0
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCH--HHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSP--DDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
.++|.+ .+.||+|+||+||+|.++.+|+.||+|.+......... ...+.+.+|+.+|++++||||+++++.+ .+.
T Consensus 11 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~ 87 (321)
T 2a2a_A 11 EDFYDI-GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY--ENR 87 (321)
T ss_dssp HHHEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE--ECS
T ss_pred hccEEE-eeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE--ecC
Confidence 456766 67799999999999999999999999999865532211 1356789999999999999999999987 457
Q ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCC----cEEEeccc
Q 012320 104 KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLG----QVKIGDLG 179 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g----~vKL~DFG 179 (466)
..+++||||+.|++|.+++.+.+.+++..+..++.||+.||.|||+.| |+||||||+||+++.+ + .+||+|||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~-~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDK-NIPIPHIKLIDFG 164 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCT-TSSSCCEEECCCT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecC-CCCcCCEEEccCc
Confidence 789999999999999999998888999999999999999999999999 9999999999999876 5 79999999
Q ss_pred hhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC--CCCC
Q 012320 180 LAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG--AFYS 256 (466)
Q Consensus 180 la~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~--~~~~ 256 (466)
++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..+....+..+.... ..+.
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 243 (321)
T 2a2a_A 165 LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITSVSYDFDEEFFS 243 (321)
T ss_dssp TCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCHHHHT
T ss_pred cceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccccChhhhc
Confidence 998776655556678999999999876 5689999999999999999999999976 56677777777665432 2234
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
..+..+++||.+||. ||.+|||+.|+++||||+...+
T Consensus 244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~ 281 (321)
T 2a2a_A 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281 (321)
T ss_dssp TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence 567899999999996 9999999999999999987554
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=410.41 Aligned_cols=256 Identities=25% Similarity=0.438 Sum_probs=225.0
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+ .+.||+|+||+||+|.++.+|+.||+|++...... ..+..+.+.+|+.+|+.++||||+++++++ .....
T Consensus 15 ~~~Y~l-~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~--~~~~~ 90 (476)
T 2y94_A 15 IGHYIL-GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIRREIQNLKLFRHPHIIKLYQVI--STPSD 90 (476)
T ss_dssp ETTEEE-EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH-HTTTHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSE
T ss_pred ecCEEE-EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE--EECCE
Confidence 367877 67799999999999999999999999999865431 122356789999999999999999999987 45678
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++....
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~-~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTT-CCEEECCCSSCEECC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecC-CCeEEEeccchhhcc
Confidence 9999999999999999998889999999999999999999999999 9999999999999977 899999999998876
Q ss_pred CCCCCccccCCCCcCCccccccC-C-CChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 186 GSKSAHSVIGTPEFMAPELYEED-Y-NELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 186 ~~~~~~~~~GT~~y~APE~l~~~-y-~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
......+.+||+.|+|||++.+. | +.++|||||||++|+|++|..||.. .+...+++.+..+... .+...+++++
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~ 244 (476)
T 2y94_A 168 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFY--TPQYLNPSVI 244 (476)
T ss_dssp TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC-SSSHHHHHHHHTTCCC--CCTTCCHHHH
T ss_pred ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCcC--CCccCCHHHH
Confidence 65666678899999999988754 4 6899999999999999999999987 5667788888887653 3345678999
Q ss_pred HHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 264 RFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
+||.+||. ||.+|||+.|+++||||+..
T Consensus 245 ~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 245 SLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 99999996 99999999999999999753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=382.07 Aligned_cols=251 Identities=25% Similarity=0.384 Sum_probs=209.8
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCCE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~ 105 (466)
++|.+. ++||+|+||+||+|.++.+|+.||+|++.... ...........|+..+..+ +||||++++++| .+...
T Consensus 57 ~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~--~~~~~ 131 (311)
T 3p1a_A 57 QSFQRL-SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF--RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW--EEGGI 131 (311)
T ss_dssp HHEEEE-EEEEEETTEEEEEEEETTTSCEEEEEEESSSC--CSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--EETTE
T ss_pred hheeee-heeccCCCeEEEEEEECCCCeEEEEEEecccc--cChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE--EeCCE
Confidence 678774 66999999999999999999999999876432 2344555666677666655 999999999988 45778
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 106 FNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
+++||||+ +++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++...
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~-~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPR-GRCKLGDFGLLVEL 207 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGG-GCEEECCCTTCEEC
T ss_pred EEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCC-CCEEEccceeeeec
Confidence 99999999 77998887765 46999999999999999999999999 9999999999999877 89999999999876
Q ss_pred cCCCCCccccCCCCcCCccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 012320 185 RGSKSAHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQR 264 (466)
Q Consensus 185 ~~~~~~~~~~GT~~y~APE~l~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~ 264 (466)
..........||+.|+|||++.+.++.++|||||||++|+|++|..||.. ...+..+..+..+.......+.++++
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~ 283 (311)
T 3p1a_A 208 GTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHG----GEGWQQLRQGYLPPEFTAGLSSELRS 283 (311)
T ss_dssp C------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSS----HHHHHHHTTTCCCHHHHTTSCHHHHH
T ss_pred ccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC----ccHHHHHhccCCCcccccCCCHHHHH
Confidence 65555556779999999999988999999999999999999999777654 23455666666665556667889999
Q ss_pred HHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 265 FIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 265 lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
||.+||. ||.+|||+.|+|+||||+.
T Consensus 284 li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 284 VLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHcCCChhhCcCHHHHHhCccccC
Confidence 9999996 9999999999999999964
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=391.16 Aligned_cols=253 Identities=25% Similarity=0.413 Sum_probs=218.7
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 103 (466)
-.++|.+ .+.||+|+||+||+|.++.+|+.||+|++.+... ...+|+.+|.++ +||||+++++++ .+.
T Consensus 20 ~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~E~~~l~~~~~hp~iv~~~~~~--~~~ 88 (342)
T 2qr7_A 20 FTDGYEV-KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DPTEEIEILLRYGQHPNIITLKDVY--DDG 88 (342)
T ss_dssp HHHHEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CCHHHHHHHHHHTTSTTBCCEEEEE--ECS
T ss_pred ccccEEE-EEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------ChHHHHHHHHHhcCCCCcCeEEEEE--EcC
Confidence 3567877 4679999999999999999999999999975432 134688888887 799999999988 557
Q ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCC---cEEEeccch
Q 012320 104 KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLG---QVKIGDLGL 180 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g---~vKL~DFGl 180 (466)
..+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||+....+ .+||+|||+
T Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 89 KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 889999999999999999998889999999999999999999999999 999999999999954433 599999999
Q ss_pred hhhhcCC-CCCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHhcCCCCC--CC
Q 012320 181 AAILRGS-KSAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSEC--ANPAQIYKKVTSGKLPG--AF 254 (466)
Q Consensus 181 a~~~~~~-~~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~--~~~~~i~~~i~~g~~p~--~~ 254 (466)
+...... ....+.+||+.|+|||++.+ .|+.++|||||||++|+|++|..||... .+..++...+..+.++. ..
T Consensus 167 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 246 (342)
T 2qr7_A 167 AKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGY 246 (342)
T ss_dssp CEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTT
T ss_pred cccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccc
Confidence 9876543 34456789999999998864 5899999999999999999999999753 56788889998887643 34
Q ss_pred CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 255 YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 255 ~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
+...+.++++||.+||. ||.+|||+.++++||||..
T Consensus 247 ~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 247 WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 45678899999999996 9999999999999999954
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=386.38 Aligned_cols=263 Identities=29% Similarity=0.402 Sum_probs=206.3
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
....+||.+. +.||+|+||+||+|.++.+|+.||+|++..... .....+.+.+|+.+|++++||||+++++.+. +
T Consensus 30 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~ 104 (329)
T 3gbz_A 30 ATSIDRYRRI-TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQHRNIIELKSVIH--H 104 (329)
T ss_dssp --CGGGEEEE-EEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEE--E
T ss_pred ccchhhEEEE-EEEEecCCeEEEEEEECCCCceEEEEEEccccc--ccccchhHHHHHHHHHHcCCCCcceEEEEEe--c
Confidence 4456789884 669999999999999999999999999875532 2334567789999999999999999999874 4
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC----CCcEEEecc
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH----LGQVKIGDL 178 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~----~g~vKL~DF 178 (466)
...+++||||+. |+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+.+||+||
T Consensus 105 ~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 105 NHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp TTEEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred CCEEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcC
Confidence 778999999996 599999999899999999999999999999999999 9999999999999532 256999999
Q ss_pred chhhhhcCC-CCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC-C
Q 012320 179 GLAAILRGS-KSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA-F 254 (466)
Q Consensus 179 Gla~~~~~~-~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~-~ 254 (466)
|++..+... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||........+.+.+.....|.. .
T Consensus 182 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 182 GLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp THHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 999876532 33445678999999998764 4899999999999999999999999875544444443332111110 0
Q ss_pred --------------------------CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 255 --------------------------YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 255 --------------------------~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
....+.++++||.+||. ||.+|||+.|+|+||||+...+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 11156789999999996 9999999999999999987654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=412.57 Aligned_cols=263 Identities=21% Similarity=0.339 Sum_probs=226.8
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+ .++||+|+||+||+|.++.+|+.||+|++.+..... ......+.+|+.+|+.++||||++++++| .+...
T Consensus 183 ~~~f~~-~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~--~~~~~ 258 (576)
T 2acx_A 183 KNTFRQ-YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAY--ETKDA 258 (576)
T ss_dssp GGGEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSSE
T ss_pred ccceEE-EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh-hHHHHHHHHHHHHHHHcCCCCEeeEEEEE--eeCCE
Confidence 456766 577999999999999999999999999998654321 12345688999999999999999999988 45778
Q ss_pred EEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 106 FNFITEMFTSGTLREYRKKYRR--VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
+|+||||+.||+|.+++...+. +++..++.++.||+.||.|||++| |+||||||+|||++.+ |.+||+|||++..
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~-g~vKL~DFGla~~ 335 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDH-GHIRISDLGLAVH 335 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCCTTCEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCC-CCeEEEeccccee
Confidence 9999999999999999987654 999999999999999999999999 9999999999999877 8999999999987
Q ss_pred hcCCCCCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHhcCCCCCCCCCCCC
Q 012320 184 LRGSKSAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECA---NPAQIYKKVTSGKLPGAFYSIQD 259 (466)
Q Consensus 184 ~~~~~~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~---~~~~i~~~i~~g~~p~~~~~~~~ 259 (466)
+.......+.+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.... ....+.+.+..... .++...+
T Consensus 336 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~--~~p~~~s 413 (576)
T 2acx_A 336 VPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE--EYSERFS 413 (576)
T ss_dssp CCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC--CCCTTSC
T ss_pred cccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc--cCCccCC
Confidence 766555566789999999998764 69999999999999999999999997642 45677777766543 3456678
Q ss_pred HHHHHHHHHhcc-CcCCCC-----CHHHHhcCCCCCchhhhhcc
Q 012320 260 LEAQRFIGRCLV-NASKRL-----SAKELLLDPFLASDEVKLLS 297 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rp-----sa~elL~hpf~~~~~~~~~~ 297 (466)
.++++||.+||. ||.+|| ++.|+++||||+...|..+.
T Consensus 414 ~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~ 457 (576)
T 2acx_A 414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLG 457 (576)
T ss_dssp HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHH
T ss_pred HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHh
Confidence 999999999996 999999 89999999999998886543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=380.55 Aligned_cols=261 Identities=24% Similarity=0.380 Sum_probs=207.7
Q ss_pred eeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 22 ~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
...-.++|.++ +.||+|+||+||+|.++ +|+.||+|++..... .......+.+|+.+|++++||||+++++++ .
T Consensus 16 ~q~l~~~y~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~ 89 (311)
T 3niz_A 16 FQGLMEKYQKL-EKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE--DEGIPSTAIREISLLKELHHPNIVSLIDVI--H 89 (311)
T ss_dssp EECSSCEEEEE-EEEEECSSCEEEEEEET-TSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEE--C
T ss_pred ecchHhhhHhh-hhccCCCCeEEEEEEEC-CCCEEEEEEEecccc--cchhhHHHHHHHHHHHHcCCCCEeeeeeEE--c
Confidence 34556889885 66999999999999986 499999999875432 233457788999999999999999999987 4
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
+...+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+|||++.+ +.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~ 165 (311)
T 3niz_A 90 SERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSD-GALKLADFGL 165 (311)
T ss_dssp CSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTT
T ss_pred cCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCC-CCEEEccCcC
Confidence 56789999999975 787777654 45999999999999999999999999 9999999999999877 8999999999
Q ss_pred hhhhcCC-CCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh--cCCCCCCC-
Q 012320 181 AAILRGS-KSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVT--SGKLPGAF- 254 (466)
Q Consensus 181 a~~~~~~-~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~--~g~~p~~~- 254 (466)
+...... ......+||+.|+|||++. ..|+.++|||||||++|+|++|..||........+.+... ....+..+
T Consensus 166 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 166 ARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245 (311)
T ss_dssp CEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred ceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence 9876432 3344567999999999875 3589999999999999999999999977554444333222 11111110
Q ss_pred ------------------------CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 255 ------------------------YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 255 ------------------------~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
....+.++++||.+||. ||.+|||++|+|+||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 12245789999999996 999999999999999998643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=389.19 Aligned_cols=259 Identities=28% Similarity=0.456 Sum_probs=219.2
Q ss_pred eeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 21 IETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 21 ~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
...++..+|..+ +.||+|+||+||+|.+..+|+.||+|++..... ......+.+.+|+.+|++++||||+++++++.
T Consensus 48 ~~~~~~~~y~~~-~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~- 124 (348)
T 1u5q_A 48 FKDDPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL- 124 (348)
T ss_dssp CCSCHHHHEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred cccchhhheeee-eEEccCCCEEEEEEEEccCCeEEEEEEEccccc-cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-
Confidence 345677888885 559999999999999999999999999875432 23445678999999999999999999999884
Q ss_pred ccCCEEEEEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 101 VDQKTFNFITEMFTSGTLREYRK-KYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~-~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
+...+++||||+. |+|.+++. ..+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||
T Consensus 125 -~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~DfG 199 (348)
T 1u5q_A 125 -REHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFG 199 (348)
T ss_dssp -ETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETT-TEEEECCCT
T ss_pred -ECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC-CCEEEeecc
Confidence 4678999999996 67877775 4567999999999999999999999999 9999999999999977 899999999
Q ss_pred hhhhhcCCCCCccccCCCCcCCcccc----ccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 012320 180 LAAILRGSKSAHSVIGTPEFMAPELY----EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFY 255 (466)
Q Consensus 180 la~~~~~~~~~~~~~GT~~y~APE~l----~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~ 255 (466)
++..... ....+||+.|+|||++ .+.|+.++|||||||++|+|++|..||... +.......+..+..+....
T Consensus 200 ~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~-~~~~~~~~~~~~~~~~~~~ 275 (348)
T 1u5q_A 200 SASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQS 275 (348)
T ss_dssp TCBSSSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCCC
T ss_pred CceecCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcCCCCCCC
Confidence 9976543 3456799999999987 356899999999999999999999999874 4444444555555555555
Q ss_pred CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 256 ~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
...+..+++||.+||. ||.+|||+.++++||||...
T Consensus 276 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 276 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 6678899999999996 99999999999999999653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=379.34 Aligned_cols=262 Identities=31% Similarity=0.397 Sum_probs=207.7
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCC-HHHHHHHHHHHHHHHhC---CCCceeEEEeEEEe
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRS-PDDLQRLYSEVHLLSTL---KHDSIIRFYTSWID 100 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~-~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~ 100 (466)
-.+||.+. +.||+|+||+||+|.++.+|+.||+|++........ ......+.+|+.+++.+ +||||+++++.+..
T Consensus 7 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 7 ATSRYEPV-AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ---CCEEE-EEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred cccceEEE-EEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 36789884 669999999999999999999999999875542111 11123456677777666 59999999998865
Q ss_pred ccCC---EEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEE
Q 012320 101 VDQK---TFNFITEMFTSGTLREYRKKYRR--VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKI 175 (466)
Q Consensus 101 ~~~~---~~~lV~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL 175 (466)
.... .+++|||++. ++|.+++.+... +++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~-~~~kl 161 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG-GTVKL 161 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTT-SCEEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCC-CCEEE
Confidence 4322 6889999996 699999987654 999999999999999999999999 9999999999999877 89999
Q ss_pred eccchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--CCCCC
Q 012320 176 GDLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS--GKLPG 252 (466)
Q Consensus 176 ~DFGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~--g~~p~ 252 (466)
+|||++............+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+.......+.. +..+.
T Consensus 162 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 162 ADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG-NSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp CSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCC-SSHHHHHHHHHHHHCCCCT
T ss_pred eeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhCCCCh
Confidence 9999998776666667788999999999775 5699999999999999999999999987 444444444432 11111
Q ss_pred C-----------------------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 253 A-----------------------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 253 ~-----------------------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
. .....+.++++||.+||. ||.+|||+.|+|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 1 012356789999999996 999999999999999998643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=376.16 Aligned_cols=254 Identities=25% Similarity=0.420 Sum_probs=204.1
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
++|.+. +.||+|+||+||+|.+ .+|+.||+|++..... .....+.+.+|+.++++++||||+++++.+. +...+
T Consensus 2 ~~y~~~-~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~ 75 (288)
T 1ob3_A 2 EKYHGL-EKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIH--TKKRL 75 (288)
T ss_dssp CSEEEE-EEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE--CSSCE
T ss_pred ccchhh-hhcccCCCEEEEEEEc-CCCCEEEEEEEecccc--ccccchhHHHHHHHHHhcCCCCEeeeeeEEc--cCCeE
Confidence 578885 6699999999999998 6799999999875432 2223366789999999999999999999874 46789
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 107 NFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
++||||+.+ +|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||++.+ |.+||+|||++....
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 76 VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINRE-GELKIADFGLARAFG 151 (288)
T ss_dssp EEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECCTTHHHHHC
T ss_pred EEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CCEEEeECccccccC
Confidence 999999975 999988764 67999999999999999999999999 9999999999999877 899999999998765
Q ss_pred CC-CCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCC---------
Q 012320 186 GS-KSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-GKLPG--------- 252 (466)
Q Consensus 186 ~~-~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-g~~p~--------- 252 (466)
.. .......||+.|+|||++.+ .++.++|||||||++|+|++|..||........+.+.+.. +..+.
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 32 23345679999999998753 5899999999999999999999999874443333332221 11100
Q ss_pred ----------------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 253 ----------------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 253 ----------------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
......+.++++||.+||. ||.+|||+.|+|+||||+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0113357889999999996 9999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=401.88 Aligned_cols=263 Identities=25% Similarity=0.424 Sum_probs=214.9
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCC----HHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRS----PDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
.++|.+ .+.||+|+||+||+|.++.+|+.||+|++.+...... ......+.+|+.+|++++||||+++++++.
T Consensus 134 ~~~y~~-~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-- 210 (419)
T 3i6u_A 134 RDEYIM-SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-- 210 (419)
T ss_dssp HTTEEE-EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE--
T ss_pred hccEEE-EeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence 467876 5779999999999999999999999999987653221 122345789999999999999999999762
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC--CCcEEEeccc
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH--LGQVKIGDLG 179 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~--~g~vKL~DFG 179 (466)
...+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+.+||+|||
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred -cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecc
Confidence 3458899999999999999988889999999999999999999999999 9999999999999754 2359999999
Q ss_pred hhhhhcCCCCCccccCCCCcCCccccc----cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC--
Q 012320 180 LAAILRGSKSAHSVIGTPEFMAPELYE----EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA-- 253 (466)
Q Consensus 180 la~~~~~~~~~~~~~GT~~y~APE~l~----~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~-- 253 (466)
+++...........+||+.|+|||++. ..|+.++|||||||++|+|++|..||........+...+..+..+..
T Consensus 288 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~ 367 (419)
T 3i6u_A 288 HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 367 (419)
T ss_dssp TTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHH
T ss_pred cceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCch
Confidence 998876655566788999999999874 45888999999999999999999999876666667777777765432
Q ss_pred CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhhh
Q 012320 254 FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVK 294 (466)
Q Consensus 254 ~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~~ 294 (466)
.+...+..+++||.+||. ||.+|||+.|+|+||||+...++
T Consensus 368 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 409 (419)
T 3i6u_A 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 409 (419)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHH
T ss_pred hhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhHH
Confidence 234567899999999996 99999999999999999887664
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=403.36 Aligned_cols=255 Identities=27% Similarity=0.379 Sum_probs=203.2
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc---
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD--- 102 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--- 102 (466)
.+||.++ +.||+|+||+||+|.++.+|+.||+|++.... ......+++.+|+.+|+.++||||++++++|....
T Consensus 61 ~~~y~~~-~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 61 LKRYQNL-KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp ETTEEEE-EEEEECSSCEEEEEEETTTTEEEEEEEEESGG--GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred cCCeEEE-EEeecCCCeEEEEEEECCCCCEEEEEEECccc--cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence 4788874 66999999999999999999999999997542 34556788999999999999999999999885432
Q ss_pred -CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 103 -QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 103 -~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
...+|+||||+.++ |.+.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++
T Consensus 138 ~~~~~~lv~E~~~~~-l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~-~~~kl~DFG~a 211 (464)
T 3ttj_A 138 EFQDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA 211 (464)
T ss_dssp TCCEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCCCC
T ss_pred cCCeEEEEEeCCCCC-HHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCC-CCEEEEEEEee
Confidence 25789999999664 666654 46999999999999999999999999 9999999999999987 89999999999
Q ss_pred hhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--CCCCC------
Q 012320 182 AILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS--GKLPG------ 252 (466)
Q Consensus 182 ~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~--g~~p~------ 252 (466)
+...........+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+. +....+..+.. |..+.
T Consensus 212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~-~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 212 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR-DYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp -----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred eecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCCHHHHHHc
Confidence 8876655667789999999999775 56999999999999999999999999874 44444333322 11000
Q ss_pred ---------------------CCCC-----------CCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 253 ---------------------AFYS-----------IQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 253 ---------------------~~~~-----------~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
.++. ..+.++++||.+||. ||.+|||++|+|+||||+.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 0000 014579999999996 9999999999999999974
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=382.26 Aligned_cols=253 Identities=21% Similarity=0.420 Sum_probs=209.1
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC---
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ--- 103 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~--- 103 (466)
++|.+ .+.||+|+||+||+|.++.+|+.||+|+++... .....+.+.+|+.+|++++||||++++++|.+...
T Consensus 6 ~~y~~-~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 6 TDFEP-IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHEEE-EEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hcCce-eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 46766 566999999999999999999999999997543 33456789999999999999999999999865432
Q ss_pred ----------------------------------------------------CEEEEEEecCCCCCHHHHHHhcCC---C
Q 012320 104 ----------------------------------------------------KTFNFITEMFTSGTLREYRKKYRR---V 128 (466)
Q Consensus 104 ----------------------------------------------------~~~~lV~E~~~ggsL~~~l~~~~~---l 128 (466)
..+++|||||.|++|.+++.+... .
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 248999999999999999987644 5
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCC-------------CCccccC
Q 012320 129 DIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-------------SAHSVIG 195 (466)
Q Consensus 129 ~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~-------------~~~~~~G 195 (466)
++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++....... .....+|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCC-CCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 66678999999999999999999 9999999999999877 899999999998765431 2234579
Q ss_pred CCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-Cc
Q 012320 196 TPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NA 273 (466)
Q Consensus 196 T~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp 273 (466)
|+.|+|||++. ..|+.++|||||||++|+|++|..|+ .....+...+..+..|.. ....++++++||.+||. ||
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~---~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p 314 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ---MERVRIITDVRNLKFPLL-FTQKYPQEHMMVQDMLSPSP 314 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH---HHHHHHHHHHHTTCCCHH-HHHHCHHHHHHHHHHHCSSG
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh---hHHHHHHHHhhccCCCcc-cccCChhHHHHHHHHccCCC
Confidence 99999999876 46999999999999999999987765 334556666666655432 23345678999999996 99
Q ss_pred CCCCCHHHHhcCCCCCc
Q 012320 274 SKRLSAKELLLDPFLAS 290 (466)
Q Consensus 274 ~~Rpsa~elL~hpf~~~ 290 (466)
.+|||+.|+|+||||+.
T Consensus 315 ~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 315 TERPEATDIIENAIFEN 331 (332)
T ss_dssp GGSCCHHHHHHSTTCCC
T ss_pred CcCCCHHHHhhchhhhc
Confidence 99999999999999974
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=382.68 Aligned_cols=254 Identities=23% Similarity=0.350 Sum_probs=200.8
Q ss_pred CceEEe--eeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEeEEEeccC
Q 012320 27 GRYGLF--EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 27 ~rY~~~--~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~ 103 (466)
.+|.+. +++||+|+||+||+|.++.+|+.||+|++... ....+.+|+.+++.+. ||||+++++++ .+.
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~l~~l~~h~niv~~~~~~--~~~ 78 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEANTQKEITALKLCEGHPNIVKLHEVF--HDQ 78 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-------GHHHHHHHHHHHHHTTTCTTBCCEEEEE--ECS
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-------hhhhHHHHHHHHHHhcCCCCeeEEEEEE--EcC
Confidence 356653 46799999999999999999999999998643 2356778999999996 99999999988 457
Q ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCC--CcEEEeccchh
Q 012320 104 KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHL--GQVKIGDLGLA 181 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~--g~vKL~DFGla 181 (466)
..+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+. ..+||+|||++
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a 156 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFA 156 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTC
T ss_pred CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccc
Confidence 789999999999999999999899999999999999999999999999 99999999999997652 27999999999
Q ss_pred hhhcCC-CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCC------CCHHHHHHHHhcCCCCCC
Q 012320 182 AILRGS-KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSEC------ANPAQIYKKVTSGKLPGA 253 (466)
Q Consensus 182 ~~~~~~-~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~------~~~~~i~~~i~~g~~p~~ 253 (466)
...... ......+||+.|+|||++. ..|+.++|||||||++|+|++|..||... ....++.+.+..+.++..
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 157 RLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp EECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred eecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 765432 3345678999999999876 46999999999999999999999999653 344678888888876433
Q ss_pred C--CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 254 F--YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 254 ~--~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
. +...+.++++||.+||. ||.+|||+.|+++||||+..
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 2 23567899999999996 99999999999999999754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=419.19 Aligned_cols=263 Identities=21% Similarity=0.376 Sum_probs=230.7
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCC
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 104 (466)
.++|.+ .++||+|+||+||+|.++.+|+.||+|++++..... ....+.+..|+.+|..+ +||||++++.+| .+..
T Consensus 340 ~~~f~~-~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~--~~~~ 415 (674)
T 3pfq_A 340 LTDFNF-LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCF--QTMD 415 (674)
T ss_dssp CTTEEE-EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH-TTTTHHHHHHHHHHTCTTCCTTBCCEEEEC--BCSS
T ss_pred ccceEE-EEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEE--EeCC
Confidence 456777 567999999999999999999999999998654321 23456788899999988 799999999987 5678
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.+|+||||+.||+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+++..
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~-g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKEN 492 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSS-SCEEECCCTTCEEC
T ss_pred EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCC-CcEEEeecceeecc
Confidence 89999999999999999999899999999999999999999999999 9999999999999987 89999999999864
Q ss_pred c-CCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 012320 185 R-GSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA 262 (466)
Q Consensus 185 ~-~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~ 262 (466)
. ......+.+||+.|+|||++. ..|+.++|||||||++|||++|..||.+ .+..++++.|..+.+. ++...+.++
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~ 569 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVA--YPKSMSKEA 569 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHSSCCC--CCTTSCHHH
T ss_pred ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCCC--CCccCCHHH
Confidence 3 334456789999999999876 5699999999999999999999999977 7888999999887653 445678999
Q ss_pred HHHHHHhcc-CcCCCCCH-----HHHhcCCCCCchhhhhccc
Q 012320 263 QRFIGRCLV-NASKRLSA-----KELLLDPFLASDEVKLLSK 298 (466)
Q Consensus 263 ~~lI~~~L~-dp~~Rpsa-----~elL~hpf~~~~~~~~~~~ 298 (466)
++||.+||. ||.+||++ +||++||||+..+|..+..
T Consensus 570 ~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~ 611 (674)
T 3pfq_A 570 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLER 611 (674)
T ss_dssp HHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTT
T ss_pred HHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHh
Confidence 999999996 99999998 9999999999988865543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=381.05 Aligned_cols=257 Identities=29% Similarity=0.474 Sum_probs=199.3
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
..++|.++ +.||+|+||+||+|.++.+|+.||+|++..... ....+.+.+|+.+|++++||||+++++.+ .+.+
T Consensus 3 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~ 76 (317)
T 2pmi_A 3 SSSQFKQL-EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKELKHENIVRLYDVI--HTEN 76 (317)
T ss_dssp -----------------CEEEEEECSSSCCEEEEEEEECCST---TCSCHHHHHHHHHHTTCCBTTBCCEEEEE--CCTT
T ss_pred cccceeEe-eEECCCCCEEEEEEEECCCCcEEEEEEeecccc---cccHHHHHHHHHHHHhcCCCCcceEEEEE--EECC
Confidence 35678775 569999999999999999999999999975542 22335678999999999999999999987 4577
Q ss_pred EEEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEecc
Q 012320 105 TFNFITEMFTSGTLREYRKKY------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDL 178 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DF 178 (466)
.+++||||+. |+|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+|||++.+ |.+||+||
T Consensus 77 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Df 152 (317)
T 2pmi_A 77 KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKR-GQLKLGDF 152 (317)
T ss_dssp EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCC
T ss_pred eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCC-CCEEECcC
Confidence 8999999997 5999988754 35999999999999999999999999 9999999999999877 89999999
Q ss_pred chhhhhcCC-CCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--CCCCCC
Q 012320 179 GLAAILRGS-KSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS--GKLPGA 253 (466)
Q Consensus 179 Gla~~~~~~-~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~--g~~p~~ 253 (466)
|++...... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+.......+.. |..+..
T Consensus 153 g~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~ 231 (317)
T 2pmi_A 153 GLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPG-TNDEEQLKLIFDIMGTPNES 231 (317)
T ss_dssp SSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHHHCSCCTT
T ss_pred ccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHHhCCCChh
Confidence 999876432 33445689999999998753 589999999999999999999999987 444444444432 111100
Q ss_pred ------------------------------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 254 ------------------------------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 254 ------------------------------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
.....+.++++||.+||. ||.+|||+.|+|+||||+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp TCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred HhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 112356789999999996 999999999999999997643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=400.78 Aligned_cols=260 Identities=26% Similarity=0.410 Sum_probs=197.6
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc---
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD--- 102 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--- 102 (466)
.++|.+ .++||+|+||+||+|.++.+|+.||+|++... .......+++.+|+.+|++++|||||++++++...+
T Consensus 52 ~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 52 PDRYEI-RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV--FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CTTEEE-CCC-------CEEEEEECC--CEEEEEEECST--TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred CCCeEE-eeEeeecCCeEEEEEEECCCCcEEEEEEechh--hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 478987 56799999999999999999999999998643 235566788999999999999999999999875432
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
...+|+||||+ +++|.+++...+.+++..++.++.||+.||.|||+.| |+||||||+|||++.+ +.+||+|||+++
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~-~~~kl~DFGla~ 204 (458)
T 3rp9_A 129 FDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQD-CSVKVCDFGLAR 204 (458)
T ss_dssp CCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-CCEEECCCTTCB
T ss_pred CceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCC-CCEeecccccch
Confidence 35799999998 6899999998888999999999999999999999999 9999999999999987 899999999997
Q ss_pred hhcCCC----------------------------CCccccCCCCcCCcccc-c-cCCCChhhHHHHHHHHHHHHh-----
Q 012320 183 ILRGSK----------------------------SAHSVIGTPEFMAPELY-E-EDYNELVDVYSFGMCVLEMFT----- 227 (466)
Q Consensus 183 ~~~~~~----------------------------~~~~~~GT~~y~APE~l-~-~~y~~~~DIwSlGvil~ellt----- 227 (466)
...... .....+||+.|+|||++ . ..|+.++|||||||++|||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 654211 23456899999999965 3 459999999999999999998
Q ss_pred ------CCCCCCCCCC--------------------HHHHHHHHhc--CC--------------------CC-------C
Q 012320 228 ------CEYPYSECAN--------------------PAQIYKKVTS--GK--------------------LP-------G 252 (466)
Q Consensus 228 ------g~~Pf~~~~~--------------------~~~i~~~i~~--g~--------------------~p-------~ 252 (466)
|..||.+... ..++ ..+.. |. ++ .
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQL-NVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHH-HHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHH-HHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 6666654221 1111 11100 10 00 0
Q ss_pred CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 253 AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 253 ~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
..+...+.++.+||.+||. ||.+|||++|+|+||||+...+
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 1123457899999999996 9999999999999999987654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=393.18 Aligned_cols=264 Identities=26% Similarity=0.353 Sum_probs=207.9
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
..-.++|.+ .++||+|+||+||+|.++.+|+.||+|++... .......+++.+|+.+|++++||||+++++.+...+
T Consensus 22 ~~i~~~y~~-~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 98 (432)
T 3n9x_A 22 VHVPDNYII-KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM--FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD 98 (432)
T ss_dssp CCCCTTEEE-EEEEEEETTEEEEEEEETTTTEEEEEEEECST--TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred ceecCCEEE-EEEEeecCCEEEEEEEECCCCcEEEEEEeCch--hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 344678987 57799999999999999999999999998743 235566788999999999999999999999875432
Q ss_pred C---CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 103 Q---KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 103 ~---~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
. ..+|+||||+. ++|.+++++...+++..++.++.||+.||.|||+.| |+||||||+|||++.+ +.+||+|||
T Consensus 99 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~-~~~kL~DFG 174 (432)
T 3n9x_A 99 LLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQD-CSVKVCDFG 174 (432)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCT
T ss_pred CCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCC-CCEEEccCC
Confidence 1 57999999985 699999998888999999999999999999999999 9999999999999887 899999999
Q ss_pred hhhhhcCCC-----------------------CCccccCCCCcCCcccc-c-cCCCChhhHHHHHHHHHHHHhCCCC---
Q 012320 180 LAAILRGSK-----------------------SAHSVIGTPEFMAPELY-E-EDYNELVDVYSFGMCVLEMFTCEYP--- 231 (466)
Q Consensus 180 la~~~~~~~-----------------------~~~~~~GT~~y~APE~l-~-~~y~~~~DIwSlGvil~elltg~~P--- 231 (466)
+++...... .....+||+.|+|||++ . ..|+.++|||||||++|||++|..|
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence 998754321 23567899999999975 3 4599999999999999999985333
Q ss_pred --------CCCCCC-----------------HHHH-----------------------HHHHhcCCCCCC-----CCCCC
Q 012320 232 --------YSECAN-----------------PAQI-----------------------YKKVTSGKLPGA-----FYSIQ 258 (466)
Q Consensus 232 --------f~~~~~-----------------~~~i-----------------------~~~i~~g~~p~~-----~~~~~ 258 (466)
|.+... ..++ .+.+........ .+...
T Consensus 255 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (432)
T 3n9x_A 255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSI 334 (432)
T ss_dssp SGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTS
T ss_pred ccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCC
Confidence 322110 1111 111111110000 11346
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
++++++||++||. ||.+|||++|+|+||||+...+
T Consensus 335 s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 335 SDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 7899999999996 9999999999999999987544
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=384.90 Aligned_cols=256 Identities=22% Similarity=0.454 Sum_probs=222.5
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHH----HHHHHHHHHHHHHhC-CCCceeEEEeEEEec
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPD----DLQRLYSEVHLLSTL-KHDSIIRFYTSWIDV 101 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~----~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 101 (466)
++|.+ .+.||+|+||+||+|.++.+|+.||+|++.......... ..+.+.+|+.+++++ +||||++++++| .
T Consensus 94 ~~y~~-~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~--~ 170 (365)
T 2y7j_A 94 QKYDP-KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY--E 170 (365)
T ss_dssp HHEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--E
T ss_pred hhccc-ceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE--e
Confidence 57877 577999999999999999999999999987654222222 246788999999999 899999999987 4
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
....+++||||+.|++|.+++.....+++..+..++.||+.||.|||+.| |+||||||+|||++.+ |.+||+|||++
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~-~~ikl~DfG~~ 247 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDN-MQIRLSDFGFS 247 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTC
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEEEecCcc
Confidence 57789999999999999999998889999999999999999999999999 9999999999999877 89999999999
Q ss_pred hhhcCCCCCccccCCCCcCCcccccc-------CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 012320 182 AILRGSKSAHSVIGTPEFMAPELYEE-------DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAF 254 (466)
Q Consensus 182 ~~~~~~~~~~~~~GT~~y~APE~l~~-------~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~ 254 (466)
..+.........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+...+...+..+......
T Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~ 326 (365)
T 2y7j_A 248 CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFSS 326 (365)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCH
T ss_pred cccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCC
Confidence 88766666667889999999998742 488999999999999999999999976 5677777778777654332
Q ss_pred --CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCC
Q 012320 255 --YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLA 289 (466)
Q Consensus 255 --~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~ 289 (466)
+...+..+++||.+||. ||.+|||+.++|+||||+
T Consensus 327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 24567789999999995 999999999999999996
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=390.35 Aligned_cols=253 Identities=24% Similarity=0.401 Sum_probs=215.5
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC--CCceeEEEeEEEeccCC
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK--HDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~~~~~ 104 (466)
.+|.+ .+.||+|+||+||+|.++. |+.||+|++..... .....+.+.+|+.+|++++ ||||+++++++. ...
T Consensus 56 ~~y~~-~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~--~~~ 129 (390)
T 2zmd_A 56 RIYSI-LKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI--TDQ 129 (390)
T ss_dssp EEEEE-EEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSS
T ss_pred CceEE-EEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc--cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe--cCC
Confidence 34655 6779999999999999876 99999999986543 4556788999999999996 599999999774 466
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.+|+||| +.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ + +.+||+|||++..+
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~-~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-D-GMLKLIDFGIANQM 204 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-S-SCEEECCCSSSCCC
T ss_pred EEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-C-CeEEEEecCccccc
Confidence 7999999 668999999999889999999999999999999999999 99999999999995 3 79999999999876
Q ss_pred cCCC---CCccccCCCCcCCcccccc------------CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC
Q 012320 185 RGSK---SAHSVIGTPEFMAPELYEE------------DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK 249 (466)
Q Consensus 185 ~~~~---~~~~~~GT~~y~APE~l~~------------~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~ 249 (466)
.... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||....+.......+..+.
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~ 284 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 284 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTT
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcc
Confidence 4332 2345689999999998753 589999999999999999999999987667767777777766
Q ss_pred CCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 250 LPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 250 ~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
....++...+.++++||.+||. ||.+|||+.|+|+||||+.
T Consensus 285 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 326 (390)
T 2zmd_A 285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326 (390)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence 5555666678899999999996 9999999999999999964
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=389.47 Aligned_cols=252 Identities=24% Similarity=0.391 Sum_probs=212.8
Q ss_pred eeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEec
Q 012320 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
.++||+|+||+||+|.++.+|+.||+|+++... ....+.+.+|+.+|++++||||+++++++ .+...+++||||
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~--~~~~~~~lv~E~ 167 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG----MKDKEEVKNEISVMNQLDHANLIQLYDAF--ESKNDIVLVMEY 167 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSEEEEEEEC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc----cccHHHHHHHHHHHHhCCCCCCCeEEEEE--EECCEEEEEEeC
Confidence 467999999999999999999999999987532 34567899999999999999999999987 456789999999
Q ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeC-CCCcEEEeccchhhhhcCCCCC
Q 012320 113 FTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNG-HLGQVKIGDLGLAAILRGSKSA 190 (466)
Q Consensus 113 ~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~-~~g~vKL~DFGla~~~~~~~~~ 190 (466)
++|++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+.. ..+.+||+|||++..+......
T Consensus 168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~ 245 (373)
T 2x4f_A 168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245 (373)
T ss_dssp CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence 9999999988654 46999999999999999999999999 999999999999842 3378999999999887665556
Q ss_pred ccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCCHHHHHHHH
Q 012320 191 HSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP--GAFYSIQDLEAQRFIG 267 (466)
Q Consensus 191 ~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~~~~~~~~lI~ 267 (466)
...+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..+....+..+..+ ...+...+.++++||.
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 324 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG-DNDAETLNNILACRWDLEDEEFQDISEEAKEFIS 324 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHH
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccCCCChhhhccCCHHHHHHHH
Confidence 6678999999999876 4589999999999999999999999987 5666666777665543 2233456889999999
Q ss_pred Hhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 268 RCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 268 ~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
+||. ||.+|||+.|+|+||||+....
T Consensus 325 ~~L~~dp~~Rps~~e~l~hp~~~~~~~ 351 (373)
T 2x4f_A 325 KLLIKEKSWRISASEALKHPWLSDHKL 351 (373)
T ss_dssp TTSCSSGGGSCCHHHHHHSHHHHCHHH
T ss_pred HHcCCChhhCCCHHHHhcCcCcCCCch
Confidence 9996 9999999999999999987654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=392.51 Aligned_cols=254 Identities=20% Similarity=0.322 Sum_probs=205.8
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHh-CCCCceeEEEeEEEe--cc
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLST-LKHDSIIRFYTSWID--VD 102 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~--~~ 102 (466)
.++|.+..++||+|+||+||+|.++.+|+.||+|++... ..+.+|+.++.+ .+||||++++++|.. .+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 467888778899999999999999999999999998621 346778888754 589999999998754 23
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC--CCcEEEecc
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH--LGQVKIGDL 178 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~--~g~vKL~DF 178 (466)
...+|+||||+.||+|.+++.+.+ .+++..++.|+.||+.||.|||+++ |+||||||+|||++.. .+.+||+||
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEec
Confidence 567899999999999999998754 5999999999999999999999999 9999999999999873 378999999
Q ss_pred chhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCCC--CC
Q 012320 179 GLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANP---AQIYKKVTSGKL--PG 252 (466)
Q Consensus 179 Gla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~---~~i~~~i~~g~~--p~ 252 (466)
|+++.........+.+||+.|+|||++. ..|+.++|||||||++|+|++|..||...... ..+...+..+.+ +.
T Consensus 209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 209 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp TTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred ccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 9998766555556788999999999886 56999999999999999999999999753321 124455655554 33
Q ss_pred CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 253 AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 253 ~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
..+...+.++++||.+||. ||.+|||+.|+|+||||..
T Consensus 289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 3345678899999999996 9999999999999999964
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=381.75 Aligned_cols=264 Identities=23% Similarity=0.377 Sum_probs=219.8
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEecc
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVD 102 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 102 (466)
+-.++|.+..+.||+|+||+||+|.++.+|+.||+|++..... .......+.+|+.+++.+ .||||+++++.+ .+
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~--~~ 100 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAEILHEIAVLELAKSCPRVINLHEVY--EN 100 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET--TEECHHHHHHHHHHHHHTTTCTTBCCEEEEE--EC
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHhccCCCCEEEEEEEE--Ee
Confidence 3467888877889999999999999999999999999886543 223456789999999999 569999999987 45
Q ss_pred CCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeC--CCCcEEEecc
Q 012320 103 QKTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNG--HLGQVKIGDL 178 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~--~~g~vKL~DF 178 (466)
...+++||||+.||+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||++. ..+.+||+||
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeC
Confidence 77899999999999999988543 67999999999999999999999999 999999999999986 2379999999
Q ss_pred chhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--CCCCCC
Q 012320 179 GLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK--LPGAFY 255 (466)
Q Consensus 179 Gla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~--~p~~~~ 255 (466)
|++............+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..+.+..+.... .+...+
T Consensus 179 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~ 257 (327)
T 3lm5_A 179 GMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG-EDNQETYLNISQVNVDYSEETF 257 (327)
T ss_dssp GGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTT
T ss_pred ccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCchHHHHHHHhcccccCchhh
Confidence 9998776555556678999999999876 5689999999999999999999999977 55666666665544 334444
Q ss_pred CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhhh
Q 012320 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVK 294 (466)
Q Consensus 256 ~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~~ 294 (466)
...+..+++||.+||. ||.+|||++++|+||||+...+.
T Consensus 258 ~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 258 SSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 5678899999999996 99999999999999999876553
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=381.77 Aligned_cols=254 Identities=24% Similarity=0.400 Sum_probs=213.7
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCC--CceeEEEeEEEeccC
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH--DSIIRFYTSWIDVDQ 103 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~ 103 (466)
.++|.+ .+.||+|+||+||+|.+. +++.||+|++.... ......+.+.+|+.+|++++| |||+++++++ .+.
T Consensus 8 ~~~y~i-~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~--~~~ 81 (343)
T 3dbq_A 8 GRIYSI-LKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE--ITD 81 (343)
T ss_dssp SCEEEE-EEEESCCSSEEEEEEECT-TSCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE--ECS
T ss_pred cCEEEE-EEEEecCCCeEEEEEEeC-CCCEEEEEEeeccc--cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE--eeC
Confidence 456666 577999999999999985 68999999998654 245566889999999999976 9999999987 457
Q ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 104 KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
..+++||| +.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++. +.+||+|||++..
T Consensus 82 ~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~~--~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 82 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD--GMLKLIDFGIANQ 156 (343)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET--TEEEECCCSSSCC
T ss_pred CEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEEC--CcEEEeecccccc
Confidence 78999999 568999999999999999999999999999999999999 999999999999973 7899999999987
Q ss_pred hcCCC---CCccccCCCCcCCccccc------------cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q 012320 184 LRGSK---SAHSVIGTPEFMAPELYE------------EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG 248 (466)
Q Consensus 184 ~~~~~---~~~~~~GT~~y~APE~l~------------~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g 248 (466)
+.... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||....+.......+...
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 236 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 236 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC
Confidence 64332 234568999999999874 458899999999999999999999998766766666666666
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 249 KLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 249 ~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
..+..++...+.++++||.+||. ||.+|||+.|+|+||||+.
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 55556667778899999999996 9999999999999999964
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=404.33 Aligned_cols=262 Identities=24% Similarity=0.388 Sum_probs=224.3
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.. .++||+|+||+||+|.++.+|+.||+|++.+..... ....+.+.+|+.+|++++||||++++++| .+...
T Consensus 184 ~~~f~~-~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~--~~~~~ 259 (543)
T 3c4z_A 184 EDWFLD-FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK-RKGYQGAMVEKKILAKVHSRFIVSLAYAF--ETKTD 259 (543)
T ss_dssp GGGEEE-EEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSSE
T ss_pred hhheEE-EEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh-hHHHHHHHHHHHHHHhcCCCCEeeEEEEE--eeCCE
Confidence 366766 577999999999999999999999999998654321 12346788999999999999999999988 45778
Q ss_pred EEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 106 FNFITEMFTSGTLREYRKKY----RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
+|+||||+.||+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ |.+||+|||++
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~-g~vkL~DFGla 336 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDD-GNVRISDLGLA 336 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCCTTC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCC-CCEEEeeccee
Confidence 99999999999999999764 36999999999999999999999999 9999999999999977 89999999999
Q ss_pred hhhcCCCC-CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHhcCCCCCCCCC
Q 012320 182 AILRGSKS-AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECA---NPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 182 ~~~~~~~~-~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~---~~~~i~~~i~~g~~p~~~~~ 256 (466)
..+..... ....+||+.|+|||++. ..|+.++|||||||++|||++|..||.... +...+.+.+..+... ++.
T Consensus 337 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~--~p~ 414 (543)
T 3c4z_A 337 VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT--YPD 414 (543)
T ss_dssp EECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCC--CCT
T ss_pred eeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccC--CCc
Confidence 87654332 34568999999999876 469999999999999999999999997642 467788888776543 345
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCC-----HHHHhcCCCCCchhhhhc
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLS-----AKELLLDPFLASDEVKLL 296 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rps-----a~elL~hpf~~~~~~~~~ 296 (466)
..+.++++||.+||. ||.+||+ +.++++||||+...|..+
T Consensus 415 ~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l 460 (543)
T 3c4z_A 415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQL 460 (543)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHH
T ss_pred ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHH
Confidence 678899999999996 9999996 589999999999887654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=366.98 Aligned_cols=263 Identities=24% Similarity=0.398 Sum_probs=225.1
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccC-C----HHHHHHHHHHHHHHHhCC-CCceeEEEeE
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMR-S----PDDLQRLYSEVHLLSTLK-HDSIIRFYTS 97 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~-~----~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~ 97 (466)
.-.++|.+ .+.||+|+||+||+|.++.+|+.||+|++....... . ....+.+.+|+.+++++. ||||+++++.
T Consensus 14 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 14 GFYENYEP-KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp -CTTTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred chhhccce-eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 44678987 567999999999999999999999999997653211 1 123467889999999995 9999999998
Q ss_pred EEeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEec
Q 012320 98 WIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGD 177 (466)
Q Consensus 98 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~D 177 (466)
+ .....+++||||+.+++|.+++.+...+++..+..++.||+.||.|||++| |+||||||+||+++.+ |.+||+|
T Consensus 93 ~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~d 167 (298)
T 1phk_A 93 Y--ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDD-MNIKLTD 167 (298)
T ss_dssp E--ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECC
T ss_pred e--ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCC-CcEEEec
Confidence 7 457889999999999999999998889999999999999999999999999 9999999999999877 8999999
Q ss_pred cchhhhhcCCCCCccccCCCCcCCccccc-------cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC
Q 012320 178 LGLAAILRGSKSAHSVIGTPEFMAPELYE-------EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL 250 (466)
Q Consensus 178 FGla~~~~~~~~~~~~~GT~~y~APE~l~-------~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~ 250 (466)
||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+...+...+..+..
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~ 246 (298)
T 1phk_A 168 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNY 246 (298)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC
T ss_pred ccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC-ccHHHHHHHHhcCCc
Confidence 99998776655566778999999999874 3588999999999999999999999976 566777777777665
Q ss_pred CCC--CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 251 PGA--FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 251 p~~--~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
... .+...+..++++|.+||. ||.+|||+.|+|+||||+....
T Consensus 247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence 432 234567899999999996 9999999999999999986543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=374.80 Aligned_cols=260 Identities=24% Similarity=0.411 Sum_probs=208.1
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+. +.||+|+||+||+|.++.+|+.||+|++.... ......+.+.+|+.++++++||||+++++++. +...
T Consensus 2 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~ 76 (311)
T 4agu_A 2 MEKYEKI-GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLKHPNLVNLLEVFR--RKRR 76 (311)
T ss_dssp -CCEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEECCCC--C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--ETTE
T ss_pred cccceEe-eEEeecCCeEEEEEEeCCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHhCCCCCccchhheee--cCCe
Confidence 3688874 66999999999999999999999999886543 24445677889999999999999999999884 4678
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+++||||+.+++|.+++...+.+++..+..++.||+.||.|||++| |+||||||+||+++.+ +.+||+|||++....
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKH-SVIKLCDFGFARLLT 153 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECC
T ss_pred EEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCC-CCEEEeeCCCchhcc
Confidence 9999999999999999988888999999999999999999999999 9999999999999877 899999999997765
Q ss_pred CC-CCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-C-------------
Q 012320 186 GS-KSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-G------------- 248 (466)
Q Consensus 186 ~~-~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-g------------- 248 (466)
.. ......+||+.|+|||++. ..++.++|||||||++|+|++|..||.+............. +
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 154 GPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred CcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 32 2344568999999999875 45899999999999999999999999874443333222110 0
Q ss_pred ------CCCCC--------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 249 ------KLPGA--------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 249 ------~~p~~--------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
..+.. .....+.++.+||.+||. ||.+|||++|+|+||||+....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 11110 012356789999999996 9999999999999999986543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=365.85 Aligned_cols=258 Identities=26% Similarity=0.410 Sum_probs=223.5
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
...++|.+ .+.||+|+||+||+|.++.+|+.||+|.+..... ......+.+.+|+.+++.++||||+++++.+ .+.
T Consensus 12 ~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~ 87 (294)
T 2rku_A 12 RSRRRYVR-GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFF--EDN 87 (294)
T ss_dssp TTTEEEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--ECS
T ss_pred CcccceEE-EEEEeecCCEEEEEEEECCCCceEEEEEechhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeeeeee--ccC
Confidence 34466766 6789999999999999999999999999986543 3455678899999999999999999999987 457
Q ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 104 KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
..+++||||+.+++|.+++.+.+.+++..+..++.||+.||.|||++| |+||||||+||+++.+ +.+||+|||++..
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~ 164 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKIGDFGLATK 164 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCC-CCEEEEeccCcee
Confidence 789999999999999999998889999999999999999999999999 9999999999999977 8999999999976
Q ss_pred hcC-CCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 012320 184 LRG-SKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLE 261 (466)
Q Consensus 184 ~~~-~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 261 (466)
... ........||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..+.+..+..+..+ .+...+..
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~--~~~~~~~~ 241 (294)
T 2rku_A 165 VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNEYS--IPKHINPV 241 (294)
T ss_dssp CCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCCC--CCTTSCHH
T ss_pred cccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhhccCC--CccccCHH
Confidence 542 23344567999999999876 4589999999999999999999999976 5666677777766543 34456789
Q ss_pred HHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 262 AQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 262 ~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
+.++|.+||. ||.+|||+.++++||||...
T Consensus 242 ~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 242 AASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp HHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 9999999996 99999999999999999653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=367.71 Aligned_cols=256 Identities=25% Similarity=0.401 Sum_probs=218.0
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
++|.+ .+.||+|+||+||+|.++.+|+.||+|++..... ....+.+.+|+.+++.++||||+++++.+ .+...+
T Consensus 7 ~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~ 80 (276)
T 2yex_A 7 EDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHR--REGNIQ 80 (276)
T ss_dssp HHEEE-EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC---TTHHHHHHHHHHHHHTCCCTTBCCEEEEE--EETTEE
T ss_pred cceEE-EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc---hhhhHHHHHHHHHHHhcCCCCceeeeeEE--EcCCEE
Confidence 57877 5669999999999999999999999999875542 23557889999999999999999999987 446789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
++||||+.+++|.+++.....+++..+..++.||+.||.|||++| |+||||||+||+++.+ +.+||+|||++..+..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRY 157 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEECEE
T ss_pred EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccC-CCEEEeeCCCccccCC
Confidence 999999999999999987788999999999999999999999999 9999999999999877 8999999999976532
Q ss_pred C---CCCccccCCCCcCCcccccc-C-CCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 012320 187 S---KSAHSVIGTPEFMAPELYEE-D-YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLE 261 (466)
Q Consensus 187 ~---~~~~~~~GT~~y~APE~l~~-~-y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 261 (466)
. .......||+.|+|||++.+ . ++.++|||||||++|+|++|..||.........+..+.............+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 237 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHH
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHH
Confidence 2 22345679999999998864 3 47789999999999999999999987555555555555544333334567889
Q ss_pred HHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 262 AQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 262 ~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
++++|.+||. ||.+|||+.|+++||||+..
T Consensus 238 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 238 PLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 9999999996 99999999999999999754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=385.62 Aligned_cols=255 Identities=24% Similarity=0.351 Sum_probs=207.9
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec---
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV--- 101 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--- 101 (466)
..++|.+ .+.||+|+||+||+|.+..+|+.||+|++..... ...+|+.+|+.++||||++++++|...
T Consensus 5 ~~~~y~~-~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 5 SSKKYSL-GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR--------YKNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp -CTTEEE-EEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred ccceEEE-EEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc--------hHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 4678887 5779999999999999999999999999874432 123699999999999999999988652
Q ss_pred ---------------------------------cCCEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHH
Q 012320 102 ---------------------------------DQKTFNFITEMFTSGTLREYRK----KYRRVDIRAIKSWARQILQGL 144 (466)
Q Consensus 102 ---------------------------------~~~~~~lV~E~~~ggsL~~~l~----~~~~l~~~~~~~i~~qIl~gL 144 (466)
+...+++||||++ |+|.+.+. ..+.+++..++.++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 2346899999997 47666554 457899999999999999999
Q ss_pred HHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHH
Q 012320 145 VYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCV 222 (466)
Q Consensus 145 ~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil 222 (466)
.|||+.| |+||||||+|||++...+.+||+|||++..+.........+||+.|+|||++.+ .|+.++|||||||++
T Consensus 155 ~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 155 GFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9999999 999999999999986558999999999987766666667789999999997753 489999999999999
Q ss_pred HHHHhCCCCCCCCCCHHHHHHHHhc-C-----------------CCCC--------CCCCCCCHHHHHHHHHhcc-CcCC
Q 012320 223 LEMFTCEYPYSECANPAQIYKKVTS-G-----------------KLPG--------AFYSIQDLEAQRFIGRCLV-NASK 275 (466)
Q Consensus 223 ~elltg~~Pf~~~~~~~~i~~~i~~-g-----------------~~p~--------~~~~~~~~~~~~lI~~~L~-dp~~ 275 (466)
|+|++|..||.+.....++.+.+.. | .+|. .++...+.++++||.+||. ||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999875544444443321 1 1111 0233467789999999996 9999
Q ss_pred CCCHHHHhcCCCCCch
Q 012320 276 RLSAKELLLDPFLASD 291 (466)
Q Consensus 276 Rpsa~elL~hpf~~~~ 291 (466)
|||+.|+|+||||+..
T Consensus 313 R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 313 RINPYEAMAHPFFDHL 328 (383)
T ss_dssp SCCHHHHHTSGGGHHH
T ss_pred CCCHHHHhcCHHHHHH
Confidence 9999999999999753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=369.64 Aligned_cols=255 Identities=26% Similarity=0.437 Sum_probs=216.7
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+ .+.||+|+||+||+|.++.++..||+|++...... .......+.+|+.++++++||||+++++++ .+...
T Consensus 8 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~ 83 (279)
T 3fdn_A 8 LEDFEI-GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYF--HDATR 83 (279)
T ss_dssp GGGEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HHTCHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSE
T ss_pred cccEEE-eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccc-hhhHHHHHHHHHHHHHcCCCCCCcchhheE--ecCCE
Confidence 467877 56799999999999999999999999998754321 112245788999999999999999999987 45678
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+++||||+.+++|.+++.+.+.+++..+..++.||+.||.|||+.| |+||||||+||+++.+ |.+||+|||++....
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~-~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSA-GELKIADFGWSVHAP 160 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTT-SCEEECSCCEESCC-
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCC-CCEEEEeccccccCC
Confidence 9999999999999999998899999999999999999999999999 9999999999999877 899999999986543
Q ss_pred CCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 012320 186 GSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQR 264 (466)
Q Consensus 186 ~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~ 264 (466)
.. ......||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..+.++.+.....+ .+...+..+++
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 236 (279)
T 3fdn_A 161 SS-RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEFT--FPDFVTEGARD 236 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCC--CCTTSCHHHHH
T ss_pred cc-cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC-CcHHHHHHHHHhCCCC--CCCcCCHHHHH
Confidence 32 234567999999999876 4588999999999999999999999976 6777777777766543 34557789999
Q ss_pred HHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 265 FIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 265 lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
||.+||. +|.+|||+.|+++||||+..
T Consensus 237 li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 237 LISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHHhccChhhCCCHHHHhhCccccCC
Confidence 9999996 99999999999999999653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=377.09 Aligned_cols=255 Identities=29% Similarity=0.496 Sum_probs=217.1
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
+...|... +.||+|+||+||+|.++.+|+.||+|++..... ...+.+.+|+.++++++||||+++++.+.. ..
T Consensus 43 ~~~~~~~~-~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~ 115 (321)
T 2c30_A 43 PRLLLDSY-VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHFNVVEMYKSYLV--GE 115 (321)
T ss_dssp HHHHEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CSHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TT
T ss_pred chhhhhcc-EEeccCCCeEEEEEEECCCCcEEEEEEEeccch----hHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CC
Confidence 33456664 569999999999999999999999999875432 234678899999999999999999998854 66
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.+++||||+.|++|.+++.+ ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++...
T Consensus 116 ~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~ 191 (321)
T 2c30_A 116 ELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQI 191 (321)
T ss_dssp EEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CcEEEeeeeeeeec
Confidence 89999999999999998864 67999999999999999999999999 9999999999999877 89999999999766
Q ss_pred cCC-CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC-CCCCCCHH
Q 012320 185 RGS-KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA-FYSIQDLE 261 (466)
Q Consensus 185 ~~~-~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~-~~~~~~~~ 261 (466)
... ......+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..+....+..+..+.. .....+.+
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2c30_A 192 SKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNSHKVSPV 270 (321)
T ss_dssp CSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCTTGGGSCHH
T ss_pred ccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCCcCccccCCHH
Confidence 433 2345678999999999876 4589999999999999999999999976 566677777766654332 23346789
Q ss_pred HHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 262 AQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 262 ~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
++++|.+||. ||.+|||+.++++||||...
T Consensus 271 l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 271 LRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 9999999996 99999999999999999653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=383.14 Aligned_cols=261 Identities=26% Similarity=0.420 Sum_probs=212.8
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccC-CHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMR-SPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
.++|.+ .+.||+|+||+||+|.++.++..||+|++....... .....+.+.+|+.+|++++||||+++++++ .+..
T Consensus 25 ~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~--~~~~ 101 (345)
T 3hko_A 25 QKKYHL-KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY--EDEQ 101 (345)
T ss_dssp HHHEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSS
T ss_pred hhheee-cceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh--ccCC
Confidence 577877 567999999999999999999999999998654322 344667899999999999999999999988 4577
Q ss_pred EEEEEEecCCCCCHHHHHHhc----------------------------------------CCCCHHHHHHHHHHHHHHH
Q 012320 105 TFNFITEMFTSGTLREYRKKY----------------------------------------RRVDIRAIKSWARQILQGL 144 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~----------------------------------------~~l~~~~~~~i~~qIl~gL 144 (466)
.+++||||+.||+|.+++... ..+++..++.++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 899999999999999988421 1246788999999999999
Q ss_pred HHHHhCCCCeEeccCCCCcEEEeCCC-CcEEEeccchhhhhcCCC-----CCccccCCCCcCCccccc---cCCCChhhH
Q 012320 145 VYLHSRDPPVIHRDLKCDNIFVNGHL-GQVKIGDLGLAAILRGSK-----SAHSVIGTPEFMAPELYE---EDYNELVDV 215 (466)
Q Consensus 145 ~yLHs~~~~IiHrDLKp~NIlv~~~~-g~vKL~DFGla~~~~~~~-----~~~~~~GT~~y~APE~l~---~~y~~~~DI 215 (466)
.|||+.+ |+||||||+|||++.+. +.+||+|||++..+.... ......||+.|+|||++. ..|+.++||
T Consensus 182 ~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 182 HYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 9999999 99999999999997651 289999999997653211 234567999999999875 468999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC--CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 216 YSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG--AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 216 wSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~--~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
|||||++|+|++|..||.. .+..+....+..+.... ......+.++++||.+||. +|.+|||+.++|+||||+...
T Consensus 260 wslG~il~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPG-VNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHHHHHCCCCCCC-CChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 9999999999999999987 45555556665555432 2333467899999999996 999999999999999997543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=370.13 Aligned_cols=257 Identities=27% Similarity=0.474 Sum_probs=225.3
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.+||.+ .+.||+|+||+||+|.++.+|+.||+|++...... ....+.+.+|+.++++++||||+++++.+ .+...
T Consensus 21 ~~~y~i-~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~ 95 (287)
T 2wei_A 21 AERYNI-VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEIL--EDSSS 95 (287)
T ss_dssp HHHEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEE--ECSSE
T ss_pred hhccee-eEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc--hHHHHHHHHHHHHHHhccCCCccEEEEEE--eCCCe
Confidence 468888 46699999999999999999999999999765432 23456789999999999999999999987 45778
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC--CCcEEEeccchhhh
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAAI 183 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~--~g~vKL~DFGla~~ 183 (466)
+++|+||+.+++|.+++.+.+.+++..+..++.||+.||.|||+.| |+||||||+||+++.+ .+.+||+|||++..
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 9999999999999999988889999999999999999999999999 9999999999999754 24799999999987
Q ss_pred hcCCCCCccccCCCCcCCccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCCCHH
Q 012320 184 LRGSKSAHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAF--YSIQDLE 261 (466)
Q Consensus 184 ~~~~~~~~~~~GT~~y~APE~l~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~--~~~~~~~ 261 (466)
...........||+.|+|||++.+.++.++|||||||++|+|++|..||.. .+..++.+.+..+..+... +...+.+
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (287)
T 2wei_A 174 FQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISDD 252 (287)
T ss_dssp BCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGTTSCHH
T ss_pred ecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCchhhhhcCHH
Confidence 765555556679999999999988899999999999999999999999977 6677788888887765433 2456789
Q ss_pred HHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 262 AQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 262 ~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
++++|.+||. +|.+|||+.++|+||||+.
T Consensus 253 ~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred HHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 9999999996 9999999999999999964
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=382.00 Aligned_cols=262 Identities=22% Similarity=0.369 Sum_probs=211.9
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
.+..++|.+. +.||+|+||+||+|.++.+|+.||+|++..... .......+.+|+.+|+.++||||+++++.+....
T Consensus 13 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 89 (351)
T 3mi9_A 13 CDEVSKYEKL-AKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (351)
T ss_dssp SCBGGGEEEE-EECSSCSTTSEEEEEETTTCCEEEEEECCCSSC--SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred cccccceeEE-EEEecCCCcEEEEEEECCCCCEEEEEEEecccc--cccchHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence 4556899885 669999999999999999999999999875543 2223356789999999999999999999886543
Q ss_pred ------CCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEE
Q 012320 103 ------QKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKI 175 (466)
Q Consensus 103 ------~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL 175 (466)
.+.+++||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||
T Consensus 90 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~-~~~kl 165 (351)
T 3mi9_A 90 SPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLKL 165 (351)
T ss_dssp -------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEE
T ss_pred cccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCC-CCEEE
Confidence 4578999999975 776666543 67999999999999999999999999 9999999999999877 89999
Q ss_pred eccchhhhhcC-----CCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-
Q 012320 176 GDLGLAAILRG-----SKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS- 247 (466)
Q Consensus 176 ~DFGla~~~~~-----~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~- 247 (466)
+|||++..+.. .......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+.......+..
T Consensus 166 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~ 244 (351)
T 3mi9_A 166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG-NTEQHQLALISQL 244 (351)
T ss_dssp CCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHH
T ss_pred ccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHH
Confidence 99999976542 222345679999999997753 489999999999999999999999987 445444444432
Q ss_pred -CCCCCCCCCC----------------------------CCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 248 -GKLPGAFYSI----------------------------QDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 248 -g~~p~~~~~~----------------------------~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
+..+...+.. .++++++||.+||. ||.+|||+.|+|+||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 3333222111 25679999999996 999999999999999997643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=379.95 Aligned_cols=262 Identities=26% Similarity=0.437 Sum_probs=215.5
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEeccccc----CCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELM----RSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~----~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
++|.+ .+.||+|+||+||+|.++.+|+.||+|++...... ........+.+|+.+|++++||||+++++.+..
T Consensus 10 ~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 86 (322)
T 2ycf_A 10 DEYIM-SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 86 (322)
T ss_dssp HHEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred hceeE-eeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence 57777 56799999999999999999999999998765421 112234568899999999999999999998732
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCC--CcEEEeccch
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHL--GQVKIGDLGL 180 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~--g~vKL~DFGl 180 (466)
. .+++||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+. +.+||+|||+
T Consensus 87 ~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 87 E-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp S-SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred C-ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 3 38999999999999999988889999999999999999999999999 99999999999998652 2499999999
Q ss_pred hhhhcCCCCCccccCCCCcCCccccc----cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC--C
Q 012320 181 AAILRGSKSAHSVIGTPEFMAPELYE----EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA--F 254 (466)
Q Consensus 181 a~~~~~~~~~~~~~GT~~y~APE~l~----~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~--~ 254 (466)
+.............||+.|+|||++. ..++.++|||||||++|+|++|..||........+...+..+..+.. .
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T 2ycf_A 164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243 (322)
T ss_dssp CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence 98765443344567999999999863 45899999999999999999999999876555556666766654321 2
Q ss_pred CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhhh
Q 012320 255 YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVK 294 (466)
Q Consensus 255 ~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~~ 294 (466)
+...+..+++||.+||. ||.+|||+.++|+||||+...++
T Consensus 244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~~ 284 (322)
T 2ycf_A 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 284 (322)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHHH
T ss_pred hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHHH
Confidence 24467899999999996 99999999999999999886653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=370.24 Aligned_cols=259 Identities=25% Similarity=0.372 Sum_probs=202.9
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
..++|.+ .+.||+|+||+||+|.+..+|+.||+|++.... ......+.+.++..+++.++||||+++++.+. +..
T Consensus 5 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--~~~ 79 (290)
T 3fme_A 5 KADDLEP-IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV--NSQEQKRLLMDLDISMRTVDCPFTVTFYGALF--REG 79 (290)
T ss_dssp CGGGEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEC-----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSS
T ss_pred cHHhhhh-HHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc--CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee--ccC
Confidence 3578887 466999999999999999999999999987543 12233344555556688889999999999884 466
Q ss_pred EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 105 TFNFITEMFTSGTLREYRKK----YRRVDIRAIKSWARQILQGLVYLHSR-DPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qIl~gL~yLHs~-~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
.+++||||+. |+|.+++.. .+.+++..++.++.||+.||.|||++ | |+||||||+||+++.+ +.+||+|||
T Consensus 80 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg 155 (290)
T 3fme_A 80 DVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINAL-GQVKMCDFG 155 (290)
T ss_dssp SEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTT-CCEEBCCC-
T ss_pred CEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCC-CCEEEeecC
Confidence 7899999996 588776653 46899999999999999999999998 8 9999999999999877 899999999
Q ss_pred hhhhhcCCCCCccccCCCCcCCcccc-----ccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 012320 180 LAAILRGSKSAHSVIGTPEFMAPELY-----EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAF 254 (466)
Q Consensus 180 la~~~~~~~~~~~~~GT~~y~APE~l-----~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~ 254 (466)
++.............||+.|+|||++ ...++.++|||||||++|+|++|..||..................+...
T Consensus 156 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 235 (290)
T 3fme_A 156 ISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP 235 (290)
T ss_dssp --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCC
T ss_pred CcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcc
Confidence 99877655555556899999999985 2458899999999999999999999998766666666666555555555
Q ss_pred CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 255 YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 255 ~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
....+.+++++|.+||. ||.+|||+.|+++||||+...
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 236 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 55678899999999996 999999999999999997543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=373.44 Aligned_cols=260 Identities=20% Similarity=0.327 Sum_probs=216.0
Q ss_pred ceeeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEeE
Q 012320 19 GYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYTS 97 (466)
Q Consensus 19 ~~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~ 97 (466)
..++....++|.+ .+.||+|+||+||+|.+..+|+.||+|++... ..+.+.+|+.+|++++ ||||+++++.
T Consensus 28 ~~~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~~~~~ 99 (330)
T 3nsz_A 28 HVVEWGNQDDYQL-VRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLRGGPNIITLADI 99 (330)
T ss_dssp CCCCCEEGGGEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEECSC-------CHHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred hhhcccCCCceEE-EEEecccCCeEEEEEEECCCCcEEEEEEeccc-------chHHHHHHHHHHHHcCCCCCEEEeeee
Confidence 3455566788988 56699999999999999999999999998632 2356889999999996 9999999998
Q ss_pred EEeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEec
Q 012320 98 WIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGD 177 (466)
Q Consensus 98 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~D 177 (466)
+.+......++||||+.+++|.+++. .+++..++.++.||+.||.|||++| |+||||||+|||++.+.+.+||+|
T Consensus 100 ~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~D 174 (330)
T 3nsz_A 100 VKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLID 174 (330)
T ss_dssp EECTTTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECC
T ss_pred eccCCCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEe
Confidence 86655778999999999999998874 4899999999999999999999999 999999999999997744899999
Q ss_pred cchhhhhcCCCCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----------
Q 012320 178 LGLAAILRGSKSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKV---------- 245 (466)
Q Consensus 178 FGla~~~~~~~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i---------- 245 (466)
||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||....+.......+
T Consensus 175 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 254 (330)
T 3nsz_A 175 WGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 254 (330)
T ss_dssp CTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred CCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhh
Confidence 99998776666666778999999999875 458999999999999999999999996655443332221
Q ss_pred ---hcCCC----------------------CCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 246 ---TSGKL----------------------PGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 246 ---~~g~~----------------------p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
..... +.......+.++++||.+||. ||.+|||++|+|+||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 11111 011122357899999999996 99999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=378.55 Aligned_cols=255 Identities=21% Similarity=0.360 Sum_probs=211.7
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
..+||.+ .++||+|+||+||+|.++.+|+.||+|++....... ..+.+.+|+.+|++++||||+++++.+......
T Consensus 7 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (319)
T 4euu_A 7 SNHLWLL-SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR---PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (319)
T ss_dssp SSEEEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS---CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCCCEEE-EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc---hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence 4567776 677999999999999999999999999987554322 346678999999999999999999988766666
Q ss_pred EEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEE----eCCCCcEEEec
Q 012320 105 TFNFITEMFTSGTLREYRKKYRR---VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFV----NGHLGQVKIGD 177 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~---l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv----~~~~g~vKL~D 177 (466)
.+++||||+.|++|.+++..... +++..+..++.||+.||.|||+.+ |+||||||+|||+ +.. +.+||+|
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~-~~~kL~D 159 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQ-SVYKLTD 159 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSC-EEEEECC
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCC-ceEEEcc
Confidence 88999999999999999986543 999999999999999999999999 9999999999998 544 6899999
Q ss_pred cchhhhhcCCCCCccccCCCCcCCccccc---------cCCCChhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH
Q 012320 178 LGLAAILRGSKSAHSVIGTPEFMAPELYE---------EDYNELVDVYSFGMCVLEMFTCEYPYSECAN---PAQIYKKV 245 (466)
Q Consensus 178 FGla~~~~~~~~~~~~~GT~~y~APE~l~---------~~y~~~~DIwSlGvil~elltg~~Pf~~~~~---~~~i~~~i 245 (466)
||++.............||+.|+|||++. ..|+.++|||||||++|+|++|..||..... ..++...+
T Consensus 160 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred CCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 99998876666666778999999999874 5689999999999999999999999964332 23344444
Q ss_pred hcCCCCC-----------------------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCC
Q 012320 246 TSGKLPG-----------------------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDP 286 (466)
Q Consensus 246 ~~g~~p~-----------------------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hp 286 (466)
..+..+. ......+..+.++|.+||. ||.+|||+.|+|+||
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 4443221 1112234578899999996 999999999999998
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=367.37 Aligned_cols=256 Identities=25% Similarity=0.435 Sum_probs=212.6
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+ .+.||+|+||+||+|.++.+|+.||+|.+...... .....+.+.+|+.+++.++||||+++++.+ .....
T Consensus 10 ~~~y~i-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~ 85 (276)
T 2h6d_A 10 IGHYVL-GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR-SLDVVGKIKREIQNLKLFRHPHIIKLYQVI--STPTD 85 (276)
T ss_dssp ETTEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEE--ECSSE
T ss_pred eccEEE-EeeecCCCCeEEEEEEECCCCceEEEEEecccccc-chhHHHHHHHHHHHHhcCCCCCEeEEEEEE--ecCCe
Confidence 368877 57799999999999999999999999998754321 122346789999999999999999999987 45678
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+++||||+.+++|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMS 162 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTT-SCEEECCCCGGGCCC
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCC-CCEEEeecccccccC
Confidence 9999999999999999998889999999999999999999999999 9999999999999877 899999999998766
Q ss_pred CCCCCccccCCCCcCCccccccC-C-CChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 186 GSKSAHSVIGTPEFMAPELYEED-Y-NELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 186 ~~~~~~~~~GT~~y~APE~l~~~-y-~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
.........||+.|+|||++.+. + +.++|||||||++|+|++|..||.. .+...+.+.+..+..+ .+...+..+.
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~--~~~~~~~~l~ 239 (276)
T 2h6d_A 163 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFY--IPEYLNRSVA 239 (276)
T ss_dssp C-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHH
T ss_pred CCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcCccc--CchhcCHHHH
Confidence 55545567899999999988754 3 5899999999999999999999976 6677788888777543 3345678999
Q ss_pred HHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 264 RFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
++|.+||. ||.+|||+.++++||||+..
T Consensus 240 ~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 240 TLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 99999996 99999999999999999653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=374.51 Aligned_cols=258 Identities=26% Similarity=0.410 Sum_probs=223.9
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
...++|.+ .+.||+|+||+||+|.++.+++.||+|++..... ......+.+.+|+.+++.++||||+++++.+ .+.
T Consensus 38 ~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~ 113 (335)
T 2owb_A 38 RSRRRYVR-GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFF--EDN 113 (335)
T ss_dssp TTTEEEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--ECS
T ss_pred ccCCceEE-EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE--ecC
Confidence 34567766 6779999999999999999999999999986543 3456678899999999999999999999987 457
Q ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 104 KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
..+++||||+.+++|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..
T Consensus 114 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 114 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKIGDFGLATK 190 (335)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCEE
T ss_pred CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCC-CCEEEeeccCcee
Confidence 789999999999999999998889999999999999999999999999 9999999999999977 8999999999977
Q ss_pred hcC-CCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 012320 184 LRG-SKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLE 261 (466)
Q Consensus 184 ~~~-~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 261 (466)
... ........||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..+.+..+..+... .+...+.+
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~~--~~~~~~~~ 267 (335)
T 2owb_A 191 VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNEYS--IPKHINPV 267 (335)
T ss_dssp CCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCC--CCTTSCHH
T ss_pred cccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHhcCCCC--CCccCCHH
Confidence 642 23344567999999999876 4589999999999999999999999976 5666677777666543 34456789
Q ss_pred HHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 262 AQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 262 ~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
+++||.+||. ||.+|||+.|+|+||||+..
T Consensus 268 ~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 268 AASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp HHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 9999999996 99999999999999999653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=366.81 Aligned_cols=260 Identities=24% Similarity=0.407 Sum_probs=217.8
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCH--HHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSP--DDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
++|.+ .+.||+|+||+||+|.++.+|+.||+|.+......... ...+.+.+|+.++++++||||+++++.+ .+..
T Consensus 5 ~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~ 81 (283)
T 3bhy_A 5 DHYEM-GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF--ENKT 81 (283)
T ss_dssp HHEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSS
T ss_pred hhhhh-HHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhee--cCCC
Confidence 46776 56699999999999999999999999999866532221 1356789999999999999999999987 4567
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCC----cEEEeccch
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLG----QVKIGDLGL 180 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g----~vKL~DFGl 180 (466)
.+++||||+.+++|.+++.+.+.+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ + .+||+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDK-NVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCS-SSSSCCEEECCCTT
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecC-CCCCCceEEEeccc
Confidence 89999999999999999998889999999999999999999999999 9999999999999865 4 799999999
Q ss_pred hhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC--CCCCC
Q 012320 181 AAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG--AFYSI 257 (466)
Q Consensus 181 a~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~--~~~~~ 257 (466)
+.............||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..+....+..+.... ..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T 3bhy_A 159 AHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-ETKQETLTNISAVNYDFDEEYFSN 237 (283)
T ss_dssp CEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred ceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC-cchHHHHHHhHhcccCCcchhccc
Confidence 98765555555677999999999876 5689999999999999999999999976 56667777776655432 22345
Q ss_pred CCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 258 QDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 258 ~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
.+..++++|.+||. ||.+|||+.++++||||+....
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 238 TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp CCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 67889999999996 9999999999999999976543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=364.86 Aligned_cols=262 Identities=29% Similarity=0.455 Sum_probs=222.5
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
..++|.+ .+.||+|+||+||+|.++.+|+.||+|.+..... +....+.+.+|+.++++++||||+++++.+.+....
T Consensus 4 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (279)
T 2w5a_A 4 RAEDYEV-LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 80 (279)
T ss_dssp CGGGEEE-EEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred chhheee-ehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence 3478877 4669999999999999999999999999986543 455678899999999999999999999988777778
Q ss_pred EEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---CCeEeccCCCCcEEEeCCCCcEEEec
Q 012320 105 TFNFITEMFTSGTLREYRKKY----RRVDIRAIKSWARQILQGLVYLHSRD---PPVIHRDLKCDNIFVNGHLGQVKIGD 177 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qIl~gL~yLHs~~---~~IiHrDLKp~NIlv~~~~g~vKL~D 177 (466)
.+++||||++|++|.+++.+. ..+++..+..++.||+.||.|||+.+ .+|+||||||+||+++.+ +.+||+|
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~-~~~kl~d 159 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGD 159 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS-SCEEECC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC-CCEEEec
Confidence 999999999999999998764 34999999999999999999999986 349999999999999877 8999999
Q ss_pred cchhhhhcCCCC-CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 012320 178 LGLAAILRGSKS-AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFY 255 (466)
Q Consensus 178 FGla~~~~~~~~-~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~ 255 (466)
||++........ .....||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..++...+..+..+. .+
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~~~-~~ 237 (279)
T 2w5a_A 160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFRR-IP 237 (279)
T ss_dssp CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCC-CC
T ss_pred CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcc-cCHHHHHHHHhhccccc-CC
Confidence 999987643322 23457999999999876 4589999999999999999999999976 56777888888887643 34
Q ss_pred CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 256 ~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
...+.+++++|.+||. ||.+|||+.|+++|||+....
T Consensus 238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 4567899999999996 999999999999999997643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=382.84 Aligned_cols=260 Identities=25% Similarity=0.479 Sum_probs=218.1
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
.-..++|.+. +.||+|+||+||+|.++.+|..||+|++.... .....+.+.+|+.+|++++||||+++++++. +
T Consensus 29 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~ 102 (360)
T 3eqc_A 29 ELKDDDFEKI-SELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFY--S 102 (360)
T ss_dssp CCCGGGEEEE-EEEEECSSCEEEEEEETTTCCEEEEEEEECCC---CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE--E
T ss_pred ccccccceee-eeecCCCCeEEEEEEECCCCcEEEEEEecccc---CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE--E
Confidence 4456789885 66999999999999999999999999987542 4556678999999999999999999999884 4
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSR-DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~-~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
...+++||||+.|++|.+++.+.+.+++..+..++.||+.||.|||+. + |+||||||+|||++.+ +.+||+|||++
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~ 179 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVS 179 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTT-CCEEECCCCCC
T ss_pred CCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCC-CCEEEEECCCC
Confidence 678999999999999999999988999999999999999999999985 8 9999999999999977 89999999999
Q ss_pred hhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------------------
Q 012320 182 AILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQI------------------- 241 (466)
Q Consensus 182 ~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i------------------- 241 (466)
...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..++
T Consensus 180 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 180 GQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP-PDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp HHHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC-CCHHHHHHHHC--------------
T ss_pred cccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhcccccccCCCCCCCc
Confidence 765432 234567999999999876 4589999999999999999999999976 333322
Q ss_pred -----------------------HHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 242 -----------------------YKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 242 -----------------------~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
...+..+..+.......+.++++||.+||. ||.+|||+.|+|+||||+....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 333 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence 233333443433444567899999999996 9999999999999999986554
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=384.38 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=207.3
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
..-.++|... +.||+|+||+||+|.++.+|+.||+|++.... .+....+++.+|+.+|++++||||+++++++....
T Consensus 21 ~~~~~~y~~~-~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 21 WEVRAVYRDL-QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 97 (367)
T ss_dssp ECCBSSEEEE-EEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred eeecceEEEe-EEeeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence 3445788884 66999999999999999999999999986432 34556678999999999999999999999875432
Q ss_pred ----CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEecc
Q 012320 103 ----QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDL 178 (466)
Q Consensus 103 ----~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DF 178 (466)
...+|+||||+ |++|.++++. +.+++..++.++.||+.||.|||+.| |+||||||+|||++.+ |.+||+||
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Df 172 (367)
T 1cm8_A 98 TLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDF 172 (367)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCC
T ss_pred ccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCC-CCEEEEee
Confidence 14579999999 8999999876 78999999999999999999999999 9999999999999987 89999999
Q ss_pred chhhhhcCCCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--CCCC---
Q 012320 179 GLAAILRGSKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS--GKLP--- 251 (466)
Q Consensus 179 Gla~~~~~~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~--g~~p--- 251 (466)
|++..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.... .....+.. |..+
T Consensus 173 g~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 173 GLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp TTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHH
T ss_pred eccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHH
Confidence 99976543 3455789999999997754 6999999999999999999999999874433 33333321 1111
Q ss_pred ------------------------CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 252 ------------------------GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 252 ------------------------~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.......++.+++||.+||. ||.+|||+.|+|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 01123457899999999996 99999999999999999753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=370.25 Aligned_cols=254 Identities=22% Similarity=0.414 Sum_probs=217.5
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+ .+.||+|+||+||+|.++.+|+.||+|.+..... ...+.+.+|+.++++++||||+++++.+ .+...
T Consensus 8 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~ 80 (304)
T 2jam_A 8 RKTFIF-MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA----FRDSSLENEIAVLKKIKHENIVTLEDIY--ESTTH 80 (304)
T ss_dssp HHHEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEE--ECSSE
T ss_pred hcccee-eeeccCCCCceEEEEEECCCCCEEEEEEEecccc----cchHHHHHHHHHHHhCCCCCeeehhhhc--ccCCE
Confidence 457766 5779999999999999999999999999875432 2335688999999999999999999987 45778
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEE---eCCCCcEEEeccchhh
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFV---NGHLGQVKIGDLGLAA 182 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv---~~~~g~vKL~DFGla~ 182 (466)
+++||||+.|++|.+++...+.+++..+..++.||+.||.|||+.| |+||||||+||++ +.+ +.+||+|||++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~-~~~kl~Dfg~~~ 157 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEEN-SKIMITDFGLSK 157 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTT-CCEEBCSCSTTC
T ss_pred EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCC-CCEEEccCCcce
Confidence 9999999999999999988889999999999999999999999999 9999999999999 444 799999999987
Q ss_pred hhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCC
Q 012320 183 ILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP--GAFYSIQD 259 (466)
Q Consensus 183 ~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~~~ 259 (466)
.... .......||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+...+...+..+..+ ...+...+
T Consensus 158 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (304)
T 2jam_A 158 MEQN-GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDDIS 235 (304)
T ss_dssp CCCC-BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHCCCCCCTTTTTTSC
T ss_pred ecCC-CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCccccccCC
Confidence 5433 2344567999999999876 4589999999999999999999999976 6677788888877643 33445678
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.++++||.+||. ||.+|||+.++|+||||+..
T Consensus 236 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 236 ESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 899999999996 99999999999999999653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=381.03 Aligned_cols=250 Identities=25% Similarity=0.391 Sum_probs=212.9
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCC----HHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRS----PDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
.++|.+ .+.||+|+||+||+|.++.+|+.||+|++........ ......+.+|+.+|++++||||++++++| .
T Consensus 23 ~~~y~~-~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~--~ 99 (335)
T 3dls_A 23 SQKYST-MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF--E 99 (335)
T ss_dssp HHHEEE-EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE--E
T ss_pred ccceEE-EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE--e
Confidence 468887 5669999999999999999999999999986653221 11334577899999999999999999988 4
Q ss_pred cCCEEEEEEecCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 102 DQKTFNFITEMFTSG-TLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 102 ~~~~~~lV~E~~~gg-sL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
+...+++||||+.+| +|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~Dfg~ 176 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAED-FTIKLIDFGS 176 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTT
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCC-CcEEEeeccc
Confidence 577899999998766 99999999889999999999999999999999999 9999999999999877 8999999999
Q ss_pred hhhhcCCCCCccccCCCCcCCcccccc-CC-CChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 012320 181 AAILRGSKSAHSVIGTPEFMAPELYEE-DY-NELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258 (466)
Q Consensus 181 a~~~~~~~~~~~~~GT~~y~APE~l~~-~y-~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 258 (466)
+............+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||..... ..... ...+...
T Consensus 177 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~--~~~~~~~ 247 (335)
T 3dls_A 177 AAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------TVEAA--IHPPYLV 247 (335)
T ss_dssp CEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------GTTTC--CCCSSCC
T ss_pred ceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------HHhhc--cCCCccc
Confidence 988766666667889999999998764 34 7899999999999999999999965211 11111 1233456
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
+.++++||.+||. ||.+|||+.++++||||+.
T Consensus 248 ~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 248 SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 7899999999996 9999999999999999975
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=377.47 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=206.8
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-----CCceeEEEeEEEe
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-----HDSIIRFYTSWID 100 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-----HpnIv~l~~~~~~ 100 (466)
.++|.+. ++||+|+||+||+|.+..+|+.||+|++.. ..........|+.+++.+. ||||+++++.+..
T Consensus 34 ~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 34 NNAFLVI-RKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp TTTEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEECS-----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred cCEEEEE-EEEcccCCeEEEEEEECCCCeEEEEEEecc-----chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 5789885 669999999999999999999999999863 2345567788999999986 9999999998854
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeC----------
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNG---------- 168 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~---------- 168 (466)
...+++||||+ +++|.+++.+.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 108 --~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 108 --YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp --TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEE
T ss_pred --CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccch
Confidence 67899999999 999999998754 5999999999999999999999999 999999999999974
Q ss_pred --------------CCCcEEEeccchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCC
Q 012320 169 --------------HLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYS 233 (466)
Q Consensus 169 --------------~~g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~ 233 (466)
..+.+||+|||++..... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred hcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 247899999999976443 234668999999999776 569999999999999999999999997
Q ss_pred CCCCHHHHHHHHhcCCCCCC------------------------C--------------------CCCCCHHHHHHHHHh
Q 012320 234 ECANPAQIYKKVTSGKLPGA------------------------F--------------------YSIQDLEAQRFIGRC 269 (466)
Q Consensus 234 ~~~~~~~i~~~i~~g~~p~~------------------------~--------------------~~~~~~~~~~lI~~~ 269 (466)
. .+..+....+.....+.. + ....+..+.+||.+|
T Consensus 261 ~-~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 339 (360)
T 3llt_A 261 T-HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI 339 (360)
T ss_dssp C-SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred C-CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence 6 444444444432211100 0 011236778999999
Q ss_pred cc-CcCCCCCHHHHhcCCCCC
Q 012320 270 LV-NASKRLSAKELLLDPFLA 289 (466)
Q Consensus 270 L~-dp~~Rpsa~elL~hpf~~ 289 (466)
|. ||.+|||+.|+|+||||+
T Consensus 340 L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 340 LQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CCSSGGGSCCHHHHTTSGGGC
T ss_pred hcCChhhCCCHHHHhcCcccC
Confidence 96 999999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=367.07 Aligned_cols=255 Identities=24% Similarity=0.414 Sum_probs=219.2
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+ .+.||+|+||+||+|.+..++..||+|++...... .......+.+|+.+++.++||||+++++++ .+...
T Consensus 13 ~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~ 88 (284)
T 2vgo_A 13 IDDFDI-GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE-KEGVEHQLRREIEIQSHLRHPNILRMYNYF--HDRKR 88 (284)
T ss_dssp GGGEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEE--ECSSE
T ss_pred hhhcee-eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccc-hHHHHHHHHHHHHHHhcCCCCCEeeEEEEE--EcCCE
Confidence 367877 57799999999999999999999999998754321 111245788999999999999999999987 45678
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+++||||+.+++|.+++.+.+.+++..+..++.||+.||.|||+.| |+||||||+||+++.+ |.+||+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYK-GELKIADFGWSVHAP 165 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECS
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCC-CCEEEecccccccCc
Confidence 9999999999999999998889999999999999999999999999 9999999999999877 899999999986554
Q ss_pred CCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 012320 186 GSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQR 264 (466)
Q Consensus 186 ~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~ 264 (466)
. .......||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+.......+..+..+ ++...+.++++
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 241 (284)
T 2vgo_A 166 S-LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS-PSHTETHRRIVNVDLK--FPPFLSDGSKD 241 (284)
T ss_dssp S-SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCCC--CCTTSCHHHHH
T ss_pred c-cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC-CCHhHHHHHHhccccC--CCCcCCHHHHH
Confidence 3 2334567999999999876 4589999999999999999999999976 5666677777766543 34556789999
Q ss_pred HHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 265 FIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 265 lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
+|.+||. ||.+|||+.++++||||+..
T Consensus 242 li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 242 LISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 9999996 99999999999999999643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=368.96 Aligned_cols=252 Identities=30% Similarity=0.453 Sum_probs=206.1
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
-+.++|.+ .+.||+|+||+||+|.+ +|..||+|++..... .....+.+.+|+.+|++++||||+++++++ .+.
T Consensus 34 i~~~~y~i-~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~ 106 (309)
T 3p86_A 34 IPWCDLNI-KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF--HAERVNEFLREVAIMKRLRHPNIVLFMGAV--TQP 106 (309)
T ss_dssp CCGGGEEE-EEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC--SHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--CST
T ss_pred CChhHcee-eeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE--EEC
Confidence 45678877 56799999999999976 589999999875542 455667899999999999999999999987 456
Q ss_pred CEEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 104 KTFNFITEMFTSGTLREYRKKYRR---VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~~---l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
..+++||||+.||+|.+++.+.+. +++..+..++.||+.||.|||+.|++|+||||||+|||++.+ +.+||+|||+
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~ 185 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGL 185 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTT-CCEEECCCC-
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCC-CcEEECCCCC
Confidence 678999999999999999987654 999999999999999999999999889999999999999877 8999999999
Q ss_pred hhhhcCC-CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 012320 181 AAILRGS-KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258 (466)
Q Consensus 181 a~~~~~~-~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 258 (466)
+...... .......||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+..+....+.........+...
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~ 264 (309)
T 3p86_A 186 SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN-LNPAQVVAAVGFKCKRLEIPRNL 264 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT-SCHHHHHHHHHHSCCCCCCCTTS
T ss_pred CccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCccC
Confidence 9765432 2234567999999999876 4589999999999999999999999977 56666666665444444556677
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
++++.+||.+||. +|.+|||+.++++
T Consensus 265 ~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 265 NPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 8899999999996 9999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=378.22 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=201.3
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
++|.++ +.||+|+||+||+|.++.+|+.||+|++..... ......+.+|+.+|++++||||+++++++ .+...+
T Consensus 2 ~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~ 75 (324)
T 3mtl_A 2 ETYIKL-DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDII--HTEKSL 75 (324)
T ss_dssp CSEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEE--ECSSCE
T ss_pred CceEEE-EEEcCCCCEEEEEEEECCCCcEEEEEEEecccc---cccchhHHHHHHHHHhcCCCCCCeeeeEE--eeCCEE
Confidence 578875 669999999999999999999999999874431 11222456799999999999999999987 456779
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 107 NFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
++||||+. |+|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+|||++.+ |.+||+|||++....
T Consensus 76 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 76 TLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINER-GELKLADFGLARAKS 151 (324)
T ss_dssp EEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTT-CCEEECSSSEEECC-
T ss_pred EEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCC-CCEEEccCccccccc
Confidence 99999996 5898888765 45999999999999999999999999 9999999999999877 899999999997654
Q ss_pred CC-CCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--CCCCCC-C-----
Q 012320 186 GS-KSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS--GKLPGA-F----- 254 (466)
Q Consensus 186 ~~-~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~--g~~p~~-~----- 254 (466)
.. ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+..+....+.. +..+.. +
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPG-STVEEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhCCCChHhchhhhc
Confidence 22 23445678999999998753 589999999999999999999999987 444444444332 111111 1
Q ss_pred --------------------CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 255 --------------------YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 255 --------------------~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
....+.++++||.+||. ||.+|||++|+|+||||.....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 12346789999999996 9999999999999999986543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=360.17 Aligned_cols=251 Identities=22% Similarity=0.354 Sum_probs=209.4
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCC
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 104 (466)
.++|.+ .+.||+|+||+||+|.++.+|+.||+|.+..... .......+.+|+..+..+ +||||+++++.+. +..
T Consensus 10 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~--~~~ 84 (289)
T 1x8b_A 10 TTEFHE-LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA--GSVDEQNALREVYAHAVLGQHSHVVRYFSAWA--EDD 84 (289)
T ss_dssp HHHEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT--TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE--ETT
T ss_pred cchhhh-hhhhcCCCceEEEEEEEcCCCceEEEEEeccccc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee--cCC
Confidence 367877 4669999999999999999999999999875432 334567889999999999 9999999999884 467
Q ss_pred EEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC-----------
Q 012320 105 TFNFITEMFTSGTLREYRKKY----RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH----------- 169 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~----~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~----------- 169 (466)
.+++||||++|++|.+++.+. +.+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~ 162 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGD 162 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccc
Confidence 899999999999999999765 67999999999999999999999999 9999999999999742
Q ss_pred -------CCcEEEeccchhhhhcCCCCCccccCCCCcCCccccccC--CCChhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q 012320 170 -------LGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYEED--YNELVDVYSFGMCVLEMFTCEYPYSECANPAQ 240 (466)
Q Consensus 170 -------~g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~~~--y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~ 240 (466)
...+||+|||++...... ....||+.|+|||++.+. ++.++|||||||++|+|++|..|+... .
T Consensus 163 ~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~ 235 (289)
T 1x8b_A 163 EDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----D 235 (289)
T ss_dssp -------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----H
T ss_pred cccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----h
Confidence 247999999999776443 234699999999988654 557999999999999999998777542 2
Q ss_pred HHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 241 IYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 241 i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
....+..+..+. .+...+.+++++|.+||. ||.+|||+.++++||||+..
T Consensus 236 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 236 QWHEIRQGRLPR-IPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHHHHTTCCCC-CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHHHHcCCCCC-CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 355566666543 345678899999999996 99999999999999999764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=368.42 Aligned_cols=260 Identities=29% Similarity=0.477 Sum_probs=214.3
Q ss_pred eeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 22 ~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
..++.++|.+. +.||+|+||+||+|.++.+|..||+|++.... ....+.+.+|+.+++.++||||+++++.+.
T Consensus 14 ~~~~~~~y~i~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-- 86 (302)
T 2j7t_A 14 DLDPNEVWEIV-GELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDYIVEIEILATCDHPYIVKLLGAYY-- 86 (302)
T ss_dssp SSCGGGTEEEE-EEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred ccCCccceeec-ceeccCCCeEEEEEEEcCCCcEEEEEEecCCC----HHHHHHHHHHHHHHhcCCCCCEeeeeeeee--
Confidence 35788999885 55999999999999999999999999987442 234577899999999999999999999884
Q ss_pred cCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 102 DQKTFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
....+++||||+++++|.+++.+ .+.+++..+..++.||+.||.|||+.| |+||||||+||+++.+ +.+||+|||+
T Consensus 87 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~ 163 (302)
T 2j7t_A 87 HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLE-GDIRLADFGV 163 (302)
T ss_dssp CC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT-SCEEECCCHH
T ss_pred eCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCC-CCEEEEECCC
Confidence 45678999999999999998876 467999999999999999999999999 9999999999999877 8999999999
Q ss_pred hhhhcC-CCCCccccCCCCcCCcccc------ccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC-
Q 012320 181 AAILRG-SKSAHSVIGTPEFMAPELY------EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG- 252 (466)
Q Consensus 181 a~~~~~-~~~~~~~~GT~~y~APE~l------~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~- 252 (466)
+..... ........||+.|+|||++ ...++.++|||||||++|+|++|..||.. .+.......+..+..+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~ 242 (302)
T 2j7t_A 164 SAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSDPPTL 242 (302)
T ss_dssp HHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCCCC
T ss_pred CccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCcc-CCHHHHHHHHhccCCccc
Confidence 854321 1223356799999999987 34588999999999999999999999977 45555555565554433
Q ss_pred CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 253 AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 253 ~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
..+...+..++++|.+||. ||.+|||+.++++||||+...
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 243 LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 2345567899999999996 999999999999999998644
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=370.80 Aligned_cols=260 Identities=28% Similarity=0.485 Sum_probs=215.3
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEec
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDV 101 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 101 (466)
.++.++|.+ .+.||+|+||+||+|.+..+|+.||+|++.... ...+.+.+|+.+++++ +||||+++++.+...
T Consensus 20 ~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 20 RDPAGIFEL-VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCTTTEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cCCCCcEEE-EEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 467899988 567999999999999999999999999987543 1235788999999999 899999999998764
Q ss_pred c----CCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEE
Q 012320 102 D----QKTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKI 175 (466)
Q Consensus 102 ~----~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL 175 (466)
. ...+++||||+.+++|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+|||++.+ +.+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~-~~~kl 170 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKL 170 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT-CCEEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCC-CCEEE
Confidence 3 56899999999999999999865 57999999999999999999999999 9999999999999876 89999
Q ss_pred eccchhhhhcCC-CCCccccCCCCcCCccccc------cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q 012320 176 GDLGLAAILRGS-KSAHSVIGTPEFMAPELYE------EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG 248 (466)
Q Consensus 176 ~DFGla~~~~~~-~~~~~~~GT~~y~APE~l~------~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g 248 (466)
+|||++...... .......||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+.......+..+
T Consensus 171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~ 249 (326)
T 2x7f_A 171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRN 249 (326)
T ss_dssp CCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHS
T ss_pred eeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcC
Confidence 999999765432 2234567999999999874 4589999999999999999999999976 4555555556666
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 249 KLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 249 ~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
..+.......+..+++||.+||. ||.+|||+.++++||||+...
T Consensus 250 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 250 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 55555556678899999999996 999999999999999997643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=385.63 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=204.4
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc----C
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD----Q 103 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----~ 103 (466)
+|.. .++||+|+||+||+|.++.+|+.||+|++..... ...+|+.+|+.++||||++++++|.... .
T Consensus 55 ~y~~-~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 55 SYTD-TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred eEEe-eeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 5766 6779999999999999999999999999874432 1236999999999999999999886532 2
Q ss_pred CEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 104 KTFNFITEMFTSGTLREYRK----KYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~----~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
.++++||||+.+ +|.+.+. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.+.+.+||+|||
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccch
Confidence 357799999975 5655543 3467999999999999999999999999 99999999999999765679999999
Q ss_pred hhhhhcCCCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-C--------
Q 012320 180 LAAILRGSKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-G-------- 248 (466)
Q Consensus 180 la~~~~~~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-g-------- 248 (466)
+++.+.........+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+.....++.+.+.. |
T Consensus 203 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 203 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp TCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9987765555566789999999998753 5999999999999999999999999875544444443321 1
Q ss_pred ---------CCCCC--------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 249 ---------KLPGA--------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 249 ---------~~p~~--------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
.+|.. +....+.++++||.+||. ||.+|||+.|+|+||||+.
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence 11110 123457899999999996 9999999999999999964
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=369.99 Aligned_cols=258 Identities=22% Similarity=0.416 Sum_probs=217.9
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+ .+.||+|+||+||+|.++.+|..||+|++............+.+.+|+.++++++||||+++++.+...+...
T Consensus 4 ~~~y~i-~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 4 IGKYLM-GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp -CCBCC-CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred ccceeE-eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 368877 5779999999999999999999999999986654333345678999999999999999999999887666778
Q ss_pred EEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 106 FNFITEMFTSGTLREYRKK--YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~--~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
+++||||+.++ |.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++..
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~-~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTG-GTLKISALGVAEA 158 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCC-CcEEeeccccccc
Confidence 99999999877 7777765 356999999999999999999999999 9999999999999877 8999999999976
Q ss_pred hcCC---CCCccccCCCCcCCccccccC---CCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 012320 184 LRGS---KSAHSVIGTPEFMAPELYEED---YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSI 257 (466)
Q Consensus 184 ~~~~---~~~~~~~GT~~y~APE~l~~~---y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 257 (466)
.... .......||+.|+|||++.+. ++.++|||||||++|+|++|..||.. .+..++...+..+..+ .+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~~--~~~~ 235 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSYA--IPGD 235 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHCCCC--CCSS
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC-chHHHHHHHHhcCCCC--CCCc
Confidence 5422 223456799999999987642 47899999999999999999999976 6777888888877653 3455
Q ss_pred CCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 258 QDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 258 ~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.+..+.+||.+||. ||.+|||+.|+++||||+..
T Consensus 236 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 67899999999996 99999999999999999754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=373.86 Aligned_cols=261 Identities=25% Similarity=0.332 Sum_probs=212.1
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
-.+||.+ .+.||+|+||+||+|.+..+|+.||+|++.... .........+.+|+.++++++||||+++++.+......
T Consensus 10 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 10 LSDRYEL-GEILGFGGMSEVHLARDLRDHRDVAVKVLRADL-ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp ETTTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECTTT-TTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ecCcEEE-EEEEccCCCEEEEEEEECCCCceEEEEEeCccc-cCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 3578987 577999999999999999999999999987543 23455667899999999999999999999988665433
Q ss_pred --EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 105 --TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 105 --~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
.+|+||||+.|++|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~ 164 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISAT-NAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETT-SCEEECCCSCC-
T ss_pred CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCC-CCEEEeeccCcc
Confidence 56899999999999999998899999999999999999999999999 9999999999999987 899999999997
Q ss_pred hhcCCC----CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC-CCCC
Q 012320 183 ILRGSK----SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG-AFYS 256 (466)
Q Consensus 183 ~~~~~~----~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~-~~~~ 256 (466)
.+.... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||............+.....+. ....
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 244 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHST
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccC
Confidence 654321 233467999999999876 4689999999999999999999999987444444444444433322 1234
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
..+.++.++|.+||. ||.+||++.++|.|+|++.
T Consensus 245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 467899999999996 9999999999999999853
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=364.95 Aligned_cols=257 Identities=27% Similarity=0.476 Sum_probs=192.4
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+ .+.||+|+||+||+|.+..+|+.||+|.+...... .....+.+.+|+.++++++||||+++++.+ .+...
T Consensus 10 ~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~ 85 (278)
T 3cok_A 10 IEDFKV-GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY-KAGMVQRVQNEVKIHCQLKHPSILELYNYF--EDSNY 85 (278)
T ss_dssp GGGEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTBCCTTBCCEEEEE--ECSSE
T ss_pred ccccee-eeeecCCCceEEEEEEEccCCceEEEEEeehhhhh-hhhHHHHHHHHHHHHHhCCCCCeEeEEEEE--ccCCe
Confidence 467877 57799999999999999999999999998754321 112346789999999999999999999987 45778
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 106 FNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
+++||||+.+++|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++...
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRN-MNIKIADFGLATQL 162 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTT-CCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CCEEEEeecceeec
Confidence 99999999999999999875 67999999999999999999999999 9999999999999877 89999999999765
Q ss_pred cCC-CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 012320 185 RGS-KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA 262 (466)
Q Consensus 185 ~~~-~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~ 262 (466)
... .......||+.|+|||++. ..++.++|||||||++|+|++|..||..... ......+..... ..+...+.++
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~ 239 (278)
T 3cok_A 163 KMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV-KNTLNKVVLADY--EMPSFLSIEA 239 (278)
T ss_dssp C----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC-C-----CCSSCC--CCCTTSCHHH
T ss_pred cCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH-HHHHHHHhhccc--CCccccCHHH
Confidence 432 2234567999999999876 4588999999999999999999999976332 233333333222 2344567899
Q ss_pred HHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 263 QRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 263 ~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
+++|.+||. ||.+|||+.++++||||....
T Consensus 240 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 240 KDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 999999996 999999999999999997643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=380.64 Aligned_cols=262 Identities=22% Similarity=0.352 Sum_probs=217.5
Q ss_pred CceEEeeeeeeeeCceEEEEEEEc---CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEecc
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDE---VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVD 102 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 102 (466)
++|.+ .++||+|+||+||+|.+. .+|+.||+|+++...........+.+.+|+.+|+++ +||||+++++.+. .
T Consensus 54 ~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~ 130 (355)
T 1vzo_A 54 ENFEL-LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--T 130 (355)
T ss_dssp GGEEE-EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE--E
T ss_pred cceEE-EEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe--e
Confidence 68877 566999999999999984 589999999987654322222335677899999999 7999999999874 4
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
...+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~DfG~a~ 207 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSN-GHVVLTDFGLSK 207 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEESCSSEEE
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CcEEEeeCCCCe
Confidence 6789999999999999999998889999999999999999999999999 9999999999999877 899999999997
Q ss_pred hhcCC--CCCccccCCCCcCCcccccc---CCCChhhHHHHHHHHHHHHhCCCCCCCC---CCHHHHHHHHhcCCCCCCC
Q 012320 183 ILRGS--KSAHSVIGTPEFMAPELYEE---DYNELVDVYSFGMCVLEMFTCEYPYSEC---ANPAQIYKKVTSGKLPGAF 254 (466)
Q Consensus 183 ~~~~~--~~~~~~~GT~~y~APE~l~~---~y~~~~DIwSlGvil~elltg~~Pf~~~---~~~~~i~~~i~~g~~p~~~ 254 (466)
.+... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||... .....+.+.+..... ..
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~ 285 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PY 285 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--CC
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC--CC
Confidence 65322 22345689999999998863 4789999999999999999999999642 345556666655543 23
Q ss_pred CCCCCHHHHHHHHHhcc-CcCCCC-----CHHHHhcCCCCCchhhhhc
Q 012320 255 YSIQDLEAQRFIGRCLV-NASKRL-----SAKELLLDPFLASDEVKLL 296 (466)
Q Consensus 255 ~~~~~~~~~~lI~~~L~-dp~~Rp-----sa~elL~hpf~~~~~~~~~ 296 (466)
+...+..+++||.+||. ||.+|| |+.|+++||||+...+..+
T Consensus 286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l 333 (355)
T 1vzo_A 286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL 333 (355)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHH
T ss_pred CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHh
Confidence 45567899999999996 999999 9999999999998776543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=379.81 Aligned_cols=255 Identities=27% Similarity=0.370 Sum_probs=199.5
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc---
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD--- 102 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--- 102 (466)
.++|.+. +.||+|+||+||+|.++.+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 24 LKRYQNL-KPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp ETTEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEEECTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred hhheeEe-eeeEecCCEEEEEEEECCCCceEEEEEecccc--CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 4789884 66999999999999999999999999987543 34556678999999999999999999999885432
Q ss_pred -CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 103 -QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 103 -~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
...+++||||+. ++|.+++. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ |.+||+|||++
T Consensus 101 ~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a 174 (371)
T 2xrw_A 101 EFQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA 174 (371)
T ss_dssp TCCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECCCCC-
T ss_pred cccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCC-CCEEEEEeecc
Confidence 237899999996 57888875 46999999999999999999999999 9999999999999977 89999999999
Q ss_pred hhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC--------
Q 012320 182 AILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG-------- 252 (466)
Q Consensus 182 ~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~-------- 252 (466)
............+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .+....+..+......+
T Consensus 175 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 175 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG-TDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred cccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 8765544455678999999999776 4699999999999999999999999987 44444444444321100
Q ss_pred ------------CC--------------C------CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 253 ------------AF--------------Y------SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 253 ------------~~--------------~------~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
.+ + ...+.++++||.+||. ||.+|||++|+|+||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 00 0 0014578999999996 9999999999999999964
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=375.57 Aligned_cols=264 Identities=25% Similarity=0.395 Sum_probs=213.9
Q ss_pred eeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 22 ~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
.....++|.+. ++||+|+||+||+|.++.+|+.||+|++.... ......+.+.+|+.++++++||||+++++++ .
T Consensus 20 ~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~ 94 (331)
T 4aaa_A 20 YFQSMEKYENL-GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRHENLVNLLEVC--K 94 (331)
T ss_dssp CCBCGGGEEEE-EEGGGGTTSSEEEEEETTTCCEEEEEEEESCS--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--E
T ss_pred hhhhhhhheee-eEEeecCCEEEEEEEECCCCceEEEEEEecCC--CchHHHHHHHHHHHHHhhCCCCCEeeEEEEe--e
Confidence 34456789884 66999999999999999999999999987543 2444566788999999999999999999987 4
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
+...+++||||+.+++|.+++...+.+++..+..++.||+.||.|||+.| |+||||||+|||++.+ +.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~ 171 (331)
T 4aaa_A 95 KKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFA 171 (331)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCTTC
T ss_pred cCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCC-CcEEEEeCCCc
Confidence 57789999999999999998888888999999999999999999999999 9999999999999877 89999999999
Q ss_pred hhhcC-CCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CC--------
Q 012320 182 AILRG-SKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-GK-------- 249 (466)
Q Consensus 182 ~~~~~-~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-g~-------- 249 (466)
..+.. ........||+.|+|||++.+ .++.++|||||||++|+|++|..||........+...+.. +.
T Consensus 172 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 172 RTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred eeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 76543 233445679999999998764 5899999999999999999999999875544444333221 11
Q ss_pred -----------CCCC--------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 250 -----------LPGA--------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 250 -----------~p~~--------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
.+.. .....+..+.+||.+||. ||.+|||+.|+|+||||+....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 315 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGF 315 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGH
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCCh
Confidence 1100 012357789999999996 9999999999999999987544
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=381.50 Aligned_cols=256 Identities=25% Similarity=0.358 Sum_probs=205.4
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc---
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD--- 102 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--- 102 (466)
.++|.. .++||+|+||+||+|.+..++. +|+|++...... ..+|+.+|+.++||||++++++|....
T Consensus 39 ~~~Y~~-~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~--------~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 108 (394)
T 4e7w_A 39 EIAYTN-CKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF--------KNRELQIMRIVKHPNVVDLKAFFYSNGDKK 108 (394)
T ss_dssp EEEEEE-EEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred cceEEE-eEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch--------HHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence 356876 6779999999999999988766 898887644321 236999999999999999999886543
Q ss_pred -CCEEEEEEecCCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEecc
Q 012320 103 -QKTFNFITEMFTSGTLREYR---KKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDL 178 (466)
Q Consensus 103 -~~~~~lV~E~~~ggsL~~~l---~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DF 178 (466)
...+++||||+.++.+.... .....+++..++.++.||+.||.|||++| |+||||||+|||++...+.+||+||
T Consensus 109 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DF 186 (394)
T 4e7w_A 109 DEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDF 186 (394)
T ss_dssp SCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCC
T ss_pred CceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeC
Confidence 23588999999776544332 23578999999999999999999999999 9999999999999954589999999
Q ss_pred chhhhhcCCCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc---------
Q 012320 179 GLAAILRGSKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS--------- 247 (466)
Q Consensus 179 Gla~~~~~~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~--------- 247 (466)
|+++.+.........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.....++...+..
T Consensus 187 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 187 GSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp TTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99988766666667789999999997753 5999999999999999999999999875544444433321
Q ss_pred ---------CCCCC--------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 248 ---------GKLPG--------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 248 ---------g~~p~--------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
..+|. .+....++++++||.+||. ||.+|||+.|+|+||||+...+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 11111 1223467899999999996 9999999999999999986543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=385.12 Aligned_cols=259 Identities=25% Similarity=0.356 Sum_probs=194.3
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEc--CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDE--VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
.++|...+++||+|+||+||+|.++ .+++.||+|++..... ...+.+|+.+|++++||||++++++|.....
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHAD 92 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC------CHHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC------CHHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence 3567777888999999999999966 5789999999864432 2457889999999999999999999987778
Q ss_pred CEEEEEEecCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEe---CCCC
Q 012320 104 KTFNFITEMFTSGTLREYRKKY---------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVN---GHLG 171 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~---------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~---~~~g 171 (466)
..+++||||+. ++|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||+. ...+
T Consensus 93 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 93 RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp TEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTT
T ss_pred CeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCC
Confidence 89999999995 5888877532 24999999999999999999999999 99999999999993 2337
Q ss_pred cEEEeccchhhhhcCC----CCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCC--------
Q 012320 172 QVKIGDLGLAAILRGS----KSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECAN-------- 237 (466)
Q Consensus 172 ~vKL~DFGla~~~~~~----~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~-------- 237 (466)
.+||+|||++..+... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.....
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 9999999999876432 23345789999999998764 489999999999999999999999965332
Q ss_pred -HHHHHHHHhc-CCCCCCCC----------------------------------CCCCHHHHHHHHHhcc-CcCCCCCHH
Q 012320 238 -PAQIYKKVTS-GKLPGAFY----------------------------------SIQDLEAQRFIGRCLV-NASKRLSAK 280 (466)
Q Consensus 238 -~~~i~~~i~~-g~~p~~~~----------------------------------~~~~~~~~~lI~~~L~-dp~~Rpsa~ 280 (466)
..++.+.+.. |..+...+ ...+..+.+||.+||. ||.+|||++
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 1233222221 11111111 1125688999999996 999999999
Q ss_pred HHhcCCCCCchhh
Q 012320 281 ELLLDPFLASDEV 293 (466)
Q Consensus 281 elL~hpf~~~~~~ 293 (466)
|+|+||||+....
T Consensus 330 e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 330 QAMQDPYFLEDPL 342 (405)
T ss_dssp HHHTSGGGTSSSC
T ss_pred HHhcChhhccCCC
Confidence 9999999986543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=362.56 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=208.0
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
-.+||.+. +.||+|+||+||+|.+..+|..||+|.+..... ......+++.+|+.++++++||||+++++++ .+.+
T Consensus 9 ~~~~y~i~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~--~~~~ 84 (294)
T 4eqm_A 9 INERYKIV-DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVSMIDVD--EEDD 84 (294)
T ss_dssp EETTEEEE-EEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE--ECSS
T ss_pred hhccEEEE-EEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-ccHHHHHHHHHHHHHHhcCCCCCCceEEEee--eeCC
Confidence 35789885 669999999999999999999999999875442 3455678899999999999999999999987 5578
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.+++||||+.|++|.+++.+.+.+++..+..++.||+.||.|||++| |+||||||+||+++.+ +.+||+|||++...
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSN-KTLKIFDFGIAKAL 161 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCSSSTTC
T ss_pred eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEEeCCCcccc
Confidence 89999999999999999999899999999999999999999999999 9999999999999877 89999999999876
Q ss_pred cCCC--CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC---CCCCCC
Q 012320 185 RGSK--SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG---AFYSIQ 258 (466)
Q Consensus 185 ~~~~--~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~---~~~~~~ 258 (466)
.... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+ .+.............+. ......
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (294)
T 4eqm_A 162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG-ETAVSIAIKHIQDSVPNVTTDVRKDI 240 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCS-SCHHHHHHHHHSSCCCCHHHHSCTTS
T ss_pred ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHhhccCCCcchhcccCC
Confidence 4332 233467999999999776 4589999999999999999999999987 44444444444444332 234456
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhcCCC
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLLDPF 287 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf 287 (466)
+..+.++|.+||. ||.+||+..+.+.+.|
T Consensus 241 ~~~l~~li~~~l~~dp~~R~~~~~~l~~~l 270 (294)
T 4eqm_A 241 PQSLSNVILRATEKDKANRYKTIQEMKDDL 270 (294)
T ss_dssp CHHHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred CHHHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence 7899999999996 9999995555554443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=375.12 Aligned_cols=260 Identities=23% Similarity=0.352 Sum_probs=204.3
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCH-HHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSP-DDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
..++|.+ .+.||+|+||+||+|.++.+|+.||+|++......... .....+.+|+.++++++||||+++++++ .+.
T Consensus 8 ~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~ 84 (346)
T 1ua2_A 8 RAKRYEK-LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF--GHK 84 (346)
T ss_dssp -----CE-EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE--CCT
T ss_pred HhcccEE-EeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE--eeC
Confidence 4578877 56799999999999999999999999998754322111 1224678999999999999999999988 456
Q ss_pred CEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 104 KTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
..+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++.
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDEN-GVLKLADFGLAK 160 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCCGGGS
T ss_pred CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCC-CCEEEEecccce
Confidence 778999999975 888888764 46899999999999999999999999 9999999999999877 899999999998
Q ss_pred hhcCC-CCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--CCCCCC-C--
Q 012320 183 ILRGS-KSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS--GKLPGA-F-- 254 (466)
Q Consensus 183 ~~~~~-~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~--g~~p~~-~-- 254 (466)
.+... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+.......+.. +..+.. +
T Consensus 161 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG-DSDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred eccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHHHcCCCChhhhhh
Confidence 76432 33455789999999998753 489999999999999999999999977 444444444432 111110 0
Q ss_pred ---------------------CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 255 ---------------------YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 255 ---------------------~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
....+.++++||.+||. ||.+|||+.|+|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 13345789999999996 999999999999999997643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=363.02 Aligned_cols=265 Identities=29% Similarity=0.519 Sum_probs=225.4
Q ss_pred hhccceeeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEE
Q 012320 15 KAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRF 94 (466)
Q Consensus 15 ~~~~~~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l 94 (466)
.+.+.-+..++..+|... +.||+|+||+||+|.++.+|+.||+|++..... ....+.+.+|+.+++.++||||+++
T Consensus 10 ~p~~~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~ 85 (303)
T 3a7i_A 10 LPGMQNLKADPEELFTKL-EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKY 85 (303)
T ss_dssp ---CTTCEECGGGTEEEE-EEEEECSSSEEEEEEETTTCCEEEEEEEETTTC---STTHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCchhcCCCChHHHHHHh-hhhcccCCeEEEEEEECCCCcEEEEEEeccccc---HHHHHHHHHHHHHHHhCCCCCEeEE
Confidence 444556677889999885 569999999999999999999999999876542 2345788999999999999999999
Q ss_pred EeEEEeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEE
Q 012320 95 YTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVK 174 (466)
Q Consensus 95 ~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vK 174 (466)
++.+. +...+++||||+.|++|.+++.+ +.+++..+..++.||+.||.|||+.| |+||||||+||+++.+ |.+|
T Consensus 86 ~~~~~--~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~k 159 (303)
T 3a7i_A 86 YGSYL--KDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEH-GEVK 159 (303)
T ss_dssp EEEEE--ETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEE
T ss_pred EEEEe--cCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCC-CCEE
Confidence 99885 46789999999999999999865 67999999999999999999999999 9999999999999877 8999
Q ss_pred EeccchhhhhcCCC-CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC
Q 012320 175 IGDLGLAAILRGSK-SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG 252 (466)
Q Consensus 175 L~DFGla~~~~~~~-~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~ 252 (466)
|+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+.......+..+..+
T Consensus 160 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~- 237 (303)
T 3a7i_A 160 LADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE-LHPMKVLFLIPKNNPP- 237 (303)
T ss_dssp ECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCC-
T ss_pred EeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC-cCHHHHHHHhhcCCCC-
Confidence 99999997764432 334567999999999876 4589999999999999999999999976 5566666666665543
Q ss_pred CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 253 AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 253 ~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
......+..++++|.+||. +|.+|||+.++++||||...
T Consensus 238 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 238 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 3445667899999999995 99999999999999999653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=361.03 Aligned_cols=251 Identities=31% Similarity=0.499 Sum_probs=207.0
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEecC
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMF 113 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~~ 113 (466)
.+||+|+||+||+|.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++.+. ....+++||||+
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~ 101 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD----SRYSQPLHEEIALHKHLKHKNIVQYLGSFS--ENGFIKIFMEQV 101 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCC----C---HHHHHHHHHHHTCCCTTBCCEEEEEE--ETTEEEEEEECC
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCc----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEE--eCCcEEEEEEeC
Confidence 37999999999999999999999999987543 234577899999999999999999999884 467899999999
Q ss_pred CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC-CC
Q 012320 114 TSGTLREYRKKYR---RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-KS 189 (466)
Q Consensus 114 ~ggsL~~~l~~~~---~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~-~~ 189 (466)
++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+||+++...+.+||+|||++...... ..
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 9999999998752 4679999999999999999999999 9999999999999974589999999999766432 22
Q ss_pred CccccCCCCcCCcccccc---CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 012320 190 AHSVIGTPEFMAPELYEE---DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFI 266 (466)
Q Consensus 190 ~~~~~GT~~y~APE~l~~---~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI 266 (466)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||......................+...+.+++++|
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 259 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFI 259 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHH
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHH
Confidence 345679999999998763 38899999999999999999999997655544433333222233344566788999999
Q ss_pred HHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 267 GRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 267 ~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
.+||. ||.+|||+.++|+||||+...
T Consensus 260 ~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 260 LKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHccCChhhCCCHHHHhcChhhhhcc
Confidence 99996 999999999999999997644
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=380.61 Aligned_cols=253 Identities=25% Similarity=0.347 Sum_probs=204.4
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC------CCCceeEEEeEEE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL------KHDSIIRFYTSWI 99 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l------~HpnIv~l~~~~~ 99 (466)
.+||.+ .++||+|+||+||+|.+..+|+.||+|+++.. ......+.+|+.+++.+ +|+||+++++.+.
T Consensus 96 ~~ry~~-~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 96 AYRYEV-LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp TTTEEE-EEEEEESSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cCcEEE-EEEcccCccEEEEEEEECCCCcEEEEEEECCc-----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 568877 56799999999999999999999999998632 33456778888888877 5779999999884
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCc--EEE
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQ--VKI 175 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~--vKL 175 (466)
....+++||||+. ++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +. +||
T Consensus 170 --~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~-~~~~vkL 243 (429)
T 3kvw_A 170 --FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQ-GRSGIKV 243 (429)
T ss_dssp --ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESST-TSCCEEE
T ss_pred --cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccC-CCcceEE
Confidence 4678999999995 69999988754 4999999999999999999999999 9999999999999876 55 999
Q ss_pred eccchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC--
Q 012320 176 GDLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG-- 252 (466)
Q Consensus 176 ~DFGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~-- 252 (466)
+|||++..... ...+.+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+......+...+.....|.
T Consensus 244 ~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~ 321 (429)
T 3kvw_A 244 IDFGSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK 321 (429)
T ss_dssp CCCTTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred eecccceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 99999975432 345678999999999775 5699999999999999999999999987444333332221100000
Q ss_pred ------------------------------------------------------CCCCCCCHHHHHHHHHhcc-CcCCCC
Q 012320 253 ------------------------------------------------------AFYSIQDLEAQRFIGRCLV-NASKRL 277 (466)
Q Consensus 253 ------------------------------------------------------~~~~~~~~~~~~lI~~~L~-dp~~Rp 277 (466)
.+....++++++||.+||. ||.+||
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp 401 (429)
T 3kvw_A 322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM 401 (429)
T ss_dssp HHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred HHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence 0011236789999999996 999999
Q ss_pred CHHHHhcCCCCCchh
Q 012320 278 SAKELLLDPFLASDE 292 (466)
Q Consensus 278 sa~elL~hpf~~~~~ 292 (466)
|+.|+|+||||+...
T Consensus 402 ta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 402 TPGQALRHPWLRRRL 416 (429)
T ss_dssp CHHHHHTSTTTC---
T ss_pred CHHHHhCChhhccCC
Confidence 999999999998643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=374.00 Aligned_cols=260 Identities=26% Similarity=0.381 Sum_probs=210.7
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
.+-.+||.+ .++||+|+||+||+|.+..+|..||+|++... ......+.+.+|+.+|++++||||+++++.+....
T Consensus 23 ~~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 98 (364)
T 3qyz_A 23 FDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF---EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 98 (364)
T ss_dssp CCCTTTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECCT---TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred ccccccEEE-EEEeecCCCeEEEEEEECCCCeEEEEEEeccc---cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCC
Confidence 344679988 46699999999999999999999999998642 24455678999999999999999999999875432
Q ss_pred ---CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 103 ---QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 103 ---~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
...+++||||+. |+|.++++. +.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||
T Consensus 99 ~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg 173 (364)
T 3qyz_A 99 IEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFG 173 (364)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCT
T ss_pred ccccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCC-CCEEEEeCc
Confidence 247899999996 599998876 67999999999999999999999999 9999999999999877 899999999
Q ss_pred hhhhhcCCC----CCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCC--
Q 012320 180 LAAILRGSK----SAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-GKL-- 250 (466)
Q Consensus 180 la~~~~~~~----~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-g~~-- 250 (466)
++....... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+......+...+.. +..
T Consensus 174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253 (364)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 997654221 234568999999999764 34899999999999999999999999774433333222110 100
Q ss_pred ------------------CC-------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 251 ------------------PG-------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 251 ------------------p~-------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
+. ......+.++++||.+||. ||.+|||+.|+|+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 00 0113457789999999996 99999999999999999753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=364.75 Aligned_cols=259 Identities=29% Similarity=0.528 Sum_probs=209.2
Q ss_pred eeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 21 IETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 21 ~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
....+..+|.+. +.||+|+||+||+|.++.+|+.||+|.+.... ..+.+.+|+.+++.++||||+++++.+.
T Consensus 23 ~~~~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~- 94 (314)
T 3com_A 23 LTKQPEEVFDVL-EKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQEIIKEISIMQQCDSPHVVKYYGSYF- 94 (314)
T ss_dssp -------CEEEE-EECC----CEEEEEEETTTCCEEEEEEEETTS------CCHHHHHHHHHHHTCCCTTBCCEEEEEE-
T ss_pred hhhcchhhhhhh-eeeccCCCeEEEEEEECCCCCEEEEEecCchH------HHHHHHHHHHHHHhCCCCCCccEEEEEE-
Confidence 445677889885 66999999999999999999999999987532 2356889999999999999999999884
Q ss_pred ccCCEEEEEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 101 VDQKTFNFITEMFTSGTLREYRK-KYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~-~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
....+++||||+.+++|.+++. ....+++..+..++.||+.||.|||+.| |+||||||+||+++.+ |.+||+|||
T Consensus 95 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg 170 (314)
T 3com_A 95 -KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTE-GHAKLADFG 170 (314)
T ss_dssp -ETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCT
T ss_pred -eCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCC-CCEEEeecc
Confidence 4678999999999999999987 4578999999999999999999999999 9999999999999877 899999999
Q ss_pred hhhhhcCC-CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-CCCCCC
Q 012320 180 LAAILRGS-KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL-PGAFYS 256 (466)
Q Consensus 180 la~~~~~~-~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~-p~~~~~ 256 (466)
++...... .......||+.|+|||++. ..++.++|||||||++|+|++|..||... +.......+..+.. ....+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~ 249 (314)
T 3com_A 171 VAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI-HPMRAIFMIPTNPPPTFRKPE 249 (314)
T ss_dssp TCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSSGG
T ss_pred cchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHhcCCCcccCCcc
Confidence 99765433 2234567999999999876 45899999999999999999999999874 44444334433332 222344
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
..+..+.++|.+||. ||.+|||+.++++||||+...
T Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 250 LWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp GSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 567899999999996 999999999999999997644
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=359.39 Aligned_cols=255 Identities=32% Similarity=0.496 Sum_probs=209.0
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec-----
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV----- 101 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~----- 101 (466)
++|.+ .+.||+|+||+||+|.++.+|+.||+|.+... ....+.+.+|+.++++++||||+++++.|.+.
T Consensus 6 ~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 6 SDFEE-IAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccchh-hheeccCCcEEEEEEEEcCCCeEEEEEEEecc-----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 56777 56799999999999999999999999998632 34567899999999999999999999988653
Q ss_pred ------cCCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEE
Q 012320 102 ------DQKTFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVK 174 (466)
Q Consensus 102 ------~~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vK 174 (466)
....+++||||+.||+|.+++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~-~~~k 156 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDES-RNVK 156 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEE
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCC-CCEE
Confidence 2467899999999999999998654 5889999999999999999999999 9999999999999877 8999
Q ss_pred EeccchhhhhcCC---------------CCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q 012320 175 IGDLGLAAILRGS---------------KSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECAN 237 (466)
Q Consensus 175 L~DFGla~~~~~~---------------~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~ 237 (466)
|+|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++ ||....+
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~ 233 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME 233 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence 9999999765421 12345679999999998763 58999999999999999998 7755445
Q ss_pred HHHHHHHHhcCC--CCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 238 PAQIYKKVTSGK--LPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 238 ~~~i~~~i~~g~--~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
...+.+.+.... +|.......+..++++|.+||. ||.+|||+.++++||||+....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (303)
T 1zy4_A 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292 (303)
T ss_dssp HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCH
T ss_pred HHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCCh
Confidence 556666666543 3444555667789999999996 9999999999999999976443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=387.83 Aligned_cols=253 Identities=15% Similarity=0.153 Sum_probs=199.4
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHH---HHHHhCCCCceeEEE-----
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEV---HLLSTLKHDSIIRFY----- 95 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei---~iL~~l~HpnIv~l~----- 95 (466)
.+.++|.+ .+.||+|+||+||+|.++.+|+.||+|++..... ......+.+.+|+ ++|++++|||||+++
T Consensus 70 ~~~~~y~~-~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~ 147 (377)
T 3byv_A 70 ERPRTLVR-GTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 147 (377)
T ss_dssp CCCEEEEE-EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC--CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred CCCceEEE-cceeecCCCEEEEEEEECCCCcEEEEEEEeeccc-cchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence 34566766 6779999999999999999999999999986543 2344667899999 455556899999998
Q ss_pred --eEEEecc----------CC-----EEEEEEecCCCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCC
Q 012320 96 --TSWIDVD----------QK-----TFNFITEMFTSGTLREYRKKYRRVDI-------RAIKSWARQILQGLVYLHSRD 151 (466)
Q Consensus 96 --~~~~~~~----------~~-----~~~lV~E~~~ggsL~~~l~~~~~l~~-------~~~~~i~~qIl~gL~yLHs~~ 151 (466)
+.+.+.+ .. ..|+||||+ +|+|.+++.+.+.+++ ..+..|+.||+.||.|||++|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 226 (377)
T 3byv_A 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 226 (377)
T ss_dssp CSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 4432211 01 378999999 7899999987666666 788889999999999999999
Q ss_pred CCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCCccccCCCCcCCcccccc------------CCCChhhHHHHH
Q 012320 152 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYEE------------DYNELVDVYSFG 219 (466)
Q Consensus 152 ~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~~------------~y~~~~DIwSlG 219 (466)
|+||||||+|||++.+ |.+||+|||++.... ......+| +.|+|||++.+ .|+.++||||||
T Consensus 227 --ivHrDikp~NIll~~~-~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 227 --LVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp --EECSCCCGGGEEECTT-CCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred --eecCCCCHHHEEEcCC-CCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 9999999999999977 899999999997532 23456678 99999998763 599999999999
Q ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 220 MCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 220 vil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
|++|+|++|..||... +.......+... ....+.++++||.+||. ||.+|||+.++++||||+...
T Consensus 301 ~il~elltg~~Pf~~~-~~~~~~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 301 LVIYWIWCADLPITKD-AALGGSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp HHHHHHHHSSCCC-------CCSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred HHHHHHHHCCCCCccc-ccccchhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 9999999999999652 222222222221 23457899999999996 999999999999999997644
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=381.27 Aligned_cols=257 Identities=27% Similarity=0.411 Sum_probs=194.2
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec-
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV- 101 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~- 101 (466)
..-.+||.+. +.||+|+||+||+|.++.+|+.||+|++.... .+....+++.+|+.+|+.++||||+++++.+...
T Consensus 25 ~~~~~~y~~~-~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 101 (367)
T 2fst_X 25 WEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 101 (367)
T ss_dssp EEEETTEEEE-EECC----CCEEEEEETTTTEEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred cCCCCceEEe-eEEeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 3345899885 66999999999999999999999999986432 3455678899999999999999999999987542
Q ss_pred ---cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEecc
Q 012320 102 ---DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDL 178 (466)
Q Consensus 102 ---~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DF 178 (466)
....+|+|+|++ +++|.+++.. +.+++..++.++.||+.||.|||+.| |+||||||+|||++.+ +.+||+||
T Consensus 102 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~-~~~kL~DF 176 (367)
T 2fst_X 102 SLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDF 176 (367)
T ss_dssp SGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECC-
T ss_pred ccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCC-CCEEEeec
Confidence 135689999999 7899998875 78999999999999999999999999 9999999999999977 89999999
Q ss_pred chhhhhcCCCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--CCC----
Q 012320 179 GLAAILRGSKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS--GKL---- 250 (466)
Q Consensus 179 Gla~~~~~~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~--g~~---- 250 (466)
|++..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.. .......+.. |..
T Consensus 177 G~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 177 GLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-HIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCSCCHHH
T ss_pred cccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHH
Confidence 99976543 2345689999999998754 69999999999999999999999998744 3333333321 110
Q ss_pred -------------------CCC----CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 251 -------------------PGA----FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 251 -------------------p~~----~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
+.. .....++++++||.+||. ||.+|||+.|+|.||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~ 317 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhh
Confidence 000 112346789999999996 9999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=364.55 Aligned_cols=259 Identities=28% Similarity=0.499 Sum_probs=190.5
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
..++|.+ .+.||+|+||+||+|.+..+|+.||+|.+..... ....+.+.+|+.++++++||||+++++.+. ...
T Consensus 13 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~ 86 (303)
T 2vwi_A 13 NRDDYEL-QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC---QTSMDELLKEIQAMSQCHHPNIVSYYTSFV--VKD 86 (303)
T ss_dssp CCCCCEE-EEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEE--SSS
T ss_pred chhhhhh-hheeccccceEEEEEEECCCCcEEEEEEEEhhhc---chhHHHHHHHHHHHhhcCCCCEeeEEEEEe--ecC
Confidence 3567877 5779999999999999999999999998865432 234567889999999999999999999884 456
Q ss_pred EEEEEEecCCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEe
Q 012320 105 TFNFITEMFTSGTLREYRKK--------YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIG 176 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~--------~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~ 176 (466)
.+++||||+.|++|.+++.. .+.+++..+..++.||+.||.|||++| |+||||||+||+++.+ |.+||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~ 163 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGED-GSVQIA 163 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT-CCEEEC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCC-CCEEEE
Confidence 78999999999999999874 456999999999999999999999999 9999999999999877 899999
Q ss_pred ccchhhhhcCCC------CCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q 012320 177 DLGLAAILRGSK------SAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG 248 (466)
Q Consensus 177 DFGla~~~~~~~------~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g 248 (466)
|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||............+ .+
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~ 242 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL-QN 242 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH-TS
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHh-cc
Confidence 999997654321 223567999999999876 468999999999999999999999998754443333333 32
Q ss_pred CCCC--------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 249 KLPG--------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 249 ~~p~--------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
..+. ......+.+++++|.+||. ||.+|||+.++++||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 2211 1234456789999999996 9999999999999999986544
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=372.15 Aligned_cols=259 Identities=24% Similarity=0.312 Sum_probs=197.3
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc---
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD--- 102 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--- 102 (466)
.++|.+ .+.||+|+||+||+|.++.+|+.||+|++..... ...+..+++..++.++||||++++++|....
T Consensus 22 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 22 MDRFQV-ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-----FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HTTEEE-C----------CEEEEETTTCCEEEEEEEECCTT-----CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred ccceEE-EEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-----ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 468887 5679999999999999999999999998865432 2235677888899999999999999986533
Q ss_pred --CCEEEEEEecCCCCCHHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHH--hCCCCeEeccCCCCcEEEeCCCCcEEE
Q 012320 103 --QKTFNFITEMFTSGTLRE---YRKKYRRVDIRAIKSWARQILQGLVYLH--SRDPPVIHRDLKCDNIFVNGHLGQVKI 175 (466)
Q Consensus 103 --~~~~~lV~E~~~ggsL~~---~l~~~~~l~~~~~~~i~~qIl~gL~yLH--s~~~~IiHrDLKp~NIlv~~~~g~vKL 175 (466)
...+++||||+.++.+.. +......+++..++.++.||+.||.||| +.| |+||||||+|||++...+.+||
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEE
Confidence 224889999997653332 2334577999999999999999999999 888 9999999999999974489999
Q ss_pred eccchhhhhcCCCCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCC-
Q 012320 176 GDLGLAAILRGSKSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG-KLP- 251 (466)
Q Consensus 176 ~DFGla~~~~~~~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g-~~p- 251 (466)
+|||++..+..........||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+.......+... ..+
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRG-DNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp CCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHHHCCCC
T ss_pred eeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCC-CChHHHHHHHHHHcCCCC
Confidence 9999998776655566778999999999774 3489999999999999999999999987 4444444433321 000
Q ss_pred ----------------------------CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 252 ----------------------------GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 252 ----------------------------~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
.......+.++++||.+||. ||.+|||+.|+|+||||+....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 00111245689999999996 9999999999999999987543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=370.15 Aligned_cols=261 Identities=23% Similarity=0.362 Sum_probs=202.2
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEeccccc-------CCHHHHHHHHHHHHHHHhCCCCceeEEEe
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELM-------RSPDDLQRLYSEVHLLSTLKHDSIIRFYT 96 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~-------~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~ 96 (466)
...++|.+ .+.||+|+||+||+|.+.. |..||+|++...... ......+.+.+|+.+|++++||||+++++
T Consensus 19 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 19 AMQSPYTV-QRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HTTCSCEE-EEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HhccceEE-eEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 34688988 5779999999999999876 999999998654321 23344578999999999999999999999
Q ss_pred EEEec---cCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCc
Q 012320 97 SWIDV---DQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQ 172 (466)
Q Consensus 97 ~~~~~---~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~ 172 (466)
++... ....+++||||+. |+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~-~~ 172 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADN-ND 172 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CC
T ss_pred eEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCC-CC
Confidence 88653 3457999999997 6888777654 47999999999999999999999999 9999999999999877 89
Q ss_pred EEEeccchhhhhcCCCCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--C
Q 012320 173 VKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS--G 248 (466)
Q Consensus 173 vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~--g 248 (466)
+||+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||... +.......+.. +
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~i~~~~~ 251 (362)
T 3pg1_A 173 ITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS-TFYNQLNKIVEVVG 251 (362)
T ss_dssp EEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHC
T ss_pred EEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHcC
Confidence 9999999998665555556678999999999775 45899999999999999999999999874 44443333321 0
Q ss_pred C------------------------CCC----CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 249 K------------------------LPG----AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 249 ~------------------------~p~----~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
. .+. ......++.+.+||.+||. ||.+|||+.|+|+||||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 0 000 0122346789999999996 99999999999999999764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=371.92 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=201.8
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC--------CCceeEEEeE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK--------HDSIIRFYTS 97 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~--------HpnIv~l~~~ 97 (466)
.+||.+ .++||+|+||+||+|.+..+|+.||+|++.. .....+.+.+|+.+|+.++ ||||+++++.
T Consensus 36 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 36 NGRYHV-IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-----AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp TTTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred CCeEEE-EEEeeecCCeeEEEEEecCCCeEEEEEEEec-----CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 588988 4669999999999999999999999999863 2345678899999999985 7889999998
Q ss_pred EEec--cCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCCCCcEEEeCCC--
Q 012320 98 WIDV--DQKTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSR-DPPVIHRDLKCDNIFVNGHL-- 170 (466)
Q Consensus 98 ~~~~--~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~-~~~IiHrDLKp~NIlv~~~~-- 170 (466)
|... +...+++||||+ +++|.+++.+. +.+++..++.++.||+.||.|||++ | |+||||||+|||++.+.
T Consensus 110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHH
T ss_pred eeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchh
Confidence 8643 456899999999 66776666554 5699999999999999999999998 8 99999999999998651
Q ss_pred ----------------------------------------------CcEEEeccchhhhhcCCCCCccccCCCCcCCccc
Q 012320 171 ----------------------------------------------GQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPEL 204 (466)
Q Consensus 171 ----------------------------------------------g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~ 204 (466)
..+||+|||++..... .....+||+.|+|||+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHH
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChh
Confidence 2799999999976543 2345679999999997
Q ss_pred cc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHh--cCCCCC------------------------
Q 012320 205 YE-EDYNELVDVYSFGMCVLEMFTCEYPYSECAN-----PAQIYKKVT--SGKLPG------------------------ 252 (466)
Q Consensus 205 l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~-----~~~i~~~i~--~g~~p~------------------------ 252 (466)
+. ..|+.++|||||||++|+|++|..||..... .......+. .|..|.
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 76 4599999999999999999999999965332 111111111 111110
Q ss_pred --------------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCC
Q 012320 253 --------------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLA 289 (466)
Q Consensus 253 --------------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~ 289 (466)
......+..+++||.+||. ||.+|||+.|+|+||||+
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0111223578899999996 999999999999999996
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=364.41 Aligned_cols=245 Identities=27% Similarity=0.393 Sum_probs=202.2
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+ .++||+|+||+||+|.++.+|+.||+|.+.. .+....+.+.+|+.+|++++||||+++++++. +...
T Consensus 9 ~~~~~~-~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~ 81 (310)
T 3s95_A 9 PSDLIH-GEVLGKGCFGQAIKVTHRETGEVMVMKELIR----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY--KDKR 81 (310)
T ss_dssp GGGEEE-EEEEECCSSEEEEEEEETTTCCEEEEEEESC----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE--ETTE
T ss_pred hhHeec-cceecCCCCEEEEEEEECCCCcEEEEEEecc----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe--cCCe
Confidence 467877 6779999999999999999999999998753 24566788999999999999999999999884 4678
Q ss_pred EEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 106 FNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
+++||||+.||+|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 82 LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVREN-KNVVVADFGLARLM 158 (310)
T ss_dssp EEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTT-SCEEECCCTTCEEC
T ss_pred eEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCC-CCEEEeecccceec
Confidence 9999999999999999987 467999999999999999999999999 9999999999999877 89999999999765
Q ss_pred cCCCC---------------CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH
Q 012320 185 RGSKS---------------AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQ----IYKK 244 (466)
Q Consensus 185 ~~~~~---------------~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~----i~~~ 244 (466)
..... ....+||+.|+|||++. ..++.++|||||||++|+|++|..||........ ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~ 238 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc
Confidence 43221 12567999999999876 4689999999999999999999999865221100 0111
Q ss_pred HhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 245 VTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 245 i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..... .+...+..+.++|.+||. ||.+|||+.++++
T Consensus 239 ~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 239 FLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11111 123455689999999996 9999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=360.24 Aligned_cols=259 Identities=25% Similarity=0.393 Sum_probs=206.6
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe--
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID-- 100 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-- 100 (466)
.+..+||.+. +.||+|+||+||+|.++.+|+.||+|++... +....+.+.+|+.++++++||||+++++.+..
T Consensus 7 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 7 FDLGSRYMDL-KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSG 81 (320)
T ss_dssp EEETTTEEEE-EECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred CccCCceeEE-EEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence 4457899885 6699999999999999999999999998743 45567889999999999999999999987632
Q ss_pred ----------ccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCC
Q 012320 101 ----------VDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHL 170 (466)
Q Consensus 101 ----------~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~ 170 (466)
.+...+++||||+. |+|.+++.+ +.+++..++.++.||+.||.|||++| |+||||||+|||++...
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTED 157 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTT
T ss_pred cccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCC
Confidence 23468999999997 699998864 67999999999999999999999999 99999999999998655
Q ss_pred CcEEEeccchhhhhcCC----CCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 012320 171 GQVKIGDLGLAAILRGS----KSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKK 244 (466)
Q Consensus 171 g~vKL~DFGla~~~~~~----~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~ 244 (466)
+.+||+|||++...... .......||+.|+|||++. ..++.++|||||||++|+|++|..||... +.......
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~-~~~~~~~~ 236 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA-HELEQMQL 236 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC-CHHHHHHH
Confidence 79999999999765421 2234557899999999764 46899999999999999999999999874 44444444
Q ss_pred HhcCCC------------------------CC----CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 245 VTSGKL------------------------PG----AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 245 i~~g~~------------------------p~----~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
+..... +. ......+.++++||.+||. ||.+|||+.|+|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 332210 00 0123457899999999996 99999999999999999754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=364.50 Aligned_cols=261 Identities=25% Similarity=0.370 Sum_probs=209.5
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec-
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV- 101 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~- 101 (466)
..-.++|.+ .+.||+|+||+||+|.++.+|+.||+|++... ........+.+|+.+|++++||||+++++.+...
T Consensus 7 ~~i~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 82 (353)
T 2b9h_A 7 YNISSDFQL-KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHENIITIFNIQRPDS 82 (353)
T ss_dssp CCSCTTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECCC---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred cccccceEE-eeEEcCCCCeEEEEEEECCCCcEEEEEeeccc---ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccc
Confidence 345678887 57799999999999999999999999998632 2445567889999999999999999999976432
Q ss_pred --cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 102 --DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 102 --~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
....+++||||+. ++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||
T Consensus 83 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~-~~~kl~Dfg 157 (353)
T 2b9h_A 83 FENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSN-CDLKVCDFG 157 (353)
T ss_dssp STTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCT
T ss_pred cCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCC-CcEEEEecc
Confidence 1367899999996 689998876 67999999999999999999999999 9999999999999877 899999999
Q ss_pred hhhhhcCCC-----------CCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q 012320 180 LAAILRGSK-----------SAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVT 246 (466)
Q Consensus 180 la~~~~~~~-----------~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~ 246 (466)
++....... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+......+.....
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 237 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 997654221 123457999999999764 4689999999999999999999999987443333222111
Q ss_pred c-CCCC------------------------C----CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 247 S-GKLP------------------------G----AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 247 ~-g~~p------------------------~----~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
. |..+ . ......+.++++||.+||. ||.+|||+.|+|+||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 1 1100 0 0113457789999999996 999999999999999998643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=370.37 Aligned_cols=259 Identities=20% Similarity=0.395 Sum_probs=218.8
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCH-------------HHHHHHHHHHHHHHhCCCCcee
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSP-------------DDLQRLYSEVHLLSTLKHDSII 92 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~-------------~~~~~~~~Ei~iL~~l~HpnIv 92 (466)
.++|.+ .+.||+|+||+||+|.+ +|+.||+|.+......... ...+.+.+|+.++++++||||+
T Consensus 30 ~~~y~~-~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 30 INDYRI-IRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp ETTEEE-EEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred cCceEE-EEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 378887 56699999999999998 8999999999865432111 1126789999999999999999
Q ss_pred EEEeEEEeccCCEEEEEEecCCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCCCCc
Q 012320 93 RFYTSWIDVDQKTFNFITEMFTSGTLREY------RKK--YRRVDIRAIKSWARQILQGLVYLHS-RDPPVIHRDLKCDN 163 (466)
Q Consensus 93 ~l~~~~~~~~~~~~~lV~E~~~ggsL~~~------l~~--~~~l~~~~~~~i~~qIl~gL~yLHs-~~~~IiHrDLKp~N 163 (466)
++++++ .+...+++||||+.|++|.++ +.+ ...+++..++.++.||+.||.|||+ .| |+||||||+|
T Consensus 107 ~~~~~~--~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~N 182 (348)
T 2pml_X 107 TCEGII--TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSN 182 (348)
T ss_dssp CCSEEE--ESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGG
T ss_pred eEEEEE--eeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHh
Confidence 999987 446789999999999999998 655 5779999999999999999999999 89 9999999999
Q ss_pred EEEeCCCCcEEEeccchhhhhcCCCCCccccCCCCcCCccccccC--CCC-hhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q 012320 164 IFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYEED--YNE-LVDVYSFGMCVLEMFTCEYPYSECANPAQ 240 (466)
Q Consensus 164 Ilv~~~~g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~~~--y~~-~~DIwSlGvil~elltg~~Pf~~~~~~~~ 240 (466)
|+++.+ +.+||+|||++...... ......||+.|+|||++.+. ++. ++|||||||++|+|++|..||.......+
T Consensus 183 il~~~~-~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 183 ILMDKN-GRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp EEECTT-SCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EEEcCC-CcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 999877 89999999999775443 34556799999999988744 555 89999999999999999999987666578
Q ss_pred HHHHHhcCCCCCCCC-----------------CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 241 IYKKVTSGKLPGAFY-----------------SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 241 i~~~i~~g~~p~~~~-----------------~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
+...+..+..+.... ...+.++++||.+||. ||.+|||+.|+++||||+...+
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~ 331 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence 888888776533211 4567899999999996 9999999999999999987654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=358.82 Aligned_cols=256 Identities=24% Similarity=0.398 Sum_probs=212.8
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC--CCceeEEEeEEEecc
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK--HDSIIRFYTSWIDVD 102 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~~~ 102 (466)
...+|.+ .+.||+|+||+||+|.++ +|+.||+|++..... .....+.+.+|+.++++++ ||||+++++++ ..
T Consensus 26 ~~~~y~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~--~~ 99 (313)
T 3cek_A 26 KGRIYSI-LKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE--IT 99 (313)
T ss_dssp TTEEEEE-EEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE--EC
T ss_pred ccceEEE-EEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc--cccchHHHHHHHHHHHhccccCCceEEEEEEe--ec
Confidence 3456766 567999999999999986 489999999976542 4556788999999999997 59999999987 44
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
...+++||| +.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++. +.+||+|||++.
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~--~~~kL~Dfg~~~ 174 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD--GMLKLIDFGIAN 174 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET--TEEEECCCSSSC
T ss_pred CCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC--CeEEEeeccccc
Confidence 678999999 668999999999899999999999999999999999999 999999999999964 799999999997
Q ss_pred hhcCCC---CCccccCCCCcCCcccccc------------CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q 012320 183 ILRGSK---SAHSVIGTPEFMAPELYEE------------DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS 247 (466)
Q Consensus 183 ~~~~~~---~~~~~~GT~~y~APE~l~~------------~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~ 247 (466)
.+.... ......||+.|+|||++.. .++.++|||||||++|+|++|..||....+.......+..
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 254 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence 764322 1235579999999998753 5888999999999999999999999876666666666666
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 248 GKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 248 g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
......++...+.+++++|.+||. ||.+|||+.|+|+||||+..
T Consensus 255 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 255 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 555445556678899999999996 99999999999999999653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=367.24 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=213.6
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEE-----EcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEe
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAI-----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYT 96 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~-----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~ 96 (466)
.-+.++|.+ .+.||+|+||+||+|. +..+++.||+|++.... .....+.+.+|+.+|+++ +||||+++++
T Consensus 18 ~~~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 18 EFPRDRLKL-GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp BCCGGGEEE-EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccceee-ceeecCCCCceEEEEEeccccccccceEEEEEEecCcC---CHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 346788987 5779999999999999 66788999999987432 445567899999999999 7999999999
Q ss_pred EEEeccCCEEEEEEecCCCCCHHHHHHhcCC-------------------------------------------------
Q 012320 97 SWIDVDQKTFNFITEMFTSGTLREYRKKYRR------------------------------------------------- 127 (466)
Q Consensus 97 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~------------------------------------------------- 127 (466)
++.+ ....+++||||+.||+|.+++.....
T Consensus 94 ~~~~-~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 94 ACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EECS-TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeec-CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 8743 34558899999999999999987543
Q ss_pred -----------------CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCC--
Q 012320 128 -----------------VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK-- 188 (466)
Q Consensus 128 -----------------l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~-- 188 (466)
+++..+..|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..+....
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCC-CcEEEEeccceeeecccccc
Confidence 899999999999999999999999 9999999999999877 799999999998654322
Q ss_pred -CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 012320 189 -SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRF 265 (466)
Q Consensus 189 -~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~l 265 (466)
......||+.|+|||++. ..|+.++|||||||++|+|++ |..||........+...+..+..+ ..+...++++.++
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 328 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQT 328 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-CCCTTCCHHHHHH
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence 233456899999999775 569999999999999999998 999998866666777777666543 3445678899999
Q ss_pred HHHhcc-CcCCCCCHHHHhcC
Q 012320 266 IGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 266 I~~~L~-dp~~Rpsa~elL~h 285 (466)
|.+||. ||.+|||+.|+++|
T Consensus 329 i~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 329 MLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCCCHHHHHHH
Confidence 999996 99999999999875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=361.76 Aligned_cols=262 Identities=21% Similarity=0.310 Sum_probs=194.0
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCe---EEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGV---EVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
-+.++|.+ .+.||+|+||+||+|.++.++. .||+|++..... .....+.+.+|+.++++++||||+++++++..
T Consensus 20 i~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 20 IPEQQFTL-GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII--ASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp CC---CEE-EEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred cChhHeEE-eceecccCCeEEEEEEEcccCCcceeEEEEEeccccc--CHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 45678877 5779999999999999888775 899999875432 33456889999999999999999999998855
Q ss_pred ccCC----EEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCC
Q 012320 101 VDQK----TFNFITEMFTSGTLREYRKKYR------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHL 170 (466)
Q Consensus 101 ~~~~----~~~lV~E~~~ggsL~~~l~~~~------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~ 170 (466)
.... ..++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+.| |+||||||+|||++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~- 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAED- 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCC-
Confidence 3321 2389999999999999986543 5999999999999999999999999 9999999999999877
Q ss_pred CcEEEeccchhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHH
Q 012320 171 GQVKIGDLGLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKV 245 (466)
Q Consensus 171 g~vKL~DFGla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i 245 (466)
+.+||+|||++........ .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.. .+..++...+
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~ 252 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG-IENAEIYNYL 252 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccc-cChHHHHHHH
Confidence 8999999999977643322 22345788999999876 558999999999999999999 8999976 5556677777
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCC-------HHHHhcCCCCCchhh
Q 012320 246 TSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLS-------AKELLLDPFLASDEV 293 (466)
Q Consensus 246 ~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rps-------a~elL~hpf~~~~~~ 293 (466)
..+..+. .+...+.+++++|.+||. ||.+||| +++++.|||+.....
T Consensus 253 ~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~ 307 (323)
T 3qup_A 253 IGGNRLK-QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307 (323)
T ss_dssp HTTCCCC-CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred hcCCCCC-CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence 6665433 334567899999999996 9999999 667789999976443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=349.69 Aligned_cols=256 Identities=23% Similarity=0.361 Sum_probs=212.1
Q ss_pred eeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHH---HHHHHHHHHHHhCCCCceeEEEeE
Q 012320 21 IETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDL---QRLYSEVHLLSTLKHDSIIRFYTS 97 (466)
Q Consensus 21 ~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~---~~~~~Ei~iL~~l~HpnIv~l~~~ 97 (466)
..+-..++|.+ .+.||+|+||+||+|.+..+++.||+|.+............ +.+.+|+.++++++||||+++++.
T Consensus 13 ~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (287)
T 4f0f_A 13 LPTLADNEIEY-EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL 91 (287)
T ss_dssp CCBCCSTTEEE-EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhhhhhcccee-hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence 44556788987 56799999999999999999999999998765543333222 678999999999999999999998
Q ss_pred EEeccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCc----
Q 012320 98 WIDVDQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQ---- 172 (466)
Q Consensus 98 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~---- 172 (466)
+ .+.. ++||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||++++||+||||||+|||++.+ +.
T Consensus 92 ~--~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~-~~~~~~ 166 (287)
T 4f0f_A 92 M--HNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL-DENAPV 166 (287)
T ss_dssp E--TTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC-CTTCSC
T ss_pred e--cCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc-CCCCce
Confidence 7 3333 6899999999999888654 57999999999999999999999998889999999999999765 44
Q ss_pred -EEEeccchhhhhcCCCCCccccCCCCcCCccccc---cCCCChhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHhc
Q 012320 173 -VKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE---EDYNELVDVYSFGMCVLEMFTCEYPYSECAN-PAQIYKKVTS 247 (466)
Q Consensus 173 -vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~---~~y~~~~DIwSlGvil~elltg~~Pf~~~~~-~~~i~~~i~~ 247 (466)
+||+|||++..... ......||+.|+|||++. ..++.++|||||||++|+|++|..||..... .......+..
T Consensus 167 ~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 244 (287)
T 4f0f_A 167 CAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244 (287)
T ss_dssp CEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH
T ss_pred eEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc
Confidence 99999999975432 344567999999999873 3478999999999999999999999976443 3334555555
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 248 GKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 248 g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
...+...+...+.+++++|.+||. ||.+|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 245 EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 555556667778899999999996 9999999999985
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=348.81 Aligned_cols=249 Identities=15% Similarity=0.247 Sum_probs=209.4
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
.-++|.+ .+.||+|+||+||+|.++ |..||+|++.... .+....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 8 ~~~~y~~-~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 8 DFKQLNF-LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD--WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CGGGCEE-EEEEEEETTEEEEEEEET--TEEEEEEEECCTT--CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CHHHhHH-HHHhcCCCcceEEEEEEC--CeeEEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 3467877 566999999999999885 8999999987653 2455667899999999999999999999988654457
Q ss_pred EEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
.+++||||++||+|.+++.+.+ .+++..+..++.||+.||.|||+++++|+||||||+||+++.+ |.++|+|||++.
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~-~~~~l~~~~~~~ 161 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED-MTARISMADVKF 161 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT-SCEEEEGGGSCC
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC-cceeEEecccee
Confidence 8899999999999999998765 4899999999999999999999999899999999999999877 899999998875
Q ss_pred hhcCCCCCccccCCCCcCCccccccC-C---CChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 012320 183 ILRGSKSAHSVIGTPEFMAPELYEED-Y---NELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258 (466)
Q Consensus 183 ~~~~~~~~~~~~GT~~y~APE~l~~~-y---~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 258 (466)
... .....||+.|+|||++.+. + +.++|||||||++|+|++|..||.. .+.......+.........+...
T Consensus 162 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~ 236 (271)
T 3kmu_A 162 SFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD-LSNMEIGMKVALEGLRPTIPPGI 236 (271)
T ss_dssp TTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTT-SCHHHHHHHHHHSCCCCCCCTTC
T ss_pred eec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccc-cChHHHHHHHHhcCCCCCCCCCC
Confidence 432 2345789999999987643 3 3479999999999999999999987 45555555555444444556677
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+.++.++|.+||. ||.+|||+.++++
T Consensus 237 ~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 237 SPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8899999999996 9999999999984
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=368.22 Aligned_cols=249 Identities=28% Similarity=0.407 Sum_probs=210.4
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEc-------CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDE-------VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTS 97 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~-------~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~ 97 (466)
.++|.+ .+.||+|+||+||+|.+. .++..||+|+++... .....+.+.+|+.+|+.+ +||||++++++
T Consensus 80 ~~~~~~-~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 80 RDKLTL-GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp GGGEEE-EEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC---BHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred HHHCEe-eeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc---CHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 467766 677999999999999874 457789999986442 445677899999999999 89999999998
Q ss_pred EEeccCCEEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCC
Q 012320 98 WIDVDQKTFNFITEMFTSGTLREYRKKYR----------------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKC 161 (466)
Q Consensus 98 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp 161 (466)
+ .+...+|+||||+.||+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||
T Consensus 156 ~--~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp 231 (370)
T 2psq_A 156 C--TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAA 231 (370)
T ss_dssp E--CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCG
T ss_pred E--ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccch
Confidence 7 45677999999999999999998753 4789999999999999999999999 99999999
Q ss_pred CcEEEeCCCCcEEEeccchhhhhcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 012320 162 DNIFVNGHLGQVKIGDLGLAAILRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECA 236 (466)
Q Consensus 162 ~NIlv~~~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~ 236 (466)
+|||++.+ |.+||+|||++....... ......||+.|+|||++. ..|+.++|||||||++|||++ |..||.+ .
T Consensus 232 ~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~-~ 309 (370)
T 2psq_A 232 RNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-I 309 (370)
T ss_dssp GGEEECTT-CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-C
T ss_pred hhEEECCC-CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC-C
Confidence 99999877 899999999998654322 233456789999999775 569999999999999999999 9999976 5
Q ss_pred CHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 237 NPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 237 ~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
+..++...+..+..+. .+...+.++.++|.+||. +|.+|||+.|++++
T Consensus 310 ~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 310 PVEELFKLLKEGHRMD-KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp CGGGHHHHHHTTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6677777777776433 345577899999999996 99999999999863
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=370.52 Aligned_cols=255 Identities=26% Similarity=0.379 Sum_probs=204.5
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
-.++|.+ .+.||+|+||+||+|.++.+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 116 (371)
T 4exu_A 40 LPKTYVS-PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 116 (371)
T ss_dssp EETTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSS
T ss_pred ccccEEE-EeEEecCCCeEEEEEEECCCCCEEEEEEecccc--cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCc
Confidence 3478877 567999999999999999999999999987543 3445567899999999999999999999988543221
Q ss_pred ----EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 105 ----TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 105 ----~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
.+++||||+. ++|.+++. ..+++..++.++.||+.||.|||+.| |+||||||+|||++.+ +.+||+|||+
T Consensus 117 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~-~~~kL~Dfg~ 190 (371)
T 4exu_A 117 RNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILDFGL 190 (371)
T ss_dssp TTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECSTTC
T ss_pred ccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCC-CCEEEEecCc
Confidence 3489999996 68888764 46999999999999999999999999 9999999999999877 8999999999
Q ss_pred hhhhcCCCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCC------
Q 012320 181 AAILRGSKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-GKLP------ 251 (466)
Q Consensus 181 a~~~~~~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-g~~p------ 251 (466)
+..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. +..+....+.. ...+
T Consensus 191 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 191 ARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK-DYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp C----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCHHHHT
T ss_pred cccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCcHHHHH
Confidence 976543 2345679999999997764 6899999999999999999999999874 44443333321 1111
Q ss_pred ---------------C-------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 252 ---------------G-------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 252 ---------------~-------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
. ......++++++||.+||. ||.+|||+.|+|+||||+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 0 0123457899999999996 99999999999999999753
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=363.11 Aligned_cols=259 Identities=23% Similarity=0.369 Sum_probs=190.8
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHH-HHHhCCCCceeEEEeEEEeccC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVH-LLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
..++|.+ .+.||+|+||+||+|.++.+|+.||+|++.... .......+..|+. +++.++||||+++++++. ..
T Consensus 20 ~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~--~~ 93 (327)
T 3aln_A 20 TAEDLKD-LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF--RE 93 (327)
T ss_dssp CSCSEEC--CEEEECSSEEEEEEEETTTTEEEEEEEEECCC---CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE--CS
T ss_pred CHHHhhe-hheeccCCCEEEEEEEEcCCCCEEEEEEeeccc---CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE--eC
Confidence 4577877 566999999999999999999999999987542 3344456666666 677789999999999884 46
Q ss_pred CEEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCCCCcEEEeCCCCcEEEec
Q 012320 104 KTFNFITEMFTSGTLREYRKK-----YRRVDIRAIKSWARQILQGLVYLHSR-DPPVIHRDLKCDNIFVNGHLGQVKIGD 177 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~-----~~~l~~~~~~~i~~qIl~gL~yLHs~-~~~IiHrDLKp~NIlv~~~~g~vKL~D 177 (466)
..+++||||+.+ +|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+|||++.+ +.+||+|
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~-~~~kl~D 169 (327)
T 3aln_A 94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRS-GNIKLCD 169 (327)
T ss_dssp SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETT-TEEEECC
T ss_pred CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCC-CCEEEcc
Confidence 789999999975 88877763 56799999999999999999999998 8 9999999999999977 8999999
Q ss_pred cchhhhhcCCCCCccccCCCCcCCccccc-----cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC
Q 012320 178 LGLAAILRGSKSAHSVIGTPEFMAPELYE-----EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG 252 (466)
Q Consensus 178 FGla~~~~~~~~~~~~~GT~~y~APE~l~-----~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~ 252 (466)
||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||............+..+..+.
T Consensus 170 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (327)
T 3aln_A 170 FGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQ 249 (327)
T ss_dssp CSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCC
T ss_pred CCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCC
Confidence 99998765544444557999999999873 4589999999999999999999999976444434444444443322
Q ss_pred ---CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 253 ---AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 253 ---~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
......+..+++||.+||. ||.+|||+.++++||||.....
T Consensus 250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294 (327)
T ss_dssp CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence 2234567899999999996 9999999999999999976443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=360.65 Aligned_cols=260 Identities=30% Similarity=0.417 Sum_probs=208.2
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEc-CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC---CCCceeEEEeEEEe
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDE-VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL---KHDSIIRFYTSWID 100 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~-~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~ 100 (466)
.+++|.+ .+.||+|+||+||+|.+. .+|+.||+|++...... ......+.+|+.+++.+ +||||+++++.+..
T Consensus 9 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 9 ADQQYEC-VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp GGGTEEE-EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT--TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred chhceee-eeeecccccEEEEEEEecCCCCEEEEEEEeccCccc--ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 3578887 566999999999999995 78999999998765431 11123455677777665 89999999998753
Q ss_pred c---cCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEE
Q 012320 101 V---DQKTFNFITEMFTSGTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKI 175 (466)
Q Consensus 101 ~---~~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL 175 (466)
. ....+++||||+. |+|.+++.+.. .+++..++.++.||+.||.|||++| |+||||||+||+++.+ |.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~-~~~kl 161 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKL 161 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEE
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCC-CCEEE
Confidence 2 4567899999997 69999998754 4999999999999999999999999 9999999999999877 89999
Q ss_pred eccchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCC--
Q 012320 176 GDLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG-KLP-- 251 (466)
Q Consensus 176 ~DFGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g-~~p-- 251 (466)
+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.... .......+... ..+
T Consensus 162 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 162 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-DVDQLGKILDVIGLPGE 240 (326)
T ss_dssp CSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCG
T ss_pred ecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHHHcCCCCc
Confidence 9999997665444445678999999999775 569999999999999999999999998744 44444433321 000
Q ss_pred ----------------------CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 252 ----------------------GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 252 ----------------------~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
.......+..+++||.+||. ||.+|||+.|+|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 01223457789999999996 999999999999999997643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=360.14 Aligned_cols=251 Identities=20% Similarity=0.313 Sum_probs=209.2
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCe---EEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEE
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGV---EVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWI 99 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 99 (466)
.-..++|.+ .++||+|+||+||+|.++.+|. .||+|.+.... .....+.+.+|+.+|++++||||+++++++
T Consensus 45 ~~~~~~y~i-~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~- 119 (325)
T 3kul_A 45 EIEASRIHI-EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY---TERQRRDFLSEASIMGQFDHPNIIRLEGVV- 119 (325)
T ss_dssp BCCGGGEEE-EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred ccChhHeEE-eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-
Confidence 344678877 5779999999999999986554 59999987432 455667899999999999999999999987
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEecc
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDL 178 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DF 178 (466)
.+...+++||||+.||+|.+++... +.+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+||
T Consensus 120 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Df 195 (325)
T 3kul_A 120 -TRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSN-LVCKVSDF 195 (325)
T ss_dssp -CGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCC
T ss_pred -EeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCC-CCEEECCC
Confidence 4566789999999999999999765 57999999999999999999999999 9999999999999877 89999999
Q ss_pred chhhhhcCCCC----CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCC
Q 012320 179 GLAAILRGSKS----AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPG 252 (466)
Q Consensus 179 Gla~~~~~~~~----~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~ 252 (466)
|++..+..... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.. .+...+...+..+..+
T Consensus 196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~~- 273 (325)
T 3kul_A 196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN-MTNRDVISSVEEGYRL- 273 (325)
T ss_dssp SSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTTCCC-
T ss_pred CcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHcCCCC-
Confidence 99987643221 22334678899999876 569999999999999999999 9999977 6667777777776433
Q ss_pred CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 253 AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 253 ~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..+...+.++.++|.+||. ||.+|||+.++++
T Consensus 274 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 274 PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2345577899999999996 9999999999984
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=368.99 Aligned_cols=257 Identities=22% Similarity=0.313 Sum_probs=213.6
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEE-----EcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEE
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAI-----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSW 98 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~-----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 98 (466)
-+.++|.+ .+.||+|+||+||+|. +..++..||+|++... ........+.+|+.++++++||||+++++++
T Consensus 68 ~~~~~~~~-~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 68 VPRKNITL-IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV---CSEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp CCGGGEEE-EEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCHhHeEE-eeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc---cChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34567877 5679999999999999 5668899999998632 2455667889999999999999999999987
Q ss_pred EeccCCEEEEEEecCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC--
Q 012320 99 IDVDQKTFNFITEMFTSGTLREYRKKYR-------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH-- 169 (466)
Q Consensus 99 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~-------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~-- 169 (466)
.+....++||||+.||+|.+++...+ .+++..+..++.||+.||.|||++| |+||||||+|||++.+
T Consensus 144 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~ 219 (367)
T 3l9p_A 144 --LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGP 219 (367)
T ss_dssp --CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSST
T ss_pred --ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCC
Confidence 44667789999999999999998753 4899999999999999999999999 9999999999999854
Q ss_pred CCcEEEeccchhhhhcC---CCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHH
Q 012320 170 LGQVKIGDLGLAAILRG---SKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKK 244 (466)
Q Consensus 170 ~g~vKL~DFGla~~~~~---~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~ 244 (466)
...+||+|||+++.+.. ........||+.|+|||++. ..|+.++|||||||++|+|++ |..||.. .+..++...
T Consensus 220 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~-~~~~~~~~~ 298 (367)
T 3l9p_A 220 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEF 298 (367)
T ss_dssp TCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHH
T ss_pred CceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHH
Confidence 13599999999976532 22334567899999999775 669999999999999999998 9999976 677788888
Q ss_pred HhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 245 VTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 245 i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
+..+..+. .+...+..+.+||.+||. +|.+|||+.+++++.+...
T Consensus 299 i~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 299 VTSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCCCC-CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 88776433 344567899999999996 9999999999999887644
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=358.85 Aligned_cols=252 Identities=22% Similarity=0.341 Sum_probs=204.7
Q ss_pred CCceEEeeeeeeeeCceEEEEEEE-cCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCC------ceeEEEeEE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAID-EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHD------SIIRFYTSW 98 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~-~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp------nIv~l~~~~ 98 (466)
.+||.+ .+.||+|+||+||+|.+ +.+|+.||+|++.. .....+.+.+|+.+++.++|+ +|+++++.+
T Consensus 13 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 13 SARYEI-VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN-----VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp TTTEEE-EEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred cCceEE-EEEEecCCCeEEEEEEecCCCCcEEEEEEEec-----CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 468988 46699999999999998 66899999999863 234567788999999988665 499999987
Q ss_pred EeccCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC-------
Q 012320 99 IDVDQKTFNFITEMFTSGTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH------- 169 (466)
Q Consensus 99 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~------- 169 (466)
.....+++||||+ +++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++..
T Consensus 87 --~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 87 --EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp --EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC
T ss_pred --ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccC
Confidence 4467899999999 999999998765 6899999999999999999999999 9999999999999763
Q ss_pred -----------CCcEEEeccchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q 012320 170 -----------LGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECAN 237 (466)
Q Consensus 170 -----------~g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~ 237 (466)
.+.+||+|||++..... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~-~~ 238 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT-HD 238 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC-SC
T ss_pred CccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CC
Confidence 26799999999976433 234568999999999776 4699999999999999999999999976 34
Q ss_pred HHHHHHHHhc--CCCCCC----------------------------------------CCCCCCHHHHHHHHHhcc-CcC
Q 012320 238 PAQIYKKVTS--GKLPGA----------------------------------------FYSIQDLEAQRFIGRCLV-NAS 274 (466)
Q Consensus 238 ~~~i~~~i~~--g~~p~~----------------------------------------~~~~~~~~~~~lI~~~L~-dp~ 274 (466)
..+....+.. +.+|.. .....+.++.+||.+||. ||.
T Consensus 239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 4433332221 111110 011224578899999996 999
Q ss_pred CCCCHHHHhcCCCCCch
Q 012320 275 KRLSAKELLLDPFLASD 291 (466)
Q Consensus 275 ~Rpsa~elL~hpf~~~~ 291 (466)
+|||+.|+|+||||+..
T Consensus 319 ~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 319 KRITLREALKHPFFDLL 335 (339)
T ss_dssp TSCCHHHHTTSGGGGGG
T ss_pred cccCHHHHhcCHHHHHH
Confidence 99999999999999753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=368.72 Aligned_cols=254 Identities=26% Similarity=0.383 Sum_probs=202.9
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CC-----ceeEEEeEEE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HD-----SIIRFYTSWI 99 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-Hp-----nIv~l~~~~~ 99 (466)
.++|.+ .++||+|+||+||+|.++.+|+.||+|+++.. ......+..|+.+++.++ |+ +|+++++.+.
T Consensus 53 ~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 53 MDRYEI-DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp TTTEEE-EEEEEEETTEEEEEEEETTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred eeeEEE-EEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 578887 56799999999999999999999999998632 334567788999998884 55 4999999884
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeC-CCCcEEEe
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNG-HLGQVKIG 176 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~-~~g~vKL~ 176 (466)
....+++||||+. ++|.+++... +.+++..++.++.||+.||.|||++..+|+||||||+|||++. ..+.+||+
T Consensus 127 --~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 127 --FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp --ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred --cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 4678999999995 5999999875 4699999999999999999999964334999999999999953 23789999
Q ss_pred ccchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--CCCC--
Q 012320 177 DLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS--GKLP-- 251 (466)
Q Consensus 177 DFGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~--g~~p-- 251 (466)
|||++..... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .+..+....+.. +..|
T Consensus 204 DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~~~~~ 280 (382)
T 2vx3_A 204 DFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG-ANEVDQMNKIVEVLGIPPAH 280 (382)
T ss_dssp CCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHHHCSCCHH
T ss_pred eccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhCCCCHH
Confidence 9999977643 344678999999999776 4699999999999999999999999987 444444444332 1110
Q ss_pred ----------------CCCC---------------C---------------------------CCCHHHHHHHHHhcc-C
Q 012320 252 ----------------GAFY---------------S---------------------------IQDLEAQRFIGRCLV-N 272 (466)
Q Consensus 252 ----------------~~~~---------------~---------------------------~~~~~~~~lI~~~L~-d 272 (466)
...+ . ..+.++++||.+||. |
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 360 (382)
T 2vx3_A 281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD 360 (382)
T ss_dssp HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence 0000 0 001378999999996 9
Q ss_pred cCCCCCHHHHhcCCCCCch
Q 012320 273 ASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 273 p~~Rpsa~elL~hpf~~~~ 291 (466)
|.+|||+.|+|+||||+..
T Consensus 361 P~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 361 PKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TTTSCCHHHHTTSGGGCC-
T ss_pred hhhCCCHHHHhcCcccccC
Confidence 9999999999999999764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=347.62 Aligned_cols=253 Identities=27% Similarity=0.404 Sum_probs=199.5
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
..++|.. .++||+|+||+||+|.+. |..||+|++............+.+.+|+.+++.++||||+++++++ .+..
T Consensus 5 ~~~~~~~-~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~ 79 (271)
T 3dtc_A 5 DFAELTL-EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC--LKEP 79 (271)
T ss_dssp CTTSEEE-EEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE--CCC-
T ss_pred chhheee-eeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE--ecCC
Confidence 3578877 577999999999999875 8999999987554332233457889999999999999999999987 4567
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC-CeEeccCCCCcEEEeCC-------CCcEEEe
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDP-PVIHRDLKCDNIFVNGH-------LGQVKIG 176 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~-~IiHrDLKp~NIlv~~~-------~g~vKL~ 176 (466)
.+++||||+.|++|.+++. .+.+++..+..++.||+.||.|||+.+. +|+||||||+||+++.. .+.+||+
T Consensus 80 ~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp -CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred ceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 7899999999999999885 4689999999999999999999999983 38899999999999752 4789999
Q ss_pred ccchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 012320 177 DLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFY 255 (466)
Q Consensus 177 DFGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~ 255 (466)
|||++....... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+.......+..+..+...+
T Consensus 159 Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~ 236 (271)
T 3dtc_A 159 DFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG-IDGLAVAYGVAMNKLALPIP 236 (271)
T ss_dssp CCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTT-SCHHHHHHHHHTSCCCCCCC
T ss_pred cCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHhhhcCCCCCCCC
Confidence 999997655432 33567999999999776 4589999999999999999999999987 45555666666666555566
Q ss_pred CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 256 ~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
...+..+.++|.+||. +|.+|||+.|++++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 7778899999999996 99999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=371.19 Aligned_cols=258 Identities=15% Similarity=0.171 Sum_probs=189.5
Q ss_pred eEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC--CCCceeEEEeEE-------E
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL--KHDSIIRFYTSW-------I 99 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l--~HpnIv~l~~~~-------~ 99 (466)
|.+ .+.||+|+||+||+|.++.+|+.||+|++..... ......+.+.+|+.+++.| +||||++++..+ .
T Consensus 64 y~~-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 64 LKL-VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE-NSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEECCST-THHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eee-eeeccCCCCEEEEEEEECCCCceeEEEEEEeccc-ccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 555 6779999999999999999999999999986542 2334566788885544444 699988866433 2
Q ss_pred eccC---------------CEEEEEEecCCCCCHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCCCeEec
Q 012320 100 DVDQ---------------KTFNFITEMFTSGTLREYRKKY-RRVDIRAI------KSWARQILQGLVYLHSRDPPVIHR 157 (466)
Q Consensus 100 ~~~~---------------~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~------~~i~~qIl~gL~yLHs~~~~IiHr 157 (466)
.... ..+|+||||+. |+|.+++... ..++.... ..++.||+.||.|||++| |+||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivHr 218 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHG 218 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEET
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--CccC
Confidence 2211 45899999998 8999999864 33444444 566799999999999999 9999
Q ss_pred cCCCCcEEEeCCCCcEEEeccchhhhhcCCCCCccccCCCCcCCcccccc---CCCChhhHHHHHHHHHHHHhCCCCCCC
Q 012320 158 DLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYEE---DYNELVDVYSFGMCVLEMFTCEYPYSE 234 (466)
Q Consensus 158 DLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~~---~y~~~~DIwSlGvil~elltg~~Pf~~ 234 (466)
||||+|||++.+ |.+||+|||++..... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||..
T Consensus 219 Dikp~NIll~~~-~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 219 HFTPDNLFIMPD-GRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp TCSGGGEEECTT-SCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred cCCHHHEEECCC-CCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 999999999977 8999999999976532 2225567899999998764 599999999999999999999999976
Q ss_pred CCCHH-HHHHH---Hh--cCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhhh
Q 012320 235 CANPA-QIYKK---VT--SGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVK 294 (466)
Q Consensus 235 ~~~~~-~i~~~---i~--~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~~ 294 (466)
..... ..+.. .. ............+..+++||.+||. ||.+|||+.++|+||||+...+.
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 362 (371)
T 3q60_A 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNE 362 (371)
T ss_dssp CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHH
T ss_pred cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHH
Confidence 42210 00110 01 1112222234568899999999996 99999999999999999876554
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=364.04 Aligned_cols=258 Identities=20% Similarity=0.330 Sum_probs=186.7
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
..-.++|.+.+++||+|+||+||+|.++.+|+.||+|++... ... ..+....++.++||||+++++.+....
T Consensus 24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~ 95 (336)
T 3fhr_A 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKA---RQEVDHHWQASGGPHIVCILDVYENMH 95 (336)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHH---HHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHH---HHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence 345688999888999999999999999999999999998632 111 122333456779999999999885432
Q ss_pred --CCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC--CCcEEEe
Q 012320 103 --QKTFNFITEMFTSGTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH--LGQVKIG 176 (466)
Q Consensus 103 --~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~--~g~vKL~ 176 (466)
...+++||||+.||+|.+++.+.+ .+++..++.++.||+.||.|||+.| |+||||||+|||++.+ .+.+||+
T Consensus 96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEEC
T ss_pred CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEe
Confidence 456899999999999999998764 6999999999999999999999999 9999999999999753 3569999
Q ss_pred ccchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhcCC--C
Q 012320 177 DLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQ---IYKKVTSGK--L 250 (466)
Q Consensus 177 DFGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~---i~~~i~~g~--~ 250 (466)
|||++..... ......+||+.|+|||++. ..|+.++|||||||++|+|++|..||........ ....+..+. +
T Consensus 174 Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (336)
T 3fhr_A 174 DFGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252 (336)
T ss_dssp CCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CC
T ss_pred ccccceeccc-cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc
Confidence 9999976543 2345667999999999875 4588999999999999999999999965332211 122233222 2
Q ss_pred CCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 251 PGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 251 p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
+...+...+.++++||.+||. ||.+|||+.|+|+||||+..
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 333445678899999999996 99999999999999999653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=354.77 Aligned_cols=250 Identities=27% Similarity=0.402 Sum_probs=210.9
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEE-----cCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEE
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAID-----EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWI 99 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 99 (466)
+..+|.+ .+.||+|+||+||+|.+ +.++..||+|++.... .....+.+.+|+.+|++++||||+++++++
T Consensus 21 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~- 95 (314)
T 2ivs_A 21 PRKNLVL-GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA---SPSELRDLLSEFNVLKQVNHPHVIKLYGAC- 95 (314)
T ss_dssp CGGGEEE-EEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred chhheee-eeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCceeeEEEEE-
Confidence 3466665 67799999999999998 4567999999986432 456678899999999999999999999987
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKYRR------------------------VDIRAIKSWARQILQGLVYLHSRDPPVI 155 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~------------------------l~~~~~~~i~~qIl~gL~yLHs~~~~Ii 155 (466)
.+...+++||||+.|++|.+++...+. +++..+..++.||+.||.|||+++ |+
T Consensus 96 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iv 172 (314)
T 2ivs_A 96 -SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LV 172 (314)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred -ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Cc
Confidence 456678999999999999999987543 899999999999999999999999 99
Q ss_pred eccCCCCcEEEeCCCCcEEEeccchhhhhcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCC
Q 012320 156 HRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEY 230 (466)
Q Consensus 156 HrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~ 230 (466)
||||||+||+++.+ +.+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++ |..
T Consensus 173 H~dikp~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 173 HRDLAARNILVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp CCCCSGGGEEEETT-TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccchheEEEcCC-CCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999977 899999999997654322 123446788999999775 558999999999999999999 999
Q ss_pred CCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 231 PYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 231 Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
||.. .+...+...+..+..+ ..+...+.++.++|.+||. ||.+|||+.+++++
T Consensus 252 p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 252 PYPG-IPPERLFNLLKTGHRM-ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp SSTT-CCGGGHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCC-CCHHHHHHHhhcCCcC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9976 5566777777776543 3445677899999999996 99999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=354.85 Aligned_cols=259 Identities=24% Similarity=0.381 Sum_probs=198.8
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
...++|... +.||+|+||+||+|.++.+|+.||+|++..... .....+.+.++..+++.++||||+++++++. +.
T Consensus 22 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~--~~ 96 (318)
T 2dyl_A 22 AEINDLENL-GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--KEENKRILMDLDVVLKSHDCPYIVQCFGTFI--TN 96 (318)
T ss_dssp CCGGGEEEE-EEC------CEEEEEETTTCCEEEEEEEETTSC--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CS
T ss_pred hhhcccccc-ceeeecCCeeEEEEEEecCCeEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCceeeEEEEEe--cC
Confidence 345678774 569999999999999999999999999875431 2223344455556788889999999999884 46
Q ss_pred CEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 104 KTFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSR-DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~-~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
..+++||||+ ++.+..+... .+.+++..+..++.||+.||.|||+. | |+||||||+||+++.+ +.+||+|||++
T Consensus 97 ~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~ 172 (318)
T 2dyl_A 97 TDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDER-GQIKLCDFGIS 172 (318)
T ss_dssp SEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTT-SCEEECCCTTC
T ss_pred CcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCC-CCEEEEECCCc
Confidence 7899999999 6677666654 57899999999999999999999995 8 9999999999999877 89999999999
Q ss_pred hhhcCCCCCccccCCCCcCCccccc------cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC-
Q 012320 182 AILRGSKSAHSVIGTPEFMAPELYE------EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAF- 254 (466)
Q Consensus 182 ~~~~~~~~~~~~~GT~~y~APE~l~------~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~- 254 (466)
.............||+.|+|||++. ..++.++|||||||++|+|++|..||....+.......+..+..+...
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (318)
T 2dyl_A 173 GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPG 252 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCS
T ss_pred hhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCc
Confidence 8766555555668999999999873 358899999999999999999999998877777777777766544322
Q ss_pred CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 255 YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 255 ~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
....+.+++++|.+||. ||.+|||+.++++||||+..
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 23467899999999996 99999999999999999754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=358.82 Aligned_cols=260 Identities=23% Similarity=0.258 Sum_probs=204.4
Q ss_pred hhhhccceeeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCcee
Q 012320 13 EAKAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSII 92 (466)
Q Consensus 13 ~~~~~~~~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv 92 (466)
++.+.-+-...-..++|.+ .++||+|+||+||+|.+. |+.||+|++.... ........|+.+|++++||||+
T Consensus 10 ~~~~~~~~n~~~~~~~y~~-~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv 81 (322)
T 3soc_A 10 SGVDLGTENLYFQSMPLQL-LEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-----KQSWQNEYEVYSLPGMKHENIL 81 (322)
T ss_dssp ----CCCCCEEETTEEEEE-EEEEECSTTCEEEEEEET--TEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBC
T ss_pred cccccCccccccchhhchh-hheecccCceEEEEEEEC--CCEEEEEEeecCc-----hHHHHHHHHHHHHhcCCCCCch
Confidence 3333333333445678877 567999999999999875 8999999986432 2345566799999999999999
Q ss_pred EEEeEEEecc--CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCeEeccCC
Q 012320 93 RFYTSWIDVD--QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSR----------DPPVIHRDLK 160 (466)
Q Consensus 93 ~l~~~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~----------~~~IiHrDLK 160 (466)
++++++.... ...+++||||+.+|+|.+++++ +.+++..+..++.||+.||.|||+. + |+|||||
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlk 158 (322)
T 3soc_A 82 QFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIK 158 (322)
T ss_dssp CEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCS
T ss_pred hhcceeccCCCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCC
Confidence 9999986644 3468999999999999999976 5699999999999999999999999 8 9999999
Q ss_pred CCcEEEeCCCCcEEEeccchhhhhcCCC---CCccccCCCCcCCcccccc------CCCChhhHHHHHHHHHHHHhCCCC
Q 012320 161 CDNIFVNGHLGQVKIGDLGLAAILRGSK---SAHSVIGTPEFMAPELYEE------DYNELVDVYSFGMCVLEMFTCEYP 231 (466)
Q Consensus 161 p~NIlv~~~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~y~APE~l~~------~y~~~~DIwSlGvil~elltg~~P 231 (466)
|+|||++.+ +.+||+|||++..+.... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..|
T Consensus 159 p~Nill~~~-~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~p 237 (322)
T 3soc_A 159 SKNVLLKNN-LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237 (322)
T ss_dssp GGGEEECTT-CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTT
T ss_pred hHhEEECCC-CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCC
Confidence 999999877 899999999997664322 2344679999999998764 366789999999999999999999
Q ss_pred CCCCC---------------CHHHHHHHHhcCCCCCCCCCC-----CCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 232 YSECA---------------NPAQIYKKVTSGKLPGAFYSI-----QDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 232 f~~~~---------------~~~~i~~~i~~g~~p~~~~~~-----~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
|.+.. ....+...+......+..... .+.++.+||.+||. ||.+|||+.|+++
T Consensus 238 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 238 ADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp SSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 96432 344455555544433332221 12458999999996 9999999999985
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=358.24 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=212.3
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEc-----CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEE
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDE-----VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSW 98 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 98 (466)
.+.++|.+ .+.||+|+||+||+|.+. .+++.||+|.+.... .....+.+.+|+.++++++||||+++++++
T Consensus 44 ~~~~~~~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 44 YPRNNIEY-VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp CCGGGCEE-EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ecHHHCee-eeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 35678877 566999999999999987 456999999987432 445667899999999999999999999987
Q ss_pred EeccCCEEEEEEecCCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCe
Q 012320 99 IDVDQKTFNFITEMFTSGTLREYRKKY------------------------RRVDIRAIKSWARQILQGLVYLHSRDPPV 154 (466)
Q Consensus 99 ~~~~~~~~~lV~E~~~ggsL~~~l~~~------------------------~~l~~~~~~~i~~qIl~gL~yLHs~~~~I 154 (466)
.+...+++||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ |
T Consensus 120 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--i 195 (343)
T 1luf_A 120 --AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--F 195 (343)
T ss_dssp --CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred --ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--e
Confidence 4567789999999999999999874 56999999999999999999999999 9
Q ss_pred EeccCCCCcEEEeCCCCcEEEeccchhhhhcCC---CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CC
Q 012320 155 IHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CE 229 (466)
Q Consensus 155 iHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~---~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~ 229 (466)
+||||||+|||++.+ +.+||+|||++...... .......||+.|+|||++. ..++.++|||||||++|+|++ |.
T Consensus 196 vH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 196 VHRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CCSCCSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred ecCCCCcceEEECCC-CeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 999999999999877 89999999999765432 2233456899999999775 569999999999999999999 99
Q ss_pred CCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 230 YPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 230 ~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.||.. .+..++...+..+..+. .+...+.++.++|.+||. +|.+|||+.++++
T Consensus 275 ~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 275 QPYYG-MAHEEVIYYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp CTTTT-SCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcCCC-CChHHHHHHHhCCCcCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 99976 66777888888876543 345567899999999996 9999999999974
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=362.88 Aligned_cols=255 Identities=27% Similarity=0.385 Sum_probs=204.9
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC-
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ- 103 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~- 103 (466)
-.++|.. .+.||+|+||+||+|.++.+|+.||+|++.... ......+++.+|+.+++.++||||+++++++.....
T Consensus 22 l~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 98 (353)
T 3coi_A 22 LPKTYVS-PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 98 (353)
T ss_dssp EETTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEESSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred cCceEEE-eeeEecCCCeEEEEEEECCCCCEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccc
Confidence 3578887 577999999999999999999999999987543 344556789999999999999999999998754322
Q ss_pred ---CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 104 ---KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 104 ---~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
..+++||||+. ++|.+++. ..+++..++.++.||+.||.|||++| |+||||||+||+++.+ |.+||+|||+
T Consensus 99 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~-~~~kl~Dfg~ 172 (353)
T 3coi_A 99 RNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILDFGL 172 (353)
T ss_dssp GGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTT-CCEEECSTTC
T ss_pred ccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCC-CcEEEeeccc
Confidence 24689999996 68887764 46999999999999999999999999 9999999999999977 8999999999
Q ss_pred hhhhcCCCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--CCC------
Q 012320 181 AAILRGSKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS--GKL------ 250 (466)
Q Consensus 181 a~~~~~~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~--g~~------ 250 (466)
+..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. +.......+.. |..
T Consensus 173 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 173 ARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK-DYLDQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp TTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS-CHHHHHHHHHHHHCBCCHHHHT
T ss_pred ccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCCHHHHH
Confidence 976543 2345679999999997754 5899999999999999999999999774 43333333321 000
Q ss_pred --------------C-------CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 251 --------------P-------GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 251 --------------p-------~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
+ .......+.++++||.+||. ||.+|||+.++|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0 11223457899999999996 99999999999999999753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=345.03 Aligned_cols=246 Identities=19% Similarity=0.361 Sum_probs=208.4
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
..+|.+ .+.||+|+||+||+|.+. ++..||+|++..... ..+.+.+|+.++++++||||+++++++ .+...
T Consensus 9 ~~~y~~-~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~ 79 (269)
T 4hcu_A 9 PSELTF-VQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVC--LEQAP 79 (269)
T ss_dssp GGGEEE-EEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEE--CSSSS
T ss_pred hhhcee-eheecCCCccEEEEEEec-CCCeEEEEEeccccc-----CHHHHHHHHHHHHhCCCCCEeeEEEEE--ecCCc
Confidence 357877 466999999999999987 478899999875432 235688999999999999999999987 45667
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 106 FNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
+++||||+++++|.+++... +.+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN-QVIKVSDFGMTRFV 156 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGG-GCEEECCTTGGGGB
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCC-CCEEeccccccccc
Confidence 99999999999999999764 56899999999999999999999999 9999999999999877 89999999999765
Q ss_pred cCCC--CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 012320 185 RGSK--SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL 260 (466)
Q Consensus 185 ~~~~--~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~ 260 (466)
.... ......||+.|+|||++. ..++.++|||||||++|+|++ |..||.. .+..++...+..+..+ ..+...+.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 234 (269)
T 4hcu_A 157 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLAST 234 (269)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCH
T ss_pred cccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhcCccC-CCCCcCCH
Confidence 4321 223445788999999876 669999999999999999999 8999976 6777788888776433 33455688
Q ss_pred HHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 261 EAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 261 ~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
.+.+++.+||. +|.+|||+.++++|
T Consensus 235 ~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 235 HVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHH
Confidence 99999999996 99999999999865
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=358.06 Aligned_cols=253 Identities=25% Similarity=0.348 Sum_probs=209.2
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEE-----cCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeE
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAID-----EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTS 97 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~ 97 (466)
-+.++|.+ .+.||+|+||+||+|.+ ..++..||+|.+.... .....+.+.+|+.+|+++ +||||+++++.
T Consensus 42 ~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 42 FPRENLEF-GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp CCGGGEEE-EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCHHHcee-eeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 35678877 67799999999999997 4567899999987432 233457899999999999 89999999998
Q ss_pred EEeccCCEEEEEEecCCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCe
Q 012320 98 WIDVDQKTFNFITEMFTSGTLREYRKKYR-----------------------RVDIRAIKSWARQILQGLVYLHSRDPPV 154 (466)
Q Consensus 98 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------------~l~~~~~~~i~~qIl~gL~yLHs~~~~I 154 (466)
+ .....+++||||+++|+|.+++.... .+++..+..++.||+.||.|||++| |
T Consensus 118 ~--~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i 193 (344)
T 1rjb_A 118 C--TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--C 193 (344)
T ss_dssp E--CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred E--eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--c
Confidence 7 44667899999999999999998653 3799999999999999999999999 9
Q ss_pred EeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CC
Q 012320 155 IHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CE 229 (466)
Q Consensus 155 iHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~ 229 (466)
+||||||+|||++.+ +.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|+| |.
T Consensus 194 vH~Dikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 272 (344)
T 1rjb_A 194 VHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 272 (344)
T ss_dssp EETTCSGGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred ccCCCChhhEEEcCC-CcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCC
Confidence 999999999999977 8999999999976643322 23456788999999775 569999999999999999998 99
Q ss_pred CCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCC
Q 012320 230 YPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDP 286 (466)
Q Consensus 230 ~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hp 286 (466)
.||........+.+.+..+.. ...+...+.++.++|.+||. ||.+|||+.+++++.
T Consensus 273 ~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 273 NPYPGIPVDANFYKLIQNGFK-MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp CSSTTCCCSHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCcccCCcHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 999886666666666666543 33445568899999999996 999999999998754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=351.88 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=212.5
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEE-----cCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEe
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAID-----EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYT 96 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~ 96 (466)
.-+.++|.+ .+.||+|+||+||+|.+ ..+++.||+|.+.... .....+.+.+|+.+|+++ +||||+++++
T Consensus 19 ~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 19 EFPRNRLSF-GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp BCCGGGEEE-EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccChhhhhH-HHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch---hHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 445688977 57799999999999984 5688999999987442 345667899999999999 9999999999
Q ss_pred EEEeccCCEEEEEEecCCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecc
Q 012320 97 SWIDVDQKTFNFITEMFTSGTLREYRKKYR------------------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRD 158 (466)
Q Consensus 97 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrD 158 (466)
.+ .+...+++||||+++|+|.+++.+.+ .+++..+..++.||+.||.|||+++ |+|||
T Consensus 95 ~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~d 170 (313)
T 1t46_A 95 AC--TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRD 170 (313)
T ss_dssp EE--CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred EE--ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCC
Confidence 87 44667899999999999999998754 4899999999999999999999999 99999
Q ss_pred CCCCcEEEeCCCCcEEEeccchhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCC
Q 012320 159 LKCDNIFVNGHLGQVKIGDLGLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYS 233 (466)
Q Consensus 159 LKp~NIlv~~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~ 233 (466)
|||+||+++.+ +.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.
T Consensus 171 lkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 249 (313)
T 1t46_A 171 LAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (313)
T ss_dssp CSGGGEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CccceEEEcCC-CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999877 8999999999987654332 23445788999999765 569999999999999999999 999998
Q ss_pred CCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 234 ECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 234 ~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
.........+.+..+.. ...+...+.+++++|.+||. ||.+|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 250 GMPVDSKFYKMIKEGFR-MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp TCCSSHHHHHHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccchhHHHHHhccCCC-CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 76666666666655533 23345567899999999996 99999999999863
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=362.38 Aligned_cols=251 Identities=29% Similarity=0.404 Sum_probs=213.3
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcC-------CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEE
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEV-------LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFY 95 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~ 95 (466)
-+.++|.+ .+.||+|+||+||+|.+.. .+..||+|++... ......+.+.+|+.+++++ +||||++++
T Consensus 66 i~~~~y~i-~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 66 LPRDRLVL-GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp CCGGGEEE-EEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cchhheEe-eeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc---cCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 34578877 5779999999999999753 4468999998744 2455668899999999999 999999999
Q ss_pred eEEEeccCCEEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccC
Q 012320 96 TSWIDVDQKTFNFITEMFTSGTLREYRKKYR----------------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDL 159 (466)
Q Consensus 96 ~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDL 159 (466)
+++ .....+++||||+.+|+|.+++.... .+++..++.|+.||+.||.|||+.+ |+||||
T Consensus 142 ~~~--~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dl 217 (382)
T 3tt0_A 142 GAC--TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDL 217 (382)
T ss_dssp EEE--CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred eee--ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCC
Confidence 987 45667899999999999999998754 4999999999999999999999999 999999
Q ss_pred CCCcEEEeCCCCcEEEeccchhhhhcCC---CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 012320 160 KCDNIFVNGHLGQVKIGDLGLAAILRGS---KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSE 234 (466)
Q Consensus 160 Kp~NIlv~~~~g~vKL~DFGla~~~~~~---~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~ 234 (466)
||+|||++.+ +.+||+|||++...... .......||+.|+|||++. ..++.++|||||||++|+|++ |..||..
T Consensus 218 kp~NIll~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 218 AARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp CGGGEEECTT-CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CcceEEEcCC-CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999877 89999999999866432 2233456789999999775 568999999999999999999 9999976
Q ss_pred CCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 235 CANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 235 ~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
.+..++.+.+..+..+. .+...+.++.+||.+||. ||.+|||+.|++++
T Consensus 297 -~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 297 -VPVEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp -CCHHHHHHHHHTTCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 67788888888776443 345677899999999996 99999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=356.47 Aligned_cols=263 Identities=23% Similarity=0.313 Sum_probs=210.7
Q ss_pred hhhhhccceeeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEE--EEEEEecccccCCHHHHHHHHHHHHHHHhC-CC
Q 012320 12 DEAKAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEV--AWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KH 88 (466)
Q Consensus 12 ~~~~~~~~~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~v--AiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~H 88 (466)
+.+.+....-..-..++|.+ .+.||+|+||+||+|.++.+|..+ |+|.+.... .....+.+.+|+.+|+++ +|
T Consensus 10 ~~~~~~~~~~p~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~h 85 (327)
T 1fvr_A 10 GKNNPDPTIYPVLDWNDIKF-QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHH 85 (327)
T ss_dssp ------CCCSSBCCGGGCEE-EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCC
T ss_pred CCCCCCCcccccccHHHccc-eeeeecCCCceEEEEEEccCCcccceeeeeecccc---chHHHHHHHHHHHHHHhccCC
Confidence 33333333333344578877 677999999999999999999866 888876322 334556789999999999 89
Q ss_pred CceeEEEeEEEeccCCEEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCC
Q 012320 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR----------------RVDIRAIKSWARQILQGLVYLHSRDP 152 (466)
Q Consensus 89 pnIv~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qIl~gL~yLHs~~~ 152 (466)
|||+++++++ .+...+++||||+++++|.+++.+.+ .+++..++.++.||+.||.|||++|
T Consensus 86 p~iv~~~~~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~- 162 (327)
T 1fvr_A 86 PNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ- 162 (327)
T ss_dssp TTBCCEEEEE--EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred Cchhhhceee--eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 9999999988 44678999999999999999998754 6999999999999999999999999
Q ss_pred CeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCC
Q 012320 153 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEY 230 (466)
Q Consensus 153 ~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~ 230 (466)
|+||||||+|||++.+ +.+||+|||++.............+|+.|+|||++. ..++.++|||||||++|+|++ |..
T Consensus 163 -ivH~dlkp~NIl~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 240 (327)
T 1fvr_A 163 -FIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 240 (327)
T ss_dssp -EECSCCSGGGEEECGG-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred -ccCCCCccceEEEcCC-CeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCC
Confidence 9999999999999877 799999999997543333334456789999999876 458999999999999999998 999
Q ss_pred CCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 231 PYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 231 Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
||.. .+..++...+..+..+ ..+...+.+++++|.+||. +|.+|||+.+++++
T Consensus 241 pf~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 241 PYCG-MTCAELYEKLPQGYRL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp TTTT-CCHHHHHHHGGGTCCC-CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCC-CcHHHHHHHhhcCCCC-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9976 6777788888776433 2344567899999999996 99999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=350.09 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=202.6
Q ss_pred CCCceEEeeeeeeeeCceEEEEEE----EcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAI----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
..++|.+ .+.||+|+||+||+|. +..+|+.||+|++... .....+.+.+|+.+|++++||||+++++.+..
T Consensus 8 ~~~~~~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 8 EERHLKF-LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CGGGEEE-EEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred CHHHhhh-hheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3467776 5669999999999998 6779999999998632 45566789999999999999999999998866
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
.+...+++||||+++|+|.+++.+.+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~-~~~kl~Dfg 159 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVKIGDFG 159 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCC-CeEEEccCc
Confidence 55667899999999999999998754 4999999999999999999999999 9999999999999977 899999999
Q ss_pred hhhhhcCCC----CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCC---------------HH
Q 012320 180 LAAILRGSK----SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECAN---------------PA 239 (466)
Q Consensus 180 la~~~~~~~----~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~---------------~~ 239 (466)
++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||..... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 998764332 123345778899999776 5699999999999999999999999853110 01
Q ss_pred HHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 240 QIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 240 ~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.+...+..+.. ...+...+.++.++|.+||. ||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 240 HLIELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccCc-CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 22333333332 22345667899999999996 9999999999974
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=342.15 Aligned_cols=247 Identities=21% Similarity=0.343 Sum_probs=207.5
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
..++|.+ .+.||+|+||+||+|.++ ++..||+|++..... ..+.+.+|+.++++++||||+++++.+ .+..
T Consensus 6 ~~~~y~~-~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~ 76 (268)
T 3sxs_A 6 KREEITL-LKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-----SEDEFFQEAQTMMKLSHPKLVKFYGVC--SKEY 76 (268)
T ss_dssp CGGGEEE-EEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-----CHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSS
T ss_pred chhheee-eeeeccCCCceEEEEEec-CceeEEEEEeccCCC-----cHHHHHHHHHHHHhCCCCCEeeEEEEE--ccCC
Confidence 4578877 466999999999999876 578899999875432 235688999999999999999999987 5567
Q ss_pred EEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
.+++||||+++++|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++..
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 77 PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRD-LCVKVSDFGMTRY 153 (268)
T ss_dssp SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTT-CCEEECCTTCEEE
T ss_pred ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCC-CCEEEccCcccee
Confidence 7999999999999999998754 5999999999999999999999999 9999999999999877 8999999999976
Q ss_pred hcCCCC--CccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 012320 184 LRGSKS--AHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259 (466)
Q Consensus 184 ~~~~~~--~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 259 (466)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.. .+.......+..+..+ ..+...+
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 231 (268)
T 3sxs_A 154 VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL-YTNSEVVLKVSQGHRL-YRPHLAS 231 (268)
T ss_dssp CCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCCC-CCCTTSC
T ss_pred cchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc-cChHHHHHHHHcCCCC-CCCCcCh
Confidence 544322 223456778999998764 68999999999999999999 9999976 5666666667666533 2345567
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
..+.++|.+||. +|.+|||+.+++++
T Consensus 232 ~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 232 DTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 899999999996 99999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=372.31 Aligned_cols=253 Identities=21% Similarity=0.360 Sum_probs=207.9
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
..++|.+ .++||+|+||+||+|.++.+|+.||+|++....... ..+.+.+|+.+|++++||||+++++++...+..
T Consensus 7 ~~~~y~i-~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 82 (396)
T 4eut_A 7 SNHLWLL-SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR---PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (396)
T ss_dssp SSEEEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS---CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCCceEE-EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc---hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence 3567766 677999999999999999999999999987554322 346678999999999999999999988766666
Q ss_pred EEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEE----eCCCCcEEEec
Q 012320 105 TFNFITEMFTSGTLREYRKKYRR---VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFV----NGHLGQVKIGD 177 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~---l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv----~~~~g~vKL~D 177 (466)
.+++||||+.||+|.+++.+... +++..++.++.||+.||.|||+.+ |+||||||+|||+ +.+ +.+||+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~-~~~kL~D 159 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQ-SVYKLTD 159 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSC-EEEEECC
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCc-eeEEEec
Confidence 88999999999999999976433 999999999999999999999999 9999999999998 544 6799999
Q ss_pred cchhhhhcCCCCCccccCCCCcCCccccc---------cCCCChhhHHHHHHHHHHHHhCCCCCCCC---CCHHHHHHHH
Q 012320 178 LGLAAILRGSKSAHSVIGTPEFMAPELYE---------EDYNELVDVYSFGMCVLEMFTCEYPYSEC---ANPAQIYKKV 245 (466)
Q Consensus 178 FGla~~~~~~~~~~~~~GT~~y~APE~l~---------~~y~~~~DIwSlGvil~elltg~~Pf~~~---~~~~~i~~~i 245 (466)
||++............+||+.|+|||++. ..|+.++|||||||++|+|++|..||... ....++...+
T Consensus 160 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp GGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred CCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 99998776655556778999999999875 35788999999999999999999999642 2234445555
Q ss_pred hcCCCCCC-----------------------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 246 TSGKLPGA-----------------------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 246 ~~g~~p~~-----------------------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..+..+.. .....+..+.++|.+||. ||.+|||+.++++
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 55543211 112234578899999996 9999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=347.48 Aligned_cols=250 Identities=22% Similarity=0.367 Sum_probs=198.6
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCC---CeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEE
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVL---GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWI 99 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 99 (466)
.-..++|.+ .+.||+|+||+||+|.+..+ +..||+|.+... ......+.+.+|+.++++++||||+++++++
T Consensus 11 ~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~- 85 (281)
T 1mp8_A 11 EIQRERIEL-GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVI- 85 (281)
T ss_dssp BCCGGGEEE-EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred EEehHHeEE-EeEeeecCCeeEEEEEEecCCCCceEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCccceEEEEE-
Confidence 345678877 57799999999999998653 567999987532 2445667899999999999999999999976
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEecc
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDL 178 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DF 178 (466)
. .+.+++||||+.+++|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+||
T Consensus 86 -~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Df 160 (281)
T 1mp8_A 86 -T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-DCVKLGDF 160 (281)
T ss_dssp -C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECC-
T ss_pred -c-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCC-CCEEECcc
Confidence 2 346789999999999999998654 6999999999999999999999999 9999999999999977 89999999
Q ss_pred chhhhhcCCCC--CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 012320 179 GLAAILRGSKS--AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAF 254 (466)
Q Consensus 179 Gla~~~~~~~~--~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~ 254 (466)
|++........ .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.. .+..++...+..+..+. .
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~-~~~~~~~~~i~~~~~~~-~ 238 (281)
T 1mp8_A 161 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERLP-M 238 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCCC-C
T ss_pred ccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCc-CCHHHHHHHHHcCCCCC-C
Confidence 99987654322 23345788999999876 569999999999999999997 8999976 45556666777665432 4
Q ss_pred CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 255 YSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 255 ~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+...+..+.++|.+||. ||.+|||+.++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 239 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 45677899999999996 9999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=362.05 Aligned_cols=256 Identities=27% Similarity=0.387 Sum_probs=203.4
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-----------CCceeE
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-----------HDSIIR 93 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-----------HpnIv~ 93 (466)
..++|.+ .+.||+|+||+||+|.++.+|+.||+|++... ....+.+.+|+.++++++ ||||++
T Consensus 17 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 17 KDARYIL-VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp TTTTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cCCeEEE-EEeeeecCCeEEEEEEecCCCcEEEEEEecCC-----ccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 5688988 56699999999999999999999999998632 335567889999999886 899999
Q ss_pred EEeEEEecc--CCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeccCCCCcEEEeC
Q 012320 94 FYTSWIDVD--QKTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSR-DPPVIHRDLKCDNIFVNG 168 (466)
Q Consensus 94 l~~~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~-~~~IiHrDLKp~NIlv~~ 168 (466)
+++.+...+ ...+++|||++ +++|.+++.+. +.+++..++.++.||+.||.|||++ | |+||||||+|||++.
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~ 167 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEI 167 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEec
Confidence 999886543 23788999999 99999999874 4599999999999999999999998 9 999999999999953
Q ss_pred C-----CCcEEEeccchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCC-----
Q 012320 169 H-----LGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECAN----- 237 (466)
Q Consensus 169 ~-----~g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~----- 237 (466)
. .+.+||+|||++..... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||.....
T Consensus 168 ~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 168 VDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp EETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred cCCCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 2 24799999999976543 234567999999999876 4599999999999999999999999975321
Q ss_pred HHHHHHHHh--cCCCCC--------------------------------------CCCCCCCHHHHHHHHHhcc-CcCCC
Q 012320 238 PAQIYKKVT--SGKLPG--------------------------------------AFYSIQDLEAQRFIGRCLV-NASKR 276 (466)
Q Consensus 238 ~~~i~~~i~--~g~~p~--------------------------------------~~~~~~~~~~~~lI~~~L~-dp~~R 276 (466)
.......+. .|.+|. .+....+.++++||.+||. ||.+|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 111111111 121111 1112334678999999996 99999
Q ss_pred CCHHHHhcCCCCCch
Q 012320 277 LSAKELLLDPFLASD 291 (466)
Q Consensus 277 psa~elL~hpf~~~~ 291 (466)
||+.|+|+||||+..
T Consensus 326 pt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 326 ADAGGLVNHPWLKDT 340 (373)
T ss_dssp BCHHHHHTCGGGTTC
T ss_pred CCHHHHhhChhhhcc
Confidence 999999999999763
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=355.69 Aligned_cols=253 Identities=20% Similarity=0.337 Sum_probs=202.7
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCC-eEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCc------eeEEEeEE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLG-VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDS------IIRFYTSW 98 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g-~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn------Iv~l~~~~ 98 (466)
.++|.+. +.||+|+||+||+|.++.++ ..||+|+++. .....+.+.+|+.+++.++|++ ++.+++.+
T Consensus 18 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 18 QERYEIV-GNLGEGTFGKVVECLDHARGKSQVALKIIRN-----VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp TTTEEEE-EEEEEETTEEEEEEEETTTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred cccEEEE-EEeeccCCeEEEEEEecCCCceEEEEEEEcc-----cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 5788884 66999999999999998877 7999999863 2345577889999999997665 88998877
Q ss_pred EeccCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEE----------
Q 012320 99 IDVDQKTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFV---------- 166 (466)
Q Consensus 99 ~~~~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv---------- 166 (466)
.....+++||||+ +++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 92 --~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 92 --NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp --EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEEC
T ss_pred --eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccc
Confidence 4467899999999 67777777655 36999999999999999999999999 9999999999999
Q ss_pred ---------eCCCCcEEEeccchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 012320 167 ---------NGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECA 236 (466)
Q Consensus 167 ---------~~~~g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~ 236 (466)
+.+ +.+||+|||++..... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||....
T Consensus 167 ~~~~~~~~~~~~-~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 167 EHKSCEEKSVKN-TSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp CC-CCCEEEESC-CCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccCC-CcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 334 7999999999976433 234568999999999775 569999999999999999999999998743
Q ss_pred CHHHHHHHHhc--CCCCCC----------------------------------------CCCCCCHHHHHHHHHhcc-Cc
Q 012320 237 NPAQIYKKVTS--GKLPGA----------------------------------------FYSIQDLEAQRFIGRCLV-NA 273 (466)
Q Consensus 237 ~~~~i~~~i~~--g~~p~~----------------------------------------~~~~~~~~~~~lI~~~L~-dp 273 (466)
..+....+.. +..|.. .....+.++.+||.+||. ||
T Consensus 244 -~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 244 -NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp -HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred -HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 3333222221 222210 001123478899999996 99
Q ss_pred CCCCCHHHHhcCCCCCchhh
Q 012320 274 SKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 274 ~~Rpsa~elL~hpf~~~~~~ 293 (466)
.+|||+.|+|+||||+....
T Consensus 323 ~~Rpt~~e~l~hp~f~~~~~ 342 (355)
T 2eu9_A 323 AQRITLAEALLHPFFAGLTP 342 (355)
T ss_dssp TTSCCHHHHTTSGGGGGCCH
T ss_pred hhCcCHHHHhcChhhcCCCh
Confidence 99999999999999987544
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=347.25 Aligned_cols=244 Identities=27% Similarity=0.454 Sum_probs=209.1
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe-----
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID----- 100 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----- 100 (466)
.++|.+ .+.||+|+||+||+|.++.+|+.||+|.+.... +.+.+|+.++++++||||+++++.+..
T Consensus 10 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 10 GMDFKE-IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHHEEE-EEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred ccccce-eeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 356777 567999999999999999999999999987432 246789999999999999999998754
Q ss_pred ---------ccCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC
Q 012320 101 ---------VDQKTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH 169 (466)
Q Consensus 101 ---------~~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~ 169 (466)
.....+++||||+.+++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDT 158 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCC
Confidence 1245689999999999999999764 67999999999999999999999999 9999999999999977
Q ss_pred CCcEEEeccchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q 012320 170 LGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG 248 (466)
Q Consensus 170 ~g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g 248 (466)
+.+||+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.. .......+..+
T Consensus 159 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---~~~~~~~~~~~ 234 (284)
T 2a19_B 159 -KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDG 234 (284)
T ss_dssp -TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---HHHHHHHHHTT
T ss_pred -CCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---HHHHHHHhhcc
Confidence 899999999998776555555678999999999876 4589999999999999999999998843 44556666666
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 249 KLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 249 ~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
.++ ...+..++++|.+||. ||.+|||+.|++++++.
T Consensus 235 ~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~ 271 (284)
T 2a19_B 235 IIS----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271 (284)
T ss_dssp CCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccc----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 544 3467789999999995 99999999999998765
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=348.05 Aligned_cols=250 Identities=30% Similarity=0.484 Sum_probs=202.9
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
.-+.++|.+ .+.||+|+||+||+|.+.. .||+|.++... ......+.+.+|+.+|++++||||++++++. .
T Consensus 20 ei~~~~y~~-~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~---~ 90 (289)
T 3og7_A 20 EIPDGQITV-GQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS---T 90 (289)
T ss_dssp BCCTTSCEE-EEEEEECSSEEEEEEESSS---EEEEEEESCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE---C
T ss_pred ccCccceee-eeEecCCCCeEEEEEEEcC---ceEEEEEeccC--CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec---c
Confidence 445788988 5679999999999997643 59999987553 3556778899999999999999999999843 3
Q ss_pred CCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
...+++||||+.|++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~ 167 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHED-NTVKIGDFGLA 167 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT-TEEEECCCC--
T ss_pred CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCC-CCEEEccceec
Confidence 45578999999999999998643 56999999999999999999999999 9999999999999987 89999999999
Q ss_pred hhhcC---CCCCccccCCCCcCCccccc----cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 012320 182 AILRG---SKSAHSVIGTPEFMAPELYE----EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAF 254 (466)
Q Consensus 182 ~~~~~---~~~~~~~~GT~~y~APE~l~----~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~ 254 (466)
..... ........||+.|+|||++. ..++.++|||||||++|+|++|..||....+...+...+..+..+...
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL 247 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT
T ss_pred cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcch
Confidence 76542 22334567999999999774 458889999999999999999999999888888888888887765443
Q ss_pred ---CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 255 ---YSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 255 ---~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
....+..+++||.+||. +|.+|||+.++++
T Consensus 248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 33566899999999996 9999999999984
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=347.21 Aligned_cols=253 Identities=29% Similarity=0.494 Sum_probs=204.8
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
..++|.+ .+.||+|+||+||+|.+..+|+.||+|++..... ......+.+.+|+.++++++||||+++++.+. ...
T Consensus 30 ~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~ 105 (310)
T 2wqm_A 30 TLANFRI-EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFI--EDN 105 (310)
T ss_dssp SGGGEEE-EEEEECC--CEEEEEEETTTCCEEEEEEECTTSS-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--ETT
T ss_pred cccceEE-EEeecCCCCceEEEEEEcCCCceEEEEeeehhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCC
Confidence 3467877 5679999999999999999999999999876443 34556788999999999999999999999885 467
Q ss_pred EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 105 TFNFITEMFTSGTLREYRKK----YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
.+++||||+.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ |.+||+|||+
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~-~~~kl~Dfg~ 182 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGL 182 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCC--
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCC-CCEEEEeccc
Confidence 89999999999999999864 456999999999999999999999999 9999999999999876 8999999999
Q ss_pred hhhhcCCC-CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCCCCCCCC
Q 012320 181 AAILRGSK-SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSEC-ANPAQIYKKVTSGKLPGAFYSI 257 (466)
Q Consensus 181 a~~~~~~~-~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~-~~~~~i~~~i~~g~~p~~~~~~ 257 (466)
+....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+. .+...+.+.+..+..+......
T Consensus 183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (310)
T 2wqm_A 183 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDH 262 (310)
T ss_dssp ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTT
T ss_pred eeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccc
Confidence 97654322 234567999999999776 56899999999999999999999999653 3556777788887776655566
Q ss_pred CCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 258 QDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 258 ~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.+.+++++|.+||. ||.+|||+.++++
T Consensus 263 ~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 263 YSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 78899999999996 9999999999985
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=345.27 Aligned_cols=247 Identities=20% Similarity=0.360 Sum_probs=205.8
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
...+|.+ .+.||+|+||+||+|.+. ++..||+|++..... ..+.+.+|+.++++++||||+++++.+ .+..
T Consensus 22 ~~~~y~~-~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~ 92 (283)
T 3gen_A 22 DPKDLTF-LKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVC--TKQR 92 (283)
T ss_dssp CGGGEEE-EEECC---CEEEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEE--CSSS
T ss_pred CHHHHHh-HhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-----CHHHHHHHHHHHhcCCCCCEeeEEEEE--ecCC
Confidence 4467777 566999999999999877 688899999875432 235688999999999999999999987 5567
Q ss_pred EEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 105 TFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
.+++||||+.+++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++..
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~-~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQ-GVVKVSDFGLSRY 169 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTT-SCEEECSTTGGGG
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCC-CCEEEcccccccc
Confidence 79999999999999999986 467999999999999999999999999 9999999999999877 8999999999976
Q ss_pred hcCCC--CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 012320 184 LRGSK--SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259 (466)
Q Consensus 184 ~~~~~--~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 259 (466)
..... ......||+.|+|||++. ..++.++|||||||++|+|++ |..||.. .+.......+..+..+ ..+...+
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 247 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAEHIAQGLRL-YRPHLAS 247 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCC
T ss_pred ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc-cChhHHHHHHhcccCC-CCCCcCC
Confidence 54321 123345788999999876 569999999999999999998 9999976 5667777777776433 3345567
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
..+.++|.+||. +|.+|||+.++++|
T Consensus 248 ~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 248 EKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 899999999996 99999999999865
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=345.42 Aligned_cols=249 Identities=23% Similarity=0.352 Sum_probs=209.4
Q ss_pred CCceEEeeeeeeeeCceEEEEEE--EcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAI--DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~--~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
..+|.+.++.||+|+||+||+|. ++.+++.||+|++.... ......+.+.+|+.+++.++||||+++++.+ ..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~---~~ 89 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGIC---EA 89 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE---ES
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE---CC
Confidence 47888866589999999999994 56778999999987543 2334567899999999999999999999987 24
Q ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 104 KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
..+++||||+.+++|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++..
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKA 166 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCCTTCEE
T ss_pred CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCC-CcEEEccCCccee
Confidence 568899999999999999999888999999999999999999999999 9999999999999977 8999999999977
Q ss_pred hcCCCC----CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 012320 184 LRGSKS----AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSI 257 (466)
Q Consensus 184 ~~~~~~----~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 257 (466)
...... .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.. .+..++...+..+..+. .+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~ 244 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERMG-CPAG 244 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCCC-CCTT
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCCC-CCCC
Confidence 644322 12234678999999876 458899999999999999999 9999976 66777888888776443 3456
Q ss_pred CCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 258 QDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 258 ~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.+..+.++|.+||. ||.+|||+.++++
T Consensus 245 ~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 245 CPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 78899999999996 9999999999974
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=353.70 Aligned_cols=255 Identities=26% Similarity=0.426 Sum_probs=203.7
Q ss_pred ceeeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEE----EEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEE
Q 012320 19 GYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEV----AWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRF 94 (466)
Q Consensus 19 ~~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~v----AiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l 94 (466)
.....-..++|.+ .++||+|+||+||+|.+..+|+.+ |+|.+.... .....+.+.+|+.++++++||||+++
T Consensus 7 ~~~~~l~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~ 82 (327)
T 3poz_A 7 ALLRILKETEFKK-IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRL 82 (327)
T ss_dssp CSSEECCGGGEEE-EEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCE
T ss_pred HHHhhcCHHHccc-ceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc---CHHHHHHHHHHHHHHHhCCCCCEeEE
Confidence 3445556788988 466999999999999998888765 566554221 23345678999999999999999999
Q ss_pred EeEEEeccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcE
Q 012320 95 YTSWIDVDQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQV 173 (466)
Q Consensus 95 ~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~v 173 (466)
++++.. . ..++|+|++.+|+|.+++.+. +.+++..+..|+.||+.||.|||+++ |+||||||+|||++.+ +.+
T Consensus 83 ~~~~~~--~-~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~-~~~ 156 (327)
T 3poz_A 83 LGICLT--S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP-QHV 156 (327)
T ss_dssp EEEEES--S-SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-TEE
T ss_pred EEEEec--C-CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCC-CCE
Confidence 998853 2 377999999999999999874 67999999999999999999999999 9999999999999877 899
Q ss_pred EEeccchhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcC
Q 012320 174 KIGDLGLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSG 248 (466)
Q Consensus 174 KL~DFGla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g 248 (466)
||+|||+++.+..... .....||+.|+|||++. ..|+.++|||||||++|+|++ |..||.. .+...+...+..+
T Consensus 157 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~ 235 (327)
T 3poz_A 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKG 235 (327)
T ss_dssp EECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTT
T ss_pred EEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccC-CCHHHHHHHHHcC
Confidence 9999999987654332 22345688999999775 569999999999999999999 9999976 5556677777666
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 249 KLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 249 ~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
..+. .+...+.++.+++.+||. +|.+|||+.+++.+
T Consensus 236 ~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 236 ERLP-QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp CCCC-CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCCC-CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 5332 345567899999999996 99999999999865
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=344.75 Aligned_cols=252 Identities=18% Similarity=0.303 Sum_probs=212.6
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEc--CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDE--VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
-+.++|.+.++.||+|+||+||+|.+. .++..||+|.+... ......+.+.+|+.++++++||||+++++.+ .
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~ 80 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVC--Q 80 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--E
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc---cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe--c
Confidence 345788888878999999999999854 57899999998754 2455678899999999999999999999987 2
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
...+++||||+.+++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||+
T Consensus 81 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~Dfg~ 156 (287)
T 1u59_A 81 -AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNR-HYAKISDFGL 156 (287)
T ss_dssp -SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEET-TEEEECCCTT
T ss_pred -CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCC-CCEEECcccc
Confidence 34589999999999999998654 56999999999999999999999999 9999999999999977 8999999999
Q ss_pred hhhhcCCCC----CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 012320 181 AAILRGSKS----AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAF 254 (466)
Q Consensus 181 a~~~~~~~~----~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~ 254 (466)
+........ .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.. .+..++...+..+..+. .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~i~~~~~~~-~ 234 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK-MKGPEVMAFIEQGKRME-C 234 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCTHHHHHHHHTTCCCC-C
T ss_pred eeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHhcCCcCC-C
Confidence 977643222 22345789999999876 568999999999999999998 9999977 45566777777776433 3
Q ss_pred CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCC
Q 012320 255 YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDP 286 (466)
Q Consensus 255 ~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hp 286 (466)
+...+.++.++|.+||. +|.+|||+.+++++.
T Consensus 235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 45678899999999996 999999999999765
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=356.21 Aligned_cols=255 Identities=23% Similarity=0.363 Sum_probs=211.0
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCH--HHHHHHHHHHHHHHhCC--CCceeEEEeEE
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSP--DDLQRLYSEVHLLSTLK--HDSIIRFYTSW 98 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~--~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~ 98 (466)
....++|.+ .++||+|+||+||+|.++.+|+.||+|++......... ...+.+.+|+.++++++ ||||+++++.+
T Consensus 39 ~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 39 EPLESQYQV-GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp -CCTTTEEE-EEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred CCccCceEE-EEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 445678877 57799999999999999999999999999866432100 12245678999999996 59999999987
Q ss_pred EeccCCEEEEEEecCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEec
Q 012320 99 IDVDQKTFNFITEMFTS-GTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGD 177 (466)
Q Consensus 99 ~~~~~~~~~lV~E~~~g-gsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~D 177 (466)
.....+++|+|++.+ ++|.+++.+.+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.+.+.+||+|
T Consensus 118 --~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 118 --ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp --ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECC
T ss_pred --ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEee
Confidence 456789999999976 899999998899999999999999999999999999 999999999999985558999999
Q ss_pred cchhhhhcCCCCCccccCCCCcCCcccccc-C-CCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 012320 178 LGLAAILRGSKSAHSVIGTPEFMAPELYEE-D-YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFY 255 (466)
Q Consensus 178 FGla~~~~~~~~~~~~~GT~~y~APE~l~~-~-y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~ 255 (466)
||++...... ......||+.|+|||++.. . ++.++|||||||++|+|++|..||.. ... +..+.. ...
T Consensus 194 fg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~---~~~----~~~~~~--~~~ 263 (320)
T 3a99_A 194 FGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DEE----IIRGQV--FFR 263 (320)
T ss_dssp CTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS---HHH----HHHCCC--CCS
T ss_pred Cccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC---hhh----hhcccc--ccc
Confidence 9999876543 3445679999999998763 3 46889999999999999999999964 222 222322 234
Q ss_pred CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 256 ~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
...+.++++||.+||. ||.+|||+.++++||||+...
T Consensus 264 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 264 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 4567899999999996 999999999999999998643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=347.28 Aligned_cols=245 Identities=19% Similarity=0.311 Sum_probs=202.0
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCC-------eEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeE
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLG-------VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTS 97 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g-------~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 97 (466)
..++|.+ .+.||+|+||+||+|.++.++ ..||+|.+.... ....+.+.+|+.++++++||||+++++.
T Consensus 6 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 6 RNEDLIF-NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH----RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp CGGGEEE-EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG----GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred chhHeee-eeeeccCCCceEEEEEEecccccccccchhhhhhhccccc----HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 4567877 567999999999999998887 579999986433 2345788999999999999999999998
Q ss_pred EEeccCCEEEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCc----
Q 012320 98 WIDVDQKTFNFITEMFTSGTLREYRKKYRR-VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQ---- 172 (466)
Q Consensus 98 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~---- 172 (466)
+ .+....++||||+.||+|.+++.+.+. +++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.
T Consensus 81 ~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~~~~ 155 (289)
T 4fvq_A 81 C--VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIRE-EDRKTG 155 (289)
T ss_dssp E--CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEEC-CBGGGT
T ss_pred E--EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecC-Cccccc
Confidence 7 446678899999999999999987654 999999999999999999999999 9999999999999876 55
Q ss_pred ----EEEeccchhhhhcCCCCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q 012320 173 ----VKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVT 246 (466)
Q Consensus 173 ----vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~ 246 (466)
+||+|||++..... .....||+.|+|||++. ..++.++|||||||++|+|++|..|+....+.........
T Consensus 156 ~~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~ 232 (289)
T 4fvq_A 156 NPPFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232 (289)
T ss_dssp BCCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred ccceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh
Confidence 99999999865432 23456899999999876 4589999999999999999996665555456555554444
Q ss_pred cCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 247 SGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 247 ~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
... ..+...+.+++++|.+||. ||.+|||+.+++++
T Consensus 233 ~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 233 DRH---QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp TTC---CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ccC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 322 1223346689999999996 99999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=349.95 Aligned_cols=253 Identities=25% Similarity=0.356 Sum_probs=212.8
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEE-----cCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeE
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAID-----EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTS 97 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~ 97 (466)
-+.++|.+ .+.||+|+||+||+|.+ ..+++.||+|++.... .....+.+.+|+.+++++ +||||+++++.
T Consensus 24 ~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 24 FPRDRLKL-GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp CCGGGEEE-EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cchhheee-eeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC---CcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 35678877 67799999999999984 5678999999987442 345567899999999999 79999999998
Q ss_pred EEeccCCEEEEEEecCCCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCC
Q 012320 98 WIDVDQKTFNFITEMFTSGTLREYRKKYRR----------------VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKC 161 (466)
Q Consensus 98 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~----------------l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp 161 (466)
+.. ....+++||||+.||+|.+++..... +++..+..++.||+.||.|||+++ |+||||||
T Consensus 100 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp 176 (316)
T 2xir_A 100 CTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA 176 (316)
T ss_dssp ECC-TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred Eec-CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCcc
Confidence 743 34568999999999999999987654 899999999999999999999999 99999999
Q ss_pred CcEEEeCCCCcEEEeccchhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 012320 162 DNIFVNGHLGQVKIGDLGLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECA 236 (466)
Q Consensus 162 ~NIlv~~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~ 236 (466)
+||+++.+ +.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++ |..||....
T Consensus 177 ~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 177 RNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGEEECGG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceEEECCC-CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 99999876 8999999999986643322 23456889999999775 569999999999999999998 999998766
Q ss_pred CHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 237 NPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 237 ~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
....+...+..+..+ ..+...++++.++|.+||. ||.+|||+.++++|
T Consensus 256 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 256 IDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp CSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHHhccCccC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 666777777766543 2345567899999999996 99999999999976
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=362.52 Aligned_cols=248 Identities=21% Similarity=0.330 Sum_probs=207.9
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+ .+.||+|+||+||+|.++.+|+.||+|.++.. ......+.+.+|+.+|++++||||+++++++ .+...
T Consensus 113 ~~~~~~-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~--~~~~~ 186 (377)
T 3cbl_A 113 HEDLVL-GEQIGRGNFGEVFSGRLRADNTLVAVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVC--TQKQP 186 (377)
T ss_dssp GGGEEE-EEEEEEETTEEEEEEEETTTCCEEEEEECCTT---SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE--CSSSS
T ss_pred hHHeEE-eeEeccCCCCeEEEEEEecCCeEEEEEEcccc---CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE--ecCCC
Confidence 356666 67799999999999999999999999988633 2345566789999999999999999999987 45667
Q ss_pred EEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 106 FNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
+++||||++||+|.+++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++...
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~-~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEK-NVLKISDFGMSREE 263 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCGGGCEEC
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCC-CcEEECcCCCceec
Confidence 899999999999999997654 6999999999999999999999999 9999999999999877 89999999999754
Q ss_pred cCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 012320 185 RGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259 (466)
Q Consensus 185 ~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 259 (466)
..... .....+|+.|+|||++. +.|+.++|||||||++|||++ |..||.. .+..++...+..+..+ ..+...+
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 341 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN-LSNQQTREFVEKGGRL-PCPELCP 341 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT-SCHHHHHHHHHTTCCC-CCCTTCC
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCC
Confidence 32211 11223567899999876 568999999999999999998 9999977 5666777777766432 2345567
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.++.++|.+||. ||.+|||+.++++
T Consensus 342 ~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 342 DAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 899999999996 9999999999974
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=348.56 Aligned_cols=253 Identities=21% Similarity=0.251 Sum_probs=200.8
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
..-++|.+ .+.||+|+||+||+|.++.+|+.||+|++..... ......+.+.+|+.++++++||||+++++++. ..
T Consensus 31 ~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~--~~ 106 (309)
T 2h34_A 31 TQFGPYRL-RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRLQEPHVVPIHDFGE--ID 106 (309)
T ss_dssp ---CCEEE-EEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG-GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE--ET
T ss_pred cEeccEEE-EEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc-cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe--eC
Confidence 33578877 5679999999999999999999999999875432 34445678999999999999999999999874 46
Q ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 104 KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
+.+++||||+.|++|.+++.+.+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++..
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~-~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSAD-DFAYLVDFGIASA 183 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECSCCC---
T ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCC-CCEEEecCccCcc
Confidence 789999999999999999998889999999999999999999999999 9999999999999877 8999999999976
Q ss_pred hcCCC--CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCCC
Q 012320 184 LRGSK--SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL-PGAFYSIQD 259 (466)
Q Consensus 184 ~~~~~--~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~-p~~~~~~~~ 259 (466)
..... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+...+...+..... +.......+
T Consensus 184 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (309)
T 2h34_A 184 TTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGIP 262 (309)
T ss_dssp -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS-CHHHHHHHHHHSCCCCGGGTSTTCC
T ss_pred ccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC-chHHHHHHHhccCCCCccccCCCCC
Confidence 54332 233567999999999876 5589999999999999999999999976 444444444444332 223345567
Q ss_pred HHHHHHHHHhcc-CcCCCC-CHHHHhc
Q 012320 260 LEAQRFIGRCLV-NASKRL-SAKELLL 284 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rp-sa~elL~ 284 (466)
.+++++|.+||. ||.+|| |++++++
T Consensus 263 ~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 263 VAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp THHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 799999999996 999999 8888874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=355.78 Aligned_cols=246 Identities=17% Similarity=0.206 Sum_probs=202.8
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCC
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 104 (466)
.++|.+ .+.||+|+||+||+|.++.+|+.||+|.+..... .+.+.+|+.+++.+ +||||+++++.+. ...
T Consensus 8 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~--~~~ 78 (330)
T 2izr_A 8 GPNFRV-GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR------APQLHLEYRFYKQLGSGDGIPQVYYFGP--CGK 78 (330)
T ss_dssp TTTEEE-EEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS------SCCHHHHHHHHHHHCSCTTSCCEEEEEE--ETT
T ss_pred cCCeEE-EEEeeccCCceEEEEEECCCCcEEEEEEeccccc------hHHHHHHHHHHHHhhCCCCCCEEEEEEe--cCC
Confidence 467877 5679999999999999999999999999875432 13578899999999 9999999999874 467
Q ss_pred EEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCc-----EEEecc
Q 012320 105 TFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQ-----VKIGDL 178 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~-----vKL~DF 178 (466)
..++||||+ |++|.+++... +.+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +. +||+||
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~-~~~~~~~~kl~DF 154 (330)
T 2izr_A 79 YNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRP-GNKTQQVIHIIDF 154 (330)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCG-GGTCTTSEEECCC
T ss_pred ccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccC-CCCCCceEEEEEc
Confidence 899999999 99999999874 68999999999999999999999999 9999999999999876 55 999999
Q ss_pred chhhhhcCCCC--------CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHhc
Q 012320 179 GLAAILRGSKS--------AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSEC--ANPAQIYKKVTS 247 (466)
Q Consensus 179 Gla~~~~~~~~--------~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~--~~~~~i~~~i~~ 247 (466)
|++..+..... ....+||+.|+|||++. ..++.++|||||||++|+|++|..||... .+..+.++.+..
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 234 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence 99987643322 24678999999999876 45999999999999999999999999763 344555666544
Q ss_pred CCCCCCCC--CCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 248 GKLPGAFY--SIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 248 g~~p~~~~--~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+..+.... ....++++++|.+||. +|.+||++.+|++
T Consensus 235 ~~~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 235 TKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hhccCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 33221111 1112389999999995 9999999998874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=346.88 Aligned_cols=250 Identities=25% Similarity=0.370 Sum_probs=202.4
Q ss_pred CceEEeeeeeeeeCceEEEEEE----EcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAI----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
.+|.+ .+.||+|+||+||+|. +..+|+.||+|++.... .....+.+.+|+.+|+.++||||+++++.+.+.+
T Consensus 21 ~~~~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 21 RFLKR-IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp GGEEE-EEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhh-hhccCCCCceEEEEEEEccccCccCeEEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 44555 6779999999999998 67899999999987543 2234567899999999999999999999987665
Q ss_pred CCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 103 QKTFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
...+++||||+.+++|.+++.+ ...+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~~ 173 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE-HQVKIGDFGLT 173 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCCTTC
T ss_pred CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCC-CCEEECccccc
Confidence 6779999999999999999954 467999999999999999999999999 9999999999999877 89999999999
Q ss_pred hhhcCCC----CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCC--------------CCCHHHHH
Q 012320 182 AILRGSK----SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSE--------------CANPAQIY 242 (466)
Q Consensus 182 ~~~~~~~----~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~--------------~~~~~~i~ 242 (466)
....... ......||+.|+|||++. ..++.++|||||||++|+|++|..|+.. ......+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 8765432 233456888999999775 5688999999999999999999987632 12223344
Q ss_pred HHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 243 KKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 243 ~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..+..+.. ...+...+.++.++|.+||. ||.+|||+.++++
T Consensus 254 ~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 254 NTLKEGKR-LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHTTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHhccCC-CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 44544443 23445677899999999996 9999999999974
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=351.60 Aligned_cols=251 Identities=28% Similarity=0.411 Sum_probs=210.5
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEc-------CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEE
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDE-------VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFY 95 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~-------~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~ 95 (466)
-+.++|.+ .+.||+|+||+||+|.+. .++..||+|++.... .....+.+.+|+.+++++ +||||++++
T Consensus 32 ~~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 32 FPRDKLTL-GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp CCGGGEEE-EEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCHhHeEE-eeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC---cHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 34578877 677999999999999975 467899999986432 455678899999999999 899999999
Q ss_pred eEEEeccCCEEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccC
Q 012320 96 TSWIDVDQKTFNFITEMFTSGTLREYRKKYR----------------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDL 159 (466)
Q Consensus 96 ~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDL 159 (466)
+++ .+...+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||
T Consensus 108 ~~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dl 183 (334)
T 2pvf_A 108 GAC--TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDL 183 (334)
T ss_dssp EEE--CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCC
T ss_pred EEE--ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCC
Confidence 987 45678899999999999999998654 3899999999999999999999999 999999
Q ss_pred CCCcEEEeCCCCcEEEeccchhhhhcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 012320 160 KCDNIFVNGHLGQVKIGDLGLAAILRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSE 234 (466)
Q Consensus 160 Kp~NIlv~~~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~ 234 (466)
||+|||++.+ +.+||+|||++....... ......+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+
T Consensus 184 kp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 262 (334)
T 2pvf_A 184 AARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262 (334)
T ss_dssp SGGGEEECTT-CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ccceEEEcCC-CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence 9999999877 899999999997654332 123345788999999775 568999999999999999999 9999976
Q ss_pred CCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 235 CANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 235 ~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
.+..++.+.+..+..+. .+...+.+++++|.+||. +|.+|||+.+++++
T Consensus 263 -~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 263 -IPVEELFKLLKEGHRMD-KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp -CCHHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCHHHHHHHHhcCCCCC-CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 66777888887775433 345567899999999996 99999999999864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=349.47 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=209.5
Q ss_pred CCCceEEeeeeeeeeCceEEEEEE----EcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAI----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
...+|.+ .+.||+|+||+||+|. +..+|+.||+|++... .....+.+.+|+.++++++||||+++++.+..
T Consensus 21 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 95 (327)
T 3lxl_A 21 EERHLKY-ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQILKALHSDFIVKYRGVSYG 95 (327)
T ss_dssp CGGGEEE-EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred chhhhhh-hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence 4467776 5679999999999998 6789999999998743 44566789999999999999999999998877
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
.+...+++||||+.|++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg 172 (327)
T 3lxl_A 96 PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESE-AHVKIADFG 172 (327)
T ss_dssp SSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCGG
T ss_pred CCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCC-CCEEEcccc
Confidence 6788899999999999999999874 56999999999999999999999999 9999999999999877 899999999
Q ss_pred hhhhhcCCC----CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCC--------------CHHH
Q 012320 180 LAAILRGSK----SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECA--------------NPAQ 240 (466)
Q Consensus 180 la~~~~~~~----~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~--------------~~~~ 240 (466)
++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.... ....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH
T ss_pred cceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH
Confidence 998764332 223456888999999876 458999999999999999999999985421 1133
Q ss_pred HHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 241 IYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 241 i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+...+..+.. ...+...+.++.++|.+||. ||.+|||+.++++
T Consensus 253 ~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 296 (327)
T 3lxl_A 253 LLELLEEGQR-LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296 (327)
T ss_dssp HHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhhcccC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 4444444443 23455678899999999996 9999999999964
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=351.10 Aligned_cols=250 Identities=22% Similarity=0.346 Sum_probs=210.9
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEc-----CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEE
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDE-----VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWI 99 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 99 (466)
..++|.+ .+.||+|+||+||+|.++ .++..||+|.+.... .......+.+|+.+++.++||||+++++.+
T Consensus 23 ~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~- 97 (322)
T 1p4o_A 23 AREKITM-SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVV- 97 (322)
T ss_dssp CGGGEEE-EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE-
T ss_pred hhhheee-eeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc---CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE-
Confidence 3467877 577999999999999877 468899999986432 345567789999999999999999999987
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKY----------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH 169 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~----------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~ 169 (466)
.+...+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||++| |+||||||+||+++.+
T Consensus 98 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 -SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED 174 (322)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT
T ss_pred -ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCC
Confidence 4566789999999999999998753 45799999999999999999999999 9999999999999977
Q ss_pred CCcEEEeccchhhhhcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHH
Q 012320 170 LGQVKIGDLGLAAILRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKK 244 (466)
Q Consensus 170 ~g~vKL~DFGla~~~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~ 244 (466)
+.+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++ |..||.. .+..++...
T Consensus 175 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~ 252 (322)
T 1p4o_A 175 -FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRF 252 (322)
T ss_dssp -CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHH
T ss_pred -CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc-CCHHHHHHH
Confidence 899999999997654322 123346789999999876 569999999999999999999 8889876 677778888
Q ss_pred HhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 245 VTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 245 i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
+..+..+. .+...+..++++|.+||. +|.+|||+.|++++
T Consensus 253 ~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 253 VMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCcCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 87776543 334567899999999996 99999999999865
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=352.31 Aligned_cols=264 Identities=21% Similarity=0.208 Sum_probs=207.6
Q ss_pred hhhhccceeeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCcee
Q 012320 13 EAKAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSII 92 (466)
Q Consensus 13 ~~~~~~~~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv 92 (466)
++....+-...-..++|.+ .+.||+|+||+||+|.++.+|+.||+|++... .....+.+.+|+.+++.++||||+
T Consensus 15 ~~~~~~g~~~~i~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv 89 (317)
T 2buj_A 15 ENLYFQGHMVIIDNKHYLF-IQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNHPNIL 89 (317)
T ss_dssp -CCSEEEEEEEETTEEEEE-EEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred cceeecccEEEECCeEEEE-EEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHHHHHHHHHHhhcCCCCee
Confidence 3334444455556788988 46699999999999999999999999998643 445677899999999999999999
Q ss_pred EEEeEEEec--cCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEE
Q 012320 93 RFYTSWIDV--DQKTFNFITEMFTSGTLREYRKK----YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFV 166 (466)
Q Consensus 93 ~l~~~~~~~--~~~~~~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv 166 (466)
++++++... ....+++||||+.+|+|.+++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~ 167 (317)
T 2buj_A 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILL 167 (317)
T ss_dssp CCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE
T ss_pred eEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE
Confidence 999988643 24578999999999999999876 467999999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeccchhhhhcCCC----------CCccccCCCCcCCcccccc----CCCChhhHHHHHHHHHHHHhCCCCC
Q 012320 167 NGHLGQVKIGDLGLAAILRGSK----------SAHSVIGTPEFMAPELYEE----DYNELVDVYSFGMCVLEMFTCEYPY 232 (466)
Q Consensus 167 ~~~~g~vKL~DFGla~~~~~~~----------~~~~~~GT~~y~APE~l~~----~y~~~~DIwSlGvil~elltg~~Pf 232 (466)
+.+ +.+||+|||++....... ......||+.|+|||++.. .++.++|||||||++|+|++|..||
T Consensus 168 ~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 246 (317)
T 2buj_A 168 GDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246 (317)
T ss_dssp CTT-SCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCC-CCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCCh
Confidence 877 899999999886542111 0123458999999998753 2789999999999999999999999
Q ss_pred CCCC-CHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 233 SECA-NPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 233 ~~~~-~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
.... ....+...+.. ..........+.++.++|.+||. ||.+|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 247 DMVFQKGDSVALAVQN-QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHHHHTTSCHHHHHHC-C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhhhcccchhhHHhhc-cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 4310 00112222222 22223334567899999999996 99999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=351.68 Aligned_cols=256 Identities=26% Similarity=0.396 Sum_probs=202.1
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCH--HHHHHHHHHHHHHHhC----CCCceeEEEe
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSP--DDLQRLYSEVHLLSTL----KHDSIIRFYT 96 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~--~~~~~~~~Ei~iL~~l----~HpnIv~l~~ 96 (466)
..-.++|.+ .+.||+|+||+||+|.++.+|+.||+|++......... .....+.+|+.+++++ +||||+++++
T Consensus 27 ~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 27 EAFEAEYRL-GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp ------CEE-EEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhceEE-eeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344678877 57799999999999999999999999998765432111 1234566799999998 8999999999
Q ss_pred EEEeccCCEEEEEEec-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEE
Q 012320 97 SWIDVDQKTFNFITEM-FTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKI 175 (466)
Q Consensus 97 ~~~~~~~~~~~lV~E~-~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL 175 (466)
++. ..+.+++|+|+ +.+++|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+||+++...+.+||
T Consensus 106 ~~~--~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 106 WFE--TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EC-------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEE
T ss_pred EEe--cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEE
Confidence 874 45678899999 789999999998889999999999999999999999999 9999999999999944489999
Q ss_pred eccchhhhhcCCCCCccccCCCCcCCcccccc-CC-CChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 012320 176 GDLGLAAILRGSKSAHSVIGTPEFMAPELYEE-DY-NELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA 253 (466)
Q Consensus 176 ~DFGla~~~~~~~~~~~~~GT~~y~APE~l~~-~y-~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~ 253 (466)
+|||++...... ......||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.. ...+ ..... .
T Consensus 182 ~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~---~~~~----~~~~~--~ 251 (312)
T 2iwi_A 182 IDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER---DQEI----LEAEL--H 251 (312)
T ss_dssp CCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS---HHHH----HHTCC--C
T ss_pred EEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC---hHHH----hhhcc--C
Confidence 999999876543 3455679999999998763 34 4589999999999999999999964 2222 22222 2
Q ss_pred CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 254 FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 254 ~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
+....+..++++|.+||. +|.+|||+.|+++||||+....
T Consensus 252 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 252 FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 334567899999999996 9999999999999999986543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=345.75 Aligned_cols=247 Identities=14% Similarity=0.206 Sum_probs=204.1
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 103 (466)
..++|.+ .+.||+|+||+||+|.+..+|+.||+|++..... .+.+.+|+.+++.+ +|+||+++++.+ .+.
T Consensus 8 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~--~~~ 78 (298)
T 1csn_A 8 VGVHYKV-GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFG--QEG 78 (298)
T ss_dssp ETTTEEE-EEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEE--EET
T ss_pred cccceEE-EEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc------cHHHHHHHHHHHHHhcCCCCCeEEeec--CCC
Confidence 3577877 5669999999999999999999999999864432 23577899999999 799999999876 457
Q ss_pred CEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCc-----EEEec
Q 012320 104 KTFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQ-----VKIGD 177 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~-----vKL~D 177 (466)
...++||||+ |++|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +. +||+|
T Consensus 79 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~-~~~~~~~~kl~D 154 (298)
T 1csn_A 79 LHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRP-NSKNANMIYVVD 154 (298)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCS-SSTTTTCEEECC
T ss_pred ceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccC-CCCCCCeEEEEE
Confidence 7899999999 999999998754 5999999999999999999999999 9999999999999765 44 99999
Q ss_pred cchhhhhcCCC--------CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHh
Q 012320 178 LGLAAILRGSK--------SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSEC--ANPAQIYKKVT 246 (466)
Q Consensus 178 FGla~~~~~~~--------~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~--~~~~~i~~~i~ 246 (466)
||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||... .+..+.+..+.
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (298)
T 1csn_A 155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 234 (298)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred CccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH
Confidence 99998765432 234567999999999876 45899999999999999999999999763 24455555554
Q ss_pred cCCCCCC---CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 247 SGKLPGA---FYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 247 ~g~~p~~---~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.+..+.. .....+.+++++|.+||. +|.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 235 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 4322111 223457899999999995 9999999999874
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=350.77 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=209.7
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCe-----EEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEe
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGV-----EVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYT 96 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~-----~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~ 96 (466)
.-+.++|.+ .+.||+|+||+||+|.+..+|. .||+|.+.... .....+.+.+|+.+|+++ +||||+++++
T Consensus 42 ~~~~~~~~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 42 EFPRNNLQF-GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA---HADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp BCCTTSEEE-EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHHHcee-eeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc---ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 344577877 6779999999999999977665 79999886432 445667899999999999 8999999999
Q ss_pred EEEeccCCEEEEEEecCCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCC
Q 012320 97 SWIDVDQKTFNFITEMFTSGTLREYRKKY--------------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCD 162 (466)
Q Consensus 97 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~--------------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~ 162 (466)
++ .....+++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+
T Consensus 118 ~~--~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~ 193 (333)
T 2i1m_A 118 AC--THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAAR 193 (333)
T ss_dssp EE--CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred EE--ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccc
Confidence 87 4566789999999999999998753 35899999999999999999999999 999999999
Q ss_pred cEEEeCCCCcEEEeccchhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 012320 163 NIFVNGHLGQVKIGDLGLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECAN 237 (466)
Q Consensus 163 NIlv~~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~ 237 (466)
|||++.+ +.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.....
T Consensus 194 NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 194 NVLLTNG-HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp GCEEEGG-GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred eEEECCC-CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence 9999977 8999999999976543222 23445788999999775 569999999999999999998 9999987665
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 238 PAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 238 ~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
...+.+.+..+. ....+...+..+.++|.+||. ||.+|||+.++++
T Consensus 273 ~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 273 NSKFYKLVKDGY-QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp SHHHHHHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 566666555543 233445567899999999996 9999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=364.37 Aligned_cols=250 Identities=25% Similarity=0.336 Sum_probs=191.3
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCCE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~ 105 (466)
++|++..++||+|+||+||.+ ...+|+.||+|++.... .+.+.+|+.+|+++ +||||+++++.+ .+...
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~-------~~~~~~E~~~l~~l~~HpnIv~~~~~~--~~~~~ 83 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF-------CDIALMEIKLLTESDDHPNVIRYYCSE--TTDRF 83 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG-------HHHHHHHHHHHHHHTTSTTBCCEEEEE--ECSSE
T ss_pred hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH-------HHHHHHHHHHHHhccCCCCcCeEEEEE--ecCCe
Confidence 444555889999999999875 45679999999986432 24578899999976 899999999977 55788
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC---------
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVD-------IRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH--------- 169 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~-------~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~--------- 169 (466)
+|+|||||. |+|.+++...+... +..+..++.||+.||.|||+++ |+||||||+|||++..
T Consensus 84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~ 160 (434)
T 2rio_A 84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQT 160 (434)
T ss_dssp EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTT
T ss_pred EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCccccccccc
Confidence 999999995 69999998754432 2345679999999999999999 9999999999999753
Q ss_pred ---CCcEEEeccchhhhhcCCC-----CCccccCCCCcCCccccc--------cCCCChhhHHHHHHHHHHHHh-CCCCC
Q 012320 170 ---LGQVKIGDLGLAAILRGSK-----SAHSVIGTPEFMAPELYE--------EDYNELVDVYSFGMCVLEMFT-CEYPY 232 (466)
Q Consensus 170 ---~g~vKL~DFGla~~~~~~~-----~~~~~~GT~~y~APE~l~--------~~y~~~~DIwSlGvil~ellt-g~~Pf 232 (466)
.+.+||+|||++..+.... .....+||+.|+|||++. ..++.++|||||||++|+|++ |..||
T Consensus 161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence 2489999999998765432 123467999999999874 358999999999999999999 99999
Q ss_pred CCCCCHHHHHHHHhcCCCCCC-C----CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 233 SECANPAQIYKKVTSGKLPGA-F----YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 233 ~~~~~~~~i~~~i~~g~~p~~-~----~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
....... ..+..+..... . ....+.+++++|.+||. ||.+|||+.++++||||....
T Consensus 241 ~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~~ 303 (434)
T 2rio_A 241 GDKYSRE---SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKS 303 (434)
T ss_dssp CSTTTHH---HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCHH
T ss_pred CCchhhH---HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCcH
Confidence 7644332 23333332211 1 11234689999999996 999999999999999998754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=335.30 Aligned_cols=246 Identities=20% Similarity=0.368 Sum_probs=208.1
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.. .+.||+|+||+||+|.+. ++..||+|.+..... ..+.+.+|+.++++++||||+++++.+ .+...
T Consensus 7 ~~~y~~-~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~ 77 (267)
T 3t9t_A 7 PSELTF-VQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVC--LEQAP 77 (267)
T ss_dssp GGGEEE-EEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-----CHHHHHHHHHHHHTCCCTTBCCEEEEE--CSSSS
T ss_pred hhheee-eeEecCCCceeEEEEEec-CCCeEEEEEccccCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEE--ccCCC
Confidence 357776 567999999999999987 688999999875432 235788999999999999999999987 44667
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 106 FNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
+++||||+++++|.+++.+. +.+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~ 154 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN-QVIKVSDFGMTRFV 154 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGG-GCEEECCTTGGGGB
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCC-CCEEEccccccccc
Confidence 89999999999999999875 56899999999999999999999999 9999999999999877 89999999999765
Q ss_pred cCCC--CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 012320 185 RGSK--SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL 260 (466)
Q Consensus 185 ~~~~--~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~ 260 (466)
.... ......||+.|+|||++. ..++.++|||||||++|+|++ |..||.. .+..++...+..+..+ ..+...+.
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~ 232 (267)
T 3t9t_A 155 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLAST 232 (267)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCH
T ss_pred ccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC-CCHHHHHHHHhcCCcC-CCCccCcH
Confidence 3321 223445788999999876 568999999999999999999 8999976 6677777778776433 33455688
Q ss_pred HHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 261 EAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 261 ~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
.++++|.+||. +|.+|||+.+++++
T Consensus 233 ~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 233 HVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999996 99999999999853
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=348.61 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=188.7
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEeEEEe-
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYTSWID- 100 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~- 100 (466)
.-...||.+ .++||+|+||+||+|.++.+|+.||+|++... .....+.+.+|+.+++++. ||||+++++.+..
T Consensus 24 ~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 24 ELGELRLRV-RRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EETTEEEEE-EEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred eccCceEEE-EEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 344567876 67799999999999999999999999988533 3456678899999999995 9999999998753
Q ss_pred -----ccCCEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCc
Q 012320 101 -----VDQKTFNFITEMFTSGTLREYRKK---YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQ 172 (466)
Q Consensus 101 -----~~~~~~~lV~E~~~ggsL~~~l~~---~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~ 172 (466)
.....+++||||+. |+|.+++.. .+.+++..+..++.||+.||.|||+.+++|+||||||+|||++.+ +.
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~-~~ 176 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GT 176 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT-SC
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC-CC
Confidence 33456899999995 799888865 467999999999999999999999998889999999999999977 89
Q ss_pred EEEeccchhhhhcCCCC-------------CccccCCCCcCCccccc----cCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 012320 173 VKIGDLGLAAILRGSKS-------------AHSVIGTPEFMAPELYE----EDYNELVDVYSFGMCVLEMFTCEYPYSEC 235 (466)
Q Consensus 173 vKL~DFGla~~~~~~~~-------------~~~~~GT~~y~APE~l~----~~y~~~~DIwSlGvil~elltg~~Pf~~~ 235 (466)
+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++|..||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 99999999976543221 11456999999999872 45889999999999999999999999653
Q ss_pred CCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCC
Q 012320 236 ANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDP 286 (466)
Q Consensus 236 ~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hp 286 (466)
.. .. +..+..........+..+++||.+||. ||.+|||+.|++++-
T Consensus 257 ~~-~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 257 AK-LR----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp --------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred hH-HH----hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 22 22 222333333344556679999999996 999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=342.07 Aligned_cols=247 Identities=23% Similarity=0.362 Sum_probs=209.8
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
...+|.+ .+.||+|+||+||+|.++.++..||+|.+... ....+.+.+|+.++++++||||+++++++ .+..
T Consensus 11 ~~~~~~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~ 82 (288)
T 3kfa_A 11 ERTDITM-KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVC--TREP 82 (288)
T ss_dssp CGGGEEE-EEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-----STHHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSS
T ss_pred cccceeE-EeecCCCCceeEEEeEecCCCEEEEEEecCcC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEE--ccCC
Confidence 4567776 56799999999999999999999999998643 23567889999999999999999999987 5567
Q ss_pred EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 105 TFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
.+++||||+.|++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++.
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGLSR 159 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGG-GCEEECCCCGGG
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCC-CCEEEccCccce
Confidence 799999999999999999874 44999999999999999999999999 9999999999999877 799999999998
Q ss_pred hhcCCCC--CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 012320 183 ILRGSKS--AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258 (466)
Q Consensus 183 ~~~~~~~--~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 258 (466)
....... .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.. .+..++...+..+..+ ..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~ 237 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRM-ERPEGC 237 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCCC-CCCTTC
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhccCCC-CCCCCC
Confidence 7654322 23345788999999776 569999999999999999999 8899976 5566666666655432 334556
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+..+.++|.+||. ||.+|||+.++++
T Consensus 238 ~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 238 PEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 7899999999996 9999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=348.97 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=206.5
Q ss_pred CCceEEeeeeeeeeCceEEEEEE----EcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAI----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
.+||..+.+.||+|+||+||+|. +..+|+.||+|++... ......+.+.+|+.+|++++||||+++++++.+.
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD---AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc---cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 57887778889999999997774 4568999999998744 2455678899999999999999999999998776
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
+...+++||||+.+|+|.+++.+ ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~-~~~kl~Dfg~a 181 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDND-RLVKIGDFGLA 181 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCGGGC
T ss_pred CCceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCC-CCEEECCcccc
Confidence 67889999999999999999976 45999999999999999999999999 9999999999999877 89999999999
Q ss_pred hhhcCCCC----CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCC--------------HHHHH
Q 012320 182 AILRGSKS----AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECAN--------------PAQIY 242 (466)
Q Consensus 182 ~~~~~~~~----~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~--------------~~~i~ 242 (466)
........ .....||+.|+|||++. ..++.++|||||||++|+|++|..||..... ...+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence 87654322 23456888999999876 4688999999999999999999999964211 11233
Q ss_pred HHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 243 KKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 243 ~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..+..+.. ...+...+.++.+||.+||. ||.+|||+.++++
T Consensus 262 ~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 262 ELLERGER-LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcccC-CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 33444433 33445677899999999996 9999999999984
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=346.53 Aligned_cols=251 Identities=20% Similarity=0.316 Sum_probs=198.7
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcC---CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEV---LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
++|.+ .++||+|+||+||+|.+.. ++..||+|.+.... ......+.+.+|+.++++++||||+++++++.+.+.
T Consensus 34 ~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 34 NLLIL-GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN--SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp GGEEE-EEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred HHeee-ccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc--cchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 56665 7789999999999998765 67799999987543 245566789999999999999999999998865443
Q ss_pred C---EEEEEEecCCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEE
Q 012320 104 K---TFNFITEMFTSGTLREYRKK------YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVK 174 (466)
Q Consensus 104 ~---~~~lV~E~~~ggsL~~~l~~------~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vK 174 (466)
. ..++||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~-~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDD-MTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECTT-SCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC-CcEE
Confidence 2 46899999999999999853 356999999999999999999999999 9999999999999877 8999
Q ss_pred EeccchhhhhcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCC
Q 012320 175 IGDLGLAAILRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGK 249 (466)
Q Consensus 175 L~DFGla~~~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~ 249 (466)
|+|||++....... ......+|+.|+|||++. ..++.++|||||||++|+|++ |..||.. .+...+...+..+.
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~ 266 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG-VQNHEMYDYLLHGH 266 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTC
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCcc-CCHHHHHHHHHcCC
Confidence 99999997654322 123345788999999876 558999999999999999999 8888876 55566677777665
Q ss_pred CCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 250 LPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 250 ~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
.+. .+...+.++.++|.+||. +|.+|||+.+++.+
T Consensus 267 ~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 267 RLK-QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCC-CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCC-CCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 433 345567899999999996 99999999999853
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=357.48 Aligned_cols=251 Identities=20% Similarity=0.329 Sum_probs=199.0
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEc---CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEE
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDE---VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWI 99 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 99 (466)
.-..++|.+ .++||+|+||+||+|.++ .++..||+|.++... .....+.+.+|+.+|++++||||+++++++
T Consensus 41 ~~~~~~~~~-~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~- 115 (373)
T 2qol_A 41 ELDATNISI-DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEASIMGQFDHPNIIRLEGVV- 115 (373)
T ss_dssp BCCGGGCCC-CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred hcCHhhcee-eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-
Confidence 334567776 677999999999999887 567889999986432 455667899999999999999999999987
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEecc
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDL 178 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DF 178 (466)
.+...+++||||++||+|.+++.+.+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+||
T Consensus 116 -~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Df 191 (373)
T 2qol_A 116 -TKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSN-LVCKVSDF 191 (373)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCC
T ss_pred -eeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCC-CCEEECcC
Confidence 45677899999999999999998754 6999999999999999999999999 9999999999999877 89999999
Q ss_pred chhhhhcCCCC----CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCC
Q 012320 179 GLAAILRGSKS----AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPG 252 (466)
Q Consensus 179 Gla~~~~~~~~----~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~ 252 (466)
|++........ .....+|+.|+|||++. ..++.++|||||||++|||++ |..||.. .+..++.+.+..+..+.
T Consensus 192 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~-~~~~~~~~~i~~~~~~~ 270 (373)
T 2qol_A 192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-MSNQDVIKAVDEGYRLP 270 (373)
T ss_dssp ----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT-CCHHHHHHHHHTTEECC
T ss_pred ccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC
Confidence 99987643221 12234578899999876 569999999999999999998 9999977 56677777777664322
Q ss_pred CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 253 AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 253 ~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.+...+..+.++|.+||. +|.+||++.++++
T Consensus 271 -~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 271 -PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp -CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 234567899999999996 9999999999975
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=339.59 Aligned_cols=249 Identities=21% Similarity=0.367 Sum_probs=203.3
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcC---CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEV---LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
..++|.+ .+.||+|+||+||+|.+.. ++..||+|.+.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-- 83 (281)
T 3cc6_A 10 AREDVVL-NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC---TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE-- 83 (281)
T ss_dssp CGGGEEE-EEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS---CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC--
T ss_pred cccceEE-EEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc---CchHHHHHHHHHHHHHhCCCCCcceEEEEEc--
Confidence 3567876 6779999999999998653 45679999887442 4456688999999999999999999999763
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
+ ...++||||+.+++|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||+
T Consensus 84 ~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~ 159 (281)
T 3cc6_A 84 E-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASP-ECVKLGDFGL 159 (281)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEET-TEEEECCCCG
T ss_pred C-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCC-CcEEeCccCC
Confidence 2 3468999999999999999765 45999999999999999999999999 9999999999999977 8999999999
Q ss_pred hhhhcCCC--CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 012320 181 AAILRGSK--SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 181 a~~~~~~~--~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 256 (466)
+....... ......+|+.|+|||++. ..++.++|||||||++|+|++ |..||.. .+...+...+..+..+. .+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~ 237 (281)
T 3cc6_A 160 SRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW-LENKDVIGVLEKGDRLP-KPD 237 (281)
T ss_dssp GGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCGGGHHHHHHHTCCCC-CCT
T ss_pred CcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCccc-CChHHHHHHHhcCCCCC-CCC
Confidence 98654332 223445788999999876 569999999999999999998 9999976 34445555666554332 344
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
..+..+.++|.+||. +|.+|||+.+++++
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 238 LCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 567899999999996 99999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=348.58 Aligned_cols=260 Identities=22% Similarity=0.316 Sum_probs=212.0
Q ss_pred eeeCCCCceEEeeeeeeeeCceEEEEEE-----EcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEE
Q 012320 21 IETDPNGRYGLFEEVLGKGAMKTVYKAI-----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95 (466)
Q Consensus 21 ~~~~~~~rY~~~~~~LG~G~fg~Vyka~-----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~ 95 (466)
+..-+.++|.+ .+.||+|+||+||+|. +..++..||+|.+... ........+.+|+.++++++||||++++
T Consensus 24 ~~~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 99 (327)
T 2yfx_A 24 LKEVPRKNITL-IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV---CSEQDELDFLMEALIISKFNHQNIVRCI 99 (327)
T ss_dssp SCBCCGGGCEE-EEECC--CSSCEEEEEC--------CCEEEEEECCSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCChhheEE-EEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc---cchhhHHHHHHHHHHHhhCCCCCCCeEE
Confidence 34456788987 4669999999999999 6678999999998632 2445667899999999999999999999
Q ss_pred eEEEeccCCEEEEEEecCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeC
Q 012320 96 TSWIDVDQKTFNFITEMFTSGTLREYRKKYR-------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNG 168 (466)
Q Consensus 96 ~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~ 168 (466)
+.+ .+...+++||||+.|++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 100 ~~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~ 175 (327)
T 2yfx_A 100 GVS--LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTC 175 (327)
T ss_dssp EEE--CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESC
T ss_pred EEE--cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEec
Confidence 987 44667899999999999999998763 4899999999999999999999999 999999999999984
Q ss_pred C--CCcEEEeccchhhhhcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHH
Q 012320 169 H--LGQVKIGDLGLAAILRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQI 241 (466)
Q Consensus 169 ~--~g~vKL~DFGla~~~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i 241 (466)
+ .+.+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++ |..||.. .+...+
T Consensus 176 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~ 254 (327)
T 2yfx_A 176 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEV 254 (327)
T ss_dssp SSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHH
T ss_pred CCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-cCHHHH
Confidence 3 2469999999997654322 233457899999999775 569999999999999999998 8899976 667777
Q ss_pred HHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 242 YKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 242 ~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
...+..+..+. .....+..+.++|.+||. ||.+|||+.++++++|...
T Consensus 255 ~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 255 LEFVTSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcCCCCC-CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 78887775433 345567899999999996 9999999999999987643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=341.42 Aligned_cols=246 Identities=27% Similarity=0.396 Sum_probs=194.6
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHh--CCCCceeEEEeEEEecc
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLST--LKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~~~ 102 (466)
-.++|.+ .+.||+|+||+||+|.+ +|+.||+|++... ....+..|.+++.. ++||||+++++.+....
T Consensus 6 ~~~~y~~-~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 6 VARDITL-LECVGKGRYGEVWRGSW--QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CGGGCEE-EEEEEECSSEEEEEEEE--TTEEEEEEEECGG-------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccCcEEE-EEeeccCCCcEEEEEEE--CCEEEEEEEeccc-------cchhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 4578877 56699999999999987 6999999998633 23455667777776 79999999999876542
Q ss_pred --CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCeEeccCCCCcEEEeCCCCc
Q 012320 103 --QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLH--------SRDPPVIHRDLKCDNIFVNGHLGQ 172 (466)
Q Consensus 103 --~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLH--------s~~~~IiHrDLKp~NIlv~~~~g~ 172 (466)
...+++||||+.+|+|.++++. ..+++..+..++.||+.||.||| +.+ |+||||||+|||++.+ +.
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~-~~ 151 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKN-GQ 151 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTT-SC
T ss_pred CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCC-CC
Confidence 4568999999999999999954 67999999999999999999999 888 9999999999999977 89
Q ss_pred EEEeccchhhhhcCCCC-----CccccCCCCcCCccccccC-------CCChhhHHHHHHHHHHHHhC----------CC
Q 012320 173 VKIGDLGLAAILRGSKS-----AHSVIGTPEFMAPELYEED-------YNELVDVYSFGMCVLEMFTC----------EY 230 (466)
Q Consensus 173 vKL~DFGla~~~~~~~~-----~~~~~GT~~y~APE~l~~~-------y~~~~DIwSlGvil~elltg----------~~ 230 (466)
+||+|||++........ ....+||+.|+|||++.+. ++.++|||||||++|+|++| ..
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 99999999976544322 2345799999999987643 44689999999999999999 88
Q ss_pred CCCCC----CCHHHHHHHHhcCCCCCCCC-----CCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 231 PYSEC----ANPAQIYKKVTSGKLPGAFY-----SIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 231 Pf~~~----~~~~~i~~~i~~g~~p~~~~-----~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
||... .....+.+.+.........+ ...+.++.++|.+||. ||.+|||+.++++
T Consensus 232 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 88542 22333444333322222222 1234679999999996 9999999999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=339.92 Aligned_cols=249 Identities=18% Similarity=0.260 Sum_probs=206.5
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCe---EEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGV---EVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
.+|.. +++||+|+||+||+|.+..++. .||+|.+... ......+.+.+|+.++++++||||+++++++.+ ..
T Consensus 21 ~~~~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~ 95 (298)
T 3pls_A 21 VVTHS-DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI---TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP-PE 95 (298)
T ss_dssp EEEEE-EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC-SS
T ss_pred eEEcc-CceeccCCCceEEEEEEecCCCceeeeeeeecccc---ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec-CC
Confidence 34443 7889999999999999755444 8999988632 245567889999999999999999999998743 23
Q ss_pred CEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 104 KTFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
...++|+||+.+|+|.+++.. ...+++..+..++.||+.||.|||+.| |+||||||+||+++.+ +.+||+|||++.
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~-~~~kl~Dfg~~~ 172 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDES-FTVKVADFGLAR 172 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-CCEEECCTTSSC
T ss_pred CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC-CcEEeCcCCCcc
Confidence 445899999999999999986 456899999999999999999999999 9999999999999877 899999999997
Q ss_pred hhcCC-----CCCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 012320 183 ILRGS-----KSAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 183 ~~~~~-----~~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 256 (466)
.+... .......||+.|+|||++.+ .++.++|||||||++|+|++|..|+....+...+...+..+..+. .+.
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 251 (298)
T 3pls_A 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP-QPE 251 (298)
T ss_dssp TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC-CCT
T ss_pred cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC-CCc
Confidence 54321 22344568999999998764 689999999999999999997777666677777777777766432 345
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..+..+.++|.+||. +|.+|||+.++++
T Consensus 252 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 252 YCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 567899999999996 9999999999985
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=340.03 Aligned_cols=259 Identities=19% Similarity=0.283 Sum_probs=205.8
Q ss_pred cceeeeCCCCceEEeeeeeeeeCceEEEEEEEcCC---CeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEE
Q 012320 18 IGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVL---GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRF 94 (466)
Q Consensus 18 ~~~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l 94 (466)
+.....++....+.+.++||+|+||+||+|.+..+ +..+|+|.+... ......+.+.+|+.++++++||||+++
T Consensus 15 ~~~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~ 91 (298)
T 3f66_A 15 VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSL 91 (298)
T ss_dssp HGGGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred hhheecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC---CCHHHHHHHHHHHHHHHhCCCCCEeee
Confidence 34444555555555578899999999999996543 446889987642 345567889999999999999999999
Q ss_pred EeEEEeccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcE
Q 012320 95 YTSWIDVDQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQV 173 (466)
Q Consensus 95 ~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~v 173 (466)
++.+.. .....++||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+
T Consensus 92 ~~~~~~-~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~ 167 (298)
T 3f66_A 92 LGICLR-SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEK-FTV 167 (298)
T ss_dssp CEEECC-SSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-CCE
T ss_pred eeEEEc-CCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCC-CCE
Confidence 997643 456788999999999999999764 56899999999999999999999999 9999999999999877 899
Q ss_pred EEeccchhhhhcCCC-----CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q 012320 174 KIGDLGLAAILRGSK-----SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS 247 (466)
Q Consensus 174 KL~DFGla~~~~~~~-----~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~ 247 (466)
||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..|+....+...+...+..
T Consensus 168 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~ 247 (298)
T 3f66_A 168 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247 (298)
T ss_dssp EECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT
T ss_pred EECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc
Confidence 999999997653321 223456788999999876 56899999999999999999955444344555666666666
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 248 GKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 248 g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+..+. .+...+..+.++|.+||. +|.+|||+.++++
T Consensus 248 ~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 248 GRRLL-QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp TCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCC-CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 65432 344567899999999996 9999999999985
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=353.37 Aligned_cols=250 Identities=22% Similarity=0.348 Sum_probs=203.4
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeE----EEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEE
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVE----VAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWI 99 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~----vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 99 (466)
-...+|.+ .++||+|+||+||+|.+..+|.. ||+|.+.... .......+.+|+.++++++||||+++++++
T Consensus 10 ~~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~- 84 (325)
T 3kex_A 10 FKETELRK-LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS---GRQSFQAVTDHMLAIGSLDHAHIVRLLGLC- 84 (325)
T ss_dssp CCTTTEEE-EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT---SCSCBCSCCHHHHHHHTCCCTTBCCEEEEE-
T ss_pred cCHhHcee-eeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc---cHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-
Confidence 34577877 56799999999999999888876 6666654322 112234577899999999999999999976
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEecc
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDL 178 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DF 178 (466)
. ...+++||||+.+|+|.+++.+. +.+++..+..|+.||+.||.|||+.| |+||||||+|||++.+ +.+||+||
T Consensus 85 -~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~-~~~kl~Df 159 (325)
T 3kex_A 85 -P-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSP-SQVQVADF 159 (325)
T ss_dssp -C-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSS-SCEEECSC
T ss_pred -c-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCC-CeEEECCC
Confidence 2 34588999999999999999875 57999999999999999999999999 9999999999999877 89999999
Q ss_pred chhhhhcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCC
Q 012320 179 GLAAILRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGA 253 (466)
Q Consensus 179 Gla~~~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~ 253 (466)
|++..+.... ......||+.|+|||++. +.++.++|||||||++|+|++ |..||.. .+..++...+..+..+.
T Consensus 160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~- 237 (325)
T 3kex_A 160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG-LRLAEVPDLLEKGERLA- 237 (325)
T ss_dssp SGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCTTHHHHHHHTTCBCC-
T ss_pred CcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccc-cCHHHHHHHHHcCCCCC-
Confidence 9998764332 234456888999999876 669999999999999999999 9999976 55566667777665332
Q ss_pred CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 254 FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 254 ~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
.+...+.++.++|.+||. ||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 238 QPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 334466789999999996 99999999999876
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=345.78 Aligned_cols=256 Identities=22% Similarity=0.335 Sum_probs=205.9
Q ss_pred ceeeeCCCCceEEeeeeeeeeCceEEEEEEEcCCC----eEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEE
Q 012320 19 GYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLG----VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRF 94 (466)
Q Consensus 19 ~~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l 94 (466)
.+...-...+|.+ .++||+|+||+||+|.++.++ ..||+|.+.... .......+.+|+.++++++||||+++
T Consensus 36 ~~~~~i~~~~~~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~ 111 (333)
T 1mqb_A 36 KFTTEIHPSCVTR-QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRL 111 (333)
T ss_dssp --CCBCCTTTEEE-EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred hccccCChHHhhc-ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 3444555678877 677999999999999987653 469999986432 44556789999999999999999999
Q ss_pred EeEEEeccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcE
Q 012320 95 YTSWIDVDQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQV 173 (466)
Q Consensus 95 ~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~v 173 (466)
++.+ .+...+++||||+.+|+|.+++.+. +.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+
T Consensus 112 ~~~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~ 186 (333)
T 1mqb_A 112 EGVI--SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSN-LVC 186 (333)
T ss_dssp EEEE--CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCE
T ss_pred EEEE--ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCC-CcE
Confidence 9987 4567899999999999999999765 67999999999999999999999999 9999999999999876 899
Q ss_pred EEeccchhhhhcCCCC----CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhc
Q 012320 174 KIGDLGLAAILRGSKS----AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTS 247 (466)
Q Consensus 174 KL~DFGla~~~~~~~~----~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~ 247 (466)
||+|||++........ .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.. .+..++...+..
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~~~~~ 265 (333)
T 1mqb_A 187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-LSNHEVMKAIND 265 (333)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHT
T ss_pred EECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHC
Confidence 9999999987643221 22334688999999876 569999999999999999999 9999976 566777788877
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 248 GKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 248 g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
+..+. .+...+..+.++|.+||. +|.+||++.+++++
T Consensus 266 ~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 266 GFRLP-TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp TCCCC-CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCcCC-CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 64332 334567899999999996 99999999999853
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=365.06 Aligned_cols=255 Identities=26% Similarity=0.305 Sum_probs=194.5
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 103 (466)
...+|.. .++||+|+||+|+. ....+|+.||+|++..... ..+.+|+.+|+++ +|||||++++.+ .+.
T Consensus 22 ~~~~y~~-~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-------~~~~~E~~~l~~l~~HpnIv~l~~~~--~~~ 90 (432)
T 3p23_A 22 GKISFCP-KDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-------SFADREVQLLRESDEHPNVIRYFCTE--KDR 90 (432)
T ss_dssp TTEEEEE-EEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-------EECHHHHHHHHHSCCCTTBCCEEEEE--EET
T ss_pred ccEEEec-CCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-------HHHHHHHHHHHhccCCCCcCeEEEEE--ecC
Confidence 3456776 67899999999763 4456799999999864332 2346799999999 899999999987 457
Q ss_pred CEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC----CCcEEEecc
Q 012320 104 KTFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH----LGQVKIGDL 178 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~----~g~vKL~DF 178 (466)
..+|+|||||. |+|.+++.... ..++..+..++.||+.||.|||+++ |+||||||+|||++.+ ...+||+||
T Consensus 91 ~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DF 167 (432)
T 3p23_A 91 QFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDF 167 (432)
T ss_dssp TEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred CEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence 78999999995 69999998654 4566677899999999999999999 9999999999999532 135889999
Q ss_pred chhhhhcCC----CCCccccCCCCcCCccccc----cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCC
Q 012320 179 GLAAILRGS----KSAHSVIGTPEFMAPELYE----EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGK 249 (466)
Q Consensus 179 Gla~~~~~~----~~~~~~~GT~~y~APE~l~----~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~ 249 (466)
|+++.+... ......+||+.|+|||++. ..++.++|||||||++|+|++ |..||... ...+....+....
T Consensus 168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~-~~~~~~~~~~~~~ 246 (432)
T 3p23_A 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS-LQRQANILLGACS 246 (432)
T ss_dssp TEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST-TTHHHHHHTTCCC
T ss_pred cceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh-hHHHHHHHhccCC
Confidence 999876533 2234567999999999885 347789999999999999999 88899653 3333322222222
Q ss_pred CCCC-CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhhh
Q 012320 250 LPGA-FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVK 294 (466)
Q Consensus 250 ~p~~-~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~~ 294 (466)
.+.. .....+..+++||.+||. ||.+|||+.++++||||....+.
T Consensus 247 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~~ 293 (432)
T 3p23_A 247 LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQ 293 (432)
T ss_dssp CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHHH
T ss_pred ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHHH
Confidence 2111 122335568999999996 99999999999999999886653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=347.88 Aligned_cols=253 Identities=26% Similarity=0.428 Sum_probs=202.6
Q ss_pred eeeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEE----EEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEE
Q 012320 20 YIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEV----AWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95 (466)
Q Consensus 20 ~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~v----AiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~ 95 (466)
....-..++|.+ .++||+|+||+||+|.+..+|+.+ |+|.+.... .....+.+.+|+.++++++||||++++
T Consensus 8 ~~~~l~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~ 83 (327)
T 3lzb_A 8 LLRILKETEFKK-IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLL 83 (327)
T ss_dssp CCEECCTTTEEE-EEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS---SCCCHHHHHHHHHHHTTCCBTTBCCCC
T ss_pred hhcccCHhHceE-EEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc---CHHHHHHHHHHHHHHHhCCCCCeeEEE
Confidence 344556788988 466999999999999998888776 555443221 233457789999999999999999999
Q ss_pred eEEEeccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEE
Q 012320 96 TSWIDVDQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVK 174 (466)
Q Consensus 96 ~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vK 174 (466)
+++.. . ..++|+|++.+|+|.+++... +.+++..+..|+.||+.||.|||+++ |+||||||+|||++.+ +.+|
T Consensus 84 ~~~~~--~-~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~k 157 (327)
T 3lzb_A 84 GICLT--S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP-QHVK 157 (327)
T ss_dssp EEEES--S-SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-TEEE
T ss_pred EEEec--C-CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCC-CCEE
Confidence 98753 2 378999999999999999874 57999999999999999999999999 9999999999999877 8999
Q ss_pred EeccchhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCC
Q 012320 175 IGDLGLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGK 249 (466)
Q Consensus 175 L~DFGla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~ 249 (466)
|+|||++..+..... .....||+.|+|||++. ..|+.++|||||||++|+|++ |..||.. .+..++...+..+.
T Consensus 158 L~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~ 236 (327)
T 3lzb_A 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGE 236 (327)
T ss_dssp ECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTC
T ss_pred EccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCC
Confidence 999999987643222 23345788999999775 569999999999999999999 9999976 55666777776665
Q ss_pred CCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 250 LPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 250 ~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.+. .+...+.++.++|.+||. ||.+|||+.|+++
T Consensus 237 ~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 237 RLP-QPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp CCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 432 345577899999999996 9999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=341.22 Aligned_cols=252 Identities=19% Similarity=0.267 Sum_probs=201.7
Q ss_pred eeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 22 ~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
+....++|.+ .+.||+|+||+||+|.++.+|+.||+|++..... .+.+.+|+.+++.++|++++..+..+. .
T Consensus 4 ~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~-~ 75 (296)
T 3uzp_A 4 ELRVGNRYRL-GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCG-A 75 (296)
T ss_dssp -CEETTTEEE-EEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS------CCHHHHHHHHHHHHTTSTTCCCEEEEE-E
T ss_pred cceeccEEEE-EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc------hhHHHHHHHHHHHhhcCCCCCcccccc-C
Confidence 3445788987 5779999999999999999999999999875432 135788999999999988777665543 4
Q ss_pred cCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEe--CCCCcEEEecc
Q 012320 102 DQKTFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVN--GHLGQVKIGDL 178 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~--~~~g~vKL~DF 178 (466)
....+++||||+ +++|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++ ...+.+||+||
T Consensus 76 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Df 152 (296)
T 3uzp_A 76 EGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred CCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence 567889999999 9999999974 467999999999999999999999999 99999999999995 23379999999
Q ss_pred chhhhhcCCCC--------CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHhc
Q 012320 179 GLAAILRGSKS--------AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECAN--PAQIYKKVTS 247 (466)
Q Consensus 179 Gla~~~~~~~~--------~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~--~~~i~~~i~~ 247 (466)
|++........ .....||+.|+|||++. ..++.++|||||||++|+|++|..||..... ..+.+..+..
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 232 (296)
T 3uzp_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred CCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc
Confidence 99987654322 24567999999999876 4689999999999999999999999975322 2223333332
Q ss_pred CCCCC---CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 248 GKLPG---AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 248 g~~p~---~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+..+. ......+.++.++|.+||. ||.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 233 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred cccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 22111 1224457899999999996 9999999999974
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=342.12 Aligned_cols=240 Identities=29% Similarity=0.466 Sum_probs=193.6
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.+ .+.||+|+||+||+|.+. ++.||+|++.. ....+.+.+|+.+|++++||||+++++.+. +.
T Consensus 7 ~~~~~~-~~~lg~G~~g~V~~~~~~--~~~vavK~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----~~ 73 (307)
T 2eva_A 7 YKEIEV-EEVVGRGAFGVVCKAKWR--AKDVAIKQIES------ESERKAFIVELRQLSRVNHPNIVKLYGACL----NP 73 (307)
T ss_dssp GGGEEE-EEEEECCSSSEEEEEEET--TEEEEEEECSS------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT----TT
T ss_pred HhHeee-eeEeecCCCceEEEEEEC--CeeEEEEEecC------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc----CC
Confidence 356766 677999999999999875 88999998752 235578899999999999999999999763 33
Q ss_pred EEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCCCeEeccCCCCcEEEeCCCCc-EEEecc
Q 012320 106 FNFITEMFTSGTLREYRKKYR---RVDIRAIKSWARQILQGLVYLHS---RDPPVIHRDLKCDNIFVNGHLGQ-VKIGDL 178 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~---~l~~~~~~~i~~qIl~gL~yLHs---~~~~IiHrDLKp~NIlv~~~~g~-vKL~DF 178 (466)
+++||||++||+|.+++.... .+++..+..++.||+.||.|||+ ++ |+||||||+|||++.+ +. +||+||
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~-~~~~kl~Df 150 (307)
T 2eva_A 74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAG-GTVLKICDF 150 (307)
T ss_dssp TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETT-TTEEEECCC
T ss_pred cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCC-CCEEEEccc
Confidence 789999999999999998754 37899999999999999999999 67 9999999999999877 55 899999
Q ss_pred chhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhcCCCCCCCCC
Q 012320 179 GLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECA-NPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 179 Gla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~-~~~~i~~~i~~g~~p~~~~~ 256 (466)
|++...... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.... ....+...+..+..+. ...
T Consensus 151 g~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~ 227 (307)
T 2eva_A 151 GTACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP-LIK 227 (307)
T ss_dssp CC--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCC-CBT
T ss_pred ccccccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCC-ccc
Confidence 999765432 23456999999999876 469999999999999999999999997543 3344555555555443 345
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..+..++++|.+||. ||.+|||+.++++
T Consensus 228 ~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 228 NLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 567899999999996 9999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=359.74 Aligned_cols=243 Identities=19% Similarity=0.347 Sum_probs=203.0
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
..++|.+ .+.||+|+||+||+|.++ |+.||+|.++... ..+.+.+|+.+|++++||||+++++.+.. ...
T Consensus 191 ~~~~~~~-~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~ 260 (450)
T 1k9a_A 191 NMKELKL-LQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKG 260 (450)
T ss_dssp CGGGEEE-EEEEEECSSEEEEEEEET--TEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEEEEC-TTS
T ss_pred ChHHeEE-EeeecCcCCeeEEEEEec--CCeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEEEEc-CCC
Confidence 3467776 567999999999999875 8899999987432 34678999999999999999999998754 344
Q ss_pred EEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRR--VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
.+++||||+.+|+|.+++.+.+. +++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DfG~a~ 337 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTK 337 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-SCEEECCCTTCE
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCC-CCEEEeeCCCcc
Confidence 78999999999999999987654 799999999999999999999999 9999999999999877 899999999997
Q ss_pred hhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 012320 183 ILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL 260 (466)
Q Consensus 183 ~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~ 260 (466)
..... .....+|+.|+|||++. ..|+.++|||||||++|||++ |..||.. .+..++...+..|..+ ..+...+.
T Consensus 338 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~-~~p~~~~~ 413 (450)
T 1k9a_A 338 EASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCPP 413 (450)
T ss_dssp ECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTT-SCTTTHHHHHHTTCCC-CCCTTCCH
T ss_pred ccccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCcCCH
Confidence 54322 23346789999999875 569999999999999999998 9999977 4445666777776432 34456788
Q ss_pred HHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 261 EAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 261 ~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
++.++|.+||. ||.+|||+.+++.
T Consensus 414 ~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 414 AVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999996 9999999999974
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=333.68 Aligned_cols=247 Identities=24% Similarity=0.385 Sum_probs=206.4
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
.-+.++|.+ .+.||+|+||+||+|.+. ++..||+|.+..... ..+.+.+|+.+|++++||||+++++.+.
T Consensus 9 ~v~~~~y~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~--- 78 (279)
T 1qpc_A 9 EVPRETLKL-VERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQHQRLVRLYAVVT--- 78 (279)
T ss_dssp BCCGGGEEE-EEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred ccCHHhhhh-eeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc-----cHHHHHHHHHHHHhCCCcCcceEEEEEc---
Confidence 345678887 466999999999999976 578899999874431 2467889999999999999999999763
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
...+++||||+.|++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+||+++.+ +.+||+|||+
T Consensus 79 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~ 155 (279)
T 1qpc_A 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDT-LSCKIADFGL 155 (279)
T ss_dssp SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTT
T ss_pred CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCC-CCEEECCCcc
Confidence 345789999999999999987543 7999999999999999999999999 9999999999999876 8999999999
Q ss_pred hhhhcCCC--CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 012320 181 AAILRGSK--SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 181 a~~~~~~~--~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 256 (466)
+....... ......+|+.|+|||++. +.++.++|||||||++|+|++ |..||.. .+..++...+..+..+ ..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~ 233 (279)
T 1qpc_A 156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-MTNPEVIQNLERGYRM-VRPD 233 (279)
T ss_dssp CEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCT
T ss_pred cccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc-cCHHHHHHHHhcccCC-CCcc
Confidence 97764332 123345788999999876 568999999999999999999 8999976 5667777777766433 3345
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..+.++.++|.+||. +|.+|||+.++++
T Consensus 234 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 234 NCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 567899999999996 9999999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=340.35 Aligned_cols=252 Identities=19% Similarity=0.274 Sum_probs=196.0
Q ss_pred eeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 21 IETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 21 ~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
++....++|.+ .+.||+|+||+||+|.+..+|+.||+|++..... ...+.+|+.+++.++|++++..+..+.
T Consensus 3 ~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~- 74 (296)
T 4hgt_A 3 MELRVGNRYRL-GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCG- 74 (296)
T ss_dssp --------CEE-EEEEEECSSSEEEEEEETTTTEEEEEEEEEC---------CCCHHHHHHHHHHHTTSTTCCCEEEEE-
T ss_pred cccccCCceEE-eeeecCCCCeEEEEEEEcCCCceEEEEeeccccc------chHHHHHHHHHHHhcCCCCCCeeeeec-
Confidence 34456788987 5779999999999999999999999998764432 235788999999999888777776553
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEE---eCCCCcEEEe
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFV---NGHLGQVKIG 176 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv---~~~~g~vKL~ 176 (466)
......++||||+ +++|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||+ +.+ +.+||+
T Consensus 75 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~-~~~kL~ 150 (296)
T 4hgt_A 75 AEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKG-NLVYII 150 (296)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGT-TCEEEC
T ss_pred CCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCC-CeEEEe
Confidence 4567889999999 9999999985 467999999999999999999999999 9999999999999 444 799999
Q ss_pred ccchhhhhcCCC--------CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH
Q 012320 177 DLGLAAILRGSK--------SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANP--AQIYKKV 245 (466)
Q Consensus 177 DFGla~~~~~~~--------~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~--~~i~~~i 245 (466)
|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||...... .+.+..+
T Consensus 151 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 230 (296)
T 4hgt_A 151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230 (296)
T ss_dssp CCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred cCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh
Confidence 999998765432 223567999999999876 46999999999999999999999999753321 1222222
Q ss_pred hcCCCCCC---CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 246 TSGKLPGA---FYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 246 ~~g~~p~~---~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.....+.. .....+.++.++|.+||. +|.+|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 231 SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 22221111 123456799999999996 9999999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=344.40 Aligned_cols=250 Identities=26% Similarity=0.401 Sum_probs=202.1
Q ss_pred CCceEEeeeeeeeeCceEEEEEE----EcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAI----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
.++|.+ .+.||+|+||+||+|. +..+|+.||+|++... .....+.+.+|+.++++++||||+++++.+...
T Consensus 40 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 40 ERHLKF-LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp GGGEEE-EEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred HHHcee-eeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 455655 6779999999999998 5678999999998743 345667899999999999999999999988655
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
+...+++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||+
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~-~~~kL~Dfg~ 191 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVKIGDFGL 191 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-TEEEECCCTT
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCC-CcEEEecCcc
Confidence 556789999999999999999876 46999999999999999999999999 9999999999999977 8999999999
Q ss_pred hhhhcCCCC----CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCC---------------HHH
Q 012320 181 AAILRGSKS----AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECAN---------------PAQ 240 (466)
Q Consensus 181 a~~~~~~~~----~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~---------------~~~ 240 (466)
+........ .....+|+.|+|||++. ..++.++|||||||++|+|++|..||..... ...
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 987654322 22345778899999876 4588999999999999999999999853110 012
Q ss_pred HHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 241 IYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 241 i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+...+..+..+ ..+...+.++.++|.+||. ||.+|||+.++++
T Consensus 272 ~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 272 LIELLKNNGRL-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHTTCCC-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhcCCCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 23333333322 2345567899999999996 9999999999984
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=340.90 Aligned_cols=246 Identities=22% Similarity=0.307 Sum_probs=199.7
Q ss_pred eeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEe
Q 012320 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITE 111 (466)
Q Consensus 32 ~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E 111 (466)
.++.||+|+||+||+|.+ ++..||+|++............+.+.+|+.++++++||||+++++++ .+...+++|||
T Consensus 35 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e 110 (307)
T 2nru_A 35 GGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS--SDGDDLCLVYV 110 (307)
T ss_dssp TCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSSSCEEEEE
T ss_pred cCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEE--ecCCceEEEEE
Confidence 367899999999999976 68899999987544333445667899999999999999999999987 45667899999
Q ss_pred cCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCC
Q 012320 112 MFTSGTLREYRKK---YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK 188 (466)
Q Consensus 112 ~~~ggsL~~~l~~---~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~ 188 (466)
|+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++.......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~ 187 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEA-FTAKISDFGLARASEKFA 187 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCEECCSCS
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCC-CcEEEeeccccccccccc
Confidence 9999999999874 346999999999999999999999999 9999999999999876 899999999997654322
Q ss_pred C---CccccCCCCcCCccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCCC---------CCC
Q 012320 189 S---AHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANP---AQIYKKVTSGKL---------PGA 253 (466)
Q Consensus 189 ~---~~~~~GT~~y~APE~l~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~---~~i~~~i~~g~~---------p~~ 253 (466)
. .....||+.|+|||++.+.++.++|||||||++|+|++|..||...... ..+.+.+..... ...
T Consensus 188 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (307)
T 2nru_A 188 QTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND 267 (307)
T ss_dssp SCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred ccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence 1 2345799999999999888999999999999999999999999764332 122233322211 011
Q ss_pred CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 254 FYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 254 ~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.....+..+.+++.+||. +|.+|||+.++++
T Consensus 268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 122234578899999996 9999999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=353.13 Aligned_cols=252 Identities=21% Similarity=0.324 Sum_probs=201.2
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
...++|.. .++||+|+||+||+|.++ +|+.||+|++... .....+.+.+|+.+++.++||||+++++.+ .+.
T Consensus 36 ~~~~~y~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~ 107 (321)
T 2qkw_B 36 EATNNFDH-KFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE----SSQGIEEFETEIETLSFCRHPHLVSLIGFC--DER 107 (321)
T ss_dssp CCCCCCSC-CCCSCBCSSSEEEEEECT-TCCEEEEEECCSC----CSSHHHHHHHHHHGGGSCCCTTBCCEEEEC--CCT
T ss_pred HHHhccCc-cceeecCCCeeEEEEEEC-CCCEEEEEEeccc----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEE--cCC
Confidence 34678876 677999999999999965 6999999987643 234567899999999999999999999987 456
Q ss_pred CEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 104 KTFNFITEMFTSGTLREYRKKYR----RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~----~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
+.+++||||+.||+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDEN-FVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTT-CCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCC-CCEEEeecc
Confidence 77899999999999999886543 5899999999999999999999999 9999999999999877 899999999
Q ss_pred hhhhhcCC---CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCH-----HH-HHHHHhcCC
Q 012320 180 LAAILRGS---KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANP-----AQ-IYKKVTSGK 249 (466)
Q Consensus 180 la~~~~~~---~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~-----~~-i~~~i~~g~ 249 (466)
++...... .......||+.|+|||++. ..++.++|||||||++|+|++|..||...... .. .......+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 99764321 2233456899999999775 67999999999999999999999999653221 11 111222222
Q ss_pred CCC--------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCC
Q 012320 250 LPG--------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDP 286 (466)
Q Consensus 250 ~p~--------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hp 286 (466)
+.. ......+..+.+++.+||. ||.+|||+.|++++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 221 1122234578899999996 999999999998654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=355.07 Aligned_cols=258 Identities=15% Similarity=0.181 Sum_probs=196.7
Q ss_pred eeeCCCCceEEeeeeeeeeCceEEEEEEEcCC-----CeEEEEEEEecccccCCHHH--------HHHHHHHHHHHHhCC
Q 012320 21 IETDPNGRYGLFEEVLGKGAMKTVYKAIDEVL-----GVEVAWNQVRLNELMRSPDD--------LQRLYSEVHLLSTLK 87 (466)
Q Consensus 21 ~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~-----g~~vAiK~i~~~~~~~~~~~--------~~~~~~Ei~iL~~l~ 87 (466)
+.....++|.+ .+.||+|+||+||+|.++.+ ++.||+|++...... ...+ ......|+..++.++
T Consensus 29 i~~~~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~e~~~~~~~~~~~~~~e~~~~~~l~ 106 (364)
T 3op5_A 29 ITDMAAAAWKV-GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP-LFTELKFYQRAAKPEQIQKWIRTRKLK 106 (364)
T ss_dssp EECTTCCEEEE-EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHH-HHHHHHHHHHHCCHHHHHHHHHHTTCS
T ss_pred eeccCCCeEEE-EEEEecCCCeEEEEeeecCccccccccceEEEEeeccchh-HHHHHHHHHhhhhhHHHHHHHHHhhcc
Confidence 33345678877 57799999999999998765 688999998754310 0000 112345666777888
Q ss_pred CCceeEEEeEEEeccC--CEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcE
Q 012320 88 HDSIIRFYTSWIDVDQ--KTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNI 164 (466)
Q Consensus 88 HpnIv~l~~~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NI 164 (466)
||||+++++++..... ..+++||||+ |++|.+++... +.+++..+..|+.||+.||.|||+++ |+||||||+||
T Consensus 107 h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Ni 183 (364)
T 3op5_A 107 YLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNL 183 (364)
T ss_dssp CCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGE
T ss_pred CCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHE
Confidence 9999999999876533 5689999999 99999999876 67999999999999999999999999 99999999999
Q ss_pred EEe--CCCCcEEEeccchhhhhcCCC--------CCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCC
Q 012320 165 FVN--GHLGQVKIGDLGLAAILRGSK--------SAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYS 233 (466)
Q Consensus 165 lv~--~~~g~vKL~DFGla~~~~~~~--------~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~ 233 (466)
|++ .+ +.+||+|||+++.+.... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 184 ll~~~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 184 LLNYKNP-DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp EEESSCT-TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEecCCC-CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 998 55 899999999997653221 1234569999999998764 59999999999999999999999997
Q ss_pred CCCCHHHHHHHHhcC---CCCC-----CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 234 ECANPAQIYKKVTSG---KLPG-----AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 234 ~~~~~~~i~~~i~~g---~~p~-----~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+.............+ .++. ......+.++.+++..|+. +|.+||++.+|++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 263 DNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp GGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 533222222111110 0000 0113456789999999996 9999999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=353.41 Aligned_cols=259 Identities=16% Similarity=0.191 Sum_probs=197.2
Q ss_pred eeeCCCCceEEeeeeeeeeCceEEEEEEEcC---CCeEEEEEEEecccccCCH--H-----HHHHHHHHHHHHHhCCCCc
Q 012320 21 IETDPNGRYGLFEEVLGKGAMKTVYKAIDEV---LGVEVAWNQVRLNELMRSP--D-----DLQRLYSEVHLLSTLKHDS 90 (466)
Q Consensus 21 ~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~---~g~~vAiK~i~~~~~~~~~--~-----~~~~~~~Ei~iL~~l~Hpn 90 (466)
+.....++|.+ .+.||+|+||+||+|.++. ++..+|+|.+......... . ....+.+|+.+++.++|||
T Consensus 31 ~~~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n 109 (345)
T 2v62_A 31 LDDMEGNQWVL-GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG 109 (345)
T ss_dssp EECTTSCEEEE-EEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred eccccCceEEE-EeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence 33344577776 6779999999999999987 8999999998754310000 0 1123667889999999999
Q ss_pred eeEEEeEEEec--cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeC
Q 012320 91 IIRFYTSWIDV--DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNG 168 (466)
Q Consensus 91 Iv~l~~~~~~~--~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~ 168 (466)
|+++++.+... +...+++||||+ |++|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGY 186 (345)
T ss_dssp CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEES
T ss_pred cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEcc
Confidence 99999988653 267899999999 9999999988789999999999999999999999999 999999999999986
Q ss_pred CCC--cEEEeccchhhhhcCCC--------CCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCC-C
Q 012320 169 HLG--QVKIGDLGLAAILRGSK--------SAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSEC-A 236 (466)
Q Consensus 169 ~~g--~vKL~DFGla~~~~~~~--------~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~-~ 236 (466)
+ + .+||+|||+++.+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||... .
T Consensus 187 ~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 265 (345)
T 2v62_A 187 K-NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK 265 (345)
T ss_dssp S-STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred C-CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 6 5 99999999997653211 1245679999999998765 5899999999999999999999999542 3
Q ss_pred CHHHHHHHHh--cCCCCCCC-----CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 237 NPAQIYKKVT--SGKLPGAF-----YSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 237 ~~~~i~~~i~--~g~~p~~~-----~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+...+..... ...+|... ....+.+++++|.+||. ||.+|||+.++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 266 DPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp CHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 3332222111 11222111 11567799999999996 9999999999974
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=337.60 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=200.6
Q ss_pred eeCCCCceEEeeeeeeeeCceEEEEEEEcC-CC--eEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEE
Q 012320 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEV-LG--VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSW 98 (466)
Q Consensus 22 ~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~-~g--~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 98 (466)
..-..++|.+ .+.||+|+||+||+|.+.. ++ ..||+|.+..... ......+.+.+|+.++++++||||+++++++
T Consensus 13 ~~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (291)
T 1u46_A 13 CLIGEKDLRL-LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 90 (291)
T ss_dssp EECCGGGEEE-EEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccchhHeee-eeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc-CCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 3445678877 5669999999999998643 33 3689998875442 2335667899999999999999999999987
Q ss_pred EeccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEec
Q 012320 99 IDVDQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGD 177 (466)
Q Consensus 99 ~~~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~D 177 (466)
.. . ..++|+||+.+++|.+++.+. +.+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|
T Consensus 91 ~~--~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~-~~~kl~D 164 (291)
T 1u46_A 91 LT--P-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATR-DLVKIGD 164 (291)
T ss_dssp CS--S-SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-TEEEECC
T ss_pred cc--C-CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCC-CCEEEcc
Confidence 43 3 378999999999999998764 57999999999999999999999999 9999999999999877 8999999
Q ss_pred cchhhhhcCCCC----CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCC
Q 012320 178 LGLAAILRGSKS----AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLP 251 (466)
Q Consensus 178 FGla~~~~~~~~----~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p 251 (466)
||++........ .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.. .+..++...+......
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~ 243 (291)
T 1u46_A 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGER 243 (291)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCC
T ss_pred ccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc-CCHHHHHHHHHccCCC
Confidence 999977644322 22346788999999876 458899999999999999999 9999976 5667777777666554
Q ss_pred CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 252 GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 252 ~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.......+.+++++|.+||. +|.+|||+.++++
T Consensus 244 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 244 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 44556678899999999996 9999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=359.68 Aligned_cols=246 Identities=23% Similarity=0.389 Sum_probs=206.2
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
-+..+|.+ .+.||+|+||+||+|.++ .+..||+|.++... ...+.+.+|+.+|++++||||+++++.+. .
T Consensus 185 i~~~~~~~-~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~---~ 254 (454)
T 1qcf_A 185 IPRESLKL-EKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVVT---K 254 (454)
T ss_dssp CCGGGEEE-EEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC---S
T ss_pred echHHeEE-EEEcccCCceEEEEEEEC-CccEEEEEEecCCC-----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe---C
Confidence 34567766 577999999999999986 47889999987543 23567899999999999999999999762 4
Q ss_pred CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 104 KTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
..+++||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DFG~a 331 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSAS-LVCKIADFGLA 331 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTT-CCEEECSTTGG
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCC-CcEEEeeCCCc
Confidence 5688999999999999999754 37899999999999999999999999 9999999999999877 89999999999
Q ss_pred hhhcCCC--CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 012320 182 AILRGSK--SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSI 257 (466)
Q Consensus 182 ~~~~~~~--~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 257 (466)
+...... ......+|+.|+|||++. +.|+.++|||||||++|||++ |..||.+ .+..++...+..+... ..+..
T Consensus 332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~-~~~~~ 409 (454)
T 1qcf_A 332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG-MSNPEVIRALERGYRM-PRPEN 409 (454)
T ss_dssp GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHHTCCC-CCCTT
T ss_pred eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCC
Confidence 8754321 122344678999999876 669999999999999999999 9999987 5667777777776432 23455
Q ss_pred CCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 258 QDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 258 ~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.+.++.++|.+||. ||.+|||+.+++.
T Consensus 410 ~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 410 CPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 67899999999996 9999999999873
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=339.90 Aligned_cols=238 Identities=19% Similarity=0.288 Sum_probs=191.5
Q ss_pred eeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHH-HhCCCCceeEEEeEEEe
Q 012320 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLL-STLKHDSIIRFYTSWID 100 (466)
Q Consensus 22 ~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL-~~l~HpnIv~l~~~~~~ 100 (466)
...-.++|++..++||+|+||+||+|.++.+|+.||+|++... ..+.+|+.++ +.++||||+++++.+..
T Consensus 12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 3444588999888999999999999999999999999998621 3467788888 55699999999998754
Q ss_pred --ccCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC--CCcEE
Q 012320 101 --VDQKTFNFITEMFTSGTLREYRKKYR--RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH--LGQVK 174 (466)
Q Consensus 101 --~~~~~~~lV~E~~~ggsL~~~l~~~~--~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~--~g~vK 174 (466)
.+...+++||||+.||+|.+++.+.+ .+++..++.++.||+.||.|||+.+ |+||||||+|||++.. .+.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~k 160 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILK 160 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEE
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEE
Confidence 23567899999999999999998764 6999999999999999999999999 9999999999999873 37899
Q ss_pred EeccchhhhhcCCCCCccccCCCCcCCccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HhcCCC
Q 012320 175 IGDLGLAAILRGSKSAHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKK----VTSGKL 250 (466)
Q Consensus 175 L~DFGla~~~~~~~~~~~~~GT~~y~APE~l~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~----i~~g~~ 250 (466)
|+|||++.... ...|+.++|||||||++|+|++|..||.... ....... +..+..
T Consensus 161 l~Dfg~a~~~~--------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~-~~~~~~~~~~~~~~~~~ 219 (299)
T 3m2w_A 161 LTDFGFAKETT--------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNH-GLAISPGMKTRIRMGQY 219 (299)
T ss_dssp ECCCTTCEECT--------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSCCSSCTTCC
T ss_pred Eeccccccccc--------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCc-chhhhHHHHHHHhhccc
Confidence 99999885432 1347889999999999999999999997532 2222111 111111
Q ss_pred CC--CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 251 PG--AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 251 p~--~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
+. ..+...+.++++||.+||. ||.+|||+.|+|+||||+..
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 11 1114467899999999996 99999999999999999754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=348.01 Aligned_cols=251 Identities=18% Similarity=0.255 Sum_probs=199.8
Q ss_pred ceeeeCC-CCceEEeeeeeeeeCceEEEEEEEcCC--------CeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCC
Q 012320 19 GYIETDP-NGRYGLFEEVLGKGAMKTVYKAIDEVL--------GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHD 89 (466)
Q Consensus 19 ~~~~~~~-~~rY~~~~~~LG~G~fg~Vyka~~~~~--------g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp 89 (466)
+.+..+. .++|.+ .+.||+|+||+||+|.++.+ ++.||+|.+... +.+.+|+.++++++||
T Consensus 33 g~~i~~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~ 102 (352)
T 2jii_A 33 GTVLTDKSGRQWKL-KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKP 102 (352)
T ss_dssp TCEEECTTSCEEEE-EEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCH
T ss_pred CceeecccCCeEEE-EEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhccc
Confidence 3344444 466666 67799999999999999884 899999998733 3578899999999999
Q ss_pred ceeE---------------EEeEEEeccCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 012320 90 SIIR---------------FYTSWIDVDQKTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDP 152 (466)
Q Consensus 90 nIv~---------------l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~ 152 (466)
||++ +++.+.. +...+++||||+ |++|.+++.+. +.+++..+..++.||+.||.|||+++
T Consensus 103 niv~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~- 179 (352)
T 2jii_A 103 LQVNKWKKLYSTPLLAIPTCMGFGVH-QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE- 179 (352)
T ss_dssp HHHHHHHHHTTCTTCSCCCCCEEEEE-TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred chhhhhhhhccCCccCccchhhcccc-CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 9988 4555432 467899999999 99999999886 78999999999999999999999999
Q ss_pred CeEeccCCCCcEEEeCCCC--cEEEeccchhhhhcCCC--------CCccccCCCCcCCcccccc-CCCChhhHHHHHHH
Q 012320 153 PVIHRDLKCDNIFVNGHLG--QVKIGDLGLAAILRGSK--------SAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMC 221 (466)
Q Consensus 153 ~IiHrDLKp~NIlv~~~~g--~vKL~DFGla~~~~~~~--------~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvi 221 (466)
|+||||||+|||++.+ + .+||+|||++..+.... ......||+.|+|||++.+ .++.++|||||||+
T Consensus 180 -ivH~Dikp~NIl~~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 257 (352)
T 2jii_A 180 -YVHGNVTAENIFVDPE-DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYC 257 (352)
T ss_dssp -CBCSCCCGGGEEEETT-EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred -ccCCCCCHHHEEEcCC-CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHH
Confidence 9999999999999976 6 89999999997654221 1234579999999998764 69999999999999
Q ss_pred HHHHHhCCCCCCCCC-CHHHHHHHHhc--CCCCCC-----CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 222 VLEMFTCEYPYSECA-NPAQIYKKVTS--GKLPGA-----FYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 222 l~elltg~~Pf~~~~-~~~~i~~~i~~--g~~p~~-----~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+|+|++|..||.... +...+...... ...+.. .+...+.++++||.+||. ||.+|||+.++++
T Consensus 258 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 258 MLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 999999999997654 44444443321 111111 112457899999999995 9999999999975
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=371.48 Aligned_cols=246 Identities=23% Similarity=0.349 Sum_probs=205.5
Q ss_pred eEEeeeeeeeeCceEEEEEEE--cCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 29 YGLFEEVLGKGAMKTVYKAID--EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
+.+..+.||+|+||+||+|.+ +.+++.||+|+++.... .....+.+.+|+.+|++++|||||++++++. ...+
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~---~~~~ 444 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGICE---AESW 444 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG--CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE---SSSE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe---cCCE
Confidence 333355799999999999954 56789999999875432 3345678999999999999999999999773 3347
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
++||||+.+|+|.+++.+.+.+++..+..|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+..
T Consensus 445 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~-~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 445 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKALRA 521 (635)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCTTHHHHTTC
T ss_pred EEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCC-CCEEEEEcCCcccccc
Confidence 899999999999999998889999999999999999999999999 9999999999999977 8999999999987654
Q ss_pred CCC----CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 012320 187 SKS----AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL 260 (466)
Q Consensus 187 ~~~----~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~ 260 (466)
... .....||+.|+|||++. ..|+.++|||||||++|||++ |..||.+ .+..++...+..+..+. .+...+.
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~-~~~~~~~~~i~~~~~~~-~p~~~~~ 599 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERMG-CPAGCPR 599 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCCC-CCTTCCH
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCCH
Confidence 321 22345788999999876 469999999999999999998 9999977 67778888888876433 3455778
Q ss_pred HHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 261 EAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 261 ~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
++.++|.+||. ||.+|||+.+|++
T Consensus 600 ~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 600 EMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 99999999996 9999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=364.44 Aligned_cols=246 Identities=22% Similarity=0.363 Sum_probs=207.7
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
..+|.+ .+.||+|+||+||+|.++.++..||+|.++... ...+.+.+|+.+|++++||||+++++++ .+...
T Consensus 219 ~~~~~~-~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~--~~~~~ 290 (495)
T 1opk_A 219 RTDITM-KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVC--TREPP 290 (495)
T ss_dssp GGGEEE-EEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSSS
T ss_pred HHHcee-eeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-----cchHHHHHHHHHHHhcCCCCEeeEEEEE--ecCCc
Confidence 345655 677999999999999999999999999986433 1356789999999999999999999987 45667
Q ss_pred EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 106 FNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
+++||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~~ 367 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGEN-HLVKVADFGLSRL 367 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG-GCEEECCTTCEEC
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCC-CcEEEeeccccee
Confidence 89999999999999999874 45899999999999999999999999 9999999999999877 8999999999987
Q ss_pred hcCCC--CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 012320 184 LRGSK--SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259 (466)
Q Consensus 184 ~~~~~--~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 259 (466)
..... ......+|+.|+|||++. +.|+.++|||||||++|||++ |..||.. .+..++.+.+..+.. ...+...+
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~ 445 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYR-MERPEGCP 445 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCC-CCCCTTCC
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCC-CCCCCCCC
Confidence 64322 122344678999999876 569999999999999999999 8999976 555667777766543 23445677
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.++.+||.+||. ||.+|||+.+|++
T Consensus 446 ~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 446 EKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 899999999996 9999999999974
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=342.31 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=190.9
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHH--HHHHHHHhCCCCceeEEEeEEEe--
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLY--SEVHLLSTLKHDSIIRFYTSWID-- 100 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~--~Ei~iL~~l~HpnIv~l~~~~~~-- 100 (466)
..++|.+ .+.||+|+||+||+|.+ +|+.||+|++.... ...+. .|+..++.++||||+++++.+..
T Consensus 11 ~~~~y~~-~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 11 DLDNLKL-LELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-------RQNFINEKNIYRVPLMEHDNIARFIVGDERVT 80 (336)
T ss_dssp CTTSEEE-EEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred ChHHhhe-eeecccCCCeEEEEEEE--CCeEEEEEEeeccc-------hhhHHHHHHHHHHHhccCcchhhheecccccc
Confidence 4578877 56699999999999965 68999999987432 12333 34444556899999999975533
Q ss_pred -ccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCeEeccCCCCcEEEeCCC
Q 012320 101 -VDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSR---------DPPVIHRDLKCDNIFVNGHL 170 (466)
Q Consensus 101 -~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~---------~~~IiHrDLKp~NIlv~~~~ 170 (466)
.+...+++||||+++|+|.+++.. ...++..+..++.||+.||.|||+. + |+||||||+|||++.+
T Consensus 81 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~- 156 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKND- 156 (336)
T ss_dssp TTSCEEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTT-
T ss_pred cCCCceEEEEEecCCCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCC-
Confidence 234578899999999999999976 4558999999999999999999999 8 9999999999999877
Q ss_pred CcEEEeccchhhhhcCC---------CCCccccCCCCcCCcccccc--------CCCChhhHHHHHHHHHHHHhCCCCCC
Q 012320 171 GQVKIGDLGLAAILRGS---------KSAHSVIGTPEFMAPELYEE--------DYNELVDVYSFGMCVLEMFTCEYPYS 233 (466)
Q Consensus 171 g~vKL~DFGla~~~~~~---------~~~~~~~GT~~y~APE~l~~--------~y~~~~DIwSlGvil~elltg~~Pf~ 233 (466)
+.+||+|||++..+... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 89999999999765432 12235579999999998764 36678999999999999999987764
Q ss_pred CCCC-----------------HHHHHHHHhcCCCCCCCCCC------CCHHHHHHHHHhcc-CcCCCCCHHHHh------
Q 012320 234 ECAN-----------------PAQIYKKVTSGKLPGAFYSI------QDLEAQRFIGRCLV-NASKRLSAKELL------ 283 (466)
Q Consensus 234 ~~~~-----------------~~~i~~~i~~g~~p~~~~~~------~~~~~~~lI~~~L~-dp~~Rpsa~elL------ 283 (466)
.... ...+...+........++.. .+.++++||.+||. ||.+|||+.|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp TTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred CccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 3221 22222223322222222221 23479999999996 999999999994
Q ss_pred cCCCCCch
Q 012320 284 LDPFLASD 291 (466)
Q Consensus 284 ~hpf~~~~ 291 (466)
.++|-++.
T Consensus 317 l~~~~~~~ 324 (336)
T 3g2f_A 317 MMIWERNK 324 (336)
T ss_dssp HHCCCC--
T ss_pred HHHHHhcc
Confidence 56776543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=352.87 Aligned_cols=253 Identities=21% Similarity=0.328 Sum_probs=196.9
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
..++|.+ .++||+|+||+||+|.++ +|+.||+|++...... .....+.+|+.+++.++||||+++++++ ....
T Consensus 28 ~~~~y~~-~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~ 100 (326)
T 3uim_A 28 ASDNFSN-KNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ---GGELQFQTEVEMISMAVHRNLLRLRGFC--MTPT 100 (326)
T ss_dssp TTTSSCS-TTEEECCSSSEEEEECCS-SSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCCCCEEE--CCSS
T ss_pred Hhhcccc-ceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc---hHHHHHHHHHHHHHhccCCCccceEEEE--ecCC
Confidence 4678877 577999999999999754 6999999998754321 1223688999999999999999999987 4466
Q ss_pred EEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CCCeEeccCCCCcEEEeCCCCcEEEec
Q 012320 105 TFNFITEMFTSGTLREYRKKYR----RVDIRAIKSWARQILQGLVYLHSR---DPPVIHRDLKCDNIFVNGHLGQVKIGD 177 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~----~l~~~~~~~i~~qIl~gL~yLHs~---~~~IiHrDLKp~NIlv~~~~g~vKL~D 177 (466)
..++||||+.+|+|.+++.... .+++..+..++.||+.||.|||++ + |+||||||+|||++.+ +.+||+|
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~-~~~kl~D 177 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEE-FEAVVGD 177 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTT-CCEEECC
T ss_pred ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCC-CCEEecc
Confidence 7889999999999999998653 399999999999999999999999 8 9999999999999877 8999999
Q ss_pred cchhhhhcCCC--CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCC----CCCHHHHHHHHh---c
Q 012320 178 LGLAAILRGSK--SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSE----CANPAQIYKKVT---S 247 (466)
Q Consensus 178 FGla~~~~~~~--~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~----~~~~~~i~~~i~---~ 247 (466)
||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.. ..........+. .
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 99998664322 233456999999999875 5689999999999999999999999951 011001111111 1
Q ss_pred -CCC--------CCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCC
Q 012320 248 -GKL--------PGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPF 287 (466)
Q Consensus 248 -g~~--------p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf 287 (466)
... +.......+..+.+++.+||. ||.+|||+.|+++|-.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 111 111112223578999999996 9999999999997653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=335.12 Aligned_cols=243 Identities=20% Similarity=0.346 Sum_probs=196.8
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
..++|.+ .+.||+|+||+||+|.++ |..||+|.+... ...+.+.+|+.++++++||||+++++.+.. ...
T Consensus 19 ~~~~y~~-~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~ 88 (278)
T 1byg_A 19 NMKELKL-LQTIGKGEFGDVMLGDYR--GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKG 88 (278)
T ss_dssp CGGGEEE-EEEEEECSSCEEEEEEET--TEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECC-C--
T ss_pred ChhhceE-EeEEecCCCceEEEEEEc--CCEEEEEEecch------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCC
Confidence 3577877 566999999999999774 899999987632 245678999999999999999999997643 345
Q ss_pred EEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRR--VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~--l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
.+++||||+.+++|.+++.+.+. +++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~ 165 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTK 165 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-SCEEECCCCC--
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCC-CcEEEeeccccc
Confidence 68899999999999999987543 899999999999999999999999 9999999999999876 899999999987
Q ss_pred hhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 012320 183 ILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL 260 (466)
Q Consensus 183 ~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~ 260 (466)
..... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.. .+...+...+..+..+ ..+...++
T Consensus 166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 241 (278)
T 1byg_A 166 EASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCPP 241 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCCC-CCCTTCCH
T ss_pred ccccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCcccCCH
Confidence 65432 23446889999999876 569999999999999999998 9999976 4556666777666432 34456788
Q ss_pred HHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 261 EAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 261 ~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.+.++|.+||. ||.+|||+.++++
T Consensus 242 ~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 242 AVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhcCChhhCCCHHHHHH
Confidence 99999999995 9999999999974
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=351.68 Aligned_cols=253 Identities=20% Similarity=0.310 Sum_probs=196.0
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCC---CeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEE
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVL---GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWI 99 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 99 (466)
..+...-+.+.++||+|+||+||+|.+..+ +..||+|.++.. ......+.+.+|+.++++++||||+++++.+.
T Consensus 84 i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 160 (373)
T 3c1x_A 84 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 160 (373)
T ss_dssp CCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC---SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEEC
T ss_pred cChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 344443334578899999999999987543 356889987532 24456788999999999999999999999764
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEecc
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDL 178 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DF 178 (466)
. ..+..++||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+||
T Consensus 161 ~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-~~~kL~DF 236 (373)
T 3c1x_A 161 R-SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEK-FTVKVADF 236 (373)
T ss_dssp C-CSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCC
T ss_pred c-CCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCC-CCEEEeec
Confidence 3 345678999999999999999865 45899999999999999999999999 9999999999999877 89999999
Q ss_pred chhhhhcCCC-----CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCC
Q 012320 179 GLAAILRGSK-----SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLP 251 (466)
Q Consensus 179 Gla~~~~~~~-----~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p 251 (466)
|++..+.... ......||+.|+|||++. ..++.++|||||||++|+|++ |..||.. .+..++...+..+..+
T Consensus 237 G~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~-~~~~~~~~~~~~~~~~ 315 (373)
T 3c1x_A 237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VNTFDITVYLLQGRRL 315 (373)
T ss_dssp ---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCSSCHHHHHHTTCCC
T ss_pred cccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCC-CCHHHHHHHHHcCCCC
Confidence 9997654322 123345788999999876 569999999999999999999 6667755 4445555666666543
Q ss_pred CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 252 GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 252 ~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
. .+...+..+.++|.+||. +|.+|||+.++++
T Consensus 316 ~-~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 316 L-QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp C-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2 344567899999999996 9999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=337.38 Aligned_cols=246 Identities=26% Similarity=0.430 Sum_probs=192.0
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC--CCCceeEEEeEEEeccC
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL--KHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l--~HpnIv~l~~~~~~~~~ 103 (466)
.++|.+ .+.||+|+||+||+|.+. |+.||+|++.... ......|.+++..+ +||||+++++.+.....
T Consensus 36 ~~~y~~-~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 36 AKQIQM-VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-------EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHCEE-EEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccceEE-EeEeecCCCeEEEEEEEC--CceEEEEEEeccc-------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 367877 566999999999999875 9999999986332 23445566666554 99999999998865432
Q ss_pred --CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCeEeccCCCCcEEEeCCCCcE
Q 012320 104 --KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSR--------DPPVIHRDLKCDNIFVNGHLGQV 173 (466)
Q Consensus 104 --~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~--------~~~IiHrDLKp~NIlv~~~~g~v 173 (466)
..+++||||+.+|+|.+++++ ..+++..+..++.||+.||.|||+. + |+||||||+|||++.+ +.+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~~~-~~~ 181 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVKKN-GTC 181 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEECTT-SCE
T ss_pred CCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEECCC-CCE
Confidence 689999999999999999976 5799999999999999999999998 7 9999999999999877 899
Q ss_pred EEeccchhhhhcCCCC-----CccccCCCCcCCccccccC-CCC------hhhHHHHHHHHHHHHhC----------CCC
Q 012320 174 KIGDLGLAAILRGSKS-----AHSVIGTPEFMAPELYEED-YNE------LVDVYSFGMCVLEMFTC----------EYP 231 (466)
Q Consensus 174 KL~DFGla~~~~~~~~-----~~~~~GT~~y~APE~l~~~-y~~------~~DIwSlGvil~elltg----------~~P 231 (466)
||+|||++..+..... ....+||+.|+|||++.+. +.. ++|||||||++|+|++| ..|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 9999999976543221 2356799999999988643 333 39999999999999999 777
Q ss_pred CCCC----CCHHHHHHHHhcCCCCCCCCC-----CCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 232 YSEC----ANPAQIYKKVTSGKLPGAFYS-----IQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 232 f~~~----~~~~~i~~~i~~g~~p~~~~~-----~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
|... .....+...+.........+. ..+.++.++|.+||. ||.+|||+.+++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 7542 223344444443333333322 234578999999996 99999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=366.29 Aligned_cols=247 Identities=18% Similarity=0.318 Sum_probs=202.9
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEc--CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDE--VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
..++.+.+..||+|+||+||+|.++ .++..||+|+++... .....+.+.+|+.+|++++|||||++++++..
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--- 407 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--- 407 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC---SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES---
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---
Confidence 3456665657999999999999875 457789999987542 22345789999999999999999999998742
Q ss_pred CEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 104 KTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
..+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~-~~vkL~DFGla~ 484 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNR-HYAKISDFGLSK 484 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCCSTTT
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCC-CcEEEeeccCcc
Confidence 4589999999999999998754 46999999999999999999999999 9999999999999977 899999999998
Q ss_pred hhcCCCC----CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 012320 183 ILRGSKS----AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 183 ~~~~~~~----~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 256 (466)
.+..... .....+|+.|+|||++. +.|+.++|||||||++|||++ |..||.. .+..++...+..+..+ ..+.
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~-~~~~~~~~~i~~~~~~-~~p~ 562 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK-MKGPEVMAFIEQGKRM-ECPP 562 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCSHHHHHHHHTTCCC-CCCT
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCC-CCCC
Confidence 7643221 12234578999999876 679999999999999999998 9999987 4556677888877643 2345
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHh
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELL 283 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL 283 (466)
..+.++.++|.+||. +|.+||++.+++
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~ 590 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRPDFLTVE 590 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 577899999999996 999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=354.09 Aligned_cols=246 Identities=21% Similarity=0.359 Sum_probs=201.1
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
-+.++|.+ .+.||+|+||+||+|.++. +..||+|.++.... ..+.+.+|+.+|++++||||+++++.+. +
T Consensus 181 i~~~~~~~-~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~- 250 (452)
T 1fmk_A 181 IPRESLRL-EVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVS--E- 250 (452)
T ss_dssp CCGGGEEE-EEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEC--S-
T ss_pred cChhHcee-eeeecCCCCeEEEEEEECC-CceEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEc--C-
Confidence 34567776 5779999999999999875 56799999875431 2357899999999999999999999763 2
Q ss_pred CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 104 KTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
..+++||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DfG~a 327 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLA 327 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCCTT
T ss_pred CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCC-CCEEECCCccc
Confidence 5688999999999999999643 56999999999999999999999999 9999999999999876 79999999999
Q ss_pred hhhcCCC--CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 012320 182 AILRGSK--SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSI 257 (466)
Q Consensus 182 ~~~~~~~--~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 257 (466)
....... ......+|+.|+|||++. +.++.++|||||||++|||++ |..||.+ .+..++...+..+..+ ..+..
T Consensus 328 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~-~~~~~ 405 (452)
T 1fmk_A 328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRM-PCPPE 405 (452)
T ss_dssp C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTT
T ss_pred eecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCC
Confidence 8764322 123345788999999775 669999999999999999999 9999976 5667777888776432 23445
Q ss_pred CCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 258 QDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 258 ~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.+..+.++|.+||. +|.+|||+.+|+.
T Consensus 406 ~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 406 CPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 67899999999996 9999999999975
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=335.65 Aligned_cols=246 Identities=25% Similarity=0.397 Sum_probs=200.0
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHh--CCCCceeEEEeEEEeccC
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLST--LKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~~~~ 103 (466)
.++|.+ .+.||+|+||+||+|.+ +|+.||+|++... ....+.+|+++++. ++||||+++++.+.....
T Consensus 41 ~~~y~~-~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 41 ARTIVL-QESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHCEE-EEEEEEETTEEEEEEEE--TTEEEEEEEECGG-------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred cccEEE-EeeecCCCCcEEEEEEE--cCccEEEEEeCch-------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 357766 67799999999999987 5999999998632 23567889999987 799999999998855332
Q ss_pred --CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCeEeccCCCCcEEEeCCCCcE
Q 012320 104 --KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLH--------SRDPPVIHRDLKCDNIFVNGHLGQV 173 (466)
Q Consensus 104 --~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLH--------s~~~~IiHrDLKp~NIlv~~~~g~v 173 (466)
..+++||||+.+|+|.+++.+ ..+++..+..++.||+.||.||| +.+ |+||||||+|||++.+ +.+
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~-~~~ 186 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKN-GTC 186 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTT-SCE
T ss_pred ccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCC-CCE
Confidence 278999999999999999976 57999999999999999999999 788 9999999999999877 899
Q ss_pred EEeccchhhhhcCCC-----CCccccCCCCcCCccccccC-------CCChhhHHHHHHHHHHHHhC----------CCC
Q 012320 174 KIGDLGLAAILRGSK-----SAHSVIGTPEFMAPELYEED-------YNELVDVYSFGMCVLEMFTC----------EYP 231 (466)
Q Consensus 174 KL~DFGla~~~~~~~-----~~~~~~GT~~y~APE~l~~~-------y~~~~DIwSlGvil~elltg----------~~P 231 (466)
||+|||++....... ......||+.|+|||++.+. ++.++|||||||++|+|++| ..|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999997765433 23456799999999988653 23689999999999999999 789
Q ss_pred CCCC----CCHHHHHHHHhcCCCCCCCCC-----CCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 232 YSEC----ANPAQIYKKVTSGKLPGAFYS-----IQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 232 f~~~----~~~~~i~~~i~~g~~p~~~~~-----~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
|... .....+.+.+.........+. .....+.++|.+||. ||.+|||+.++++|
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 8653 244566666655554433332 122478899999995 99999999999864
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=350.35 Aligned_cols=241 Identities=19% Similarity=0.233 Sum_probs=187.7
Q ss_pred CCCceEEeeeeeeeeCceEEEEE-----EEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC---CCceeEEEe
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKA-----IDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK---HDSIIRFYT 96 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka-----~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~ 96 (466)
..++|.+ .++||+|+||+||+| .+..+++.||+|++.... ...+..|+.+++.++ |+||+++++
T Consensus 63 ~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 63 GSKLVYV-HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-------PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp SSSEEEE-EEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-------HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred CCEEEEE-EEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-------hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 3466666 677999999999999 478889999999986332 245677888888886 999999999
Q ss_pred EEEeccCCEEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC--
Q 012320 97 SWIDVDQKTFNFITEMFTSGTLREYRKK-----YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH-- 169 (466)
Q Consensus 97 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~-----~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~-- 169 (466)
.+. ..+..++||||+.||+|.+++.. .+.+++..+..|+.||+.||.|||+++ |+||||||+|||++..
T Consensus 135 ~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 135 AHL--FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp EEE--CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGT
T ss_pred eee--cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEeccccc
Confidence 874 46678999999999999999974 456999999999999999999999999 9999999999999871
Q ss_pred --------CCcEEEeccchhhhhc---CCCCCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q 012320 170 --------LGQVKIGDLGLAAILR---GSKSAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECAN 237 (466)
Q Consensus 170 --------~g~vKL~DFGla~~~~---~~~~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~ 237 (466)
.+.+||+|||++..+. ........+||+.|+|||++.+ .|+.++|||||||++|+|+||..||.....
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 3899999999996543 2333456789999999998764 589999999999999999999999954222
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 238 PAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 238 ~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
... .....++. ...+..+.+++..||. +|.+|++..+.+.
T Consensus 291 ~~~----~~~~~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 291 GEC----KPEGLFRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp TEE----EECSCCTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred Cce----eechhccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 100 00111111 1235678999999996 8888865544443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=341.94 Aligned_cols=247 Identities=23% Similarity=0.393 Sum_probs=204.0
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
+.++|.+ .++||+|+||+||+|.+.. .+|+|.+..... .....+.+.+|+.++++++||||+++++.+. +..
T Consensus 31 ~~~~~~~-~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~ 102 (319)
T 2y4i_B 31 PFEQLEI-GELIGKGRFGQVYHGRWHG---EVAIRLIDIERD--NEDQLKAFKREVMAYRQTRHENVVLFMGACM--SPP 102 (319)
T ss_dssp CCSCEEC-CCBCCCSSSSEEEEEEESS---SEEEEECCCCSC--CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE--CSS
T ss_pred CHHHeEE-eeEeccCCceEEEEEEEcC---eEEEEEeecCCC--CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe--cCC
Confidence 4578877 6779999999999998864 499998875432 2223356778999999999999999999874 456
Q ss_pred EEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
.+++||||+.|++|.+++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+|||++ + |.+||+|||++..
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~-~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-N-GKVVITDFGLFSI 178 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC----CCEECCCSCCC-
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-C-CCEEEeecCCccc
Confidence 7999999999999999997754 6999999999999999999999999 99999999999997 3 7999999999765
Q ss_pred hcC------CCCCccccCCCCcCCcccccc----------CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Q 012320 184 LRG------SKSAHSVIGTPEFMAPELYEE----------DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS 247 (466)
Q Consensus 184 ~~~------~~~~~~~~GT~~y~APE~l~~----------~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~ 247 (466)
... ........||+.|+|||++.. .++.++|||||||++|+|++|..||.. .+...+...+..
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~~~~~ 257 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGT 257 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS-CCHHHHHHHHHT
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhcc
Confidence 421 122334569999999998753 478899999999999999999999976 667777777877
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 248 GKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 248 g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+..+.......+.++.++|.+||. +|.+|||+.++++
T Consensus 258 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 258 GMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp TCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 776655555567789999999996 9999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=375.82 Aligned_cols=264 Identities=27% Similarity=0.372 Sum_probs=208.7
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe---
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID--- 100 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--- 100 (466)
...++|.+ .+.||+|+||+||+|.++.+|..||+|++... ......+.+.+|+.+|++++||||+++++.+..
T Consensus 11 ~~~grY~i-~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~---~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 11 QTCGPWEM-KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE---LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK 86 (676)
T ss_dssp ------CC-CCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC---CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred CCCCCeEE-EEEEeeCCCeEEEEEEECCCCcEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence 34588987 56699999999999999999999999987643 245667889999999999999999999987632
Q ss_pred -ccCCEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCC--cEE
Q 012320 101 -VDQKTFNFITEMFTSGTLREYRKKYR---RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLG--QVK 174 (466)
Q Consensus 101 -~~~~~~~lV~E~~~ggsL~~~l~~~~---~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g--~vK 174 (466)
......++||||+.||+|.+++.+.. .+++..++.++.||+.||.|||+.| |+||||||+||+++.+.+ .+|
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vK 164 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHK 164 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEE
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEE
Confidence 12567889999999999999998754 5999999999999999999999999 999999999999986521 489
Q ss_pred EeccchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------
Q 012320 175 IGDLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKV-------- 245 (466)
Q Consensus 175 L~DFGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i-------- 245 (466)
|+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.....+.+....+
T Consensus 165 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 165 IIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244 (676)
T ss_dssp ECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred EcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence 99999998876666566778999999999876 569999999999999999999999997643333221111
Q ss_pred -----hcCCC--------CCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 246 -----TSGKL--------PGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 246 -----~~g~~--------p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
..+.. |.......+..+.+||.+||. ||.+|||+.++++||||+....
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~ 306 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence 01111 111223346789999999996 9999999999999999976443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=349.87 Aligned_cols=251 Identities=19% Similarity=0.193 Sum_probs=194.3
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEeccccc----CCHHHHHHHHHHHHHHHhCC---------CCc
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELM----RSPDDLQRLYSEVHLLSTLK---------HDS 90 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~----~~~~~~~~~~~Ei~iL~~l~---------Hpn 90 (466)
-+.++|.+ .+.||+|+||+||+|.+ +|+.||+|++...... ......+.+.+|+.+|+.++ |||
T Consensus 17 ~~~~~y~~-~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n 93 (336)
T 2vuw_A 17 LPTEKLQR-CEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG 93 (336)
T ss_dssp SCHHHHHT-CEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred cccccchh-eeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence 34578877 46699999999999988 6899999999866431 12223467889999998885 777
Q ss_pred eeEEEeEEEec----------------------------cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHH
Q 012320 91 IIRFYTSWIDV----------------------------DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQ 142 (466)
Q Consensus 91 Iv~l~~~~~~~----------------------------~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~ 142 (466)
||++.+.+... +...+|+||||+.+|++.+.+.+ +.+++..++.+++||+.
T Consensus 94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTA 172 (336)
T ss_dssp BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHH
T ss_pred hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHH
Confidence 77777765421 26789999999999976666644 67899999999999999
Q ss_pred HHHHHH-hCCCCeEeccCCCCcEEEeCCCC--------------------cEEEeccchhhhhcCCCCCccccCCCCcCC
Q 012320 143 GLVYLH-SRDPPVIHRDLKCDNIFVNGHLG--------------------QVKIGDLGLAAILRGSKSAHSVIGTPEFMA 201 (466)
Q Consensus 143 gL~yLH-s~~~~IiHrDLKp~NIlv~~~~g--------------------~vKL~DFGla~~~~~~~~~~~~~GT~~y~A 201 (466)
||.||| +++ |+||||||+|||++.+ | .+||+|||+|+..... ..+||+.|+|
T Consensus 173 aL~~lH~~~~--ivHrDlKp~NILl~~~-~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~a 245 (336)
T 2vuw_A 173 SLAVAEASLR--FEHRDLHWGNVLLKKT-SLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHHHC--CBCSCCCGGGEEEEEC-SCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTC
T ss_pred HHHHHHHhCC--EeECCCCHHHEEEecc-CCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccC
Confidence 999999 899 9999999999999876 5 8999999999876532 4589999999
Q ss_pred ccccccCCCChhhHHHHHHH-HHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCC----CCCCCCCHHHHHHHHHhccCcCC
Q 012320 202 PELYEEDYNELVDVYSFGMC-VLEMFTCEYPYSECANPAQIYKKVTSG-KLPG----AFYSIQDLEAQRFIGRCLVNASK 275 (466)
Q Consensus 202 PE~l~~~y~~~~DIwSlGvi-l~elltg~~Pf~~~~~~~~i~~~i~~g-~~p~----~~~~~~~~~~~~lI~~~L~dp~~ 275 (466)
||++.+..+.++||||+|++ .+++++|..||........+...+... ..+. ..+...++++++||.+||.-
T Consensus 246 PE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~--- 322 (336)
T 2vuw_A 246 EDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNF--- 322 (336)
T ss_dssp SGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGS---
T ss_pred hhhhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhcc---
Confidence 99998777899999998776 777888999984311112233333321 2211 11233567899999999962
Q ss_pred CCCHHHHh-cCCCCC
Q 012320 276 RLSAKELL-LDPFLA 289 (466)
Q Consensus 276 Rpsa~elL-~hpf~~ 289 (466)
.||.|+| +||||+
T Consensus 323 -dsa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 323 -SSATDLLCQHSLFK 336 (336)
T ss_dssp -SSHHHHHHHCGGGC
T ss_pred -CCHHHHHhcCCCcC
Confidence 2999999 999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=355.54 Aligned_cols=245 Identities=21% Similarity=0.366 Sum_probs=204.7
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
+.++|.+ .+.||+|+||+||+|.++. +..||+|+++.... ..+.+.+|+.+|++++||||+++++.+. + .
T Consensus 265 ~~~~~~~-~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~--~-~ 334 (535)
T 2h8h_A 265 PRESLRL-EVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVS--E-E 334 (535)
T ss_dssp CGGGEEE-EEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEC--S-S
T ss_pred chhhhhh-heecccCCCeEEEEEEECC-CceEEEEEeCCCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEe--e-c
Confidence 4567766 6779999999999999875 56799999875432 2357899999999999999999999763 2 5
Q ss_pred EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 105 TFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
.+++||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~ 411 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLAR 411 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCTTSTT
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCC-CcEEEcccccce
Confidence 688999999999999999743 56999999999999999999999999 9999999999999876 799999999997
Q ss_pred hhcCCC--CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 012320 183 ILRGSK--SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258 (466)
Q Consensus 183 ~~~~~~--~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 258 (466)
.+.... ......+|+.|+|||++. ..|+.++|||||||++|||++ |..||.+ .+..++...+..+... ..+...
T Consensus 412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~-~~~~~~ 489 (535)
T 2h8h_A 412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRM-PCPPEC 489 (535)
T ss_dssp TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTC
T ss_pred ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCC
Confidence 654321 122345678999999775 669999999999999999999 8999977 5667777888776432 234456
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+..+.+||.+||. ||.+|||+.+|+.
T Consensus 490 ~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 490 PESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7899999999996 9999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=347.33 Aligned_cols=261 Identities=18% Similarity=0.267 Sum_probs=206.0
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
-.++|.+ .++||+|+||+||+|.+..+|+.||+|++...... ..+.+|+.+++.++|++++..+..+ .....
T Consensus 5 i~~~y~i-~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~il~~L~~~~~i~~i~~~-~~~~~ 76 (483)
T 3sv0_A 5 VGNKFRL-GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------PQLLYESKIYRILQGGTGIPNVRWF-GVEGD 76 (483)
T ss_dssp ETTTEEC-CCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS------CCHHHHHHHHHHTTTSTTCCCEEEE-EEETT
T ss_pred cCCcEEE-EEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc------HHHHHHHHHHHHhcCCCCCCeEEEE-EeeCC
Confidence 3578877 56699999999999999999999999987754421 2477899999999875444433333 24577
Q ss_pred EEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEe--CCCCcEEEeccchh
Q 012320 105 TFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVN--GHLGQVKIGDLGLA 181 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~--~~~g~vKL~DFGla 181 (466)
..++||||+ +++|.+++.. .+.+++..+..|+.||+.||.|||+++ |+||||||+|||++ ...+.+||+|||++
T Consensus 77 ~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 889999999 9999999986 467999999999999999999999999 99999999999994 23379999999999
Q ss_pred hhhcCCCC--------CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCCC
Q 012320 182 AILRGSKS--------AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECA--NPAQIYKKVTSGKL 250 (466)
Q Consensus 182 ~~~~~~~~--------~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~--~~~~i~~~i~~g~~ 250 (466)
+.+..... ....+||+.|+|||++. ..++.++|||||||++|+|++|..||.... ...+.+..+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (483)
T 3sv0_A 154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (483)
T ss_dssp EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence 87654322 22668999999999776 469999999999999999999999997643 34444444443322
Q ss_pred CC---CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHh----------cCCCCCchhhhhc
Q 012320 251 PG---AFYSIQDLEAQRFIGRCLV-NASKRLSAKELL----------LDPFLASDEVKLL 296 (466)
Q Consensus 251 p~---~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL----------~hpf~~~~~~~~~ 296 (466)
.. ......+.++.+||.+||. +|.+||++.+|+ .++|+...+|...
T Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~ 293 (483)
T 3sv0_A 234 ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTIL 293 (483)
T ss_dssp HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHH
T ss_pred cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhh
Confidence 11 1123456799999999996 999999999875 4777777777543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=356.98 Aligned_cols=247 Identities=22% Similarity=0.377 Sum_probs=204.1
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcC---CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEV---LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
.++|.+ .+.||+|+||+||+|.+.. .+..||+|.+... ......+.+.+|+.+|++++||||+++++.+ .
T Consensus 389 ~~~y~i-~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~--~- 461 (656)
T 2j0j_A 389 RERIEL-GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVI--T- 461 (656)
T ss_dssp GGGEEE-EEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST---TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--C-
T ss_pred cccEEE-eeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE--e-
Confidence 356766 6779999999999999865 3577999987532 2445667899999999999999999999976 2
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
.+.+++||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~-~~vkL~DFG~a 538 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-DCVKLGDFGLS 538 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCCCCC
T ss_pred cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCC-CCEEEEecCCC
Confidence 345889999999999999998654 6999999999999999999999999 9999999999999977 89999999999
Q ss_pred hhhcCCCC--CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 012320 182 AILRGSKS--AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSI 257 (466)
Q Consensus 182 ~~~~~~~~--~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 257 (466)
........ .....||+.|+|||++. ..|+.++|||||||++|||++ |..||.+ .+..++...+..+..+. .+..
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~ 616 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERLP-MPPN 616 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHHTCCCC-CCTT
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCCCCC-CCcc
Confidence 87644322 22345788999999876 569999999999999999997 8999976 56677777777765433 3455
Q ss_pred CCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 258 QDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 258 ~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.+..+.++|.+||. ||.+|||+.+++.
T Consensus 617 ~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 617 CPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 67899999999996 9999999999974
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=347.42 Aligned_cols=252 Identities=16% Similarity=0.163 Sum_probs=189.0
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCC-Ccee-------------
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH-DSII------------- 92 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv------------- 92 (466)
.|...++++||+|+||+||+|.+..+|+.||+|++..... ......+.+.+|+.+++.++| +|+.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC-ccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3434557889999999999999999999999998874432 222335778999999999977 2211
Q ss_pred --------EEEeEEEecc---CCEEEEEEecCCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCe
Q 012320 93 --------RFYTSWIDVD---QKTFNFITEMFTSGTLREYRKK-------YRRVDIRAIKSWARQILQGLVYLHSRDPPV 154 (466)
Q Consensus 93 --------~l~~~~~~~~---~~~~~lV~E~~~ggsL~~~l~~-------~~~l~~~~~~~i~~qIl~gL~yLHs~~~~I 154 (466)
.+...+.... ...++++|+++ +++|.++++. .+.+++..+..++.||+.||.|||+++ |
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i 232 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--L 232 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--c
Confidence 1111111111 22356667765 7899998852 234778889999999999999999999 9
Q ss_pred EeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCCccccCCCCcCCcccc----------c-cCCCChhhHHHHHHHHH
Q 012320 155 IHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELY----------E-EDYNELVDVYSFGMCVL 223 (466)
Q Consensus 155 iHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l----------~-~~y~~~~DIwSlGvil~ 223 (466)
+||||||+|||++.+ |.+||+|||+++..... ....+| +.|+|||++ . ..|+.++|||||||++|
T Consensus 233 iHrDiKp~NILl~~~-~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp ECSCCCGGGEEECTT-CCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecC-CeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 999999999999987 89999999998764332 455678 999999987 3 23788999999999999
Q ss_pred HHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 224 EMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 224 elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
+|++|..||.. .+.......+..+ ....+.++++||.+||. ||.+|||+.++++||||+....
T Consensus 309 elltg~~Pf~~-~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~ 372 (413)
T 3dzo_A 309 WIWCADLPNTD-DAALGGSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 372 (413)
T ss_dssp HHHHSSCCCCT-TGGGSCSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred HHHHCCCCCCC-cchhhhHHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHH
Confidence 99999999976 3332333333221 12356899999999996 9999999999999999976543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=361.21 Aligned_cols=241 Identities=20% Similarity=0.300 Sum_probs=197.6
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcC-CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC-
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEV-LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ- 103 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~- 103 (466)
.++|.+ .++||+|+||+||+|.++. +|+.||+|++... ........+.+|+.+|++++||||+++++++...+.
T Consensus 79 ~~~y~i-~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 79 AGQYEV-KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS---GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp TTTEEE-EEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS---CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CCceEE-EEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc---CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 378988 5669999999999999976 7999999987643 244566788999999999999999999998865432
Q ss_pred --CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 104 --KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 104 --~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
..+|+||||+.|++|.+++.. .+++..+..|+.||+.||.|||++| |+||||||+|||++. +.+||+|||++
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~--~~~kl~DFG~a 228 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTE--EQLKLIDLGAV 228 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECS--SCEEECCCTTC
T ss_pred CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeC--CcEEEEecccc
Confidence 127999999999999988765 8999999999999999999999999 999999999999986 48999999999
Q ss_pred hhhcCCCCCccccCCCCcCCccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC-CCCCCCH
Q 012320 182 AILRGSKSAHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA-FYSIQDL 260 (466)
Q Consensus 182 ~~~~~~~~~~~~~GT~~y~APE~l~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~-~~~~~~~ 260 (466)
+..... ...+||+.|+|||++.+.++.++|||||||++|+|++|..||..... ..++.. .....+.
T Consensus 229 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~----------~~~~~~~~~~~~~~ 295 (681)
T 2pzi_A 229 SRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYV----------DGLPEDDPVLKTYD 295 (681)
T ss_dssp EETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEEC----------SSCCTTCHHHHHCH
T ss_pred hhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccc----------ccccccccccccCH
Confidence 876443 45679999999999887789999999999999999999988854110 011111 1112346
Q ss_pred HHHHHHHHhcc-CcCCCCCHHHHhcCCCCC
Q 012320 261 EAQRFIGRCLV-NASKRLSAKELLLDPFLA 289 (466)
Q Consensus 261 ~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~ 289 (466)
.+.++|.+||. ||.+||++.+.+.|+|+.
T Consensus 296 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 296 SYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 78999999996 999999999999998874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=318.56 Aligned_cols=224 Identities=19% Similarity=0.171 Sum_probs=181.9
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.+||.+. +.||+|+||+||+|.+..+|+.||+|++..... ......+.+.+|+.++++++||||+++++++. +.+.
T Consensus 30 ~~~y~i~-~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~--~~~~ 105 (286)
T 3uqc_A 30 NGRYRLL-IFHGGVPPLQFWQALDTALDRQVALTFVDPQGV-LPDDVLQETLSRTLRLSRIDKPGVARVLDVVH--TRAG 105 (286)
T ss_dssp TTTEEEE-EEEEBSTTCEEEEEEETTTTEEEEEEESCTTCC-SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--ETTE
T ss_pred cCcEEEE-EEEcccCCeEEEEEEecCCCceEEEEEECcccc-cCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE--ECCc
Confidence 4889885 679999999999999999999999999875442 34556688999999999999999999999874 4678
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+|+||||+.|++|.+++++ + .....+..|+.||+.||.|||++| |+||||||+|||++.+ |.+||+++
T Consensus 106 ~~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~-g~~kl~~~------- 173 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSID-GDVVLAYP------- 173 (286)
T ss_dssp EEEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETT-SCEEECSC-------
T ss_pred EEEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCC-CCEEEEec-------
Confidence 9999999999999999854 3 466678889999999999999999 9999999999999977 89999843
Q ss_pred CCCCCccccCCCCcCCccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--HHhcCCCCC--CCCCCCCHH
Q 012320 186 GSKSAHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYK--KVTSGKLPG--AFYSIQDLE 261 (466)
Q Consensus 186 ~~~~~~~~~GT~~y~APE~l~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~--~i~~g~~p~--~~~~~~~~~ 261 (466)
.|++| ++.++|||||||++|+|++|..||.+......+.. +...+..+. ......+.+
T Consensus 174 ------------~~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T 3uqc_A 174 ------------ATMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ 235 (286)
T ss_dssp ------------CCCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHH
T ss_pred ------------cccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHH
Confidence 34443 78999999999999999999999976433211100 011121111 122446788
Q ss_pred HHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 262 AQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 262 ~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
++++|.+||. ||.+| |+.|+++
T Consensus 236 l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 236 ISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp HHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred HHHHHHHHcccCCccC-CHHHHHH
Confidence 9999999996 99999 9999985
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=308.21 Aligned_cols=230 Identities=11% Similarity=0.029 Sum_probs=155.7
Q ss_pred eeeeeCceEEEEEEEcCCCeEEEEEEEecccccC------CHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccCCEEE
Q 012320 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMR------SPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 35 ~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~------~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~~~ 107 (466)
-++.|+.|.+..++...+|+.+|+|.+.+..... +....+.+.+|+++|+++ .|+||+++++++ ++++.+|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~--ed~~~~y 318 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG--ENAQSGW 318 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE--ECSSEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE--EECCEEE
Confidence 3678899999999999999999999998653221 223456799999999999 799999999988 5678999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~ 187 (466)
|||||++|++|.+++.+.+++++. .|++||+.||.|||++| ||||||||+|||++.+ |.+||+|||+|+.....
T Consensus 319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~d-g~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDAR-QHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTT-SCEEECCCTTEESCC--
T ss_pred EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCC-CCEEEeecccCeeCCCC
Confidence 999999999999999999999875 47899999999999999 9999999999999877 89999999999876533
Q ss_pred -CCCccccCCCCcCCccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 012320 188 -KSAHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFI 266 (466)
Q Consensus 188 -~~~~~~~GT~~y~APE~l~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI 266 (466)
....+.+||+.|||||++.+.+...+|+||+|+++++|.++..|+ ...+.. . +... ..+..+.
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~---------~~~l~~-~-~~~~-----~~~~~l~ 456 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW---------LYAVWQ-E-PVER-----WNFVLLL 456 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH---------HHHHHT-S-CGGG-----CSHHHHH
T ss_pred CccccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh---------HHHhhc-C-CCCC-----CcHHHHH
Confidence 345678999999999999998999999999999988776554332 111111 1 1111 1234455
Q ss_pred HHhcc-CcCCCCCHHHHhcCCCC
Q 012320 267 GRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 267 ~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
..++. +|..|+.......++|.
T Consensus 457 ~~l~~~~~~~~~~~~~~~~~~~~ 479 (569)
T 4azs_A 457 ALFEKKAKLPSAEQQRGATEQWI 479 (569)
T ss_dssp HHHHTGGGSCCGGGSSCCHHHHH
T ss_pred HHHhCCCCCCCCChhhhccchhH
Confidence 55553 66667766655555554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-29 Score=268.19 Aligned_cols=193 Identities=20% Similarity=0.209 Sum_probs=143.5
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCC----HHHHHHHHHHHHHHHhCCCCceeEEEeEEE
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRS----PDDLQRLYSEVHLLSTLKHDSIIRFYTSWI 99 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 99 (466)
.+..++.+-.++||+|+||+||+| +..+..+|+|+...+..... ....+++.+|+++|++++||||+++..++.
T Consensus 332 ~~~~~~~~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 409 (540)
T 3en9_A 332 IKGKKRKIPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV 409 (540)
T ss_dssp ----------------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE
T ss_pred ccccccCCCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE
Confidence 334445455778999999999999 55688999998765443211 112456899999999999999994333333
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
. ....|+||||++|++|.+++.+ +..++.||+.||.|||+++ |+||||||+|||++. .+||+|||
T Consensus 410 ~--~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~---~~kL~DFG 474 (540)
T 3en9_A 410 D--LDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK---DLYIIDFG 474 (540)
T ss_dssp E--TTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS---SEEECCCT
T ss_pred e--CCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC---eEEEEECc
Confidence 3 4446899999999999999875 6689999999999999999 999999999999986 89999999
Q ss_pred hhhhhcCCCC--------CccccCCCCcCCccccc---cCCCChhhHHHHHHHHHHHHhCCCCCC
Q 012320 180 LAAILRGSKS--------AHSVIGTPEFMAPELYE---EDYNELVDVYSFGMCVLEMFTCEYPYS 233 (466)
Q Consensus 180 la~~~~~~~~--------~~~~~GT~~y~APE~l~---~~y~~~~DIwSlGvil~elltg~~Pf~ 233 (466)
+++....... ..+.+||+.|||||++. ..|+..+|+||..+-..+.+.++.+|.
T Consensus 475 la~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 475 LGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp TCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 9987654321 23678999999999887 458889999999998888887777764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.4e-25 Score=216.41 Aligned_cols=145 Identities=15% Similarity=0.156 Sum_probs=113.9
Q ss_pred eeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccC-----CH---------HHHHHHHHHHHHHHhCCCCceeEEEeE
Q 012320 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMR-----SP---------DDLQRLYSEVHLLSTLKHDSIIRFYTS 97 (466)
Q Consensus 32 ~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~-----~~---------~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 97 (466)
+.+.||+|+||.||+|.+ .+|+.||+|.++...... .. .....+.+|+.+|++++| +++++.
T Consensus 94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~ 169 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKV 169 (282)
T ss_dssp EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCE
T ss_pred ecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeE
Confidence 458899999999999999 889999999986433110 00 135678999999999984 444443
Q ss_pred EEeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEec
Q 012320 98 WIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGD 177 (466)
Q Consensus 98 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~D 177 (466)
+ +. +..++||||++|++|.+ +. ......++.||+.||.|||++| |+||||||+|||++ + |.+||+|
T Consensus 170 ~-~~--~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~-~~vkl~D 235 (282)
T 1zar_A 170 Y-AW--EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-E-EGIWIID 235 (282)
T ss_dssp E-EE--ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-T-TEEEECC
T ss_pred E-ec--cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-C-CcEEEEE
Confidence 3 22 34589999999999987 31 2345579999999999999999 99999999999999 5 8999999
Q ss_pred cchhhhhcCCCCCccccCCCCcCCccccc
Q 012320 178 LGLAAILRGSKSAHSVIGTPEFMAPELYE 206 (466)
Q Consensus 178 FGla~~~~~~~~~~~~~GT~~y~APE~l~ 206 (466)
||++.. +..++|||++.
T Consensus 236 FG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp CTTCEE------------TTSTTHHHHHH
T ss_pred CCCCeE------------CCCCCHHHHHH
Confidence 999853 45678999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=7.8e-21 Score=183.54 Aligned_cols=144 Identities=19% Similarity=0.190 Sum_probs=108.8
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeE--EEEEEEecccccCC--------------------HHHHHHHHHHHHHHH
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVE--VAWNQVRLNELMRS--------------------PDDLQRLYSEVHLLS 84 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~--vAiK~i~~~~~~~~--------------------~~~~~~~~~Ei~iL~ 84 (466)
+.++.+.+.||+|+||+||+|.+..+|+. ||+|+++....... ......+.+|+.+|+
T Consensus 46 ~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 125 (258)
T 1zth_A 46 GYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE 125 (258)
T ss_dssp TSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred CCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence 34445578899999999999999888999 99998764321100 012246889999999
Q ss_pred hCCCCce--eEEEeEEEeccCCEEEEEEecCCC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCCeEe
Q 012320 85 TLKHDSI--IRFYTSWIDVDQKTFNFITEMFTS-G----TLREYRKKYRRVDIRAIKSWARQILQGLVYLH-SRDPPVIH 156 (466)
Q Consensus 85 ~l~HpnI--v~l~~~~~~~~~~~~~lV~E~~~g-g----sL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLH-s~~~~IiH 156 (466)
.+.|++| ...+.. ...++||||+.+ | +|.++... .++..+..++.||+.||.||| +.| |+|
T Consensus 126 ~l~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g--ivH 194 (258)
T 1zth_A 126 RAKEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE--LVH 194 (258)
T ss_dssp HHHHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC--EEC
T ss_pred HHHhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC--EEe
Confidence 9988764 334331 135799999942 3 77776432 235577889999999999999 999 999
Q ss_pred ccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 157 RDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 157 rDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS---SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC---cEEEEECcccccC
Confidence 999999999986 8999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=1.2e-17 Score=169.53 Aligned_cols=138 Identities=16% Similarity=0.215 Sum_probs=98.2
Q ss_pred eEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEeccccc-----------C--CHHH---H--HHHHHHHHHHHhCCCCc
Q 012320 29 YGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELM-----------R--SPDD---L--QRLYSEVHLLSTLKHDS 90 (466)
Q Consensus 29 Y~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~-----------~--~~~~---~--~~~~~Ei~iL~~l~Hpn 90 (466)
|.+ ...||.|++|.||+|.+. +|+.||+|+++..... . .... . -...+|...|.++.+.+
T Consensus 97 Y~I-~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 97 YSV-GSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SEE-EEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEe-cCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 444 677999999999999985 6999999987643211 0 0000 0 11245777787775444
Q ss_pred ee--EEEeEEEeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeC
Q 012320 91 II--RFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNG 168 (466)
Q Consensus 91 Iv--~l~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~ 168 (466)
+. ..+. ... .++||||+.|++|..+. ....+..++.||+.+|.|||+.| ||||||||.|||++.
T Consensus 175 v~vp~p~~----~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 175 FPVPEPIA----QSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHG--LIHGDFNEFNILIRE 240 (397)
T ss_dssp CSCCCEEE----EET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEE
T ss_pred CCCCeeee----ccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeC
Confidence 32 2222 112 26999999999886532 22345678899999999999999 999999999999986
Q ss_pred CCC----------cEEEeccchhhh
Q 012320 169 HLG----------QVKIGDLGLAAI 183 (466)
Q Consensus 169 ~~g----------~vKL~DFGla~~ 183 (466)
+ | .+.|+||+.+..
T Consensus 241 d-gd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 E-KDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp E-ECSSCTTSEEEEEEECCCTTCEE
T ss_pred C-CCcccccccccceEEEEeCCccc
Confidence 5 4 389999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=3.1e-11 Score=115.55 Aligned_cols=140 Identities=16% Similarity=0.077 Sum_probs=103.5
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEeEEEeccCCEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~~ 106 (466)
.|.. ...+|.|+.+.||++... |..+++|....... . ....+.+|+.+|+.+. +..+.+++... .+.+..
T Consensus 15 ~~~~-~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~-~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~--~~~~~~ 85 (263)
T 3tm0_A 15 KYRC-VKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK-G---TTYDVEREKDMMLWLEGKLPVPKVLHFE--RHDGWS 85 (263)
T ss_dssp TSEE-EECCSCCSSSEEEEEECS--SCEEEEEEECGGGT-T---STTCHHHHHHHHHHHTTTSCCCCEEEEE--EETTEE
T ss_pred ccee-EeeccCCCCCeEEEEECC--CCcEEEEeCCcccC-C---CHHHHHHHHHHHHHHhcCCCCCeEEEEE--ecCCce
Confidence 3544 456888899999999643 68899998764321 1 1235788999999884 66777888765 346788
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRD----------------------------------- 151 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~----------------------------------- 151 (466)
|+|||+++|.+|.+... +......++.++..+|..||+..
T Consensus 86 ~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999999987521 22334567899999999999811
Q ss_pred ----------------------CCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 152 ----------------------PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 152 ----------------------~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
+.++|+|++|.||+++.. +.+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT-EEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC-cEEEEEEchhcc
Confidence 238999999999999754 456799998763
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=98.74 E-value=4.8e-12 Score=100.00 Aligned_cols=64 Identities=33% Similarity=0.438 Sum_probs=58.7
Q ss_pred CCceEEEEEeeCCC---CCCc---ceeecCcCCCCChhHHHHHHHHcccCCCCCHHHHHHHHHHHHHHhC
Q 012320 336 DDTIFLKVQIADKD---GPGR---NIYFPFDILNDTPLDVAREMVKELEITDWEPFEIAKMIDEEISVLV 399 (466)
Q Consensus 336 ~~~i~l~~~~~d~~---~~~r---~i~f~f~~~~dt~~~va~Emv~~~~~~~~d~~~ia~~i~~~~~~~~ 399 (466)
...++|+||+.|.. |..| +|.|+||+++|||.+||+|||+++++.++|...||++|+..|..+-
T Consensus 23 ~~~i~L~LRi~Dpkk~~gk~KeNeaIeF~Fdle~Dta~eVA~EMVe~~~l~e~D~~~VaklI~~~v~~~~ 92 (98)
T 2lru_A 23 KIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESGYVCEGDHKTMAKAIKDRVSLIK 92 (98)
Confidence 35799999999984 6677 9999999999999999999999999999999999999999987764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.00 E-value=9.6e-10 Score=104.21 Aligned_cols=131 Identities=15% Similarity=0.011 Sum_probs=91.8
Q ss_pred eeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCc--eeEEEeEEEeccCCEEEEEE
Q 012320 33 EEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDS--IIRFYTSWIDVDQKTFNFIT 110 (466)
Q Consensus 33 ~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~~~~~~~~~~lV~ 110 (466)
..+.+.|..+.||++.. .+|..+++|..... ....+.+|+.+++.+.+.+ +.+++... .+.+..++||
T Consensus 25 ~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~--~~~~~~~~v~ 94 (264)
T 1nd4_A 25 AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-------ALNELQDEAARLSWLATTGVPCAAVLDVV--TEAGRDWLLL 94 (264)
T ss_dssp EECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-------TTSCHHHHHHHHHHHHTTTCCBCCEEEEE--ECSSCEEEEE
T ss_pred EecccCCCCceEEEEec-CCCCeEEEEeCCcc-------cchhhhHHHHHHHHHHhCCCCCCeEEEec--cCCCCCEEEE
Confidence 34334566799999954 46788999986532 1135678999999885434 45577654 3455688999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 012320 111 EMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRD--------------------------------------- 151 (466)
Q Consensus 111 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~--------------------------------------- 151 (466)
|+++|.+|. . ...+. ..++.++...|..||+..
T Consensus 95 e~i~G~~l~--~---~~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 95 GEVPGQDLL--S---SHLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp ECCSSEETT--T---SCCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred EecCCcccC--c---CcCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 999998884 1 12222 355777888888888653
Q ss_pred -----------------CCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 152 -----------------PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 152 -----------------~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
+.++|+|++|.||+++.+ +.+.|+|||.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~liD~~~a~ 213 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT-EEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC-cEEEEEcchhcc
Confidence 119999999999999865 456799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.97 E-value=1e-09 Score=110.16 Aligned_cols=143 Identities=13% Similarity=0.207 Sum_probs=100.9
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEe--cccccCCHHHHHHHHHHHHHHHhCC--CCceeEEEeEEEecc-CCEEEE
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVR--LNELMRSPDDLQRLYSEVHLLSTLK--HDSIIRFYTSWIDVD-QKTFNF 108 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~--~~~~~~~~~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~~~-~~~~~l 108 (466)
+.|+.|.++.||++... +..+++|+.. ..... .....+.+|+.+|+.|. +..+.+++..+.+.+ .+..|+
T Consensus 44 ~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~---~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL---PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EECCC-CCSCEEEEECS--SCEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred EEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC---CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 44899999999998754 4678888654 22211 12346788999999986 455777777542221 145789
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 012320 109 ITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSR-------------------------------------- 150 (466)
Q Consensus 109 V~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~-------------------------------------- 150 (466)
|||+++|..+.+. ....++......++.++...|..||+.
T Consensus 119 vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 119 IMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9999999887531 124577888889999999999999973
Q ss_pred ------------------CCCeEeccCCCCcEEEeCCCC-cEEEeccchhhh
Q 012320 151 ------------------DPPVIHRDLKCDNIFVNGHLG-QVKIGDLGLAAI 183 (466)
Q Consensus 151 ------------------~~~IiHrDLKp~NIlv~~~~g-~vKL~DFGla~~ 183 (466)
.+.++|+|++|.||+++.+.+ .+.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 134999999999999986632 369999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.94 E-value=1.5e-09 Score=106.48 Aligned_cols=181 Identities=18% Similarity=0.171 Sum_probs=120.3
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCc--eeEEEeEEEeccC---CEEE
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDS--IIRFYTSWIDVDQ---KTFN 107 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~Hpn--Iv~l~~~~~~~~~---~~~~ 107 (466)
+.++.|.+..||++. ..+++|.-. .......+.+|+.+|+.+ .+.. +.+.+... ... ..-|
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~------~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~--~~~~~~~~~~ 92 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPK------HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTG--MPSETYQMSF 92 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEES------SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEEC--CCCSSCSCSC
T ss_pred EecCCCCcceEEEEC-----CEEEEEecC------CcchHHHHHHHHHHHHHHHhcCCCCCCceEeec--CCCCCCCcce
Confidence 348999999999972 457888643 223457789999999887 3333 23343321 222 2347
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRD------------------------------------ 151 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~------------------------------------ 151 (466)
+||++++|.+|.+... ..++......++.|+...|..||+..
T Consensus 93 ~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 93 AGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp EEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred EEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 8999999998865432 35778888888889988888888621
Q ss_pred --------------------CCeEeccCCCCcEEEeCC-CCcEEEeccchhhhhcCCCCCccccCCCCc---CCccccc-
Q 012320 152 --------------------PPVIHRDLKCDNIFVNGH-LGQVKIGDLGLAAILRGSKSAHSVIGTPEF---MAPELYE- 206 (466)
Q Consensus 152 --------------------~~IiHrDLKp~NIlv~~~-~g~vKL~DFGla~~~~~~~~~~~~~GT~~y---~APE~l~- 206 (466)
+.++|+|++|.||+++.+ .+.+.|+||+.+..-... ........+ ..|+...
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~---~Dl~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD---NDFISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT---HHHHTTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH---HHHHHHHhhccccCHHHHHH
Confidence 238999999999999874 246899999987543211 111111111 2333221
Q ss_pred --cCC------------CChhhHHHHHHHHHHHHhCCCCC
Q 012320 207 --EDY------------NELVDVYSFGMCVLEMFTCEYPY 232 (466)
Q Consensus 207 --~~y------------~~~~DIwSlGvil~elltg~~Pf 232 (466)
..| ....+.|++|.+++.+.+|..+|
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 112 12268999999999999998776
|
| >2v3s_A Serine/threonine-protein kinase OSR1; ATP-binding, magnesium, metal-binding, nucleotide-binding, phosphorylation, polymorphism, transferase; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.81 E-value=9.3e-09 Score=80.29 Aligned_cols=59 Identities=17% Similarity=0.219 Sum_probs=57.2
Q ss_pred ceEEEEEeeCCCCCCcceeecCcCCCCChhHHHHHHHHcccCCCCCHHHHHHHHHHHHH
Q 012320 338 TIFLKVQIADKDGPGRNIYFPFDILNDTPLDVAREMVKELEITDWEPFEIAKMIDEEIS 396 (466)
Q Consensus 338 ~i~l~~~~~d~~~~~r~i~f~f~~~~dt~~~va~Emv~~~~~~~~d~~~ia~~i~~~~~ 396 (466)
++.|.+|+++..+++++|.|+|...+|||..||+|||+++.++..|+..+|+++++.|.
T Consensus 2 pv~LvLRlRn~~rELnDIrFeF~~g~DTaegiA~ELv~AgLVDg~D~~vVAanL~klv~ 60 (96)
T 2v3s_A 2 PISLVLRLRNSKKELNDIRFEFTPGRDTAEGVSQELISAGLVDGRDLVIVAANLQKIVE 60 (96)
T ss_dssp CEEEEEEEECTTSCEEEEEEEECTTTCCHHHHHHHHHHTTSSCGGGHHHHHHHHHHHHH
T ss_pred CeeEEEEeccccchhcceEEEeecCCCcHHHHHHHHHHCCCcccccHHHHHHHHHHHHh
Confidence 67899999999999999999999999999999999999999999999999999999996
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=2.2e-06 Score=81.74 Aligned_cols=134 Identities=16% Similarity=0.107 Sum_probs=94.8
Q ss_pred eeeeCce-EEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEeEEEeccCCEEEEEEecC
Q 012320 36 LGKGAMK-TVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYTSWIDVDQKTFNFITEMF 113 (466)
Q Consensus 36 LG~G~fg-~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~~~lV~E~~ 113 (466)
+..|..| .||+......+..+.+|.-. ......+.+|...|+.+. +-.+-+.+... .+.+..++|||++
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~-------~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~--~~~~~~~lvme~l 102 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGK-------GSVANDVTDEMVRLNWLTAFMPLPTIKHFI--RTPDDAWLLTTAI 102 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEE-------THHHHHHHHHHHHHHHHTTTSCCCCEEEEE--EETTEEEEEEECC
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECC-------CCCHhHHHHHHHHHHHhccCCCcCeEEEEE--EECCeEEEEEEee
Confidence 4556665 69998887778889999754 224456788999999883 32345566544 3456788999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 012320 114 TSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRD------------------------------------------ 151 (466)
Q Consensus 114 ~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~------------------------------------------ 151 (466)
+|.++.+..... ......+..++...|.-||+..
T Consensus 103 ~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 103 PGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp CSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred CCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 999988765432 2233456677777777777532
Q ss_pred --------------CCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 152 --------------PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 152 --------------~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
+.++|+|+.|.||+++.. +.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~-~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEG-KLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECC-eEEEEEECccccc
Confidence 127999999999999865 5667999997743
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=3.4e-06 Score=82.64 Aligned_cols=136 Identities=22% Similarity=0.138 Sum_probs=91.4
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCC---ceeEEEeEEEeccCCEEEEEE
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHD---SIIRFYTSWIDVDQKTFNFIT 110 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp---nIv~l~~~~~~~~~~~~~lV~ 110 (466)
+.++.|....||+. |..+++|+-. .......+.+|+.+|+.+.+. .+.+.+.... ...+..++||
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-~~~g~~~~v~ 92 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPK------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK-RSDGNPFVGY 92 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEES------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-CTTSCEEEEE
T ss_pred eecCCCcceeEEEE-----CCEEEEEecC------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-cCCCceEEEE
Confidence 34788999999998 5678888632 334557889999999998642 2344444332 2345567999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 012320 111 EMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRD--------------------------------------- 151 (466)
Q Consensus 111 E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~--------------------------------------- 151 (466)
|+++|.+|.... ...++......++.|+...|..||+..
T Consensus 93 e~i~G~~l~~~~--~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 93 RKVQGQILGEDG--MAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp ECCCSEECHHHH--HTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred eccCCeECchhh--hhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 999998887632 123445555555555555555555432
Q ss_pred -------------------CCeEeccCCCCcEEEeC--CCCc-EEEeccchhhh
Q 012320 152 -------------------PPVIHRDLKCDNIFVNG--HLGQ-VKIGDLGLAAI 183 (466)
Q Consensus 152 -------------------~~IiHrDLKp~NIlv~~--~~g~-vKL~DFGla~~ 183 (466)
+.++|+|++|.||+++. ..+. +.|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 23699999999999986 1244 58999997754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=1.2e-05 Score=81.35 Aligned_cols=79 Identities=16% Similarity=0.179 Sum_probs=48.0
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccc-cCC--HHHHHHHHHHHHHHHhCC-C-Cc-eeEEEeEEEeccCCEEE
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNEL-MRS--PDDLQRLYSEVHLLSTLK-H-DS-IIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~-~~~--~~~~~~~~~Ei~iL~~l~-H-pn-Iv~l~~~~~~~~~~~~~ 107 (466)
+.||.|.++.||++.....+..+++|+...... ... .....++..|.++|+.+. + |. +.+++. .+. ...+
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~--~d~--~~~~ 111 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDT--EMAV 111 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EET--TTTE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE--EcC--CccE
Confidence 459999999999998766678999998653211 000 012345677999998873 2 33 345554 232 2346
Q ss_pred EEEecCCCC
Q 012320 108 FITEMFTSG 116 (466)
Q Consensus 108 lV~E~~~gg 116 (466)
+|||++.|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999774
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.90 E-value=0.0001 Score=72.23 Aligned_cols=30 Identities=23% Similarity=0.387 Sum_probs=25.7
Q ss_pred CCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 152 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 152 ~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
+.++|+|++|.||+++.+ +.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~-~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGEN-EQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGG-GCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCC-CcEEEEehhhcc
Confidence 349999999999999765 689999999663
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00021 Score=70.98 Aligned_cols=80 Identities=9% Similarity=-0.036 Sum_probs=49.4
Q ss_pred eee-eeeCceEEEEEEEc--C----CCeEEEEEEEecccc--cCCHHHHHHHHHHHHHHHhCC-C--CceeEEEeEEEec
Q 012320 34 EVL-GKGAMKTVYKAIDE--V----LGVEVAWNQVRLNEL--MRSPDDLQRLYSEVHLLSTLK-H--DSIIRFYTSWIDV 101 (466)
Q Consensus 34 ~~L-G~G~fg~Vyka~~~--~----~g~~vAiK~i~~~~~--~~~~~~~~~~~~Ei~iL~~l~-H--pnIv~l~~~~~~~ 101 (466)
+.| +.|....+|++... . +|..+++|....... ... ...+.+|+.+|+.|. + -.+.+++... .
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~--~ 100 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIE--T 100 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEE--C
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEc--c
Confidence 457 88999999988643 1 266788887543220 001 134667888888773 2 3455666543 2
Q ss_pred cC---CEEEEEEecCCCCCH
Q 012320 102 DQ---KTFNFITEMFTSGTL 118 (466)
Q Consensus 102 ~~---~~~~lV~E~~~ggsL 118 (466)
+. +..++|||+++|..+
T Consensus 101 ~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 101 TGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp SSTTTSSCEEEEECCCCBCC
T ss_pred CCCccCCceEEEEecCCCCh
Confidence 22 345789999988654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0015 Score=64.15 Aligned_cols=74 Identities=16% Similarity=0.036 Sum_probs=53.8
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC---CCceeEEEeEEEeccCCEEEEEE
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK---HDSIIRFYTSWIDVDQKTFNFIT 110 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~~~lV~ 110 (466)
+.|+.|.+..+|+... .+..+++|+-... ....+..|...|+.|. ...+.+.+... ...+..++||
T Consensus 42 ~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~--~~~g~~~lvm 110 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND--EVQTVFVKINERS-------YRSMFRAEADQLALLAKTNSINVPLVYGIG--NSQGHSFLLL 110 (312)
T ss_dssp EEECCSSSSEEEEEES--SSCEEEEEEEEGG-------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEE--ECSSEEEEEE
T ss_pred EEeCCccceeeeEEEE--CCCeEEEEeCCcc-------cHHHHHHHHHHHHHHHhhCCCCcceEEEEe--ecCCceEEEE
Confidence 3489999999999864 4678888875521 2456788999888873 35566776643 3456789999
Q ss_pred ecCCCCCH
Q 012320 111 EMFTSGTL 118 (466)
Q Consensus 111 E~~~ggsL 118 (466)
|+++|..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0012 Score=67.35 Aligned_cols=29 Identities=21% Similarity=0.359 Sum_probs=25.0
Q ss_pred CeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 153 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 153 ~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
.++|+|++|.|||++.+ + ++|+||+.+..
T Consensus 233 ~liHGDl~~~Nil~~~~-~-~~lID~e~a~~ 261 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQD-S-TQVIDPEFSFY 261 (420)
T ss_dssp EEECSCCSGGGEEECSS-C-EEECCCTTCEE
T ss_pred eEEecCCCCCcEEEeCC-C-CEEEeCccccc
Confidence 39999999999999865 4 99999987753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0055 Score=56.65 Aligned_cols=120 Identities=18% Similarity=0.138 Sum_probs=80.0
Q ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH-hCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCCCcccc
Q 012320 117 TLREYRKKY-RRVDIRAIKSWARQILQGLVYLH-SRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVI 194 (466)
Q Consensus 117 sL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLH-s~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~~~~~~ 194 (466)
+|.+.++.. .+++|++++.++.|.+.+|.-+- +..+ ..+=+.|..|++..+ |.|.+.+ ..+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~d-G~V~f~~-~~s~-----------~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRD-GAVTLAP-AADD-----------A 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETT-SCEEECC-C---------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecC-Cceeccc-cccc-----------c
Confidence 788988765 68999999999999999987762 2221 133445789999877 8887664 1110 1
Q ss_pred CCCCcCCccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc
Q 012320 195 GTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV 271 (466)
Q Consensus 195 GT~~y~APE~l~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~ 271 (466)
....+.|||.....-+.+.=|||||+++|.-+--..| .......++++..||..|..
T Consensus 99 ~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~--------------------e~eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 99 GEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK--------------------ENEERELSPPLEQLIDHMAN 155 (229)
T ss_dssp --------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC--------------------TTEEECCCHHHHHHHHHHTT
T ss_pred cccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC--------------------cccchhhCHHHHHHHHHHHh
Confidence 2335678887765667889999999999998753222 23345577889999988874
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0021 Score=62.17 Aligned_cols=28 Identities=21% Similarity=0.305 Sum_probs=23.4
Q ss_pred eEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 154 VIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 154 IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
++|+|+.|.||+. .+ +.+.|+||..+..
T Consensus 175 l~HgDl~~~Nil~-~~-~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFLD-TG-ERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEEE-CS-SCEEECCCTTCEE
T ss_pred eeccCCCcCCEEE-CC-CCEEEEecccccC
Confidence 8999999999994 34 6789999987743
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.73 E-value=0.012 Score=56.29 Aligned_cols=73 Identities=11% Similarity=-0.033 Sum_probs=47.8
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-C--CceeEEEeEEEeccCCEEEEEE
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-H--DSIIRFYTSWIDVDQKTFNFIT 110 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-H--pnIv~l~~~~~~~~~~~~~lV~ 110 (466)
+.+|.|..+.||++... +|+.|.+|+-..... .....+..|+..|+.|. . -.+.+.+.. + . -++||
T Consensus 21 ~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~----~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~--~~lv~ 89 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELA-DGTPLFVKALPDDAP----ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--D--RTLAM 89 (288)
T ss_dssp EEEEEETTEEEEEEEET-TSCEEEEEECCTTCC----CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--T--TEEEE
T ss_pred EecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCc----chhhHHHHHHHHHHHHHhhCCCCcceEEec--c--C--ceEEE
Confidence 44899999999999754 688999997542221 11234677999998873 2 123444442 2 2 25889
Q ss_pred ecCCCCC
Q 012320 111 EMFTSGT 117 (466)
Q Consensus 111 E~~~ggs 117 (466)
|++.++.
T Consensus 90 e~l~~~~ 96 (288)
T 3f7w_A 90 EWVDERP 96 (288)
T ss_dssp ECCCCCC
T ss_pred EeecccC
Confidence 9988764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0073 Score=59.09 Aligned_cols=31 Identities=26% Similarity=0.388 Sum_probs=25.6
Q ss_pred CeEeccCCCCcEEEeCC---CCcEEEeccchhhh
Q 012320 153 PVIHRDLKCDNIFVNGH---LGQVKIGDLGLAAI 183 (466)
Q Consensus 153 ~IiHrDLKp~NIlv~~~---~g~vKL~DFGla~~ 183 (466)
.++|+|+.+.||+++.+ .+.+.|+||+.+..
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 49999999999999763 14789999997754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0093 Score=57.88 Aligned_cols=140 Identities=15% Similarity=0.104 Sum_probs=72.8
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-----CCceeEEE-eEEEeccCCEEE
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-----HDSIIRFY-TSWIDVDQKTFN 107 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-----HpnIv~l~-~~~~~~~~~~~~ 107 (466)
+.|+.|....||++... .| .+++|...... ..+.+..|+.+++.|. -|.++... +..+....+..+
T Consensus 28 ~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~------~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTT-KD-PLILTLYEKRV------EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEECC---EEEEEEEES-SC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eccCCCcccceEEEEeC-Cc-cEEEEEeCCCC------CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 34788989999998653 23 67888775321 1234556777777763 23333210 000001134578
Q ss_pred EEEecCCCCCHH-----H----------HHHhcCCC--------CHHHHHHH---------------HHHHHHHHHHHHh
Q 012320 108 FITEMFTSGTLR-----E----------YRKKYRRV--------DIRAIKSW---------------ARQILQGLVYLHS 149 (466)
Q Consensus 108 lV~E~~~ggsL~-----~----------~l~~~~~l--------~~~~~~~i---------------~~qIl~gL~yLHs 149 (466)
+|+++++|..+. . +......+ ........ ...+...+..+..
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 999999886431 1 11110111 11100000 0113344555542
Q ss_pred C-----CCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 150 R-----DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 150 ~-----~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
. ...++|+|+.|.||+++.+ +.+.|+||+.+.
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~-~~~~lIDf~~a~ 216 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGD-ELSGLIDFYFAC 216 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETT-EEEEECCCTTCE
T ss_pred hCcccCCcccCCCCCCccCEEEeCC-ceEEEecchhcc
Confidence 1 1239999999999999865 455899998664
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0087 Score=58.23 Aligned_cols=76 Identities=11% Similarity=-0.021 Sum_probs=44.9
Q ss_pred eeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCC--CceeEEEeE---EEeccCCEEEEE
Q 012320 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH--DSIIRFYTS---WIDVDQKTFNFI 109 (466)
Q Consensus 35 ~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~---~~~~~~~~~~lV 109 (466)
.|+ |....||++.. ..|+.+++|....... + ...+..|+.+++.|.. -.+.+.+.. .+....+..++|
T Consensus 33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~--~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERW--T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEC-CSSSEEEEECC-TTCCCEEEEEECTTTS--C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred eec-CcccceEEEEc-CCCCEEEEEEcCCCCC--C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 366 88899998753 3466789998752211 2 2455668888877731 123333321 001124566789
Q ss_pred EecCCCCC
Q 012320 110 TEMFTSGT 117 (466)
Q Consensus 110 ~E~~~ggs 117 (466)
+++++|..
T Consensus 106 ~~~i~G~~ 113 (328)
T 1zyl_A 106 FPSVGGRQ 113 (328)
T ss_dssp EECCCCEE
T ss_pred EEecCCCC
Confidence 99998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.33 E-value=0.013 Score=59.94 Aligned_cols=71 Identities=11% Similarity=0.079 Sum_probs=45.7
Q ss_pred eeeeeeCceEEEEEEEcC-------CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCce-eEEEeEEEeccCCE
Q 012320 34 EVLGKGAMKTVYKAIDEV-------LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI-IRFYTSWIDVDQKT 105 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~ 105 (466)
+.|+.|....||++.... .+..+.+|+.... .. .+.+..|..+++.|...++ .+++..+ . +.
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~---~~~li~E~~~l~~L~~~g~~P~l~~~~--~--~g 148 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ET---ESHLVAESVIFTLLSERHLGPKLYGIF--S--GG 148 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CC---HHHHHHHHHHHHHHHHTTSSSCEEEEE--T--TE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEe--C--CC
Confidence 348889999999997643 3578888876321 11 1345579988888742233 5566543 2 22
Q ss_pred EEEEEecCCCC
Q 012320 106 FNFITEMFTSG 116 (466)
Q Consensus 106 ~~lV~E~~~gg 116 (466)
+|+||++|.
T Consensus 149 --~v~e~l~G~ 157 (429)
T 1nw1_A 149 --RLEEYIPSR 157 (429)
T ss_dssp --EEECCCCEE
T ss_pred --EEEEEeCCc
Confidence 789999863
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.28 E-value=0.014 Score=60.32 Aligned_cols=73 Identities=12% Similarity=0.113 Sum_probs=45.1
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCce-eEEEeEEEeccCCEEEEEEec
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI-IRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~~~lV~E~ 112 (466)
+.|+.|-...+|++.....+..+.+|+..... . . .-.-..|..+|+.|...++ .+++..+ . +. +|+||
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~-~---~idR~~E~~vl~~L~~~gl~P~ll~~~--~--~G--~v~e~ 182 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-D-E---IINREREKKISCILYNKNIAKKIYVFF--T--NG--RIEEF 182 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C-C-S---CSCHHHHHHHHHHHTTSSSBCCEEEEE--T--TE--EEEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-h-h---hcCHHHHHHHHHHHHhcCCCCCEEEEe--C--Ce--EEEEe
Confidence 44888999999999876545888888764221 0 0 0011468888988854444 4666644 2 22 48999
Q ss_pred CCCCC
Q 012320 113 FTSGT 117 (466)
Q Consensus 113 ~~ggs 117 (466)
++|.+
T Consensus 183 I~G~~ 187 (458)
T 2qg7_A 183 MDGYA 187 (458)
T ss_dssp CCSEE
T ss_pred eCCcc
Confidence 98743
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.12 E-value=0.01 Score=59.73 Aligned_cols=138 Identities=13% Similarity=0.170 Sum_probs=78.9
Q ss_pred eeeeeeCceEEEEEEEcC-------CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEeEEEeccCCE
Q 012320 34 EVLGKGAMKTVYKAIDEV-------LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~ 105 (466)
+.|..|....+|++.... .+..+.+|+--. ... ......+|..+++.|. +.-..+++..+ .+ .
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~--g 126 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--ILQ---GVDSLVLESVMFAILAERSLGPQLYGVF--PE--G 126 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----C---CHHHHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--ccc---hHHHHHHHHHHHHHHHhcCCCCeEEEEc--CC--c
Confidence 347779999999997642 357888887421 111 2345568999888873 32234556543 22 2
Q ss_pred EEEEEecCCCCCHH--------------HHHHhc-------C-CC--CHHHHHHHHHHHHH-------------------
Q 012320 106 FNFITEMFTSGTLR--------------EYRKKY-------R-RV--DIRAIKSWARQILQ------------------- 142 (466)
Q Consensus 106 ~~lV~E~~~ggsL~--------------~~l~~~-------~-~l--~~~~~~~i~~qIl~------------------- 142 (466)
+|+||++|..|. ..+.+- + .. -..++..|..|+-.
T Consensus 127 --~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 204 (379)
T 3feg_A 127 --RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD 204 (379)
T ss_dssp --EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred --cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence 889999885442 111110 1 11 13567777765532
Q ss_pred HHHHH----HhCC--CCeEeccCCCCcEEEeCC---CCcEEEeccchhh
Q 012320 143 GLVYL----HSRD--PPVIHRDLKCDNIFVNGH---LGQVKIGDLGLAA 182 (466)
Q Consensus 143 gL~yL----Hs~~--~~IiHrDLKp~NIlv~~~---~g~vKL~DFGla~ 182 (466)
.+..| ...+ ..++|+|+.+.||+++.+ .+.+.|+||..+.
T Consensus 205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 12222 2222 239999999999999865 3589999998774
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.92 E-value=0.034 Score=54.77 Aligned_cols=30 Identities=20% Similarity=0.340 Sum_probs=25.7
Q ss_pred CeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 153 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 153 ~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
.++|+|+.|.||+++.+ +.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~-~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNE-ESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGG-GCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCC-CeEEEEECCCCee
Confidence 49999999999999865 6899999987643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.85 E-value=0.01 Score=58.95 Aligned_cols=73 Identities=12% Similarity=0.155 Sum_probs=40.5
Q ss_pred eeeeeeCceEEEEEEEcC--------CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCc-eeEEEeEEEeccCC
Q 012320 34 EVLGKGAMKTVYKAIDEV--------LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDS-IIRFYTSWIDVDQK 104 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~--------~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~ 104 (466)
+.|+.|....+|++.... .+..+.+|+..... ........|..+++.+...+ +.+++..+ .+
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~ 109 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-----DELYNTISEFEVYKTMSKYKIAPQLLNTF----NG 109 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TT
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-----cceecHHHHHHHHHHHHhcCCCCceEEec----CC
Confidence 347889999999997643 13678888654211 11112356888888773223 34555433 22
Q ss_pred EEEEEEecCCCCC
Q 012320 105 TFNFITEMFTSGT 117 (466)
Q Consensus 105 ~~~lV~E~~~ggs 117 (466)
++|+||++|..
T Consensus 110 --~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 --GRIEEWLYGDP 120 (369)
T ss_dssp --EEEEECCCSEE
T ss_pred --cEEEEEecCCc
Confidence 57899998753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=91.07 E-value=0.59 Score=47.52 Aligned_cols=73 Identities=7% Similarity=0.035 Sum_probs=43.9
Q ss_pred eeeeeeCceEEEEEEEcCC-------CeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEeEEEeccCCE
Q 012320 34 EVLGKGAMKTVYKAIDEVL-------GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~-------g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~ 105 (466)
+.|..|....+|++..... +..+.+++-.... +..-...+|..+++.+. +.-..++++.+ .+
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-----~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~- 145 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-----GKFYDSKVELDVFRYLSNINIAPNIIADF----PE- 145 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC------CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TT-
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-----chhcCHHHHHHHHHHHHhcCCCCCEEEEc----CC-
Confidence 3477899999999976521 5778888743211 11112246788887773 22234455432 22
Q ss_pred EEEEEecCCCCC
Q 012320 106 FNFITEMFTSGT 117 (466)
Q Consensus 106 ~~lV~E~~~ggs 117 (466)
++|+||++|..
T Consensus 146 -~~I~efI~G~~ 156 (424)
T 3mes_A 146 -GRIEEFIDGEP 156 (424)
T ss_dssp -EEEEECCCSEE
T ss_pred -CEEEEEeCCcc
Confidence 57899999865
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.05 E-value=0.068 Score=55.15 Aligned_cols=62 Identities=13% Similarity=0.030 Sum_probs=16.8
Q ss_pred eeeeeeeeCceEEEEEEEcCCCeEEEE------EEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEE
Q 012320 32 FEEVLGKGAMKTVYKAIDEVLGVEVAW------NQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSW 98 (466)
Q Consensus 32 ~~~~LG~G~fg~Vyka~~~~~g~~vAi------K~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 98 (466)
+.+.|| ||.||++.......+||+ |..+-... +.+....+.+|..+++.++|||+++.+..-
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~--~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV--SEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-------------------------------------CBCCCEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccc--cccccccccccccccccccccccCCCcceE
Confidence 455577 999999987665567888 55432221 234456788899999999999999988753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 466 | ||||
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-80 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-52 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-52 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-51 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-48 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-47 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-47 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-44 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-44 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-43 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-42 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-42 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-42 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-41 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-41 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-41 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-41 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-41 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-40 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-40 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-39 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-38 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-37 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-37 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-36 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-36 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-34 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-14 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (632), Expect = 5e-80
Identities = 133/271 (49%), Positives = 182/271 (67%), Gaps = 6/271 (2%)
Query: 21 IETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEV 80
+ +GR+ F+ +G+G+ KTVYK +D VEVAW +++ +L + + QR E
Sbjct: 2 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEA 59
Query: 81 HLLSTLKHDSIIRFYTSWIDV--DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWAR 138
+L L+H +I+RFY SW +K +TE+ TSGTL+ Y K+++ + I+ ++SW R
Sbjct: 60 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR 119
Query: 139 QILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPE 198
QIL+GL +LH+R PP+IHRDLKCDNIF+ G G VKIGDLGLA + R S + +VIGTPE
Sbjct: 120 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA-KAVIGTPE 178
Query: 199 FMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258
FMAPE+YEE Y+E VDVY+FGMC+LEM T EYPYSEC N AQIY++VTSG P +F +
Sbjct: 179 FMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 238
Query: 259 DLEAQRFIGRCL-VNASKRLSAKELLLDPFL 288
E + I C+ N +R S K+LL F
Sbjct: 239 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-59
Identities = 77/267 (28%), Positives = 119/267 (44%), Gaps = 15/267 (5%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
+G G+ K + G + W ++ + + + Q L SEV+LL LKH +I
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNI 65
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRR----VDIRAIKSWARQILQGLVYL 147
+R+Y ID T + E G L K + +D + Q+ L
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 148 HSR---DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-RGSKSAHSVIGTPEFMAPE 203
H R V+HRDLK N+F++G VK+GD GLA IL + A + +GTP +M+PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE 184
Query: 204 LYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA 262
YNE D++S G + E+ P+ + ++ K+ GK Y D E
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREGKFRRIPYRYSD-EL 242
Query: 263 QRFIGRCL-VNASKRLSAKELLLDPFL 288
I R L + R S +E+L +P +
Sbjct: 243 NEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 188 bits (479), Expect = 6e-57
Identities = 77/302 (25%), Positives = 126/302 (41%), Gaps = 17/302 (5%)
Query: 20 YIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSE 79
+ + DP + E +G G+ VY A D VA ++ +S + Q + E
Sbjct: 8 FFKDDPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVVAIKKMSY-SGKQSNEKWQDIIKE 65
Query: 80 VHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQ 139
V L L+H + I++ ++ + T + E + + I +
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLR--EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHG 123
Query: 140 ILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF 199
LQGL YLHS +IHRD+K NI ++ G VK+GD G A+I+ A+S +GTP +
Sbjct: 124 ALQGLAYLHSH--NMIHRDVKAGNILLSEP-GLVKLGDFGSASIM---APANSFVGTPYW 177
Query: 200 MAPELYEED----YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFY 255
MAPE+ Y+ VDV+S G+ +E+ + P N + + P
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQS 236
Query: 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNETELEK 314
+ F+ CL R +++ LL F+ + L Q+ EL+
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER-PPTVIMDLIQRTKDAVRELDN 295
Query: 315 LQ 316
LQ
Sbjct: 296 LQ 297
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 1e-56
Identities = 67/262 (25%), Positives = 123/262 (46%), Gaps = 12/262 (4%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
LGKG VY A ++ +A + + + +L EV + S L+H +I
Sbjct: 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNI 68
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRD 151
+R Y + D + I E GT+ +K + D + ++ ++ L Y HS+
Sbjct: 69 LRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 125
Query: 152 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYEED-YN 210
VIHRD+K +N+ + G++KI D G + S+ ++ GT +++ PE+ E ++
Sbjct: 126 -RVIHRDIKPENLLLGSA-GELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHD 182
Query: 211 ELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCL 270
E VD++S G+ E + P+ E + YK+++ + F A+ I R L
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFT--FPDFVTEGARDLISRLL 239
Query: 271 V-NASKRLSAKELLLDPFLASD 291
N S+R +E+L P++ ++
Sbjct: 240 KHNPSQRPMLREVLEHPWITAN 261
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 6e-56
Identities = 85/268 (31%), Positives = 130/268 (48%), Gaps = 14/268 (5%)
Query: 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLL 83
DP +Y FE+ +G+GA TVY A+D G EVA Q+ L + + + +E+ ++
Sbjct: 17 DPKKKYTRFEK-IGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVM 71
Query: 84 STLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQG 143
K+ +I+ + S++ + E G+L + + +D I + R+ LQ
Sbjct: 72 RENKNPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 128
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA-ILRGSKSAHSVIGTPEFMAP 202
L +LHS VIHRD+K DNI + G VK+ D G A I +++GTP +MAP
Sbjct: 129 LEFLHSN--QVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 203 E-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLE 261
E + + Y VD++S G+ +EM E PY +Y T+G
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245
Query: 262 AQRFIGRCLV-NASKRLSAKELLLDPFL 288
+ F+ RCL + KR SAKELL FL
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 7e-55
Identities = 77/287 (26%), Positives = 131/287 (45%), Gaps = 21/287 (7%)
Query: 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVH 81
+ +P + + LG GA VYKA ++ V A + +S ++L+ E+
Sbjct: 7 DLNPEDFWEI-IGELGDGAFGKVYKAQNKETSVLAAAKVID----TKSEEELEDYMVEID 61
Query: 82 LLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQI 140
+L++ H +I++ ++ + + E G + + R + I+ +Q
Sbjct: 62 ILASCDHPNIVKLLDAFYY--ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQT 119
Query: 141 LQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-RGSKSAHSVIGTPEF 199
L L YLH +IHRDLK NI G +K+ D G++A R + S IGTP +
Sbjct: 120 LDALNYLHDNK--IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYW 176
Query: 200 MAPELY------EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG- 252
MAPE+ + Y+ DV+S G+ ++EM E P+ E NP ++ K+ + P
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIAKSEPPTL 235
Query: 253 AFYSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVKLLSK 298
A S + F+ +CL N R + +LL PF+ D K + +
Sbjct: 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRE 282
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 1e-52
Identities = 64/263 (24%), Positives = 118/263 (44%), Gaps = 14/263 (5%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
+ LG+GA V A++ V VA V + R+ D + + E+ + L H+++
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPENIKKEICINKMLNHENV 65
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRD 151
++FY + E + G L + + + + + Q++ G+VYLH
Sbjct: 66 VKFYGHRRE--GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 152 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG---SKSAHSVIGTPEFMAPELY--E 206
+ HRD+K +N+ ++ +KI D GLA + R + + + GT ++APEL
Sbjct: 124 --ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 207 EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFI 266
E + E VDV+S G+ + M E P+ + ++ Q Y K + D +
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240
Query: 267 GRCLV-NASKRLSAKELLLDPFL 288
+ LV N S R++ ++ D +
Sbjct: 241 HKILVENPSARITIPDIKKDRWY 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 178 bits (453), Expect = 1e-52
Identities = 63/291 (21%), Positives = 120/291 (41%), Gaps = 15/291 (5%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
E LG GA V++ +++ G + P D + +E+ +++ L H +
Sbjct: 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINT----PYPLDKYTVKNEISIMNQLHHPKL 88
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVYLHSR 150
I + ++ D+ I E + G L + + ++ + ++ RQ +GL ++H
Sbjct: 89 INLHDAF--EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 151 DPPVIHRDLKCDNIFV-NGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE-ED 208
++H D+K +NI VKI D GLA L + T EF APE+ + E
Sbjct: 147 S--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP 204
Query: 209 YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL--EAQRFI 266
D+++ G+ + + P++ + + + V + + EA+ FI
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263
Query: 267 GRCLV-NASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNETELEKLQ 316
L KRL+ + L P+L D L S+ ++ + + EK
Sbjct: 264 KNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYA 314
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 6e-52
Identities = 67/325 (20%), Positives = 137/325 (42%), Gaps = 17/325 (5%)
Query: 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
+Y + E LG+G V++ ++ V++ D + E+ +L+ +
Sbjct: 6 KY-MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIAR 59
Query: 88 HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVY 146
H +I+ + S+ +++ I E + + E ++ R I S+ Q+ + L +
Sbjct: 60 HRNILHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117
Query: 147 LHSRDPPVIHRDLKCDNIFV-NGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELY 205
LHS + H D++ +NI +KI + G A L+ + + PE+ APE++
Sbjct: 118 LHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175
Query: 206 EED-YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL--EA 262
+ D + D++S G V + + P+ QI + + + + + +++ EA
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPF-LAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 263 QRFIGRCLV-NASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNETELEKLQLSDDP 321
F+ R LV R++A E L P+L ++ +K K L K L+
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVV 294
Query: 322 PRTDMTITGKLNPEDDTIFLKVQIA 346
++ G + + KV++A
Sbjct: 295 SAARISCGGAIRSQKGVSVAKVKVA 319
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 8e-52
Identities = 65/304 (21%), Positives = 122/304 (40%), Gaps = 51/304 (16%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
LG G V+K + G+ +A + L P ++ E+ +L I
Sbjct: 10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYI 66
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRD 151
+ FY ++ + E G+L + KK R+ + + + +++GL YL +
Sbjct: 67 VGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK- 123
Query: 152 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE-LYEEDYN 210
++HRD+K NI VN G++K+ D G++ L S + +S +GT +M+PE L Y+
Sbjct: 124 HKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYS 181
Query: 211 ELVDVYSFGMCVLEMFTCEYPYS------------------------------------- 233
D++S G+ ++EM YP
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241
Query: 234 ----ECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288
++ + + P + LE Q F+ +CL+ N ++R K+L++ F+
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
Query: 289 ASDE 292
+
Sbjct: 302 KRSD 305
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (443), Expect = 1e-51
Identities = 63/299 (21%), Positives = 121/299 (40%), Gaps = 15/299 (5%)
Query: 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLL 83
D Y F +VLG GA V A D+ VA + L + +E+ +L
Sbjct: 6 DIRDIY-DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL---EGKEGSMENEIAVL 61
Query: 84 STLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQG 143
+KH +I+ + I ++ + G L + + R Q+L
Sbjct: 62 HKIKHPNIVALDDIY--ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 119
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVNGHL--GQVKIGDLGLAAILRGSKSAHSVIGTPEFMA 201
+ YLH ++HRDLK +N+ ++ I D GL+ + + GTP ++A
Sbjct: 120 VKYLHD--LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVA 177
Query: 202 P-ELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL 260
P L ++ Y++ VD +S G+ + P+ + N A++++++ + D+
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDI 236
Query: 261 --EAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNETELEKLQ 316
A+ FI + + KR + ++ L P++A D + + + K +
Sbjct: 237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWK 295
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-51
Identities = 75/271 (27%), Positives = 122/271 (45%), Gaps = 24/271 (8%)
Query: 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLS 84
P+G+ + +G G+ TVYK +VA + + +P LQ +EV +L
Sbjct: 6 PDGQI-TVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAP--TPQQLQAFKNEVGVLR 59
Query: 85 TLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQG 143
+H +I+ F +T+ +L + + ++ + ARQ QG
Sbjct: 60 KTRHVNILLFMGYS---TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL---RGSKSAHSVIGTPEFM 200
+ YLH++ +IHRDLK +NIF++ VKIGD GLA + GS + G+ +M
Sbjct: 117 MDYLHAK--SIIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 201 APELYEED----YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYS 256
APE+ Y+ DVY+FG+ + E+ T + PYS N QI V G L
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233
Query: 257 IQD---LEAQRFIGRCL-VNASKRLSAKELL 283
++ +R + CL +R ++L
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 173 bits (440), Expect = 1e-50
Identities = 62/299 (20%), Positives = 121/299 (40%), Gaps = 16/299 (5%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
E LG GA V++ + G A V D + + E+ +S L+H ++
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTL 85
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVYLHSR 150
+ + ++ D I E + G L E ++ ++ + RQ+ +GL ++H
Sbjct: 86 VNLHDAFED--DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 151 DPPVIHRDLKCDNIFVNGHL-GQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE-ED 208
+ +H DLK +NI ++K+ D GL A L +S GT EF APE+ E +
Sbjct: 144 N--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 201
Query: 209 YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL--EAQRFI 266
D++S G+ + + P+ N + + V S + + + + FI
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260
Query: 267 GRCLV-NASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNETELEKLQLSDDPPRT 324
+ L+ + + R++ + L P+L +++ + + K + P
Sbjct: 261 RKLLLADPNTRMTIHQALEHPWLTPGNAPGR-DSQIPSSRYTKIRDSIKTKYDAWPEPL 318
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 3e-49
Identities = 69/296 (23%), Positives = 128/296 (43%), Gaps = 27/296 (9%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
F ++LG+G+ TV A + E A + +++ + + + E ++S L H
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFF 70
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRD 151
++ Y ++ D + F +G L +Y +K D + + +I+ L YLH
Sbjct: 71 VKLYFTFQ--DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-- 126
Query: 152 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS---AHSVIGTPEFMAPE-LYEE 207
+IHRDLK +NI +N ++I D G A +L A+S +GT ++++PE L E+
Sbjct: 127 KGIIHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 208 DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIG 267
+ D+++ G + ++ P+ N I++K+ + F +A+ +
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKIIKLEYD--FPEKFFPKARDLVE 242
Query: 268 RCLV-NASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNETELEKLQLSDDPP 322
+ LV +A+KRL +E+ L PF E L P
Sbjct: 243 KLLVLDATKRLGCEEMEGYGPLK-------------AHPFFESVTWENLHQQTPPK 285
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 165 bits (419), Expect = 2e-48
Identities = 60/273 (21%), Positives = 113/273 (41%), Gaps = 22/273 (8%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRS-----PDDLQRLYSEVHLLSTL 86
+E+LG+G V + I + E A + + + + EV +L +
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 87 K-HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLV 145
H +II+ ++ F + ++ G L +Y + + + + R +L+ +
Sbjct: 67 SGHPNIIQLKDTYET--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124
Query: 146 YLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELY 205
LH + ++HRDLK +NI ++ +K+ D G + L + V GTP ++APE+
Sbjct: 125 ALHKLN--IVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 181
Query: 206 E-------EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258
E Y + VD++S G+ + + P+ + + + SG
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWD 240
Query: 259 DL--EAQRFIGRCL-VNASKRLSAKELLLDPFL 288
D + + R L V KR +A+E L PF
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-47
Identities = 65/292 (22%), Positives = 126/292 (43%), Gaps = 15/292 (5%)
Query: 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNEL--MRSPDDLQRLYSEVH 81
+ + Y E LG G V K ++ G++ A ++ R + + EV
Sbjct: 7 NVDDYY-DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 82 LLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQIL 141
+L ++H ++I + + ++ I E+ G L ++ + + + +QIL
Sbjct: 66 ILKEIQHPNVITLHEVYE--NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 123
Query: 142 QGLVYLHSRDPPVIHRDLKCDNIFV---NGHLGQVKIGDLGLAAILRGSKSAHSVIGTPE 198
G+ YLHS + H DLK +NI + N ++KI D GLA + ++ GTPE
Sbjct: 124 NGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 181
Query: 199 FMAPELYEED-YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK--LPGAFY 255
F+APE+ + D++S G+ + + P+ + V++ ++
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANVSAVNYEFEDEYF 240
Query: 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPF 306
S A+ FI R LV + KR++ ++ L P++ + + + + F
Sbjct: 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQF 292
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 6e-47
Identities = 66/340 (19%), Positives = 131/340 (38%), Gaps = 34/340 (10%)
Query: 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL 86
Y + +VLG G V + ++ + A ++ D + EV L
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARREVELHWRA 61
Query: 87 -KHDSIIRFYTSWIDV--DQKTFNFITEMFTSGTLREY--RKKYRRVDIRAIKSWARQIL 141
+ I+R + ++ +K + E G L + + R + I
Sbjct: 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 121
Query: 142 QGLVYLHSRDPPVIHRDLKCDNIFVNGHL--GQVKIGDLGLAAILRGSKSAHSVIGTPEF 199
+ + YLHS + + HRD+K +N+ +K+ D G A S + TP +
Sbjct: 122 EAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY 179
Query: 200 MAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPY---SECANPAQIYKKVTSGK--LPGA 253
+APE+ E Y++ D++S G+ + + P+ A + ++ G+ P
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239
Query: 254 FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNETEL 312
+S E + I L ++R++ E + P++ TK+ Q P L
Sbjct: 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS-------TKVPQTPLHTSRVL 292
Query: 313 EKLQLSDDPPRTDMT-ITGKLNPEDDTIFLKVQIADKDGP 351
++ + + + +MT + + + I +K +I D P
Sbjct: 293 KEDKERWEDVKEEMTSALATMRVDYEQIKIK-KIEDASNP 331
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-46
Identities = 68/329 (20%), Positives = 138/329 (41%), Gaps = 29/329 (8%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
+ ++LGKG V ++ G A +R E++ + D++ +E +L +H +
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRD 151
+ F+ E G L + + R + + +I+ L YLHSR
Sbjct: 68 TALK--YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR- 124
Query: 152 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS-AHSVIGTPEFMAPELYE-EDY 209
V++RD+K +N+ ++ G +KI D GL + + GTPE++APE+ E DY
Sbjct: 125 -DVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 210 NELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRC 269
VD + G+ + EM P+ + ++++ + ++ F EA+ +
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGL 239
Query: 270 LV-NASKRLS-----AKELLLDPFLAS-DEVKLLSKT-----------KLNQKPFLNETE 311
L + +RL AKE++ F S + ++ K +++ + F +E
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFT 299
Query: 312 LEKLQLSDDPPRTDMTITGKLNPEDDTIF 340
+ + ++ + + E+ +F
Sbjct: 300 AQSITITPPDRYDSLGLLELDQREEQEMF 328
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 154 bits (389), Expect = 3e-44
Identities = 65/272 (23%), Positives = 109/272 (40%), Gaps = 14/272 (5%)
Query: 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLST 85
+ RY E+LG G M V+ A D L +VA +R +L R P R E +
Sbjct: 6 SDRY-ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAA 63
Query: 86 LKHDSIIRFYTSWIDVDQ--KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQG 143
L H +I+ Y + + E TLR+ + + Q
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 144 LVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS----AHSVIGTPEF 199
L + H +IHRD+K NI ++ VK+ D G+A + S + +VIGT ++
Sbjct: 124 LNFSHQN--GIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 200 MAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL-PGAFYSI 257
++PE + + DVYS G + E+ T E P++ + + Y+ V + P A +
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240
Query: 258 QDLEAQRFIGRCL-VNASKRLSAKELLLDPFL 288
+ + + L N R + +
Sbjct: 241 LSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 7e-44
Identities = 55/272 (20%), Positives = 108/272 (39%), Gaps = 21/272 (7%)
Query: 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNEL--MRSPDDLQRLYSEVHLL 83
+Y +LG G +VY I + VA V + + + R+ EV LL
Sbjct: 3 ESQY-QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 84 STLK--HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQIL 141
+ +IR + + L ++ + + +S+ Q+L
Sbjct: 62 KKVSSGFSGVIRLLDWFER-PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 142 QGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMA 201
+ + + H+ V+HRD+K +NI ++ + G++K+ D G A+L+ + GT +
Sbjct: 121 EAVRHCHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSP 177
Query: 202 PELY--EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259
PE + V+S G+ + +M + P+ +++ G++ F
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------DEEIIRGQVF--FRQRVS 228
Query: 260 LEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290
E Q I CL S R + +E+ P++
Sbjct: 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 152 bits (386), Expect = 2e-43
Identities = 48/270 (17%), Positives = 96/270 (35%), Gaps = 17/270 (6%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
E+V+G G V ++ G + ++ + + + SE ++ H ++
Sbjct: 30 IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 89
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVYLHSR 150
I + ITE +G+L + R+ + + + R I G+ YL
Sbjct: 90 IHLE--GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA-- 145
Query: 151 DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSV------IGTPEFMAPEL 204
D +HRDL NI VN + K+ D GL+ L S + + APE
Sbjct: 146 DMNYVHRDLAARNILVNSN-LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204
Query: 205 YE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263
+ + DV+S+G+ + E+ + + +
Sbjct: 205 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPS-ALH 263
Query: 264 RFIGRCL-VNASKRLSAKELL--LDPFLAS 290
+ + C + + R +++ LD + +
Sbjct: 264 QLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 152 bits (386), Expect = 3e-43
Identities = 69/275 (25%), Positives = 130/275 (47%), Gaps = 19/275 (6%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
LG G+ V+ G A ++ E++ ++ E +LS + H I
Sbjct: 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK-KEIVVRLKQVEHTNDERLMLSIVTHPFI 66
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRD 151
IR + ++ D + I + G L +K +R K +A ++ L YLHS
Sbjct: 67 IRMWGTFQ--DAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS-- 122
Query: 152 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE-LYEEDYN 210
+I+RDLK +NI ++ + G +KI D G A + +++ GTP+++APE + + YN
Sbjct: 123 KDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPDVT--YTLCGTPDYIAPEVVSTKPYN 179
Query: 211 ELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCL 270
+ +D +SFG+ + EM P+ + +N + Y+K+ + +L F + + + + R +
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAELR--FPPFFNEDVKDLLSRLI 236
Query: 271 V-NASKRL-----SAKELLLDPFLAS-DEVKLLSK 298
+ S+RL +++ P+ KLLS+
Sbjct: 237 TRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSR 271
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 3e-43
Identities = 70/320 (21%), Positives = 142/320 (44%), Gaps = 21/320 (6%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLS-TLKHDS 90
++LGKG+ V+ A + A ++ +++ DD++ E +LS +H
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALK-KDVVLMDDDVECTMVEKRVLSLAWEHPF 64
Query: 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSR 150
+ + ++ ++ F+ E G L + + + D+ +A +I+ GL +LHS+
Sbjct: 65 LTHMFCTF--QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 151 DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSKSAHSVIGTPEFMAPE-LYEED 208
+++RDLK DNI ++ G +KI D G+ G ++ GTP+++APE L +
Sbjct: 123 G--IVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179
Query: 209 YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGR 268
YN VD +SFG+ + EM + P+ + +++ + + + EA+ + +
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVK 236
Query: 269 CLV-NASKRLSAK-ELLLDPFLASDEVKLLSKTKLNQKPFL----NETELEKL--QLSDD 320
V KRL + ++ P + L + ++ PF + + + ++
Sbjct: 237 LFVREPEKRLGVRGDIRQHPLFREINWEELERKEI-DPPFRPKVKSPFDCSNFDKEFLNE 295
Query: 321 PPRTDMTITGKLNPEDDTIF 340
PR +N D +F
Sbjct: 296 KPRLSFADRALINSMDQNMF 315
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-42
Identities = 48/256 (18%), Positives = 101/256 (39%), Gaps = 19/256 (7%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
+ +GKG V G +VA +++ Q +E +++ L+H ++
Sbjct: 11 LLQTIGKGEFGDVMLGDYR--GNKVAVKC------IKNDATAQAFLAEASVMTQLRHSNL 62
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREY--RKKYRRVDIRAIKSWARQILQGLVYLHS 149
++ ++ + +TE G+L +Y + + + ++ + + + YL
Sbjct: 63 VQLLGVIVEEKGGLY-IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 150 RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE-LYEED 208
+HRDL N+ V+ K+ D GL S + + ++ APE L E+
Sbjct: 122 N--NFVHRDLAARNVLVSED-NVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALREKK 176
Query: 209 YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGR 268
++ DV+SFG+ + E+++ + +V G A +
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP-AVYEVMKN 235
Query: 269 CL-VNASKRLSAKELL 283
C ++A+ R S +L
Sbjct: 236 CWHLDAAMRPSFLQLR 251
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-42
Identities = 48/257 (18%), Positives = 96/257 (37%), Gaps = 17/257 (6%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
F + +G G V+ +VA +R + E ++ L H +
Sbjct: 9 FVQEIGSGQFGLVHLGYWLN-KDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVYLHSR 150
++ Y ++ Q + E G L +Y R + + + +G+ YL
Sbjct: 63 VQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE-- 118
Query: 151 DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS--VIGTPEFMAPE-LYEE 207
+ VIHRDL N V + +K+ D G+ + + S ++ +PE
Sbjct: 119 EACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 208 DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIG 267
Y+ DV+SFG+ + E+F+ E + +++ + +++G + + +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-YKPRLASTHVYQIMN 236
Query: 268 RCL-VNASKRLSAKELL 283
C R + LL
Sbjct: 237 HCWKERPEDRPAFSRLL 253
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-42
Identities = 56/269 (20%), Positives = 103/269 (38%), Gaps = 21/269 (7%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
E LG G V+ +VA ++ + +E +L+ L+H +
Sbjct: 17 LVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSP-----DAFLAEANLMKQLQHQRL 70
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRV--DIRAIKSWARQILQGLVYLHS 149
+R Y + ITE +G+L ++ K + I + A QI +G+ ++
Sbjct: 71 VRLYAVVTQ---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 150 RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH--SVIGTPEFMAP-ELYE 206
R IHRDL+ NI V+ KI D GLA ++ ++ ++ AP +
Sbjct: 128 R--NYIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 207 EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFI 266
+ DV+SFG+ + E+ T ++ + + G + + E + +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE-ELYQLM 243
Query: 267 GRCL-VNASKRLSAKELL--LDPFLASDE 292
C R + L L+ F + E
Sbjct: 244 RLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-42
Identities = 68/327 (20%), Positives = 124/327 (37%), Gaps = 48/327 (14%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
+V+G G+ VY+A G VA +V ++ + E+ ++ L H +I
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--------RFKNRELQIMRKLDHCNI 75
Query: 92 IR----FYTSWIDVDQKTFNFITEMFTSG---TLREYRKKYRRVDIRAIKSWARQILQGL 144
+R FY+S D+ N + + R Y + + + + +K + Q+ + L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 145 VYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPEL 204
Y+HS + HRD+K N+ ++ +K+ D G A L + S I + + APEL
Sbjct: 136 AYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 205 Y--EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYK------------------- 243
DY +DV+S G + E+ + + + Q+ +
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 244 -------KVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVKL 295
++ + F EA R L + RL+ E F DE++
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELRD 311
Query: 296 LSKTKLNQKPFLNETELEKLQLSDDPP 322
+ N + +LS +PP
Sbjct: 312 PNVKLPNGRDTPALFNFTTQELSSNPP 338
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 6e-42
Identities = 55/259 (21%), Positives = 99/259 (38%), Gaps = 17/259 (6%)
Query: 33 EEVLGKGAMKTVYKAIDEV--LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDS 90
++ LG G TV K ++ + VA L P L +E +++ L +
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVK--ILKNEANDPALKDELLAEANVMQQLDNPY 69
Query: 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSR 150
I+R + +++ + EM G L +Y ++ R V + I Q+ G+ YL
Sbjct: 70 IVRMIGIC---EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 151 DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS----KSAHSVIGTPEFMAPE-LY 205
+HRDL N+ + KI D GL+ LR K+ ++ APE +
Sbjct: 127 --NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 206 EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRF 265
++ DV+SFG+ + E F+ +++ + G+ G E
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR-EMYDL 242
Query: 266 IGRCL-VNASKRLSAKELL 283
+ C + R +
Sbjct: 243 MNLCWTYDVENRPGFAAVE 261
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 1e-41
Identities = 66/306 (21%), Positives = 114/306 (37%), Gaps = 36/306 (11%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDS 90
F++V+G+G V KA + G+ + R+ E S DD + E+ +L L H +
Sbjct: 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPN 72
Query: 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKY----------------RRVDIRAIK 134
II + E G L ++ +K + + +
Sbjct: 73 IINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 135 SWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVI 194
+A + +G+ YL IHRDL NI V + KI D GL+
Sbjct: 131 HFAADVARGMDYLSQ--KQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGR 187
Query: 195 GTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA 253
+MA E L Y DV+S+G+ + E+ + A++Y+K+ G
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 247
Query: 254 FYSIQDLEAQRFIGRCL-VNASKRLSAKELLLDPFLASDEVKLLSKTKLNQKPFLNETEL 312
+ D E + +C +R S ++L L++ +K ++N T
Sbjct: 248 PLNCDD-EVYDLMRQCWREKPYERPSFAQIL----------VSLNRMLEERKTYVNTTLY 296
Query: 313 EKLQLS 318
EK +
Sbjct: 297 EKFTYA 302
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 1e-41
Identities = 59/262 (22%), Positives = 102/262 (38%), Gaps = 17/262 (6%)
Query: 32 FEEVLGKGAMKTVYKAIDEVL---GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH 88
E LG G+ V + + V VA ++ +++ P+ + EV+ + +L H
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK-PDVLSQPEAMDDFIREVNAMHSLDH 70
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYR-KKYRRVDIRAIKSWARQILQGLVYL 147
++IR Y + +TE+ G+L + K + + +A Q+ +G+ YL
Sbjct: 71 RNLIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 148 HSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH----SVIGTPEFMAPE 203
S+ IHRDL N+ + VKIGD GL L + + + APE
Sbjct: 128 ESK--RFIHRDLAARNLLLATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 204 -LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA 262
L ++ D + FG+ + EMFT N +QI K+ +
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244
Query: 263 QRFIGRCL-VNASKRLSAKELL 283
+ +C R + L
Sbjct: 245 YNVMVQCWAHKPEDRPTFVALR 266
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-41
Identities = 54/273 (19%), Positives = 110/273 (40%), Gaps = 20/273 (7%)
Query: 32 FEEVLGKGAMKTVYKAID---EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH 88
+G+G V++ I E + VA ++ + S ++ E + H
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVA---IKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVYL 147
I++ + I E+ T G LR + + + +D+ ++ +A Q+ L YL
Sbjct: 68 PHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 148 HSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS--VIGTPEFMAPE-L 204
S+ +HRD+ N+ V+ + VK+GD GL+ + S + ++MAPE +
Sbjct: 125 ESK--RFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 205 YEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQR 264
+ DV+ FG+C+ E+ + + ++ +G+ +
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP-TLYS 240
Query: 265 FIGRCL-VNASKRLSAKELL--LDPFLASDEVK 294
+ +C + S+R EL L L ++ +
Sbjct: 241 LMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 273
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 2e-41
Identities = 66/276 (23%), Positives = 123/276 (44%), Gaps = 21/276 (7%)
Query: 32 FEEVLGKGAMKTVYKAID----EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
+VLG GA TVYK + E + + VA ++R SP + + E ++++++
Sbjct: 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVD 69
Query: 88 HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYR-KKYRRVDIRAIKSWARQILQGLVY 146
+ + R + T IT++ G L +Y + + + + +W QI +G+ Y
Sbjct: 70 NPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH---SVIGTPEFMAPE 203
L R ++HRDL N+ V VKI D GLA +L + + ++MA E
Sbjct: 127 LEDR--RLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 204 -LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA 262
+ Y DV+S+G+ V E+ T + ++I + G+ I ++
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-PQPPICTIDV 242
Query: 263 QRFIGRCL-VNASKRLSAKELLLDP-FLASDEVKLL 296
+ +C ++A R +EL+++ +A D + L
Sbjct: 243 YMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL 278
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-41
Identities = 52/298 (17%), Positives = 108/298 (36%), Gaps = 21/298 (7%)
Query: 6 QLAGAADEAKAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAID---EVLGVEVAWNQVR 62
L+ E + ++ P+ F EV+G+G VY + + A +
Sbjct: 5 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 64
Query: 63 LNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYR 122
+ ++ + +E ++ H +++ + + + G LR +
Sbjct: 65 R---ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFI 120
Query: 123 K-KYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181
+ + ++ + + Q+ +G+ +L +HRDL N ++ VK+ D GLA
Sbjct: 121 RNETHNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEK-FTVKVADFGLA 177
Query: 182 AILRGSKSAH-----SVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSEC 235
+ + ++MA E L + + DV+SFG+ + E+ T P
Sbjct: 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237
Query: 236 ANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCL-VNASKRLSAKELL--LDPFLAS 290
N I + G+ D + +C A R S EL+ + ++
Sbjct: 238 VNTFDITVYLLQGRRLLQPEYCPD-PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 4e-41
Identities = 62/288 (21%), Positives = 113/288 (39%), Gaps = 35/288 (12%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDL-QRLYSEVHLLSTLKHDSII 92
+ LG+G TVYKA D+ VA +++L + D + + E+ LL L H +II
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 93 RFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDP 152
++ + + + + + + + IK++ LQGL YLH
Sbjct: 64 GLLDAFG--HKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119
Query: 153 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS-VIGTPEFMAPELYEED--Y 209
++HRDLK +N+ ++ + G +K+ D GLA A++ + T + APEL Y
Sbjct: 120 WILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 210 NELVDVYSFGMCVLEMFTCEYPYS-------------------------ECANPAQIYKK 244
VD+++ G + E+ C+ P + K
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 245 VTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291
G +S + I + N R++A + L + ++
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 147 bits (372), Expect = 7e-41
Identities = 65/281 (23%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
+ LG G+ V + G A + + + ++ +E +L + +++
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPP 153
S+ D + E G + + ++ R + +A QI+ YLHS D
Sbjct: 106 LEFSFK--DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD-- 161
Query: 154 VIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE-LYEEDYNEL 212
+I+RDLK +N+ ++ G +++ D G A ++G ++ GTPE +APE + + YN+
Sbjct: 162 LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGRT--WTLCGTPEALAPEIILSKGYNKA 218
Query: 213 VDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCL-V 271
VD ++ G+ + EM P+ P QIY+K+ SGK+ F S + + + L V
Sbjct: 219 VDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQV 275
Query: 272 NASKRL-----SAKELLLDPFLASDEVKLLSKTKLNQKPFL 307
+ +KR ++ + A+ + + + K+ + PF+
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKV-EAPFI 315
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 8e-41
Identities = 51/257 (19%), Positives = 98/257 (38%), Gaps = 17/257 (6%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
F + LG G V +VA ++ + E ++ L H+ +
Sbjct: 8 FLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE-----DEFIEEAKVMMNLSHEKL 61
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVYLHSR 150
++ Y Q+ ITE +G L Y R+ R + + + + + + YL S+
Sbjct: 62 VQLYGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 151 DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS--VIGTPEFMAPELYE-E 207
+HRDL N VN G VK+ D GL+ + + S + PE+
Sbjct: 120 --QFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 208 DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIG 267
++ D+++FG+ + E+++ E ++ + + G + + +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-YRPHLASEKVYTIMY 235
Query: 268 RCL-VNASKRLSAKELL 283
C A +R + K LL
Sbjct: 236 SCWHEKADERPTFKILL 252
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-40
Identities = 50/269 (18%), Positives = 104/269 (38%), Gaps = 21/269 (7%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
E LG+G V+ VA ++ + + E ++ L+H+ +
Sbjct: 21 LEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-----EAFLQEAQVMKKLRHEKL 74
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREY--RKKYRRVDIRAIKSWARQILQGLVYLHS 149
++ Y ++ +TE + G+L ++ + + + + + A QI G+ Y+
Sbjct: 75 VQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 150 RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSK--SAHSVIGTPEFMAPE-LYE 206
+HRDL+ NI V + K+ D GLA ++ ++ + ++ APE
Sbjct: 132 M--NYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 207 EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFI 266
+ DV+SFG+ + E+ T ++ +V G + +
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE-SLHDLM 247
Query: 267 GRCL-VNASKRLSAKELL--LDPFLASDE 292
+C +R + + L L+ + S E
Sbjct: 248 CQCWRKEPEERPTFEYLQAFLEDYFTSTE 276
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (364), Expect = 2e-40
Identities = 58/274 (21%), Positives = 104/274 (37%), Gaps = 23/274 (8%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
+ LG G VY+ + + + VA ++ +++ E ++ +KH ++
Sbjct: 21 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNL 75
Query: 92 IRFYTSWIDVDQKTFNFITEMFTSGTLREY--RKKYRRVDIRAIKSWARQILQGLVYLHS 149
++ + F ITE T G L +Y + V + A QI + YL
Sbjct: 76 VQLLGVC--TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 150 RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS--VIGTPEFMAP-ELYE 206
+ IHRDL N V + VK+ D GL+ ++ G ++ AP L
Sbjct: 134 K--NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 207 EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFI 266
++ DV++FG+ + E+ T + +Q+Y+ + + +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMERPEGCPEKVYELM 249
Query: 267 GRCL-VNASKRLSAKELL--LDPFL----ASDEV 293
C N S R S E+ + SDEV
Sbjct: 250 RACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 283
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 146 bits (369), Expect = 2e-40
Identities = 67/321 (20%), Positives = 129/321 (40%), Gaps = 19/321 (5%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDD--LQRLYSEVHLLSTLKHD 89
++G+G VY G A + + + + L+ST
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67
Query: 90 SIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHS 149
I+ ++ D+ +FI ++ G L + ++ ++ +A +I+ GL ++H+
Sbjct: 68 FIVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 150 RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYEED- 208
R V++RDLK NI ++ H G V+I DLGLA K H+ +GT +MAPE+ ++
Sbjct: 126 RF--VVYRDLKPANILLDEH-GHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQKGV 181
Query: 209 -YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIG 267
Y+ D +S G + ++ P+ + + + + E + +
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241
Query: 268 RCL-VNASKRLS-----AKELLLDPFLASDEVKLLSKTKLNQKPFLNETELEKLQLSDDP 321
L + ++RL A+E+ PF S + +++ K P + + D
Sbjct: 242 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKY-PPPLIPPRGEVNAADAFDI 300
Query: 322 PRTDMTITG--KLNPEDDTIF 340
D T KL D ++
Sbjct: 301 GSFDEEDTKGIKLLDSDQELY 321
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-40
Identities = 46/273 (16%), Positives = 97/273 (35%), Gaps = 22/273 (8%)
Query: 20 YIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVL--GVEVAWNQVRLNELMRSPDDLQRLY 77
+++ D + + LG G +V + + + ++VA ++ D + +
Sbjct: 4 FLKRD---NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMM 57
Query: 78 SEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSW 136
E ++ L + I+R + + EM G L ++ K + + +
Sbjct: 58 REAQIMHQLDNPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 114
Query: 137 ARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH----S 192
Q+ G+ YL + +HRDL N+ + KI D GL+ L S + +
Sbjct: 115 LHQVSMGMKYLEEK--NFVHRDLAARNVLLVNR-HYAKISDFGLSKALGADDSYYTARSA 171
Query: 193 VIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP 251
++ APE + ++ DV+S+G+ + E + + ++ + GK
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 231
Query: 252 GAFYSIQDLEAQRFIGRCL-VNASKRLSAKELL 283
E + C R +
Sbjct: 232 ECPPECPP-ELYALMSDCWIYKWEDRPDFLTVE 263
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 6e-40
Identities = 61/311 (19%), Positives = 115/311 (36%), Gaps = 49/311 (15%)
Query: 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLL 83
D +Y + +G+G V+KA G +VA +V + E+ +L
Sbjct: 7 DEVSKYEKLAK-IGQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPITALREIKIL 63
Query: 84 STLKHDSIIRFY------TSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWA 137
LKH++++ S + + + + + + + IK
Sbjct: 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 123
Query: 138 RQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH-----S 192
+ +L GL Y+H ++HRD+K N+ + G +K+ D GLA +K++ +
Sbjct: 124 QMLLNGLYYIHR--NKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYTN 180
Query: 193 VIGTPEFMAPE--LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYK------- 243
+ T + PE L E DY +D++ G + EM+T Q+
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240
Query: 244 ---------------------KVTSGKLPGAFYS-IQDLEAQRFIGRCLV-NASKRLSAK 280
K K+ + ++D A I + LV + ++R+ +
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
Query: 281 ELLLDPFLASD 291
+ L F SD
Sbjct: 301 DALNHDFFWSD 311
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-39
Identities = 59/280 (21%), Positives = 107/280 (38%), Gaps = 23/280 (8%)
Query: 32 FEEVLGKGAMKTVYKAI----DEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
++V+G G VYK + V VA ++ + E ++
Sbjct: 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDFLGEAGIMGQFS 67
Query: 88 HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREY-RKKYRRVDIRAIKSWARQILQGLVY 146
H +IIR K ITE +G L ++ R+K + + R I G+ Y
Sbjct: 68 HHNIIRLEGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 147 LHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL----RGSKSAHSVIGTPEFMAP 202
L + +HRDL NI VN + K+ D GL+ +L + + + AP
Sbjct: 126 LAN--MNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 203 E-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLE 261
E + + DV+SFG+ + E+ T + ++ K + G
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS-A 241
Query: 262 AQRFIGRCL-VNASKRLSAKELL--LDPFLAS-DEVKLLS 297
+ + +C ++R +++ LD + + D +K L+
Sbjct: 242 IYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLA 281
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-38
Identities = 60/283 (21%), Positives = 101/283 (35%), Gaps = 36/283 (12%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMR--SPDDLQRLYSEVHLLSTL-KH 88
F +VLG GA V A + QV + L + + L SE+ +++ L H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRR--------------------- 127
++I+ + I E G L Y + R
Sbjct: 101 ENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158
Query: 128 --VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185
+ + +A Q+ +G+ +L + +HRDL N+ V VKI D GLA +
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHG-KVVKICDFGLARDIM 215
Query: 186 GSKSAH---SVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQI 241
+ + ++MAPE L+E Y DV+S+G+ + E+F+
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
Query: 242 YKKVTSGKLPGAFYSIQDLEAQRFIGRCL-VNASKRLSAKELL 283
+ K+ E + C ++ KR S L
Sbjct: 276 FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-38
Identities = 73/328 (22%), Positives = 121/328 (36%), Gaps = 45/328 (13%)
Query: 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLL 83
D RY +G+GA V A D V V VA ++ E QR E+ +L
Sbjct: 5 DVGPRY-TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKIL 60
Query: 84 STLKHDSIIRFYTSWIDVDQKTF-NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQ 142
+H++II + + G K + + I + QIL+
Sbjct: 61 LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILR 120
Query: 143 GLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH----SVIGTPE 198
GL Y+HS V+HRDLK N+ +N +KI D GLA + + T
Sbjct: 121 GLKYIHSA--NVLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 199 FMAPELY--EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA--- 253
+ APE+ + Y + +D++S G + EM + + Q+ + P
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237
Query: 254 -------------------------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPF 287
+ D +A + + L N KR+ ++ L P+
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297
Query: 288 LASDEVKLLSKTKLNQKPFLNETELEKL 315
L ++ S + + PF + EL+ L
Sbjct: 298 L--EQYYDPSDEPIAEAPFKFDMELDDL 323
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 3e-38
Identities = 77/297 (25%), Positives = 120/297 (40%), Gaps = 36/297 (12%)
Query: 26 NGRYGLFEEVLGKGAMKTVYKAID-EVLGVEVAWNQVRLNELMRS-PDDLQRLYSEVHLL 83
+ +Y +G+GA V+KA D + G VA +VR+ P R + + L
Sbjct: 6 DQQYEC-VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 84 STLKHDSIIRFYTSWIDVDQKTFN---FITEMFTSGTLREY-RKKYRRVDIRAIKSWARQ 139
T +H +++R + + E + V IK Q
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 140 ILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEF 199
+L+GL +LHS V+HRDLK NI V GQ+K+ D GLA I + SV+ T +
Sbjct: 125 LLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWY 181
Query: 200 MAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258
APE L + Y VD++S G EMF + + ++ Q+ K + LPG +
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 259 DL------------------------EAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290
D+ + + +CL N +KR+SA L P+
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 139 bits (350), Expect = 4e-38
Identities = 52/298 (17%), Positives = 112/298 (37%), Gaps = 51/298 (17%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDS 90
LG+G V++AI+ +V ++ P +++ E+ +L L+ +
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRGGPN 91
Query: 91 IIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSR 150
II D +T + E + ++ Y+ + I+ + +IL+ L Y HS
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSM 148
Query: 151 DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYEED-- 208
++HRD+K N+ ++ ++++ D GLA + + + + F PEL +
Sbjct: 149 --GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206
Query: 209 YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVT---------------------- 246
Y+ +D++S G + M + P+ + ++
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 247 -------------SGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290
+ + EA F+ + L + RL+A+E + P+ +
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 7e-38
Identities = 67/288 (23%), Positives = 114/288 (39%), Gaps = 38/288 (13%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
E +G+G VYKA +++ G VA ++RL+ + E+ LL L H +I++
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 65
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDP 152
+ + E + + + IKS+ Q+LQGL + HS
Sbjct: 66 LLDVIHT--ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-- 121
Query: 153 PVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL-RGSKSAHSVIGTPEFMAPELYEED--Y 209
V+HRDLK N+ +N G +K+ D GLA ++ + T + APE+ Y
Sbjct: 122 RVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 210 NELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQ----------- 258
+ VD++S G EM T + + Q+++ + P
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 259 ---------------DLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290
D + + + + L + +KR+SAK L PF
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 136 bits (343), Expect = 2e-37
Identities = 49/282 (17%), Positives = 102/282 (36%), Gaps = 30/282 (10%)
Query: 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLST 85
RY +G G+ +Y D G EVA +L +L+ E +
Sbjct: 6 GNRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAI------KLECVKTKHPQLHIESKIYKM 58
Query: 86 LKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLV 145
++ I W + + E+ + R+ ++ + A Q++ +
Sbjct: 59 MQGGVGIPTI-RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 117
Query: 146 YLHSRDPPVIHRDLKCDNIFV--NGHLGQVKIGDLGLAAILRGSKS--------AHSVIG 195
Y+HS++ IHRD+K DN + V I D GLA R +++ ++ G
Sbjct: 118 YIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175
Query: 196 TPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCE--YPYSECANPAQIYKKVTSGKLPG 252
T + + + + + D+ S G ++ + + A Q Y++++ K+
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235
Query: 253 AFYSIQD---LEAQRFIGRCL-VNASKRLSA---KELLLDPF 287
+ E ++ C + + ++L + F
Sbjct: 236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 135 bits (341), Expect = 3e-37
Identities = 62/285 (21%), Positives = 107/285 (37%), Gaps = 38/285 (13%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
E +G+G VYKA + G A ++RL E+ +L LKH +I++
Sbjct: 8 EKIGEGTYGVVYKAQNN-YGETFALKKIRLE--KEDEGIPSTTIREISILKELKHSNIVK 64
Query: 94 FYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPP 153
Y +K + E + ++ KS+ Q+L G+ Y H R
Sbjct: 65 LYDVIHT--KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR--R 120
Query: 154 VIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR-GSKSAHSVIGTPEFMAPELYEED--YN 210
V+HRDLK N+ +N G++KI D GLA + I T + AP++ Y+
Sbjct: 121 VLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 211 ELVDVYSFGMCVLEMFTCEYPYSECANPAQIYK--------------------------K 244
+D++S G EM + + Q+ +
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 245 VTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288
V +F D + + L + ++R++AK+ L +
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 7e-37
Identities = 59/286 (20%), Positives = 120/286 (41%), Gaps = 24/286 (8%)
Query: 32 FEEVLGKGAMKTVYKAID---EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH 88
+VLG GA V+ G A ++ +++ + +E +L ++
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 89 DSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLH 148
+ + + I + G L + + R ++ + +I+ L +LH
Sbjct: 88 SPFLVTLHYAFQ-TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH 146
Query: 149 SRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG--SKSAHSVIGTPEFMAPELY- 205
+I+RD+K +NI ++ + G V + D GL+ ++ A+ GT E+MAP++
Sbjct: 147 KL--GIIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 206 --EEDYNELVDVYSFGMCVLEMFTCEYPY---SECANPAQIYKKVTSGKLPGAFYSIQDL 260
+ +++ VD +S G+ + E+ T P+ E + A+I +++ + P +
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSA 261
Query: 261 EAQRFIGRCLV-NASKRLS-----AKELLLDPFLAS-DEVKLLSKT 299
A+ I R L+ + KRL A E+ F + L +K
Sbjct: 262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKK 307
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (339), Expect = 8e-37
Identities = 53/286 (18%), Positives = 94/286 (32%), Gaps = 43/286 (15%)
Query: 32 FEEVLGKGAMKTVYKAIDEVL-----GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL 86
+ +G+GA V++A L VA ++ S D E L++
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAALMAEF 73
Query: 87 KHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRR------------------- 127
+ +I++ K + E G L E+ +
Sbjct: 74 DNPNIVKLLGVCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 128 -----VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182
+ ARQ+ G+ YL +HRDL N V + VKI D GL+
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGEN-MVVKIADFGLSR 188
Query: 183 ILRGSKSAH---SVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANP 238
+ + + +M PE ++ Y DV+++G+ + E+F+
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248
Query: 239 AQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCL-VNASKRLSAKELL 283
++ V G + A LE + C + R S +
Sbjct: 249 EEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 9e-37
Identities = 62/306 (20%), Positives = 113/306 (36%), Gaps = 51/306 (16%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSI 91
+E +GKG V++ G EVA E + +E++ L+H++I
Sbjct: 7 LQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENI 59
Query: 92 IRFYTSWIDVDQ--KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHS 149
+ F + + +++ G+L +Y +Y V + + A GL +LH
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHM 118
Query: 150 ------RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG-----SKSAHSVIGTPE 198
P + HRDLK NI V + G I DLGLA + + +GT
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 199 FMAPELYEE-------DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG--- 248
+MAPE+ ++ + + D+Y+ G+ E+ + Y +
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
Query: 249 ---------------KLPGAFYSIQDLEA-QRFIGRCL-VNASKRLSAKELL--LDPFLA 289
+P + S + L + + C N + RL+A + L
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
Query: 290 SDEVKL 295
+ +K+
Sbjct: 298 QEGIKM 303
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 1e-36
Identities = 64/293 (21%), Positives = 116/293 (39%), Gaps = 39/293 (13%)
Query: 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK 87
+Y E+ +G+G TV+KA + VA +VRL++ E+ LL LK
Sbjct: 3 KYEKLEK-IGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELK 59
Query: 88 HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYL 147
H +I+R + K + E + + +D +KS+ Q+L+GL +
Sbjct: 60 HKNIVRLHDVLH--SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 148 HSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS-VIGTPEFMAPELY- 205
HSR V+HRDLK N+ +N + G++K+ + GLA +S + T + P++
Sbjct: 118 HSR--NVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 206 -EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL---- 260
+ Y+ +D++S G E+ P + K++ +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 261 -----------------------EAQRFIGRCLV-NASKRLSAKELLLDPFLA 289
+ + L N +R+SA+E L P+ +
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-36
Identities = 60/281 (21%), Positives = 109/281 (38%), Gaps = 37/281 (13%)
Query: 32 FEEVLGKGAMKTVYKAIDEVL-----GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL 86
F + LG GA V +A L + VA ++ + + + L SE+ +LS L
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYL 83
Query: 87 K-HDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR------------------R 127
H +I+ + ITE G L + ++ R
Sbjct: 84 GNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 128 VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187
+D+ + S++ Q+ +G+ +L S++ IHRDL NI + KI D GLA ++
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHG-RITKICDFGLARDIKND 198
Query: 188 KSAHS---VIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYK 243
+ ++MAPE ++ Y DV+S+G+ + E+F+ +
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 244 KVTSGKLPGAFYSIQDLEAQRFIGRCL-VNASKRLSAKELL 283
K+ E + C + KR + K+++
Sbjct: 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 6e-35
Identities = 54/269 (20%), Positives = 100/269 (37%), Gaps = 23/269 (8%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMR--SPDDLQRLYSEVHLLSTLKHD 89
LG+G+ VY+ + + + + +V + + S + +E ++
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 90 SIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRV----------DIRAIKSWARQ 139
++R I E+ T G L+ Y + R + + A +
Sbjct: 84 HVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 140 ILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH---SVIGT 196
I G+ YL++ +HRDL N V VKIGD G+ + + +
Sbjct: 142 IADGMAYLNAN--KFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 197 PEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFY 255
+M+PE L + + DV+SFG+ + E+ T + + Q+ + V G L
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 258
Query: 256 SIQDLEAQRFIGRCL-VNASKRLSAKELL 283
+ D + C N R S E++
Sbjct: 259 NCPD-MLFELMRMCWQYNPKMRPSFLEII 286
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 8e-35
Identities = 68/309 (22%), Positives = 121/309 (39%), Gaps = 41/309 (13%)
Query: 15 KAHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQ 74
+ + + Y + +G GA V A+D G +VA ++ +S +
Sbjct: 6 RQEVTKTAWEVRAVYRD-LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP--FQSELFAK 62
Query: 75 RLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF--NFITEMFTSGTLREYRKKYRRVDIRA 132
R Y E+ LL ++H+++I + + +F M GT K+ ++
Sbjct: 63 RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR 122
Query: 133 IKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHS 192
I+ Q+L+GL Y+H+ HRDLK N+ VN ++KI D GLA
Sbjct: 123 IQFLVYQMLKGLRYIHAAGII--HRDLKPGNLAVNED-CELKILDFGLARQA--DSEMTG 177
Query: 193 VIGTPEFMAPELY--EEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL 250
+ T + APE+ Y + VD++S G + EM T + + + Q+ + +
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 251 P----------------------------GAFYSIQDLEAQRFIGRCLV-NASKRLSAKE 281
P + + A + + LV +A +R++A E
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297
Query: 282 LLLDPFLAS 290
L P+ S
Sbjct: 298 ALAHPYFES 306
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 1e-34
Identities = 57/276 (20%), Positives = 100/276 (36%), Gaps = 28/276 (10%)
Query: 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRS--PDDLQRLYSEVHLLSTLKHD 89
+ LG+GA V +A + V + L + + L SE+ +L + H
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 90 SIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRR----------------VDIRAI 133
+ I E G L Y + R + + +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 134 KSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAH-- 191
++ Q+ +G+ +L SR IHRDL NI ++ VKI D GLA +
Sbjct: 137 ICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRK 193
Query: 192 -SVIGTPEFMA-PELYEEDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSG 248
++MA +++ Y DV+SFG+ + E+F+ PY + +++ G
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 253
Query: 249 KLPGAFYSIQDLEAQRFIGRCL-VNASKRLSAKELL 283
E + + C S+R + EL+
Sbjct: 254 TRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 288
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 1e-34
Identities = 71/289 (24%), Positives = 118/289 (40%), Gaps = 40/289 (13%)
Query: 32 FEEVLGKGAMKTVYKAIDEVL-------GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLS 84
+ LG+GA V A L +VA ++ + + DL L SE+ ++
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMK 73
Query: 85 TL-KHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYR----------------R 127
+ KH +II + I E + G LREY + R +
Sbjct: 74 MIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 128 VDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187
+ + + S A Q+ +G+ YL S+ IHRDL N+ V +KI D GLA +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASK--KCIHRDLAARNVLVTED-NVMKIADFGLARDIHHI 188
Query: 188 KS---AHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYK 243
+ ++MAPE L++ Y DV+SFG+ + E+FT +++K
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248
Query: 244 KVTSGKLPGAFYSIQDLEAQRFIGRCL-VNASKRLSAKELL--LDPFLA 289
+ G + + E + C S+R + K+L+ LD +A
Sbjct: 249 LLKEGHRMDKPSNCTN-ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 123 bits (310), Expect = 1e-32
Identities = 34/276 (12%), Positives = 89/276 (32%), Gaps = 29/276 (10%)
Query: 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLST 85
Y +G+G+ +++ + + +VA + D +L E
Sbjct: 4 GVHY-KVGRRIGEGSFGVIFEGTNLLNNQQVAI------KFEPRRSDAPQLRDEYRTYKL 56
Query: 86 LKHDSIIRFYTSWIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLV 145
L + I + + ++ R+ ++ + A+Q+L +
Sbjct: 57 LAGCTGIPNVYYFGQEGLHNV-LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115
Query: 146 YLHSRDPPVIHRDLKCDNIFVN----GHLGQVKIGDLGLAAILRGSKS--------AHSV 193
+H + +++RD+K DN + + + + D G+ R + ++
Sbjct: 116 SIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 173
Query: 194 IGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT--CEYPYSECANPAQIYKKVTSGKL 250
GT +M+ + + + D+ + G + + + A Q Y+++ K
Sbjct: 174 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233
Query: 251 PGAFYSIQD---LEAQRFIGRCL-VNASKRLSAKEL 282
+ E +++ + L
Sbjct: 234 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYL 269
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 6e-32
Identities = 66/332 (19%), Positives = 124/332 (37%), Gaps = 56/332 (16%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
+ +G GA V A D VL VA ++ ++ +R Y E+ L+ + H +II
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--FQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 94 FYTSWIDVDQ----KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHS 149
+ + + E+ + + + + D + Q+L G+ +LHS
Sbjct: 81 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLHS 137
Query: 150 RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPE-LYEED 208
IHRDLK NI V +KI D GLA S + T + APE +
Sbjct: 138 AGI--IHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 209 YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFY------------- 255
Y E VD++S G + EM + + Q K + P +
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 256 --------------------------SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288
++ +A+ + + LV + +KR+S + L P++
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314
Query: 289 ASDEVKLLSKTKLNQKPFLNETELEKLQLSDD 320
+ ++ + P + + +L++ + + +
Sbjct: 315 --NVWYDPAEVEA-PPPQIYDKQLDEREHTIE 343
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 8e-32
Identities = 68/289 (23%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIR 93
+G GA +V A D G+ VA ++ +S +R Y E+ LL +KH+++I
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--FQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 94 FYTSWIDVD--QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRD 151
+ ++ + G K +++ ++ QIL+GL Y+HS D
Sbjct: 82 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 152 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELY--EEDY 209
+IHRDLK N+ VN ++KI D GLA + T + APE+ Y
Sbjct: 142 --IIHRDLKPSNLAVNED-CELKILDFGLARHT--DDEMTGYVATRWYRAPEIMLNWMHY 196
Query: 210 NELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQ----------- 258
N+ VD++S G + E+ T + + Q+ + PGA +
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256
Query: 259 -----------------DLEAQRFIGRCLV-NASKRLSAKELLLDPFLA 289
+ A + + LV ++ KR++A + L + A
Sbjct: 257 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (264), Expect = 6e-26
Identities = 66/339 (19%), Positives = 118/339 (34%), Gaps = 77/339 (22%)
Query: 16 AHIGYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQR 75
A G E + RY + LG G TV+ A D V VA VR +++ +
Sbjct: 4 AFKG--EPYKDARY-ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-----EA 55
Query: 76 LYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEMFTSGT--------------LREY 121
E+ LL + + + + K + +G
Sbjct: 56 AEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK 115
Query: 122 RKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVN-----GHLGQVKIG 176
+ ++R + + +K ++Q+L GL Y+H R +IH D+K +N+ + +L Q+KI
Sbjct: 116 KYEHRGIPLIYVKQISKQLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQIKIA 174
Query: 177 DLGLAAILRGSKSAHSVIGTPEFMAPE-LYEEDYNELVDVYSFGMCVLEMFTCEYPYS-- 233
DLG A + + I T E+ +PE L + D++S + E+ T ++ +
Sbjct: 175 DLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232
Query: 234 ----------------------------------ECANPAQIYKKVTSGKLPG------- 252
N + + ++ K
Sbjct: 233 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE 292
Query: 253 --AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288
F + E F+ L + KR A L+ P+L
Sbjct: 293 KYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 331
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 67.5 bits (164), Expect = 8e-14
Identities = 22/199 (11%), Positives = 57/199 (28%), Gaps = 21/199 (10%)
Query: 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNEL------MRSPDDLQRLYSEVHLLSTLK 87
+++G+G V+ E E ++ + + +
Sbjct: 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 88 HDSIIRFYTSWI--DVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLV 145
++ + + + + E+ + L R + IL+ +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPD-------EVLDMILEEVA 117
Query: 146 YLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELY 205
+ R ++H DL N+ V+ + I D + + + + +
Sbjct: 118 KFYHR--GIVHGDLSQYNVLVSEE--GIWIIDFPQSVEVGEEGWREILERDVRNII-TYF 172
Query: 206 EEDYNELVDVYSFGMCVLE 224
Y D+ S +L+
Sbjct: 173 SRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 466 | |||
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.03 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.9 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.46 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.31 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.86 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.39 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-64 Score=487.83 Aligned_cols=266 Identities=50% Similarity=0.914 Sum_probs=242.4
Q ss_pred eeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 21 IETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 21 ~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
+....+|||+++.+.||+|+||+||+|.++.+|+.||+|.+..... .....+.+.+|+++|++++|||||++|++|.+
T Consensus 2 ~g~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 79 (270)
T d1t4ha_ 2 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 79 (270)
T ss_dssp CEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCcCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee
Confidence 4567899999999999999999999999999999999999986653 45567889999999999999999999999865
Q ss_pred c--cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEecc
Q 012320 101 V--DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDL 178 (466)
Q Consensus 101 ~--~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DF 178 (466)
. ++..+|+|||||+||+|.+++.+.+.+++..++.|++||+.||+|||+++++|+||||||+|||+++..+.+||+||
T Consensus 80 ~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DF 159 (270)
T d1t4ha_ 80 TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 159 (270)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred ccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeec
Confidence 3 35678999999999999999999999999999999999999999999998889999999999999865589999999
Q ss_pred chhhhhcCCCCCccccCCCCcCCccccccCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 012320 179 GLAAILRGSKSAHSVIGTPEFMAPELYEEDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258 (466)
Q Consensus 179 Gla~~~~~~~~~~~~~GT~~y~APE~l~~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 258 (466)
|+|+.... ....+.+|||.|||||++.+.|+.++|||||||++|||++|..||.+..+..++++.+..+..|..+....
T Consensus 160 Gla~~~~~-~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (270)
T d1t4ha_ 160 GLATLKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 238 (270)
T ss_dssp TGGGGCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCC
T ss_pred CcceeccC-CccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccC
Confidence 99986443 34567889999999999999999999999999999999999999998889999999999988877777788
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCC
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLLDPFLA 289 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~ 289 (466)
++++++||.+||. ||++|||++|+|+||||+
T Consensus 239 ~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 239 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 8999999999996 999999999999999985
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-60 Score=464.29 Aligned_cols=258 Identities=33% Similarity=0.510 Sum_probs=225.0
Q ss_pred eeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 22 ~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
..||..||.++++ ||+|+||+||+|.++.+|+.||+|++.+.... ..+.+.+|+.+|++++|||||+++++|.
T Consensus 15 ~~dp~~~Y~~~~~-iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~-- 87 (293)
T d1yhwa1 15 VGDPKKKYTRFEK-IGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYL-- 87 (293)
T ss_dssp SSCTTTTBCSCEE-CCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred CCCcccccEEEEE-EecCcCcEEEEEEECCCCCEEEEEEEecccCh----HHHHHHHHHHHHHhCCCCCEeeEeEEEE--
Confidence 4578889998655 99999999999999999999999999865431 2467899999999999999999999984
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
+.+.+|+|||||+||+|.+++.+ +.+++..++.|++||+.||.|||++| |+||||||+|||++.+ |.+||+|||+|
T Consensus 88 ~~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~-~~vkl~DFG~a 163 (293)
T d1yhwa1 88 VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFC 163 (293)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTC
T ss_pred ECCEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCC-CcEeeccchhh
Confidence 46789999999999999998765 67999999999999999999999999 9999999999999877 89999999999
Q ss_pred hhhcCC-CCCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 012320 182 AILRGS-KSAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259 (466)
Q Consensus 182 ~~~~~~-~~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 259 (466)
+.+... ......+||+.|||||++.+ .|+.++|||||||++|+|++|..||.+......++..+..+..+...+...+
T Consensus 164 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s 243 (293)
T d1yhwa1 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243 (293)
T ss_dssp EECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSC
T ss_pred eeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCC
Confidence 876543 34556789999999998764 5999999999999999999999999875555556666666655555566778
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
.++++||.+||. ||.+|||+.|+|+||||+.
T Consensus 244 ~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 999999999996 9999999999999999964
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-60 Score=461.92 Aligned_cols=255 Identities=25% Similarity=0.412 Sum_probs=219.4
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
++|.+ .+.||+|+||+||+|.++.+|+.||+|++.+... .+..+++.+|+.+|++++|||||++++++. +++.+
T Consensus 5 ~dy~~-~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~--~~~~~ 78 (271)
T d1nvra_ 5 EDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRR--EGNIQ 78 (271)
T ss_dssp TEEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEE--ETTEE
T ss_pred cceEE-EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHHHHHHHHHHHHHhCCCCCEeeEeeeec--cCcee
Confidence 56877 5679999999999999999999999999986542 234467899999999999999999999884 47789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
|+|||||+||+|.+++.+.+.+++..++.+++||+.||.|||++| |+||||||+|||++.+ |.+||+|||+|+.+..
T Consensus 79 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~-~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRY 155 (271)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCEECEE
T ss_pred EEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCC-CCEEEccchhheeecc
Confidence 999999999999999988889999999999999999999999999 9999999999999877 8999999999987643
Q ss_pred C---CCCccccCCCCcCCcccccc-CC-CChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHH
Q 012320 187 S---KSAHSVIGTPEFMAPELYEE-DY-NELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLE 261 (466)
Q Consensus 187 ~---~~~~~~~GT~~y~APE~l~~-~y-~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 261 (466)
. ....+.+||+.|||||++.+ .| +.++|||||||++|+|++|..||....+....+..+.........+...+.+
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 235 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 235 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHH
T ss_pred CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHH
Confidence 2 23456789999999998864 44 6789999999999999999999987666666666666665555555667899
Q ss_pred HHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 262 AQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 262 ~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
+++||.+||. ||.+|||++|+|+||||+.
T Consensus 236 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 236 PLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 9999999996 9999999999999999974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-59 Score=455.79 Aligned_cols=253 Identities=26% Similarity=0.441 Sum_probs=224.6
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
.+|.+ .+.||+|+||+||+|.++.+|+.||+|++.+.... .....+.+.+|+.+|++++|||||++++++ .+++.+
T Consensus 6 ~dy~i-~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~--~~~~~~ 81 (263)
T d2j4za1 6 EDFEI-GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYF--HDATRV 81 (263)
T ss_dssp GGEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEE--ECSSEE
T ss_pred hHeEE-EEEEecCCCcEEEEEEECCCCcEEEEEEEchHHcc-ChHHHHHHHHHHHHHHhcCCCCCCeEEEEE--EECCEE
Confidence 46876 56799999999999999999999999999865432 122346788999999999999999999988 457789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
|+|||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++.+ |.+||+|||+|.....
T Consensus 82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~-~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSA-GELKIADFGWSVHAPS 158 (263)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCCSCSCCCC
T ss_pred EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCC-CCEeecccceeeecCC
Confidence 999999999999999999899999999999999999999999999 9999999999999977 8999999999977654
Q ss_pred CCCCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 012320 187 SKSAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRF 265 (466)
Q Consensus 187 ~~~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~l 265 (466)
. .....+||+.|||||++.+ .|+.++|||||||++|+|++|..||.+ .+..++++.+..+.++ ++...++++++|
T Consensus 159 ~-~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~l 234 (263)
T d2j4za1 159 S-RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEFT--FPDFVTEGARDL 234 (263)
T ss_dssp C-CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCCC--CCTTSCHHHHHH
T ss_pred C-cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC--CCccCCHHHHHH
Confidence 3 3456789999999998875 599999999999999999999999976 7888899999887753 445678999999
Q ss_pred HHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 266 IGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 266 I~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
|.+||. ||.+|||++|+|+||||+.
T Consensus 235 i~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 235 ISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 999996 9999999999999999964
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-59 Score=453.33 Aligned_cols=256 Identities=30% Similarity=0.470 Sum_probs=212.4
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
+.|.++ +.||+|+||+||+|.++.+|+.||+|.+..... +....+.+.+|+++|++++|||||+++++|.+.....+
T Consensus 4 edy~~~-~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 4 EDYEVL-YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp GGEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEECCTTS--CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred hhCEEe-EEEecCCCeEEEEEEECCCCCEEEEEEEChhhC--CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 458775 669999999999999999999999999986653 45567889999999999999999999999987667789
Q ss_pred EEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---CCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 107 NFITEMFTSGTLREYRKK----YRRVDIRAIKSWARQILQGLVYLHSRD---PPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~----~~~l~~~~~~~i~~qIl~gL~yLHs~~---~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
|+|||||+||+|.+++.+ .+.+++..++.|+.||+.||.|||+.+ .+|+||||||+|||++.+ |.+||+|||
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~-~~vkl~DFG 159 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFG 159 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT-SCEEECCHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC-CcEEEeecc
Confidence 999999999999999864 367999999999999999999999865 349999999999999987 899999999
Q ss_pred hhhhhcCC-CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 012320 180 LAAILRGS-KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSI 257 (466)
Q Consensus 180 la~~~~~~-~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 257 (466)
+++.+... ....+.+||+.|||||++. ..|+.++|||||||++|||+||..||.. .+..++..++..+..+. .+..
T Consensus 160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~ 237 (269)
T d2java1 160 LARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFRR-IPYR 237 (269)
T ss_dssp HHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCC-CCTT
T ss_pred ceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCCC-CCcc
Confidence 99887543 3345678999999999886 5699999999999999999999999976 77888999999888764 4456
Q ss_pred CCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCC
Q 012320 258 QDLEAQRFIGRCLV-NASKRLSAKELLLDPFL 288 (466)
Q Consensus 258 ~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~ 288 (466)
.++++++||.+||. ||.+|||+.|+|+|||+
T Consensus 238 ~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 78899999999996 99999999999999996
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-59 Score=458.46 Aligned_cols=260 Identities=25% Similarity=0.435 Sum_probs=225.7
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+|.+ .++||+|+||+||+|.++.+|+.||+|++.+.... .....+.+.+|+++|++++|||||+++++| .+.+.+|
T Consensus 9 dy~i-~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~--~~~~~~~ 84 (288)
T d1uu3a_ 9 DFKF-GKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTF--QDDEKLY 84 (288)
T ss_dssp GEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCSTTBCCEEEEE--ECSSEEE
T ss_pred CCEE-EEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHcc-CHHHHHHHHHHHHHHHHcCCCCeeEEEEEE--EECCEEE
Confidence 4766 67799999999999999999999999999865432 223456789999999999999999999988 4578899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~ 187 (466)
+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ |.+||+|||+|+.+...
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~-~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNED-MHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEECC--
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCC-ceEEecccccceecccC
Confidence 99999999999999999999999999999999999999999999 9999999999999977 89999999999876432
Q ss_pred ---CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 188 ---KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 188 ---~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
....+.+||+.|||||++. ..|+.++|||||||++|+|++|..||.. .+..++++++..+.+. ++...+++++
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~ 238 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLEYD--FPEKFFPKAR 238 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCCC--CCTTCCHHHH
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC-cCHHHHHHHHHcCCCC--CCccCCHHHH
Confidence 2344678999999999886 4699999999999999999999999976 7888899999888753 4456788999
Q ss_pred HHHHHhcc-CcCCCCCHHH------HhcCCCCCchhhhhcc
Q 012320 264 RFIGRCLV-NASKRLSAKE------LLLDPFLASDEVKLLS 297 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rpsa~e------lL~hpf~~~~~~~~~~ 297 (466)
+||.+||. ||.+|||++| +++||||+..+|..+.
T Consensus 239 ~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~ 279 (288)
T d1uu3a_ 239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 279 (288)
T ss_dssp HHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred HHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhh
Confidence 99999996 9999999998 5889999987775543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-59 Score=463.11 Aligned_cols=259 Identities=27% Similarity=0.434 Sum_probs=228.2
Q ss_pred eeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 21 IETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 21 ~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
...||..+|..+++ ||+|+||+||+|.++.+|+.||+|++.+... ......+.+.+|+.+|++++|||||+++++|.
T Consensus 9 ~~~dp~~~y~~l~~-lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~- 85 (309)
T d1u5ra_ 9 FKDDPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL- 85 (309)
T ss_dssp CCSCHHHHEEEEEE-EEECSSSEEEEEEETTTTEEEEEEEEECCSS-CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-
T ss_pred cccCcHHhcEeeEE-EecCCCeEEEEEEECCCCcEEEEEEEchhhc-cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE-
Confidence 44578889998755 9999999999999999999999999986543 33456678999999999999999999999884
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
+++.+|+|||||.||+|..++...+.+++..++.|++||+.||.|||++| |+||||||+|||++.+ |.+||+|||+
T Consensus 86 -~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~-~~~Kl~DFG~ 161 (309)
T d1u5ra_ 86 -REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGS 161 (309)
T ss_dssp -ETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETT-TEEEECCCTT
T ss_pred -ECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCC-CCEEEeeccc
Confidence 46789999999999999988888889999999999999999999999999 9999999999999977 8999999999
Q ss_pred hhhhcCCCCCccccCCCCcCCccccc----cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 012320 181 AAILRGSKSAHSVIGTPEFMAPELYE----EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 181 a~~~~~~~~~~~~~GT~~y~APE~l~----~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 256 (466)
|..... ....+||+.|||||++. +.|+.++|||||||++|||++|..||.+ .+..+....+..+..|.....
T Consensus 162 a~~~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~ 237 (309)
T d1u5ra_ 162 ASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNESPALQSG 237 (309)
T ss_dssp CBSSSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCCCCSCT
T ss_pred ccccCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCCCC
Confidence 976543 34568999999999874 3589999999999999999999999987 556666677777776666666
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
..++++++||.+||. ||.+|||+.|+|+||||..
T Consensus 238 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred CCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 778999999999996 9999999999999999964
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-58 Score=453.25 Aligned_cols=265 Identities=24% Similarity=0.397 Sum_probs=229.7
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCC--HHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRS--PDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
+-++||.+ .+.||+|+||+||+|.++.+|+.||+|++.+...... ....+.+.+|+.+|++++|||||+++++| .
T Consensus 7 ~i~d~Y~~-~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~--~ 83 (293)
T d1jksa_ 7 NVDDYYDT-GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY--E 83 (293)
T ss_dssp CGGGTEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE--E
T ss_pred CcccCEEE-eEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE--E
Confidence 34568877 5669999999999999999999999999987654322 12357889999999999999999999988 5
Q ss_pred cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCC---CcEEEecc
Q 012320 102 DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHL---GQVKIGDL 178 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~---g~vKL~DF 178 (466)
+...+|+|||||+||+|.+++.+.+.+++..++.+++||+.||.|||+++ |+||||||+|||++.+. +.+||+||
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred ECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecch
Confidence 57889999999999999999999899999999999999999999999999 99999999999997652 25999999
Q ss_pred chhhhhcCCCCCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC--CC
Q 012320 179 GLAAILRGSKSAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA--FY 255 (466)
Q Consensus 179 Gla~~~~~~~~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~--~~ 255 (466)
|++..........+..||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+..+++..+..+..+.. .+
T Consensus 162 G~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~ 240 (293)
T d1jksa_ 162 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYF 240 (293)
T ss_dssp TTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCCCCCHHHH
T ss_pred hhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCCCchhc
Confidence 99988776666777889999999998874 599999999999999999999999976 778888888888765432 34
Q ss_pred CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhhh
Q 012320 256 SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEVK 294 (466)
Q Consensus 256 ~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~~ 294 (466)
...+.++++||.+||. ||.+|||++|+|+||||+...+.
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 280 (293)
T d1jksa_ 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280 (293)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC----
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChh
Confidence 5678899999999996 99999999999999999876553
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-59 Score=458.20 Aligned_cols=259 Identities=29% Similarity=0.492 Sum_probs=223.4
Q ss_pred eeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 22 ~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
+.||.+.|.++ +.||+|+||+||+|.++.+|+.||+|+++... ....+.+.+|+++|++++|||||+++++|.
T Consensus 7 ~~~p~d~Y~i~-~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-- 79 (288)
T d2jfla1 7 DLNPEDFWEII-GELGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFY-- 79 (288)
T ss_dssp SSCGGGTEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEECSS----SGGGGGTHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred CCCcccCeEEe-EEEeeCCCcEEEEEEECCCCeEEEEEEECcCC----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--
Confidence 57788899885 55999999999999999999999999987542 345577899999999999999999999884
Q ss_pred cCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 102 DQKTFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
+.+.+|+|||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ |.+||+|||+
T Consensus 80 ~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~-~~~Kl~DFG~ 156 (288)
T d2jfla1 80 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLD-GDIKLADFGV 156 (288)
T ss_dssp ETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTT
T ss_pred eCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCC-CCEEEEechh
Confidence 47789999999999999998765 467999999999999999999999999 9999999999999977 8999999999
Q ss_pred hhhhcCC-CCCccccCCCCcCCccccc------cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC-
Q 012320 181 AAILRGS-KSAHSVIGTPEFMAPELYE------EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG- 252 (466)
Q Consensus 181 a~~~~~~-~~~~~~~GT~~y~APE~l~------~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~- 252 (466)
|+..... ....+.+||+.|||||++. ..|+.++|||||||++|+|+||..||.+ .+..++..++..+..+.
T Consensus 157 a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~-~~~~~~~~~i~~~~~~~~ 235 (288)
T d2jfla1 157 SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE-LNPMRVLLKIAKSEPPTL 235 (288)
T ss_dssp CEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTT-SCGGGHHHHHHHSCCCCC
T ss_pred hhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCCCC
Confidence 9754321 2234678999999999863 3489999999999999999999999987 55666777777766443
Q ss_pred CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 253 AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 253 ~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
..+...+.++++||.+||. ||.+|||+.|+|+||||+..
T Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 3445678899999999996 99999999999999999754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-58 Score=457.21 Aligned_cols=257 Identities=23% Similarity=0.381 Sum_probs=208.0
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
-.++|.+ .++||+|+||+||+|.++.+|+.||+|++.+.... ...+.+.+|+.+|++++|||||+++++| .+++
T Consensus 7 i~d~Y~~-~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~--~~~~ 80 (307)
T d1a06a_ 7 IRDIYDF-RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE---GKEGSMENEIAVLHKIKHPNIVALDDIY--ESGG 80 (307)
T ss_dssp GGGTEEE-EEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEE--ECSS
T ss_pred CccceEE-EEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh---hHHHHHHHHHHHHHhCCCCCCCcEEEEE--EECC
Confidence 3466876 57799999999999999999999999999865532 2335688999999999999999999988 4578
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeC--CCCcEEEeccchhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNG--HLGQVKIGDLGLAA 182 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~--~~g~vKL~DFGla~ 182 (466)
.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||+.. +.|.+||+|||+++
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred EEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeE
Confidence 89999999999999999999899999999999999999999999999 999999999999963 34799999999998
Q ss_pred hhcCCCCCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC--CCCCCCC
Q 012320 183 ILRGSKSAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG--AFYSIQD 259 (466)
Q Consensus 183 ~~~~~~~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~--~~~~~~~ 259 (466)
.........+.+||+.|||||++.+ .|+.++|||||||++|+|++|..||.+ .+..+++..+..+..+. ..+...+
T Consensus 159 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s 237 (307)
T d1a06a_ 159 MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDIS 237 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred EccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCCCCCccccCCC
Confidence 8766666677899999999998864 599999999999999999999999977 67788888888876543 3445678
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
+++++||.+||. ||.+|||++|+|+||||+.
T Consensus 238 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 238 DSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 899999999996 9999999999999999975
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-58 Score=459.44 Aligned_cols=260 Identities=24% Similarity=0.425 Sum_probs=231.2
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
+.|.+ .++||+|+||+||+|.++.+|+.||+|++++.... .....+.+.+|+.+|++++|||||+++++| .+...+
T Consensus 5 ~dy~~-~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~--~~~~~~ 80 (337)
T d1o6la_ 5 NDFDY-LKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAF--QTHDRL 80 (337)
T ss_dssp GGEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEE--ECSSEE
T ss_pred HhcEE-EEEEecCcCeEEEEEEECCCCCEEEEEEEchhhcc-CHHHHHHHHHHHHHHHhCCCCCEEEEEeee--cccccc
Confidence 45777 46799999999999999999999999999866432 223457789999999999999999999988 557899
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
|+|||||+||+|.+++.+.+.+++..++.+++||+.||+|||++| |+||||||+|||++.+ |.+||+|||+|+....
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~-g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCSCC
T ss_pred ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCC-CCEEEeeccccccccc
Confidence 999999999999999999999999999999999999999999999 9999999999999987 8999999999987643
Q ss_pred -CCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 012320 187 -SKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQR 264 (466)
Q Consensus 187 -~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~ 264 (466)
.....+.+|||.|||||++. ..|+.++|||||||++|||++|..||.+ .+..++++.+..+.++ ++...++++++
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~d 234 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIR--FPRTLSPEAKS 234 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHH
T ss_pred CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC-cCHHHHHHHHhcCCCC--CCccCCHHHHH
Confidence 44556789999999999886 5699999999999999999999999987 7888899999988753 45668899999
Q ss_pred HHHHhcc-CcCCCCC-----HHHHhcCCCCCchhhhhc
Q 012320 265 FIGRCLV-NASKRLS-----AKELLLDPFLASDEVKLL 296 (466)
Q Consensus 265 lI~~~L~-dp~~Rps-----a~elL~hpf~~~~~~~~~ 296 (466)
||.+||. ||.+|++ ++|+++||||+..+|..+
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l 272 (337)
T d1o6la_ 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred HHHhhccCCchhhcccccccHHHHHcCcccccCCHHHH
Confidence 9999996 9999995 899999999998777543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-58 Score=461.08 Aligned_cols=258 Identities=25% Similarity=0.473 Sum_probs=215.5
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
+++|.++ +.||+|+||+||+|.++.+|+.||+|++++.. ++...+++.+|+.+|++++|||||+++++|. +...
T Consensus 5 ~d~y~~~-~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~ 78 (322)
T d1s9ja_ 5 DDDFEKI-SELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFY--SDGE 78 (322)
T ss_dssp GGGEEEE-EEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE--CSSE
T ss_pred ccCCEEE-EEEecCCCeEEEEEEECCCCcEEEEEEEChhh---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECCE
Confidence 5689886 55999999999999999999999999987543 3345578899999999999999999999884 5778
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHS-RDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs-~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
+|+|||||.||+|.+++.+.+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++.+ |.+||+|||+|+.+
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~-~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQL 155 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTT-CCEEECCCCCCHHH
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCC-CCEEEeeCCCcccc
Confidence 99999999999999999998999999999999999999999997 58 9999999999999877 89999999999876
Q ss_pred cCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------------
Q 012320 185 RGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQ----------------------- 240 (466)
Q Consensus 185 ~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~----------------------- 240 (466)
... ...+.+||+.|||||++. ..|+.++||||+||++|||++|..||........
T Consensus 156 ~~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 156 IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp HHH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred CCC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 542 345679999999999876 4699999999999999999999999975332111
Q ss_pred ------------------HHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 241 ------------------IYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 241 ------------------i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
....+.....|.......+.++++||.+||. ||.+||||+|+|+||||+...+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 1111222222222334467899999999996 9999999999999999986544
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.9e-57 Score=456.49 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=226.9
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
-++|.+ .+.||+|+||+||+|.++.+|+.||+|++... .....+.+.+|+.+|++++|||||+++++|. +.+.
T Consensus 25 l~~Y~i-~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~ 97 (350)
T d1koaa2 25 LDHYDI-HEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFE--DDNE 97 (350)
T ss_dssp GGTEEE-EEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE--ETTE
T ss_pred ccCeEE-EEEEecCcCeEEEEEEECCCCCEEEEEEEccc----chhhHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECCE
Confidence 458987 46699999999999999999999999998743 3345678999999999999999999999884 4778
Q ss_pred EEEEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC-CCcEEEeccchhhh
Q 012320 106 FNFITEMFTSGTLREYRK-KYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH-LGQVKIGDLGLAAI 183 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~-~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~-~g~vKL~DFGla~~ 183 (466)
+|+|||||+||+|.+++. +.+.+++..++.|++||+.||.|||++| |+||||||+|||++.+ .|.+||+|||+++.
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 999999999999999985 4567999999999999999999999999 9999999999999643 47899999999988
Q ss_pred hcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCCH
Q 012320 184 LRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP--GAFYSIQDL 260 (466)
Q Consensus 184 ~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~~~~ 260 (466)
+.......+.+||+.|||||++. ..|+.++|||||||++|+|++|..||.+ .+..+++..+..+... .......+.
T Consensus 176 ~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~ 254 (350)
T d1koaa2 176 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISE 254 (350)
T ss_dssp CCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCCGGGGGCCH
T ss_pred cccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 77766667789999999999886 4599999999999999999999999976 6788888888877643 333455788
Q ss_pred HHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchhh
Q 012320 261 EAQRFIGRCLV-NASKRLSAKELLLDPFLASDEV 293 (466)
Q Consensus 261 ~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~~ 293 (466)
++++||.+||. ||++|||++|+|+||||+...+
T Consensus 255 ~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 99999999996 9999999999999999987544
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.3e-57 Score=453.87 Aligned_cols=256 Identities=24% Similarity=0.381 Sum_probs=225.4
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
++|.+ .+.||+|+||+||+|.++.+|+.||+|++++.. ....+.+.+|+.+|++++|||||+++++| .++..+
T Consensus 29 d~Y~i-~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~--~~~~~~ 101 (352)
T d1koba_ 29 DYYDI-LEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAF--EDKYEM 101 (352)
T ss_dssp GTEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEE--ECSSEE
T ss_pred cceEE-EEEEecCCCeEEEEEEECCCCCEEEEEEECCcc----hhHHHHHHHHHHHHHhCCCCCCCcEEEEE--EECCEE
Confidence 56776 567999999999999999999999999987543 34557788999999999999999999988 457889
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeC-CCCcEEEeccchhhhh
Q 012320 107 NFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNG-HLGQVKIGDLGLAAIL 184 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~-~~g~vKL~DFGla~~~ 184 (466)
|+|||||+||+|.+++.+. .++++..++.|+.||+.||.|||++| |+||||||+|||++. ..|.+||+|||+|+.+
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceec
Confidence 9999999999999987654 46999999999999999999999999 999999999999973 3489999999999988
Q ss_pred cCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCCHH
Q 012320 185 RGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL--PGAFYSIQDLE 261 (466)
Q Consensus 185 ~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~~~~ 261 (466)
.......+..||+.|||||++. ..|+.++|||||||++|+|+||..||.+ .+..+++..+..+.. +...+...+++
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 258 (352)
T d1koba_ 180 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPE 258 (352)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred CCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 7766677789999999999876 4599999999999999999999999976 667778888887765 34455667899
Q ss_pred HHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 262 AQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 262 ~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
+++||.+||. ||.+|||+.|+|+||||+...
T Consensus 259 ~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 259 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 9999999996 999999999999999998643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-56 Score=446.00 Aligned_cols=257 Identities=26% Similarity=0.454 Sum_probs=227.4
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
.|.+ .+.||+|+||+||+|.++.+|+.||+|++++.... .....+.+.+|+.+|++++|||||++++++ .+...+|
T Consensus 5 dy~i-~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~--~~~~~~~ 80 (316)
T d1fota_ 5 DFQI-LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTF--QDAQQIF 80 (316)
T ss_dssp GEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEE--ECSSEEE
T ss_pred HeEE-EEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHhccCcChhheeeeE--eeCCeee
Confidence 4766 46699999999999999999999999999865432 223457889999999999999999999988 4578999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS 187 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~ 187 (466)
+|||||.||+|..++.....+++..++.+++||+.||.|||++| |+||||||+|||++.+ |.+||+|||+|+....
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~-g~vkL~DFG~a~~~~~- 156 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN-GHIKITDFGFAKYVPD- 156 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTT-SCEEECCCSSCEECSS-
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCC-CCEEEecCccceEecc-
Confidence 99999999999999999999999999999999999999999999 9999999999999977 8999999999987643
Q ss_pred CCCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 012320 188 KSAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFI 266 (466)
Q Consensus 188 ~~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI 266 (466)
...+.+||+.|||||++.+ .|+.++|||||||++|+|++|..||.+ .+..+++.++..+..+ ++...+++++++|
T Consensus 157 -~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li 232 (316)
T d1fota_ 157 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAELR--FPPFFNEDVKDLL 232 (316)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHHH
T ss_pred -ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC-cCHHHHHHHHHcCCCC--CCCCCCHHHHHHH
Confidence 3456789999999998875 599999999999999999999999977 7888888999888653 3456788999999
Q ss_pred HHhcc-CcCCCC-----CHHHHhcCCCCCchhhhhc
Q 012320 267 GRCLV-NASKRL-----SAKELLLDPFLASDEVKLL 296 (466)
Q Consensus 267 ~~~L~-dp~~Rp-----sa~elL~hpf~~~~~~~~~ 296 (466)
.+||. ||.+|+ |++++|+||||++..|..+
T Consensus 233 ~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l 268 (316)
T d1fota_ 233 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 268 (316)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHH
T ss_pred HHHhhhCHHhccccchhhHHHHHcCcccccCCHHHH
Confidence 99995 999996 9999999999999877654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-56 Score=450.89 Aligned_cols=260 Identities=23% Similarity=0.420 Sum_probs=229.3
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.++|.++ +.||+|+||+||+|.++.+|+.||+|++.+.... .....+.+.+|+++|++++|||||+++++| .+...
T Consensus 40 ld~y~i~-~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~--~~~~~ 115 (350)
T d1rdqe_ 40 LDQFDRI-KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSF--KDNSN 115 (350)
T ss_dssp GGGEEEE-EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSE
T ss_pred ccCeEEE-EEeecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHHcCCCcEeeccccc--ccccc
Confidence 3689886 5599999999999999999999999999865432 223456789999999999999999999988 45778
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+++||||+.||+|..++.+.+.+++..++.|+.||+.||.|||+++ ||||||||+|||++.+ |.+||+|||+|+.+.
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~-g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECS
T ss_pred cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCC-CCEEeeeceeeeecc
Confidence 9999999999999999999999999999999999999999999999 9999999999999877 899999999998765
Q ss_pred CCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 012320 186 GSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQR 264 (466)
Q Consensus 186 ~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~ 264 (466)
. ...+.+||+.|||||++. ..|+.++|||||||++|+|+||..||.+ .+...++.++..+..+ .+...++++++
T Consensus 193 ~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~ 267 (350)
T d1rdqe_ 193 G--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKVR--FPSHFSSDLKD 267 (350)
T ss_dssp S--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTCCHHHHH
T ss_pred c--ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC-cCHHHHHHHHhcCCCC--CCccCCHHHHH
Confidence 4 345678999999999876 4599999999999999999999999976 7888899999888754 34567889999
Q ss_pred HHHHhcc-CcCCCC-----CHHHHhcCCCCCchhhhhcc
Q 012320 265 FIGRCLV-NASKRL-----SAKELLLDPFLASDEVKLLS 297 (466)
Q Consensus 265 lI~~~L~-dp~~Rp-----sa~elL~hpf~~~~~~~~~~ 297 (466)
||.+||. ||.+|+ |+++|++||||+..+|..+.
T Consensus 268 li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~ 306 (350)
T d1rdqe_ 268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306 (350)
T ss_dssp HHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHH
T ss_pred HHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHH
Confidence 9999996 999984 99999999999988775543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-57 Score=448.05 Aligned_cols=255 Identities=22% Similarity=0.367 Sum_probs=224.1
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
-+||.+ .+.||+|+||+||+|.++.+|+.||+|+++++. .+...+.+|+++|++++|||||+++++|. +++.
T Consensus 4 ~~rY~i-~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~--~~~~ 75 (321)
T d1tkia_ 4 YEKYMI-AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFE--SMEE 75 (321)
T ss_dssp TTTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEE--ETTE
T ss_pred ccceEE-EEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-----ccHHHHHHHHHHHHhCCCCCCCeEEEEEE--ECCE
Confidence 368987 566999999999999999999999999997543 34456889999999999999999999884 4778
Q ss_pred EEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC-CCcEEEeccchhhh
Q 012320 106 FNFITEMFTSGTLREYRKKYR-RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH-LGQVKIGDLGLAAI 183 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~-~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~-~g~vKL~DFGla~~ 183 (466)
+|+|||||+||+|.+++.+.+ .+++..++.|+.||+.||.|||++| |+||||||+|||++.+ .+.+||+|||++..
T Consensus 76 ~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhc
Confidence 999999999999999998765 7999999999999999999999999 9999999999999754 35899999999988
Q ss_pred hcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC--CCCCCCCH
Q 012320 184 LRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPG--AFYSIQDL 260 (466)
Q Consensus 184 ~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~--~~~~~~~~ 260 (466)
........+.+||+.|+|||++. ..|+.++|||||||++|+|++|..||.. .+..+++..|..+.+.. ..+...+.
T Consensus 154 ~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T d1tkia_ 154 LKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp CCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred cccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCChhhccCCCH
Confidence 76666667788999999999776 4599999999999999999999999976 77888889898877543 23345688
Q ss_pred HHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 261 EAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 261 ~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
++++||.+||. ||.+|||+.|+|+||||+..
T Consensus 233 ~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 99999999996 99999999999999999653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.4e-56 Score=432.32 Aligned_cols=257 Identities=23% Similarity=0.414 Sum_probs=226.4
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCC-----HHHHHHHHHHHHHHHhCC-CCceeEEEeEEEe
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRS-----PDDLQRLYSEVHLLSTLK-HDSIIRFYTSWID 100 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~-----~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~ 100 (466)
.+|.+ .+.||+|+||+||+|.++.+|+.||+|++++...... ....+++.+|+.+|++++ |||||+++++|
T Consensus 3 ~~y~~-~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-- 79 (277)
T d1phka_ 3 ENYEP-KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-- 79 (277)
T ss_dssp TTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred ccCEE-ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec--
Confidence 57877 6779999999999999999999999999987654321 123456889999999996 99999999988
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
.+++.+|+|||||+||+|.++++..+.+++..++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+
T Consensus 80 ~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~-~~~kl~DFG~ 156 (277)
T d1phka_ 80 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDD-MNIKLTDFGF 156 (277)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTT
T ss_pred ccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCC-CCeEEccchh
Confidence 467899999999999999999999999999999999999999999999999 9999999999999877 8999999999
Q ss_pred hhhhcCCCCCccccCCCCcCCccccc-------cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--C
Q 012320 181 AAILRGSKSAHSVIGTPEFMAPELYE-------EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL--P 251 (466)
Q Consensus 181 a~~~~~~~~~~~~~GT~~y~APE~l~-------~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~--p 251 (466)
++.+.........+||+.|+|||++. ..|+.++||||+||++|+|++|..||.+ .+...+.+.+..+.. +
T Consensus 157 a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~-~~~~~~~~~i~~~~~~~~ 235 (277)
T d1phka_ 157 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFG 235 (277)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCC
T ss_pred eeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC-CCHHHHHHHHHhCCCCCC
Confidence 98877666667788999999999764 2378899999999999999999999987 677778888887764 3
Q ss_pred CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 252 GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 252 ~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
.......++++++||.+||. ||.+|||++|+|+||||+.
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 33445678999999999996 9999999999999999974
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-55 Score=446.66 Aligned_cols=261 Identities=22% Similarity=0.362 Sum_probs=219.0
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEeccccc--CCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELM--RSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~--~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
+.|.+ .++||+|+||+||+|.++.+|+.||+|++.+.... .......+...|+.+++.++|||||+++++| .+.+
T Consensus 4 ddy~i-~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~--~~~~ 80 (364)
T d1omwa3 4 NDFSV-HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF--HTPD 80 (364)
T ss_dssp TTEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE--ECSS
T ss_pred HhCee-eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE--EECC
Confidence 46776 57799999999999999999999999999765431 1122223344557788888999999999988 4577
Q ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 105 TFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
.+|+|||||+||+|.+++.+.+.+++..++.|++||+.||.|||++| |+||||||+|||++.+ |.+||+|||+|+.+
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~-g~iKl~DFGla~~~ 157 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDF 157 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-SCEEECCCTTCEEC
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCC-CcEEEeeeceeeec
Confidence 89999999999999999999999999999999999999999999999 9999999999999877 89999999999876
Q ss_pred cCCCCCccccCCCCcCCccccc-c-CCCChhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCCCCCCCCCCCCH
Q 012320 185 RGSKSAHSVIGTPEFMAPELYE-E-DYNELVDVYSFGMCVLEMFTCEYPYSECA--NPAQIYKKVTSGKLPGAFYSIQDL 260 (466)
Q Consensus 185 ~~~~~~~~~~GT~~y~APE~l~-~-~y~~~~DIwSlGvil~elltg~~Pf~~~~--~~~~i~~~i~~g~~p~~~~~~~~~ 260 (466)
... .....+||+.|||||++. + .|+.++|||||||++|+|+||..||.... +...+.+.+.... ...+...++
T Consensus 158 ~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~s~ 234 (364)
T d1omwa3 158 SKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--VELPDSFSP 234 (364)
T ss_dssp SSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCC--CCCCSSSCH
T ss_pred CCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC--CCCCCCCCH
Confidence 543 345678999999999875 3 48999999999999999999999997533 3344444444333 344566789
Q ss_pred HHHHHHHHhcc-CcCCCCC-----HHHHhcCCCCCchhhhhc
Q 012320 261 EAQRFIGRCLV-NASKRLS-----AKELLLDPFLASDEVKLL 296 (466)
Q Consensus 261 ~~~~lI~~~L~-dp~~Rps-----a~elL~hpf~~~~~~~~~ 296 (466)
++++||.+||. ||.+||| |+|+++||||++..|..+
T Consensus 235 ~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~ 276 (364)
T d1omwa3 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 276 (364)
T ss_dssp HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHH
T ss_pred HHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHH
Confidence 99999999996 9999999 799999999999877544
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-56 Score=440.22 Aligned_cols=259 Identities=24% Similarity=0.441 Sum_probs=224.6
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHH-hCCCCceeEEEeEEEeccCCE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLS-TLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~-~l~HpnIv~l~~~~~~~~~~~ 105 (466)
..|.+ .++||+|+||+||+|.++.+|+.||+|++++..... ....+.+..|+.++. .++|||||+++++| .+++.
T Consensus 2 ddy~i-~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~--~~~~~ 77 (320)
T d1xjda_ 2 EDFIL-HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTF--QTKEN 77 (320)
T ss_dssp TTEEE-EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEE--ECSSE
T ss_pred CCeEE-eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC-hHHHHHHHHHHHHHHHhCCCCcEEEEEEEE--ccCCc
Confidence 45766 577999999999999999999999999998654321 223456677777765 68999999999988 45788
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 106 FNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
+|+||||++||+|.+++.+.+.+++..++.+++||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+++...
T Consensus 78 ~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~-~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 78 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKD-GHIKIADFGMCKENM 154 (320)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCCC
T ss_pred eeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCC-Cceeccccchhhhcc
Confidence 9999999999999999999999999999999999999999999999 9999999999999977 899999999998664
Q ss_pred C-CCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 186 G-SKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 186 ~-~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
. .......+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .+..++++++..+.. .++...+++++
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~ 231 (320)
T d1xjda_ 155 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNP--FYPRWLEKEAK 231 (320)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHH
T ss_pred cccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCccCCHHHH
Confidence 3 33345578999999999876 4699999999999999999999999976 788889999988764 34556789999
Q ss_pred HHHHHhcc-CcCCCCCHH-HHhcCCCCCchhhhh
Q 012320 264 RFIGRCLV-NASKRLSAK-ELLLDPFLASDEVKL 295 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rpsa~-elL~hpf~~~~~~~~ 295 (466)
+||.+||. ||.+|||+. ++++||||+...+..
T Consensus 232 dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~ 265 (320)
T d1xjda_ 232 DLLVKLFVREPEKRLGVRGDIRQHPLFREINWEE 265 (320)
T ss_dssp HHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHH
T ss_pred HHHHHhcccCCCCCcCHHHHHHhCchhccCCHHH
Confidence 99999996 999999996 899999998866643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-56 Score=444.66 Aligned_cols=254 Identities=20% Similarity=0.325 Sum_probs=212.8
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHh-CCCCceeEEEeEEEec--c
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLST-LKHDSIIRFYTSWIDV--D 102 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~~--~ 102 (466)
.++|.+++++||+|+||+||+|.++.+|+.||+|+++.. ..+.+|+.++.+ ++|||||+++++|.+. .
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 468999888999999999999999999999999998632 346789998765 4899999999988542 3
Q ss_pred CCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC--CCcEEEecc
Q 012320 103 QKTFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH--LGQVKIGDL 178 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~--~g~vKL~DF 178 (466)
+..+|+|||||+||+|.+++.+. ..+++..++.|++||+.||.|||++| |+||||||+|||++.. .+.+||+||
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Ccccccccccccccccccccccccccc
Confidence 56799999999999999999874 46999999999999999999999999 9999999999999853 367999999
Q ss_pred chhhhhcCCCCCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHhcCCC--CC
Q 012320 179 GLAAILRGSKSAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECAN---PAQIYKKVTSGKL--PG 252 (466)
Q Consensus 179 Gla~~~~~~~~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~---~~~i~~~i~~g~~--p~ 252 (466)
|+|+...........+||+.|||||++.+ .|+.++|||||||++|+|+||..||.+... ...+...+..+.. |.
T Consensus 159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~ 238 (335)
T d2ozaa1 159 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238 (335)
T ss_dssp TTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred ceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 99988776666778899999999998875 599999999999999999999999965332 2223344444443 22
Q ss_pred CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 253 AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 253 ~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
..+...++++++||.+||. ||++|||+.|+|+||||+.
T Consensus 239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 2334567899999999996 9999999999999999964
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-55 Score=433.53 Aligned_cols=253 Identities=23% Similarity=0.348 Sum_probs=205.9
Q ss_pred eeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHH-HHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEec
Q 012320 34 EVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPD-DLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
++||+|+||+||+|.++.+|+.||+|++++.......+ ..+.+.+|+.+|++++|||||+++++| .+++.+|+||||
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~--~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF--GHKSNISLVFDF 81 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE--CCTTCCEEEEEC
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee--ccCCceeehhhh
Confidence 56999999999999999999999999987655322221 235788999999999999999999988 456779999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCC-CCCc
Q 012320 113 FTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS-KSAH 191 (466)
Q Consensus 113 ~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~-~~~~ 191 (466)
+.|+++..++...+.+++..++.|++||+.||+|||++| |+||||||+|||++.+ |.+||+|||+++..... ....
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~-~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCC-CccccccCccccccCCCccccc
Confidence 999988887777788999999999999999999999999 9999999999999977 89999999999876543 3445
Q ss_pred cccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--CCCCCC--------------
Q 012320 192 SVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS--GKLPGA-------------- 253 (466)
Q Consensus 192 ~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~--g~~p~~-------------- 253 (466)
+.+||+.|+|||++. ..|+.++|||||||++|||+||..||.+ .+..+...++.. |..+..
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~-~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG-DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCC-CCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 678999999999775 3489999999999999999999999977 444444444432 111000
Q ss_pred ----------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 254 ----------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 254 ----------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
.....+.++++||.+||+ ||++||||+|+|+||||+...
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 012456799999999996 999999999999999997643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-55 Score=425.85 Aligned_cols=251 Identities=23% Similarity=0.374 Sum_probs=212.2
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCH--HHHHHHHHHHHHHHhCC--CCceeEEEeEEEec
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSP--DDLQRLYSEVHLLSTLK--HDSIIRFYTSWIDV 101 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~--~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~~ 101 (466)
.+||.+ .++||+|+||+||+|+++.+|+.||+|++.+....... ....++.+|+.+|++++ |||||+++++| .
T Consensus 3 ~~~Y~i-~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~--~ 79 (273)
T d1xwsa_ 3 ESQYQV-GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF--E 79 (273)
T ss_dssp TTTEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE--E
T ss_pred CCeEEE-eEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE--e
Confidence 578877 67899999999999999999999999999865432111 12234678999999986 89999999988 5
Q ss_pred cCCEEEEEEecCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 102 DQKTFNFITEMFTS-GTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 102 ~~~~~~lV~E~~~g-gsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
+.+.+++||||+.+ +++.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++.+.+.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 80 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECcccc
Confidence 57789999999976 689999998899999999999999999999999999 999999999999997667999999999
Q ss_pred hhhhcCCCCCccccCCCCcCCcccccc-C-CCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 012320 181 AAILRGSKSAHSVIGTPEFMAPELYEE-D-YNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQ 258 (466)
Q Consensus 181 a~~~~~~~~~~~~~GT~~y~APE~l~~-~-y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 258 (466)
|+.... ....+.+||+.|||||++.+ . ++.++|||||||++|+|++|..||.. .. .+..+.. .++...
T Consensus 158 a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~---~~----~i~~~~~--~~~~~~ 227 (273)
T d1xwsa_ 158 GALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DE----EIIRGQV--FFRQRV 227 (273)
T ss_dssp CEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS---HH----HHHHCCC--CCSSCC
T ss_pred ceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC---ch----HHhhccc--CCCCCC
Confidence 976543 34556789999999998763 3 46789999999999999999999964 22 2334443 244567
Q ss_pred CHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 259 DLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 259 ~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
+.++++||.+||. ||++|||++|+|+||||++.
T Consensus 228 s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 8999999999996 99999999999999999763
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-53 Score=418.20 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=206.6
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
.+|.++ +.||+|+||+||+|.++.+|+.||+|+++.... .....+++.+|+++|++++|||||+++++|. +...+
T Consensus 2 d~Y~~~-~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~--~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKV-EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIH--TENKL 76 (298)
T ss_dssp TTEEEE-EEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEE--ETTEE
T ss_pred CCCEec-cEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEEeccccc--cccce
Confidence 478886 559999999999999999999999999975432 2223467899999999999999999999984 47789
Q ss_pred EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhc
Q 012320 107 NFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILR 185 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~ 185 (466)
|+||||+.++.+...... .+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+|+...
T Consensus 77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~-~~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFG 153 (298)
T ss_dssp EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECSTTHHHHHC
T ss_pred eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeeccc-CcceeccCCcceecc
Confidence 999999966544433333 456999999999999999999999999 9999999999999877 799999999998775
Q ss_pred C-CCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCC--------
Q 012320 186 G-SKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-GKLPGA-------- 253 (466)
Q Consensus 186 ~-~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-g~~p~~-------- 253 (466)
. .......+||+.|+|||++.. .++.++|||||||++|+|++|..||.+......+++.+.. +.....
T Consensus 154 ~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp CCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred CCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence 4 334556789999999997653 3689999999999999999999999875545555444332 111100
Q ss_pred -----------------CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 254 -----------------FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 254 -----------------~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.....+.++++||.+||+ ||.+|||+.|||+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 012345789999999996 99999999999999999753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=419.99 Aligned_cols=262 Identities=29% Similarity=0.390 Sum_probs=210.2
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCC-CeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC---CCCceeEEEeEE
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVL-GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL---KHDSIIRFYTSW 98 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~-g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~ 98 (466)
+..++||.++++ ||+|+||+||+|.+..+ ++.||+|+++...... .....+.+|+.+|+.| +||||++++++|
T Consensus 3 c~~~~~Y~i~~~-LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~ 79 (305)
T d1blxa_ 3 CRADQQYECVAE-IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVC 79 (305)
T ss_dssp CCGGGTEEEEEE-EEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred CCCcCCEEEEEE-EecccCeEEEEEEEECCCCEEEEEEEEehhhccc--hHHHHHHHHHHHHHHHhhcCCCCcceeeeee
Confidence 345689988654 99999999999999765 6789999997654321 1223456677777665 899999999988
Q ss_pred Eec---cCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEE
Q 012320 99 IDV---DQKTFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVK 174 (466)
Q Consensus 99 ~~~---~~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vK 174 (466)
... ....++++||++.++.+...... ...+++..++.+++||+.||+|||+++ |+||||||+|||++.. |.+|
T Consensus 80 ~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~-~~~k 156 (305)
T d1blxa_ 80 TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIK 156 (305)
T ss_dssp EEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEE
T ss_pred cccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCC-CCee
Confidence 643 24578999999988877655443 356999999999999999999999999 9999999999999877 8999
Q ss_pred EeccchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--CCC-
Q 012320 175 IGDLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS--GKL- 250 (466)
Q Consensus 175 L~DFGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~--g~~- 250 (466)
|+|||++............+||+.|||||++. ..|+.++||||+||++|||++|..||.. .+..+....+.. +..
T Consensus 157 l~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 157 LADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG-SSDVDQLGKILDVIGLPG 235 (305)
T ss_dssp ECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHHHCCCC
T ss_pred ecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCC-CCHHHHHHHHHHhhCCCc
Confidence 99999998765555566788999999999775 6699999999999999999999999987 455554444432 100
Q ss_pred ----------------------CCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 251 ----------------------PGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 251 ----------------------p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
...+....++.+++||.+||. ||.+||||.|+|+||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 011234457899999999996 99999999999999999754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.9e-53 Score=409.70 Aligned_cols=255 Identities=26% Similarity=0.370 Sum_probs=207.9
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC--
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ-- 103 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~-- 103 (466)
.+||.+ .+.||+|+||+||+|.++.+|+.||+|++++... .+....+++.+|+.+|++++|||||++++++...+.
T Consensus 6 ~drY~i-~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 6 SDRYEL-GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp TTTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT-TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred cceeEE-eEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc-cCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 578977 5779999999999999999999999999986543 455667889999999999999999999999876543
Q ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 104 KTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
..+|+|||||+|++|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++.+ +.++|+|||.+..
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~-~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISAT-NAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETT-SCEEECCCTTCEE
T ss_pred ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCcc-ccceeehhhhhhh
Confidence 468999999999999999999999999999999999999999999999 9999999999999987 8999999998865
Q ss_pred hcCC----CCCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhcCCCC-CCCCC
Q 012320 184 LRGS----KSAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKK-VTSGKLP-GAFYS 256 (466)
Q Consensus 184 ~~~~----~~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~-i~~g~~p-~~~~~ 256 (466)
.... ....+.+||+.|||||++.+ .|+.++|||||||++|+|+||..||.+ .+..++..+ +..+..+ .....
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-DSPVSVAYQHVREDPIPPSARHE 239 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHCCCCCGGGTSS
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC-cCHHHHHHHHHhcCCCCCchhcc
Confidence 5322 23456789999999998874 599999999999999999999999987 455555444 4444333 23445
Q ss_pred CCCHHHHHHHHHhcc-CcCCCC-CHHHHhcCCC
Q 012320 257 IQDLEAQRFIGRCLV-NASKRL-SAKELLLDPF 287 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rp-sa~elL~hpf 287 (466)
..++++++||.+||. ||.+|| |+++++ |+|
T Consensus 240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l~-~~l 271 (277)
T d1o6ya_ 240 GLSADLDAVVLKALAKNPENRYQTAAEMR-ADL 271 (277)
T ss_dssp SCCHHHHHHHHHHTCSSGGGSCSSHHHHH-HHH
T ss_pred CCCHHHHHHHHHHccCCHhHCHhHHHHHH-HHH
Confidence 678899999999996 999999 566554 444
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.7e-53 Score=415.27 Aligned_cols=254 Identities=25% Similarity=0.407 Sum_probs=207.6
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
+||.++++ ||+|+||+||+|.++ +|+.||+|+++.... +....+++.+|+.+|++++|||||++++.|. +.+.+
T Consensus 2 ~~Y~~~~~-iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEK-IGEGTYGVVYKAQNN-YGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIH--TKKRL 75 (286)
T ss_dssp CSEEEEEE-EEEETTEEEEEEEET-TSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE--CSSCE
T ss_pred CCceeccE-EecCCCcEEEEEEeC-CCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEeeeeecc--cCCce
Confidence 58988755 999999999999986 789999999976543 2233578899999999999999999999984 46778
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
++++|++.++.+..+....+.+++..++.+++||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++.....
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~-~~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINRE-GELKIADFGLARAFGI 152 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC
T ss_pred eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCC-CCEEecccccceeccc
Confidence 999999988888888777889999999999999999999999999 9999999999999887 8999999999988654
Q ss_pred C-CCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--CCCC----------
Q 012320 187 S-KSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS--GKLP---------- 251 (466)
Q Consensus 187 ~-~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~--g~~p---------- 251 (466)
. .......||+.|+|||++. ..++.++|||||||++|||++|..||.+. +..+...++.. +..+
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV-SEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred CccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC-CHHHHHHHHHHhhCCCChhhccchhhh
Confidence 3 2344567999999999875 34799999999999999999999999874 44444333321 1100
Q ss_pred ---------------CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 252 ---------------GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 252 ---------------~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
.......++.+++||++||+ ||++||||+|+|+||||+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 01223456799999999996 9999999999999999963
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-53 Score=411.59 Aligned_cols=250 Identities=30% Similarity=0.455 Sum_probs=209.1
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
-+.++|.+ .+.||+|+||+||+|..+ ..||||+++.... +....+.+.+|+.+|++++|||||++++++ . .
T Consensus 5 i~~~~~~~-~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~--~-~ 75 (276)
T d1uwha_ 5 IPDGQITV-GQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYS--T-A 75 (276)
T ss_dssp CCTTCCCC-CSEEEECSSCEEEEEESS---SEEEEEECCCSSC--CTTHHHHHHHHHHHHTTCCCTTBCCEEEEE--C-S
T ss_pred cccccEEE-EEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeeeEEE--e-c
Confidence 35678876 577999999999999754 3699999875543 445678899999999999999999999865 2 3
Q ss_pred CEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 104 KTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
..+++|||||+||+|.+++.+. +.+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 76 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~-~~~Kl~DFGla~ 152 (276)
T d1uwha_ 76 PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHED-LTVKIGDFGLAT 152 (276)
T ss_dssp SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT-SSEEECCCCCSC
T ss_pred cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCC-CCEEEcccccee
Confidence 4578999999999999999765 56999999999999999999999999 9999999999999987 899999999997
Q ss_pred hhcCC---CCCccccCCCCcCCccccc----cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC--
Q 012320 183 ILRGS---KSAHSVIGTPEFMAPELYE----EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGA-- 253 (466)
Q Consensus 183 ~~~~~---~~~~~~~GT~~y~APE~l~----~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~-- 253 (466)
..... ....+..||+.|||||++. +.|+.++|||||||++|||+||..||.+..+...+...+..+..++.
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~ 232 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS 232 (276)
T ss_dssp C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGG
T ss_pred eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcch
Confidence 76432 2345678999999999874 24899999999999999999999999987888888888888765443
Q ss_pred -CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 254 -FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 254 -~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
.+...+.++++||.+||. ||.+|||+.|++.+
T Consensus 233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 344567899999999995 99999999999865
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.6e-52 Score=417.71 Aligned_cols=259 Identities=21% Similarity=0.345 Sum_probs=215.9
Q ss_pred eeeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEeEEE
Q 012320 21 IETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYTSWI 99 (466)
Q Consensus 21 ~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~ 99 (466)
++....++|.++ ++||+|+||+||+|+++.+|+.||+|+++... .+++.+|+.+|++++ ||||++++++|.
T Consensus 29 ~~~~~~d~y~i~-~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~Ei~il~~l~~hpnIv~~~~~~~ 100 (328)
T d3bqca1 29 VEWGNQDDYQLV-RKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVK 100 (328)
T ss_dssp CCCCCGGGEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEECSSC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cCCCCCcCeEEE-EEEecCcCeEEEEEEECCCCCEEEEEEECHHH-------HHHHHHHHHHHHhccCCCCCcEEEEEEE
Confidence 444455789885 56999999999999999999999999986322 356889999999995 999999999987
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccc
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLG 179 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFG 179 (466)
......+++|||||.+++|..+ .+.+++..++.+++||+.||.|||++| |+||||||+|||++.+.+.+||+|||
T Consensus 101 ~~~~~~~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG 175 (328)
T d3bqca1 101 DPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWG 175 (328)
T ss_dssp CTTTCSEEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGG
T ss_pred ecCCCceeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccc
Confidence 6667789999999999999765 357999999999999999999999999 99999999999999764579999999
Q ss_pred hhhhhcCCCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc----------
Q 012320 180 LAAILRGSKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS---------- 247 (466)
Q Consensus 180 la~~~~~~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~---------- 247 (466)
+|............+||+.|+|||++.+ .|+.++||||+||++|+|++|..||....+.......+..
T Consensus 176 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 176 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255 (328)
T ss_dssp GCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred cceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence 9988776666777889999999997653 4899999999999999999999999876655443322210
Q ss_pred ---CC----------------------CCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCchh
Q 012320 248 ---GK----------------------LPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASDE 292 (466)
Q Consensus 248 ---g~----------------------~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~~ 292 (466)
.. .+.......++++++||++||. ||.+||||+|+|+||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 00 0111223457899999999996 999999999999999998643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-52 Score=417.10 Aligned_cols=262 Identities=21% Similarity=0.356 Sum_probs=210.9
Q ss_pred eeCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 22 ~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
.+++.+||.++++ ||+|+||+||+|.++.+|+.||||++.+... ......++.+|+.+|++++||||+++++.+...
T Consensus 5 ~~~~~~rY~i~~~-LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~ 81 (318)
T d3blha1 5 FCDEVSKYEKLAK-IGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTK 81 (318)
T ss_dssp TSCBGGGEEEEEE-EEECSSSEEEEEEETTTCCEEEEEEC----C--TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred CCCccCCEEEEEE-EecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHHhcCCCccceEeeeecc
Confidence 4677899998655 9999999999999999999999999876543 223446788999999999999999999987543
Q ss_pred ------cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEE
Q 012320 102 ------DQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKI 175 (466)
Q Consensus 102 ------~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL 175 (466)
....+|+||||+.++.+..+......+++..++.+++||+.||.|||+++ |+||||||+|||++.+ +.+||
T Consensus 82 ~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~-~~~kl 158 (318)
T d3blha1 82 ASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLKL 158 (318)
T ss_dssp ---------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEE
T ss_pred cccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCC-CcEEe
Confidence 24568999999988887776666788999999999999999999999999 9999999999999987 89999
Q ss_pred eccchhhhhcCC-----CCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-
Q 012320 176 GDLGLAAILRGS-----KSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS- 247 (466)
Q Consensus 176 ~DFGla~~~~~~-----~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~- 247 (466)
+|||++..+... ....+.+||+.|+|||++. ..|+.++|||||||++|||++|..||.+ .+.......+..
T Consensus 159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~-~~~~~~~~~i~~~ 237 (318)
T d3blha1 159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG-NTEQHQLALISQL 237 (318)
T ss_dssp CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHH
T ss_pred eecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC-CCHHHHHHHHHHh
Confidence 999999765422 2234568999999999765 3589999999999999999999999976 455554444432
Q ss_pred -CCCCCCCC----------------------------CCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 248 -GKLPGAFY----------------------------SIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 248 -g~~p~~~~----------------------------~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
+..+.... ...++++++||.+||. ||++||||+|+|+||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 22211110 0125678899999996 9999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=409.14 Aligned_cols=245 Identities=23% Similarity=0.360 Sum_probs=207.0
Q ss_pred eeeeeeCceEEEEEEEc--CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEEEEEe
Q 012320 34 EVLGKGAMKTVYKAIDE--VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFNFITE 111 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~lV~E 111 (466)
+.||+|+||+||+|.++ .+++.||+|+++... .++...+.+.+|+.+|++++|||||++++++. + +.+++|||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~--~-~~~~lvmE 87 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICE--A-ESWMLVME 87 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--S-SSEEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh--CCHHHHHHHHHHHHHHHhCCCCCCceEEEEec--c-CCEEEEEE
Confidence 46999999999999854 467899999986443 23455678999999999999999999999873 2 34789999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcCCCC--
Q 012320 112 MFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS-- 189 (466)
Q Consensus 112 ~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~-- 189 (466)
||++|+|.+++.+.+.+++..+..|+.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+++.+.....
T Consensus 88 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~-~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 88 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCCTTCEECCTTCSEE
T ss_pred cCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhccccc-Ccccccchhhhhhcccccccc
Confidence 9999999999999999999999999999999999999999 9999999999999987 8999999999987654322
Q ss_pred --CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 012320 190 --AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRF 265 (466)
Q Consensus 190 --~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~l 265 (466)
.....||+.|||||++. +.|+.++|||||||++|||+| |..||.+ .+..++...+..|..+. .+...+.++++|
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~~-~p~~~~~~~~~l 242 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERMG-CPAGCPREMYDL 242 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCCC-CCTTCCHHHHHH
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCcccCHHHHHH
Confidence 23457999999999775 569999999999999999998 8999987 66788889998886543 345678899999
Q ss_pred HHHhcc-CcCCCCCHHHH---hcCCCC
Q 012320 266 IGRCLV-NASKRLSAKEL---LLDPFL 288 (466)
Q Consensus 266 I~~~L~-dp~~Rpsa~el---L~hpf~ 288 (466)
|.+||. ||.+|||+.++ |+|+|+
T Consensus 243 i~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 243 MNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 999996 99999999998 566665
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-52 Score=410.84 Aligned_cols=247 Identities=22% Similarity=0.339 Sum_probs=213.5
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
-.+|.+ .+.||+|+||+||+|.++.+|+.||+|+++... ...+++.+|+.+|++++|||||+++++| .+...
T Consensus 16 ~~~~~~-~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~--~~~~~ 87 (287)
T d1opja_ 16 RTDITM-KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVC--TREPP 87 (287)
T ss_dssp GGGEEE-EEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSSS
T ss_pred HHHeEE-eeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-----chHHHHHHHHHHHHhCCCCCEecCCccE--eeCCe
Confidence 356766 567999999999999999999999999986433 2346789999999999999999999988 45677
Q ss_pred EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 106 FNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
+++|||||++|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~-~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGLSRL 164 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCCCTTT
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCC-CcEEEccccceee
Confidence 89999999999999998764 56899999999999999999999999 9999999999999987 8999999999987
Q ss_pred hcCCCC--CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 012320 184 LRGSKS--AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL 260 (466)
Q Consensus 184 ~~~~~~--~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~ 260 (466)
...... .....||+.|||||++. +.|+.++|||||||++|||++|..||....+..++++.+..+..+ ..+...+.
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~-~~~~~~~~ 243 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-ERPEGCPE 243 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC-CCCTTCCH
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC-CCCccchH
Confidence 654332 22345899999999765 679999999999999999999888887778888898888877543 34556788
Q ss_pred HHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 261 EAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 261 ~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
++++||.+||. ||.+|||+.|+++
T Consensus 244 ~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 244 KVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 99999999996 9999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-52 Score=418.38 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=207.3
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec----cC
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV----DQ 103 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~----~~ 103 (466)
+|.. .++||+|+||+||+|.++.+|+.||+|++...... ..+|+.+|++++||||++++++|... +.
T Consensus 21 ~Y~~-~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 21 SYTD-TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS--------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred CcEe-eeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH--------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 6877 47799999999999999999999999999755421 23699999999999999999998653 34
Q ss_pred CEEEEEEecCCCCCHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 104 KTFNFITEMFTSGTLREY---RKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~---l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
.++|+|||||+++.+..+ ......+++..++.|++||+.||+|||++| |+||||||+|||++.+...+||+|||+
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccc
Confidence 578999999977644433 334567999999999999999999999999 999999999999987745899999999
Q ss_pred hhhhcCCCCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-C---------
Q 012320 181 AAILRGSKSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-G--------- 248 (466)
Q Consensus 181 a~~~~~~~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-g--------- 248 (466)
+..+.......+.+||+.|+|||++. ..|+.++||||+||++|||++|..||........+.+.+.. |
T Consensus 170 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred hhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 98877666677789999999999654 45899999999999999999999999874444443332210 1
Q ss_pred --------CCCC--------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 249 --------KLPG--------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 249 --------~~p~--------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.++. ......++++++||.+||. ||.+||||.|+|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 1111 1123467899999999996 99999999999999999754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=404.06 Aligned_cols=256 Identities=25% Similarity=0.356 Sum_probs=218.8
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
.||.+++ .||+|+||+||+|.++.+|+.||||+++.... .....+++.+|+.+|++++||||+++++.| .+...+
T Consensus 2 ~ry~~i~-~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~--~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLE-KIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVL--HSDKKL 76 (292)
T ss_dssp CSEEEEE-EEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSEE
T ss_pred CCCEeee-EEecCcCeEEEEEEECCCCcEEEEEEEehhhC--ChHHHHHHHHHHHHHHhcCcCCEEeecccc--ccccce
Confidence 5898865 59999999999999999999999999976542 344668899999999999999999999988 457789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 107 NFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
++|+|++.|++|..++...+.+++..++.+++|++.||+|||++| |+||||||+|||++.+ +.+||+|||.+.....
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~-~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRN-GELKLANFGLARAFGI 153 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCS
T ss_pred eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccC-CceeeeecchhhcccC
Confidence 999999999999999998899999999999999999999999999 9999999999999977 7999999999987654
Q ss_pred CC-CCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-------------
Q 012320 187 SK-SAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKL------------- 250 (466)
Q Consensus 187 ~~-~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~------------- 250 (466)
.. ......+++.|+|||++.. .++.++|||||||++|||++|..||....+..+...++.....
T Consensus 154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 33 3344567889999997753 3789999999999999999999998777787777666542110
Q ss_pred --------------CCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 251 --------------PGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 251 --------------p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
........++.+++||++||. ||.+||||+|+|+||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 011223456789999999996 9999999999999999974
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=414.91 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=206.8
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCC-----eEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEe
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLG-----VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWID 100 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~ 100 (466)
++|.+ .++||+|+||+||+|.+..++ ..||+|.+.... .......+.+|+.+|+++ +|||||++++++
T Consensus 37 ~~~~l-~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-- 110 (325)
T d1rjba_ 37 ENLEF-GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGAC-- 110 (325)
T ss_dssp GGEEE-EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred HHeEE-eeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc---CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE--
Confidence 56765 678999999999999987654 479999886433 233456789999999998 899999999988
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEec
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKKY-----------------------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHR 157 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~~-----------------------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHr 157 (466)
.+.+.+|+|||||+||+|.+++.+. +.+++..+..|+.||+.||.|||+++ |+||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHR 188 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHR 188 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEET
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeec
Confidence 4567799999999999999999754 24899999999999999999999999 9999
Q ss_pred cCCCCcEEEeCCCCcEEEeccchhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCC
Q 012320 158 DLKCDNIFVNGHLGQVKIGDLGLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPY 232 (466)
Q Consensus 158 DLKp~NIlv~~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf 232 (466)
||||+|||++.+ +.+||+|||+|+....... ..+..||+.|||||++. +.|+.++|||||||++|||+| |..||
T Consensus 189 DlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 189 DLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp TCSGGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred cCchhccccccC-CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 999999999987 8999999999987654332 23567899999999775 679999999999999999998 89999
Q ss_pred CCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 233 SECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 233 ~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
.+......+.+.+..+. ....+...+.++++||.+||. ||++|||++||++|
T Consensus 268 ~~~~~~~~~~~~~~~~~-~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 268 PGIPVDANFYKLIQNGF-KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TTCCCSHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCC-CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 87666666666666554 334556678899999999996 99999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-52 Score=416.62 Aligned_cols=259 Identities=26% Similarity=0.377 Sum_probs=207.1
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
.+-..||.++ +.||+|+||+||+|.++.+|+.||||++++.. .+....+++.+|+.+|++++|||||+++++|...+
T Consensus 14 ~~~~~~Y~~i-~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 14 WEVRAVYRDL-QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 90 (346)
T ss_dssp ECCBSSEEEE-EEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred eecCCcEEEE-EEEecCCCeEEEEEEECCCCCEEEEEEEchhh--cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence 3456899986 55999999999999999999999999987543 35566788999999999999999999999986432
Q ss_pred ----CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEecc
Q 012320 103 ----QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDL 178 (466)
Q Consensus 103 ----~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DF 178 (466)
...+|+||||+ |.+|..+++ .+++++..++.+++||+.||.|||++| |+||||||+|||++.+ +.+||+||
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~-~~~kl~Df 165 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDF 165 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCC
T ss_pred cccccceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccc-cccccccc
Confidence 23689999999 778887765 478999999999999999999999999 9999999999999987 89999999
Q ss_pred chhhhhcCCCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCC-----
Q 012320 179 GLAAILRGSKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-GKL----- 250 (466)
Q Consensus 179 Gla~~~~~~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-g~~----- 250 (466)
|+|+.... .....+||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+......+...... +..
T Consensus 166 g~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 166 GLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp TTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 99976543 3456789999999997753 4789999999999999999999999874433333222110 110
Q ss_pred ------------------C----CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 251 ------------------P----GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 251 ------------------p----~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
. .......++++++||.+||. ||.+||||+|+|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0 11223457899999999996 99999999999999999753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.4e-52 Score=407.85 Aligned_cols=252 Identities=19% Similarity=0.302 Sum_probs=201.2
Q ss_pred eCCCCceEEeeeeeeeeCceEEEEEEEcCCCe---EEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEE
Q 012320 23 TDPNGRYGLFEEVLGKGAMKTVYKAIDEVLGV---EVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWI 99 (466)
Q Consensus 23 ~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 99 (466)
....++|.+ .++||+|+||+||+|.++.+|+ .||+|.+... .+....+.+.+|+.+|++++|||||++++++
T Consensus 22 ~i~~~~~~~-~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~- 96 (299)
T d1jpaa_ 22 EIDISCVKI-EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNVIHLEGVV- 96 (299)
T ss_dssp BCCGGGEEE-EEEEEECSSSEEEEEEECC---CCEEEEEEECCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred hhChhhcEE-eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCCccEEEEE-
Confidence 344467766 7889999999999999987765 5788876533 2455667899999999999999999999987
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEecc
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDL 178 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DF 178 (466)
.+...+++|||||+||+|.+++.+. +.+++..+..|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+||
T Consensus 97 -~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~-~~~Kl~DF 172 (299)
T d1jpaa_ 97 -TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSN-LVCKVSDF 172 (299)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCC
T ss_pred -eeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCC-CcEEECCc
Confidence 4566789999999999999988774 57999999999999999999999999 9999999999999977 89999999
Q ss_pred chhhhhcCCCCC------ccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCC
Q 012320 179 GLAAILRGSKSA------HSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKL 250 (466)
Q Consensus 179 Gla~~~~~~~~~------~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~ 250 (466)
|+++.+...... ....||+.|||||++. +.|+.++|||||||++|||+| |..||.+ .+..++...+..+..
T Consensus 173 Gla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~-~~~~~~~~~i~~~~~ 251 (299)
T d1jpaa_ 173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MTNQDVINAIEQDYR 251 (299)
T ss_dssp -----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCC
T ss_pred ccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCC
Confidence 999876543221 2245799999999876 569999999999999999998 8999977 667788888887754
Q ss_pred CCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 251 PGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 251 p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
++ .+...+.++++||.+||. ||.+|||+.|++++
T Consensus 252 ~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 252 LP-PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CC-CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CC-CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 33 344577899999999995 99999999998753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=399.67 Aligned_cols=245 Identities=19% Similarity=0.328 Sum_probs=199.8
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
+|.. .+.||+|+||+||+|.++ ++..||||+++.... ..+.+.+|+.++++++|||||++++++ .++..++
T Consensus 6 ~~~~-~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~--~~~~~~~ 76 (263)
T d1sm2a_ 6 ELTF-VQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVC--LEQAPIC 76 (263)
T ss_dssp CEEE-EEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSSSCE
T ss_pred HcEE-EEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC-----cHHHHHHHHHHHHhcCCCCccccccee--ccCCceE
Confidence 5766 566999999999999986 578899999874332 235789999999999999999999987 4466789
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 108 FITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
+||||+++|+|.+++.+. ..+++..+..|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++....
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLD 153 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGG-GCEEECSCC-------
T ss_pred EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCC-CCeEecccchheeccC
Confidence 999999999999998755 56899999999999999999999999 9999999999999987 8999999999987654
Q ss_pred CC--CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 012320 187 SK--SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQ 263 (466)
Q Consensus 187 ~~--~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~ 263 (466)
.. ......||+.|||||++. +.|+.++|||||||++|||+|+..|+....+..++...+..+..+ ..+...++++.
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~-~~p~~~~~~l~ 232 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-YKPRLASTHVY 232 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC-CCCTTSCHHHH
T ss_pred CCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC-CCccccCHHHH
Confidence 32 233467999999999876 569999999999999999999655655557888898988887543 34566788999
Q ss_pred HHHHHhcc-CcCCCCCHHHHhcC
Q 012320 264 RFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 264 ~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
+||.+||. ||++|||++|+++|
T Consensus 233 ~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 233 QIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 99999996 99999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-52 Score=404.81 Aligned_cols=251 Identities=23% Similarity=0.356 Sum_probs=212.4
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCC
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQK 104 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 104 (466)
|-.+|.+ .+.||+|+||+||+|.++ ++..||||+++.... ..+.+.+|+.+|++++|||||++++++. .+
T Consensus 11 ~~~~~~~-~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~---~~ 80 (272)
T d1qpca_ 11 PRETLKL-VERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQHQRLVRLYAVVT---QE 80 (272)
T ss_dssp CGGGEEE-EEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEC---SS
T ss_pred CHHHeEE-eEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC-----CHHHHHHHHHHHHhCCCCCEeEEEeeec---cC
Confidence 4467876 566999999999999986 578999999874432 2357899999999999999999999763 34
Q ss_pred EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 105 TFNFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
.+++||||+++|+|.+++... .++++..+..|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~-~~~Kl~DFGla~ 157 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDT-LSCKIADFGLAR 157 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCE
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecc-cceeeccccceE
Confidence 578999999999999976433 46999999999999999999999999 9999999999999987 899999999998
Q ss_pred hhcCCC--CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCC
Q 012320 183 ILRGSK--SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQD 259 (466)
Q Consensus 183 ~~~~~~--~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 259 (466)
.+.... ......||+.|||||++. +.|+.++|||||||++|||+||..|+....+..++.+.+..+..+. .+...+
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~~ 236 (272)
T d1qpca_ 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-RPDNCP 236 (272)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTCC
T ss_pred EccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CcccCh
Confidence 765432 234567999999999876 5699999999999999999997777666688888999998876443 345678
Q ss_pred HHHHHHHHHhcc-CcCCCCCHHHHhc--CCCCC
Q 012320 260 LEAQRFIGRCLV-NASKRLSAKELLL--DPFLA 289 (466)
Q Consensus 260 ~~~~~lI~~~L~-dp~~Rpsa~elL~--hpf~~ 289 (466)
.++++||.+||. ||.+|||+.++++ ++||.
T Consensus 237 ~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 899999999996 9999999999987 67764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=414.46 Aligned_cols=259 Identities=26% Similarity=0.372 Sum_probs=205.0
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc--
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD-- 102 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-- 102 (466)
-+.||.++ +.||+|+||+||+|.++.+|+.||||++++.. .....+++.+|+.+|++++||||+++++.+....
T Consensus 6 i~~rY~~~-~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 6 VGPRYTNL-SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81 (345)
T ss_dssp CCTTEEEE-EECC---CCCEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred cCCCeEEE-EEEeeccCeEEEEEEECCCCcEEEEEEEehhc---ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccc
Confidence 35689886 55999999999999999999999999987533 4556678999999999999999999999875432
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
....+++++++.||+|.+++.. +++++..++.+++||+.||+|||++| |+||||||+|||++.+ |.+||+|||++.
T Consensus 82 ~~~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~-~~~kl~DfG~a~ 157 (345)
T d1pmea_ 82 QMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFGLAR 157 (345)
T ss_dssp TCCCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCE
T ss_pred ccceEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCC-CCEEEcccCcee
Confidence 1123444566779999999975 57999999999999999999999999 9999999999999977 899999999997
Q ss_pred hhcCC----CCCccccCCCCcCCccccc--cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-------
Q 012320 183 ILRGS----KSAHSVIGTPEFMAPELYE--EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK------- 249 (466)
Q Consensus 183 ~~~~~----~~~~~~~GT~~y~APE~l~--~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~------- 249 (466)
..... ......+||+.|+|||++. ..|+.++||||+||++|+|++|..||............+....
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 65332 2245568999999999874 3488999999999999999999999976443333322221100
Q ss_pred --------------CCC-------CCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCch
Q 012320 250 --------------LPG-------AFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLASD 291 (466)
Q Consensus 250 --------------~p~-------~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~~ 291 (466)
.+. ......+.++++||.+||. ||.+||||+|+|+||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 000 0123456789999999996 99999999999999999753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=402.40 Aligned_cols=250 Identities=18% Similarity=0.334 Sum_probs=210.0
Q ss_pred CceEEeee-eeeeeCceEEEEEEEcC--CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 27 GRYGLFEE-VLGKGAMKTVYKAIDEV--LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 27 ~rY~~~~~-~LG~G~fg~Vyka~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
.+|.+ .+ .||+|+||+||+|.++. ++..||||+++... .....+++.+|+.+|++++|||||++++++. +
T Consensus 8 ~~~~~-~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~- 80 (285)
T d1u59a_ 8 DNLLI-ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ--A- 80 (285)
T ss_dssp GGEEE-EEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--S-
T ss_pred cCeEE-CCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc---CHHHHHHHHHHHHHHHhCCCCCEeeEeeeec--c-
Confidence 34555 44 49999999999998754 46689999986432 4566788999999999999999999999763 2
Q ss_pred CEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 104 KTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
+.+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~-~~~Kl~DFGla~ 157 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNR-HYAKISDFGLSK 157 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEET-TEEEECCCTTCE
T ss_pred CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccC-Cceeeccchhhh
Confidence 3578999999999999997654 57999999999999999999999999 9999999999999977 899999999998
Q ss_pred hhcCCCC----CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 012320 183 ILRGSKS----AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 183 ~~~~~~~----~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 256 (466)
.+..... .....||+.|||||++. +.|+.++|||||||++|||+| |..||.+ .+..++...+..|..+. .+.
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~-~~~~~~~~~i~~~~~~~-~p~ 235 (285)
T d1u59a_ 158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK-MKGPEVMAFIEQGKRME-CPP 235 (285)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCTHHHHHHHHTTCCCC-CCT
T ss_pred cccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCC
Confidence 7644322 23456899999999876 569999999999999999998 8999987 45567888888887554 345
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHH---hcCCCC
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKEL---LLDPFL 288 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~el---L~hpf~ 288 (466)
..++++.+||.+||. +|++|||+.++ |+|+|+
T Consensus 236 ~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 678899999999996 99999999887 566665
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=396.42 Aligned_cols=252 Identities=21% Similarity=0.322 Sum_probs=206.5
Q ss_pred eeCCCCceEEeeeeeeeeCceEEEEEEEcCCC----eEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeE
Q 012320 22 ETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLG----VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTS 97 (466)
Q Consensus 22 ~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 97 (466)
|.+| ..|.+ .++||+|+||+||+|.++.++ ..||||++.... .......+.+|+.+|++++|||||+++++
T Consensus 3 ei~~-~~~~~-~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~H~nIv~~~g~ 77 (283)
T d1mqba_ 3 EIHP-SCVTR-QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGV 77 (283)
T ss_dssp BCCT-TTEEE-EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCCH-HHeEe-eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc---ChHHHHHHHHHHHHHHhcCCCCEeeeeEE
Confidence 3444 35776 788999999999999987665 579999986432 44556678999999999999999999998
Q ss_pred EEeccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEe
Q 012320 98 WIDVDQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIG 176 (466)
Q Consensus 98 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~ 176 (466)
+ .+...+++||||+.++++.+++... +.+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+
T Consensus 78 ~--~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~-~~~Kl~ 152 (283)
T d1mqba_ 78 I--SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSN-LVCKVS 152 (283)
T ss_dssp E--CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEEC
T ss_pred E--ecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCC-CeEEEc
Confidence 7 4566789999999999999987655 67999999999999999999999999 9999999999999987 899999
Q ss_pred ccchhhhhcCCC----CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC
Q 012320 177 DLGLAAILRGSK----SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLP 251 (466)
Q Consensus 177 DFGla~~~~~~~----~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p 251 (466)
|||+++.+.... ......||+.|||||++. +.|+.++|||||||++|||++|..||....+..++++.+..+..+
T Consensus 153 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~ 232 (283)
T d1mqba_ 153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 232 (283)
T ss_dssp CCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred ccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC
Confidence 999998764322 223356899999999776 569999999999999999999877776668889999999888654
Q ss_pred CCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 252 GAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 252 ~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
+ .+...+.+++++|.+||. +|.+|||+.|+++
T Consensus 233 ~-~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 233 P-TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp C-CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred C-CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 3 345577899999999995 9999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-51 Score=392.42 Aligned_cols=244 Identities=20% Similarity=0.368 Sum_probs=210.3
Q ss_pred ceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEEE
Q 012320 28 RYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTFN 107 (466)
Q Consensus 28 rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~~ 107 (466)
.|.. .+.||+|+||+||+|.++ ++..||||++++... ..+.+.+|+.++++++||||+++++++ .+++.++
T Consensus 5 ~~~~-~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-----~~~~~~~Ev~~~~~l~HpnIv~~~g~~--~~~~~~~ 75 (258)
T d1k2pa_ 5 DLTF-LKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVC--TKQRPIF 75 (258)
T ss_dssp CCCC-CCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-----CHHHHHHHHHHHHTCCCTTBCCEEEEE--CCSSSEE
T ss_pred HCEE-eEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-----CHHHHHHHHHHHHhcCCCceeeEEEEE--eeCCceE
Confidence 4554 577999999999999985 788999999885542 235689999999999999999999987 4567799
Q ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhhcC
Q 012320 108 FITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRG 186 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~~~ 186 (466)
+||||+.+|+|.+++.. ...+++..+..++.||+.||.|||++| |+||||||+||+++.+ +.+||+|||+++.+..
T Consensus 76 iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~-~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTT-CCEEECCCSSCCBCSS
T ss_pred EEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCC-CcEEECcchhheeccC
Confidence 99999999999998654 467999999999999999999999999 9999999999999977 8999999999976643
Q ss_pred CC--CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 012320 187 SK--SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA 262 (466)
Q Consensus 187 ~~--~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~ 262 (466)
.. ......||+.|+|||++. ..|+.++|||||||++|||+| |..||.. .+..++..++..+..+ ..+...+.++
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~~l 230 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAEHIAQGLRL-YRPHLASEKV 230 (258)
T ss_dssp SSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHH
T ss_pred CCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCC-CCHHHHHHHHHhCCCC-CCcccccHHH
Confidence 32 223467899999999876 669999999999999999998 8999977 5678888889887643 3556778899
Q ss_pred HHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 263 QRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 263 ~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
++||.+||. ||++|||++++++|
T Consensus 231 ~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 231 YTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHHH
Confidence 999999996 99999999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=408.98 Aligned_cols=261 Identities=21% Similarity=0.357 Sum_probs=217.4
Q ss_pred CceEEeeeeeeeeCceEEEEEEE---cCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCC-CceeEEEeEEEecc
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAID---EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH-DSIIRFYTSWIDVD 102 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~---~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~ 102 (466)
.+|.+ .+.||+|+||+||+|.+ +.+|+.||+|++++.....+....+.+.+|+++|++++| |||+++++.+ .+
T Consensus 24 ~~y~~-~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~--~~ 100 (322)
T d1vzoa_ 24 ENFEL-LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF--QT 100 (322)
T ss_dssp GGEEE-EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE--EE
T ss_pred hceEE-EEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee--cc
Confidence 55777 46699999999999987 557999999999766543333345678899999999976 8999999987 44
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
...+++||||+.||+|.+++...+.+++..++.+++||+.||.|||+.+ |+||||||+|||++.+ |.+||+|||+++
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~-~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSN-GHVVLTDFGLSK 177 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEESCSSEEE
T ss_pred CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCC-CCEEEeeccchh
Confidence 6789999999999999999999999999999999999999999999999 9999999999999987 899999999997
Q ss_pred hhcC--CCCCccccCCCCcCCcccccc---CCCChhhHHHHHHHHHHHHhCCCCCCCC---CCHHHHHHHHhcCCCCCCC
Q 012320 183 ILRG--SKSAHSVIGTPEFMAPELYEE---DYNELVDVYSFGMCVLEMFTCEYPYSEC---ANPAQIYKKVTSGKLPGAF 254 (466)
Q Consensus 183 ~~~~--~~~~~~~~GT~~y~APE~l~~---~y~~~~DIwSlGvil~elltg~~Pf~~~---~~~~~i~~~i~~g~~p~~~ 254 (466)
.+.. .....+..||+.|+|||.+.. .++.++|||||||++|+|++|..||... .....+.+....+.. ..
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~--~~ 255 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PY 255 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--CC
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC--CC
Confidence 6543 223456789999999997753 4788999999999999999999999653 234445555544443 34
Q ss_pred CCCCCHHHHHHHHHhcc-CcCCCC-----CHHHHhcCCCCCchhhhh
Q 012320 255 YSIQDLEAQRFIGRCLV-NASKRL-----SAKELLLDPFLASDEVKL 295 (466)
Q Consensus 255 ~~~~~~~~~~lI~~~L~-dp~~Rp-----sa~elL~hpf~~~~~~~~ 295 (466)
+...+.++++||++||. ||.+|| ||+|+|+||||+...+..
T Consensus 256 ~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~ 302 (322)
T d1vzoa_ 256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD 302 (322)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHH
T ss_pred cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHH
Confidence 45678999999999996 999999 589999999999876643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-51 Score=410.67 Aligned_cols=254 Identities=26% Similarity=0.368 Sum_probs=197.2
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec----c
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV----D 102 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~----~ 102 (466)
.||.++ ++||+|+||+||+|.++.+|+.||+|++..... +.....++.+|+.+|++++|||||+++++|... .
T Consensus 17 ~~Y~i~-~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 17 KRYQNL-KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp TTEEEE-EECSCC--CEEEEEEETTTTEEEEEEEEESTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred CCeEEE-EEeecCcCeEEEEEEECCCCCEEEEEEEChhhc--CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 688885 559999999999999999999999999985542 456667899999999999999999999998644 3
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
...+|+|||||.|+.+. .+ ...+++..++.+++||+.||.|||++| |+||||||+|||++.+ +.+|++|||+++
T Consensus 94 ~~~~~iv~Ey~~~~l~~-~~--~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~-~~~kl~df~~~~ 167 (355)
T d2b1pa1 94 FQDVYLVMELMDANLCQ-VI--QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLAR 167 (355)
T ss_dssp CCEEEEEEECCSEEHHH-HH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCCCC--
T ss_pred CceeEEEEeccchHHHH-hh--hcCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccc-cceeeechhhhh
Confidence 47899999999765554 33 467999999999999999999999999 9999999999999987 899999999998
Q ss_pred hhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--------------
Q 012320 183 ILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTS-------------- 247 (466)
Q Consensus 183 ~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~-------------- 247 (466)
...........+||+.|+|||++. ..|+.++||||+||++|+|++|.+||.+. +......++..
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~-~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR-DYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred ccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC-CHHHHHHHHHHhccCCCHHHHHHhh
Confidence 877666667788999999999876 56999999999999999999999999763 44433333321
Q ss_pred --------CCCCCC-----------C-------CCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 248 --------GKLPGA-----------F-------YSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 248 --------g~~p~~-----------~-------~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
+..+.. . ....+.++++||++||. ||++||||+|||+||||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 110000 0 01124578999999996 9999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-51 Score=408.50 Aligned_cols=255 Identities=27% Similarity=0.395 Sum_probs=206.4
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec---c
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV---D 102 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~---~ 102 (466)
.+||.++ +.||+|+||+||+|.++.+|+.||||++++.. .+....+++.+|+.+|++++|||||+++++|... +
T Consensus 17 ~~rY~i~-~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~ 93 (348)
T d2gfsa1 17 PERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 93 (348)
T ss_dssp ETTEEEE-EECGGGTTSSEEEEEETTTTEEEEEEECSCTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred CCCeEEE-EEEecCCCeEEEEEEECCCCCEEEEEEECchh--cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccc
Confidence 4789886 55999999999999999999999999987543 3555667899999999999999999999987532 2
Q ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
....++|++++.||+|.+++.. +++++..++.+++||+.||.|||++| |+||||||+|||++.+ |.+|++|||++.
T Consensus 94 ~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~-~~~kl~dfg~a~ 169 (348)
T d2gfsa1 94 EFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLAR 169 (348)
T ss_dssp TCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCC----
T ss_pred cCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCcccccccc-ccccccccchhc
Confidence 2344566778889999998854 68999999999999999999999999 9999999999999987 899999999997
Q ss_pred hhcCCCCCccccCCCCcCCcccccc--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--C--------
Q 012320 183 ILRGSKSAHSVIGTPEFMAPELYEE--DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGK--L-------- 250 (466)
Q Consensus 183 ~~~~~~~~~~~~GT~~y~APE~l~~--~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~--~-------- 250 (466)
... ....+..||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+.......+.... .
T Consensus 170 ~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 170 HTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG-TDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred ccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHHhcCCCChHHhhhc
Confidence 543 33456779999999997543 368999999999999999999999977 44444444443211 0
Q ss_pred ---------------CCC----CCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcCCCCCc
Q 012320 251 ---------------PGA----FYSIQDLEAQRFIGRCLV-NASKRLSAKELLLDPFLAS 290 (466)
Q Consensus 251 ---------------p~~----~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hpf~~~ 290 (466)
+.. .....++++++||.+||. ||.+||||+|+|+||||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 000 123457889999999996 9999999999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=391.22 Aligned_cols=249 Identities=22% Similarity=0.371 Sum_probs=200.8
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCC---CeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEec
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVL---GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDV 101 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 101 (466)
+-.+|.+ .+.||+|+||+||+|.+..+ +..||+|.++.. ......+.+.+|+.+|++++|||||++++++.
T Consensus 5 ~~~~~~l-~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-- 78 (273)
T d1mp8a_ 5 QRERIEL-GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-- 78 (273)
T ss_dssp CGGGEEE-EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--
T ss_pred CHHHeEE-EEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence 3457877 67799999999999998654 456888877532 24556678999999999999999999999872
Q ss_pred cCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccch
Q 012320 102 DQKTFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGL 180 (466)
Q Consensus 102 ~~~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGl 180 (466)
.+.+|+||||+.+|+|.+++.+ .+.+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||+
T Consensus 79 -~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~-~~~Kl~DfG~ 154 (273)
T d1mp8a_ 79 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-DCVKLGDFGL 154 (273)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECC---
T ss_pred -cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCC-CcEEEccchh
Confidence 3568899999999999998765 457999999999999999999999999 9999999999999987 8999999999
Q ss_pred hhhhcCCC--CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 012320 181 AAILRGSK--SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 181 a~~~~~~~--~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 256 (466)
++.+.... ......||+.|+|||++. +.|+.++|||||||++|||+| |..||.. .+..++++.+..+..++ .+.
T Consensus 155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~ 232 (273)
T d1mp8a_ 155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERLP-MPP 232 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCCC-CCT
T ss_pred heeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCCC-CCC
Confidence 98765332 234567899999999876 579999999999999999998 7888866 66778888888887543 455
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
..+.++++||.+||. ||.+|||+.||++|
T Consensus 233 ~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 678899999999996 99999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-50 Score=391.56 Aligned_cols=251 Identities=20% Similarity=0.323 Sum_probs=207.7
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
..+|.+ .+.||+|+||+||+|+++.+ ..||+|+++.... ..+.+.+|+.+|++++|||||++|+++. + +.
T Consensus 16 ~~~~~i-~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~~g~~~--~-~~ 85 (285)
T d1fmka3 16 RESLRL-EVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVS--E-EP 85 (285)
T ss_dssp GGGEEE-EEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEC--S-SS
T ss_pred HHHEEE-eeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC-----CHHHHHHHHHHHHhcccCCEeEEEEEEe--c-CC
Confidence 357776 66699999999999998765 6799999864432 2357899999999999999999999873 2 34
Q ss_pred EEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhh
Q 012320 106 FNFITEMFTSGTLREYRKK--YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAI 183 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~~--~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~ 183 (466)
+++||||+.+|+|..++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~-~~~kl~DfGla~~ 162 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARL 162 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCCTTC-
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCC-CcEEEcccchhhh
Confidence 7899999999999988753 467999999999999999999999999 9999999999999877 8999999999987
Q ss_pred hcCCC--CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCH
Q 012320 184 LRGSK--SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSGKLPGAFYSIQDL 260 (466)
Q Consensus 184 ~~~~~--~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~ 260 (466)
..... ......||+.|+|||++. +.++.++|||||||++|||+||..||....+..++...+..+..++ .+...+.
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~ 241 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPE 241 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTSCH
T ss_pred ccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CCcccCH
Confidence 64332 233467999999999775 6799999999999999999998777777788888999888776443 4556788
Q ss_pred HHHHHHHHhcc-CcCCCCCHHHHhc--CCCCCc
Q 012320 261 EAQRFIGRCLV-NASKRLSAKELLL--DPFLAS 290 (466)
Q Consensus 261 ~~~~lI~~~L~-dp~~Rpsa~elL~--hpf~~~ 290 (466)
++++||.+||. ||++|||+++++. ++||+.
T Consensus 242 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 99999999996 9999999999987 888865
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-50 Score=393.59 Aligned_cols=252 Identities=24% Similarity=0.339 Sum_probs=202.2
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcC-----CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEE
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEV-----LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSW 98 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~ 98 (466)
|-.+|.+ .+.||+|+||+||+|.+.. +++.||+|+++... .....+.+.+|+.++.++ +|||||.+++.+
T Consensus 11 ~~~~y~~-~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 11 PRDRLKL-GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp CGGGEEE-EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cHHHEEE-eeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---CcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 3467877 5679999999999999653 56889999886432 345567788898888887 689999999876
Q ss_pred EeccCCEEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCC
Q 012320 99 IDVDQKTFNFITEMFTSGTLREYRKKY----------------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCD 162 (466)
Q Consensus 99 ~~~~~~~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~ 162 (466)
. .+...+++|||||++|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+
T Consensus 87 ~-~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~ 163 (299)
T d1ywna1 87 T-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAAR 163 (299)
T ss_dssp C-STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred c-cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCcc
Confidence 4 3456789999999999999999753 24889999999999999999999999 999999999
Q ss_pred cEEEeCCCCcEEEeccchhhhhcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhC-CCCCCCCCC
Q 012320 163 NIFVNGHLGQVKIGDLGLAAILRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTC-EYPYSECAN 237 (466)
Q Consensus 163 NIlv~~~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg-~~Pf~~~~~ 237 (466)
|||++.+ +.+||+|||+|+...... ...+..||+.|||||++. +.|+.++|||||||++|||+|| ..||.....
T Consensus 164 NILl~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 164 NILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GEEECGG-GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ceeECCC-CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 9999977 899999999998654322 234568999999999776 5699999999999999999986 467877666
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 238 PAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 238 ~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
...+.+.+..+..+. .+...+++++++|.+||. ||.+|||+.|+++|
T Consensus 243 ~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 243 DEEFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp SHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 777778887776543 455678899999999996 99999999999976
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=394.30 Aligned_cols=249 Identities=23% Similarity=0.300 Sum_probs=207.5
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeE--EEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeEEEeccC
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVE--VAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~--vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 103 (466)
+.|.+ .++||+|+||+||+|.++.+|.. ||||+++... ..+..+.+.+|+++|+++ +|||||++++++. ++
T Consensus 10 ~~~~~-~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~--~~ 83 (309)
T d1fvra_ 10 NDIKF-QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACE--HR 83 (309)
T ss_dssp GGCEE-EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEE--ET
T ss_pred HHcEE-EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc---ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe--cC
Confidence 45655 67899999999999999999876 5666654222 334567899999999999 7999999999885 46
Q ss_pred CEEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEe
Q 012320 104 KTFNFITEMFTSGTLREYRKKY----------------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVN 167 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~ 167 (466)
+.+++||||++||+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG 161 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEc
Confidence 7899999999999999999754 56999999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeccchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Q 012320 168 GHLGQVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVT 246 (466)
Q Consensus 168 ~~~g~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~ 246 (466)
.+ +.+||+|||+++............||+.|+|||.+. +.|+.++|||||||++|||++|..|+....+..+++..+.
T Consensus 162 ~~-~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~ 240 (309)
T d1fvra_ 162 EN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240 (309)
T ss_dssp GG-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred CC-CceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 87 799999999998765544555667999999999775 5699999999999999999997655444588999999998
Q ss_pred cCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 247 SGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 247 ~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
.+..+. .+...++++++||.+||. ||++|||++|++++
T Consensus 241 ~~~~~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 241 QGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GTCCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 886543 345678899999999996 99999999999976
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=394.03 Aligned_cols=248 Identities=27% Similarity=0.431 Sum_probs=202.1
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCe----EEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEecc
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGV----EVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVD 102 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 102 (466)
..|.+ .++||+|+||+||+|.+..+|+ +||+|.++... +....+.+.+|+.+|++++|||||++++++.+
T Consensus 9 ~dy~~-~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-- 82 (317)
T d1xkka_ 9 TEFKK-IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLT-- 82 (317)
T ss_dssp TTEEE-EEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred HHCEE-eeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 34777 4779999999999999988876 57777765322 23345779999999999999999999998753
Q ss_pred CCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 103 QKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 103 ~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
...++++|++.+|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 83 -~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~-~~~kl~DFGla 158 (317)
T d1xkka_ 83 -STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP-QHVKITDFGLA 158 (317)
T ss_dssp -SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-TEEEECCCSHH
T ss_pred -CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCC-CCeEeeccccc
Confidence 3467889999999999887664 67999999999999999999999999 9999999999999987 89999999999
Q ss_pred hhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 012320 182 AILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 182 ~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 256 (466)
+.+..... .....||+.|||||++. +.|+.++|||||||++|||+| |..||.+ .+..++...+..|..++ .+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~-~~~~~~~~~i~~~~~~~-~p~ 236 (317)
T d1xkka_ 159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-QPP 236 (317)
T ss_dssp HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCGGGHHHHHHHTCCCC-CCT
T ss_pred eecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCc
Confidence 88654322 23456899999999765 669999999999999999998 7778865 56677888888876543 345
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHhcCC
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELLLDP 286 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL~hp 286 (466)
..+.++++||.+||. ||.+|||+.|++.|.
T Consensus 237 ~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 237 ICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 678899999999996 999999999999873
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-49 Score=389.78 Aligned_cols=249 Identities=22% Similarity=0.327 Sum_probs=211.3
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEc-----CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEE
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDE-----VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWI 99 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 99 (466)
|.++|.+. +.||+|+||+||+|..+ .++..||||+++... ..+..+++.+|+.+|++++||||+++++++
T Consensus 11 p~~~~~~~-~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~- 85 (301)
T d1lufa_ 11 PRNNIEYV-RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVC- 85 (301)
T ss_dssp CGGGCEEE-EEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred CHHHcEEe-EEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc---ChHHHHHHHHHHHHHHhcCCCCcccceeee-
Confidence 77889885 55999999999999875 467899999986432 455667899999999999999999999988
Q ss_pred eccCCEEEEEEecCCCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 012320 100 DVDQKTFNFITEMFTSGTLREYRKKYR------------------------RVDIRAIKSWARQILQGLVYLHSRDPPVI 155 (466)
Q Consensus 100 ~~~~~~~~lV~E~~~ggsL~~~l~~~~------------------------~l~~~~~~~i~~qIl~gL~yLHs~~~~Ii 155 (466)
.....+++||||+.+|+|.+++.... .+++..+..++.||+.||+|||+++ |+
T Consensus 86 -~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iv 162 (301)
T d1lufa_ 86 -AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FV 162 (301)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred -ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eE
Confidence 45677899999999999999986532 3888999999999999999999999 99
Q ss_pred eccCCCCcEEEeCCCCcEEEeccchhhhhcCC---CCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCC-
Q 012320 156 HRDLKCDNIFVNGHLGQVKIGDLGLAAILRGS---KSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEY- 230 (466)
Q Consensus 156 HrDLKp~NIlv~~~~g~vKL~DFGla~~~~~~---~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~- 230 (466)
||||||+|||++.+ +.+||+|||+|+.+... ....+..||+.|+|||++. ..|+.++|||||||++|||++|..
T Consensus 163 HrDlKp~NILld~~-~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 163 HRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CSCCSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred eeEEcccceEECCC-CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 99999999999987 89999999999876432 2234567899999999776 569999999999999999999875
Q ss_pred CCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 231 PYSECANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 231 Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
||.+ .+..++...+..+..+. .+...++++.+||.+||. +|++|||+.|+++
T Consensus 242 p~~~-~~~~e~~~~v~~~~~~~-~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 242 PYYG-MAHEEVIYYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTTT-SCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCC-CCHHHHHHHHHcCCCCC-CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5554 78888999999988654 345567899999999996 9999999999964
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=382.41 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=197.2
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcC-C--CeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEV-L--GVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ 103 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~-~--g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 103 (466)
.+|.++ +.||+|+||+||+|.+.. + +..||||++.+... ...+..+.+.+|+.+|++++|||||++|+++. +
T Consensus 8 ~d~~~~-~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~-~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~--~- 82 (273)
T d1u46a_ 8 KDLRLL-EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL--T- 82 (273)
T ss_dssp GGEEEE-EECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--S-
T ss_pred HHeEEE-EEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe--e-
Confidence 567775 559999999999998643 3 35789998875543 33455678999999999999999999999873 2
Q ss_pred CEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 104 KTFNFITEMFTSGTLREYRKK-YRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 104 ~~~~lV~E~~~ggsL~~~l~~-~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
..+++||||+.+|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~-~~vkl~DfGl~~ 159 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATR-DLVKIGDFGLMR 159 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-TEEEECCCTTCE
T ss_pred cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccc-cceeeccchhhh
Confidence 357899999999999987655 467999999999999999999999999 9999999999999987 799999999998
Q ss_pred hhcCCCC----CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 012320 183 ILRGSKS----AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYS 256 (466)
Q Consensus 183 ~~~~~~~----~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 256 (466)
.+..... .....||+.|+|||++. +.|+.++|||||||++|||+| |..||.+ .+..++...+.........+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~ 238 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRPE 238 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCCCT
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC-cCHHHHHHHHHhCCCCCCCcc
Confidence 7644322 23456788999999876 458999999999999999998 8999976 677777777776655445556
Q ss_pred CCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 257 IQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 257 ~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..+.+++++|.+||. ||++|||+.||++
T Consensus 239 ~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 239 DCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 678899999999996 9999999999863
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=385.35 Aligned_cols=259 Identities=19% Similarity=0.277 Sum_probs=211.0
Q ss_pred ceeeeCCCCceEEeeeeeeeeCceEEEEEEEcCCC---eEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEE
Q 012320 19 GYIETDPNGRYGLFEEVLGKGAMKTVYKAIDEVLG---VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFY 95 (466)
Q Consensus 19 ~~~~~~~~~rY~~~~~~LG~G~fg~Vyka~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~ 95 (466)
+.+...+......++++||+|+||+||+|.+..++ ..||||.++.. .+....+++.+|+++|++++|||||+++
T Consensus 18 ~~~~~~~~~~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~~~ 94 (311)
T d1r0pa_ 18 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLL 94 (311)
T ss_dssp GGGBCCGGGEEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC---CCHHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred hceEeChHHceeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCEeEEe
Confidence 33444444444445889999999999999986543 46999988632 3566778999999999999999999999
Q ss_pred eEEEeccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEE
Q 012320 96 TSWIDVDQKTFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVK 174 (466)
Q Consensus 96 ~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vK 174 (466)
+++.. .++.+++|||||.+|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+|
T Consensus 95 g~~~~-~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~-~~~k 170 (311)
T d1r0pa_ 95 GICLR-SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEK-FTVK 170 (311)
T ss_dssp EEEEE-TTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-CCEE
T ss_pred EEEEe-cCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCC-CCEE
Confidence 98754 356789999999999999988754 45788899999999999999999999 9999999999999977 8999
Q ss_pred EeccchhhhhcCCC-----CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Q 012320 175 IGDLGLAAILRGSK-----SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANPAQIYKKVTSG 248 (466)
Q Consensus 175 L~DFGla~~~~~~~-----~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i~~~i~~g 248 (466)
|+|||+++...... ......||+.|+|||++. +.++.++|||||||++|||+||..||....+..++...+..|
T Consensus 171 L~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g 250 (311)
T d1r0pa_ 171 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 250 (311)
T ss_dssp ECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT
T ss_pred EecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence 99999998764322 122356899999999765 679999999999999999999888887767777888888888
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 249 KLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 249 ~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
..+. .+...+.++.+||.+||. ||.+|||+.|+++|
T Consensus 251 ~~~~-~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 251 RRLL-QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp CCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCC-CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 7554 445677899999999996 99999999999976
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-49 Score=379.49 Aligned_cols=242 Identities=19% Similarity=0.345 Sum_probs=198.1
Q ss_pred CceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCEE
Q 012320 27 GRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKTF 106 (466)
Q Consensus 27 ~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~~ 106 (466)
..|.. .+.||+|+||+||+|.++ |..||+|+++.. ...+.+.+|+++|++++||||+++++++.+ +++.+
T Consensus 7 ~~~~~-~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~~ 76 (262)
T d1byga_ 7 KELKL-LQTIGKGEFGDVMLGDYR--GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGL 76 (262)
T ss_dssp GGEEE-EEEEEECSSCEEEEEEET--TEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECC-C--CC
T ss_pred HHeEE-eEEEecCCCeEEEEEEEC--CeEEEEEEECcH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEe-cCCcE
Confidence 35655 577999999999999874 889999998633 234678999999999999999999998754 34558
Q ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEeccchhhhh
Q 012320 107 NFITEMFTSGTLREYRKKY--RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAIL 184 (466)
Q Consensus 107 ~lV~E~~~ggsL~~~l~~~--~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~~~ 184 (466)
++||||+++|+|.+++.+. ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.+ |.+||+|||+++..
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~-~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEA 153 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-SCEEECCCCC----
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCC-CCEeecccccceec
Confidence 9999999999999998654 35899999999999999999999999 9999999999999987 89999999999865
Q ss_pred cCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCHHH
Q 012320 185 RGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSECANPAQIYKKVTSGKLPGAFYSIQDLEA 262 (466)
Q Consensus 185 ~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~~ 262 (466)
.. ......+|+.|+|||++. +.|+.++|||||||++|||+| |..||.. .+..++...+..+..+. .+...++++
T Consensus 154 ~~--~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~ 229 (262)
T d1byga_ 154 SS--TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKMD-APDGCPPAV 229 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCCCC-CCTTCCHHH
T ss_pred CC--CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHH
Confidence 43 234567899999999775 679999999999999999998 6666655 67788889998877654 345677899
Q ss_pred HHHHHHhcc-CcCCCCCHHHHhcC
Q 012320 263 QRFIGRCLV-NASKRLSAKELLLD 285 (466)
Q Consensus 263 ~~lI~~~L~-dp~~Rpsa~elL~h 285 (466)
++||.+||. ||.+|||+.+++++
T Consensus 230 ~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 230 YEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcccCHhHCcCHHHHHHH
Confidence 999999996 99999999999863
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=382.10 Aligned_cols=249 Identities=29% Similarity=0.410 Sum_probs=206.8
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCC-------eEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEe
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLG-------VEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYT 96 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g-------~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~ 96 (466)
|-++|.+ .+.||+|+||+||+|.+..++ ..||+|+++... .......+.+|+..+.++ +|||||++++
T Consensus 11 ~~~~~~l-~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~e~~~l~~~~~HpnIv~~~~ 86 (299)
T d1fgka_ 11 PRDRLVL-GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLG 86 (299)
T ss_dssp CGGGEEE-EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cHHHeEE-eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc---ChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence 4578887 577999999999999876554 579999886433 445667889999999888 8999999999
Q ss_pred EEEeccCCEEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCC
Q 012320 97 SWIDVDQKTFNFITEMFTSGTLREYRKKY----------------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLK 160 (466)
Q Consensus 97 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~----------------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLK 160 (466)
++. ++..+++|||||.+|+|.+++... ..+++..+..++.||+.||+|||+++ |+|||||
T Consensus 87 ~~~--~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiK 162 (299)
T d1fgka_ 87 ACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLA 162 (299)
T ss_dssp EEC--SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred ccc--cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeec
Confidence 884 467799999999999999999754 35899999999999999999999999 9999999
Q ss_pred CCcEEEeCCCCcEEEeccchhhhhcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 012320 161 CDNIFVNGHLGQVKIGDLGLAAILRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSEC 235 (466)
Q Consensus 161 p~NIlv~~~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~~ 235 (466)
|+|||++.+ +.+||+|||+++...... ......||+.|+|||++. +.|+.++|||||||++|||++ |..||.+
T Consensus 163 p~NiLl~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~- 240 (299)
T d1fgka_ 163 ARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG- 240 (299)
T ss_dssp GGGEEECTT-CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-
T ss_pred ccceeecCC-CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC-
Confidence 999999987 899999999998764332 234567999999999775 679999999999999999998 6777755
Q ss_pred CCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 236 ANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 236 ~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.+..++++.+..+..+. .+...+.++++||.+||. ||++|||+.|+++
T Consensus 241 ~~~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 241 VPVEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CCHHHHHHHHHTTCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHcCCCCC-CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 77888999998876543 455678899999999996 9999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-48 Score=382.87 Aligned_cols=251 Identities=25% Similarity=0.366 Sum_probs=209.7
Q ss_pred CCCCceEEeeeeeeeeCceEEEEEEE-----cCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhC-CCCceeEEEeE
Q 012320 24 DPNGRYGLFEEVLGKGAMKTVYKAID-----EVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTL-KHDSIIRFYTS 97 (466)
Q Consensus 24 ~~~~rY~~~~~~LG~G~fg~Vyka~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~ 97 (466)
-|.++|.+ .+.||+|+||+||+|.+ ..+++.||+|+++... .......+.+|+.+++++ +|||||+++++
T Consensus 20 ~~~~~~~l-~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 20 FPRNRLSF-GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp CCGGGEEE-EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCHHHeEE-eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc---CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 45578877 67899999999999985 4578899999987543 455667899999999999 69999999998
Q ss_pred EEeccCCEEEEEEecCCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccC
Q 012320 98 WIDVDQKTFNFITEMFTSGTLREYRKKYR------------------RVDIRAIKSWARQILQGLVYLHSRDPPVIHRDL 159 (466)
Q Consensus 98 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------------~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDL 159 (466)
+ .+...+++|||||++|+|.+++.+.. .+++..+..++.||+.||.|||+++ |+||||
T Consensus 96 ~--~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDL 171 (311)
T d1t46a_ 96 C--TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDL 171 (311)
T ss_dssp E--CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred E--eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccc
Confidence 7 45667899999999999999987643 5899999999999999999999999 999999
Q ss_pred CCCcEEEeCCCCcEEEeccchhhhhcCCCC---CccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 012320 160 KCDNIFVNGHLGQVKIGDLGLAAILRGSKS---AHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFT-CEYPYSE 234 (466)
Q Consensus 160 Kp~NIlv~~~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~ellt-g~~Pf~~ 234 (466)
||+||+++.+ +.+||+|||+++....... ....+||+.|+|||++. +.++.++|||||||++|||+| |.+||..
T Consensus 172 Kp~NIl~~~~-~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~ 250 (311)
T d1t46a_ 172 AARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (311)
T ss_dssp SGGGEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cccccccccc-CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCC
Confidence 9999999987 8999999999987654322 23467899999999776 568999999999999999999 5555655
Q ss_pred CCCHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 235 CANPAQIYKKVTSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 235 ~~~~~~i~~~i~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
......+.+.+..+..+ ..+...+.++++||.+||. ||.+|||+.+|++
T Consensus 251 ~~~~~~~~~~i~~~~~~-~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 251 MPVDSKFYKMIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CCSSHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHhcCCCC-CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 44445566666665433 4456678899999999996 9999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=378.20 Aligned_cols=248 Identities=22% Similarity=0.342 Sum_probs=209.6
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEc-----CCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEe
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDE-----VLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWID 100 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 100 (466)
-++|.+ .+.||+|+||+||+|.++ .++..||||+++... .......+.+|+.++++++|||||++++.+
T Consensus 19 ~~~~~l-~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~-- 92 (308)
T d1p4oa_ 19 REKITM-SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVV-- 92 (308)
T ss_dssp GGGEEE-EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE--
T ss_pred HHHeEE-eeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc---ChHHHHHHHHHHHHHHHcCCCCEeeeeeEE--
Confidence 368876 567999999999999875 346899999986432 445667899999999999999999999987
Q ss_pred ccCCEEEEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCC
Q 012320 101 VDQKTFNFITEMFTSGTLREYRKKY----------RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHL 170 (466)
Q Consensus 101 ~~~~~~~lV~E~~~ggsL~~~l~~~----------~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~ 170 (466)
.....+++||||+.+|+|.+++... ..++...+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~- 169 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED- 169 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT-
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCC-
Confidence 4466789999999999999988643 34788999999999999999999999 9999999999999977
Q ss_pred CcEEEeccchhhhhcCCC---CCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCC-CCCCCCCCHHHHHHHH
Q 012320 171 GQVKIGDLGLAAILRGSK---SAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCE-YPYSECANPAQIYKKV 245 (466)
Q Consensus 171 g~vKL~DFGla~~~~~~~---~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~-~Pf~~~~~~~~i~~~i 245 (466)
+.+||+|||+++.+.... ......||+.|+|||.+. +.|+.++|||||||++|||+||. .||. ..+..+++..+
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~-~~~~~~~~~~i 248 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ-GLSNEQVLRFV 248 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT-TSCHHHHHHHH
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC-CCCHHHHHHHH
Confidence 899999999998664322 233456899999999776 56899999999999999999985 5565 47888889999
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 246 TSGKLPGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 246 ~~g~~p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
..+..+.. +...+..+.++|.+||. +|.+|||++++++
T Consensus 249 ~~~~~~~~-p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 249 MEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhCCCCCC-cccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 88876543 45567899999999996 9999999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=370.70 Aligned_cols=246 Identities=24% Similarity=0.333 Sum_probs=190.9
Q ss_pred EEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccC--CEEE
Q 012320 30 GLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQ--KTFN 107 (466)
Q Consensus 30 ~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~--~~~~ 107 (466)
.++.+.||+|+||+||+|.+ +|+.||+|+++... ........|+..+++++|||||++++++.+.+. ..++
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 35578899999999999975 69999999886432 122223345555667899999999999876543 3789
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeEeccCCCCcEEEeCCCCcEEEeccchh
Q 012320 108 FITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSR------DPPVIHRDLKCDNIFVNGHLGQVKIGDLGLA 181 (466)
Q Consensus 108 lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~------~~~IiHrDLKp~NIlv~~~~g~vKL~DFGla 181 (466)
+||||+.+|+|.+++++ ..+++..+..++.|++.||.|||+. .++|+||||||+|||++.+ +.+||+|||++
T Consensus 78 lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~-~~~Kl~DFGl~ 155 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLA 155 (303)
T ss_dssp EEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT-SCEEECCCTTC
T ss_pred EEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC-CCeEEEecCcc
Confidence 99999999999999987 4799999999999999999999974 1239999999999999877 89999999999
Q ss_pred hhhcCCC-----CCccccCCCCcCCccccccC-------CCChhhHHHHHHHHHHHHhCCCCCCC--------------C
Q 012320 182 AILRGSK-----SAHSVIGTPEFMAPELYEED-------YNELVDVYSFGMCVLEMFTCEYPYSE--------------C 235 (466)
Q Consensus 182 ~~~~~~~-----~~~~~~GT~~y~APE~l~~~-------y~~~~DIwSlGvil~elltg~~Pf~~--------------~ 235 (466)
+...... .....+||+.|||||++... ++.++|||||||++|||+||..||.. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 8764432 23456899999999987643 56789999999999999999877632 1
Q ss_pred CCHHHHHHHHhcCCCCCCCCCCC-----CHHHHHHHHHhcc-CcCCCCCHHHHhc
Q 012320 236 ANPAQIYKKVTSGKLPGAFYSIQ-----DLEAQRFIGRCLV-NASKRLSAKELLL 284 (466)
Q Consensus 236 ~~~~~i~~~i~~g~~p~~~~~~~-----~~~~~~lI~~~L~-dp~~Rpsa~elL~ 284 (466)
.+...+.+.+..+.+.+..+... ...+.+++.+||. ||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 23455555555555433322221 1358899999996 9999999999975
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.1e-46 Score=363.87 Aligned_cols=252 Identities=19% Similarity=0.270 Sum_probs=194.2
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCceeEEEeEEEeccCCE
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 105 (466)
.+||.+ .+.||+|+||+||+|.++.+|+.||+|++..... .+.+..|+++++.++|+|+|..+..+. .+...
T Consensus 6 g~rY~l-~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~E~~i~~~l~~~~~i~~~~~~~-~~~~~ 77 (299)
T d1ckia_ 6 GNRYRL-GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCG-AEGDY 77 (299)
T ss_dssp TTTEEE-EEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT------SCCHHHHHHHHHHSTTSTTCCCEEEEE-EETTE
T ss_pred CCEEEE-eEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc------CHHHHHHHHHHHHccCCCcccEEEEEE-ecCCE
Confidence 478988 5669999999999999999999999998875432 134778999999998877665554443 45678
Q ss_pred EEEEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCC--CCcEEEeccchhh
Q 012320 106 FNFITEMFTSGTLREYRK-KYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGH--LGQVKIGDLGLAA 182 (466)
Q Consensus 106 ~~lV~E~~~ggsL~~~l~-~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~--~g~vKL~DFGla~ 182 (466)
.++||||+ +++|.+.+. ..+.+++..+..++.||+.||+|||++| |+||||||+|||++.. ...+||+|||+|+
T Consensus 78 ~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 78 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred EEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcce
Confidence 89999999 556655554 4568999999999999999999999999 9999999999998643 3479999999998
Q ss_pred hhcCCC--------CCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHhcCCC-
Q 012320 183 ILRGSK--------SAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSECANPAQI--YKKVTSGKL- 250 (466)
Q Consensus 183 ~~~~~~--------~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~~~~~~i--~~~i~~g~~- 250 (466)
.+.... ...+.+||+.|||||++.+ .|+.++|||||||++|||+||..||......... +.+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC
Confidence 765332 2345689999999998764 5999999999999999999999999764332222 112211111
Q ss_pred --CCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHH---hcCCCC
Q 012320 251 --PGAFYSIQDLEAQRFIGRCLV-NASKRLSAKEL---LLDPFL 288 (466)
Q Consensus 251 --p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~el---L~hpf~ 288 (466)
+.......++++.+||.+|+. +|.+||++.++ |+|+|.
T Consensus 235 ~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 111234567899999999995 99999998754 666653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.6e-45 Score=360.07 Aligned_cols=246 Identities=15% Similarity=0.224 Sum_probs=199.5
Q ss_pred CCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCC-CceeEEEeEEEeccCC
Q 012320 26 NGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH-DSIIRFYTSWIDVDQK 104 (466)
Q Consensus 26 ~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~ 104 (466)
++||.+ .+.||+|+||+||+|+++.+|+.||+|++..... ...+.+|++.++.++| +||+.+++.+ ....
T Consensus 4 g~~Y~i-~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~--~~~~ 74 (293)
T d1csna_ 4 GVHYKV-GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFG--QEGL 74 (293)
T ss_dssp TTTEEE-EEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEE--EETT
T ss_pred CCceEE-EEEEecCCCeEEEEEEECCCCCEEEEEEEccccC------cHHHHHHHHHHHHhcCCCCCCEEEEEe--ecCC
Confidence 478977 5779999999999999999999999998864331 2346789999999965 8999999877 4577
Q ss_pred EEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeC----CCCcEEEeccc
Q 012320 105 TFNFITEMFTSGTLREYRKKY-RRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNG----HLGQVKIGDLG 179 (466)
Q Consensus 105 ~~~lV~E~~~ggsL~~~l~~~-~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~----~~g~vKL~DFG 179 (466)
..++||||+ |++|.+++... ..+++..+..++.|++.||+|||++| |+||||||+|||++. ..+.+||+|||
T Consensus 75 ~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 75 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred ccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccc
Confidence 899999999 78999988765 46999999999999999999999999 999999999999964 23689999999
Q ss_pred hhhhhcCC--------CCCccccCCCCcCCcccccc-CCCChhhHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHhcC
Q 012320 180 LAAILRGS--------KSAHSVIGTPEFMAPELYEE-DYNELVDVYSFGMCVLEMFTCEYPYSEC--ANPAQIYKKVTSG 248 (466)
Q Consensus 180 la~~~~~~--------~~~~~~~GT~~y~APE~l~~-~y~~~~DIwSlGvil~elltg~~Pf~~~--~~~~~i~~~i~~g 248 (466)
+|+.+... ....+.+||+.|||||++.+ .|+.++|||||||++|||+||..||.+. .+....++.+...
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~ 231 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc
Confidence 99876432 12345689999999998764 5999999999999999999999999643 3444445444332
Q ss_pred CC---CCCCCCCCCHHHHHHHHHhcc-CcCCCCCHHHHh
Q 012320 249 KL---PGAFYSIQDLEAQRFIGRCLV-NASKRLSAKELL 283 (466)
Q Consensus 249 ~~---p~~~~~~~~~~~~~lI~~~L~-dp~~Rpsa~elL 283 (466)
+. +.......++++.+++..|+. +|.+||+.+.+.
T Consensus 232 ~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 232 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred cCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 21 111223456789999999995 999999987664
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8e-45 Score=365.66 Aligned_cols=256 Identities=25% Similarity=0.342 Sum_probs=195.8
Q ss_pred CCCceEEeeeeeeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-----------CCceeE
Q 012320 25 PNGRYGLFEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-----------HDSIIR 93 (466)
Q Consensus 25 ~~~rY~~~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-----------HpnIv~ 93 (466)
-++||.++ ++||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+|+.++ ||||++
T Consensus 11 ~~~rY~i~-~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~ 84 (362)
T d1q8ya_ 11 KDARYILV-RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 84 (362)
T ss_dssp TTTTEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cCCcEEEE-EEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEE
Confidence 35899885 66999999999999999999999999987432 34467788999988875 578999
Q ss_pred EEeEEEeccCCEEEEEEecCCCCCH-HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeccCCCCcEEEeCC
Q 012320 94 FYTSWIDVDQKTFNFITEMFTSGTL-REYRK--KYRRVDIRAIKSWARQILQGLVYLHS-RDPPVIHRDLKCDNIFVNGH 169 (466)
Q Consensus 94 l~~~~~~~~~~~~~lV~E~~~ggsL-~~~l~--~~~~l~~~~~~~i~~qIl~gL~yLHs-~~~~IiHrDLKp~NIlv~~~ 169 (466)
+++++........+++++++..+.. ..... ....+++..++.+++||+.||.|||+ .| |+||||||+|||++..
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 85 LLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIV 162 (362)
T ss_dssp CCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEE
T ss_pred EEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeecc
Confidence 9998876667777777777655443 33222 34679999999999999999999998 88 9999999999999765
Q ss_pred CC-----cEEEeccchhhhhcCCCCCccccCCCCcCCccccc-cCCCChhhHHHHHHHHHHHHhCCCCCCCCCCH-----
Q 012320 170 LG-----QVKIGDLGLAAILRGSKSAHSVIGTPEFMAPELYE-EDYNELVDVYSFGMCVLEMFTCEYPYSECANP----- 238 (466)
Q Consensus 170 ~g-----~vKL~DFGla~~~~~~~~~~~~~GT~~y~APE~l~-~~y~~~~DIwSlGvil~elltg~~Pf~~~~~~----- 238 (466)
.. .+|++|||.+..... .....+||+.|+|||++. ..|+.++||||+||++++|++|+.||......
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~ 240 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CcccccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence 21 499999999976543 345678999999999765 56999999999999999999999999643211
Q ss_pred -HHHHHHHh-cCCC------------------------C--------------CCCCCCCCHHHHHHHHHhcc-CcCCCC
Q 012320 239 -AQIYKKVT-SGKL------------------------P--------------GAFYSIQDLEAQRFIGRCLV-NASKRL 277 (466)
Q Consensus 239 -~~i~~~i~-~g~~------------------------p--------------~~~~~~~~~~~~~lI~~~L~-dp~~Rp 277 (466)
..+...+. -|.. + .......+.++++||.+||. ||.+||
T Consensus 241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp 320 (362)
T d1q8ya_ 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 320 (362)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence 11111110 0110 0 00112235689999999996 999999
Q ss_pred CHHHHhcCCCCCc
Q 012320 278 SAKELLLDPFLAS 290 (466)
Q Consensus 278 sa~elL~hpf~~~ 290 (466)
||+|+|+||||+.
T Consensus 321 ta~e~L~Hp~f~~ 333 (362)
T d1q8ya_ 321 DAGGLVNHPWLKD 333 (362)
T ss_dssp CHHHHHTCGGGTT
T ss_pred CHHHHhcCcccCC
Confidence 9999999999984
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=2.8e-25 Score=202.87 Aligned_cols=164 Identities=17% Similarity=0.200 Sum_probs=121.7
Q ss_pred eeeeeeeeCceEEEEEEEcCCCeEEEEEEEeccccc-----C---------CHHHHHHHHHHHHHHHhCCCCceeEEEeE
Q 012320 32 FEEVLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELM-----R---------SPDDLQRLYSEVHLLSTLKHDSIIRFYTS 97 (466)
Q Consensus 32 ~~~~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~-----~---------~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 97 (466)
+++.||+|+||+||+|.+. +|+.||+|+++..... . ..........|+..|.++.|++++..++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4788999999999999985 6999999987542210 0 01122345678999999999999998864
Q ss_pred EEeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeccCCCCcEEEeCCCCcEEEec
Q 012320 98 WIDVDQKTFNFITEMFTSGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRDPPVIHRDLKCDNIFVNGHLGQVKIGD 177 (466)
Q Consensus 98 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~~~IiHrDLKp~NIlv~~~~g~vKL~D 177 (466)
. .. +++|||+.+..+. .++...+..++.||+.+|.|||++| |+||||||+|||++.+ .++|+|
T Consensus 83 ~----~~--~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~--~~~liD 145 (191)
T d1zara2 83 E----GN--AVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE--GIWIID 145 (191)
T ss_dssp E----TT--EEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT--EEEECC
T ss_pred c----CC--EEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC--CEEEEE
Confidence 2 22 5899999886543 3556667889999999999999999 9999999999999854 699999
Q ss_pred cchhhhhcCCCCCccccCCCCcCC------ccccccCCCChhhHHHHHH
Q 012320 178 LGLAAILRGSKSAHSVIGTPEFMA------PELYEEDYNELVDVYSFGM 220 (466)
Q Consensus 178 FGla~~~~~~~~~~~~~GT~~y~A------PE~l~~~y~~~~DIwSlGv 220 (466)
||+|.....+.. . .|.. .+.+.+.|+.++|+||+.-
T Consensus 146 FG~a~~~~~~~~-~------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 146 FPQSVEVGEEGW-R------EILERDVRNIITYFSRTYRTEKDINSAID 187 (191)
T ss_dssp CTTCEETTSTTH-H------HHHHHHHHHHHHHHHHHHCCCCCHHHHHH
T ss_pred CCCcccCCCCCc-H------HHHHHHHHHHHHHHcCCCCCcccHHHHHH
Confidence 999976543221 1 1111 1233467899999999643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.03 E-value=6e-06 Score=76.00 Aligned_cols=133 Identities=15% Similarity=0.029 Sum_probs=83.5
Q ss_pred eeeeCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEeEEEeccCCEEEEEEecCC
Q 012320 36 LGKGAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYTSWIDVDQKTFNFITEMFT 114 (466)
Q Consensus 36 LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~~~lV~E~~~ 114 (466)
.+.++.+.||+.. ..+..+.+|+....... ....+.+|..+|..+. +--+.+++... .+.+..++||++++
T Consensus 22 ~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~----~~~~~~~E~~~l~~l~~~vpvP~vl~~~--~~~~~~~lv~~~l~ 93 (263)
T d1j7la_ 22 TEGMSPAKVYKLV--GENENLYLKMTDSRYKG----TTYDVEREKDMMLWLEGKLPVPKVLHFE--RHDGWSNLLMSEAD 93 (263)
T ss_dssp SCCCSSSEEEEEE--CSSCEEEEEEECGGGTT----STTCHHHHHHHHHHHTTTSCCCCEEEEE--EETTEEEEEEECCS
T ss_pred CCCCCCCcEEEEE--eCCCeEEEEEcCCCccc----chhhHHHHHHHHHHHhccCCCCcEEEEE--ecCCceEEEEEecc
Confidence 3344557899874 45667778876533321 1234677888887763 32234444433 34677889999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 012320 115 SGTLREYRKKYRRVDIRAIKSWARQILQGLVYLHSRD------------------------------------------- 151 (466)
Q Consensus 115 ggsL~~~l~~~~~l~~~~~~~i~~qIl~gL~yLHs~~------------------------------------------- 151 (466)
|.++.+.... ......++.++...+..||+..
T Consensus 94 G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T d1j7la_ 94 GVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp SEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHH
T ss_pred cccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHH
Confidence 9888654321 1122334555555566666432
Q ss_pred --------------CCeEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 152 --------------PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 152 --------------~~IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
+.++|+|+.|.|||++.+ +.+-|+||+.+.
T Consensus 169 ~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDwe~a~ 212 (263)
T d1j7la_ 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHSCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCE
T ss_pred HHHHHHHhcCCcCCcEEEEeeccCcceeecCC-ceEEEeechhcc
Confidence 127999999999999864 455699998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.90 E-value=1.4e-05 Score=78.70 Aligned_cols=79 Identities=16% Similarity=0.176 Sum_probs=48.5
Q ss_pred eeeeeCceEEEEEEEcCCCeEEEEEEEeccccc--C-CHHHHHHHHHHHHHHHhC-CC--CceeEEEeEEEeccCCEEEE
Q 012320 35 VLGKGAMKTVYKAIDEVLGVEVAWNQVRLNELM--R-SPDDLQRLYSEVHLLSTL-KH--DSIIRFYTSWIDVDQKTFNF 108 (466)
Q Consensus 35 ~LG~G~fg~Vyka~~~~~g~~vAiK~i~~~~~~--~-~~~~~~~~~~Ei~iL~~l-~H--pnIv~l~~~~~~~~~~~~~l 108 (466)
.||.|....||++.+...|+.+++|+-...... . .+....+...|.+.|+.+ .+ ..+.++|. .+.+ ..++
T Consensus 33 eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~--~~~l 108 (392)
T d2pula1 33 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTE--MAVT 108 (392)
T ss_dssp ECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETT--TTEE
T ss_pred EeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCC--CCEE
Confidence 389999999999998888889999975421110 0 111234566788888876 33 34556664 3333 3458
Q ss_pred EEecCCCCC
Q 012320 109 ITEMFTSGT 117 (466)
Q Consensus 109 V~E~~~ggs 117 (466)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.46 E-value=0.00019 Score=65.09 Aligned_cols=73 Identities=12% Similarity=-0.016 Sum_probs=45.9
Q ss_pred eeeeCc-eEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCC--CceeEEEeEEEeccCCEEEEEEec
Q 012320 36 LGKGAM-KTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKH--DSIIRFYTSWIDVDQKTFNFITEM 112 (466)
Q Consensus 36 LG~G~f-g~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~~~~lV~E~ 112 (466)
+..|.. +.||++... .|..+.+|...... ...+..|+..|+.+.. -.+.+++... .+.+..++||++
T Consensus 18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~-------~~~l~~E~~~l~~L~~~gvpvP~v~~~~--~~~~~~~~v~~~ 87 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVV--TEAGRDWLLLGE 87 (255)
T ss_dssp CSCTTSSCEEEEEECT-TSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEE--ECSSCEEEEEEC
T ss_pred cCCcccCCeEEEEEeC-CCCEEEEEeCCccC-------HhHHHHHHHHHHHHHhcCCCCCceeeec--ccccceEEEEEe
Confidence 445544 678988653 46667788654222 2346678888877632 2345566543 445678899999
Q ss_pred CCCCCH
Q 012320 113 FTSGTL 118 (466)
Q Consensus 113 ~~ggsL 118 (466)
++|.++
T Consensus 88 i~G~~~ 93 (255)
T d1nd4a_ 88 VPGQDL 93 (255)
T ss_dssp CSSEET
T ss_pred eecccc
Confidence 988665
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.31 E-value=0.0046 Score=58.35 Aligned_cols=72 Identities=14% Similarity=0.071 Sum_probs=42.3
Q ss_pred eCceEEEEEEEcCCCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCCCCc-----eeEEEeEEEeccCCEEEEEEecC
Q 012320 39 GAMKTVYKAIDEVLGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLKHDS-----IIRFYTSWIDVDQKTFNFITEMF 113 (466)
Q Consensus 39 G~fg~Vyka~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-----Iv~l~~~~~~~~~~~~~lV~E~~ 113 (466)
+.--.||++..+ +|..|++|+.+.... + .+.+..|+..|..|.... .+..-+.-........+.+++++
T Consensus 33 s~EN~vy~v~~~-dg~~~VlK~~rp~~~--s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~ 106 (325)
T d1zyla1 33 SYENRVYQFQDE-DRRRFVVKFYRPERW--T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 106 (325)
T ss_dssp CSSSEEEEECCT-TCCCEEEEEECTTTS--C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred cccceeEEEEcC-CCCEEEEEEeCCCCC--C---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeec
Confidence 444689999653 588899998763321 2 345677888888773211 11111110112245677889998
Q ss_pred CCC
Q 012320 114 TSG 116 (466)
Q Consensus 114 ~gg 116 (466)
.|.
T Consensus 107 ~G~ 109 (325)
T d1zyla1 107 GGR 109 (325)
T ss_dssp CCE
T ss_pred CCc
Confidence 764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.86 E-value=0.012 Score=56.79 Aligned_cols=73 Identities=14% Similarity=0.097 Sum_probs=46.0
Q ss_pred eeeeeeCceEEEEEEEcC-------CCeEEEEEEEecccccCCHHHHHHHHHHHHHHHhCC-CCceeEEEeEEEeccCCE
Q 012320 34 EVLGKGAMKTVYKAIDEV-------LGVEVAWNQVRLNELMRSPDDLQRLYSEVHLLSTLK-HDSIIRFYTSWIDVDQKT 105 (466)
Q Consensus 34 ~~LG~G~fg~Vyka~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~ 105 (466)
+.|+.|-.-.+|++.... .+..|.+++.- .. .. .....+|..+++.+. +.-..+++..+ . +
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~--~~---~idr~~E~~i~~~ls~~gl~Pkll~~~--~--~- 116 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP--ET---ESHLVAESVIFTLLSERHLGPKLYGIF--S--G- 116 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEE--T--T-
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc--ch---hhHHHHHHHHHHHHHhCCCCCeEEEEc--C--C-
Confidence 448889999999997653 34556666543 11 11 123457888888874 43334677654 2 2
Q ss_pred EEEEEecCCCCCH
Q 012320 106 FNFITEMFTSGTL 118 (466)
Q Consensus 106 ~~lV~E~~~ggsL 118 (466)
.+|+||+.|..|
T Consensus 117 -g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 -GRLEEYIPSRPL 128 (395)
T ss_dssp -EEEECCCCEEEC
T ss_pred -ceEEEEeccccC
Confidence 478999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.39 E-value=0.012 Score=54.74 Aligned_cols=28 Identities=39% Similarity=0.476 Sum_probs=24.5
Q ss_pred eEeccCCCCcEEEeCCCCcEEEeccchhh
Q 012320 154 VIHRDLKCDNIFVNGHLGQVKIGDLGLAA 182 (466)
Q Consensus 154 IiHrDLKp~NIlv~~~~g~vKL~DFGla~ 182 (466)
+||+|+.++||+++++ +..-|+||+.+.
T Consensus 185 iIHgDl~~dNvl~~~~-~v~gvIDF~~~~ 212 (316)
T d2ppqa1 185 VIHADLFQDNVFFLGD-ELSGLIDFYFAC 212 (316)
T ss_dssp EECSCCCGGGEEEETT-EEEEECCCTTCE
T ss_pred cccCCcchhhhhcccc-cceeEecccccc
Confidence 9999999999999976 456899999774
|